[
  {
    "PregnancyIndexLink": ["cetirizine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "352/ 01 A 003 /06/19",
    "CODE_DCI": "01 A 003",
    "DCI": "CETIRIZINE DICHLORHYDRATE",
    "NOM_COMMERCIALE": "ARTIZ",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "10MG",
    "COND": "B/10",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "31/7/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "7/8/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Allergologie"]
  },
  {
    "PregnancyIndexLink": ["cetirizine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "450/ 01 A 003 /07/13",
    "CODE_DCI": "01 A 003",
    "DCI": "CETIRIZINE DICHLORHYDRATE",
    "NOM_COMMERCIALE": "CETIRIZINE MYLAN",
    "FORME": "COMP. PELLI.SEC.",
    "DOSAGE": "10MG",
    "COND": "B/15",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MYLAN SAS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/4/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "30/7/2013",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Allergologie"]
  },
  {
    "PregnancyIndexLink": ["cetirizine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "462/ 01 A 003 /13",
    "CODE_DCI": "01 A 003",
    "DCI": "CETIRIZINE DICHLORHYDRATE",
    "NOM_COMMERCIALE": "CETIRIZINE PHYSIOPHARM",
    "FORME": "COMP. PELLI. SEC.",
    "DOSAGE": "10MG",
    "COND": "B/10",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHYSIOPHARM SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/5/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "12/5/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Allergologie"]
  },
  {
    "PregnancyIndexLink": ["cetirizine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "035/01 A 003/17",
    "CODE_DCI": "01 A 003",
    "DCI": "CETIRIZINE DICHLORHYDRATE",
    "NOM_COMMERCIALE": "GRIPEX ALLERGIE",
    "FORME": "COMP. PELLI.SEC.",
    "DOSAGE": "10MG",
    "COND": "B/07",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMALLIANCE EURL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/9/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "10/9/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Allergologie"]
  },
  {
    "PregnancyIndexLink": ["cetirizine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "304/ 01 A 003 /04/17",
    "CODE_DCI": "01 A 003",
    "DCI": "CETIRIZINE DICHLORHYDRATE",
    "NOM_COMMERCIALE": "HISTARIZINE",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "10MG",
    "COND": "B/10",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GEOPHARM SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/1/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "7/1/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Allergologie"]
  },
  {
    "PregnancyIndexLink": ["cetirizine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "468/ 01 A 003 /15",
    "CODE_DCI": "01 A 003",
    "DCI": "CETIRIZINE DICHLORHYDRATE",
    "NOM_COMMERCIALE": "NADEC",
    "FORME": "COMP. PELLI. SEC",
    "DOSAGE": "10MG",
    "COND": "B/15",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NADPHARMADIC PRODUCTION SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/12/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "2/12/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Allergologie"]
  },
  {
    "PregnancyIndexLink": ["cetirizine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "235/ 01 A 003 /16",
    "CODE_DCI": "01 A 003",
    "DCI": "CETIRIZINE DICHLORHYDRATE",
    "NOM_COMMERCIALE": "RHITENE",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "10MG",
    "COND": "B/15",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOGALENIC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/1/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "17/1/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Allergologie"]
  },
  {
    "PregnancyIndexLink": ["cetirizine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "380/ 01 A 003 /16",
    "CODE_DCI": "01 A 003",
    "DCI": "CETIRIZINE DICHLORHYDRATE",
    "NOM_COMMERCIALE": "ZYRTIRIZINE",
    "FORME": "COMP. PELLI. SEC",
    "DOSAGE": "10MG",
    "COND": "B/10",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HUP.P.PHARMA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/7/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "26/7/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Allergologie"]
  },
  {
    "PregnancyIndexLink": ["cetirizine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "077/01 A 003/17",
    "CODE_DCI": "01 A 003",
    "DCI": "CETIRIZINE DICHLORHYDRATE",
    "NOM_COMMERCIALE": "ZYTREX",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "10MG",
    "COND": "B/10",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LAM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/1/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "17/1/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Allergologie"]
  },
  {
    "PregnancyIndexLink": ["pheniramine"],
    "InteractionIndexLink": ["dexchlorpheniramine"],
    "N_ENREGISTREMENT": "003/ 01 A 005 /97/21",
    "CODE_DCI": "01 A 005",
    "DCI": "Maléate de Déxchlorphéniramine",
    "NOM_COMMERCIALE": "HISTAGAN",
    "FORME": "Comprimé sécable",
    "DOSAGE": "2MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EPE GROUPE INDUSTRIEL SAIDAL/SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/8/1997",
    "DATE_D_ENREGISTREMENT_FINAL": "17/1/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Allergologie"]
  },
  {
    "PregnancyIndexLink": ["pheniramine"],
    "InteractionIndexLink": ["dexchlorpheniramine"],
    "N_ENREGISTREMENT": "503/01 A 007/16",
    "CODE_DCI": "01 A 007",
    "DCI": "DEXCHLORPHENIRAMINE MALEATE",
    "NOM_COMMERCIALE": "DEXCHLORPHENIRAMINE AFRO",
    "FORME": "SOL BUVABLE",
    "DOSAGE": "0.5MG/5ML",
    "COND": "F/125 ML+CUILLERE DE MESURE  DE 5ML GRADUEE",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "AFRO PHARM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/11/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "9/11/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Allergologie"]
  },
  {
    "PregnancyIndexLink": ["pheniramine"],
    "InteractionIndexLink": ["dexchlorpheniramine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "01 A 007",
    "DCI": "DEXCHLORPHENIRAMINE MALEATE",
    "NOM_COMMERCIALE": "DORAMINE",
    "FORME": "SIROP",
    "DOSAGE": "0.5MG/5ML",
    "COND": "FL/125ML",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Allergologie"]
  },
  {
    "PregnancyIndexLink": ["pheniramine"],
    "InteractionIndexLink": ["dexchlorpheniramine"],
    "N_ENREGISTREMENT": "035/01 A 007/17",
    "CODE_DCI": "01 A 007",
    "DCI": "DEXCHLORPHENIRAMINE MALEATE",
    "NOM_COMMERCIALE": "FENIRAMINE",
    "FORME": "SIROP",
    "DOSAGE": "0.5 MG/5ML (0.01%)",
    "COND": "b/01 fl de 125 ml +cuillère de mesue de 5 ml",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMALLIANCE EURL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "3/8/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "3/8/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Allergologie"]
  },
  {
    "PregnancyIndexLink": ["pheniramine"],
    "InteractionIndexLink": ["dexchlorpheniramine"],
    "N_ENREGISTREMENT": "065/01 A 007/17",
    "CODE_DCI": "01 A 007",
    "DCI": "DEXCHLORPHENIRAMINE MALEATE",
    "NOM_COMMERCIALE": "GENARITYNE",
    "FORME": "SIROP",
    "DOSAGE": "0.5MG/5ML(0.01 %)",
    "COND": "FL./125ML",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GENERIC LAB",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/6/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "12/6/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Allergologie"]
  },
  {
    "PregnancyIndexLink": ["pheniramine"],
    "InteractionIndexLink": ["dexchlorpheniramine"],
    "N_ENREGISTREMENT": "003/01 A 007/97/20",
    "CODE_DCI": "01 A 007",
    "DCI": "DEXCHLORPHENIRAMINE MALEATE",
    "NOM_COMMERCIALE": "HISTAGAN",
    "FORME": "SIROP.",
    "DOSAGE": "05MG/5ML (0.01%)",
    "COND": "FLC 125ML",
    "LISTE": "LISTE II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EPE GROUPE INDUSTRIEL SAIDAL/SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/12/1997",
    "DATE_D_ENREGISTREMENT_FINAL": "22/11/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Allergologie"]
  },
  {
    "PregnancyIndexLink": ["doxylamine"],
    "InteractionIndexLink": ["doxylamine"],
    "N_ENREGISTREMENT": "320/01 A 008/19",
    "CODE_DCI": "01 A 008",
    "DCI": "DOXYLAMINE SUCCINATE",
    "NOM_COMMERCIALE": "DORLAMINE",
    "FORME": "SIROP",
    "DOSAGE": "",
    "COND": "FL/200ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "AGD PHARM SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/7/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "24/7/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["doxylamine"],
    "InteractionIndexLink": ["doxylamine"],
    "N_ENREGISTREMENT": "003/ 01 A 008 /98/17",
    "CODE_DCI": "01 A 008",
    "DCI": "DOXYLAMINE SUCCINATE",
    "NOM_COMMERCIALE": "SULAMINE",
    "FORME": "SIROP",
    "DOSAGE": "6.25MG/5ML",
    "COND": "FL/125 ML",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EPE GROUPE INDUSTRIEL SAIDAL/SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "5/1/1997",
    "DATE_D_ENREGISTREMENT_FINAL": "8/10/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["mequitazine"],
    "N_ENREGISTREMENT": "235/01 A 009/20",
    "CODE_DCI": "01 A 009",
    "DCI": "MEQUITAZINE",
    "NOM_COMMERCIALE": "MEQUITAZ",
    "FORME": "COMP SEC",
    "DOSAGE": "5MG",
    "COND": "B/14",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOGALENIC SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "16/7/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "16/7/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["mequitazine"],
    "N_ENREGISTREMENT": "013/01 A 009/98/16",
    "CODE_DCI": "01 A 009",
    "DCI": "MEQUITAZINE",
    "NOM_COMMERCIALE": "NATAZINE",
    "FORME": "COMPRIME",
    "DOSAGE": "5MG",
    "COND": "B/14",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDUSTRIA FARMACEUTICA NOVA ARGENTIA SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "Italie",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/7/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "5/3/2017",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["mequitazine"],
    "N_ENREGISTREMENT": "318/01 A 009/20",
    "CODE_DCI": "01 A 009",
    "DCI": "MEQUITAZINE",
    "NOM_COMMERCIALE": "PRIMAL",
    "FORME": "COMP. SEC.",
    "DOSAGE": "05MG",
    "COND": "B/ 14",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES PHARMIDAL/NS SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "16/12/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "16/12/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["mequitazine"],
    "N_ENREGISTREMENT": "099/ 01 A 009 /98",
    "CODE_DCI": "01 A 009",
    "DCI": "MEQUITAZINE",
    "NOM_COMMERCIALE": "PRIMALAN",
    "FORME": "COMPRIME",
    "DOSAGE": "5MG",
    "COND": "B/14",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PIERRE FABRE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/11/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "12/11/1998",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["promethazine"],
    "InteractionIndexLink": ["promethazine"],
    "N_ENREGISTREMENT": "487/ 01 A 011 /06/14",
    "CODE_DCI": "01 A 011",
    "DCI": "PROMETHAZINE CHLORHYDRATE EXPRIME EN PROMETHAZINE",
    "NOM_COMMERCIALE": "PRANOK",
    "FORME": "SOL. INJ.",
    "DOSAGE": "50MG/02ML",
    "COND": "B/100 AMP. 02ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GLOBAL PHARMATECH PRIVATE LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/7/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "2/11/2014",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["mequitazine"],
    "N_ENREGISTREMENT": "318/01 A 032/18",
    "CODE_DCI": "01 A 032",
    "DCI": "MEQUITAZINE",
    "NOM_COMMERCIALE": "PRIMAL",
    "FORME": "SIROP",
    "DOSAGE": "0.5MG/ML",
    "COND": "FL/60ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMIDAL N.S.",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/6/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "18/6/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["loratadine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "268/ 01 A 033 /05/18",
    "CODE_DCI": "01 A 033",
    "DCI": "LORATADINE",
    "NOM_COMMERCIALE": "AKARYD",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "10MG",
    "COND": "B/20",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MERINAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "14/6/2005",
    "DATE_D_ENREGISTREMENT_FINAL": "10/9/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Allergologie"]
  },
  {
    "PregnancyIndexLink": ["loratadine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "003/ 01 A 033 /03/17",
    "CODE_DCI": "01 A 033",
    "DCI": "LORATADINE",
    "NOM_COMMERCIALE": "ALLERTINE",
    "FORME": "COMPRIME",
    "DOSAGE": "10MG",
    "COND": "B/20",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EPE GROUPE INDUSTRIEL SAIDAL/SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/8/2003",
    "DATE_D_ENREGISTREMENT_FINAL": "30/10/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Allergologie"]
  },
  {
    "PregnancyIndexLink": ["loratadine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "035/ 01 A 033 /98/13",
    "CODE_DCI": "01 A 033",
    "DCI": "LORATADINE",
    "NOM_COMMERCIALE": "LORADINE",
    "FORME": "COMPRIME",
    "DOSAGE": "10MG",
    "COND": "B/20",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMALLIANCE EURL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/3/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "19/8/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Allergologie"]
  },
  {
    "PregnancyIndexLink": ["loratadine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "447/ 01 A 033 /14",
    "CODE_DCI": "01 A 033",
    "DCI": "LORATADINE",
    "NOM_COMMERCIALE": "LORATADINE BEKER",
    "FORME": "COMPRIME",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES BEKER SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/12/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "15/12/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Allergologie"]
  },
  {
    "PregnancyIndexLink": ["loratadine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "149/ 01 A 033 /13",
    "CODE_DCI": "01 A 033",
    "DCI": "LORATADINE",
    "NOM_COMMERCIALE": "LORATADINE NOVAGENERICS",
    "FORME": "COMPRIME",
    "DOSAGE": "10MG",
    "COND": "B/20",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVAPHARM TRADING SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/9/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "9/9/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Allergologie"]
  },
  {
    "PregnancyIndexLink": ["loratadine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "039/ 01 A 033 /16",
    "CODE_DCI": "01 A 033",
    "DCI": "LORATADINE",
    "NOM_COMMERCIALE": "LORATAL",
    "FORME": "COMPRIME",
    "DOSAGE": "10MG",
    "COND": "B/20",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOPHAL SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/3/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "13/3/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Allergologie"]
  },
  {
    "PregnancyIndexLink": ["loratadine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "01 A 033",
    "DCI": "LORATADINE",
    "NOM_COMMERCIALE": "LORATAN",
    "FORME": "COMPRIME",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Allergologie"]
  },
  {
    "PregnancyIndexLink": ["loratadine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "528/ 01 A 033 /18",
    "CODE_DCI": "01 A 033",
    "DCI": "LORATADINE",
    "NOM_COMMERCIALE": "LORATINE",
    "FORME": "COMPRIME",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JANIS MED SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/12/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "25/12/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Allergologie"]
  },
  {
    "PregnancyIndexLink": ["loratadine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "293/ 01 A 033 /04/12",
    "CODE_DCI": "01 A 033",
    "DCI": "LORATADINE",
    "NOM_COMMERCIALE": "LUTEDINE",
    "FORME": "GLES.",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOCARE SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/11/2004",
    "DATE_D_ENREGISTREMENT_FINAL": "20/5/2012",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Allergologie"]
  },
  {
    "PregnancyIndexLink": ["loratadine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "418/ 01 A 033 /09/17",
    "CODE_DCI": "01 A 033",
    "DCI": "LORATADINE",
    "NOM_COMMERCIALE": "NEOTADINE",
    "FORME": "COMPRIME",
    "DOSAGE": "10MG",
    "COND": "B/10 ET B/20",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NEOMEDIC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/6/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "9/1/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Allergologie"]
  },
  {
    "PregnancyIndexLink": ["loratadine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "242/ 01 A 033 /12",
    "CODE_DCI": "01 A 033",
    "DCI": "LORATADINE",
    "NOM_COMMERCIALE": "ORIN",
    "FORME": "COMPRIME",
    "DOSAGE": "10MG",
    "COND": "B/10",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GROUPE SANTE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/9/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "25/9/2012",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Allergologie"]
  },
  {
    "PregnancyIndexLink": ["loratadine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "01 A 033",
    "DCI": "LORATADINE",
    "NOM_COMMERCIALE": "RESTAMINE",
    "FORME": "COMPRIME",
    "DOSAGE": "10MG",
    "COND": "B/10 -  B/20",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Allergologie"]
  },
  {
    "PregnancyIndexLink": ["loratadine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "01 A 033",
    "DCI": "LORATADINE",
    "NOM_COMMERCIALE": "RITADOLE",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "10MG",
    "COND": "B/20",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Allergologie"]
  },
  {
    "PregnancyIndexLink": ["loratadine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "01 A 033",
    "DCI": "LORATADINE",
    "NOM_COMMERCIALE": "TIRLOR",
    "FORME": "COMPRIME",
    "DOSAGE": "10MG",
    "COND": "B/20",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Allergologie"]
  },
  {
    "PregnancyIndexLink": ["loratadine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "01 A 034",
    "DCI": "LORATADINE",
    "NOM_COMMERCIALE": "ALLERMEX",
    "FORME": "SIROP",
    "DOSAGE": "1 MG / ML",
    "COND": "FLACON DE 60 ML",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Allergologie"]
  },
  {
    "PregnancyIndexLink": ["loratadine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "003/ 01 A 034/06/21",
    "CODE_DCI": "01 A 034",
    "DCI": "LORATADINE",
    "NOM_COMMERCIALE": "ALLERTINE",
    "FORME": "SIROP",
    "DOSAGE": "0.1% (1MG/ML)",
    "COND": "FLC/60ML",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EPE GROUPE INDUSTRIEL SAIDAL/SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/02/06",
    "DATE_D_ENREGISTREMENT_FINAL": "23/05/21",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Allergologie"]
  },
  {
    "PregnancyIndexLink": ["loratadine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "01 A 034",
    "DCI": "LORATADINE",
    "NOM_COMMERCIALE": "ALLERTINE",
    "FORME": "SIROP",
    "DOSAGE": "0.01",
    "COND": "125 ML",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Allergologie"]
  },
  {
    "PregnancyIndexLink": ["loratadine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "01 A 034",
    "DCI": "LORATADINE",
    "NOM_COMMERCIALE": "CLARADINE",
    "FORME": "SOL. BUV.",
    "DOSAGE": "1MG/ML",
    "COND": "FL./60ML",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Allergologie"]
  },
  {
    "PregnancyIndexLink": ["loratadine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "01 A 034",
    "DCI": "LORATADINE",
    "NOM_COMMERCIALE": "CLARDINE",
    "FORME": "SOL. BUV.",
    "DOSAGE": "1MG/ML",
    "COND": "FL./60ML",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Allergologie"]
  },
  {
    "PregnancyIndexLink": ["loratadine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "01 A 034",
    "DCI": "LORATADINE",
    "NOM_COMMERCIALE": "HOCINOR",
    "FORME": "SIROP",
    "DOSAGE": "1MG/ML",
    "COND": "F/125ML",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Allergologie"]
  },
  {
    "PregnancyIndexLink": ["loratadine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "528/ 01 A 034 /18",
    "CODE_DCI": "01 A 034",
    "DCI": "LORATADINE",
    "NOM_COMMERCIALE": "LORATINE",
    "FORME": "SIROP",
    "DOSAGE": "1MG/ML",
    "COND": "FL./125 ML AVEC CUILLERE MESURE",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JANIS MED SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "8/8/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "8/8/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Allergologie"]
  },
  {
    "PregnancyIndexLink": ["loratadine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "01 A 034",
    "DCI": "Loratadine",
    "NOM_COMMERCIALE": "Loradine",
    "FORME": "Solution buvable",
    "DOSAGE": "0.1g/100 ml",
    "COND": "Flacon 100 ml",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Allergologie"]
  },
  {
    "PregnancyIndexLink": ["fexofenadine"],
    "InteractionIndexLink": ["fexofenadine"],
    "N_ENREGISTREMENT": "492/ 01 A 039 /15",
    "CODE_DCI": "01 A 039",
    "DCI": "Fexofenadine chlorhydrate",
    "NOM_COMMERCIALE": "FASTOFEN 120",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "120MG",
    "COND": "B/20",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOPRODIM SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/7/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "2/2/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOS",
    "availableInAlgeria": true,
    "DrugCategories": ["Allergologie"]
  },
  {
    "PregnancyIndexLink": ["fexofenadine"],
    "InteractionIndexLink": ["fexofenadine"],
    "N_ENREGISTREMENT": "352/ 01 A 039 /07/17",
    "CODE_DCI": "01 A 039",
    "DCI": "Fexofenadine chlorhydrate",
    "NOM_COMMERCIALE": "FEXODINE",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "120MG",
    "COND": "B/15",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/5/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "31/12/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Allergologie"]
  },
  {
    "PregnancyIndexLink": ["fexofenadine"],
    "InteractionIndexLink": ["fexofenadine"],
    "N_ENREGISTREMENT": "447/01 A 039/17",
    "CODE_DCI": "01 A 039",
    "DCI": "Fexofenadine chlorhydrate",
    "NOM_COMMERCIALE": "FEXOFENADINE BEKER",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "120MG",
    "COND": "B/15",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEKER SARL (SARL LABORATOIRE BEKER ALGERIE)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/2/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "12/2/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Allergologie"]
  },
  {
    "PregnancyIndexLink": ["fexofenadine"],
    "InteractionIndexLink": ["fexofenadine"],
    "N_ENREGISTREMENT": "195/ 01 A 039 /07/12",
    "CODE_DCI": "01 A 039",
    "DCI": "Fexofenadine chlorhydrate",
    "NOM_COMMERCIALE": "FEXOFENADINE IVAL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "120MG",
    "COND": "B/15",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMA IVAL SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/5/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "10/12/2012",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Allergologie"]
  },
  {
    "PregnancyIndexLink": ["fexofenadine"],
    "InteractionIndexLink": ["fexofenadine"],
    "N_ENREGISTREMENT": "149/ 01 A 039 /14",
    "CODE_DCI": "01 A 039",
    "DCI": "Fexofenadine chlorhydrate",
    "NOM_COMMERCIALE": "FEXOFENADINE NOVAGENERICS",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "120MG",
    "COND": "B/15",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVAPHARM TRADING SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/5/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "4/5/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Allergologie"]
  },
  {
    "PregnancyIndexLink": ["fexofenadine"],
    "InteractionIndexLink": ["fexofenadine"],
    "N_ENREGISTREMENT": "039/ 01 A 039 /11/17",
    "CODE_DCI": "01 A 039",
    "DCI": "Fexofenadine chlorhydrate",
    "NOM_COMMERCIALE": "FEXONIDAL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "120MG",
    "COND": "B/15",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOCIETE PHARMACEUTIQUE ALGERIENNE (SOPHAL)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/9/2011",
    "DATE_D_ENREGISTREMENT_FINAL": "12/4/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Allergologie"]
  },
  {
    "PregnancyIndexLink": ["fexofenadine"],
    "InteractionIndexLink": ["fexofenadine"],
    "N_ENREGISTREMENT": "268/ 01 A 039 /07/18",
    "CODE_DCI": "01 A 039",
    "DCI": "Fexofenadine chlorhydrate",
    "NOM_COMMERCIALE": "RIFEX 120",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "120MG",
    "COND": "B/20",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MERINAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/2/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "3/9/2018",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Allergologie"]
  },
  {
    "PregnancyIndexLink": ["fexofenadine"],
    "InteractionIndexLink": ["fexofenadine"],
    "N_ENREGISTREMENT": "035/01 A 039/17",
    "CODE_DCI": "01 A 039",
    "DCI": "Fexofenadine chlorhydrate",
    "NOM_COMMERCIALE": "TELFADINE",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "120MG",
    "COND": "B/20",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMALLIANCE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/2/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "7/2/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Allergologie"]
  },
  {
    "PregnancyIndexLink": ["fexofenadine"],
    "InteractionIndexLink": ["fexofenadine"],
    "N_ENREGISTREMENT": "392/ 01 A 039 /00/15",
    "CODE_DCI": "01 A 039",
    "DCI": "Fexofenadine chlorhydrate",
    "NOM_COMMERCIALE": "TELFAST",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "120MG",
    "COND": "B/15",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANOFI AVENTIS ALGERIE SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/11/2000",
    "DATE_D_ENREGISTREMENT_FINAL": "7/6/2006",
    "TYPE": "Ré",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Allergologie"]
  },
  {
    "PregnancyIndexLink": ["fexofenadine"],
    "InteractionIndexLink": ["fexofenadine"],
    "N_ENREGISTREMENT": "392/ 01 A 039 /00/20",
    "CODE_DCI": "01 A 039",
    "DCI": "Fexofenadine chlorhydrate",
    "NOM_COMMERCIALE": "TELFAST",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "120MG",
    "COND": "B/15",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANOFI AVENTIS ALGERIE SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/11/00",
    "DATE_D_ENREGISTREMENT_FINAL": "26/05/21",
    "TYPE": "Ré",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Allergologie"]
  },
  {
    "PregnancyIndexLink": ["fexofenadine"],
    "InteractionIndexLink": ["fexofenadine"],
    "N_ENREGISTREMENT": "492/ 01 A 040 /15",
    "CODE_DCI": "01 A 040",
    "DCI": "Fexofenadine chlorhydrate",
    "NOM_COMMERCIALE": "FASTOFEN 180",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "180MG",
    "COND": "B/20",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOPRODIM SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "31/3/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "2/2/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Allergologie"]
  },
  {
    "PregnancyIndexLink": ["fexofenadine"],
    "InteractionIndexLink": ["fexofenadine"],
    "N_ENREGISTREMENT": "352/ 01 A 040 /07/17",
    "CODE_DCI": "01 A 040",
    "DCI": "Fexofenadine chlorhydrate",
    "NOM_COMMERCIALE": "FEXODINE",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "180MG",
    "COND": "B/15",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/5/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "27/12/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Allergologie"]
  },
  {
    "PregnancyIndexLink": ["fexofenadine"],
    "InteractionIndexLink": ["fexofenadine"],
    "N_ENREGISTREMENT": "447/01 A 040/17",
    "CODE_DCI": "01 A 040",
    "DCI": "Fexofenadine chlorhydrate",
    "NOM_COMMERCIALE": "FEXOFENADINE BEKER",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "180MG",
    "COND": "B/20",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEKER SARL (SARL LABORATOIRE BEKER ALGERIE)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/2/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "7/2/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Allergologie"]
  },
  {
    "PregnancyIndexLink": ["fexofenadine"],
    "InteractionIndexLink": ["fexofenadine"],
    "N_ENREGISTREMENT": "195/ 01 A 040 /07/14",
    "CODE_DCI": "01 A 040",
    "DCI": "Fexofenadine chlorhydrate",
    "NOM_COMMERCIALE": "FEXOFENADINE IVAL",
    "FORME": "COMP. PELLI. SEC.",
    "DOSAGE": "180MG",
    "COND": "B/15",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMA IVAL SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/5/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "13/10/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Allergologie"]
  },
  {
    "PregnancyIndexLink": ["fexofenadine"],
    "InteractionIndexLink": ["fexofenadine"],
    "N_ENREGISTREMENT": "149/ 01 A 040 /15",
    "CODE_DCI": "01 A 040",
    "DCI": "Fexofenadine chlorhydrate",
    "NOM_COMMERCIALE": "FEXOFENADINE NOVAGENERICS",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "180MG",
    "COND": "B/15",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL NOVAPHARM TRADING",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/12/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "2/12/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Allergologie"]
  },
  {
    "PregnancyIndexLink": ["fexofenadine"],
    "InteractionIndexLink": ["fexofenadine"],
    "N_ENREGISTREMENT": "039/ 01 A 040 /11/18",
    "CODE_DCI": "01 A 040",
    "DCI": "Fexofenadine chlorhydrate",
    "NOM_COMMERCIALE": "FEXONIDAL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "180MG",
    "COND": "B/15",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOCIETE PHARMACEUTIQUE ALGERIENNE (SOPHAL)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/9/2011",
    "DATE_D_ENREGISTREMENT_FINAL": "5/6/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Allergologie"]
  },
  {
    "PregnancyIndexLink": ["fexofenadine"],
    "InteractionIndexLink": ["fexofenadine"],
    "N_ENREGISTREMENT": "268/ 01 A 040 /07/18",
    "CODE_DCI": "01 A 040",
    "DCI": "Fexofenadine chlorhydrate",
    "NOM_COMMERCIALE": "RIFEX 180",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "180MG",
    "COND": "B/20",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MERINAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/2/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "3/9/2018",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Allergologie"]
  },
  {
    "PregnancyIndexLink": ["fexofenadine"],
    "InteractionIndexLink": ["fexofenadine"],
    "N_ENREGISTREMENT": "392/ 01 A 040 /00/15",
    "CODE_DCI": "01 A 040",
    "DCI": "Fexofenadine chlorhydrate",
    "NOM_COMMERCIALE": "TELFAST",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "180MG",
    "COND": "B/15",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANOFI AVENTIS ALGERIE SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/11/2000",
    "DATE_D_ENREGISTREMENT_FINAL": "24/6/2015",
    "TYPE": "Ré",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Allergologie"]
  },
  {
    "PregnancyIndexLink": ["fexofenadine"],
    "InteractionIndexLink": ["fexofenadine"],
    "N_ENREGISTREMENT": "392/ 01 A 040 /00/21",
    "CODE_DCI": "01 A 040",
    "DCI": "Fexofenadine chlorhydrate",
    "NOM_COMMERCIALE": "TELFAST",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "180MG",
    "COND": "B/15",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANOFI AVENTIS ALGERIE SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/11/00",
    "DATE_D_ENREGISTREMENT_FINAL": "26/05/21",
    "TYPE": "Ré",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Allergologie"]
  },
  {
    "PregnancyIndexLink": ["cetirizine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "352/01 A 041/16",
    "CODE_DCI": "01 A 041",
    "DCI": "CETIRIZINE DICHLORHYDRATE",
    "NOM_COMMERCIALE": "ARTIZ",
    "FORME": "SOL BUV EN GTTES",
    "DOSAGE": "10MG/ML",
    "COND": "B /FL 15 ML COMPTE GOUTTES",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI PHARMACEUTICALS MANUFACTURING COMPANY",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/12/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "4/12/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Allergologie"]
  },
  {
    "PregnancyIndexLink": ["cetirizine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "065/01 A 041/17",
    "CODE_DCI": "01 A 041",
    "DCI": "CETIRIZINE DICHLORHYDRATE",
    "NOM_COMMERCIALE": "CETIRIZINE GL",
    "FORME": "SOL BUV EN GTTES",
    "DOSAGE": "10MG/ML",
    "COND": "B/1 FL DE 15 ML +01 SERINGUE DOSEUSE",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GENERICLAB SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/2/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "27/2/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Allergologie"]
  },
  {
    "PregnancyIndexLink": ["cetirizine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "462/01 A 041/19",
    "CODE_DCI": "01 A 041",
    "DCI": "CETIRIZINE DICHLORHYDRATE",
    "NOM_COMMERCIALE": "CETIRIZINE PHYSIOPHARM",
    "FORME": "SOL BUV EN GTTES",
    "DOSAGE": "10MG/ML",
    "COND": "B/1 FL DE 30 ML +01 PIPETTE GRADUEE",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHYSIOP¨HARM SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Allergologie"]
  },
  {
    "PregnancyIndexLink": ["cetirizine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "20/ 01 A 041/470",
    "CODE_DCI": "01 A 041",
    "DCI": "CETIRIZINE",
    "NOM_COMMERCIALE": "CYRTEX",
    "FORME": "SOL. BUVABLE EN GOUTTE",
    "DOSAGE": "10MG/ML",
    "COND": "B/ 1 FLC DE 15ML",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL LABORATOIRES MM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/7/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "26/7/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Allergologie"]
  },
  {
    "PregnancyIndexLink": ["cetirizine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "235/ 01 A 041 /14",
    "CODE_DCI": "01 A 041",
    "DCI": "CETIRIZINE DICHLORHYDRATE",
    "NOM_COMMERCIALE": "RHITENE",
    "FORME": "SOL BUV EN GTTES",
    "DOSAGE": "10MG/ML",
    "COND": "B/01FL COMPTE GTTES DE 15ML",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOGALENIC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/4/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "15/4/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Allergologie"]
  },
  {
    "PregnancyIndexLink": ["cetirizine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "242/ 01 A 041 /19",
    "CODE_DCI": "01 A 041",
    "DCI": "CETIRIZINE DICHLORHYDRATE",
    "NOM_COMMERCIALE": "TRIZ",
    "FORME": "SOL BUV EN GTTES",
    "DOSAGE": "10MG/ML",
    "COND": "B/01FL  DE 15 ML",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GROUPE SANTE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Allergologie"]
  },
  {
    "PregnancyIndexLink": ["cetirizine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "285/ 01 A 041 /13/19",
    "CODE_DCI": "01 A 041",
    "DCI": "CETIRIZINE DICHLORHYDRATE",
    "NOM_COMMERCIALE": "ZETIREC",
    "FORME": "SOL. BUV. GTTES.",
    "DOSAGE": "10MG/ML",
    "COND": "B/01FL COMPTE GTTES DE 15ML",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "UNION PHARMACEUTIQUE CONSTANTINOISE (UPC)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/8/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "4/11/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Allergologie"]
  },
  {
    "PregnancyIndexLink": ["cetirizine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "073/01 A 041/19",
    "CODE_DCI": "01 A 041",
    "DCI": "CETIRIZINE DICHLORHYDRATE",
    "NOM_COMMERCIALE": "ZITRINE",
    "FORME": "SOL BUV EN GTTES",
    "DOSAGE": "10MG/ML",
    "COND": "B /FL 30ML COMPTE GOUTTES",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ISOPHARM SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/3/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "13/3/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Allergologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["rupatadine"],
    "N_ENREGISTREMENT": "20/09/01 A043/352",
    "CODE_DCI": "01 A 043",
    "DCI": "RUPATADINE S/F FUMARATE",
    "NOM_COMMERCIALE": "ROPAD",
    "FORME": "COMP",
    "DOSAGE": "10MG",
    "COND": "B/20",
    "LISTE": "LISTE II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SPA EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "16/07/20",
    "DATE_D_ENREGISTREMENT_FINAL": "16/07/20",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["diphenhydramine"],
    "InteractionIndexLink": ["diphenhydramine"],
    "N_ENREGISTREMENT": "406/ 01 A 044 /08/16",
    "CODE_DCI": "01 A 044",
    "DCI": "DIPHENHYDRAMINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "HUDU",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "50MG",
    "COND": "B/20",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEIT JALA PHARMACEUTICALS Co",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PALESTINE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/12/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "10/7/2016",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["desloratadine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "352/ 01 A 047 /12/17",
    "CODE_DCI": "01 A 047",
    "DCI": "Desloratadine",
    "NOM_COMMERCIALE": "AIRDITINE",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "5MG",
    "COND": "B/10",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/3/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "31/12/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Allergologie"]
  },
  {
    "PregnancyIndexLink": ["desloratadine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "285/ 01 A 047 /20",
    "CODE_DCI": "01 A 047",
    "DCI": "Desloratadine",
    "NOM_COMMERCIALE": "DARISLOR",
    "FORME": "Comprimé pelliculé",
    "DOSAGE": "5MG",
    "COND": "B/15 et B/30",
    "LISTE": "LISTE II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "Union Pharmaceutique Constantinoise (UPC) / SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/12/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "15/12/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Allergologie"]
  },
  {
    "PregnancyIndexLink": ["desloratadine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "285/01 A 047/20",
    "CODE_DCI": "01 A 047",
    "DCI": "DESLORATADINE",
    "NOM_COMMERCIALE": "DARISLOR",
    "FORME": "COMP. PELL.",
    "DOSAGE": "05MG",
    "COND": "B/ 15 ET B/ 30",
    "LISTE": "LISTE II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SPA UNION PHARMACEUTIQUE CONSTANTINOISE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/12/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "15/12/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Allergologie"]
  },
  {
    "PregnancyIndexLink": ["desloratadine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "21/01 A 047/235",
    "CODE_DCI": "01 A 047",
    "DCI": "DESLORATADINE",
    "NOM_COMMERCIALE": "DESDOLE BGL",
    "FORME": "COMP. PELL.",
    "DOSAGE": "05MG",
    "COND": "B/ 15 ET B/30",
    "LISTE": "LISTE II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES SARL BIOGALENIC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "08/06/21",
    "DATE_D_ENREGISTREMENT_FINAL": "08/06/21",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Allergologie"]
  },
  {
    "PregnancyIndexLink": ["desloratadine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "01 A 047",
    "DCI": "Desloratadine",
    "NOM_COMMERCIALE": "DESLOR",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "5MG",
    "COND": "B/15 B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Allergologie"]
  },
  {
    "PregnancyIndexLink": ["desloratadine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "323/01 A 047/20",
    "CODE_DCI": "01 A 047",
    "DCI": "DESLORATADINE",
    "NOM_COMMERCIALE": "DESLORADEX",
    "FORME": "COMP. PELL.",
    "DOSAGE": "05MG",
    "COND": "B/15 ET B/30",
    "LISTE": "LISTE II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CONTINENTAL PHARM LABORATOIRE/ SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/12/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "22/12/2020",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Allergologie"]
  },
  {
    "PregnancyIndexLink": ["desloratadine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "318/01 A 047/17",
    "CODE_DCI": "01 A 047",
    "DCI": "Desloratadine",
    "NOM_COMMERCIALE": "DESLORAL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "5MG",
    "COND": "B/30 ET B/15",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMIDAL N.S. SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/7/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "30/7/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Allergologie"]
  },
  {
    "PregnancyIndexLink": ["desloratadine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "035/01 A 047/17",
    "CODE_DCI": "01 A 047",
    "DCI": "Desloratadine",
    "NOM_COMMERCIALE": "LORADESS",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "5MG",
    "COND": "B/10",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMALLIANCE EURL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/3/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "12/3/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Allergologie"]
  },
  {
    "PregnancyIndexLink": ["desloratadine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "293/01 A 047/17",
    "CODE_DCI": "01 A 047",
    "DCI": "Desloratadine",
    "NOM_COMMERCIALE": "UDINE",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "5MG",
    "COND": "B/10 B/15 B /30",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOCARE SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/3/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "19/3/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Allergologie"]
  },
  {
    "PregnancyIndexLink": ["desloratadine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "352/ 01 A 048 /12/17",
    "CODE_DCI": "01 A 048",
    "DCI": "Desloratadine",
    "NOM_COMMERCIALE": "AIRDITINE",
    "FORME": "SIROP",
    "DOSAGE": "0.5MG/ML",
    "COND": "B/1FL. DE 120ML + BOUCHON DOSEUR GRADUE",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/3/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "31/12/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Allergologie"]
  },
  {
    "PregnancyIndexLink": ["desloratadine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "285/ 01 A 048 /21",
    "CODE_DCI": "01 A 048",
    "DCI": "Desloratadine",
    "NOM_COMMERCIALE": "DARISLOR",
    "FORME": "SIROP",
    "DOSAGE": "0.5MG/ML",
    "COND": "B/1 Flacon de 120ML + pipette graduée de 5ML",
    "LISTE": "LISTE II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "Union Pharmaceutique Constantinoise (UPC) / SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/2/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "4/2/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Allergologie"]
  },
  {
    "PregnancyIndexLink": ["desloratadine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "317/ 01 A 048 /18",
    "CODE_DCI": "01 A 048",
    "DCI": "Desloratadine",
    "NOM_COMMERCIALE": "DESLOR",
    "FORME": "SIROP",
    "DOSAGE": "0.5MG/ML",
    "COND": "B/1FL. DE 150ML + UNE SERING. MESURE GRADUEE",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INPHA-MEDIS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "14/6/2011",
    "DATE_D_ENREGISTREMENT_FINAL": "14/6/2011",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Allergologie"]
  },
  {
    "PregnancyIndexLink": ["desloratadine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "01 A 048",
    "DCI": "Desloratadine",
    "NOM_COMMERCIALE": "DESLORAL",
    "FORME": "SOL.BUV.",
    "DOSAGE": "0.5MG/ML",
    "COND": "FL/120ML\nGOBELET DOSEUR",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Allergologie"]
  },
  {
    "PregnancyIndexLink": ["desloratadine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "088/01 A 048/20",
    "CODE_DCI": "01 A 048",
    "DCI": "DESLORATADINE",
    "NOM_COMMERCIALE": "DESLORINE",
    "FORME": "SOL. BUVABLE",
    "DOSAGE": "0.5MG/ML",
    "COND": "FLC DE 120ML",
    "LISTE": "LISTE II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES PHARMAGHREB",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/12/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "7/12/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Allergologie"]
  },
  {
    "PregnancyIndexLink": ["desloratadine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "035/ 01 A 048  /15",
    "CODE_DCI": "01 A 048",
    "DCI": "Desloratadine",
    "NOM_COMMERCIALE": "LORADESS",
    "FORME": "SIROP",
    "DOSAGE": "0.5ML/ML",
    "COND": "B/1FL DE 120 ML + PIPETTE GRADUéE EN ML",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMALLIANCE EUR L",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/12/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "27/12/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Allergologie"]
  },
  {
    "PregnancyIndexLink": ["desloratadine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "263/ 01 A 048  /21",
    "CODE_DCI": "01 A 048",
    "DCI": "Desloratadine",
    "NOM_COMMERCIALE": "ODESTA",
    "FORME": "Solution buvable",
    "DOSAGE": "0.5ML/ML",
    "COND": "B/1FL DE 120 ML + seringue graduée",
    "LISTE": "LISTE II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOPHARM / SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/2/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "17/2/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Allergologie"]
  },
  {
    "PregnancyIndexLink": ["desloratadine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "304/ 01 A 048 /18",
    "CODE_DCI": "01 A 048",
    "DCI": "Desloratadine",
    "NOM_COMMERCIALE": "RESTINE",
    "FORME": "SIROP",
    "DOSAGE": "0.5MG/ML",
    "COND": "B/1FL. DE 100 ML + SERINGUE GRADUEE A 5ML",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES GEOPHARM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "31/10/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "31/10/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Allergologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "001/ 01 A 049 /12 /17",
    "CODE_DCI": "01 A 049",
    "DCI": "Bilastine",
    "NOM_COMMERCIALE": "BILAXTEN",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "20MG",
    "COND": "B/10 ET B/20",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMA ALGERIA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/3/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "26/9/2017",
    "TYPE": "Ré",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Allergologie"]
  },
  {
    "PregnancyIndexLink": ["fexofenadine"],
    "InteractionIndexLink": ["fexofenadine"],
    "N_ENREGISTREMENT": "149/01 A 050/17",
    "CODE_DCI": "01 A 050",
    "DCI": "Fexofenadine chlorhydrate",
    "NOM_COMMERCIALE": "FEXOFENADINE NOVAGENERICS",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "30MG",
    "COND": "B/30",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVAPHARM TRADING SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/4/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "12/4/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["mequitazine"],
    "N_ENREGISTREMENT": "099/ 01 A 051 /13",
    "CODE_DCI": "01 A 051",
    "DCI": "MEQUITAZINE",
    "NOM_COMMERCIALE": "PRIMALAN",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "10MG",
    "COND": "B/14",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PIERRE FABRE MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/2/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "4/2/2013",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["cyproheptadine"],
    "InteractionIndexLink": ["cyproheptadine"],
    "N_ENREGISTREMENT": "079/ 01 A 053 /15",
    "CODE_DCI": "01 A 053",
    "DCI": "CYPROHEPTADINE CHLORHYDRATE EXPRIME EN CYPROHEPTADINE",
    "NOM_COMMERCIALE": "HEPTAFORT",
    "FORME": "SIROP",
    "DOSAGE": "2MG/5ML",
    "COND": "FL./125ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE ALGERIEN DE DEVELOPPEMENT PHARMACEUTIQUE (LAD PHARMA)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "3/3/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "3/3/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["cyproheptadine"],
    "InteractionIndexLink": ["cyproheptadine"],
    "N_ENREGISTREMENT": "17/96/01 A 053/003",
    "CODE_DCI": "01 A 053",
    "DCI": "CYPROHEPTADINE CHLORHYDRATE EXPRIME EN CYPRHOPTADINE",
    "NOM_COMMERCIALE": "HEPTAGYL",
    "FORME": "SIROP",
    "DOSAGE": "2MG/5ML (0.04%)",
    "COND": "FLC/150ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES EPE GROUPE INDUSTRIEL SAIDAL/ SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "14/02/96",
    "DATE_D_ENREGISTREMENT_FINAL": "23/03/17",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["cyproheptadine"],
    "InteractionIndexLink": ["cyproheptadine"],
    "N_ENREGISTREMENT": "400/01 A 053/17",
    "CODE_DCI": "01 A 053",
    "DCI": "CYPROHEPTADINE CHLORHYDRATE EXPRIME EN CYPROHEPTADINE",
    "NOM_COMMERCIALE": "PERIAMEX",
    "FORME": "SIROP",
    "DOSAGE": "2MG/5ML",
    "COND": "FL/100 ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "KPMA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/1/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "9/1/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["levocetirizine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "418/01 A 054/17",
    "CODE_DCI": "01 A 054",
    "DCI": "LéVOCéTIRIZINE DICHLORHYDRATE",
    "NOM_COMMERCIALE": "LEVOZEN",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "5 MG",
    "COND": "B/14 ET B/28",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NEOMEDIC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/2/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "7/2/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Allergologie"]
  },
  {
    "PregnancyIndexLink": ["levocetirizine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "231/01 A 054/18",
    "CODE_DCI": "01 A 054",
    "DCI": "LéVOCéTIRIZINE DICHLORHYDRATE",
    "NOM_COMMERCIALE": "RIZINAL 5",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "5 MG",
    "COND": "B/20",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SALEM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/4/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "22/4/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Allergologie"]
  },
  {
    "PregnancyIndexLink": ["levocetirizine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "293/ 01 A 054 /15",
    "CODE_DCI": "01 A 054",
    "DCI": "LéVOCéTIRIZINE DICHLORHYDRATE",
    "NOM_COMMERCIALE": "XYCARE",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "5 MG",
    "COND": "B/14 ET B/28",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOCARE SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/12/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "2/12/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Allergologie"]
  },
  {
    "PregnancyIndexLink": ["levocetirizine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "352/01 A 054/19",
    "CODE_DCI": "01 A 054",
    "DCI": "LEVOCETIRIZINE DICHLORHYDRATE",
    "NOM_COMMERCIALE": "XYRIZINE",
    "FORME": "COMP PELL",
    "DOSAGE": "5MG",
    "COND": "B/14",
    "LISTE": "LISTE II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/12/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "30/12/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Allergologie"]
  },
  {
    "PregnancyIndexLink": ["levocetirizine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "380/01 A 054/20",
    "CODE_DCI": "01 A 054",
    "DCI": "Dichlorhydrate de Lévocétirizine",
    "NOM_COMMERCIALE": "ZYRAL",
    "FORME": "Comprimé pelliculé",
    "DOSAGE": "5MG",
    "COND": "B/14",
    "LISTE": "LISTE II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HUP.P.PHARMA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/11/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "1/3/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Allergologie"]
  },
  {
    "PregnancyIndexLink": ["levocetirizine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "20/01 A054/380",
    "CODE_DCI": "01 A 054",
    "DCI": "LEVOCETIRIZINE DICHLORHYDRATE",
    "NOM_COMMERCIALE": "ZYRAL",
    "FORME": "COMP PELL",
    "DOSAGE": "5MG",
    "COND": "B/14",
    "LISTE": "LISTE II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "laboratoires HUP.P PHARMA Sarl",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/03/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "28/03/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Allergologie"]
  },
  {
    "PregnancyIndexLink": ["levocetirizine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "20/01 A054/380",
    "CODE_DCI": "01 A 054",
    "DCI": "LEVOCETIRIZINE DICHLORHYDRATE",
    "NOM_COMMERCIALE": "ZYRAL",
    "FORME": "COMP PELL",
    "DOSAGE": "5MG",
    "COND": "B/14",
    "LISTE": "LISTE II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "laboratoires HUP.P PHARMA Sarl",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/03/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "28/03/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Allergologie"]
  },
  {
    "PregnancyIndexLink": ["cyproheptadine"],
    "InteractionIndexLink": ["cyproheptadine"],
    "N_ENREGISTREMENT": "457/ 01 A 055 /16",
    "CODE_DCI": "01 A 055",
    "DCI": "CYPROHEPTADINE CHLORHYDRATE EXPRIME EN CYPROHEPTADINE",
    "NOM_COMMERCIALE": "CIPROMINE",
    "FORME": "COMPRIME",
    "DOSAGE": "4MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOMEDIAL SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/1/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "10/1/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "268/01 A 056/17",
    "CODE_DCI": "01 A 056",
    "DCI": "EBASTINE",
    "NOM_COMMERCIALE": "EBASTA",
    "FORME": "CP ORODISPERSIBLE",
    "DOSAGE": "10 MG",
    "COND": "B/10 ET DE B/30",
    "LISTE": "LISTE II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MERINAL SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/6/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "13/6/2017",
    "TYPE": "Gé",
    "STATUT": "F PREMIX",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Allergologie"]
  },
  {
    "PregnancyIndexLink": ["fexofenadine"],
    "InteractionIndexLink": ["fexofenadine"],
    "N_ENREGISTREMENT": "352/01 A 057/19",
    "CODE_DCI": "01 A 057",
    "DCI": "Fexofenadine chlorhydrate",
    "NOM_COMMERCIALE": "FEXODINE",
    "FORME": "SUSP BUV",
    "DOSAGE": "30 MG/ 5 ML",
    "COND": "FL/125ML",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ELKENDI INDUSTRIE DE MEDICAMENT SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/3/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "20/3/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["levocetirizine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "352/01 A 058/20",
    "CODE_DCI": "01 A 058",
    "DCI": "LEVOCETIRIZINE DICHLORHYDRATE",
    "NOM_COMMERCIALE": "XYRIZINE",
    "FORME": "SOL. BUVABLE",
    "DOSAGE": "50MG\n2.5MG/5ML",
    "COND": "B/ A FLC DE 200ML",
    "LISTE": "LISTE II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SPA/ EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "16/12/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "16/12/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["levocetirizine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "352/01 A 058/20",
    "CODE_DCI": "01 A 058",
    "DCI": "LEVOCETIRIZINE DICHLORHYDRATE",
    "NOM_COMMERCIALE": "XYRIZINE",
    "FORME": "SOL. BUVABLE",
    "DOSAGE": "50MG\n2.5MG/5ML",
    "COND": "B/ A FLC DE 200ML",
    "LISTE": "LISTE II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SPA/ EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "16/12/20",
    "DATE_D_ENREGISTREMENT_FINAL": "16/12/20",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["mequitazine"],
    "N_ENREGISTREMENT": "235/01 A 051/20",
    "CODE_DCI": "01 A051",
    "DCI": "MEQUITAZINE",
    "NOM_COMMERCIALE": "MEQUITAZ",
    "FORME": "COMP SEC",
    "DOSAGE": "10MG",
    "COND": "B/14",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOGALENIC SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "16/7/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "16/7/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["allergen pollen extract of 5 grasses"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "130/ 01 D 029 /00/14",
    "CODE_DCI": "01 D 029",
    "DCI": "EXTRAITS ALLERGENIQUES DERMATOPHAGOIDES PTERONYSSINUS",
    "NOM_COMMERCIALE": "ALUSTAL",
    "FORME": "SUSP. INJ.",
    "DOSAGE": "0.1IR/ML+1IR/ML+10IR/ML",
    "COND": "B/03FL.",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "STALLERGENES S.A.",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/3/2000",
    "DATE_D_ENREGISTREMENT_FINAL": "1/9/2014",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "12 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["allergen pollen extract of 5 grasses"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "130/ 01 D 030 /00/14",
    "CODE_DCI": "01 D 030",
    "DCI": "EXTRAITS ALLERGENIQUS DERMATOPHAGOIDES PTERONYSSINUS",
    "NOM_COMMERCIALE": "ALUSTAL",
    "FORME": "SUSP. INJ.",
    "DOSAGE": "10IR/ML",
    "COND": "B/01 FL.",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "STALLERGENES S.A.",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/3/2000",
    "DATE_D_ENREGISTREMENT_FINAL": "1/9/2014",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "12 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["allergen pollen extract of 5 grasses"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "130/ 01 D 037 /00/14",
    "CODE_DCI": "01 D 037",
    "DCI": "EXTRAITS ALLERGENIQUES MELANGE DE 5 GRAMINES",
    "NOM_COMMERCIALE": "ALUSTAL",
    "FORME": "SUSP. INJ.",
    "DOSAGE": "0.1IR/ML+1IR/ML+10IR/ML",
    "COND": "B/03FL.",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "STALLERGENES S.A.",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/3/2000",
    "DATE_D_ENREGISTREMENT_FINAL": "1/9/2014",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "12 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["allergen pollen extract of 5 grasses"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "130/ 01 D 038 /00/14",
    "CODE_DCI": "01 D 038",
    "DCI": "EXTRAITS ALLERGENIQUES MELANGE DE 5 GRAMINES",
    "NOM_COMMERCIALE": "ALUSTAL",
    "FORME": "SUSP. INJ.",
    "DOSAGE": "10IR/ML",
    "COND": "B/01 FL.",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "STALLERGENES S.A.",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/3/2000",
    "DATE_D_ENREGISTREMENT_FINAL": "1/9/2014",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "12 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["allergen pollen extract of 5 grasses"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "130/ 01 D 052 /15",
    "CODE_DCI": "01 D 052",
    "DCI": "EXTRAITS ALLERGENIQUES DERMARTOPHAGOIDES PTERONYSSINUS / DERMATOPHAGOIDES FARINEA (50/50)",
    "NOM_COMMERCIALE": "STALORAL",
    "FORME": "SOLUTION SUBLINGUALE D'UN MELANGE D'EXTRAITS ALLERGENIQUE POUR IMMUNOTHERAPIE SPECIFIQUE",
    "DOSAGE": "10+100+300 IR/ML - 300 IR/ML",
    "COND": "COFFRET DE 03 FL. DE 10ML DE SOLUTION (10+100+300 IR/ML) - COFFRET DE 01 FL. DE 10ML DE SOLUTION (300 IR/ML)",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "STALLERGENES S.A.",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/6/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "18/6/2015",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["fentanyl"],
    "InteractionIndexLink": ["fentanyl"],
    "N_ENREGISTREMENT": "499/02 A 001/98/21",
    "CODE_DCI": "02 A 001",
    "DCI": "Fentanyl citrate exprimé en Fentanyl",
    "NOM_COMMERCIALE": "FENTANYL PIRAMAL",
    "FORME": "SOL.INJ.",
    "DOSAGE": "0.1MG/AMP. (0.1MG/2ML)",
    "COND": "B/5AMP. DE 2ML",
    "LISTE": "Stupéfiants",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PIRAMAL CRITICAL CARE LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ROYAUME-UNI",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/4/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "14/3/2021",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["fentanyl"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "499/ 02 A 001 /98/19",
    "CODE_DCI": "02 A 001",
    "DCI": "ALFENTANYL",
    "NOM_COMMERCIALE": "RAPIFEN",
    "FORME": "SOL.INJ.",
    "DOSAGE": "1MG/2ML",
    "COND": "B/05 AMPS",
    "LISTE": "Stupéfiants",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PIRAMAL CRITICAL CARE LTD",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ROYAUME UNI",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/4/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "10/2/2020",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["fentanyl"],
    "InteractionIndexLink": ["fentanyl"],
    "N_ENREGISTREMENT": "095/ 02 A 002 /08/15",
    "CODE_DCI": "02 A 002",
    "DCI": "FENTANYL CITRATE EXPRIME EN FENTANYL",
    "NOM_COMMERCIALE": "FENTANYL JANSSEN",
    "FORME": "SOL.INJ.",
    "DOSAGE": "0.05MG/ML (0.5MG/10ML)",
    "COND": "B/10AMP. DE 10ML",
    "LISTE": "Stupéfiants",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JANSSEN CILAG",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/2/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "29/12/2015",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["fentanyl"],
    "InteractionIndexLink": ["fentanyl"],
    "N_ENREGISTREMENT": "095/02 A 001/98/16",
    "CODE_DCI": "02 A 002",
    "DCI": "FENTANYL CITRATE EXPRIME EN FENTANYL",
    "NOM_COMMERCIALE": "FENTANYL JANSSEN",
    "FORME": "SOL.INJ.",
    "DOSAGE": "0.1MG/AMP.",
    "COND": "B/5",
    "LISTE": "Stupéfiants",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JANSSEN CILAG",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/4/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "11/9/2016",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["fentanyl"],
    "InteractionIndexLink": ["fentanyl"],
    "N_ENREGISTREMENT": "499/ 02 A 002 /08/21",
    "CODE_DCI": "02 A 002",
    "DCI": "Fentanyl citrate exprimé en Fentanyl",
    "NOM_COMMERCIALE": "FENTANYL PIRAMAL",
    "FORME": "SOL.INJ.",
    "DOSAGE": "0.05MG/ML (0.5MG/10ML)",
    "COND": "B/10AMP. DE 10ML",
    "LISTE": "Stupéfiants",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PIRAMAL CRITICAL CARE LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ROYAUME-UNI",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/2/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "14/3/2021",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["sufentanil"],
    "InteractionIndexLink": ["sufentanil"],
    "N_ENREGISTREMENT": "095/ 02 A 041 /99/15",
    "CODE_DCI": "02 A 041",
    "DCI": "SUFENTANIL CITRATE EXPRIME EN SUFENTANIL",
    "NOM_COMMERCIALE": "SUFENTA",
    "FORME": "SOL INJ  IV OU PERIDURALE",
    "DOSAGE": "250µG/5ML",
    "COND": "B/10AMP. DE 5ML",
    "LISTE": "Stupéfiants",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JANSSEN CILAG",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/6/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "18/3/2015",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["sufentanil"],
    "InteractionIndexLink": ["sufentanil"],
    "N_ENREGISTREMENT": "095/ 02 A 055 /05/16",
    "CODE_DCI": "02 A 055",
    "DCI": "SUFENTANIL CITRATE EXPRIME EN SUFENTANIL",
    "NOM_COMMERCIALE": "SUFENTA",
    "FORME": "SOL INJ IV OU PERIDURALE",
    "DOSAGE": "5µG/ML (10µG/2ML - 50µG/10ML)",
    "COND": "B/5AMP. DE 2ML - B/10AMP.DE 10ML",
    "LISTE": "Stupéfiants",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JANSSEN CILAG",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/9/2005",
    "DATE_D_ENREGISTREMENT_FINAL": "25/4/2016",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["remifentanil"],
    "InteractionIndexLink": ["remifentanil"],
    "N_ENREGISTREMENT": "450/ 02 A 062 /15",
    "CODE_DCI": "02 A 062",
    "DCI": "CHLORHYDRATE DE REMIFENTANIL",
    "NOM_COMMERCIALE": "REMIFENTANIL MYLAN",
    "FORME": "POUDRE POUR SOL INJ OU POUR PERF IV",
    "DOSAGE": "2MG/ FLACON",
    "COND": "BOITE DE 10 FLACONS DE 5 ML",
    "LISTE": "Stupéfiants",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MYLAN SAS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "France",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/12/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "2/12/2015",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["remifentanil"],
    "InteractionIndexLink": ["remifentanil"],
    "N_ENREGISTREMENT": "450/ 02 A 063 /15",
    "CODE_DCI": "02 A 063",
    "DCI": "CHLORHYDRATE DE REMIFENTANIL",
    "NOM_COMMERCIALE": "REMIFENTANIL MYLAN",
    "FORME": "POUDRE POUR SOL INJ OU POUR PERF IV",
    "DOSAGE": "5MG/FLACON",
    "COND": "BOITE DE 10 FLACONS DE 10 ML",
    "LISTE": "Stupéfiants",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MYLAN SAS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "France",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/12/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "2/12/2015",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["halothane"],
    "InteractionIndexLink": ["halothane"],
    "N_ENREGISTREMENT": "449/02 B 006/17",
    "CODE_DCI": "02 B 006",
    "DCI": "HALOTHANE",
    "NOM_COMMERCIALE": "HALOTHANE BP",
    "FORME": "LIQUIDE POUR INHALATION PAR VAPEUR",
    "DOSAGE": "100%( 498 MG/250ML)",
    "COND": "B/01 FL DE 250 ML",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PIRAMAL ENTERPRISES LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/3/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "19/3/2017",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "60 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["isoflurane"],
    "InteractionIndexLink": ["isoflurane"],
    "N_ENREGISTREMENT": "298/ 02 B 007 /12",
    "CODE_DCI": "02 B 007",
    "DCI": "ISOFLURANE",
    "NOM_COMMERCIALE": "AERRANE",
    "FORME": "LIQUIDE. P. INHAL. PAR VAPEUR",
    "DOSAGE": "100ML/100ML - 250ML/250ML",
    "COND": "CARTON DE 06 FL. DE 100ML ET CARTON DE 06 FL. DE 250ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BAXTER HEALTHCARE COPORATION",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ETATS UNIS D'AMERIQUE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/8/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "26/8/2012",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "60 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["isoflurane"],
    "InteractionIndexLink": ["isoflurane"],
    "N_ENREGISTREMENT": "498/ 02 B 007 /99/16",
    "CODE_DCI": "02 B 007",
    "DCI": "ISOFLURANE",
    "NOM_COMMERCIALE": "FORENE",
    "FORME": "LIQUIDE. P. INHAL. PAR VAPEUR",
    "DOSAGE": "100ML/100ML",
    "COND": "B/01FL. DE 100 ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ABBVIE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "France",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/5/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "2/2/2016",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "60 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["ketamine"],
    "InteractionIndexLink": ["ketamine"],
    "N_ENREGISTREMENT": "352/ 02 B 009 /09/19",
    "CODE_DCI": "02 B 009",
    "DCI": "KETAMINE CHLORHYDRATE EXPRIME EN KETAMINE",
    "NOM_COMMERCIALE": "KETAMILE",
    "FORME": "SOL. INJ.",
    "DOSAGE": "50MG/ML",
    "COND": "B/01FL. DE 10ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "11/7/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "14/8/2019",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["ketamine"],
    "InteractionIndexLink": ["ketamine"],
    "N_ENREGISTREMENT": "433/02 B 009/20",
    "CODE_DCI": "02 B 009",
    "DCI": "Kétamine Chlorhydrate exprimé en Kétamine",
    "NOM_COMMERCIALE": "KETARAZ",
    "FORME": "Solution injectable IM/IV",
    "DOSAGE": "50MG/ML",
    "COND": "B/10 AMPS et 50 AMPS",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRATER RAZES SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "14/4/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "14/4/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["propofol"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "332/ 02 B 011 /08/16",
    "CODE_DCI": "02 B 011",
    "DCI": "PROPOFOL",
    "NOM_COMMERCIALE": "PROPOFOL FRESENIUS 1%",
    "FORME": "EMULSION  INJ. IV ET POUR PERF.IV",
    "DOSAGE": "1% (OU 10MG/ML) ( OU 200MG/20ML)",
    "COND": "B/5AMP./20ML (200MG/20ML)",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRESENIUS KABI",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/2/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "19/7/2016",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["propofol"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "352/ 02 B 011 /07/18",
    "CODE_DCI": "02 B 011",
    "DCI": "PROPOFOL",
    "NOM_COMMERCIALE": "PROVIVE",
    "FORME": "EMULSION IV PERF.",
    "DOSAGE": "1% (OU 10MG/ML)",
    "COND": "B/05 FL DE 20ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/11/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "15/2/2018",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["thiopental"],
    "N_ENREGISTREMENT": "542/ 02 B 012/18",
    "CODE_DCI": "02 B 012",
    "DCI": "Thiopental sodique et carbonate de sodium exprimé en thiopental sodium",
    "NOM_COMMERCIALE": "THIOPENTAL VUAB inj.plv.sol.0.5 g",
    "FORME": "PDRE.SOL.INJ.",
    "DOSAGE": "0.5G",
    "COND": "B/01FL",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "VUAB PHARMA a.s.",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "REPUBLIQUE TCHEQUE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/4/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "18/4/2018",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["thiopental"],
    "N_ENREGISTREMENT": "542/ 02 B 013 /18",
    "CODE_DCI": "02 B 013",
    "DCI": "Thiopental sodique et carbonate de sodium exprimé en thiopental sodium",
    "NOM_COMMERCIALE": "THIOPENTAL VUAB inj.plv.sol.1.0 g",
    "FORME": "PDRE.SOL.INJ.",
    "DOSAGE": "1G",
    "COND": "B/01FL",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "VUAB PHARMA a.s.",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "REPUBLIQUE TCHEQUE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/4/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "18/4/2018",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "483/02 B 014/16",
    "CODE_DCI": "02 B 014",
    "DCI": "OXYGENE MEDICINAL GAZ",
    "NOM_COMMERCIALE": "OXYGENE MEDICINAL AIR LIQUID 200BAR",
    "FORME": "GAZ LIQUIDE POUR INHALATION D'UNE PURETE ≥99.50 %",
    "DOSAGE": "",
    "COND": "Bouteille de 5 litres munide robinet VIPR. BOUTEILLE DE 5 L ET 50 L",
    "LISTE": "",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SIDAL SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/2/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "22/2/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "570/02 B 014/21",
    "CODE_DCI": "02 B 014",
    "DCI": "Oxygène médicinal liquide (sous une pression de 1 à 15 bar. de -180° à -150°C  )",
    "NOM_COMMERCIALE": "OXYGENE MEDICINAL LIQUIDE  CALGAZ AlLGERIE",
    "FORME": "Gaz pour inhalation",
    "DOSAGE": "Pureté  ≥ 99.50 %",
    "COND": "Récipient cryogénique mobile de 23 530L",
    "LISTE": "",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CALGAZ ALGERIE / EURL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/2/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "17/2/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "06 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "483/02 B 014/13/19",
    "CODE_DCI": "02 B 014",
    "DCI": "OXYGENE  PURETE 99.50 %  SOUS PRESSION DE 10 BAR A 15 BAR  DE -155° C A -145 ° C",
    "NOM_COMMERCIALE": "OXYGENE MEDICINAL LIQUIDE AIR LIQUIDE",
    "FORME": "GAZ POUR INHAL",
    "DOSAGE": "",
    "COND": "RESRVOIR CRYOGENIQUE MOBILE",
    "LISTE": "",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SIDAL SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/12/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "24/3/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "3 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "593/ 02 B 016 /99/17",
    "CODE_DCI": "02 B 016",
    "DCI": "Oxygene médicinal liquide",
    "NOM_COMMERCIALE": "OXYGENE MEDICINAL LIQUIDE LINDE GAS ALGERIE",
    "FORME": "GAZ POUR INHAL",
    "DOSAGE": "OXYGENE PURTE  > OU = à 99.5 %  SOUS PRESSION 1 A 15 BAR DE -180°C A-150°C",
    "COND": "RECIPIENT CRYOGENIQUE MOBILE 7000 L-12000 L-26000L",
    "LISTE": "",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LINDE GAS ALGERIE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/7/1997",
    "DATE_D_ENREGISTREMENT_FINAL": "27/12/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "03 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "21/99/02 B 016/539",
    "CODE_DCI": "02 B 016",
    "DCI": "OXYGENE MEDICINAL LIQUIDE",
    "NOM_COMMERCIALE": "OXYGENE MEDICINAL LIQUIDE LINDE GAS ALGERIE",
    "FORME": "GAZ POUR INHALATION EN RECIPIENT CRYOGENIQUE MOBILE SOUS UNE PRESSION DE 1 A 15 BAR DE -180° A -150°",
    "DOSAGE": "PURETE ≥ 99.5%",
    "COND": "CITERNES DE 7000L. 12000L. 26000",
    "LISTE": "",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LINDE GAS ALGERIE SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/12/99",
    "DATE_D_ENREGISTREMENT_FINAL": "18/04/21",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "03 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["sevoflurane"],
    "InteractionIndexLink": ["sevoflurane"],
    "N_ENREGISTREMENT": "298/ 02 B 057 /16",
    "CODE_DCI": "02 B 057",
    "DCI": "SEVOFLURANE",
    "NOM_COMMERCIALE": "SEVOFLURANE USP",
    "FORME": "LIQUIDE P. INHAL. PAR VAPEUR",
    "DOSAGE": "100ML/100ML DE LIQUIDE POUR INHALATION PAR VAPEUR",
    "COND": "CARTON DE 06 FL. DE 250ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BAXTER HEALTHCARE COPORATION",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "USA",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/1/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "25/1/2016",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["sevoflurane"],
    "InteractionIndexLink": ["sevoflurane"],
    "N_ENREGISTREMENT": "498/ 02 B 057 /05/16",
    "CODE_DCI": "02 B 057",
    "DCI": "SEVOFLURANE",
    "NOM_COMMERCIALE": "SEVORANE",
    "FORME": "LIQUIDE P. INHAL. PAR VAPEUR",
    "DOSAGE": "100ML/100ML DE LIQUIDE POUR INHALATION PAR VAPEUR",
    "COND": "FL/250ML AVEC SYSTÈME DE FERMETURE FIXE QUIK-FIL",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ABBVIE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/11/2005",
    "DATE_D_ENREGISTREMENT_FINAL": "24/5/2016",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "095/ 02 B 058 /08/19",
    "CODE_DCI": "02 B 058",
    "DCI": "ETOMIDATE",
    "NOM_COMMERCIALE": "HYPNOMIDATE",
    "FORME": "SOL. INJ. IV",
    "DOSAGE": "2MG/ML",
    "COND": "B/05 AMP. DE 10ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PIRAMAL CRITICAL CARE LTD",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ROYAUME UNI",
    "DATE_D_ENREGISTREMENT_INITIAL": "23/12/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "3/12/2019",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["sugammadex"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "005/ 02 B 061 /14",
    "CODE_DCI": "02 B 061",
    "DCI": "SUGAMMADEX SODIQUE EXPRIME EN SUGAMMADEX",
    "NOM_COMMERCIALE": "BRIDION",
    "FORME": "SOL. INJ. IV",
    "DOSAGE": "100MG/ML (200MG/2ML) (500MG/5ML)",
    "COND": "B/10 FL DE 2ML ET B/10 FL DE 5ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ORGANON N.V.",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PAYS BAS",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/10/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "1/10/2014",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["propofol"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "467/ 02 B 64 /15",
    "CODE_DCI": "02 B 064",
    "DCI": "PROPOFOL",
    "NOM_COMMERCIALE": "DIPRIVAN",
    "FORME": "EMULSION INJECTABLE IV EN SURINGUE Pré-remplie",
    "DOSAGE": "10MG/ML",
    "COND": "B/1 SERINGUE PRE REMPLIE DE 50 ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ASPEN PHARMA SCHWEIZ GMBH",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SUISSE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/12/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "27/12/2015",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["propofol"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "256/ 02 B 065 /15",
    "CODE_DCI": "02 B 065",
    "DCI": "PROPOFOL",
    "NOM_COMMERCIALE": "DIPRIVAN",
    "FORME": "EMULSION INJECTABLE EN SURINGUE Pré-remplie",
    "DOSAGE": "20mg/ml",
    "COND": "B/1 DE 50 ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ASPEN PHARMA SCHWEIZ GMBH",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ROYAUME UNI",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/12/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "27/12/2015",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["bupivacaine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "433 / 02 C 016 / 19",
    "CODE_DCI": "02 C 016",
    "DCI": "Bupivacaïne Hydrochloride exprimé en Bupivacaïne Hydrochloride Anhydre",
    "NOM_COMMERCIALE": "BUPIVACAINE RAZES",
    "FORME": "SOLUTION INJECTABLE INTRARACHIDIENNE",
    "DOSAGE": "0.5 %( 20MG/4ML)",
    "COND": "B/10 AMPOULES ETB/50 AMPOULES ( AMPOULE DE 5 ML)",
    "LISTE": "LISTE II",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRATER RAZES SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/6/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "12/6/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["lidocaine"],
    "InteractionIndexLink": ["lidocaine"],
    "N_ENREGISTREMENT": "023/ 02 C 018 /96/15",
    "CODE_DCI": "02 C 018",
    "DCI": "LIDOCAINE  CHLORHYDRATE",
    "NOM_COMMERCIALE": "UNICAINE 1%",
    "FORME": "SOL.INJ.",
    "DOSAGE": "1 %",
    "COND": "B/50 AMP. DE 10ML",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "UNIMED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "TUNISIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/10/1996",
    "DATE_D_ENREGISTREMENT_FINAL": "30/7/2015",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["lidocaine"],
    "InteractionIndexLink": ["lidocaine", "naphazoline"],
    "N_ENREGISTREMENT": "036/ 02 C 025 /98/16",
    "CODE_DCI": "02 C 025",
    "DCI": "LIDOCAINE/NAPHAZOLINE",
    "NOM_COMMERCIALE": "XYLOCAINE NAPHAZOLINE",
    "FORME": "SOL.NON.INJ.",
    "DOSAGE": "5% / 0.02%",
    "COND": "FL/24ML",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ASTRA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/10/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "12/3/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["lidocaine"],
    "InteractionIndexLink": ["lidocaine"],
    "N_ENREGISTREMENT": "231/ 02 C 027 /21",
    "CODE_DCI": "02 C 027",
    "DCI": "Chlorhydrate de Lidocaïne  exprimé en Chlorhydrate de Lidocaïne anhydre",
    "NOM_COMMERCIALE": "LIDOCAINE LS",
    "FORME": "Gel oral",
    "DOSAGE": "2%  ( 2G/100G DE GEL)",
    "COND": "T/100G",
    "LISTE": "LISTE II",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SALEM / SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/2/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "4/2/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["lidocaine"],
    "InteractionIndexLink": ["lidocaine"],
    "N_ENREGISTREMENT": "036/ 02 C 027 /98/16",
    "CODE_DCI": "02 C 027",
    "DCI": "LIDOCAINE VISQUEUSE",
    "NOM_COMMERCIALE": "XYLOCAINE VISQUEUSE",
    "FORME": "GEL ORAL",
    "DOSAGE": "2 %",
    "COND": "T/100G",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ASTRA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/10/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "12/3/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [
      "adrenaline (epinephrine)",
      "adrenaline",
      "mepivacaine"
    ],
    "InteractionIndexLink": ["adrenaline"],
    "N_ENREGISTREMENT": "331/ 02 C 028 /06/16",
    "CODE_DCI": "02 C 028",
    "DCI": "MEPIVACAINE  (CHLORHYDRATE) / ADRENALINE (TARTRATE)",
    "NOM_COMMERCIALE": "MEDICAINE 2% AVEC ADRENALINE 1/100 000",
    "FORME": "SOL. INJ. EN CARPULES",
    "DOSAGE": "2% / 1/100 000  (OU 2G / 0.001G / 100ML)",
    "COND": "B/50 CARPULES DE 1.8ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MEDIS (LABORATOIRES DES MEDICAMENTS STERILES)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "TUNISIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "3/4/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "11/5/2016",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["mepivacaine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "18/02 C 030/299",
    "CODE_DCI": "02 C 030",
    "DCI": "MEPIVACAINE HYDROCHLORIDE",
    "NOM_COMMERCIALE": "SCANDINIBSA 3%",
    "FORME": "SOL. INJ.",
    "DOSAGE": "30MG/ML",
    "COND": "B/50 CARTOUCHE DE 1.8ML",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INIBSA DENTAL. S.L.U.",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ESPAGNE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/12/18",
    "DATE_D_ENREGISTREMENT_FINAL": "10/12/18",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "60 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [
      "lidocaine",
      "prilocaine (with or without felypressin)"
    ],
    "InteractionIndexLink": ["lidocaine", "prilocaine"],
    "N_ENREGISTREMENT": "263/ 02 C 046 /18",
    "CODE_DCI": "02 C 046",
    "DCI": "Lidocaine / Prilocaine",
    "NOM_COMMERCIALE": "BIOMLA",
    "FORME": "CREME",
    "DOSAGE": "5% (2.5G/100G /2.5G/100G)",
    "COND": "T/30 G",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOPHARM SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/9/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "24/9/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [
      "lidocaine",
      "prilocaine (with or without felypressin)"
    ],
    "InteractionIndexLink": ["lidocaine", "prilocaine"],
    "N_ENREGISTREMENT": "418/ 02 C 046 /21",
    "CODE_DCI": "02 C 046",
    "DCI": "Lidocaine / Prilocaine",
    "NOM_COMMERCIALE": "NEOMLA",
    "FORME": "Crème pour application cutanée",
    "DOSAGE": "5% (2.5G/100G /2.5G/100G)",
    "COND": "T/30 G",
    "LISTE": "LISTE II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NEOMEDIC / SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "14/3/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "14/3/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["articaine", "adrenaline"],
    "InteractionIndexLink": ["adrenaline"],
    "N_ENREGISTREMENT": "18/02 C 053/299",
    "CODE_DCI": "02 C 053",
    "DCI": "ARTICAINE HYDROCHLORIDE/ ADRENALINE TARTRATE",
    "NOM_COMMERCIALE": "ARTINIBSA 4% avec Epinephrine 1: 100.000",
    "FORME": "SOL. INJ.",
    "DOSAGE": "40MG/ 0.001MG PAR 1ML",
    "COND": "B/50 CARTOUCHE DE 1.8ML",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INIBSA DENTAL. S.L.U.",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ESPAGNE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/12/18",
    "DATE_D_ENREGISTREMENT_FINAL": "10/12/18",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["vecuronium"],
    "InteractionIndexLink": ["vecuronium"],
    "N_ENREGISTREMENT": "463/02 D 038/10/16",
    "CODE_DCI": "02 D 038",
    "DCI": "VECURONIUM BROMURE",
    "NOM_COMMERCIALE": "NEOVEC",
    "FORME": "LYOPH. ET SOLV. SOL. INJ. IV",
    "DOSAGE": "4MG/FL. DE LYOPH.",
    "COND": "B/01FL. DE PDRE. + 01AMP. DE 2ML DE SOLV.(EPPI)",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GLAND PHARMA LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/6/2010",
    "DATE_D_ENREGISTREMENT_FINAL": "4/1/2017",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["vecuronium"],
    "InteractionIndexLink": ["vecuronium"],
    "N_ENREGISTREMENT": "330/ 02 D 038 /12",
    "CODE_DCI": "02 D 038",
    "DCI": "VECURONIUM BROMURE",
    "NOM_COMMERCIALE": "VECURON",
    "FORME": "LYOPH. ET SOLV. P. SOL. INJ. IV",
    "DOSAGE": "4MG/FL. DE LYOPH.",
    "COND": "B/10FL. DE LYOPH.+ 10AMP. DE 2ML DE SOLV. (EPPI)",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SUN PHARMACEUTICALS INDUSTRIES LTD",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/1/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "10/1/2012",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["atracurium"],
    "InteractionIndexLink": ["atracurium"],
    "N_ENREGISTREMENT": "001/ 02 D 047 /05/13",
    "CODE_DCI": "02 D 047",
    "DCI": "ATRACURIUM BESYLATE",
    "NOM_COMMERCIALE": "ATACURE",
    "FORME": "SOL. INJ. IV",
    "DOSAGE": "10MG/ML (50MG/5ML)",
    "COND": "B/05AMP DE 5ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMACEUTICALS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/10/2005",
    "DATE_D_ENREGISTREMENT_FINAL": "2/5/2013",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["rocuronium"],
    "InteractionIndexLink": ["rocuronium"],
    "N_ENREGISTREMENT": "001/02 D 049/17",
    "CODE_DCI": "02 D 049",
    "DCI": "ROCURONIUM BROMURE",
    "NOM_COMMERCIALE": "RONIUM",
    "FORME": "SOL.INJ.",
    "DOSAGE": "50MG/5ML ( 10 MG/ML)",
    "COND": "B/10",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMACEUTICALS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/9/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "10/9/2017",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["acide acetylsalicylique"],
    "InteractionIndexLink": ["acide acetylsalicylique"],
    "N_ENREGISTREMENT": "20/97/03 A001/003",
    "CODE_DCI": "03 A 001",
    "DCI": "ACIDE ACETYLSALICYLIQUE",
    "NOM_COMMERCIALE": "ACEPRAL",
    "FORME": "COMP.",
    "DOSAGE": "500MG",
    "COND": "B/20",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES EPE GROUPE INDUSTRIEL SAIDAL/ SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/08/20",
    "DATE_D_ENREGISTREMENT_FINAL": "13/08/20",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["acide acetylsalicylique"],
    "InteractionIndexLink": ["acide acetylsalicylique"],
    "N_ENREGISTREMENT": "039/ 03 A 004 /06/14",
    "CODE_DCI": "03 A 004",
    "DCI": "ACETYLSALICYLATE DE DL LYSINE EXPRIME EN ACIDE ACETYLSALICYLIQUE",
    "NOM_COMMERCIALE": "ASPIGAL",
    "FORME": "PDRE.ET SOLV. P. SOL. INJ. IM/IV",
    "DOSAGE": "500MG/FL. DE PDRE.",
    "COND": "B/01FL. DE PDRE +01AMP. DE 5ML DE SOLV. (EPPI) ET B/50FL. DE PDRE",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "B/50 RESERVEE AUX HOP.",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOCIETE PHARMACEUTIQUE ALGERIENNE (SOPHAL)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/04/06",
    "DATE_D_ENREGISTREMENT_FINAL": "19/04/06",
    "TYPE": "Gé",
    "STATUT": "C IIaire",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["acide acetylsalicylique"],
    "InteractionIndexLink": ["acide acetylsalicylique"],
    "N_ENREGISTREMENT": "039/ 03 A 004 /06/14",
    "CODE_DCI": "03 A 004",
    "DCI": "ACETYLSALICYLATE DE DL LYSINE EXPRIME EN ACIDE ACETYLSALICYLIQUE",
    "NOM_COMMERCIALE": "ASPIGAL 900",
    "FORME": "PDRE.ET SOLV. P. SOL. INJ. IM/IV",
    "DOSAGE": "500MG/FL. DE PDRE.",
    "COND": "B/01FL. DE PDRE +01AMP. DE 5ML DE SOLV. (EPPI) ET B/50FL. DE PDRE",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "B/50 RESERVEE AUX HOP.",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOCIETE PHARMACEUTIQUE ALGERIENNE (SOPHAL)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/4/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "19/4/2006",
    "TYPE": "Gé",
    "STATUT": "C IIaire",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["acide acetylsalicylique"],
    "InteractionIndexLink": ["acide acetylsalicylique"],
    "N_ENREGISTREMENT": "376/ 03 A 024 /03/16",
    "CODE_DCI": "03 A 024",
    "DCI": "ACETYLSALICYLATE DE DL LYSINE EXPRIME EN ACIDE ACETYLSALICYLIQUE",
    "NOM_COMMERCIALE": "ASPEGIC ENFANT",
    "FORME": "PDRE. SOL. BUV. EN SACH.-DOSE",
    "DOSAGE": "250MG/SACH.-DOSE",
    "COND": "B/20 SACHETS",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANOFI-AVENTIS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/7/2003",
    "DATE_D_ENREGISTREMENT_FINAL": "6/3/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["acide acetylsalicylique"],
    "InteractionIndexLink": ["acide acetylsalicylique"],
    "N_ENREGISTREMENT": "376/ 03 A 025 /97/16",
    "CODE_DCI": "03 A 025",
    "DCI": "ACETYLSALICYLATE DE DL LYSINE EXPRIME EN ACIDE ACETYLSALICYLIQUE",
    "NOM_COMMERCIALE": "ASPEGIC 500",
    "FORME": "PDRE. SOL. BUV. EN SACH.-DOSE",
    "DOSAGE": "500MG/SACH.-DOSE",
    "COND": "B/20 SACHETS",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANOFI AVENTIS OTC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "8/11/1997",
    "DATE_D_ENREGISTREMENT_FINAL": "31/1/2018",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["acide acetylsalicylique"],
    "InteractionIndexLink": ["acide acetylsalicylique", "acide ascorbique"],
    "N_ENREGISTREMENT": "201/ 03 A 033 /00/14",
    "CODE_DCI": "03 A 033",
    "DCI": "ACIDE ACETYLSALICYLIQUE/ ACIDE ASCORBIQUE",
    "NOM_COMMERCIALE": "ASPIRINE UPSA VITAMINE C TAMPONNEE EFFERVESCENTE",
    "FORME": "COMP. EFFERV",
    "DOSAGE": "330MG/200MG",
    "COND": "B/20",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PROPHARMAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/7/2000",
    "DATE_D_ENREGISTREMENT_FINAL": "21/1/2014",
    "TYPE": "Ré",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["acide acetylsalicylique"],
    "InteractionIndexLink": ["acide acetylsalicylique"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "03 A 069",
    "DCI": "ACETYLSALICYLATE DE DL LYSINE EXPRIME EN ACIDE ACETYLSALICYLIQUE",
    "NOM_COMMERCIALE": "ASPEGIC ADULTE",
    "FORME": "PDRE. SOL. BUV. EN SACH.-DOSE",
    "DOSAGE": "1G/SACH.-DOSE",
    "COND": "B/20 SACHETS",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["acide acetylsalicylique"],
    "InteractionIndexLink": ["acide acetylsalicylique", "cafeine"],
    "N_ENREGISTREMENT": "395/03 A 102/08/16",
    "CODE_DCI": "03 A 102",
    "DCI": "ACIDE ACETYLSALICYLIQUE / CAFEINE",
    "NOM_COMMERCIALE": "ASPRO ACCEL",
    "FORME": "COMP. PELLI. SEC.",
    "DOSAGE": "500MG/50MG",
    "COND": "B/20",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BAYER SANTE FAMILLIALE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "23/3/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "23/3/2008",
    "TYPE": "11/09/1216",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["acide acetylsalicylique"],
    "InteractionIndexLink": ["acide acetylsalicylique"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "03 A 104",
    "DCI": "ACETYLSALICYLATE DE DL LYSINE EXPRIME EN ACIDE ACETYLSALICYLIQUE",
    "NOM_COMMERCIALE": "ASPEGIC NOURRISSON",
    "FORME": "PDRE. SOL. BUV. SACHET",
    "DOSAGE": "100MG/SACH.-DOSE",
    "COND": "B/20 SACHETS",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "318/ 03 B 005 /16",
    "CODE_DCI": "03 B 005",
    "DCI": "PARACETAMOL",
    "NOM_COMMERCIALE": "DOLI-BIEN",
    "FORME": "COMPRIME",
    "DOSAGE": "500MG",
    "COND": "B/16",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL PHARMIDAL N.S",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/7/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "26/7/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "03 B 005",
    "DCI": "PARACETAMOL",
    "NOM_COMMERCIALE": "DOLICRANE",
    "FORME": "COMPRIME",
    "DOSAGE": "500MG",
    "COND": "B/20",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "392/03 B 005/98/20",
    "CODE_DCI": "03 B 005",
    "DCI": "PARACETAMOL",
    "NOM_COMMERCIALE": "DOLIPRANE",
    "FORME": "COMPRIME",
    "DOSAGE": "500MG",
    "COND": "B/16",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES SANOFIS AVENTIS ALGERIE SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/4/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "9/12/2020",
    "TYPE": "Ré",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "268/ 03 B 005 /06/21",
    "CODE_DCI": "03 B 005",
    "DCI": "Paracétamol",
    "NOM_COMMERCIALE": "DOLYC",
    "FORME": "Comprimé",
    "DOSAGE": "500MG",
    "COND": "B/20",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MERINAL / SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/4/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "14/4/2021",
    "TYPE": "Gé",
    "STATUT": "F prémix",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "16/06/03 B055/268",
    "CODE_DCI": "03 B 005",
    "DCI": "PARACÉTAMOL",
    "NOM_COMMERCIALE": "DOLYC",
    "FORME": "COMP",
    "DOSAGE": "500MG",
    "COND": "B/20",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES MERINAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/4/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "5/10/2020",
    "TYPE": "Gé",
    "STATUT": "F Prémix",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "21/06/03 B 005/268",
    "CODE_DCI": "03 B 005",
    "DCI": "PARACETAMOL",
    "NOM_COMMERCIALE": "DOLYC",
    "FORME": "COMPRIME",
    "DOSAGE": "500MG",
    "COND": "B/20",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES MERINAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "05/10/06",
    "DATE_D_ENREGISTREMENT_FINAL": "14/04/21",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "201/ 03 B 005 /96/17",
    "CODE_DCI": "03 B 005",
    "DCI": "PARACETAMOL",
    "NOM_COMMERCIALE": "EFFERALGAN",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "500MG",
    "COND": "B/16",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PROPHARMAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/10/1996",
    "DATE_D_ENREGISTREMENT_FINAL": "4/9/2017",
    "TYPE": "Ré",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "235/ 03 B 005 /00/13",
    "CODE_DCI": "03 B 005",
    "DCI": "PARACETAMOL",
    "NOM_COMMERCIALE": "EXPANDOL",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "500MG",
    "COND": "B/20",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIO-GALENIC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "5/8/2000",
    "DATE_D_ENREGISTREMENT_FINAL": "7/7/2013",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "079/ 03 B 005 /97/13",
    "CODE_DCI": "03 B 005",
    "DCI": "PARACETAMOL",
    "NOM_COMMERCIALE": "MIGRAMOL",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "500MG",
    "COND": "B/20",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE ALGERIEN DE DEVELOPPEMENT PHARMACEUTIQUE (LAD PHARMA) SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/12/1997",
    "DATE_D_ENREGISTREMENT_FINAL": "29/12/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "039/ 03 B 005 /98/18",
    "CODE_DCI": "03 B 005",
    "DCI": "PARACETAMOL",
    "NOM_COMMERCIALE": "PARACETAL",
    "FORME": "COMPRIME",
    "DOSAGE": "500MG",
    "COND": "B/16",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOCIETE PHARMACEUTIQUE ALGERIENNE (SOPHAL)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/2/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "24/1/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "039/ 03 B 005 /98/17",
    "CODE_DCI": "03 B 005",
    "DCI": "PARACETAMOL",
    "NOM_COMMERCIALE": "PARACETAL",
    "FORME": "COMPRIME",
    "DOSAGE": "500MG",
    "COND": "B/16",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOCIETE PHARMACEUTIQUE ALGERIENNE (SOPHAL)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "02/02/98",
    "DATE_D_ENREGISTREMENT_FINAL": "24/01/18",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "462/ 03 B 005 /15",
    "CODE_DCI": "03 B 005",
    "DCI": "PARACETAMOL",
    "NOM_COMMERCIALE": "PARACETAMOL PHYSIOPHARM",
    "FORME": "COMPRIME",
    "DOSAGE": "500MG",
    "COND": "B/20",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHYSIOPHARM SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/2/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "10/2/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "003/ 03 B 005 /96/19",
    "CODE_DCI": "03 B 005",
    "DCI": "PARACETAMOL",
    "NOM_COMMERCIALE": "PARALGAN",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "500MG",
    "COND": "B/20",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EPE  GROUPE INDUSTRIEL SAIDAL/SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/5/1996",
    "DATE_D_ENREGISTREMENT_FINAL": "15/12/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "03 B 005",
    "DCI": "PARACETAMOL",
    "NOM_COMMERCIALE": "PAROL",
    "FORME": "COMPRIME",
    "DOSAGE": "500MG",
    "COND": "B/20",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "03 B 005",
    "DCI": "Paracétamol",
    "NOM_COMMERCIALE": "Sapramol",
    "FORME": "Sachet",
    "DOSAGE": "500 mg",
    "COND": "Boite de 12.",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "03 B 005",
    "DCI": "PARACETAMOL",
    "NOM_COMMERCIALE": "TYLENOL",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "500MG",
    "COND": "B/20 ET B/100",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "235/ 03 B 006 /11/18",
    "CODE_DCI": "03 B 006",
    "DCI": "PARACETAMOL",
    "NOM_COMMERCIALE": "EXPANDOL",
    "FORME": "PDRE. P. SOL. BUV. EN SACH.-DOSE",
    "DOSAGE": "100MG",
    "COND": "B/12",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIO-GALENIC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/10/2011",
    "DATE_D_ENREGISTREMENT_FINAL": "1/8/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "03 B 006",
    "DCI": "PARACETAMOL",
    "NOM_COMMERCIALE": "ISOMOL",
    "FORME": "SOL.  BUV.",
    "DOSAGE": "100MG/5ML",
    "COND": "F/100ML",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "10/03 B 006/293",
    "CODE_DCI": "03 B 006",
    "DCI": "PARACETAMOL",
    "NOM_COMMERCIALE": "PARACETAMOL BIOCARE",
    "FORME": "GRANULE POUR SOLUTION BUVABLE EN SACHETS-DOSE",
    "DOSAGE": "100MG/SACHET-DOSE",
    "COND": "B/12",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE SARL BIOCARE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/11/10",
    "DATE_D_ENREGISTREMENT_FINAL": "24/11/10",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "462/ 03 B 006 /15",
    "CODE_DCI": "03 B 006",
    "DCI": "PARACETAMOL",
    "NOM_COMMERCIALE": "PARACETAMOL PHYSIOPHARM",
    "FORME": "PDRE. P. SOL. BUV. EN SACH.-DOSE",
    "DOSAGE": "100MG",
    "COND": "B/12",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL PHYSIOPHARM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "8/11/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "8/11/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "003/ 03 B 006 /21",
    "CODE_DCI": "03 B 006",
    "DCI": "Paracétamol",
    "NOM_COMMERCIALE": "PARALGAN",
    "FORME": "Poudre  P/Sol  buvable en Sachet Dose",
    "DOSAGE": "100MG",
    "COND": "B/12",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EPE GROUPE INDUSTRIEL SAIDAL / SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/4/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "4/4/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "003/ 03 B 006 /21",
    "CODE_DCI": "03 B 006",
    "DCI": "Paracétamol",
    "NOM_COMMERCIALE": "PARALGAN",
    "FORME": "Poudre P/Sol buvable en Sachet Dose",
    "DOSAGE": "100MG",
    "COND": "B/12",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EPE GROUPE INDUSTRIEL SAIDAL / SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "04/04/21",
    "DATE_D_ENREGISTREMENT_FINAL": "04/04/21",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "03 B 006",
    "DCI": "Paracétamol",
    "NOM_COMMERCIALE": "Sapramol",
    "FORME": "Sachet",
    "DOSAGE": "100 mg",
    "COND": "Boite de 12.",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "03 B 007",
    "DCI": "PARACETAMOL",
    "NOM_COMMERCIALE": "CETALGINE",
    "FORME": "SUPPO.",
    "DOSAGE": "100MG",
    "COND": "B/10",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "03 B 007",
    "DCI": "PARACETAMOL",
    "NOM_COMMERCIALE": "DOLIPRANE",
    "FORME": "SUPPO SEC",
    "DOSAGE": "100MG",
    "COND": "B/10",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "03 B 007",
    "DCI": "PARACETAMOL",
    "NOM_COMMERCIALE": "DOLPRIV",
    "FORME": "SUPPO.",
    "DOSAGE": "100MG",
    "COND": "B/10",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "400/ 03 B 007 / 16",
    "CODE_DCI": "03 B 007",
    "DCI": "PARACETAMOL",
    "NOM_COMMERCIALE": "DOLYMEX",
    "FORME": "SUPPO.",
    "DOSAGE": "100MG",
    "COND": "B/10",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "KPMA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/7/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "26/7/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "263/ 03 B 007 /16",
    "CODE_DCI": "03 B 007",
    "DCI": "PARACETAMOL",
    "NOM_COMMERCIALE": "PAROL",
    "FORME": "SUPPO.",
    "DOSAGE": "100MG",
    "COND": "B/10",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOPHARM SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/2/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "2/2/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "366/ 03 B 007 /07/13",
    "CODE_DCI": "03 B 007",
    "DCI": "PARACETAMOL",
    "NOM_COMMERCIALE": "SUPPFADOL 100",
    "FORME": "SUPPO.",
    "DOSAGE": "100MG",
    "COND": "B/10",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "4A SANTE INDUSTRIE SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/5/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "12/4/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["codeine", "paracetamol"],
    "InteractionIndexLink": ["codeine", "paracetamol"],
    "N_ENREGISTREMENT": "20/03 B026/055",
    "CODE_DCI": "03 B 026",
    "DCI": "PARACÉTAMOL/ CODÉINE PHOSPHATE HÉMIHYDRATÉ",
    "NOM_COMMERCIALE": "CODOL",
    "FORME": "COMP",
    "DOSAGE": "400MG/ 20 MG",
    "COND": "B/20",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES GEOPHARM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/10/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "18/10/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["codeine", "paracetamol"],
    "InteractionIndexLink": ["codeine", "paracetamol"],
    "N_ENREGISTREMENT": "235/ 03 B 026 /16",
    "CODE_DCI": "03 B 026",
    "DCI": "Paracétamol / Codéine phosphate hémihydraté",
    "NOM_COMMERCIALE": "COEXPANDOL",
    "FORME": "COMPRIME",
    "DOSAGE": "400MG/20MG",
    "COND": "B/16",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOGALENIC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/4/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "25/4/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["codeine", "paracetamol"],
    "InteractionIndexLink": ["codeine", "paracetamol"],
    "N_ENREGISTREMENT": "003/ 03 B 026 /09/18",
    "CODE_DCI": "03 B 026",
    "DCI": "Paracétamol / Codéine phosphate hémihydraté",
    "NOM_COMMERCIALE": "COPARALGAN",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "400MG/20MG",
    "COND": "B/20",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EPE GROUPE INDUSTRIEL SAIDAL/SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/7/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "27/5/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["codeine", "paracetamol"],
    "InteractionIndexLink": ["codeine", "paracetamol"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "03 B 026",
    "DCI": "Paracétamol / Codéine phosphate hémihydraté",
    "NOM_COMMERCIALE": "COPARAMOL",
    "FORME": "COMPRIME",
    "DOSAGE": "400MG/20MG",
    "COND": "B/20",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["codeine", "paracetamol"],
    "InteractionIndexLink": ["codeine", "paracetamol"],
    "N_ENREGISTREMENT": "077/03 B 026/17",
    "CODE_DCI": "03 B 026",
    "DCI": "PARACETAMOL /PHOSPHATE DE CODEINE HEMIHYDRATE",
    "NOM_COMMERCIALE": "PARAC-CO",
    "FORME": "COMPRIME",
    "DOSAGE": "400MG/20MG",
    "COND": "B/20",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LAM SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/1/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "17/1/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["codeine", "paracetamol"],
    "InteractionIndexLink": ["codeine", "paracetamol"],
    "N_ENREGISTREMENT": "462/03 B 026/20",
    "CODE_DCI": "03 B 026",
    "DCI": "PARACETAMOL /CODEINE PHOSPHATE HEMIHYDRATE",
    "NOM_COMMERCIALE": "PARACETAMOL CODEINE PHYSIOPHARM",
    "FORME": "COMP",
    "DOSAGE": "400MG/20MG",
    "COND": "B/20",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHYSIOPHARM SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/5/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "4/5/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["codeine", "paracetamol"],
    "InteractionIndexLink": ["codeine", "paracetamol"],
    "N_ENREGISTREMENT": "348/03 B 027/17",
    "CODE_DCI": "03 B 027",
    "DCI": "PARACETAMOL/CODEINE PHOSPHATE HEMIHYDRATE",
    "NOM_COMMERCIALE": "CODOFEBRIL",
    "FORME": "CP EFFERVESCENT SECABLE",
    "DOSAGE": "500 MG/30 MG",
    "COND": "B/ 01 TUBE DE 16",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "API",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/3/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "20/3/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["codeine", "paracetamol"],
    "InteractionIndexLink": ["codeine", "paracetamol"],
    "N_ENREGISTREMENT": "268/03 B 028/16",
    "CODE_DCI": "03 B 028",
    "DCI": "PARACETAMOL/CODEINE PHOSPHATE HEMIHYDRATE",
    "NOM_COMMERCIALE": "CO-DOLYC",
    "FORME": "COMPRIME",
    "DOSAGE": "500MG/30MG",
    "COND": "B/20",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES MERINAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/11/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "2/11/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["codeine", "paracetamol"],
    "InteractionIndexLink": ["codeine", "paracetamol"],
    "N_ENREGISTREMENT": "231/03 B 028/16",
    "CODE_DCI": "03 B 028",
    "DCI": "PARACETAMOL/CODEINE PHOSPHATE HEMIHYDRATE",
    "NOM_COMMERCIALE": "COPARAMOL FORT",
    "FORME": "COMPRIME",
    "DOSAGE": "500MG/30MG",
    "COND": "B/20",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES SALEM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/10/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "19/10/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["codeine", "paracetamol"],
    "InteractionIndexLink": ["codeine", "paracetamol"],
    "N_ENREGISTREMENT": "017/ 03 B 028 /99/16",
    "CODE_DCI": "03 B 028",
    "DCI": "Paracétamol / Codéine phosphate hémihydraté",
    "NOM_COMMERCIALE": "DAFALGAN CODEINE",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "500MG/30MG",
    "COND": "B/16",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BRISTOL MYERS SQUIBB",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/6/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "11/5/2016",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["codeine", "paracetamol"],
    "InteractionIndexLink": ["codeine", "paracetamol"],
    "N_ENREGISTREMENT": "21/99/03 B 028/201",
    "CODE_DCI": "03 B 028",
    "DCI": "PARACETAMOL/ PHOSPHATE DE CODEINE HEMIHYDRATE",
    "NOM_COMMERCIALE": "EFFERALGAN CODEINE",
    "FORME": "COMP. PELL.",
    "DOSAGE": "500MG/ 30MG",
    "COND": "B/16",
    "LISTE": "",
    "P1": "HOPP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES PROPHARMAL SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "1105/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "23/05/21",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["codeine", "paracetamol"],
    "InteractionIndexLink": ["codeine", "paracetamol"],
    "N_ENREGISTREMENT": "468/ 03 B 028 /16",
    "CODE_DCI": "03 B 028",
    "DCI": "Paracétamol / Codéine phosphate hémihydraté",
    "NOM_COMMERCIALE": "PLANADIX CONFORT +",
    "FORME": "COMPRIME",
    "DOSAGE": "500MG/30MG",
    "COND": "B/16",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NADPHARMADIC PRODUCTION SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/7/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "4/7/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "03 B 041",
    "DCI": "PARACETAMOL",
    "NOM_COMMERCIALE": "CETALGINE",
    "FORME": "SUPPO.",
    "DOSAGE": "150MG",
    "COND": "B/10",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "03 B 041",
    "DCI": "PARACETAMOL",
    "NOM_COMMERCIALE": "DOLIPRANE",
    "FORME": "SUPPO",
    "DOSAGE": "150MG",
    "COND": "B/10",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "03 B 041",
    "DCI": "PARACETAMOL",
    "NOM_COMMERCIALE": "DOLPRIV",
    "FORME": "SUPPO.",
    "DOSAGE": "150MG",
    "COND": "B/10",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "263/ 03 B  041 /16",
    "CODE_DCI": "03 B 041",
    "DCI": "PARACETAMOL",
    "NOM_COMMERCIALE": "PAROL",
    "FORME": "SUPPO.",
    "DOSAGE": "150MG",
    "COND": "B/10",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOPHARM SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/2/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "2/2/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "366/ 03 B 041 /07/13",
    "CODE_DCI": "03 B 041",
    "DCI": "PARACETAMOL",
    "NOM_COMMERCIALE": "SUPPFADOL 150",
    "FORME": "SUPPO.",
    "DOSAGE": "150MG",
    "COND": "B/10",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "4A SANTE INDUSTRIE SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/5/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "15/4/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "03 B 042",
    "DCI": "PARACETAMOL",
    "NOM_COMMERCIALE": "CETALGINE",
    "FORME": "SUPP0",
    "DOSAGE": "200MG",
    "COND": "B/10",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "03 B 042",
    "DCI": "PARACETAMOL",
    "NOM_COMMERCIALE": "DOLIPRANE",
    "FORME": "SUPPO.",
    "DOSAGE": "200MG",
    "COND": "B/10",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "03 B 042",
    "DCI": "PARACETAMOL",
    "NOM_COMMERCIALE": "DOLPRIV",
    "FORME": "SUPPO.",
    "DOSAGE": "200MG",
    "COND": "B/10",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "400/ 03 B 042 /16",
    "CODE_DCI": "03 B 042",
    "DCI": "PARACETAMOL",
    "NOM_COMMERCIALE": "DOLYMEX",
    "FORME": "SUPPO",
    "DOSAGE": "200MG",
    "COND": "B/10",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "KPMA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/7/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "19/7/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "263/ 03 B 042 /16",
    "CODE_DCI": "03 B 042",
    "DCI": "PARACETAMOL",
    "NOM_COMMERCIALE": "PAROL",
    "FORME": "SUPPO.",
    "DOSAGE": "200MG",
    "COND": "B/10",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOPHARM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/1/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "17/1/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "366/ 03 B 042 /07/13",
    "CODE_DCI": "03 B 042",
    "DCI": "PARACETAMOL",
    "NOM_COMMERCIALE": "SUPPFADOL 200",
    "FORME": "SUPPO.",
    "DOSAGE": "200MG",
    "COND": "B/10",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "4A SANTE INDUSTRIE SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/5/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "15/4/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "03 B 043",
    "DCI": "PARACETAMOL",
    "NOM_COMMERCIALE": "CETALGINE",
    "FORME": "SUPP0.",
    "DOSAGE": "300MG",
    "COND": "B/10",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "03 B 043",
    "DCI": "PARACETAMOL",
    "NOM_COMMERCIALE": "DOLIPRANE",
    "FORME": "SUPPO",
    "DOSAGE": "300MG",
    "COND": "B/10",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "03 B 043",
    "DCI": "PARACETAMOL",
    "NOM_COMMERCIALE": "DOLPRIV",
    "FORME": "SUPPO.",
    "DOSAGE": "300MG",
    "COND": "B/10",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "400/ 03 B 043 /16",
    "CODE_DCI": "03 B 043",
    "DCI": "PARACETAMOL",
    "NOM_COMMERCIALE": "DOLYMEX",
    "FORME": "SUPPO",
    "DOSAGE": "300MG",
    "COND": "B/10",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "KPMA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/7/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "19/7/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "263/ 03 B 043 /16",
    "CODE_DCI": "03 B 043",
    "DCI": "PARACETAMOL",
    "NOM_COMMERCIALE": "PAROL",
    "FORME": "SUPP0.",
    "DOSAGE": "300MG",
    "COND": "B/10",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOPHARM SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/2/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "2/2/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "366/ 03 B 043 /07/13",
    "CODE_DCI": "03 B 043",
    "DCI": "PARACETAMOL",
    "NOM_COMMERCIALE": "SUPPFADOL 300",
    "FORME": "SUPPO.",
    "DOSAGE": "300MG",
    "COND": "B/10",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "4A SANTE INDUSTRIE SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/5/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "15/4/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "235/ 03 B 044 /11",
    "CODE_DCI": "03 B 044",
    "DCI": "PARACETAMOL",
    "NOM_COMMERCIALE": "EXPANDOL",
    "FORME": "PDRE. P. SOL. BUV. SACH.-DOSE",
    "DOSAGE": "150MG",
    "COND": "B/12",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIO-GALENIC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/8/2011",
    "DATE_D_ENREGISTREMENT_FINAL": "29/12/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "293/ 03 B 044 /15",
    "CODE_DCI": "03 B 044",
    "DCI": "PARACETAMOL",
    "NOM_COMMERCIALE": "PARACETAMOL BIOCARE",
    "FORME": "PDRE. SOL. BUV. EN SACH.",
    "DOSAGE": "150MG",
    "COND": "B/12",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOCARE SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/12/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "2/12/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "462/ 03 B 044 /15",
    "CODE_DCI": "03 B 044",
    "DCI": "PARACETAMOL",
    "NOM_COMMERCIALE": "PARACETAMOL PHYSIOPHARM",
    "FORME": "PDRE. P. SOL. BUV. SACH.-DOSE",
    "DOSAGE": "150MG",
    "COND": "B/12",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL PHYSIOPHARM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "3/11/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "3/11/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "03 B 044",
    "DCI": "Paracétamol",
    "NOM_COMMERCIALE": "Sapramol",
    "FORME": "Sachet",
    "DOSAGE": "150 mg",
    "COND": "Boite de 12.",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "03 B 045",
    "DCI": "PARACETAMOL",
    "NOM_COMMERCIALE": "EXPANDOL",
    "FORME": "PDRE. P. SOL. BUV. SACH.-DOSE",
    "DOSAGE": "200MG",
    "COND": "B/12",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "10/03 B 045/293",
    "CODE_DCI": "03 B 045",
    "DCI": "PARACETAMOL",
    "NOM_COMMERCIALE": "PARACETAMOL BIOCARE",
    "FORME": "GRANULE POUR SOLUTION BUVABLE EN SACHETS-DOSE",
    "DOSAGE": "200MG/SACHET-DOSE",
    "COND": "B/12",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE SARL BIOCARE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/11/10",
    "DATE_D_ENREGISTREMENT_FINAL": "24/11/10",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "462/ 03 B 045 /16",
    "CODE_DCI": "03 B 045",
    "DCI": "PARACETAMOL",
    "NOM_COMMERCIALE": "PARACETAMOL PHYSIOPHARM",
    "FORME": "PDRE. P. SOL. BUV. SACH.-DOSE",
    "DOSAGE": "200MG",
    "COND": "B/12",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHYSIOPHARM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/3/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "13/3/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "003/ 03 B 045 /21",
    "CODE_DCI": "03 B 045",
    "DCI": "Paracétamol",
    "NOM_COMMERCIALE": "PARALGAN",
    "FORME": "Poudre  P/Sol  buvable en Sachet Dose",
    "DOSAGE": "200MG",
    "COND": "B/12",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EPE GROUPE INDUSTRIEL SAIDAL / SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/4/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "4/4/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "003/ 03 B 045 /21",
    "CODE_DCI": "03 B 045",
    "DCI": "Paracétamol",
    "NOM_COMMERCIALE": "PARALGAN",
    "FORME": "Poudre P/Sol buvable en Sachet Dose",
    "DOSAGE": "200MG",
    "COND": "B/12",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EPE GROUPE INDUSTRIEL SAIDAL / SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "04/04/21",
    "DATE_D_ENREGISTREMENT_FINAL": "04/04/21",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "03 B 045",
    "DCI": "Paracétamol",
    "NOM_COMMERCIALE": "Sapramol",
    "FORME": "Sachet",
    "DOSAGE": "200 mg",
    "COND": "Boite de 12.",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "16/00/03 B046/392",
    "CODE_DCI": "03 B 046",
    "DCI": "PARACETAMOL",
    "NOM_COMMERCIALE": "DOLIPRANE",
    "FORME": "PDRE. P. SOL. BUV. SACH.-DOSE",
    "DOSAGE": "300MG",
    "COND": "B/12",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANOFI AVENTIS ALGERIE SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/7/2000",
    "DATE_D_ENREGISTREMENT_FINAL": "19/5/2020",
    "TYPE": "Ré",
    "STATUT": "F Prémix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "03 B 046",
    "DCI": "PARACETAMOL",
    "NOM_COMMERCIALE": "EXPANDOL",
    "FORME": "PDRE. P. SOL. BUV. SACH.-DOSE",
    "DOSAGE": "300MG",
    "COND": "B/12",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "10/03 B 046/293",
    "CODE_DCI": "03 B 046",
    "DCI": "PARACETAMOL",
    "NOM_COMMERCIALE": "PARACETAMOL BIOCARE",
    "FORME": "GRANULE POUR SOLUTION BUVABLE EN SACHETS-DOSE",
    "DOSAGE": "300MG/SACHET-DOSE",
    "COND": "B/12",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE SARL BIOCARE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/11/10",
    "DATE_D_ENREGISTREMENT_FINAL": "24/11/10",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "003/ 03 B 046 /21",
    "CODE_DCI": "03 B 046",
    "DCI": "Paracétamol",
    "NOM_COMMERCIALE": "PARALGAN",
    "FORME": "Poudre  P/Sol  buvable en Sachet Dose",
    "DOSAGE": "300MG",
    "COND": "B/12",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EPE GROUPE INDUSTRIEL SAIDAL / SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/4/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "7/4/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "003/ 03 B 046 /21",
    "CODE_DCI": "03 B 046",
    "DCI": "Paracétamol",
    "NOM_COMMERCIALE": "PARALGAN",
    "FORME": "Poudre P/Sol buvable en Sachet Dose",
    "DOSAGE": "300MG",
    "COND": "B/12",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EPE GROUPE INDUSTRIEL SAIDAL / SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "07/04/21",
    "DATE_D_ENREGISTREMENT_FINAL": "07/04/21",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "03 B 046",
    "DCI": "PARACÉTAMOL",
    "NOM_COMMERCIALE": "PARALGAN®",
    "FORME": "Poudre pour solution buvable en sachets",
    "DOSAGE": "300 mg",
    "COND": "Boite de 12",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "03 B 046",
    "DCI": "Paracétamol",
    "NOM_COMMERCIALE": "Sapramol",
    "FORME": "Sachet",
    "DOSAGE": "300 mg",
    "COND": "Boite de 12.",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol", "pseudoephedrine"],
    "InteractionIndexLink": ["paracetamol", "pseudoephedrine"],
    "N_ENREGISTREMENT": "231/03 B 057/17",
    "CODE_DCI": "03 B 057",
    "DCI": "PARACETAMOL /  PSEUDOEPHEDRINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "PARAMOL RHUME",
    "FORME": "COMPRIME",
    "DOSAGE": "500MG/30MG",
    "COND": "B/20",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SALEM LABORATOIRES",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/7/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "2/7/2017",
    "TYPE": "Gé",
    "STATUT": "FPREMIX",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["paracetamol", "pseudoephedrine"],
    "InteractionIndexLink": ["paracetamol", "pseudoephedrine"],
    "N_ENREGISTREMENT": "468/ 03 B 057 /16",
    "CODE_DCI": "03 B 057",
    "DCI": "PARACETAMOL/PSEUDOEPHEDRINE (SOUS FORME DE CHLORHYDRATE)",
    "NOM_COMMERCIALE": "PLANADIX RHUME",
    "FORME": "COMPRIME",
    "DOSAGE": "500MG/30MG",
    "COND": "B/16",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NADPHARMADIC PRODUCTION SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/6/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "13/6/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "503/03 B 061/16",
    "CODE_DCI": "03 B 061",
    "DCI": "PARACETAMOL",
    "NOM_COMMERCIALE": "ACETADOL",
    "FORME": "SOL. BUV.",
    "DOSAGE": "3 %",
    "COND": "B/1 FL DE 100ML+PIPETTE GRADUEE",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "AFRO PHARM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/11/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "15/11/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "318/ 03 B 061 /19",
    "CODE_DCI": "03 B 061",
    "DCI": "PARACETAMOL",
    "NOM_COMMERCIALE": "DOLI-BIEN",
    "FORME": "SOL. BUV.",
    "DOSAGE": "3 %",
    "COND": "FL/100ML +PIPETTE GRADUéE EN KG",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMIDAL N/S SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/5/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "13/5/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "03 B 061",
    "DCI": "PARACETAMOL",
    "NOM_COMMERCIALE": "DOLI-BIEN",
    "FORME": "SOL. BUV.",
    "DOSAGE": "0.03",
    "COND": "FL/100ML +PIPETTE GRADUéE EN KG",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "035/ 03 B 061 /08/16",
    "CODE_DCI": "03 B 061",
    "DCI": "PARACETAMOL",
    "NOM_COMMERCIALE": "DOLPRIV",
    "FORME": "SOL. BUV.",
    "DOSAGE": "3 %",
    "COND": "FL/100ML +PIPETTE GRADUéE EN KG",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMALLIANCE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "23/12/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "10/1/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "03 B 061",
    "DCI": "PARACETAMOL",
    "NOM_COMMERCIALE": "DOLPRIV",
    "FORME": "SOL. BUV.",
    "DOSAGE": "0.03",
    "COND": "FL/100ML +PIPETTE GRADUéE EN KG",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "201/ 03 B 061 /96/17",
    "CODE_DCI": "03 B 061",
    "DCI": "PARACETAMOL",
    "NOM_COMMERCIALE": "EFFERALGAN PEDIATRIQUE",
    "FORME": "SOL. BUV.",
    "DOSAGE": "3 %",
    "COND": "FL/90MLou FL/150 ML+ GOBLET DOSEUR  GRADUE EN KG",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PROPHARMAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/8/1996",
    "DATE_D_ENREGISTREMENT_FINAL": "8/10/2017",
    "TYPE": "Ré",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "03 B 061",
    "DCI": "PARACETAMOL",
    "NOM_COMMERCIALE": "EFFERALGAN PEDIATRIQUE",
    "FORME": "SOL. BUV.",
    "DOSAGE": "0.03",
    "COND": "FL/90MLou FL/150 ML+ GOBLET DOSEUR  GRADUE EN KG",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "077/ 03 B 061 /03/14",
    "CODE_DCI": "03 B 061",
    "DCI": "PARACETAMOL",
    "NOM_COMMERCIALE": "PEDIAMOL",
    "FORME": "SOL.BUV.",
    "DOSAGE": "3 %",
    "COND": "FL./125ML+ SERINGUE GRADUEE EN KG-ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE ALGERIEN DU MEDICAMENT (LAM) SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/10/2003",
    "DATE_D_ENREGISTREMENT_FINAL": "4/5/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "03 B 061",
    "DCI": "PARACETAMOL",
    "NOM_COMMERCIALE": "PEDIAMOL",
    "FORME": "SOL.BUV.",
    "DOSAGE": "0.03",
    "COND": "FL./125ML+ SERINGUE GRADUEE EN KG-ML",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "235 / 03 B 066 /16",
    "CODE_DCI": "03 B 066",
    "DCI": "PARACETAMOL",
    "NOM_COMMERCIALE": "EXPANDOL",
    "FORME": "POUDRE POUR SOLUT BUVABLE EN SACHET",
    "DOSAGE": "500MG",
    "COND": "B/12",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOGALENIC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/2/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "15/2/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "10/03 B 066/293",
    "CODE_DCI": "03 B 066",
    "DCI": "PARACETAMOL",
    "NOM_COMMERCIALE": "PARACETAMOL BIOCARE",
    "FORME": "GRANULE POUR SOLUTION BUVABLE EN SACHETS-DOSE",
    "DOSAGE": "500MG/SACHET-DOSE",
    "COND": "B/12",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE SARL BIOCARE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/11/10",
    "DATE_D_ENREGISTREMENT_FINAL": "24/11/10",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "462 / 03 B 066 /16",
    "CODE_DCI": "03 B 066",
    "DCI": "PARACETAMOL",
    "NOM_COMMERCIALE": "PARACETAMOL PHYSIOPHARM",
    "FORME": "POUDRE POUR SOLUT BUVABLE EN SACHET",
    "DOSAGE": "500MG",
    "COND": "B/12",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL PHYSIOPHARM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/6/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "26/6/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "039/03 B 067/16",
    "CODE_DCI": "03 B 067",
    "DCI": "PARACETAMOL",
    "NOM_COMMERCIALE": "PARACETAL",
    "FORME": "SOL. INJ. P. PERF. IV.",
    "DOSAGE": "10MG/ML (1000MG/100ML)",
    "COND": "B/12 FL. DE 100ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOPHAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/7/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "10/7/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "039/03 B 067/16",
    "CODE_DCI": "03 B 067",
    "DCI": "PARACETAMOL",
    "NOM_COMMERCIALE": "PARACETAL",
    "FORME": "SOL. INJ. P. PERF. IV.",
    "DOSAGE": "10MG/ML (1000MG/100ML)",
    "COND": "B/12 FL. DE 100ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOPHAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/07/16",
    "DATE_D_ENREGISTREMENT_FINAL": "10/07/16",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "088/ 03 B 067 /15",
    "CODE_DCI": "03 B 067",
    "DCI": "PARACETAMOL",
    "NOM_COMMERCIALE": "PARACETAMOL PHARMAGHREB",
    "FORME": "SOL. INJ. P. PERF. IV.",
    "DOSAGE": "10MG/ML (500MG/50ML) (1000MG/100ML)",
    "COND": "B/12 FL. DE 50ML ; B/12 FL. DE 100ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMAGHREB",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/7/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "30/7/2015",
    "TYPE": "Gé",
    "STATUT": "C IIaire",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "323/ 03 B 067 /16",
    "CODE_DCI": "03 B 067",
    "DCI": "PARACETAMOL",
    "NOM_COMMERCIALE": "PERMIDOL",
    "FORME": "SOLUTION POUR PERFUSION IV 10MG/ML",
    "DOSAGE": "10MG/ML",
    "COND": "B/01 FLACON DE 100ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CONTINENTAL PHARM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/2/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "29/2/2016",
    "TYPE": "Gé",
    "STATUT": "c",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "433/ 03 B 067 /10/18",
    "CODE_DCI": "03 B 067",
    "DCI": "PARACETAMOL",
    "NOM_COMMERCIALE": "SAPRAMOL",
    "FORME": "SOL. INJ. P. PERF. IV",
    "DOSAGE": "10MG/ML (500MG/50ML) (1000MG/100ML)",
    "COND": "FL./50ML (CAISSE DE 12 FL.) - FL./100ML (CAISSE DE 12 FL.)",
    "LISTE": "",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRATER RAZES SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/10/2010",
    "DATE_D_ENREGISTREMENT_FINAL": "27/10/2010",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "201/ 03 B 080 /19",
    "CODE_DCI": "03 B 080",
    "DCI": "PARACETAMOL",
    "NOM_COMMERCIALE": "EFFERALGAN",
    "FORME": "COMP. EFFERV.",
    "DOSAGE": "1G",
    "COND": "B/08",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PROPHARMAL SOUS LICENCE  DE UPSA SAS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/5/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "7/5/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "318/ 03 B 081 /16",
    "CODE_DCI": "03 B 081",
    "DCI": "PARACETAMOL",
    "NOM_COMMERCIALE": "DOLI-BIEN",
    "FORME": "COMPRIME",
    "DOSAGE": "1G",
    "COND": "B/08",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL PHARMIDAL N.S",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/8/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "1/8/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "03 B 081",
    "DCI": "PARACETAMOL",
    "NOM_COMMERCIALE": "DOLICRANE",
    "FORME": "COMPRIME",
    "DOSAGE": "1G",
    "COND": "BOITE DE 10",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "03 B 081",
    "DCI": "PARACETAMOL",
    "NOM_COMMERCIALE": "DOLIPRANE",
    "FORME": "COMPRIME",
    "DOSAGE": "1G",
    "COND": "B/08",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "268/ 03 B 081 /12",
    "CODE_DCI": "03 B 081",
    "DCI": "PARACETAMOL",
    "NOM_COMMERCIALE": "DOLYC",
    "FORME": "COMPRIME",
    "DOSAGE": "1G",
    "COND": "B/10",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MERINAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/1/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "18/1/2012",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "268/03 B 081/12/20",
    "CODE_DCI": "03 B 081",
    "DCI": "PARACETAMOL",
    "NOM_COMMERCIALE": "DOLYC",
    "FORME": "COMPRIME",
    "DOSAGE": "1000MG",
    "COND": "B/10",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES MERINAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/1/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "9/12/2020",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "20/12/03 B 081/268",
    "CODE_DCI": "03 B 081",
    "DCI": "PARACETAMOL",
    "NOM_COMMERCIALE": "DOLYC",
    "FORME": "COMPRIME",
    "DOSAGE": "1000MG",
    "COND": "B/10",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES MERINAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/01/12",
    "DATE_D_ENREGISTREMENT_FINAL": "09/12/20",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "235/ 03 B 081 /08/18",
    "CODE_DCI": "03 B 081",
    "DCI": "PARACETAMOL",
    "NOM_COMMERCIALE": "EXPANDOL",
    "FORME": "COMPRIME",
    "DOSAGE": "1G",
    "COND": "B/10",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIO-GALENIC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/3/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "22/4/2018",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "079/ 03 B 081 /14",
    "CODE_DCI": "03 B 081",
    "DCI": "PARACETAMOL",
    "NOM_COMMERCIALE": "MIGRAMOL",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "1G",
    "COND": "B/10",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE ALGERIEN DE DEVELOPPEMENT PHARMACEUTIQUE (LAD PHARMA) SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/11/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "13/11/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "309/ 03 B 081 /12/17",
    "CODE_DCI": "03 B 081",
    "DCI": "PARACETAMOL",
    "NOM_COMMERCIALE": "PANADOL 1G",
    "FORME": "COMP. PELLI. SEC.",
    "DOSAGE": "1G",
    "COND": "B/08",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES  DE DIAGNOSTIC MAGHREBINS (LDM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/7/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "10/10/2017",
    "TYPE": "Ré",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "19/13/03 B 081/003",
    "CODE_DCI": "03 B 081",
    "DCI": "PARACETAMOL",
    "NOM_COMMERCIALE": "PARALGAN",
    "FORME": "COMP. SEC.",
    "DOSAGE": "1000MG",
    "COND": "B/10",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EPE GROUPE INDUSTRIEL SAIDAL/SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "09/11/13",
    "DATE_D_ENREGISTREMENT_FINAL": "28/01/19",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "462/ 03 B 081 /14",
    "CODE_DCI": "03 B 081",
    "DCI": "PARACETAMOL",
    "NOM_COMMERCIALE": "PARACETAMOL PHYSIOPHARM",
    "FORME": "COMPRIME",
    "DOSAGE": "1G",
    "COND": "B/08",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHYSIOPHARM SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/6/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "22/6/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "003/ 03 B 081 /13",
    "CODE_DCI": "03 B 081",
    "DCI": "PARACETAMOL",
    "NOM_COMMERCIALE": "PARALGAN",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "1G",
    "COND": "B/10",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SAIDAL GROUPE INDUSTRIEL EPE/SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/4/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "2/4/2013",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "03 B 081",
    "DCI": "PARACETAMOL",
    "NOM_COMMERCIALE": "PARALGAN",
    "FORME": "CPR. SEC",
    "DOSAGE": "1000 MG",
    "COND": "BT/10",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "231/ 03 B 081 /06/15",
    "CODE_DCI": "03 B 081",
    "DCI": "PARACETAMOL",
    "NOM_COMMERCIALE": "PARAMOL",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "1G",
    "COND": "B/10 ET B/25",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SALEM LABORATOIRES",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "31/7/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "18/1/2015",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["cafeine", "paracetamol"],
    "N_ENREGISTREMENT": "447/03 B 088/17",
    "CODE_DCI": "03 B 088",
    "DCI": "PARACETAMOL/CAFEINE ANHYDRE",
    "NOM_COMMERCIALE": "APAP CAFEINE BEKER",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "500MG / 65MG",
    "COND": "B/20",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL LABORATOIRE BEKER",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/3/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "29/3/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["cafeine", "paracetamol"],
    "N_ENREGISTREMENT": "235/ 03 B 088 /14",
    "CODE_DCI": "03 B 088",
    "DCI": "PARACETAMOL / CAFEINE",
    "NOM_COMMERCIALE": "EXPANDOL PLUS",
    "FORME": "COMPRIME",
    "DOSAGE": "500MG/65MG",
    "COND": "B/16",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIO-GALENIC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/10/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "27/10/2014",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["cafeine", "paracetamol"],
    "N_ENREGISTREMENT": "293/03 B 088/17",
    "CODE_DCI": "03 B 088",
    "DCI": "PARACETAMOL / CAFEINE",
    "NOM_COMMERCIALE": "EXTRADOL",
    "FORME": "COMPRIME",
    "DOSAGE": "500MG/65MG",
    "COND": "B/16 ET B/20",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOCARE SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/4/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "12/4/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["cafeine", "paracetamol"],
    "N_ENREGISTREMENT": "418/ 03 B 088 /13",
    "CODE_DCI": "03 B 088",
    "DCI": "PARACETAMOL / CAFEINE",
    "NOM_COMMERCIALE": "PACET EXTRA",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "500MG/65MG",
    "COND": "B/16",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NEOMEDIC SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/9/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "30/9/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["cafeine", "paracetamol"],
    "N_ENREGISTREMENT": "309/ 03 B 088 /07/17",
    "CODE_DCI": "03 B 088",
    "DCI": "PARACETAMOL / CAFEINE",
    "NOM_COMMERCIALE": "PANADOL EXTRA",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "500MG/65MG",
    "COND": "B/16",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES  DE DIAGNOSTICS MAGHREBINS (LDM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/6/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "25/9/2017",
    "TYPE": "Ré",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["cafeine", "paracetamol"],
    "N_ENREGISTREMENT": "468/ 03 B 088 /12",
    "CODE_DCI": "03 B 088",
    "DCI": "PARACETAMOL / CAFEINE",
    "NOM_COMMERCIALE": "PLANADIX EXTRA",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "500MG/65MG",
    "COND": "B/16",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NADPHARMADIC PRODUCTION",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/1/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "2/4/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "366/ 03 B 096 /07/13",
    "CODE_DCI": "03 B 096",
    "DCI": "PARACETAMOL",
    "NOM_COMMERCIALE": "SUPPFADOL 170",
    "FORME": "SUPPO.",
    "DOSAGE": "170MG",
    "COND": "B/10",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "4A SANTE INDUSTRIE SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/11/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "21/7/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "03 B 100",
    "DCI": "PARACETAMOL",
    "NOM_COMMERCIALE": "SUPPFADOL",
    "FORME": "SUPPO.",
    "DOSAGE": "80MG",
    "COND": "B/10",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["cafeine", "paracetamol"],
    "N_ENREGISTREMENT": "231/ 03 B 114 /14",
    "CODE_DCI": "03 B 114",
    "DCI": "PARACETAMOL/ CAFEINE ANHYDRE",
    "NOM_COMMERCIALE": "PARAMOL EXTRA",
    "FORME": "COMPRIME",
    "DOSAGE": "500MG/50MG",
    "COND": "B/20",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SALEM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "16/2/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "16/2/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "392/ 03 B 117 /13",
    "CODE_DCI": "03 B 117",
    "DCI": "PARACETAMOL",
    "NOM_COMMERCIALE": "DOLIPRANE 2.4%",
    "FORME": "SUSP. BUV. SANS SUCRE EDULCOREE A LA SACCHARINE SODIQUE ET AU SORBITOL AROME FRAISE",
    "DOSAGE": "120MG/5ML",
    "COND": "B/01FL. DE 125ML + UNE CUILLERE MESURE GRADUEE A 5ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANOFI AVENTIS ALGERIE S.P.A",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/7/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "2/7/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "392/ 03 B 117 /13",
    "CODE_DCI": "03 B 117",
    "DCI": "PARACETAMOL",
    "NOM_COMMERCIALE": "DOLYMEX",
    "FORME": "SUSP. BUV. SANS SUCRE EDULCOREE A LA SACCHARINE SODIQUE ET AU SORBITOL AROME FRAISE",
    "DOSAGE": "120MG/5ML",
    "COND": "B/01FL. DE 125ML + UNE CUILLERE MESURE GRADUEE A 5ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANOFI AVENTIS ALGERIE S.P.A",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "02/07/13",
    "DATE_D_ENREGISTREMENT_FINAL": "02/07/13",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "03 B 117",
    "DCI": "PARACETAMOL",
    "NOM_COMMERCIALE": "DOLYMEX SIROP",
    "FORME": "SIROP",
    "DOSAGE": "0.024",
    "COND": "FLACON DE 125 ML",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "079/ 03 B 117 /13",
    "CODE_DCI": "03 B 117",
    "DCI": "PARACETAMOL",
    "NOM_COMMERCIALE": "MIGRAMOL PEDIATRIQUE",
    "FORME": "SIROP",
    "DOSAGE": "120MG/5ML (2.4G/100ML)",
    "COND": "B/01FL. DE 125ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE  ALGERIEN DE DEVELOPPEMENT  PHARMACEUTIQUE SARL (LAD PHARMA)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/3/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "26/3/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "003/ 03 B 117 /99/13",
    "CODE_DCI": "03 B 117",
    "DCI": "PARACETAMOL",
    "NOM_COMMERCIALE": "PARALGAN",
    "FORME": "SOL.BUV.",
    "DOSAGE": "120MG/5ML",
    "COND": "B/01FL. DE 125ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SAIDAL SAIDALGROUPE INDUSTRIEL EPE/SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/1/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "3/11/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["acide ascorbique", "paracetamol"],
    "N_ENREGISTREMENT": "201/ 03 B 118 /14",
    "CODE_DCI": "03 B 118",
    "DCI": "PARACETAMOL / ACIDE ASCORBIQUE",
    "NOM_COMMERCIALE": "EFFERALGAN VITAMINE C",
    "FORME": "COMP EFFERV",
    "DOSAGE": "500MG/200MG",
    "COND": "B/16",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PROPHARMAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/6/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "15/6/2014",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["morphine"],
    "InteractionIndexLink": ["morphine"],
    "N_ENREGISTREMENT": "017/ 03 B 119 /14",
    "CODE_DCI": "03 B 119",
    "DCI": "Morphine sulfate",
    "NOM_COMMERCIALE": "SKENAN LP",
    "FORME": "MICROGRANULES LP EN GLES",
    "DOSAGE": "10MG",
    "COND": "B/14",
    "LISTE": "Stupéfiants",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BRISTOL-MYERS SQUIBB (BMS)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/6/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "22/6/2014",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["morphine"],
    "InteractionIndexLink": ["morphine"],
    "N_ENREGISTREMENT": "517 / 03 B 120 /14",
    "CODE_DCI": "03 B 120",
    "DCI": "Morphine sulfate",
    "NOM_COMMERCIALE": "SKENAN LP",
    "FORME": "MICROGRANULES LP EN GLES",
    "DOSAGE": "30MG",
    "COND": "B/14",
    "LISTE": "Stupéfiants",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ETHYPHARM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/12/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "25/12/2018",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["morphine"],
    "InteractionIndexLink": ["morphine"],
    "N_ENREGISTREMENT": "517/ 03 B 121 /14",
    "CODE_DCI": "03 B 121",
    "DCI": "Morphine sulfate",
    "NOM_COMMERCIALE": "SKENAN LP",
    "FORME": "MICROGRANULES LP EN GLES",
    "DOSAGE": "60MG",
    "COND": "B/14",
    "LISTE": "Stupéfiants",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ETHYPHARM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/6/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "22/6/2014",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["morphine"],
    "InteractionIndexLink": ["morphine"],
    "N_ENREGISTREMENT": "517/ 03 B 122 /14",
    "CODE_DCI": "03 B 122",
    "DCI": "Morphine sulfate",
    "NOM_COMMERCIALE": "SKENAN LP",
    "FORME": "MICROGRANULES LP EN GLES",
    "DOSAGE": "100MG",
    "COND": "B/14",
    "LISTE": "Stupéfiants",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ETHYPHARM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/6/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "22/6/2014",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "15/03 B 123/293",
    "CODE_DCI": "03 B 123",
    "DCI": "PARACETAMOL",
    "NOM_COMMERCIALE": "PARACETAMOL BIOCARE",
    "FORME": "GRANULE POUR SOLUTION BUVABLE EN SACHETS-DOSE",
    "DOSAGE": "1000MG/SACHET-DOSE",
    "COND": "B/08",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE SARL BIOCARE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "02/12/15",
    "DATE_D_ENREGISTREMENT_FINAL": "02/12/15",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "462/ 03 B 123 /16",
    "CODE_DCI": "03 B 123",
    "DCI": "PARACETAMOL",
    "NOM_COMMERCIALE": "PARACETAMOL PHYSIOPHARM",
    "FORME": "POUDRE POUR SOLUT BUVABLE EN SACHET",
    "DOSAGE": "1000MG",
    "COND": "B/12 SACHETS",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL PHYSIOPHARM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/6/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "26/6/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "468/03 B 125/17",
    "CODE_DCI": "03 B 125",
    "DCI": "PARACETAMOL",
    "NOM_COMMERCIALE": "PLANADIX LIQUIZ",
    "FORME": "SUS BUV EN STICK UNIDOSE",
    "DOSAGE": "200MG/STICK",
    "COND": "B/15 STICK DE 5ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NADPHARMADIC PRODUCTION SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/11/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "26/11/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "468/03 B 126/17",
    "CODE_DCI": "03 B 126",
    "DCI": "PARACETAMOL",
    "NOM_COMMERCIALE": "PLANADIX LIQUIZ",
    "FORME": "SUS BUV EN STICK UNIDOSE",
    "DOSAGE": "300MG/STICK",
    "COND": "B/15 STICK DE 7.5 ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NADPHARMADIC PRODUCTION SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/11/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "26/11/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["buprenorphine"],
    "InteractionIndexLink": ["buprenorphine"],
    "N_ENREGISTREMENT": "003/ 03 F 013 /09/14",
    "CODE_DCI": "03 F 013",
    "DCI": "CHLORHYDRATE  de BUPRENORPHINE EXPRIME EN BUPRENORPHINE",
    "NOM_COMMERCIALE": "BUPRINAL",
    "FORME": "SOL. INJ. IM/IV/SC/VOIE MEDULLAIRE",
    "DOSAGE": "0.3MG/ML",
    "COND": "B/05 AMP. DE 2ML CONTENANT 1ML DE SOLUTION ET B/50 AMP DE 2 ML CONTENANT 1 ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EPE  GROUPE INDUSTRIEL SAIDAL SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/1/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "21/9/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["buprenorphine"],
    "InteractionIndexLink": ["buprenorphine"],
    "N_ENREGISTREMENT": "304/03 F 013/21",
    "CODE_DCI": "03 F 013",
    "DCI": "Chlorhydrate de Buprénorphine exprimé en Buprénorphine base",
    "NOM_COMMERCIALE": "TEMGEPHINE",
    "FORME": "Solution injectable",
    "DOSAGE": "0.3MG/ML",
    "COND": "B/05 AMP. DE 1ML ET B/50 AMP. DE 1ML",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "B/50 RESERVEE AUX HÔPITAUX",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GEOPHARM / SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/2/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "7/2/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["buprenorphine"],
    "InteractionIndexLink": ["buprenorphine"],
    "N_ENREGISTREMENT": "433/03 F 013/20",
    "CODE_DCI": "03 F 013",
    "DCI": "Chlorhydrate de Buprénorphine exprimé en Buprénorphine base",
    "NOM_COMMERCIALE": "TEMGINAL",
    "FORME": "SOL INJ IM/IV ou S/C ou Voie Médullaire",
    "DOSAGE": "0.3MG/ML",
    "COND": "B/05 AMP. DE 1ML ET B/50 AMP. DE 1ML",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "B/50 RESERVEE AUX HÔPITAUX",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRATER RAZES SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/4/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "12/4/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["tramadol"],
    "InteractionIndexLink": ["tramadol"],
    "N_ENREGISTREMENT": "268/ 03 F 047 /12",
    "CODE_DCI": "03 F 047",
    "DCI": "TRAMADOL CHLORHYDRATE EXPRIME EN TRAMADOL",
    "NOM_COMMERCIALE": "DOLEX",
    "FORME": "GLES.",
    "DOSAGE": "50MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MERINAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/1/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "18/1/2012",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "48 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["tramadol"],
    "InteractionIndexLink": ["tramadol"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "03 F 047",
    "DCI": "TRAMADOL CHLORHYDRATE EXPRIME EN TRAMADOL",
    "NOM_COMMERCIALE": "DOLTRAM",
    "FORME": "GLES.",
    "DOSAGE": "50MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["tramadol"],
    "InteractionIndexLink": ["tramadol"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "03 F 047",
    "DCI": "TRAMADOL CHLORHYDRATE EXPRIME EN TRAMADOL",
    "NOM_COMMERCIALE": "DUOFEM",
    "FORME": "GLES.",
    "DOSAGE": "50MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["tramadol"],
    "InteractionIndexLink": ["tramadol"],
    "N_ENREGISTREMENT": "289/ 03 F 047 /07/19",
    "CODE_DCI": "03 F 047",
    "DCI": "TRAMADOL CHLORHYDRATE EXPRIME EN TRAMADOL",
    "NOM_COMMERCIALE": "SUPRAMADOL",
    "FORME": "GLES.",
    "DOSAGE": "50MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRATER  RAZES FORME SECHE SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/9/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "25/6/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["tramadol"],
    "InteractionIndexLink": ["tramadol"],
    "N_ENREGISTREMENT": "317/ 03 F 047 /12/17",
    "CODE_DCI": "03 F 047",
    "DCI": "TRAMADOL CHLORHYDRATE EXPRIME EN TRAMADOL",
    "NOM_COMMERCIALE": "TRAMADIS",
    "FORME": "GLES.",
    "DOSAGE": "50MG",
    "COND": "B/10",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INPHA-MEDIS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/2/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "31/12/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "60 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["tramadol"],
    "InteractionIndexLink": ["tramadol"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "03 F 047",
    "DCI": "Tramadol",
    "NOM_COMMERCIALE": "TRAMADIS Gélule",
    "FORME": "Gélule",
    "DOSAGE": "50mg/gélule",
    "COND": "bt de 10",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["tramadol"],
    "InteractionIndexLink": ["tramadol"],
    "N_ENREGISTREMENT": "447/03 F 047/17",
    "CODE_DCI": "03 F 047",
    "DCI": "TRAMADOL CHLORHYDRATE EXPRIME EN TRAMADOL",
    "NOM_COMMERCIALE": "TRAMADOL BEKER",
    "FORME": "GLES.",
    "DOSAGE": "50MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEKER SARL (SARL LABORATOIRE BEKER ALGERIE)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/5/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "28/5/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["tramadol"],
    "InteractionIndexLink": ["tramadol"],
    "N_ENREGISTREMENT": "231/ 03 F 047 /08/17",
    "CODE_DCI": "03 F 047",
    "DCI": "TRAMADOL CHLORHYDRATE EXPRIME EN TRAMADOL",
    "NOM_COMMERCIALE": "TRAMADOL LS",
    "FORME": "GLES.",
    "DOSAGE": "50MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SALEM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "14/7/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "5/11/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["tramadol"],
    "InteractionIndexLink": ["tramadol"],
    "N_ENREGISTREMENT": "149/ 03 F 047 /14",
    "CODE_DCI": "03 F 047",
    "DCI": "TRAMADOL CHLORHYDRATE EXPRIME EN TRAMADOL",
    "NOM_COMMERCIALE": "TRAMADOL NOVAGENERICS",
    "FORME": "GELULE",
    "DOSAGE": "50MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVAPHARM TRADING",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/3/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "19/3/2014",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["tramadol"],
    "InteractionIndexLink": ["tramadol"],
    "N_ENREGISTREMENT": "418/ 03 F 047 /13",
    "CODE_DCI": "03 F 047",
    "DCI": "TRAMADOL CHLORHYDRATE EXPRIME EN TRAMADOL",
    "NOM_COMMERCIALE": "TRAMAL",
    "FORME": "GLES.",
    "DOSAGE": "50MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NEOMEDIC SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "11/6/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "11/6/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["tramadol"],
    "InteractionIndexLink": ["tramadol"],
    "N_ENREGISTREMENT": "100/ 03 F 047 /15",
    "CODE_DCI": "03 F 047",
    "DCI": "TRAMADOL CHLORHYDRATE EXPRIME EN TRAMADOL",
    "NOM_COMMERCIALE": "TRAMEX",
    "FORME": "GLES.",
    "DOSAGE": "50MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "KHROUB PHAARMAVEUTICAL MANUFACTURING ALGERIA (KPMA) SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/12/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "2/12/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["tramadol"],
    "InteractionIndexLink": ["tramadol"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "03 F 047",
    "DCI": "TRAMADOL CHLORHYDRATE EXPRIME EN TRAMADOL",
    "NOM_COMMERCIALE": "ZODID",
    "FORME": "GLES.",
    "DOSAGE": "50MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["tramadol"],
    "InteractionIndexLink": ["tramadol"],
    "N_ENREGISTREMENT": "366/ 03 F 049 /16",
    "CODE_DCI": "03 F 049",
    "DCI": "CHLORHYDRATE DE TRAMADOL",
    "NOM_COMMERCIALE": "TRAMADINE",
    "FORME": "SUPPO",
    "DOSAGE": "100MG",
    "COND": "B/10",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL 4 A SANTE INDUSTRIE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "11/4/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "11/4/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["tramadol"],
    "InteractionIndexLink": ["tramadol"],
    "N_ENREGISTREMENT": "231/ 03 F 049 /05",
    "CODE_DCI": "03 F 049",
    "DCI": "TRAMADOL CHLORHYDRATE EXPRIME EN TRAMADOL",
    "NOM_COMMERCIALE": "TRAMADOL LS",
    "FORME": "SUPPO.",
    "DOSAGE": "100MG",
    "COND": "B/10",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SALEM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/3/2005",
    "DATE_D_ENREGISTREMENT_FINAL": "6/3/2005",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["adenosine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "541/ 03 F 082 /06 /18",
    "CODE_DCI": "03 F 082",
    "DCI": "Adénosine triphosphate",
    "NOM_COMMERCIALE": "ATEPADENE",
    "FORME": "GLES.",
    "DOSAGE": "30MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE XO",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "31/7/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "2/4/2018",
    "TYPE": "Ré",
    "STATUT": "C( LGPA)",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["adenosine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "149/ 03 F 082 /17",
    "CODE_DCI": "03 F 082",
    "DCI": "Adénosine triphosphate disodique trihydraté exprimé en adénosine triphosphate disodique",
    "NOM_COMMERCIALE": "ATP NOVAGENERICS",
    "FORME": "GLES.",
    "DOSAGE": "30MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVAPHARM TRADING SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/12/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "25/12/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24  MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["tramadol"],
    "InteractionIndexLink": ["tramadol"],
    "N_ENREGISTREMENT": "447/03 F 107/17",
    "CODE_DCI": "03 F 107",
    "DCI": "TRAMADOL CHLORHYDRATE EXPRIME EN TRAMADOL",
    "NOM_COMMERCIALE": "TRAMADOL  BEKER LP",
    "FORME": "CP PELL LP",
    "DOSAGE": "100MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEKER SARL (SARL LABORATOIRE BEKER ALGERIE)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/6/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "12/6/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["tramadol"],
    "InteractionIndexLink": ["tramadol"],
    "N_ENREGISTREMENT": "433/ 03 F 111 /16",
    "CODE_DCI": "03 F 111",
    "DCI": "TRAMADOL CHLORHYDRATE EXPRIME EN TRAMADOL",
    "NOM_COMMERCIALE": "SUPRAMADOL",
    "FORME": "SOL. INJ.IM/IV .",
    "DOSAGE": "50MG/ML",
    "COND": "B/05 ET B/50 AMPOULE DE 02ML (100MG/2ML)",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "B/50 AMPOULES RESERVES AUX HOPITAUX",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SPA LABORATOIRES FRATER-RAZES",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/7/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "26/7/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["tramadol"],
    "InteractionIndexLink": ["tramadol"],
    "N_ENREGISTREMENT": "317/ 03 F 111 /12",
    "CODE_DCI": "03 F 111",
    "DCI": "TRAMADOL CHLORHYDRATE EXPRIME EN TRAMADOL",
    "NOM_COMMERCIALE": "TRAMADIS",
    "FORME": "SOL. INJ. IV / PERF. IV",
    "DOSAGE": "50MG/ML (100MG/2ML)",
    "COND": "B/05 AMP. DE 2ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INPHA-MEDIS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/4/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "19/4/2012",
    "TYPE": "Gé",
    "STATUT": "C IIaire",
    "DUREE_DE_STABILITE": "48 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["paracetamol", "tramadol"],
    "InteractionIndexLink": ["paracetamol", "tramadol"],
    "N_ENREGISTREMENT": "21/03/ F115/447",
    "CODE_DCI": "03 F 115",
    "DCI": "PARACETAMOL/ TRAMADOL HYDROCHLORYDE",
    "NOM_COMMERCIALE": "APAP TRAMADOL BEKER",
    "FORME": "COMP PELL",
    "DOSAGE": "325MG/ 37.5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL LABORATOIRE BEKER",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/04/21",
    "DATE_D_ENREGISTREMENT_FINAL": "26/04/21",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol", "tramadol"],
    "InteractionIndexLink": ["paracetamol", "tramadol"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "03 F 115",
    "DCI": "Paracétamol/tramadol",
    "NOM_COMMERCIALE": "APAPP TRAMADOL",
    "FORME": "comprimé pelliculé 325/37.5mg",
    "DOSAGE": "325/37.5MG",
    "COND": "B/20",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol", "tramadol"],
    "InteractionIndexLink": ["paracetamol", "tramadol"],
    "N_ENREGISTREMENT": "418/ 03 F 115 /15",
    "CODE_DCI": "03 F 115",
    "DCI": "Paracétamol/ Tramadol chlorhydrate",
    "NOM_COMMERCIALE": "CETADOL",
    "FORME": "GLES.",
    "DOSAGE": "325MG / 37.5MG",
    "COND": "B/20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NEOMEDIC SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "3/3/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "3/3/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol", "tramadol"],
    "InteractionIndexLink": ["paracetamol", "tramadol"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "03 F 115",
    "DCI": "Paracétamol/ Tramadol chlorhydrate",
    "NOM_COMMERCIALE": "DI-DOLEX",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "325MG / 37.5MG",
    "COND": "B/20",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol", "tramadol"],
    "InteractionIndexLink": ["paracetamol", "tramadol"],
    "N_ENREGISTREMENT": "035/ 03 F 115 /14",
    "CODE_DCI": "03 F 115",
    "DCI": "Paracétamol/ Tramadol chlorhydrate",
    "NOM_COMMERCIALE": "DOLMATOL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "325MG / 37.5MG",
    "COND": "B/10 ET B/20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMALLIANCE EURL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/7/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "6/7/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol", "tramadol"],
    "InteractionIndexLink": ["paracetamol", "tramadol"],
    "N_ENREGISTREMENT": "479/ 03 F 115 /13",
    "CODE_DCI": "03 F 115",
    "DCI": "Paracétamol/ Tramadol chlorhydrate",
    "NOM_COMMERCIALE": "DOLOKIL",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "325MG / 37.5MG",
    "COND": "B/20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BAC PHARMA SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/4/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "15/4/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol", "tramadol"],
    "InteractionIndexLink": ["paracetamol", "tramadol"],
    "N_ENREGISTREMENT": "003/03 F 115/20",
    "CODE_DCI": "03 F 115",
    "DCI": "PARACETAMOL/ TRAMADOL CHLORHYDRATE",
    "NOM_COMMERCIALE": "DOLTRAM PLUS",
    "FORME": "COMP. PELL.",
    "DOSAGE": "325MG/ 37.5MG",
    "COND": "B/20",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EPE GROUPE INDUSTRIEL SAIDAL/SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/12/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "27/12/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol", "tramadol"],
    "InteractionIndexLink": ["paracetamol", "tramadol"],
    "N_ENREGISTREMENT": "003/03 F 115/20",
    "CODE_DCI": "03 F 115",
    "DCI": "PARACETAMOL/ TRAMADOL CHLORHYDRATE",
    "NOM_COMMERCIALE": "DOLTRAM PLUS",
    "FORME": "COMP. PELL.",
    "DOSAGE": "325MG/ 37.5MG",
    "COND": "B/20",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EPE GROUPE INDUSTRIEL SAIDAL/SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/12/20",
    "DATE_D_ENREGISTREMENT_FINAL": "27/12/20",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol", "tramadol"],
    "InteractionIndexLink": ["paracetamol", "tramadol"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "03 F 115",
    "DCI": "PARACETAMOL/TRAMADOL",
    "NOM_COMMERCIALE": "DOLTRAM®PLUS",
    "FORME": "Comprimé pelliculé",
    "DOSAGE": "37.5 mg/325 mg",
    "COND": "Etui de 20 comprimés",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol", "tramadol"],
    "InteractionIndexLink": ["paracetamol", "tramadol"],
    "N_ENREGISTREMENT": "470/ 03 F 115 /13",
    "CODE_DCI": "03 F 115",
    "DCI": "Paracétamol/ Tramadol chlorhydrate",
    "NOM_COMMERCIALE": "EXTRAMADOL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "325MG / 37.5MG",
    "COND": "B/20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MM LABORATOIRES SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/3/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "20/3/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol", "tramadol"],
    "InteractionIndexLink": ["paracetamol", "tramadol"],
    "N_ENREGISTREMENT": "231/ 03 F 115 /16",
    "CODE_DCI": "03 F 115",
    "DCI": "Paracétamol/ Tramadol chlorhydrate",
    "NOM_COMMERCIALE": "PARAMOL PLUS",
    "FORME": "GELULE",
    "DOSAGE": "325MG / 37.5MG",
    "COND": "B/20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SALEM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/1/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "10/1/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol", "tramadol"],
    "InteractionIndexLink": ["paracetamol", "tramadol"],
    "N_ENREGISTREMENT": "468/ 03 F 115 /14",
    "CODE_DCI": "03 F 115",
    "DCI": "Paracétamol/ Tramadol chlorhydrate",
    "NOM_COMMERCIALE": "PLANADIX ADVANCE",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "325MG / 37.5MG",
    "COND": "B/20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NADPHARMADIC PRODUCTION",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/7/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "13/7/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol", "tramadol"],
    "InteractionIndexLink": ["paracetamol", "tramadol"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "03 F 115",
    "DCI": "Paracétamol/ Tramadol chlorhydrate",
    "NOM_COMMERCIALE": "PRADOL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "325MG / 37.5MG",
    "COND": "B/20",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol", "tramadol"],
    "InteractionIndexLink": ["paracetamol", "tramadol"],
    "N_ENREGISTREMENT": "235/ 03 F 115 /16",
    "CODE_DCI": "03 F 115",
    "DCI": "Paracétamol/ Tramadol chlorhydrate",
    "NOM_COMMERCIALE": "PRADOLE",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "325MG / 37.5MG",
    "COND": "B/20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOGALENIC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/9/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "27/9/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol", "tramadol"],
    "InteractionIndexLink": ["paracetamol", "tramadol"],
    "N_ENREGISTREMENT": "289/03 F 115/16",
    "CODE_DCI": "03 F 115",
    "DCI": "Paracétamol/ Tramadol chlorhydrate",
    "NOM_COMMERCIALE": "SUPRADOLEX",
    "FORME": "GLES.",
    "DOSAGE": "325MG / 37.5MG",
    "COND": "B/20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRATER RAZES RORME SECHE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/12/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "19/12/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol", "tramadol"],
    "InteractionIndexLink": ["paracetamol", "tramadol"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "03 F 115",
    "DCI": "Paracétamol/ Tramadol chlorhydrate",
    "NOM_COMMERCIALE": "TRAPAL",
    "FORME": "GLES.",
    "DOSAGE": "325MG / 37.5MG",
    "COND": "B/20",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol", "tramadol"],
    "InteractionIndexLink": ["paracetamol", "tramadol"],
    "N_ENREGISTREMENT": "318/03 F 115/17",
    "CODE_DCI": "03 F 115",
    "DCI": "Paracétamol/ Tramadol chlorhydrate",
    "NOM_COMMERCIALE": "XALDOL",
    "FORME": "GELULE",
    "DOSAGE": "325MG / 37.5MG",
    "COND": "B/20 ET B/10",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMIDAL N.S. SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/9/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "7/9/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["paracetamol", "tramadol"],
    "InteractionIndexLink": ["paracetamol", "tramadol"],
    "N_ENREGISTREMENT": "263/ 03 F 115 /10/16",
    "CODE_DCI": "03 F 115",
    "DCI": "Paracétamol/ Tramadol chlorhydrate",
    "NOM_COMMERCIALE": "XAMADOL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "325MG / 37.5MG",
    "COND": "B/20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOPHARM SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/12/2010",
    "DATE_D_ENREGISTREMENT_FINAL": "27/9/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Antalgiques"]
  },
  {
    "PregnancyIndexLink": ["tramadol"],
    "InteractionIndexLink": ["tramadol"],
    "N_ENREGISTREMENT": "352/ 03 F 131 /18",
    "CODE_DCI": "03 F 131",
    "DCI": "Tramadol hydrochloride",
    "NOM_COMMERCIALE": "TRAMCETA LP",
    "FORME": "COMP. PELLI. LP",
    "DOSAGE": "300 MG",
    "COND": "B/20",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SPA  EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "16/12/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "16/12/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["oxycodone"],
    "InteractionIndexLink": ["oxycodone"],
    "N_ENREGISTREMENT": "537/ 03 G 127 /17",
    "CODE_DCI": "03 G 127",
    "DCI": "Oxycodone chlorhydrate",
    "NOM_COMMERCIALE": "OXYNORM",
    "FORME": "GLES",
    "DOSAGE": "5MG",
    "COND": "B/56",
    "LISTE": "STUPéFIANT",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NAPP PHARMACEUTICALS LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ROYAUME UNI",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/12/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "18/12/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "48 mois",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["oxycodone"],
    "InteractionIndexLink": ["oxycodone"],
    "N_ENREGISTREMENT": "537/ 03 G 128 /17",
    "CODE_DCI": "03 G 128",
    "DCI": "Oxycodone chlorhydrate",
    "NOM_COMMERCIALE": "OXYNORM",
    "FORME": "GLES",
    "DOSAGE": "10MG",
    "COND": "B/56",
    "LISTE": "STUPéFIANT",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NAPP PHARMACEUTICALS LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ROYAUME UNI",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/12/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "18/12/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "48 mois",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["oxycodone"],
    "InteractionIndexLink": ["oxycodone"],
    "N_ENREGISTREMENT": "537/ 03 G 129 /17",
    "CODE_DCI": "03 G 129",
    "DCI": "Oxycodone chlorhydrate",
    "NOM_COMMERCIALE": "OXYNORM",
    "FORME": "GLES",
    "DOSAGE": "20MG",
    "COND": "B/56",
    "LISTE": "STUPéFIANT",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NAPP PHARMACEUTICALS LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ROYAUME UNI",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/12/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "18/12/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "48 mois",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["oxycodone"],
    "InteractionIndexLink": ["oxycodone"],
    "N_ENREGISTREMENT": "537/ 03 G 130 /17",
    "CODE_DCI": "03 G 130",
    "DCI": "Oxycodone chlorhydrate",
    "NOM_COMMERCIALE": "OXYNORM",
    "FORME": "SOL POUR  INJ OU  PERFUSION   ( IV/SC)",
    "DOSAGE": "10 MG /ML 20MG/2ML",
    "COND": "B/ 05 AMPOULES DE 1 ML ET  B/ 05 AMPOULES DE 2 ML",
    "LISTE": "STUPéFIANT",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NAPP PHARMACEUTICALS LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ROYAUME UNI",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/12/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "18/12/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "60 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["ketoprofen"],
    "InteractionIndexLink": ["dexketoprofene trometamol"],
    "N_ENREGISTREMENT": "203/03 H 124 /15",
    "CODE_DCI": "03 H 124",
    "DCI": "DEXKETOPROFENE (TROMETAMOL)",
    "NOM_COMMERCIALE": "ENANTUM",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "25 MG",
    "COND": "B/20",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MENARINI",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ESPAGNE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/12/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "13/12/2015",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["clarithromycin"],
    "InteractionIndexLink": ["clarithromycine"],
    "N_ENREGISTREMENT": "035/13 E 215/19",
    "CODE_DCI": "035/13 E 215/19",
    "DCI": "CLARITHROMYCINE",
    "NOM_COMMERCIALE": "RITOCINE",
    "FORME": "COMP PELL",
    "DOSAGE": "500MG",
    "COND": "B/10",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMALLIANCE EURL",
    "DATE_D_ENREGISTREMENT_INITIAL": "ALGERIE",
    "DATE_D_ENREGISTREMENT_FINAL": "11/12/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["diclofenac"],
    "InteractionIndexLink": ["diclofenac"],
    "N_ENREGISTREMENT": "003/ 04 B 004 /05/13",
    "CODE_DCI": "04 B 004",
    "DCI": "Diclofénac sodique",
    "NOM_COMMERCIALE": "CLOFENAL",
    "FORME": "SOL.INJ.IM",
    "DOSAGE": "25MG/ML (75MG/3ML)",
    "COND": "B/02AMP. DE 3ML ET B/50AMP. DE 3ML",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "B/50AMP. RESERVEE AUX HÔPITAUX",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SAIDAL GROUPE SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "23/10/2005",
    "DATE_D_ENREGISTREMENT_FINAL": "2/5/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["diclofenac"],
    "InteractionIndexLink": ["diclofenac"],
    "N_ENREGISTREMENT": "433/ 04 B 004 /12/18",
    "CODE_DCI": "04 B 004",
    "DCI": "Diclofénac sodique",
    "NOM_COMMERCIALE": "DICLAMID",
    "FORME": "SOL. INJ. IM",
    "DOSAGE": "25MG/ML (75MG/3ML)",
    "COND": "B/02AMP. DE 3ML ET B/50AMP. DE 3ML",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "B/50AMP. RESERVEE AUX HÔPITAUX",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRATER-RAZES SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/8/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "10/9/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["diclofenac"],
    "InteractionIndexLink": ["diclofenac"],
    "N_ENREGISTREMENT": "304/ 04 B 004 /21",
    "CODE_DCI": "04 B 004",
    "DCI": "Diclofénac sodique",
    "NOM_COMMERCIALE": "GEOFENAC",
    "FORME": "Solution injectable",
    "DOSAGE": "25MG/ML (75MG/3ML)",
    "COND": "B/02 AMP. DE 3ML  ET B/50 AMP. DE 3ML",
    "LISTE": "LISTE II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "B/50 RESERVEE AUX HÔPITAUX",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GEOPHARM / SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/2/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "15/2/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["diclofenac"],
    "InteractionIndexLink": ["diclofenac"],
    "N_ENREGISTREMENT": "380/ 04 B 004 /14",
    "CODE_DCI": "04 B 004",
    "DCI": "Diclofénac sodique",
    "NOM_COMMERCIALE": "VOLTAFENE",
    "FORME": "SOL INJ IM",
    "DOSAGE": "25MG/ML (75MG/3ML)",
    "COND": "B/02 AMP. DE 3ML",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HUP.P.PHARMA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/4/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "28/4/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["diclofenac"],
    "InteractionIndexLink": ["diclofenac"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "04 B 005",
    "DCI": "Diclofénac sodique",
    "NOM_COMMERCIALE": "VOLTUM",
    "FORME": "COMP.GASTRORESIST.",
    "DOSAGE": "25MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["diclofenac"],
    "InteractionIndexLink": ["diclofenac"],
    "N_ENREGISTREMENT": "263/ 04 B 006 /03/15",
    "CODE_DCI": "04 B 006",
    "DCI": "Diclofénac sodique",
    "NOM_COMMERCIALE": "BIOFENAC",
    "FORME": "COMP. PELLI. GASTRORESIST.",
    "DOSAGE": "50MG",
    "COND": "B/30",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOPHARM SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "23/3/2003",
    "DATE_D_ENREGISTREMENT_FINAL": "3/3/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["diclofenac"],
    "InteractionIndexLink": ["diclofenac"],
    "N_ENREGISTREMENT": "20/07/04 B006/003",
    "CODE_DCI": "04 B 006",
    "DCI": "DICLOFÉNAC SODIQUE",
    "NOM_COMMERCIALE": "CLOFENAL",
    "FORME": "GLES. A MICROGRANULES GASTRORESIST.",
    "DOSAGE": "50MG",
    "COND": "B/30",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES SAIDAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/5/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "29/9/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["diclofenac"],
    "InteractionIndexLink": ["diclofenac"],
    "N_ENREGISTREMENT": "039/04 B 006/98/17",
    "CODE_DCI": "04 B 006",
    "DCI": "Diclofénac sodique",
    "NOM_COMMERCIALE": "DICLOFAL",
    "FORME": "CP PELLICULE GASTRO RESISTANT",
    "DOSAGE": "50MG",
    "COND": "B/30",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOCIETE PHARMACEUTIQUE ALGERIENNE (SOPHAL)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/3/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "29/1/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["diclofenac"],
    "InteractionIndexLink": ["diclofenac"],
    "N_ENREGISTREMENT": "18/98/04 B006/039",
    "CODE_DCI": "04 B 006",
    "DCI": "Diclofénac sodique",
    "NOM_COMMERCIALE": "DICLOFAL",
    "FORME": "CP PELLICULE GASTRO RESISTANT",
    "DOSAGE": "50MG",
    "COND": "B/30",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOCIETE PHARMACEUTIQUE ALGERIENNE (SOPHAL)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/03/98",
    "DATE_D_ENREGISTREMENT_FINAL": "29/01/17",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["diclofenac"],
    "InteractionIndexLink": ["diclofenac"],
    "N_ENREGISTREMENT": "055/ 04 B 006 /98/18",
    "CODE_DCI": "04 B 006",
    "DCI": "Diclofénac sodique",
    "NOM_COMMERCIALE": "DICLOGESIC",
    "FORME": "COMP. PELLI. GASTRORESIST.",
    "DOSAGE": "50MG",
    "COND": "B/30",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOHDER",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/4/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "2/4/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["diclofenac"],
    "InteractionIndexLink": ["diclofenac"],
    "N_ENREGISTREMENT": "361/ 04 B 006 /19",
    "CODE_DCI": "04 B 006",
    "DCI": "Diclofénac sodique",
    "NOM_COMMERCIALE": "DICLOGESIC",
    "FORME": "COMP. PELLI. GASTRORESIST.LP",
    "DOSAGE": "50MG",
    "COND": "B/20",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "DAR AL DAWA DEVELOPMENT & INVESTMENT Co Ltd",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/8/1988",
    "DATE_D_ENREGISTREMENT_FINAL": "2/8/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["diclofenac"],
    "InteractionIndexLink": ["diclofenac"],
    "N_ENREGISTREMENT": "11/05/04 B 006/293",
    "CODE_DCI": "04 B 006",
    "DCI": "DICLOFENAC SODIQUE",
    "NOM_COMMERCIALE": "FLOVENAC",
    "FORME": "MICROGRANULES en GLES GASTRORESISTANTS",
    "DOSAGE": "50MG",
    "COND": "B/20",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE SARL BIOCARE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "08/01/05",
    "DATE_D_ENREGISTREMENT_FINAL": "01/01/10",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["diclofenac"],
    "InteractionIndexLink": ["diclofenac"],
    "N_ENREGISTREMENT": "304/ 04 B 006 /04/17",
    "CODE_DCI": "04 B 006",
    "DCI": "Diclofénac sodique",
    "NOM_COMMERCIALE": "GEOFENAC",
    "FORME": "CP. PELL. GASTRORESIST.",
    "DOSAGE": "50MG",
    "COND": "B/20",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL GEOPHARM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/10/2004",
    "DATE_D_ENREGISTREMENT_FINAL": "11/12/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["diclofenac"],
    "InteractionIndexLink": ["diclofenac"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "04 B 006",
    "DCI": "Diclofénac sodique",
    "NOM_COMMERCIALE": "VOLTUM",
    "FORME": "COMP. GASTRORESIST.",
    "DOSAGE": "50MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["diclofenac"],
    "InteractionIndexLink": ["diclofenac"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "04 B 006",
    "DCI": "Diclofénac sodique",
    "NOM_COMMERCIALE": "VOTREX",
    "FORME": "COMP. GASTRORESIST.",
    "DOSAGE": "50MG",
    "COND": "B/20",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["diclofenac"],
    "InteractionIndexLink": ["diclofenac"],
    "N_ENREGISTREMENT": "065/ 04 B 006 /04/14",
    "CODE_DCI": "04 B 006",
    "DCI": "Diclofénac sodique",
    "NOM_COMMERCIALE": "XINAC-50",
    "FORME": "COMP. PELLI. GASTRESIST.",
    "DOSAGE": "50MG",
    "COND": "B/20",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GENERICLAB SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "21/11/2004",
    "DATE_D_ENREGISTREMENT_FINAL": "2/11/2014",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["diclofenac"],
    "InteractionIndexLink": ["diclofenac"],
    "N_ENREGISTREMENT": "263/ 04 B 007 /03/16",
    "CODE_DCI": "04 B 007",
    "DCI": "Diclofénac sodique",
    "NOM_COMMERCIALE": "BIOFENAC",
    "FORME": "COMP. PELLI. LP",
    "DOSAGE": "100MG",
    "COND": "B/20",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOPHARM SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "23/3/2003",
    "DATE_D_ENREGISTREMENT_FINAL": "16/2/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["diclofenac"],
    "InteractionIndexLink": ["diclofenac"],
    "N_ENREGISTREMENT": "003/ 04 B 007 /07/20",
    "CODE_DCI": "04 B 007",
    "DCI": "Diclofénac sodique",
    "NOM_COMMERCIALE": "CLOFENAL LP",
    "FORME": "GLES.GASTRO. RESIST. L.P.",
    "DOSAGE": "100MG",
    "COND": "B/20",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EPE GROUPE INDUSTRIEL SAIDAL/SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/5/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "MANQUE DATE DE RENOUVELLEMENT",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["diclofenac"],
    "InteractionIndexLink": ["diclofenac"],
    "N_ENREGISTREMENT": "149/ 04 B 007 /13",
    "CODE_DCI": "04 B 007",
    "DCI": "Diclofénac sodique",
    "NOM_COMMERCIALE": "DICLOFENAC NOVAGENERICS LP",
    "FORME": "GLES. LP",
    "DOSAGE": "100MG",
    "COND": "B/20",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVAPHARM TRADING SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/8/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "27/9/2016",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["diclofenac"],
    "InteractionIndexLink": ["diclofenac"],
    "N_ENREGISTREMENT": "055/04 B 007/98/16",
    "CODE_DCI": "04 B 007",
    "DCI": "Diclofénac sodique",
    "NOM_COMMERCIALE": "DICLOGESIC RETARD",
    "FORME": "COMP. PELLI. LP",
    "DOSAGE": "100MG",
    "COND": "B/10",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "DAR AL DAWA DEVELOPMENT & INVESTMENT Co Ltd",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/8/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "12/3/2017",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "48 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["diclofenac"],
    "InteractionIndexLink": ["diclofenac"],
    "N_ENREGISTREMENT": "293/ 04 B 007 /05/14",
    "CODE_DCI": "04 B 007",
    "DCI": "Diclofénac sodique",
    "NOM_COMMERCIALE": "FLOVENAC LP",
    "FORME": "MICROGRANULES LP en GLES",
    "DOSAGE": "100MG",
    "COND": "B/10",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOCARE SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "8/1/2005",
    "DATE_D_ENREGISTREMENT_FINAL": "1/6/2014",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["diclofenac"],
    "InteractionIndexLink": ["diclofenac"],
    "N_ENREGISTREMENT": "190/04 B 007/98/17",
    "CODE_DCI": "04 B 007",
    "DCI": "Diclofénac sodique",
    "NOM_COMMERCIALE": "ROFENAC LP",
    "FORME": "CP PELL LP",
    "DOSAGE": "100MG",
    "COND": "B/10",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SAUDI PHARMACEUTICAL INDUSTRIES & MEDICAL APPLIANCES COORPORATION (SPIMACO)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SAUDITE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/11/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "7/3/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["diclofenac"],
    "InteractionIndexLink": ["diclofenac"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "04 B 007",
    "DCI": "Diclofénac sodique",
    "NOM_COMMERCIALE": "ROFENAC LP 100",
    "FORME": "comprimé pelliculé à libération prolongée",
    "DOSAGE": "100 mg",
    "COND": "boîte de 10",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["diclofenac"],
    "InteractionIndexLink": ["diclofenac"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "04 B 007",
    "DCI": "Diclofénac sodique",
    "NOM_COMMERCIALE": "VOLTUM",
    "FORME": "GLES. A µGRLES. LP",
    "DOSAGE": "100MG",
    "COND": "B/10",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["diclofenac"],
    "InteractionIndexLink": ["diclofenac"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "04 B 007",
    "DCI": "Diclofénac sodique",
    "NOM_COMMERCIALE": "VOTREX RETARD",
    "FORME": "COMP. PELLI. LP",
    "DOSAGE": "100MG",
    "COND": "B/10",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["diclofenac"],
    "InteractionIndexLink": ["diclofenac"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "04 B 008",
    "DCI": "DICLOFENAC",
    "NOM_COMMERCIALE": "CLOFENAL",
    "FORME": "SUP ENF",
    "DOSAGE": "25 MG",
    "COND": "B/10",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["diclofenac"],
    "InteractionIndexLink": ["diclofenac"],
    "N_ENREGISTREMENT": "003/ 04 B 008 /99/18",
    "CODE_DCI": "04 B 008",
    "DCI": "Diclofénac sodique",
    "NOM_COMMERCIALE": "CLOFENAL ENFANT",
    "FORME": "SUPPO.",
    "DOSAGE": "25MG",
    "COND": "B/10",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EPE GROUPE INDUSTRIEL SAIDAL/SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/6/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "18/4/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["diclofenac"],
    "InteractionIndexLink": ["diclofenac"],
    "N_ENREGISTREMENT": "366/ 04 B 008 /15",
    "CODE_DCI": "04 B 008",
    "DCI": "Diclofénac sodique",
    "NOM_COMMERCIALE": "DICLOFAR",
    "FORME": "SUPPO",
    "DOSAGE": "25MG",
    "COND": "B/10",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "4 A SANTé INDUSTRIE SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/12/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "13/12/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["diclofenac"],
    "InteractionIndexLink": ["diclofenac"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "04 B 008",
    "DCI": "Diclofénac sodique",
    "NOM_COMMERCIALE": "VOLTUM",
    "FORME": "SUPPO. ENFANTS",
    "DOSAGE": "25MG",
    "COND": "B/10",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["diclofenac"],
    "InteractionIndexLink": ["diclofenac"],
    "N_ENREGISTREMENT": "263/ 04 B 009 /05/13",
    "CODE_DCI": "04 B 009",
    "DCI": "Diclofénac sodique",
    "NOM_COMMERCIALE": "BIOFENAC",
    "FORME": "SUPPO.",
    "DOSAGE": "100MG",
    "COND": "B/10",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOPHARM ALGERIE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/8/2005",
    "DATE_D_ENREGISTREMENT_FINAL": "30/7/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["diclofenac"],
    "InteractionIndexLink": ["diclofenac"],
    "N_ENREGISTREMENT": "003/ 04 B 009 /98/18",
    "CODE_DCI": "04 B 009",
    "DCI": "Diclofénac sodique",
    "NOM_COMMERCIALE": "CLOFENAL",
    "FORME": "SUPPO.",
    "DOSAGE": "100MG",
    "COND": "B/10",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EPE GROUPE INDUSTRIEL SAIDAL/SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/5/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "30/4/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["diclofenac"],
    "InteractionIndexLink": ["diclofenac"],
    "N_ENREGISTREMENT": "400/ 04 B 009 /16",
    "CODE_DCI": "04 B 009",
    "DCI": "Diclofénac sodique",
    "NOM_COMMERCIALE": "VOLTAMEX",
    "FORME": "SUPPO.",
    "DOSAGE": "100MG",
    "COND": "B/10",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "KPMA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/4/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "19/4/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["diclofenac"],
    "InteractionIndexLink": ["diclofenac"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "04 B 009",
    "DCI": "Diclofénac sodique",
    "NOM_COMMERCIALE": "VOLTUM",
    "FORME": "SUPPO.",
    "DOSAGE": "100MG",
    "COND": "B/10",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["ibuprofen"],
    "InteractionIndexLink": ["ibuprofene"],
    "N_ENREGISTREMENT": "470/04 B 010/20",
    "CODE_DCI": "04 B 010",
    "DCI": "IBUPROFENE",
    "NOM_COMMERCIALE": "ADFEN",
    "FORME": "COMP PELL",
    "DOSAGE": "400MG",
    "COND": "B/20",
    "LISTE": "LISTE II AVERIFIER",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MM (SARL LABORATOIRES MM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/5/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "4/5/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["ibuprofen"],
    "InteractionIndexLink": ["ibuprofene"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "04 B 010",
    "DCI": "IBUPROFENE",
    "NOM_COMMERCIALE": "ANTALFEN",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "400MG",
    "COND": "B/20",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["ibuprofen"],
    "InteractionIndexLink": ["ibuprofene"],
    "N_ENREGISTREMENT": "317/ 04 B 010 /16",
    "CODE_DCI": "04 B 010",
    "DCI": "IBUPROFENE",
    "NOM_COMMERCIALE": "CALMOFEN",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "400MG",
    "COND": "B/20",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INPHA MEDIS SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/8/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "9/8/2016",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["ibuprofen"],
    "InteractionIndexLink": ["ibuprofene"],
    "N_ENREGISTREMENT": "380/ 04 B 010 /16",
    "CODE_DCI": "04 B 010",
    "DCI": "IBUPROFENE",
    "NOM_COMMERCIALE": "HUBIFEN",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "400MG",
    "COND": "B/20",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HUP.P.PHARMA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/8/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "1/8/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["ibuprofen"],
    "InteractionIndexLink": ["ibuprofene"],
    "N_ENREGISTREMENT": "039/ 04 B 010 /13/18",
    "CODE_DCI": "04 B 010",
    "DCI": "IBUPROFENE",
    "NOM_COMMERCIALE": "IBUPROFAL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "400MG",
    "COND": "B/20",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOCIETE PHARMACEUTIQUE ALGERIENNE (SOPHAL)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/1/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "14/5/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["ibuprofen"],
    "InteractionIndexLink": ["ibuprofene"],
    "N_ENREGISTREMENT": "447/ 04 B 010 /15",
    "CODE_DCI": "04 B 010",
    "DCI": "IBUPROFENE",
    "NOM_COMMERCIALE": "IBUPROFENE BEKER",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "400MG",
    "COND": "B/20 ET B/100 (POUR EXPORTATION)",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL LABORATOIRE BEKER ALGERIE)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/12/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "2/12/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["ibuprofen"],
    "InteractionIndexLink": ["ibuprofene"],
    "N_ENREGISTREMENT": "318/04 B 010/19",
    "CODE_DCI": "04 B 010",
    "DCI": "IBUPROFENE",
    "NOM_COMMERCIALE": "NARUFENE",
    "FORME": "COMP PELL",
    "DOSAGE": "400MG",
    "COND": "B/20",
    "LISTE": "LISTE II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMIDAL N.S SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/12/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "18/12/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["ibuprofen"],
    "InteractionIndexLink": ["ibuprofene"],
    "N_ENREGISTREMENT": "418/ 04 B 010 /14",
    "CODE_DCI": "04 B 010",
    "DCI": "IBUPROFENE",
    "NOM_COMMERCIALE": "NEOFEN",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "400MG",
    "COND": "B/20",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NEOMEDIC SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/10/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "1/10/2014",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["ibuprofen"],
    "InteractionIndexLink": ["ibuprofene"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "04 B 010",
    "DCI": "IBUPROFENE",
    "NOM_COMMERCIALE": "NEUPREN",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "400MG",
    "COND": "B/20",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["ibuprofen"],
    "InteractionIndexLink": ["ibuprofene"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "04 B 010",
    "DCI": "IBUPROFENE",
    "NOM_COMMERCIALE": "PROF",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "400MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["ibuprofen"],
    "InteractionIndexLink": ["ibuprofene"],
    "N_ENREGISTREMENT": "190/ 04 B 010 /98/17",
    "CODE_DCI": "04 B 010",
    "DCI": "IBUPROFENE",
    "NOM_COMMERCIALE": "SAPOFEN",
    "FORME": "COMPRIME",
    "DOSAGE": "400MG",
    "COND": "B/20",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SAUDI PHARMACEUTICAL INDUSTRIES & MEDICAL APPLIANCES COORPORATION (SPIMACO)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ARABIE SAOUDITE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/11/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "4/9/2017",
    "TYPE": "Gé",
    "STATUT": "F PREMIX",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["ibuprofen"],
    "InteractionIndexLink": ["ibuprofene"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "04 B 010",
    "DCI": "Ibuprofène",
    "NOM_COMMERCIALE": "SAPOFEN® 400",
    "FORME": "comprimé pelliculé",
    "DOSAGE": "400 mg",
    "COND": "boîte de 20",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["ibuprofen"],
    "InteractionIndexLink": ["ibuprofene"],
    "N_ENREGISTREMENT": "468/ 04 B 010 /14",
    "CODE_DCI": "04 B 010",
    "DCI": "IBUPROFENE",
    "NOM_COMMERCIALE": "UBACTIVE 400MG",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "400MG",
    "COND": "B/20",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NADPHARMADIC PRODUCTION",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/7/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "27/7/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["ibuprofen"],
    "InteractionIndexLink": ["ibuprofene"],
    "N_ENREGISTREMENT": "268/ 04 B 010 /12/18",
    "CODE_DCI": "04 B 010",
    "DCI": "IBUPROFENE",
    "NOM_COMMERCIALE": "XYDOL 400",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "400MG",
    "COND": "B/20",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MERINAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/10/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "21/2/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["indometacin"],
    "InteractionIndexLink": ["indometacine"],
    "N_ENREGISTREMENT": "003/04 B 013/96/20",
    "CODE_DCI": "04 B 013",
    "DCI": "INDOMETACINE",
    "NOM_COMMERCIALE": "INDOMET",
    "FORME": "GELULES",
    "DOSAGE": "25MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EPE GROUPE INDUSTRIEL SAIDAL/SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/12/1996",
    "DATE_D_ENREGISTREMENT_FINAL": "22/11/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["ketoprofen"],
    "InteractionIndexLink": ["ketoprofene"],
    "N_ENREGISTREMENT": "17/04 B017/400",
    "CODE_DCI": "04 B 017",
    "DCI": "KETOPROFENE",
    "NOM_COMMERCIALE": "KETOMEX",
    "FORME": "SUPPO",
    "DOSAGE": "100MG",
    "COND": "B/10",
    "LISTE": "LISTE II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "KPMA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "23/10/17",
    "DATE_D_ENREGISTREMENT_FINAL": "23/10/17",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["ketoprofen"],
    "InteractionIndexLink": ["ketoprofene"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "04 B 017",
    "DCI": "KETOPROFENE",
    "NOM_COMMERCIALE": "PROFENID",
    "FORME": "SUPPO.",
    "DOSAGE": "100MG",
    "COND": "B/12",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["ketoprofen"],
    "InteractionIndexLink": ["ketoprofene"],
    "N_ENREGISTREMENT": "20/04 B018/543",
    "CODE_DCI": "04 B 018",
    "DCI": "KETOPROFENE",
    "NOM_COMMERCIALE": "BIOPROFEN",
    "FORME": "SOL INJ",
    "DOSAGE": "100MG/2ML",
    "COND": "B/5 AMPOULES DE 2ML",
    "LISTE": "LISTE II",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOTHERA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/9/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "29/9/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["ketoprofen"],
    "InteractionIndexLink": ["ketoprofene"],
    "N_ENREGISTREMENT": "304/ 04 B 018 /20",
    "CODE_DCI": "04 B 018",
    "DCI": "Kétoprofène",
    "NOM_COMMERCIALE": "KETOFLEX",
    "FORME": "Solution injectable (IM)",
    "DOSAGE": "50MG/ML (100MG/2ML)",
    "COND": "B/05 AMP. DE 2ML ET B/50 AMP. DE 2ML",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "B/50 RESERVEE AUX HOPITAUX",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GEOPHARM / SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "8/11/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "9/5/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["ketoprofen"],
    "InteractionIndexLink": ["ketoprofene"],
    "N_ENREGISTREMENT": "188/ 04 B 018 /99/16",
    "CODE_DCI": "04 B 018",
    "DCI": "KETOPROFENE",
    "NOM_COMMERCIALE": "KETONAL",
    "FORME": "SOL.INJ.IM",
    "DOSAGE": "50MG/ML (100MG/2ML)",
    "COND": "B/10",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LEK",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SLOVENIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "16/3/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "29/1/2017",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["ketoprofen"],
    "InteractionIndexLink": ["ketoprofene"],
    "N_ENREGISTREMENT": "433/ 04 B 018 /15",
    "CODE_DCI": "04 B 018",
    "DCI": "KETOPROFENE",
    "NOM_COMMERCIALE": "KETONEED",
    "FORME": "SOL.INJ.IM",
    "DOSAGE": "50MG/ML (100MG/2ML)",
    "COND": "B/05 AMP. DE 2ML ET B/50 AMP. DE 2ML",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "B/50 RESERVEE AUX HOPITAUX",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRATER RAZES SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/6/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "18/6/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["ketoprofen"],
    "InteractionIndexLink": ["ketoprofene"],
    "N_ENREGISTREMENT": "376/ 04 B 018 /96/16",
    "CODE_DCI": "04 B 018",
    "DCI": "KETOPROFENE",
    "NOM_COMMERCIALE": "PROFENID",
    "FORME": "SOL.INJ.IM",
    "DOSAGE": "50MG/ML (100MG/2ML)",
    "COND": "B/06 AMP. DE 2ML",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANOFI AVENTIS FRANCE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/10/1996",
    "DATE_D_ENREGISTREMENT_FINAL": "29/1/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["naproxen"],
    "InteractionIndexLink": ["naproxene"],
    "N_ENREGISTREMENT": "317/ 04 B 019 /15",
    "CODE_DCI": "04 B 019",
    "DCI": "NAPROXENE SODIQUE",
    "NOM_COMMERCIALE": "NAPROLGIC",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "275MG",
    "COND": "B/30",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INPHA MEDIS SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/9/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "22/9/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["naproxen"],
    "InteractionIndexLink": ["naproxene"],
    "N_ENREGISTREMENT": "097/04 B 019/17",
    "CODE_DCI": "04 B 019",
    "DCI": "NAPROXENE SODIQUE",
    "NOM_COMMERCIALE": "NAPROX",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "275MG",
    "COND": "B/20",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANAMED SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/1/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "29/1/2017",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["naproxen"],
    "InteractionIndexLink": ["naproxene"],
    "N_ENREGISTREMENT": "20/ 04 B 019/470",
    "CODE_DCI": "04 B 019",
    "DCI": "NAPROXENE SODIQUE",
    "NOM_COMMERCIALE": "NEXOPAIN",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "275MG",
    "COND": "B/20",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL LABORATOIRES MM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/7/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "26/7/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["naproxen"],
    "InteractionIndexLink": ["naproxene"],
    "N_ENREGISTREMENT": "166/ 04 B 019 /98/15",
    "CODE_DCI": "04 B 019",
    "DCI": "NAPROXENE SODIQUE",
    "NOM_COMMERCIALE": "NEXORPAN",
    "FORME": "COMPRIME",
    "DOSAGE": "275MG",
    "COND": "B/20",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "RAM PHARMACEUTICAL INDUSTRIES",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "16/8/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "9/8/2015",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["naproxen"],
    "InteractionIndexLink": ["naproxene"],
    "N_ENREGISTREMENT": "380/ 04 B 019 /14",
    "CODE_DCI": "04 B 019",
    "DCI": "NAPROXENE SODIQUE",
    "NOM_COMMERCIALE": "NHUPAIN",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "275MG",
    "COND": "B/20",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HUP.P.PHARMA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/11/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "13/11/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["naproxen"],
    "InteractionIndexLink": ["naproxene"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "04 B 019",
    "DCI": "NAPROXENE SODIQUE",
    "NOM_COMMERCIALE": "NOPAIN",
    "FORME": "COMPRIME",
    "DOSAGE": "275MG",
    "COND": "B/20",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["naproxen"],
    "InteractionIndexLink": ["naproxene"],
    "N_ENREGISTREMENT": "317/ 04 B 020 /16",
    "CODE_DCI": "04 B 020",
    "DCI": "NAPROXENE SODIQUE ANHYDRE",
    "NOM_COMMERCIALE": "NAPROLGIC",
    "FORME": "COMP. PELLI. SEC.",
    "DOSAGE": "550MG",
    "COND": "B/16",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INPHA MEDIS SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/6/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "13/6/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["naproxen"],
    "InteractionIndexLink": ["naproxene"],
    "N_ENREGISTREMENT": "097/04 B 020/16",
    "CODE_DCI": "04 B 020",
    "DCI": "NAPROXENE SODIQUE",
    "NOM_COMMERCIALE": "NAPROX",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "550MG",
    "COND": "B/10",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANAMED SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/2/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "7/2/2017",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["naproxen"],
    "InteractionIndexLink": ["naproxene"],
    "N_ENREGISTREMENT": "20/ 04 B 020/470",
    "CODE_DCI": "04 B 020",
    "DCI": "NAPROXENE SODIQUE",
    "NOM_COMMERCIALE": "NEXOPAIN",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "550MG",
    "COND": "B/10",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL LABORATOIRES MM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/7/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "26/7/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["naproxen"],
    "InteractionIndexLink": ["naproxene"],
    "N_ENREGISTREMENT": "380/ 04 B 020 /14",
    "CODE_DCI": "04 B 020",
    "DCI": "NAPROXENE SODIQUE",
    "NOM_COMMERCIALE": "NHUPAIN",
    "FORME": "COMP. PELLI. SEC.",
    "DOSAGE": "550MG",
    "COND": "B/10",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HUP.P.PHARMA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/10/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "13/10/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["naproxen"],
    "InteractionIndexLink": ["naproxene"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "04 B 020",
    "DCI": "NAPROXENE SODIQUE",
    "NOM_COMMERCIALE": "NOPAIN DS",
    "FORME": "COMPRIME",
    "DOSAGE": "550MG",
    "COND": "B/10",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["piroxicam"],
    "InteractionIndexLink": ["piroxicam"],
    "N_ENREGISTREMENT": "360/ 04 B 022 /06/13",
    "CODE_DCI": "04 B 022",
    "DCI": "PIROXICAM SOUS FORME DE COMPLEXE PIROXICAM - BETA - CYCLODEXTRINE EXPRIME EN PIROXICAM",
    "NOM_COMMERCIALE": "CYCLADOL",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "20MG",
    "COND": "B/14",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMETIC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/12/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "5/3/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["piroxicam"],
    "InteractionIndexLink": ["piroxicam"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "04 B 022",
    "DCI": "PIROXICAM",
    "NOM_COMMERCIALE": "FELCAM",
    "FORME": "GLES.",
    "DOSAGE": "20MG",
    "COND": "B/10",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["piroxicam"],
    "InteractionIndexLink": ["piroxicam"],
    "N_ENREGISTREMENT": "035/ 04 B 022 /19",
    "CODE_DCI": "04 B 022",
    "DCI": "PIROXICAM",
    "NOM_COMMERCIALE": "FELCAM FAST",
    "FORME": "CP DISPERSIBLE SEC",
    "DOSAGE": "20MG",
    "COND": "B/10",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMALLIANCE EURL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/5/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "29/5/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["piroxicam"],
    "InteractionIndexLink": ["piroxicam"],
    "N_ENREGISTREMENT": "263/ 04 B 022 /09/17",
    "CODE_DCI": "04 B 022",
    "DCI": "PIROXICAM",
    "NOM_COMMERCIALE": "FENOXAM",
    "FORME": "COMP. DISPERS. SEC.",
    "DOSAGE": "20MG",
    "COND": "B/10",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOPHARM SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "23/9/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "27/2/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["piroxicam"],
    "InteractionIndexLink": ["piroxicam"],
    "N_ENREGISTREMENT": "289/ 04 B 022 /08/16",
    "CODE_DCI": "04 B 022",
    "DCI": "PIROXICAM",
    "NOM_COMMERCIALE": "FRADENE",
    "FORME": "GLES.",
    "DOSAGE": "20MG",
    "COND": "B/20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRATER RAZES FORME SECHE  SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/3/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "15/2/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["piroxicam"],
    "InteractionIndexLink": ["piroxicam"],
    "N_ENREGISTREMENT": "352/04 B 022/17",
    "CODE_DCI": "04 B 022",
    "DCI": "PIROXICAM",
    "NOM_COMMERCIALE": "ORTHOCAM",
    "FORME": "CP DISPERSIBLE SEC",
    "DOSAGE": "20MG",
    "COND": "B/10",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI DU MEDICAMENT SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/3/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "19/3/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["piroxicam"],
    "InteractionIndexLink": ["piroxicam"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "04 B 022",
    "DCI": "PIROXICAM",
    "NOM_COMMERCIALE": "PIROXEN",
    "FORME": "COMP. DISPERS.",
    "DOSAGE": "20MG",
    "COND": "B/12",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["piroxicam"],
    "InteractionIndexLink": ["piroxicam"],
    "N_ENREGISTREMENT": "462/ 04 B 022 /15",
    "CODE_DCI": "04 B 022",
    "DCI": "PIROXICAM",
    "NOM_COMMERCIALE": "PIROXICAM  PHYSIOPHARM",
    "FORME": "COMP ORODISPERSIBLE",
    "DOSAGE": "20MG",
    "COND": "B/10",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHYSIOPHARM SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/12/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "13/12/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["piroxicam"],
    "InteractionIndexLink": ["piroxicam"],
    "N_ENREGISTREMENT": "149/ 04 B 022 /14",
    "CODE_DCI": "04 B 022",
    "DCI": "PIROXICAM",
    "NOM_COMMERCIALE": "PIROXICAM NOVAGENERICS",
    "FORME": "GLES.",
    "DOSAGE": "20MG",
    "COND": "PILULIER/15",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVAPHARM TRADING",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/6/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "1/6/2014",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["piroxicam"],
    "InteractionIndexLink": ["piroxicam"],
    "N_ENREGISTREMENT": "462/ 04 B 022 /13",
    "CODE_DCI": "04 B 022",
    "DCI": "PIROXICAM",
    "NOM_COMMERCIALE": "PIROXICAM PHYSIOPHARM",
    "FORME": "GLES.",
    "DOSAGE": "20MG",
    "COND": "B/10",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHYSIOPHARM SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/10/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "27/10/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["piroxicam"],
    "InteractionIndexLink": ["piroxicam"],
    "N_ENREGISTREMENT": "380/ 04 B 022 /12/18",
    "CODE_DCI": "04 B 022",
    "DCI": "PIROXICAM",
    "NOM_COMMERCIALE": "PRELDENE",
    "FORME": "GLES.",
    "DOSAGE": "20MG",
    "COND": "B/10",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HUP.P.PHARMA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/11/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "8/4/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["piroxicam"],
    "InteractionIndexLink": ["piroxicam"],
    "N_ENREGISTREMENT": "418/ 04 B 022 /14",
    "CODE_DCI": "04 B 022",
    "DCI": "PIROXICAM",
    "NOM_COMMERCIALE": "ROXICAM",
    "FORME": "GLES",
    "DOSAGE": "20MG",
    "COND": "B/10",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NEOMEDIC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/7/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "27/7/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["piroxicam"],
    "InteractionIndexLink": ["piroxicam"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "04 B 023",
    "DCI": "PIROXICAM",
    "NOM_COMMERCIALE": "PAINOXAM",
    "FORME": "SUPPO.",
    "DOSAGE": "20MG",
    "COND": "B/15",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["piroxicam"],
    "InteractionIndexLink": ["piroxicam"],
    "N_ENREGISTREMENT": "17/04 B023/400",
    "CODE_DCI": "04 B 023",
    "DCI": "PIROXICAM",
    "NOM_COMMERCIALE": "PIROMEX",
    "FORME": "SUPPO",
    "DOSAGE": "20 MG",
    "COND": "B/10",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "KPMA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "23/10/17",
    "DATE_D_ENREGISTREMENT_FINAL": "23/10/17",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["piroxicam"],
    "InteractionIndexLink": ["piroxicam"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "04 B 023",
    "DCI": "PIROXICAM",
    "NOM_COMMERCIALE": "PIROXAL",
    "FORME": "SUPPO",
    "DOSAGE": "20MG",
    "COND": "B/10",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["piroxicam"],
    "InteractionIndexLink": ["piroxicam"],
    "N_ENREGISTREMENT": "045/ 04 B 024 /98/16",
    "CODE_DCI": "04 B 024",
    "DCI": "PIROXICAM",
    "NOM_COMMERCIALE": "FELDENE",
    "FORME": "SOL. INJ. IM",
    "DOSAGE": "20MG/ML",
    "COND": "B/02 AMP. DE 1ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PFIZER",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/12/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "11/9/2016",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "60MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["piroxicam"],
    "InteractionIndexLink": ["piroxicam"],
    "N_ENREGISTREMENT": "433/04 B 024/09/16",
    "CODE_DCI": "04 B 024",
    "DCI": "PIROXICAM",
    "NOM_COMMERCIALE": "FRADENE",
    "FORME": "SOL. INJ. IM",
    "DOSAGE": "20MG/ML",
    "COND": "B/02 AMP. DE 1ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRATER RAZES SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/5/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "20/12/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["piroxicam"],
    "InteractionIndexLink": ["piroxicam"],
    "N_ENREGISTREMENT": "317/ 04 B 024 /12",
    "CODE_DCI": "04 B 024",
    "DCI": "PIROXICAM",
    "NOM_COMMERCIALE": "PIROXEN",
    "FORME": "SOL. INJ. IM",
    "DOSAGE": "20MG/ML",
    "COND": "B/02 AMP. DE 1ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INPHA-MEDIS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/4/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "19/4/2012",
    "TYPE": "Gé",
    "STATUT": "C IIaire",
    "DUREE_DE_STABILITE": "60 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["piroxicam"],
    "InteractionIndexLink": ["piroxicam"],
    "N_ENREGISTREMENT": "380/ 04 B 024 /14",
    "CODE_DCI": "04 B 024",
    "DCI": "PIROXICAM",
    "NOM_COMMERCIALE": "PRELDENE",
    "FORME": "SOL. INJ. IM",
    "DOSAGE": "20MG/ML",
    "COND": "B/02 AMP. DE 1ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HUP.P.PHARMA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/10/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "28/10/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["piroxicam"],
    "InteractionIndexLink": ["piroxicam"],
    "N_ENREGISTREMENT": "003/04 B 024/07/20",
    "CODE_DCI": "04 B 024",
    "DCI": "PIROXICAM",
    "NOM_COMMERCIALE": "PRIXAM",
    "FORME": "SOL. INJ",
    "DOSAGE": "20MG/ML",
    "COND": "B/ 02 AMPOULES DE 1ML",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EPE GROUPE INDUSTRIEL SAIDAL/SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/3/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "27/12/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["piroxicam"],
    "InteractionIndexLink": ["piroxicam"],
    "N_ENREGISTREMENT": "003/04 B 024/07/20",
    "CODE_DCI": "04 B 024",
    "DCI": "PIROXICAM",
    "NOM_COMMERCIALE": "PRIXAM",
    "FORME": "SOL. INJ",
    "DOSAGE": "20MG/ML",
    "COND": "B/ 02 AMPOULES DE 1ML",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EPE GROUPE INDUSTRIEL SAIDAL/SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/03/07",
    "DATE_D_ENREGISTREMENT_FINAL": "27/12/20",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["acide niflumique"],
    "N_ENREGISTREMENT": "003/ 04 B 029 /11/19",
    "CODE_DCI": "04 B 029",
    "DCI": "ACIDE NIFLUMIQUE",
    "NOM_COMMERCIALE": "FLUCIDAL",
    "FORME": "GELULE",
    "DOSAGE": "250MG",
    "COND": "B/30",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SAIDAL GROUPE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/10/2011",
    "DATE_D_ENREGISTREMENT_FINAL": "16/6/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["acide niflumique"],
    "N_ENREGISTREMENT": "457/ 04 B 029 /12",
    "CODE_DCI": "04 B 029",
    "DCI": "ACIDE NIFLUMIQUE",
    "NOM_COMMERCIALE": "INFLAMINE",
    "FORME": "GLES.",
    "DOSAGE": "250MG",
    "COND": "B/30",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOMEDIAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/1/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "30/1/2012",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["acide niflumique"],
    "N_ENREGISTREMENT": "231/ 04 B 029 /08/16",
    "CODE_DCI": "04 B 029",
    "DCI": "ACIDE NIFLUMIQUE",
    "NOM_COMMERCIALE": "NIFLUMENE",
    "FORME": "GELULE",
    "DOSAGE": "250MG",
    "COND": "B/30",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SALEM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "14/7/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "4/2/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["acide niflumique"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "04 B 030",
    "DCI": "ACIDE NIFLUMIQUE",
    "NOM_COMMERCIALE": "NIFLUMATE",
    "FORME": "SUP AD",
    "DOSAGE": "700 MG",
    "COND": "BT/10",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["morniflumate"],
    "N_ENREGISTREMENT": "20/06/04 B 030/003",
    "CODE_DCI": "04 B 030",
    "DCI": "MORNIFLUMATE",
    "NOM_COMMERCIALE": "NIFLUMATE ADULTES",
    "FORME": "SUPPO.",
    "DOSAGE": "700MG",
    "COND": "B/10",
    "LISTE": "LISTE II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EPE GROUPE INDUSTRIEL SAIDAL/SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "16/02/06",
    "DATE_D_ENREGISTREMENT_FINAL": "22/11/20",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["morniflumate"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "04 B 030",
    "DCI": "MORNIFLUMATE",
    "NOM_COMMERCIALE": "NIFLUMENE",
    "FORME": "SUPPO.",
    "DOSAGE": "700MG",
    "COND": "B/08",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["morniflumate"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "04 B 030",
    "DCI": "MORNIFLUMATE",
    "NOM_COMMERCIALE": "NIFLURIC",
    "FORME": "SUPPO.",
    "DOSAGE": "700MG",
    "COND": "B/10",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["morniflumate"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "04 B 030",
    "DCI": "MORNIFLUMATE",
    "NOM_COMMERCIALE": "USENIL",
    "FORME": "SUPPO. ADULTE",
    "DOSAGE": "700MG",
    "COND": "B/08",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["acide niflumique"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "04 B 031",
    "DCI": "NIFLUMIC ACID (acide niflumique)",
    "NOM_COMMERCIALE": "NIFLUMATE",
    "FORME": "SUP ENF",
    "DOSAGE": "400 MG",
    "COND": "BT/10",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["morniflumate"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "04 B 031",
    "DCI": "MORNIFLUMATE",
    "NOM_COMMERCIALE": "NIFLUMENE",
    "FORME": "SUPPO.",
    "DOSAGE": "400MG",
    "COND": "B/08",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["morniflumate"],
    "N_ENREGISTREMENT": "366/ 04 B 031 /07/13",
    "CODE_DCI": "04 B 031",
    "DCI": "MORNIFLUMATE",
    "NOM_COMMERCIALE": "NIFLURIC",
    "FORME": "SUPPO.",
    "DOSAGE": "400MG",
    "COND": "B/10",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "4A SANTE INDUSTRIE SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/11/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "30/7/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["morniflumate"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "04 B 031",
    "DCI": "MORNIFLUMATE",
    "NOM_COMMERCIALE": "USENIL",
    "FORME": "SUPPO. SEC.ENFANT",
    "DOSAGE": "400MG",
    "COND": "B/08",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["ketoprofen"],
    "InteractionIndexLink": ["ketoprofene"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "04 B 032",
    "DCI": "KETOPROFENE",
    "NOM_COMMERCIALE": "KETOFEN LP",
    "FORME": "GLES. LP",
    "DOSAGE": "200MG",
    "COND": "B/20",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["ketoprofen"],
    "InteractionIndexLink": ["ketoprofene"],
    "N_ENREGISTREMENT": "392/ 04 B 032 /99/12",
    "CODE_DCI": "04 B 032",
    "DCI": "KETOPROFENE",
    "NOM_COMMERCIALE": "PROFENID LP",
    "FORME": "COMP. ENRO. LP",
    "DOSAGE": "200MG",
    "COND": "B/14",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANOFI AVENTIS ALGERIE SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/6/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "20/3/2012",
    "TYPE": "Ré",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["flurbiprofen"],
    "InteractionIndexLink": ["flurbiprofene"],
    "N_ENREGISTREMENT": "097/ 04 B 033 /07/15",
    "CODE_DCI": "04 B 033",
    "DCI": "FLURBIPROFENE",
    "NOM_COMMERCIALE": "ANTADINE",
    "FORME": "COMP. ENRO.",
    "DOSAGE": "100MG",
    "COND": "B/20",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANAMED SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/11/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "31/3/2015",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["flurbiprofen"],
    "InteractionIndexLink": ["flurbiprofene"],
    "N_ENREGISTREMENT": "035/ 04 B 033 /15/21",
    "CODE_DCI": "04 B 033",
    "DCI": "Flurbiprofène",
    "NOM_COMMERCIALE": "ANTALFEN-GYN (ex ANTAPROFEN )",
    "FORME": "Comprimé pelliculé",
    "DOSAGE": "100MG",
    "COND": "B/20",
    "LISTE": "LISTE II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMALLIANCE EURL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/12/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "28/3/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["flurbiprofen"],
    "InteractionIndexLink": ["flurbiprofene"],
    "N_ENREGISTREMENT": "304/ 04 B 033 /06/15",
    "CODE_DCI": "04 B 033",
    "DCI": "FLURBIPROFENE",
    "NOM_COMMERCIALE": "FLUBIFENE",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "100MG",
    "COND": "B/20",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GEOPHARM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/7/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "31/5/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["flurbiprofen"],
    "InteractionIndexLink": ["flurbiprofene"],
    "N_ENREGISTREMENT": "317/ 04 B 033 /16",
    "CODE_DCI": "04 B 033",
    "DCI": "FLURBIPROFENE",
    "NOM_COMMERCIALE": "FLUDIS",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "100MG",
    "COND": "B/16",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INPHA-MEDIS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/8/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "9/8/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["flurbiprofen"],
    "InteractionIndexLink": ["flurbiprofene"],
    "N_ENREGISTREMENT": "468/ 04 B 033 /14",
    "CODE_DCI": "04 B 033",
    "DCI": "FLURBIPROFENE",
    "NOM_COMMERCIALE": "FLURBINAD",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "100MG",
    "COND": "B/20",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NADPHARMADIC PRODUCTION SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/11/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "2/11/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["flurbiprofen"],
    "InteractionIndexLink": ["flurbiprofene"],
    "N_ENREGISTREMENT": "039/ 04 B 033 /13",
    "CODE_DCI": "04 B 033",
    "DCI": "FLURBIPROFENE",
    "NOM_COMMERCIALE": "FLURBIPROFAL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "100MG",
    "COND": "B/16",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOCIETE PHARMACEUTIQUE ALGERIENNE (SOPHAL)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/5/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "15/2/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["flurbiprofen"],
    "InteractionIndexLink": ["flurbiprofene"],
    "N_ENREGISTREMENT": "380/ 04 B 033 /15",
    "CODE_DCI": "04 B 033",
    "DCI": "FLURBIPROFENE",
    "NOM_COMMERCIALE": "HUPTADYS",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "100MG",
    "COND": "B/20",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HUP.P.PHARMA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/4/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "26/4/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["flurbiprofen"],
    "InteractionIndexLink": ["flurbiprofene"],
    "N_ENREGISTREMENT": "235/ 04 B 033 /16",
    "CODE_DCI": "04 B 033",
    "DCI": "FLURBIPROFENE",
    "NOM_COMMERCIALE": "MENODIS",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "100MG",
    "COND": "B/16",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOGALENIC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/4/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "27/4/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["flurbiprofen"],
    "InteractionIndexLink": ["flurbiprofene"],
    "N_ENREGISTREMENT": "268/ 04 B 033 /15",
    "CODE_DCI": "04 B 033",
    "DCI": "FLURBIPROFENE",
    "NOM_COMMERCIALE": "XYDOL GYN",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "100MG",
    "COND": "B/20",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MERINAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/1/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "18/1/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["ketoprofen"],
    "InteractionIndexLink": ["ketoprofene"],
    "N_ENREGISTREMENT": "549/ 04 B 034 /19",
    "CODE_DCI": "04 B 034",
    "DCI": "KETOPROFENE",
    "NOM_COMMERCIALE": "EVOFENID",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "100MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL / EVOLAB",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/4/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "24/4/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["ketoprofen"],
    "InteractionIndexLink": ["ketoprofene"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "04 B 034",
    "DCI": "KETOPROFENE",
    "NOM_COMMERCIALE": "PROFENID",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "100MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["celecoxib"],
    "InteractionIndexLink": ["celecoxib"],
    "N_ENREGISTREMENT": "510/04 B 035/17",
    "CODE_DCI": "04 B 035",
    "DCI": "CELECOXIB",
    "NOM_COMMERCIALE": "ARBREX",
    "FORME": "GLES.",
    "DOSAGE": "100MG",
    "COND": "B/20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALEMBIC MAMI SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/1/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "29/1/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["celecoxib"],
    "InteractionIndexLink": ["celecoxib"],
    "N_ENREGISTREMENT": "045/ 04 B 035 /00/12",
    "CODE_DCI": "04 B 035",
    "DCI": "CELECOXIB",
    "NOM_COMMERCIALE": "CELEBREX",
    "FORME": "GLES.",
    "DOSAGE": "100MG",
    "COND": "B/20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PFIZER PHARM ALGERIE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/5/2000",
    "DATE_D_ENREGISTREMENT_FINAL": "24/4/2012",
    "TYPE": "Ré",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["celecoxib"],
    "InteractionIndexLink": ["celecoxib"],
    "N_ENREGISTREMENT": "380/ 04 B 035 /14/19",
    "CODE_DCI": "04 B 035",
    "DCI": "CELECOXIB",
    "NOM_COMMERCIALE": "CELECOBREX HUP",
    "FORME": "GLES.",
    "DOSAGE": "100MG",
    "COND": "B/20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HUP.P.PHARMA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/11/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "25/12/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["celecoxib"],
    "InteractionIndexLink": ["celecoxib"],
    "N_ENREGISTREMENT": "400/ 04 B 035 /14",
    "CODE_DCI": "04 B 035",
    "DCI": "CELECOXIB",
    "NOM_COMMERCIALE": "CELECOMEX",
    "FORME": "GLES.",
    "DOSAGE": "100MG",
    "COND": "B/20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "KHROUB PHARMACEUTICAL MANUFACTURING ALGERIA (KPMA) SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/10/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "15/10/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["celecoxib"],
    "InteractionIndexLink": ["celecoxib"],
    "N_ENREGISTREMENT": "035/04 B 035/16",
    "CODE_DCI": "04 B 035",
    "DCI": "CELECOXIB",
    "NOM_COMMERCIALE": "CELECOX",
    "FORME": "GLES.",
    "DOSAGE": "100MG",
    "COND": "B/10 +B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EURL PHARMALLIANCE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/12/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "4/12/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["celecoxib"],
    "InteractionIndexLink": ["celecoxib"],
    "N_ENREGISTREMENT": "447/ 04 B 035 /14",
    "CODE_DCI": "04 B 035",
    "DCI": "CELECOXIB",
    "NOM_COMMERCIALE": "CELECOXIB BEKER",
    "FORME": "GLES",
    "DOSAGE": "100MG",
    "COND": "B/20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES BEKER SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/11/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "13/11/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["celecoxib"],
    "InteractionIndexLink": ["celecoxib"],
    "N_ENREGISTREMENT": "309/ 04 B 035 /14",
    "CODE_DCI": "04 B 035",
    "DCI": "CELECOXIB",
    "NOM_COMMERCIALE": "CELECOXIB LDM",
    "FORME": "GLES",
    "DOSAGE": "100MG",
    "COND": "B/20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE DE DIAGNOSTIC MAGHREBINS (LDM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/6/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "1/6/2014",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["celecoxib"],
    "InteractionIndexLink": ["celecoxib"],
    "N_ENREGISTREMENT": "428/ 04 B 035 /15",
    "CODE_DCI": "04 B 035",
    "DCI": "CELECOXIB",
    "NOM_COMMERCIALE": "CELECOXIB ZENTIVA",
    "FORME": "GLES.",
    "DOSAGE": "100MG",
    "COND": "B/24",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "WINTHROP PHARMA SAIDAL SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/6/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "24/6/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["celecoxib"],
    "InteractionIndexLink": ["celecoxib"],
    "N_ENREGISTREMENT": "418/ 04 B 035 /14",
    "CODE_DCI": "04 B 035",
    "DCI": "CELECOXIB",
    "NOM_COMMERCIALE": "CELVEX",
    "FORME": "GLES",
    "DOSAGE": "100MG",
    "COND": "B/20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NEOMEDIC SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/11/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "2/11/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["celecoxib"],
    "InteractionIndexLink": ["celecoxib"],
    "N_ENREGISTREMENT": "001/ 04 B 035 /14",
    "CODE_DCI": "04 B 035",
    "DCI": "CELECOXIB",
    "NOM_COMMERCIALE": "CIREXA",
    "FORME": "GLES",
    "DOSAGE": "100MG",
    "COND": "B/20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMA ALGERIA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/7/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "13/7/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["celecoxib"],
    "InteractionIndexLink": ["celecoxib"],
    "N_ENREGISTREMENT": "289/ 04 B 035 /12",
    "CODE_DCI": "04 B 035",
    "DCI": "CELECOXIB",
    "NOM_COMMERCIALE": "COXIBREX",
    "FORME": "GLES.",
    "DOSAGE": "100MG",
    "COND": "B/20 ET B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRATER RAZES FORME SECHE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/10/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "15/10/2012",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["celecoxib"],
    "InteractionIndexLink": ["celecoxib"],
    "N_ENREGISTREMENT": "268/ 04 B 035 /13/18",
    "CODE_DCI": "04 B 035",
    "DCI": "CELECOXIB",
    "NOM_COMMERCIALE": "INICOX 100",
    "FORME": "GLES.",
    "DOSAGE": "100MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MERINAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/2/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "30/5/2018",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["celecoxib"],
    "InteractionIndexLink": ["celecoxib"],
    "N_ENREGISTREMENT": "528/04 B 035",
    "CODE_DCI": "04 B 035",
    "DCI": "CELECOXIB",
    "NOM_COMMERCIALE": "MEDIBREX",
    "FORME": "GLES",
    "DOSAGE": "100MG",
    "COND": "B/10 ET B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JANIS MED SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["celecoxib"],
    "InteractionIndexLink": ["celecoxib"],
    "N_ENREGISTREMENT": "149/ 04 B 035 /14",
    "CODE_DCI": "04 B 035",
    "DCI": "CELECOXIB",
    "NOM_COMMERCIALE": "NOVABREX",
    "FORME": "GLES",
    "DOSAGE": "100MG",
    "COND": "B/20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVAPHARM TRADING SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/4/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "1/4/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["celecoxib"],
    "InteractionIndexLink": ["celecoxib"],
    "N_ENREGISTREMENT": "352/ 04 B 035 /12",
    "CODE_DCI": "04 B 035",
    "DCI": "CELECOXIB",
    "NOM_COMMERCIALE": "RUMABREX",
    "FORME": "GLES.",
    "DOSAGE": "100MG",
    "COND": "B/24",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/3/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "20/3/2012",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "48 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["celecoxib"],
    "InteractionIndexLink": ["celecoxib"],
    "N_ENREGISTREMENT": "510/04 B 036/17",
    "CODE_DCI": "04 B 036",
    "DCI": "CELECOXIB",
    "NOM_COMMERCIALE": "ARBREX",
    "FORME": "GLES.",
    "DOSAGE": "200MG",
    "COND": "B/10",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALEMBIC MAMI SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/1/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "29/1/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["celecoxib"],
    "InteractionIndexLink": ["celecoxib"],
    "N_ENREGISTREMENT": "045/ 04 B 036 /00/12",
    "CODE_DCI": "04 B 036",
    "DCI": "CELECOXIB",
    "NOM_COMMERCIALE": "CELEBREX",
    "FORME": "GLES.",
    "DOSAGE": "200MG",
    "COND": "B/10 - B/15 - B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PFIZER PHARM ALGERIE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/5/2000",
    "DATE_D_ENREGISTREMENT_FINAL": "7/3/2012",
    "TYPE": "Ré",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["celecoxib"],
    "InteractionIndexLink": ["celecoxib"],
    "N_ENREGISTREMENT": "380/ 04 B 036 /14",
    "CODE_DCI": "04 B 036",
    "DCI": "CELECOXIB",
    "NOM_COMMERCIALE": "CELECOBREX HUP",
    "FORME": "GLES.",
    "DOSAGE": "200MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HUP.P.PHARMA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/12/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "30/12/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36  MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["celecoxib"],
    "InteractionIndexLink": ["celecoxib"],
    "N_ENREGISTREMENT": "400/ 04 B 036 /14",
    "CODE_DCI": "04 B 036",
    "DCI": "CELECOXIB",
    "NOM_COMMERCIALE": "CELECOMEX",
    "FORME": "GLES",
    "DOSAGE": "200MG",
    "COND": "B/10 ET B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "KHROUB PHARMACEUTICAL MANUFACTURING ALGERIA (KPMA) SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/11/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "2/11/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["celecoxib"],
    "InteractionIndexLink": ["celecoxib"],
    "N_ENREGISTREMENT": "447/ 04 B 036 /15",
    "CODE_DCI": "04 B 036",
    "DCI": "CELECOXIB",
    "NOM_COMMERCIALE": "CELECOXIB BEKER",
    "FORME": "GLES.",
    "DOSAGE": "200MG",
    "COND": "B/10 ET B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEKER SARL (SARL LABORATOIRE BEKER ALGERIE)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/7/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "30/7/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["celecoxib"],
    "InteractionIndexLink": ["celecoxib"],
    "N_ENREGISTREMENT": "309/ 04 B 036 /14",
    "CODE_DCI": "04 B 036",
    "DCI": "CELECOXIB",
    "NOM_COMMERCIALE": "CELECOXIB LDM",
    "FORME": "GLES",
    "DOSAGE": "200MG",
    "COND": "B/10",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE DE DIAGNOSTIC MAGHREBINS (LDM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/6/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "6/10/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["celecoxib"],
    "InteractionIndexLink": ["celecoxib"],
    "N_ENREGISTREMENT": "20/04 B036/462",
    "CODE_DCI": "04 B 036",
    "DCI": "CELECOXIB",
    "NOM_COMMERCIALE": "CELECOXIB PHYSIOPHARM",
    "FORME": "GELULES",
    "DOSAGE": "200MG",
    "COND": "B/10",
    "LISTE": "LISTE I",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES SARL PHYSIOPHARM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/10/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "25/10/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["celecoxib"],
    "InteractionIndexLink": ["celecoxib"],
    "N_ENREGISTREMENT": "039/ 04 B 036 /16",
    "CODE_DCI": "04 B 036",
    "DCI": "CELECOXIB",
    "NOM_COMMERCIALE": "CELEXAL",
    "FORME": "GLES",
    "DOSAGE": "200MG",
    "COND": "B/10",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOCIETE PHARMACEUTIQUE ALGERIENNE (SOPHAL)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/6/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "22/6/2016",
    "TYPE": "Gé",
    "STATUT": "f",
    "DUREE_DE_STABILITE": "24mois",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["celecoxib"],
    "InteractionIndexLink": ["celecoxib"],
    "N_ENREGISTREMENT": "418/ 04 B 036 /12",
    "CODE_DCI": "04 B 036",
    "DCI": "CELECOXIB",
    "NOM_COMMERCIALE": "CELVEX",
    "FORME": "GLES.",
    "DOSAGE": "200MG",
    "COND": "B/10 ET B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NEOMEDIC SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "21/10/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "21/10/2012",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["celecoxib"],
    "InteractionIndexLink": ["celecoxib"],
    "N_ENREGISTREMENT": "001/ 04 B 036 /14",
    "CODE_DCI": "04 B 036",
    "DCI": "CELECOXIB",
    "NOM_COMMERCIALE": "CIREXA",
    "FORME": "GLES",
    "DOSAGE": "200MG",
    "COND": "B/10",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMA ALGERIA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/5/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "12/5/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["celecoxib"],
    "InteractionIndexLink": ["celecoxib"],
    "N_ENREGISTREMENT": "289/ 04 B 036 /12",
    "CODE_DCI": "04 B 036",
    "DCI": "CELECOXIB",
    "NOM_COMMERCIALE": "COXIBREX",
    "FORME": "GLES.",
    "DOSAGE": "200MG",
    "COND": "B/10 ET B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRATER RAZES FORME SECHE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/10/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "15/10/2012",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["celecoxib"],
    "InteractionIndexLink": ["celecoxib"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "04 B 036",
    "DCI": "Celecoxib",
    "NOM_COMMERCIALE": "Celecox",
    "FORME": "Gélule",
    "DOSAGE": "200 mg",
    "COND": "Boite 10 et boite de 30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["celecoxib"],
    "InteractionIndexLink": ["celecoxib"],
    "N_ENREGISTREMENT": "268/ 04 B 036 /13/18",
    "CODE_DCI": "04 B 036",
    "DCI": "CELECOXIB",
    "NOM_COMMERCIALE": "INICOX 200",
    "FORME": "GLES.",
    "DOSAGE": "200MG",
    "COND": "B/20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MERINAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/2/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "30/5/2018",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["celecoxib"],
    "InteractionIndexLink": ["celecoxib"],
    "N_ENREGISTREMENT": "528/04 B 036/19",
    "CODE_DCI": "04 B 036",
    "DCI": "CELECOXIB",
    "NOM_COMMERCIALE": "MEDIBREX",
    "FORME": "GLES",
    "DOSAGE": "200MG",
    "COND": "B/10 ET B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JANIS MED SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["celecoxib"],
    "InteractionIndexLink": ["celecoxib"],
    "N_ENREGISTREMENT": "003/ 04 B 036 /15",
    "CODE_DCI": "04 B 036",
    "DCI": "CELECOXIB",
    "NOM_COMMERCIALE": "NOTOREX",
    "FORME": "GLES.",
    "DOSAGE": "200MG",
    "COND": "B/10",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GROUPE INDUSTRIEL SAIDAL EPE/SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/5/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "4/5/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["celecoxib"],
    "InteractionIndexLink": ["celecoxib"],
    "N_ENREGISTREMENT": "149/ 04 B 036 /14",
    "CODE_DCI": "04 B 036",
    "DCI": "CELECOXIB",
    "NOM_COMMERCIALE": "NOVABREX",
    "FORME": "GLES",
    "DOSAGE": "200MG",
    "COND": "B/10 ET B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVAPHARM TRADING SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/5/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "21/3/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["celecoxib"],
    "InteractionIndexLink": ["celecoxib"],
    "N_ENREGISTREMENT": "352/ 04 B 036 /12",
    "CODE_DCI": "04 B 036",
    "DCI": "CELECOXIB",
    "NOM_COMMERCIALE": "RUMABREX",
    "FORME": "GLES.",
    "DOSAGE": "200MG",
    "COND": "B/12",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/3/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "29/3/2012",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "48 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["diclofenac"],
    "InteractionIndexLink": ["diclofenac"],
    "N_ENREGISTREMENT": "149/ 04 B 037 /15",
    "CODE_DCI": "04 B 037",
    "DCI": "Diclofénac sodique",
    "NOM_COMMERCIALE": "BIDICLO LP",
    "FORME": "MICROGRAULES A LIBéRATION PROLONGéE EN Gélule",
    "DOSAGE": "75mg",
    "COND": "B/30",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVA PHARM TRADING",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/12/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "27/12/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["diclofenac"],
    "InteractionIndexLink": ["diclofenac"],
    "N_ENREGISTREMENT": "263/ 04 B 037 /07/15",
    "CODE_DCI": "04 B 037",
    "DCI": "Diclofénac sodique",
    "NOM_COMMERCIALE": "BIOFENAC LP",
    "FORME": "COMP. PELLI. LP",
    "DOSAGE": "75MG",
    "COND": "B/30",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOPHARM SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/3/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "6/9/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["diclofenac"],
    "InteractionIndexLink": ["diclofenac"],
    "N_ENREGISTREMENT": "003/ 04 B 037 /07/18",
    "CODE_DCI": "04 B 037",
    "DCI": "Diclofénac sodique",
    "NOM_COMMERCIALE": "CLOFENAL LP",
    "FORME": "GLES. L.P.",
    "DOSAGE": "75MG",
    "COND": "B/30",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EPE GROUPE INDUSTRIEL SAIDAL/SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/5/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "19/3/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["diclofenac"],
    "InteractionIndexLink": ["diclofenac"],
    "N_ENREGISTREMENT": "039/ 04 B 037/17",
    "CODE_DCI": "04 B 037",
    "DCI": "Diclofénac sodique",
    "NOM_COMMERCIALE": "DICLOFAL LP",
    "FORME": "COMP. PELLI. LP",
    "DOSAGE": "75MG",
    "COND": "B/20",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOPHAL SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/4/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "12/4/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["diclofenac"],
    "InteractionIndexLink": ["diclofenac"],
    "N_ENREGISTREMENT": "235/ 04 B 037/19",
    "CODE_DCI": "04 B 037",
    "DCI": "Diclofénac sodique",
    "NOM_COMMERCIALE": "DICLOFLEX LP 75 MG",
    "FORME": "COMP. PELLI. LP",
    "DOSAGE": "75MG",
    "COND": "B/30",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOGALENIC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/2/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "4/2/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["diclofenac"],
    "InteractionIndexLink": ["diclofenac"],
    "N_ENREGISTREMENT": "10/04 B 037/293",
    "CODE_DCI": "04 B 037",
    "DCI": "DICLOFENAC SODIQUE",
    "NOM_COMMERCIALE": "FLOVENAC LP",
    "FORME": "MICROGRANULES LP en GLES",
    "DOSAGE": "75MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE SARL BIOCARE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "21/10/10",
    "DATE_D_ENREGISTREMENT_FINAL": "21/10/10",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["ibuprofen"],
    "InteractionIndexLink": ["ibuprofene"],
    "N_ENREGISTREMENT": "470/04 B 040/20",
    "CODE_DCI": "04 B 040",
    "DCI": "IBUPROFENE",
    "NOM_COMMERCIALE": "ADFEN",
    "FORME": "COMP PELL",
    "DOSAGE": "200MG",
    "COND": "B/20",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MM (SARL LABORATOIRES MM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/5/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "4/5/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["ibuprofen"],
    "InteractionIndexLink": ["ibuprofene"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "04 B 040",
    "DCI": "IBUPROFENE",
    "NOM_COMMERCIALE": "ANTALFEN",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "200MG",
    "COND": "B/15",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["ibuprofen"],
    "InteractionIndexLink": ["ibuprofene"],
    "N_ENREGISTREMENT": "293/ 04 B 040 /05/12",
    "CODE_DCI": "04 B 040",
    "DCI": "IBUPROFENE",
    "NOM_COMMERCIALE": "BUTAFEN",
    "FORME": "GLES. A MICROGRLES.",
    "DOSAGE": "200MG",
    "COND": "B/20",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOCARE SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "8/1/2005",
    "DATE_D_ENREGISTREMENT_FINAL": "4/3/2012",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["ibuprofen"],
    "InteractionIndexLink": ["ibuprofene"],
    "N_ENREGISTREMENT": "317/ 04 B 040 /21",
    "CODE_DCI": "04 B 040",
    "DCI": "Ibuprofène",
    "NOM_COMMERCIALE": "CALMOFEN",
    "FORME": "Comprimé pelliculé",
    "DOSAGE": "200MG",
    "COND": "B/20",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INPHA-MEDIS /SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/4/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "12/4/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["ibuprofen"],
    "InteractionIndexLink": ["ibuprofene"],
    "N_ENREGISTREMENT": "380/ 04 B 040 /16",
    "CODE_DCI": "04 B 040",
    "DCI": "IBUPROFENE",
    "NOM_COMMERCIALE": "HUBIFEN",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "200MG",
    "COND": "B/20",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HUP.P.PHARMA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/3/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "13/3/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["ibuprofen"],
    "InteractionIndexLink": ["ibuprofene"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "04 B 040",
    "DCI": "IBUPROFENE",
    "NOM_COMMERCIALE": "IBUMAL",
    "FORME": "CPR",
    "DOSAGE": "200 MG",
    "COND": "BT/20",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["ibuprofen"],
    "InteractionIndexLink": ["ibuprofene"],
    "N_ENREGISTREMENT": "039/ 04 B 040 /13/18",
    "CODE_DCI": "04 B 040",
    "DCI": "IBUPROFENE",
    "NOM_COMMERCIALE": "IBUPROFAL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "200MG",
    "COND": "B/20",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOCIETE PHARMACEUTIQUE ALGERIENNE (SOPHAL)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/1/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "23/7/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["ibuprofen"],
    "InteractionIndexLink": ["ibuprofene"],
    "N_ENREGISTREMENT": "447/ 04 B 040 /15",
    "CODE_DCI": "04 B 040",
    "DCI": "IBUPROFENE",
    "NOM_COMMERCIALE": "IBUPROFNE BEKER",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "200MG",
    "COND": "B/30",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEKER SARL (SARL LABORATOIRE BEKER ALGERIE)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/4/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "26/4/2015",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["ibuprofen"],
    "InteractionIndexLink": ["ibuprofene"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "04 B 040",
    "DCI": "IBUPROFENE",
    "NOM_COMMERCIALE": "NEUPREN",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "200MG",
    "COND": "B/20",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["ibuprofen"],
    "InteractionIndexLink": ["ibuprofene"],
    "N_ENREGISTREMENT": "400/04 B 040/17",
    "CODE_DCI": "04 B 040",
    "DCI": "IBUPROFENE",
    "NOM_COMMERCIALE": "SAPOMEX",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "200MG",
    "COND": "B/20",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "KPMA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/1/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "29/1/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["ibuprofen"],
    "InteractionIndexLink": ["ibuprofene"],
    "N_ENREGISTREMENT": "468/ 04 B 040 /14",
    "CODE_DCI": "04 B 040",
    "DCI": "IBUPROFENE",
    "NOM_COMMERCIALE": "UBACTIVE 200MG",
    "FORME": "COMP PELL SEC",
    "DOSAGE": "200MG",
    "COND": "B/20",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NADPHARMADIC PRODUCTION",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/7/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "13/7/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["ibuprofen"],
    "InteractionIndexLink": ["ibuprofene"],
    "N_ENREGISTREMENT": "201/ 04 B 040 /00/16",
    "CODE_DCI": "04 B 040",
    "DCI": "IBUPROFENE",
    "NOM_COMMERCIALE": "UPFEN",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "200MG",
    "COND": "B/20",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PROPHARMAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/8/2000",
    "DATE_D_ENREGISTREMENT_FINAL": "11/4/2016",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36 moIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["ibuprofen"],
    "InteractionIndexLink": ["ibuprofene"],
    "N_ENREGISTREMENT": "268/ 04 B 040 /05/18",
    "CODE_DCI": "04 B 040",
    "DCI": "IBUPROFENE",
    "NOM_COMMERCIALE": "XYDOL 200",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "200MG",
    "COND": "B/20",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MERINAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/3/2005",
    "DATE_D_ENREGISTREMENT_FINAL": "21/2/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["ibuprofen"],
    "InteractionIndexLink": ["ibuprofene"],
    "N_ENREGISTREMENT": "470/04 B 042/20",
    "CODE_DCI": "04 B 042",
    "DCI": "IBUPROFENE",
    "NOM_COMMERCIALE": "ADFEN",
    "FORME": "SUSP BUV",
    "DOSAGE": "2MG/ML (100MG/5ML)",
    "COND": "FL./180ML+ SERINGUE GRADUEE",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MM (SARL LABORATOIRES MM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/5/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "4/5/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["ibuprofen"],
    "InteractionIndexLink": ["ibuprofene"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "04 B 042",
    "DCI": "IBUPROFENE",
    "NOM_COMMERCIALE": "ALGIFEN",
    "FORME": "SUSP. BUV.",
    "DOSAGE": "20MG/ML (100MG/5ML)",
    "COND": "FL./180ML+SERING DE 5ML P. ADMINIST. OR. GRADUEE EN KG DE POIDS CORPOREL ; B/01 FL. DE 200ML + PIPETTE GRADUEE EN KG ET ML",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["ibuprofen"],
    "InteractionIndexLink": ["ibuprofene"],
    "N_ENREGISTREMENT": "035/ 04 B 042 /08/15",
    "CODE_DCI": "04 B 042",
    "DCI": "IBUPROFENE",
    "NOM_COMMERCIALE": "ANTALFEN",
    "FORME": "SUSP. BUV.",
    "DOSAGE": "20MG/ML (100MG/5ML)",
    "COND": "FL./200ML + PIPETTE GRADUEE",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMALLIANCE EURL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "8/4/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "10/2/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["ibuprofen"],
    "InteractionIndexLink": ["ibuprofene"],
    "N_ENREGISTREMENT": "462/04 B 042/21",
    "CODE_DCI": "04 B 042",
    "DCI": "Ibuprofène",
    "NOM_COMMERCIALE": "ARDIL",
    "FORME": "Suspension buvable",
    "DOSAGE": "20MG/ML (100MG/5ML)",
    "COND": "FL./200ML+ Pipette graduée",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHYSIOPHARM / SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/2/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "15/2/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["ibuprofen"],
    "InteractionIndexLink": ["ibuprofene"],
    "N_ENREGISTREMENT": "317/04 B 042/16",
    "CODE_DCI": "04 B 042",
    "DCI": "IBUPROFENE",
    "NOM_COMMERCIALE": "CALMOFEN",
    "FORME": "SUSP.BUVABLE",
    "DOSAGE": "100MG/5ML",
    "COND": "FL 125ML+PIPETTE GRADUEE EN KG",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INPHA-MEDIS SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/11/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "2/11/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["ibuprofen"],
    "InteractionIndexLink": ["ibuprofene"],
    "N_ENREGISTREMENT": "079/ 04 B 042 /15",
    "CODE_DCI": "04 B 042",
    "DCI": "IBUPROFENE",
    "NOM_COMMERCIALE": "IBUFEN",
    "FORME": "SOL. BUV.",
    "DOSAGE": "20MG/ML (100MG/5ML)",
    "COND": "FL/125 ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES  ALGERIEN DE DEVELOPPEMENT PHARMACEUTIQUE SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/12/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "2/12/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["ibuprofen"],
    "InteractionIndexLink": ["ibuprofene"],
    "N_ENREGISTREMENT": "077/ 04 B 042 /08/15",
    "CODE_DCI": "04 B 042",
    "DCI": "IBUPROFENE",
    "NOM_COMMERCIALE": "LAMIFENE",
    "FORME": "SOL. BUV.",
    "DOSAGE": "20MG/ML (100MG/5ML)",
    "COND": "FL./125ML + PIPETTE GRADUEE",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE ALGERIEN DU MEDICAMENT (LAM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/9/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "10/2/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["ibuprofen"],
    "InteractionIndexLink": ["ibuprofene"],
    "N_ENREGISTREMENT": "318/ 04 B 042 /07/13",
    "CODE_DCI": "04 B 042",
    "DCI": "IBUPROFENE",
    "NOM_COMMERCIALE": "NARUFENE 2%",
    "FORME": "SUSP. BUV. GOÛT PÊCHE",
    "DOSAGE": "20MG/ML (100MG/5ML)",
    "COND": "B/1FL. DE 125ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMIDAL N.S. SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/6/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "30/9/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["ibuprofen"],
    "InteractionIndexLink": ["ibuprofene"],
    "N_ENREGISTREMENT": "235/ 04 B 042 /16",
    "CODE_DCI": "04 B 042",
    "DCI": "IBUPROFENE",
    "NOM_COMMERCIALE": "NEUPREN",
    "FORME": "SOL. BUV.",
    "DOSAGE": "20MG/ML (100MG/5ML)",
    "COND": "FL/200 ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOGALENIC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/3/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "13/3/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["ibuprofen"],
    "InteractionIndexLink": ["ibuprofene"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "04 B 042",
    "DCI": "IBUPROFENE",
    "NOM_COMMERCIALE": "PACIFENE",
    "FORME": "SUSP.BUV.",
    "DOSAGE": "20 mg/ml",
    "COND": "Boite d'un flc de 125 ml et une pipette graduée en ml et en kg",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["ibuprofen"],
    "InteractionIndexLink": ["ibuprofene"],
    "N_ENREGISTREMENT": "503/ 04 B 042 /16",
    "CODE_DCI": "04 B 042",
    "DCI": "IBUPROFENE",
    "NOM_COMMERCIALE": "POLYPHENE",
    "FORME": "SUSP. BUV.",
    "DOSAGE": "20MG/ML",
    "COND": "FL/100ML +PIPETTE GRADUéE EN KG",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "AFRO PHARM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "11/4/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "11/4/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["ibuprofen"],
    "InteractionIndexLink": ["ibuprofene"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "04 B 042",
    "DCI": "IBUPROFENE",
    "NOM_COMMERCIALE": "PROF",
    "FORME": "SUSP. BUV.",
    "DOSAGE": "20MG/ML (100MG/5ML)",
    "COND": "FL./100ML + BOUCHON DOSEUR",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["ibuprofen"],
    "InteractionIndexLink": ["ibuprofene"],
    "N_ENREGISTREMENT": "311/ 04 B 042 /15",
    "CODE_DCI": "04 B 042",
    "DCI": "IBUPROFENE",
    "NOM_COMMERCIALE": "RUMIFEN",
    "FORME": "SUSP. BUV.",
    "DOSAGE": "100MG/5ML",
    "COND": "FL./145ML + PIPETTE DE 5ML GRADUEE EN KG",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE GROUPEMENT PHARMACEUTIQUE ALGERIEN (LGPA) SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/10/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "12/10/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["ibuprofen"],
    "InteractionIndexLink": ["ibuprofene"],
    "N_ENREGISTREMENT": "20/04 B 042/268",
    "CODE_DCI": "04 B 042",
    "DCI": "IBUPROFENE",
    "NOM_COMMERCIALE": "XYDOL ENFANTS NOURISSONS",
    "FORME": "SUSP. BUVABLE",
    "DOSAGE": "20MG/ML",
    "COND": "FLC/200ML EN VERRE AMBR2+SERINGUE POUR ADM. ORALE",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES MERINAL SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/08/20",
    "DATE_D_ENREGISTREMENT_FINAL": "10/08/20",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["ibuprofen"],
    "InteractionIndexLink": ["ibuprofene"],
    "N_ENREGISTREMENT": "035/ 04 B 044 /14",
    "CODE_DCI": "04 B 044",
    "DCI": "IBUPROFENE",
    "NOM_COMMERCIALE": "ANTALFEN",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "600MG",
    "COND": "B/10 ET B/30",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMALLIANCE EURL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/6/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "15/6/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["ibuprofen"],
    "InteractionIndexLink": ["ibuprofene"],
    "N_ENREGISTREMENT": "293/ 04 B 044 /12",
    "CODE_DCI": "04 B 044",
    "DCI": "IBUPROFENE",
    "NOM_COMMERCIALE": "BUTAFEN",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "600MG",
    "COND": "B/30",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOCARE SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/11/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "27/11/2012",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["ibuprofen"],
    "InteractionIndexLink": ["ibuprofene"],
    "N_ENREGISTREMENT": "380/ 04 B 044 /16",
    "CODE_DCI": "04 B 044",
    "DCI": "IBUPROFENE",
    "NOM_COMMERCIALE": "HUBIFEN",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "600MG",
    "COND": "B/30",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HUP.P.PHARMA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/7/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "19/7/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["ibuprofen"],
    "InteractionIndexLink": ["ibuprofene"],
    "N_ENREGISTREMENT": "392/ 04 B 044 /18",
    "CODE_DCI": "04 B 044",
    "DCI": "IBUPROFENE",
    "NOM_COMMERCIALE": "IBUPRANE",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "600MG",
    "COND": "B/20",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANOFI AVENTIS ALGERIE SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/11/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "29/11/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["ibuprofen"],
    "InteractionIndexLink": ["ibuprofene"],
    "N_ENREGISTREMENT": "039/ 04 B 044 /13/18",
    "CODE_DCI": "04 B 044",
    "DCI": "IBUPROFENE",
    "NOM_COMMERCIALE": "IBUPROFAL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "600MG",
    "COND": "B/20",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOCIETE PHARMACEUTIQUE ALGERIENNE (SOPHAL)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/3/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "30/5/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["ibuprofen"],
    "InteractionIndexLink": ["ibuprofene"],
    "N_ENREGISTREMENT": "447/ 04 B 044 /15",
    "CODE_DCI": "04 B 044",
    "DCI": "IBUPROFENE",
    "NOM_COMMERCIALE": "IBUPROFENE BEKER",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "600MG",
    "COND": "B/20",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEKER SARL (SARL LABORATOIRE BEKER ALGERIE)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/7/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "9/7/2015",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["ibuprofen"],
    "InteractionIndexLink": ["ibuprofene"],
    "N_ENREGISTREMENT": "318/04 B 044/19",
    "CODE_DCI": "04 B 044",
    "DCI": "IBUPROFENE",
    "NOM_COMMERCIALE": "NARUFENE",
    "FORME": "COMP PELL",
    "DOSAGE": "600MG",
    "COND": "B/30",
    "LISTE": "LISTE II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMIDAL N.S SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/12/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "18/12/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["ibuprofen"],
    "InteractionIndexLink": ["ibuprofene"],
    "N_ENREGISTREMENT": "418/ 04 B 044 /14",
    "CODE_DCI": "04 B 044",
    "DCI": "IBUPROFENE",
    "NOM_COMMERCIALE": "NEOFEN",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "600MG",
    "COND": "B/30",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NEOMEDIC SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/11/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "13/11/2014",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["ibuprofen"],
    "InteractionIndexLink": ["ibuprofene"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "04 B 044",
    "DCI": "IBUPROFENE",
    "NOM_COMMERCIALE": "NEUPREN",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "600MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["ibuprofen"],
    "InteractionIndexLink": ["ibuprofene"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "04 B 044",
    "DCI": "Ibuprofène",
    "NOM_COMMERCIALE": "SAPOFEN",
    "FORME": "comprimé pelliculé",
    "DOSAGE": "600 mg",
    "COND": "boîte de 30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["ibuprofen"],
    "InteractionIndexLink": ["ibuprofene"],
    "N_ENREGISTREMENT": "190/04 B 044/03/17",
    "CODE_DCI": "04 B 044",
    "DCI": "IBUPROFENE",
    "NOM_COMMERCIALE": "SAPOFEN 600",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "600MG",
    "COND": "B/30",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SPIMACO ADDAWAEH",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ARABIE SAOUDITE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/3/2003",
    "DATE_D_ENREGISTREMENT_FINAL": "28/5/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["ibuprofen"],
    "InteractionIndexLink": ["ibuprofene"],
    "N_ENREGISTREMENT": "400/04B 044/17",
    "CODE_DCI": "04 B 044",
    "DCI": "IBUPROFENE",
    "NOM_COMMERCIALE": "SAPOMEX",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "600MG",
    "COND": "B/30",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "KPMA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/1/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "29/1/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["ibuprofen"],
    "InteractionIndexLink": ["ibuprofene"],
    "N_ENREGISTREMENT": "468/ 04 B 044 /14",
    "CODE_DCI": "04 B 044",
    "DCI": "IBUPROFENE",
    "NOM_COMMERCIALE": "UBACTIVE 600MG",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "600MG",
    "COND": "B/30",
    "LISTE": "LISTE II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NADPHARMADIC PRODUCTION",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/7/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "27/7/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["ibuprofen"],
    "InteractionIndexLink": ["ibuprofene"],
    "N_ENREGISTREMENT": "268/ 04 B 044 /15",
    "CODE_DCI": "04 B 044",
    "DCI": "IBUPROFENE",
    "NOM_COMMERCIALE": "XYDOL 600",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "600MG",
    "COND": "B/30",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MERINAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/1/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "25/1/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "348/04 B 045/17",
    "CODE_DCI": "04 B 045",
    "DCI": "DIACEREINE",
    "NOM_COMMERCIALE": "ARTROPI",
    "FORME": "GELULE",
    "DOSAGE": "50MG",
    "COND": "B/20",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL ALGERIAN PHARMACEUTICAL INSTITUT (API)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/3/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "12/3/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "097/04 B 045/17",
    "CODE_DCI": "04 B 045",
    "DCI": "DIACEREINE",
    "NOM_COMMERCIALE": "DIACENE 50",
    "FORME": "GELULE",
    "DOSAGE": "50MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANAMED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/1/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "9/1/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["diclofenac"],
    "InteractionIndexLink": ["diclofenac"],
    "N_ENREGISTREMENT": "366/ 04 B 046 /15",
    "CODE_DCI": "04 B 046",
    "DCI": "Diclofénac sodique",
    "NOM_COMMERCIALE": "DICLOFAR",
    "FORME": "SUPPO.",
    "DOSAGE": "50MG",
    "COND": "B/10",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL 4 A SANTE INDUSTRIE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/12/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "13/12/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["ketoprofen"],
    "InteractionIndexLink": ["ketoprofene"],
    "N_ENREGISTREMENT": "527/04 B 049/17",
    "CODE_DCI": "04 B 049",
    "DCI": "KETOPROFENE",
    "NOM_COMMERCIALE": "HARUFEN",
    "FORME": "PATCH",
    "DOSAGE": "30MG",
    "COND": "B/7",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SINIL PHARMACEUTICAL CO LTD",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "KOREA",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/7/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "19/7/2017",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["ketoprofen"],
    "InteractionIndexLink": ["ketoprofene"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "04 B 049",
    "DCI": "KETOPROFENE",
    "NOM_COMMERCIALE": "KEFENTECH",
    "FORME": "PATCH",
    "DOSAGE": "30MG",
    "COND": "SACHET DE 07",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["ibuprofen"],
    "InteractionIndexLink": ["ibuprofene"],
    "N_ENREGISTREMENT": "293/ 04 B 052 /12",
    "CODE_DCI": "04 B 052",
    "DCI": "IBUPROFENE",
    "NOM_COMMERCIALE": "BUTAFEN LP",
    "FORME": "MICROGRANULES LP EN GLES.",
    "DOSAGE": "400MG",
    "COND": "B/20",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOCARE SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/2/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "15/2/2012",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["ketoprofen"],
    "InteractionIndexLink": ["ketoprofene"],
    "N_ENREGISTREMENT": "376/ 04 B 053 /07/16",
    "CODE_DCI": "04 B 053",
    "DCI": "KETOPROFENE",
    "NOM_COMMERCIALE": "PROFEMIGR",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "150MG",
    "COND": "B/10",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANOFI AVENTIS FRANCE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/11/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "26/1/2016",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "60MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["piroxicam"],
    "InteractionIndexLink": ["piroxicam"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "04 B 054",
    "DCI": "PIROXICAM  (SOUS FORME COMPLEXE PIROXICAM BETA CYCLODEXTRINE)",
    "NOM_COMMERCIALE": "CYCLADOL",
    "FORME": "COMP. EFFERV.",
    "DOSAGE": "20MG  (COMPLEXE PIROXICAM BETA CYCLODEXTRINE 191.2MG)",
    "COND": "B/14",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["ketoprofen"],
    "InteractionIndexLink": ["ketoprofene"],
    "N_ENREGISTREMENT": "010/ 04 B 057/97/14",
    "CODE_DCI": "04 B 057",
    "DCI": "KETOPROFENE",
    "NOM_COMMERCIALE": "FLEXEN",
    "FORME": "PDRE. ET SOLV. P. SOL. INJ.",
    "DOSAGE": "100MG/FL. DE PDRE.",
    "COND": "B/06FL. DE PDRE + 06AMP. DE 2.5ML DE SOLV. (EPPI)",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LIFEPHARMASPA- ITALFARMACO GROUPE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ITALIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/11/1997",
    "DATE_D_ENREGISTREMENT_FINAL": "12/5/2014",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["meloxicam"],
    "InteractionIndexLink": ["meloxicam"],
    "N_ENREGISTREMENT": "549/ 04 B 058/21",
    "CODE_DCI": "04 B 058",
    "DCI": "Méloxicam",
    "NOM_COMMERCIALE": "EVOXICAM",
    "FORME": "Comprimé",
    "DOSAGE": "15MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EVOLAB / SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/3/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "4/3/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["meloxicam"],
    "InteractionIndexLink": ["meloxicam"],
    "N_ENREGISTREMENT": "178/ 04 B 058 /09/16",
    "CODE_DCI": "04 B 058",
    "DCI": "MELOXICAM",
    "NOM_COMMERCIALE": "MELOX",
    "FORME": "COMPRIME",
    "DOSAGE": "15MG",
    "COND": "B/10 ET B/100",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "B/100 RESERVEE AUX HÔPITAUX",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MEDOCHEMIE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CHYPRE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/12/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "12/3/2017",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["ibuprofen", "paracetamol"],
    "InteractionIndexLink": ["ibuprofene", "paracetamol"],
    "N_ENREGISTREMENT": "321/ 04 B 059 /08/16",
    "CODE_DCI": "04 B 059",
    "DCI": "IBUPROFENE / PARACETAMOL",
    "NOM_COMMERCIALE": "DOLISED",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "200MG/400MG",
    "COND": "B/20",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOVITAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "23/3/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "4/10/2016",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["meloxicam"],
    "InteractionIndexLink": ["meloxicam"],
    "N_ENREGISTREMENT": "549/ 04 B 060 /21",
    "CODE_DCI": "04 B 060",
    "DCI": "Méloxicam",
    "NOM_COMMERCIALE": "EVOXICAM",
    "FORME": "Comprimé",
    "DOSAGE": "7.5MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EVOLAB / SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/3/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "4/3/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["meloxicam"],
    "InteractionIndexLink": ["meloxicam"],
    "N_ENREGISTREMENT": "178/ 04 B 060 /09/16",
    "CODE_DCI": "04 B 060",
    "DCI": "MELOXICAM",
    "NOM_COMMERCIALE": "MELOX",
    "FORME": "COMPRIME",
    "DOSAGE": "7.5MG",
    "COND": "B/10 - B/100*",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "B/100 RESERVEE AUX HÔPITAUX",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MEDOCHEMIE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CHYPRE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/12/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "12/3/2017",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["diclofenac"],
    "InteractionIndexLink": ["diclofenac"],
    "N_ENREGISTREMENT": "267/ 04 B 061 /14",
    "CODE_DCI": "04 B 061",
    "DCI": "DICLOFENAC POTASSIQUE",
    "NOM_COMMERCIALE": "VOLTARENE DOLO",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "12.5MG",
    "COND": "B/30",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVARTIS SANTE FAMILIALE S.A.S",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/4/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "15/4/2014",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["diclofenac"],
    "InteractionIndexLink": ["diclofenac"],
    "N_ENREGISTREMENT": "173/ 04 B 062 /06/17",
    "CODE_DCI": "04 B 062",
    "DCI": "Diclofénac sodique",
    "NOM_COMMERCIALE": "DIVIDO",
    "FORME": "Gélule à double libération",
    "DOSAGE": "75MG",
    "COND": "B/20",
    "LISTE": "LISTE II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "TABUK  /  EURL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/12/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "15/2/2021",
    "TYPE": "Gé",
    "STATUT": "F prémix (TABUK et  EL KENDI)",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["diclofenac"],
    "InteractionIndexLink": ["diclofenac"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "04 B 063",
    "DCI": "DICLOFENAC POTASSIQUE",
    "NOM_COMMERCIALE": "RAPIDUS 50",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "50MG",
    "COND": "B/20",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["diclofenac"],
    "InteractionIndexLink": ["diclofenac"],
    "N_ENREGISTREMENT": "225/ 04 B 063 /12",
    "CODE_DCI": "04 B 063",
    "DCI": "DICLOFENAC POTASSIQUE",
    "NOM_COMMERCIALE": "VOTREX RAPID",
    "FORME": "COMP. ENRO.",
    "DOSAGE": "50MG",
    "COND": "B/20",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JAZEERA PHARMACEUTICALS INDUSTRIES",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ARABIE SAOUDITE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/10/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "15/10/2012",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["morniflumate"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "04 B 064",
    "DCI": "MORNIFLUMATE",
    "NOM_COMMERCIALE": "NIFLUMENE",
    "FORME": "SUPPO.",
    "DOSAGE": "200MG",
    "COND": "B/08",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["morniflumate"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "04 B 064",
    "DCI": "MORNIFLUMATE",
    "NOM_COMMERCIALE": "NIFLURIC",
    "FORME": "SUPPO.",
    "DOSAGE": "200MG",
    "COND": "B/10",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["ketoprofen"],
    "InteractionIndexLink": ["ketoprofene"],
    "N_ENREGISTREMENT": "392/ 04 B 068 /13",
    "CODE_DCI": "04 B 068",
    "DCI": "KETOPROFENE",
    "NOM_COMMERCIALE": "PROFENID ENFANT ET NOURRISON",
    "FORME": "SIROP",
    "DOSAGE": "1MG/ML",
    "COND": "B/01FL. DE 150ML + 01 SERING. P. ADMINIST. ORAL. DE 10ML",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANOFI AVENTIS ALGERIE S.P.A",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/4/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "24/4/2013",
    "TYPE": "Ré",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["acide mefenamique"],
    "InteractionIndexLink": ["acide mefenamique"],
    "N_ENREGISTREMENT": "190/ 04 B 070 /14",
    "CODE_DCI": "04 B 070",
    "DCI": "ACIDE MEFENAMIQUE",
    "NOM_COMMERCIALE": "MAFEPAIN",
    "FORME": "COMP ENRO SEC",
    "DOSAGE": "500MG",
    "COND": "B/20",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SPIMACO ADDWAEH",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ARABIE SAOUDITE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/7/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "6/7/2014",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "48 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["parecoxib"],
    "InteractionIndexLink": ["parecoxib"],
    "N_ENREGISTREMENT": "045/ 04 B 071 /15",
    "CODE_DCI": "04 B 071",
    "DCI": "PARéCOXIB",
    "NOM_COMMERCIALE": "DYNASTAT",
    "FORME": "POUDRE POUR SOL INJ IM/IV",
    "DOSAGE": "40MG / FLACON",
    "COND": "B/10",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PFIZER LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ROYAUME UNI",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/12/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "13/12/2015",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["ibuprofen"],
    "InteractionIndexLink": ["ibuprofene"],
    "N_ENREGISTREMENT": "289/ 04 B 072 /16",
    "CODE_DCI": "04 B 072",
    "DCI": "IBUPROFENE",
    "NOM_COMMERCIALE": "SAPBUFEN",
    "FORME": "GRANULES P/SOL. BUV. EN SACHET ADULTE",
    "DOSAGE": "600MG",
    "COND": "B/12",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRATER RAZES FORME SECHE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/4/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "19/4/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["diclofenac"],
    "InteractionIndexLink": ["diclofenac"],
    "N_ENREGISTREMENT": "263/ 04 B 073 /16",
    "CODE_DCI": "04 B 073",
    "DCI": "DICLOFENAC POTASSIUM",
    "NOM_COMMERCIALE": "BIOFENAC FAST",
    "FORME": "POUDRE POUR SOLUTION BUVABLE EN SACHET",
    "DOSAGE": "50MG/SACHET",
    "COND": "B/10 SACHETS",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOPHARM SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/7/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "4/7/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["diclofenac"],
    "InteractionIndexLink": ["diclofenac"],
    "N_ENREGISTREMENT": "001/ 04 B 073 /15",
    "CODE_DCI": "04 B 073",
    "DCI": "DICLOFENAC POTASSIUM",
    "NOM_COMMERCIALE": "VOTREX RAPID",
    "FORME": "GRANULES P/SOL. BUV. EN SACHET ADULTE",
    "DOSAGE": "50MG/SACHET",
    "COND": "B/10 SACHETS",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMA ALGERIA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/10/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "3/11/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Anti Inflamatoires"]
  },
  {
    "PregnancyIndexLink": ["etoricoxib"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "352/ 04 B 074 /18",
    "CODE_DCI": "04 B 074",
    "DCI": "Etoricoxib",
    "NOM_COMMERCIALE": "ETOFAN",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "120 MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INduSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/10/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "9/10/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["etoricoxib"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "289 / 04 B  074    / 20",
    "CODE_DCI": "04 B 074",
    "DCI": "Etoricoxib",
    "NOM_COMMERCIALE": "ETORIXIA",
    "FORME": "Comprimé pelliculé",
    "DOSAGE": "120MG",
    "COND": "B/20",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRATER RAZES FORME SECHE SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/12/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "26/12/2020",
    "TYPE": "Gé",
    "STATUT": "F prémix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["etoricoxib"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "352/ 04 B 075 /18",
    "CODE_DCI": "04 B 075",
    "DCI": "Etoricoxib",
    "NOM_COMMERCIALE": "ETOFAN",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "60 MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INduSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/10/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "9/10/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["etoricoxib"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "289 / 04 B 075 / 20",
    "CODE_DCI": "04 B 075",
    "DCI": "Etoricoxib",
    "NOM_COMMERCIALE": "ETORIXIA",
    "FORME": "Comprimé pelliculé",
    "DOSAGE": "60MG",
    "COND": "B/20",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRATER RAZES FORME SECHE SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/12/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "26/12/2020",
    "TYPE": "Gé",
    "STATUT": "F prémix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["etoricoxib"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "352/ 04 B 076/18",
    "CODE_DCI": "04 B 076",
    "DCI": "Etoricoxib",
    "NOM_COMMERCIALE": "ETOFAN",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "90 MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INduSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/10/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "9/10/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["etoricoxib"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "289/ 04 B 076 /20",
    "CODE_DCI": "04 B 076",
    "DCI": "Etoricoxib",
    "NOM_COMMERCIALE": "ETORIXIA",
    "FORME": "Comprimé pelliculé",
    "DOSAGE": "90MG",
    "COND": "B/20",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRATER RAZES FORME SECHE SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/12/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "26/12/2020",
    "TYPE": "Gé",
    "STATUT": "F prémix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["ibuprofen"],
    "InteractionIndexLink": ["ibuprofene"],
    "N_ENREGISTREMENT": "011 / 04 B 077 / 18",
    "CODE_DCI": "04 B 077",
    "DCI": "Ibuprofene Lysine",
    "NOM_COMMERCIALE": "ARFEN",
    "FORME": "SOL INJ IM",
    "DOSAGE": "400 MG /3 ML",
    "COND": "B/06 AMP. DE 3ML",
    "LISTE": "LISTE II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE ITALIANO BIOCHIMICO FARMACEUTICO LISA PHARMA SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ITALIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/11/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "26/11/2018",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["ibuprofen", "paracetamol"],
    "InteractionIndexLink": ["ibuprofene", "paracetamol"],
    "N_ENREGISTREMENT": "477/04 B 078/20",
    "CODE_DCI": "04 B 078",
    "DCI": "PARACETAMOL/ IBUPROFENE",
    "NOM_COMMERCIALE": "APAP IBUPROFENE BEKER",
    "FORME": "COMP. PELL.",
    "DOSAGE": "500MG/ 200MG",
    "COND": "B/20",
    "LISTE": "LISTE II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL LABORATOIRES BEKER",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/12/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "29/12/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "104/ 04 C 026 /00/15",
    "CODE_DCI": "04 C 026",
    "DCI": "ALPHA-AMYLASE",
    "NOM_COMMERCIALE": "MEGAMYLASE",
    "FORME": "COMP. ENRO.",
    "DOSAGE": "3000 U CEIP",
    "COND": "B/24",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "TOP PHARM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "21/6/2000",
    "DATE_D_ENREGISTREMENT_FINAL": "4/10/2015",
    "TYPE": "Gé",
    "STATUT": "C Iaire",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "077/ 04 C 027 /15",
    "CODE_DCI": "04 C 027",
    "DCI": "ALPHA-AMYLASE",
    "NOM_COMMERCIALE": "LAMYLASE",
    "FORME": "SIROP",
    "DOSAGE": "20 000 U CEIP/100ML",
    "COND": "FL./100ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE ALGERIEN DU MEDICAMENT (LAM) SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/5/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "13/5/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "12 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "392/04 C 027/96/16",
    "CODE_DCI": "04 C 027",
    "DCI": "ALPHA-AMYLASE",
    "NOM_COMMERCIALE": "MAXILASE",
    "FORME": "SIROP ENF. ET AD.",
    "DOSAGE": "20 000 U CEIP/100ML",
    "COND": "FL/125ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANOFI AVENTIS ALGERIE SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "23/10/1996",
    "DATE_D_ENREGISTREMENT_FINAL": "28/3/2009",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "12 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["bleomycin"],
    "InteractionIndexLink": ["bleomycine"],
    "N_ENREGISTREMENT": "016/ 05 A 004 /98/16",
    "CODE_DCI": "05 A 004",
    "DCI": "BLEOMYCINE",
    "NOM_COMMERCIALE": "BLEOMYCINE",
    "FORME": "PDRE.SOL.INJ.",
    "DOSAGE": "15MG",
    "COND": "B/01",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BELLON",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/11/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "7/3/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["bleomycin"],
    "InteractionIndexLink": ["bleomycine"],
    "N_ENREGISTREMENT": "516/05 A 004/16",
    "CODE_DCI": "05 A 004",
    "DCI": "BLEOMYCINE",
    "NOM_COMMERCIALE": "BLOICIN -S",
    "FORME": "PDRE.SOL.INJ.",
    "DOSAGE": "15MG (15 UI)",
    "COND": "B/01",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "KOREA UNITED PHARM INC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "COREE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/2/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "12/2/2017",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["dacarbazine"],
    "InteractionIndexLink": ["dacarbazine"],
    "N_ENREGISTREMENT": "516/05 A 013/16",
    "CODE_DCI": "05 A 013",
    "DCI": "DACARBAZINE",
    "NOM_COMMERCIALE": "DTI",
    "FORME": "PDRE P. SOL A DILUER P. PERF IV",
    "DOSAGE": "100MG",
    "COND": "B/10FL.",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "KOREA UNITED PHARM INC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "COREE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/2/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "12/2/2017",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["hydroxycarbamide"],
    "InteractionIndexLink": ["hydroxycarbamide"],
    "N_ENREGISTREMENT": "017/ 05 A 021 /99/15",
    "CODE_DCI": "05 A 021",
    "DCI": "HYDROXYCARBAMIDE",
    "NOM_COMMERCIALE": "HYDREA",
    "FORME": "GLES",
    "DOSAGE": "500MG",
    "COND": "B/20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BRISTOL MYERS SQUIBB",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/2/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "6/5/2015",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["hydroxycarbamide"],
    "InteractionIndexLink": ["hydroxycarbamide"],
    "N_ENREGISTREMENT": "001/ 05 A 021 /20",
    "CODE_DCI": "05 A 021",
    "DCI": "Hydroxycarbamide",
    "NOM_COMMERCIALE": "HYDROCURE",
    "FORME": "Gélule",
    "DOSAGE": "500MG",
    "COND": "B/20",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMA ALGERIA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "21/10/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "21/10/2020",
    "TYPE": "Gé",
    "STATUT": "F prémix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["hydroxycarbamide"],
    "InteractionIndexLink": ["hydroxycarbamide"],
    "N_ENREGISTREMENT": "20/05 A021/001",
    "CODE_DCI": "05 A 021",
    "DCI": "HYDROXYCARBAMIDE",
    "NOM_COMMERCIALE": "HYDROCURE",
    "FORME": "GÉLULE",
    "DOSAGE": "500MG",
    "COND": "B/20",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL HIKMA PHARMA ALGERIA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "21/10/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "21/10/2020",
    "TYPE": "Gé",
    "STATUT": "F Prémix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["melphalan"],
    "InteractionIndexLink": ["melphalan"],
    "N_ENREGISTREMENT": "467/ 05 A 024 /99/19",
    "CODE_DCI": "05 A 024",
    "DCI": "MELPHALAN",
    "NOM_COMMERCIALE": "ALKERAN",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "2MG",
    "COND": "B/25",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ASPEN PHARMA TRADING  LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "Irlande",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/9/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "14/8/2019",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["methotrexate"],
    "InteractionIndexLink": ["methotrexate"],
    "N_ENREGISTREMENT": "182/ 05 A 032 /08/16",
    "CODE_DCI": "05 A 032",
    "DCI": "METHOTREXATE",
    "NOM_COMMERCIALE": "CYTOTREX",
    "FORME": "COMPRIME",
    "DOSAGE": "2.5MG",
    "COND": "B/20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CIPLA LTD",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/5/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "6/3/2017",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cancerologie"]
  },
  {
    "PregnancyIndexLink": ["methotrexate"],
    "InteractionIndexLink": ["methotrexate"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "05 A 032",
    "DCI": "METHOTREXATE",
    "NOM_COMMERCIALE": "METHOTREXAT EBEWE",
    "FORME": "COMPRIME",
    "DOSAGE": "2.5MG",
    "COND": "B/50",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cancerologie"]
  },
  {
    "PregnancyIndexLink": ["gemcitabine"],
    "InteractionIndexLink": ["gemcitabine"],
    "N_ENREGISTREMENT": "001/ 05 A 085 /14",
    "CODE_DCI": "05 A 085",
    "DCI": "GEMCITABINE CHLORHYDRATE EXPRIME EN GEMCITABINE",
    "NOM_COMMERCIALE": "MECITABINE",
    "FORME": "PDRE. LYOP. P. SOL. P. PERF. IV.",
    "DOSAGE": "1000MG",
    "COND": "B/01 FL. DE PDRE.",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMACEUTICALS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/11/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "30/11/2014",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["gemcitabine"],
    "InteractionIndexLink": ["gemcitabine"],
    "N_ENREGISTREMENT": "001/ 05 A 094 /15",
    "CODE_DCI": "05 A 094",
    "DCI": "GEMCITABINE CHLORHYDRATE EXPRIME EN GEMCITABINE",
    "NOM_COMMERCIALE": "MECITABINE",
    "FORME": "PDRE LYOPHILISEE P/INJ. EN PERF. IV",
    "DOSAGE": "200MG/FL. DE PDRE",
    "COND": "B/01 FL. DE PDRE",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMACEUTICALS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/2/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "26/2/2015",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["azathioprine"],
    "InteractionIndexLink": ["azathioprine"],
    "N_ENREGISTREMENT": "450/ 05 B 043 /06/15",
    "CODE_DCI": "05 B 043",
    "DCI": "AZATHIOPRINE",
    "NOM_COMMERCIALE": "AZATHIOPRINE MYLAN",
    "FORME": "COMP. PELLI. SEC.",
    "DOSAGE": "50MG",
    "COND": "B/100",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MYLAN SAS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/10/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "18/3/2015",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cancerologie"]
  },
  {
    "PregnancyIndexLink": ["azathioprine"],
    "InteractionIndexLink": ["azathioprine"],
    "N_ENREGISTREMENT": "467/ 05 B 043 /99/12",
    "CODE_DCI": "05 B 043",
    "DCI": "AZATHIOPRINE",
    "NOM_COMMERCIALE": "IMUREL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "50MG",
    "COND": "B/100",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ASPEN PHARMA TRADING LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "IRLANDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/9/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "23/12/2012",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "60 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cancerologie"]
  },
  {
    "PregnancyIndexLink": ["ciclosporin"],
    "InteractionIndexLink": ["ciclosporine"],
    "N_ENREGISTREMENT": "182/ 05 B 048 /08/16",
    "CODE_DCI": "05 B 048",
    "DCI": "CICLOSPORINE",
    "NOM_COMMERCIALE": "IMUSPORIN 25",
    "FORME": "CAPSULE MOLLE",
    "DOSAGE": "25MG",
    "COND": "B/50",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CIPLA LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "23/2/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "11/9/2016",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["ciclosporin"],
    "InteractionIndexLink": ["ciclosporine"],
    "N_ENREGISTREMENT": "182/ 05 B 082 /08/16",
    "CODE_DCI": "05 B 082",
    "DCI": "CICLOSPORINE",
    "NOM_COMMERCIALE": "IMUSPORIN 50",
    "FORME": "CAPSULE MOLLE",
    "DOSAGE": "50MG",
    "COND": "B/50",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CIPLA LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/1/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "6/3/2017",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["tacrolimus"],
    "InteractionIndexLink": ["tacrolimus"],
    "N_ENREGISTREMENT": "157/ 05 B 092 /14",
    "CODE_DCI": "05 B 092",
    "DCI": "TACROLIMUS MONOHYDRATE EXPRIME EN TACROLIMUS",
    "NOM_COMMERCIALE": "TACROLIMUS CINFA",
    "FORME": "GLES",
    "DOSAGE": "1MG",
    "COND": "B/100",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CINFA S.A.",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ESPAGNE",
    "DATE_D_ENREGISTREMENT_INITIAL": "21/9/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "21/9/2014",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["tacrolimus"],
    "InteractionIndexLink": ["tacrolimus"],
    "N_ENREGISTREMENT": "157/ 05 B 093 /14",
    "CODE_DCI": "05 B 093",
    "DCI": "TACROLIMUS MONOHYDRATE EXPRIME EN TACROLIMUS",
    "NOM_COMMERCIALE": "TACROLIMUS CINFA",
    "FORME": "GLES",
    "DOSAGE": "5MG",
    "COND": "B/100",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CINFA S.A.",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ESPAGNE",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/9/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "1/9/2014",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["tacrolimus"],
    "InteractionIndexLink": ["tacrolimus"],
    "N_ENREGISTREMENT": "157/ 05 B 101 /14",
    "CODE_DCI": "05 B 101",
    "DCI": "TACROLIMUS MONOHYDRATE EXPRIME EN TACROLIMUS",
    "NOM_COMMERCIALE": "TACROLIMUS CINFA",
    "FORME": "GLES",
    "DOSAGE": "0.5MG",
    "COND": "B/100",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CINFA S.A.",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ESPAGNE",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/9/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "1/9/2014",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["imatinib"],
    "InteractionIndexLink": ["imatinib"],
    "N_ENREGISTREMENT": "330/ 05 C 105 /12",
    "CODE_DCI": "05 C 105",
    "DCI": "Imatinib mesylate exprime en Imatinib",
    "NOM_COMMERCIALE": "IMALEK 100",
    "FORME": "COMPRIME",
    "DOSAGE": "100MG",
    "COND": "B/10",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SUN PHARMACEUTICALS INDUSTRIES LTD",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/1/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "10/1/2012",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["imatinib"],
    "InteractionIndexLink": ["imatinib"],
    "N_ENREGISTREMENT": "330/ 05 C 113 /12",
    "CODE_DCI": "05 C 113",
    "DCI": "Imatinib mesylate exprime en Imatinib",
    "NOM_COMMERCIALE": "IMALEK 400",
    "FORME": "COMPRIME",
    "DOSAGE": "400MG",
    "COND": "B/06",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SUN PHARMACEUTICALS INDUSTRIES LTD",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/1/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "10/1/2012",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["imatinib"],
    "InteractionIndexLink": ["imatinib"],
    "N_ENREGISTREMENT": "182/ 05 C 113 /09/16",
    "CODE_DCI": "05 C 113",
    "DCI": "Imatinib mesylate exprime en Imatinib",
    "NOM_COMMERCIALE": "IMATIB 400",
    "FORME": "COMPRIME",
    "DOSAGE": "400mg",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CIPLA LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/7/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "6/3/2017",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["sunitinib"],
    "InteractionIndexLink": ["sunitinib"],
    "N_ENREGISTREMENT": "045/ 05 C 118 /07/13",
    "CODE_DCI": "05 C 118",
    "DCI": "SUNITINIB MALATE EXPRIME EN SUNITINIB",
    "NOM_COMMERCIALE": "SUTENT",
    "FORME": "GLES.",
    "DOSAGE": "12.5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PFIZER LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ROYAUME UNI",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/6/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "27/11/2013",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["sunitinib"],
    "InteractionIndexLink": ["sunitinib"],
    "N_ENREGISTREMENT": "045/ 05 C 119 /07/13",
    "CODE_DCI": "05 C 119",
    "DCI": "SUNITINIB MALATE EXPRIME EN SUNITINIB",
    "NOM_COMMERCIALE": "SUTENT",
    "FORME": "GLES.",
    "DOSAGE": "25MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PFIZER LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ROYAUME UNI",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/6/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "18/2/2013",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["sunitinib"],
    "InteractionIndexLink": ["sunitinib"],
    "N_ENREGISTREMENT": "045/ 05 C 120 /07/14",
    "CODE_DCI": "05 C 120",
    "DCI": "SUNITINIB MALATE EXPRIME EN SUNITINIB",
    "NOM_COMMERCIALE": "SUTENT",
    "FORME": "GLES.",
    "DOSAGE": "50MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PFIZER LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ROYAUME UNI",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/6/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "18/11/2014",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["lapatinib"],
    "InteractionIndexLink": ["lapatinib"],
    "N_ENREGISTREMENT": "068/ 05 C 137 /09/17",
    "CODE_DCI": "05 C 137",
    "DCI": "LAPATINIB DITOSYLATE EXPRIME EN LAPATINIB",
    "NOM_COMMERCIALE": "TYKERB",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "250MG",
    "COND": "B/70",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVARTIS PHARMA SCHWEIZ AG",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SUISSE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/5/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "25/12/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["dasatinib"],
    "InteractionIndexLink": ["dasatinib"],
    "N_ENREGISTREMENT": "001/ 05 C 144 /21",
    "CODE_DCI": "05 C 144",
    "DCI": "Dasatinib monohydraté exprimé en Dasatinib",
    "NOM_COMMERCIALE": "ELPIX",
    "FORME": "Comprimé pelliculé",
    "DOSAGE": "20MG",
    "COND": "B/60",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMA ALGERIA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "21/3/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "21/3/2021",
    "TYPE": "Gé",
    "STATUT": "F prémix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["dasatinib"],
    "InteractionIndexLink": ["dasatinib"],
    "N_ENREGISTREMENT": "017/ 05 C 144 /09/17",
    "CODE_DCI": "05 C 144",
    "DCI": "DASATINIB MONOHYDRATEE",
    "NOM_COMMERCIALE": "SPRYCEL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "20MG",
    "COND": "B/60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BRISTOL MYERS SQUIBB PHARMA EEIG",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ROYAUME UNI",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/10/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "7/1/2018",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["dasatinib"],
    "InteractionIndexLink": ["dasatinib"],
    "N_ENREGISTREMENT": "001/ 05 C 145 /21",
    "CODE_DCI": "05 C 145",
    "DCI": "Dasatinib monohydraté exprimé en Dasatinib",
    "NOM_COMMERCIALE": "ELPIX",
    "FORME": "Comprimé pelliculé",
    "DOSAGE": "50MG",
    "COND": "B/60",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMA ALGERIA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "21/3/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "21/3/2021",
    "TYPE": "Gé",
    "STATUT": "F prémix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["dasatinib"],
    "InteractionIndexLink": ["dasatinib"],
    "N_ENREGISTREMENT": "001/ 05 C 146 /21",
    "CODE_DCI": "05 C 146",
    "DCI": "Dasatinib monohydraté exprimé en Dasatinib",
    "NOM_COMMERCIALE": "ELPIX",
    "FORME": "Comprimé pelliculé",
    "DOSAGE": "70MG",
    "COND": "B/60",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMA ALGERIA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "21/3/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "21/3/2021",
    "TYPE": "Gé",
    "STATUT": "F prémix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["nilotinib"],
    "InteractionIndexLink": ["nilotinib"],
    "N_ENREGISTREMENT": "068/ 05 C 148 /13",
    "CODE_DCI": "05 C 148",
    "DCI": "NILOTINIB CHLORHYDRATE MONOHYDRATE EXPRIME EN NILOTINIB",
    "NOM_COMMERCIALE": "TASIGNA",
    "FORME": "GLES.",
    "DOSAGE": "200MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVARTIS PHARMA SCHWEIZ AG",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SUISSE",
    "DATE_D_ENREGISTREMENT_INITIAL": "21/7/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "21/7/2013",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["gefitinib"],
    "InteractionIndexLink": ["gefitinib"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "05 C 163",
    "DCI": "GEFITINIB",
    "NOM_COMMERCIALE": "IRESSA",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "250MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ASRAZENECA AB",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SUEDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/8/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "19/8/2013",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "48 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["pazopanib"],
    "InteractionIndexLink": ["pazopanib"],
    "N_ENREGISTREMENT": "262/ 05 C 166 /14",
    "CODE_DCI": "05 C 166",
    "DCI": "PAZOPANIB CHLORHYDRATE EXPRIME EN PAZOPANIB",
    "NOM_COMMERCIALE": "VOTRIENT",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "200MG",
    "COND": "PILULIER/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVARTIS PHARMA SCHWEIZ AG",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SUISSE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/4/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "15/4/2014",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["pazopanib"],
    "InteractionIndexLink": ["pazopanib"],
    "N_ENREGISTREMENT": "068/ 05 C 167 /14",
    "CODE_DCI": "05 C 167",
    "DCI": "PAZOPANIB CHLORHYDRATE EXPRIME EN PAZOPANIB",
    "NOM_COMMERCIALE": "VOTRIENT",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "400MG",
    "COND": "PILULIER/60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVARTIS PHARMA SCHWEIZ AG",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SUISSE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/4/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "15/4/2014",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["erlotinib"],
    "InteractionIndexLink": ["erlotinib"],
    "N_ENREGISTREMENT": "488/ 05 C 174 /14",
    "CODE_DCI": "05 C 174",
    "DCI": "ERLOTINIB CHLORHYDRATE EXPRIME EN ERLOTINIB",
    "NOM_COMMERCIALE": "BIRLOTIB",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "100MG",
    "COND": "PILULIER/10",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BDR PHARMACEUTICALS INTERNATIONAL PVT LTD",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/12/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "30/12/2014",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["erlotinib"],
    "InteractionIndexLink": ["erlotinib"],
    "N_ENREGISTREMENT": "001/ 05 C 174 /21",
    "CODE_DCI": "05 C 174",
    "DCI": "Erlotinib Chlorhydrate exprimé en Erlotinib",
    "NOM_COMMERCIALE": "MIRATA",
    "FORME": "Comprimé pelliculé",
    "DOSAGE": "100MG",
    "COND": "B/10",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMA ALGERIA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "14/4/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "14/4/2021",
    "TYPE": "Gé",
    "STATUT": "F prémix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["erlotinib"],
    "InteractionIndexLink": ["erlotinib"],
    "N_ENREGISTREMENT": "488/ 05 C 175 /14",
    "CODE_DCI": "05 C 175",
    "DCI": "ERLOTINIB CHLORHYDRATE EXPRIME EN ERLOTINIB",
    "NOM_COMMERCIALE": "BIRLOTIB",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "150MG",
    "COND": "PILULIER/10",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BDR PHARMACEUTICALS INTERNATIONAL PVT LTD",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/12/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "30/12/2014",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["erlotinib"],
    "InteractionIndexLink": ["erlotinib"],
    "N_ENREGISTREMENT": "001/ 05 C 175 /21",
    "CODE_DCI": "05 C 175",
    "DCI": "Erlotinib Chlorhydrate exprimé en Erlotinib",
    "NOM_COMMERCIALE": "MIRATA",
    "FORME": "Comprimé pelliculé",
    "DOSAGE": "150MG",
    "COND": "B/10",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMA ALGERIA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "14/4/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "14/4/2021",
    "TYPE": "Gé",
    "STATUT": "F prémix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["regorafenib"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "424/ 05 C 179 /15",
    "CODE_DCI": "05 C 179",
    "DCI": "REGORAFENIB",
    "NOM_COMMERCIALE": "STIVARGRA",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "40MG",
    "COND": "B/1 FLACON DE 28  B/3 FLACONS DE 28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BAYER PHARMA AG",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "Allemagne",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/12/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "29/12/2015",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["everolimus"],
    "InteractionIndexLink": ["everolimus"],
    "N_ENREGISTREMENT": "068/05 C 186/17",
    "CODE_DCI": "05 C 186",
    "DCI": "EVEROLIMUS",
    "NOM_COMMERCIALE": "AFINITOR",
    "FORME": "COMPRIME",
    "DOSAGE": "5MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVARTIS PHARMA SCHWEIZ AG",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SUISSE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/3/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "29/3/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["everolimus"],
    "InteractionIndexLink": ["everolimus"],
    "N_ENREGISTREMENT": "068/05 C 187/17",
    "CODE_DCI": "05 C 187",
    "DCI": "EVEROLIMUS",
    "NOM_COMMERCIALE": "AFINITOR",
    "FORME": "COMPRIME",
    "DOSAGE": "10 MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVARTIS PHARMA SCHWEIZ AG",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SUISSE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/3/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "29/3/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["afatinib"],
    "InteractionIndexLink": ["afatinib"],
    "N_ENREGISTREMENT": "152/ 05 C 192/17",
    "CODE_DCI": "05 C 192",
    "DCI": "Afatinib dimaléate exprimé en afatinib",
    "NOM_COMMERCIALE": "GIOTRIF",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "20 MG",
    "COND": "B/ 28",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BOEHRINGER INGELHEIM INTERNATIONAL GMBH",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALLEMAGNE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/1/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "7/1/2018",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["afatinib"],
    "InteractionIndexLink": ["afatinib"],
    "N_ENREGISTREMENT": "152/ 05 C 193 /18",
    "CODE_DCI": "05 C 193",
    "DCI": "Afatinib dimaléate exprimé en afatinib",
    "NOM_COMMERCIALE": "GIOTRIF",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "30 MG",
    "COND": "B/ 28",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BOEHRINGER INGELHEIM INTERNATIONAL GMBH",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALLEMAGNE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/4/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "18/4/2018",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["afatinib"],
    "InteractionIndexLink": ["afatinib"],
    "N_ENREGISTREMENT": "152/ 05 C 194 /18",
    "CODE_DCI": "05 C 194",
    "DCI": "Afatinib dimaléate exprimé en afatinib",
    "NOM_COMMERCIALE": "GIOTRIF",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "40 MG",
    "COND": "B/ 28",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BOEHRINGER INGELHEIM INTERNATIONAL GMBH",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALLEMAGNE",
    "DATE_D_ENREGISTREMENT_INITIAL": "8/4/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "8/4/2018",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["palbociclib"],
    "InteractionIndexLink": ["palbociclib"],
    "N_ENREGISTREMENT": "045/ 05 C 196 /18",
    "CODE_DCI": "05 C 196",
    "DCI": "Palbociclib",
    "NOM_COMMERCIALE": "IBRANCE",
    "FORME": "GéLULE",
    "DOSAGE": "75 MG",
    "COND": "PILULIER DE 21",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PFIZER INC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ETATS UNIS D'AMERIQUE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/1/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "7/1/2018",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["palbociclib"],
    "InteractionIndexLink": ["palbociclib"],
    "N_ENREGISTREMENT": "045/ 05 C 197 /18",
    "CODE_DCI": "05 C 197",
    "DCI": "Palbociclib",
    "NOM_COMMERCIALE": "IBRANCE",
    "FORME": "GéLULE",
    "DOSAGE": "100 MG",
    "COND": "PILULIER DE 21",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PFIZER INC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ETATS UNIS D'AMERIQUE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/1/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "7/1/2018",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["palbociclib"],
    "InteractionIndexLink": ["palbociclib"],
    "N_ENREGISTREMENT": "045/ 05C 198 /18",
    "CODE_DCI": "05 C 198",
    "DCI": "Palbociclib",
    "NOM_COMMERCIALE": "IBRANCE",
    "FORME": "GéLULE",
    "DOSAGE": "125 MG",
    "COND": "PILULIER DE 21",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PFIZER INC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ETATS UNIS D'AMERIQUE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/1/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "7/1/2018",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["crizotinib"],
    "InteractionIndexLink": ["crizotinib"],
    "N_ENREGISTREMENT": "045/ 05 C 199/18",
    "CODE_DCI": "05 C 199",
    "DCI": "Crizotinib",
    "NOM_COMMERCIALE": "XALKORI",
    "FORME": "GéLULE",
    "DOSAGE": "200 MG",
    "COND": "PILULIER DE  60",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PFIZER CANADA INC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CANADA",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/5/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "22/5/2018",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["crizotinib"],
    "InteractionIndexLink": ["crizotinib"],
    "N_ENREGISTREMENT": "045/ 05 C 200 /18",
    "CODE_DCI": "05 C 200",
    "DCI": "Crizotinib",
    "NOM_COMMERCIALE": "XALKORI",
    "FORME": "GéLULE",
    "DOSAGE": "250 MG",
    "COND": "PILULIER DE  60",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PFIZER CANADA INC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CANADA",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/5/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "22/5/2018",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["nilotinib"],
    "InteractionIndexLink": ["nilotinib"],
    "N_ENREGISTREMENT": "068/ 05 C 201 /18",
    "CODE_DCI": "05 C 201",
    "DCI": "NILOTINIB CHLORHYDRATE MONOHYDRATE EXPRIME EN NILOTINIB",
    "NOM_COMMERCIALE": "TASIGNA",
    "FORME": "GLES.",
    "DOSAGE": "150 MG",
    "COND": "B/112",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVARTIS PHARMA SCHWEIZ AG",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SUISSE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/3/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "19/3/2018",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["ibrutinib"],
    "InteractionIndexLink": ["ibrutinib"],
    "N_ENREGISTREMENT": "095/ 05 C 213 /18",
    "CODE_DCI": "05 C 213",
    "DCI": "Ibrutinib",
    "NOM_COMMERCIALE": "IMBRUVICA",
    "FORME": "GLES.",
    "DOSAGE": "140 MG",
    "COND": "PILULIER DE 90",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JANSSEN CILAG INTERNATIONAL N.V.",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "Belgique",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/9/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "7/9/2018",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36  MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["axitinib"],
    "InteractionIndexLink": ["axitinib"],
    "N_ENREGISTREMENT": "045/ 05 C 214 /19",
    "CODE_DCI": "05 C 214",
    "DCI": "Axitinib",
    "NOM_COMMERCIALE": "INLYTA",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "1 MG",
    "COND": "B/56",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PFIZER AG",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SUISSE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/3/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "24/3/2019",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["axitinib"],
    "InteractionIndexLink": ["axitinib"],
    "N_ENREGISTREMENT": "045/ 05 C 215 /19",
    "CODE_DCI": "05 C 215",
    "DCI": "Axitinib",
    "NOM_COMMERCIALE": "INLYTA",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "5 MG",
    "COND": "B/56",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PFIZER AG",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SUISSE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/3/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "17/3/2019",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["afatinib"],
    "InteractionIndexLink": ["afatinib"],
    "N_ENREGISTREMENT": "152/ 05 C 195 /18",
    "CODE_DCI": "05 C195",
    "DCI": "Afatinib dimaléate exprimé en afatinib",
    "NOM_COMMERCIALE": "GIOTRIF",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "50 MG",
    "COND": "B/ 28",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BOEHRINGER INGELHEIM INTERNATIONAL GMBH",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALLEMAGNE",
    "DATE_D_ENREGISTREMENT_INITIAL": "8/4/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "8/4/2018",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["rituximab"],
    "InteractionIndexLink": ["rituximab"],
    "N_ENREGISTREMENT": "128/ 05 D 109 /06/17",
    "CODE_DCI": "05 D 109",
    "DCI": "RITUXIMAB",
    "NOM_COMMERCIALE": "MABTHERA",
    "FORME": "SOL. CONC. A DILUER P. PERF.",
    "DOSAGE": "10MG/ML (100MG/10ML ET 500MG/50ML)",
    "COND": "B/2FL. DE 10ML  ET  B/1FL. DE 50ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ROCHE PHARMA (SCHWEIZ) Ltd",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SUISSE",
    "DATE_D_ENREGISTREMENT_INITIAL": "23/7/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "12/3/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "30 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["rituximab"],
    "InteractionIndexLink": ["rituximab"],
    "N_ENREGISTREMENT": "21/05 D 109/080",
    "CODE_DCI": "05 D 109",
    "DCI": "RITUXIMAB",
    "NOM_COMMERCIALE": "RIXATHON",
    "FORME": "SOL. CONCENTREE A DILUER POUR PERFUSION",
    "DOSAGE": "10MG/ML",
    "COND": "B/ 2 FLC 10 ML (100MG/10ML) ET B/1 FLC DE 50ML (500MG/50ML)",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANDOZ GmbH Autriche",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "AUTRICHE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/05/21",
    "DATE_D_ENREGISTREMENT_FINAL": "12/05/21",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS (2° A 8°)",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["trastuzumab emtansine (rch)"],
    "InteractionIndexLink": ["trastuzumab emtansine"],
    "N_ENREGISTREMENT": "494/ 05 D 112 /15",
    "CODE_DCI": "05 D 112",
    "DCI": "TRASTUZUMAB",
    "NOM_COMMERCIALE": "CANMAB 150",
    "FORME": "PDRE. ET SOLV. P. SOL. A DILUER P. PERF. IV",
    "DOSAGE": "150MG/FL. DE PDRE",
    "COND": "B/01 FL. DE PDRE. + B/01 FL. DE SOLV. DE 10ML (EAU BACTERIOSTATIQUE POUR INJECTION)",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOCON LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/9/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "2/9/2015",
    "TYPE": "Bio",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["trastuzumab emtansine (rch)"],
    "InteractionIndexLink": ["trastuzumab emtansine"],
    "N_ENREGISTREMENT": "128/ 05 D 112 /06/14",
    "CODE_DCI": "05 D 112",
    "DCI": "TRASTUZUMAB",
    "NOM_COMMERCIALE": "HERCEPTIN",
    "FORME": "LYOPH. SOL. INJ.",
    "DOSAGE": "150MG/FL. DE LYOPH.",
    "COND": "B/01FL. DE LYOPH.",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ROCHE PHARMA (SCHWEIZ) Ltd",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SUISSE",
    "DATE_D_ENREGISTREMENT_INITIAL": "23/7/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "21/1/2014",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "48 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["trastuzumab emtansine (rch)"],
    "InteractionIndexLink": ["trastuzumab emtansine"],
    "N_ENREGISTREMENT": "21/05 D 112/001",
    "CODE_DCI": "05 D 112",
    "DCI": "TRASTUZUMAB",
    "NOM_COMMERCIALE": "HERZUMA",
    "FORME": "POUDRE POUR SOL. A DILUER POUR PERFUSION",
    "DOSAGE": "150MG",
    "COND": "B/1 FLC DE 20ML",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMA ALGERIA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "08/06/21",
    "DATE_D_ENREGISTREMENT_FINAL": "08/06/21",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS (2° A 8°)",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["trastuzumab emtansine (rch)"],
    "InteractionIndexLink": ["trastuzumab emtansine"],
    "N_ENREGISTREMENT": "21/05 D 112/481",
    "CODE_DCI": "05 D 112",
    "DCI": "TRASTUZUMAB",
    "NOM_COMMERCIALE": "KANJINTI",
    "FORME": "POUDRE POUR SOL. A DILUER POUR PERFUSION",
    "DOSAGE": "150MG",
    "COND": "B/1 FLC DE 20ML",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "AMGEN EUROPE B.V. (ABR)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PAYS BAS",
    "DATE_D_ENREGISTREMENT_INITIAL": "09/05/21",
    "DATE_D_ENREGISTREMENT_FINAL": "09/05/21",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS (2° A 8°)",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["trastuzumab emtansine (rch)"],
    "InteractionIndexLink": ["trastuzumab emtansine"],
    "N_ENREGISTREMENT": "21/05 D 112/045",
    "CODE_DCI": "05 D 112",
    "DCI": "TRASTUZUMAB",
    "NOM_COMMERCIALE": "TRAZIMERA",
    "FORME": "POUDRE POUR SOL. A DILUER POUR PERFUSION",
    "DOSAGE": "150MG/FLC DE POUDRE",
    "COND": "B/1 FLC DE 15 ML",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PFIZER EUROPE MA EEIG",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BELGIQUE",
    "DATE_D_ENREGISTREMENT_INITIAL": "06/06/21",
    "DATE_D_ENREGISTREMENT_FINAL": "06/06/21",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "48 MOIS (2° A 8°)",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["bevacizumab"],
    "InteractionIndexLink": ["bevacizumab"],
    "N_ENREGISTREMENT": "21/05 D 134/481",
    "CODE_DCI": "05 D 134",
    "DCI": "BEVACIZUMAB",
    "NOM_COMMERCIALE": "MVASI",
    "FORME": "POUDRE POUR SOL. A DILUER POUR PERFUSION",
    "DOSAGE": "25MG/ML",
    "COND": "B/1 FLC DE 4ML ET B/ 1 FLC DE 16 ML (400MG/16ML)",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "AMGEN TECHNOLOGY UNLIMITED COMPANY (AMGEN DUN LAOGHAIRE)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "IRLANDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "03/05/21",
    "DATE_D_ENREGISTREMENT_FINAL": "03/05/21",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS (2° A 8°)",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["cetuximab"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "062/ 05 D 157 /12",
    "CODE_DCI": "05 D 157",
    "DCI": "CETUXIMAB",
    "NOM_COMMERCIALE": "ERBITUX",
    "FORME": "SOL. INJ. P. PERF.",
    "DOSAGE": "5MG/ML (100MG/20ML - 500MG/100ML)",
    "COND": "B/1FL. DE 20ML ET B/1FL. DE 100ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MERCK KG Aa",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALLEMAGNE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/1/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "10/1/2012",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["panitumumab"],
    "InteractionIndexLink": ["panitumumab"],
    "N_ENREGISTREMENT": "481/ 05 D 169 /15",
    "CODE_DCI": "05 D 169",
    "DCI": "PANITUMUMAB",
    "NOM_COMMERCIALE": "VECTIBIX",
    "FORME": "SOL. A DILUER P. PERF. IV",
    "DOSAGE": "20MG/ML (100MG/5ML) (400MG/20ML)",
    "COND": "B/01 FL. DE 5ML ; B/01 FL. DE 20ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "AMGEN EUROPE B.V.",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PAYS BAS",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/8/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "9/8/2015",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["infliximab"],
    "InteractionIndexLink": ["infliximab"],
    "N_ENREGISTREMENT": "095/ 05 D 170 /14",
    "CODE_DCI": "05 D 170",
    "DCI": "INFLIXIMAB",
    "NOM_COMMERCIALE": "REMICADE",
    "FORME": "PDRE P. SOL A DILUER P. PERF IV",
    "DOSAGE": "100MG/FL (10MG/ML APRES RECONSTITUTION)",
    "COND": "B/01FL",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JANSSEN BIOLOGICS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PAYS BAS",
    "DATE_D_ENREGISTREMENT_INITIAL": "23/9/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "23/9/2014",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["infliximab"],
    "InteractionIndexLink": ["infliximab"],
    "N_ENREGISTREMENT": "001/05 D 170/17",
    "CODE_DCI": "05 D 170",
    "DCI": "INFLIXIMAB",
    "NOM_COMMERCIALE": "REMSIMA",
    "FORME": "PDRE P. SOL A DILUER P. PERF  IV",
    "DOSAGE": "100MG/FL",
    "COND": "B/01FL DE POUDRE",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMA ALGERIA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "14/9/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "14/9/2017",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["trastuzumab emtansine (rch)"],
    "InteractionIndexLink": ["trastuzumab emtansine"],
    "N_ENREGISTREMENT": "450/ 05 D 178 /15",
    "CODE_DCI": "05 D 178",
    "DCI": "Trastuzumab",
    "NOM_COMMERCIALE": "HERTRAZ 440",
    "FORME": "PDRE. ET SOLV. P. SOL. A DILUER P. PERF. IV",
    "DOSAGE": "440MG/FL. DE PDRE.",
    "COND": "B/01 FL. DE PDRE. + B/02 FL. DE SOLV. DE 10ML (EAU BACTERIOSTATIQUE POUR INJECTION)",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MYLAN LABORATORIES LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/9/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "2/9/2015",
    "TYPE": "",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["brentuximab vedotin"],
    "InteractionIndexLink": ["brentuximab"],
    "N_ENREGISTREMENT": "411/05 D 189/17",
    "CODE_DCI": "05 D 189",
    "DCI": "BRENTUXIMAB VEDOTIN TAKEDA",
    "NOM_COMMERCIALE": "ADCETRIS",
    "FORME": "POUDRE POUR SOLUTION A DILUER POUR PERFUSION",
    "DOSAGE": "5 MG / ML",
    "COND": "B/01 FLACON",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "TAKEDA PHARMA A/S",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "DANEMARK",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/12/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "13/12/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["pembrolizumab"],
    "InteractionIndexLink": ["pembrolizumab"],
    "N_ENREGISTREMENT": "024/ 05 D 202 /17",
    "CODE_DCI": "05 D 202",
    "DCI": "Pembrolizumab",
    "NOM_COMMERCIALE": "KEYTRUDA",
    "FORME": "SOLUTION à DILUER POUR PERFUSION",
    "DOSAGE": "25 MG/ML",
    "COND": "B/ 01 FL DE 04  ML ( 100 MG/4ML)",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MERCK SCHARP & DOHME LTD",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ROYAUME UNI",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/1/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "7/1/2018",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["trastuzumab emtansine (rch)"],
    "InteractionIndexLink": ["trastuzumab emtansine"],
    "N_ENREGISTREMENT": "128/05 D 203/17",
    "CODE_DCI": "05 D 203",
    "DCI": "Trastuzumab emtansine",
    "NOM_COMMERCIALE": "KADCYLA",
    "FORME": "POUDRE POUR SOLUTION A DILUER POUR PERFUSION",
    "DOSAGE": "20 MG/ML",
    "COND": "B/01 FL.100MG DE PDRE (100MG/5ML) ET  B/01 FL. 160MG ( 160MG/8ML)",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ROCHE PHARMA (SCHWEIZ) AG",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SUISSE",
    "DATE_D_ENREGISTREMENT_INITIAL": "16/1/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "16/1/2018",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["pertuzumab"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "128 / 05 D 204 /17",
    "CODE_DCI": "05 D 204",
    "DCI": "Pertuzumab",
    "NOM_COMMERCIALE": "PERJETA",
    "FORME": "SOLUTION à DILUER POUR PERFUSION IV",
    "DOSAGE": "30 MG/ML",
    "COND": "B/ 01 FL DE 14  ML ( 420 MG/14ML)",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ROCHE PHARMA (SWHWEIZ) AG",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SUISSE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/1/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "7/1/2018",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["nivolumab"],
    "InteractionIndexLink": ["nivolumab"],
    "N_ENREGISTREMENT": "017 / 05 D 205 /18",
    "CODE_DCI": "05 D 205",
    "DCI": "Nivolumab",
    "NOM_COMMERCIALE": "OPDIVO",
    "FORME": "SOLUTION à DILUER POUR PERFUSION",
    "DOSAGE": "10 MG/ML",
    "COND": "B/ 01 FL DE 4  ML ( 40 MG/4ML) ET B/ 01 FL DE 10  ML ( 100 MG/10 ML)",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BRISTOL-MYERS SQUIBB PHARMA EEIG",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ROYAUME UNI",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/4/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "1/4/2018",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["blinatumomab (rch)"],
    "InteractionIndexLink": ["blinatumomab"],
    "N_ENREGISTREMENT": "481/05 D 216/19",
    "CODE_DCI": "05 D 216",
    "DCI": "BLINATUMOMAB",
    "NOM_COMMERCIALE": "BLINCYTO",
    "FORME": "LYOPHILISAT A DILUER P/ SOL INJ I.V",
    "DOSAGE": "35µG/FLACON",
    "COND": "B/01 FL DE LYOPHILISAT (12.5µG/ML) ET 01 FL/10ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "AMGEN INC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "USA",
    "DATE_D_ENREGISTREMENT_INITIAL": "16/7/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "16/7/2019",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "60 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["ramucirumab (rmc)"],
    "InteractionIndexLink": ["ramucirumab"],
    "N_ENREGISTREMENT": "034/ 05 D 220/ 19",
    "CODE_DCI": "05 D 220",
    "DCI": "Ramucirumab",
    "NOM_COMMERCIALE": "CYRAMZA",
    "FORME": "SOL A DILUER P. PERF IV",
    "DOSAGE": "10 MG/ML",
    "COND": "B/01 FL DE 10 ML (100MG/10ML) ET  B/01 DE FL 50 ML ( 500MG/50 ML)",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ELI LILLY AND COMPANY",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "USA",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/2/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "10/2/2019",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["golimumab"],
    "InteractionIndexLink": ["golimumab"],
    "N_ENREGISTREMENT": "20/05 D222/095",
    "CODE_DCI": "05 D 222",
    "DCI": "GOLIMUMAB",
    "NOM_COMMERCIALE": "SIMPONI",
    "FORME": "SOL INJ S/C EN STYLO PREREMPLI",
    "DOSAGE": "50MG/STYLO",
    "COND": "B/1 STYLO DE 0.5 ML",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES JANSSEN BIOLOGICS B.V.",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PAYS BAS",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/08/20",
    "DATE_D_ENREGISTREMENT_FINAL": "13/08/20",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "18 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["leuprorelin"],
    "InteractionIndexLink": ["leuproreline"],
    "N_ENREGISTREMENT": "411/ 05 E 121 /08/17",
    "CODE_DCI": "05 E 121",
    "DCI": "LEUPRORELINE",
    "NOM_COMMERCIALE": "ENANTONE LP",
    "FORME": "PDRE. ET SOLV. POUR SUSP. INJ. S.C./I.M.  L.P.",
    "DOSAGE": "1.875 MG/ML (OU 3.75MG/2ML)",
    "COND": "B/1FL. DE PDRE. + 1AMP./2ML SOLV. + 1SERIN",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "TAKEDA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/7/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "21/6/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["leuprorelin"],
    "InteractionIndexLink": ["leuproreline"],
    "N_ENREGISTREMENT": "411/ 05 E 122 /08/17",
    "CODE_DCI": "05 E 122",
    "DCI": "Leuproréline acétate",
    "NOM_COMMERCIALE": "ENANTONE LP 11.25MG",
    "FORME": "MICROSPHERES ET SOL. POUR USAGE PARENT.S.C./I.M.  LP",
    "DOSAGE": "11.25MG/ FL. DE PDRE",
    "COND": "B/1FL. DE PDRE. + 1AMP./2ML SOLV. + 1SERIN.DE 2.5ML+ 3 AIGUILLES",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "TAKEDA FRANCE SAS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/7/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "14/6/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["tamoxifen"],
    "InteractionIndexLink": ["tamoxifene"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "05 E 136",
    "DCI": "TAMOXIFENE CITRATE EXPRIME EN TAMOXIFENE",
    "NOM_COMMERCIALE": "CYTOTAM-20",
    "FORME": "COMPRIME",
    "DOSAGE": "20MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cancerologie"]
  },
  {
    "PregnancyIndexLink": ["tamoxifen"],
    "InteractionIndexLink": ["tamoxifene"],
    "N_ENREGISTREMENT": "450/ 05 E 136 /07/15",
    "CODE_DCI": "05 E 136",
    "DCI": "TAMOXIFENE CITRATE EXPRIME EN TAMOXIFENE",
    "NOM_COMMERCIALE": "TAMOXIFENE MYLAN",
    "FORME": "COMPRIME",
    "DOSAGE": "20MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MYLAN SAS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/4/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "31/3/2015",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cancerologie"]
  },
  {
    "PregnancyIndexLink": ["triptorelin"],
    "InteractionIndexLink": ["triptoreline"],
    "N_ENREGISTREMENT": "020/ 05 E 140 /06/17",
    "CODE_DCI": "05 E 140",
    "DCI": "TRIPTORELINE PAMOATE EXPRIME EN TRIPTORELINE",
    "NOM_COMMERCIALE": "DECAPEPTYL  L.P.",
    "FORME": "PDRE. ET SOLVT. P.SUSP. INJ. IM ET S/C LP SUR 03MOIS",
    "DOSAGE": "11.25MG/FL. DE PDRE.",
    "COND": "B/01FL. DE PDRE + 01AMP. DE DE 2ML DE SOLVT. + SERINGUE + 03 AIGUILLES",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "IPSEN PHARMA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "31/7/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "14/6/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cancerologie"]
  },
  {
    "PregnancyIndexLink": ["abacavir"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "285/05 E 162/19",
    "CODE_DCI": "05 E 162",
    "DCI": "Abacavir sulfate experime en abacavir",
    "NOM_COMMERCIALE": "ABIRATERONE UPC",
    "FORME": "COMP",
    "DOSAGE": "250MG",
    "COND": "B/01 FL 120",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "UNION PHARMACEUTIQUE CONSTANTINOISE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "16/12/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "16/12/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["abacavir"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "488/05 E 162/19",
    "CODE_DCI": "05 E 162",
    "DCI": "Abacavir sulfate experime en abacavir",
    "NOM_COMMERCIALE": "ABIRON",
    "FORME": "COMP",
    "DOSAGE": "250MG",
    "COND": "B/120",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BDR PHARMACEUTICALS INTERNATIONAL P.V.T L.T.D",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/11/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "27/11/2019",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["abiraterone"],
    "InteractionIndexLink": ["abiraterone"],
    "N_ENREGISTREMENT": "001/ 05 E 162 /21",
    "CODE_DCI": "05 E 162",
    "DCI": "Acétate d'abiratérone",
    "NOM_COMMERCIALE": "ABREMIA",
    "FORME": "Comprimé",
    "DOSAGE": "250MG",
    "COND": "B/120",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMA ALGERIA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/2/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "7/2/2021",
    "TYPE": "Gé",
    "STATUT": "F prémix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["abacavir"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "095/ 05 E 162 /13",
    "CODE_DCI": "05 E 162",
    "DCI": "Abacavir sulfate experime en abacavir",
    "NOM_COMMERCIALE": "ZYTIGA",
    "FORME": "COMPRIME",
    "DOSAGE": "250MG",
    "COND": "B/1FL. DE 120",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JANSSEN-CILAG INTERNATIONA N.V",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BELGIQUE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/6/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "4/6/2013",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["fulvestrant"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "256/ 05 E 164 /13",
    "CODE_DCI": "05 E 164",
    "DCI": "FULVESTRANT",
    "NOM_COMMERCIALE": "FASLODEX",
    "FORME": "SOL. INJ. IM EN SERING. PREREMPL.",
    "DOSAGE": "250MG/SERING. DE 5ML",
    "COND": "B/2SERING. PREREMPL. DE 5ML AVEC 02AIGUILLES PROTEGEES (BD SAFETYGLIDE)",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ASTRAZENECA UK LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ROYAUME UNI",
    "DATE_D_ENREGISTREMENT_INITIAL": "8/10/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "8/10/2013",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["leuprorelin"],
    "InteractionIndexLink": ["leuproreline"],
    "N_ENREGISTREMENT": "374/ 05 E 171 /14",
    "CODE_DCI": "05 E 171",
    "DCI": "LEUPRORELINE ACETATE",
    "NOM_COMMERCIALE": "ELIGARD",
    "FORME": "PDRE. ET SOLV. P. SOL. INJ. SC DIFFUSION LENTE SUR 3 MOIS",
    "DOSAGE": "22.5MG",
    "COND": "B/01KIT DE 2 PLATEAUX THERMOFORMES CONTENANT : (01 SERING. PREREMP. D. SOLV. (SERING. A) + 01 PISTON A TIGE LONGUE) + (01 SERING. PREREMP. D. PDRE. (SERING. B) + 01 AIGUILLE STERILE 20G)",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ASTELLAS PHARMA EUROPE B.V.",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PAYS BAS",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/12/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "11/5/2016",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cancerologie"]
  },
  {
    "PregnancyIndexLink": ["leuprorelin"],
    "InteractionIndexLink": ["leuproreline"],
    "N_ENREGISTREMENT": "374/ 05 E 172 /14",
    "CODE_DCI": "05 E 172",
    "DCI": "LEUPRORELINE ACETATE",
    "NOM_COMMERCIALE": "ELIGARD",
    "FORME": "PDRE. ET SOLV. P. SOL. INJ. SC DIFFUSION LENTE SUR 6 MOIS",
    "DOSAGE": "45MG",
    "COND": "B/01KIT DE 2 PLATEAUX THERMOFORMES CONTENANT : (01 SERING. PREREMP. D. SOLV. (SERING. A) + 01 PISTON A TIGE LONGUE) + (01 SERING. PREREMP. D. PDRE. (SERING. B) + 01 AIGUILLE STERILE 18G)",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ASTELLAS PHARMA EUROPE B.V.",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PAYS BAS",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/12/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "11/5/2016",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cancerologie"]
  },
  {
    "PregnancyIndexLink": ["enzalutamide"],
    "InteractionIndexLink": ["enzalutamide"],
    "N_ENREGISTREMENT": "374/ 05 E 190 /17",
    "CODE_DCI": "05 E 190",
    "DCI": "Enzalutamide",
    "NOM_COMMERCIALE": "XTANDI",
    "FORME": "CAPSULE MOLLE",
    "DOSAGE": "40MG",
    "COND": "B/04 POCHETTES DE 08 (112 CAPS MOLLES )",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ASTELLAS PHARMA EUROPE B.V.",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PAYS BAS",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/12/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "13/12/2017",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["acide zoledronique"],
    "N_ENREGISTREMENT": "001/ 05 F 123 /14",
    "CODE_DCI": "05 F 123",
    "DCI": "ACIDE ZOLEDRONIQUE MONOHYDRATE (EXPRIME EN ACIDE ZOLEDRONIQUE)",
    "NOM_COMMERCIALE": "ACIDE ZOLEDRONIQUE HIKMA",
    "FORME": "PDRE LYOPHILISEE P/ PERF IV",
    "DOSAGE": "4MG/FLACON",
    "COND": "B/01 FL DE PDRE",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMACEUTICALS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/6/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "1/6/2014",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cancerologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["acide zoledronique"],
    "N_ENREGISTREMENT": "330/ 05 F 123 /12",
    "CODE_DCI": "05 F 123",
    "DCI": "ACIDE ZOLEDRONIQUE MONOHYDRATEE EXPRIME EN ACIDE ZOLEDRONIQUE ANHYDRE",
    "NOM_COMMERCIALE": "ZOBONE",
    "FORME": "LYOPH. P. SOL. INJ. IV",
    "DOSAGE": "4MG/FL. DE LYOPH.",
    "COND": "B/01FL. DE LYOPH. DE CONTENANCE DE 5ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SUN PHARMACEUTICALS INDUSTRIES LTD",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/1/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "10/1/2012",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cancerologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["acide zoledronique"],
    "N_ENREGISTREMENT": "128/05 F 123/10/16",
    "CODE_DCI": "05 F 123",
    "DCI": "ACIDE ZOLEDRONIQUE MONOHYDRATEE EXPRIME EN ACIDE ZOLEDRONIQUE ANHYDRE",
    "NOM_COMMERCIALE": "ZOLDRIA",
    "FORME": "LYOPH. ET SOLV. P. SOL. A DILUER P. PERF. IV",
    "DOSAGE": "4MG/FL. DE PDRE.",
    "COND": "B/1FL. DE PDRE. + 1AMP. DE 5ML DE SOLV. (EPPI)",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CIPLA LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "11/2/2010",
    "DATE_D_ENREGISTREMENT_FINAL": "4/1/2017",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cancerologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["acide zoledronique"],
    "N_ENREGISTREMENT": "176/ 05 F 123 /12",
    "CODE_DCI": "05 F 123",
    "DCI": "ACIDE ZOLEDRONIQUE MONOHYDRATEE EXPRIME EN ACIDE ZOLEDRONIQUE ANHYDRE",
    "NOM_COMMERCIALE": "ZOLENAT",
    "FORME": "SOL. CONC. P. PERF. IV",
    "DOSAGE": "4MG/FL. DE CONC.",
    "COND": "B/01FL. DE 5ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MUSTAFA NEVZAT ILAÇ SANAYII A.Ş",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "TURQUIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/5/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "6/5/2012",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cancerologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["acide zoledronique"],
    "N_ENREGISTREMENT": "433/ 05 F 123 /15/20",
    "CODE_DCI": "05 F 123",
    "DCI": "Acide zolédronique monohydraté exprimé en acide zolédronique anhydre",
    "NOM_COMMERCIALE": "ZOLIDRO",
    "FORME": "SOL. A DILUER P. PERF. IV",
    "DOSAGE": "0.8MG/ML (4MG/5ML)",
    "COND": "B/01 FL. DE 5ML",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRATER RAZES SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/6/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "27/8/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cancerologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["acide zoledronique"],
    "N_ENREGISTREMENT": "068/ 05 F 123 /08",
    "CODE_DCI": "05 F 123",
    "DCI": "ACIDE ZOLEDRONIQUE",
    "NOM_COMMERCIALE": "ZOMETA",
    "FORME": "SOL. A DILUER PERF.IV",
    "DOSAGE": "0.8MG/ML (4MG/5ML)",
    "COND": "B/01FL. DE 5ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVARTIS PHARMA SCHWEIZ AG",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SUISSE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/2/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "20/2/2008",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cancerologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["acide zoledronique"],
    "N_ENREGISTREMENT": "20/05 F 123/543",
    "CODE_DCI": "05 F 123",
    "DCI": "ACIDE ZOLEDRONIQUE",
    "NOM_COMMERCIALE": "ZOTHERA",
    "FORME": "SOL. A DILUER POUR PERFUSION IV",
    "DOSAGE": "4MG/5ML",
    "COND": "B/ 1 FLC DE 5ML",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES BIOTHERA SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/12/20",
    "DATE_D_ENREGISTREMENT_FINAL": "23/05/21",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cancerologie"]
  },
  {
    "PregnancyIndexLink": ["clodronate"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "424/ 05 F 153 /12",
    "CODE_DCI": "05 F 153",
    "DCI": "CLODRONATE DISODIQUE TETRAHYDRATE",
    "NOM_COMMERCIALE": "BONEFOS",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "800MG",
    "COND": "B/100",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BAYER OY",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FINLANDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "3/5/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "3/5/2012",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["acide zoledronique"],
    "N_ENREGISTREMENT": "068/ 05 F 165/14",
    "CODE_DCI": "05 F 165",
    "DCI": "ACIDE ZOLEDRONIQUE MONOHYDRATE EXPRIME EN ACIDE ZOLEDRONIQUE",
    "NOM_COMMERCIALE": "ACLASTA",
    "FORME": "SOL INJ P/PERF",
    "DOSAGE": "5MG/100ML",
    "COND": "B/01FL DE 100ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVARTIS PHARMA SCHWEIZ AG",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SUISSE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/1/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "6/1/2014",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["acide zoledronique"],
    "N_ENREGISTREMENT": "21/05 F165/380",
    "CODE_DCI": "05 F 165",
    "DCI": "ACIDE ZOLEDRONIQUE MONOHYDRATE EXPRIME EN ACIDE ZOLEDRONIQUE",
    "NOM_COMMERCIALE": "ZOLEDRIC",
    "FORME": "SOL.INJ P.PERF IV",
    "DOSAGE": "5MG/100ML",
    "COND": "FL/100ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "laboratoires HUP.P PHARMA Sarl",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/3/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "28/3/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["acide zoledronique"],
    "N_ENREGISTREMENT": "433 / 05 F 165 /20",
    "CODE_DCI": "05 F 165",
    "DCI": "Acide zolédronique monohydraté exprimé en acide zolédronique",
    "NOM_COMMERCIALE": "ZOLESTA",
    "FORME": "SOL. P/PERF IV",
    "DOSAGE": "5MG/100ML",
    "COND": "B/01FL DE 100ML",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRATER RAZES SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/3/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "25/3/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["acide zoledronique"],
    "N_ENREGISTREMENT": "521 / 05 F 165/18",
    "CODE_DCI": "05 F 165",
    "DCI": "Acide zoledronique monohydrate exprime en acide zoledronique",
    "NOM_COMMERCIALE": "ZOLTONAR",
    "FORME": "SOL  P/PERF",
    "DOSAGE": "5MG/100ML",
    "COND": "B/01FL DE 100ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "WORLD MEDECINE ILAC SAN VE TIC AS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "TURQUIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/4/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "1/4/2018",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["denosumab"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "481/ 05 F 176 /15",
    "CODE_DCI": "05 F 176",
    "DCI": "DENOSUMAB",
    "NOM_COMMERCIALE": "XGEVA",
    "FORME": "SOL. INJ. SC",
    "DOSAGE": "70MG/ML (120MG/1.7ML)",
    "COND": "B/01 FL. USAGE UNIQUE 1.7ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "AMGEN EUROPE B.V.",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PAYS BAS",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/4/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "12/4/2015",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["carmustine"],
    "InteractionIndexLink": ["carmustine"],
    "N_ENREGISTREMENT": "471/ 05 G 006 /13",
    "CODE_DCI": "05 G 006",
    "DCI": "CARMUSTINE",
    "NOM_COMMERCIALE": "CONSIUM",
    "FORME": "PDRE. P. SOL. INJ. IV",
    "DOSAGE": "100MG/FL. DE PDRE.",
    "COND": "B/1FL. DE PDRE.",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EMCURE PHARMACEUTICALS LTD",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "14/1/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "14/1/2013",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["cyclophosphamide"],
    "InteractionIndexLink": ["cyclophosphamide"],
    "N_ENREGISTREMENT": "298/ 05 G 009 /09/16",
    "CODE_DCI": "05 G 009",
    "DCI": "CYCLOPHOSPHAMIDE MONOHYDRATEE EXPRIME EN CYCLOPHOSPHAMIDE",
    "NOM_COMMERCIALE": "ENDOXAN",
    "FORME": "PDRE. P. SOL. INJ. IV",
    "DOSAGE": "200MG/FL. DE PDRE.",
    "COND": "B/1FL. DE PDRE. DE CONTENANCE 20ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BAXTER ONCOLOGY Gmbh",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALLEMAGNE",
    "DATE_D_ENREGISTREMENT_INITIAL": "11/7/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "19/7/2016",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["cyclophosphamide"],
    "InteractionIndexLink": ["cyclophosphamide"],
    "N_ENREGISTREMENT": "298/ 05 G 011 /12",
    "CODE_DCI": "05 G 011",
    "DCI": "CYCLOPHOSPHAMIDE MONOHYDRATEE EXPRIME EN CYCLOPHOSPHAMIDE",
    "NOM_COMMERCIALE": "ENDOXAN",
    "FORME": "COMP. ENRO.",
    "DOSAGE": "50MG",
    "COND": "B/50",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BAXTER ONCOLOGY GmbH",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALLEMAGNE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/7/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "13/7/2012",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["daunorubicin"],
    "InteractionIndexLink": ["daunorubicine"],
    "N_ENREGISTREMENT": "376 / 05 G 014 /96/17",
    "CODE_DCI": "05 G 014",
    "DCI": "DAUNORUBICINE CHLORHYDRATE EXPRIME EN DAUNORUBICINE",
    "NOM_COMMERCIALE": "CERUBIDINE",
    "FORME": "PDRE.SOL.POUR PERFUSION IV",
    "DOSAGE": "20MG",
    "COND": "B/10FL.",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANOFI AVENTIS France",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/10/1996",
    "DATE_D_ENREGISTREMENT_FINAL": "26/11/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "18 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["daunorubicin"],
    "InteractionIndexLink": ["daunorubicine"],
    "N_ENREGISTREMENT": "516/05 G 014/17",
    "CODE_DCI": "05 G 014",
    "DCI": "DAUNORUBICINE CHLORHYDRATE EXPRIME EN DAUNORUBICINE",
    "NOM_COMMERCIALE": "DAUNOCIN",
    "FORME": "POUDRE POUR SOLUTION INJECTABLE",
    "DOSAGE": "20 MG /FL",
    "COND": "B/01 FL DE POUDRE",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "KOREA UNITED PHARM INC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "COREE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/1/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "29/1/2017",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "18 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["daunorubicin"],
    "InteractionIndexLink": ["daunorubicine"],
    "N_ENREGISTREMENT": "182/ 05 G 014 /14",
    "CODE_DCI": "05 G 014",
    "DCI": "DAUNORUBICINE CHLORHYDRATE EXPRIME EN DAUNORUBICINE",
    "NOM_COMMERCIALE": "DAUNOTEC",
    "FORME": "LYOPHILISAT ET SOLVANT POUR SOL. INJ.",
    "DOSAGE": "20MG/FL. DE LYOPHILISAT",
    "COND": "B/01 FL. DE LYOPHILISAT + 01 FL. DE 10ML DE SOLVANT (NACL 0.9%)",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CIPLA LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/3/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "19/3/2014",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["doxorubicin"],
    "InteractionIndexLink": ["doxorubicine"],
    "N_ENREGISTREMENT": "182/ 05 G 015 /13",
    "CODE_DCI": "05 G 015",
    "DCI": "DOXORUBICINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "ONCODOX-10",
    "FORME": "LYOPH. P. SOL. INJ. IV",
    "DOSAGE": "10MG/FL. DE LYOPH.",
    "COND": "B/1FL. DE LYOPH.",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CIIPLA LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/5/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "29/5/2013",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["doxorubicin"],
    "InteractionIndexLink": ["doxorubicine"],
    "N_ENREGISTREMENT": "182/ 05 G 016 /13",
    "CODE_DCI": "05 G 016",
    "DCI": "DOXORUBICINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "ONCODOX-50",
    "FORME": "LYOPH. P. SOL. INJ. IV",
    "DOSAGE": "50MG/FL. DE LYOPH.",
    "COND": "B/1FL. DE LYOPH.",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CIIPLA LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/5/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "29/5/2013",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["etoposide"],
    "InteractionIndexLink": ["etoposide"],
    "N_ENREGISTREMENT": "450/ 05 G 019 /12",
    "CODE_DCI": "05 G 019",
    "DCI": "ETOPOSIDE",
    "NOM_COMMERCIALE": "ETOPOSIDE MYLAN",
    "FORME": "SOL. A DILUER P. PERF. IV",
    "DOSAGE": "20MG/ML (100MG/5ML)",
    "COND": "B/10FL. DE 5ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MYLAN SAS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "8/11/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "8/11/2012",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["vinblastine"],
    "InteractionIndexLink": ["vinblastine"],
    "N_ENREGISTREMENT": "516/05 G 038/17",
    "CODE_DCI": "05 G 038",
    "DCI": "VINBLASTINE SULFATE",
    "NOM_COMMERCIALE": "VELBASTINE",
    "FORME": "POUDRE ET SOLVANT POUR SOL INJ IV",
    "DOSAGE": "10 MG",
    "COND": "B/1 FLACON DE POUDRE ET 1 AMP DE 10 ML DE SOLVANT",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "KOREA UNITED PHARM INC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "COREE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/1/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "17/1/2017",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["fluorouracil"],
    "InteractionIndexLink": ["fluorouracile"],
    "N_ENREGISTREMENT": "516/05 G 059/16",
    "CODE_DCI": "05 G 059",
    "DCI": "FLUOROURACILE",
    "NOM_COMMERCIALE": "UTORAL",
    "FORME": "SOL INJ",
    "DOSAGE": "50MG/ML",
    "COND": "b/ 10 ampoules de 5 ml  (250 mg/5ml) .b/10 fl de 10 ml (500 mg/ml) .B/10 FL DE 20ML (1g/20ml)",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "KOREA UNITED PHARM INC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "COREE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/1/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "4/1/2017",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["docetaxel"],
    "InteractionIndexLink": ["docetaxel"],
    "N_ENREGISTREMENT": "330/ 05 G 071 /12",
    "CODE_DCI": "05 G 071",
    "DCI": "DOCETAXEL ANHYDRE",
    "NOM_COMMERCIALE": "DOCEFREZ 20",
    "FORME": "LYOPH. ET SOLV. P. PERF. IV",
    "DOSAGE": "20MG/FL. DE LYOPH.",
    "COND": "B/1FL. DE LYOPH.+1FL. DE 1ML DE SOLV. (POLYSORBATE-ETHANOL)",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SUN PHARMACEUTICALS INDUSTRIES LTD",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/1/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "10/1/2012",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["docetaxel"],
    "InteractionIndexLink": ["docetaxel"],
    "N_ENREGISTREMENT": "536/ 05 G 071 /19",
    "CODE_DCI": "05 G 071",
    "DCI": "DOCETAXEL ANHYDRE",
    "NOM_COMMERCIALE": "DOXTORED",
    "FORME": "SOL A DILUER. P. PERF. IV",
    "DOSAGE": "20MG/ML",
    "COND": "B/1FL. DE SOLUTION A DILUER DE 1 ML +1FL. DE SOLUTION A DILUER DE 4 ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "DR REDDY'S LABORATOIRES LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/6/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "26/6/2019",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["docetaxel"],
    "InteractionIndexLink": ["docetaxel"],
    "N_ENREGISTREMENT": "230/ 05 G 071 /97/13",
    "CODE_DCI": "05 G 071",
    "DCI": "DOCETAXEL TRIHYDRATE",
    "NOM_COMMERCIALE": "TAXOTERE",
    "FORME": "SOL. A DILUER P. PERF IV",
    "DOSAGE": "20MG/FL. DE 1ML",
    "COND": "B/1FL. DE 1ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "AVENTIS PHARMA S.A",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/8/1997",
    "DATE_D_ENREGISTREMENT_FINAL": "31/7/2013",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["docetaxel"],
    "InteractionIndexLink": ["docetaxel"],
    "N_ENREGISTREMENT": "330/ 05 G 072 /12",
    "CODE_DCI": "05 G 072",
    "DCI": "DOCETAXEL ANHYDRE",
    "NOM_COMMERCIALE": "DOCEFREZ 80",
    "FORME": "LYOPH. ET SOLV. P. PERF. IV",
    "DOSAGE": "80MG/FL. DE LYOPH.",
    "COND": "B/1FL. DE LYOPH.+1FL. DE 4ML DE SOLV. (POLYSORBATE-ETHANOL)",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SUN PHARMACEUTICALS INDUSTRIES LTD",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/1/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "10/1/2012",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["docetaxel"],
    "InteractionIndexLink": ["docetaxel"],
    "N_ENREGISTREMENT": "176/05 G 072/19",
    "CODE_DCI": "05 G 072",
    "DCI": "DOCETAXEL ANHYDRE",
    "NOM_COMMERCIALE": "TAXADOC",
    "FORME": "CONCENTRE ET SOLVANT P/ SOL A DILUER P/ PERF IV",
    "DOSAGE": "40MG/ML",
    "COND": "B/ 01 FL  DE SOLUTION CONCENTRE DE 2ML (80MG/2ML)+ 01 FL DE SOLVANT DE 6ML ET B/01 FL DE SOLUTION CONCENTRE DE 0.5ML  (20MG/0.5ML)+01 FL DE SOLVANT DE 1.5ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MUSTAFA  NEVZAT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "TURQUIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "16/7/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "16/7/2019",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["docetaxel"],
    "InteractionIndexLink": ["docetaxel"],
    "N_ENREGISTREMENT": "230/ 05 G 072 /97/13",
    "CODE_DCI": "05 G 072",
    "DCI": "DOCETAXEL TRIHYDRATE",
    "NOM_COMMERCIALE": "TAXOTERE",
    "FORME": "SOL. A DILUER P. PERF IV",
    "DOSAGE": "80MG/FL. DE 4ML",
    "COND": "B/1FL. DE 4ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "AVENTIS PHARMA S.A",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/8/1997",
    "DATE_D_ENREGISTREMENT_FINAL": "8/10/2013",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["fludarabine"],
    "InteractionIndexLink": ["fludarabine"],
    "N_ENREGISTREMENT": "339/ 05 G 075 /05/13",
    "CODE_DCI": "05 G 075",
    "DCI": "FLUDARABINE PHOSPHATE",
    "NOM_COMMERCIALE": "FLUDARA",
    "FORME": "LYOPH. P. SOL. INJ. P. PERF. IV",
    "DOSAGE": "50MG/FL. DE PDRE",
    "COND": "B/5FL. DE PDRE.",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GENZYME EUROPE BV",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PAYS BAS",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/9/2005",
    "DATE_D_ENREGISTREMENT_FINAL": "18/2/2013",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["irinotecan"],
    "InteractionIndexLink": ["irinotecan"],
    "N_ENREGISTREMENT": "001/05 G 076 / 20",
    "CODE_DCI": "05 G 076",
    "DCI": "Chlorhydrate d'Irinotécan trihydraté",
    "NOM_COMMERCIALE": "COLONTECANE",
    "FORME": "SOL. CONCENTRÉE.P. PERF. IV",
    "DOSAGE": "500MG",
    "COND": "B/120",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMACEUTICALS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/8/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "27/8/2020",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["irinotecan"],
    "InteractionIndexLink": ["irinotecan"],
    "N_ENREGISTREMENT": "182/ 05 G 076 /12",
    "CODE_DCI": "05 G 076",
    "DCI": "IRINOTECAN CHLORHYDRATE TRIHYDRATE",
    "NOM_COMMERCIALE": "ERTICAN",
    "FORME": "SOL. INJ. P. PERF. IV",
    "DOSAGE": "20MG/ML (40MG/2ML - 100MG/5ML)",
    "COND": "B/1FL. DE 2ML ET B/1FL. DE 5ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CIPLA LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/12/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "6/12/2012",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["irinotecan"],
    "InteractionIndexLink": ["irinotecan"],
    "N_ENREGISTREMENT": "450/ 05 G 076 /14",
    "CODE_DCI": "05 G 076",
    "DCI": "IRINOTECAN CHLORHYDRATE TRIHYDRATE",
    "NOM_COMMERCIALE": "IRINOTECAN MYLAN",
    "FORME": "SOL A DILUER P. PERF IV",
    "DOSAGE": "20MG/ML (100MG/5ML) (40MG/2ML)",
    "COND": "B/01FL DE 5ML ET B/01FL DE 2ML",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MYLAN SAS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "23/9/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "23/9/2014",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["irinotecan"],
    "InteractionIndexLink": ["irinotecan"],
    "N_ENREGISTREMENT": "176/ 05 G 076 /14",
    "CODE_DCI": "05 G 076",
    "DCI": "IRINOTECAN CHLORHYDRATE TRIHYDRATE",
    "NOM_COMMERCIALE": "TEKAMEN",
    "FORME": "SOL. P. PERF. IV",
    "DOSAGE": "20MG/ML (40MG/2ML) (100MG/5ML)",
    "COND": "B/01FL. DE 2 ML ET B/01FL. DE 5ML",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MUSTAFA NEVZAT ILAC SANAYII A.S (MN PHARMACEUTICALS)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "TURQUIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/10/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "13/10/2014",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["gemcitabine"],
    "InteractionIndexLink": ["gemcitabine"],
    "N_ENREGISTREMENT": "471/ 05 G 085 /13",
    "CODE_DCI": "05 G 085",
    "DCI": "GEMCITABINE CHLORHYDRATE EXPRIME EN GEMCITABINE",
    "NOM_COMMERCIALE": "CITAFINE",
    "FORME": "PDRE. P. SOL. INJ. IV",
    "DOSAGE": "1G/FL. DE PDRE.",
    "COND": "B/1FL. DE PDRE.",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EMCURE PHARMACEUTICALS LTD",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "14/1/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "14/1/2013",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["gemcitabine"],
    "InteractionIndexLink": ["gemcitabine"],
    "N_ENREGISTREMENT": "524/05 G 085/20",
    "CODE_DCI": "05 G 085",
    "DCI": "GEMCITABINE CHLORHYDRATE EXPRIME EN GEMCITABINE",
    "NOM_COMMERCIALE": "GEMTERO",
    "FORME": "LYOPHILISAT POUR SOLUTION POUR PERFUSION IV",
    "DOSAGE": "1G/FLC",
    "COND": "B/ 1 FLC",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HETERO LABS LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDIA",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/8/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "27/8/2020",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["oxaliplatin"],
    "InteractionIndexLink": ["oxaliplatine"],
    "N_ENREGISTREMENT": "450/ 05 G 089 /12",
    "CODE_DCI": "05 G 089",
    "DCI": "OXALIPLATINE",
    "NOM_COMMERCIALE": "OXALIPLATINE MYLAN",
    "FORME": "PDRE. P. SOL. P. PERF.",
    "DOSAGE": "50MG/FL. DE PDRE. (5MG/ML DE SOL. RECONSTITUEE)",
    "COND": "B/1FL. DE PDRE.",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MYLAN SAS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "5/12/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "5/12/2012",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["oxaliplatin"],
    "InteractionIndexLink": ["oxaliplatine"],
    "N_ENREGISTREMENT": "330/ 05 G 089 /12",
    "CODE_DCI": "05 G 089",
    "DCI": "OXALIPLATINE",
    "NOM_COMMERCIALE": "OXIPLAT 50",
    "FORME": "CONC. A DILUER P. PERF. IV",
    "DOSAGE": "50MG/FL. DE CONC. (5MG/ML OU 50MG/10ML)",
    "COND": "B/1FL. DE CONC. DE 10ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SUN PHARMACEUTICALS INDUSTRIES LTD",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/1/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "10/1/2012",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["oxaliplatin"],
    "InteractionIndexLink": ["oxaliplatine"],
    "N_ENREGISTREMENT": "450/ 05 G 090 /12",
    "CODE_DCI": "05 G 090",
    "DCI": "OXALIPLATINE",
    "NOM_COMMERCIALE": "OXALIPLATINE MYLAN",
    "FORME": "PDRE. P. SOL. P. PERF.",
    "DOSAGE": "100MG/FL. DE PDRE. (5MG/ML DE SOL. RECONSTITUEE)",
    "COND": "B/1FL. DE PDRE.",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MYLAN SAS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "5/12/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "5/12/2012",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["oxaliplatin"],
    "InteractionIndexLink": ["oxaliplatine"],
    "N_ENREGISTREMENT": "330/ 05 G 090 /12",
    "CODE_DCI": "05 G 090",
    "DCI": "OXALIPLATINE",
    "NOM_COMMERCIALE": "OXIPLAT 100",
    "FORME": "CONC. A DILUER P. PERF. IV",
    "DOSAGE": "100MG/FL. DE CONC. (5MG/ML OU 100MG/20ML)",
    "COND": "B/1FL. DE CONC. DE 20ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SUN PHARMACEUTICALS INDUSTRIES LTD",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/1/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "10/1/2012",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["paclitaxel"],
    "InteractionIndexLink": ["paclitaxel"],
    "N_ENREGISTREMENT": "182/ 05 G 100 /04/13",
    "CODE_DCI": "05 G 100",
    "DCI": "PACLITAXEL",
    "NOM_COMMERCIALE": "PACLITAX",
    "FORME": "SOL. A DILUER P. PERF.",
    "DOSAGE": "6MG/ML (30MG/5ML - 100MG/16.5ML - 300MG/50ML)",
    "COND": "B/1FL/5ML -  B/1FL/16.7ML ET B/1FL. DE 50ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CIPLA LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/1/2004",
    "DATE_D_ENREGISTREMENT_FINAL": "10/1/2013",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["pemetrexed"],
    "InteractionIndexLink": ["pemetrexed"],
    "N_ENREGISTREMENT": "555/05 G 102/20",
    "CODE_DCI": "05 G 102",
    "DCI": "PEMETREXED DISODIQUE EXPRIME EN PEMETREXED",
    "NOM_COMMERCIALE": "A-XED 500",
    "FORME": "PDRE. LYOPH. P. SOL. A DILUER P. PERF. IV.",
    "DOSAGE": "500MG/FL. DE PDRE.",
    "COND": "B/01FL. DE PDRE.",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ACCURE LABS PVT LTD",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/2/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "17/2/2020",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["pemetrexed"],
    "InteractionIndexLink": ["pemetrexed"],
    "N_ENREGISTREMENT": "034/ 05 G 102 /06/13",
    "CODE_DCI": "05 G 102",
    "DCI": "PEMETREXED DISODIQUE EXPRIME EN PEMETREXED",
    "NOM_COMMERCIALE": "ALIMTA",
    "FORME": "PDRE. LYOPH. P. SOL. A DILUER P. PERF.",
    "DOSAGE": "500MG/FL. DE PDRE.",
    "COND": "B/01FL. DE PDRE.",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ELI LILLY NEDERLAND B.V.",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PAYS BAS",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/12/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "7/5/2013",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["pemetrexed"],
    "InteractionIndexLink": ["pemetrexed"],
    "N_ENREGISTREMENT": "488/05 G 102/19",
    "CODE_DCI": "05 G 102",
    "DCI": "PEMETREXED DISODIQUE EXPRIME EN PEMETREXED",
    "NOM_COMMERCIALE": "BDPEM",
    "FORME": "PDRE LYOPHILISEE P/INJ",
    "DOSAGE": "500MG/FL DE PDRE",
    "COND": "B/01 FL 50ML",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BDR PHARMACEUTICALS INTERNATIONAL P.V.T L.T.D",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/12/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "15/12/2019",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["pemetrexed"],
    "InteractionIndexLink": ["pemetrexed"],
    "N_ENREGISTREMENT": "478/05 G 102/19",
    "CODE_DCI": "05 G 102",
    "DCI": "PEMETREXED DISODIUM",
    "NOM_COMMERCIALE": "PEMETREXED INTAS",
    "FORME": "PDRE LYOPHILISEE P/ISOL A DILUER P/PERF IVNJ",
    "DOSAGE": "500MG",
    "COND": "B/01 FL DE PDRE",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INTAS PHARMACEUTICALS LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "31/12/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "31/12/2019",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["pemetrexed"],
    "InteractionIndexLink": ["pemetrexed"],
    "N_ENREGISTREMENT": "536/ 05 G 102 /19",
    "CODE_DCI": "05 G 102",
    "DCI": "PEMETREXED DISODIQUE HEMIPENTAHYDRATE EXPRIME EN PEMETREXED",
    "NOM_COMMERCIALE": "PODOXRED",
    "FORME": "PDRE. LYOPH. P. SOL. A DILUER P. PERF. IV.",
    "DOSAGE": "500MG/FL. DE PDRE.",
    "COND": "B/01 FL. DE PDRE.",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "Dr REDDY'S LABORATORIES LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/11/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "20/11/2019",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["pemetrexed"],
    "InteractionIndexLink": ["pemetrexed"],
    "N_ENREGISTREMENT": "176/ 05 G 102 /15",
    "CODE_DCI": "05 G 102",
    "DCI": "PEMETREXED DISODIQUE HEMIPENTAHYDRATE EXPRIME EN PEMETREXED",
    "NOM_COMMERCIALE": "PREXET",
    "FORME": "PDRE. LYOPH. P. SOL. A DILUER P. PERF. IV.",
    "DOSAGE": "500MG/FL. DE PDRE.",
    "COND": "B/01 FL. DE PDRE.",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MUSTAFA NEFZET ILAC SANAYII A.S.",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "TURQUIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/9/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "2/9/2015",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["epirubicin"],
    "InteractionIndexLink": ["epirubicine"],
    "N_ENREGISTREMENT": "478/ 05 G 103 /13",
    "CODE_DCI": "05 G 103",
    "DCI": "EPIRUBICINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "EPINTAS",
    "FORME": "SOL. INJ. P. PERF. IV",
    "DOSAGE": "2MG/ML (10MG/5ML  ET 50MG/25ML)",
    "COND": "B/01FL. DE 5ML ET B/01FL. DE 25ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INTAS PHARMACEUTICALS LTD",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/4/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "2/4/2013",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["epirubicin"],
    "InteractionIndexLink": ["epirubicine"],
    "N_ENREGISTREMENT": "450/ 05 G 103 /17",
    "CODE_DCI": "05 G 103",
    "DCI": "EPIRUBICINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "EPIRUBICINE MYLAN",
    "FORME": "SOL. P. PERF. IV",
    "DOSAGE": "2MG/ML (10MG/5ML - 50MG/25ML- 100MG/50ML  ET 200MG/100ML)",
    "COND": "B/01FL. DE 5ML - B/01FL. DE 25ML - B/01 FL DE 50 ML ET B/01FL. DE 100ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MYLAN SAS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "11/12/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "11/12/2017",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["epirubicin"],
    "InteractionIndexLink": ["epirubicine"],
    "N_ENREGISTREMENT": "323/ 05 G 103 /16",
    "CODE_DCI": "05 G 103",
    "DCI": "EPIRUBICINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "EPIRUDEX",
    "FORME": "SOL. P. PERF. IV",
    "DOSAGE": "2MG/ML (10MG/5ML - 50MG/25ML )",
    "COND": "B/01FL. DE 5ML - B/01FL. DE 25ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL CONTINENTAL PHARM LABORATOIRE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/2/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "4/2/2016",
    "TYPE": "Gé",
    "STATUT": "C",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["epirubicin"],
    "InteractionIndexLink": ["epirubicine"],
    "N_ENREGISTREMENT": "001/ 05 G 103 /13",
    "CODE_DCI": "05 G 103",
    "DCI": "EPIRUBICINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "PIRUCIN",
    "FORME": "SOL. P. PERF. IV",
    "DOSAGE": "2MG/ML (10MG/5ML - 50MG/25ML ET 200MG/100ML)",
    "COND": "B/01FL. DE 5ML - B/01FL. DE 25ML ET B/01FL. DE 100ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMACEUTICALS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/1/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "14/3/2016",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["ifosfamide"],
    "InteractionIndexLink": ["ifosfamide"],
    "N_ENREGISTREMENT": "516/05 G 106/16",
    "CODE_DCI": "05 G 106",
    "DCI": "IFOSFAMIDE",
    "NOM_COMMERCIALE": "IFOXAN",
    "FORME": "PDRE. SOL. INJ. IV",
    "DOSAGE": "1G/FL. DE PDRE.",
    "COND": "B/1FL",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "KOREA UNITED PHARM INC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "COREE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/1/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "4/1/2017",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["capecitabine"],
    "InteractionIndexLink": ["capecitabine"],
    "N_ENREGISTREMENT": "20/05 G108/001",
    "CODE_DCI": "05 G 108",
    "DCI": "CAPECITABINE",
    "NOM_COMMERCIALE": "CAPTIB",
    "FORME": "COMP PELL",
    "DOSAGE": "500MG",
    "COND": "B/120",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL HIKMA PHARMA ALGERIA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "21/10/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "21/10/2020",
    "TYPE": "Gé",
    "STATUT": "F Prémix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["capecitabine"],
    "InteractionIndexLink": ["capecitabine"],
    "N_ENREGISTREMENT": "001/05 G 108 / 20",
    "CODE_DCI": "05 G 108",
    "DCI": "Capécitabine",
    "NOM_COMMERCIALE": "CAPTIB",
    "FORME": "Comprimé pelliculé",
    "DOSAGE": "500MG",
    "COND": "B/120",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMA ALGERIA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "21/10/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "21/10/2020",
    "TYPE": "Gé",
    "STATUT": "F prémix",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["vinorelbine tartrate"],
    "InteractionIndexLink": ["vinorelbine"],
    "N_ENREGISTREMENT": "099/ 05 G 115 /06/17",
    "CODE_DCI": "05 G 115",
    "DCI": "VINORELBINE",
    "NOM_COMMERCIALE": "NAVELBINE",
    "FORME": "CAPSULE MOLLE",
    "DOSAGE": "30MG",
    "COND": "B/1",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PIERRE FABRE MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "23/7/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "20/7/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["ifosfamide"],
    "InteractionIndexLink": ["ifosfamide"],
    "N_ENREGISTREMENT": "298/ 05 G 138 /09/16",
    "CODE_DCI": "05 G 138",
    "DCI": "IFOSFAMIDE",
    "NOM_COMMERCIALE": "HOLOXAN",
    "FORME": "PDRE. SOL. INJ. IV",
    "DOSAGE": "2G/FL. DE PDRE.",
    "COND": "B/01FL. DE PDRE. DE CONTENANCE DE 50ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BAXTER ONCOLOGY Gmbh",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALLEMAGNE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/7/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "26/7/2016",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "60 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["fludarabine"],
    "InteractionIndexLink": ["fludarabine"],
    "N_ENREGISTREMENT": "339/ 05 G 141 /09/18",
    "CODE_DCI": "05 G 141",
    "DCI": "FLUDARABINE PHOSPHATE",
    "NOM_COMMERCIALE": "FLUDARA",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "10MG",
    "COND": "FL./20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GENZYME EUROPE BV",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PAYS BAS",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/7/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "16/7/2018",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["bortezomib"],
    "InteractionIndexLink": ["bortezomib"],
    "N_ENREGISTREMENT": "524/05 G 147/17",
    "CODE_DCI": "05 G 147",
    "DCI": "BORTEZOMIB ESTER BORONIQUE DE MANNITOL EXPRIME EN BORTEZOMIB",
    "NOM_COMMERCIALE": "BORTERO",
    "FORME": "LYOPH POUR SOL INJ",
    "DOSAGE": "3.5MG/FL.",
    "COND": "B/1FL.",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HETERO LABS LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "21/3/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "21/3/2017",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["bortezomib"],
    "InteractionIndexLink": ["bortezomib"],
    "N_ENREGISTREMENT": "478/ 05 G 147 /19",
    "CODE_DCI": "05 G 147",
    "DCI": "BORTEZOMIB ESTER BORONIQUE DE MANNITOL EXPRIME EN BORTEZOMIB",
    "NOM_COMMERCIALE": "BORTEZOMIB INTAS",
    "FORME": "PDRE. SOL. INJ.IV / SC",
    "DOSAGE": "3.5MG/FL. DE PDRE.",
    "COND": "B/ 01 FL DE PDRE",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INTAS PHARMACEUTICALS LTD",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/1/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "13/1/2019",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["bortezomib"],
    "InteractionIndexLink": ["bortezomib"],
    "N_ENREGISTREMENT": "095/ 05 G 147 /09/18",
    "CODE_DCI": "05 G 147",
    "DCI": "BORTEZOMIB ESTER BORONIQUE DE MANNITOL EXPRIME EN BORTEZOMIB",
    "NOM_COMMERCIALE": "VELCADE",
    "FORME": "PDRE. SOL. INJ. IV",
    "DOSAGE": "3.5MG/FL. DE PDRE. (OU 1MG/ML DE SOL. RECONSTITUEE)",
    "COND": "B/1FL. DE PDRE. DE CONTENANCE 10ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JANSSEN CILAG INTERNATIONAL N.V.",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BELGIQUE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/10/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "16/7/2018",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["pemetrexed"],
    "InteractionIndexLink": ["pemetrexed"],
    "N_ENREGISTREMENT": "176/ 05 G 152 /15",
    "CODE_DCI": "05 G 152",
    "DCI": "Pémétrexed hémipentahydraté disodique",
    "NOM_COMMERCIALE": "PREXET",
    "FORME": "POUDRE LYOPHILISé POUR SOLUTION à DILUER POUR PERFUSION IV",
    "DOSAGE": "100 MG/ FLACON (20mg/ ml)",
    "COND": "boite de 1 flacon de poudre de 5ml",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MUSTAFA NEVZAT ILAÇ SANAYII A.Ş",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "TURQUIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "3/11/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "3/11/2015",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["cytarabine"],
    "InteractionIndexLink": ["cytarabine"],
    "N_ENREGISTREMENT": "286/ 05 G 156 /12",
    "CODE_DCI": "05 G 156",
    "DCI": "CYTARABINE",
    "NOM_COMMERCIALE": "ARASID 100 - ARASID 500 - ARASID 1000",
    "FORME": "SOL. INJ. P. PERF. IV OU SC",
    "DOSAGE": "100M/ML (500MG/5ML - 1000MG/10ML)",
    "COND": "B/1FL. DE 1ML - B/1FL. DE 5ML - B/1FL. DE 10ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CHIMIE PHARMACIE COMMERCE MULTIPLE SARL (CPCM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/1/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "10/1/2012",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["cytarabine"],
    "InteractionIndexLink": ["cytarabine"],
    "N_ENREGISTREMENT": "182/ 05 G 156 /13",
    "CODE_DCI": "05 G 156",
    "DCI": "CYTARABINE",
    "NOM_COMMERCIALE": "ZECYTE-100",
    "FORME": "SOL. INJ. IV",
    "DOSAGE": "100MG/ML",
    "COND": "B/1FL. DE 1ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CIPLA LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "11/6/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "11/6/2013",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["vinflunine"],
    "InteractionIndexLink": ["vinflunine"],
    "N_ENREGISTREMENT": "099/ 05 G 158 /12",
    "CODE_DCI": "05 G 158",
    "DCI": "VINFLUNINE DITRATRATE EXPRIME EN VINFLUNINE",
    "NOM_COMMERCIALE": "JAVLOR",
    "FORME": "SOL. A DILUER P. PERF. IV",
    "DOSAGE": "25MG/ML (50MG/2ML ET 250MG/10ML)",
    "COND": "B/1FL. DE 2ML ET B/1FL. DE 10ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PIERRE FABRE MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/8/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "26/8/2012",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["temozolomide"],
    "InteractionIndexLink": ["temozolomide"],
    "N_ENREGISTREMENT": "182/ 05 G 159 /13",
    "CODE_DCI": "05 G 159",
    "DCI": "TEMOZOLOMIDE",
    "NOM_COMMERCIALE": "TEMOSIDE-20",
    "FORME": "GLES.",
    "DOSAGE": "20MG",
    "COND": "B/1PILUL. DE 05",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CIPLA LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/2/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "18/2/2013",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["bendamustine hydrochloride"],
    "InteractionIndexLink": ["bendamustine"],
    "N_ENREGISTREMENT": "534/ 05 G 173 /17",
    "CODE_DCI": "05 G 173",
    "DCI": "BENDAMUSTINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "BENDAMUSTINE HYDROCHLORIDE ACCORD",
    "FORME": "PDRE. P. SOL. A DILIER P. PERF. IV.",
    "DOSAGE": "2.5MG/ML (APRES RECONSTITUTION)",
    "COND": "B/05 FL. DE 25MG -B/01 FL. DE 100MG - B/05 FL. DE 100MG",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ACCORD HEALTHCARE LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "UK",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/11/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "26/11/2017",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["bendamustine hydrochloride"],
    "InteractionIndexLink": ["bendamustine"],
    "N_ENREGISTREMENT": "374/ 05 G 173 /14",
    "CODE_DCI": "05 G 173",
    "DCI": "BENDAMUSTINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "RIBOMUSTIN",
    "FORME": "PDRE. P. SOL. A DILIER P. PERF. IV.",
    "DOSAGE": "2.5MG/ML (APRES RECONSTITUTION)",
    "COND": "B/05 FL. DE 25MG -B/01 FL. DE 100MG - B/05 FL. DE 100MG",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ASTELLAS PHARMA GMBH",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALLEMAGNE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/11/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "30/11/2014",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["cabazitaxel"],
    "InteractionIndexLink": ["cabazitaxel"],
    "N_ENREGISTREMENT": "536/ 05 G 177 /18",
    "CODE_DCI": "05 G 177",
    "DCI": "CABAZITAXEL",
    "NOM_COMMERCIALE": "BACAZIRED",
    "FORME": "SOL. A DILUER ET SOLVANT P./SOL. P./PERF. IV",
    "DOSAGE": "40MG/ML (60MG/1.5ML)",
    "COND": "B/01 FL. DE 1.5ML DE SOL. A DILUER + 01 FL. DE 4.5ML DE SOLVANT",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "DR .REDY'S LABORAOIRES LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/10/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "4/10/2018",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["cabazitaxel"],
    "InteractionIndexLink": ["cabazitaxel"],
    "N_ENREGISTREMENT": "376/ 05 G 177 /15",
    "CODE_DCI": "05 G 177",
    "DCI": "CABAZITAXEL",
    "NOM_COMMERCIALE": "JEVTANA",
    "FORME": "SOL. A DILUER ET SOLVANT P./SOL. P./PERF. IV",
    "DOSAGE": "40MG/ML (60MG/1.5ML)",
    "COND": "B/01 FL. DE 1.5ML DE SOL. A DILUER + 01 FL. DE 4.5ML DE SOLVANT (ETHANOL 96°. EPPI)",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANOFI-AVENTIS GROUPE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/10/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "19/10/2015",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["doxorubicin"],
    "InteractionIndexLink": ["doxorubicine"],
    "N_ENREGISTREMENT": "323/ 05 G 180 /16",
    "CODE_DCI": "05 G 180",
    "DCI": "CHLORHYDRATE DOXORUBICINE",
    "NOM_COMMERCIALE": "RUBIDEX",
    "FORME": "SOL INJ POUR PER IV",
    "DOSAGE": "2MG/ML ( 10MG/5ML) ET (50MG/25ML)",
    "COND": "B DE 1 FL 5ML ET B DE 1 FL 25 ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL CONTINENTAL PHARM LABORATOIRE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/2/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "4/2/2016",
    "TYPE": "Gé",
    "STATUT": "C",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["azacitidine"],
    "InteractionIndexLink": ["azacitidine"],
    "N_ENREGISTREMENT": "506/05 G 185/16",
    "CODE_DCI": "05 G 185",
    "DCI": "AZACITIDINE",
    "NOM_COMMERCIALE": "VIDAZA",
    "FORME": "PDRE P. SUSP. INJ S/C",
    "DOSAGE": "25 MG/ML",
    "COND": "B/1 FL",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CELGENE EUROPE LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ROYAUME UNI",
    "DATE_D_ENREGISTREMENT_INITIAL": "5/3/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "5/3/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "48 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["azacitidine"],
    "InteractionIndexLink": ["azacitidine"],
    "N_ENREGISTREMENT": "536/05 G 185/17",
    "CODE_DCI": "05 G 185",
    "DCI": "AZACITIDINE",
    "NOM_COMMERCIALE": "WINDUZA",
    "FORME": "PDRE LYOPHILISEE P. SUSP. INJ",
    "DOSAGE": "25 MG/ML ( 100 MG/FL )",
    "COND": "B/1 FL",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "DR .REDY'S LABORAOIRES LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "5/11/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "5/11/2017",
    "TYPE": "GE",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["chlorambucil"],
    "InteractionIndexLink": ["chlorambucil"],
    "N_ENREGISTREMENT": "467/05 G 188/17",
    "CODE_DCI": "05 G 188",
    "DCI": "CHLORAMBUCIL",
    "NOM_COMMERCIALE": "LEUKERAN",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "2 MG",
    "COND": "B/01 FL DE 25",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ASPEN PHARMA TRADING LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "IRLANDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/3/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "19/3/2017",
    "TYPE": "RE",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["eribulin"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "446 /05 G 191/ 19",
    "CODE_DCI": "05 G 191",
    "DCI": "Eribuline mesilate experime en eribuline",
    "NOM_COMMERCIALE": "HALAVEN",
    "FORME": "SOL INJ IV",
    "DOSAGE": "0.44 MG/ML",
    "COND": "B/1 FL DE 2 ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EISAI EUROPE LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ROYAUME UNI",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/5/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "29/5/2019",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "48 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["melphalan"],
    "InteractionIndexLink": ["melphalan"],
    "N_ENREGISTREMENT": "467/ 05 G 209 /17",
    "CODE_DCI": "05 G 209",
    "DCI": "Melphalan",
    "NOM_COMMERCIALE": "ALKERAN TM",
    "FORME": "POUDRE ET SOLVANT POUR SOLUTION INJECTABLE  (POUDRE ET SOLVANT POUR SOLUTION POUR PERFUSION )",
    "DOSAGE": "50MG/10 ML",
    "COND": "B/ 01 FL DE POUDRE + 01 FL DE SOLVANT DE 10 ML",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ASPEN PHARMA TRADING LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "IRELAND",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/12/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "27/12/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["carfilzomib"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "546/ 05 G 210 /18",
    "CODE_DCI": "05 G 210",
    "DCI": "Carfilzomib",
    "NOM_COMMERCIALE": "KYPROLIS",
    "FORME": "POUDRE LYOPHILISEE STERILE POUR SOLUTION INJECTABLE",
    "DOSAGE": "60MG/ FL",
    "COND": "B/ 01 FL DE POUDRE",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ONXY PHARMACEUTICALS INC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "USA",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/7/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "24/7/2018",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["pralatrexate"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "530/ 05 G 212 /18",
    "CODE_DCI": "05 G 212",
    "DCI": "Pralatrexate",
    "NOM_COMMERCIALE": "FOLOTYN",
    "FORME": "SOLUTION POUR PERFUSION IV",
    "DOSAGE": "20 MG/ML",
    "COND": "B/ 01 FL DE 01 ML",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MUNDIPHARMA MEDICAL COMPANY",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SUISSE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/9/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "27/9/2018",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "48 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["bendamustine hydrochloride"],
    "InteractionIndexLink": ["bendamustine"],
    "N_ENREGISTREMENT": "524 / 05 G 221/ 19",
    "CODE_DCI": "05 G 221",
    "DCI": "Bendamustine chlorhydrate monohydrate experime en Bendamustine chlorhydrate",
    "NOM_COMMERCIALE": "BENTERO 100",
    "FORME": "LYOPHILISAT POUR SOLUTION A DILUER POUR PERFUSION IV",
    "DOSAGE": "100 MG/FL",
    "COND": "B/1 FL DE LYOPHILISAT DE 20 ML ( 5MG/ML APRES RECONSTITUTION)",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HETERO LABS LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/6/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "26/6/2019",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["mesna"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "298/ 05 J 149 /12",
    "CODE_DCI": "05 J 149",
    "DCI": "MESNA",
    "NOM_COMMERCIALE": "UROMITEXAN",
    "FORME": "SOL. INJ. IV",
    "DOSAGE": "100MG/ML (400MG/4ML)",
    "COND": "B/05AMP. DE 4ML",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BAXTER ONCOLOGY Gmbh",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALLEMAGNE",
    "DATE_D_ENREGISTREMENT_INITIAL": "14/5/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "14/5/2012",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "352/ 05 K 154 /18",
    "CODE_DCI": "05 K 154",
    "DCI": "Ondanserton",
    "NOM_COMMERCIALE": "ONDAPHREN",
    "FORME": "COMP ORODISPERSIBLE",
    "DOSAGE": "4 MG",
    "COND": "B/04",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SPA EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/7/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "25/7/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cancerologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "352/ 05 K 155 /18",
    "CODE_DCI": "05 K 155",
    "DCI": "Ondanserton",
    "NOM_COMMERCIALE": "ONDAPHREN",
    "FORME": "COMP ORODISPERSIBLE",
    "DOSAGE": "8 MG",
    "COND": "B/04",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SPA EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/7/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "25/7/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "547/ 05 K 217 /18",
    "CODE_DCI": "05 K 217",
    "DCI": "AKYNZEO",
    "NOM_COMMERCIALE": "Nétupitant / palonosétron exprimé  en palonosétron",
    "FORME": "GELULE",
    "DOSAGE": "300 MG / 0.5 MG",
    "COND": "B/01",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HELSINN BIREX PHARMACEUTICALS LTD",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "IRLANDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "23/12/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "23/12/2018",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["lenalidomide"],
    "InteractionIndexLink": ["lenalidomide"],
    "N_ENREGISTREMENT": "506/ 05 L 181 /16",
    "CODE_DCI": "05 L 181",
    "DCI": "LENALIDOMIDE",
    "NOM_COMMERCIALE": "REVLIMID",
    "FORME": "GELULE",
    "DOSAGE": "5MG",
    "COND": "B/21",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CELGENE EUROPE LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ROYAUME UNI",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/6/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "12/6/2016",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["lenalidomide"],
    "InteractionIndexLink": ["lenalidomide"],
    "N_ENREGISTREMENT": "506/ 05 L 182 /16",
    "CODE_DCI": "05 L 182",
    "DCI": "LENALIDOMIDE",
    "NOM_COMMERCIALE": "REVLIMID",
    "FORME": "GELULE",
    "DOSAGE": "10MG",
    "COND": "B/21",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CELGENE EUROPE LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ROYAUME UNI",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/6/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "12/6/2016",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["lenalidomide"],
    "InteractionIndexLink": ["lenalidomide"],
    "N_ENREGISTREMENT": "506/ 05 L 183 /16",
    "CODE_DCI": "05 L 183",
    "DCI": "LENALIDOMIDE",
    "NOM_COMMERCIALE": "REVLIMID",
    "FORME": "GELULE",
    "DOSAGE": "15MG",
    "COND": "B/21",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CELGENE EUROPE LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ROYAUME UNI",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/6/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "12/6/2016",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["lenalidomide"],
    "InteractionIndexLink": ["lenalidomide"],
    "N_ENREGISTREMENT": "506/ 05 L 184 /16",
    "CODE_DCI": "05 L 184",
    "DCI": "LENALIDOMIDE",
    "NOM_COMMERCIALE": "REVLIMID",
    "FORME": "GELULE",
    "DOSAGE": "25MG",
    "COND": "B/21",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CELGENE EUROPE LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ROYAUME UNI",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/6/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "12/6/2016",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["aflibercept"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "376/ 05 L 211 /18",
    "CODE_DCI": "05 L 211",
    "DCI": "Aflibercept SANOFI",
    "NOM_COMMERCIALE": "ZALTRAP",
    "FORME": "SOLUTION à DILUER POUR PERFUSION IV",
    "DOSAGE": "25MG/ML",
    "COND": "B/1FL DE 4 ML(100MG/4ML) B/1FL DE 8 ML (200MG/8ML)",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANOFI AVENTIS GROUPE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "31/12/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "31/12/2018",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["vemurafenib"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "128/ 05 M 206 / 19",
    "CODE_DCI": "05 M 206",
    "DCI": "Vemurafenib",
    "NOM_COMMERCIALE": "ZELBORAF",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "240 MG",
    "COND": "B/56",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ROCHE PHARMA (SCHWEIZ) AG",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SUISSE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/2/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "10/2/2019",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["radium (223Ra) dichloride"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "424 /05 M 219/ 18",
    "CODE_DCI": "05 M 219",
    "DCI": "Dichlorure de Radium - 223",
    "NOM_COMMERCIALE": "XOFIGO",
    "FORME": "SOL INJ IV",
    "DOSAGE": "1100 KBq / ML (6.6 MBq/FL)",
    "COND": "B/01 FL DE 6 ML",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BAYER AG",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "Allemagne",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/12/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "27/12/2018",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "28 JOURS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["vismodegib"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "128/ 05 P 208/18",
    "CODE_DCI": "05 P 208",
    "DCI": "Vismodegib",
    "NOM_COMMERCIALE": "ERIVEDGE",
    "FORME": "GéLULE",
    "DOSAGE": "150 MG",
    "COND": "PILULIER DE 28",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ROCHE PHARMA (SCHWEIZ) AG",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SUISSE",
    "DATE_D_ENREGISTREMENT_INITIAL": "16/1/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "16/1/2018",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["telmisartan"],
    "InteractionIndexLink": ["telmisartan"],
    "N_ENREGISTREMENT": "097 / 06 E 264 /16",
    "CODE_DCI": "06  E 264",
    "DCI": "TELMISARTAN",
    "NOM_COMMERCIALE": "CARDIMED",
    "FORME": "COMPRIME",
    "DOSAGE": "80MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANAMED SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/3/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "13/3/2016",
    "TYPE": "Gé",
    "STATUT": "Fpremix",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": false,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["adrenaline (epinephrine)", "adrenaline"],
    "InteractionIndexLink": ["adrenaline"],
    "N_ENREGISTREMENT": "433/ 06 A 002 /14/20",
    "CODE_DCI": "06 A 002",
    "DCI": "Adrénaline tartrate exprimé en Adrénaline",
    "NOM_COMMERCIALE": "ADRENALINE RAZES SANS SULFITE",
    "FORME": "Solution injectable",
    "DOSAGE": "1MG/ML",
    "COND": "B/50 AMPS 1ML",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRATER RAZES SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "31/3/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "11/2/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["adrenaline (epinephrine)", "adrenaline"],
    "InteractionIndexLink": ["adrenaline"],
    "N_ENREGISTREMENT": "543/ 06 A 002 /19",
    "CODE_DCI": "06 A 002",
    "DCI": "ADRENALINE TARTRATE EXPRIME EN ADRENALINE",
    "NOM_COMMERCIALE": "DRINAL",
    "FORME": "SOL INJ EN AMP",
    "DOSAGE": "1MG/ML",
    "COND": "B/100 AMPS DE 1 ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOTHERA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/6/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "10/6/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["adrenaline (epinephrine)", "adrenaline"],
    "InteractionIndexLink": ["adrenaline"],
    "N_ENREGISTREMENT": "433/06 A 008/17",
    "CODE_DCI": "06 A 008",
    "DCI": "ADRENALINE TARTRATE EXPRIME EN ADRENALINE",
    "NOM_COMMERCIALE": "NORADRENALINE RAZES",
    "FORME": "SOLUTION à DILUER POUR PERFUSION IV",
    "DOSAGE": "8MG/4ML",
    "COND": "B/50 AMP",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRATER RAZES SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/3/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "7/3/2017",
    "TYPE": "GE",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["dobutamine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "330/ 06 A 253 /08/18",
    "CODE_DCI": "06 A 253",
    "DCI": "DOBUTAMINE",
    "NOM_COMMERCIALE": "CARDIJECT",
    "FORME": "LYOPH. SOL. INJ. IV",
    "DOSAGE": "250MG/FL. DE PDRE.",
    "COND": "B/01 FL.DE PDRE.",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SUN PHARMACEUTICAL INDUSTRIES LTD",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "31/5/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "23/1/2019",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "18 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["diltiazem"],
    "InteractionIndexLink": ["diltiazem"],
    "N_ENREGISTREMENT": "376/ 06 B 009 /97/16",
    "CODE_DCI": "06 B 009",
    "DCI": "DILTIAZEM CHLORHYDRATE",
    "NOM_COMMERCIALE": "TILDIEM",
    "FORME": "COMPRIME",
    "DOSAGE": "60MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANOFI AVENTIS FRANCE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/11/1997",
    "DATE_D_ENREGISTREMENT_FINAL": "6/3/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["diltiazem"],
    "InteractionIndexLink": ["diltiazem"],
    "N_ENREGISTREMENT": "392/ 06 B 010 /97/15",
    "CODE_DCI": "06 B 010",
    "DCI": "DILTIAZEM CHLORHYDRATE",
    "NOM_COMMERCIALE": "MONO-TILDIEM LP",
    "FORME": "MICROGLES. LP EN GLES.",
    "DOSAGE": "300MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANOFI AVENTIS ALGERIE SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/11/1997",
    "DATE_D_ENREGISTREMENT_FINAL": "9/7/2015",
    "TYPE": "Ré",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["nicardipine"],
    "InteractionIndexLink": ["nicardipine"],
    "N_ENREGISTREMENT": "426/ 06 B 015 /13",
    "CODE_DCI": "06 B 015",
    "DCI": "NICARDIPINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "CARDIPEN LP",
    "FORME": "MICROGRLES. LP EN GLES.",
    "DOSAGE": "50MG",
    "COND": "B/60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ABDI IBRAHIM REMEDE PHARMA SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "21/7/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "21/7/2013",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["nicardipine"],
    "InteractionIndexLink": ["nicardipine"],
    "N_ENREGISTREMENT": "552/ 06 B 015 /96/19",
    "CODE_DCI": "06 B 015",
    "DCI": "NICARDIPINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "LOXEN LP",
    "FORME": "MICROGRLES. LP EN GLES.",
    "DOSAGE": "50MG",
    "COND": "B/60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CARDIXO",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "21/10/1996",
    "DATE_D_ENREGISTREMENT_FINAL": "24/7/2019",
    "TYPE": "Ré",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["nicardipine"],
    "InteractionIndexLink": ["nicardipine"],
    "N_ENREGISTREMENT": "470/ 06 B 015 /13",
    "CODE_DCI": "06 B 015",
    "DCI": "NICARDIPINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "LOXIDIPINE LP",
    "FORME": "MICRGLES. LP EN GLES.",
    "DOSAGE": "50MG",
    "COND": "B/60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MM (SARL LABORATOIRES MM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/4/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "2/4/2013",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["nicardipine"],
    "InteractionIndexLink": ["nicardipine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "06 B 015",
    "DCI": "NICARDIPINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "NICARDIL LP",
    "FORME": "GLES. MICROGRANULES LP",
    "DOSAGE": "50MG",
    "COND": "B/60",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["nicardipine"],
    "InteractionIndexLink": ["nicardipine"],
    "N_ENREGISTREMENT": "10/06 B 015/293",
    "CODE_DCI": "06 B 015",
    "DCI": "NICARDIPINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "NICARDIPINE BIOCARE LP",
    "FORME": "GELULE A MICRO-GRANULES LP",
    "DOSAGE": "50MG",
    "COND": "B/60",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE SARL BIOCARE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "21/11/10",
    "DATE_D_ENREGISTREMENT_FINAL": "21/11/10",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["nicardipine"],
    "InteractionIndexLink": ["nicardipine"],
    "N_ENREGISTREMENT": "065/ 06 B 015 /12",
    "CODE_DCI": "06 B 015",
    "DCI": "NICARDIPINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "PULSAGEN LP",
    "FORME": "GLES. A MICROGRANULES LP",
    "DOSAGE": "50MG",
    "COND": "B/60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GENERICLAB SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/1/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "30/1/2012",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["nicardipine"],
    "InteractionIndexLink": ["nicardipine"],
    "N_ENREGISTREMENT": "068/ 06 B 016 /96/14",
    "CODE_DCI": "06 B 016",
    "DCI": "NICARDIPINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "LOXEN",
    "FORME": "SOL.INJ. IV",
    "DOSAGE": "1MG/ML (10MG/10ML)",
    "COND": "B/5 AMP DE 10ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVARTIS PHARMA SAS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "16/10/1996",
    "DATE_D_ENREGISTREMENT_FINAL": "1/9/2014",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["nicardipine"],
    "InteractionIndexLink": ["nicardipine"],
    "N_ENREGISTREMENT": "433/ 06 B 016 /14",
    "CODE_DCI": "06 B 016",
    "DCI": "NICARDIPINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "NICARDEX",
    "FORME": "SOLUTION INJECTABLE IV",
    "DOSAGE": "1MG/ML (10MG/10ML)",
    "COND": "B/05 AMPS DE 10ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRATER RAZES SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/6/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "30/4/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["nicardipine"],
    "InteractionIndexLink": ["nicardipine"],
    "N_ENREGISTREMENT": "543/ 06 B 016 /19",
    "CODE_DCI": "06 B 016",
    "DCI": "NICARDIPINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "NICARDIPINE BIOTHERA",
    "FORME": "SOLUTION INJECTABLE IV",
    "DOSAGE": "1MG/ML (10MG/10ML)",
    "COND": "B/05 AMPS DE 10ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOTHERA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/6/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "1/6/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["nifedipine"],
    "InteractionIndexLink": ["nifedipine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "06 B 017",
    "DCI": "NIFEDIPINE",
    "NOM_COMMERCIALE": "ADIPINE",
    "FORME": "COMPRIME",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["nifedipine"],
    "InteractionIndexLink": ["nifedipine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "06 B 018",
    "DCI": "NIFEDIPINE",
    "NOM_COMMERCIALE": "ADIPINE",
    "FORME": "GLES. A µGRLES.  LP",
    "DOSAGE": "20MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["amlodipine"],
    "InteractionIndexLink": ["amlodipine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "06 B 123",
    "DCI": "Amlodipine bésilate exprimé en amlodipine",
    "NOM_COMMERCIALE": "AMLIBON",
    "FORME": "COMPRIME",
    "DOSAGE": "5MG",
    "COND": "B/30 ET  B/90",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["amlodipine"],
    "InteractionIndexLink": ["amlodipine"],
    "N_ENREGISTREMENT": "318 / 06 B 123 /15",
    "CODE_DCI": "06 B 123",
    "DCI": "Amlodipine bésilate exprimé en amlodipine",
    "NOM_COMMERCIALE": "AMLODAL",
    "FORME": "COMPRIME",
    "DOSAGE": "5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL PHARMIDAL N.S",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/12/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "27/12/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["amlodipine"],
    "InteractionIndexLink": ["amlodipine"],
    "N_ENREGISTREMENT": "039/ 06 B 123 /05/16",
    "CODE_DCI": "06 B 123",
    "DCI": "Amlodipine bésilate exprimé en amlodipine",
    "NOM_COMMERCIALE": "AMLODIPAL",
    "FORME": "GLES",
    "DOSAGE": "5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOPHAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "14/6/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "15/2/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["amlodipine"],
    "InteractionIndexLink": ["amlodipine"],
    "N_ENREGISTREMENT": "447/ 06 B 123 /14",
    "CODE_DCI": "06 B 123",
    "DCI": "Amlodipine bésilate exprimé en amlodipine",
    "NOM_COMMERCIALE": "AMLODIPINE BEKER",
    "FORME": "GLES",
    "DOSAGE": "5MG",
    "COND": "B/30 ET B/90",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEKER SARL (SARL LABORATOIRE BEKER ALGERIE)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/6/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "26/7/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["amlodipine"],
    "InteractionIndexLink": ["amlodipine"],
    "N_ENREGISTREMENT": "309/ 06 B 123 /15",
    "CODE_DCI": "06 B 123",
    "DCI": "Amlodipine bésilate exprimé en amlodipine",
    "NOM_COMMERCIALE": "AMLODIPINE LDM",
    "FORME": "GLES.",
    "DOSAGE": "5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES DE DIAGNOSTIC MAGHREBINS (LDM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/12/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "2/12/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["amlodipine"],
    "InteractionIndexLink": ["amlodipine"],
    "N_ENREGISTREMENT": "470/ 06 B 123 /13/18",
    "CODE_DCI": "06 B 123",
    "DCI": "Amlodipine bésilate exprimé en amlodipine",
    "NOM_COMMERCIALE": "AMLODIPINE MM",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MM (SARL LABORATOIRES MM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/8/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "9/1/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["amlodipine"],
    "InteractionIndexLink": ["amlodipine"],
    "N_ENREGISTREMENT": "426/ 06 B 123 /12",
    "CODE_DCI": "06 B 123",
    "DCI": "Amlodipine bésilate exprimé en amlodipine",
    "NOM_COMMERCIALE": "AMLOMED",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ABDI IBRAHIM REMEDE PHARMA SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "16/12/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "16/12/2012",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["amlodipine"],
    "InteractionIndexLink": ["amlodipine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "06 B 123",
    "DCI": "Amlodipine bésilate exprimé en amlodipine",
    "NOM_COMMERCIALE": "AMLOPINE",
    "FORME": "GLES.",
    "DOSAGE": "5MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["amlodipine"],
    "InteractionIndexLink": ["amlodipine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "06 B 123",
    "DCI": "Amlodipine bésilate exprimé en amlodipine",
    "NOM_COMMERCIALE": "AMLORIDAL",
    "FORME": "GLES.",
    "DOSAGE": "5MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["amlodipine"],
    "InteractionIndexLink": ["amlodipine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "06 B 123",
    "DCI": "Amlodipine sous forme bésylate",
    "NOM_COMMERCIALE": "Alodipine",
    "FORME": "Gélule",
    "DOSAGE": "5 mg",
    "COND": "Boite de 30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["amlodipine"],
    "InteractionIndexLink": ["amlodipine"],
    "N_ENREGISTREMENT": "18/06 B123/293",
    "CODE_DCI": "06 B 123",
    "DCI": "AMLODIPINE",
    "NOM_COMMERCIALE": "DIMLOR",
    "FORME": "GELULE",
    "DOSAGE": "5MG",
    "COND": "B/30 B/90",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOCARE SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/04/18",
    "DATE_D_ENREGISTREMENT_FINAL": "22/04/18",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["amlodipine"],
    "InteractionIndexLink": ["amlodipine"],
    "N_ENREGISTREMENT": "18/06 B123/380",
    "CODE_DCI": "06 B 123",
    "DCI": "AMLODIPINE BESILATE EXPRIME EN AMLODIPINE",
    "NOM_COMMERCIALE": "HUMLOR",
    "FORME": "GELULE",
    "DOSAGE": "5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "laboratoires HUP.P PHARMA Sarl",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/5/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "17/05/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["amlodipine"],
    "InteractionIndexLink": ["amlodipine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "06 B 123",
    "DCI": "Amlodipine bésilate exprimé en amlodipine",
    "NOM_COMMERCIALE": "LOTENSE",
    "FORME": "GLES.",
    "DOSAGE": "5MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["amlodipine"],
    "InteractionIndexLink": ["amlodipine"],
    "N_ENREGISTREMENT": "001/ 06 B 123 /12/19",
    "CODE_DCI": "06 B 123",
    "DCI": "Amlodipine bésilate exprimé en amlodipine",
    "NOM_COMMERCIALE": "LOWVASC",
    "FORME": "GLES.",
    "DOSAGE": "5MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMA ALGERIA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/9/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "21/1/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["amlodipine"],
    "InteractionIndexLink": ["amlodipine"],
    "N_ENREGISTREMENT": "289/06 B 123/07/19",
    "CODE_DCI": "06 B 123",
    "DCI": "Amlodipine bésilate exprimé en amlodipine",
    "NOM_COMMERCIALE": "TENSODIPINE",
    "FORME": "GLES.",
    "DOSAGE": "5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRATER RAZES FORME SECHE SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/9/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "25/6/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["amlodipine"],
    "InteractionIndexLink": ["amlodipine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "06 B 243",
    "DCI": "Amlodipine bésilate exprimé en amlodipine",
    "NOM_COMMERCIALE": "ALODIPINE",
    "FORME": "GLES.",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["amlodipine"],
    "InteractionIndexLink": ["amlodipine"],
    "N_ENREGISTREMENT": "050/ 06 B 243 /07/18",
    "CODE_DCI": "06 B 243",
    "DCI": "Amlodipine bésilate exprimé en amlodipine",
    "NOM_COMMERCIALE": "AMLIBON",
    "FORME": "COMPRIME",
    "DOSAGE": "10MG",
    "COND": "B/30 ET B/90",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANDOZ SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "31/12/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "8/8/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["amlodipine"],
    "InteractionIndexLink": ["amlodipine"],
    "N_ENREGISTREMENT": "304/06 B 243/20",
    "CODE_DCI": "06 B 243",
    "DCI": "Amlodipine bésilate exprimé en Amlodipine",
    "NOM_COMMERCIALE": "AMLOCARDINE",
    "FORME": "Gélule",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GEOPHARM / SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/12/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "29/12/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["amlodipine"],
    "InteractionIndexLink": ["amlodipine"],
    "N_ENREGISTREMENT": "304/06 B 243/20",
    "CODE_DCI": "06 B 243",
    "DCI": "AMPLODIPINE BESILATE EXPRIME EN AMLODIPINE",
    "NOM_COMMERCIALE": "AMLOCARDINE",
    "FORME": "GELULE",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES GEOPHARM SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/12/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "29/12/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["amlodipine"],
    "InteractionIndexLink": ["amlodipine"],
    "N_ENREGISTREMENT": "318/ 06 B 243 /15",
    "CODE_DCI": "06 B 243",
    "DCI": "Amlodipine bésilate exprimé en amlodipine",
    "NOM_COMMERCIALE": "AMLODAL",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "10MG",
    "COND": "B/30 ET B/90",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMIDAL NS SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/7/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "26/7/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["amlodipine"],
    "InteractionIndexLink": ["amlodipine"],
    "N_ENREGISTREMENT": "447/ 06 B 243 /14/20",
    "CODE_DCI": "06 B 243",
    "DCI": "Amlodipine bésilate exprimé en amlodipine",
    "NOM_COMMERCIALE": "AMLODIPINE BEKER",
    "FORME": "GLES",
    "DOSAGE": "10MG",
    "COND": "B/30 ET B/90",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEKER SARL (SARL LABORATOIRE BEKER ALGERIE)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/3/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "22/1/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["amlodipine"],
    "InteractionIndexLink": ["amlodipine"],
    "N_ENREGISTREMENT": "309/ 06 B 243/15",
    "CODE_DCI": "06 B 243",
    "DCI": "Amlodipine bésilate exprimé en amlodipine",
    "NOM_COMMERCIALE": "AMLODIPINE LDM",
    "FORME": "GLES.",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES DE DIAGNOSTIC MAGHREBINS (LDM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/12/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "13/12/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["amlodipine"],
    "InteractionIndexLink": ["amlodipine"],
    "N_ENREGISTREMENT": "18/06 B 243/293",
    "CODE_DCI": "06 B 243",
    "DCI": "AMLODIPINE",
    "NOM_COMMERCIALE": "DIMLOR",
    "FORME": "GELULE",
    "DOSAGE": "10MG",
    "COND": "B/30 B/90",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOCARE SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/04/18",
    "DATE_D_ENREGISTREMENT_FINAL": "22/04/18",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["amlodipine"],
    "InteractionIndexLink": ["amlodipine"],
    "N_ENREGISTREMENT": "18/06 B243/380",
    "CODE_DCI": "06 B 243",
    "DCI": "AMLODIPINE BESILATE EXPRIME EN AMLODIPINE",
    "NOM_COMMERCIALE": "HUMLOR",
    "FORME": "GELULE",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "laboratoires HUP.P PHARMA Sarl",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/5/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "17/5/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["amlodipine"],
    "InteractionIndexLink": ["amlodipine"],
    "N_ENREGISTREMENT": "289/06 B 243/07/19",
    "CODE_DCI": "06 B 243",
    "DCI": "Amlodipine bésilate exprimé en amlodipine",
    "NOM_COMMERCIALE": "TENSODIPINE",
    "FORME": "GLES.",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRATER RAZES FORME SECHE SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/9/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "8/5/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["amlodipine", "candesartan cilexetil"],
    "InteractionIndexLink": ["amlodipine", "candesartan cilexetil"],
    "N_ENREGISTREMENT": "001/06 B 315/17",
    "CODE_DCI": "06 B 315",
    "DCI": "AMLODIPINE BESIATE EXPRIME EN AMLODIPINE /CANDESARTAN COLEXETIL",
    "NOM_COMMERCIALE": "UNISIA",
    "FORME": "COMPRIME",
    "DOSAGE": "5MG/8MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMA ALGERIA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/2/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "20/2/2017",
    "TYPE": "Gé",
    "STATUT": "F PREMIX",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["molsidomine"],
    "InteractionIndexLink": ["molsidomine"],
    "N_ENREGISTREMENT": "318/06 C 022/19",
    "CODE_DCI": "06 C 022",
    "DCI": "MOLSIDOMINE",
    "NOM_COMMERCIALE": "ANGORAL",
    "FORME": "COMP SEC",
    "DOSAGE": "2MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMIDAL N.S SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/12/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "18/12/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["molsidomine"],
    "InteractionIndexLink": ["molsidomine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "06 C 022",
    "DCI": "MOLSIDOMINE",
    "NOM_COMMERCIALE": "CORVASAL",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "2MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["molsidomine"],
    "InteractionIndexLink": ["molsidomine"],
    "N_ENREGISTREMENT": "457/ 06 C 022 /13",
    "CODE_DCI": "06 C 022",
    "DCI": "MOLSIDOMINE",
    "NOM_COMMERCIALE": "DIALOMINE",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "2MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOMEDIAL SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/6/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "4/6/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["molsidomine"],
    "InteractionIndexLink": ["molsidomine"],
    "N_ENREGISTREMENT": "003/ 06 C 022 /06/19",
    "CODE_DCI": "06 C 022",
    "DCI": "MOLSIDOMINE",
    "NOM_COMMERCIALE": "INVERTER",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "2MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EPE  GROUPE INDUSTRIEL SAIDAL SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/6/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "16/6/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["molsidomine"],
    "InteractionIndexLink": ["molsidomine"],
    "N_ENREGISTREMENT": "352/06 C 022/20",
    "CODE_DCI": "06 C 022",
    "DCI": "MOLSIDOMINE",
    "NOM_COMMERCIALE": "MANTIXA",
    "FORME": "COMP SEC",
    "DOSAGE": "2MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "16/7/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "16/7/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["molsidomine"],
    "InteractionIndexLink": ["molsidomine"],
    "N_ENREGISTREMENT": "447/ 06 C 022 /14",
    "CODE_DCI": "06 C 022",
    "DCI": "MOLSIDOMINE",
    "NOM_COMMERCIALE": "MOLSIDOMINE BEKER",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "2MG",
    "COND": "B/30 ET B/90",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES BEKER",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/7/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "27/7/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["molsidomine"],
    "InteractionIndexLink": ["molsidomine"],
    "N_ENREGISTREMENT": "21/07/06 C 022/195",
    "CODE_DCI": "06 C 022",
    "DCI": "MOLSIDOMINE",
    "NOM_COMMERCIALE": "MOLSIMED",
    "FORME": "COMP. SEC.",
    "DOSAGE": "02MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE SARL WORLD MEDECINE LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/05/21",
    "DATE_D_ENREGISTREMENT_FINAL": "12/05/21",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["molsidomine"],
    "InteractionIndexLink": ["molsidomine"],
    "N_ENREGISTREMENT": "268/ 06 C 022 /10/18",
    "CODE_DCI": "06 C 022",
    "DCI": "MOLSIDOMINE",
    "NOM_COMMERCIALE": "VAZOTEK 2",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "2MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MERINAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/10/2010",
    "DATE_D_ENREGISTREMENT_FINAL": "13/2/2018",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["molsidomine"],
    "InteractionIndexLink": ["molsidomine"],
    "N_ENREGISTREMENT": "318/06 C 023/19",
    "CODE_DCI": "06 C 023",
    "DCI": "MOLSIDOMINE",
    "NOM_COMMERCIALE": "ANGORAL",
    "FORME": "COMP",
    "DOSAGE": "4MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMIDAL N.S SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/12/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "18/12/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["molsidomine"],
    "InteractionIndexLink": ["molsidomine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "06 C 023",
    "DCI": "MOLSIDOMINE",
    "NOM_COMMERCIALE": "CORVASAL",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "4MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["molsidomine"],
    "InteractionIndexLink": ["molsidomine"],
    "N_ENREGISTREMENT": "003/ 06 C 023 /06/20",
    "CODE_DCI": "06 C 023",
    "DCI": "MOLSIDOMINE",
    "NOM_COMMERCIALE": "INVERTER",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "04MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EPE GROUPE INDUSTRIEL SAIDAL SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/06/06",
    "DATE_D_ENREGISTREMENT_FINAL": "31/03/20",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["molsidomine"],
    "InteractionIndexLink": ["molsidomine"],
    "N_ENREGISTREMENT": "352/06 C 023/20",
    "CODE_DCI": "06 C 023",
    "DCI": "MOLSIDOMINE",
    "NOM_COMMERCIALE": "MANTIXA",
    "FORME": "COMP",
    "DOSAGE": "4MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "16/7/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "16/7/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["molsidomine"],
    "InteractionIndexLink": ["molsidomine"],
    "N_ENREGISTREMENT": "447/ 06 C 023 /14",
    "CODE_DCI": "06 C 023",
    "DCI": "MOLSIDOMINE",
    "NOM_COMMERCIALE": "MOLSIDOMINE BEKER",
    "FORME": "COMPRIME",
    "DOSAGE": "4MG",
    "COND": "B/30 ET B/90",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES BEKER",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/10/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "1/10/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["molsidomine"],
    "InteractionIndexLink": ["molsidomine"],
    "N_ENREGISTREMENT": "21/07/06 C 023/195",
    "CODE_DCI": "06 C 023",
    "DCI": "MOLSIDOMINE",
    "NOM_COMMERCIALE": "MOLSIMED",
    "FORME": "COMP. SEC.",
    "DOSAGE": "04MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE SARL WORLD MEDECINE LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/05/21",
    "DATE_D_ENREGISTREMENT_FINAL": "12/05/21",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["molsidomine"],
    "InteractionIndexLink": ["molsidomine"],
    "N_ENREGISTREMENT": "268/ 06 C 023 /10/18",
    "CODE_DCI": "06 C 023",
    "DCI": "MOLSIDOMINE",
    "NOM_COMMERCIALE": "VAZOTEK 4",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "4MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MERINAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/10/2010",
    "DATE_D_ENREGISTREMENT_FINAL": "15/2/2018",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["tirofiban hydrochloride"],
    "InteractionIndexLink": ["tirofiban"],
    "N_ENREGISTREMENT": "473/ 06 C 210 /06/19",
    "CODE_DCI": "06 C 210",
    "DCI": "TIROFIBAN CHLORHYDRATE MONOHYDRATE EXPRIME EN TIROFIBAN",
    "NOM_COMMERCIALE": "AGRASTAT",
    "FORME": "SOL. A DILUER P. PERF. IV",
    "DOSAGE": "0.25MG/ML",
    "COND": "B/01FL. DE 50ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "IROKO CARDIO (UK) LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ROYAUME UNI",
    "DATE_D_ENREGISTREMENT_INITIAL": "23/7/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "8/5/2019",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "48 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["ivabradine"],
    "InteractionIndexLink": ["ivabradine"],
    "N_ENREGISTREMENT": "040/ 06 C 282 /09/16",
    "CODE_DCI": "06 C 282",
    "DCI": "IVABRADINE CHLORHYDRATE EXPRIME EN IVABRADINE",
    "NOM_COMMERCIALE": "PROCORALAN",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "7.5MG",
    "COND": "B/56",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SERVIER",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/7/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "11/9/2016",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["abacavir"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "531/ 06 C 317 /17",
    "CODE_DCI": "06 C 317",
    "DCI": "Abacavir sulfate experime en abacavir",
    "NOM_COMMERCIALE": "CLOTINAB",
    "FORME": "SOLUTION INJ IV OU  POUR PERFUSION",
    "DOSAGE": "2MG/ML ( 10MG/5ML)",
    "COND": "B/01 FLACON DE 5 ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ISU ABXIS CO. LTD",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CORéE",
    "DATE_D_ENREGISTREMENT_INITIAL": "5/11/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "5/11/2017",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["amiodarone"],
    "InteractionIndexLink": ["amiodarone"],
    "N_ENREGISTREMENT": "505/ 06 D 040 /19",
    "CODE_DCI": "06 D 040",
    "DCI": "Amiodarone chlorhydrate",
    "NOM_COMMERCIALE": "AMIODARONE CLORIDRATO BIOINDUSTRIA L.I.M",
    "FORME": "SOL.INJ",
    "DOSAGE": "50MG/ML (150MG/3ML)",
    "COND": "B/05 AMP. DE 3ML",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOINDUSTRIA LABORATORIO ITALIANO MEDICINALI SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ITALIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "5/5/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "5/5/2019",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["amiodarone"],
    "InteractionIndexLink": ["amiodarone"],
    "N_ENREGISTREMENT": "376/ 06 D 040 /97/17",
    "CODE_DCI": "06 D 040",
    "DCI": "Amiodarone chlorhydrate",
    "NOM_COMMERCIALE": "CORDARONE",
    "FORME": "SOL.INJ.IV.",
    "DOSAGE": "50MG/ML (150MG/3ML)",
    "COND": "B/06 AMP. DE 3ML",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANOFI SYNTHELABO",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/11/1997",
    "DATE_D_ENREGISTREMENT_FINAL": "6/3/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["amiodarone"],
    "InteractionIndexLink": ["amiodarone"],
    "N_ENREGISTREMENT": "380/ 06 D 041 /14",
    "CODE_DCI": "06 D 041",
    "DCI": "Amiodarone chlorhydrate",
    "NOM_COMMERCIALE": "AMIODARONE HUP",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "200MG",
    "COND": "B/30",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HUP.P.PHARMA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/7/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "13/7/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["amiodarone"],
    "InteractionIndexLink": ["amiodarone"],
    "N_ENREGISTREMENT": "255/ 06 D 041 /97/19",
    "CODE_DCI": "06 D 041",
    "DCI": "Amiodarone chlorhydrate",
    "NOM_COMMERCIALE": "CORDARONE",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "200MG",
    "COND": "B/30",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "WINTHROP PHARMA SAIDAL SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "8/11/1997",
    "DATE_D_ENREGISTREMENT_FINAL": "25/11/2019",
    "TYPE": "Ré",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["amiodarone"],
    "InteractionIndexLink": ["amiodarone"],
    "N_ENREGISTREMENT": "035/ 06 D 041 /15",
    "CODE_DCI": "06 D 041",
    "DCI": "Amiodarone chlorhydrate",
    "NOM_COMMERCIALE": "TRIAXONE",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "200MG",
    "COND": "B/30",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMALLIANCE EURL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/11/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "10/11/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["flecainide"],
    "InteractionIndexLink": ["flecainide"],
    "N_ENREGISTREMENT": "149/06 D 046/19",
    "CODE_DCI": "06 D 046",
    "DCI": "FLECAINIDE ACETATE",
    "NOM_COMMERCIALE": "FLECACARD",
    "FORME": "COMP SEC",
    "DOSAGE": "100MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVAPHARM TRADING SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/1/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "28/1/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["flecainide"],
    "InteractionIndexLink": ["flecainide"],
    "N_ENREGISTREMENT": "053/ 06 D 046 /02/16",
    "CODE_DCI": "06 D 046",
    "DCI": "FLECAINIDE ACETATE",
    "NOM_COMMERCIALE": "FLECAINE",
    "FORME": "COMPRIME",
    "DOSAGE": "100MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "3M SANTE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/11/2002",
    "DATE_D_ENREGISTREMENT_FINAL": "31/1/2018",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "60 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["flecainide"],
    "InteractionIndexLink": ["flecainide"],
    "N_ENREGISTREMENT": "470 / 06 D 046 /21",
    "CODE_DCI": "06 D 046",
    "DCI": "Acétate de Flécaïnide",
    "NOM_COMMERCIALE": "FLECAR",
    "FORME": "Comprimé sécable",
    "DOSAGE": "100MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE M.M / SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "21/3/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "21/3/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["captopril"],
    "InteractionIndexLink": ["captopril"],
    "N_ENREGISTREMENT": "285/ 06 E 052 /97/16",
    "CODE_DCI": "06 E 052",
    "DCI": "CAPTOPRIL",
    "NOM_COMMERCIALE": "LOPRIL",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "25MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "UPC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/12/1997",
    "DATE_D_ENREGISTREMENT_FINAL": "4/2/2016",
    "TYPE": "Ré",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["captopril"],
    "InteractionIndexLink": ["captopril"],
    "N_ENREGISTREMENT": "079/06 E 052/99",
    "CODE_DCI": "06 E 052",
    "DCI": "CAPTOPRIL",
    "NOM_COMMERCIALE": "TENSIOPRIL",
    "FORME": "COMPRIME",
    "DOSAGE": "25MG",
    "COND": "B/20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LAD PHARMA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "21/4/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "21/4/1999",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["captopril"],
    "InteractionIndexLink": ["captopril"],
    "N_ENREGISTREMENT": "268/ 06 E 052 /98/16",
    "CODE_DCI": "06 E 052",
    "DCI": "CAPTOPRIL",
    "NOM_COMMERCIALE": "TENSOPREL",
    "FORME": "COMP. QUADRISEC.",
    "DOSAGE": "25MG",
    "COND": "B/60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MERINAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "23/5/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "11/5/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["captopril"],
    "InteractionIndexLink": ["captopril"],
    "N_ENREGISTREMENT": "285/ 06 E 053 /97/16",
    "CODE_DCI": "06 E 053",
    "DCI": "CAPTOPRIL",
    "NOM_COMMERCIALE": "LOPRIL",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "50MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "UPC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/12/1997",
    "DATE_D_ENREGISTREMENT_FINAL": "10/1/2016",
    "TYPE": "Ré",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["captopril"],
    "InteractionIndexLink": ["captopril"],
    "N_ENREGISTREMENT": "079/06 E 053/98/17",
    "CODE_DCI": "06 E 053",
    "DCI": "CAPTOPRIL",
    "NOM_COMMERCIALE": "TENSIOPRIL",
    "FORME": "COMPRIME",
    "DOSAGE": "50MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LAD PHARMA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/2/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "10/8/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["captopril"],
    "InteractionIndexLink": ["captopril"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "06 E 053",
    "DCI": "CAPTOPRIL",
    "NOM_COMMERCIALE": "TENSOPREL",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "50MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["clonidine"],
    "InteractionIndexLink": ["clonidine"],
    "N_ENREGISTREMENT": "012/ 06 E 056 /98/14",
    "CODE_DCI": "06 E 056",
    "DCI": "CLONIDINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "CRONIDINE",
    "FORME": "COMPRIME",
    "DOSAGE": "0.15MG",
    "COND": "B/20",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CROVIS PHILCOM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ITALIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/8/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "1/5/2014",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["enalapril"],
    "InteractionIndexLink": ["enalapril"],
    "N_ENREGISTREMENT": "450/ 06 E 059 /06/12",
    "CODE_DCI": "06 E 059",
    "DCI": "ENALAPRIL MALEATE",
    "NOM_COMMERCIALE": "ENALAPRIL MYLAN",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "5MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MYLAN SAS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "5/8/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "5/12/2012",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["enalapril"],
    "InteractionIndexLink": ["enalapril"],
    "N_ENREGISTREMENT": "450/ 06 E 060 /06/12",
    "CODE_DCI": "06 E 060",
    "DCI": "ENALAPRIL MALEATE",
    "NOM_COMMERCIALE": "ENALAPRIL MYLAN",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "20MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MYLAN SAS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "5/8/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "8/11/2012",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["methyldopa"],
    "InteractionIndexLink": ["methyldopa"],
    "N_ENREGISTREMENT": "268/ 06 E 061 /99/18",
    "CODE_DCI": "06 E 061",
    "DCI": "METHYLDOPA SESQUIHYDRATEE EXPRIME EN METHYLDOPA ANHYDRE",
    "NOM_COMMERCIALE": "ALDOMET",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "250MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL MERINAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "16/1/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "21/3/2018",
    "TYPE": "Ré",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["losartan"],
    "InteractionIndexLink": ["losartan"],
    "N_ENREGISTREMENT": "418/ 06 E 126 /12",
    "CODE_DCI": "06 E 126",
    "DCI": "LOSARTAN POTASSIQUE",
    "NOM_COMMERCIALE": "ANGIZAR",
    "FORME": "COMP. PELLI. SEC.",
    "DOSAGE": "50MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NEOMEDIC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/1/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "18/1/2012",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["losartan"],
    "InteractionIndexLink": ["losartan"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "06 E 126",
    "DCI": "LOSARTAN POTASSIQUE",
    "NOM_COMMERCIALE": "BEKTAL",
    "FORME": "COMP. PELLI. SEC.",
    "DOSAGE": "50MG",
    "COND": "B/28 ET B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["losartan"],
    "InteractionIndexLink": ["losartan"],
    "N_ENREGISTREMENT": "024/ 06 E 126/97/17",
    "CODE_DCI": "06 E 126",
    "DCI": "LOSARTAN POTASSIQUE",
    "NOM_COMMERCIALE": "COZAAR",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "50MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MSD FRANCE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "France",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/2/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "26/11/2017",
    "TYPE": "Ré",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["losartan"],
    "InteractionIndexLink": ["losartan"],
    "N_ENREGISTREMENT": "468/ 06 E 126 /12",
    "CODE_DCI": "06 E 126",
    "DCI": "LOSARTAN POTASSIQUE",
    "NOM_COMMERCIALE": "HYSARTAN",
    "FORME": "COMP. PELLI. SEC.",
    "DOSAGE": "50MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NADPHARMADIC PRODUCTION SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/11/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "7/11/2012",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["losartan"],
    "InteractionIndexLink": ["losartan"],
    "N_ENREGISTREMENT": "309/ 06 E 126 /12/18",
    "CODE_DCI": "06 E 126",
    "DCI": "LOSARTAN POTASSIQUE",
    "NOM_COMMERCIALE": "LOSARTAN LDM",
    "FORME": "COMP. PELLI. SEC.",
    "DOSAGE": "50MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES  DE DIAGNOSTICS MAGHREBINS (LDM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/2/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "15/2/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["losartan"],
    "InteractionIndexLink": ["losartan"],
    "N_ENREGISTREMENT": "304/06 E 126/06/17",
    "CODE_DCI": "06 E 126",
    "DCI": "LOSARTAN POTASSIQUE",
    "NOM_COMMERCIALE": "LOZARTAN GEO",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "50MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GEOPHARM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "11/11/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "12/2/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["losartan"],
    "InteractionIndexLink": ["losartan"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "06 E 126",
    "DCI": "Losartan",
    "NOM_COMMERCIALE": "NORTA 50mg",
    "FORME": "comp pel séc",
    "DOSAGE": "50mg/comp",
    "COND": "bt de 30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["ramipril"],
    "InteractionIndexLink": ["ramipril"],
    "N_ENREGISTREMENT": "447/ 06 E 127 /14",
    "CODE_DCI": "06 E 127",
    "DCI": "RAMIPRIL",
    "NOM_COMMERCIALE": "RAMIPRIL BEKER",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "2.5MG",
    "COND": "B/30 ET B/90",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES BEKER",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/6/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "1/6/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["ramipril"],
    "InteractionIndexLink": ["ramipril"],
    "N_ENREGISTREMENT": "035/06 E 127/17",
    "CODE_DCI": "06 E 127",
    "DCI": "RAMIPRIL",
    "NOM_COMMERCIALE": "TANATRIL",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "2.5MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMALLIANCE EURL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/7/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "30/7/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["ramipril"],
    "InteractionIndexLink": ["ramipril"],
    "N_ENREGISTREMENT": "289/06 E 127/07/16",
    "CODE_DCI": "06 E 127",
    "DCI": "RAMIPRIL",
    "NOM_COMMERCIALE": "TRIAMPEX",
    "FORME": "GLES.",
    "DOSAGE": "2.5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRATER SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/9/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "19/10/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["ramipril"],
    "InteractionIndexLink": ["ramipril"],
    "N_ENREGISTREMENT": "392/ 06 E 127 /99/21",
    "CODE_DCI": "06 E 127",
    "DCI": "Ramipril",
    "NOM_COMMERCIALE": "TRIATEC",
    "FORME": "Comprimé  sécable",
    "DOSAGE": "2.5MG",
    "COND": "B/28",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANOFI AVENTIS ALGERIE /  SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/2/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "15/2/2021",
    "TYPE": "Ré",
    "STATUT": "F prémix",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["ramipril"],
    "InteractionIndexLink": ["ramipril"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "06 E 127",
    "DCI": "Ramipril",
    "NOM_COMMERCIALE": "Triampex 2.5mg",
    "FORME": "Gélule",
    "DOSAGE": "2.5 mg",
    "COND": "Boite de 30.",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["ramipril"],
    "InteractionIndexLink": ["ramipril"],
    "N_ENREGISTREMENT": "050/ 06 E 128 /12",
    "CODE_DCI": "06 E 128",
    "DCI": "RAMIPRIL",
    "NOM_COMMERCIALE": "RAMINORM",
    "FORME": "COMPRIME",
    "DOSAGE": "5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANDOZ SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "21/10/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "21/10/2012",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["ramipril"],
    "InteractionIndexLink": ["ramipril"],
    "N_ENREGISTREMENT": "447/ 06 E 128 /13/18",
    "CODE_DCI": "06 E 128",
    "DCI": "RAMIPRIL",
    "NOM_COMMERCIALE": "RAMIPRIL BEKER",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "5MG",
    "COND": "B/30 ET B/90",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEKER SARL (SARL LABORATOIRE BEKER ALGERIE)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "31/7/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "30/7/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "18 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["ramipril"],
    "InteractionIndexLink": ["ramipril"],
    "N_ENREGISTREMENT": "462/06 E 128/20",
    "CODE_DCI": "06 E 128",
    "DCI": "RAMIPRIL",
    "NOM_COMMERCIALE": "RAMIPRIL PHYSIOPHARM",
    "FORME": "COMP. SEC",
    "DOSAGE": "5MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES SARL PHYSIOPHARM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/11/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "22/11/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["ramipril"],
    "InteractionIndexLink": ["ramipril"],
    "N_ENREGISTREMENT": "035/06 E 128/17",
    "CODE_DCI": "06 E 128",
    "DCI": "RAMIPRIL",
    "NOM_COMMERCIALE": "TANATRIL",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMALLIANCE EURL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "16/7/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "16/7/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["ramipril"],
    "InteractionIndexLink": ["ramipril"],
    "N_ENREGISTREMENT": "392/ 06 E 128 /99/21",
    "CODE_DCI": "06 E 128",
    "DCI": "Ramipril",
    "NOM_COMMERCIALE": "TRIATEC",
    "FORME": "Comprimé  sécable",
    "DOSAGE": "5MG",
    "COND": "B/28",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANOFI AVENTIS ALGERIE /  SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/2/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "15/2/2021",
    "TYPE": "Ré",
    "STATUT": "F prémix",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["ramipril"],
    "InteractionIndexLink": ["ramipril"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "06 E 128",
    "DCI": "Ramipril",
    "NOM_COMMERCIALE": "Triampex",
    "FORME": "Gélule",
    "DOSAGE": "5 mg",
    "COND": "Boite de 30.",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["quinapril"],
    "InteractionIndexLink": ["quinapril"],
    "N_ENREGISTREMENT": "045/ 06 E 129 /97/15",
    "CODE_DCI": "06 E 129",
    "DCI": "QUINAPRIL CHLORHYDRATE EXPRIME EN QUINAPRIL",
    "NOM_COMMERCIALE": "ACUITEL",
    "FORME": "COMP. ENRO. SEC.",
    "DOSAGE": "5MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PFIZER HOLDING FRANCE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/5/1997",
    "DATE_D_ENREGISTREMENT_FINAL": "27/5/1997",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["quinapril"],
    "InteractionIndexLink": ["quinapril"],
    "N_ENREGISTREMENT": "045/ 06 E 130 /97/15",
    "CODE_DCI": "06 E 130",
    "DCI": "QUINAPRIL CHLORHYDRATE EXPRIME EN QUINAPRIL",
    "NOM_COMMERCIALE": "ACUITEL",
    "FORME": "COMP. ENRO. SEC.",
    "DOSAGE": "20MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PFIZER HOLDING FRANCE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/5/1997",
    "DATE_D_ENREGISTREMENT_FINAL": "18/6/2015",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "quinapril"],
    "InteractionIndexLink": ["hydrochlorothiazide", "quinapril"],
    "N_ENREGISTREMENT": "045/ 06 E 131 /97/16",
    "CODE_DCI": "06 E 131",
    "DCI": "QUINAPRIL CHLORHYDRATE EXPRIME EN QUINAPRIL / HYDROCHLOROTHIAZIDE",
    "NOM_COMMERCIALE": "ACUILIX",
    "FORME": "COMP .PELLI .SEC",
    "DOSAGE": "20MG/12.5MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PFIZER",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/5/1997",
    "DATE_D_ENREGISTREMENT_FINAL": "12/3/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "quinapril"],
    "InteractionIndexLink": ["hydrochlorothiazide", "quinapril"],
    "N_ENREGISTREMENT": "376/ 06 E 131 /13",
    "CODE_DCI": "06 E 131",
    "DCI": "QUINAPRIL CHLORHYDRATE EXPRIME EN QUINAPRIL / HYDROCHLOROTHIAZIDE",
    "NOM_COMMERCIALE": "QUINAPRIL / HYDROCHLOROTHIAZIDE WINTHROP",
    "FORME": "COMP. PELLI. SEC.",
    "DOSAGE": "20MG/12.5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANOFI-AVENTIS FRANCE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/1/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "20/1/2013",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "captopril"],
    "InteractionIndexLink": ["captopril", "hydrochlorothiazide"],
    "N_ENREGISTREMENT": "055/06 E 137/03/17",
    "CODE_DCI": "06 E 137",
    "DCI": "CAPTOPRIL / HYDROCHLOROTHIAZIDE",
    "NOM_COMMERCIALE": "CAPOCARD PLUS",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "50MG/25MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "DAR AL DAWA DEVELOPMENT & INVESTMENT Co Ltd",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/8/2003",
    "DATE_D_ENREGISTREMENT_FINAL": "30/7/2017",
    "TYPE": "Gé",
    "STATUT": "Fpremix",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "captopril"],
    "InteractionIndexLink": ["captopril", "hydrochlorothiazide"],
    "N_ENREGISTREMENT": "268/ 06 E 137 /14/19",
    "CODE_DCI": "06 E 137",
    "DCI": "CAPTOPRIL/HYDROCHLOROTHIAZIDE",
    "NOM_COMMERCIALE": "CO-TENSOPREL",
    "FORME": "COMPRIME",
    "DOSAGE": "50MG/25MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MERINAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/3/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "11/12/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "captopril"],
    "InteractionIndexLink": ["captopril", "hydrochlorothiazide"],
    "N_ENREGISTREMENT": "017/ 06 E 137 /99/16",
    "CODE_DCI": "06 E 137",
    "DCI": "CAPTOPRIL / HYDROCHLOROTHIAZIDE",
    "NOM_COMMERCIALE": "ECAZIDE",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "50MG/25MG",
    "COND": "B/28 ET B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL UNION PHARMACEUTIQUE CONSTANTINOISE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/5/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "5/9/2016",
    "TYPE": "Ré",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "captopril"],
    "InteractionIndexLink": ["captopril", "hydrochlorothiazide"],
    "N_ENREGISTREMENT": "231/ 06 E 137 /12",
    "CODE_DCI": "06 E 137",
    "DCI": "CAPTOPRIL / HYDROCHLOROTHIAZIDE",
    "NOM_COMMERCIALE": "PRIAZIDE",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "50MG/25MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SALEM LABORATOIRES",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "21/8/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "21/8/2012",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["ramipril"],
    "InteractionIndexLink": ["ramipril"],
    "N_ENREGISTREMENT": "035/06 E 139/17",
    "CODE_DCI": "06 E 139",
    "DCI": "RAMIPRIL",
    "NOM_COMMERCIALE": "TANATRIL",
    "FORME": "COMPRIME",
    "DOSAGE": "1.25MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMALLIANCE EURL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/6/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "29/6/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["ramipril"],
    "InteractionIndexLink": ["ramipril"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "06 E 139",
    "DCI": "RAMIPRIL",
    "NOM_COMMERCIALE": "TRIATEC",
    "FORME": "COMPRIME",
    "DOSAGE": "1.25MG",
    "COND": "B/28",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["moxonidine"],
    "InteractionIndexLink": ["moxonidine"],
    "N_ENREGISTREMENT": "447/06 E 143/16",
    "CODE_DCI": "06 E 143",
    "DCI": "MOXONIDINE",
    "NOM_COMMERCIALE": "MOXONIDINE BEKER",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "0.2MG",
    "COND": "B/30 ET B/90",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL BEKER",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/11/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "9/11/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["moxonidine"],
    "InteractionIndexLink": ["moxonidine"],
    "N_ENREGISTREMENT": "263/06 E 143/21",
    "CODE_DCI": "06 E 143",
    "DCI": "Moxonidine",
    "NOM_COMMERCIALE": "MOXOTENS",
    "FORME": "Comprimé pelliculé",
    "DOSAGE": "0.2MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOPHARM / SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "14/3/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "14/3/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["moxonidine"],
    "InteractionIndexLink": ["moxonidine"],
    "N_ENREGISTREMENT": "147/ 06 E 143 /99/017",
    "CODE_DCI": "06 E 143",
    "DCI": "MOXONIDINE",
    "NOM_COMMERCIALE": "PHYSIOTENS 0.2",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "0.2MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ABBOTT PRODUCTS SAS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/5/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "29/6/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["moxonidine"],
    "InteractionIndexLink": ["moxonidine"],
    "N_ENREGISTREMENT": "447/ 06 E 144 / 16",
    "CODE_DCI": "06 E 144",
    "DCI": "MOXONIDINE",
    "NOM_COMMERCIALE": "MOXONIDINE BEKER",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "0.4MG",
    "COND": "B/30 ET B/90",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL BEKER",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "5/9/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "5/9/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["moxonidine"],
    "InteractionIndexLink": ["moxonidine"],
    "N_ENREGISTREMENT": "263/ 06 E 144 / 21",
    "CODE_DCI": "06 E 144",
    "DCI": "Moxonidine",
    "NOM_COMMERCIALE": "MOXOTENS",
    "FORME": "Comprimé pelliculé",
    "DOSAGE": "0.4MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOPHARM / SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "14/3/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "14/3/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["moxonidine"],
    "InteractionIndexLink": ["moxonidine"],
    "N_ENREGISTREMENT": "147/ 06 E 144 /99/17",
    "CODE_DCI": "06 E 144",
    "DCI": "MOXONIDINE",
    "NOM_COMMERCIALE": "PHYSIOTENS 0.4",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "0.4MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ABBOTT PRODUCTS SAS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/5/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "29/6/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["valsartan"],
    "InteractionIndexLink": ["valsartan"],
    "N_ENREGISTREMENT": "035 / 06 E 146 /15",
    "CODE_DCI": "06 E 146",
    "DCI": "Valsartan",
    "NOM_COMMERCIALE": "VALACLOR 40",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "40MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMALLIANCE EURL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/2/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "22/2/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["valsartan"],
    "InteractionIndexLink": ["valsartan"],
    "N_ENREGISTREMENT": "001/ 06 E 147 /14",
    "CODE_DCI": "06 E 147",
    "DCI": "Valsartan",
    "NOM_COMMERCIALE": "ARBITAN",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "80MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMA ALGERIA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/4/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "6/10/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["valsartan"],
    "InteractionIndexLink": ["valsartan"],
    "N_ENREGISTREMENT": "518/06 E 147/16",
    "CODE_DCI": "06 E 147",
    "DCI": "Valsartan",
    "NOM_COMMERCIALE": "DIVALAN",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "80MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "TAPHCO SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "8/11/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "8/11/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["valsartan"],
    "InteractionIndexLink": ["valsartan"],
    "N_ENREGISTREMENT": "380/ 06 E 147 /19",
    "CODE_DCI": "06 E 147",
    "DCI": "Valsartan",
    "NOM_COMMERCIALE": "HUREG",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "80MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HUP.P.PHARMA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/1/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "24/1/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["valsartan"],
    "InteractionIndexLink": ["valsartan"],
    "N_ENREGISTREMENT": "317/ 06 E 147 /14",
    "CODE_DCI": "06 E 147",
    "DCI": "Valsartan",
    "NOM_COMMERCIALE": "RETA 80",
    "FORME": "COMP PELL SEC",
    "DOSAGE": "80MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INPHA-MEDIS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/6/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "15/6/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["valsartan"],
    "InteractionIndexLink": ["valsartan"],
    "N_ENREGISTREMENT": "352/ 06 E 147 /10/15",
    "CODE_DCI": "06 E 147",
    "DCI": "Valsartan",
    "NOM_COMMERCIALE": "SARTEG",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "80MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/5/2010",
    "DATE_D_ENREGISTREMENT_FINAL": "27/12/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["valsartan"],
    "InteractionIndexLink": ["valsartan"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "06 E 147",
    "DCI": "Valsartan",
    "NOM_COMMERCIALE": "TABUVAN",
    "FORME": "Comprimé pelliculé",
    "DOSAGE": "80mg",
    "COND": "B 30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["valsartan"],
    "InteractionIndexLink": ["valsartan"],
    "N_ENREGISTREMENT": "068/ 06 E 147 /99/19",
    "CODE_DCI": "06 E 147",
    "DCI": "Valsartan",
    "NOM_COMMERCIALE": "TAREG",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "80MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVARTIS PHARMA SCHWEIZ AG",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SUISSE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/6/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "3/12/2019",
    "TYPE": "Ré",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["valsartan"],
    "InteractionIndexLink": ["valsartan"],
    "N_ENREGISTREMENT": "035 / 06 E 147 /15",
    "CODE_DCI": "06 E 147",
    "DCI": "Valsartan",
    "NOM_COMMERCIALE": "VALACLOR 80",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "80MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMALLIANCE EURL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "3/3/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "3/3/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["valsartan"],
    "InteractionIndexLink": ["valsartan"],
    "N_ENREGISTREMENT": "447/ 06 E 147 /11/17",
    "CODE_DCI": "06 E 147",
    "DCI": "Valsartan",
    "NOM_COMMERCIALE": "VALASTAN",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "80MG",
    "COND": "B/30 ET B/90",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEKER SARL (SARL LABORATOIRE BEKER ALGERIE)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/2/2011",
    "DATE_D_ENREGISTREMENT_FINAL": "28/2/2011",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["valsartan"],
    "InteractionIndexLink": ["valsartan"],
    "N_ENREGISTREMENT": "268/ 06 E 147 /12",
    "CODE_DCI": "06 E 147",
    "DCI": "Valsartan",
    "NOM_COMMERCIALE": "VALEX 80",
    "FORME": "COMP. PELLI. SEC.",
    "DOSAGE": "80MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MERINAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/3/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "20/3/2012",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["valsartan"],
    "InteractionIndexLink": ["valsartan"],
    "N_ENREGISTREMENT": "320/ 06 E 147 /08/13",
    "CODE_DCI": "06 E 147",
    "DCI": "Valsartan",
    "NOM_COMMERCIALE": "VALSAN",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "80MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIAN GENERICS DEVELOPMENT  PHARMA  (AGD PHARMA)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "23/3/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "29/5/2013",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["valsartan"],
    "InteractionIndexLink": ["valsartan"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "06 E 147",
    "DCI": "Valsartan",
    "NOM_COMMERCIALE": "VALSARTAL",
    "FORME": "COMP. PELLI. SEC.",
    "DOSAGE": "80MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["valsartan"],
    "InteractionIndexLink": ["valsartan"],
    "N_ENREGISTREMENT": "309/ 06 E 147 /13",
    "CODE_DCI": "06 E 147",
    "DCI": "Valsartan",
    "NOM_COMMERCIALE": "VALSARTAN LDM",
    "FORME": "COMP. PELLI. SEC.",
    "DOSAGE": "80MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES  DE DIAGNOSTICS MAGHREBINS (LDM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/6/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "25/6/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["valsartan"],
    "InteractionIndexLink": ["valsartan"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "06 E 147",
    "DCI": "Valsartan",
    "NOM_COMMERCIALE": "VALSIS",
    "FORME": "COMP. PELLI. SEC.",
    "DOSAGE": "80MG",
    "COND": "B/28",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["valsartan"],
    "InteractionIndexLink": ["valsartan"],
    "N_ENREGISTREMENT": "470/ 06 E 147 /12/18",
    "CODE_DCI": "06 E 147",
    "DCI": "Valsartan",
    "NOM_COMMERCIALE": "VESTAG",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "80MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MM (SARL LABORATOIRES MM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "11/11/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "22/4/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["valsartan"],
    "InteractionIndexLink": ["valsartan"],
    "N_ENREGISTREMENT": "544/ 06 E 147 /18",
    "CODE_DCI": "06 E 147",
    "DCI": "Valsartan",
    "NOM_COMMERCIALE": "VIASART",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "80MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL WORLD MEDECINE LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/7/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "24/7/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["valsartan"],
    "InteractionIndexLink": ["valsartan"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "06 E 147",
    "DCI": "Valsartan",
    "NOM_COMMERCIALE": "Valaclor",
    "FORME": "Comprimé pelliculé",
    "DOSAGE": "80 mg",
    "COND": "Boite 30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["irbesartan"],
    "InteractionIndexLink": ["irbesartan"],
    "N_ENREGISTREMENT": "352/ 06 E 156 /10/16",
    "CODE_DCI": "06 E 156",
    "DCI": "Irbesartan",
    "NOM_COMMERCIALE": "APROSART",
    "FORME": "COMPRIME",
    "DOSAGE": "150MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/9/2010",
    "DATE_D_ENREGISTREMENT_FINAL": "12/4/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["irbesartan"],
    "InteractionIndexLink": ["irbesartan"],
    "N_ENREGISTREMENT": "392/ 06 E 156 /01/20",
    "CODE_DCI": "06 E 156",
    "DCI": "Irbesartan",
    "NOM_COMMERCIALE": "APROVEL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "150MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANOFI AVENTIS ALGERIE SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/2/2001",
    "DATE_D_ENREGISTREMENT_FINAL": "9/12/2020",
    "TYPE": "Ré",
    "STATUT": "Fgrain",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["irbesartan"],
    "InteractionIndexLink": ["irbesartan"],
    "N_ENREGISTREMENT": "268/ 06 E 156 /13/18",
    "CODE_DCI": "06 E 156",
    "DCI": "Irbesartan",
    "NOM_COMMERCIALE": "ARADEX 150",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "150MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MERINAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/5/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "3/9/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["irbesartan"],
    "InteractionIndexLink": ["irbesartan"],
    "N_ENREGISTREMENT": "426/ 06 E 156 /13",
    "CODE_DCI": "06 E 156",
    "DCI": "Irbesartan",
    "NOM_COMMERCIALE": "ARAVEL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "150MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "REMEDE PHARMA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/3/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "10/3/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["irbesartan"],
    "InteractionIndexLink": ["irbesartan"],
    "N_ENREGISTREMENT": "039/06 E 156/20",
    "CODE_DCI": "06 E 156",
    "DCI": "IRBESARTAN",
    "NOM_COMMERCIALE": "AROVAL",
    "FORME": "COMP. PELL.",
    "DOSAGE": "150MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES SOCIETE PHARMACEUTIQUE ALGERIENNE-SOPHAL SPA-",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/12/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "13/12/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["irbesartan"],
    "InteractionIndexLink": ["irbesartan"],
    "N_ENREGISTREMENT": "097/ 06 E 156 /16",
    "CODE_DCI": "06 E 156",
    "DCI": "Irbesartan",
    "NOM_COMMERCIALE": "CARDIOTENS",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "150MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANAMED SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/9/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "27/9/2016",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["irbesartan"],
    "InteractionIndexLink": ["irbesartan"],
    "N_ENREGISTREMENT": "055/ 06 E 156 /19",
    "CODE_DCI": "06 E 156",
    "DCI": "Irbesartan",
    "NOM_COMMERCIALE": "GIZLAN",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "150MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "DAR AL DAWA DEVELOPMENT & INVESTMENT Co Ltd",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/3/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "6/3/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["irbesartan"],
    "InteractionIndexLink": ["irbesartan"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "06 E 156",
    "DCI": "Irbésartan",
    "NOM_COMMERCIALE": "Gizlan 150",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "150MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["irbesartan"],
    "InteractionIndexLink": ["irbesartan"],
    "N_ENREGISTREMENT": "18/06 E156/380",
    "CODE_DCI": "06 E 156",
    "DCI": "IRBESARTAN",
    "NOM_COMMERCIALE": "HUPROVEL",
    "FORME": "COMP PELL",
    "DOSAGE": "150MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "laboratoires HUP.P PHARMA Sarl",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "14/11/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "14/11/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["irbesartan"],
    "InteractionIndexLink": ["irbesartan"],
    "N_ENREGISTREMENT": "468/ 06 E 156 /13",
    "CODE_DCI": "06 E 156",
    "DCI": "Irbesartan",
    "NOM_COMMERCIALE": "IRBAC",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "150MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BAC PHARMA SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "21/7/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "21/7/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["irbesartan"],
    "InteractionIndexLink": ["irbesartan"],
    "N_ENREGISTREMENT": "518/06 E 156/17",
    "CODE_DCI": "06 E 156",
    "DCI": "Irbesartan",
    "NOM_COMMERCIALE": "IRBE 150",
    "FORME": "COMPRIME",
    "DOSAGE": "150MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "TAPHCO SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/5/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "28/5/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["irbesartan"],
    "InteractionIndexLink": ["irbesartan"],
    "N_ENREGISTREMENT": "492/06 E 156/20",
    "CODE_DCI": "06 E 156",
    "DCI": "IRBESARTAN",
    "NOM_COMMERCIALE": "IRBEDIM",
    "FORME": "COMP. PELL.",
    "DOSAGE": "150MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES SPA SOPRODIM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/12/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "29/12/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["irbesartan"],
    "InteractionIndexLink": ["irbesartan"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "06 E 156",
    "DCI": "Irbesartan",
    "NOM_COMMERCIALE": "IRBEK",
    "FORME": "COMPRIME",
    "DOSAGE": "150MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["irbesartan"],
    "InteractionIndexLink": ["irbesartan"],
    "N_ENREGISTREMENT": "263/ 06 E 156 /10/16",
    "CODE_DCI": "06 E 156",
    "DCI": "Irbesartan",
    "NOM_COMMERCIALE": "IRBEVEL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "150MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOPHARM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/3/2010",
    "DATE_D_ENREGISTREMENT_FINAL": "13/3/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["irbesartan"],
    "InteractionIndexLink": ["irbesartan"],
    "N_ENREGISTREMENT": "035 / 06 E 156 /18",
    "CODE_DCI": "06 E 156",
    "DCI": "Irbesartan",
    "NOM_COMMERCIALE": "IRBISART",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "150MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMALLIANCE EURL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "11/2/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "11/2/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["irbesartan"],
    "InteractionIndexLink": ["irbesartan"],
    "N_ENREGISTREMENT": "418/ 06 E 156 /14",
    "CODE_DCI": "06 E 156",
    "DCI": "Irbesartan",
    "NOM_COMMERCIALE": "IROVEL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "150MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NEOMEDIC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "8/6/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "8/6/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["irbesartan"],
    "InteractionIndexLink": ["irbesartan"],
    "N_ENREGISTREMENT": "470/ 06 E 156 /12/18",
    "CODE_DCI": "06 E 156",
    "DCI": "Irbesartan",
    "NOM_COMMERCIALE": "ZIBRAT",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "150MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MM LABORATOIRES SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "5/12/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "2/4/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["irbesartan"],
    "InteractionIndexLink": ["irbesartan"],
    "N_ENREGISTREMENT": "352/ 06 E 157 /10/16",
    "CODE_DCI": "06 E 157",
    "DCI": "Irbesartan",
    "NOM_COMMERCIALE": "APROSART",
    "FORME": "COMPRIME",
    "DOSAGE": "300MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/10/2010",
    "DATE_D_ENREGISTREMENT_FINAL": "12/4/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["irbesartan"],
    "InteractionIndexLink": ["irbesartan"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "06 E 157",
    "DCI": "Irbesartan",
    "NOM_COMMERCIALE": "APROVEL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "300MG",
    "COND": "B/28",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["irbesartan"],
    "InteractionIndexLink": ["irbesartan"],
    "N_ENREGISTREMENT": "268/ 06 E 157 /13/18",
    "CODE_DCI": "06 E 157",
    "DCI": "Irbesartan",
    "NOM_COMMERCIALE": "ARADEX 300",
    "FORME": "COMPRIME",
    "DOSAGE": "300MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MERINAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/5/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "18/7/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["irbesartan"],
    "InteractionIndexLink": ["irbesartan"],
    "N_ENREGISTREMENT": "426/ 06 E 157 /13",
    "CODE_DCI": "06 E 157",
    "DCI": "Irbesartan",
    "NOM_COMMERCIALE": "ARAVEL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "300MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "REMEDE PHARMA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/3/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "10/3/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["irbesartan"],
    "InteractionIndexLink": ["irbesartan"],
    "N_ENREGISTREMENT": "039/06 E 157/20",
    "CODE_DCI": "06 E 157",
    "DCI": "IRBESARTAN",
    "NOM_COMMERCIALE": "AROVAL",
    "FORME": "COMP. PELL.",
    "DOSAGE": "150MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES SOCIETE PHARMACEUTIQUE ALGERIENNE-SOPHAL SPA-",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/12/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "13/12/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["irbesartan"],
    "InteractionIndexLink": ["irbesartan"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "06 E 157",
    "DCI": "IRBESARTAN",
    "NOM_COMMERCIALE": "AROVAL",
    "FORME": "Comp",
    "DOSAGE": "300mg",
    "COND": "Boîte de 30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["irbesartan"],
    "InteractionIndexLink": ["irbesartan"],
    "N_ENREGISTREMENT": "097/ 06 E 157 /16",
    "CODE_DCI": "06 E 157",
    "DCI": "Irbesartan",
    "NOM_COMMERCIALE": "CARDIOTENS 300",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "300MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANAMED SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "5/9/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "5/9/2016",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["irbesartan"],
    "InteractionIndexLink": ["irbesartan"],
    "N_ENREGISTREMENT": "055/ 06 E 157 /19",
    "CODE_DCI": "06 E 157",
    "DCI": "Irbesartan",
    "NOM_COMMERCIALE": "GIZLAN 300",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "300MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "DAR AL DAWA DEVELOPMENT & INVESTMENT Co Ltd",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/3/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "6/3/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["irbesartan"],
    "InteractionIndexLink": ["irbesartan"],
    "N_ENREGISTREMENT": "18/06 E157/380",
    "CODE_DCI": "06 E 157",
    "DCI": "IRBESARTAN",
    "NOM_COMMERCIALE": "HUPROVEL",
    "FORME": "COMP PELL",
    "DOSAGE": "300MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "laboratoires HUP.P PHARMA Sarl",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "14/11/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "14/11/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["irbesartan"],
    "InteractionIndexLink": ["irbesartan"],
    "N_ENREGISTREMENT": "479/ 06 E 157 /13",
    "CODE_DCI": "06 E 157",
    "DCI": "Irbesartan",
    "NOM_COMMERCIALE": "IRBAC",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "300MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BAC PHARMA SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/7/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "7/7/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["irbesartan"],
    "InteractionIndexLink": ["irbesartan"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "06 E 157",
    "DCI": "Irbesartan",
    "NOM_COMMERCIALE": "IRBEK",
    "FORME": "COMPRIME",
    "DOSAGE": "300MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["irbesartan"],
    "InteractionIndexLink": ["irbesartan"],
    "N_ENREGISTREMENT": "263/ 06 E 157 /10/16",
    "CODE_DCI": "06 E 157",
    "DCI": "Irbesartan",
    "NOM_COMMERCIALE": "IRBEVEL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "300MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOPHARM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/3/2010",
    "DATE_D_ENREGISTREMENT_FINAL": "11/4/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["irbesartan"],
    "InteractionIndexLink": ["irbesartan"],
    "N_ENREGISTREMENT": "418/ 06 E 157 /14",
    "CODE_DCI": "06 E 157",
    "DCI": "Irbesartan",
    "NOM_COMMERCIALE": "IROVEL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "300MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NEOMEDIC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/4/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "15/4/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["irbesartan"],
    "InteractionIndexLink": ["irbesartan"],
    "N_ENREGISTREMENT": "470/ 06 E 157 /12/18",
    "CODE_DCI": "06 E 157",
    "DCI": "Irbesartan",
    "NOM_COMMERCIALE": "ZIBRAT",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "300MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MM LABORATOIRES SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "5/12/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "2/4/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "valsartan"],
    "InteractionIndexLink": ["hydrochlorothiazide", "valsartan"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "06 E 158",
    "DCI": "Valsartan / Hydrochlorothiazide",
    "NOM_COMMERCIALE": "CO VALASTAN",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "80MG/12.5MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "valsartan"],
    "InteractionIndexLink": ["hydrochlorothiazide", "valsartan"],
    "N_ENREGISTREMENT": "001/ 06 E 158 /14",
    "CODE_DCI": "06 E 158",
    "DCI": "Valsartan / Hydrochlorothiazide",
    "NOM_COMMERCIALE": "CO-ARBITAN",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "80MG/12.5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMA ALGERIA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/5/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "6/10/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "valsartan"],
    "InteractionIndexLink": ["hydrochlorothiazide", "valsartan"],
    "N_ENREGISTREMENT": "468/ 06 E 158 /14",
    "CODE_DCI": "06 E 158",
    "DCI": "Valsartan / Hydrochlorothiazide",
    "NOM_COMMERCIALE": "CO-LIPIRINAD",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "80MG / 12.5MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NADPHARMADIC PRODUCTION SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/10/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "13/10/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "valsartan"],
    "InteractionIndexLink": ["hydrochlorothiazide", "valsartan"],
    "N_ENREGISTREMENT": "317/ 06 E 158 /16",
    "CODE_DCI": "06 E 158",
    "DCI": "Valsartan / Hydrochlorothiazide",
    "NOM_COMMERCIALE": "CO-RETA",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "80MG/12.5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INPHA-MEDIS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "16/2/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "16/2/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "valsartan"],
    "InteractionIndexLink": ["hydrochlorothiazide", "valsartan"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "06 E 158",
    "DCI": "Valsartan/Hydrochlorothiazide",
    "NOM_COMMERCIALE": "CO-Tabuvan",
    "FORME": "Comprimé pelliculé",
    "DOSAGE": "80/12.5 mg",
    "COND": "B 30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "valsartan"],
    "InteractionIndexLink": ["hydrochlorothiazide", "valsartan"],
    "N_ENREGISTREMENT": "268/ 06 E 158/14",
    "CODE_DCI": "06 E 158",
    "DCI": "Valsartan / Hydrochlorothiazide",
    "NOM_COMMERCIALE": "CO-VALEX",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "80MG/12.5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MERINAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/1/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "2/2/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "valsartan"],
    "InteractionIndexLink": ["hydrochlorothiazide", "valsartan"],
    "N_ENREGISTREMENT": "352/ 06 E 158 /10/16",
    "CODE_DCI": "06 E 158",
    "DCI": "Valsartan / Hydrochlorothiazide",
    "NOM_COMMERCIALE": "COSARTEG",
    "FORME": "COMP. ENRO.",
    "DOSAGE": "80MG/12.5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/6/2010",
    "DATE_D_ENREGISTREMENT_FINAL": "17/1/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "valsartan"],
    "InteractionIndexLink": ["hydrochlorothiazide", "valsartan"],
    "N_ENREGISTREMENT": "068/06 E 158/01/20",
    "CODE_DCI": "06 E 158",
    "DCI": "Valsartan / Hydrochlorothiazide",
    "NOM_COMMERCIALE": "COTAREG",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "80MG/12.5MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVARTIS PHARMA SCHWEIZ AG",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SUISSE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/6/2001",
    "DATE_D_ENREGISTREMENT_FINAL": "9/4/2020",
    "TYPE": "Ré",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "valsartan"],
    "InteractionIndexLink": ["hydrochlorothiazide", "valsartan"],
    "N_ENREGISTREMENT": "470/ 06 E 158 /12/18",
    "CODE_DCI": "06 E 158",
    "DCI": "Valsartan / Hydrochlorothiazide",
    "NOM_COMMERCIALE": "COVESTAG",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "80MG/12.5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MM LABORATOIRES SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/9/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "1/8/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "valsartan"],
    "InteractionIndexLink": ["hydrochlorothiazide", "valsartan"],
    "N_ENREGISTREMENT": "149/ 06 E 158 /14",
    "CODE_DCI": "06 E 158",
    "DCI": "Valsartan / Hydrochlorothiazide",
    "NOM_COMMERCIALE": "NOVAVALZ PLUS",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "80MG/12.5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVAPHARM TRADING SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "16/2/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "16/2/2014",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "valsartan"],
    "InteractionIndexLink": ["hydrochlorothiazide", "valsartan"],
    "N_ENREGISTREMENT": "035/ 06 E 158 /16",
    "CODE_DCI": "06 E 158",
    "DCI": "Valsartan / Hydrochlorothiazide",
    "NOM_COMMERCIALE": "VALACLOR PLUS",
    "FORME": "COMPRIME",
    "DOSAGE": "80MG/12.5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMALLIANCE EURL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/2/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "15/2/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "valsartan"],
    "InteractionIndexLink": ["hydrochlorothiazide", "valsartan"],
    "N_ENREGISTREMENT": "309/ 06 E 158 /14",
    "CODE_DCI": "06 E 158",
    "DCI": "Valsartan / Hydrochlorothiazide",
    "NOM_COMMERCIALE": "VALSARTAN+HCTZ LDM",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "80MG/12.5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE DE DIAGNOSTIC MAGHREBINS (LDM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/4/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "13/4/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["perindopril"],
    "InteractionIndexLink": ["perindopril ter-butylamine"],
    "N_ENREGISTREMENT": "447/ 06 E 165 /12",
    "CODE_DCI": "06 E 165",
    "DCI": "PERINDOPRIL TER-BUTYLAMINE",
    "NOM_COMMERCIALE": "PERINDOPRIL BEKER",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "4MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEKER SARL (SARL LABORATOIRE BEKER ALGERIE)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/10/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "2/2/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["perindopril"],
    "InteractionIndexLink": ["perindopril ter-butylamine"],
    "N_ENREGISTREMENT": "352/ 06  E 165 /16",
    "CODE_DCI": "06 E 165",
    "DCI": "PERINDOPRIL ERBUMINE",
    "NOM_COMMERCIALE": "PERINDOSYL",
    "FORME": "COMPRIME",
    "DOSAGE": "4MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES EL KENDI INDUSTRIE DU MEDICAMENT SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/7/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "26/7/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["valsartan"],
    "InteractionIndexLink": ["valsartan"],
    "N_ENREGISTREMENT": "001/ 06 E 166 /14",
    "CODE_DCI": "06 E 166",
    "DCI": "Valsartan",
    "NOM_COMMERCIALE": "ARBITAN",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "160MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMA ALGERIA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/4/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "5/9/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["valsartan"],
    "InteractionIndexLink": ["valsartan"],
    "N_ENREGISTREMENT": "518/06 E 166/16",
    "CODE_DCI": "06 E 166",
    "DCI": "Valsartan",
    "NOM_COMMERCIALE": "DIVALAN",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "160MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "TAPHCO SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/11/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "9/11/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["valsartan"],
    "InteractionIndexLink": ["valsartan"],
    "N_ENREGISTREMENT": "380/ 06 E 166 /19",
    "CODE_DCI": "06 E 166",
    "DCI": "Valsartan",
    "NOM_COMMERCIALE": "HUREG",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "160MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HUP.P.PHARMA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/1/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "24/1/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["valsartan"],
    "InteractionIndexLink": ["valsartan"],
    "N_ENREGISTREMENT": "317/ 06 E 166 /14",
    "CODE_DCI": "06 E 166",
    "DCI": "Valsartan",
    "NOM_COMMERCIALE": "RETA 160",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "160MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INPHA-MEDIS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/6/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "15/6/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["valsartan"],
    "InteractionIndexLink": ["valsartan"],
    "N_ENREGISTREMENT": "352/ 06 E 166 /10/15",
    "CODE_DCI": "06 E 166",
    "DCI": "Valsartan",
    "NOM_COMMERCIALE": "SARTEG",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "160MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/5/2010",
    "DATE_D_ENREGISTREMENT_FINAL": "27/12/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["valsartan"],
    "InteractionIndexLink": ["valsartan"],
    "N_ENREGISTREMENT": "068/ 06 E 166 /02/19",
    "CODE_DCI": "06 E 166",
    "DCI": "Valsartan",
    "NOM_COMMERCIALE": "TAREG",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "160MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVARTIS PHARMA SCHWEIZ AG",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SUISSE",
    "DATE_D_ENREGISTREMENT_INITIAL": "16/3/2002",
    "DATE_D_ENREGISTREMENT_FINAL": "3/12/2019",
    "TYPE": "Ré",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["valsartan"],
    "InteractionIndexLink": ["valsartan"],
    "N_ENREGISTREMENT": "035 / 06 E 166 /15",
    "CODE_DCI": "06 E 166",
    "DCI": "Valsartan",
    "NOM_COMMERCIALE": "VALACLOR 160",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "160MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMALLIANCE EURL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/7/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "30/7/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["valsartan"],
    "InteractionIndexLink": ["valsartan"],
    "N_ENREGISTREMENT": "447/ 06 E 166 /09/18",
    "CODE_DCI": "06 E 166",
    "DCI": "Valsartan",
    "NOM_COMMERCIALE": "VALASTAN",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "160MG",
    "COND": "B/30 - B/90",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEKER SARL (SARL LABORATOIRE BEKER ALGERIE)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/9/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "18/4/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["valsartan"],
    "InteractionIndexLink": ["valsartan"],
    "N_ENREGISTREMENT": "268/ 06 E 166 /12",
    "CODE_DCI": "06 E 166",
    "DCI": "Valsartan",
    "NOM_COMMERCIALE": "VALEX 160",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "160MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MERINAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/3/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "20/3/2012",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["valsartan"],
    "InteractionIndexLink": ["valsartan"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "06 E 166",
    "DCI": "Valsartan",
    "NOM_COMMERCIALE": "VALSARTAL",
    "FORME": "COMP. PELLI. SEC.",
    "DOSAGE": "160MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["valsartan"],
    "InteractionIndexLink": ["valsartan"],
    "N_ENREGISTREMENT": "309/ 06 E 166 /13",
    "CODE_DCI": "06 E 166",
    "DCI": "Valsartan",
    "NOM_COMMERCIALE": "VALSARTAN LDM",
    "FORME": "COMP. PELLI. SEC.",
    "DOSAGE": "160MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES  DE DIAGNOSTIC MAGHREBINS (LDM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/2/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "18/2/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["valsartan"],
    "InteractionIndexLink": ["valsartan"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "06 E 166",
    "DCI": "Valsartan",
    "NOM_COMMERCIALE": "VALSIS",
    "FORME": "COMP. PELLI. SEC.",
    "DOSAGE": "160MG",
    "COND": "B/28",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["valsartan"],
    "InteractionIndexLink": ["valsartan"],
    "N_ENREGISTREMENT": "470/ 06 E 166 /12/18",
    "CODE_DCI": "06 E 166",
    "DCI": "Valsartan",
    "NOM_COMMERCIALE": "VESTAG",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "160MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MM LABORATOIRES SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "5/12/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "22/4/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["valsartan"],
    "InteractionIndexLink": ["valsartan"],
    "N_ENREGISTREMENT": "544/ 06 E 166 /18",
    "CODE_DCI": "06 E 166",
    "DCI": "Valsartan",
    "NOM_COMMERCIALE": "VIASART",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "160MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL/WORLD MEDECINE LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "5/6/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "5/6/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "losartan"],
    "InteractionIndexLink": ["hydrochlorothiazide", "losartan"],
    "N_ENREGISTREMENT": "468/ 06 E 167 /13",
    "CODE_DCI": "06 E 167",
    "DCI": "LOSARTAN POTASSIQUE /  HYDROCHLOROTHIAZIDE",
    "NOM_COMMERCIALE": "CO-HYSARTAN",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "50MG/12.5MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NADPHARMADIC PRODUCTION SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/1/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "13/1/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "losartan"],
    "InteractionIndexLink": ["hydrochlorothiazide", "losartan"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "06 E 167",
    "DCI": "LOSARTAN POTASSIQUE /  HYDROCHLOROTHIAZIDE",
    "NOM_COMMERCIALE": "CO-NORTA",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "50MG/12.5MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "losartan"],
    "InteractionIndexLink": ["hydrochlorothiazide", "losartan"],
    "N_ENREGISTREMENT": "447/ 06 E 167 /11/17",
    "CODE_DCI": "06 E 167",
    "DCI": "LOSARTAN POTASSIQUE /  HYDROCHLOROTHIAZIDE",
    "NOM_COMMERCIALE": "COBEKTAL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "50MG/12.5MG",
    "COND": "B/28 ET B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES BEKER",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "5/1/2011",
    "DATE_D_ENREGISTREMENT_FINAL": "30/7/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "losartan"],
    "InteractionIndexLink": ["hydrochlorothiazide", "losartan"],
    "N_ENREGISTREMENT": "024/ 06 E 167 /03/19",
    "CODE_DCI": "06 E 167",
    "DCI": "LOSARTAN POTASSIQUE /  HYDROCHLOROTHIAZIDE",
    "NOM_COMMERCIALE": "HYZAAR",
    "FORME": "COMPRIME",
    "DOSAGE": "50MG/12.5MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MSD FRANCE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "16/4/2003",
    "DATE_D_ENREGISTREMENT_FINAL": "28/2/2019",
    "TYPE": "Ré",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "losartan"],
    "InteractionIndexLink": ["hydrochlorothiazide", "losartan"],
    "N_ENREGISTREMENT": "304/06 E 167/17",
    "CODE_DCI": "06 E 167",
    "DCI": "LOSARTAN POTASSIQUE /  HYDROCHLOROTHIAZIDE",
    "NOM_COMMERCIALE": "THIAZARTAN",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "50MG/12.5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GEOPHARM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/6/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "29/6/2017",
    "TYPE": "GE",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["lercanidipine"],
    "InteractionIndexLink": ["lercanidipine"],
    "N_ENREGISTREMENT": "263/ 06 E 168 /19",
    "CODE_DCI": "06 E 168",
    "DCI": "LERCANIDIPINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "CORDIPINE",
    "FORME": "COMP. PELLI. SEC.",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOPHARM / SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/4/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "30/4/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["lercanidipine"],
    "InteractionIndexLink": ["lercanidipine"],
    "N_ENREGISTREMENT": "352/ 06 E 168 /14/21",
    "CODE_DCI": "06 E 168",
    "DCI": "Chlorhydrate de Lercanidipine",
    "NOM_COMMERCIALE": "DEPADIUM",
    "FORME": "Comprimé pelliculé",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/9/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "4/4/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["lercanidipine"],
    "InteractionIndexLink": ["lercanidipine"],
    "N_ENREGISTREMENT": "418/06 E 168/20",
    "CODE_DCI": "06 E 168",
    "DCI": "LERCANIDIPINE HYDROCHLORIDE",
    "NOM_COMMERCIALE": "DINAZIP",
    "FORME": "COMP PELL SEC",
    "DOSAGE": "10MG",
    "COND": "B/28",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NEOMEDIC SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/1/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "20/1/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["lercanidipine"],
    "InteractionIndexLink": ["lercanidipine"],
    "N_ENREGISTREMENT": "149/06 E 168/17",
    "CODE_DCI": "06 E 168",
    "DCI": "LERCANIDIPINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "LERCA",
    "FORME": "COMP. PELLI. SEC.",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVAPHARM TRADING",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/6/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "12/6/2017",
    "TYPE": "GE",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["lercanidipine"],
    "InteractionIndexLink": ["lercanidipine"],
    "N_ENREGISTREMENT": "447/ 06 E 168 /15/21",
    "CODE_DCI": "06 E 168",
    "DCI": "Chlorhydrate de Lercanidipine",
    "NOM_COMMERCIALE": "LERCANIDIPINE BEKER",
    "FORME": "Comprimé pelliculé sécable",
    "DOSAGE": "10MG",
    "COND": "B/30 ET B/90",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEKER / SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/10/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "30/3/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["lercanidipine"],
    "InteractionIndexLink": ["lercanidipine"],
    "N_ENREGISTREMENT": "269/ 06 E 168 /01/18",
    "CODE_DCI": "06 E 168",
    "DCI": "LERCANIDIPINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "ZANIDIP",
    "FORME": "COMP PELL SEC",
    "DOSAGE": "10MG",
    "COND": "B/30 ET B/90",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BOUCHARA-RECORDATI",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/9/2001",
    "DATE_D_ENREGISTREMENT_FINAL": "10/1/2018",
    "TYPE": "Ré",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["candesartan cilexetil"],
    "InteractionIndexLink": ["candesartan cilexetil"],
    "N_ENREGISTREMENT": "20/06 E196/380",
    "CODE_DCI": "06 E 196",
    "DCI": "CANDESARTAN CILEXETIL",
    "NOM_COMMERCIALE": "ATASARTAN",
    "FORME": "COMP SECABLE",
    "DOSAGE": "4MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HUP.P PHARMA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "31/5/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "31/5/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["candesartan cilexetil"],
    "InteractionIndexLink": ["candesartan cilexetil"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "06 E 196",
    "DCI": "Candésartan cilexetil",
    "NOM_COMMERCIALE": "Canderax",
    "FORME": "Comprimé pelliculé",
    "DOSAGE": "4 mg",
    "COND": "Boite 30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["candesartan cilexetil"],
    "InteractionIndexLink": ["candesartan cilexetil"],
    "N_ENREGISTREMENT": "352/ 06 E 196 /14",
    "CODE_DCI": "06 E 196",
    "DCI": "CANDESARTAN CILEXETIL",
    "NOM_COMMERCIALE": "SARCAND",
    "FORME": "COMPRIME",
    "DOSAGE": "4MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "21/1/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "21/1/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["candesartan cilexetil"],
    "InteractionIndexLink": ["candesartan cilexetil"],
    "N_ENREGISTREMENT": "317/06 E 196/17",
    "CODE_DCI": "06 E 196",
    "DCI": "CANDESARTAN CILEXETIL",
    "NOM_COMMERCIALE": "TENSIONORM",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "4MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INPHA-MEDIS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/6/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "18/6/2017",
    "TYPE": "GE",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["candesartan cilexetil"],
    "InteractionIndexLink": ["candesartan cilexetil"],
    "N_ENREGISTREMENT": "447/ 06 E 197 /12",
    "CODE_DCI": "06 E 197",
    "DCI": "CANDESARTAN CILEXETIL",
    "NOM_COMMERCIALE": "ATABEK",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "8MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEKER SARL (SARL LABORATOIRE BEKER ALGERIE)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/9/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "25/9/2012",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["candesartan cilexetil"],
    "InteractionIndexLink": ["candesartan cilexetil"],
    "N_ENREGISTREMENT": "256/ 06 E 197 /02/17",
    "CODE_DCI": "06 E 197",
    "DCI": "CANDESARTAN CILEXETIL",
    "NOM_COMMERCIALE": "ATACAND",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "8MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ASTRA ZENECA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SWEDEN",
    "DATE_D_ENREGISTREMENT_INITIAL": "16/3/2002",
    "DATE_D_ENREGISTREMENT_FINAL": "8/10/2017",
    "TYPE": "Ré",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["candesartan cilexetil"],
    "InteractionIndexLink": ["candesartan cilexetil"],
    "N_ENREGISTREMENT": "20/06 E197/380",
    "CODE_DCI": "06 E 197",
    "DCI": "CANDESARTAN CILEXETIL",
    "NOM_COMMERCIALE": "ATASARTAN",
    "FORME": "COMP SECABLES",
    "DOSAGE": "8MG",
    "COND": "B/31",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "laboratoires HUP.P PHARMA Sarl",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/8/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "26/8/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["candesartan cilexetil"],
    "InteractionIndexLink": ["candesartan cilexetil"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "06 E 197",
    "DCI": "CANDESARTAN CILEXETIL",
    "NOM_COMMERCIALE": "BLOPRESS 8MG",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "8MG",
    "COND": "B/28",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["candesartan cilexetil"],
    "InteractionIndexLink": ["candesartan cilexetil"],
    "N_ENREGISTREMENT": "035 / 06 E 197 /15",
    "CODE_DCI": "06 E 197",
    "DCI": "CANDESARTAN CILEXETIL",
    "NOM_COMMERCIALE": "CANDERAX",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "8MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMALLIANCE EURL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/7/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "30/7/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["candesartan cilexetil"],
    "InteractionIndexLink": ["candesartan cilexetil"],
    "N_ENREGISTREMENT": "235/ 06 E 197 /15",
    "CODE_DCI": "06 E 197",
    "DCI": "CANDESARTAN CILEXETIL",
    "NOM_COMMERCIALE": "CARDAXEL BGL",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "8MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOGALENIC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "3/3/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "3/3/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["candesartan cilexetil"],
    "InteractionIndexLink": ["candesartan cilexetil"],
    "N_ENREGISTREMENT": "352/ 06 E 197/14",
    "CODE_DCI": "06 E 197",
    "DCI": "CANDESARTAN CILEXETIL",
    "NOM_COMMERCIALE": "SARCAND",
    "FORME": "COMPRIME",
    "DOSAGE": "8MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/1/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "6/1/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["candesartan cilexetil"],
    "InteractionIndexLink": ["candesartan cilexetil"],
    "N_ENREGISTREMENT": "317/ 06 E 197 /19",
    "CODE_DCI": "06 E 197",
    "DCI": "CANDESARTAN CILEXETIL",
    "NOM_COMMERCIALE": "TENSIONORM",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "8MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INPHA MEDIS SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/5/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "20/5/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["ramipril"],
    "InteractionIndexLink": ["ramipril"],
    "N_ENREGISTREMENT": "050/ 06 E 201 /12",
    "CODE_DCI": "06 E 201",
    "DCI": "RAMIPRIL",
    "NOM_COMMERCIALE": "RAMINORM",
    "FORME": "COMPRIME",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANDOZ SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/9/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "25/9/2012",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["ramipril"],
    "InteractionIndexLink": ["ramipril"],
    "N_ENREGISTREMENT": "447/ 06 E 201 /13/18",
    "CODE_DCI": "06 E 201",
    "DCI": "RAMIPRIL",
    "NOM_COMMERCIALE": "RAMIPRIL BEKER",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "10MG",
    "COND": "B/30 et B/90",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEKER SARL (SARL LABORATOIRE BEKER ALGERIE)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "31/7/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "30/7/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "18 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["ramipril"],
    "InteractionIndexLink": ["ramipril"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "06 E 201",
    "DCI": "RAMIPRIL",
    "NOM_COMMERCIALE": "RAMITEC",
    "FORME": "COMP. QUADRISEC.",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["ramipril"],
    "InteractionIndexLink": ["ramipril"],
    "N_ENREGISTREMENT": "352/06 E 201/20",
    "CODE_DCI": "06 E 201",
    "DCI": "RAMIPRIL",
    "NOM_COMMERCIALE": "RAMITRIM",
    "FORME": "COMP. SEC.",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SPA/ EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/12/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "7/12/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["ramipril"],
    "InteractionIndexLink": ["ramipril"],
    "N_ENREGISTREMENT": "035/06 E 201/17",
    "CODE_DCI": "06 E 201",
    "DCI": "RAMIPRIL",
    "NOM_COMMERCIALE": "TANATRIL",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMALLIANCE EURL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "16/7/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "16/7/2017",
    "TYPE": "G",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["ramipril"],
    "InteractionIndexLink": ["ramipril"],
    "N_ENREGISTREMENT": "392/ 06 E 201 /04/021",
    "CODE_DCI": "06 E 201",
    "DCI": "Ramipril",
    "NOM_COMMERCIALE": "TRIATEC",
    "FORME": "Comprimé  sécable",
    "DOSAGE": "10MG",
    "COND": "B/28",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANOFI AVENTIS ALGERIE /  SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/2/2004",
    "DATE_D_ENREGISTREMENT_FINAL": "15/2/2021",
    "TYPE": "Ré",
    "STATUT": "F prémix",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["imidapril"],
    "InteractionIndexLink": ["imidapril"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "06 E 212",
    "DCI": "IMIDAPRIL CHLORHYDRATE",
    "NOM_COMMERCIALE": "IMINOPRIL 5",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "5MG",
    "COND": "B/28",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["imidapril"],
    "InteractionIndexLink": ["imidapril"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "06 E 213",
    "DCI": "IMIDAPRIL CHLORHYDRATE",
    "NOM_COMMERCIALE": "IMINOPRIL 10",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "10MG",
    "COND": "B/28",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "irbesartan"],
    "InteractionIndexLink": ["hydrochlorothiazide", "irbesartan"],
    "N_ENREGISTREMENT": "352/ 06 E 219 /10/16",
    "CODE_DCI": "06 E 219",
    "DCI": "Irbesartan / Hydrochlorothiazide",
    "NOM_COMMERCIALE": "CO APROSART",
    "FORME": "COMP. ENRO.",
    "DOSAGE": "150MG/12.5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/3/2010",
    "DATE_D_ENREGISTREMENT_FINAL": "19/7/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "irbesartan"],
    "InteractionIndexLink": ["hydrochlorothiazide", "irbesartan"],
    "N_ENREGISTREMENT": "510/ 06 E 219 /16",
    "CODE_DCI": "06 E 219",
    "DCI": "Irbesartan / Hydrochlorothiazide",
    "NOM_COMMERCIALE": "CO AVSART",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "150MG/12.5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALEMBIC MAMI SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "5/9/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "5/9/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "irbesartan"],
    "InteractionIndexLink": ["hydrochlorothiazide", "irbesartan"],
    "N_ENREGISTREMENT": "268/ 06 E 219 /15",
    "CODE_DCI": "06 E 219",
    "DCI": "Irbesartan / Hydrochlorothiazide",
    "NOM_COMMERCIALE": "CO-ARADEX 150/12.5",
    "FORME": "COMPRIME",
    "DOSAGE": "150MG/12.5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MERINAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "31/5/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "31/5/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "irbesartan"],
    "InteractionIndexLink": ["hydrochlorothiazide", "irbesartan"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "06 E 219",
    "DCI": "Irbesartan / Hydrochlorothiazide",
    "NOM_COMMERCIALE": "CO-IRBEK",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "150MG/12.5MG",
    "COND": "B/30 et B/90",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "irbesartan"],
    "InteractionIndexLink": ["hydrochlorothiazide", "irbesartan"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "06 E 219",
    "DCI": "Irbesartan / Hydrochlorothiazide",
    "NOM_COMMERCIALE": "CO-IRBEVEL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "150MG / 12.5MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "irbesartan"],
    "InteractionIndexLink": ["hydrochlorothiazide", "irbesartan"],
    "N_ENREGISTREMENT": "392/ 06 E 219 /06/14",
    "CODE_DCI": "06 E 219",
    "DCI": "Irbesartan / Hydrochlorothiazide",
    "NOM_COMMERCIALE": "COAPROVEL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "150MG/12.5MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANOFI AVENTIS ALGERIE SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "23/7/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "27/7/2014",
    "TYPE": "Ré",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "irbesartan"],
    "InteractionIndexLink": ["hydrochlorothiazide", "irbesartan"],
    "N_ENREGISTREMENT": "392/06 E 219/06/20",
    "CODE_DCI": "06 E 219",
    "DCI": "IRBESARTAN/ HYDROCHLOROTHIAZIDE",
    "NOM_COMMERCIALE": "COAPROVEL",
    "FORME": "COMP. PELL.",
    "DOSAGE": "150MG/ 12.5MG",
    "COND": "B/28",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES SANOFIS AVENTIS ALGERIE SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "23/7/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "9/12/2020",
    "TYPE": "Ré",
    "STATUT": "Fgrain",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "irbesartan"],
    "InteractionIndexLink": ["hydrochlorothiazide", "irbesartan"],
    "N_ENREGISTREMENT": "426/ 06 E 219 /13",
    "CODE_DCI": "06 E 219",
    "DCI": "Irbesartan / Hydrochlorothiazide",
    "NOM_COMMERCIALE": "COARAVEL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "150MG/12.5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "REMEDE PHARMA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/6/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "25/6/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "irbesartan"],
    "InteractionIndexLink": ["hydrochlorothiazide", "irbesartan"],
    "N_ENREGISTREMENT": "470/ 06 E 219 /12",
    "CODE_DCI": "06 E 219",
    "DCI": "Irbesartan / Hydrochlorothiazide",
    "NOM_COMMERCIALE": "COZIBRAT",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "150MG/12.5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MM (SARL LABORATOIRES MM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "16/12/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "16/12/2012",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "irbesartan"],
    "InteractionIndexLink": ["hydrochlorothiazide", "irbesartan"],
    "N_ENREGISTREMENT": "055/ 06 E 219 /19",
    "CODE_DCI": "06 E 219",
    "DCI": "Irbesartan / Hydrochlorothiazide",
    "NOM_COMMERCIALE": "GIZLAN-PLUS 150/12.5",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "150MG/12.5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "DAR AL DAWA DEVELOPMENT & INVESTMENT Co Ltd",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/3/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "6/3/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "irbesartan"],
    "InteractionIndexLink": ["hydrochlorothiazide", "irbesartan"],
    "N_ENREGISTREMENT": "5445/ 06 E 219 /11/19",
    "CODE_DCI": "06 E 219",
    "DCI": "Irbesartan / Hydrochlorothiazide",
    "NOM_COMMERCIALE": "IPISART PLUS",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "150MG/12.5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "WORLD MEDECINE LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/9/2011",
    "DATE_D_ENREGISTREMENT_FINAL": "24/7/2019",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "irbesartan"],
    "InteractionIndexLink": ["hydrochlorothiazide", "irbesartan"],
    "N_ENREGISTREMENT": "518/ 06 E 219 /17",
    "CODE_DCI": "06 E 219",
    "DCI": "Irbesartan / Hydrochlorothiazide",
    "NOM_COMMERCIALE": "IRBE PLUS 150/12.5",
    "FORME": "COMPRIME",
    "DOSAGE": "150MG/12.5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "TASSILI ARAB PHARMACEUTICAL COMPANY / SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/10/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "30/10/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "irbesartan"],
    "InteractionIndexLink": ["hydrochlorothiazide", "irbesartan"],
    "N_ENREGISTREMENT": "035 / 06 E 219 /18",
    "CODE_DCI": "06 E 219",
    "DCI": "Irbesartan / Hydrochlorothiazide",
    "NOM_COMMERCIALE": "IRBISART +",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "150MG/12.5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMALLIANCE EURL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "16/7/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "16/7/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "irbesartan"],
    "InteractionIndexLink": ["hydrochlorothiazide", "irbesartan"],
    "N_ENREGISTREMENT": "352/ 06 E 220 /10/16",
    "CODE_DCI": "06 E 220",
    "DCI": "Irbesartan / Hydrochlorothiazide",
    "NOM_COMMERCIALE": "CO APROSART",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "300MG/12.5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/3/2010",
    "DATE_D_ENREGISTREMENT_FINAL": "15/2/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "irbesartan"],
    "InteractionIndexLink": ["hydrochlorothiazide", "irbesartan"],
    "N_ENREGISTREMENT": "510/ 06 E  220 /16",
    "CODE_DCI": "06 E 220",
    "DCI": "Irbesartan / Hydrochlorothiazide",
    "NOM_COMMERCIALE": "CO AVASART",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "300MG/12.5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALEMBIC MAMI SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/4/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "27/4/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "irbesartan"],
    "InteractionIndexLink": ["hydrochlorothiazide", "irbesartan"],
    "N_ENREGISTREMENT": "268/ 06 E 220 /15",
    "CODE_DCI": "06 E 220",
    "DCI": "Irbesartan / Hydrochlorothiazide",
    "NOM_COMMERCIALE": "CO-ARADEX 300/12.5",
    "FORME": "COMPRIME",
    "DOSAGE": "300MG/12.5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MERINAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/8/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "9/8/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "irbesartan"],
    "InteractionIndexLink": ["hydrochlorothiazide", "irbesartan"],
    "N_ENREGISTREMENT": "447/ 06 E 220 /10/17",
    "CODE_DCI": "06 E 220",
    "DCI": "Irbesartan / Hydrochlorothiazide",
    "NOM_COMMERCIALE": "CO-IRBEK",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "300MG/12.5MG",
    "COND": "B/30 ET B/90",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEKER SARL (SARL LABORATOIRE BEKER ALGERIE)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/12/2010",
    "DATE_D_ENREGISTREMENT_FINAL": "23/3/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "irbesartan"],
    "InteractionIndexLink": ["hydrochlorothiazide", "irbesartan"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "06 E 220",
    "DCI": "Irbesartan / Hydrochlorothiazide",
    "NOM_COMMERCIALE": "CO-IRBEVEL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "300MG / 12.5MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "irbesartan"],
    "InteractionIndexLink": ["hydrochlorothiazide", "irbesartan"],
    "N_ENREGISTREMENT": "392/ 06 E 220 /06/14",
    "CODE_DCI": "06 E 220",
    "DCI": "Irbesartan / Hydrochlorothiazide",
    "NOM_COMMERCIALE": "COAPROVEL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "300MG/12.5MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANOFI AVENTIS ALGERIE SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "23/7/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "27/7/2014",
    "TYPE": "Ré",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "irbesartan"],
    "InteractionIndexLink": ["hydrochlorothiazide", "irbesartan"],
    "N_ENREGISTREMENT": "392/06 E 220/06/20",
    "CODE_DCI": "06 E 220",
    "DCI": "IRBESARTAN/ HYDROCHLOROTHIAZIDE",
    "NOM_COMMERCIALE": "COAPROVEL",
    "FORME": "COMP. PELL.",
    "DOSAGE": "300MG/ 12.5MG",
    "COND": "B/28",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES SANOFIS AVENTIS ALGERIE SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "23/7/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "9/12/2020",
    "TYPE": "Ré",
    "STATUT": "Fgrain",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "irbesartan"],
    "InteractionIndexLink": ["hydrochlorothiazide", "irbesartan"],
    "N_ENREGISTREMENT": "470/ 06 E 220 /12",
    "CODE_DCI": "06 E 220",
    "DCI": "Irbesartan / Hydrochlorothiazide",
    "NOM_COMMERCIALE": "COZIBRAT",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "300MG/12.5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MM (SARL LABORATOIRES MM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "16/12/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "16/12/2012",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "irbesartan"],
    "InteractionIndexLink": ["hydrochlorothiazide", "irbesartan"],
    "N_ENREGISTREMENT": "055/ 06 E  220 /19",
    "CODE_DCI": "06 E 220",
    "DCI": "Irbesartan / Hydrochlorothiazide",
    "NOM_COMMERCIALE": "GIZLAN-PLUS 300/12.5",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "300MG/12.5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "DAR AL DAWA DEVELOPMENT & INVESTMENT Co Ltd",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/3/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "6/3/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "irbesartan"],
    "InteractionIndexLink": ["hydrochlorothiazide", "irbesartan"],
    "N_ENREGISTREMENT": "544/ 06 E 220 /11/19",
    "CODE_DCI": "06 E 220",
    "DCI": "Irbesartan / Hydrochlorothiazide",
    "NOM_COMMERCIALE": "IPISART PLUS",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "300MG/12.5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "WORLD MEDECINE LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/9/2011",
    "DATE_D_ENREGISTREMENT_FINAL": "24/7/2019",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "irbesartan"],
    "InteractionIndexLink": ["hydrochlorothiazide", "irbesartan"],
    "N_ENREGISTREMENT": "035/ 06 E  220 /18",
    "CODE_DCI": "06 E 220",
    "DCI": "Irbesartan / Hydrochlorothiazide",
    "NOM_COMMERCIALE": "IRBISART +",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "300MG/12.5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMALLIANCE EURL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/3/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "19/3/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "irbesartan"],
    "InteractionIndexLink": ["hydrochlorothiazide", "irbesartan"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "06 E 220",
    "DCI": "Irbesartan / Hydrochlorothiazide",
    "NOM_COMMERCIALE": "Irbisart+",
    "FORME": "Comprimé pelliculé",
    "DOSAGE": "300 mg /  25 mg",
    "COND": "Boite de 30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["indapamide", "perindopril"],
    "InteractionIndexLink": ["indapamide", "perindopril ter-butylamine"],
    "N_ENREGISTREMENT": "447/ 06 E 227 /14",
    "CODE_DCI": "06 E 227",
    "DCI": "PERINDOPRIL TER-BUTYLAMINE / INDAPAMIDE",
    "NOM_COMMERCIALE": "EVERYL",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "2MG/0.625MG",
    "COND": "B/30 ET B/90",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEKER SARL (SARL LABORATOIRE BEKER ALGERIE)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/6/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "1/6/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["indapamide", "perindopril"],
    "InteractionIndexLink": ["indapamide", "perindopril ter-butylamine"],
    "N_ENREGISTREMENT": "352/ 06 E 227 /15",
    "CODE_DCI": "06 E 227",
    "DCI": "PERINDOPRIL ERBUMINE / INDAPAMIDE",
    "NOM_COMMERCIALE": "FLUTERAX",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "2MG/0.625MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/12/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "13/12/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["indapamide", "perindopril"],
    "InteractionIndexLink": ["indapamide", "perindopril ter-butylamine"],
    "N_ENREGISTREMENT": "447/ 06 E 228 /14",
    "CODE_DCI": "06 E 228",
    "DCI": "PERINDOPRIL TER-BUTYLAMINE / INDAPAMIDE",
    "NOM_COMMERCIALE": "BIEVERYL",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "4MG /1.25MG",
    "COND": "B/30 ET B/90",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEKER SARL (SARL LABORATOIRE BEKER ALGERIE)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/7/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "6/7/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["indapamide", "perindopril"],
    "InteractionIndexLink": ["indapamide", "perindopril ter-butylamine"],
    "N_ENREGISTREMENT": "149/ 06 E 228 /14",
    "CODE_DCI": "06 E 228",
    "DCI": "PERINDOPRIL TER-BUTYLAMINE / INDAPAMIDE",
    "NOM_COMMERCIALE": "BINOVAX",
    "FORME": "COMPRIME",
    "DOSAGE": "4MG/1.25MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVAPHARM TRADING SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "8/6/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "8/6/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["indapamide", "perindopril"],
    "InteractionIndexLink": ["indapamide", "perindopril ter-butylamine"],
    "N_ENREGISTREMENT": "352/ 06 E 228 /14",
    "CODE_DCI": "06 E 228",
    "DCI": "PERINDOPRIL TER-BUTYLAMINE / INDAPAMIDE",
    "NOM_COMMERCIALE": "FLUTERAX",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "4MG/1.25MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL-KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/7/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "13/7/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [
      "hydrochlorothiazide",
      "candesartan cilexetil",
      "chlorothiazide"
    ],
    "InteractionIndexLink": ["candesartan cilexetil", "hydrochlorothiazide"],
    "N_ENREGISTREMENT": "118/ 06 E 230 /09/16",
    "CODE_DCI": "06 E 230",
    "DCI": "CANDESARTAN CILEXETIL / HYDROCHLOROTHIAZIDE",
    "NOM_COMMERCIALE": "BLOPRESS 8 PLUS",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "8MG / 12.5MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ARAB PHARMACEUTICAL MANUFACTURING COMPANY LTD (APM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/6/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "25/4/2016",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": [
      "hydrochlorothiazide",
      "candesartan cilexetil",
      "chlorothiazide"
    ],
    "InteractionIndexLink": ["candesartan cilexetil", "hydrochlorothiazide"],
    "N_ENREGISTREMENT": "035/ 06 E 230 /15",
    "CODE_DCI": "06 E 230",
    "DCI": "CANDESARTAN CILEXETIL / HYDROCHLOROTHIAZIDE",
    "NOM_COMMERCIALE": "CANDERAX PLUS",
    "FORME": "COMPRIME",
    "DOSAGE": "8MG/12.5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMALLIANCE EURL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/10/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "4/10/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": [
      "hydrochlorothiazide",
      "candesartan cilexetil",
      "chlorothiazide"
    ],
    "InteractionIndexLink": ["candesartan cilexetil", "hydrochlorothiazide"],
    "N_ENREGISTREMENT": "235/ 06 E 230 /15",
    "CODE_DCI": "06 E 230",
    "DCI": "CANDESARTAN CILEXETIL/ HYDROCHLOROTHIAZIDE",
    "NOM_COMMERCIALE": "CARDAXEL PLUS",
    "FORME": "COMPRIME",
    "DOSAGE": "8MG/12.5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOGALENIC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "8/11/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "8/11/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": [
      "hydrochlorothiazide",
      "candesartan cilexetil",
      "chlorothiazide"
    ],
    "InteractionIndexLink": ["candesartan cilexetil", "hydrochlorothiazide"],
    "N_ENREGISTREMENT": "352/ 06 E 230 /14/19",
    "CODE_DCI": "06 E 230",
    "DCI": "CANDESARTAN CILEXETIL/ HYDROCHLOROTHIAZIDE",
    "NOM_COMMERCIALE": "CO SARCAND",
    "FORME": "COMPRIME",
    "DOSAGE": "8MG/12.5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL-KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/1/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "14/2/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": [
      "hydrochlorothiazide",
      "candesartan cilexetil",
      "chlorothiazide"
    ],
    "InteractionIndexLink": ["candesartan cilexetil", "hydrochlorothiazide"],
    "N_ENREGISTREMENT": "447/ 06 E 230 /12/17",
    "CODE_DCI": "06 E 230",
    "DCI": "CANDESARTAN CILEXETIL/ HYDROCHLOROTHIAZIDE",
    "NOM_COMMERCIALE": "CO-ATABEK",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "8MG/12.5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEKER SARL (SARL LABORATOIRE BEKER ALGERIE)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/10/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "31/12/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": [
      "hydrochlorothiazide",
      "candesartan cilexetil",
      "chlorothiazide"
    ],
    "InteractionIndexLink": ["candesartan cilexetil", "hydrochlorothiazide"],
    "N_ENREGISTREMENT": "256/ 06 E 230 /06/17",
    "CODE_DCI": "06 E 230",
    "DCI": "CANDESARTAN (SOUS FORME DE CILEXETIL) /  HYDROCHLOROTHIAZIDE",
    "NOM_COMMERCIALE": "HYTACAND",
    "FORME": "COMPRIME",
    "DOSAGE": "8MG/ 12.5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ASTRA ZENECA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "France",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/12/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "7/3/2017",
    "TYPE": "Ré",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": [
      "hydrochlorothiazide",
      "candesartan cilexetil",
      "chlorothiazide"
    ],
    "InteractionIndexLink": ["candesartan cilexetil", "hydrochlorothiazide"],
    "N_ENREGISTREMENT": "118/ 06 E 231 /09/16",
    "CODE_DCI": "06 E 231",
    "DCI": "CANDESARTAN CILEXETIL / HYDROCHLOROTHIAZIDE",
    "NOM_COMMERCIALE": "BLOPRESS 16 PLUS",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "16MG / 12.5MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ARAB PHARMACEUTICAL MANUFACTURING COMPANY LTD (APM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/6/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "24/5/2016",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": [
      "hydrochlorothiazide",
      "candesartan cilexetil",
      "chlorothiazide"
    ],
    "InteractionIndexLink": ["candesartan cilexetil", "hydrochlorothiazide"],
    "N_ENREGISTREMENT": "035/ 06 E 231 /15",
    "CODE_DCI": "06 E 231",
    "DCI": "CANDESARTAN CILEXETIL / HYDROCHLOROTHIAZIDE",
    "NOM_COMMERCIALE": "CANDERAX PLUS",
    "FORME": "COMPRIME",
    "DOSAGE": "16MG/12.5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMALLIANCE EURL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/7/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "26/7/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": [
      "hydrochlorothiazide",
      "candesartan cilexetil",
      "chlorothiazide"
    ],
    "InteractionIndexLink": ["candesartan cilexetil", "hydrochlorothiazide"],
    "N_ENREGISTREMENT": "235/ 06 E 231 /15",
    "CODE_DCI": "06 E 231",
    "DCI": "CANDESARTAN CILEXETIL / HYDROCHLOROTHIAZIDE",
    "NOM_COMMERCIALE": "CARDAXEL PLUS",
    "FORME": "COMPRIME",
    "DOSAGE": "16MG / 12.5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOGALENIC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/12/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "13/12/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": [
      "hydrochlorothiazide",
      "candesartan cilexetil",
      "chlorothiazide"
    ],
    "InteractionIndexLink": ["candesartan cilexetil", "hydrochlorothiazide"],
    "N_ENREGISTREMENT": "352/ 06 E 231 /14/19",
    "CODE_DCI": "06 E 231",
    "DCI": "CANDESARTAN CILEXETIL/ HYDROCHLOROTHIAZIDE",
    "NOM_COMMERCIALE": "CO SARCAND",
    "FORME": "COMPRIME",
    "DOSAGE": "16MG/12.5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "21/1/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "14/2/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": [
      "hydrochlorothiazide",
      "candesartan cilexetil",
      "chlorothiazide"
    ],
    "InteractionIndexLink": ["candesartan cilexetil", "hydrochlorothiazide"],
    "N_ENREGISTREMENT": "447/ 06 E 231 /12/17",
    "CODE_DCI": "06 E 231",
    "DCI": "CANDESARTAN CILEXETIL/ HYDROCHLOROTHIAZIDE",
    "NOM_COMMERCIALE": "CO-ATABEK",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "16MG/12.5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEKER SARL (SARL LABORATOIRE BEKER ALGERIE)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/10/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "31/12/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": [
      "hydrochlorothiazide",
      "candesartan cilexetil",
      "chlorothiazide"
    ],
    "InteractionIndexLink": ["candesartan cilexetil", "hydrochlorothiazide"],
    "N_ENREGISTREMENT": "256/ 06 E 231 /06/17",
    "CODE_DCI": "06 E 231",
    "DCI": "CANDESARTAN  (SOUS FORME DE CILEXETIL)/ HYDROCHLOROTHIAZIDE",
    "NOM_COMMERCIALE": "HYTACAND",
    "FORME": "COMPRIME",
    "DOSAGE": "16MG/12.5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ASTRA ZENECA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "France",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/1/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "27/2/2017",
    "TYPE": "Ré",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["candesartan cilexetil"],
    "InteractionIndexLink": ["candesartan cilexetil"],
    "N_ENREGISTREMENT": "447/ 06 E 234 /12",
    "CODE_DCI": "06 E 234",
    "DCI": "CANDESARTAN CILEXETIL",
    "NOM_COMMERCIALE": "ATABEK",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "16MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEKER SARL (SARL LABORATOIRE BEKER ALGERIE)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/10/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "15/10/2012",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["candesartan cilexetil"],
    "InteractionIndexLink": ["candesartan cilexetil"],
    "N_ENREGISTREMENT": "256/ 06 E 234 /07/17",
    "CODE_DCI": "06 E 234",
    "DCI": "CANDESARTAN  (SOUS FORME DE CILEXETIL)",
    "NOM_COMMERCIALE": "ATACAND",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "16MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ASTRA ZENECA AB",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SWEDEN",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/2/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "10/9/2017",
    "TYPE": "Ré",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["candesartan cilexetil"],
    "InteractionIndexLink": ["candesartan cilexetil"],
    "N_ENREGISTREMENT": "20/06 E234/380",
    "CODE_DCI": "06 E 234",
    "DCI": "CANDESARTAN CILEXETIL",
    "NOM_COMMERCIALE": "ATASARTAN",
    "FORME": "COMP SECABLES",
    "DOSAGE": "16MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "laboratoires HUP.P PHARMA Sarl",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/8/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "26/8/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["candesartan cilexetil"],
    "InteractionIndexLink": ["candesartan cilexetil"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "06 E 234",
    "DCI": "CANDESARTAN CILEXETIL",
    "NOM_COMMERCIALE": "BLOPRESS 16MG",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "16MG",
    "COND": "B/28",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["candesartan cilexetil"],
    "InteractionIndexLink": ["candesartan cilexetil"],
    "N_ENREGISTREMENT": "035/ 06 E 234 /15",
    "CODE_DCI": "06 E 234",
    "DCI": "CANDESARTAN CILEXETIL",
    "NOM_COMMERCIALE": "CANDERAX",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "16MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMALLIANCE EURL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/7/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "15/7/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["candesartan cilexetil"],
    "InteractionIndexLink": ["candesartan cilexetil"],
    "N_ENREGISTREMENT": "235/ 06 E 234 /15",
    "CODE_DCI": "06 E 234",
    "DCI": "CANDESARTAN CILEXETIL",
    "NOM_COMMERCIALE": "CARDAXEL BGL",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "16MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOGALENIC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/2/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "22/2/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["candesartan cilexetil"],
    "InteractionIndexLink": ["candesartan cilexetil"],
    "N_ENREGISTREMENT": "352/ 06 E 234/14/18",
    "CODE_DCI": "06 E 234",
    "DCI": "CANDESARTAN CILEXETIL",
    "NOM_COMMERCIALE": "SARCAND",
    "FORME": "COMPRIME",
    "DOSAGE": "16MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/1/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "21/1/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["candesartan cilexetil"],
    "InteractionIndexLink": ["candesartan cilexetil"],
    "N_ENREGISTREMENT": "317/ 06 E 234 /19",
    "CODE_DCI": "06 E 234",
    "DCI": "CANDESARTAN CILEXETIL",
    "NOM_COMMERCIALE": "TENSIONORM",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "16MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INPHA MEDIS SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/5/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "20/5/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "valsartan"],
    "InteractionIndexLink": ["hydrochlorothiazide", "valsartan"],
    "N_ENREGISTREMENT": "447/ 06 E 237 /14",
    "CODE_DCI": "06 E 237",
    "DCI": "Valsartan / Hydrochlorothiazide",
    "NOM_COMMERCIALE": "CO VALASTAN",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "160MG/12.5MG",
    "COND": "B/28 ET B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEKER SARL (SARL LABORATOIRE BEKER ALGERIE)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/3/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "19/3/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "valsartan"],
    "InteractionIndexLink": ["hydrochlorothiazide", "valsartan"],
    "N_ENREGISTREMENT": "195/ 06 E 237 /13",
    "CODE_DCI": "06 E 237",
    "DCI": "Valsartan / Hydrochlorothiazide",
    "NOM_COMMERCIALE": "CO VALSARTAN IVAL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "160MG/12.5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMA IVAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/4/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "7/4/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "valsartan"],
    "InteractionIndexLink": ["hydrochlorothiazide", "valsartan"],
    "N_ENREGISTREMENT": "001/ 06 E 237 /14/19",
    "CODE_DCI": "06 E 237",
    "DCI": "Valsartan / Hydrochlorothiazide",
    "NOM_COMMERCIALE": "CO-ARBITAN",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "160MG/12.5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMA ALGERIA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/4/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "1/4/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "valsartan"],
    "InteractionIndexLink": ["hydrochlorothiazide", "valsartan"],
    "N_ENREGISTREMENT": "268/ 06 E 237/14",
    "CODE_DCI": "06 E 237",
    "DCI": "Valsartan / Hydrochlorothiazide",
    "NOM_COMMERCIALE": "CO-VALEX",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "160MG/12.5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MERINAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/1/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "26/6/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "valsartan"],
    "InteractionIndexLink": ["hydrochlorothiazide", "valsartan"],
    "N_ENREGISTREMENT": "352/ 06 E 237 /10/16",
    "CODE_DCI": "06 E 237",
    "DCI": "Valsartan / Hydrochlorothiazide",
    "NOM_COMMERCIALE": "COSARTEG",
    "FORME": "COMP. ENRO.",
    "DOSAGE": "160MG/12.5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/6/2010",
    "DATE_D_ENREGISTREMENT_FINAL": "2/2/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "valsartan"],
    "InteractionIndexLink": ["hydrochlorothiazide", "valsartan"],
    "N_ENREGISTREMENT": "068/ 06 E 237 /07/19",
    "CODE_DCI": "06 E 237",
    "DCI": "Valsartan / Hydrochlorothiazide",
    "NOM_COMMERCIALE": "COTAREG",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "160MG / 12.5MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVARTIS PHARMA AG SCHWEIZ AG",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SUISSE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/3/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "4/2/2019",
    "TYPE": "Ré",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "valsartan"],
    "InteractionIndexLink": ["hydrochlorothiazide", "valsartan"],
    "N_ENREGISTREMENT": "470/ 06 E 237 /12/18",
    "CODE_DCI": "06 E 237",
    "DCI": "Valsartan / Hydrochlorothiazide",
    "NOM_COMMERCIALE": "COVESTAG",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "160MG/12.5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MM LABORATOIRES SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "21/8/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "1/8/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "valsartan"],
    "InteractionIndexLink": ["hydrochlorothiazide", "valsartan"],
    "N_ENREGISTREMENT": "518/06 E 237/16",
    "CODE_DCI": "06 E 237",
    "DCI": "Valsartan / Hydrochlorothiazide",
    "NOM_COMMERCIALE": "DIVALAN PLUS",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "160MG / 12.5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "TAPHCO SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/12/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "4/12/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "valsartan"],
    "InteractionIndexLink": ["hydrochlorothiazide", "valsartan"],
    "N_ENREGISTREMENT": "149/ 06 E 237 /14",
    "CODE_DCI": "06 E 237",
    "DCI": "Valsartan / Hydrochlorothiazide",
    "NOM_COMMERCIALE": "NOVAVALZ PLUS",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "160MG/12.5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVAPHARM TRADING SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "16/2/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "16/2/2014",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "valsartan"],
    "InteractionIndexLink": ["hydrochlorothiazide", "valsartan"],
    "N_ENREGISTREMENT": "320/ 06 E 237 /09/15",
    "CODE_DCI": "06 E 237",
    "DCI": "Valsartan / Hydrochlorothiazide",
    "NOM_COMMERCIALE": "THIA-VALSAN",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "160MG/12.5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIAN GENERICS DEVELOPMENT  PHARMA  (AGD PHARMA)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/5/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "3/11/2015",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "valsartan"],
    "InteractionIndexLink": ["hydrochlorothiazide", "valsartan"],
    "N_ENREGISTREMENT": "035/ 06  E 237 /16",
    "CODE_DCI": "06 E 237",
    "DCI": "Valsartan / Hydrochlorothiazide",
    "NOM_COMMERCIALE": "VALACLOR PLUS",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "160MG/12.5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMALLIANCE EURL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/4/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "12/4/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "valsartan"],
    "InteractionIndexLink": ["hydrochlorothiazide", "valsartan"],
    "N_ENREGISTREMENT": "309/ 06 E 237 /14",
    "CODE_DCI": "06 E 237",
    "DCI": "Valsartan / Hydrochlorothiazide",
    "NOM_COMMERCIALE": "VALSARTAN/ HYDROCHLOROTHIAZIDE LDM",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "160MG/12.5MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE DE DIAGNOSTIC MAGHREBINS (LDM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/4/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "28/4/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "valsartan"],
    "InteractionIndexLink": ["hydrochlorothiazide", "valsartan"],
    "N_ENREGISTREMENT": "447/ 06 E 238 /11/18",
    "CODE_DCI": "06 E 238",
    "DCI": "Valsartan / Hydrochlorothiazide",
    "NOM_COMMERCIALE": "CO VALASTAN",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "160MG/25MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEKER SARL (SARL LABORATOIRE BEKER ALGERIE)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/8/2011",
    "DATE_D_ENREGISTREMENT_FINAL": "18/4/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "valsartan"],
    "InteractionIndexLink": ["hydrochlorothiazide", "valsartan"],
    "N_ENREGISTREMENT": "001/ 06 E 238 /14",
    "CODE_DCI": "06 E 238",
    "DCI": "Valsartan / Hydrochlorothiazide",
    "NOM_COMMERCIALE": "CO-ARBITAN",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "160MG/25MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMA ALGERIA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/4/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "1/4/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "valsartan"],
    "InteractionIndexLink": ["hydrochlorothiazide", "valsartan"],
    "N_ENREGISTREMENT": "317/ 06 E 238 /16",
    "CODE_DCI": "06 E 238",
    "DCI": "Valsartan / Hydrochlorothiazide",
    "NOM_COMMERCIALE": "CO-RETA",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "160MG/25MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INPHA-MEDIS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/2/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "4/2/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "valsartan"],
    "InteractionIndexLink": ["hydrochlorothiazide", "valsartan"],
    "N_ENREGISTREMENT": "268/ 06 E 238/14",
    "CODE_DCI": "06 E 238",
    "DCI": "Valsartan / Hydrochlorothiazide",
    "NOM_COMMERCIALE": "CO-VALEX",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "160MG/25MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MERINAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/1/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "6/1/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "valsartan"],
    "InteractionIndexLink": ["hydrochlorothiazide", "valsartan"],
    "N_ENREGISTREMENT": "195/ 06 E 238 /14",
    "CODE_DCI": "06 E 238",
    "DCI": "Valsartan / Hydrochlorothiazide",
    "NOM_COMMERCIALE": "CO-VALSARTAN IVAL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "160MG / 25MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMA IVAL SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/11/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "18/11/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "valsartan"],
    "InteractionIndexLink": ["hydrochlorothiazide", "valsartan"],
    "N_ENREGISTREMENT": "068/ 06 E 238 /07/19",
    "CODE_DCI": "06 E 238",
    "DCI": "Valsartan / Hydrochlorothiazide",
    "NOM_COMMERCIALE": "COTAREG",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "160MG/25MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVARTIS PHARMA AG SCHWEIZ AG",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SUISSE",
    "DATE_D_ENREGISTREMENT_INITIAL": "3/4/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "4/2/2019",
    "TYPE": "Ré",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "valsartan"],
    "InteractionIndexLink": ["hydrochlorothiazide", "valsartan"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "06 E 238",
    "DCI": "Valsartan / Hydrochlorothiazide",
    "NOM_COMMERCIALE": "Co Sarteg",
    "FORME": "Comprimé pelliculé",
    "DOSAGE": "160mg/25mg",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "valsartan"],
    "InteractionIndexLink": ["hydrochlorothiazide", "valsartan"],
    "N_ENREGISTREMENT": "149/ 06 E 238 /14",
    "CODE_DCI": "06 E 238",
    "DCI": "Valsartan / Hydrochlorothiazide",
    "NOM_COMMERCIALE": "NOVAVALZ PLUS",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "160MG/25MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVAPHARM TRADING SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/3/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "9/3/2014",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "valsartan"],
    "InteractionIndexLink": ["hydrochlorothiazide", "valsartan"],
    "N_ENREGISTREMENT": "320/ 06 E 238 /09/15",
    "CODE_DCI": "06 E 238",
    "DCI": "Valsartan / Hydrochlorothiazide",
    "NOM_COMMERCIALE": "THIA-VALSAN",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "160MG/25MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIAN GENERICS DEVELOPMENT  PHARMA  (AGD PHARMA)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/5/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "3/11/2015",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "valsartan"],
    "InteractionIndexLink": ["hydrochlorothiazide", "valsartan"],
    "N_ENREGISTREMENT": "035/ 06 E 238 /16",
    "CODE_DCI": "06 E 238",
    "DCI": "Valsartan / Hydrochlorothiazide",
    "NOM_COMMERCIALE": "VALACLOR PLUS",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "160MG/25MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMALLIANCE EURL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/1/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "10/1/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "valsartan"],
    "InteractionIndexLink": ["hydrochlorothiazide", "valsartan"],
    "N_ENREGISTREMENT": "309/06 E 238/17",
    "CODE_DCI": "06 E 238",
    "DCI": "Valsartan / Hydrochlorothiazide",
    "NOM_COMMERCIALE": "VLASARTAN+HCTZ LDM",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "160MG/25MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LDM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/4/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "12/4/2017",
    "TYPE": "G",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "losartan"],
    "InteractionIndexLink": ["hydrochlorothiazide", "losartan"],
    "N_ENREGISTREMENT": "317/ 06 E 239 /11",
    "CODE_DCI": "06 E 239",
    "DCI": "LOSARTAN POTASSIQUE/ HYDROCHLOROTHIAZIDE",
    "NOM_COMMERCIALE": "CO-NORTA FORT",
    "FORME": "COMP. PELLI. SEC.",
    "DOSAGE": "100MG/25MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INPHA-MEDIS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/5/2011",
    "DATE_D_ENREGISTREMENT_FINAL": "4/5/2011",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "losartan"],
    "InteractionIndexLink": ["hydrochlorothiazide", "losartan"],
    "N_ENREGISTREMENT": "447/ 06 E 239 /11/17",
    "CODE_DCI": "06 E 239",
    "DCI": "LOSARTAN POTASSIQUE/ HYDROCHLOROTHIAZIDE",
    "NOM_COMMERCIALE": "COBEKTAL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "100MG/25MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEKER SARL (SARL LABORATOIRE BEKER ALGERIE)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "5/1/2011",
    "DATE_D_ENREGISTREMENT_FINAL": "27/2/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "losartan"],
    "InteractionIndexLink": ["hydrochlorothiazide", "losartan"],
    "N_ENREGISTREMENT": "528/06 E 239/19",
    "CODE_DCI": "06 E 239",
    "DCI": "LOSARTAN POTASSIQUE/ HYDROCHLOROTHIAZIDE",
    "NOM_COMMERCIALE": "FORLYSART",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "100MG/25MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JANIS MED SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "losartan"],
    "InteractionIndexLink": ["hydrochlorothiazide", "losartan"],
    "N_ENREGISTREMENT": "024/06 E 239/07/19",
    "CODE_DCI": "06 E 239",
    "DCI": "LOSARTAN POTASSIQUE/ HYDROCHLOROTHIAZIDE",
    "NOM_COMMERCIALE": "FORTZAAR",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "100MG/25MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MSD FRANCE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/7/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "28/2/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["losartan"],
    "InteractionIndexLink": ["losartan"],
    "N_ENREGISTREMENT": "447/ 06 E 240 /11/16",
    "CODE_DCI": "06 E 240",
    "DCI": "LOSARTAN POTASSIQUE",
    "NOM_COMMERCIALE": "BEKTAL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "100MG",
    "COND": "B/30 ET B/90",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEKER SARL (SARL LABORATOIRE BEKER ALGERIE)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/2/2011",
    "DATE_D_ENREGISTREMENT_FINAL": "5/9/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["losartan"],
    "InteractionIndexLink": ["losartan"],
    "N_ENREGISTREMENT": "024/ 06 E 240 /07/17",
    "CODE_DCI": "06 E 240",
    "DCI": "LOSARTAN POTASSIQUE",
    "NOM_COMMERCIALE": "COZAAR",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "100MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MSD FRANCE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "France",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/3/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "29/6/2017",
    "TYPE": "Ré",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["losartan"],
    "InteractionIndexLink": ["losartan"],
    "N_ENREGISTREMENT": "468/ 06 E 240 /12/18",
    "CODE_DCI": "06 E 240",
    "DCI": "LOSARTAN POTASSIQUE",
    "NOM_COMMERCIALE": "HYSARTAN",
    "FORME": "COMP. PELLI. SEC.",
    "DOSAGE": "100MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NADPHARMADIC PRODUCTION",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/10/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "5/2/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["losartan"],
    "InteractionIndexLink": ["losartan"],
    "N_ENREGISTREMENT": "309/ 06 E 240 /15",
    "CODE_DCI": "06 E 240",
    "DCI": "LOSARTAN POTASSIQUE",
    "NOM_COMMERCIALE": "LOSARTAN LDM",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "100MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES DE DIAGNOSTIC MAGHREBINS (LDM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/12/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "2/12/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["losartan"],
    "InteractionIndexLink": ["losartan"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "06 E 240",
    "DCI": "LOSARTAN POTASSIQUE",
    "NOM_COMMERCIALE": "NORTA FORT",
    "FORME": "COMP. PELLI. SEC.",
    "DOSAGE": "100MG",
    "COND": "B/28",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["perindopril"],
    "InteractionIndexLink": ["perindopril ter-butylamine"],
    "N_ENREGISTREMENT": "447/ 06 E 246 /12/19",
    "CODE_DCI": "06 E 246",
    "DCI": "PERINDOPRIL TER-BUTYLAMINE",
    "NOM_COMMERCIALE": "PERINDOPRIL BEKER",
    "FORME": "COMPRIME",
    "DOSAGE": "8MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEKER SARL (SARL LABORATOIRE BEKER ALGERIE)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/10/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "23/1/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["perindopril"],
    "InteractionIndexLink": ["perindopril ter-butylamine"],
    "N_ENREGISTREMENT": "352/ 06 E 246 /14",
    "CODE_DCI": "06 E 246",
    "DCI": "PERINDOPRIL TER-BUTYLAMINE",
    "NOM_COMMERCIALE": "PERINDOSYL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "8MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL-KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "8/6/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "8/6/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["perindopril"],
    "InteractionIndexLink": ["perindopril ter-butylamine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "06 E 246",
    "DCI": "Périndopril erbumine",
    "NOM_COMMERCIALE": "Perindosyl",
    "FORME": "Comprimé pelliculé",
    "DOSAGE": "8mg",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "irbesartan"],
    "InteractionIndexLink": ["hydrochlorothiazide", "irbesartan"],
    "N_ENREGISTREMENT": "510/ 06 E 256 /16",
    "CODE_DCI": "06 E 256",
    "DCI": "IRBESARTAN / HYDROCHLOROTHIAZIDE",
    "NOM_COMMERCIALE": "CO  AVASART",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "300MG/25MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALEMBIC MAMI SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/4/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "27/4/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "irbesartan"],
    "InteractionIndexLink": ["hydrochlorothiazide", "irbesartan"],
    "N_ENREGISTREMENT": "352 / 06 E 256 /12/17",
    "CODE_DCI": "06 E 256",
    "DCI": "IRBESARTAN / HYDROCHLOROTHIAZIDE",
    "NOM_COMMERCIALE": "CO APROSART",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "300MG / 25MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "23/12/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "27/12/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "irbesartan"],
    "InteractionIndexLink": ["hydrochlorothiazide", "irbesartan"],
    "N_ENREGISTREMENT": "268/ 06 E 256 /15",
    "CODE_DCI": "06 E 256",
    "DCI": "IRBESARTAN / HYDROCHLOROTHIAZIDE",
    "NOM_COMMERCIALE": "CO-ARADEX 300/25",
    "FORME": "COMPRIME",
    "DOSAGE": "300MG/25MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MERINAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/6/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "24/6/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "irbesartan"],
    "InteractionIndexLink": ["hydrochlorothiazide", "irbesartan"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "06 E 256",
    "DCI": "IRBESARTAN / HYDROCHLOROTHIAZIDE",
    "NOM_COMMERCIALE": "CO-IRBEK",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "300MG/25MG",
    "COND": "B/30 ET B/90",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "irbesartan"],
    "InteractionIndexLink": ["hydrochlorothiazide", "irbesartan"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "06 E 256",
    "DCI": "IRBESARTAN / HYDROCHLOROTHIAZIDE",
    "NOM_COMMERCIALE": "CO-IRBEVEL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "300MG / 25MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "irbesartan"],
    "InteractionIndexLink": ["hydrochlorothiazide", "irbesartan"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "06 E 256",
    "DCI": "IRBESARTAN / HYDROCHLOROTHIAZIDE",
    "NOM_COMMERCIALE": "COAPROVEL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "300MG/25MG",
    "COND": "B/28",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "irbesartan"],
    "InteractionIndexLink": ["hydrochlorothiazide", "irbesartan"],
    "N_ENREGISTREMENT": "055/ 06 E 256 /19",
    "CODE_DCI": "06 E 256",
    "DCI": "IRBESARTAN / HYDROCHLOROTHIAZIDE",
    "NOM_COMMERCIALE": "GIZLAN-PLUS 300/25",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "300MG/25MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "DAR AL DAWA DEVELOPMENT & INVESTMENT Co Ltd",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/3/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "6/3/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "irbesartan"],
    "InteractionIndexLink": ["hydrochlorothiazide", "irbesartan"],
    "N_ENREGISTREMENT": "035/ 06 E 256 /18",
    "CODE_DCI": "06 E 256",
    "DCI": "IRBESARTAN / HYDROCHLOROTHIAZIDE",
    "NOM_COMMERCIALE": "IRBISART +",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "300MG/25MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMALIANCE EURL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "16/7/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "16/7/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["amlodipine", "valsartan"],
    "InteractionIndexLink": ["amlodipine", "valsartan"],
    "N_ENREGISTREMENT": "309/ 06 E 257 /14",
    "CODE_DCI": "06 E 257",
    "DCI": "Amlodipine Besilate Exprime En Amlodipine / Valsartan",
    "NOM_COMMERCIALE": "AMLODIPINE+VALSARTAN LDM",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "5MG/80MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES  DE DIAGNOSTIC MAGHREBINS (LDM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/11/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "30/11/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["amlodipine", "valsartan"],
    "InteractionIndexLink": ["amlodipine", "valsartan"],
    "N_ENREGISTREMENT": "039/ 06 E 257 /15",
    "CODE_DCI": "06 E 257",
    "DCI": "Amlodipine Besilate Exprime En Amlodipine / Valsartan",
    "NOM_COMMERCIALE": "AMLOVAL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "5MG/80MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOPHAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/12/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "2/12/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["amlodipine", "valsartan"],
    "InteractionIndexLink": ["amlodipine", "valsartan"],
    "N_ENREGISTREMENT": "293/ 06 E 257 /18",
    "CODE_DCI": "06 E 257",
    "DCI": "Amlodipine Besilate Exprime En Amlodipine / Valsartan",
    "NOM_COMMERCIALE": "BIOFORGE",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "5MG/80MG",
    "COND": "B/30 ET B/90",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOCARE SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "16/7/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "16/7/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["amlodipine", "valsartan"],
    "InteractionIndexLink": ["amlodipine", "valsartan"],
    "N_ENREGISTREMENT": "447/ 06 E 257 /16",
    "CODE_DCI": "06 E 257",
    "DCI": "Amlodipine Besilate Exprime En Amlodipine / Valsartan",
    "NOM_COMMERCIALE": "DARTIX",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "5MG/80MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL LABORATOIRES BEKER",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/7/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "26/7/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["amlodipine", "valsartan"],
    "InteractionIndexLink": ["amlodipine", "valsartan"],
    "N_ENREGISTREMENT": "001/06 E 257/16",
    "CODE_DCI": "06 E 257",
    "DCI": "Amlodipine Besilate Exprime En Amlodipine / Valsartan",
    "NOM_COMMERCIALE": "EXBITAN",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "5MG/80MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMA ALGERIA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/12/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "4/12/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["amlodipine", "valsartan"],
    "InteractionIndexLink": ["amlodipine", "valsartan"],
    "N_ENREGISTREMENT": "068/ 06 E 257 /19",
    "CODE_DCI": "06 E 257",
    "DCI": "AMLODIPINE BESYLATE EXPRIME EN AMLODIPINE/ VALSARTAN",
    "NOM_COMMERCIALE": "EXFORGE",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "5MG/80MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVARTIS PHARMA SCHWEIZ AG",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SUISSE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/7/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "Ré",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["amlodipine", "valsartan"],
    "InteractionIndexLink": ["amlodipine", "valsartan"],
    "N_ENREGISTREMENT": "418/06 E 257/16",
    "CODE_DCI": "06 E 257",
    "DCI": "Amlodipine Besilate Exprime En Amlodipine / Valsartan",
    "NOM_COMMERCIALE": "EXFORMEDIC",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "5MG/80MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NEOMEDIC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/11/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "15/11/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["amlodipine", "valsartan"],
    "InteractionIndexLink": ["amlodipine", "valsartan"],
    "N_ENREGISTREMENT": "035/ 06 E 257 /15",
    "CODE_DCI": "06 E 257",
    "DCI": "Amlodipine Besilate Exprime En Amlodipine / Valsartan",
    "NOM_COMMERCIALE": "EXSART",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "5MG/80MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMALLIANCE EURL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "31/5/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "31/5/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["amlodipine", "valsartan"],
    "InteractionIndexLink": ["amlodipine", "valsartan"],
    "N_ENREGISTREMENT": "352/ 06 E 257 /11/17",
    "CODE_DCI": "06 E 257",
    "DCI": "Amlodipine Besilate Exprime En Amlodipine / Valsartan",
    "NOM_COMMERCIALE": "EXVAL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "5MG/80MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/10/2011",
    "DATE_D_ENREGISTREMENT_FINAL": "30/10/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["amlodipine", "valsartan"],
    "InteractionIndexLink": ["amlodipine", "valsartan"],
    "N_ENREGISTREMENT": "173/06 E 257/20",
    "CODE_DCI": "06 E 257",
    "DCI": "AMLODIPINE BESILATE EXPRIME EN AMLODIPINE/ VALSARTAN",
    "NOM_COMMERCIALE": "LOTEVAN",
    "FORME": "COMP. PELL.",
    "DOSAGE": "05MG/ 80MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES EURL TABUK ALGERIE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/12/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "15/12/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["amlodipine", "valsartan"],
    "InteractionIndexLink": ["amlodipine", "valsartan"],
    "N_ENREGISTREMENT": "470/06 E 257/16",
    "CODE_DCI": "06 E 257",
    "DCI": "Amlodipine Besilate Exprime En Amlodipine / Valsartan",
    "NOM_COMMERCIALE": "VESTAMOL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "5MG/80MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MM SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/12/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "4/12/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["amlodipine", "valsartan"],
    "InteractionIndexLink": ["amlodipine", "valsartan"],
    "N_ENREGISTREMENT": "309/ 06 E 258 /14",
    "CODE_DCI": "06 E 258",
    "DCI": "Amlodipine Besilate Exprime En Amlodipine / Valsartan",
    "NOM_COMMERCIALE": "AMLODIPINE+VALSARTAN LDM",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "5MG/160MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE DE DIAGNOSTIC MAGHREBINS (LDM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/6/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "1/6/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["amlodipine", "valsartan"],
    "InteractionIndexLink": ["amlodipine", "valsartan"],
    "N_ENREGISTREMENT": "039/ 06 E 258 /15",
    "CODE_DCI": "06 E 258",
    "DCI": "Amlodipine Besilate Exprime En Amlodipine / Valsartan",
    "NOM_COMMERCIALE": "AMLOVAL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "5MG/160MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOPHAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/12/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "2/12/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["amlodipine", "valsartan"],
    "InteractionIndexLink": ["amlodipine", "valsartan"],
    "N_ENREGISTREMENT": "468/06 E 258/17",
    "CODE_DCI": "06 E 258",
    "DCI": "Amlodipine Besilate Exprime En Amlodipine / Valsartan",
    "NOM_COMMERCIALE": "AMPLID",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "5MG/160MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NADPHARMADIC PRODUCTION SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "5/11/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "5/11/2017",
    "TYPE": "GE",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["amlodipine", "valsartan"],
    "InteractionIndexLink": ["amlodipine", "valsartan"],
    "N_ENREGISTREMENT": "055/06 E 258/19",
    "CODE_DCI": "06 E 258",
    "DCI": "Amlodipine Besilate Exprime En Amlodipine / Valsartan",
    "NOM_COMMERCIALE": "ANGIOSAR",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "5MG/160MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "DAR AL DAWA DEVELOPMENT & INVESTMENT Co Ltd",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/4/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "30/4/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["amlodipine", "valsartan"],
    "InteractionIndexLink": ["amlodipine", "valsartan"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "06 E 258",
    "DCI": "Valsartan  / Amlodipine",
    "NOM_COMMERCIALE": "Angiosar 160/5",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "160MG/5MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["amlodipine", "valsartan"],
    "InteractionIndexLink": ["amlodipine", "valsartan"],
    "N_ENREGISTREMENT": "447/06 E 258/17",
    "CODE_DCI": "06 E 258",
    "DCI": "Amlodipine Besilate Exprime En Amlodipine / Valsartan",
    "NOM_COMMERCIALE": "DARTIX",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "5MG/160MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL BEKER",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/9/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "7/9/2017",
    "TYPE": "G",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["amlodipine", "valsartan"],
    "InteractionIndexLink": ["amlodipine", "valsartan"],
    "N_ENREGISTREMENT": "001/06 E 258/16",
    "CODE_DCI": "06 E 258",
    "DCI": "Amlodipine Besilate Exprime En Amlodipine / Valsartan",
    "NOM_COMMERCIALE": "EXBITAN",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "5MG/160MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMA ALGERIA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/12/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "4/12/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["amlodipine", "valsartan"],
    "InteractionIndexLink": ["amlodipine", "valsartan"],
    "N_ENREGISTREMENT": "068/ 06 E 258 /08/19",
    "CODE_DCI": "06 E 258",
    "DCI": "Amlodipine Besilate Exprime En Amlodipine / Valsartan",
    "NOM_COMMERCIALE": "EXFORGE",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "5MG/160MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVARTIS PHARMA SCHWEIZ AG",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SUISSE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/7/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "25/8/2017",
    "TYPE": "Ré",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["amlodipine", "valsartan"],
    "InteractionIndexLink": ["amlodipine", "valsartan"],
    "N_ENREGISTREMENT": "418/06 E 258/16",
    "CODE_DCI": "06 E 258",
    "DCI": "Amlodipine Besilate Exprime En Amlodipine / Valsartan",
    "NOM_COMMERCIALE": "EXFORMEDIC",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "5MG/160MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NEOMEDIC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/12/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "4/12/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["amlodipine", "valsartan"],
    "InteractionIndexLink": ["amlodipine", "valsartan"],
    "N_ENREGISTREMENT": "035/06 E 258/17",
    "CODE_DCI": "06 E 258",
    "DCI": "Amlodipine Besilate Exprime En Amlodipine / Valsartan",
    "NOM_COMMERCIALE": "EXSART",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "5MG/160MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMALLIANCE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/5/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "28/5/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["amlodipine", "valsartan"],
    "InteractionIndexLink": ["amlodipine", "valsartan"],
    "N_ENREGISTREMENT": "352/ 06 E 258 /11/17",
    "CODE_DCI": "06 E 258",
    "DCI": "Amlodipine Besilate Exprime En Amlodipine / Valsartan",
    "NOM_COMMERCIALE": "EXVAL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "5MG/160MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/10/2011",
    "DATE_D_ENREGISTREMENT_FINAL": "30/10/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["amlodipine", "valsartan"],
    "InteractionIndexLink": ["amlodipine", "valsartan"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "06 E 258",
    "DCI": "AMLODIPINE/VALSARTAN",
    "NOM_COMMERCIALE": "LOTEVAN",
    "FORME": "Comp",
    "DOSAGE": "5mg/160mg",
    "COND": "B 30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["amlodipine", "valsartan"],
    "InteractionIndexLink": ["amlodipine", "valsartan"],
    "N_ENREGISTREMENT": "510/06 E 258/17",
    "CODE_DCI": "06 E 258",
    "DCI": "Amlodipine Besilate Exprime En Amlodipine / Valsartan",
    "NOM_COMMERCIALE": "VALAMLO ALEMBIC MAMI",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "5MG/160MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALEMBIC MAMI SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/6/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "18/6/2017",
    "TYPE": "Gé",
    "STATUT": "F PREMIX",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["amlodipine", "valsartan"],
    "InteractionIndexLink": ["amlodipine", "valsartan"],
    "N_ENREGISTREMENT": "470/ 06 E 258 /13",
    "CODE_DCI": "06 E 258",
    "DCI": "Amlodipine Besilate Exprime En Amlodipine / Valsartan",
    "NOM_COMMERCIALE": "VESTAMOL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "5MG/160MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MM (SARL LABORATOIRES MM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "21/7/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "21/7/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["amlodipine", "valsartan"],
    "InteractionIndexLink": ["amlodipine", "valsartan"],
    "N_ENREGISTREMENT": "309/ 06 E 259 /14",
    "CODE_DCI": "06 E 259",
    "DCI": "Amlodipine Besilate Exprime En Amlodipine / Valsartan",
    "NOM_COMMERCIALE": "AMLODIPINE+VALSARTAN LDM",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "10MG/160MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES  DE DIAGNOSTIC MAGHREBINS (LDM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/11/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "30/11/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["amlodipine", "valsartan"],
    "InteractionIndexLink": ["amlodipine", "valsartan"],
    "N_ENREGISTREMENT": "039/ 06 E 259 /15",
    "CODE_DCI": "06 E 259",
    "DCI": "Amlodipine Besilate Exprime En Amlodipine / Valsartan",
    "NOM_COMMERCIALE": "AMLOVAL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "10MG/160MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOPHAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/12/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "2/12/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["amlodipine", "valsartan"],
    "InteractionIndexLink": ["amlodipine", "valsartan"],
    "N_ENREGISTREMENT": "468/06 E 259/17",
    "CODE_DCI": "06 E 259",
    "DCI": "Amlodipine Besilate Exprime En Amlodipine / Valsartan",
    "NOM_COMMERCIALE": "AMPLID",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "10MG/160MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NADPHARMADIC PRODUCTION SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "5/11/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "5/11/2017",
    "TYPE": "GE",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24  MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["amlodipine", "valsartan"],
    "InteractionIndexLink": ["amlodipine", "valsartan"],
    "N_ENREGISTREMENT": "055/ 06 E 259 /19",
    "CODE_DCI": "06 E 259",
    "DCI": "Amlodipine Besilate Exprime En Amlodipine / Valsartan",
    "NOM_COMMERCIALE": "ANGIOSAR",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "10MG/160MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "DAR AL DAWA DEVELOPMENT & INVESTMENT Co Ltd",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/4/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "30/4/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["amlodipine", "valsartan"],
    "InteractionIndexLink": ["amlodipine", "valsartan"],
    "N_ENREGISTREMENT": "447/  06 E 259 /16",
    "CODE_DCI": "06 E 259",
    "DCI": "Amlodipine Besilate Exprime En Amlodipine / Valsartan",
    "NOM_COMMERCIALE": "DARTIX",
    "FORME": "GELULE",
    "DOSAGE": "10MG/160MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL BEKER",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "11/4/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "11/4/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["fenofibrate"],
    "InteractionIndexLink": ["fenofibrate"],
    "N_ENREGISTREMENT": "001/06 E 259/17",
    "CODE_DCI": "06 E 259",
    "DCI": "FENOFIBRATE MICRONISE",
    "NOM_COMMERCIALE": "EXBITAN",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "10MG/160MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMA ALGERIA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/1/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "9/1/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["amlodipine", "valsartan"],
    "InteractionIndexLink": ["amlodipine", "valsartan"],
    "N_ENREGISTREMENT": "068/ 06 E 259 /08/19",
    "CODE_DCI": "06 E 259",
    "DCI": "AMLODIPINE BESYLATE EXPRIME EN AMLODIPINE/ VALSARTAN",
    "NOM_COMMERCIALE": "EXFORGE",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "10MG/160MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVARTIS PHARMA SCHWEIZ AG",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SUISSE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/7/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "27/7/2008",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["amlodipine", "valsartan"],
    "InteractionIndexLink": ["amlodipine", "valsartan"],
    "N_ENREGISTREMENT": "418/06 E 259/16",
    "CODE_DCI": "06 E 259",
    "DCI": "Amlodipine Besilate Exprime En Amlodipine / Valsartan",
    "NOM_COMMERCIALE": "EXFORMEDIC",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "10MG/160MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL NEOMEDIC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "8/11/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "8/11/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["amlodipine", "valsartan"],
    "InteractionIndexLink": ["amlodipine", "valsartan"],
    "N_ENREGISTREMENT": "035/ 06 E 259 /15",
    "CODE_DCI": "06 E 259",
    "DCI": "Amlodipine Besilate Exprime En Amlodipine / Valsartan",
    "NOM_COMMERCIALE": "EXSART",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "10MG/160MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMALLIANCE EURL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "31/5/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "31/5/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["amlodipine", "valsartan"],
    "InteractionIndexLink": ["amlodipine", "valsartan"],
    "N_ENREGISTREMENT": "352/ 06 E 259 /11/17",
    "CODE_DCI": "06 E 259",
    "DCI": "Amlodipine Besilate Exprime En Amlodipine / Valsartan",
    "NOM_COMMERCIALE": "EXVAL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "10MG/160MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/10/2011",
    "DATE_D_ENREGISTREMENT_FINAL": "30/10/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["amlodipine", "valsartan"],
    "InteractionIndexLink": ["amlodipine", "valsartan"],
    "N_ENREGISTREMENT": "173/06 E 259/20",
    "CODE_DCI": "06 E 259",
    "DCI": "AMLODIPINE BESILATE EXPRIME EN AMLODIPINE/ VALSARTAN",
    "NOM_COMMERCIALE": "LOTEVAN",
    "FORME": "COMP. PELL.",
    "DOSAGE": "10MG/ 160MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES EURL TABUK ALGERIE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/12/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "15/12/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["amlodipine", "valsartan"],
    "InteractionIndexLink": ["amlodipine", "valsartan"],
    "N_ENREGISTREMENT": "470/06 E 259/16",
    "CODE_DCI": "06 E 259",
    "DCI": "Amlodipine Besilate Exprime En Amlodipine / Valsartan",
    "NOM_COMMERCIALE": "VESTAMOL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "10MG/160MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES MM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "8/11/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "8/11/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["telmisartan"],
    "InteractionIndexLink": ["telmisartan"],
    "N_ENREGISTREMENT": "447 / 06 E 263 /16",
    "CODE_DCI": "06 E 263",
    "DCI": "TELMISARTAN",
    "NOM_COMMERCIALE": "BEKERDIS",
    "FORME": "COMPRIME",
    "DOSAGE": "40MG",
    "COND": "B/30 ET B/90",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL LABORATOIRES BEKER",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/3/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "13/3/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["telmisartan"],
    "InteractionIndexLink": ["telmisartan"],
    "N_ENREGISTREMENT": "097/ 06 E 263 /16",
    "CODE_DCI": "06 E 263",
    "DCI": "TELMISARTAN",
    "NOM_COMMERCIALE": "CARDIMED",
    "FORME": "COMPRIME",
    "DOSAGE": "40MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL SANAMED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/3/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "13/3/2016",
    "TYPE": "Gé",
    "STATUT": "Fpremix",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["telmisartan"],
    "InteractionIndexLink": ["telmisartan"],
    "N_ENREGISTREMENT": "152/ 06 E 263 /08/19",
    "CODE_DCI": "06 E 263",
    "DCI": "TELMISARTAN",
    "NOM_COMMERCIALE": "MICARDIS",
    "FORME": "COMPRIME",
    "DOSAGE": "40MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BOEHRINGER INGELHEIM INTERNATIONAL Gmbh",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALLEMAGNE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/12/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "26/8/2019",
    "TYPE": "Ré",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "48 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["telmisartan"],
    "InteractionIndexLink": ["telmisartan"],
    "N_ENREGISTREMENT": "321/ 06 E 263 /18",
    "CODE_DCI": "06 E 263",
    "DCI": "Telmisartan",
    "NOM_COMMERCIALE": "MIZART",
    "FORME": "Comprimé",
    "DOSAGE": "40MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOVITAL SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/6/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "25/6/2018",
    "TYPE": "Gé",
    "STATUT": "F granules",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["telmisartan"],
    "InteractionIndexLink": ["telmisartan"],
    "N_ENREGISTREMENT": "289 / 06 E 263 /15",
    "CODE_DCI": "06 E 263",
    "DCI": "TELMISARTAN",
    "NOM_COMMERCIALE": "TELMIDIS",
    "FORME": "COMPRIME",
    "DOSAGE": "40MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRATER RAZES FORME SECHE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "31/5/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "31/5/2015",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["telmisartan"],
    "InteractionIndexLink": ["telmisartan"],
    "N_ENREGISTREMENT": "293/ 06 E 263 /18",
    "CODE_DCI": "06 E 263",
    "DCI": "TELMISARTAN",
    "NOM_COMMERCIALE": "TELMISA",
    "FORME": "COMPRIME",
    "DOSAGE": "40MG",
    "COND": "B/30 ET B/90",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOCARE SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/12/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "24/12/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["telmisartan"],
    "InteractionIndexLink": ["telmisartan"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "06 E 263",
    "DCI": "TELMISARTAN",
    "NOM_COMMERCIALE": "TELMISA",
    "FORME": "comprimés",
    "DOSAGE": "40 mg",
    "COND": "B/90",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["telmisartan"],
    "InteractionIndexLink": ["telmisartan"],
    "N_ENREGISTREMENT": "428/ 06 E 263 /16",
    "CODE_DCI": "06 E 263",
    "DCI": "TELMISARTAN",
    "NOM_COMMERCIALE": "TELMISARTAN ZENTIVA",
    "FORME": "COMPRIME",
    "DOSAGE": "40MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "WINTHROP PHARMA SAIDAL SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "11/5/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "11/5/2016",
    "TYPE": "Gé",
    "STATUT": "Fpremix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["telmisartan"],
    "InteractionIndexLink": ["telmisartan"],
    "N_ENREGISTREMENT": "035/06 E 263/17",
    "CODE_DCI": "06 E 263",
    "DCI": "TELMISARTAN",
    "NOM_COMMERCIALE": "TELMISARTE",
    "FORME": "COMPRIME",
    "DOSAGE": "40MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EURL PHARMALLIANCE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/2/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "27/2/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["telmisartan"],
    "InteractionIndexLink": ["telmisartan"],
    "N_ENREGISTREMENT": "352/ 06 E 263 /16",
    "CODE_DCI": "06 E 263",
    "DCI": "TELMISARTAN",
    "NOM_COMMERCIALE": "TENSOTEL",
    "FORME": "COMPRIME",
    "DOSAGE": "40MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/6/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "26/6/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["telmisartan"],
    "InteractionIndexLink": ["telmisartan"],
    "N_ENREGISTREMENT": "447/ 06 E 264 /16",
    "CODE_DCI": "06 E 264",
    "DCI": "TELMISARTAN",
    "NOM_COMMERCIALE": "BEKERDIS",
    "FORME": "COMPRIME",
    "DOSAGE": "80MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEKER SARL (SARL LABORATOIRE BEKER ALGERIE)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/4/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "12/4/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["telmisartan"],
    "InteractionIndexLink": ["telmisartan"],
    "N_ENREGISTREMENT": "152/ 06 E 264 /08/19",
    "CODE_DCI": "06 E 264",
    "DCI": "TELMISARTAN",
    "NOM_COMMERCIALE": "MICARDIS",
    "FORME": "COMPRIME",
    "DOSAGE": "80MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BOEHRINGER INGELHEIM INTERNATIONAL Gmbh",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALLEMAGNE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/12/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "26/8/2019",
    "TYPE": "Ré",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "48 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["telmisartan"],
    "InteractionIndexLink": ["telmisartan"],
    "N_ENREGISTREMENT": "289/06 E 264/16",
    "CODE_DCI": "06 E 264",
    "DCI": "TELMISARTAN",
    "NOM_COMMERCIALE": "TELMIDIS",
    "FORME": "COMPRIME",
    "DOSAGE": "80MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRATZER RAZES FORME SECHE SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/11/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "3/5/2021",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["telmisartan"],
    "InteractionIndexLink": ["telmisartan"],
    "N_ENREGISTREMENT": "293/ 06 E 264 /18",
    "CODE_DCI": "06 E 264",
    "DCI": "TELMISARTAN",
    "NOM_COMMERCIALE": "TELMISA",
    "FORME": "COMPRIME",
    "DOSAGE": "80MG",
    "COND": "B/30 ET B/90",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOCARE SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/12/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "24/12/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["telmisartan"],
    "InteractionIndexLink": ["telmisartan"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "06 E 264",
    "DCI": "TELMISARTAN",
    "NOM_COMMERCIALE": "TELMISA",
    "FORME": "comprimés",
    "DOSAGE": "80 mg",
    "COND": "B/90",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["telmisartan"],
    "InteractionIndexLink": ["telmisartan"],
    "N_ENREGISTREMENT": "309/06 E 264/20",
    "CODE_DCI": "06 E 264",
    "DCI": "TELMISARTAN",
    "NOM_COMMERCIALE": "TELMISARTAN",
    "FORME": "COMRPIME",
    "DOSAGE": "80MG",
    "COND": "B/28",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES DE DIAGNOSTIC MAGHREBIN",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/12/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "29/12/2020",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["telmisartan"],
    "InteractionIndexLink": ["telmisartan"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "06 E 264",
    "DCI": "TELMISARTAN",
    "NOM_COMMERCIALE": "TELMISARTAN LDM",
    "FORME": "COMP",
    "DOSAGE": "80MG",
    "COND": "B/28",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["telmisartan"],
    "InteractionIndexLink": ["telmisartan"],
    "N_ENREGISTREMENT": "428/ 06 E  264 /16",
    "CODE_DCI": "06 E 264",
    "DCI": "TELMISARTAN",
    "NOM_COMMERCIALE": "TELMISARTAN ZENTIVA",
    "FORME": "COMPRIME",
    "DOSAGE": "80MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "WINTHROP PHARMA SAIDAL SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "16/2/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "16/2/2016",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["telmisartan"],
    "InteractionIndexLink": ["telmisartan"],
    "N_ENREGISTREMENT": "035/06 E 264/17",
    "CODE_DCI": "06 E 264",
    "DCI": "TELMISARTAN",
    "NOM_COMMERCIALE": "TELMISARTE",
    "FORME": "COMPRIME",
    "DOSAGE": "80MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMALLIANCE EURL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/2/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "27/2/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["telmisartan"],
    "InteractionIndexLink": ["telmisartan"],
    "N_ENREGISTREMENT": "039/06 E 264/20",
    "CODE_DCI": "06 E 264",
    "DCI": "TELMISARTAN",
    "NOM_COMMERCIALE": "TELSTAL",
    "FORME": "COMPRIME",
    "DOSAGE": "80MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES SOCIETE PHARMACEUTIQUE ALGERIENNE-SOPHAL SPA-",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/12/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "13/12/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["telmisartan"],
    "InteractionIndexLink": ["telmisartan"],
    "N_ENREGISTREMENT": "352/ 06 E 264 /16",
    "CODE_DCI": "06 E 264",
    "DCI": "TELMISARTAN",
    "NOM_COMMERCIALE": "TENSOTEL",
    "FORME": "COMPRIME",
    "DOSAGE": "80MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ELKENDI INDUSTRIE DE MEDICAMENT SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/3/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "13/3/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "telmisartan"],
    "InteractionIndexLink": ["hydrochlorothiazide", "telmisartan"],
    "N_ENREGISTREMENT": "447/ 06 E 265 /19",
    "CODE_DCI": "06 E 265",
    "DCI": "TELMISARTAN/HYDROCHLOROTHIAZIDE",
    "NOM_COMMERCIALE": "CO BEKERDIS",
    "FORME": "COMPRIME",
    "DOSAGE": "40MG/12.5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEKER SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "14/5/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "14/5/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "telmisartan"],
    "InteractionIndexLink": ["hydrochlorothiazide", "telmisartan"],
    "N_ENREGISTREMENT": "352/ 06 E 265 /18",
    "CODE_DCI": "06 E 265",
    "DCI": "TELMISARTAN/HYDROCHLOROTHIAZIDE",
    "NOM_COMMERCIALE": "CO TENSOTEL",
    "FORME": "COMPRIME",
    "DOSAGE": "40MG/12.5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/4/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "26/4/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "telmisartan"],
    "InteractionIndexLink": ["hydrochlorothiazide", "telmisartan"],
    "N_ENREGISTREMENT": "152/ 06 E 265 /08/16",
    "CODE_DCI": "06 E 265",
    "DCI": "TELMISARTAN/HYDROCHLOROTHIAZIDE",
    "NOM_COMMERCIALE": "MICARDIS PLUS",
    "FORME": "COMPRIME",
    "DOSAGE": "40MG/12.5MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BOEHRINGER INGELHEIM INTERNATIONAL Gmbh",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALLEMAGNE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/12/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "16/4/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide"],
    "InteractionIndexLink": ["hydrochlorothiazide"],
    "N_ENREGISTREMENT": "321/06 E 265/20",
    "CODE_DCI": "06 E 265",
    "DCI": "TELMISARTEN/HYDROCHLOROTHIAZIDE",
    "NOM_COMMERCIALE": "MIZART PLUS",
    "FORME": "COMP",
    "DOSAGE": "40MG/12.5MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOVITAL SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/5/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "4/5/2020",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "telmisartan"],
    "InteractionIndexLink": ["hydrochlorothiazide", "telmisartan"],
    "N_ENREGISTREMENT": "035/06 E 265/17",
    "CODE_DCI": "06 E 265",
    "DCI": "TELMISARTAN/HYDROCHLOROTHIAZIDE",
    "NOM_COMMERCIALE": "TELMISARTE +",
    "FORME": "COMPRIME",
    "DOSAGE": "40MG/12.5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMALLIANCE EURL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/6/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "18/6/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "telmisartan"],
    "InteractionIndexLink": ["hydrochlorothiazide", "telmisartan"],
    "N_ENREGISTREMENT": "447/06 E 266/19",
    "CODE_DCI": "06 E 266",
    "DCI": "TELMISARTAN/HYDROCHLOROTHIAZIDE",
    "NOM_COMMERCIALE": "CO BEKERDIS",
    "FORME": "COMPRIME",
    "DOSAGE": "80MG/12.5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEKER SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/4/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "28/4/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "telmisartan"],
    "InteractionIndexLink": ["hydrochlorothiazide", "telmisartan"],
    "N_ENREGISTREMENT": "152/ 06 E 266 /08/15",
    "CODE_DCI": "06 E 266",
    "DCI": "TELMISARTAN/HYDROCHLOROTHIAZIDE",
    "NOM_COMMERCIALE": "MICARDIS PLUS",
    "FORME": "COMPRIME",
    "DOSAGE": "80MG/12.5MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BOEHRINGER INGELHEIM INTERNATIONAL Gmbh",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALLEMAGNE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/12/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "13/12/2015",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "telmisartan"],
    "InteractionIndexLink": ["hydrochlorothiazide", "telmisartan"],
    "N_ENREGISTREMENT": "321/ 06 E 266 /20",
    "CODE_DCI": "06 E 266",
    "DCI": "Telmisartan / Hydrochlorothiazide",
    "NOM_COMMERCIALE": "MIZART PLUS",
    "FORME": "Comprimé",
    "DOSAGE": "80MG/12.5MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOVITAL SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/2/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "13/7/2020",
    "TYPE": "Gé",
    "STATUT": "F DC granules",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "telmisartan"],
    "InteractionIndexLink": ["hydrochlorothiazide", "telmisartan"],
    "N_ENREGISTREMENT": "035/06 E 266/17",
    "CODE_DCI": "06 E 266",
    "DCI": "TELMISARTAN/HYDROCHLOROTHIAZIDE",
    "NOM_COMMERCIALE": "TELMISARTE+",
    "FORME": "COMPRIME",
    "DOSAGE": "80MG/12.5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMALLIANCE EURL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/6/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "29/6/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "ramipril"],
    "InteractionIndexLink": ["hydrochlorothiazide", "ramipril"],
    "N_ENREGISTREMENT": "035/ 06 E 277/ 17",
    "CODE_DCI": "06 E 277",
    "DCI": "Ramipril / Hydrochlorothiazide",
    "NOM_COMMERCIALE": "TANATRIL +",
    "FORME": "COMPRIME",
    "DOSAGE": "5MG/12.5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMALLIANCE EURL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "5/11/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "5/11/2017",
    "TYPE": "GE",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "ramipril"],
    "InteractionIndexLink": ["hydrochlorothiazide", "ramipril"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "06 E 277",
    "DCI": "RAMIPRIL / HYDROCHLOROTHIAZIDE",
    "NOM_COMMERCIALE": "TRITAZIDE",
    "FORME": "COMPRIME",
    "DOSAGE": "5MG/12.5MG",
    "COND": "B/28",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "ramipril"],
    "InteractionIndexLink": ["hydrochlorothiazide", "ramipril"],
    "N_ENREGISTREMENT": "035/ 06 E 278 /17",
    "CODE_DCI": "06 E 278",
    "DCI": "Ramipril / Hydrochlorothiazide",
    "NOM_COMMERCIALE": "TANATRIL +",
    "FORME": "COMPRIME",
    "DOSAGE": "10MG/25MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMALLIANCE Eurl",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/12/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "25/12/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "ramipril"],
    "InteractionIndexLink": ["hydrochlorothiazide", "ramipril"],
    "N_ENREGISTREMENT": "392/ 06 E 278 /10/21",
    "CODE_DCI": "06 E 278",
    "DCI": "Ramipril / Hydrochlorothiazide",
    "NOM_COMMERCIALE": "TRITAZIDE",
    "FORME": "COMPRIME",
    "DOSAGE": "10MG/25MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANOFI AVENTIS ALGERIE SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/3/2010",
    "DATE_D_ENREGISTREMENT_FINAL": "25/4/2021",
    "TYPE": "Ré",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["perindopril"],
    "InteractionIndexLink": ["perindopril ter-butylamine"],
    "N_ENREGISTREMENT": "040/ 06 E 283 /09/15",
    "CODE_DCI": "06 E 283",
    "DCI": "PERINDOPRIL ARGININE",
    "NOM_COMMERCIALE": "COVERSYL",
    "FORME": "COMP. PELLI. SEC.",
    "DOSAGE": "5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SERVIER",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/8/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "13/12/2015",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["perindopril"],
    "InteractionIndexLink": ["perindopril ter-butylamine"],
    "N_ENREGISTREMENT": "040/ 06 E 284 /09/15",
    "CODE_DCI": "06 E 284",
    "DCI": "PERINDOPRIL ARGININE",
    "NOM_COMMERCIALE": "COVERSYL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SERVIER",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/8/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "13/12/2015",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "ramipril"],
    "InteractionIndexLink": ["hydrochlorothiazide", "ramipril"],
    "N_ENREGISTREMENT": "035 / 06 E 289 /17",
    "CODE_DCI": "06 E 289",
    "DCI": "Ramipril / Hydrochlorothiazide",
    "NOM_COMMERCIALE": "TANATRIL +",
    "FORME": "COMPRIME",
    "DOSAGE": "10MG/12.5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMALLIANCE EURL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/11/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "26/11/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "ramipril"],
    "InteractionIndexLink": ["hydrochlorothiazide", "ramipril"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "06 E 289",
    "DCI": "Ramipril / Hydrochlorothiazide",
    "NOM_COMMERCIALE": "TRITAZIDE",
    "FORME": "COMPRIME",
    "DOSAGE": "10MG/12.5MG",
    "COND": "B/28",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["indapamide", "perindopril"],
    "InteractionIndexLink": ["indapamide", "perindopril ter-butylamine"],
    "N_ENREGISTREMENT": "040/ 06 E 300 /13/19",
    "CODE_DCI": "06 E 300",
    "DCI": "PERINDOPRIL ARGININE / INDAPAMIDE",
    "NOM_COMMERCIALE": "PRETERAX ARGININE",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "2.5MG/0.625MG",
    "COND": "PILULIER/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SERVIER",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/4/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "30/12/2019",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["indapamide", "perindopril"],
    "InteractionIndexLink": ["indapamide", "perindopril ter-butylamine"],
    "N_ENREGISTREMENT": "040/ 06 E 301 /13/19",
    "CODE_DCI": "06 E 301",
    "DCI": "PERINDOPRIL ARGININE / INDAPAMIDE",
    "NOM_COMMERCIALE": "BIPRETERAX ARGININE",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "5MG/1.25MG",
    "COND": "PILULIER/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SERVIER",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/4/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "30/12/2019",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "valsartan"],
    "InteractionIndexLink": ["hydrochlorothiazide", "valsartan"],
    "N_ENREGISTREMENT": "352/ 06 E 307 /15",
    "CODE_DCI": "06 E 307",
    "DCI": "Valsartan / Hydrochlorothiazide",
    "NOM_COMMERCIALE": "CO SARTEG",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "320MG/25MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/1/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "25/1/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["valsartan"],
    "InteractionIndexLink": ["valsartan"],
    "N_ENREGISTREMENT": "352 / 06 E 308 /14",
    "CODE_DCI": "06 E 308",
    "DCI": "Valsartan",
    "NOM_COMMERCIALE": "SARTEG",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "320MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/12/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "15/12/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["valsartan"],
    "InteractionIndexLink": ["valsartan"],
    "N_ENREGISTREMENT": "510/06 E 308/17",
    "CODE_DCI": "06 E 308",
    "DCI": "Valsartan",
    "NOM_COMMERCIALE": "VALCARD ALEMBIC MAMI",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "320MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALEMBIC MAMI SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/6/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "12/6/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["amlodipine", "irbesartan"],
    "InteractionIndexLink": ["amlodipine", "irbesartan"],
    "N_ENREGISTREMENT": "242/06 E 310/21",
    "CODE_DCI": "06 E 310",
    "DCI": "Amlodipine bésilate exprimé en Amlodipine / Irbésartan",
    "NOM_COMMERCIALE": "AMLESAR",
    "FORME": "Comprimé pelliculé",
    "DOSAGE": "5MG/150 MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GROUPE SANTE / SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/2/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "17/2/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["amlodipine", "irbesartan"],
    "InteractionIndexLink": ["amlodipine", "irbesartan"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "06 E 310",
    "DCI": "AMLODIPINE/IRBESARTAN",
    "NOM_COMMERCIALE": "AMLESAR",
    "FORME": "COMP",
    "DOSAGE": "150MG/5MG",
    "COND": "Boite de 30 Cp",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["amlodipine", "irbesartan"],
    "InteractionIndexLink": ["amlodipine", "irbesartan"],
    "N_ENREGISTREMENT": "392 / 06 E 310 /15",
    "CODE_DCI": "06 E 310",
    "DCI": "IRBESARTAN/BéSILATE D'AMLODIPINE",
    "NOM_COMMERCIALE": "APROVASC",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "150MG/5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANOFI AVENTIS ALGERIE SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/12/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "13/12/2015",
    "TYPE": "Ré",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["amlodipine", "irbesartan"],
    "InteractionIndexLink": ["amlodipine", "irbesartan"],
    "N_ENREGISTREMENT": "352/06 E 310/17",
    "CODE_DCI": "06 E 310",
    "DCI": "AMLODIPINE BESILATE/IRBESARTAN",
    "NOM_COMMERCIALE": "EXIRB",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "5MG/150 MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/4/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "12/4/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["amlodipine", "irbesartan"],
    "InteractionIndexLink": ["amlodipine", "irbesartan"],
    "N_ENREGISTREMENT": "392/ 06 E 311 /15",
    "CODE_DCI": "06 E 311",
    "DCI": "IRBéSARTAN/BéSILATE D'AMLODIPINE",
    "NOM_COMMERCIALE": "APROVASC",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "300MG/5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANOFI AVENTIS ALGERIE SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/12/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "13/12/2015",
    "TYPE": "Ré",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["amlodipine", "irbesartan"],
    "InteractionIndexLink": ["amlodipine", "irbesartan"],
    "N_ENREGISTREMENT": "352/06 E 311/17",
    "CODE_DCI": "06 E 311",
    "DCI": "IRBéSARTAN/BéSILATE D'AMLODIPINE",
    "NOM_COMMERCIALE": "EXIRB",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "300MG/5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/4/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "26/4/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["amlodipine", "irbesartan"],
    "InteractionIndexLink": ["amlodipine", "irbesartan"],
    "N_ENREGISTREMENT": "392/ 06 E 312 /15",
    "CODE_DCI": "06 E 312",
    "DCI": "IRBESARTAN/ AMLODIPINE (BESILATE)",
    "NOM_COMMERCIALE": "APROVASC",
    "FORME": "COMP.PELLI SéCABLE",
    "DOSAGE": "300MG/10MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANOFI AVENTIS ALGERIE SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "31/12/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "31/12/2015",
    "TYPE": "Ré",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "telmisartan"],
    "InteractionIndexLink": ["hydrochlorothiazide", "telmisartan"],
    "N_ENREGISTREMENT": "447/06 E 316/19",
    "CODE_DCI": "06 E 316",
    "DCI": "TELMISARTAN/HYDROCHLOROTHIAZIDE",
    "NOM_COMMERCIALE": "CO BEKERDIS",
    "FORME": "COMPRIME",
    "DOSAGE": "80MG/25 MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEKER SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "telmisartan"],
    "InteractionIndexLink": ["hydrochlorothiazide", "telmisartan"],
    "N_ENREGISTREMENT": "035/06 E 316/17",
    "CODE_DCI": "06 E 316",
    "DCI": "TELMISARTAN/HYDROCHLOROTHIAZIDE",
    "NOM_COMMERCIALE": "TELMISARTE +",
    "FORME": "COMPRIME",
    "DOSAGE": "80MG/25 MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMALLIANCE EURL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/6/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "29/6/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["amlodipine", "irbesartan"],
    "InteractionIndexLink": ["amlodipine", "irbesartan"],
    "N_ENREGISTREMENT": "392 / 06 E 318/17",
    "CODE_DCI": "06 E 318",
    "DCI": "IRBéSARTAN/BéSILATE D'AMLODIPINE",
    "NOM_COMMERCIALE": "APROVASC",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "150MG/10MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANOFI AVENTIS ALGERIE SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/12/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "27/12/2017",
    "TYPE": "Ré",
    "STATUT": "Fpremix",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["amlodipine", "perindopril"],
    "InteractionIndexLink": ["amlodipine", "perindopril ter-butylamine"],
    "N_ENREGISTREMENT": "040/06 E 319/18",
    "CODE_DCI": "06 E 319",
    "DCI": "AMLODIPINE BESILATE EXPRIME EN AMLODIPINE/PERINDOPRIL EXPRIME EN PERINDOPRIL ARGININE",
    "NOM_COMMERCIALE": "COVERAM",
    "FORME": "COMP",
    "DOSAGE": "5MG/5MG",
    "COND": "PILULIR/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SERVIER",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "France",
    "DATE_D_ENREGISTREMENT_INITIAL": "21/2/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "21/2/2018",
    "TYPE": "Ré",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["amlodipine", "perindopril"],
    "InteractionIndexLink": ["amlodipine", "perindopril ter-butylamine"],
    "N_ENREGISTREMENT": "040/06 E 320/18",
    "CODE_DCI": "06 E 320",
    "DCI": "AMLODIPINE BESILATE EXPRIME EN AMLODIPINE/PERINDOPRIL EXPRIME EN PERINDOPRIL ARGININE",
    "NOM_COMMERCIALE": "COVERAM",
    "FORME": "COMP",
    "DOSAGE": "5MG/10MG",
    "COND": "PILULIR/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SERVIER",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "France",
    "DATE_D_ENREGISTREMENT_INITIAL": "21/2/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "21/2/2018",
    "TYPE": "Ré",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["amlodipine", "perindopril"],
    "InteractionIndexLink": ["amlodipine", "perindopril ter-butylamine"],
    "N_ENREGISTREMENT": "040/06 E 321/18",
    "CODE_DCI": "06 E 321",
    "DCI": "AMLODIPINE BESILATE EXPRIME EN AMLODIPINE/PERINDOPRIL EXPRIME EN PERINDOPRIL ARGININE",
    "NOM_COMMERCIALE": "COVERAM",
    "FORME": "COMP",
    "DOSAGE": "10MG/5MG",
    "COND": "PILULIR/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SERVIER",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "France",
    "DATE_D_ENREGISTREMENT_INITIAL": "21/2/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "21/2/2018",
    "TYPE": "Ré",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["amlodipine", "perindopril"],
    "InteractionIndexLink": ["amlodipine", "perindopril ter-butylamine"],
    "N_ENREGISTREMENT": "040/06 E 322/18",
    "CODE_DCI": "06 E 322",
    "DCI": "AMLODIPINE BESILATE EXPRIME EN AMLODIPINE/PERINDOPRIL EXPRIME EN PERINDOPRIL ARGININE",
    "NOM_COMMERCIALE": "COVERAM",
    "FORME": "COMP",
    "DOSAGE": "10MG/10MG",
    "COND": "PILULIR/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SERVIER",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "France",
    "DATE_D_ENREGISTREMENT_INITIAL": "21/2/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "21/2/2018",
    "TYPE": "Ré",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["indapamide", "perindopril"],
    "InteractionIndexLink": ["indapamide", "perindopril ter-butylamine"],
    "N_ENREGISTREMENT": "040/06 E 329/19",
    "CODE_DCI": "06 E 329",
    "DCI": "PERINDOPRIL ARGININE/INDAPAMIDE",
    "NOM_COMMERCIALE": "BIPRETERAX ARGININE",
    "FORME": "COMP PELL",
    "DOSAGE": "10MG/2.5MG",
    "COND": "PILULIRER/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SERVIER",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "8/1/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "8/1/2020",
    "TYPE": "Ré",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["acebutolol"],
    "InteractionIndexLink": ["acebutolol"],
    "N_ENREGISTREMENT": "521/ 06 F 067 /10/18",
    "CODE_DCI": "06 F 067",
    "DCI": "ACEBUTOLOL CHLORHYDRATE",
    "NOM_COMMERCIALE": "ACEBUTOLOL IVAL",
    "FORME": "COMP. PELLI. SEC.",
    "DOSAGE": "200MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL WORLD MEDECINE LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/1/2010",
    "DATE_D_ENREGISTREMENT_FINAL": "13/8/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["acebutolol"],
    "InteractionIndexLink": ["acebutolol"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "06 F 067",
    "DCI": "ACEBUTOLOL CHLORHYDRATE",
    "NOM_COMMERCIALE": "CLOXTON",
    "FORME": "COMP. PELLI. SEC.",
    "DOSAGE": "200MG",
    "COND": "B/20",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["acebutolol"],
    "InteractionIndexLink": ["acebutolol"],
    "N_ENREGISTREMENT": "268/ 06 F 067 /06/13",
    "CODE_DCI": "06 F 067",
    "DCI": "ACEBUTOLOL CHLORHYDRATE",
    "NOM_COMMERCIALE": "SEBUTOL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "200MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MERINAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/4/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "5/3/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["acebutolol"],
    "InteractionIndexLink": ["acebutolol"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "06 F 067",
    "DCI": "ACEBUTOLOL CHLORHYDRATE",
    "NOM_COMMERCIALE": "SECTRAL",
    "FORME": "COMP. PELLI. SEC.",
    "DOSAGE": "200MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["acebutolol"],
    "InteractionIndexLink": ["acebutolol"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "06 F 068",
    "DCI": "ACEBUTOLOL CHLORHYDRATE",
    "NOM_COMMERCIALE": "SECTRAL",
    "FORME": "COMP. PELLI. SEC.",
    "DOSAGE": "400MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["atenolol"],
    "InteractionIndexLink": ["atenolol"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "06 F 069",
    "DCI": "ATENOLOL",
    "NOM_COMMERCIALE": "ATENOR",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "100MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["atenolol"],
    "InteractionIndexLink": ["atenolol"],
    "N_ENREGISTREMENT": "235 / 06 F 069 /21",
    "CODE_DCI": "06 F 069",
    "DCI": "Aténolol",
    "NOM_COMMERCIALE": "CARDINOL BGL",
    "FORME": "Comprimé pelliculé sécable",
    "DOSAGE": "100MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOGALENIC / SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/3/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "28/3/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["atenolol"],
    "InteractionIndexLink": ["atenolol"],
    "N_ENREGISTREMENT": "518/06 F 069/17",
    "CODE_DCI": "06 F 069",
    "DCI": "ATENOLOL",
    "NOM_COMMERCIALE": "DAGHTAN 100",
    "FORME": "COMP PELL SEC",
    "DOSAGE": "100MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "TAPHCO SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/4/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "12/4/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["atenolol"],
    "InteractionIndexLink": ["atenolol"],
    "N_ENREGISTREMENT": "097/06 F 069/19",
    "CODE_DCI": "06 F 069",
    "DCI": "ATENOLOL",
    "NOM_COMMERCIALE": "TENORMED",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "100MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANAMED SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/4/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "15/4/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["metoprolol"],
    "InteractionIndexLink": ["metoprolol"],
    "N_ENREGISTREMENT": "307/ 06 F 071 /97/15",
    "CODE_DCI": "06 F 071",
    "DCI": "Metoprolol tartrate",
    "NOM_COMMERCIALE": "LOPRESSOR  LP",
    "FORME": "COMP.SEC. L.P.",
    "DOSAGE": "200MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "DAIICHI SANKYO FRANCE PHARMA  S.A.S",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "8/11/1997",
    "DATE_D_ENREGISTREMENT_FINAL": "2/12/2015",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "60 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["metoprolol"],
    "InteractionIndexLink": ["metoprolol"],
    "N_ENREGISTREMENT": "418/06 F 071",
    "CODE_DCI": "06 F 071",
    "DCI": "METOPROLOL TARTRATE",
    "NOM_COMMERCIALE": "LOPROX",
    "FORME": "COMP PELL SEC LP",
    "DOSAGE": "200MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NEOMEDIC SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/12/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "22/12/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["metoprolol"],
    "InteractionIndexLink": ["metoprolol"],
    "N_ENREGISTREMENT": "263 / 06 F 071 /19",
    "CODE_DCI": "06 F 071",
    "DCI": "Metoprolol tartrate",
    "NOM_COMMERCIALE": "LORESTA",
    "FORME": "COMP. SEC. LP",
    "DOSAGE": "200MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOPHARM SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "21/1/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "21/1/2019",
    "TYPE": "Gé",
    "STATUT": "F premix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["metoprolol"],
    "InteractionIndexLink": ["metoprolol"],
    "N_ENREGISTREMENT": "012/ 06 F 071 /99/14",
    "CODE_DCI": "06 F 071",
    "DCI": "Metoprolol tartrate",
    "NOM_COMMERCIALE": "METOCROVIS",
    "FORME": "COMPRIME A LIBERATION PROLONGEE",
    "DOSAGE": "200MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CROVIS PHILCOM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ITALIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/11/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "22/6/2014",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["metoprolol"],
    "InteractionIndexLink": ["metoprolol"],
    "N_ENREGISTREMENT": "289 / 06 F 071 /15",
    "CODE_DCI": "06 F 071",
    "DCI": "METOPROLOL SUCCINATE EXPRIME EN METOPROLOL",
    "NOM_COMMERCIALE": "METOPRESS",
    "FORME": "microgranulés a LP EN gélules",
    "DOSAGE": "200MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRATER RAZES FORME SECHE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/10/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "26/10/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["metoprolol"],
    "InteractionIndexLink": ["metoprolol"],
    "N_ENREGISTREMENT": "574/06 F 071/20",
    "CODE_DCI": "06 F 071",
    "DCI": "METOPROLOL TARTRATE",
    "NOM_COMMERCIALE": "SOPRESSOR",
    "FORME": "COMP. PELL. SEC. LP",
    "DOSAGE": "200MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "laboratoires SPA SOPROPHAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/12/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "29/12/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["propranolol"],
    "InteractionIndexLink": ["propranolol"],
    "N_ENREGISTREMENT": "242/ 06 F 073 /13",
    "CODE_DCI": "06 F 073",
    "DCI": "PROPRANOLOL CHLORHYDRATE",
    "NOM_COMMERCIALE": "FEDICARD",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "40MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GROUPE SANTE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/1/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "10/1/2013",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["propranolol"],
    "InteractionIndexLink": ["propranolol"],
    "N_ENREGISTREMENT": "418/ 06 F 073 /19",
    "CODE_DCI": "06 F 073",
    "DCI": "PROPRANOLOL CHLORHYDRATE",
    "NOM_COMMERCIALE": "NEOCARDIL",
    "FORME": "COMP.SEC",
    "DOSAGE": "40MG",
    "COND": "B/50",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NEOMEDIC SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/3/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "25/3/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["atenolol"],
    "InteractionIndexLink": ["atenolol"],
    "N_ENREGISTREMENT": "235/06 F 149/21",
    "CODE_DCI": "06 F 149",
    "DCI": "Aténolol",
    "NOM_COMMERCIALE": "CARDINOL BGL",
    "FORME": "Comprimé pelliculé sécable",
    "DOSAGE": "50MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOGALENIC / SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/3/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "28/3/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["atenolol"],
    "InteractionIndexLink": ["atenolol"],
    "N_ENREGISTREMENT": "518/06 F 149/17",
    "CODE_DCI": "06 F 149",
    "DCI": "ATENOLOL",
    "NOM_COMMERCIALE": "DAGHTAN 50",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "50MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "TAPHCO SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/5/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "28/5/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["bisoprolol"],
    "InteractionIndexLink": ["bisoprolol"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "06 F 162",
    "DCI": "BISOPROLOL FUMARATE",
    "NOM_COMMERCIALE": "BIPROTENS",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["bisoprolol"],
    "InteractionIndexLink": ["bisoprolol"],
    "N_ENREGISTREMENT": "447/ 06 F 162 /14/19",
    "CODE_DCI": "06 F 162",
    "DCI": "BISOPROLOL FUMARATE",
    "NOM_COMMERCIALE": "BISOPROLOL BEKER",
    "FORME": "COMP PELL SEC",
    "DOSAGE": "10MG",
    "COND": "B/30 ET B/90",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEKER SARL (SARL LABORATOIRE BEKER ALGERIE)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/7/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "27/1/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["bisoprolol"],
    "InteractionIndexLink": ["bisoprolol"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "06 F 162",
    "DCI": "BISOPROLOL FUMARATE",
    "NOM_COMMERCIALE": "BISOPROLOL HUP",
    "FORME": "COMP. PELLI. SEC.",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["bisoprolol"],
    "InteractionIndexLink": ["bisoprolol"],
    "N_ENREGISTREMENT": "470/ 06 F 162 /13/19",
    "CODE_DCI": "06 F 162",
    "DCI": "BISOPROLOL FUMARATE",
    "NOM_COMMERCIALE": "BISOPROLOL MM",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MM (SARL LABORATOIRES MM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/1/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "20/5/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["bisoprolol"],
    "InteractionIndexLink": ["bisoprolol"],
    "N_ENREGISTREMENT": "173/06 F 162/20",
    "CODE_DCI": "06 F 162",
    "DCI": "BISOPROLOL FUMARATE",
    "NOM_COMMERCIALE": "BISOTAB",
    "FORME": "COMP PELL SEC",
    "DOSAGE": "5MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "TABUK ALGERIE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "11/2/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "11/2/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["bisoprolol"],
    "InteractionIndexLink": ["bisoprolol"],
    "N_ENREGISTREMENT": "173/06 F 162/20",
    "CODE_DCI": "06 F 162",
    "DCI": "BISOPROLOL FUMARATE",
    "NOM_COMMERCIALE": "BISOTAB",
    "FORME": "COMP PELL SEC",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "TABUK ALGERIE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "11/2/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "11/2/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["bisoprolol"],
    "InteractionIndexLink": ["bisoprolol"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "06 F 162",
    "DCI": "BISOPROLOL FUMARATE",
    "NOM_COMMERCIALE": "BONACOR",
    "FORME": "COMP. PELLI SEC.",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["bisoprolol"],
    "InteractionIndexLink": ["bisoprolol"],
    "N_ENREGISTREMENT": "268/ 06 F 162 /12",
    "CODE_DCI": "06 F 162",
    "DCI": "BISOPROLOL FUMARATE",
    "NOM_COMMERCIALE": "BYZOLEX",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MERINAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "23/4/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "23/4/2012",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["bisoprolol"],
    "InteractionIndexLink": ["bisoprolol"],
    "N_ENREGISTREMENT": "263/ 06 F 162 /15",
    "CODE_DCI": "06 F 162",
    "DCI": "BISOPROLOL FUMARATE",
    "NOM_COMMERCIALE": "CIRBESA",
    "FORME": "COMPRIME",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOPHARM SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/2/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "6/10/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["bisoprolol"],
    "InteractionIndexLink": ["bisoprolol"],
    "N_ENREGISTREMENT": "426/ 06 F 162 /13",
    "CODE_DCI": "06 F 162",
    "DCI": "BISOPROLOL FUMARATE",
    "NOM_COMMERCIALE": "DETENPRESS",
    "FORME": "COMP. PELLI. SEC.",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ABDI IBRAHIM REMEDE PHARMA SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/6/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "25/6/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["bisoprolol"],
    "InteractionIndexLink": ["bisoprolol"],
    "N_ENREGISTREMENT": "097/ 06 F 162 /09/15",
    "CODE_DCI": "06 F 162",
    "DCI": "BISOPROLOL FUMARATE",
    "NOM_COMMERCIALE": "DIPROLOL",
    "FORME": "COMP PELL SEC",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL SANAMED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/2/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "3/12/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["bisoprolol"],
    "InteractionIndexLink": ["bisoprolol"],
    "N_ENREGISTREMENT": "035/ 06 F 162 /13",
    "CODE_DCI": "06 F 162",
    "DCI": "BISOPROLOL FUMARATE",
    "NOM_COMMERCIALE": "PRODOL",
    "FORME": "COMP. PELLI. SEC.",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMALLIANCE EURL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/5/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "12/5/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["bisoprolol"],
    "InteractionIndexLink": ["bisoprolol"],
    "N_ENREGISTREMENT": "055/ 06 F 162 /18",
    "CODE_DCI": "06 F 162",
    "DCI": "BISOPROLOL FUMARATE",
    "NOM_COMMERCIALE": "PROMIVOL",
    "FORME": "COMP.PELLI SEC.",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "DAR AL DAWA DEVELOPMENT & INVESTMENT Co Ltd",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "31/5/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "31/5/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["bisoprolol"],
    "InteractionIndexLink": ["bisoprolol"],
    "N_ENREGISTREMENT": "544 / 06 F 162 /18",
    "CODE_DCI": "06 F 162",
    "DCI": "BISOPROLOL FUMARATE",
    "NOM_COMMERCIALE": "RIZOPROL",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "WORLD MEDECINE LIMITED SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/8/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "20/8/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["metoprolol"],
    "InteractionIndexLink": ["metoprolol"],
    "N_ENREGISTREMENT": "097/ 06 F 204 /05/14",
    "CODE_DCI": "06 F 204",
    "DCI": "Metoprolol tartrate",
    "NOM_COMMERCIALE": "LOPRESS",
    "FORME": "COMP.PELLI. QUADRISECABLE",
    "DOSAGE": "100MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMALLIANCE EURL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/6/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "26/6/2019",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["metoprolol"],
    "InteractionIndexLink": ["metoprolol"],
    "N_ENREGISTREMENT": "035/ 06 F 204 /19",
    "CODE_DCI": "06 F 204",
    "DCI": "Metoprolol tartrate",
    "NOM_COMMERCIALE": "PROSSOR",
    "FORME": "COMP.PELLI. SECABLE",
    "DOSAGE": "100MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANAMED SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/2/2005",
    "DATE_D_ENREGISTREMENT_FINAL": "18/11/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["metoprolol"],
    "InteractionIndexLink": ["metoprolol"],
    "N_ENREGISTREMENT": "242/06 F 204/19",
    "CODE_DCI": "06 F 204",
    "DCI": "METOPROLOL SUCCINATE",
    "NOM_COMMERCIALE": "TOLOL",
    "FORME": "GLES LP A MICROGRANULES",
    "DOSAGE": "100MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GROUPE SANTE SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "11/12/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "11/12/2019",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["carvedilol"],
    "InteractionIndexLink": ["carvedilol"],
    "N_ENREGISTREMENT": "380/06 F 208/19",
    "CODE_DCI": "06 F 208",
    "DCI": "CARVEDILOL",
    "NOM_COMMERCIALE": "CARDEX",
    "FORME": "COMP SEC",
    "DOSAGE": "6.25MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HUP.P.PHARMA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/11/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "25/11/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["carvedilol"],
    "InteractionIndexLink": ["carvedilol"],
    "N_ENREGISTREMENT": "309/ 06 F 208 /07/13",
    "CODE_DCI": "06 F 208",
    "DCI": "CARVEDILOL",
    "NOM_COMMERCIALE": "CARVEDILOL LDM",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "6.25MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES  DE DIAGNOSTICS MAGHREBINS (LDM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/9/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "15/9/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["carvedilol"],
    "InteractionIndexLink": ["carvedilol"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "06 F 208",
    "DCI": "CARVEDILOL",
    "NOM_COMMERCIALE": "DILACARD",
    "FORME": "COMPRIME",
    "DOSAGE": "6.25MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["carvedilol"],
    "InteractionIndexLink": ["carvedilol"],
    "N_ENREGISTREMENT": "309/ 06 F 209 /07/13",
    "CODE_DCI": "06 F 209",
    "DCI": "CARVEDILOL",
    "NOM_COMMERCIALE": "CARVEDILOL LDM",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "25MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES  DE DIAGNOSTICS MAGHREBINS (LDM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/9/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "20/1/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["carvedilol"],
    "InteractionIndexLink": ["carvedilol"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "06 F 209",
    "DCI": "CARVEDILOL",
    "NOM_COMMERCIALE": "DILACARD",
    "FORME": "COMPRIME",
    "DOSAGE": "25MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["carvedilol"],
    "InteractionIndexLink": ["carvedilol"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "06 F 250",
    "DCI": "CARVEDILOL",
    "NOM_COMMERCIALE": "DILACARD",
    "FORME": "COMPRIME",
    "DOSAGE": "12.5MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["carvedilol"],
    "InteractionIndexLink": ["carvedilol"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "06 F 252",
    "DCI": "CARVEDILOL",
    "NOM_COMMERCIALE": "DILACARD",
    "FORME": "COMPRIME",
    "DOSAGE": "3.125MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["bisoprolol"],
    "InteractionIndexLink": ["bisoprolol"],
    "N_ENREGISTREMENT": "352/ 06 F 267 /12/17",
    "CODE_DCI": "06 F 267",
    "DCI": "BISOPROLOL FUMARATE",
    "NOM_COMMERCIALE": "BIPROTENS",
    "FORME": "COMP.PELL.SEC",
    "DOSAGE": "5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/1/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "10/10/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "48MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["bisoprolol"],
    "InteractionIndexLink": ["bisoprolol"],
    "N_ENREGISTREMENT": "447/ 06 F 267 /14",
    "CODE_DCI": "06 F 267",
    "DCI": "BISOPROLOL FUMARATE",
    "NOM_COMMERCIALE": "BISOPROLOL BEKER",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "5MG",
    "COND": "B/30 ET B/90",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEKER SARL (SARL LABORATOIRE BEKER ALGERIE)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "8/6/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "27/1/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["bisoprolol"],
    "InteractionIndexLink": ["bisoprolol"],
    "N_ENREGISTREMENT": "19/16 F267/380",
    "CODE_DCI": "06 F 267",
    "DCI": "BISOPROLOL SOUS FORME D'HEMIFUMARATE",
    "NOM_COMMERCIALE": "BISOPROLOL HUP",
    "FORME": "COMP",
    "DOSAGE": "5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "laboratoires HUP.P PHARMA Sarl",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["bisoprolol"],
    "InteractionIndexLink": ["bisoprolol"],
    "N_ENREGISTREMENT": "470/06 F 267/16",
    "CODE_DCI": "06 F 267",
    "DCI": "BISOPROLOL FUMARATE",
    "NOM_COMMERCIALE": "BISOPROLOL MM",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL LABORATOIRES MM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/10/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "19/10/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["bisoprolol"],
    "InteractionIndexLink": ["bisoprolol"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "06 F 267",
    "DCI": "BISOPROLOL FUMARATE",
    "NOM_COMMERCIALE": "BISOTAB",
    "FORME": "COMP PELL SEC",
    "DOSAGE": "5MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["bisoprolol"],
    "InteractionIndexLink": ["bisoprolol"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "06 F 267",
    "DCI": "BISOPROLOL FUMARATE",
    "NOM_COMMERCIALE": "BONACOR",
    "FORME": "COMP. PELLI SEC.",
    "DOSAGE": "5MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["bisoprolol"],
    "InteractionIndexLink": ["bisoprolol"],
    "N_ENREGISTREMENT": "268/ 06 F 267 /19",
    "CODE_DCI": "06 F 267",
    "DCI": "BISOPROLOL S/F HEMIFUMARATE",
    "NOM_COMMERCIALE": "BYZOLEX",
    "FORME": "COMPRIME QUADRI-SECABLE",
    "DOSAGE": "5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MERINAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/6/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "2/6/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["bisoprolol"],
    "InteractionIndexLink": ["bisoprolol"],
    "N_ENREGISTREMENT": "263/ 06 F 267 /18",
    "CODE_DCI": "06 F 267",
    "DCI": "BISOPROLOL FUMARATE",
    "NOM_COMMERCIALE": "CIRBESA",
    "FORME": "COMP.PELL.SEC",
    "DOSAGE": "5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOPHARM / SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/5/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "30/5/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["bisoprolol"],
    "InteractionIndexLink": ["bisoprolol"],
    "N_ENREGISTREMENT": "097/ 06 F 267 /15",
    "CODE_DCI": "06 F 267",
    "DCI": "BISOPROLOL FUMARATE",
    "NOM_COMMERCIALE": "DIPROLOL",
    "FORME": "COMP. PELLI. SEC.",
    "DOSAGE": "5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANAMED SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/12/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "2/12/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["bisoprolol"],
    "InteractionIndexLink": ["bisoprolol"],
    "N_ENREGISTREMENT": "035/ 06 F 267 /13",
    "CODE_DCI": "06 F 267",
    "DCI": "BISOPROLOL FUMARATE",
    "NOM_COMMERCIALE": "PRODOL",
    "FORME": "COMP. PELLI. SEC.",
    "DOSAGE": "5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMALLIANCE EURL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/9/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "15/9/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["nebivolol"],
    "InteractionIndexLink": ["nebivolol"],
    "N_ENREGISTREMENT": "352/ 06 F 273 /18",
    "CODE_DCI": "06 F 273",
    "DCI": "NEBIVOLOL CHLORHYDRATE EXPRIME EN NEBIVOLOL",
    "NOM_COMMERCIALE": "NEBCAR",
    "FORME": "COMP. QUADRISEC.",
    "DOSAGE": "5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SPA EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/10/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "9/10/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["nebivolol"],
    "InteractionIndexLink": ["nebivolol"],
    "N_ENREGISTREMENT": "203/ 06 F 273 /09/17",
    "CODE_DCI": "06 F 273",
    "DCI": "NEBIVOLOL CHLORHYDRATE EXPRIME EN NEBIVOLOL",
    "NOM_COMMERCIALE": "TEMERIT",
    "FORME": "COMP. QUADRISEC.",
    "DOSAGE": "5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MENARINI INTERNATIONAL OPERATIONS Luxembourg SA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "Luxembourg",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/2/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "29/6/2017",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["nebivolol"],
    "InteractionIndexLink": ["nebivolol"],
    "N_ENREGISTREMENT": "18/06 F273/380",
    "CODE_DCI": "06 F 273",
    "DCI": "NEBIVOLOL",
    "NOM_COMMERCIALE": "TEMERIVOL",
    "FORME": "COMP QUADRISECABLES",
    "DOSAGE": "5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "laboratoires HUP.P PHARMA Sarl",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/06/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "18/06/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "bisoprolol"],
    "InteractionIndexLink": ["bisoprolol", "hydrochlorothiazide"],
    "N_ENREGISTREMENT": "352/ 06 F 299 /13/18",
    "CODE_DCI": "06 F 299",
    "DCI": "BISOPROLOL FUMARATE / HYDROCHLOROTHIAZIDE",
    "NOM_COMMERCIALE": "CO BIPROTENS",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "5MG/6.25MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/3/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "8/4/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "bisoprolol"],
    "InteractionIndexLink": ["bisoprolol", "hydrochlorothiazide"],
    "N_ENREGISTREMENT": "447/06 F 299/19",
    "CODE_DCI": "06 F 299",
    "DCI": "BISOPROLOL FUMARATE/HYDROCHLOROTHIAZIDE",
    "NOM_COMMERCIALE": "CO-BISOPROLOL BEKER",
    "FORME": "COMP PELL",
    "DOSAGE": "5MG/6.25MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEKER LABORATOIRES SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "3/12/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "3/12/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "bisoprolol"],
    "InteractionIndexLink": ["bisoprolol", "hydrochlorothiazide"],
    "N_ENREGISTREMENT": "352/ 06 F 302 /13/18",
    "CODE_DCI": "06 F 302",
    "DCI": "BISOPROLOL FUMARATE / HYDROCHLOROTHIAZIDE",
    "NOM_COMMERCIALE": "CO BIPROTENS",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "10MG/6.25MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/5/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "3/6/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "bisoprolol"],
    "InteractionIndexLink": ["bisoprolol", "hydrochlorothiazide"],
    "N_ENREGISTREMENT": "447/06 F 302/19",
    "CODE_DCI": "06 F 302",
    "DCI": "BISOPROLOL FUMARATE/HYDROCHLOROTHIAZIDE",
    "NOM_COMMERCIALE": "CO-BISOPROLOL BEKER",
    "FORME": "COMP PELL",
    "DOSAGE": "10MG/6.25MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEKER LABORATOIRES SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/12/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "30/12/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["metoprolol"],
    "InteractionIndexLink": ["metoprolol"],
    "N_ENREGISTREMENT": "289/ 06 F 309 /15",
    "CODE_DCI": "06 F 309",
    "DCI": "METOPROLOL SUCCINATE EXPRIME EN METOPROLOL",
    "NOM_COMMERCIALE": "METOPRESS",
    "FORME": "GLES. LP.",
    "DOSAGE": "100MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRATER RAZES FORME SECHE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "3/3/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "3/3/2015",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["nebivolol"],
    "InteractionIndexLink": ["nebivolol"],
    "N_ENREGISTREMENT": "352/ 06 F 323 /18",
    "CODE_DCI": "06 F 323",
    "DCI": "NEBIVOLOL CHLORHYDRATE EXPRIME EN NEBIVOLOL",
    "NOM_COMMERCIALE": "NEBCAR",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "2.5 MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SPA EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "11/11/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "11/11/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["bisoprolol"],
    "InteractionIndexLink": ["bisoprolol"],
    "N_ENREGISTREMENT": "17/12/06 F162/268",
    "CODE_DCI": "06 F162",
    "DCI": "BISOPROLOL SOUS FORME D'HEMIFUMARATE",
    "NOM_COMMERCIALE": "BYZOLEX",
    "FORME": "COMP.SEC.",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES MERINAL SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "23/04/12",
    "DATE_D_ENREGISTREMENT_FINAL": "23/10/17",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["digoxin and other cardiac glycosides"],
    "InteractionIndexLink": ["digoxine"],
    "N_ENREGISTREMENT": "286/ 06 G 079 /08/16",
    "CODE_DCI": "06 G 079",
    "DCI": "DIGOXINE",
    "NOM_COMMERCIALE": "DIGOXINE CPCM",
    "FORME": "COMPRIME",
    "DOSAGE": "0.25MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CHIMIE PHARMACIE COMMERCE MULTIPLE SARL (CPCM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/2/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "27/4/2016",
    "TYPE": "Gé",
    "STATUT": "C Iaire",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["digoxin and other cardiac glycosides"],
    "InteractionIndexLink": ["digoxine"],
    "N_ENREGISTREMENT": "065/ 06 G 079 /98/14",
    "CODE_DCI": "06 G 079",
    "DCI": "DIGOXINE",
    "NOM_COMMERCIALE": "NAGOXIN",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "0.25MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GENERICLAB SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/7/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "30/1/2014",
    "TYPE": "Gé",
    "STATUT": "C Iaire",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["digoxin and other cardiac glycosides"],
    "InteractionIndexLink": ["digoxine"],
    "N_ENREGISTREMENT": "455/ 06 G 080 /99/15",
    "CODE_DCI": "06 G 080",
    "DCI": "DIGOXINE",
    "NOM_COMMERCIALE": "XINECOR",
    "FORME": "SOL. BUV.",
    "DOSAGE": "0.05MG/ML",
    "COND": "FL./50ML + PIPETTE GRADUEE",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GENCOPHARM SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/11/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "19/10/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "402/06 G 324/19",
    "CODE_DCI": "06 G 324",
    "DCI": "LEVOSIMENDAN",
    "NOM_COMMERCIALE": "SIMDAX",
    "FORME": "CONCENTRE P/ SOL P/ PERF I.V",
    "DOSAGE": "2.5MG/ML",
    "COND": "B/01 FL DE 5ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ORION CORPORATION. ORION PHARMA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FINLANDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/7/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["acetazolamide"],
    "InteractionIndexLink": ["acetazolamide"],
    "N_ENREGISTREMENT": "242/ 06 H 084 /02/16",
    "CODE_DCI": "06 H 084",
    "DCI": "ACETAZOLAMIDE",
    "NOM_COMMERCIALE": "LYNOX",
    "FORME": "COMPRIME",
    "DOSAGE": "250MG",
    "COND": "B/20",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GROUPE SANTE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "16/10/2002",
    "DATE_D_ENREGISTREMENT_FINAL": "22/5/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["furosemide"],
    "InteractionIndexLink": ["furosemide"],
    "N_ENREGISTREMENT": "21/06 H087/317",
    "CODE_DCI": "06 H 087",
    "DCI": "FUROSEMIDE",
    "NOM_COMMERCIALE": "FUROLIX",
    "FORME": "SOL INJ IV/IM",
    "DOSAGE": "20MG/2ML",
    "COND": "B/05 AMP. DE 2ML",
    "LISTE": "LISTE II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INPHA MEDIS SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/04/21",
    "DATE_D_ENREGISTREMENT_FINAL": "22/04/21",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["furosemide"],
    "InteractionIndexLink": ["furosemide"],
    "N_ENREGISTREMENT": "21/06 H087/317",
    "CODE_DCI": "06 H 087",
    "DCI": "FUROSEMIDE",
    "NOM_COMMERCIALE": "FUROLIX",
    "FORME": "SOL INJ IV/IM",
    "DOSAGE": "20MG/2ML",
    "COND": "B/05 AMP. DE 2ML",
    "LISTE": "LISTE II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INPHA MEDIS SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/04/21",
    "DATE_D_ENREGISTREMENT_FINAL": "22/04/21",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["furosemide"],
    "InteractionIndexLink": ["furosemide"],
    "N_ENREGISTREMENT": "17/06 H087/380",
    "CODE_DCI": "06 H 087",
    "DCI": "FUROSEMIDE",
    "NOM_COMMERCIALE": "FUROSILIX",
    "FORME": "SOL INJ IV lente OU IM",
    "DOSAGE": "20MG/2ML",
    "COND": "1- B/5 AMPOULES DE 2ML 2- B/50 AMPOULES DE 2ML",
    "LISTE": "Liste I",
    "P1": "1- HOP 2- HOP",
    "P2": "1- OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "laboratoires HUP.P PHARMA Sarl",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "08/04/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "08/04/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["furosemide"],
    "InteractionIndexLink": ["furosemide"],
    "N_ENREGISTREMENT": "433/ 06 H 087 /15",
    "CODE_DCI": "06 H 087",
    "DCI": "FUROSEMIDE",
    "NOM_COMMERCIALE": "RAZOLIX",
    "FORME": "SOL. INJ. IV./IM.",
    "DOSAGE": "20MG/2ML",
    "COND": "B/05 AMP. DE 2ML ; B/50 AMP. DE 2ML",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "B/50 RESERVEE AUX HÔPITAUX",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRATER RAZES SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/9/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "22/4/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["furosemide"],
    "InteractionIndexLink": ["furosemide"],
    "N_ENREGISTREMENT": "380/ 06 H 090 /12/18",
    "CODE_DCI": "06 H 090",
    "DCI": "FUROSEMIDE",
    "NOM_COMMERCIALE": "FUROSEMIDE HUP",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "40MG",
    "COND": "B/20",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HUP.P.PHARMA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/11/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "8/4/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["furosemide"],
    "InteractionIndexLink": ["furosemide"],
    "N_ENREGISTREMENT": "003/ 06 H 090 /96/21",
    "CODE_DCI": "06 H 090",
    "DCI": "Furosémide",
    "NOM_COMMERCIALE": "FUROZAL",
    "FORME": "Comprimé  sécable",
    "DOSAGE": "40MG",
    "COND": "B/20",
    "LISTE": "LISTE II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EPE  GROUPE INDUSTRIEL SAIDAL /  SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/12/1996",
    "DATE_D_ENREGISTREMENT_FINAL": "10/2/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["furosemide"],
    "InteractionIndexLink": ["furosemide"],
    "N_ENREGISTREMENT": "242/06 H 090/20",
    "CODE_DCI": "06 H 090",
    "DCI": "FUROSEMIDE",
    "NOM_COMMERCIALE": "MEFDOL GS",
    "FORME": "COMP SEC",
    "DOSAGE": "40MG",
    "COND": "B/20",
    "LISTE": "LISTE II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GROUPE SANTE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/5/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "19/5/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["furosemide"],
    "InteractionIndexLink": ["furosemide"],
    "N_ENREGISTREMENT": "012/ 06 H 091 /99/13",
    "CODE_DCI": "06 H 091",
    "DCI": "FUROSEMIDE",
    "NOM_COMMERCIALE": "FUROSAN",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "500MG",
    "COND": "B/20",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FARMACEUTICI CROVIS PH. IL. COM SRL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ITALIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/11/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "21/10/2013",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["amiloride", "hydrochlorothiazide"],
    "InteractionIndexLink": ["amiloride", "hydrochlorothiazide"],
    "N_ENREGISTREMENT": "055/ 06 H 094 /98/12",
    "CODE_DCI": "06 H 094",
    "DCI": "AMILORIDE CHLORHYDRATE / HYDROCHLOROTHIAZIDE",
    "NOM_COMMERCIALE": "AMURETIC",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "5MG/50MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "DAR AL DAWA DEVELOPMENT & INVESTMENT Co Ltd",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/8/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "25/9/2012",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["amiloride", "hydrochlorothiazide"],
    "InteractionIndexLink": ["amiloride", "hydrochlorothiazide"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "06 H 094",
    "DCI": "AMILORIDE CHLORHYDRATE / HYDROCHLOROTHIAZIDE",
    "NOM_COMMERCIALE": "DUDREX",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "5MG/50MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["spironolactone"],
    "InteractionIndexLink": ["spironolactone"],
    "N_ENREGISTREMENT": "045/ 06 H 095 /97/16",
    "CODE_DCI": "06 H 095",
    "DCI": "SPIRONOLACTONE MICRONISEE",
    "NOM_COMMERCIALE": "ALDACTONE",
    "FORME": "COMP.PELLI.SEC.",
    "DOSAGE": "75MG",
    "COND": "B/30",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PFIZER HOLDING FRANCE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/8/1997",
    "DATE_D_ENREGISTREMENT_FINAL": "12/3/2017",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["spironolactone"],
    "InteractionIndexLink": ["spironolactone"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "06 H 095",
    "DCI": "SPIRONOLACTONE MICRONISEE",
    "NOM_COMMERCIALE": "SPIRONOLONE",
    "FORME": "COMP. PELLI. SEC.",
    "DOSAGE": "75MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["spironolactone"],
    "InteractionIndexLink": ["altizide", "spironolactone"],
    "N_ENREGISTREMENT": "045/06 H 096/97/16",
    "CODE_DCI": "06 H 096",
    "DCI": "SPIRONOLACTONE/ALTIZIDE",
    "NOM_COMMERCIALE": "ALDACTAZINE",
    "FORME": "COMP.PELLI.SEC.",
    "DOSAGE": "25MG/15MG",
    "COND": "B/30",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PFIZER HOLDING FRANCE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/8/1997",
    "DATE_D_ENREGISTREMENT_FINAL": "4/1/2017",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["spironolactone"],
    "InteractionIndexLink": ["altizide", "spironolactone"],
    "N_ENREGISTREMENT": "235/ 06 H 096 /13",
    "CODE_DCI": "06 H 096",
    "DCI": "SPIRONOLACTONE / ALTIZIDE",
    "NOM_COMMERCIALE": "SPIROZIDE",
    "FORME": "COMP. PELLI. SEC.",
    "DOSAGE": "25MG/15MG",
    "COND": "B/30",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIO-GALENIC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/4/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "24/4/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["indapamide"],
    "InteractionIndexLink": ["indapamide"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "06 H 163",
    "DCI": "INDAPAMIDE",
    "NOM_COMMERCIALE": "ADEX LP",
    "FORME": "COMP. PELLI. LP",
    "DOSAGE": "1.5MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["indapamide"],
    "InteractionIndexLink": ["indapamide"],
    "N_ENREGISTREMENT": "040/ 06 H 163 /03/15",
    "CODE_DCI": "06 H 163",
    "DCI": "INDAPAMIDE",
    "NOM_COMMERCIALE": "FLUDEX LP",
    "FORME": "COMP. PELLI. LP",
    "DOSAGE": "1.5MG",
    "COND": "B/30",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SERVIER",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/4/2003",
    "DATE_D_ENREGISTREMENT_FINAL": "26/7/2016",
    "TYPE": "Ré",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["indapamide"],
    "InteractionIndexLink": ["indapamide"],
    "N_ENREGISTREMENT": "352/ 06 H 163 /09/20",
    "CODE_DCI": "06 H 163",
    "DCI": "Indapamide",
    "NOM_COMMERCIALE": "FLUMIDE   LP",
    "FORME": "Comprimé pelliculé à libération prolongée",
    "DOSAGE": "1.5MG",
    "COND": "B/30",
    "LISTE": "LISTE II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT / SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/10/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "15/2/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["indapamide"],
    "InteractionIndexLink": ["indapamide"],
    "N_ENREGISTREMENT": "352/06 H 163/09/20",
    "CODE_DCI": "06 H 163",
    "DCI": "INDAPAMIDE",
    "NOM_COMMERCIALE": "FLUMIDE LP",
    "FORME": "COMP. PELL. LP",
    "DOSAGE": "1.5MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SPA/ EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/10/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "29/12/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["indapamide"],
    "InteractionIndexLink": ["indapamide"],
    "N_ENREGISTREMENT": "352/ 06 H 163 /09/20",
    "CODE_DCI": "06 H 163",
    "DCI": "Indapamide",
    "NOM_COMMERCIALE": "FLUMIDE LP",
    "FORME": "Comprimé pelliculé à libération prolongée",
    "DOSAGE": "1.5MG",
    "COND": "B/30",
    "LISTE": "LISTE II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT / SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/10/09",
    "DATE_D_ENREGISTREMENT_FINAL": "15/02/21",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["indapamide"],
    "InteractionIndexLink": ["indapamide"],
    "N_ENREGISTREMENT": "447/ 06 H 163 /14/20",
    "CODE_DCI": "06 H 163",
    "DCI": "INDAPAMIDE",
    "NOM_COMMERCIALE": "INDAPAMIDE BEKER",
    "FORME": "COMP. PELLI. LP",
    "DOSAGE": "1.5MG",
    "COND": "B/30 ET B/90",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEKER SARL (SARL LABORATOIRE BEKER ALGERIE)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/4/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "19/5/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "06 H 163",
    "DCI": "Flumide LP",
    "NOM_COMMERCIALE": "Indapamide",
    "FORME": "Comprimé pelliculé LP",
    "DOSAGE": "1.5mg",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "447/ 06 J 100 /14",
    "CODE_DCI": "06 J 100",
    "DCI": "NAFTIDROFURYL HYDROGENO-OXALATE",
    "NOM_COMMERCIALE": "NAFTILENE",
    "FORME": "GLES",
    "DOSAGE": "100MG",
    "COND": "B/30 ET B/90",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEKER SARL (SARL LABORATOIRE BEKER ALGERIE)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/6/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "1/6/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "062/ 06 J 100 /97/16",
    "CODE_DCI": "06 J 100",
    "DCI": "NAFTIDROFURYL",
    "NOM_COMMERCIALE": "PRAXILENE",
    "FORME": "GLES.",
    "DOSAGE": "100MG",
    "COND": "B/20",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MERCK SANTE SAS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/8/1997",
    "DATE_D_ENREGISTREMENT_FINAL": "2/2/2016",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "16/06 J 101/235",
    "CODE_DCI": "06 J 101",
    "DCI": "NAFTIDROFURYL HYDROGENO-OXALATE",
    "NOM_COMMERCIALE": "NAFRONYL LP",
    "FORME": "COMP. PELL. LP",
    "DOSAGE": "200MG",
    "COND": "B/20",
    "LISTE": "LISTE II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES BIOGALENIC SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "05/09/16",
    "DATE_D_ENREGISTREMENT_FINAL": "05/09/16",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "418/ 06 J 101 /11/19",
    "CODE_DCI": "06 J 101",
    "DCI": "NAFTIDROFURYL HYDROGENO-OXALATE",
    "NOM_COMMERCIALE": "NAFTIRETARD LP",
    "FORME": "CP PELL. LP",
    "DOSAGE": "200MG",
    "COND": "B/20",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NEOMEDIC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/7/2011",
    "DATE_D_ENREGISTREMENT_FINAL": "29/4/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["pentoxifylline"],
    "InteractionIndexLink": ["pentoxifylline"],
    "N_ENREGISTREMENT": "380/06 J 105/17",
    "CODE_DCI": "06 J 105",
    "DCI": "PENTOXIFYLLINE",
    "NOM_COMMERCIALE": "PENTORENTAL",
    "FORME": "COMP. PELLI. LP",
    "DOSAGE": "400MG",
    "COND": "B/20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HUP.P.PHARMA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/5/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "28/5/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["ticlopidine"],
    "InteractionIndexLink": ["ticlopidine"],
    "N_ENREGISTREMENT": "376/ 06 J 106 /97/16",
    "CODE_DCI": "06 J 106",
    "DCI": "TICLOPIDINE   (SOUS FORME DE CHLORHYDRATE)",
    "NOM_COMMERCIALE": "TICLID",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "250MG",
    "COND": "B/20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANOFI AVENTIS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "8/11/1997",
    "DATE_D_ENREGISTREMENT_FINAL": "6/3/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "06 J 107",
    "DCI": "TRIMETAZIDINE DICHLORHYDRATE",
    "NOM_COMMERCIALE": "TRIMETAZIDINE B",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "20MG",
    "COND": "B/60",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "06 J 107",
    "DCI": "TRIMETAZIDINE DICHLORHYDRATE",
    "NOM_COMMERCIALE": "VASTOR",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "20MG",
    "COND": "B/60",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "06 J 107",
    "DCI": "TRIMETAZIDINE DICHLORHYDRATE",
    "NOM_COMMERCIALE": "VEINOTREL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "20MG",
    "COND": "B/60",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["clopidogrel"],
    "InteractionIndexLink": ["clopidogrel"],
    "N_ENREGISTREMENT": "039/ 06 J 159 /13",
    "CODE_DCI": "06 J 159",
    "DCI": "CLOPIDOGREL HYDROGENOSULFATE EXPRIME EN CLOPIDOGREL",
    "NOM_COMMERCIALE": "CLODIPRAL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "75MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOCIETE PHARMACEUTIQUE ALGERIENNE (SOPHAL)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/10/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "20/10/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["clopidogrel"],
    "InteractionIndexLink": ["clopidogrel"],
    "N_ENREGISTREMENT": "309/ 06 J 159/ 13",
    "CODE_DCI": "06 J 159",
    "DCI": "CLOPIDOGREL HYDROGENOSULFATE EXPRIME EN CLOPIDOGREL",
    "NOM_COMMERCIALE": "CLOPIDOGREL LDM",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "75MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES  DE DIAGNOSTIC MAGHREBINS (LDM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/12/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "2/12/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["clopidogrel"],
    "InteractionIndexLink": ["clopidogrel"],
    "N_ENREGISTREMENT": "149/ 06 J 159 /14",
    "CODE_DCI": "06 J 159",
    "DCI": "CLOPIDOGREL HYDROGENE EXPRIME EN CLOPIDOGREL",
    "NOM_COMMERCIALE": "CLOPIDOGREL NOVAGENERICS",
    "FORME": "MICROGRANULES EN GLES",
    "DOSAGE": "75MG",
    "COND": "PILULIER/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVAPHARM TRADING SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/4/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "15/4/2014",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["clopidogrel"],
    "InteractionIndexLink": ["clopidogrel"],
    "N_ENREGISTREMENT": "035/ 06 J 159 /09/15",
    "CODE_DCI": "06 J 159",
    "DCI": "CLOPIDOGREL HYDROGENOSULFATE EXPRIME EN CLOPIDOGREL",
    "NOM_COMMERCIALE": "DAZIL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "75MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMALLIANCE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/7/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "26/10/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["clopidogrel"],
    "InteractionIndexLink": ["clopidogrel"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "06 J 159",
    "DCI": "CLOPIDOGREL HYDROGENOSULFATE EXPRIME EN CLOPIDOGREL",
    "NOM_COMMERCIALE": "PIDOGREL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "75MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["clopidogrel"],
    "InteractionIndexLink": ["clopidogrel"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "06 J 159",
    "DCI": "CLOPIDOGREL HYDROGENOSULFATE EXPRIME EN CLOPIDOGREL",
    "NOM_COMMERCIALE": "PLAGREL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "75MG",
    "COND": "B/28",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["clopidogrel"],
    "InteractionIndexLink": ["clopidogrel"],
    "N_ENREGISTREMENT": "392/06 J 159/16",
    "CODE_DCI": "06 J 159",
    "DCI": "CLOPIDOGREL HYDROGENOSULFATE EXPRIME EN CLOPIDOGREL",
    "NOM_COMMERCIALE": "PLAVIX",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "75 MG",
    "COND": "B/28",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANOFI-AVENTIS ALGERIE SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/09/02",
    "DATE_D_ENREGISTREMENT_FINAL": "26/05/21",
    "TYPE": "Gé",
    "STATUT": "Fpremix",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "06 J 226",
    "DCI": "TRIMETAZIDINE DICHLORHYDRATE",
    "NOM_COMMERCIALE": "RIMETAZE LM",
    "FORME": "COMP. PELLI. LM",
    "DOSAGE": "35MG",
    "COND": "B/60",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "040/ 06 J 226 /07/18",
    "CODE_DCI": "06 J 226",
    "DCI": "TRIMETAZIDINE DICHLORHYDRATE",
    "NOM_COMMERCIALE": "VASTAREL",
    "FORME": "COMP. PELLI. LM",
    "DOSAGE": "35MG",
    "COND": "B/60",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SERVIER ( LDM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/3/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "1/4/2018",
    "TYPE": "Ré",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["clopidogrel"],
    "InteractionIndexLink": ["clopidogrel"],
    "N_ENREGISTREMENT": "512/06 J 313/16",
    "CODE_DCI": "06 J 313",
    "DCI": "CLOPIDOGREL HYDROGENOSULFATE EXPRIME EN CLOPIDOGREL",
    "NOM_COMMERCIALE": "PLAVIX",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "300 MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANOFI CLIR SNC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "5/3/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "5/3/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "077/ 06 K 108 /07/16",
    "CODE_DCI": "06 K 108",
    "DCI": "DIOSMINE",
    "NOM_COMMERCIALE": "LAMOVEN",
    "FORME": "COMPRIME",
    "DOSAGE": "300MG",
    "COND": "B/20",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE ALGERIEN DU MEDICAMENT (LAM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/12/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "17/4/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "450/ 06 K 160 /07/12",
    "CODE_DCI": "06 K 160",
    "DCI": "DIOSMINE",
    "NOM_COMMERCIALE": "DIOSMINE MYLAN",
    "FORME": "COMPRIME",
    "DOSAGE": "600MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MYLAN SAS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/4/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "10/12/2012",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "318/06 K 160/20",
    "CODE_DCI": "06 K 160",
    "DCI": "DIOSMINE",
    "NOM_COMMERCIALE": "DIOSMINE NS",
    "FORME": "COMP. PELL.",
    "DOSAGE": "600MG",
    "COND": "B/ 30",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES PHARMIDAL/NS SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "16/12/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "16/12/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "211/ 06 K 193 /02/16",
    "CODE_DCI": "06 K 193",
    "DCI": "HYDROSMINE",
    "NOM_COMMERCIALE": "VENOSMIL",
    "FORME": "GLES",
    "DOSAGE": "200MG",
    "COND": "B/60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FAES",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ESPAGNE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/2/2002",
    "DATE_D_ENREGISTREMENT_FINAL": "27/2/2017",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "60 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "040/ 06 K 199 /04/16",
    "CODE_DCI": "06 K 199",
    "DCI": "FRACTION FLAVONOIQUE PURIFIEE MICRONISEE (SOIT EN DIOSMINE ET FLAVONOIDES EXPRIMES EN  HESPERIDINE)",
    "NOM_COMMERCIALE": "DAFLON",
    "FORME": "COMP. ENRO.",
    "DOSAGE": "500MG (450MG EN DIOSMINE ET 50MG EN FLAVONOIDES EXPRIMES EN HESPERIDINE)",
    "COND": "B/15  ET  B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SERVIER",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/1/2004",
    "DATE_D_ENREGISTREMENT_FINAL": "5/3/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "149/ 06 K 199 /21",
    "CODE_DCI": "06 K 199",
    "DCI": "Fraction flavonoïque purifiée micronisée  correspondant à: Diosmine 90% et Flavonoïdes exprimés en Hespéridine 10%",
    "NOM_COMMERCIALE": "FLAVON",
    "FORME": "Comprimé pelliculé",
    "DOSAGE": "500MG (450MG EN DIOSMINE ET 50MG EN FLAVONOIDES EXPRIMES EN HESPERIDINE)",
    "COND": "B/15  ET  B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVAPHARM TRADING / SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/2/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "7/2/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["ginkgo"],
    "N_ENREGISTREMENT": "520/ 06 K 255 /97/16",
    "CODE_DCI": "06 K 255",
    "DCI": "GINKGO BILOBA.EXTRAIT STANDARTISE TITRE A 24% D'HETEROSIDES DE GINKGO ET DE 6% DE GINKGOLIDES-BILOBALIDE / HEPTAMINOL (SOUS FORME DE CHLORHYDRATE) / TROXERUTINE",
    "NOM_COMMERCIALE": "GINKOR FORT",
    "FORME": "GLES.",
    "DOSAGE": "0.014G/0.3G/0.3G",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "TONIPHARM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/3/1997",
    "DATE_D_ENREGISTREMENT_FINAL": "5/3/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["fenofibrate"],
    "InteractionIndexLink": ["fenofibrate"],
    "N_ENREGISTREMENT": "380/ 06 M 120 /12",
    "CODE_DCI": "06 M 120",
    "DCI": "FENOFIBRATE (MICRONISE)",
    "NOM_COMMERCIALE": "FENOFIBRATE HUP",
    "FORME": "GLES.",
    "DOSAGE": "200MG",
    "COND": "B/30",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HUP.P.PHARMA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "8/5/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "8/5/2012",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["fenofibrate"],
    "InteractionIndexLink": ["fenofibrate"],
    "N_ENREGISTREMENT": "003/ 06 M 120 /09/16",
    "CODE_DCI": "06 M 120",
    "DCI": "FENOFIBRATE MICRONISE",
    "NOM_COMMERCIALE": "LIPOCARD",
    "FORME": "GLES.",
    "DOSAGE": "200MG",
    "COND": "B/30",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EPE GROUPE INDUSTRIEL SAIDAL/SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/7/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "8/5/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["fenofibrate"],
    "InteractionIndexLink": ["fenofibrate"],
    "N_ENREGISTREMENT": "289/ 06 M 120 /07/17",
    "CODE_DCI": "06 M 120",
    "DCI": "FENOFIBRATE",
    "NOM_COMMERCIALE": "LIPOFIBRATE",
    "FORME": "GLES.",
    "DOSAGE": "200MG",
    "COND": "B/30",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRATER RAZES FORME SECHE SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/9/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "26/11/2017",
    "TYPE": "Gé",
    "STATUT": "F PREMIX",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["pravastatin"],
    "InteractionIndexLink": ["pravastatine"],
    "N_ENREGISTREMENT": "285/ 06 M 134 /01/17",
    "CODE_DCI": "06 M 134",
    "DCI": "PRAVASTATINE (SOUS FORME SODIQUE)",
    "NOM_COMMERCIALE": "ELISOR",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "20MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "UNION PHARMACEUTIQUE  CONSTANTINOISE SARL (UPC)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "11/9/2001",
    "DATE_D_ENREGISTREMENT_FINAL": "3/8/2017",
    "TYPE": "Ré",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["pravastatin"],
    "InteractionIndexLink": ["pravastatine"],
    "N_ENREGISTREMENT": "352/ 06 M 134 /12",
    "CODE_DCI": "06 M 134",
    "DCI": "PRAVASTATINE SODIQUE",
    "NOM_COMMERCIALE": "PRASIVAST",
    "FORME": "COMPRIME",
    "DOSAGE": "20MG",
    "COND": "PILULIER DE 30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/2/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "15/2/2012",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["simvastatin"],
    "InteractionIndexLink": ["simvastatine"],
    "N_ENREGISTREMENT": "268/ 06 M 136 /07/18",
    "CODE_DCI": "06 M 136",
    "DCI": "SIMVASTATINE",
    "NOM_COMMERCIALE": "KOLESTINE 20",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "20MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MERINAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/5/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "8/4/2018",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["simvastatin"],
    "InteractionIndexLink": ["simvastatine"],
    "N_ENREGISTREMENT": "293/ 06 M 136 /11",
    "CODE_DCI": "06 M 136",
    "DCI": "SIMVASTATINE",
    "NOM_COMMERCIALE": "SIMVASTATINE BIOCARE",
    "FORME": "GLES.A  µGRLES.",
    "DOSAGE": "20MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOCARE SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/3/2011",
    "DATE_D_ENREGISTREMENT_FINAL": "1/3/2011",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["simvastatin"],
    "InteractionIndexLink": ["simvastatine"],
    "N_ENREGISTREMENT": "309/ 06 M 136 /07/13",
    "CODE_DCI": "06 M 136",
    "DCI": "SIMVASTATINE",
    "NOM_COMMERCIALE": "SIMVASTATINE LDM",
    "FORME": "COMP. PELLI. SEC.",
    "DOSAGE": "20MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES  DE DIAGNOSTIC MAGHREBINS (LDM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/3/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "11/6/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["simvastatin"],
    "InteractionIndexLink": ["simvastatine"],
    "N_ENREGISTREMENT": "428/ 06 M 136 /14",
    "CODE_DCI": "06 M 136",
    "DCI": "SIMVASTATINE",
    "NOM_COMMERCIALE": "SIMVASTATINE WINTHROP",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "20MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "WINTHROP PHARMA SAIDAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "21/1/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "21/1/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["simvastatin"],
    "InteractionIndexLink": ["simvastatine"],
    "N_ENREGISTREMENT": "001/ 06 M 136 /00/13",
    "CODE_DCI": "06 M 136",
    "DCI": "SIMVASTATINE",
    "NOM_COMMERCIALE": "SIVACOR",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "20MG",
    "COND": "B/10 ET B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMA ALGERIA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/7/2000",
    "DATE_D_ENREGISTREMENT_FINAL": "24/4/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["simvastatin"],
    "InteractionIndexLink": ["simvastatine"],
    "N_ENREGISTREMENT": "447/ 06 M 136 /09/18",
    "CODE_DCI": "06 M 136",
    "DCI": "SIMVASTATINE",
    "NOM_COMMERCIALE": "SOCOB",
    "FORME": "COMP. PELLI. SEC.",
    "DOSAGE": "20MG",
    "COND": "B/30 ET B/90",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEKER SARL (SARL LABORATOIRE BEKER ALGERIE)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/9/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "1/4/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["simvastatin"],
    "InteractionIndexLink": ["simvastatine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "06 M 136",
    "DCI": "Simvastatine",
    "NOM_COMMERCIALE": "Vasta",
    "FORME": "Comprimé pelliculé",
    "DOSAGE": "20mg",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["simvastatin"],
    "InteractionIndexLink": ["simvastatine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "06 M 136",
    "DCI": "Simvastatine",
    "NOM_COMMERCIALE": "Zostine",
    "FORME": "Comprimé pelliculé",
    "DOSAGE": "20 mg",
    "COND": "Boite 30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["fluvastatin"],
    "InteractionIndexLink": ["fluvastatine"],
    "N_ENREGISTREMENT": "447/ 06 M 151 /13/18",
    "CODE_DCI": "06 M 151",
    "DCI": "Fluvastatine sodique exprimé en Fluvastatine",
    "NOM_COMMERCIALE": "COLESTOR",
    "FORME": "Gélule",
    "DOSAGE": "40MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEKER / SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/9/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "31/3/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["fluvastatin"],
    "InteractionIndexLink": ["fluvastatine"],
    "N_ENREGISTREMENT": "309/ 06 M 151 /14",
    "CODE_DCI": "06 M 151",
    "DCI": "FLUVASTATINE SODIQUE",
    "NOM_COMMERCIALE": "FLUVASTATINE LDM",
    "FORME": "GLES.",
    "DOSAGE": "40MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES DE DIAGNOSTIC MAGHREBINS (LDM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/11/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "13/11/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["fluvastatin"],
    "InteractionIndexLink": ["fluvastatine"],
    "N_ENREGISTREMENT": "068/ 06 M 151 /00/13",
    "CODE_DCI": "06 M 151",
    "DCI": "FLUVASTATINE SODIQUE EXRIME EN FLUVASTATINE",
    "NOM_COMMERCIALE": "LESCOL",
    "FORME": "GLES.",
    "DOSAGE": "40MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVARTIS PHARMA SCHWEIZ AG",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SUISSE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/6/2000",
    "DATE_D_ENREGISTREMENT_FINAL": "2/4/2013",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["fluvastatin"],
    "InteractionIndexLink": ["fluvastatine"],
    "N_ENREGISTREMENT": "418/ 06 M 151 /21",
    "CODE_DCI": "06 M 151",
    "DCI": "Fluvastatine sodique exprimé en Fluvastatine",
    "NOM_COMMERCIALE": "LUVASCOL",
    "FORME": "Gélule",
    "DOSAGE": "40MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NEOMEDIC / SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "31/3/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "31/3/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["atorvastatin"],
    "InteractionIndexLink": ["atorvastatine"],
    "N_ENREGISTREMENT": "352/ 06 M 198 /12",
    "CODE_DCI": "06 M 198",
    "DCI": "ATORVASTATINE CALCIQUE TRIHYDRATEE EXPRIME EN ATORVASTATINE",
    "NOM_COMMERCIALE": "AROVAN",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/9/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "25/9/2012",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["atorvastatin"],
    "InteractionIndexLink": ["atorvastatine"],
    "N_ENREGISTREMENT": "317/06 M 198/10/16",
    "CODE_DCI": "06 M 198",
    "DCI": "ATORVASTATINE CALCIQUE TRIHYDRATEE EXPRIME EN ATORVASTATINE",
    "NOM_COMMERCIALE": "ATOR 10MG",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "10MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INPHA-MEDIS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/5/2010",
    "DATE_D_ENREGISTREMENT_FINAL": "9/11/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["atorvastatin"],
    "InteractionIndexLink": ["atorvastatine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "06 M 198",
    "DCI": "Atorvastatine",
    "NOM_COMMERCIALE": "ATOR 10mg",
    "FORME": "comp pel",
    "DOSAGE": "10mg/comp",
    "COND": "bt de 28",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["atorvastatin"],
    "InteractionIndexLink": ["atorvastatine"],
    "N_ENREGISTREMENT": "447/ 06 M 198 /11/16",
    "CODE_DCI": "06 M 198",
    "DCI": "ATORVASTATINE CALCIQUE TRIHYDRATEE EXPRIME EN ATORVASTATINE",
    "NOM_COMMERCIALE": "ATORIN 10MG",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "10MG",
    "COND": "B/30 ET B/90",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEKER SARL (SARL LABORATOIRE BEKER ALGERIE)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/5/2011",
    "DATE_D_ENREGISTREMENT_FINAL": "5/9/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["atorvastatin"],
    "InteractionIndexLink": ["atorvastatine"],
    "N_ENREGISTREMENT": "472/ 06 M 198 /15",
    "CODE_DCI": "06 M 198",
    "DCI": "ATORVASTATINE CALCIQUE TRIHYDRATEE EXPRIME EN ATORVASTATINE",
    "NOM_COMMERCIALE": "ATORVASTATINE GEBER",
    "FORME": "GELULE",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GEBER HEALTH EURL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/1/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "18/1/2015",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["atorvastatin"],
    "InteractionIndexLink": ["atorvastatine"],
    "N_ENREGISTREMENT": "195/ 06 M 198 /07/12",
    "CODE_DCI": "06 M 198",
    "DCI": "ATORVASTATINE CALCIQUE TRIHYDRATEE EXPRIME EN ATORVASTATINE",
    "NOM_COMMERCIALE": "ATORVASTATINE IVAL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "10MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMA IVAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/5/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "26/8/2012",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["atorvastatin"],
    "InteractionIndexLink": ["atorvastatine"],
    "N_ENREGISTREMENT": "309/ 06 M 198 /16",
    "CODE_DCI": "06 M 198",
    "DCI": "ATORVASTATINE CALCIQUE TRIHYDRATEE EXPRIME EN ATORVASTATINE",
    "NOM_COMMERCIALE": "ATORVASTATINE LDM",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LDM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/3/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "13/3/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["atorvastatin"],
    "InteractionIndexLink": ["atorvastatine"],
    "N_ENREGISTREMENT": "470/ 06 M 198 /14",
    "CODE_DCI": "06 M 198",
    "DCI": "ATORVASTATINE CALCIQUE TRIHYDRATEE EXPRIME EN ATORVASTATINE",
    "NOM_COMMERCIALE": "ATORVASTATINE MM",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES MM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/3/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "19/3/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["atorvastatin"],
    "InteractionIndexLink": ["atorvastatine"],
    "N_ENREGISTREMENT": "293/06 M 198/17",
    "CODE_DCI": "06 M 198",
    "DCI": "ATORVASTATINE CALCIQUE TRIHYDRATEE EXPRIME EN ATORVASTATINE",
    "NOM_COMMERCIALE": "LIPICARE",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "10MG",
    "COND": "B/28 ET B/30 ET B/90",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOCARE SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/6/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "18/6/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["atorvastatin"],
    "InteractionIndexLink": ["atorvastatine"],
    "N_ENREGISTREMENT": "055/ 06 M 198 /08/20",
    "CODE_DCI": "06 M 198",
    "DCI": "ATORVASTATINE CALCIQUE TRIHYDRATEE EXPRIME EN ATORVASTATINE",
    "NOM_COMMERCIALE": "LIPODAR 10",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "DAR AL DAWA DEVELOPMENT & INVESTMENT Co Ltd",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "31/5/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "4/5/2020",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["atorvastatin"],
    "InteractionIndexLink": ["atorvastatine"],
    "N_ENREGISTREMENT": "492/06 M 198/17",
    "CODE_DCI": "06 M 198",
    "DCI": "ATORVASTATINE CALCIQUE TRIHYDRATEE EXPRIME EN ATORVASTATINE",
    "NOM_COMMERCIALE": "LIPONIL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOPRODIM SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/5/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "7/5/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["atorvastatin"],
    "InteractionIndexLink": ["atorvastatine"],
    "N_ENREGISTREMENT": "468/ 06 M 198 /14",
    "CODE_DCI": "06 M 198",
    "DCI": "ATORVASTATINE CALCIQUE TRIHYDRATEE EXPRIME EN ATORVASTATINE",
    "NOM_COMMERCIALE": "LIPOSTATINE",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NADPHARMADIC PRODUCTION SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/11/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "2/11/2014",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["atorvastatin"],
    "InteractionIndexLink": ["atorvastatine"],
    "N_ENREGISTREMENT": "190/06 M 198/17",
    "CODE_DCI": "06 M 198",
    "DCI": "ATORVASTATINE CALCIQUE TRIHYDRATEE EXPRIME EN ATORVASTATINE",
    "NOM_COMMERCIALE": "LIPOVAST 10",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SPIMACO ADDAWAEH",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ARABIE SAOUDITE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/5/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "28/5/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["atorvastatin"],
    "InteractionIndexLink": ["atorvastatine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "06 M 198",
    "DCI": "Atorvastatine calcique trihydratée",
    "NOM_COMMERCIALE": "LIPOVAST ® 10",
    "FORME": "comprimé pelliculé",
    "DOSAGE": "10 mg",
    "COND": "boîte de 30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["atorvastatin"],
    "InteractionIndexLink": ["atorvastatine"],
    "N_ENREGISTREMENT": "149/ 06 M 198 /13",
    "CODE_DCI": "06 M 198",
    "DCI": "ATORVASTATINE CALCIQUE TRIHYDRATEE EXPRIME EN ATORVASTATINE",
    "NOM_COMMERCIALE": "NOVATHOR",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "10MG",
    "COND": "PILULIER DE 30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVAPHARM TRADING SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/10/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "27/10/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["atorvastatin"],
    "InteractionIndexLink": ["atorvastatine"],
    "N_ENREGISTREMENT": "177/ 06 M 198 /06/12",
    "CODE_DCI": "06 M 198",
    "DCI": "ATORVASTATINE CALCIQUE TRIHYDRATEE EXPRIME EN ATORVASTATINE",
    "NOM_COMMERCIALE": "TARDEN",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ABDI IBRAHIM ILAÇ SANAYI VE TICARET A.Ş",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "TURQUIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/7/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "5/12/2012",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["atorvastatin"],
    "InteractionIndexLink": ["atorvastatine"],
    "N_ENREGISTREMENT": "035/ 06 M 198 /13",
    "CODE_DCI": "06 M 198",
    "DCI": "ATORVASTATINE CALCIQUE TRIHYDRATEE EXPRIME EN ATORVASTATINE",
    "NOM_COMMERCIALE": "TEOLAR",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMALLIANCE EURL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "31/7/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "31/7/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["atorvastatin"],
    "InteractionIndexLink": ["atorvastatine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "06 M 198",
    "DCI": "ATORVASTATINE CALCIQUE TRIHYDRATEE EXPRIME EN ATORVASTATINE",
    "NOM_COMMERCIALE": "TORVAST",
    "FORME": "COMPRIME",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["atorvastatin"],
    "InteractionIndexLink": ["atorvastatine"],
    "N_ENREGISTREMENT": "380/06 M 198/16",
    "CODE_DCI": "06 M 198",
    "DCI": "ATORVASTATINE CALCIQUE TRIHYDRATEE EXPRIME EN ATORVASTATINE",
    "NOM_COMMERCIALE": "TORVASTATINE",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HUP.P.PHARMA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/10/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "19/10/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["atorvastatin"],
    "InteractionIndexLink": ["atorvastatine"],
    "N_ENREGISTREMENT": "050/06 M 198/19",
    "CODE_DCI": "06 M 198",
    "DCI": "ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE",
    "NOM_COMMERCIALE": "TULIP",
    "FORME": "COMP OPELL",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANDOZ SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "14/1/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "14/1/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["atorvastatin"],
    "InteractionIndexLink": ["atorvastatine"],
    "N_ENREGISTREMENT": "268/ 06 M 198 /08/15",
    "CODE_DCI": "06 M 198",
    "DCI": "ATORVASTATINE CALCIQUE TRIHYDRATEE EXPRIME EN ATORVASTATINE",
    "NOM_COMMERCIALE": "VASKOL 10",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MERINAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "23/12/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "24/6/2015",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["simvastatin"],
    "InteractionIndexLink": ["simvastatine"],
    "N_ENREGISTREMENT": "268/ 06 M 203 /13",
    "CODE_DCI": "06 M 203",
    "DCI": "SIMVASTATINE",
    "NOM_COMMERCIALE": "KOLESTINE",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "40MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MERINAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "5/3/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "5/3/2013",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["simvastatin"],
    "InteractionIndexLink": ["simvastatine"],
    "N_ENREGISTREMENT": "309/ 06 M 203 /07/13",
    "CODE_DCI": "06 M 203",
    "DCI": "SIMVASTATINE",
    "NOM_COMMERCIALE": "SIMVASTATINE LDM",
    "FORME": "COMP. PELLI. SEC.",
    "DOSAGE": "40MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES  DE DIAGNOSTIC MAGHREBINS (LDM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/3/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "9/7/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["simvastatin"],
    "InteractionIndexLink": ["simvastatine"],
    "N_ENREGISTREMENT": "447/ 06 M 203 /09/18",
    "CODE_DCI": "06 M 203",
    "DCI": "SIMVASTATINE",
    "NOM_COMMERCIALE": "SOCOB",
    "FORME": "COMP. ENRO.",
    "DOSAGE": "40MG",
    "COND": "B/30ET B/90",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEKER SARL (SARL LABORATOIRE BEKER ALGERIE)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/9/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "1/4/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["simvastatin"],
    "InteractionIndexLink": ["simvastatine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "06 M 203",
    "DCI": "SIMVASTATINE",
    "NOM_COMMERCIALE": "ZOSTINE",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "40MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["fenofibrate"],
    "InteractionIndexLink": ["fenofibrate"],
    "N_ENREGISTREMENT": "320/ 06 M 214 /16",
    "CODE_DCI": "06 M 214",
    "DCI": "FENOFIBRATE",
    "NOM_COMMERCIALE": "FENATE",
    "FORME": "MICROGRANULES EN GLES",
    "DOSAGE": "160MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ZIM LABORATOIRES",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/3/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "13/3/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["fenofibrate"],
    "InteractionIndexLink": ["fenofibrate"],
    "N_ENREGISTREMENT": "470/ 06 M 214 /13/18",
    "CODE_DCI": "06 M 214",
    "DCI": "FENOFIBRATE",
    "NOM_COMMERCIALE": "FENOFIBRATE MM",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "160MG",
    "COND": "B/30",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MM (SARL LABORATOIRES MM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/3/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "9/4/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["fenofibrate"],
    "InteractionIndexLink": ["fenofibrate"],
    "N_ENREGISTREMENT": "320/ 06 M 214 /16",
    "CODE_DCI": "06 M 214",
    "DCI": "Fénofibrate",
    "NOM_COMMERCIALE": "FENOFIBRATE PHYSIOPHARM",
    "FORME": "Comprimé pelliculé",
    "DOSAGE": "160MG",
    "COND": "B/30",
    "LISTE": "LISTE II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHYSIOPHARM / SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/2/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "7/2/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["fenofibrate"],
    "InteractionIndexLink": ["fenofibrate"],
    "N_ENREGISTREMENT": "019/ 06 M 214 /07/15",
    "CODE_DCI": "06 M 214",
    "DCI": "FENOFIBRATE",
    "NOM_COMMERCIALE": "LIPANTHYL",
    "FORME": "COMP. PELLI.  LM",
    "DOSAGE": "160MG",
    "COND": "B/30",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FOURNIER SAS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/3/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "4/5/2015",
    "TYPE": "Ré",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["atorvastatin"],
    "InteractionIndexLink": ["atorvastatine"],
    "N_ENREGISTREMENT": "352/ 06 M 225 /12",
    "CODE_DCI": "06 M 225",
    "DCI": "ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE",
    "NOM_COMMERCIALE": "AROVAN",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "20MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/9/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "25/9/2012",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["atorvastatin"],
    "InteractionIndexLink": ["atorvastatine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "06 M 225",
    "DCI": "ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE",
    "NOM_COMMERCIALE": "ATOR 20MG",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "20MG",
    "COND": "B/28",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["atorvastatin"],
    "InteractionIndexLink": ["atorvastatine"],
    "N_ENREGISTREMENT": "447/ 06 M 225 /11/16",
    "CODE_DCI": "06 M 225",
    "DCI": "ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE",
    "NOM_COMMERCIALE": "ATORIN 20MG",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "20MG",
    "COND": "B/30 ET B/90",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEKER SARL (SARL LABORATOIRE BEKER ALGERIE)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/5/2011",
    "DATE_D_ENREGISTREMENT_FINAL": "5/9/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["atorvastatin"],
    "InteractionIndexLink": ["atorvastatine"],
    "N_ENREGISTREMENT": "472/ 06 M 225 /15",
    "CODE_DCI": "06 M 225",
    "DCI": "ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE",
    "NOM_COMMERCIALE": "ATORVASTATINE GEBER",
    "FORME": "GELULE",
    "DOSAGE": "20MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GEBER HEALTH EURL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/1/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "18/1/2015",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["atorvastatin"],
    "InteractionIndexLink": ["atorvastatine"],
    "N_ENREGISTREMENT": "195/ 06 M 225 /13",
    "CODE_DCI": "06 M 225",
    "DCI": "ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE",
    "NOM_COMMERCIALE": "ATORVASTATINE IVAL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "20MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMA IVAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/5/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "29/5/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["atorvastatin"],
    "InteractionIndexLink": ["atorvastatine"],
    "N_ENREGISTREMENT": "309/ 06 M 225 /16",
    "CODE_DCI": "06 M 225",
    "DCI": "ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE",
    "NOM_COMMERCIALE": "ATORVASTATINE LDM",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "20MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LDM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/2/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "15/2/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["atorvastatin"],
    "InteractionIndexLink": ["atorvastatine"],
    "N_ENREGISTREMENT": "293/06 M 225/17",
    "CODE_DCI": "06 M 225",
    "DCI": "ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE",
    "NOM_COMMERCIALE": "LIPICARE",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "20MG",
    "COND": "B/28 ET B/30 ET B/90",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOCARE SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/6/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "18/6/2017",
    "TYPE": "GE",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["atorvastatin"],
    "InteractionIndexLink": ["atorvastatine"],
    "N_ENREGISTREMENT": "055/ 06 M 225 /08/13",
    "CODE_DCI": "06 M 225",
    "DCI": "ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE",
    "NOM_COMMERCIALE": "LIPODAR 20",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "20MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "DAR AL DAWA DEVELOPMENT & INVESTMENT Co Ltd",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "31/5/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "2/4/2013",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["atorvastatin"],
    "InteractionIndexLink": ["atorvastatine"],
    "N_ENREGISTREMENT": "492/06 M 225/17",
    "CODE_DCI": "06 M 225",
    "DCI": "ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE",
    "NOM_COMMERCIALE": "LIPONIL 20",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "20MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOPRODIM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/5/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "2/5/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["atorvastatin"],
    "InteractionIndexLink": ["atorvastatine"],
    "N_ENREGISTREMENT": "468/ 06 M 225 /15",
    "CODE_DCI": "06 M 225",
    "DCI": "ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE",
    "NOM_COMMERCIALE": "LIPOSTATINE",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "20MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NADPHARMADIC PRODUCTION SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/1/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "18/1/2015",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["atorvastatin"],
    "InteractionIndexLink": ["atorvastatine"],
    "N_ENREGISTREMENT": "190/06 M 225/17",
    "CODE_DCI": "06 M 225",
    "DCI": "ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE",
    "NOM_COMMERCIALE": "LIPOVAST 20",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "20MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SPIMACO ADDAWAEH",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ARABIE SAOUDITE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/5/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "28/5/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["atorvastatin"],
    "InteractionIndexLink": ["atorvastatine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "06 M 225",
    "DCI": "Atorvastatine calcique trihydratée",
    "NOM_COMMERCIALE": "LIPOVAST ® 20",
    "FORME": "comprimé pelliculé",
    "DOSAGE": "20 mg",
    "COND": "boîte de 30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["atorvastatin"],
    "InteractionIndexLink": ["atorvastatine"],
    "N_ENREGISTREMENT": "149/ 06 M 225 /15",
    "CODE_DCI": "06 M 225",
    "DCI": "ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE",
    "NOM_COMMERCIALE": "NOVATHOR",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "20MG",
    "COND": "PILULIER/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVAPHARM TRADING SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/1/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "18/1/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36  MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["atorvastatin"],
    "InteractionIndexLink": ["atorvastatine"],
    "N_ENREGISTREMENT": "045/ 06 M 225 /0718",
    "CODE_DCI": "06 M 225",
    "DCI": "ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE",
    "NOM_COMMERCIALE": "TAHOR",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "20MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PFIZER PHARM ALGERIE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/7/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "10/4/2018",
    "TYPE": "Ré",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["atorvastatin"],
    "InteractionIndexLink": ["atorvastatine"],
    "N_ENREGISTREMENT": "177/ 06 M 225 /06/12",
    "CODE_DCI": "06 M 225",
    "DCI": "ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE",
    "NOM_COMMERCIALE": "TARDEN",
    "FORME": "COMP. PELLI. SEC.",
    "DOSAGE": "20MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ABDI IBRAHIM ILAÇ SANAYI VE TICARET A.Ş",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "TURQUIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/7/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "19/7/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["atorvastatin"],
    "InteractionIndexLink": ["atorvastatine"],
    "N_ENREGISTREMENT": "035/ 06 M 225 /13",
    "CODE_DCI": "06 M 225",
    "DCI": "ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE",
    "NOM_COMMERCIALE": "TEOLAR",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "20MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMALLIANCE EURL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/7/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "27/9/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["atorvastatin"],
    "InteractionIndexLink": ["atorvastatine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "06 M 225",
    "DCI": "ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE",
    "NOM_COMMERCIALE": "TORVAST",
    "FORME": "COMPRIME",
    "DOSAGE": "20MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["atorvastatin"],
    "InteractionIndexLink": ["atorvastatine"],
    "N_ENREGISTREMENT": "380/06 M 225/16",
    "CODE_DCI": "06 M 225",
    "DCI": "ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE",
    "NOM_COMMERCIALE": "TORVASTATINE",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "20MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HUP.P.PHARMA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/11/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "15/11/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["atorvastatin"],
    "InteractionIndexLink": ["atorvastatine"],
    "N_ENREGISTREMENT": "050/06 M 225/19",
    "CODE_DCI": "06 M 225",
    "DCI": "ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE",
    "NOM_COMMERCIALE": "TULIP",
    "FORME": "COMP OPELL",
    "DOSAGE": "20MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANDOZ SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/1/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "15/1/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["atorvastatin"],
    "InteractionIndexLink": ["atorvastatine"],
    "N_ENREGISTREMENT": "268/ 06 M 225 /12",
    "CODE_DCI": "06 M 225",
    "DCI": "ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE",
    "NOM_COMMERCIALE": "VASKOL 20",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "20MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MERINAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/3/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "20/3/2012",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["atorvastatin"],
    "InteractionIndexLink": ["atorvastatine"],
    "N_ENREGISTREMENT": "575/06 M 225/20",
    "CODE_DCI": "06 M 225",
    "DCI": "ATORVASTATINE",
    "NOM_COMMERCIALE": "VASTINE",
    "FORME": "COMP. PELL.",
    "DOSAGE": "20MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PUR LAB Sarl",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/12/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "29/12/2020",
    "TYPE": "Gé",
    "STATUT": "FPrémix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["atorvastatin"],
    "InteractionIndexLink": ["atorvastatine"],
    "N_ENREGISTREMENT": "352/ 06 M 232 /13/18",
    "CODE_DCI": "06 M 232",
    "DCI": "ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE",
    "NOM_COMMERCIALE": "AROVAN",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "40MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/3/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "2/4/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["atorvastatin"],
    "InteractionIndexLink": ["atorvastatine"],
    "N_ENREGISTREMENT": "317/06 M 232 /11/16",
    "CODE_DCI": "06 M 232",
    "DCI": "ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE",
    "NOM_COMMERCIALE": "ATOR 40MG",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "40MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INPHA-MEDIS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/5/2011",
    "DATE_D_ENREGISTREMENT_FINAL": "9/11/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["atorvastatin"],
    "InteractionIndexLink": ["atorvastatine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "06 M 232",
    "DCI": "Atorvastatine",
    "NOM_COMMERCIALE": "ATOR 40mg",
    "FORME": "comp pel",
    "DOSAGE": "40mg/comp",
    "COND": "bt de 28",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["atorvastatin"],
    "InteractionIndexLink": ["atorvastatine"],
    "N_ENREGISTREMENT": "447/06 M 232/11/16",
    "CODE_DCI": "06 M 232",
    "DCI": "ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE",
    "NOM_COMMERCIALE": "ATORIN 40MG",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "40MG",
    "COND": "B/30 ET B/90",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEKER SARL (SARL LABORATOIRE BEKER ALGERIE)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/5/2011",
    "DATE_D_ENREGISTREMENT_FINAL": "8/11/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["atorvastatin"],
    "InteractionIndexLink": ["atorvastatine"],
    "N_ENREGISTREMENT": "472/ 06 M 232 /15",
    "CODE_DCI": "06 M 232",
    "DCI": "ATORVASTATINE CALCIQUE TRIHYDRATEE EXPRIME EN ATORVASTATINE",
    "NOM_COMMERCIALE": "ATORVASTATINE GEBER",
    "FORME": "GELULE",
    "DOSAGE": "40MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GEBER HEALTH EURL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/2/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "10/2/2015",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["atorvastatin"],
    "InteractionIndexLink": ["atorvastatine"],
    "N_ENREGISTREMENT": "521 / 06 M 232 /14",
    "CODE_DCI": "06 M 232",
    "DCI": "ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE",
    "NOM_COMMERCIALE": "ATORVASTATINE IVAL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "40MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL WORLD MEDECINE LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/7/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "27/7/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["atorvastatin"],
    "InteractionIndexLink": ["atorvastatine"],
    "N_ENREGISTREMENT": "309/ 06 M 232 /16",
    "CODE_DCI": "06 M 232",
    "DCI": "ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE",
    "NOM_COMMERCIALE": "ATORVASTATINE LDM",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "40MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LDM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "16/2/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "16/2/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["atorvastatin"],
    "InteractionIndexLink": ["atorvastatine"],
    "N_ENREGISTREMENT": "293/06 M 232/17",
    "CODE_DCI": "06 M 232",
    "DCI": "ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE",
    "NOM_COMMERCIALE": "LIPICARE",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "40MG",
    "COND": "B/28 ET B/30 ET B/90",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOCARE SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/6/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "18/6/2017",
    "TYPE": "GE",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["atorvastatin"],
    "InteractionIndexLink": ["atorvastatine"],
    "N_ENREGISTREMENT": "492/06 M 232/17",
    "CODE_DCI": "06 M 232",
    "DCI": "ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE",
    "NOM_COMMERCIALE": "LIPONIL 40",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "40MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOPRODIM SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/6/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "12/6/2017",
    "TYPE": "GE",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["atorvastatin"],
    "InteractionIndexLink": ["atorvastatine"],
    "N_ENREGISTREMENT": "190/06 M 232/17",
    "CODE_DCI": "06 M 232",
    "DCI": "ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE",
    "NOM_COMMERCIALE": "LIPOVAST",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "40MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SPIMACO ADDAWAEAH",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ARABIE SAOUDITE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/5/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "28/5/2017",
    "TYPE": "GE",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["atorvastatin"],
    "InteractionIndexLink": ["atorvastatine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "06 M 232",
    "DCI": "Atorvastatine calcique trihydratée",
    "NOM_COMMERCIALE": "LIPOVAST ® 40",
    "FORME": "comprimé pelliculé",
    "DOSAGE": "40 mg",
    "COND": "boîte de 30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["atorvastatin"],
    "InteractionIndexLink": ["atorvastatine"],
    "N_ENREGISTREMENT": "149/ 06 M 232 /14",
    "CODE_DCI": "06 M 232",
    "DCI": "ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE",
    "NOM_COMMERCIALE": "NOVATHOR",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "40MG",
    "COND": "PILULIER/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVAPHARM TRADING SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/4/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "6/10/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["atorvastatin"],
    "InteractionIndexLink": ["atorvastatine"],
    "N_ENREGISTREMENT": "045/ 06 M 232 /07/18",
    "CODE_DCI": "06 M 232",
    "DCI": "ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE",
    "NOM_COMMERCIALE": "TAHOR",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "40MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PFIZER PHARM ALGERIE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "31/12/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "10/4/2018",
    "TYPE": "Ré",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["atorvastatin"],
    "InteractionIndexLink": ["atorvastatine"],
    "N_ENREGISTREMENT": "177/ 06 M 232 /08/13",
    "CODE_DCI": "06 M 232",
    "DCI": "ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE",
    "NOM_COMMERCIALE": "TARDEN",
    "FORME": "COMP.PELLI.SEC.",
    "DOSAGE": "40MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ABDI IBRAHIM ILAÇ SANAYI VE TICARET A.S",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "TURQUIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/1/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "20/3/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["atorvastatin"],
    "InteractionIndexLink": ["atorvastatine"],
    "N_ENREGISTREMENT": "035/ 06 M 232 /14",
    "CODE_DCI": "06 M 232",
    "DCI": "ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE",
    "NOM_COMMERCIALE": "TEOLAR",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "40MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMALLIANCE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/3/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "19/3/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["atorvastatin"],
    "InteractionIndexLink": ["atorvastatine"],
    "N_ENREGISTREMENT": "001/ 06 M 232 /07/16",
    "CODE_DCI": "06 M 232",
    "DCI": "ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE",
    "NOM_COMMERCIALE": "TORVAST",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "40MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMA ALGERIA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "31/12/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "13/3/2016",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["atorvastatin"],
    "InteractionIndexLink": ["atorvastatine"],
    "N_ENREGISTREMENT": "050/06 M 232/19",
    "CODE_DCI": "06 M 232",
    "DCI": "ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE",
    "NOM_COMMERCIALE": "TULIP",
    "FORME": "COMP OPELL",
    "DOSAGE": "40MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANDOZ SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/1/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "15/1/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["atorvastatin"],
    "InteractionIndexLink": ["atorvastatine"],
    "N_ENREGISTREMENT": "575/06 M 232/20",
    "CODE_DCI": "06 M 232",
    "DCI": "ATORVASTATINE",
    "NOM_COMMERCIALE": "VASTINE",
    "FORME": "COMP. PELL.",
    "DOSAGE": "40MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PUR LAB Sarl",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/12/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "29/12/2020",
    "TYPE": "Gé",
    "STATUT": "FPrémix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["atorvastatin"],
    "InteractionIndexLink": ["atorvastatine"],
    "N_ENREGISTREMENT": "352/ 06 M 233 /13/18",
    "CODE_DCI": "06 M 233",
    "DCI": "ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE",
    "NOM_COMMERCIALE": "AROVAN",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "80MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "11/6/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "16/6/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["atorvastatin"],
    "InteractionIndexLink": ["atorvastatine"],
    "N_ENREGISTREMENT": "317/ 06 M 233 /12",
    "CODE_DCI": "06 M 233",
    "DCI": "ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE",
    "NOM_COMMERCIALE": "ATOR",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "80MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INPHA-MEDIS SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/10/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "15/10/2012",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["atorvastatin"],
    "InteractionIndexLink": ["atorvastatine"],
    "N_ENREGISTREMENT": "447/06 M 233/11/16",
    "CODE_DCI": "06 M 233",
    "DCI": "ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE",
    "NOM_COMMERCIALE": "ATORIN 80MG",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "80MG",
    "COND": "B/30 ET B/90",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEKER SARL (SARL LABORATOIRE BEKER ALGERIE)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/5/2011",
    "DATE_D_ENREGISTREMENT_FINAL": "4/12/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["atorvastatin"],
    "InteractionIndexLink": ["atorvastatine"],
    "N_ENREGISTREMENT": "309/06 M 233/17",
    "CODE_DCI": "06 M 233",
    "DCI": "ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE",
    "NOM_COMMERCIALE": "ATORVASTATINE LDM",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "80MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LDM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/5/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "28/5/2017",
    "TYPE": "G",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["atorvastatin"],
    "InteractionIndexLink": ["atorvastatine"],
    "N_ENREGISTREMENT": "470/ 06 M 233 /14",
    "CODE_DCI": "06 M 233",
    "DCI": "ATORVASTATINE CALCIQUE TRIHYDRATEE EXPRIME EN ATORVASTATINE",
    "NOM_COMMERCIALE": "ATORVASTATINE MM",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "80MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES MM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/4/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "22/4/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["atorvastatin"],
    "InteractionIndexLink": ["atorvastatine"],
    "N_ENREGISTREMENT": "293/06 M 233/17",
    "CODE_DCI": "06 M 233",
    "DCI": "ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE",
    "NOM_COMMERCIALE": "LIPICARE",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "80MG",
    "COND": "B/28 ET B/30 ET B/90",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOCARE SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/6/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "12/6/2017",
    "TYPE": "GE",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["atorvastatin"],
    "InteractionIndexLink": ["atorvastatine"],
    "N_ENREGISTREMENT": "149/ 06 M 233 /14",
    "CODE_DCI": "06 M 233",
    "DCI": "ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE",
    "NOM_COMMERCIALE": "NOVATHOR",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "80MG",
    "COND": "PILULIER/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVAPHARM TRADING SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/4/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "1/4/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["atorvastatin"],
    "InteractionIndexLink": ["atorvastatine"],
    "N_ENREGISTREMENT": "035/ 06 M 233 /14",
    "CODE_DCI": "06 M 233",
    "DCI": "ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE",
    "NOM_COMMERCIALE": "TEOLAR",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "80MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMALLIANCE EURL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/3/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "9/3/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["atorvastatin"],
    "InteractionIndexLink": ["atorvastatine"],
    "N_ENREGISTREMENT": "001/06 M 233/13",
    "CODE_DCI": "06 M 233",
    "DCI": "ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE",
    "NOM_COMMERCIALE": "TORVAST",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "80MG",
    "COND": "PILULIER / 30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMA ALGERIA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/11/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "2/2/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["atorvastatin"],
    "InteractionIndexLink": ["atorvastatine"],
    "N_ENREGISTREMENT": "380/06 M 233/17",
    "CODE_DCI": "06 M 233",
    "DCI": "ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE",
    "NOM_COMMERCIALE": "TORVASTATINE",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "80MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HUP.P.PHARMA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/1/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "9/1/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["atorvastatin"],
    "InteractionIndexLink": ["atorvastatine"],
    "N_ENREGISTREMENT": "575/06 M 233/20",
    "CODE_DCI": "06 M 233",
    "DCI": "ATORVASTATINE",
    "NOM_COMMERCIALE": "VASTINE",
    "FORME": "COMP. PELL.",
    "DOSAGE": "80MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PUR LAB Sarl",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/12/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "29/12/2020",
    "TYPE": "Gé",
    "STATUT": "FPrémix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["fluvastatin"],
    "InteractionIndexLink": ["fluvastatine"],
    "N_ENREGISTREMENT": "447/ 06 M 236 /15",
    "CODE_DCI": "06 M 236",
    "DCI": "FLUVASTATINE SODIQUE EXPRIME EN FLUVASTATINE",
    "NOM_COMMERCIALE": "COLESTOR LP",
    "FORME": "COMP. PELLI. LP.",
    "DOSAGE": "80MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEKER SARL (SARL LABORATOIRE BEKER ALGERIE)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/10/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "12/10/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["fluvastatin"],
    "InteractionIndexLink": ["fluvastatine"],
    "N_ENREGISTREMENT": "001/ 06 M 236 /12/19",
    "CODE_DCI": "06 M 236",
    "DCI": "FLUVASTATINE SODIQUE EXPRIME EN FLUVASTATINE",
    "NOM_COMMERCIALE": "CORED XL",
    "FORME": "COMP. PELLI. LP",
    "DOSAGE": "80MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMA ALGERIA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/10/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "21/1/2019",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["fluvastatin"],
    "InteractionIndexLink": ["fluvastatine"],
    "N_ENREGISTREMENT": "352/ 06 M 236 /14",
    "CODE_DCI": "06 M 236",
    "DCI": "FLUVASTATINE SODIQUE EXPRIME EN FLUVASTATINE",
    "NOM_COMMERCIALE": "FLUVACOL LP",
    "FORME": "COMP. PELLI. LP",
    "DOSAGE": "80MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/12/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "15/12/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["fluvastatin"],
    "InteractionIndexLink": ["fluvastatine"],
    "N_ENREGISTREMENT": "097/06 M 236/17",
    "CODE_DCI": "06 M 236",
    "DCI": "FLUVASTATINE SODIQUE EXPRIME EN FLUVASTATINE",
    "NOM_COMMERCIALE": "FLUVASTAN",
    "FORME": "COMP. PELLI. LP",
    "DOSAGE": "80MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL SANAMED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/6/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "18/6/2017",
    "TYPE": "Gé",
    "STATUT": "F PREMIX",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["fluvastatin"],
    "InteractionIndexLink": ["fluvastatine"],
    "N_ENREGISTREMENT": "309/ 06 M 236 /15",
    "CODE_DCI": "06 M 236",
    "DCI": "FLUVASTATINE SODIQUE EXPRIME EN FLUVASTATINE",
    "NOM_COMMERCIALE": "FLUVASTATINE LDM",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "80MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES DE DIAGNOSTIC MAGHREBINS (LDM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/11/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "10/11/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["fluvastatin"],
    "InteractionIndexLink": ["fluvastatine"],
    "N_ENREGISTREMENT": "149/06 M 236/19",
    "CODE_DCI": "06 M 236",
    "DCI": "FLUVASTATINE SODIUM EXPRIME EN FLUVASTATINE",
    "NOM_COMMERCIALE": "FLUVASTATINE NOVAGENERICS",
    "FORME": "COMP PELL A LIBERATION PROLONGEE",
    "DOSAGE": "80MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVAPHARM TRADING SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["fluvastatin"],
    "InteractionIndexLink": ["fluvastatine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "06 M 236",
    "DCI": "Fluvastatine",
    "NOM_COMMERCIALE": "Fluvacol",
    "FORME": "Comprimé LP",
    "DOSAGE": "80mg",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["fluvastatin"],
    "InteractionIndexLink": ["fluvastatine"],
    "N_ENREGISTREMENT": "418/06 M 236/20",
    "CODE_DCI": "06 M 236",
    "DCI": "FLUVASTATINE SODIQUE",
    "NOM_COMMERCIALE": "LUVASCOL",
    "FORME": "COMP PELL LP",
    "DOSAGE": "80MG",
    "COND": "B/28",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NEOMEDIC SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/1/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "20/1/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["rosuvastatin"],
    "InteractionIndexLink": ["rosuvastatine"],
    "N_ENREGISTREMENT": "352/06 M 269/17",
    "CODE_DCI": "06 M 269",
    "DCI": "Rosuvastatine calcique exprimé en rosuvastatine",
    "NOM_COMMERCIALE": "CRESOVAST",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "23/7/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "23/7/2017",
    "TYPE": "GE",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["rosuvastatin"],
    "InteractionIndexLink": ["rosuvastatine"],
    "N_ENREGISTREMENT": "035/ 06 M 269 /16",
    "CODE_DCI": "06 M 269",
    "DCI": "Rosuvastatine calcique exprimé en rosuvastatine",
    "NOM_COMMERCIALE": "CRESTATINE",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMALLIANCE EURL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "16/2/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "16/2/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["rosuvastatin"],
    "InteractionIndexLink": ["rosuvastatine"],
    "N_ENREGISTREMENT": "361/06 M 269/20",
    "CODE_DCI": "06 M 269",
    "DCI": "ROSUVASTATINE CALCIQUE EXPRIME EN ROSUVASTATINE",
    "NOM_COMMERCIALE": "ROSITTA 10",
    "FORME": "COMP. PELL.",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "DAR AL DAWA DEVELOPMENT AND INVESTMENT Co. Ltd.",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/11/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "25/11/2020",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["rosuvastatin"],
    "InteractionIndexLink": ["rosuvastatine"],
    "N_ENREGISTREMENT": "173/06 M 269/21",
    "CODE_DCI": "06 M 269",
    "DCI": "Rosuvastatine calcique exprimé en Rosuvastatine",
    "NOM_COMMERCIALE": "ROSUTAB",
    "FORME": "Comprimé pelliculé",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EURL TABUK ALGERIE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/3/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "29/3/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["rosuvastatin"],
    "InteractionIndexLink": ["rosuvastatine"],
    "N_ENREGISTREMENT": "309/06 M 269/19",
    "CODE_DCI": "06 M 269",
    "DCI": "Rosuvastatine calcique exprimé en rosuvastatine",
    "NOM_COMMERCIALE": "ROSUVASTATINE LDM",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LDM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/3/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "25/3/2019",
    "TYPE": "GE",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["rosuvastatin"],
    "InteractionIndexLink": ["rosuvastatine"],
    "N_ENREGISTREMENT": "289/06 M 269/17",
    "CODE_DCI": "06 M 269",
    "DCI": "Rosuvastatine calcique exprimé en rosuvastatine",
    "NOM_COMMERCIALE": "ROSUVASTOR",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRATER RAZES FORME SECHE SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "8/10/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "8/10/2017",
    "TYPE": "GE",
    "STATUT": "F PREMIX",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["rosuvastatin"],
    "InteractionIndexLink": ["rosuvastatine"],
    "N_ENREGISTREMENT": "055/06 M 269/20",
    "CODE_DCI": "06 M 269",
    "DCI": "Rosuvastatine calcique exprimé en Rosuvastatine",
    "NOM_COMMERCIALE": "ROZITTA",
    "FORME": "Comprimé pelliculé",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "DAR AL DAWA DEVELOPMENT & INVESTMENT Co. Ltd",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/11/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "15/2/2021",
    "TYPE": "Gé",
    "STATUT": "Fabricant (MEDIPHARMA International)",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["rosuvastatin"],
    "InteractionIndexLink": ["rosuvastatine"],
    "N_ENREGISTREMENT": "544/06 M 269/18",
    "CODE_DCI": "06 M 269",
    "DCI": "Rosuvastatine calcique exprimé en rosuvastatine",
    "NOM_COMMERCIALE": "RUVAST",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL/WORLD MEDECINE LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "5/6/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "5/8/2018",
    "TYPE": "GE",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["rosuvastatin"],
    "InteractionIndexLink": ["rosuvastatine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "06 M 269",
    "DCI": "Rosuvastatine",
    "NOM_COMMERCIALE": "Rozitta 10",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["rosuvastatin"],
    "InteractionIndexLink": ["rosuvastatine"],
    "N_ENREGISTREMENT": "001/ 06 M 269 /15",
    "CODE_DCI": "06 M 269",
    "DCI": "Rosuvastatine calcique exprimé en rosuvastatine",
    "NOM_COMMERCIALE": "SUPERSTAT",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "10MG",
    "COND": "B/30 ET B/90",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMA ALGERIA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/6/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "24/6/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["rosuvastatin"],
    "InteractionIndexLink": ["rosuvastatine"],
    "N_ENREGISTREMENT": "20/06 M269/242",
    "CODE_DCI": "06 M 269",
    "DCI": "ROSUVASTATINE CALCIUM",
    "NOM_COMMERCIALE": "VASTAT",
    "FORME": "COMP PELL",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES GROUPE SANTE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "21/10/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "21/10/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["rosuvastatin"],
    "InteractionIndexLink": ["rosuvastatine"],
    "N_ENREGISTREMENT": "352/ 06 M 270 /14",
    "CODE_DCI": "06 M 270",
    "DCI": "Rosuvastatine calcique exprimé en rosuvastatine",
    "NOM_COMMERCIALE": "CRESOVAST",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "20MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "21/9/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "21/9/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["rosuvastatin"],
    "InteractionIndexLink": ["rosuvastatine"],
    "N_ENREGISTREMENT": "304/ 06 M 270 /19",
    "CODE_DCI": "06 M 270",
    "DCI": "Rosuvastatine calcique exprimé en rosuvastatine",
    "NOM_COMMERCIALE": "CRESTAT",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "20MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GEOPHARM SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["rosuvastatin"],
    "InteractionIndexLink": ["rosuvastatine"],
    "N_ENREGISTREMENT": "035/ 06 M 270 /16",
    "CODE_DCI": "06 M 270",
    "DCI": "Rosuvastatine calcique exprimé en rosuvastatine",
    "NOM_COMMERCIALE": "CRESTATINE",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "20MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMALLIANCE EURL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "16/2/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "16/2/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["rosuvastatin"],
    "InteractionIndexLink": ["rosuvastatine"],
    "N_ENREGISTREMENT": "055/06 M 270/20",
    "CODE_DCI": "06 M 270",
    "DCI": "ROSUVASTATINE CALCIQUE EXPRIME EN ROSUVASTATINE",
    "NOM_COMMERCIALE": "ROSITTA 20",
    "FORME": "COMP. PELL.",
    "DOSAGE": "20MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "DAR AL DAWA DEVELOPMENT AND INVESTMENT Co. Ltd.",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/12/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "22/12/2020",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["rosuvastatin"],
    "InteractionIndexLink": ["rosuvastatine"],
    "N_ENREGISTREMENT": "173/ 06 M 270 /21",
    "CODE_DCI": "06 M 270",
    "DCI": "Rosuvastatine calcique exprimé en Rosuvastatine",
    "NOM_COMMERCIALE": "ROSUTAB",
    "FORME": "Comprimé pelliculé",
    "DOSAGE": "20MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "TABUK ALGERIE / EURL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "14/3/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "14/3/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["rosuvastatin"],
    "InteractionIndexLink": ["rosuvastatine"],
    "N_ENREGISTREMENT": "309/ 06 M 270 /19",
    "CODE_DCI": "06 M 270",
    "DCI": "Rosuvastatine calcique exprimé en rosuvastatine",
    "NOM_COMMERCIALE": "ROSUVASTATINE LDM",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "20MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LDM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["rosuvastatin"],
    "InteractionIndexLink": ["rosuvastatine"],
    "N_ENREGISTREMENT": "289/06 M 270/17",
    "CODE_DCI": "06 M 270",
    "DCI": "Rosuvastatine calcique exprimé en rosuvastatine",
    "NOM_COMMERCIALE": "ROSUVASTOR",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "20MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRATER RAZES FORME SECHE SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/10/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "24/10/2017",
    "TYPE": "GE",
    "STATUT": "F PREMIX",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["rosuvastatin"],
    "InteractionIndexLink": ["rosuvastatine"],
    "N_ENREGISTREMENT": "544/06 M 270/18",
    "CODE_DCI": "06 M 270",
    "DCI": "Rosuvastatine calcique exprimé en rosuvastatine",
    "NOM_COMMERCIALE": "RUVAST",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "20MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL/WORLD MEDECINE LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "5/6/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "5/6/2018",
    "TYPE": "GE",
    "STATUT": "F PREMIX",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["rosuvastatin"],
    "InteractionIndexLink": ["rosuvastatine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "06 M 270",
    "DCI": "Rosuvastatine calcium",
    "NOM_COMMERCIALE": "Rosuvastatin",
    "FORME": "Comprimé pelliculé",
    "DOSAGE": "20 mg",
    "COND": "B 30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["rosuvastatin"],
    "InteractionIndexLink": ["rosuvastatine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "06 M 270",
    "DCI": "Rosuvastatine",
    "NOM_COMMERCIALE": "Rozitta 20",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "20MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["rosuvastatin"],
    "InteractionIndexLink": ["rosuvastatine"],
    "N_ENREGISTREMENT": "001/ 06 M 270 /15",
    "CODE_DCI": "06 M 270",
    "DCI": "Rosuvastatine calcique exprimé en rosuvastatine",
    "NOM_COMMERCIALE": "SUPERSTAT",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "20MG",
    "COND": "B/30 ET B/90",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMA ALGERIA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/6/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "24/6/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["rosuvastatin"],
    "InteractionIndexLink": ["rosuvastatine"],
    "N_ENREGISTREMENT": "20/06 M270/242",
    "CODE_DCI": "06 M 270",
    "DCI": "ROSUVASTATINE CALCIUM",
    "NOM_COMMERCIALE": "VASTAT",
    "FORME": "COMP PELL",
    "DOSAGE": "20MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES GROUPE SANTE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "21/10/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "21/10/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["amlodipine", "atorvastatin"],
    "InteractionIndexLink": ["amlodipine", "atorvastatine"],
    "N_ENREGISTREMENT": "352/ 06 M 290 /12/18",
    "CODE_DCI": "06 M 290",
    "DCI": "AMLODIPINE BESILATE EXPRIME EN AMLODIPINE / ATORVASTATINE CALCIQUE TRIHYDRATEE EXPRIME EN ATORVASTATINE",
    "NOM_COMMERCIALE": "TORVAPINE",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "5MG/10MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/9/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "2/4/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["pravastatin"],
    "InteractionIndexLink": ["pravastatine"],
    "N_ENREGISTREMENT": "352/ 06 M 294 /12/17",
    "CODE_DCI": "06 M 294",
    "DCI": "PRAVASTATINE SODIQUE",
    "NOM_COMMERCIALE": "PRASIVAST",
    "FORME": "COMPRIME",
    "DOSAGE": "40MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/1/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "27/12/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["pravastatin"],
    "InteractionIndexLink": ["pravastatine"],
    "N_ENREGISTREMENT": "352/ 06 M 295 /12",
    "CODE_DCI": "06 M 295",
    "DCI": "PRAVASTATINE SODIQUE",
    "NOM_COMMERCIALE": "PRASIVAST",
    "FORME": "COMPRIME",
    "DOSAGE": "10MG",
    "COND": "PILULIER DE 30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/2/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "15/2/2012",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["rosuvastatin"],
    "InteractionIndexLink": ["rosuvastatine"],
    "N_ENREGISTREMENT": "352/06 M 296/19",
    "CODE_DCI": "06 M 296",
    "DCI": "ROSUVASTATINE CALCIUM",
    "NOM_COMMERCIALE": "CRESOVAST",
    "FORME": "COMP PELL",
    "DOSAGE": "5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/12/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "30/12/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["rosuvastatin"],
    "InteractionIndexLink": ["rosuvastatine"],
    "N_ENREGISTREMENT": "317/06 M 296/19",
    "CODE_DCI": "06 M 296",
    "DCI": "Rosuvastatine calcique exprimé en rosuvastatine",
    "NOM_COMMERCIALE": "CRESTADIS",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "5MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INPHA MEDIS SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "21/1/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "21/1/2019",
    "TYPE": "G",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["rosuvastatin"],
    "InteractionIndexLink": ["rosuvastatine"],
    "N_ENREGISTREMENT": "256/ 06 M 296 /12",
    "CODE_DCI": "06 M 296",
    "DCI": "Rosuvastatine calcique exprimé en rosuvastatine",
    "NOM_COMMERCIALE": "CRESTOR",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "5MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ASTRAZENECA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/8/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "26/8/2012",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["rosuvastatin"],
    "InteractionIndexLink": ["rosuvastatine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "06 M 296",
    "DCI": "Rosuvastatine",
    "NOM_COMMERCIALE": "Crestadis 5",
    "FORME": "comp pel",
    "DOSAGE": "05mg/comp",
    "COND": "bt de 28",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["rosuvastatin"],
    "InteractionIndexLink": ["rosuvastatine"],
    "N_ENREGISTREMENT": "289/06 M 296/17",
    "CODE_DCI": "06 M 296",
    "DCI": "Rosuvastatine calcique exprimé en rosuvastatine",
    "NOM_COMMERCIALE": "ROSUVASTOR",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRATER RAZES FORME SECHE SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/10/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "24/10/2017",
    "TYPE": "G",
    "STATUT": "F PREMIX",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["rosuvastatin"],
    "InteractionIndexLink": ["rosuvastatine"],
    "N_ENREGISTREMENT": "001/06 M 296/19",
    "CODE_DCI": "06 M 296",
    "DCI": "Rosuvastatine calcique exprimé en rosuvastatine",
    "NOM_COMMERCIALE": "SUPERSTAT",
    "FORME": "COMP PELL",
    "DOSAGE": "5MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMA ALGERIA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["amlodipine", "atorvastatin"],
    "InteractionIndexLink": ["amlodipine", "atorvastatine"],
    "N_ENREGISTREMENT": "352/ 06 M 297 /12/18",
    "CODE_DCI": "06 M 297",
    "DCI": "AMLODIPINE BESILATE EXPRIME EN AMLODIPINE / ATORVASTATINE CALCIQUE TRIHYDRATEE EXPRIME EN ATORVASTATINE",
    "NOM_COMMERCIALE": "TORVAPINE",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "10MG/10MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/10/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "2/4/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["ezetimibe"],
    "InteractionIndexLink": ["ezetimibe"],
    "N_ENREGISTREMENT": "024/ 06 M 298 /13",
    "CODE_DCI": "06 M 298",
    "DCI": "EZETIMIBE",
    "NOM_COMMERCIALE": "EZETROL",
    "FORME": "COMPRIME",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MERCK SHARP & DOHME LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ROYAUME UNI",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/2/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "5/5/2021",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["ezetimibe"],
    "InteractionIndexLink": ["ezetimibe"],
    "N_ENREGISTREMENT": "263/06 M 298/17",
    "CODE_DCI": "06 M 298",
    "DCI": "EZETIMIBE",
    "NOM_COMMERCIALE": "METAZID",
    "FORME": "COMPRIME",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOPHARM SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/5/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "28/5/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["ezetimibe", "simvastatin"],
    "InteractionIndexLink": ["ezetimibe", "simvastatine"],
    "N_ENREGISTREMENT": "024/ 06 M 303 /13",
    "CODE_DCI": "06 M 303",
    "DCI": "EZETIMIBE / SIMVASTATINE",
    "NOM_COMMERCIALE": "INEGY",
    "FORME": "COMPRIME",
    "DOSAGE": "10MG/20MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MSD SP LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ROYAUME UNI",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/7/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "2/7/2013",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["ezetimibe", "simvastatin"],
    "InteractionIndexLink": ["ezetimibe", "simvastatine"],
    "N_ENREGISTREMENT": "024/ 06 M 304 /13",
    "CODE_DCI": "06 M 304",
    "DCI": "EZETIMIBE / SIMVASTATINE",
    "NOM_COMMERCIALE": "INEGY",
    "FORME": "COMPRIME",
    "DOSAGE": "10MG/40MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MSD SP LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ROYAUME UNI",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/7/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "2/7/2013",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["rosuvastatin"],
    "InteractionIndexLink": ["rosuvastatine"],
    "N_ENREGISTREMENT": "352/06 M 328/20",
    "CODE_DCI": "06 M 328",
    "DCI": "ROSUVASTATINE CALCIUM",
    "NOM_COMMERCIALE": "CRESOVAST",
    "FORME": "COMP PELL",
    "DOSAGE": "40MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "8/1/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "8/1/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["bosentan"],
    "InteractionIndexLink": ["bosentan"],
    "N_ENREGISTREMENT": "182/ 06 N 305 /15",
    "CODE_DCI": "06 N 305",
    "DCI": "BOSENTAN MONOHYDRATE EXPRIME EN BOSENTAN",
    "NOM_COMMERCIALE": "BOSENTAS",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "62.5MG",
    "COND": "B/20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CIPLA LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/9/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "2/9/2015",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["bosentan"],
    "InteractionIndexLink": ["bosentan"],
    "N_ENREGISTREMENT": "352/ 06 N 305 /18",
    "CODE_DCI": "06 N 305",
    "DCI": "BOSENTAN MONOHYDRTAE EXPRIME EN BOSENTAN",
    "NOM_COMMERCIALE": "ERATAN",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "62.5MG",
    "COND": "B/60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "31/1/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "31/1/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["bosentan"],
    "InteractionIndexLink": ["bosentan"],
    "N_ENREGISTREMENT": "495/ 06 N 305 /15",
    "CODE_DCI": "06 N 305",
    "DCI": "BOSENTAN MONOHYDRATE EXPRIME EN BOSENTAN",
    "NOM_COMMERCIALE": "PMS-BOSENTAN",
    "FORME": "COMPRIME",
    "DOSAGE": "62.5MG",
    "COND": "B/60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMASCIENCE INC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CANADA",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/9/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "13/9/2015",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["bosentan"],
    "InteractionIndexLink": ["bosentan"],
    "N_ENREGISTREMENT": "482/ 06 N 305 /13",
    "CODE_DCI": "06 N 305",
    "DCI": "BOSENTAN MONOHYDRTAE EXPRIME EN BOSENTAN",
    "NOM_COMMERCIALE": "TRACLEER",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "62.5MG",
    "COND": "B/56",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ACTELION PHARMACEUTICALS LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SUISSE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/9/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "30/9/2013",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["bosentan"],
    "InteractionIndexLink": ["bosentan"],
    "N_ENREGISTREMENT": "482/ 06 N 306 /13",
    "CODE_DCI": "06 N 306",
    "DCI": "BOSENTAN MONOHYDRTAE EXPRIME EN BOSENTAN",
    "NOM_COMMERCIALE": "",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "125MG",
    "COND": "B/56",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ACTELION PHARMACEUTICALS LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SUISSE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/9/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "30/9/2013",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["bosentan"],
    "InteractionIndexLink": ["bosentan"],
    "N_ENREGISTREMENT": "182/ 06 N 306 /15",
    "CODE_DCI": "06 N 306",
    "DCI": "BOSENTAN MONOHYDRATE EXPRIME EN BOSENTAN",
    "NOM_COMMERCIALE": "BOSENTAS",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "125MG",
    "COND": "B/20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CIPLA LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/9/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "2/9/2015",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["bosentan"],
    "InteractionIndexLink": ["bosentan"],
    "N_ENREGISTREMENT": "352/ 06 N 306 /18",
    "CODE_DCI": "06 N 306",
    "DCI": "BOSENTAN MONOHYDRTAE EXPRIME EN BOSENTAN",
    "NOM_COMMERCIALE": "ERATAN",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "125MG",
    "COND": "B/60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "31/1/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "31/1/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["bosentan"],
    "InteractionIndexLink": ["bosentan"],
    "N_ENREGISTREMENT": "495/ 06 N 306 /15",
    "CODE_DCI": "06 N 306",
    "DCI": "BOSENTAN MONOHYDRATE EXPRIME EN BOSENTAN",
    "NOM_COMMERCIALE": "PMS-BOSENTAN",
    "FORME": "COMPRIME",
    "DOSAGE": "125MG",
    "COND": "B/60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMASCIENCE INC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CANADA",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/9/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "13/9/2015",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["bosentan"],
    "InteractionIndexLink": ["bosentan"],
    "N_ENREGISTREMENT": "293/06 N 306/20",
    "CODE_DCI": "06 N 306",
    "DCI": "BOSENTAN MONOHYDRATE",
    "NOM_COMMERCIALE": "TRACARE",
    "FORME": "COMP PELL",
    "DOSAGE": "125MG",
    "COND": "B/56",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOCARE SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/2/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "10/2/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["iloprost"],
    "InteractionIndexLink": ["iloprost trometamol"],
    "N_ENREGISTREMENT": "424/06 N 314/16",
    "CODE_DCI": "06 N 314",
    "DCI": "ILOPROST TROMETANOL EXPRIME EN ILOPROST",
    "NOM_COMMERCIALE": "VENTAVIS",
    "FORME": "SOLUTION POUR INHALATION PAR NEBULISEUR",
    "DOSAGE": "10 UG/ML",
    "COND": "B/30 AMP DE 2ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BAYER PHARMA AG",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALLEMAGNE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/1/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "19/1/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["amlodipine", "valsartan"],
    "InteractionIndexLink": ["amlodipine", "valsartan"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "06 e 257",
    "DCI": "AMLODIPINE/VALSARTAN",
    "NOM_COMMERCIALE": "LOTEVAN",
    "FORME": "COMP",
    "DOSAGE": "80mg/5mg",
    "COND": "B 30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["amlodipine", "valsartan"],
    "InteractionIndexLink": ["amlodipine", "valsartan"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "06 e 259",
    "DCI": "AMLODIPINE/VALSARTAN",
    "NOM_COMMERCIALE": "LOTEVAN",
    "FORME": "COMP",
    "DOSAGE": "160mg/10mg",
    "COND": "B 30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["atorvastatin"],
    "InteractionIndexLink": ["atorvastatine"],
    "N_ENREGISTREMENT": "380/06 M 232/16",
    "CODE_DCI": "06M 232",
    "DCI": "ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE",
    "NOM_COMMERCIALE": "TORVASTATINE",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "40MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HUP.P.PHARMA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/11/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "9/11/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "285/ 07 A 001 /18",
    "CODE_DCI": "07 A 001",
    "DCI": "Asiaticoside (Triterpènes de CENTELLA ASIATICA",
    "NOM_COMMERCIALE": "MADECOSID",
    "FORME": "Poudre",
    "DOSAGE": "2 %",
    "COND": "Flacon de 2G",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "Union Pharmaceutique Constantinoise (UPC) / SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/3/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "7/3/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["zinc"],
    "N_ENREGISTREMENT": "003/ 07 A 006 /97/18",
    "CODE_DCI": "07 A 006",
    "DCI": "OXYDE DE ZINC / HUILE DE FOIE DE MORUE",
    "NOM_COMMERCIALE": "HFM",
    "FORME": "PDE.DERM.",
    "DOSAGE": "27G/20G/100G",
    "COND": "T/40G",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EPE GROUPE INDUSTRIEL SAIDAL/SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/8/1997",
    "DATE_D_ENREGISTREMENT_FINAL": "29/7/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["zinc"],
    "N_ENREGISTREMENT": "149/07 A 130/17",
    "CODE_DCI": "07 A 130",
    "DCI": "OXYDE DE ZINC",
    "NOM_COMMERCIALE": "CALMOZINC",
    "FORME": "PDE",
    "DOSAGE": "46 %",
    "COND": "T/30G",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVAPHARM TRADING",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/3/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "12/3/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["zinc"],
    "N_ENREGISTREMENT": "545/ 07 A 130 /98/18",
    "CODE_DCI": "07 A 130",
    "DCI": "OXYDE DE ZINC",
    "NOM_COMMERCIALE": "OXYPLASTINE",
    "FORME": "PDE",
    "DOSAGE": "46% (46 G)",
    "COND": "T/65G",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALLIANCE France SAS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/3/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "18/6/2018",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "263/07 A 185/19",
    "CODE_DCI": "07 A 185",
    "DCI": "DEXPANTHENOL",
    "NOM_COMMERCIALE": "APAISA BEBE",
    "FORME": "POMMADE",
    "DOSAGE": "5 %",
    "COND": "TUBE/30G",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOPHARM SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/9/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "22/9/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["benzoyl peroxide"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "123/ 07 B 013 /98/14",
    "CODE_DCI": "07 B 013",
    "DCI": "PEROXYDE DE BENZOYLE",
    "NOM_COMMERCIALE": "CUTACNYL",
    "FORME": "GEL.DERM.",
    "DOSAGE": "5 %",
    "COND": "T/40G",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GALDERMA INTERNATIONAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/12/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "6/7/2014",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["benzoyl peroxide"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "07 B 013",
    "DCI": "PEROXYDE DE BENZOYLE",
    "NOM_COMMERCIALE": "CUTACNYL",
    "FORME": "GEL.DERM.",
    "DOSAGE": "0.05",
    "COND": "T/40G",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["benzoyl peroxide"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "123/ 07 B 014 /98/14",
    "CODE_DCI": "07 B 014",
    "DCI": "PEROXYDE DE BENZOYLE",
    "NOM_COMMERCIALE": "CUTACNYL",
    "FORME": "GEL. DERM.",
    "DOSAGE": "10 %",
    "COND": "T/40G",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GALDERMA INTERNATIONAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/12/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "9/12/1998",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["benzoyl peroxide"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "07 B 014",
    "DCI": "PEROXYDE DE BENZOYLE",
    "NOM_COMMERCIALE": "CUTACNYL",
    "FORME": "GEL. DERM.",
    "DOSAGE": "0.1",
    "COND": "T/40G",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["ACIDE TRETINOIQUE"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "099/ 07 B 087 /99/16",
    "CODE_DCI": "07 B 087",
    "DCI": "ACIDE TRETINOIQUE",
    "NOM_COMMERCIALE": "LOCACID",
    "FORME": "CREME DERM.",
    "DOSAGE": "0.05 %",
    "COND": "T/30G",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PIERRE FABRE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/5/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "5/3/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["minoxidil"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "318/ 07 B 091 /13",
    "CODE_DCI": "07 B 091",
    "DCI": "MINOXIDIL",
    "NOM_COMMERCIALE": "MINOXIDIL NS",
    "FORME": "SOL. P. APPL. LOCALE",
    "DOSAGE": "5 %",
    "COND": "B/1FL. DE 120ML AVEC PULVERISATEUR ET PIPETTE GRADUEE",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMIDAL NS SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/5/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "29/5/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["minoxidil"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "088/ 07 B 091 /21",
    "CODE_DCI": "07 B 091",
    "DCI": "Minoxidil",
    "NOM_COMMERCIALE": "MINOXYL 5%",
    "FORME": "SOL. P. APPL. LOCALE",
    "DOSAGE": "5% (5G/100ML)",
    "COND": "B/1FL. DE 60ML AVEC PULVERISATEUR ET APPLICATEUR",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES PHARMAGHREB",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/3/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "30/3/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["adapalene"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "352/07 B 109/20",
    "CODE_DCI": "07 B 109",
    "DCI": "ADAPALENE",
    "NOM_COMMERCIALE": "ACNAL",
    "FORME": "GEL",
    "DOSAGE": "30G",
    "COND": "TUBE DE 30G",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SPA/ EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/12/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "17/12/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["adapalene"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "352/07 B 109/20",
    "CODE_DCI": "07 B 109",
    "DCI": "ADAPALENE",
    "NOM_COMMERCIALE": "ACNAL",
    "FORME": "GEL",
    "DOSAGE": "0.1%",
    "COND": "TUBE DE 30G",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SPA/ EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/12/20",
    "DATE_D_ENREGISTREMENT_FINAL": "17/12/20",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["adapalene"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "149/ 07 B 109 /13",
    "CODE_DCI": "07 B 109",
    "DCI": "ADAPALENE",
    "NOM_COMMERCIALE": "ADAPALENE NOVAGENERICS",
    "FORME": "GEL P. APPLI. LOCALE",
    "DOSAGE": "0.1%",
    "COND": "T/30G",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVAPHARM TRADING SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/9/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "5/9/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["adapalene"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "07 B 109",
    "DCI": "Adapalène",
    "NOM_COMMERCIALE": "Acnal",
    "FORME": "Gel",
    "DOSAGE": "0.001",
    "COND": "T/30g",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["adapalene"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "123/ 07 B 109 /00/17",
    "CODE_DCI": "07 B 109",
    "DCI": "ADAPALENE",
    "NOM_COMMERCIALE": "DIFFERINE",
    "FORME": "GEL. APPLI. LOCALE",
    "DOSAGE": "0.1%",
    "COND": "T/30G",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GALDERMA INTERNATIONAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "11/11/2000",
    "DATE_D_ENREGISTREMENT_FINAL": "17/5/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Cardiologie et angiologie"]
  },
  {
    "PregnancyIndexLink": ["benzoyl peroxide"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "123/ 07 B 113 /00/14",
    "CODE_DCI": "07 B 113",
    "DCI": "PEROXYDE DE BENZOYLE",
    "NOM_COMMERCIALE": "CUTACNYL",
    "FORME": "GEL. DERM.",
    "DOSAGE": "2.5%",
    "COND": "T/40G",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GALDERMA INTERNATIONAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "8/7/2000",
    "DATE_D_ENREGISTREMENT_FINAL": "6/7/2014",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["benzoyl peroxide"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "07 B 113",
    "DCI": "PEROXYDE DE BENZOYLE",
    "NOM_COMMERCIALE": "CUTACNYL",
    "FORME": "GEL. DERM.",
    "DOSAGE": "0.025",
    "COND": "T/40G",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["minoxidil"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "318/ 07 B 146 /13/19",
    "CODE_DCI": "07 B 146",
    "DCI": "MINOXIDIL",
    "NOM_COMMERCIALE": "MINOXIDIL NS",
    "FORME": "SOL. P. APPL. CUTANEE",
    "DOSAGE": "2 %",
    "COND": "B/1FL DE 120ML AVEC PULVERISATEUR ET PIPETTE GRADUEE",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMIDAL NS SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/8/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "5/5/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["minoxidil"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "088/07 B 146/19",
    "CODE_DCI": "07 B 146",
    "DCI": "MINOXIDIL",
    "NOM_COMMERCIALE": "MINOXYL",
    "FORME": "SOL P/ APPL LOCALE",
    "DOSAGE": "2 %",
    "COND": "FL/60ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMAGHREB",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/12/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "19/12/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["clindamycin"],
    "InteractionIndexLink": ["clindamycine"],
    "N_ENREGISTREMENT": "406/ 07 B 147 /08/16",
    "CODE_DCI": "07 B 147",
    "DCI": "Clindamycine phosphate exprimé en clindamycine",
    "NOM_COMMERCIALE": "DENACINE",
    "FORME": "SOL. P. APPL. LOCALE",
    "DOSAGE": "1% (10MG/ML)",
    "COND": "FL./30ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEIT JALA PHARMACEUTICALS Co",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PALESTINE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/12/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "10/7/2016",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["clindamycin"],
    "InteractionIndexLink": ["clindamycine"],
    "N_ENREGISTREMENT": "173/ 07 B 147 /06/18",
    "CODE_DCI": "07 B 147",
    "DCI": "Clindamycine phosphate exprimé en clindamycine",
    "NOM_COMMERCIALE": "DERMA-T",
    "FORME": "SOL. APPLI. LOCALE",
    "DOSAGE": "1% (10MG/ML)",
    "COND": "FL/30ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "TABUK PHARMACEUTICAL MANUFACTURING COMPANY",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ARABIE SAOUDITE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/12/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "11/2/2018",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["adapalene"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "149 / 07 B 157 /18",
    "CODE_DCI": "07 B 157",
    "DCI": "ADAPALENE",
    "NOM_COMMERCIALE": "ADAPALENE NOVAGENERICS",
    "FORME": "CREME P. APPLI. CUTANEE",
    "DOSAGE": "0.1%",
    "COND": "T/30G",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVA PHARM TRADING SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "31/1/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "31/1/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["adapalene"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "07 B 157",
    "DCI": "adapalène",
    "NOM_COMMERCIALE": "Adapalène novagenerics 0.1%",
    "FORME": "gel  dermique",
    "DOSAGE": "0.001",
    "COND": "TUBE DE 30 G",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["adapalene"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "07 B 157",
    "DCI": "adapalène",
    "NOM_COMMERCIALE": "Adapalène novagenerics 0.1%",
    "FORME": "crème",
    "DOSAGE": "0.001",
    "COND": "tube de 30 g",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["adapalene"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "123/ 07 B 157 /08/15",
    "CODE_DCI": "07 B 157",
    "DCI": "ADAPALENE",
    "NOM_COMMERCIALE": "DIFFERINE",
    "FORME": "CREME P. APPLI. CUTANEE",
    "DOSAGE": "0.1%",
    "COND": "T/30G",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GALDERMA INTERNATIONAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/12/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "3/3/2015",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["adapalene"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "07 B 157",
    "DCI": "ADAPALENE",
    "NOM_COMMERCIALE": "DIFFERINE",
    "FORME": "CREME P. APPLI. CUTANEE",
    "DOSAGE": "0.001",
    "COND": "T/30G",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["clindamycin"],
    "InteractionIndexLink": ["clindamycine"],
    "N_ENREGISTREMENT": "352/07 B 159/16",
    "CODE_DCI": "07 B 159",
    "DCI": "Clindamycine phosphate exprimé en clindamycine",
    "NOM_COMMERCIALE": "ACNESTOP",
    "FORME": "GEL DERM.",
    "DOSAGE": "1% (10MG/ML)",
    "COND": "T/30G",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/11/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "2/11/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["clindamycin"],
    "InteractionIndexLink": ["clindamycine"],
    "N_ENREGISTREMENT": "406/ 07 B 159 /09/16",
    "CODE_DCI": "07 B 159",
    "DCI": "Clindamycine phosphate exprimé en clindamycine",
    "NOM_COMMERCIALE": "DENACINE EMULGEL",
    "FORME": "GEL DERM.",
    "DOSAGE": "1% (10MG/ML)",
    "COND": "T/30G",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEIT JALA PHARMACEUTICALS Co",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PALESTINE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/3/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "10/7/2016",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["sodium fusidate (fusidic acid)"],
    "InteractionIndexLink": ["acide fusidique"],
    "N_ENREGISTREMENT": "149/07 C 016/149",
    "CODE_DCI": "07 C 016",
    "DCI": "ACIDE FUSIDIQUE SOUS FORME DE FUSIDATE DE SODIUM",
    "NOM_COMMERCIALE": "ACFUSID",
    "FORME": "PDE.DERM.",
    "DOSAGE": "2 %",
    "COND": "T/15G",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVAPHARM TRADING SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/2/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "12/2/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["sodium fusidate (fusidic acid)"],
    "InteractionIndexLink": ["acide fusidique"],
    "N_ENREGISTREMENT": "311/ 07 C 016 /15",
    "CODE_DCI": "07 C 016",
    "DCI": "ACIDE FUSIDIQUE SOUS FORME DE FUSIDATE DE SODIUM",
    "NOM_COMMERCIALE": "EFFUCINE",
    "FORME": "PDE. DERM",
    "DOSAGE": "2 %",
    "COND": "T./15G",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL GROUPEMENT PHARMACEUTIQUE ALGERIEN LGPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/12/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "13/12/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["sodium fusidate (fusidic acid)"],
    "InteractionIndexLink": ["acide fusidique"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "07 C 016",
    "DCI": "ACIDE FUSIDIQUE SOUS FORME DE FUSIDATE DE SODIUM",
    "NOM_COMMERCIALE": "FUCIDANE",
    "FORME": "PDE. DERM",
    "DOSAGE": "0.02",
    "COND": "T./15G",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["sodium fusidate (fusidic acid)"],
    "InteractionIndexLink": ["acide fusidique"],
    "N_ENREGISTREMENT": "083/ 07 C 016 /98/12",
    "CODE_DCI": "07 C 016",
    "DCI": "ACIDE FUSIDIQUE SOUS FORME DE FUSIDATE DE SODIUM",
    "NOM_COMMERCIALE": "FUCIDINE",
    "FORME": "PDE.DERM.",
    "DOSAGE": "2 %",
    "COND": "T/15G",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LEO PHARMA A/S",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "DANEMARK",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/11/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "19/7/2016",
    "TYPE": "Ré",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["sodium fusidate (fusidic acid)"],
    "InteractionIndexLink": ["acide fusidique"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "07 C 016",
    "DCI": "ACIDE FUSIDIQUE SOUS FORME DE FUSIDATE DE SODIUM",
    "NOM_COMMERCIALE": "FUCIDINE",
    "FORME": "PDE.DERM.",
    "DOSAGE": "0.02",
    "COND": "T/15G",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["sodium fusidate (fusidic acid)"],
    "InteractionIndexLink": ["acide fusidique"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "07 C 016",
    "DCI": "ACIDE FUSIDIQUE SOUS FORME DE FUSIDATE DE SODIUM",
    "NOM_COMMERCIALE": "Zeta",
    "FORME": "Pommade",
    "DOSAGE": "0.02",
    "COND": "T/15gm",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["ACIDE FUSIDIQUE"],
    "InteractionIndexLink": ["acide fusidique"],
    "N_ENREGISTREMENT": "149/ 07 C 017 /18",
    "CODE_DCI": "07 C 017",
    "DCI": "ACIDE FUSIDIQUE",
    "NOM_COMMERCIALE": "ACFUSID",
    "FORME": "CREME DERM.",
    "DOSAGE": "2% (2G/100G)",
    "COND": "T/15G",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVA PHARM TRADING SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/4/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "25/4/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["ACIDE FUSIDIQUE"],
    "InteractionIndexLink": ["acide fusidique"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "07 C 017",
    "DCI": "ACIDE FUSIDIQUE",
    "NOM_COMMERCIALE": "ACIFUDAL",
    "FORME": "CREME DERM.",
    "DOSAGE": "0.02",
    "COND": "T/15G",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["ACIDE FUSIDIQUE"],
    "InteractionIndexLink": ["acide fusidique"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "07 C 017",
    "DCI": "ACIDE FUSIDIQUE",
    "NOM_COMMERCIALE": "Zeta",
    "FORME": "Crème",
    "DOSAGE": "0.02",
    "COND": "T/15gm",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["metronidazole"],
    "InteractionIndexLink": ["metronidazole"],
    "N_ENREGISTREMENT": "123/ 07 C 018 /98/14",
    "CODE_DCI": "07 C 018",
    "DCI": "METRONIDAZOLE",
    "NOM_COMMERCIALE": "ROZEX",
    "FORME": "GEL.DERM.",
    "DOSAGE": "0.75 %",
    "COND": "T/30G",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GALDERMA INTERNATIONAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/12/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "6/7/2014",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["neomycin", "nystatin", "triamcinolone (topical)"],
    "InteractionIndexLink": ["triamcinolone"],
    "N_ENREGISTREMENT": "366/ 07 C 020 /09/17",
    "CODE_DCI": "07 C 020",
    "DCI": "NYSTATINE / TRIAMCINOLONE ACETONIDE / NEOMYCINE SULFATE EXPRIME EN NEOMYCINE",
    "NOM_COMMERCIALE": "MICOTYDE",
    "FORME": "PDE. DERM.",
    "DOSAGE": "10MUI/100MG/250MG/100G",
    "COND": "T/15G",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "4A SANTE INDUSTRIE SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "8/12/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "3/8/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["neomycin", "nystatin", "triamcinolone (topical)"],
    "InteractionIndexLink": ["triamcinolone"],
    "N_ENREGISTREMENT": "003/ 07 C 020 /97/17",
    "CODE_DCI": "07 C 020",
    "DCI": "TRIAMCINOLONE S/F TRIAMCINOLONE ACETONIDE /NEOMYCINE S/F NEOMYCINE  SULFATE / NYSTATINE",
    "NOM_COMMERCIALE": "MYCOCIDE",
    "FORME": "PDE. DERM.",
    "DOSAGE": "0.10 G/0.25 MUI/10 MUI ( PAR 100 G DE PDE)",
    "COND": "T/15G",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EPE /GROUPE INDUSTRIEL SAIDAL Spa",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "5/3/1997",
    "DATE_D_ENREGISTREMENT_FINAL": "30/10/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["neomycin", "nystatin", "triamcinolone (topical)"],
    "InteractionIndexLink": ["triamcinolone"],
    "N_ENREGISTREMENT": "400/07 C 020/17",
    "CODE_DCI": "07 C 020",
    "DCI": "NYSTATINE / TRIAMCINOLONE ACETONIDE / NEOMYCINE SULFATE EXPRIME EN NEOMYCINE",
    "NOM_COMMERCIALE": "MYCOMEX",
    "FORME": "PDE. DERM.",
    "DOSAGE": "10MUI/0.1G/0.25G",
    "COND": "T/15G",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "KPMA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/4/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "12/4/2017",
    "TYPE": "G",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["neomycin", "nystatin", "triamcinolone (topical)"],
    "InteractionIndexLink": ["triamcinolone"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "07 C 020",
    "DCI": "NYSTATINE / TRIAMCINOLONE ACETONIDE / NEOMYCINE SULFATE EXPRIME EN NEOMYCINE",
    "NOM_COMMERCIALE": "MYCOMEX",
    "FORME": "CREME",
    "DOSAGE": "10MUI/100MG/250MG/100G",
    "COND": "TUBE DE 15 G",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["mupirocin"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "305/ 07 C 104 /00/15",
    "CODE_DCI": "07 C 104",
    "DCI": "MUPIROCINE",
    "NOM_COMMERCIALE": "BACTROBAN",
    "FORME": "PDE. DERM.",
    "DOSAGE": "2 %",
    "COND": "T/15G",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GLAXOSMITHKLINE ALGERIE SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/4/2000",
    "DATE_D_ENREGISTREMENT_FINAL": "9/3/2015",
    "TYPE": "Ré",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["mupirocin"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "352/ 07 C 104 /12/18",
    "CODE_DCI": "07 C 104",
    "DCI": "MUPIROCINE",
    "NOM_COMMERCIALE": "INFECTOBAN",
    "FORME": "PDE. DERM.",
    "DOSAGE": "2 %",
    "COND": "T/15G",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "21/8/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "28/1/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "18 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["mupirocin"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "07 C 104",
    "DCI": "MUPIROCINE",
    "NOM_COMMERCIALE": "INFECTOBAN",
    "FORME": "PDE. DERM.",
    "DOSAGE": "0.02",
    "COND": "T/15G",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["mupirocin"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "546 / 07 C 104 /21",
    "CODE_DCI": "07 C 104",
    "DCI": "Mupirocine",
    "NOM_COMMERCIALE": "MICROBAN",
    "FORME": "Pommade dermique",
    "DOSAGE": "2% (2G/100G)",
    "COND": "T/15G",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ONYX Industrie Pharmaceutique / SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "21/3/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "21/3/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["mupirocin"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "07 C 104",
    "DCI": "Mupirocine",
    "NOM_COMMERCIALE": "MICROBAN",
    "FORME": "Pommade Dermique",
    "DOSAGE": "0.02",
    "COND": "T/15g",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["mupirocin"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "149/ 07 C 104 /15",
    "CODE_DCI": "07 C 104",
    "DCI": "MUPIROCINE",
    "NOM_COMMERCIALE": "MUPIROCINE NOVAGENERICS 2%",
    "FORME": "PDE. DERM.",
    "DOSAGE": "2 %",
    "COND": "T/15G",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVAPHARM TRADING SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "14/7/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "14/7/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "207/ 07 C 182 /16",
    "CODE_DCI": "07 C 182",
    "DCI": "NADIFLOXACINE",
    "NOM_COMMERCIALE": "NADIXA",
    "FORME": "CREME DERM.",
    "DOSAGE": "1 %",
    "COND": "T/25G",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FERRER INTERNACIONAL S.A",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "Espagne",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/6/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "26/6/2016",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["clotrimazole"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "400/ 07 D 024 /16",
    "CODE_DCI": "07 D 024",
    "DCI": "CLOTRIMAZOLE",
    "NOM_COMMERCIALE": "CLOTERMEX",
    "FORME": "CREME DERM.",
    "DOSAGE": "1 %",
    "COND": "T/30G",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "KPMA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/8/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "9/8/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["clotrimazole"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "07 D 024",
    "DCI": "CLOTRIMAZOLE",
    "NOM_COMMERCIALE": "CLOTERMEX",
    "FORME": "CREME",
    "DOSAGE": "0.01",
    "COND": "TUBE DE 30 G",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["clotrimazole"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "07 D 024",
    "DCI": "CLOTRIMAZOLE",
    "NOM_COMMERCIALE": "MYCOMAZOLE",
    "FORME": "CREME DERM.",
    "DOSAGE": "0.01",
    "COND": "T/30G",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["clotrimazole"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "406/ 07 D 024 /13",
    "CODE_DCI": "07 D 024",
    "DCI": "CLOTRIMAZOLE",
    "NOM_COMMERCIALE": "MYCOTEN",
    "FORME": "CREME DERM.",
    "DOSAGE": "1 %",
    "COND": "T/20G",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEIT JALA PHARMACEUTICAL COMPANY",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PALESTINE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/5/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "29/5/2013",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["econazole"],
    "InteractionIndexLink": ["econazole"],
    "N_ENREGISTREMENT": "378/ 07 D 025 /21",
    "CODE_DCI": "07 D 025",
    "DCI": "Nitrate d'éconazole",
    "NOM_COMMERCIALE": "ECONAZOLE BR",
    "FORME": "Crème dermique",
    "DOSAGE": "1 %",
    "COND": "T/30G",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOREM / SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/2/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "10/2/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["econazole"],
    "InteractionIndexLink": ["econazole"],
    "N_ENREGISTREMENT": "309/ 07 D 025 /19",
    "CODE_DCI": "07 D 025",
    "DCI": "ECONAZOLE NITRATE",
    "NOM_COMMERCIALE": "ECONAZOLE LDM",
    "FORME": "CREME.DERM.",
    "DOSAGE": "1 %",
    "COND": "T/30G",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LDM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/5/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "20/5/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["econazole"],
    "InteractionIndexLink": ["econazole"],
    "N_ENREGISTREMENT": "003/ 07 D 025 /00/19",
    "CODE_DCI": "07 D 025",
    "DCI": "ECONAZOLE NITRATE",
    "NOM_COMMERCIALE": "PHANAZOL",
    "FORME": "CREME.DERM.",
    "DOSAGE": "1 %",
    "COND": "T/30G",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SAIDAL GROUPE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "11/11/2000",
    "DATE_D_ENREGISTREMENT_FINAL": "21/4/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["econazole"],
    "InteractionIndexLink": ["econazole"],
    "N_ENREGISTREMENT": "149/ 07 D 026 /15",
    "CODE_DCI": "07 D 026",
    "DCI": "ECONAZOLE NITRATE",
    "NOM_COMMERCIALE": "ECONAZOLE NOVAGENERICS",
    "FORME": "LAIT DERMIQUE",
    "DOSAGE": "1 %",
    "COND": "FL./30ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVAPHARM TRADING SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/9/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "6/9/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["econazole"],
    "InteractionIndexLink": ["econazole"],
    "N_ENREGISTREMENT": "088/ 07 D 026 /21",
    "CODE_DCI": "07 D 026",
    "DCI": "Nitrate d'éconazole",
    "NOM_COMMERCIALE": "ECONAZYL",
    "FORME": "Emulsion fluide pour application locale (Lait dermique)",
    "DOSAGE": "1% (1G/100G d'émulsion)",
    "COND": "B/1 FL de 30ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES PHARMAGHREB",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/3/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "30/3/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["econazole"],
    "InteractionIndexLink": ["econazole"],
    "N_ENREGISTREMENT": "088/07 D 027/19",
    "CODE_DCI": "07 D 027",
    "DCI": "ECONAZOLE NITRATE",
    "NOM_COMMERCIALE": "ECONAZYL 1% SOLUTION",
    "FORME": "SOL P/ APPL LOCALE",
    "DOSAGE": "1 %",
    "COND": "FL PULVERISATEUR /30G",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMAGHREB",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/1/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "9/1/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["ketoconazole"],
    "InteractionIndexLink": ["ketoconazole"],
    "N_ENREGISTREMENT": "149/ 07 D 028 /13/18",
    "CODE_DCI": "07 D 028",
    "DCI": "Ketoconazole",
    "NOM_COMMERCIALE": "KETOCREM",
    "FORME": "CREME DERM.",
    "DOSAGE": "2 %",
    "COND": "T/15G",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVAPHARM TRADING SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/4/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "30/4/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["ketoconazole"],
    "InteractionIndexLink": ["ketoconazole"],
    "N_ENREGISTREMENT": "079/ 07 D 028 /07/13",
    "CODE_DCI": "07 D 028",
    "DCI": "Ketoconazole",
    "NOM_COMMERCIALE": "KETODEL",
    "FORME": "CREME DERM.",
    "DOSAGE": "2 %",
    "COND": "T/15G",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE  ALGERIEN DE DEVELOPPEMENT  PHARMACEUTIQUE   (LAD PHARMA)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/11/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "30/9/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["ketoconazole"],
    "InteractionIndexLink": ["ketoconazole"],
    "N_ENREGISTREMENT": "095/ 07 D 028 /98/14",
    "CODE_DCI": "07 D 028",
    "DCI": "Ketoconazole",
    "NOM_COMMERCIALE": "KETODERM",
    "FORME": "CREME DERM.",
    "DOSAGE": "2 %",
    "COND": "T/15G",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JANSSEN CILAG",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/4/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "28/10/2014",
    "TYPE": "Ré",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["ketoconazole"],
    "InteractionIndexLink": ["ketoconazole"],
    "N_ENREGISTREMENT": "17/06/07 D 028/003",
    "CODE_DCI": "07 D 028",
    "DCI": "KETOCONAZOLE",
    "NOM_COMMERCIALE": "KETOSKIN",
    "FORME": "CREME DERMIQUE",
    "DOSAGE": "2.00 %",
    "COND": "TUBE DE 15G",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES EPE GROUPE INDUSTRIEL SAIDAL/ SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "14/02/06",
    "DATE_D_ENREGISTREMENT_FINAL": "23/10/17",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["ketoconazole"],
    "InteractionIndexLink": ["ketoconazole"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "07 D 028",
    "DCI": "Ketoconazole",
    "NOM_COMMERCIALE": "KETOSKIN",
    "FORME": "CREME DERM.",
    "DOSAGE": "0.02",
    "COND": "T/15G",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["ketoconazole"],
    "InteractionIndexLink": ["ketoconazole"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "07 D 028",
    "DCI": "Ketoconazole",
    "NOM_COMMERCIALE": "MYCOZOL",
    "FORME": "CREME DERM.",
    "DOSAGE": "0.02",
    "COND": "T/15G",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["ketoconazole"],
    "InteractionIndexLink": ["ketoconazole"],
    "N_ENREGISTREMENT": "352/ 07 D 028 /11/18",
    "CODE_DCI": "07 D 028",
    "DCI": "Ketoconazole",
    "NOM_COMMERCIALE": "VAVO",
    "FORME": "CREME DERM.",
    "DOSAGE": "2 %",
    "COND": "T/15G",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/12/2011",
    "DATE_D_ENREGISTREMENT_FINAL": "8/4/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["ketoconazole"],
    "InteractionIndexLink": ["ketoconazole"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "07 D 029",
    "DCI": "kétoconazole",
    "NOM_COMMERCIALE": "KETOCONAZOLE  novagenerics  2%",
    "FORME": "gel moussant",
    "DOSAGE": "0.02",
    "COND": "tube de 20 g",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["ketoconazole"],
    "InteractionIndexLink": ["ketoconazole"],
    "N_ENREGISTREMENT": "149/ 07 D 029 /13",
    "CODE_DCI": "07 D 029",
    "DCI": "Ketoconazole",
    "NOM_COMMERCIALE": "KETOCONAZOLE NOVAGENERICS",
    "FORME": "GEL MOUSSANT EN RECIPIENT UNIDOSE",
    "DOSAGE": "2 %",
    "COND": "T/20G",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVAPHARM TRADING SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/10/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "20/10/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["nystatin"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "003/ 07 D 032 /98/17",
    "CODE_DCI": "07 D 032",
    "DCI": "NYSTATINE",
    "NOM_COMMERCIALE": "MYCOTINE",
    "FORME": "PDE DERM.",
    "DOSAGE": "100 000 UI/G",
    "COND": "T/15G",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EPE GROUPE INDUSTRIEL SAIDAL/SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "5/3/1997",
    "DATE_D_ENREGISTREMENT_FINAL": "8/10/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["ketoconazole"],
    "InteractionIndexLink": ["ketoconazole"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "07 D 092",
    "DCI": "ketoconazole",
    "NOM_COMMERCIALE": "KETOCONAZOLE  novagenerics 2%",
    "FORME": "gel moussant en sachet-dose",
    "DOSAGE": "0.02",
    "COND": "BOITE DE 08",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["ketoconazole"],
    "InteractionIndexLink": ["ketoconazole"],
    "N_ENREGISTREMENT": "149/07 D 092/20",
    "CODE_DCI": "07 D 092",
    "DCI": "KETOCONAZOLE",
    "NOM_COMMERCIALE": "KETOCONAZOLE NOVAGENERICS",
    "FORME": "GEL MOUSSANT EN SACHET DOSE",
    "DOSAGE": "2 %",
    "COND": "B/08 SACHET- DOSE DE 6G",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVAPHARM TRADING SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/1/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "9/1/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["terbinafine"],
    "InteractionIndexLink": ["terbinafine"],
    "N_ENREGISTREMENT": "311/ 07 D 094 /15",
    "CODE_DCI": "07 D 094",
    "DCI": "TERBINAFINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "DERMAFINE",
    "FORME": "CREME DERM.",
    "DOSAGE": "1 %",
    "COND": "B/01 TUBE DE 15G",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES GROUPEMENT PHARMACEUTIQUE ALGERIEN (LGPA) SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/2/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "22/2/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["terbinafine"],
    "InteractionIndexLink": ["terbinafine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "07 D 094",
    "DCI": "TERBINAFINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "DERMAFINE",
    "FORME": "CREME DERM.",
    "DOSAGE": "0.01",
    "COND": "B/01 TUBE DE 15G",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["terbinafine"],
    "InteractionIndexLink": ["terbinafine"],
    "N_ENREGISTREMENT": "17/06/07 D 094/003",
    "CODE_DCI": "07 D 094",
    "DCI": "TERBINAFINE",
    "NOM_COMMERCIALE": "LAMIDAZ",
    "FORME": "CREME DERMIQUE",
    "DOSAGE": "1.00 %",
    "COND": "TUBE DE 15G",
    "LISTE": "LISTE II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES EPE GROUPE INDUSTRIEL SAIDAL/ SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "14/02/06",
    "DATE_D_ENREGISTREMENT_FINAL": "30/10/17",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["terbinafine"],
    "InteractionIndexLink": ["terbinafine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "07 D 094",
    "DCI": "TERBINAFINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "LAMIDAZ",
    "FORME": "CREME DERM.",
    "DOSAGE": "0.01",
    "COND": "T/15G",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["terbinafine"],
    "InteractionIndexLink": ["terbinafine"],
    "N_ENREGISTREMENT": "21/07 D 094/462",
    "CODE_DCI": "07 D 094",
    "DCI": "CHLORHYDRATE DE TERBINAFINE",
    "NOM_COMMERCIALE": "MANTIXA",
    "FORME": "CREME DERMIQUE",
    "DOSAGE": "1.00 %",
    "COND": "TUBE DE 15G",
    "LISTE": "LISTE II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES SARL/PHYSIOPHARM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/04/21",
    "DATE_D_ENREGISTREMENT_FINAL": "25/04/21",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["terbinafine"],
    "InteractionIndexLink": ["terbinafine"],
    "N_ENREGISTREMENT": "035/ 07 D 094 /15",
    "CODE_DCI": "07 D 094",
    "DCI": "TERBINAFINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "TERBIFINE",
    "FORME": "CREME",
    "DOSAGE": "1 %",
    "COND": "T/15G",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMALLIANCE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/12/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "29/12/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["terbinafine"],
    "InteractionIndexLink": ["terbinafine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "07 D 094",
    "DCI": "TERBINAFINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "TERBIL",
    "FORME": "CREME",
    "DOSAGE": "0.01",
    "COND": "T/15G",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["terbinafine"],
    "InteractionIndexLink": ["terbinafine"],
    "N_ENREGISTREMENT": "400/ 07 D 094 /16",
    "CODE_DCI": "07 D 094",
    "DCI": "TERBINAFINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "TERBINAMEX",
    "FORME": "CREME",
    "DOSAGE": "1 %",
    "COND": "T/15G",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "KPMA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/4/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "19/4/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["terbinafine"],
    "InteractionIndexLink": ["terbinafine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "07 D 094",
    "DCI": "TERBINAFINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "TERBINAMEX",
    "FORME": "CREME",
    "DOSAGE": "0.01",
    "COND": "TUBE DE 15 G",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["terbinafine"],
    "InteractionIndexLink": ["terbinafine"],
    "N_ENREGISTREMENT": "263/ 07 D 094 /15",
    "CODE_DCI": "07 D 094",
    "DCI": "TERBINAFINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "TERBINAN",
    "FORME": "CREME",
    "DOSAGE": "1 %",
    "COND": "T/15G",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOPHARM SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/4/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "12/4/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["terbinafine"],
    "InteractionIndexLink": ["terbinafine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "07 D 094",
    "DCI": "TERBINAFINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "TERBINAN",
    "FORME": "CREME",
    "DOSAGE": "0.01",
    "COND": "T/15G",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["terbinafine"],
    "InteractionIndexLink": ["terbinafine"],
    "N_ENREGISTREMENT": "149/ 07 D 094 /15",
    "CODE_DCI": "07 D 094",
    "DCI": "TERBINAFINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "TERFINEX",
    "FORME": "CREME DERM.",
    "DOSAGE": "1 %",
    "COND": "T/15G",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL NOVAPHARM TRADING",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/2/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "2/2/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["terbinafine"],
    "InteractionIndexLink": ["terbinafine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "07 D 094",
    "DCI": "terbinafine",
    "NOM_COMMERCIALE": "TERFINEX CREME 1%",
    "FORME": "crème",
    "DOSAGE": "0.01",
    "COND": "tube de 15g",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["terbinafine"],
    "InteractionIndexLink": ["terbinafine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "07 D 094",
    "DCI": "Terbinafine Chlorhydrate",
    "NOM_COMMERCIALE": "Terbifine",
    "FORME": "Crème Dermique",
    "DOSAGE": "0.15 g (1%)",
    "COND": "Tube 15g",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "07 D 108",
    "DCI": "SERTACONAZOLE NITRATE",
    "NOM_COMMERCIALE": "DERMOFIX",
    "FORME": "Crème",
    "DOSAGE": "0.02",
    "COND": "Tube 10g",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "546/ 07 D 108 /21",
    "CODE_DCI": "07 D 108",
    "DCI": "Nitrate de Sertaconazole",
    "NOM_COMMERCIALE": "DERMONYX",
    "FORME": "Crème",
    "DOSAGE": "2 %",
    "COND": "T/15G",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ONYX Industrie Pharmaceutique / SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "21/3/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "21/3/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "07 D 108",
    "DCI": "SERTACONAZOLE NITRATE",
    "NOM_COMMERCIALE": "DERMOX",
    "FORME": "Crème",
    "DOSAGE": "0.02",
    "COND": "Tube 20g",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "352/ 07 D 108 /18",
    "CODE_DCI": "07 D 108",
    "DCI": "Sertaconazole nitrate",
    "NOM_COMMERCIALE": "OVUZOLE",
    "FORME": "CREME",
    "DOSAGE": "2 %",
    "COND": "T/20G",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SPA EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/5/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "27/5/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "07 D 108",
    "DCI": "Sertaconazole",
    "NOM_COMMERCIALE": "Ovuzole",
    "FORME": "Crème",
    "DOSAGE": "0.02",
    "COND": "T/20g",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "088/07 D 108/20",
    "CODE_DCI": "07 D 108",
    "DCI": "NITRATE DE SERTACONAZOLE",
    "NOM_COMMERCIALE": "SERTOFIX",
    "FORME": "CREME DERMIQUE",
    "DOSAGE": "2 %",
    "COND": "TUBE DE 20G",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES PHARMAGHREB",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/12/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "29/12/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["amorolfine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "123/ 07 D 110 /00/15",
    "CODE_DCI": "07 D 110",
    "DCI": "AMOROLFINE CHLORHYDRATE EXPRIME EN AMOROLFINE",
    "NOM_COMMERCIALE": "LOCERYL",
    "FORME": "VERNIS A ONGLES MEDICAMENTEUX",
    "DOSAGE": "5 %",
    "COND": "B/01FL de 2.5ML + 10 SPATULES",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GALDERMA INTERNATIONAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "11/12/2000",
    "DATE_D_ENREGISTREMENT_FINAL": "12/4/2015",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["amorolfine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "07 D 110",
    "DCI": "AMOROLFINE CHLORHYDRATE EXPRIME EN AMOROLFINE",
    "NOM_COMMERCIALE": "LOCERYL",
    "FORME": "VERNIS A ONGLES MEDICAMENTEUX",
    "DOSAGE": "0.05",
    "COND": "B/01FL de 2.5ML + 10 SPATULES",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["amorolfine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "149/07 D 110/20",
    "CODE_DCI": "07 D 110",
    "DCI": "AMOROLFINE CHLORHYDRATE EXPRIME EN AMOROLFINE",
    "NOM_COMMERCIALE": "NOCIRINE",
    "FORME": "VERNIS A ONGLES MEDICAMENTEUX",
    "DOSAGE": "5 %",
    "COND": "FLC 2.5ML AVEC 10 SPATULES",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES SARL/ NOVA PHARM TRADING",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/12/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "27/12/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["amorolfine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "07 D 110",
    "DCI": "AMOROLFINE",
    "NOM_COMMERCIALE": "NOCIRINE",
    "FORME": "vernis  a ongle",
    "DOSAGE": "0.05",
    "COND": "flacon de 2.5 ml avec 10 spatules",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "07 D 131",
    "DCI": "NAFTIFINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "EXODERIL",
    "FORME": "SOL. DERM.",
    "DOSAGE": "0.01",
    "COND": "FL/10ML",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "07 D 132",
    "DCI": "NAFTIFINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "EXODERIL",
    "FORME": "CREME DERM.",
    "DOSAGE": "0.01",
    "COND": "T/15G",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "07 D 139",
    "DCI": "SERTACONAZOLE NITRATE",
    "NOM_COMMERCIALE": "DERMOFIX",
    "FORME": "GEL",
    "DOSAGE": "0.02",
    "COND": "T/100G",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["ketoconazole"],
    "InteractionIndexLink": ["ketoconazole"],
    "N_ENREGISTREMENT": "406/ 07 D 141 /13",
    "CODE_DCI": "07 D 141",
    "DCI": "Ketoconazole",
    "NOM_COMMERCIALE": "DANDREX",
    "FORME": "SHAMPOING",
    "DOSAGE": "2 %",
    "COND": "FL/100ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEIT JALA PHARMACEUTICAL COMPANY",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PALESTINE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/6/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "4/6/2013",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["ketoconazole"],
    "InteractionIndexLink": ["ketoconazole"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "07 D 141",
    "DCI": "Ketoconazole",
    "NOM_COMMERCIALE": "DANDREX",
    "FORME": "SHAMPOING",
    "DOSAGE": "0.02",
    "COND": "FL/100ML",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["ketoconazole"],
    "InteractionIndexLink": ["ketoconazole"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "07 D 141",
    "DCI": "kétoconazole",
    "NOM_COMMERCIALE": "KETOCONAZOLE  novagenerics 2%",
    "FORME": "shampoing",
    "DOSAGE": "0.02",
    "COND": "FLACON DE 100 ML",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["ketoconazole"],
    "InteractionIndexLink": ["ketoconazole"],
    "N_ENREGISTREMENT": "149/ 07 D 141 / 18",
    "CODE_DCI": "07 D 141",
    "DCI": "Ketoconazole",
    "NOM_COMMERCIALE": "KETOCONAZOLE NOVAGENERICS",
    "FORME": "SHAMPOING",
    "DOSAGE": "2 %",
    "COND": "FL./100ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL NOVAPHARM TRADING",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "16/1/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "16/1/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24  MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["ketoconazole"],
    "InteractionIndexLink": ["ketoconazole"],
    "N_ENREGISTREMENT": "088 / 07 D 141 /21",
    "CODE_DCI": "07 D 141",
    "DCI": "Kétoconazole",
    "NOM_COMMERCIALE": "KETONAZOLE",
    "FORME": "Gel moussant",
    "DOSAGE": "2 %",
    "COND": "Flacon de 100ML",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMAGHREB",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "14/3/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "14/3/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["ketoconazole"],
    "InteractionIndexLink": ["ketoconazole"],
    "N_ENREGISTREMENT": "173/ 07 D 141 /07/17",
    "CODE_DCI": "07 D 141",
    "DCI": "Ketoconazole",
    "NOM_COMMERCIALE": "VAVO SHAMPOO",
    "FORME": "SHAMPOING",
    "DOSAGE": "2 %",
    "COND": "FL./100ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "TABUK PHARMACEUTICAL MANUFACTURING COMPANY",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ARABIE SAOUDITE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/2/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "7/1/2018",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["ciclopirox"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "149/07 D 148/17",
    "CODE_DCI": "07 D 148",
    "DCI": "CICLOPIROX OLAMINE",
    "NOM_COMMERCIALE": "MYCODERM",
    "FORME": "CREME",
    "DOSAGE": "1% ( 1g/100 g)",
    "COND": "T/30G",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVAPHARM TRADING SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/6/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "18/6/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["ciclopirox"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "07 D 148",
    "DCI": "ciclopirox olamine",
    "NOM_COMMERCIALE": "MYCODERM",
    "FORME": "crème",
    "DOSAGE": "0.01",
    "COND": "tube de 30 g",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["ciclopirox"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "352/07 D 148/20",
    "CODE_DCI": "07 D 148",
    "DCI": "CICLOPIROX OLAMINE",
    "NOM_COMMERCIALE": "STOPMYCOSE",
    "FORME": "CREME",
    "DOSAGE": "1% (1G/100G)",
    "COND": "T/30G",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/5/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "4/5/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["ciclopirox"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "186/ 07 D 149 /06/16",
    "CODE_DCI": "07 D 149",
    "DCI": "CICLOPIROX OLAMINE",
    "NOM_COMMERCIALE": "MYCOSTER",
    "FORME": "SOL. APPL. CUTANEE",
    "DOSAGE": "1 %",
    "COND": "FL./30ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PIERRE FABRE DERMATOLOGIE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/1/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "5/3/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["ciclopirox"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "186/ 07 D 151 /07/17",
    "CODE_DCI": "07 D 151",
    "DCI": "CICLOPIROX",
    "NOM_COMMERCIALE": "MYCOSTER",
    "FORME": "SOL. FILMOGENE APPLI. LOCALE",
    "DOSAGE": "8 %",
    "COND": "F/3ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PIERRE FABRE DERMATOLOGIE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "16/4/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "5/3/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["ciclopirox"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "07 D 151",
    "DCI": "CICLOPIROX",
    "NOM_COMMERCIALE": "MYCOSTER",
    "FORME": "SOL. FILMOGENE APPLI. LOCALE",
    "DOSAGE": "0.08",
    "COND": "F/3ML",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["terbinafine"],
    "InteractionIndexLink": ["terbinafine"],
    "N_ENREGISTREMENT": "267/ 07 D 156 /08/16",
    "CODE_DCI": "07 D 156",
    "DCI": "TERBINAFINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "LAMISIL",
    "FORME": "SOL. PULV. CUTANEE",
    "DOSAGE": "1 %",
    "COND": "FL./15ML",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVARTIS SANTE FAMILIALE SAS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/1/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "26/7/2016",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["terbinafine"],
    "InteractionIndexLink": ["terbinafine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "07 D 156",
    "DCI": "TERBINAFINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "TERBIDAL 1%",
    "FORME": "SOL P. APPLIC. LOCALE",
    "DOSAGE": "0.01",
    "COND": "B/01 FLACON PULVERISATEUR DE 15ML",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["terbinafine"],
    "InteractionIndexLink": ["terbinafine"],
    "N_ENREGISTREMENT": "267/ 07 D 178 /13",
    "CODE_DCI": "07 D 178",
    "DCI": "TERBINAFINE CHLORHYDRATE EXPRIME EN TERBINAFINE",
    "NOM_COMMERCIALE": "LAMISILATE MONODOSE",
    "FORME": "SOL. P. APPL. CUTANEE",
    "DOSAGE": "1 %",
    "COND": "T/4G",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVARTIS SANTE FAMILIALE SAS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/9/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "15/9/2013",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "20/07 D108/207",
    "CODE_DCI": "07 D 181",
    "DCI": "SERTACONAZOLE NITRATE",
    "NOM_COMMERCIALE": "DERMOFIX",
    "FORME": "SOLUTION DERMIQUE EN SPRAY",
    "DOSAGE": "2 %",
    "COND": "F/30ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES BIOPHARM SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/12/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "25/10/2020",
    "TYPE": "Ré",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["aciclovir (topical)"],
    "InteractionIndexLink": ["aciclovir"],
    "N_ENREGISTREMENT": "035/ 07 E 033 /98/13",
    "CODE_DCI": "07 E 033",
    "DCI": "ACICLOVIR",
    "NOM_COMMERCIALE": "CLOVIRAX",
    "FORME": "CREME DERM.",
    "DOSAGE": "5 %",
    "COND": "T/2G ET T/10G",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMALLIANCE EURL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/3/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "13/8/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["aciclovir (topical)"],
    "InteractionIndexLink": ["aciclovir"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "07 E 033",
    "DCI": "Aciclovir",
    "NOM_COMMERCIALE": "Clovirax",
    "FORME": "Crème Dermique",
    "DOSAGE": "0.05",
    "COND": "Tube de 2gr",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["aciclovir (topical)"],
    "InteractionIndexLink": ["aciclovir"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "07 E 033",
    "DCI": "Aciclovir",
    "NOM_COMMERCIALE": "Clovirax",
    "FORME": "Crème Dermique",
    "DOSAGE": "0.05",
    "COND": "Tube de 10gr",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["aciclovir (topical)"],
    "InteractionIndexLink": ["aciclovir"],
    "N_ENREGISTREMENT": "149/ 07 E 033 /13/19",
    "CODE_DCI": "07 E 033",
    "DCI": "ACICLOVIR",
    "NOM_COMMERCIALE": "NOVACLOVIR",
    "FORME": "CREME DERM.",
    "DOSAGE": "5 %",
    "COND": "T/15G ET T/02G",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVAPHARM TRADING SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/9/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "19/7/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["aciclovir (topical)"],
    "InteractionIndexLink": ["aciclovir"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "07 E 033",
    "DCI": "aciclovir",
    "NOM_COMMERCIALE": "Novaclovir 5% crème",
    "FORME": "crème dermique",
    "DOSAGE": "200 mg",
    "COND": "TUBE DE 15 G ET DE 2 G",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["aciclovir (topical)"],
    "InteractionIndexLink": ["aciclovir"],
    "N_ENREGISTREMENT": "079/ 07 E 033 /07/14",
    "CODE_DCI": "07 E 033",
    "DCI": "ACICLOVIR",
    "NOM_COMMERCIALE": "VIRAVIR",
    "FORME": "CREME DERM.",
    "DOSAGE": "5 %",
    "COND": "T/3G ET T/5G",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE ALGERIEN DE DEVELOPPEMENT PHARMACEUTIQUE (LAD PHARMA) SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/11/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "4/5/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["crotamiton"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "088/07 G 036/19",
    "CODE_DCI": "07 G 036",
    "DCI": "CROTAMITON",
    "NOM_COMMERCIALE": "E-RAX",
    "FORME": "CREME DERMIQUE",
    "DOSAGE": "10 %",
    "COND": "TUBE/0G",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMAGHREB",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/12/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "19/12/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["crotamiton"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "17/10/07 G 036/003",
    "CODE_DCI": "07 G 036",
    "DCI": "CROTAMITON",
    "NOM_COMMERCIALE": "PRURAX",
    "FORME": "CREME DERMIQUE",
    "DOSAGE": "10.00 %",
    "COND": "TUBE DE 40G",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES EPE GROUPE INDUSTRIEL SAIDAL/ SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "16/03/10",
    "DATE_D_ENREGISTREMENT_FINAL": "27/12/17",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["betamethasone"],
    "InteractionIndexLink": ["betamethasone"],
    "N_ENREGISTREMENT": "109/ 07 H 038 /99/17",
    "CODE_DCI": "07 H 038",
    "DCI": "BETAMETHASONE",
    "NOM_COMMERCIALE": "BETADERME",
    "FORME": "CREME DERM.",
    "DOSAGE": "0.1%",
    "COND": "T/20G",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EIPICO",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EGYPTE",
    "DATE_D_ENREGISTREMENT_INITIAL": "21/4/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "27/2/2017",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["betamethasone dipropionate"],
    "InteractionIndexLink": ["betamethasone"],
    "N_ENREGISTREMENT": "149/ 07 H 038 /16",
    "CODE_DCI": "07 H 038",
    "DCI": "BETAMETHASONE DIPROPIONATE",
    "NOM_COMMERCIALE": "BETAMETHASONE NOVAGENERICS",
    "FORME": "CREME",
    "DOSAGE": "0.05 %",
    "COND": "T/15G",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL NOVAPHARM TRADING",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/2/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "22/2/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["betamethasone dipropionate"],
    "InteractionIndexLink": ["betamethasone"],
    "N_ENREGISTREMENT": "462/ 07 H 038 /21",
    "CODE_DCI": "07 H 038",
    "DCI": "Dipropionate de Bétaméthasone exprimé en Bétaméthasone",
    "NOM_COMMERCIALE": "BETAMETHASONE PHYSIOPHARM",
    "FORME": "Crème dermique",
    "DOSAGE": "0.05 %",
    "COND": "T/15G",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHYSIOPHARM / SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/4/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "7/4/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["betamethasone dipropionate"],
    "InteractionIndexLink": ["betamethasone"],
    "N_ENREGISTREMENT": "263/ 07 H 038 /12",
    "CODE_DCI": "07 H 038",
    "DCI": "BETAMETHASONE DIPROPIONATE EXPRIME EN BETAMETHASONE",
    "NOM_COMMERCIALE": "CELETASONE",
    "FORME": "CREME DERM.",
    "DOSAGE": "0.05 %",
    "COND": "T/15G",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOPHARM SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/11/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "27/11/2012",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["betamethasone dipropionate"],
    "InteractionIndexLink": ["betamethasone"],
    "N_ENREGISTREMENT": "149/ 07 H 039 /13",
    "CODE_DCI": "07 H 039",
    "DCI": "BETAMETHASONE DIPROPIONATE EXPRIME EN BETAMETHASONE",
    "NOM_COMMERCIALE": "BETAMETHASONE NOVAGENERICS",
    "FORME": "PDE. DERM.",
    "DOSAGE": "0.05 %",
    "COND": "T/15G",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVAPHARM TRADING",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "5/3/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "5/3/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["betamethasone dipropionate"],
    "InteractionIndexLink": ["betamethasone"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "07 H 039",
    "DCI": "Bétaméthasone dipropionate",
    "NOM_COMMERCIALE": "BETAMETHASONE PHYSIOPHARM",
    "FORME": "Pommade dermique",
    "DOSAGE": "0.0005",
    "COND": "Tube de 15g",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["betamethasone dipropionate"],
    "InteractionIndexLink": ["betamethasone"],
    "N_ENREGISTREMENT": "003/ 07 H 039 /99/16",
    "CODE_DCI": "07 H 039",
    "DCI": "BETAMETHASONE DIPROPIONATE EXPRIME EN BETAMETHASONE",
    "NOM_COMMERCIALE": "BETASONE",
    "FORME": "PDE.DERM.",
    "DOSAGE": "0.05 %",
    "COND": "T/15G",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EPE GROUPE INDUSTRIEL SAIDAL/SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/1/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "28/12/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["betamethasone dipropionate"],
    "InteractionIndexLink": ["betamethasone"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "07 H 039",
    "DCI": "BETAMETHASONE DIPROPIONATE EXPRIME EN BETAMETHASONE",
    "NOM_COMMERCIALE": "BETASONE",
    "FORME": "PDE.DERM.",
    "DOSAGE": "0.0005",
    "COND": "T/15G",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["betamethasone dipropionate"],
    "InteractionIndexLink": ["betamethasone"],
    "N_ENREGISTREMENT": "20/07 H039/462",
    "CODE_DCI": "07 H 039",
    "DCI": "DIPROPIONATE DE BÉTAMÉTHASONE EXPRIMÉE EN BÉTAMÉTHASONE",
    "NOM_COMMERCIALE": "BETHAMETHASONE PHYSIOPHARM",
    "FORME": "POMMADE DERMIQUE",
    "DOSAGE": "0.05%",
    "COND": "TUBE/ 15G",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES SARL PHYSIOPHARM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/10/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "18/10/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["betamethasone"],
    "InteractionIndexLink": ["betamethasone"],
    "N_ENREGISTREMENT": "455/ 07 H 040 /99/12",
    "CODE_DCI": "07 H 040",
    "DCI": "BETAMETHASONE",
    "NOM_COMMERCIALE": "BETSOL",
    "FORME": "LOTION DERM.",
    "DOSAGE": "0.05 %",
    "COND": "B/1FL. DE 15ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GENCOPHARM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "16/11/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "13/8/2012",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["betamethasone"],
    "InteractionIndexLink": ["betamethasone"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "07 H 040",
    "DCI": "BETAMETHASONE",
    "NOM_COMMERCIALE": "BETSOL",
    "FORME": "LOTION DERM.",
    "DOSAGE": "0.0005",
    "COND": "B/1FL. DE 15ML",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": [
      "betamethasone acetate",
      "betamethasone",
      "betamethasone dipropionate",
      "betamethasone valerate"
    ],
    "InteractionIndexLink": ["betamethasone"],
    "N_ENREGISTREMENT": "235/ 07 H 040 /13/19",
    "CODE_DCI": "07 H 040",
    "DCI": "BETAMETHASONE DIPROPIONATE EXPRIME EN BETHAMETHASONE",
    "NOM_COMMERCIALE": "DERMASONE",
    "FORME": "LOTION DERM.",
    "DOSAGE": "0.05 %",
    "COND": "FL./15G",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIO-GALENIC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "3/11/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "23/1/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["betamethasone dipropionate"],
    "InteractionIndexLink": ["betamethasone"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "07 H 040",
    "DCI": "BETAMETHASONE DIPROPIONATE EXPRIME EN BETHAMETHASONE",
    "NOM_COMMERCIALE": "DERMASONE",
    "FORME": "LOTION DERM.",
    "DOSAGE": "0.0005",
    "COND": "FL./15G",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["betamethasone dipropionate", "ACIDE SALICYLIQUE"],
    "InteractionIndexLink": ["betamethasone", "acide acetylsalicylique"],
    "N_ENREGISTREMENT": "003/ 07 H 041 /09/18",
    "CODE_DCI": "07 H 041",
    "DCI": "BETAMETHASONE DIPROPIONATE EXPRIME EN BETAMETHASONE / ACIDE SALICYLIQUE",
    "NOM_COMMERCIALE": "BETACYL",
    "FORME": "PDE. DERM.",
    "DOSAGE": "0.05G%/3G%",
    "COND": "T/15G",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EPE GROUPE INDUSTRIEL SAIDAL/SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/3/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "19/3/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["betamethasone dipropionate", "ACIDE SALICYLIQUE"],
    "InteractionIndexLink": ["betamethasone", "acide acetylsalicylique"],
    "N_ENREGISTREMENT": "149/ 07 H 041 /13",
    "CODE_DCI": "07 H 041",
    "DCI": "BETAMETHASONE DIPROPIONATE EXPRIME EN BETAMETHASONE / ACIDE SALICYLIQUE",
    "NOM_COMMERCIALE": "BETAMETHASONE-ACIDE SALICYLIQUE NOVAGENERICS",
    "FORME": "PDE. DERM.",
    "DOSAGE": "0.05G/3G/100G",
    "COND": "T/15G",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVAPHARM TRADING SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/3/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "10/3/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["desonide"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "186/ 07 H 042 /08/16",
    "CODE_DCI": "07 H 042",
    "DCI": "DESONIDE",
    "NOM_COMMERCIALE": "LOCATOP",
    "FORME": "CREME DERM.",
    "DOSAGE": "0.1%",
    "COND": "T./30G",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PIERRE FABRE DERMATOLOGIE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/4/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "5/3/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["desonide"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "07 H 042",
    "DCI": "DESONIDE",
    "NOM_COMMERCIALE": "LOCATOP",
    "FORME": "CREME DERM.",
    "DOSAGE": "0.001",
    "COND": "T./30G",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["desonide"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "352/07 H 042/20",
    "CODE_DCI": "07 H 042",
    "DCI": "DESONIDE",
    "NOM_COMMERCIALE": "LOCAZONE",
    "FORME": "CREME DERMIQUE",
    "DOSAGE": "0.1% (0.1G/100G)",
    "COND": "B/ 01 TUBE 15G",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SPA/ EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/12/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "29/12/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["dexamethasone"],
    "InteractionIndexLink": ["dexamethasone"],
    "N_ENREGISTREMENT": "012/ 07 H 043 /98/14",
    "CODE_DCI": "07 H 043",
    "DCI": "DEXAMETHASONE",
    "NOM_COMMERCIALE": "DESACROVIS",
    "FORME": "PDE. DERM.",
    "DOSAGE": "0.050G/100G (OU 0.05%)",
    "COND": "T/30G",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CROVIS PHILCOM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ITALIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/7/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "22/6/2014",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["hydrocortisone"],
    "InteractionIndexLink": ["hydrocortisone"],
    "N_ENREGISTREMENT": "149/ 07 H 117 /19",
    "CODE_DCI": "07 H 117",
    "DCI": "HYDROCORTISONE ACEPONATE",
    "NOM_COMMERCIALE": "ECZECORT",
    "FORME": "CREME LIPOPHILE",
    "DOSAGE": "0.127%",
    "COND": "T/30G",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVAPHARM TRADING",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "16/1/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "16/1/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["hydrocortisone"],
    "InteractionIndexLink": ["hydrocortisone"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "07 H 117",
    "DCI": "HYDROCORTISONE ACEPONATE",
    "NOM_COMMERCIALE": "ECZECORT",
    "FORME": "CREME LIPOPHILE",
    "DOSAGE": "0.00127",
    "COND": "T/30G",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["hydrocortisone"],
    "InteractionIndexLink": ["hydrocortisone"],
    "N_ENREGISTREMENT": "123/ 07 H 117 /01/16",
    "CODE_DCI": "07 H 117",
    "DCI": "HYDROCORTISONE ACEPONATE",
    "NOM_COMMERCIALE": "EFFICORT LIPOPHILE",
    "FORME": "CREME LIPOPHILE",
    "DOSAGE": "0.127%",
    "COND": "T/30G",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GALDERMA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/1/2001",
    "DATE_D_ENREGISTREMENT_FINAL": "26/7/2016",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["hydrocortisone"],
    "InteractionIndexLink": ["hydrocortisone"],
    "N_ENREGISTREMENT": "123/ 07 H 118 /01/15",
    "CODE_DCI": "07 H 118",
    "DCI": "HYDROCORTISONE ACEPONATE",
    "NOM_COMMERCIALE": "EFFICORT HYDROPHILE",
    "FORME": "CREME HYDROPHILE",
    "DOSAGE": "0.127%",
    "COND": "T/30G",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GALDERMA INTERNATIONAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/1/2001",
    "DATE_D_ENREGISTREMENT_FINAL": "31/5/2015",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["hydrocortisone"],
    "InteractionIndexLink": ["hydrocortisone"],
    "N_ENREGISTREMENT": "149/07 H 126/19",
    "CODE_DCI": "07 H 126",
    "DCI": "HYDROCORTISONE SOUS FORME DE HYDROCORTISONE 17-BUTYRATE",
    "NOM_COMMERCIALE": "LOCACORT",
    "FORME": "CREME",
    "DOSAGE": "0.10 %",
    "COND": "TUBE/30G",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVAPHARM TRADING SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/6/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "24/6/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["hydrocortisone"],
    "InteractionIndexLink": ["hydrocortisone"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "07 H 126",
    "DCI": "HYDROCORTISONE SOUS FORME DE HYDROCORTISONE 17-BUTYRATE",
    "NOM_COMMERCIALE": "LOCACORT",
    "FORME": "CREME",
    "DOSAGE": "0.001",
    "COND": "TUBE/30G",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["hydrocortisone"],
    "InteractionIndexLink": ["hydrocortisone"],
    "N_ENREGISTREMENT": "083/ 07 H 126 /03/19",
    "CODE_DCI": "07 H 126",
    "DCI": "HYDROCORTISONE (SOUS FORME D'HYDROCORTISONE 17-BUTYRATE)",
    "NOM_COMMERCIALE": "LOCOID",
    "FORME": "CRÈME",
    "DOSAGE": "0.1%",
    "COND": "T/30G",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LEO PHARMA A/S",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "DANMARK",
    "DATE_D_ENREGISTREMENT_INITIAL": "16/4/2003",
    "DATE_D_ENREGISTREMENT_FINAL": "24/11/2019",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["hydrocortisone"],
    "InteractionIndexLink": ["hydrocortisone"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "07 H 126",
    "DCI": "HYDROCORTISONE (SOUS FORME D'HYDROCORTISONE 17-BUTYRATE)",
    "NOM_COMMERCIALE": "LOCOID",
    "FORME": "CRÈME",
    "DOSAGE": "0.001",
    "COND": "T/30G",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["hydrocortisone"],
    "InteractionIndexLink": ["hydrocortisone"],
    "N_ENREGISTREMENT": "374/ 07 H 127 /02/16",
    "CODE_DCI": "07 H 127",
    "DCI": "HYDROCORTISONE (SOUS FORME D'HYDROCORTISONE 17-BUTYRATE)",
    "NOM_COMMERCIALE": "LOCOID",
    "FORME": "CRÈME EPAISSE",
    "DOSAGE": "0.1%",
    "COND": "T/30G",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ASTELLAS  PHARMA S.A.S.",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/6/2002",
    "DATE_D_ENREGISTREMENT_FINAL": "26/7/2016",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["hydrocortisone"],
    "InteractionIndexLink": ["hydrocortisone"],
    "N_ENREGISTREMENT": "083/ 07 H 127 /02/19",
    "CODE_DCI": "07 H 127",
    "DCI": "HYDROCORTISONE (SOUS FORME D'HYDROCORTISONE 17-BUTYRATE)",
    "NOM_COMMERCIALE": "LOCOID",
    "FORME": "CRÈME EPAISSE",
    "DOSAGE": "0.1%",
    "COND": "T/30G",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LEO PHARMA A/S",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "DANMARK",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/6/2002",
    "DATE_D_ENREGISTREMENT_FINAL": "24/11/2019",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["hydrocortisone"],
    "InteractionIndexLink": ["hydrocortisone"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "07 H 127",
    "DCI": "HYDROCORTISONE (SOUS FORME D'HYDROCORTISONE 17-BUTYRATE)",
    "NOM_COMMERCIALE": "LOCOID",
    "FORME": "CRÈME EPAISSE",
    "DOSAGE": "0.001",
    "COND": "T/30G",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["hydrocortisone"],
    "InteractionIndexLink": ["hydrocortisone"],
    "N_ENREGISTREMENT": "374/ 07 H 128 /03/16",
    "CODE_DCI": "07 H 128",
    "DCI": "HYDROCORTISONE (SOUS FORME D'HYDROCORTISONE 17-BUTYRATE)",
    "NOM_COMMERCIALE": "LOCOID",
    "FORME": "LOTION",
    "DOSAGE": "0.1%",
    "COND": "FL/30ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ASTELLAS  PHARMA S.A.S.",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "16/4/2003",
    "DATE_D_ENREGISTREMENT_FINAL": "4/1/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["hydrocortisone"],
    "InteractionIndexLink": ["hydrocortisone"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "07 H 128",
    "DCI": "HYDROCORTISONE (SOUS FORME D'HYDROCORTISONE 17-BUTYRATE)",
    "NOM_COMMERCIALE": "LOCOID",
    "FORME": "LOTION",
    "DOSAGE": "0.001",
    "COND": "FL/30ML",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["hydrocortisone"],
    "InteractionIndexLink": ["hydrocortisone"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "07 H 129",
    "DCI": "HYDROCORTISONE (SOUS FORME D'HYDROCORTISONE 17-BUTYRATE)",
    "NOM_COMMERCIALE": "LOCOID",
    "FORME": "PDE.",
    "DOSAGE": "0.001",
    "COND": "T/30G",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["mometasone"],
    "InteractionIndexLink": ["mometasone"],
    "N_ENREGISTREMENT": "386/ 07 H 160 /09/16",
    "CODE_DCI": "07 H 160",
    "DCI": "MOMETASONE (SOUS FORME DE FUROATE)",
    "NOM_COMMERCIALE": "CORTISAF",
    "FORME": "CREME DERM.",
    "DOSAGE": "0.10 %",
    "COND": "T/30G",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JAMJOOM PHARMACEUTICAL INDUSTRY",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ARABIE SAOUDITE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/4/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "29/1/2017",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["mometasone", "ACIDE SALICYLIQUE"],
    "InteractionIndexLink": ["mometasone", "acide acetylsalicylique"],
    "N_ENREGISTREMENT": "386/ 07 H 162 /09/16",
    "CODE_DCI": "07 H 162",
    "DCI": "MOMETASONE FUROATE MONOHYDRATE / ACIDE SALICYLIQUE",
    "NOM_COMMERCIALE": "CORSALIC",
    "FORME": "PDE.DERM.",
    "DOSAGE": "0.1%/ 5%",
    "COND": "T/30G",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JAMJOOM PHARMACEUTICAL INDUSTRY",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ARABIE SAOUDITE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/4/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "6/3/2017",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["betamethasone dipropionate"],
    "InteractionIndexLink": ["betamethasone"],
    "N_ENREGISTREMENT": "149/ 07 H 165 /13",
    "CODE_DCI": "07 H 165",
    "DCI": "BETAMETHASONE DIPROPIONATE EXPRIME EN BETHAMETHASONE",
    "NOM_COMMERCIALE": "BETAMETHASONE NOVAGENERICS",
    "FORME": "PDE. DERM.",
    "DOSAGE": "0.1%",
    "COND": "T/15G",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVAPHARM TRADING SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/3/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "26/3/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["betamethasone dipropionate"],
    "InteractionIndexLink": ["betamethasone"],
    "N_ENREGISTREMENT": "003/07 H 165/99/16",
    "CODE_DCI": "07 H 165",
    "DCI": "BETAMETHASONE DIPROPIONATE EXPRIME EN BETAMETHASONE",
    "NOM_COMMERCIALE": "BETASONE",
    "FORME": "PDE.DERM.",
    "DOSAGE": "0.1%",
    "COND": "T/15G",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SAIDAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/1/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "9/11/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["betamethasone dipropionate"],
    "InteractionIndexLink": ["betamethasone"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "07 H 165",
    "DCI": "BETAMETHASONE DIPROPIONATE EXPRIME EN BETAMETHASONE",
    "NOM_COMMERCIALE": "BETASONE",
    "FORME": "PDE.DERM.",
    "DOSAGE": "0.001",
    "COND": "T/15G",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["betamethasone"],
    "InteractionIndexLink": ["betamethasone"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "07 H 165",
    "DCI": "Betamethasone",
    "NOM_COMMERCIALE": "Tabeta",
    "FORME": "Pommade",
    "DOSAGE": "0.001",
    "COND": "B/15gm",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "352/07 H 174/16",
    "CODE_DCI": "07 H 174",
    "DCI": "CLOBETASOL PROPIONATE",
    "NOM_COMMERCIALE": "CLOBECORT",
    "FORME": "CREME DERM.",
    "DOSAGE": "0.05%",
    "COND": "T/156",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/12/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "4/12/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "07 H 174",
    "DCI": "CLOBETASOL PROPIONATE",
    "NOM_COMMERCIALE": "CLOTASOL",
    "FORME": "CREME DERM.",
    "DOSAGE": "0.05%",
    "COND": "T/45G",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "07 H 174",
    "DCI": "clobetasol propionate",
    "NOM_COMMERCIALE": "Clobecort",
    "FORME": "Crème",
    "DOSAGE": "0.0005",
    "COND": "B/15gm",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "07 H 175",
    "DCI": "CLOBETASOL PROPIONATE",
    "NOM_COMMERCIALE": "CLOTASOL",
    "FORME": "GEL P. APPLI. CAPILLAIRE",
    "DOSAGE": "0.05%",
    "COND": "T/45G",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "352/07 H 176/16",
    "CODE_DCI": "07 H 176",
    "DCI": "CLOBETASOL PROPIONATE",
    "NOM_COMMERCIALE": "CLOBECORT",
    "FORME": "PDE. DERM.",
    "DOSAGE": "0.05 %",
    "COND": "T/15G",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/12/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "4/12/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "263/ 07 H 176 /16",
    "CODE_DCI": "07 H 176",
    "DCI": "CLOBETASOL PROPIONATE",
    "NOM_COMMERCIALE": "CLOTASOL",
    "FORME": "PDE.DERM.",
    "DOSAGE": "0.05 %",
    "COND": "T/45G",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOPHARM SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/3/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "13/3/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "07 H 176",
    "DCI": "CLOBETASOL PROPIONATE",
    "NOM_COMMERCIALE": "CLOTASOL",
    "FORME": "PDE.DERM.",
    "DOSAGE": "0.0005",
    "COND": "T/45G",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "07 H 176",
    "DCI": "clobetasol propionate",
    "NOM_COMMERCIALE": "Clobecort",
    "FORME": "Pommade",
    "DOSAGE": "0.0005",
    "COND": "B/15gm",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "386/ 07 H 176 /12",
    "CODE_DCI": "07 H 176",
    "DCI": "CLOBETASOL PROPIONATE",
    "NOM_COMMERCIALE": "PROCLO JAM",
    "FORME": "PDE. DERM.",
    "DOSAGE": "0.05 %",
    "COND": "T/30G",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JAMJOOM PHARMACEUTICAL INDUSTRY",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ARABIE SAOUDITE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/5/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "20/5/2012",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "207/ 07 H 183 /16",
    "CODE_DCI": "07 H 183",
    "DCI": "PREDNICARBATE",
    "NOM_COMMERCIALE": "PEITEL",
    "FORME": "CREME .DERM.",
    "DOSAGE": "0.25 %",
    "COND": "T/30G",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FERRER INTERNACIONALS.A.",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "Espagne",
    "DATE_D_ENREGISTREMENT_INITIAL": "11/4/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "11/4/2016",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [
      "tretinoin",
      "isotretinoin (systemic)",
      "isotretinoin (topical)",
      "tretinoin (oral)"
    ],
    "InteractionIndexLink": ["isotretinoine"],
    "N_ENREGISTREMENT": "186/ 07 L 058 /06/16",
    "CODE_DCI": "07 L 058",
    "DCI": "ISOTRETINOINE",
    "NOM_COMMERCIALE": "CURACNE 10MG",
    "FORME": "CAPSULE MOLLE",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PIERRE FABRE DERMATOLOGIE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "31/7/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "5/3/2017",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["tretinoin (oral)"],
    "InteractionIndexLink": ["isotretinoine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "07 L 059",
    "DCI": "ISOTRETINOINE",
    "NOM_COMMERCIALE": "CURACNE  20MG",
    "FORME": "CAPSULE MOLLE",
    "DOSAGE": "20MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["calcipotriol"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "149/ 07 L 099 /18",
    "CODE_DCI": "07 L 099",
    "DCI": "Calcipotriol monohydrate exprime en calcipotriol anhydre",
    "NOM_COMMERCIALE": "CALCIPOTRIOL novagenerics",
    "FORME": "POMMADE .DERM.",
    "DOSAGE": "50 UG/G",
    "COND": "T/30G",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVAPHARM TRADING SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/11/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "27/11/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["calcipotriol"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "07 L 099",
    "DCI": "CALCIPOTRIOL",
    "NOM_COMMERCIALE": "CALCIPOTRIOL novagenerics®",
    "FORME": "pommade",
    "DOSAGE": "50 µg/g",
    "COND": "TUBE DE 30 G",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["calcipotriol"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "21/07 L099/378",
    "CODE_DCI": "07 L 099",
    "DCI": "CALCIPOTRIOL MONOHYDRATE EXPRIME EN CALCIPOTRIOL ANHYDRE",
    "NOM_COMMERCIALE": "DIAVOREM",
    "FORME": "POMMADE",
    "DOSAGE": "50µG/G",
    "COND": "TUBE/ 30G",
    "LISTE": "LISTE II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL / BIOREM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/04/21",
    "DATE_D_ENREGISTREMENT_FINAL": "18/04/21",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["calcipotriol"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "352/ 07 L 099 /18",
    "CODE_DCI": "07 L 099",
    "DCI": "Calcipotriol monohydrate exprime en calcipotriol anhydre",
    "NOM_COMMERCIALE": "PSORANEX",
    "FORME": "POMMADE .DERM.",
    "DOSAGE": "50 UG/G",
    "COND": "T/30G",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SPA EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/5/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "27/5/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "07 L 099",
    "DCI": "Calcipooaiol",
    "NOM_COMMERCIALE": "Psoranex",
    "FORME": "Pommade",
    "DOSAGE": "0.00005",
    "COND": "T/30g",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["tretinoin (oral)"],
    "InteractionIndexLink": ["isotretinoine"],
    "N_ENREGISTREMENT": "186/ 07 L 144 /06/17",
    "CODE_DCI": "07 L 144",
    "DCI": "ISOTRETINOINE",
    "NOM_COMMERCIALE": "CURACNE  5MG",
    "FORME": "CAPSULE MOLLE",
    "DOSAGE": "5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PIERRE FABRE DERMATOLOGIE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "31/7/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "5/3/2017",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "07 P 071",
    "DCI": "HEXAMIDINE DI-ISETHIONATE",
    "NOM_COMMERCIALE": "ISOMEDINE",
    "FORME": "SOL.DERM.",
    "DOSAGE": "0.001",
    "COND": "FL/50ML",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["povidone iodée"],
    "N_ENREGISTREMENT": "459/ 07 P 076 /97/18",
    "CODE_DCI": "07 P 076",
    "DCI": "POVIDONE IODEE",
    "NOM_COMMERCIALE": "BETADINE SCRUB",
    "FORME": "SOL.DERM. (MOUSSANTE)",
    "DOSAGE": "4 %",
    "COND": "FL/125ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE MEDA PHARMA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/8/1997",
    "DATE_D_ENREGISTREMENT_FINAL": "26/11/2018",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "314/ 07 P 077 /05/19",
    "CODE_DCI": "07 P 077",
    "DCI": "POLYVIDONE IODEE",
    "NOM_COMMERCIALE": "BETADERMINE",
    "FORME": "SOL.DERM.",
    "DOSAGE": "10 %",
    "COND": "FL/120ML ET FL/500ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "RIADH PHARM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "5/6/2005",
    "DATE_D_ENREGISTREMENT_FINAL": "16/6/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "079/ 07 P 077 /99/19",
    "CODE_DCI": "07 P 077",
    "DCI": "POLYVIDONE IODEE",
    "NOM_COMMERCIALE": "POLYLAD",
    "FORME": "SOL. DERM.",
    "DOSAGE": "10% (10G/100ML)",
    "COND": "FL/125 ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE  ALGERIEN DE DEVELOPPEMENT  PHARMACEUTIQUE   (LAD)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/7/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "29/4/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "18 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["sulfadiazine"],
    "InteractionIndexLink": ["sulfadiazine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "07 P 079",
    "DCI": "Sulfadiazine Argentique",
    "NOM_COMMERCIALE": "FLAMAZOLE",
    "FORME": "Crème",
    "DOSAGE": "0.01",
    "COND": "Tube de 40 g",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["sulfadiazine"],
    "InteractionIndexLink": ["sulfadiazine"],
    "N_ENREGISTREMENT": "149/ 07 P 079 /15",
    "CODE_DCI": "07 P 079",
    "DCI": "SULFADIAZINE ARGENTIQUE",
    "NOM_COMMERCIALE": "SULFADIAZINE NOVAGENERICS",
    "FORME": "CREME DERM.",
    "DOSAGE": "1 %",
    "COND": "T/50G",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVAPHARM TRADING SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/7/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "26/7/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["sulfadiazine"],
    "InteractionIndexLink": ["sulfadiazine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "07 P 079",
    "DCI": "SULFADIAZINE argentique",
    "NOM_COMMERCIALE": "SULFADIAZINE novagenerics 1%",
    "FORME": "crème",
    "DOSAGE": "0.01",
    "COND": "TUBE DE 50 G",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["sulfadiazine"],
    "InteractionIndexLink": ["sulfadiazine"],
    "N_ENREGISTREMENT": "079/ 07 P 079 /04/18",
    "CODE_DCI": "07 P 079",
    "DCI": "SULFADIAZINE ARGENTIQUE",
    "NOM_COMMERCIALE": "SULFAZINE",
    "FORME": "CREME",
    "DOSAGE": "1 %",
    "COND": "T/ 15G- POT/200G",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE ALGERIEN DE DEVELOPPEMENT PHARMACEUTIQUE  (LAD)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/4/2004",
    "DATE_D_ENREGISTREMENT_FINAL": "31/12/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "07 P 136",
    "DCI": "Trolamine",
    "NOM_COMMERCIALE": "BRUFINE",
    "FORME": "émulsion",
    "DOSAGE": "0.0067",
    "COND": "Tube de 93 gr",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["sulfadiazine"],
    "InteractionIndexLink": ["sulfadiazine"],
    "N_ENREGISTREMENT": "079/ 07 P 137 /02/20",
    "CODE_DCI": "07 P 137",
    "DCI": "FACTEUR DE CROISSANCE EPIDERMIQUE(FCE HUM-REC) / SULFADIAZINE ARGENTIQUE",
    "NOM_COMMERCIALE": "HEBERMIN",
    "FORME": "CREME",
    "DOSAGE": "0.001G/1G",
    "COND": "T/15G  ET POT /200G",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE  ALGERIEN DE DEVELOPPEMENT  PHARMACEUTIQUE   (LAD)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "16/4/2002",
    "DATE_D_ENREGISTREMENT_FINAL": "16/2/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "314/07 P 164/16",
    "CODE_DCI": "07 P 164",
    "DCI": "IODE BISUBLIME / ALCOOL ETHYLIQUE",
    "NOM_COMMERCIALE": "ALCOOL IODE 1% RPP",
    "FORME": "SOL HYDROALCOOLIQUE EN APP CUTANEE",
    "DOSAGE": "1 %",
    "COND": "FL./1L",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EURL RIADH PHARM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/12/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "19/12/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "20/07 P136/418",
    "CODE_DCI": "07 P 181",
    "DCI": "TROLAMINE",
    "NOM_COMMERCIALE": "BRUFINE",
    "FORME": "EMULSION P.APPLICATION CUTANÉE",
    "DOSAGE": "0.670G/100",
    "COND": "TUBE/ 93G ET 186G",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES NEOMEDIC SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/10/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "25/10/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["benzyl benzoate"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "314/ 07 R 179 /19",
    "CODE_DCI": "07 R 179",
    "DCI": "BENZOATE DE BENZYLE",
    "NOM_COMMERCIALE": "ASCABINE FORTE",
    "FORME": "SOL. APPLI. CUTANEE",
    "DOSAGE": "25G/100G",
    "COND": "FL/125ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "RIADH PHARMA EURL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "16/4/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "16/4/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["benzyl benzoate"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "318/ 07 R 179 /14",
    "CODE_DCI": "07 R 179",
    "DCI": "BENZOATE DE BENZYLE",
    "NOM_COMMERCIALE": "ASCALOL",
    "FORME": "SOL. APPLI. LOCALE",
    "DOSAGE": "25G/100G",
    "COND": "FL/125ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMIDAL NS SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/6/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "1/6/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["betamethasone dipropionate", "calcipotriol"],
    "InteractionIndexLink": ["betamethasone"],
    "N_ENREGISTREMENT": "083/ 07 S 152 /08/15",
    "CODE_DCI": "07 S 152",
    "DCI": "CALCIPOTRIOL HYDRATE EXPRIME EN CALCIPOTRIOL / BETAMETHASONE DIPROPIONATE EXPRIME EN BETAMETHASONE",
    "NOM_COMMERCIALE": "DAIVOBET",
    "FORME": "PDE.",
    "DOSAGE": "50µG/0.5MG/G",
    "COND": "T/60G",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LEO PHARMACEUTICAL PRODUCTS SARATH LTD",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SUISSE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/12/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "9/3/2015",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["betamethasone dipropionate", "calcipotriol"],
    "InteractionIndexLink": ["betamethasone"],
    "N_ENREGISTREMENT": "378/ 07 S 152 /21",
    "CODE_DCI": "07 S 152",
    "DCI": "Calcipotriol monohydraté exprimé en Calcipotriol / Dipropionate de bétaméthasone exprimé en Bétaméthasone",
    "NOM_COMMERCIALE": "DAIVOREM PLUS",
    "FORME": "Pommade",
    "DOSAGE": "50µG/0.5MG /G",
    "COND": "T/60G",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOREM / SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/4/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "4/4/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["betamethasone dipropionate", "calcipotriol"],
    "InteractionIndexLink": ["betamethasone"],
    "N_ENREGISTREMENT": "352/ 07 S 152 /19",
    "CODE_DCI": "07 S 152",
    "DCI": "CALCIPOTRIOL HYDRATE EXPRIME EN CALCIPOTRIOL / BETAMETHASONE DIPROPIONATE EXPRIME EN BETAMETHASONE",
    "NOM_COMMERCIALE": "PSORASONE",
    "FORME": "PDE.",
    "DOSAGE": "50µG/0.5MG/G",
    "COND": "T/30G",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/5/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "7/5/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": ["betamethasone dipropionate", "calcipotriol"],
    "InteractionIndexLink": ["betamethasone"],
    "N_ENREGISTREMENT": "149/07 S 152/20",
    "CODE_DCI": "07 S 152",
    "DCI": "CALCIPOTRIOL HYDRATE EXPRIME EN CALCIPOTRIOL/ BETAMETHASONE DIPROPIONATE EXPRIME EN BETAMETHASONE",
    "NOM_COMMERCIALE": "PSORIABET",
    "FORME": "POMMADE",
    "DOSAGE": "50µG/ 0.5MG",
    "COND": "1 TUBE DE 60G",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL NOVAPHARM TRADING",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/11/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "22/11/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Dermatologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["glycerol", "paraffine"],
    "N_ENREGISTREMENT": "099/ 07 T 177 /13",
    "CODE_DCI": "07 T 177",
    "DCI": "GLYCEROL / VASELINE / PARAFFINE LIQUIDE",
    "NOM_COMMERCIALE": "DEXERYL",
    "FORME": "CREME DERM.",
    "DOSAGE": "15G/8G/2G/100G",
    "COND": "T/250G",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PIERRE FABRE MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "France",
    "DATE_D_ENREGISTREMENT_INITIAL": "5/3/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "5/3/2013",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["propanolol"],
    "N_ENREGISTREMENT": "186 / 07 U 184/ 18",
    "CODE_DCI": "07 U 184",
    "DCI": "Propanolol chlorhydrate exprimé en propanolol",
    "NOM_COMMERCIALE": "HEMANGIOL",
    "FORME": "SOL BUV",
    "DOSAGE": "3.75 MG/ML",
    "COND": "B/01 FL DE 120 ML + 01 SEREINGUE GRADUEE EN MG",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PIERRE FABRE DERMATOLOGIE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "France",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/11/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "29/11/2018",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["apremilast"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "477/07 V 187/21",
    "CODE_DCI": "07 V 187",
    "DCI": "APREMILAST",
    "NOM_COMMERCIALE": "PSORIASIX",
    "FORME": "COMP. PELL.",
    "DOSAGE": "10MG",
    "COND": "B/12",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL LABORATOIRES BEKER",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "21/3/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "21/3/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["apremilast"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "477/07 V 188/21",
    "CODE_DCI": "07 V 188",
    "DCI": "APREMILAST",
    "NOM_COMMERCIALE": "PSORIASIX",
    "FORME": "COMP. PELL.",
    "DOSAGE": "30MG",
    "COND": "B/30 ET B/60",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL LABORATOIRES BEKER",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/2/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "17/2/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "168/ 08 A 002 /99/17",
    "CODE_DCI": "08 A 002",
    "DCI": "GADOTERATE DE MEGLUMINE",
    "NOM_COMMERCIALE": "DOTAREM",
    "FORME": "SOL.INJ.IV",
    "DOSAGE": "0.5MMOL/ML",
    "COND": "FL/10 ML - 15ML - 20ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GUERBET",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/6/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "16/7/2018",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Diagnostic"]
  },
  {
    "PregnancyIndexLink": ["gadobutrol"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "424/ 08 A 069 /10/16",
    "CODE_DCI": "08 A 069",
    "DCI": "GADOBUTROL",
    "NOM_COMMERCIALE": "GADOVIST",
    "FORME": "SOL. INJ. IV",
    "DOSAGE": "604.72MG/ML (SOIT 157.25MG/ML EN GADOLINIUM)",
    "COND": "FL./7.5ML - FL./15ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BAYER  PHARMA AG",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALLEMAGNE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/6/2010",
    "DATE_D_ENREGISTREMENT_FINAL": "10/7/2016",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Diagnostic"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "424/ 08 C 008 /97/13",
    "CODE_DCI": "08 C 008",
    "DCI": "AMIDOTRIZOATE DE SODIUM / AMIDOTRIZOATE DE MEGLUMINE",
    "NOM_COMMERCIALE": "GASTROGRAFINE",
    "FORME": "SOL.BUV. OU REC. (APPLIC. GASTRO-INTESTINALE)",
    "DOSAGE": "I =370MG/ML (10G/66G/100ML)",
    "COND": "B/1FL. DE 100ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BAYER PHARMA AG",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALLEMAGNE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/11/1997",
    "DATE_D_ENREGISTREMENT_FINAL": "29/5/2013",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["iohexol"],
    "InteractionIndexLink": ["iohexol"],
    "N_ENREGISTREMENT": "276/08 C 017/08/16",
    "CODE_DCI": "08 C 017",
    "DCI": "IOHEXOL",
    "NOM_COMMERCIALE": "CONTRAPAQUE 300",
    "FORME": "SOL. INJ.",
    "DOSAGE": "I =300MG/ML (647MG/ML)",
    "COND": "B/1FL.DE 100ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "UNIQUE PHARMACEUTICAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "23/12/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "11/9/2016",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Diagnostic"]
  },
  {
    "PregnancyIndexLink": ["iohexol"],
    "InteractionIndexLink": ["iohexol"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "08 C 017",
    "DCI": "Iohexol",
    "NOM_COMMERCIALE": "CONTRAPAQUE 300",
    "FORME": "sol. inj.",
    "DOSAGE": "(300 mg d'iode/ml) correspondant à 647mg/ml d'Iohexol",
    "COND": "B/1FL de 100ml",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Diagnostic"]
  },
  {
    "PregnancyIndexLink": ["iohexol"],
    "InteractionIndexLink": ["iohexol"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "08 C 017",
    "DCI": "IOHEXOL",
    "NOM_COMMERCIALE": "OMNIPAQUE",
    "FORME": "SOL.INJ",
    "DOSAGE": "I =300MG/ML",
    "COND": "FL/10 ML.50ML.100ML",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Diagnostic"]
  },
  {
    "PregnancyIndexLink": ["iohexol"],
    "InteractionIndexLink": ["iohexol"],
    "N_ENREGISTREMENT": "276/ 08 C 018 /08/16",
    "CODE_DCI": "08 C 018",
    "DCI": "IOHEXOL",
    "NOM_COMMERCIALE": "CONTRAPAQUE 350",
    "FORME": "SOL. INJ.",
    "DOSAGE": "755MG/ML (I =350MG/ML)",
    "COND": "B/1FL.DE 100ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "UNIQUE PHARMACEUTICAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "23/12/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "29/1/2017",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Diagnostic"]
  },
  {
    "PregnancyIndexLink": ["iohexol"],
    "InteractionIndexLink": ["iohexol"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "08 C 018",
    "DCI": "Iohexol",
    "NOM_COMMERCIALE": "CONTRAPAQUE 350",
    "FORME": "Sol. Inj.",
    "DOSAGE": "I=350mg/ml (755mg/ml d'iohexol)",
    "COND": "FL/100ML",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Diagnostic"]
  },
  {
    "PregnancyIndexLink": ["iohexol"],
    "InteractionIndexLink": ["iohexol"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "08 C 018",
    "DCI": "IOHEXOL",
    "NOM_COMMERCIALE": "OMNIPAQUE",
    "FORME": "SOL.INJ",
    "DOSAGE": "I =350MG/ML",
    "COND": "FL/50 ML. 100ML",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Diagnostic"]
  },
  {
    "PregnancyIndexLink": ["iopamidol"],
    "InteractionIndexLink": ["iopamidol"],
    "N_ENREGISTREMENT": "276/08 C 020/09/16",
    "CODE_DCI": "08 C 020",
    "DCI": "IOPAMIDOL",
    "NOM_COMMERCIALE": "PAMIDOL 300",
    "FORME": "SOL. INJ.",
    "DOSAGE": "I =300MG/ML",
    "COND": "FL./50ML - FL./100ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "UNIQUE PHARMACEUTICAL LABORATORIES",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/12/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "11/9/2016",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "48MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Diagnostic"]
  },
  {
    "PregnancyIndexLink": ["iopamidol"],
    "InteractionIndexLink": ["iopamidol"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "08 C 020",
    "DCI": "Iopamidol en Iode élément",
    "NOM_COMMERCIALE": "PAMIDOL 300",
    "FORME": "Sol. Inj.",
    "DOSAGE": "300mg/ml",
    "COND": "FL/100ml",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Diagnostic"]
  },
  {
    "PregnancyIndexLink": ["iopamidol"],
    "InteractionIndexLink": ["iopamidol"],
    "N_ENREGISTREMENT": "276/08 C 021/09/16",
    "CODE_DCI": "08 C 021",
    "DCI": "IOPAMIDOL EN IODE ELEMENT",
    "NOM_COMMERCIALE": "PAMIDOL 370",
    "FORME": "SOL. INJ.",
    "DOSAGE": "I =370MG/ML",
    "COND": "FL./50ML - FL./100ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "UNIQUE PHARMACEUTICAL LABORATORIES",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/12/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "11/9/2016",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "48MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Diagnostic"]
  },
  {
    "PregnancyIndexLink": ["iopamidol"],
    "InteractionIndexLink": ["iopamidol"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "08 C 021",
    "DCI": "Iopamidol en Iode élément",
    "NOM_COMMERCIALE": "PAMIDOL 370",
    "FORME": "Sol. Inj.",
    "DOSAGE": "370mg/ml",
    "COND": "FL/50ml",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Diagnostic"]
  },
  {
    "PregnancyIndexLink": ["acide ioxaglique"],
    "InteractionIndexLink": ["acide ioxaglique"],
    "N_ENREGISTREMENT": "168/ 08 C 047 /98/13",
    "CODE_DCI": "08 C 047",
    "DCI": "IOXITALAMATE DE MEGLUMINE (acide ioxaglique)",
    "NOM_COMMERCIALE": "TELEBRIX 30 MEGLUMINE",
    "FORME": "SOL INJ",
    "DOSAGE": "660.3MG/ML (I=300MG/ML)",
    "COND": "FL/50ML - 100ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GUERBET",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/9/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "2/12/2013",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["iopromide"],
    "InteractionIndexLink": ["iopromide"],
    "N_ENREGISTREMENT": "424/ 08 C 055 /00/13",
    "CODE_DCI": "08 C 055",
    "DCI": "IOPROMIDE",
    "NOM_COMMERCIALE": "ULTRAVIST 300",
    "FORME": "SOL. INJ",
    "DOSAGE": "623.4MG/ML (TENEUR EN IODE 300MG/ML)",
    "COND": "B/1FL.  DE 50ML - B/1FL.  DE 100 ML - B/10FL.  DE 50ML - B/10FL.  DE 100ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "B/10FL  DE 50ML ET B/10FL  DE 100ML RESERVEES AUX HÔPITAUX",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BAYER PHARMA AG",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALLEMAGNE",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/3/2000",
    "DATE_D_ENREGISTREMENT_FINAL": "29/5/2013",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Diagnostic"]
  },
  {
    "PregnancyIndexLink": ["iopromide"],
    "InteractionIndexLink": ["iopromide"],
    "N_ENREGISTREMENT": "424/ 08 C 056 /00/13",
    "CODE_DCI": "08 C 056",
    "DCI": "IOPROMIDE",
    "NOM_COMMERCIALE": "ULTRAVIST 370",
    "FORME": "SOL. INJ.",
    "DOSAGE": "768.86MG/ML (TENEUR EN IODE 370MG/ML)",
    "COND": "B/1FL.  DE 50ML - B/1FL.  DE 100 ML - B/10FL.  DE 50ML - B/10FL.  DE 100ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "B/10FL  DE 50ML ET B/10FL  DE 100ML RESERVEES AUX HÔPITAUX",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BAYER PHARMA AG",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALLEMAGNE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/2/2000",
    "DATE_D_ENREGISTREMENT_FINAL": "7/7/2013",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Diagnostic"]
  },
  {
    "PregnancyIndexLink": ["iobitridol"],
    "InteractionIndexLink": ["iobitridol"],
    "N_ENREGISTREMENT": "168/ 08 C 061 /00/19",
    "CODE_DCI": "08 C 061",
    "DCI": "IOBITRIDOL",
    "NOM_COMMERCIALE": "XENETIX 300",
    "FORME": "SOL. INJ. INTRA-VASC. ET INTRA-CAVITAIRE",
    "DOSAGE": "I=300MG/ML",
    "COND": "FL./50ML ET FL./100ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GUERBET",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/11/2000",
    "DATE_D_ENREGISTREMENT_FINAL": "16/7/2019",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["iobitridol"],
    "InteractionIndexLink": ["iobitridol"],
    "N_ENREGISTREMENT": "168/ 08 C 062 /00/19",
    "CODE_DCI": "08 C 062",
    "DCI": "IOBITRIDOL",
    "NOM_COMMERCIALE": "XENETIX 350",
    "FORME": "SOL. INJ. INTRA-VASC. ET INTRA-CAVITAIRE",
    "DOSAGE": "I=350MG/ML",
    "COND": "FL./50ML ET FL./100ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GUERBET",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/11/2000",
    "DATE_D_ENREGISTREMENT_FINAL": "16/7/2019",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Diagnostic"]
  },
  {
    "PregnancyIndexLink": ["acide ioxaglique"],
    "InteractionIndexLink": ["acide ioxaglique"],
    "N_ENREGISTREMENT": "168/ 08 C 064 /00/15",
    "CODE_DCI": "08 C 064",
    "DCI": "IOXITALAMATE DE MEGLUMINE (acide ioxaglique)  / IOXITALAMATE DE SODIUM",
    "NOM_COMMERCIALE": "TELEBRIX 35",
    "FORME": "SOL. INJ.",
    "DOSAGE": "650.9MG/96.6MG/ML (I=350MG/ML)",
    "COND": "FL./50ML - FL./100ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GUERBET",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/6/2000",
    "DATE_D_ENREGISTREMENT_FINAL": "29/4/2015",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["acide ioxaglique"],
    "InteractionIndexLink": ["acide ioxaglique"],
    "N_ENREGISTREMENT": "168/ 08 C 065 / 01/16",
    "CODE_DCI": "08 C 065",
    "DCI": "IOXAGLATE DE SODIUM ET DE MEGLUMINE, (acide ioxaglique)",
    "NOM_COMMERCIALE": "HEXABRIX 320",
    "FORME": "SOL INJ INTRA-VASC. - INTRA-UTERINE -INTRA-ARTICULAIRE",
    "DOSAGE": "I=320MG/ML",
    "COND": "FL /20 ML +FL /100 ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GUERBET",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/8/2001",
    "DATE_D_ENREGISTREMENT_FINAL": "4/1/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["testosterone"],
    "InteractionIndexLink": ["testosterone"],
    "N_ENREGISTREMENT": "005/ 09 A 074 /97/16",
    "CODE_DCI": "09 A 074",
    "DCI": "TESTOSTERONE UNDECANOATE",
    "NOM_COMMERCIALE": "ANDRIOL TESTOCAPS",
    "FORME": "CAPSULE ORALE",
    "DOSAGE": "40MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ORGANON NV",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PAYS BAS",
    "DATE_D_ENREGISTREMENT_INITIAL": "8/11/1997",
    "DATE_D_ENREGISTREMENT_FINAL": "1/1/2018",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["letrozole"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "323/ 09 A 120 /16",
    "CODE_DCI": "09 A 120",
    "DCI": "LETROZOLE",
    "NOM_COMMERCIALE": "LETRODEX",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "2.5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL CONTINENTAL PHARM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/1/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "24/1/2016",
    "TYPE": "Gé",
    "STATUT": "C",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["letrozole"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "157 / 09 A 120 /15",
    "CODE_DCI": "09 A 120",
    "DCI": "LETROZOLE",
    "NOM_COMMERCIALE": "LETROZOLE CINFA",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "2.5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CINFA S.A.",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ESPAGNE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/2/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "26/2/2015",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["letrozole"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "285/09 A 120/20",
    "CODE_DCI": "09 A 120",
    "DCI": "LETROZOLE",
    "NOM_COMMERCIALE": "LETROZOLE UPC",
    "FORME": "COMP PELL",
    "DOSAGE": "2.5MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "UNION PHARMACEUTIQUE CONSTANTINOISE (UPC)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/3/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "18/3/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["letrozole"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "001/ 09 A 120 /21",
    "CODE_DCI": "09 A 120",
    "DCI": "Létrozole",
    "NOM_COMMERCIALE": "LIFUNOR",
    "FORME": "Comprimé pelliculé",
    "DOSAGE": "2.5MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMA ALGERIA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/3/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "1/3/2021",
    "TYPE": "Gé",
    "STATUT": "F mélange final",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["bicalutamide"],
    "InteractionIndexLink": ["bicalutamide"],
    "N_ENREGISTREMENT": "323/ 09 A 137 /16",
    "CODE_DCI": "09 A 137",
    "DCI": "BICALUTAMIDE",
    "NOM_COMMERCIALE": "BICADEX",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "50MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL CONTINENTA L PHARM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/1/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "24/1/2016",
    "TYPE": "Gé",
    "STATUT": "C",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["bicalutamide"],
    "InteractionIndexLink": ["bicalutamide"],
    "N_ENREGISTREMENT": "157/ 09 A 137 /14",
    "CODE_DCI": "09 A 137",
    "DCI": "BICALUTAMIDE",
    "NOM_COMMERCIALE": "BICALUTAMIDE CINFA",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "50MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CINFA S.A.",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ESPAGNE",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/9/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "1/9/2014",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["bicalutamide"],
    "InteractionIndexLink": ["bicalutamide"],
    "N_ENREGISTREMENT": "285/ 09 A 137 /20",
    "CODE_DCI": "09 A 137",
    "DCI": "Bicalutamide",
    "NOM_COMMERCIALE": "BICALUTAMIDE UPC",
    "FORME": "Comprimé pelliculé",
    "DOSAGE": "50MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "Union Pharmaceutique Constantinoise (UPC) / SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/12/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "7/12/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["bicalutamide"],
    "InteractionIndexLink": ["bicalutamide"],
    "N_ENREGISTREMENT": "285/09 A 137/20",
    "CODE_DCI": "09 A 137",
    "DCI": "BICALUTAMIDE",
    "NOM_COMMERCIALE": "BICALUTAMIDE UPC",
    "FORME": "COMP. PELL.",
    "DOSAGE": "50MG",
    "COND": "B/ 30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SPA UNION PHARMACEUTIQUE CONSTANTINOISE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/12/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "7/12/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["bicalutamide"],
    "InteractionIndexLink": ["bicalutamide"],
    "N_ENREGISTREMENT": "256/ 09 A 137 /05/16",
    "CODE_DCI": "09 A 137",
    "DCI": "BICALUTAMIDE",
    "NOM_COMMERCIALE": "CASODEX",
    "FORME": "COMP. ENRO.",
    "DOSAGE": "50MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ASTRA ZENECA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/11/2005",
    "DATE_D_ENREGISTREMENT_FINAL": "12/3/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "60 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["bicalutamide"],
    "InteractionIndexLink": ["bicalutamide"],
    "N_ENREGISTREMENT": "352/ 09 A 137 /19",
    "CODE_DCI": "09 A 137",
    "DCI": "BICALUTAMIDE",
    "NOM_COMMERCIALE": "CLAMUDEX",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "50MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/5/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "29/5/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["exemestane"],
    "InteractionIndexLink": ["exemestane"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "09 A 142",
    "DCI": "EXEMESTANE",
    "NOM_COMMERCIALE": "AROMASINE",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "25MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["tamoxifen"],
    "InteractionIndexLink": ["tamoxifene"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "09 B 004",
    "DCI": "TAMOXIFENE",
    "NOM_COMMERCIALE": "NOLVADEX",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["tamoxifen"],
    "InteractionIndexLink": ["tamoxifene"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "09 B 075",
    "DCI": "TAMOXIFENE",
    "NOM_COMMERCIALE": "NOLVADEX",
    "FORME": "COMPRIME",
    "DOSAGE": "20MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["tamoxifen"],
    "InteractionIndexLink": ["tamoxifene"],
    "N_ENREGISTREMENT": "141/ 09 B 075 /98/16",
    "CODE_DCI": "09 B 075",
    "DCI": "TAMOXIFENE",
    "NOM_COMMERCIALE": "TAMOXIFEN EBEWE 20MG",
    "FORME": "COMPRIME",
    "DOSAGE": "20MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EBEWE PHARMA GES mbh Nfg KG",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "AUTRICHE",
    "DATE_D_ENREGISTREMENT_INITIAL": "8/11/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "16/4/2017",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["anastrozole"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "323/ 09 B 139 /16",
    "CODE_DCI": "09 B 139",
    "DCI": "ANASTROZOLE",
    "NOM_COMMERCIALE": "ANASTRODEX",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "1MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL CONTINENTAL PHARM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/1/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "24/1/2016",
    "TYPE": "Gé",
    "STATUT": "C",
    "DUREE_DE_STABILITE": "60MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["anastrozole"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "157/ 09 B 139 /14",
    "CODE_DCI": "09 B 139",
    "DCI": "ANASTROZOLE",
    "NOM_COMMERCIALE": "ANASTROZOLE CINFA",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "1MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CINFA S.A",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ESPAGNE",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/9/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "1/9/2014",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "30 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["anastrozole"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "285/09 B 139/20",
    "CODE_DCI": "09 B 139",
    "DCI": "ANASTROZOLE",
    "NOM_COMMERCIALE": "ANASTROZOLE UPC",
    "FORME": "COMP PELL",
    "DOSAGE": "1MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "UNION PHARMACEUTIQUE CONSTANTINOISE (UPC)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/3/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "18/3/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["anastrozole"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "569/ 09 B 139 /05/21",
    "CODE_DCI": "09 B 139",
    "DCI": "Anastrozole",
    "NOM_COMMERCIALE": "ARIMIDEX",
    "FORME": "Comprimé pelliculé",
    "DOSAGE": "1MG",
    "COND": "B/30 ET B/90",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "Laboratoire Juvisé Pharmaceuticals",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/11/2005",
    "DATE_D_ENREGISTREMENT_FINAL": "21/2/2021",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "60 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["anastrozole"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "569/09 B 139/05/21",
    "CODE_DCI": "09 B 139",
    "DCI": "ANASTROZOLE",
    "NOM_COMMERCIALE": "ARIMIDEX",
    "FORME": "COMP. PELL.",
    "DOSAGE": "01MG",
    "COND": "B/30 ET B/90",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE JUVISE PHARMA.",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/3/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "21/2/2021",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "60 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["anastrozole"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "502/ 09 B 139 /15",
    "CODE_DCI": "09 B 139",
    "DCI": "ANASTROZOLE",
    "NOM_COMMERCIALE": "GERDOL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "1MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GERDA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/12/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "9/12/2015",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["danazol"],
    "InteractionIndexLink": ["danazol"],
    "N_ENREGISTREMENT": "255/ 09 C 005 /98/17",
    "CODE_DCI": "09 C 005",
    "DCI": "DANAZOL",
    "NOM_COMMERCIALE": "DANATROL",
    "FORME": "GLES",
    "DOSAGE": "200MG",
    "COND": "BT/100",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANOFI SYNTHELABO FRANCE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/1/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "4/9/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["bromocriptine (oral)"],
    "InteractionIndexLink": ["bromocriptine"],
    "N_ENREGISTREMENT": "068/ 09 D 006 /97/17",
    "CODE_DCI": "09 D 006",
    "DCI": "BROMOCRIPTINE",
    "NOM_COMMERCIALE": "PARLODEL",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "2.5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVARTIS SCHWEIZ AG",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SUISSE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/6/1997",
    "DATE_D_ENREGISTREMENT_FINAL": "7/3/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["cabergoline"],
    "InteractionIndexLink": ["cabergoline"],
    "N_ENREGISTREMENT": "378/ 09 D 168 /21",
    "CODE_DCI": "09 D 168",
    "DCI": "Cabergoline",
    "NOM_COMMERCIALE": "CABERGOLINE BR",
    "FORME": "Comprimé",
    "DOSAGE": "0.5MG",
    "COND": "PILULIER/08",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOREM / SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "31/3/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "31/3/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["cabergoline"],
    "InteractionIndexLink": ["cabergoline"],
    "N_ENREGISTREMENT": "293/09 D 168/17",
    "CODE_DCI": "09 D 168",
    "DCI": "CABERGOLINE",
    "NOM_COMMERCIALE": "CABERNEX",
    "FORME": "COMPRIME",
    "DOSAGE": "0.5MG",
    "COND": "B/08",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOCARE SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/5/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "7/5/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["cabergoline"],
    "InteractionIndexLink": ["cabergoline"],
    "N_ENREGISTREMENT": "045/ 09 D 168 /13",
    "CODE_DCI": "09 D 168",
    "DCI": "CABERGOLINE",
    "NOM_COMMERCIALE": "DOSTINEX",
    "FORME": "COMPRIME",
    "DOSAGE": "0.5MG",
    "COND": "PILULIER/08",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PFIZER HOLDING FRANCE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/2/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "18/2/2013",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["cabergoline"],
    "InteractionIndexLink": ["cabergoline"],
    "N_ENREGISTREMENT": "149/ 09 D 168 /18",
    "CODE_DCI": "09 D 168",
    "DCI": "CABERGOLINE",
    "NOM_COMMERCIALE": "DOSTINOVA",
    "FORME": "COMPRIME",
    "DOSAGE": "0.5MG",
    "COND": "B/08",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVA PHARM TRADING SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/11/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "12/11/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["econazole"],
    "InteractionIndexLink": ["econazole"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "09 D 168",
    "DCI": "econazole",
    "NOM_COMMERCIALE": "ECONAZOLE novagenerics",
    "FORME": "émulsion fluide",
    "DOSAGE": "0.01",
    "COND": "flacon de 30 ml",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["cabergoline"],
    "InteractionIndexLink": ["cabergoline"],
    "N_ENREGISTREMENT": "235/09 D 168/20",
    "CODE_DCI": "09 D 168",
    "DCI": "CABERGOLINE",
    "NOM_COMMERCIALE": "PROLATINEX BGL",
    "FORME": "COMPRIME",
    "DOSAGE": "0.5MG",
    "COND": "B/08",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES BIOGALENIC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/12/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "27/12/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["carbimazole"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "065/ 09 E 007 /13",
    "CODE_DCI": "09 E 007",
    "DCI": "CARBIMAZOLE",
    "NOM_COMMERCIALE": "ATHYROZOL",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "5MG",
    "COND": "B/50",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GENERICLAB SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/4/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "15/4/2013",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["carbimazole"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "378/ 09 E 007 /20",
    "CODE_DCI": "09 E 007",
    "DCI": "Carbimazole",
    "NOM_COMMERCIALE": "CARBIMAZOLE BR",
    "FORME": "Comprimé",
    "DOSAGE": "5MG",
    "COND": "B/50",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOREM / SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/3/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "28/3/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["carbimazole"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "09 E 007",
    "DCI": "CARBIMAZOLE",
    "NOM_COMMERCIALE": "CARBIMAZOLE GS",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "5MG",
    "COND": "B/50",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["carbimazole"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "012/ 09 E 007 /98/13",
    "CODE_DCI": "09 E 007",
    "DCI": "CARBIMAZOLE",
    "NOM_COMMERCIALE": "CROVIMAZOLE",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "5MG",
    "COND": "B/50",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FARMACEUTICI CROVIS PH. IL. COM SRL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ITALIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "8/11/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "27/10/2013",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["carbimazole"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "549/ 09 E 007 /21",
    "CODE_DCI": "09 E 007",
    "DCI": "Carbimazole",
    "NOM_COMMERCIALE": "EVOCARBIZOLE",
    "FORME": "Comprimé sécable",
    "DOSAGE": "5MG",
    "COND": "B/50",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EVOLAB / SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/3/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "28/3/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["benzyl benzoate"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "269/ 09 E 112 /99/15",
    "CODE_DCI": "09 E 112",
    "DCI": "BENZYLTHIOURACILE",
    "NOM_COMMERCIALE": "BASDENE",
    "FORME": "COMPRIME",
    "DOSAGE": "25MG",
    "COND": "B/50",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BOUCHARA-RECORDATI",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/12/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "30/7/2015",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "60 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["nandrolone"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "467/ 09 F 082 /03/17",
    "CODE_DCI": "09 F 082",
    "DCI": "NANDROLONE DECANOATE",
    "NOM_COMMERCIALE": "DECA-DURABOLIN",
    "FORME": "SOL INJ HUILEUSE IM",
    "DOSAGE": "50MG/ML",
    "COND": "B/1AMP DE 1ML",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ASPEN PHARMA SCHWEIZ GMBH",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SUISSE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/6/2003",
    "DATE_D_ENREGISTREMENT_FINAL": "29/1/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "60 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["estradiol"],
    "InteractionIndexLink": ["estradiol"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "09 G 014",
    "DCI": "ESTRADIOL (VALERATE)",
    "NOM_COMMERCIALE": "PROGYNOVA 2",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "2MG",
    "COND": "B/20",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["betamethasone dipropionate"],
    "InteractionIndexLink": ["betamethasone"],
    "N_ENREGISTREMENT": "20/09 H017/468",
    "CODE_DCI": "09 H 017",
    "DCI": "BETAMETHASONE DIPROPIONATE EXPRIME EN BETAMETASONE / BETAMETHASONE PHOSPHATE EXPRIME EN BETAMETHASONE",
    "NOM_COMMERCIALE": "DIPRONAD",
    "FORME": "SUSP INJ IM OU LOCALE",
    "DOSAGE": "7MG /ML",
    "COND": "B/ 01 SERINGUE PRÉ-REMPLIE DE 2.25ML AVEC 02 AIGUILLES",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES SARL NADPHARMADIC PRODUCTION",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "14/10/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "14/10/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["betamethasone"],
    "InteractionIndexLink": ["betamethasone"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "09 H 017",
    "DCI": "BETAMETHASONE",
    "NOM_COMMERCIALE": "DIPRONAD",
    "FORME": "SOL INJ",
    "DOSAGE": "7MG/500MG/2.00MG",
    "COND": "12:00 AM",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["betamethasone dipropionate"],
    "InteractionIndexLink": ["betamethasone"],
    "N_ENREGISTREMENT": "027/ 09 H 017 /97/16",
    "CODE_DCI": "09 H 017",
    "DCI": "BETAMETHASONE DIPROPIONATE EXPRIME EN BETAMETASONE / BETAMETHASONE PHOSPHATE EXPRIME EN BETAMETHASONE",
    "NOM_COMMERCIALE": "DIPROSTENE",
    "FORME": "SUSP.INJ.",
    "DOSAGE": "5MG/2MG/SERINGUE",
    "COND": "1SERINGUE  PRE REMPLE  + 2 AIGUILLES",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SCHERING PLOUGH",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/4/1997",
    "DATE_D_ENREGISTREMENT_FINAL": "31/1/2018",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["betamethasone dipropionate"],
    "InteractionIndexLink": ["betamethasone"],
    "N_ENREGISTREMENT": "380/ 09 H 017 /15",
    "CODE_DCI": "09 H 017",
    "DCI": "BETAMETHASONE DIPROPIONATE EXPRIME EN BETAMETASONE / BETAMETHASONE PHOSPHATE EXPRIME EN BETAMETHASONE",
    "NOM_COMMERCIALE": "HUPPROSTENE",
    "FORME": "SUSP. INJ.",
    "DOSAGE": "5MG/2MG/1ML",
    "COND": "B/01 AMP DE 1ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HUP.P.PHARMA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/1/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "12/1/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["betamethasone dipropionate"],
    "InteractionIndexLink": ["betamethasone"],
    "N_ENREGISTREMENT": "543/ 09 H 018 /21",
    "CODE_DCI": "09 H 018",
    "DCI": "Acétate de Bétaméthasone exprimé en Bétaméthasone / Phosphate disodique de Bétaméthasone exprimé en Bétaméthasone",
    "NOM_COMMERCIALE": "BIOLESTENE CHRONODOSE",
    "FORME": "Suspension injectable IM/LOCALE",
    "DOSAGE": "2.7MG/3MG/ML",
    "COND": "B/01 AMP. DE 1ML",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOTHERA  / SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "21/3/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "21/3/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["betamethasone acetate"],
    "InteractionIndexLink": ["betamethasone"],
    "N_ENREGISTREMENT": "027/ 09 H 018 /97/15",
    "CODE_DCI": "09 H 018",
    "DCI": "BETAMETHASONE (ACETATE) / BETAMETHASONE  (PHOSPHATE DISODIQUE)",
    "NOM_COMMERCIALE": "CELESTENE CHRONODOSE",
    "FORME": "SUSP.INJ.",
    "DOSAGE": "2.7MG/3MG/AMP.",
    "COND": "B/1AMP. +1SERINGUE + 2AIGUILLES",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MSD FRANCE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "5/3/1997",
    "DATE_D_ENREGISTREMENT_FINAL": "8/11/2015",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "18 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["betamethasone acetate"],
    "InteractionIndexLink": ["betamethasone"],
    "N_ENREGISTREMENT": "380/ 09 H 018 /14",
    "CODE_DCI": "09 H 018",
    "DCI": "BETAMETHASONE ACETATE EXPRIME EN BETAMETHASONE / BETAMETHASONE PHOSPHATE DISODIQUE EXPRIME EN BETAMETHASONE",
    "NOM_COMMERCIALE": "HELESTENE CHRONODOSE",
    "FORME": "SUSP. INJ IM/LOCALE",
    "DOSAGE": "2.7MG/3MG/ML",
    "COND": "B/01 AMP.",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HUP.P.PHARMA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/11/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "30/11/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "18 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["betamethasone"],
    "InteractionIndexLink": ["betamethasone"],
    "N_ENREGISTREMENT": "318/09 H 020/16",
    "CODE_DCI": "09 H 020",
    "DCI": "BETAMETHASONE",
    "NOM_COMMERCIALE": "B-CORTOSONE",
    "FORME": "SOL.BUV. GTTES",
    "DOSAGE": "0.5MG/ML (0.05%)",
    "COND": "B/30ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMIDAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/12/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "4/12/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["betamethasone"],
    "InteractionIndexLink": ["betamethasone"],
    "N_ENREGISTREMENT": "235/09 H 020/16",
    "CODE_DCI": "09 H 020",
    "DCI": "BETAMETHASONE",
    "NOM_COMMERCIALE": "BETABIO",
    "FORME": "SOL.BUV. GTTES",
    "DOSAGE": "0.5MG/ML (0.05%)",
    "COND": "B/ FL 30ML+PIPETTE GRADUEE",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOGALENIC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/11/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "15/11/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["betamethasone"],
    "InteractionIndexLink": ["betamethasone"],
    "N_ENREGISTREMENT": "455/ 09 H 020 /99/16",
    "CODE_DCI": "09 H 020",
    "DCI": "BETAMETHASONE",
    "NOM_COMMERCIALE": "BETACROVIS",
    "FORME": "SOL.BUV. GTTES",
    "DOSAGE": "0.5MG/ML (0.05%)",
    "COND": "FL/40ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GENCOPHARM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/11/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "13/3/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["betamethasone"],
    "InteractionIndexLink": ["betamethasone"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "09 H 020",
    "DCI": "BETAMETHASONE",
    "NOM_COMMERCIALE": "BETAMETHASONE  INPHA MEDIS",
    "FORME": "SOL. BUV. GTTES.",
    "DOSAGE": "0.5MG/ML (0.05%)",
    "COND": "B/1FL DE 30ML +SERINGUE GRADUEE",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["betamethasone"],
    "InteractionIndexLink": ["betamethasone"],
    "N_ENREGISTREMENT": "462/ 09 H 020 /16",
    "CODE_DCI": "09 H 020",
    "DCI": "BETAMETHASONE",
    "NOM_COMMERCIALE": "BETAMETHASONE PHYSIOPHARM",
    "FORME": "SOL. BUV. GTTES.",
    "DOSAGE": "0.5MG/ML (0.05%)",
    "COND": "B/1FL DE 30ML+ PIPETTE GRADUEE EN ML  (2ml)",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL PHYSIOPHARM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/3/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "13/3/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["betamethasone"],
    "InteractionIndexLink": ["betamethasone"],
    "N_ENREGISTREMENT": "317/09 H 020/17",
    "CODE_DCI": "09 H 020",
    "DCI": "BETAMETHASONE",
    "NOM_COMMERCIALE": "BETASTENE",
    "FORME": "SOL. BUV. GTTES.",
    "DOSAGE": "0.5MG/ML (0.05%)",
    "COND": "B/1FL DE 30ML +SERINGUE GRADUEE",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INPHA MEDIS SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/1/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "17/1/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["betamethasone"],
    "InteractionIndexLink": ["betamethasone"],
    "N_ENREGISTREMENT": "503/ 09 H 020 /15",
    "CODE_DCI": "09 H 020",
    "DCI": "BETAMETHASONE",
    "NOM_COMMERCIALE": "BETASTENE",
    "FORME": "SOL. BUV. GTTES.",
    "DOSAGE": "0.5MG/ML (0.05%)",
    "COND": "B/1FL. COMPTE-GTTES. DE 30ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SPA/ AFRO PHARM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/12/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "2/12/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["betamethasone"],
    "InteractionIndexLink": ["betamethasone"],
    "N_ENREGISTREMENT": "263/ 09 H 020 /14",
    "CODE_DCI": "09 H 020",
    "DCI": "BETAMETHASONE",
    "NOM_COMMERCIALE": "CELETASONE",
    "FORME": "SOL.BUV. GTTES",
    "DOSAGE": "0.5MG/ML (0.05%)",
    "COND": "B/01 FL 30ML+01 SERINGUE DOSEUSE GRADUEE",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOPHARM ALGERIE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "16/2/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "16/2/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["betamethasone"],
    "InteractionIndexLink": ["betamethasone"],
    "N_ENREGISTREMENT": "457/ 09 H 020 /13",
    "CODE_DCI": "09 H 020",
    "DCI": "BETAMETHASONE",
    "NOM_COMMERCIALE": "LESTONE",
    "FORME": "SOL. BUV. GTTES.",
    "DOSAGE": "0.5MG/ML (0.05%)",
    "COND": "B/1FL. COMPTE-GTTES. DE 30ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOMEDIAL SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/1/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "13/1/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["betamethasone"],
    "InteractionIndexLink": ["betamethasone"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "09 H 020",
    "DCI": "BETAMETHASONE",
    "NOM_COMMERCIALE": "TABETA",
    "FORME": "SOL. BUV. GTTES.",
    "DOSAGE": "0.5MG/ML (0.05%)",
    "COND": "F/30ML + PIPETTE GRADUEE",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["dexamethasone"],
    "InteractionIndexLink": ["dexamethasone"],
    "N_ENREGISTREMENT": "433/09 H 021/16",
    "CODE_DCI": "09 H 021",
    "DCI": "DEXAMETHASONE PHOSPHATE SODIQUE EXPRIME EN DEXAMETHASONE PHOSPHATE",
    "NOM_COMMERCIALE": "DEXAMETYD",
    "FORME": "SOL.INJ IM/IV OU LOCAL EN AMP",
    "DOSAGE": "4MG/ML",
    "COND": "B/5AMP  1ML ET 2 ML ET  5ML + B/50 AMP 1ML ET 2 ML ET 5ML",
    "LISTE": "LISTE I",
    "P1": "HOF (B/50+B/5)",
    "P2": "OFF (b/5)",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRATER RAZES SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/11/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "7/11/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["dexamethasone"],
    "InteractionIndexLink": ["dexamethasone"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "09 H 021",
    "DCI": "DEXAMETHASONE",
    "NOM_COMMERCIALE": "DEXASONE",
    "FORME": "SOL. INJ.",
    "DOSAGE": "4MG/ML",
    "COND": "B/5AMP./1ML",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["dexamethasone"],
    "InteractionIndexLink": ["dexamethasone"],
    "N_ENREGISTREMENT": "543/ 09 H 021 /21",
    "CODE_DCI": "09 H 021",
    "DCI": "Phosphate sodique de dexaméthasone exprimé en Phosphate de Dexaméthasone",
    "NOM_COMMERCIALE": "DEXTHERA",
    "FORME": "Solution injectable IV.IM ou Locale",
    "DOSAGE": "4MG/ML",
    "COND": "B/5AMP  de 1ML.  2ML  et  5ML + B/50 AMP de 1ML. 2ML et  5ML",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "B/50 RESERVEE AUX HÔPITAUX",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOTHERA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "14/4/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "14/4/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["dexamethasone"],
    "InteractionIndexLink": ["dexamethasone"],
    "N_ENREGISTREMENT": "012/ 09 H 023 /98/14",
    "CODE_DCI": "09 H 023",
    "DCI": "DEXAMETHASONE",
    "NOM_COMMERCIALE": "DESACROVIS",
    "FORME": "COMPRIME",
    "DOSAGE": "0.5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CROVIS PHILCOM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ITALIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "8/11/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "22/6/2014",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["hydrocortisone"],
    "InteractionIndexLink": ["hydrocortisone"],
    "N_ENREGISTREMENT": "458/ 09 H 026 /99/15",
    "CODE_DCI": "09 H 026",
    "DCI": "HYDROCORTISONE SUCCINATE SODIQUE EXPRIME EN HYDROCORTISONE",
    "NOM_COMMERCIALE": "RAPICORT",
    "FORME": "LYOPH. ET SOLV. P. SOL.INJ. IV",
    "DOSAGE": "100MG/AMP. DE LYOPH;",
    "COND": "B/05 AMP. DE LYOPH. + 05 AMP. DE 2ML DE SOLV. (EPPI)",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ISTITUTO FARMACOBIOLOGICO MALESCI SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ITALIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/4/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "19/10/2015",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["hydrocortisone"],
    "InteractionIndexLink": ["hydrocortisone"],
    "N_ENREGISTREMENT": "376/ 09 H 028 /99/16",
    "CODE_DCI": "09 H 028",
    "DCI": "HYDROCORTISONE",
    "NOM_COMMERCIALE": "HYDROCORTISONE ROUSSEL",
    "FORME": "COMPRIME",
    "DOSAGE": "10MG",
    "COND": "B/25",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANOFI AVENTIS FRANCE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/1/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "11/9/2016",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["methylprednisolone"],
    "InteractionIndexLink": ["methylprednisolone"],
    "N_ENREGISTREMENT": "161/ 09 H 029 /99/13",
    "CODE_DCI": "09 H 029",
    "DCI": "METHYLPREDNISOLONE SUCCINATE DE SODIUM EXPRIME EN METHYLPREDNISOLONE",
    "NOM_COMMERCIALE": "LEMOD-SOLU",
    "FORME": "LYOPH. ET SOLV. P. SOL. INJ. IM/IV",
    "DOSAGE": "20MG",
    "COND": "B/1FL. DE LYOPH. + 1AMP. DE 1ML DE SOLV. (EPPI AVEC 0.9% D'ALCOOL BENZYLIQUE)",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HEMOFARM A.D",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SERBIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/6/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "10/3/2013",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["methylprednisolone"],
    "InteractionIndexLink": ["methylprednisolone"],
    "N_ENREGISTREMENT": "011/ 09 H 029 /99/18",
    "CODE_DCI": "09 H 029",
    "DCI": "METHYLPREDNISOLONE SUCCINATE SODIQUE EXPRIME EN METHYLPREDNISOLONE",
    "NOM_COMMERCIALE": "LISAMETHYLE",
    "FORME": "LYOPH. ET SOLV. P. SOL. INJ. IM/IV",
    "DOSAGE": "20MG/FL. DE LYOPH.",
    "COND": "B/1FL. DE LYOPH. + 1AMP. DE 2ML DE SOLV. (EPPI)  ET  *B/50FL. DE LYOPH. + 50AMP. DE 2ML DE SOLV. (EPPI)",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "*B/50+50 RESERVE AUX HOP.",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LISAPHARMA SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ITALIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/11/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "24/7/2018",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["methylprednisolone"],
    "InteractionIndexLink": ["methylprednisolone"],
    "N_ENREGISTREMENT": "039/ 09 H 029 /05/17",
    "CODE_DCI": "09 H 029",
    "DCI": "METHYLPREDNISOLONE",
    "NOM_COMMERCIALE": "MEPRENAL",
    "FORME": "PDRE.SOL.INJ.",
    "DOSAGE": "20MG",
    "COND": "B/1+1 ET B/50",
    "LISTE": "Liste I",
    "P1": "HOP ( B/50  + b/1+1)",
    "P2": "OFF (B/1+1)",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOCIETE PHARMACEUTIQUE ALGERIENNE (SOPHAL)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/5/2005",
    "DATE_D_ENREGISTREMENT_FINAL": "5/11/2017",
    "TYPE": "Gé",
    "STATUT": "C",
    "DUREE_DE_STABILITE": "36 mois",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["methylprednisolone"],
    "InteractionIndexLink": ["methylprednisolone"],
    "N_ENREGISTREMENT": "450/ 09 H 029 /07/13",
    "CODE_DCI": "09 H 029",
    "DCI": "METHYLPREDNISOLONE HEMISUCCINATE EXPRIME EN METHYLPREDNISOLONE",
    "NOM_COMMERCIALE": "METHYLPREDNISOLONE MYLAN",
    "FORME": "PDRE. P. SOL. INJ. IM/ IV",
    "DOSAGE": "20MG/FL. DE PDRE.",
    "COND": "B/20FL. DE PDRE.",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MYLAN SAS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/8/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "10/3/2013",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["methylprednisolone"],
    "InteractionIndexLink": ["methylprednisolone"],
    "N_ENREGISTREMENT": "076/09 H 029/98/16",
    "CODE_DCI": "09 H 029",
    "DCI": "METHYLPREDNISOLONE",
    "NOM_COMMERCIALE": "SOLU-MEDROL",
    "FORME": "PDRE.SOL.INJ.",
    "DOSAGE": "20MG/2ML",
    "COND": "B/1+1",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMACIA S A S",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/12/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "4/1/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["methylprednisolone"],
    "InteractionIndexLink": ["methylprednisolone"],
    "N_ENREGISTREMENT": "286/ 09 H 030 /12",
    "CODE_DCI": "09 H 030",
    "DCI": "METHYLPREDNISOLONE SUCCINATE SODIQUE EXPRIME EN METHYLPREDNISOLONE",
    "NOM_COMMERCIALE": "INPREDNI 40",
    "FORME": "PDRE. P. SOL. INJ. IM/IV",
    "DOSAGE": "40MG/FL. DE PDRE.",
    "COND": "B/50FL. DE PDRE.",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CHIMIE PHARMACIE COMMERCE MULTIPLE SARL (CPCM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/1/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "10/1/2012",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["methylprednisolone"],
    "InteractionIndexLink": ["methylprednisolone"],
    "N_ENREGISTREMENT": "161/ 09 H 030 /99/13",
    "CODE_DCI": "09 H 030",
    "DCI": "METHYLPREDNISOLONE SUCCINATE SODIQUE EXPRIME EN METHYLPREDNISOLONE",
    "NOM_COMMERCIALE": "LEMOD-SOLU",
    "FORME": "LYOPHI. P. SOL. INJ. IM/IV",
    "DOSAGE": "40MG/FL. DE LYOPH.",
    "COND": "B/1FL. DE LYOPH. + 1AMP. DE 1ML DE SOLV. (EPPI AVEC 0.9% D'ALCOOL BENZYLIQUE)",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HEMOFARM A.D",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SERBIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/6/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "10/3/2013",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["methylprednisolone"],
    "InteractionIndexLink": ["methylprednisolone"],
    "N_ENREGISTREMENT": "011/ 09 H 030 /96/15",
    "CODE_DCI": "09 H 030",
    "DCI": "METHYLPREDNISOLONE SUCCINATE SODIQUE EXPRIME EN METHYLPREDNISOLONE",
    "NOM_COMMERCIALE": "LISAMETHYLE",
    "FORME": "PDRE. ET SOLV. P. SOL. INJ. IM/IV",
    "DOSAGE": "40MG/FL. DE PDRE",
    "COND": "B/01FL. DE PDRE + 1AMP. DE 2ML DE SOLV. (EPPI)  ET  B/50FL. DE PDRE. + 50AMP. DE 2ML DE SOLV. (EPPI)",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "B/50+50 RESERVEE AUX HÔPITAUX",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LISAPHARMA SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ITALIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/10/1996",
    "DATE_D_ENREGISTREMENT_FINAL": "26/2/2015",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["methylprednisolone"],
    "InteractionIndexLink": ["methylprednisolone"],
    "N_ENREGISTREMENT": "039/ 09 H 030 /05/17",
    "CODE_DCI": "09 H 030",
    "DCI": "METHYLPREDNISOLONE",
    "NOM_COMMERCIALE": "MEPRENAL",
    "FORME": "PDRE.SOL.INJ.",
    "DOSAGE": "40MG",
    "COND": "B/01+01 ET B/50",
    "LISTE": "Liste I",
    "P1": "HOP ( B/50  + b/1+1)",
    "P2": "OFF (B/50 )",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOCIETE PHARMACEUTIQUE ALGERIENNE (SOPHAL)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/5/2005",
    "DATE_D_ENREGISTREMENT_FINAL": "5/11/2017",
    "TYPE": "Gé",
    "STATUT": "C",
    "DUREE_DE_STABILITE": "36 mois",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["methylprednisolone"],
    "InteractionIndexLink": ["methylprednisolone"],
    "N_ENREGISTREMENT": "450/ 09 H 030 /03/13",
    "CODE_DCI": "09 H 030",
    "DCI": "METHYLPREDNISOLONE HEMISUCCINATE EXPRIME EN METHYLPREDNISOLONE",
    "NOM_COMMERCIALE": "METHYLPREDNISOLONE MYLAN",
    "FORME": "PDRE. P. SOL. INJ. IM/IV",
    "DOSAGE": "40MG/FL. DE PDRE.",
    "COND": "B/20FL. DE PDRE.",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MYLAN SAS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/4/2003",
    "DATE_D_ENREGISTREMENT_FINAL": "25/6/2013",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["methylprednisolone"],
    "InteractionIndexLink": ["methylprednisolone"],
    "N_ENREGISTREMENT": "011/ 09 H 031 /98/18",
    "CODE_DCI": "09 H 031",
    "DCI": "METHYLPREDNISOLONE (SOUS FORME DE SUCCINATE SODIQUE)",
    "NOM_COMMERCIALE": "LISAMETHYLE",
    "FORME": "PDRE. ET SOLV. P. SOL. INJ. IM/IV",
    "DOSAGE": "120MG/FL. DE PDRE.",
    "COND": "B/1FL. DE PDRE + 1AMP. DE 2ML DE SOLV. (EPPI)  ET B/50FL. DE PDRE. +50AMP. DE 2ML DE SOLV. (EPPI)",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "B/50+50*RESERVEE AUX HÔPITAUX",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LISAPHARMA SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ITALIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/7/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "24/7/2018",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 mois",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["methylprednisolone"],
    "InteractionIndexLink": ["methylprednisolone"],
    "N_ENREGISTREMENT": "450/ 09 H 031 /01/13",
    "CODE_DCI": "09 H 031",
    "DCI": "METHYLPREDNISOLONE HEMISUCCINATE EXPRIME EN METHYLPREDNISOLONE",
    "NOM_COMMERCIALE": "METHYLPREDNISONE MYLAN",
    "FORME": "PDRE. P. SOL. INJ. IM/IV",
    "DOSAGE": "120MG/FL. DE PDRE.",
    "COND": "B/20FL. DE PDRE.",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MYLAN SAS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/1/2001",
    "DATE_D_ENREGISTREMENT_FINAL": "10/3/2013",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["methylprednisolone"],
    "InteractionIndexLink": ["methylprednisolone"],
    "N_ENREGISTREMENT": "077/09 H 033/18",
    "CODE_DCI": "09 H 033",
    "DCI": "METHYLPREDNISOLONE",
    "NOM_COMMERCIALE": "CORTTILAM",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "4MG",
    "COND": "B/20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "Laboratoire Algérien du médicament (L.A.M)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/8/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "1/8/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["methylprednisolone"],
    "InteractionIndexLink": ["methylprednisolone"],
    "N_ENREGISTREMENT": "380/09 H 033/17",
    "CODE_DCI": "09 H 033",
    "DCI": "METHYLPREDNISOLONE",
    "NOM_COMMERCIALE": "HUPPOMEDROL",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "4MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HUP.P.PHARMA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/5/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "7/5/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["methylprednisolone"],
    "InteractionIndexLink": ["methylprednisolone"],
    "N_ENREGISTREMENT": "348/ 09 H 033 /16",
    "CODE_DCI": "09 H 033",
    "DCI": "METHYLPREDNISOLONE",
    "NOM_COMMERCIALE": "MP4",
    "FORME": "COMPRIME",
    "DOSAGE": "4MG",
    "COND": "B/20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIAN PHARMACEUTICAL INSTITUT SARL ( API)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/8/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "9/8/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["methylprednisolone"],
    "InteractionIndexLink": ["methylprednisolone"],
    "N_ENREGISTREMENT": "176/ 09 H 033 /98/17",
    "CODE_DCI": "09 H 033",
    "DCI": "METHYLPREDNISOLONE",
    "NOM_COMMERCIALE": "PREDNOL",
    "FORME": "COMPRIME",
    "DOSAGE": "4MG",
    "COND": "B/20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MUSTAFA NEVZAT ILAC SANAYI AS ( MN PHARMACEUTICAL)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "TURQUIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "23/12/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "2/8/2017",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 mois",
    "availableInAlgeria": true,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["methylprednisolone"],
    "InteractionIndexLink": ["methylprednisolone"],
    "N_ENREGISTREMENT": "235/09 H 033/17",
    "CODE_DCI": "09 H 033",
    "DCI": "METHYLPREDNISOLONE",
    "NOM_COMMERCIALE": "TERAPRED",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "4MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOGALENIC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "16/7/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "16/7/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["prednisolone"],
    "InteractionIndexLink": ["prednisolone"],
    "N_ENREGISTREMENT": "001/ 09 H 034 /14",
    "CODE_DCI": "09 H 034",
    "DCI": "PREDNISOLONE METASULFOBENZOATE SODIQUE EXPRIME EN PREDNISOLONE",
    "NOM_COMMERCIALE": "REDNILEF",
    "FORME": "COMP EFFERV",
    "DOSAGE": "5MG",
    "COND": "PILULIER/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMA ALGERIA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/3/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "9/3/2014",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["prednisolone"],
    "InteractionIndexLink": ["prednisolone"],
    "N_ENREGISTREMENT": "001/ 09 H 035 /14",
    "CODE_DCI": "09 H 035",
    "DCI": "PREDNISOLONE METASULFOBENZOATE SODIQUE EXPRIME EN PREDNISOLONE",
    "NOM_COMMERCIALE": "REDNILEF",
    "FORME": "COMP EFFERV",
    "DOSAGE": "20MG",
    "COND": "PILULIER/20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMA ALGERIA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/3/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "9/3/2014",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["prednisone"],
    "InteractionIndexLink": ["prednisone"],
    "N_ENREGISTREMENT": "468/ 09 H 038 /13/20",
    "CODE_DCI": "09 H 038",
    "DCI": "PREDNISONE",
    "NOM_COMMERCIALE": "NADCORTYL",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NADPHARMADIC PRODUCTION SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "3/7/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "8/1/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["prednisone"],
    "InteractionIndexLink": ["prednisone"],
    "N_ENREGISTREMENT": "003/ 09 H 038 /97/17",
    "CODE_DCI": "09 H 038",
    "DCI": "PREDNISONE",
    "NOM_COMMERCIALE": "PRECORTYL",
    "FORME": "COMPRIME",
    "DOSAGE": "5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EPE  GROUPE INDUSTRIEL SAIDAL SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "23/3/1997",
    "DATE_D_ENREGISTREMENT_FINAL": "12/6/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["methylprednisolone"],
    "InteractionIndexLink": ["methylprednisolone"],
    "N_ENREGISTREMENT": "109/ 09 H 090 /17",
    "CODE_DCI": "09 H 090",
    "DCI": "Méthylprednisolone acétate",
    "NOM_COMMERCIALE": "EPIZOLONE-DEPOT",
    "FORME": "SUSPENSION AQUEUSE INJECTABLE",
    "DOSAGE": "40MG/ML",
    "COND": "B/ 01 FL DE 40MG/ML ET B/ 01 FL DE 80 MG/2ML",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EGYPTIAN INTYERNATIONAL PHARMACEUTICAL INDUSTRIES COMPANY (EPICO)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EGYPTE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/12/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "25/12/2017",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["methylprednisolone"],
    "InteractionIndexLink": ["methylprednisolone"],
    "N_ENREGISTREMENT": "011/ 09 H 090 /99/13",
    "CODE_DCI": "09 H 090",
    "DCI": "METHYLPREDNISOLONE ACETATE",
    "NOM_COMMERCIALE": "LISAMETACE",
    "FORME": "SUSP.INJ.",
    "DOSAGE": "40MG/ML",
    "COND": "B/1AMP. DE 1ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ITALIANO BIOCHIMICO FARMACEUTICO LISAPHARMA SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ITALIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "8/12/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "8/10/2013",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["triamcinolone (systemic)"],
    "InteractionIndexLink": ["triamcinolone"],
    "N_ENREGISTREMENT": "380/ 09 H 091 /15",
    "CODE_DCI": "09 H 091",
    "DCI": "TRIAMCINOLONE ACETONIDE",
    "NOM_COMMERCIALE": "HUPPACORT RETARD",
    "FORME": "SUSP. INJ. IM OU LOCALE",
    "DOSAGE": "40MG/ML",
    "COND": "B/01 AMP. DE 1ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HUP.P.PHARMA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/1/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "25/1/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["triamcinolone (systemic)"],
    "InteractionIndexLink": ["triamcinolone"],
    "N_ENREGISTREMENT": "017/ 09 H 091 /97/16",
    "CODE_DCI": "09 H 091",
    "DCI": "TRIAMCINOLONE ACETONIDE",
    "NOM_COMMERCIALE": "KENACORT RETARD",
    "FORME": "SUSP.INJ.",
    "DOSAGE": "40MG",
    "COND": "B/1AMP. DE 1ML + 1SERING. DE 5ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BRISTOL MYERS SQUIBB",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/4/1997",
    "DATE_D_ENREGISTREMENT_FINAL": "2/2/2016",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["triamcinolone (systemic)"],
    "InteractionIndexLink": ["triamcinolone"],
    "N_ENREGISTREMENT": "011/ 09 H 091 /98/18",
    "CODE_DCI": "09 H 091",
    "DCI": "TRIAMCINOLONE ACETONIDE",
    "NOM_COMMERCIALE": "LISATRIAM",
    "FORME": "SUSP.INJ.",
    "DOSAGE": "40MG/ML",
    "COND": "B/01AMP. DE 1ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ITALIANO BIOCHIMICO FARMACEUTICO LISAPHARMA SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ITALIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/7/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "28/1/2018",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["triamcinolone (systemic)"],
    "InteractionIndexLink": ["triamcinolone"],
    "N_ENREGISTREMENT": "543/09 H 091/20",
    "CODE_DCI": "09 H 091",
    "DCI": "TRIAMCINOLONE ACETONIDE",
    "NOM_COMMERCIALE": "THERACORT",
    "FORME": "SUSP. INJ",
    "DOSAGE": "04MG/ML",
    "COND": "B/AMPOULE DE 2ML CONTENANT 1ML DE SUSP.",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES BIOTHERA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/12/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "29/12/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["methylprednisolone"],
    "InteractionIndexLink": ["methylprednisolone"],
    "N_ENREGISTREMENT": "380/ 09 H 092 /16",
    "CODE_DCI": "09 H 092",
    "DCI": "METHYLPREDNISOLONE",
    "NOM_COMMERCIALE": "HUPPOMEDROL",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "16MG",
    "COND": "B/20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HUP.P.PHARMA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/7/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "17/7/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["methylprednisolone"],
    "InteractionIndexLink": ["methylprednisolone"],
    "N_ENREGISTREMENT": "348/09 H 092/16",
    "CODE_DCI": "09 H 092",
    "DCI": "METHYLPREDNISOLONE",
    "NOM_COMMERCIALE": "MP 16",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "16MG",
    "COND": "B/10",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "API SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/12/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "19/12/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["methylprednisolone"],
    "InteractionIndexLink": ["methylprednisolone"],
    "N_ENREGISTREMENT": "235/09 H 092/17",
    "CODE_DCI": "09 H 092",
    "DCI": "METHYLPREDNISOLONE",
    "NOM_COMMERCIALE": "TERAPRED",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "16MG",
    "COND": "B/20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOGALENIC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/6/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "12/6/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["betamethasone"],
    "InteractionIndexLink": ["betamethasone"],
    "N_ENREGISTREMENT": "235/9 H 133/16",
    "CODE_DCI": "09 H 133",
    "DCI": "BETAMETHASONE",
    "NOM_COMMERCIALE": "BETABIO",
    "FORME": "COMP. DISPERS. SEC.",
    "DOSAGE": "2MG",
    "COND": "PILULIER DE 20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOGALENIC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/11/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "15/11/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["betamethasone"],
    "InteractionIndexLink": ["betamethasone"],
    "N_ENREGISTREMENT": "263/ 09 H 133 /12",
    "CODE_DCI": "09 H 133",
    "DCI": "BETAMETHASONE",
    "NOM_COMMERCIALE": "CELETASONE",
    "FORME": "COMP. DISPERS.",
    "DOSAGE": "2MG",
    "COND": "B/20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOPHARM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/1/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "18/1/2012",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["betamethasone"],
    "InteractionIndexLink": ["betamethasone"],
    "N_ENREGISTREMENT": "21/12/09 H133/263",
    "CODE_DCI": "09 H 133",
    "DCI": "BETAMETHASONE",
    "NOM_COMMERCIALE": "CELETASONE",
    "FORME": "COMP. DISPERS.",
    "DOSAGE": "2MG",
    "COND": "B/20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES BIOPHARM/ SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/01/12",
    "DATE_D_ENREGISTREMENT_FINAL": "26/04/21",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["methylprednisolone"],
    "InteractionIndexLink": ["methylprednisolone"],
    "N_ENREGISTREMENT": "450/ 09 H 135 /06/13",
    "CODE_DCI": "09 H 135",
    "DCI": "METHYLPREDNISOLONE HEMISUCCINATE EXPRIME EN METHYLPREDNISOLONE",
    "NOM_COMMERCIALE": "METHYLPREDNISOLONE MYLAN",
    "FORME": "PDRE. P. SOL INJ I.V.",
    "DOSAGE": "1G/FL. DE PDRE.",
    "COND": "B/10FL.DE PDRE.*",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MYLAN SAS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/7/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "15/4/2013",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["prednisolone"],
    "InteractionIndexLink": ["prednisolone"],
    "N_ENREGISTREMENT": "235/ 09 H 143 /12/18",
    "CODE_DCI": "09 H 143",
    "DCI": "PREDNISOLONE METASULFOBENZOATE SODIQUE EXPRIME EN PREDNISOLONE",
    "NOM_COMMERCIALE": "DEPRISOLE",
    "FORME": "COMP. ORODISPERS.",
    "DOSAGE": "5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIO-GALENIC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/4/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "19/11/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["prednisolone"],
    "InteractionIndexLink": ["prednisolone"],
    "N_ENREGISTREMENT": "077/ 09 H 143 /19",
    "CODE_DCI": "09 H 143",
    "DCI": "PREDNISOLONE METASULFOBENZOATE SODIQUE EXPRIME EN PREDNISOLONE",
    "NOM_COMMERCIALE": "LAMISOLONE",
    "FORME": "COMP. ORODISPERS.",
    "DOSAGE": "5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE ALGERIEN DU MEDICAMENT SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/4/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "29/4/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["prednisolone"],
    "InteractionIndexLink": ["prednisolone"],
    "N_ENREGISTREMENT": "317/ 09 H 143 /16",
    "CODE_DCI": "09 H 143",
    "DCI": "PREDNISOLONE",
    "NOM_COMMERCIALE": "OROPRED",
    "FORME": "COMP. ORODISPERS.",
    "DOSAGE": "5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INPHA-MEDIS SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "11/4/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "11/4/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["prednisolone"],
    "InteractionIndexLink": ["prednisolone"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "09 H 143",
    "DCI": "Prednisolone",
    "NOM_COMMERCIALE": "Oropred 5mg",
    "FORME": "comp orodispersible",
    "DOSAGE": "5mg/comp",
    "COND": "bt de 30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["prednisolone"],
    "InteractionIndexLink": ["prednisolone"],
    "N_ENREGISTREMENT": "462/ 09 H 143 /16",
    "CODE_DCI": "09 H 143",
    "DCI": "PREDNISOLONE",
    "NOM_COMMERCIALE": "PHYSIOLONE",
    "FORME": "COMP. ORODISPERS.",
    "DOSAGE": "5MG",
    "COND": "B/20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL PHYSIOPHARM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/3/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "13/3/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["prednisolone"],
    "InteractionIndexLink": ["prednisolone"],
    "N_ENREGISTREMENT": "400/09 H 143/17",
    "CODE_DCI": "09 H 143",
    "DCI": "PREDNISOLONE",
    "NOM_COMMERCIALE": "PREDNAMEX",
    "FORME": "COMP. ORODISPERS.",
    "DOSAGE": "5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "KPMA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/2/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "7/2/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["prednisolone"],
    "InteractionIndexLink": ["prednisolone"],
    "N_ENREGISTREMENT": "468/ 09 H 143 /15",
    "CODE_DCI": "09 H 143",
    "DCI": "PREDNISOLONE",
    "NOM_COMMERCIALE": "PREDNICORT",
    "FORME": "COMP. ORODISPERS.",
    "DOSAGE": "5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NADPHARMADIC PRODUCTION SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/6/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "9/6/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["prednisolone"],
    "InteractionIndexLink": ["prednisolone"],
    "N_ENREGISTREMENT": "470/09 H 143/16",
    "CODE_DCI": "09 H 143",
    "DCI": "PREDNISOLONE METASULFOBENZOATE SODIQUE EXPRIME EN PREDNISOLONE",
    "NOM_COMMERCIALE": "PREDNISOLONE MM ORO",
    "FORME": "COMP ORODISPERSIBLE",
    "DOSAGE": "5MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL LABORATOIRES MM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/11/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "2/11/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["prednisolone"],
    "InteractionIndexLink": ["prednisolone"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "09 H 143",
    "DCI": "PREDNISOLONE METASULFOBENZOATE SODIQUE EXPRIME EN PREDNISOLONE",
    "NOM_COMMERCIALE": "SOLUPRED ORO",
    "FORME": "COMP. ORODISPERS.",
    "DOSAGE": "5MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["prednisolone"],
    "InteractionIndexLink": ["prednisolone"],
    "N_ENREGISTREMENT": "320/ 09 H 143 /07/12",
    "CODE_DCI": "09 H 143",
    "DCI": "PREDNISOLONE",
    "NOM_COMMERCIALE": "SWOR",
    "FORME": "COMP. ORODISPERS.",
    "DOSAGE": "5MG",
    "COND": "PILUL./30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIAN GENERICS DEVELOPMENT  PHARMA  (AGD PHARM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/3/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "15/10/2012",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["prednisolone"],
    "InteractionIndexLink": ["prednisolone"],
    "N_ENREGISTREMENT": "348/09 H 144/16",
    "CODE_DCI": "09 H 144",
    "DCI": "PREDNISOLONE METASULFOBENZOATE DE SODIUM EXPRIME EN PREDNISOLONE",
    "NOM_COMMERCIALE": "CORTIPRED ORO",
    "FORME": "COMP ORODISPERSIBLE",
    "DOSAGE": "20MG",
    "COND": "B/20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "API SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/12/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "19/12/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["prednisolone"],
    "InteractionIndexLink": ["prednisolone"],
    "N_ENREGISTREMENT": "235/ 09 H 144 /14",
    "CODE_DCI": "09 H 144",
    "DCI": "PREDNISOLONE METASULFOBENZOATE DE SODIUM EXPRIME EN PREDNISOLONE",
    "NOM_COMMERCIALE": "DEPRISOLE",
    "FORME": "COMP ORODISPERSIBLE",
    "DOSAGE": "20MG",
    "COND": "B/20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIO-GALENIC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "31/3/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "31/3/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["prednisolone"],
    "InteractionIndexLink": ["prednisolone"],
    "N_ENREGISTREMENT": "518/09 H 144/18",
    "CODE_DCI": "09 H 144",
    "DCI": "PREDNISOLONE METASULFOBENZOATE DE SODIUM EXPRIME EN PREDNISOLONE",
    "NOM_COMMERCIALE": "KORTIKAN 20",
    "FORME": "COMP ORODISPERSIBLE",
    "DOSAGE": "20MG",
    "COND": "B/20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "TASSILI ARAB PHARMACEUTICAL COMPANY / SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/4/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "30/4/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["prednisolone"],
    "InteractionIndexLink": ["prednisolone"],
    "N_ENREGISTREMENT": "077/ 09 H 144 /19",
    "CODE_DCI": "09 H 144",
    "DCI": "Prednisolone s/f metasulfobenzoate sodique",
    "NOM_COMMERCIALE": "LAMISOLONE",
    "FORME": "COMP. ORODISPERS",
    "DOSAGE": "20MG",
    "COND": "B/20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE ALGERIEN DU MEDICAMENT SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/4/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "29/4/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["prednisolone"],
    "InteractionIndexLink": ["prednisolone"],
    "N_ENREGISTREMENT": "317/ 09 H 144 /15",
    "CODE_DCI": "09 H 144",
    "DCI": "PREDNISOLONE METASULFOBENZOATE SODIQUE EXPRIME EN PREDNISOLONE",
    "NOM_COMMERCIALE": "OROPRED",
    "FORME": "COMP. ORODISPERS.",
    "DOSAGE": "20MG",
    "COND": "B/20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INPHA-MEDIS SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/1/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "18/1/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["prednisolone"],
    "InteractionIndexLink": ["prednisolone"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "09 H 144",
    "DCI": "Prednisolone",
    "NOM_COMMERCIALE": "Oropred 20mg",
    "FORME": "comp orodispersible",
    "DOSAGE": "20mg/comp",
    "COND": "bt de 20",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["prednisolone"],
    "InteractionIndexLink": ["prednisolone"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "09 H 144",
    "DCI": "Prednisolone",
    "NOM_COMMERCIALE": "Oropred 20mg",
    "FORME": "comp orodispersible",
    "DOSAGE": "20mg/comp",
    "COND": "bt de 20",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["prednisolone"],
    "InteractionIndexLink": ["prednisolone"],
    "N_ENREGISTREMENT": "462/ 09 H 144 /15",
    "CODE_DCI": "09 H 144",
    "DCI": "PREDNISOLONE",
    "NOM_COMMERCIALE": "PHYSIOLONE",
    "FORME": "COMP. ORODISPERS.",
    "DOSAGE": "20MG",
    "COND": "B/20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHYSIOPHARM SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/12/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "2/12/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["prednisolone"],
    "InteractionIndexLink": ["prednisolone"],
    "N_ENREGISTREMENT": "039/ 09 H 144 /13",
    "CODE_DCI": "09 H 144",
    "DCI": "PREDNISOLONE METASULFOBENZOATE SODIQUE EXPRIME EN PREDNISOLONE",
    "NOM_COMMERCIALE": "PREDNAL",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "20MG",
    "COND": "B/20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOCIETE PHARMACEUTIQUE ALGERIENNE (SOPHAL)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/5/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "12/5/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["prednisolone"],
    "InteractionIndexLink": ["prednisolone"],
    "N_ENREGISTREMENT": "400/09 H 144/17",
    "CODE_DCI": "09 H 144",
    "DCI": "PREDNISOLONE",
    "NOM_COMMERCIALE": "PREDNAMEX",
    "FORME": "COMP. ORODISPERS.",
    "DOSAGE": "20MG",
    "COND": "B/20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "KPMA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/3/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "7/3/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["prednisolone"],
    "InteractionIndexLink": ["prednisolone"],
    "N_ENREGISTREMENT": "468/ 09 H 144 /15",
    "CODE_DCI": "09 H 144",
    "DCI": "PREDNISOLONE",
    "NOM_COMMERCIALE": "PREDNICORT",
    "FORME": "COMP. ORODISPERS.",
    "DOSAGE": "20MG",
    "COND": "B/20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NADPHARMADIC PRODUCTION SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "31/5/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "31/5/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["prednisolone"],
    "InteractionIndexLink": ["prednisolone"],
    "N_ENREGISTREMENT": "470/09 H 144/14/19",
    "CODE_DCI": "09 H 144",
    "DCI": "PREDNISOLONE METASULFOBENZOATE DE SODIUM",
    "NOM_COMMERCIALE": "PREDNISOLONE MM ORO",
    "FORME": "COMP ORODISPERSIBLE",
    "DOSAGE": "20MG",
    "COND": "B/20",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES MM SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/12/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "22/12/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["prednisolone"],
    "InteractionIndexLink": ["prednisolone"],
    "N_ENREGISTREMENT": "470/ 09 H 144 /14/19",
    "CODE_DCI": "09 H 144",
    "DCI": "PREDNISOLONE METASULFOBENZOATE SODIQUE EXPRIME EN PREDNISOLONE",
    "NOM_COMMERCIALE": "PREDNISOLONE MM ORO",
    "FORME": "COMP ORO DISPER",
    "DOSAGE": "20MG",
    "COND": "B/20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MM LABORATOIRES SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/3/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "22/12/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["prednisolone"],
    "InteractionIndexLink": ["prednisolone"],
    "N_ENREGISTREMENT": "380/ 09 H 144 /16",
    "CODE_DCI": "09 H 144",
    "DCI": "PREDNISOLONE",
    "NOM_COMMERCIALE": "SOLOPRED HUP",
    "FORME": "COMP. ORODISPERS.",
    "DOSAGE": "20MG",
    "COND": "B/20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HUP.P.PHARMA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/2/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "2/2/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["prednisolone"],
    "InteractionIndexLink": ["prednisolone"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "09 H 144",
    "DCI": "PREDNISOLONE METASULFOBENZOATE SODIQUE EXPRIME EN PREDNISOLONE",
    "NOM_COMMERCIALE": "SOLUPRED ORO",
    "FORME": "COMP. ORODISPERS.",
    "DOSAGE": "20MG",
    "COND": "B/20",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["prednisolone"],
    "InteractionIndexLink": ["prednisolone"],
    "N_ENREGISTREMENT": "320/ 09 H 144 /07/13",
    "CODE_DCI": "09 H 144",
    "DCI": "PREDNISOLONE",
    "NOM_COMMERCIALE": "SWOR",
    "FORME": "COMP. ORODISPERS. SEC.",
    "DOSAGE": "20MG",
    "COND": "PILUL./20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIAN GENERICS DEVELOPMENT  PHARMA  (AGD PHARM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/3/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "4/2/2013",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["prednisolone"],
    "InteractionIndexLink": ["prednisolone"],
    "N_ENREGISTREMENT": "320/09 H 144/07/20",
    "CODE_DCI": "09 H 144",
    "DCI": "PREDNISOLONE",
    "NOM_COMMERCIALE": "SWOR",
    "FORME": "COMP. ORODISPERS. SEC.",
    "DOSAGE": "20MG",
    "COND": "PILUL./20",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES AGD PHARM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/3/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "7/3/2017",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["prednisolone"],
    "InteractionIndexLink": ["prednisolone"],
    "N_ENREGISTREMENT": "320/09 H 144/09/07/20",
    "CODE_DCI": "09 H 144",
    "DCI": "PREDNISOLONE",
    "NOM_COMMERCIALE": "SWOR",
    "FORME": "COMP. ORO. SEC",
    "DOSAGE": "20MG",
    "COND": "B/20",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES AGD PHARM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/3/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "25/11/2020",
    "TYPE": "Gé",
    "STATUT": "",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["prednisolone"],
    "InteractionIndexLink": ["prednisolone"],
    "N_ENREGISTREMENT": "317/ 09 H 163 /16",
    "CODE_DCI": "09 H 163",
    "DCI": "PREDNISOLONE",
    "NOM_COMMERCIALE": "OROPRED",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "30MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INPHA MEDIS SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "11/4/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "11/4/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["prednisolone"],
    "InteractionIndexLink": ["prednisolone"],
    "N_ENREGISTREMENT": "318/09 H 174/16",
    "CODE_DCI": "09 H 174",
    "DCI": "PREDNISOLONE METASULFOBENZOATE SODIQUE EXPRIME EN PREDNISOLONE",
    "NOM_COMMERCIALE": "CORTIDAL",
    "FORME": "SOLUTION BUVABLE",
    "DOSAGE": "1MG/ML",
    "COND": "FL 50ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMIDAL N.S. SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/11/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "9/11/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["prednisolone"],
    "InteractionIndexLink": ["prednisolone"],
    "N_ENREGISTREMENT": "462/ 09 H 174 /16",
    "CODE_DCI": "09 H 174",
    "DCI": "PREDNISOLONE",
    "NOM_COMMERCIALE": "PHYSIOLONE",
    "FORME": "SOLUTION BUVABLE",
    "DOSAGE": "1MG/ML",
    "COND": "01 FLACON DE 60 ML + PIPETTE GRADUEE",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL PHYSIOPHARM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/2/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "22/2/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["prednisolone"],
    "InteractionIndexLink": ["prednisolone"],
    "N_ENREGISTREMENT": "001/ 09 H 178 20",
    "CODE_DCI": "09 H 178",
    "DCI": "Prednisolone Sodium Phosphate exprimé en prednisolone",
    "NOM_COMMERCIALE": "PREDO",
    "FORME": "Solution buvable",
    "DOSAGE": "15MG/5ML",
    "COND": "Flacon de 120ml",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMA ALGERIA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/2/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "25/2/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["desmopressin"],
    "InteractionIndexLink": ["desmopressine"],
    "N_ENREGISTREMENT": "275/ 09 J 042 /03/15",
    "CODE_DCI": "09 J 042",
    "DCI": "DESMOPRESSINE ACETATE TRIHYDRATE",
    "NOM_COMMERCIALE": "MINIRIN SPRAY",
    "FORME": "SOL. ENDONASALE EN FLACON PULVERISATEUR",
    "DOSAGE": "0.1MG/ML (10µG/DOSE)",
    "COND": "FL./2.5ML (25DOSES)",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FERRING S.A.S",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/1/2003",
    "DATE_D_ENREGISTREMENT_FINAL": "3/3/2015",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["gonadotrophin - human menopausal"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "275/ 09 J 046 /07/14",
    "CODE_DCI": "09 J 046",
    "DCI": "MENOTROPINE OU HORMONE GONADOTROPHINE POST MENOPAUSIQUE HUMAINE HMG EXPRIME EN HORMONE FOLLICULOSTIMULANTE FSH / HORMONE LUTEINISANTE LH",
    "NOM_COMMERCIALE": "MENOPUR",
    "FORME": "PDRE. ET SOLV.",
    "DOSAGE": "75UI FSH / 75UI LH",
    "COND": "B/05FL. DE PDRE. + 05 AMP. DE SOLVT. DE 1ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FERRING SAS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/1/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "1/6/2014",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["triptorelin"],
    "InteractionIndexLink": ["triptoreline"],
    "N_ENREGISTREMENT": "020/ 09 J 052 /99/15",
    "CODE_DCI": "09 J 052",
    "DCI": "TRIPTORELINE",
    "NOM_COMMERCIALE": "DECAPEPTYL",
    "FORME": "PDRE.ET SOLV. POUR SOL.INJ. SC",
    "DOSAGE": "0.1MG/ML",
    "COND": "B/ 7FL. DE LYOPH. + 7AMP. SOLV. 01ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "IPSEN PHARMA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/2/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "26/2/2015",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["triptorelin"],
    "InteractionIndexLink": ["triptoreline"],
    "N_ENREGISTREMENT": "020/ 09 J 053 /97/15",
    "CODE_DCI": "09 J 053",
    "DCI": "TRIPTORELINE ACETATE EXPRIME EN TRIPTORELINE",
    "NOM_COMMERCIALE": "DECAPEPTYL LP 3.75MG",
    "FORME": "PDRE. ET SOLV. P. SUSP.INJ. IM FORME LP SUR 28JOURS",
    "DOSAGE": "3.75MG",
    "COND": "B/01FL. DE PDRE. + 01 AMP. DE SOLV. (MANNITOL) DE 2ML + 02 AIGUILLES + 01 SERINGUE",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "IPSEN N.V.",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BELGIQUE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/3/1997",
    "DATE_D_ENREGISTREMENT_FINAL": "31/3/2015",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["goserelin"],
    "InteractionIndexLink": ["gosereline"],
    "N_ENREGISTREMENT": "256/ 09 J 095 /99/15",
    "CODE_DCI": "09 J 095",
    "DCI": "GOSERELINE ACETATE EXPRIME EN GOSERELINE",
    "NOM_COMMERCIALE": "ZOLADEX",
    "FORME": "IMPLANT S.C. EN SERINGUE PRE REMPLIE",
    "DOSAGE": "3.6MG",
    "COND": "B/01 SERINGUE AVEC SYSTÈME DE SECURITE",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ASTRA ZENECA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/6/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "15/7/2015",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["follitropin alfa"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "219/ 09 J 129 /02/16",
    "CODE_DCI": "09 J 129",
    "DCI": "FOLLITROPINE ALFA (HORMONE FOLLICULOSTIMULATE HUMAINE RECOMBINANTE (FSH RECOMBINANTE))",
    "NOM_COMMERCIALE": "GONAL-F",
    "FORME": "PDRE ET SOLVANT  SOL. INJ. SC",
    "DOSAGE": "75UI/ML (5.5μG/ML)",
    "COND": "B/1FL DE PDRE + UNE SERINGUE PRE REMPLIE  DE 1ML SOLVANT (EAU PREPARATION INJECTABLE)",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SERONO EUROPE LTD.",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ROYAUME UNI",
    "DATE_D_ENREGISTREMENT_INITIAL": "14/12/2002",
    "DATE_D_ENREGISTREMENT_FINAL": "5/2/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["goserelin"],
    "InteractionIndexLink": ["gosereline"],
    "N_ENREGISTREMENT": "256/ 09 J 138 /05/15",
    "CODE_DCI": "09 J 138",
    "DCI": "GOSERELINE ACETATE EXPRIME EN GOSERELINE",
    "NOM_COMMERCIALE": "ZOLADEX",
    "FORME": "IMPLANT S.C. EN SERINGUE PRE REMPLIE",
    "DOSAGE": "10.8MG",
    "COND": "B/01 SERINGUE AVEC SYSTÈME DE SECURITE",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ASTRA ZENECA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/11/2005",
    "DATE_D_ENREGISTREMENT_FINAL": "26/2/2015",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["somatropin"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "062/ 09 J 141 /06/14",
    "CODE_DCI": "09 J 141",
    "DCI": "SOMATROPINE OU HORMONE DE CROISSANCE HUMAINE RECOMBINANTE",
    "NOM_COMMERCIALE": "SAIZEN CLICKEASY",
    "FORME": "PDRE.ET SOLVT. SOL. INJ. SC MULTIDOSE",
    "DOSAGE": "8MG/1.37ML",
    "COND": "B/01FL PDRE.+01CART. SOLVT. PRE-ASSEMBLES DANS UN DISPOSITIF DE RECONSTITUTION CLICK EASY",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MERCK SERONO SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ITALIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "23/7/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "15/12/2014",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["somatropin"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "069/ 09 J 147 /06/17",
    "CODE_DCI": "09 J 147",
    "DCI": "SOMATROPINE",
    "NOM_COMMERCIALE": "NORDITROPINE NORDIFLEX",
    "FORME": "SOL. INJ.  S.C. EN STYLO PREREMPLI",
    "DOSAGE": "5MG/1.5ML",
    "COND": "B/1STYLO  PRE REMPLI  DE 1.5ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVO NORDISK A/S",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "DANEMARK",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/12/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "31/1/2018",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["somatropin"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "18/09 J 147/080",
    "CODE_DCI": "09 J 147",
    "DCI": "SOMATROPINE",
    "NOM_COMMERCIALE": "OMNITROPE",
    "FORME": "SOL. INJ. SC. EN CARTOUCHE",
    "DOSAGE": "5MG/1.5ML",
    "COND": "B/5 CARTOUCHE DE 1.5ML",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES SANDOZ GmbH",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "AUTRICHE",
    "DATE_D_ENREGISTREMENT_INITIAL": "01/02/18",
    "DATE_D_ENREGISTREMENT_FINAL": "01/02/18",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["cetrorelix", "IX facteur"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "062/ 09 J 148 /06/15",
    "CODE_DCI": "09 J 148",
    "DCI": "CETRORELIX ACETATE EXPRIME EN CETRORELIX",
    "NOM_COMMERCIALE": "CETROTIDE",
    "FORME": "PDRE ET SOLV. SOL. INJ. SC",
    "DOSAGE": "0.25MG/FL. DE PDRE",
    "COND": "B/01FL. PDRE + 01 SERING. PRE REMPL. SOLV. (EPPI) + 01 AIGUILLE 20G + 01 AIGUILLE HYPODERMIQUE 27G + 02 TAMPONS IMBIBES D'ALCOOL",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MERCK SERONO EUROPE LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ROYAUME UNI",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/2/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "25/1/2015",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["follitropin alfa"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "09 J 152",
    "DCI": "FOLLITROPINE ALFA (HORMONE FOLLICULOSTIMULATE HUMAINE RECOMBINANTE (FSH RECOMBINANTE)",
    "NOM_COMMERCIALE": "GONAL-F",
    "FORME": "SOL. INJ SC  EN MULTIDOSE",
    "DOSAGE": "300UI/0.5ML (22µG/0.5ML)",
    "COND": "B/1STYLO PREREMPLI DE 0.5ML + 05AIGUILLES POUR STYLO",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["follitropin alfa"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "09 J 153",
    "DCI": "FOLLITROPINE ALFA (OU HORMONE FOLLICULOSTIMULATE HUMAINE RECOMBINANTE - FSH RECOMBINANTE)",
    "NOM_COMMERCIALE": "GONAL-F",
    "FORME": "SOL. INJ SC  EN MULTIDOSE",
    "DOSAGE": "450UI/0.75ML (33µG/0.75ML)",
    "COND": "B/1STYLO PREREMPLI DE 0.75ML + 07AIGUILLES POUR STYLO",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["follitropin alfa"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "062/ 09 J 154 /09/16",
    "CODE_DCI": "09 J 154",
    "DCI": "FOLLITROPINE ALFA (HORMONE FOLLICULOSTIMULATE HUMAINE RECOMBINANTE (FSH RECOMBINANTE)",
    "NOM_COMMERCIALE": "GONAL-F",
    "FORME": "SOL. INJ SC  EN MULTIDOSE",
    "DOSAGE": "900UI/1.5ML (66µG/1.5ML)",
    "COND": "B/1STYLO PREREMPLI DE 1.5ML + 14AIGUILLES POUR STYLO",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MERCK SERONO EUROPE LTD",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ROYAUME UNI",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/3/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "5/2/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["desmopressin"],
    "InteractionIndexLink": ["desmopressine"],
    "N_ENREGISTREMENT": "275/ 09 J 170 /12",
    "CODE_DCI": "09 J 170",
    "DCI": "DESMOPRESSINE",
    "NOM_COMMERCIALE": "MINIRINMELT",
    "FORME": "LYOPH. ORAL SUBLINGUAL",
    "DOSAGE": "60µG/LYOPH.",
    "COND": "B/30",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FERRING SAS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "23/12/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "23/12/2012",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": [
      "follitropin alfa",
      "follitropin beta",
      "follitropin delta"
    ],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "024/ 09 J 175 /16",
    "CODE_DCI": "09 J 175",
    "DCI": "FOLLITROPINE BETA (HORMONE FOLLICULO-STIMULANTE- (FSH) RECOMBINANTE)",
    "NOM_COMMERCIALE": "PUREGON",
    "FORME": "SOLUTION INJECTABLE EN CARTOUCHE POUR STYLO",
    "DOSAGE": "300UI/0.36ML",
    "COND": "B/01 CARTOUCHE AVEC 06 AIGUILLES",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MERCK SHARP &DHOME LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "UNITED KINGDOM",
    "DATE_D_ENREGISTREMENT_INITIAL": "11/5/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "11/5/2016",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": false,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["follitropin beta"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "024/ 09 J 176 /16",
    "CODE_DCI": "09 J 176",
    "DCI": "FOLLITROPINE BETA (HORMONE FOLLICULO-STIMULANTE- (FSH) RECOMBINANTE)",
    "NOM_COMMERCIALE": "PUREGON",
    "FORME": "SOLUTION INJECTABLE EN CARTOUCHE POUR STYLO",
    "DOSAGE": "600UI/0.72ML",
    "COND": "B/01 CARTOUCHE AVEC 06 AIGUILLES",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MERCK SHARP &DHOME LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "UNITED KINGDOM",
    "DATE_D_ENREGISTREMENT_INITIAL": "11/5/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "11/5/2016",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": false,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["somatropin"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "080 / 09 J 177 /18",
    "CODE_DCI": "09 J 177",
    "DCI": "Somatropine recombinante  SANDOZ",
    "NOM_COMMERCIALE": "OMNITROPE",
    "FORME": "SOLUTION INJECTABLE SC EN CARTOUCHE",
    "DOSAGE": "5mg/1.5ml",
    "COND": "B/05  CARTOUCHES DE 1.5 ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANDOZ GmbH",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "AUTRICHE",
    "DATE_D_ENREGISTREMENT_INITIAL": "11/2/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "11/2/2018",
    "TYPE": "Biosimilaire",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["thyroxine"],
    "InteractionIndexLink": ["levothyroxine"],
    "N_ENREGISTREMENT": "431/ 09 K 056 /16",
    "CODE_DCI": "09 K 056",
    "DCI": "LEVOTHYROXINE  SODIQUE",
    "NOM_COMMERCIALE": "BERLTHYROX",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "50µG",
    "COND": "B/50 ET B/100",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BERLIN CHEMIE AG",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALLEMAGNE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/6/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "13/6/2016",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["thyroxine"],
    "InteractionIndexLink": ["levothyroxine"],
    "N_ENREGISTREMENT": "062/ 09 K 056 /99/14",
    "CODE_DCI": "09 K 056",
    "DCI": "LEVOTHYROXINE  SODIQUE",
    "NOM_COMMERCIALE": "LEVOTHYROX",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "50µG",
    "COND": "B/30",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MERCK SANTE S.A.S",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "31/1/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "1/10/2014",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["thyroxine"],
    "InteractionIndexLink": ["levothyroxine"],
    "N_ENREGISTREMENT": "177 / 09 K 056 /18",
    "CODE_DCI": "09 K 056",
    "DCI": "LEVOTHYROXINE  SODIQUE",
    "NOM_COMMERCIALE": "LEVOTIRON",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "50µG",
    "COND": "B/100",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ABDI IBRAHIM ILAC SAN.VE TIC .AS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "TURQUIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "5/6/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "5/6/2018",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["thyroxine"],
    "InteractionIndexLink": ["levothyroxine"],
    "N_ENREGISTREMENT": "431/ 09 K 057 /16",
    "CODE_DCI": "09 K 057",
    "DCI": "LEVOTHYROXINE  SODIQUE",
    "NOM_COMMERCIALE": "BERLTHYROX",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "100µG",
    "COND": "B/50 ET B/100",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BERLIN CHEMIE AG",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALLEMAGNE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/6/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "13/6/2016",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["thyroxine"],
    "InteractionIndexLink": ["levothyroxine"],
    "N_ENREGISTREMENT": "062/ 09 K 057 /99/14",
    "CODE_DCI": "09 K 057",
    "DCI": "LEVOTHYROXINE  SODIQUE",
    "NOM_COMMERCIALE": "LEVOTHYROX",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "100µG",
    "COND": "B/30",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MERCK SANTE S.A.S",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "31/1/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "1/10/2014",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["thyroxine"],
    "InteractionIndexLink": ["levothyroxine"],
    "N_ENREGISTREMENT": "062/ 09 K 150 /07/14",
    "CODE_DCI": "09 K 150",
    "DCI": "LEVOTHYROXINE SODIQUE",
    "NOM_COMMERCIALE": "LEVOTHYROX",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "25µG",
    "COND": "B/30",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MERCK SANTE S.A.S",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/6/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "6/7/2014",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["thyroxine"],
    "InteractionIndexLink": ["levothyroxine"],
    "N_ENREGISTREMENT": "177/ 09 K 150 /19",
    "CODE_DCI": "09 K 150",
    "DCI": "LEVOTHYROXINE SODIQUE",
    "NOM_COMMERCIALE": "LEVOTIRON",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "25µG",
    "COND": "B/100",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ABDI IBRAHIM ILAC SAN.VE TIC .AS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "TURQUIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/3/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "24/3/2019",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["thyroxine"],
    "InteractionIndexLink": ["levothyroxine"],
    "N_ENREGISTREMENT": "062/ 09 K 151 /07/14",
    "CODE_DCI": "09 K 151",
    "DCI": "LEVOTHYROXINE SODIQUE",
    "NOM_COMMERCIALE": "LEVOTHYROX",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "75µG",
    "COND": "B/30",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MERCK SANTE S.A.S",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/6/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "6/7/2014",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["thyroxine"],
    "InteractionIndexLink": ["levothyroxine"],
    "N_ENREGISTREMENT": "177/ 09 K 151 /19",
    "CODE_DCI": "09 K 151",
    "DCI": "LEVOTHYROXINE SODIQUE",
    "NOM_COMMERCIALE": "LEVOTIRON",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "75µG",
    "COND": "B/100",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ABDI IBRAHIM ILAC SAN.VE TIC .AS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "TURQUIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "8/4/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "8/4/2019",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["clomifene"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "378/ 09 L 058 /19",
    "CODE_DCI": "09 L 058",
    "DCI": "CLOMIFENE CITRATE",
    "NOM_COMMERCIALE": "BIOMID BR",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "50MG",
    "COND": "B/05",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/4/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "17/4/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["clomifene"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "09 L 058",
    "DCI": "CLOMIFÈNE CITRATE",
    "NOM_COMMERCIALE": "BIOMID BR",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "·  50mg",
    "COND": "-Boite de 5 comprimés sécables.",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["clomifene"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "376/ 09 L 058 /97/15",
    "CODE_DCI": "09 L 058",
    "DCI": "CLOMIFENE CITRATE",
    "NOM_COMMERCIALE": "CLOMID",
    "FORME": "COMPRIME",
    "DOSAGE": "50MG",
    "COND": "B/5",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANOFI AVENTIS FRANCE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/11/1997",
    "DATE_D_ENREGISTREMENT_FINAL": "5/12/2015",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["clomifene"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "097/ 09 L 058 /18",
    "CODE_DCI": "09 L 058",
    "DCI": "CLOMIFENE CITRATE",
    "NOM_COMMERCIALE": "CLOMINE",
    "FORME": "COMPRIME",
    "DOSAGE": "50MG",
    "COND": "B/10",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL SANAMED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/12/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "25/12/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["clomifene"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "012/ 09 L 058 /98/14",
    "CODE_DCI": "09 L 058",
    "DCI": "CLOMIFENE CITRATE",
    "NOM_COMMERCIALE": "CROVIFENE",
    "FORME": "COMPRIME",
    "DOSAGE": "50MG",
    "COND": "B/10",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CROVIS PHILCOM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ITALIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/7/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "6/7/2014",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["clomifene"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "321/09 L 058/19",
    "CODE_DCI": "09 L 058",
    "DCI": "Clomifène citrate",
    "NOM_COMMERCIALE": "LOMIFEN",
    "FORME": "Comprimé",
    "DOSAGE": "50MG",
    "COND": "B/10",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOVITAL/ SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/10/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "17/1/2021",
    "TYPE": "Gé",
    "STATUT": "F prémix",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["dydrogesterone with estradiol"],
    "InteractionIndexLink": ["dydrogesterone"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "09 N 060",
    "DCI": "DYDROGESTERONE",
    "NOM_COMMERCIALE": "DUPHASTON",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "10MG",
    "COND": "B/10",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["hydroxyprogesterone"],
    "InteractionIndexLink": ["hydroxyprogesterone"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "09 N 062",
    "DCI": "HYDROXYPROGESTERONE CAPROATE",
    "NOM_COMMERCIALE": "PROGESTERONE RETARD PHARLON",
    "FORME": "SOL.INJ. IM",
    "DOSAGE": "500MG/2/ML",
    "COND": "B/3AMP.",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "005/ 09 N 063 /96/16",
    "CODE_DCI": "09 N 063",
    "DCI": "LYNESTRENOL",
    "NOM_COMMERCIALE": "ORGAMETRIL",
    "FORME": "COMPRIME",
    "DOSAGE": "5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ORGANON N.V.",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PAYS BAS",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/9/1996",
    "DATE_D_ENREGISTREMENT_FINAL": "1/1/2018",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "60 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["nomegestrol with estradiol"],
    "InteractionIndexLink": ["nomegestrol"],
    "N_ENREGISTREMENT": "285/ 09 N 066 /18",
    "CODE_DCI": "09 N 066",
    "DCI": "Acétate de Nomégestrol",
    "NOM_COMMERCIALE": "LUTEROL",
    "FORME": "Comprimé sécable",
    "DOSAGE": "5MG",
    "COND": "B/10",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "Union Pharmaceutique Constantinoise (UPC) / SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/4/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "18/3/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["nomegestrol with estradiol"],
    "InteractionIndexLink": ["nomegestrol"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "09 N 066",
    "DCI": "ACETATE DE NOMEGESTROL",
    "NOM_COMMERCIALE": "NOMEGESTROL",
    "FORME": "COMP.SEC.",
    "DOSAGE": "5mg",
    "COND": "B/10",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["progesterone"],
    "InteractionIndexLink": ["progesterone"],
    "N_ENREGISTREMENT": "169/ 09 N 067 /99/15",
    "CODE_DCI": "09 N 067",
    "DCI": "PROGESTERONE",
    "NOM_COMMERCIALE": "PROGESTOGEL",
    "FORME": "GEL pour applicat cutanée",
    "DOSAGE": "1G%",
    "COND": "T/80G",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BESINS INTERNATIONAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/1/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "8/11/2015",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["progesterone"],
    "InteractionIndexLink": ["progesterone"],
    "N_ENREGISTREMENT": "515/ 09 N 109 /16",
    "CODE_DCI": "09 N 109",
    "DCI": "PROGESTERONE",
    "NOM_COMMERCIALE": "PROGEVA",
    "FORME": "CAPSULE MOLLE ORALE ET VAGINALE",
    "DOSAGE": "100MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EFFIK",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "France",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/7/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "26/7/2016",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["progesterone"],
    "InteractionIndexLink": ["progesterone"],
    "N_ENREGISTREMENT": "169/ 09 N 109 /99/21",
    "CODE_DCI": "09 N 109",
    "DCI": "Progestèrone",
    "NOM_COMMERCIALE": "UTROGESTAN",
    "FORME": "Capsule molle orale ou  vaginale",
    "DOSAGE": "100MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BESINS INTERNATIONAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "31/1/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "21/2/2021",
    "TYPE": "Ré",
    "STATUT": "C onditionneur / Libérateur   (LGPE)",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["progesterone"],
    "InteractionIndexLink": ["progesterone"],
    "N_ENREGISTREMENT": "515/ 09 N 155 /16",
    "CODE_DCI": "09 N 155",
    "DCI": "PROGESTERONE",
    "NOM_COMMERCIALE": "PROGEVA",
    "FORME": "CAPSULE MOLLE ORALE ET VAGINALE",
    "DOSAGE": "200MG",
    "COND": "B/15",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EFFIK",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/7/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "26/7/2016",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["progesterone"],
    "InteractionIndexLink": ["progesterone"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "09 N 155",
    "DCI": "PROGESTERONE MICRONISEE",
    "NOM_COMMERCIALE": "UTROGESTAN",
    "FORME": "CAPSULE MOLLE ORALE OU VAGINALE",
    "DOSAGE": "200MG",
    "COND": "B/15",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["octreotide"],
    "InteractionIndexLink": ["octreotide"],
    "N_ENREGISTREMENT": "505/ 09 P 109 /16",
    "CODE_DCI": "09 P 109",
    "DCI": "OCTREOTIDE ACETATE",
    "NOM_COMMERCIALE": "OCTREOTIDE BIOINDUSTRIA L.I.M",
    "FORME": "SOLUTION INJECTABLE POUR PERFUSION IV ET S/C",
    "DOSAGE": "100µG/ML",
    "COND": "B/10AMPOULES DE 1ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOINDUSTRIA L.I.M",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ITALIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/1/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "18/1/2016",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["octreotide"],
    "InteractionIndexLink": ["octreotide"],
    "N_ENREGISTREMENT": "505/ 09 P 110 /16",
    "CODE_DCI": "09 P 110",
    "DCI": "OCTREOTIDE ACETATE",
    "NOM_COMMERCIALE": "OCTREOTIDE BIOINDUSTRIA L.I.M",
    "FORME": "SOLUTION INJECTABLE POUR PERFUSION IV ET S/C",
    "DOSAGE": "500µG/ML",
    "COND": "B/10AMPOULES DE 1ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOINDUSTRIA L.I.M",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "Italie",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/1/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "18/1/2016",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["lanreotide"],
    "InteractionIndexLink": ["lanreotide"],
    "N_ENREGISTREMENT": "020/ 09 R 156 /08/15",
    "CODE_DCI": "09 R 156",
    "DCI": "LANREOTIDE ACETATE EXPRIME EN LANREOTIDE",
    "NOM_COMMERCIALE": "SOMATULINE LP",
    "FORME": "SOL. INJ. SC PROFONDE LP EN SERING. PREREMPL.",
    "DOSAGE": "60MG/SERING. DE 0.5ML",
    "COND": "B/01SERINGUE PREREMPLIE DE 0.5ML AVEC UN SYSTÈME DE SECURITE + AIGUILLE",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "IPSEN PHARMA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "23/2/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "12/4/2015",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["lanreotide"],
    "InteractionIndexLink": ["lanreotide"],
    "N_ENREGISTREMENT": "020/ 09 R 157 /08/15",
    "CODE_DCI": "09 R 157",
    "DCI": "LANREOTIDE ACETATE EXPRIME EN LANREOTIDE",
    "NOM_COMMERCIALE": "SOMATULINE LP",
    "FORME": "SOL. INJ. SC PROFONDE LP  EN SERING. PREREMPL.",
    "DOSAGE": "90MG/SERING. DE 0.5ML",
    "COND": "B/01SERINGUE PREREMPLIE DE 0.5ML AVEC UN SYSTÈME DE SECURITE + AIGUILLE",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "IPSEN PHARMA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "23/2/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "12/4/2015",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["lanreotide"],
    "InteractionIndexLink": ["lanreotide"],
    "N_ENREGISTREMENT": "020/ 09 R 158 /08/15",
    "CODE_DCI": "09 R 158",
    "DCI": "LANREOTIDE ACETATE EXPRIME EN LANREOTIDE",
    "NOM_COMMERCIALE": "SOMATULINE LP",
    "FORME": "SOL. INJ. SC PROFONDE LP  EN SERING. PREREMPL.",
    "DOSAGE": "120MG/SERING. DE 0.5ML",
    "COND": "B/01SERINGUE PREREMPLIE DE 0.5ML AVEC UN SYSTÈME DE SECURITE + AIGUILLE",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "IPSEN PHARMA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "23/2/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "26/2/2015",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Endocrinologie et hormones"]
  },
  {
    "PregnancyIndexLink": ["cinacalcet"],
    "InteractionIndexLink": ["cinacalcet"],
    "N_ENREGISTREMENT": "20/09 S171/293",
    "CODE_DCI": "09 S 171",
    "DCI": "CINACALCET HYDROCHLORIDE",
    "NOM_COMMERCIALE": "CINACARE",
    "FORME": "COMP PELL",
    "DOSAGE": "30MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE BIOCARE SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/06/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "10/06/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["cinacalcet"],
    "InteractionIndexLink": ["cinacalcet"],
    "N_ENREGISTREMENT": "173/09 S 171/16",
    "CODE_DCI": "09 S 171",
    "DCI": "CINACALCET CHLORHYDRATE EXPRIME EN CINACALCET",
    "NOM_COMMERCIALE": "ENDOLET",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "30MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "TABUK ALGERIE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/12/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "28/12/2016",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["cinacalcet"],
    "InteractionIndexLink": ["cinacalcet"],
    "N_ENREGISTREMENT": "481/ 09 S 171 /13",
    "CODE_DCI": "09 S 171",
    "DCI": "CINACALCET CHLORHYDRATE EXPRIME EN CINACALCET",
    "NOM_COMMERCIALE": "MIMPARA",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "30MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "AMGEN EUROPE B.V",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PAYS BAS",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/9/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "27/12/2015",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "60 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["cinacalcet"],
    "InteractionIndexLink": ["cinacalcet"],
    "N_ENREGISTREMENT": "20/09/ S172/293",
    "CODE_DCI": "09 S 172",
    "DCI": "CINACALCET HYDROCHLORIDE",
    "NOM_COMMERCIALE": "CINACARE",
    "FORME": "COMP PELL",
    "DOSAGE": "60MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE BIOCARE SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/06/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "10/06/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["cinacalcet"],
    "InteractionIndexLink": ["cinacalcet"],
    "N_ENREGISTREMENT": "173/09 S 172/16",
    "CODE_DCI": "09 S 172",
    "DCI": "CINACALCET CHLORHYDRATE EXPRIME EN CINACALCET",
    "NOM_COMMERCIALE": "ENDOLET",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "60MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "TABUK ALGERIE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/12/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "28/12/2016",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["cinacalcet"],
    "InteractionIndexLink": ["cinacalcet"],
    "N_ENREGISTREMENT": "481/ 09 S 172 /13",
    "CODE_DCI": "09 S 172",
    "DCI": "CINACALCET CHLORHYDRATE EXPRIME EN CINACALCET",
    "NOM_COMMERCIALE": "MIMPARA",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "60MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "AMGEN EUROPE B.V",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PAYS BAS",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/9/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "27/12/2015",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "60 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["cinacalcet"],
    "InteractionIndexLink": ["cinacalcet"],
    "N_ENREGISTREMENT": "20/09/ S173/293",
    "CODE_DCI": "09 S 173",
    "DCI": "CINACALCET HYDROCHLORIDE",
    "NOM_COMMERCIALE": "CINACARE",
    "FORME": "COMP PELL",
    "DOSAGE": "90MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE BIOCARE SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/06/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "10/06/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["cinacalcet"],
    "InteractionIndexLink": ["cinacalcet"],
    "N_ENREGISTREMENT": "173/09 S 173/17",
    "CODE_DCI": "09 S 173",
    "DCI": "CINACALCET CHLORHYDRATE EXPRIME EN CINACALCET",
    "NOM_COMMERCIALE": "ENDOLET",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "90MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "TABUK ALGERIE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "11/1/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "11/1/2017",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["cinacalcet"],
    "InteractionIndexLink": ["cinacalcet"],
    "N_ENREGISTREMENT": "481/ 09 S 173 /13",
    "CODE_DCI": "09 S 173",
    "DCI": "CINACALCET CHLORHYDRATE EXPRIME EN CINACALCET",
    "NOM_COMMERCIALE": "MIMPARA",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "90MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "AMGEN EUROPE B.V",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PAYS BAS",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/9/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "27/12/2015",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "60 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["acide folique"],
    "InteractionIndexLink": ["acide folique"],
    "N_ENREGISTREMENT": "20/12 E 020/235",
    "CODE_DCI": "1.20E+21",
    "DCI": "ACIDE FOLIQUE",
    "NOM_COMMERCIALE": "ANEFOL",
    "FORME": "COMP.",
    "DOSAGE": "05MG",
    "COND": "B/60",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES BIOGALENIC SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/02/20",
    "DATE_D_ENREGISTREMENT_FINAL": "26/02/20",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["acide folique"],
    "InteractionIndexLink": ["acide folique"],
    "N_ENREGISTREMENT": "21/12 E020/578",
    "CODE_DCI": "1.20E+21",
    "DCI": "ACIDE FOLIQUE",
    "NOM_COMMERCIALE": "OPTIFOLATES",
    "FORME": "COMP",
    "DOSAGE": "5MG",
    "COND": "B/60",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL OPTIPHARM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/04/21",
    "DATE_D_ENREGISTREMENT_FINAL": "18/04/21",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["acide folique"],
    "InteractionIndexLink": ["acide folique"],
    "N_ENREGISTREMENT": "20/97/12 E 020/003",
    "CODE_DCI": "1.20E+21",
    "DCI": "ACIDE FOLIQUE",
    "NOM_COMMERCIALE": "ZANITRA",
    "FORME": "COMP.",
    "DOSAGE": "5MG",
    "COND": "B/60",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES EPE GROUPE INDUSTRIEL SAIDAL/ SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "14/02/97",
    "DATE_D_ENREGISTREMENT_FINAL": "27/01/20",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["spiramycine"],
    "InteractionIndexLink": ["spiramycine"],
    "N_ENREGISTREMENT": "20/09/13 E 154/003",
    "CODE_DCI": "1.30E+155",
    "DCI": "SPIRAMYCINE",
    "NOM_COMMERCIALE": "ROVADAL",
    "FORME": "SIROP",
    "DOSAGE": "0.375MUI/5ML",
    "COND": "FLC/150ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES EPE GROUPE INDUSTRIEL SAIDAL/ SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "31/03/20",
    "DATE_D_ENREGISTREMENT_FINAL": "31/03/20",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "18 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["azithromycin"],
    "InteractionIndexLink": ["azithromycine"],
    "N_ENREGISTREMENT": "352/ 13 E 176 /06/18",
    "CODE_DCI": "1.30E+177",
    "DCI": "Azithromycine dihydrate exprimé en Azithromycine",
    "NOM_COMMERCIALE": "ZETRON",
    "FORME": "Gélule",
    "DOSAGE": "250MG",
    "COND": "B/06",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "31/07/06",
    "DATE_D_ENREGISTREMENT_FINAL": "14/03/21",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["spiramycine"],
    "InteractionIndexLink": ["spiramycine"],
    "N_ENREGISTREMENT": "16/13 E031/400",
    "CODE_DCI": "1.30E+32",
    "DCI": "SPIRAMYCINE",
    "NOM_COMMERCIALE": "SPIRAMEX",
    "FORME": "COMP PELL",
    "DOSAGE": "1.5 MUI",
    "COND": "B/16",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "KPMA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "06/10/16",
    "DATE_D_ENREGISTREMENT_FINAL": "06/10/16",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["spiramycine"],
    "InteractionIndexLink": ["spiramycine"],
    "N_ENREGISTREMENT": "16/13 E032/400",
    "CODE_DCI": "1.30E+33",
    "DCI": "SPIRAMYCINE",
    "NOM_COMMERCIALE": "SPIRAMEX",
    "FORME": "COMP PELL",
    "DOSAGE": "3 MUI",
    "COND": "B/10",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "KPMA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "06/10/16",
    "DATE_D_ENREGISTREMENT_FINAL": "06/10/16",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["omeprazole"],
    "InteractionIndexLink": ["omeprazole"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "10 A  113",
    "DCI": "Oméprazole",
    "NOM_COMMERCIALE": "Proton",
    "FORME": "Gélule gasto-résistante",
    "DOSAGE": "10 mg",
    "COND": "Pilulier 28",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["omeprazole"],
    "InteractionIndexLink": ["omeprazole"],
    "N_ENREGISTREMENT": "293/10 A 001/04/16",
    "CODE_DCI": "10 A 001",
    "DCI": "OMEPRAZOLE",
    "NOM_COMMERCIALE": "ANTAG",
    "FORME": "GLES. A MICROG. GASTRORESIST.",
    "DOSAGE": "20MG",
    "COND": "B/14+B/28",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOCARE SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/1/2004",
    "DATE_D_ENREGISTREMENT_FINAL": "8/2/2010",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["omeprazole"],
    "InteractionIndexLink": ["omeprazole"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "10 A 001",
    "DCI": "OMEPRAZOLE",
    "NOM_COMMERCIALE": "LOMAC",
    "FORME": "GLES. A MICROG. GASTRORESIST.",
    "DOSAGE": "20MG",
    "COND": "PILULIER DE 15",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["omeprazole"],
    "InteractionIndexLink": ["omeprazole"],
    "N_ENREGISTREMENT": "418/10 A 001/09/16",
    "CODE_DCI": "10 A 001",
    "DCI": "OMEPRAZOLE",
    "NOM_COMMERCIALE": "NEOGASTRIC",
    "FORME": "GLES. A MICROG. GASTRORESIST.",
    "DOSAGE": "20MG",
    "COND": "B/14+B/28",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NEOMEDIC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/7/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "19/10/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["omeprazole"],
    "InteractionIndexLink": ["omeprazole"],
    "N_ENREGISTREMENT": "286/10 A 001/03/16",
    "CODE_DCI": "10 A 001",
    "DCI": "OMEPRAZOLE",
    "NOM_COMMERCIALE": "OMED-20",
    "FORME": "GLES. A MICROG. GASTRORESIST.",
    "DOSAGE": "20MG",
    "COND": "B/14",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CHIMIE PHARMACIE COMMERCE MULTIPLE SARL (CPCM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/8/2003",
    "DATE_D_ENREGISTREMENT_FINAL": "19/10/2016",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["omeprazole"],
    "InteractionIndexLink": ["omeprazole"],
    "N_ENREGISTREMENT": "055/ 10 A 001 /02/19",
    "CODE_DCI": "10 A 001",
    "DCI": "OMEPRAZOLE",
    "NOM_COMMERCIALE": "OMEDAR",
    "FORME": "COMP. PELLI. GASTRORESIST.",
    "DOSAGE": "20MG",
    "COND": "B/30",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "DAR AL DAWA DEVELOPMENT & INVESTMENT Co Ltd",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "11/8/2002",
    "DATE_D_ENREGISTREMENT_FINAL": "23/1/2019",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["omeprazole"],
    "InteractionIndexLink": ["omeprazole"],
    "N_ENREGISTREMENT": "400/ 10 A 001 /14",
    "CODE_DCI": "10 A 001",
    "DCI": "OMEPRAZOLE",
    "NOM_COMMERCIALE": "OMEPRAMEX",
    "FORME": "MICROGRANULES GASTRO-RESISTANTS/GELULE",
    "DOSAGE": "20MG",
    "COND": "B/14",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "KPMA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/3/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "19/3/2014",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["omeprazole"],
    "InteractionIndexLink": ["omeprazole"],
    "N_ENREGISTREMENT": "472/ 10 A 001 /13/18",
    "CODE_DCI": "10 A 001",
    "DCI": "OMEPRAZOLE",
    "NOM_COMMERCIALE": "OMEPRAZOLE GEBER",
    "FORME": "MICRGLES. GASTRORESIST. EN GLES.",
    "DOSAGE": "20MG",
    "COND": "B/30",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GEBERHEALTH (LABORATOIRES EURL GEBERHEALTH)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/3/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "10/9/2018",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["omeprazole"],
    "InteractionIndexLink": ["omeprazole"],
    "N_ENREGISTREMENT": "470/ 10 A 001 /12/18",
    "CODE_DCI": "10 A 001",
    "DCI": "OMEPRAZOLE",
    "NOM_COMMERCIALE": "OMEPRAZOLE MM",
    "FORME": "MICROGLES. GASTRORESIST. EN GLES.",
    "DOSAGE": "20MG",
    "COND": "B/14",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MM (SARL LABORATOIRES MM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "21/8/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "30/4/2018",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["omeprazole"],
    "InteractionIndexLink": ["omeprazole"],
    "N_ENREGISTREMENT": "149/ 10 A 001 /14",
    "CODE_DCI": "10 A 001",
    "DCI": "OMEPRAZOLE",
    "NOM_COMMERCIALE": "OMEPRAZOLE NOVAGENERICS",
    "FORME": "MICROGRANULES GASTRO-RESISTANTS/GELULE",
    "DOSAGE": "20MG",
    "COND": "B/01 PILULIER 14",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVAPHARM TRADING",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "31/3/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "31/3/2014",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["omeprazole"],
    "InteractionIndexLink": ["omeprazole"],
    "N_ENREGISTREMENT": "462/10 A 001/21",
    "CODE_DCI": "10 A 001",
    "DCI": "Oméprazole",
    "NOM_COMMERCIALE": "OMEPRAZOLE PHYSIOPHARM",
    "FORME": "Gélule de microgranules gastro-résistantes",
    "DOSAGE": "20MG",
    "COND": "B/14",
    "LISTE": "LISTE II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHYSIOPHARM / SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/2/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "17/2/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["omeprazole"],
    "InteractionIndexLink": ["omeprazole"],
    "N_ENREGISTREMENT": "001/ 10 A 001 /15",
    "CODE_DCI": "10 A 001",
    "DCI": "OMEPRAZOLE",
    "NOM_COMMERCIALE": "OPRACIDE",
    "FORME": "MICRO-GRANUL. GASTRO-RESIST. EN GLES.",
    "DOSAGE": "20MG",
    "COND": "PILULIER/28",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMA ALGERIA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/10/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "4/10/2015",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["omeprazole"],
    "InteractionIndexLink": ["omeprazole"],
    "N_ENREGISTREMENT": "361/10 A 001/20",
    "CODE_DCI": "10 A 001",
    "DCI": "OMEPRAZOLE",
    "NOM_COMMERCIALE": "OZOL",
    "FORME": "GLES A MICROGRANULES GASTRO-RESISTANTS",
    "DOSAGE": "20MG",
    "COND": "B/15",
    "LISTE": "LISTE II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOHDER GROUP",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/1/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "22/1/2020",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["omeprazole"],
    "InteractionIndexLink": ["omeprazole"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "10 A 001",
    "DCI": "Omeprazole",
    "NOM_COMMERCIALE": "Omedar 20",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "20MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["omeprazole"],
    "InteractionIndexLink": ["omeprazole"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "10 A 001",
    "DCI": "Oméprazole",
    "NOM_COMMERCIALE": "Proton",
    "FORME": "Gélule gasto-résistante",
    "DOSAGE": "20 mg",
    "COND": "Pilulier 14",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["omeprazole"],
    "InteractionIndexLink": ["omeprazole"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "10 A 001",
    "DCI": "Oméprazole",
    "NOM_COMMERCIALE": "Proton",
    "FORME": "Gélule gasto-résistante",
    "DOSAGE": "20 mg",
    "COND": "Pilulier 28",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["omeprazole"],
    "InteractionIndexLink": ["omeprazole"],
    "N_ENREGISTREMENT": "268/ 10 A 001 /98/16",
    "CODE_DCI": "10 A 001",
    "DCI": "OMEPRAZOLE",
    "NOM_COMMERCIALE": "ZIMOR",
    "FORME": "GLES. A MICROG. GASTRORESIST.",
    "DOSAGE": "20MG",
    "COND": "B/14 ET B/28",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MERINAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "23/5/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "11/5/2016",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["omeprazole"],
    "InteractionIndexLink": ["omeprazole"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "10 A 001",
    "DCI": "OMEPRAZOLE",
    "NOM_COMMERCIALE": "ZIMOR",
    "FORME": "GLES. A MICROG. GASTRORESIST.",
    "DOSAGE": "20MG",
    "COND": "B/28",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["ranitidine"],
    "InteractionIndexLink": ["ranitidine"],
    "N_ENREGISTREMENT": "543/10 A 002/20",
    "CODE_DCI": "10 A 002",
    "DCI": "RANITIDINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "RANICARE",
    "FORME": "SOL INJ",
    "DOSAGE": "50MG/2ML",
    "COND": "B/05 AMPS DE 2ML ET B/50 AMPS DE 2ML",
    "LISTE": "LISTE II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOTHERA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/3/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "19/3/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["ranitidine"],
    "InteractionIndexLink": ["ranitidine"],
    "N_ENREGISTREMENT": "433/ 10 A 002 /13",
    "CODE_DCI": "10 A 002",
    "DCI": "RANITIDINE CHLORHYDRATE EXPRIME EN RANITIDINE",
    "NOM_COMMERCIALE": "RATIDEX",
    "FORME": "SOL. INJ. IM/IV",
    "DOSAGE": "25MG/ML (50MG/2ML)",
    "COND": "B/5AMP. DE 2ML ET B/50AMP. DE 2ML",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "B/50AMP. DE 2ML RESERVEE AUX HOPITAUX",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRATER-RAZES SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/1/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "10/1/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["ranitidine"],
    "InteractionIndexLink": ["ranitidine"],
    "N_ENREGISTREMENT": "001/ 10 A 002 /05/13",
    "CODE_DCI": "10 A 002",
    "DCI": "RANITIDINE CHLORHYDRATE EXPRIME EN RANITIDINE",
    "NOM_COMMERCIALE": "ROLAN",
    "FORME": "SOL. INJ. IM/IV",
    "DOSAGE": "25MG/ML (50MG/2ML)",
    "COND": "B/05 AMP.2ML",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMACEUTICALS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/9/2005",
    "DATE_D_ENREGISTREMENT_FINAL": "15/4/2013",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["ranitidine"],
    "InteractionIndexLink": ["ranitidine"],
    "N_ENREGISTREMENT": "20/08/10 A 003/003",
    "CODE_DCI": "10 A 003",
    "DCI": "RANITIDINE CHLORHYDRATE EXPRIME EN RANITIDINE",
    "NOM_COMMERCIALE": "LATIDINE",
    "FORME": "GELULES",
    "DOSAGE": "150MG",
    "COND": "B/30",
    "LISTE": "LISTE II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES EPE GROUPE INDUSTRIEL SAIDAL/ SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/05/07",
    "DATE_D_ENREGISTREMENT_FINAL": "27/02/20",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["ranitidine"],
    "InteractionIndexLink": ["ranitidine"],
    "N_ENREGISTREMENT": "293/10 A 003 /04/15",
    "CODE_DCI": "10 A 003",
    "DCI": "RANITIDINE CHLORHYDRATE EXPRIME EN RANITIDINE",
    "NOM_COMMERCIALE": "RANICARE",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "150 MG",
    "COND": "B/30",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOCARE SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/1/2004",
    "DATE_D_ENREGISTREMENT_FINAL": "26/10/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["ranitidine"],
    "InteractionIndexLink": ["ranitidine"],
    "N_ENREGISTREMENT": "400/10 A 003/13",
    "CODE_DCI": "10 A 003",
    "DCI": "RANITIDINE CHLORHYDRATE EXPRIME EN RANITIDINE",
    "NOM_COMMERCIALE": "RANIMEX",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "150MG",
    "COND": "B/30 ET B/60",
    "LISTE": "LISTE II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE KHROUB PHARMACEUTICAL MANUFACTURING ALGERIA SARL (KPMA)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/11/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "2/2/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["ranitidine"],
    "InteractionIndexLink": ["ranitidine"],
    "N_ENREGISTREMENT": "035/ 10 A 003 /97/19",
    "CODE_DCI": "10 A 003",
    "DCI": "RANITIDINE CHLORHYDRATE EXPRIME EN RANITIDINE",
    "NOM_COMMERCIALE": "RANITEX",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "150MG",
    "COND": "B/20 - B/30 ET B/60",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMALLIANCE EURL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "16/8/1997",
    "DATE_D_ENREGISTREMENT_FINAL": "29/7/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["ranitidine"],
    "InteractionIndexLink": ["ranitidine"],
    "N_ENREGISTREMENT": "039/ 10 A 003 /98/18",
    "CODE_DCI": "10 A 003",
    "DCI": "RANITIDINE CHLORHYDRATE EXPRIME EN RANITIDINE",
    "NOM_COMMERCIALE": "RANITIDAL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "150 MG",
    "COND": "B/20",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOPHAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/10/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "17/5/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["ranitidine"],
    "InteractionIndexLink": ["ranitidine"],
    "N_ENREGISTREMENT": "268/ 10 A 003 /98/15",
    "CODE_DCI": "10 A 003",
    "DCI": "RANITIDINE CHLORHYDRATE EXPRIME EN RANITIDINE",
    "NOM_COMMERCIALE": "RANITIDINE MABO",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "150MG",
    "COND": "B/30 - B/60",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MERINAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/5/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "29/1/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["ranitidine"],
    "InteractionIndexLink": ["ranitidine"],
    "N_ENREGISTREMENT": "268/ 10 A 003 /03/15",
    "CODE_DCI": "10 A 003",
    "DCI": "RANITIDINE CHLORHYDRATE EXPRIME EN RANITIDINE",
    "NOM_COMMERCIALE": "RANITIDINE MABO",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "150MG",
    "COND": "B/30 - B/60",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MERINAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/01/03",
    "DATE_D_ENREGISTREMENT_FINAL": "29/01/15",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["omeprazole"],
    "InteractionIndexLink": ["omeprazole"],
    "N_ENREGISTREMENT": "001/ 10 A 087 /06/15",
    "CODE_DCI": "10 A 087",
    "DCI": "OMEPRAZOLE SODIQUE EXPRIME EN OMEPRAZOLE",
    "NOM_COMMERCIALE": "OPRACIDE",
    "FORME": "PDRE. LYOPH. P. PERF. IV",
    "DOSAGE": "40MG/FL. DE PDRE.",
    "COND": "B/01FL. DE PDRE.",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMACEUTICALS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/12/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "6/5/2015",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["omeprazole"],
    "InteractionIndexLink": ["omeprazole"],
    "N_ENREGISTREMENT": "329/ 10 A 087 /13",
    "CODE_DCI": "10 A 087",
    "DCI": "OMEPRAZOLE SODIQUE EXPRIME EN OMEPRAZOLE",
    "NOM_COMMERCIALE": "RISEK",
    "FORME": "PDRE. LYOPH. P. SOL. INJ. PERF.",
    "DOSAGE": "40MG/FL. DE PDRE.",
    "COND": "B/1FL. DE PDRE.",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GULF PHARMACEUTICAL INDUSTRIES  (JULPHAR)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EMIRATS ARABES UNIS",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/2/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "4/2/2013",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["ranitidine"],
    "InteractionIndexLink": ["ranitidine"],
    "N_ENREGISTREMENT": "293/ 10 A 102 /15",
    "CODE_DCI": "10 A 102",
    "DCI": "RANITIDINE CHLORHYDRATE EXPRIME EN RANITIDINE",
    "NOM_COMMERCIALE": "RANICARE",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "300MG",
    "COND": "B/10 ET B/14",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOCARE SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/10/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "26/10/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["ranitidine"],
    "InteractionIndexLink": ["ranitidine"],
    "N_ENREGISTREMENT": "400/ 10 A 102 /13",
    "CODE_DCI": "10 A 102",
    "DCI": "RANITIDINE CHLORHYDRATE EXPRIME EN RANITIDINE",
    "NOM_COMMERCIALE": "RANIMEX",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "300MG",
    "COND": "B/20",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "KHROUB PHARMACEUTICAL MANUFACTURING ALGERIA (KPMA)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/11/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "19/11/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["omeprazole"],
    "InteractionIndexLink": ["omeprazole"],
    "N_ENREGISTREMENT": "286/ 10 A 113 /14",
    "CODE_DCI": "10 A 113",
    "DCI": "OMEPRAZOLE",
    "NOM_COMMERCIALE": "OMED RGO",
    "FORME": "GELULE A MICROGRANULES GASTRO-RESISTANTS",
    "DOSAGE": "10MG",
    "COND": "B/14",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CHIMIE PHARMACIE COMMERCE MULTIPLE (CPCM) SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "31/3/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "31/3/2014",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["omeprazole"],
    "InteractionIndexLink": ["omeprazole"],
    "N_ENREGISTREMENT": "472/ 10 A 113 /13",
    "CODE_DCI": "10 A 113",
    "DCI": "OMEPRAZOLE",
    "NOM_COMMERCIALE": "OMEPRAZOLE GEBER",
    "FORME": "MICRGLES. GASTRORESIST. EN GLES.",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GEBERHEALTH EURL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/3/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "20/3/2013",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["pantoprazole"],
    "InteractionIndexLink": ["pantoprazole"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "10 A 134",
    "DCI": "PANTOPRAZOLE",
    "NOM_COMMERCIALE": "POTONEX",
    "FORME": "COMP A ENROBAGE ENTERIQUE",
    "DOSAGE": "40MG",
    "COND": "B/14 & 28",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["lansoprazole"],
    "InteractionIndexLink": ["lansoprazole"],
    "N_ENREGISTREMENT": "035/ 10 A 167 /07/19",
    "CODE_DCI": "10 A 167",
    "DCI": "LANSOPRAZOLE",
    "NOM_COMMERCIALE": "ESOPROTON",
    "FORME": "GLES A  MICROG. GASTRORESIST.",
    "DOSAGE": "30MG",
    "COND": "PILULIER/14 ET 28",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMALLIANCE EURL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/12/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "3/12/2019",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["lansoprazole"],
    "InteractionIndexLink": ["lansoprazole"],
    "N_ENREGISTREMENT": "289/10 A 167/18",
    "CODE_DCI": "10 A 167",
    "DCI": "Lansoprazole",
    "NOM_COMMERCIALE": "LANSOPOMP",
    "FORME": "Gélule Gastro-résistante",
    "DOSAGE": "30 MG",
    "COND": "B/30",
    "LISTE": "LISTE II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRATER RAZES FORME SECHE SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/10/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "19/5/2020",
    "TYPE": "Gé",
    "STATUT": "F prémix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["lansoprazole"],
    "InteractionIndexLink": ["lansoprazole"],
    "N_ENREGISTREMENT": "544/10 A 167/09/19",
    "CODE_DCI": "10 A 167",
    "DCI": "LANSOPRAZOLE",
    "NOM_COMMERCIALE": "LANZOMED",
    "FORME": "GELULES",
    "DOSAGE": "30 MG",
    "COND": "B/15",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL WORLD MEDICINE LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "8/12/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "10/11/2019",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["lansoprazole"],
    "InteractionIndexLink": ["lansoprazole"],
    "N_ENREGISTREMENT": "378/10 A 167/19",
    "CODE_DCI": "10 A 167",
    "DCI": "Lansoprazole",
    "NOM_COMMERCIALE": "LANZOREM",
    "FORME": "Gélules à microgranules gastro-résistants",
    "DOSAGE": "30 MG",
    "COND": "B/15 ET B/30",
    "LISTE": "LISTE II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOREM / SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/3/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "14/3/2021",
    "TYPE": "Gé",
    "STATUT": "F prémix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["lansoprazole"],
    "InteractionIndexLink": ["lansoprazole"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "10 A 167",
    "DCI": "LANSOPRAZOLE",
    "NOM_COMMERCIALE": "LANZOREM",
    "FORME": "GELULE A MICRO GRANULES",
    "DOSAGE": "·  30mg",
    "COND": "B/15",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["lansoprazole"],
    "InteractionIndexLink": ["lansoprazole"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "10 A 167",
    "DCI": "LANSOPRAZOLE",
    "NOM_COMMERCIALE": "LANZOREM",
    "FORME": "GELULE A MICRO GRANULES",
    "DOSAGE": "·  30mg",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["lansoprazole"],
    "InteractionIndexLink": ["lansoprazole"],
    "N_ENREGISTREMENT": "001/10 A 167/17",
    "CODE_DCI": "10 A 167",
    "DCI": "LANSOPRAZOLE",
    "NOM_COMMERCIALE": "ZOPRA",
    "FORME": "GELULES A MICROGRANULES GASTRO-RESISTANTES",
    "DOSAGE": "30 MG",
    "COND": "B/15",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMA ALGERIA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/11/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "30/11/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["esomeprazole"],
    "InteractionIndexLink": ["esomeprazole"],
    "N_ENREGISTREMENT": "293/ 10 A 180 /19",
    "CODE_DCI": "10 A 180",
    "DCI": "Esoméprazole Magnésium Trihydrate Exprimé En Esoméprazole",
    "NOM_COMMERCIALE": "ANTIUM",
    "FORME": "GRANULES EN GELULE GASTRO-RESISTANTS",
    "DOSAGE": "20MG",
    "COND": "B/14 ET B/28",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOCARE LABORATOIRES SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/5/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "7/5/2019",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["esomeprazole"],
    "InteractionIndexLink": ["esomeprazole"],
    "N_ENREGISTREMENT": "317/ 10 A 180 /13",
    "CODE_DCI": "10 A 180",
    "DCI": "Esoméprazole Magnésium Trihydrate Exprimé En Esoméprazole",
    "NOM_COMMERCIALE": "ESORAL",
    "FORME": "GRANULES EN GELULE GASTRO-RESISTANTS",
    "DOSAGE": "20MG",
    "COND": "B/16 ETB/28",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INPHA-MEDIS SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/6/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "4/6/2013",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["esomeprazole"],
    "InteractionIndexLink": ["esomeprazole"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "10 A 180",
    "DCI": " Esomeprazole",
    "NOM_COMMERCIALE": "ESORAL 20 mg Bte 16",
    "FORME": "Gélule",
    "DOSAGE": "20mg/comp",
    "COND": "B/16   ET    B/28",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["esomeprazole"],
    "InteractionIndexLink": ["esomeprazole"],
    "N_ENREGISTREMENT": "352/ 10 A 180 /13",
    "CODE_DCI": "10 A 180",
    "DCI": "Esoméprazole Magnésium Trihydrate Exprimé En Esoméprazole",
    "NOM_COMMERCIALE": "KENZOPRAZOL",
    "FORME": "GRANULES EN GELULE GASTRO-RESISTANTS",
    "DOSAGE": "20MG",
    "COND": "B/20",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/1/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "10/1/2013",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["esomeprazole"],
    "InteractionIndexLink": ["esomeprazole"],
    "N_ENREGISTREMENT": "035/ 10 A 180 /14",
    "CODE_DCI": "10 A 180",
    "DCI": "Esoméprazole Magnésium Trihydrate Exprimé En Esoméprazole",
    "NOM_COMMERCIALE": "LISINOX",
    "FORME": "COMP. PELLI. GASTRORESIST.",
    "DOSAGE": "20MG",
    "COND": "B/07 - B/14 - B/28",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EURL PHARMALLIANCE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/12/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "25/12/2014",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["esomeprazole"],
    "InteractionIndexLink": ["esomeprazole"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "10 A 180",
    "DCI": "Esoméprazole",
    "NOM_COMMERCIALE": "Lisinox",
    "FORME": "Comprimé pelliculé gastro-résistant",
    "DOSAGE": "20 mg",
    "COND": "Boite 28",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["esomeprazole"],
    "InteractionIndexLink": ["esomeprazole"],
    "N_ENREGISTREMENT": "149/ 10 A 180 /14",
    "CODE_DCI": "10 A 180",
    "DCI": "Esoméprazole Magnésium Trihydrate Exprimé En Esoméprazole",
    "NOM_COMMERCIALE": "PROXIUM",
    "FORME": "GRANULES EN GELULE GASTRO-RESISTANTS",
    "DOSAGE": "20MG",
    "COND": "FL/14",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVAPHARM TRADING SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/4/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "15/4/2014",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["esomeprazole"],
    "InteractionIndexLink": ["esomeprazole"],
    "N_ENREGISTREMENT": "293/ 10 A 181 /19",
    "CODE_DCI": "10 A 181",
    "DCI": "Esoméprazole Magnésium Trihydrate Exprimé En Esoméprazole",
    "NOM_COMMERCIALE": "ANTIUM",
    "FORME": "GRANULES EN GELULE GASTRO-RESISTANTS",
    "DOSAGE": "40MG",
    "COND": "B/28",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOCARE LABORATOIRES SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/5/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "7/5/2019",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["esomeprazole"],
    "InteractionIndexLink": ["esomeprazole"],
    "N_ENREGISTREMENT": "263/10 A 181/20",
    "CODE_DCI": "10 A 181",
    "DCI": "ESOMEPRAZOLE MAGNESIUM TRIHYDRATE",
    "NOM_COMMERCIALE": "BIOMAC",
    "FORME": "GLES A MICROGRANULES GASTRO RESIST",
    "DOSAGE": "40MG",
    "COND": "PILULIER/14",
    "LISTE": "LISTE II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOPHARM SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/2/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "12/2/2020",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["esomeprazole"],
    "InteractionIndexLink": ["esomeprazole"],
    "N_ENREGISTREMENT": "263/10 A 181/20",
    "CODE_DCI": "10 A 181",
    "DCI": "ESOMEPRAZOLE MAGNESIUM TRIHYDRATE",
    "NOM_COMMERCIALE": "BIOMAC",
    "FORME": "GLES A MICROGRANULES GASTRO-RESISTANTS",
    "DOSAGE": "40MG",
    "COND": "B/14",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOPHARM SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/2/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "12/2/2020",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["esomeprazole"],
    "InteractionIndexLink": ["esomeprazole"],
    "N_ENREGISTREMENT": "317/ 10 A 181 /13",
    "CODE_DCI": "10 A 181",
    "DCI": "Esoméprazole Magnésium Trihydrate Exprimé En Esoméprazole",
    "NOM_COMMERCIALE": "ESORAL",
    "FORME": "GRANULES EN GELULE GASTRO-RESISTANTS",
    "DOSAGE": "40MG",
    "COND": "B/16 ET B/28",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INPHA-MEDIS SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/6/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "4/6/2013",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["esomeprazole"],
    "InteractionIndexLink": ["esomeprazole"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "10 A 181",
    "DCI": " Esomeprazole",
    "NOM_COMMERCIALE": "ESORAL 40 mg Bte 16",
    "FORME": "Gélule",
    "DOSAGE": "40mg/comp",
    "COND": "B/16 ET B/28",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["esomeprazole"],
    "InteractionIndexLink": ["esomeprazole"],
    "N_ENREGISTREMENT": "035/ 10 A 181 /14",
    "CODE_DCI": "10 A 181",
    "DCI": "Esoméprazole Magnésium Trihydrate Exprimé En Esoméprazole",
    "NOM_COMMERCIALE": "LISINOX",
    "FORME": "COMPRIME PELLICULE GASTRO-RESISTANT",
    "DOSAGE": "40MG",
    "COND": "B/07 - B/14 - B/28",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EURL PHARMALLIANCE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/12/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "25/12/2014",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["esomeprazole"],
    "InteractionIndexLink": ["esomeprazole"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "10 A 181",
    "DCI": "Esoméprazole",
    "NOM_COMMERCIALE": "Lisinox",
    "FORME": "comprimé pelliculé gastro-résistant",
    "DOSAGE": "40 mg",
    "COND": "Boite 28",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["esomeprazole"],
    "InteractionIndexLink": ["esomeprazole"],
    "N_ENREGISTREMENT": "149/ 10 A 181 /18",
    "CODE_DCI": "10 A 181",
    "DCI": "Esoméprazole Magnésium Trihydrate Exprimé En Esoméprazole",
    "NOM_COMMERCIALE": "PROXIUM",
    "FORME": "GRANULES EN GELULE GASTRO-RESISTANTS",
    "DOSAGE": "40MG",
    "COND": "B/14 ET B/28",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVAPHARM TRADING SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/2/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "12/2/2018",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["esomeprazole"],
    "InteractionIndexLink": ["esomeprazole"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "10 A 181",
    "DCI": "Esoméprazole",
    "NOM_COMMERCIALE": "esomac",
    "FORME": "Gélule à microgranule gastro-résistante",
    "DOSAGE": "40mg",
    "COND": "B/14 ET b/28",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["lansoprazole"],
    "InteractionIndexLink": ["lansoprazole"],
    "N_ENREGISTREMENT": "289/10 A 188/20",
    "CODE_DCI": "10 A 188",
    "DCI": "Lansoprazole",
    "NOM_COMMERCIALE": "LANSOPOMP",
    "FORME": "Gélule Gastro-résistante",
    "DOSAGE": "15 MG",
    "COND": "B/30",
    "LISTE": "LISTE II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRATER RAZES SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/8/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "26/082020",
    "TYPE": "Gé",
    "STATUT": "F prémix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["lansoprazole"],
    "InteractionIndexLink": ["lansoprazole"],
    "N_ENREGISTREMENT": "20/10 A188/289",
    "CODE_DCI": "10 A 188",
    "DCI": "LANSOPRAZOLE",
    "NOM_COMMERCIALE": "LANZOPOMP",
    "FORME": "GELULES GASTRO-RÉSISTANTES",
    "DOSAGE": "15MG",
    "COND": "B/30",
    "LISTE": "LISTE II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES FRATER RAZES FORME SECHE SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/8/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "26/8/2020",
    "TYPE": "Gé",
    "STATUT": "F Prémix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["esomeprazole"],
    "InteractionIndexLink": ["esomeprazole"],
    "N_ENREGISTREMENT": "256/ 10 A 197 /12",
    "CODE_DCI": "10 A 197",
    "DCI": "Esoméprazole Sodique Exprimé En Esoméprazole",
    "NOM_COMMERCIALE": "INEXIUM",
    "FORME": "PDRE. P. SOL. INJ. IV OU PERF.",
    "DOSAGE": "40MG/FL. DE PDRE.",
    "COND": "B/10FL. DE PDRE.",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ASTRAZENECA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/7/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "13/7/2012",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["charbon vegetal officinal"],
    "N_ENREGISTREMENT": "425/ 10 B 009 /96/16",
    "CODE_DCI": "10 B 009",
    "DCI": "CHARBON  VEGETAL",
    "NOM_COMMERCIALE": "CARBOPHOS",
    "FORME": "COMPRIME A CROQUER",
    "DOSAGE": "400MG",
    "COND": "B/40",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "TRADIPHAR",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/8/1996",
    "DATE_D_ENREGISTREMENT_FINAL": "22/2/2016",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "60MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["magnesium (hydroxyde de)"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "10 B 010",
    "DCI": "HYDROXIDE ALUMINIUM/HYDROXIDE DE MAGNESIUM",
    "NOM_COMMERCIALE": "MAALOX",
    "FORME": "SUSP BUV",
    "DOSAGE": "125mg/1600 mg",
    "COND": "Fl/200 ml",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["magnesium (hydroxyde de)"],
    "N_ENREGISTREMENT": "392/ 10 B 010 /96/21",
    "CODE_DCI": "10 B 010",
    "DCI": "Hydroxyde de magnésium / Hydroxyde d'aluminium",
    "NOM_COMMERCIALE": "MAALOX MAUX D'ESTOMAC",
    "FORME": "SUSP.BUV. GOÛT MENTHE",
    "DOSAGE": "3.5G/4G/100ML",
    "COND": "B/1FL DE 250ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANOFI AVENTIS ALGERIE /  SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/10/1996",
    "DATE_D_ENREGISTREMENT_FINAL": "15/2/2021",
    "TYPE": "Ré",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["magnesium (hydroxyde de)"],
    "N_ENREGISTREMENT": "003/ 10 B 010 /06/19",
    "CODE_DCI": "10 B 010",
    "DCI": "HYDROXYDE D'ALUMINIUM / HYDROXYDE DE MAGNESIUM",
    "NOM_COMMERCIALE": "SAILOX",
    "FORME": "SUSP. BUV.",
    "DOSAGE": "3.50G/4.00G/100ML",
    "COND": "FL/250ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EPE GROUPE INDUSTRIEL SAIDAL/ SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/12/1996",
    "DATE_D_ENREGISTREMENT_FINAL": "25/12/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["diosmectite"],
    "N_ENREGISTREMENT": "380/10 B 015/17",
    "CODE_DCI": "10 B 015",
    "DCI": "DIOSMECTITE",
    "NOM_COMMERCIALE": "DIOSMECTA",
    "FORME": "PDRE. P. SUSP. BUV. EN SACHET-DOSE",
    "DOSAGE": "3G/SACHET",
    "COND": "B/30 SACHETS",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HUPP PHARMA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/4/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "12/4/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["diosmectite"],
    "N_ENREGISTREMENT": "020 / 10 B 015 /17",
    "CODE_DCI": "10 B 015",
    "DCI": "DIOSMECTITE",
    "NOM_COMMERCIALE": "SMECTA FRAISE",
    "FORME": "PDRE. P. SUSP. BUV. EN SACHET-DOSE",
    "DOSAGE": "3G/SACHET",
    "COND": "B/18 SACHETS",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "IPSEN PHARMA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/1/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "4/1/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["diosmectite"],
    "N_ENREGISTREMENT": "020/ 10 B 015 /97/19",
    "CODE_DCI": "10 B 015",
    "DCI": "DIOSMECTITE",
    "NOM_COMMERCIALE": "SMECTA ORANGE-VANILLE",
    "FORME": "PDRE. P. SUSP. BUV. EN SACHET-DOSE",
    "DOSAGE": "3G/SACHET",
    "COND": "B/30 SACHETS",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "IPSEN PHARMA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "31/3/1997",
    "DATE_D_ENREGISTREMENT_FINAL": "17/6/2019",
    "TYPE": "Ré",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["diosmectite"],
    "N_ENREGISTREMENT": "268/ 10 B 015 /15",
    "CODE_DCI": "10 B 015",
    "DCI": "DIOSMECTITE",
    "NOM_COMMERCIALE": "SMEDYL",
    "FORME": "PDRE. P. SUSP. BUV. EN SACHET-DOSE",
    "DOSAGE": "3G/SACHET",
    "COND": "B/30 SACHETS",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MERINAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/1/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "25/1/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "020/ 10 B 088 /96/20",
    "CODE_DCI": "10 B 088",
    "DCI": "MONTMORILLONITE BEIDELLITIQUE",
    "NOM_COMMERCIALE": "BEDELIX",
    "FORME": "PDRE . ORAL . RECT .",
    "DOSAGE": "3G",
    "COND": "B/30 SACHETS",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "IPSEN CONSUMER HEALTHCARE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/10/1996",
    "DATE_D_ENREGISTREMENT_FINAL": "18/3/2020",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["magnesium (hydroxyde de)"],
    "N_ENREGISTREMENT": "388/ 10 B 105 /15",
    "CODE_DCI": "10 B 105",
    "DCI": "HYDROXYDE D'ALUMINIUM / HYDROXYDE DE MAGNESIUM",
    "NOM_COMMERCIALE": "HYSALOX",
    "FORME": "SUSP. BUV. EN SACHET-DOSE",
    "DOSAGE": "525MG/600MG/SACHET",
    "COND": "B/30 SACHETS",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HYSA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/7/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "9/7/2015",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "418/10 B 119/19",
    "CODE_DCI": "10 B 119",
    "DCI": "PHLOROGLUCINOL DIHYDRATE/ SIMETICONE",
    "NOM_COMMERCIALE": "METEOLAX",
    "FORME": "GLES",
    "DOSAGE": "80MG/125MG",
    "COND": "B/60",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NEOMEDIC SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/12/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "22/12/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "015/ 10 B 119 /04/15",
    "CODE_DCI": "10 B 119",
    "DCI": "SIMETICONE / PHLOROGLUCINOL",
    "NOM_COMMERCIALE": "METEOXANE",
    "FORME": "GLES",
    "DOSAGE": "125MG/80MG",
    "COND": "B/60",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALFA WASSERMANN PHARMA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/4/2004",
    "DATE_D_ENREGISTREMENT_FINAL": "13/12/2015",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "231/ 10 B 119 /17",
    "CODE_DCI": "10 B 119",
    "DCI": "SIMETICONE / PHLOROGLUCINOL",
    "NOM_COMMERCIALE": "SIMEXANE 125/80",
    "FORME": "GLES",
    "DOSAGE": "125MG/80MG",
    "COND": "B/60",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SALEM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/10/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "30/10/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "265/ 10 B 125 /02/14",
    "CODE_DCI": "10 B 125",
    "DCI": "DIMETICONE/GAIAZULENE",
    "NOM_COMMERCIALE": "PEPSANE",
    "FORME": "GEL BUV EN SACHETS-DOSE",
    "DOSAGE": "3G/0.004G/SACHET",
    "COND": "B/30 SACHETS",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ROSA-PHYTOPHARMA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "14/5/2002",
    "DATE_D_ENREGISTREMENT_FINAL": "15/12/2014",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["papaverine"],
    "InteractionIndexLink": ["charbon active"],
    "N_ENREGISTREMENT": "476/ 10 B 143 /05/18",
    "CODE_DCI": "10 B 143",
    "DCI": "PAPAVERINE CHLORHYDRATE/CHARBON ACTIVE",
    "NOM_COMMERCIALE": "ACTICARBINE",
    "FORME": "COMP. ENRO.",
    "DOSAGE": "14MG/70MG",
    "COND": "B/42",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MAG PHARM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/11/2005",
    "DATE_D_ENREGISTREMENT_FINAL": "30/10/2018",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "60 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["calcium carbimide"],
    "InteractionIndexLink": ["calcium"],
    "N_ENREGISTREMENT": "523/ 10 B 182 /09/17",
    "CODE_DCI": "10 B 182",
    "DCI": "CALCIUM CARBONATE / CARBONATE DE MAGNESIUM LOURD / DIMETICONE (DCI) ACTIVE",
    "NOM_COMMERCIALE": "RENNIE DEFLATINE",
    "FORME": "COMPRIME A CROQUER SANS SUCRE",
    "DOSAGE": "680MG/80MG/25MG",
    "COND": "B/18",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BAYER SANTE FAMILLALE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/2/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "27/2/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "447/ 10 B 194 /12",
    "CODE_DCI": "10 B 194",
    "DCI": "SIMETICONE",
    "NOM_COMMERCIALE": "FREEGAS",
    "FORME": "COMPRIME A CROQUER SANS SUCRE A LA MENTHE",
    "DOSAGE": "80MG",
    "COND": "B/24",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEKER SARL (SARL LABORATOIRE BEKER ALGERIE)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/1/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "30/1/2012",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "268/ 10 C 017 /06/14",
    "CODE_DCI": "10 C 017",
    "DCI": "NIFUROXAZIDE",
    "NOM_COMMERCIALE": "DYSENTYL",
    "FORME": "GLES.",
    "DOSAGE": "200MG",
    "COND": "B/30",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MERINAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/4/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "1/6/2014",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "462/ 10 C 017/13",
    "CODE_DCI": "10 C 017",
    "DCI": "NIFUROXAZIDE",
    "NOM_COMMERCIALE": "NIFUROXAZIDE PHYSIOPHARM",
    "FORME": "GLES",
    "DOSAGE": "200MG",
    "COND": "B/30",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHYSIOPHARM SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "11/12/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "11/12/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "10 C 017",
    "DCI": "NIFUROXAZIDE",
    "NOM_COMMERCIALE": "XEFURYL",
    "FORME": "GLES.",
    "DOSAGE": "200MG",
    "COND": "B/28",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "079/ 10 C 018 /13",
    "CODE_DCI": "10 C 018",
    "DCI": "NIFUROXAZIDE",
    "NOM_COMMERCIALE": "FUROXID",
    "FORME": "SUSP. BUV.",
    "DOSAGE": "4 %",
    "COND": "FL./90ML",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE  ALGERIEN DE DEVELOPPEMENT  PHARMACEUTIQUE SARL (LAD PHARMA)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/4/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "15/4/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "317/ 10 C 018 /16",
    "CODE_DCI": "10 C 018",
    "DCI": "NIFUROXAZIDE",
    "NOM_COMMERCIALE": "IFFUROXAZIDE",
    "FORME": "SUSP.BUV.",
    "DOSAGE": "220MG/5ML",
    "COND": "B/01 FL DE 90ML + GOBLET DOSEUR",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INPHA MEDIS SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/7/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "4/7/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "457/ 10 C 018 /14",
    "CODE_DCI": "10 C 018",
    "DCI": "NIFUROXAZIDE",
    "NOM_COMMERCIALE": "MEROXAZIDE",
    "FORME": "SUSP. BUV.",
    "DOSAGE": "4 %",
    "COND": "B/01 FL. DE 90ML + GOBLET DOSEUR",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOMEDIAL SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/11/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "30/11/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "003/ 10 C 018 /01/17",
    "CODE_DCI": "10 C 018",
    "DCI": "NIFUROXAZIDE",
    "NOM_COMMERCIALE": "NIFAZIDE",
    "FORME": "SUSP.BUV.",
    "DOSAGE": "220MG/5ML",
    "COND": "FL/90ML",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SAIDAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "16/6/2001",
    "DATE_D_ENREGISTREMENT_FINAL": "12/4/2017",
    "TYPE": "Gé",
    "STATUT": "f",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "503/10 C 018/16",
    "CODE_DCI": "10 C 018",
    "DCI": "NIFUROXAZIDE",
    "NOM_COMMERCIALE": "NIFUROXAZIDE AFRO",
    "FORME": "SUSP.BUV.",
    "DOSAGE": "4 %",
    "COND": "FL /90ML",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "AFROPHARM SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/12/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "28/12/2016",
    "TYPE": "GF",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "462/10 C 018/16",
    "CODE_DCI": "10 C 018",
    "DCI": "NIFUROXAZIDE",
    "NOM_COMMERCIALE": "NIFUROXAZIDE PHYSIOPHARM",
    "FORME": "SUSP.BUV.",
    "DOSAGE": "4 %",
    "COND": "FL /90ML",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHYSIOPHARM SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/11/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "7/11/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "10 C 018",
    "DCI": "NIFUROXAZIDE",
    "NOM_COMMERCIALE": "NIFUROXAZIDE PHYSIOPHARM",
    "FORME": "SUSP.BUV.",
    "DOSAGE": "0.04",
    "COND": "FL /90ML",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "10 D 031",
    "DCI": "TIEMONIUM METHYLSULFATE",
    "NOM_COMMERCIALE": "VISCERAL",
    "FORME": "SUPPO.",
    "DOSAGE": "20MG",
    "COND": "B/10",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "10 D 032",
    "DCI": "TIEMONIUM METHYLSULFATE",
    "NOM_COMMERCIALE": "ISOSPALGINE",
    "FORME": "SIROP",
    "DOSAGE": "10MG/5ML",
    "COND": "FL/150ML",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "10 D 032",
    "DCI": "TIEMONIUM METHYLSULFATE",
    "NOM_COMMERCIALE": "TIMADLINE",
    "FORME": "SIROP",
    "DOSAGE": "10MG/5ML",
    "COND": "FL/125ML",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "003/ 10 D 032 /99/17",
    "CODE_DCI": "10 D 032",
    "DCI": "TIEMONIUM METHYLSULFATE",
    "NOM_COMMERCIALE": "TIMONAL",
    "FORME": "SIROP",
    "DOSAGE": "10MG/5ML",
    "COND": "FL/125ML",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EPE  GROUPE INDUSTRIEL SAIDAL SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/1/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "4/9/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "20/10 D0332/400",
    "CODE_DCI": "10 D 032",
    "DCI": "TIÉMONIUM MÉTHYLE SULFATE",
    "NOM_COMMERCIALE": "TIMONEX",
    "FORME": "SOL BUVABLE",
    "DOSAGE": "10MG/ 05ML",
    "COND": "FL/ 150ML",
    "LISTE": "LISTE II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES KHROUB PHARMACEUTICAL MANUFACTURING ALGERIA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/5/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "19/5/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "20/10 D032/400",
    "CODE_DCI": "10 D 032",
    "DCI": "TIÉMONIUM MÉTHYLE SULFATE",
    "NOM_COMMERCIALE": "TIMONEX",
    "FORME": "SOL BUVABLE",
    "DOSAGE": "10MG/ 05ML",
    "COND": "FL/ 150ML",
    "LISTE": "LISTE II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "KPMA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/05/20",
    "DATE_D_ENREGISTREMENT_FINAL": "19/05/20",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "10 D 032",
    "DCI": "TIEMONIUM METHYLSULFATE",
    "NOM_COMMERCIALE": "TIMONEX",
    "FORME": "SOL BUV",
    "DOSAGE": "10 MG / 5 ML",
    "COND": "FLACON DE 150 ML",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "10 D 135",
    "DCI": "PRIFINIUM BROMURE",
    "NOM_COMMERCIALE": "RIABAL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "30MG",
    "COND": "B/20",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["mebeverine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "10 E 035",
    "DCI": "Mebeverine chlorhydrate",
    "NOM_COMMERCIALE": "DESPAVINE",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "100MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["mebeverine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "289/ 10 E 035 /12",
    "CODE_DCI": "10 E 035",
    "DCI": "Mebeverine chlorhydrate",
    "NOM_COMMERCIALE": "DUSPAVERINE",
    "FORME": "MICROGLES. EN GLES.",
    "DOSAGE": "100MG",
    "COND": "B/30",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRATER RAZES FORME SECHE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "23/12/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "23/12/2012",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["mebeverine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "003/10 E 035/09/20",
    "CODE_DCI": "10 E 035",
    "DCI": "MEBEVERINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "MEBEVERINE-SAIDAL",
    "FORME": "COMP. ENROBE",
    "DOSAGE": "100MG",
    "COND": "B/ 30",
    "LISTE": "LISTE II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EPE GROUPE INDUSTRIEL SAIDAL/SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/12/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "27/12/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["mebeverine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "065/ 10 E 035 /14",
    "CODE_DCI": "10 E 035",
    "DCI": "Mebeverine chlorhydrate",
    "NOM_COMMERCIALE": "SPASCOL",
    "FORME": "MICROGRANULES  EN GELULE",
    "DOSAGE": "100MG",
    "COND": "B/30",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GENERICLAB",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/3/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "9/3/2014",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "147/ 10 E 036 /97/16",
    "CODE_DCI": "10 E 036",
    "DCI": "PINAVERIUM BROMURE",
    "NOM_COMMERCIALE": "DICETEL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "50MG",
    "COND": "B/20",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ABBOTT PRODUCTS SAS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/6/1997",
    "DATE_D_ENREGISTREMENT_FINAL": "17/1/2016",
    "TYPE": "Ré",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "149/10 E 036/16",
    "CODE_DCI": "10 E 036",
    "DCI": "PINAVERIUM BROMURE",
    "NOM_COMMERCIALE": "PINAVERIUM NOVAGENERICS",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "50MG",
    "COND": "B/20",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVAPHARM TRADING",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/12/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "28/12/2016",
    "TYPE": "G",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "039/ 10 E 038 /14",
    "CODE_DCI": "10 E 038",
    "DCI": "PHLOROGLUCINOL HYDRATE/ TRIMETHYLPHLOROGLUCINOL",
    "NOM_COMMERCIALE": "PHLOCINAL",
    "FORME": "SOL INJ IM/IV",
    "DOSAGE": "10MG/0.01MG/1ML (40MG/0.04MG/4ML)",
    "COND": "B/06 AMPS 4ML ET B/100 AMPS 4ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOCIETE PHARMACEUTIQUE ALGERIENNE (SOPHAL)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "16/7/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "16/7/2014",
    "TYPE": "Gé",
    "STATUT": "C IIaire",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "543/ 10 E 038 /21",
    "CODE_DCI": "10 E 038",
    "DCI": "Phloroglucinol dihydraté / Triméthylphloroglucinol",
    "NOM_COMMERCIALE": "PHLOROXIM",
    "FORME": "Solution injectable",
    "DOSAGE": "10MG / 0.01MG /1ML(40MG / 0.04MG /4ML)",
    "COND": "B/5 AMP. DE 4ML . B/6 AMP. DE 4ML. B/50 AMP. DE 4ML",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "B/50 AMP RESERVEE A L'HOPITAL",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOTHERA / SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "14/3/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "14/3/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "433/ 10 E 038 /14",
    "CODE_DCI": "10 E 038",
    "DCI": "PHLOROGLUCINOL HYDRATE/ TRIMETHYLPHLOROGLUCINOL",
    "NOM_COMMERCIALE": "SPASMODYL",
    "FORME": "SOL INJ IM/IV",
    "DOSAGE": "10MG/0.01MG/1ML (40MG/0.04MG/4ML)",
    "COND": "B/05 AMP DE 4ML ET B/50 AMP DE 4ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "B/50 AMP RESERVEE A L'HOPITAL",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRATER RAZES",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/8/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "4/7/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "10 E 039",
    "DCI": "PHLOROGLUCINOL / TRIMETHYLPHLOROGLUCINOL",
    "NOM_COMMERCIALE": "SPASMINE",
    "FORME": "SUPPO.",
    "DOSAGE": "150MG/150MG",
    "COND": "B/10",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "147/ 10 E 104 /99/15",
    "CODE_DCI": "10 E 104",
    "DCI": "PINAVERIUM BROMURE",
    "NOM_COMMERCIALE": "DICETEL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "100MG",
    "COND": "B/20",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ABBOTT PRODUCTS SAS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/5/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "13/5/2015",
    "TYPE": "Ré",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "447/ 10 E 104 /13/18",
    "CODE_DCI": "10 E 104",
    "DCI": "PINAVERIUM BROMURE",
    "NOM_COMMERCIALE": "PINATEL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "100MG",
    "COND": "B/28",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEKER SARL (SARL LABORATOIRE BEKER ALGERIE)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/3/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "14/8/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "065/ 10 E 104 /14",
    "CODE_DCI": "10 E 104",
    "DCI": "PINAVERIUM BROMURE",
    "NOM_COMMERCIALE": "PINAVERIUM GL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "100MG",
    "COND": "B/20",
    "LISTE": "LISTE II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GENERICLAB SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "16/2/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "16/2/2014",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "149/ 10 E 104 /13/18",
    "CODE_DCI": "10 E 104",
    "DCI": "PINAVERIUM BROMURE",
    "NOM_COMMERCIALE": "PINAVERIUM NOVAGENERICS",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "100MG",
    "COND": "B/30",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVAPHARM TRADING",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/2/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "31/12/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "035/ 10 E 108/16",
    "CODE_DCI": "10 E 108",
    "DCI": "Phloroglucinol dihydraté",
    "NOM_COMMERCIALE": "EUFOR",
    "FORME": "COMP. ORODISPERS.",
    "DOSAGE": "80MG",
    "COND": "B/10 ET B/30",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMALLIANCE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "5/9/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "5/9/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "035/10 E 108/17",
    "CODE_DCI": "10 E 108",
    "DCI": "Phloroglucinol dihydraté",
    "NOM_COMMERCIALE": "EUFOR",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "80MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMALLIANCE EURL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/5/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "28/5/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "549/ 10 E 108/21",
    "CODE_DCI": "10 E 108",
    "DCI": "Phloroglucinol dihydraté",
    "NOM_COMMERCIALE": "EVOGLUCINOL",
    "FORME": "Comprimé orodispersible",
    "DOSAGE": "80MG",
    "COND": "B/10",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EVOLAB / SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/3/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "4/3/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "468/ 10 E 108 /14",
    "CODE_DCI": "10 E 108",
    "DCI": "Phloroglucinol dihydraté",
    "NOM_COMMERCIALE": "LEVOSPASME",
    "FORME": "COMP. ORODISPERS.",
    "DOSAGE": "80MG",
    "COND": "B/10",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NADPHARMADIC PRODUCTION SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/10/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "1/10/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "348/10 E 108/17",
    "CODE_DCI": "10 E 108",
    "DCI": "Phloroglucinol dihydraté",
    "NOM_COMMERCIALE": "OROSPASM",
    "FORME": "COMP. ORODISPERS.",
    "DOSAGE": "80MG",
    "COND": "B/10",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "API SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/1/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "9/1/2017",
    "TYPE": "G",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "235/ 10 E 108 /15",
    "CODE_DCI": "10 E 108",
    "DCI": "Phloroglucinol dihydraté",
    "NOM_COMMERCIALE": "PHLOROGLUCINOL BGL",
    "FORME": "COMP. ORODISPERS.",
    "DOSAGE": "80MG",
    "COND": "B/10",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOGALENIC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/10/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "19/10/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "380/ 10 E 108 /11",
    "CODE_DCI": "10 E 108",
    "DCI": "Phloroglucinol dihydraté",
    "NOM_COMMERCIALE": "PHLOROGLUCINOL HUP",
    "FORME": "COMP. ORODISPERS.",
    "DOSAGE": "80MG",
    "COND": "B/10",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HUP.P.PHARMA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/3/2011",
    "DATE_D_ENREGISTREMENT_FINAL": "1/3/2011",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "521/ 10 E 108 /09/15",
    "CODE_DCI": "10 E 108",
    "DCI": "Phloroglucinol dihydraté",
    "NOM_COMMERCIALE": "PHLOROGLUCINOL IVAL",
    "FORME": "COMP. ORODISPERS.",
    "DOSAGE": "80MG",
    "COND": "B/10",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL WORLD MEDICINE LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/6/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "31/3/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "470/ 10 E 108 /13",
    "CODE_DCI": "10 E 108",
    "DCI": "Phloroglucinol dihydraté",
    "NOM_COMMERCIALE": "PHLOROGLUCINOL MM",
    "FORME": "COMP. ORODISPERS.",
    "DOSAGE": "80MG",
    "COND": "B/10",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MM (SARL LABORATOIRES MM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "21/7/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "21/7/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "549/ 10 E 108/21",
    "CODE_DCI": "10 E 108",
    "DCI": "Phloroglucinol dihydraté",
    "NOM_COMMERCIALE": "PHLOROGLUCINOL PHYSIOPHARM",
    "FORME": "Comprimé orodispersible",
    "DOSAGE": "80MG",
    "COND": "B/10",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHYSIOPHARM / SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/2/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "17/2/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "293/ 10 E 108 /15",
    "CODE_DCI": "10 E 108",
    "DCI": "Phloroglucinol dihydraté",
    "NOM_COMMERCIALE": "PHLOROXIM",
    "FORME": "COMP. DISPERS. ET ORODISPERS.",
    "DOSAGE": "80MG",
    "COND": "B/10",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOCARE SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "31/5/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "31/5/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "10 E 108",
    "DCI": "Phloroglucinol dihydraté",
    "NOM_COMMERCIALE": "PHLOSPAM 80",
    "FORME": "comprimé orodispersible",
    "DOSAGE": "80 mg",
    "COND": "boîte de 20",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "518/10 E 108/17",
    "CODE_DCI": "10 E 108",
    "DCI": "Phloroglucinol dihydraté",
    "NOM_COMMERCIALE": "PHLOSPASM",
    "FORME": "COMP. ORODISPERS.",
    "DOSAGE": "80MG",
    "COND": "B/20",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "TAPHCO",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/3/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "7/3/2017",
    "TYPE": "GE",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "268/ 10 E 108 /15",
    "CODE_DCI": "10 E 108",
    "DCI": "Phloroglucinol dihydraté",
    "NOM_COMMERCIALE": "SPACYL",
    "FORME": "COMP. ORODISPERS.",
    "DOSAGE": "80MG",
    "COND": "B/10 ET B/20",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MERINAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/7/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "30/7/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "10 E 108",
    "DCI": "Phloroglucinol dihydraté",
    "NOM_COMMERCIALE": "SPACYL",
    "FORME": "COMP. ORODISPERS.",
    "DOSAGE": "80MG",
    "COND": "B/20",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "097/10 E 108/20",
    "CODE_DCI": "10 E 108",
    "DCI": "PHLOROGLUCINOL TRIHYDRATE",
    "NOM_COMMERCIALE": "SPASFODINE",
    "FORME": "COMP. ORODISPERS.",
    "DOSAGE": "80MG",
    "COND": "B/10",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANAMED SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "MANQUE DATE",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "400/ 10 E 108 /16",
    "CODE_DCI": "10 E 108",
    "DCI": "Phloroglucinol dihydraté",
    "NOM_COMMERCIALE": "SPASFOMEX",
    "FORME": "COMP. ORODISPERS.",
    "DOSAGE": "80MG",
    "COND": "B/10",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "KPMA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/7/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "26/7/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "077/ 10 E 108/16",
    "CODE_DCI": "10 E 108",
    "DCI": "Phloroglucinol dihydraté",
    "NOM_COMMERCIALE": "SPASLAM",
    "FORME": "COMP. ORODISPERS.",
    "DOSAGE": "80MG",
    "COND": "B/10",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE ALGERIEN DU MEDICAMENT SARL (LAM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "5/9/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "5/9/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "289/10 E 108/09/19",
    "CODE_DCI": "10 E 108",
    "DCI": "Phloroglucinol dihydraté",
    "NOM_COMMERCIALE": "SPASMODYL",
    "FORME": "COMP. ORODISPERS.",
    "DOSAGE": "80MG",
    "COND": "B/10",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRATER RAZES FORME SECHE SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/9/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "27/8/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "231/10 E 108/17",
    "CODE_DCI": "10 E 108",
    "DCI": "Phloroglucinol dihydraté",
    "NOM_COMMERCIALE": "SPASMOL",
    "FORME": "COMP. ORODISPERS.",
    "DOSAGE": "80MG",
    "COND": "B/10",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SALEM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/9/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "10/9/2017",
    "TYPE": "G",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["mebeverine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "147/ 10 E 116 /01/16",
    "CODE_DCI": "10 E 116",
    "DCI": "Mebeverine chlorhydrate",
    "NOM_COMMERCIALE": "DUSPATALIN",
    "FORME": "MICROGLES. LP EN GLES.",
    "DOSAGE": "200MG",
    "COND": "B/30",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ABBOTT PRODUCTS SAS ( BIOPHARM SPA)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/1/2001",
    "DATE_D_ENREGISTREMENT_FINAL": "19/7/2016",
    "TYPE": "Ré",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["mebeverine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "289/ 10 E 116 /13",
    "CODE_DCI": "10 E 116",
    "DCI": "Mebeverine chlorhydrate",
    "NOM_COMMERCIALE": "DUSPAVERINE",
    "FORME": "MICROGLES. LP EN GLES.",
    "DOSAGE": "200MG",
    "COND": "B/30",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRATER RAZES FORME SECHE SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "31/7/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "31/7/2013",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["mebeverine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "447/ 10 E 116 /17",
    "CODE_DCI": "10 E 116",
    "DCI": "Mebeverine chlorhydrate",
    "NOM_COMMERCIALE": "MEBEVERINE BEKER LP",
    "FORME": "MICROGLES. LP EN GLES.",
    "DOSAGE": "200MG",
    "COND": "B/30",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEKER SARL (SARL LABORATOIRE BEKER ALGERIE)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/11/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "27/11/2017",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["mebeverine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "418/ 10 E 116 /12",
    "CODE_DCI": "10 E 116",
    "DCI": "Mebeverine chlorhydrate",
    "NOM_COMMERCIALE": "SPALVERINE",
    "FORME": "GLES.",
    "DOSAGE": "200MG",
    "COND": "B/30",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NEOMEDIC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/1/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "18/1/2012",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["mebeverine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "065/ 10 E 116 /08/15",
    "CODE_DCI": "10 E 116",
    "DCI": "Mebeverine chlorhydrate",
    "NOM_COMMERCIALE": "SPASCOL LP",
    "FORME": "GLES. A MICROGRANULES LP",
    "DOSAGE": "200MG",
    "COND": "B/30",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GENERICLAB SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/3/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "11/4/2016",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "067/ 10 E 128 /03/15",
    "CODE_DCI": "10 E 128",
    "DCI": "ALVERINE/SIMETICONE",
    "NOM_COMMERCIALE": "METEOSPASMYL",
    "FORME": "CAPSULE ORALE",
    "DOSAGE": "60MG/300MG",
    "COND": "B/20. B/30. b/40",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MAYOLY SPINDLER",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/9/2003",
    "DATE_D_ENREGISTREMENT_FINAL": "26/10/2015",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 mois",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "19/10 E198/380",
    "CODE_DCI": "10 E 198",
    "DCI": "PHLOROGLUCINOL DIHYDRATE",
    "NOM_COMMERCIALE": "SPAFON",
    "FORME": "SOL INJ IM/IV",
    "DOSAGE": "40MG/4ML",
    "COND": "B/10 AMPOULES DE 4ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "laboratoires HUP.P PHARMA Sarl",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "02/04/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "02/04/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "259/ 10 E 198 /02/13",
    "CODE_DCI": "10 E 198",
    "DCI": "Phloroglucinol dihydraté",
    "NOM_COMMERCIALE": "SPASMEX",
    "FORME": "SOL.INJ. IM/IV",
    "DOSAGE": "10MG/ML (40MG/4ML)",
    "COND": "B/10AMP. DE 4ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SCHARPER SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ITALIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "23/1/2002",
    "DATE_D_ENREGISTREMENT_FINAL": "18/2/2013",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "468/10 E 207/20",
    "CODE_DCI": "10 E 207",
    "DCI": "PHLOROGLUCINOL DIHYDRATE",
    "NOM_COMMERCIALE": "LEVOSPASME",
    "FORME": "COMP ORODISPERSIBLE",
    "DOSAGE": "160MG",
    "COND": "B/10",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NADPHARMADIC PRODUCTION SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "MANQUE DATE SUR LA DE",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "518/10 E 207/17",
    "CODE_DCI": "10 E 207",
    "DCI": "Phloroglucinol dihydraté",
    "NOM_COMMERCIALE": "PHLOSPAM",
    "FORME": "COMP ORODISPERSIBLE",
    "DOSAGE": "160 MG",
    "COND": "B/20",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "TAPHCO SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/4/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "12/4/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "10 E 207",
    "DCI": "Phloroglucinol dihydraté",
    "NOM_COMMERCIALE": "PHLOSPAM 160",
    "FORME": "comprimé orodispersible",
    "DOSAGE": "160 mg",
    "COND": "boîte de 20",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "231/10 E 207/17",
    "CODE_DCI": "10 E 207",
    "DCI": "Phloroglucinol dihydraté",
    "NOM_COMMERCIALE": "SPASMOL",
    "FORME": "COMP ORODISPERSIBLE",
    "DOSAGE": "160 MG",
    "COND": "B/10",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SALEM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/12/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "27/12/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["metoclopramide"],
    "InteractionIndexLink": ["metoclopramide"],
    "N_ENREGISTREMENT": "433/ 10 F 042 /15",
    "CODE_DCI": "10 F 042",
    "DCI": "METOCLOPRAMIDE CHLORHYDRATE MONOHYDRATE EXPRIME EN CHLORHYDRATE DE METOCLOPRAMIDE",
    "NOM_COMMERCIALE": "MODENUM",
    "FORME": "SOL. INJ. IM/IV",
    "DOSAGE": "10MG/2ML",
    "COND": "B/10 ET B/50",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "B/50 RESERVEE AUX HÔPITAUX",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRATER RAZES SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/7/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "2/2/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["metoclopramide"],
    "InteractionIndexLink": ["metoclopramide"],
    "N_ENREGISTREMENT": "18/10 F042/380",
    "CODE_DCI": "10 F 042",
    "DCI": "METOCLOPRAMIDE HYDROCHLORIDE",
    "NOM_COMMERCIALE": "PRIMPERENE",
    "FORME": "SOL INJ IM/IV",
    "DOSAGE": "10MG/2ML",
    "COND": "1- B/10 AMPOULES DE 2ML 2- B/50 AMPOULES DE 2ML",
    "LISTE": "Liste I",
    "P1": "1- HOP2- HOP",
    "P2": "1- OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "laboratoires HUP.P PHARMA Sarl",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/05/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "27/05/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["metoclopramide"],
    "InteractionIndexLink": ["metoclopramide"],
    "N_ENREGISTREMENT": "320/10 F 043/20",
    "CODE_DCI": "10 F 043",
    "DCI": "METOCLOPRAMIDE",
    "NOM_COMMERCIALE": "PRIMPA",
    "FORME": "COMPRIME.",
    "DOSAGE": "10MG",
    "COND": "B/40",
    "LISTE": "LISTE II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES AGD PHARM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "5/10/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "5/10/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["metoclopramide"],
    "InteractionIndexLink": ["metoclopramide"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "10 F 044",
    "DCI": "METOCLOPRAMIDE CHLORHYDRATE ANHYDRE",
    "NOM_COMMERCIALE": "CLOPRAMID",
    "FORME": "SOL.BUV",
    "DOSAGE": "0.001",
    "COND": "FL/125ML",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["metoclopramide"],
    "InteractionIndexLink": ["metoclopramide"],
    "N_ENREGISTREMENT": "077/ 10 F 044 /03/21",
    "CODE_DCI": "10 F 044",
    "DCI": "Chlorhydrate de métoclopramide monohydraté exprimé en Chlorhydrate de métoclopramide anhydre",
    "NOM_COMMERCIALE": "METOCLAM",
    "FORME": "Solution buvable",
    "DOSAGE": "0.1% (0.1G/100ML)",
    "COND": "F/200ML",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE ALGERIEN DU MEDICAMENT  (LAM) / SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/6/2003",
    "DATE_D_ENREGISTREMENT_FINAL": "21/2/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["metoclopramide"],
    "InteractionIndexLink": ["metoclopramide"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "10 F 044",
    "DCI": "METOCLOPRAMIDE",
    "NOM_COMMERCIALE": "METOCLAM",
    "FORME": "SOL. BUV.",
    "DOSAGE": "0.001",
    "COND": "F/200ML",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["domperidone"],
    "InteractionIndexLink": ["domperidone"],
    "N_ENREGISTREMENT": "447/10 F 046/17",
    "CODE_DCI": "10 F 046",
    "DCI": "DOMPERIDONE",
    "NOM_COMMERCIALE": "DOMPERIDONE BEKER",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "10MG",
    "COND": "B/40",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEKER SARL (SARL LABORATOIRE BEKER ALGERIE)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/2/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "12/2/2017",
    "TYPE": "G",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["domperidone"],
    "InteractionIndexLink": ["domperidone"],
    "N_ENREGISTREMENT": "400/10 F 046/21",
    "CODE_DCI": "10 F 046",
    "DCI": "DOMPERIDONE",
    "NOM_COMMERCIALE": "DOMPERIMEX",
    "FORME": "COMP. PELL",
    "DOSAGE": "10 MG",
    "COND": "B/ 30",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "KPMA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "14/4/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "14/4/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["domperidone"],
    "InteractionIndexLink": ["domperidone"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "10 F 046",
    "DCI": "Dompéridone",
    "NOM_COMMERCIALE": "Dompermex",
    "FORME": "Comprimé",
    "DOSAGE": "10 mg",
    "COND": "Boite 30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["domperidone"],
    "InteractionIndexLink": ["domperidone"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "10 F 046",
    "DCI": "Dompéridone",
    "NOM_COMMERCIALE": "Domperone",
    "FORME": "Comprimé",
    "DOSAGE": "10 mg",
    "COND": "Boite 40",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["domperidone"],
    "InteractionIndexLink": ["domperidone"],
    "N_ENREGISTREMENT": "518/10 F 046/17",
    "CODE_DCI": "10 F 046",
    "DCI": "DOMPERIDONE",
    "NOM_COMMERCIALE": "EMETIKAN 10",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "TAPHCO SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/6/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "18/6/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["domperidone"],
    "InteractionIndexLink": ["domperidone"],
    "N_ENREGISTREMENT": "380/ 10 F 046 /14",
    "CODE_DCI": "10 F 046",
    "DCI": "DOMPERIDONE MALEATE EXPRIME EN DOMPERIDONE",
    "NOM_COMMERCIALE": "EMIDIUM HUP",
    "FORME": "COMPRIME",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HUP.P.PHARMA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/12/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "30/12/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["domperidone"],
    "InteractionIndexLink": ["domperidone"],
    "N_ENREGISTREMENT": "457/ 10 F 046 /13",
    "CODE_DCI": "10 F 046",
    "DCI": "DOMPERIDONE",
    "NOM_COMMERCIALE": "MERIDONE",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOMEDIAL SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/1/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "20/1/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["domperidone"],
    "InteractionIndexLink": ["domperidone"],
    "N_ENREGISTREMENT": "077/ 10 F 046 /16",
    "CODE_DCI": "10 F 046",
    "DCI": "DOMPERIDONE",
    "NOM_COMMERCIALE": "MOTIDONE",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "10MG",
    "COND": "B/40",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIEN DU MEDICAMENT SARL (LAM SARL)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/5/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "22/5/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["domperidone"],
    "InteractionIndexLink": ["domperidone"],
    "N_ENREGISTREMENT": "095/ 10 F 046 /98/12",
    "CODE_DCI": "10 F 046",
    "DCI": "DOMPERIDONE",
    "NOM_COMMERCIALE": "MOTILIUM",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "10MG",
    "COND": "B/40",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JANSSEN CILAG SA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/4/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "2/7/2012",
    "TYPE": "Ré",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["domperidone"],
    "InteractionIndexLink": ["domperidone"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "10 F 046",
    "DCI": "DOMPERIDONE",
    "NOM_COMMERCIALE": "PERIDIUM",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["domperidone"],
    "InteractionIndexLink": ["domperidone"],
    "N_ENREGISTREMENT": "235/ 10 F 047 /12/18",
    "CODE_DCI": "10 F 047",
    "DCI": "DOMPERIDONE",
    "NOM_COMMERCIALE": "DOMPERIDONE BGL",
    "FORME": "SUSP. BUV.",
    "DOSAGE": "1MG/ML",
    "COND": "B/1FL. DE 200ML + 1SERING. P. ADMINIST. OR. GRADUE EN KG",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIO-GALENIC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/1/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "4/3/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["domperidone"],
    "InteractionIndexLink": ["domperidone"],
    "N_ENREGISTREMENT": "400/10 F 047/17",
    "CODE_DCI": "10 F 047",
    "DCI": "DOMPERIDONE",
    "NOM_COMMERCIALE": "DOMPERIMEX",
    "FORME": "SUSP. BUV.",
    "DOSAGE": "1MG/ML",
    "COND": "FL./200ML + PIPETTE GRADUEE",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "KPMA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/4/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "12/4/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["domperidone"],
    "InteractionIndexLink": ["domperidone"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "10 F 047",
    "DCI": "DOMPERIDONE",
    "NOM_COMMERCIALE": "DOMPERIMEX",
    "FORME": "SUSP BUV",
    "DOSAGE": "1 MG / ML",
    "COND": "B/1FL. DE 200ML + 1SERING. P. ADMINIST. OR. GRADUE EN KG",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["domperidone"],
    "InteractionIndexLink": ["domperidone"],
    "N_ENREGISTREMENT": "035/ 10 F 047 /16",
    "CODE_DCI": "10 F 047",
    "DCI": "DOMPERIDONE",
    "NOM_COMMERCIALE": "DOMPERONE",
    "FORME": "SUSP.BUV.",
    "DOSAGE": "1MG/ML",
    "COND": "FL/200ML + PIPETTE GRADUEE EN KG ET GOBLET DOSEUR",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMALLIANCE EURL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/2/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "4/2/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["domperidone"],
    "InteractionIndexLink": ["domperidone"],
    "N_ENREGISTREMENT": "242/ 10 F 047 /09/16",
    "CODE_DCI": "10 F 047",
    "DCI": "DOMPERIDONE",
    "NOM_COMMERCIALE": "DOPRIN",
    "FORME": "SUSP. BUV.",
    "DOSAGE": "1MG/ML",
    "COND": "FL./100ML",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GROUPE SANTE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/2/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "6/10/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["domperidone"],
    "InteractionIndexLink": ["domperidone"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "10 F 047",
    "DCI": "Dompéridone",
    "NOM_COMMERCIALE": "Domperidone BGL",
    "FORME": "Suspension buvable",
    "DOSAGE": "1 mg/ml",
    "COND": "Flacon 200 ml",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["domperidone"],
    "InteractionIndexLink": ["domperidone"],
    "N_ENREGISTREMENT": "20/10 F 047/470",
    "CODE_DCI": "10 F 047",
    "DCI": "DOMPERIDONE",
    "NOM_COMMERCIALE": "GASTRODONE",
    "FORME": "SUSP. BUVABLE AVEC SERINGUE DOSEUSE",
    "DOSAGE": "01MG/ML",
    "COND": "B/ 1 FLC DE 200ML",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL LABORATOIRES MM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "16/8/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "16/8/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["domperidone"],
    "InteractionIndexLink": ["domperidone"],
    "N_ENREGISTREMENT": "317/ 10 F 047 /15",
    "CODE_DCI": "10 F 047",
    "DCI": "DOMPERIDONE",
    "NOM_COMMERCIALE": "MEDILIUM",
    "FORME": "SUSP.BUV.",
    "DOSAGE": "1MG/ML",
    "COND": "FL/200ML + PIPETTE GRADUEE EN KG",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INPHA MEDIS SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/12/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "13/12/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["domperidone"],
    "InteractionIndexLink": ["domperidone"],
    "N_ENREGISTREMENT": "077/ 10 F 047 /09/14",
    "CODE_DCI": "10 F 047",
    "DCI": "DOMPERIDONE",
    "NOM_COMMERCIALE": "MOTIDONE",
    "FORME": "SUSP. BUV.",
    "DOSAGE": "1MG/ML",
    "COND": "FL./200ML+ PIPETTE GRADUEE EN KG/ML",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE ALGERIEN DU MEDICAMENT (LAM) SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/3/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "8/6/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["domperidone"],
    "InteractionIndexLink": ["domperidone"],
    "N_ENREGISTREMENT": "095/ 10 F 047 /98/14",
    "CODE_DCI": "10 F 047",
    "DCI": "DOMPERIDONE",
    "NOM_COMMERCIALE": "MOTILIUM",
    "FORME": "SUSP.BUV.",
    "DOSAGE": "1MG/ML",
    "COND": "FL/200ML + SERING. P. ADMINIST. ORALE. DE 5ML GRADUEE EN KG",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JANSSEN CILAG",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/4/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "30/11/2014",
    "TYPE": "Ré",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["domperidone"],
    "InteractionIndexLink": ["domperidone"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "10 F 047",
    "DCI": "Domperidone",
    "NOM_COMMERCIALE": "Medilium 1mg/ml",
    "FORME": "susp buv",
    "DOSAGE": "1mg/ml",
    "COND": "flacon 200ml",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["domperidone"],
    "InteractionIndexLink": ["domperidone"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "10 F 047",
    "DCI": "DOMPERIDONE",
    "NOM_COMMERCIALE": "NAUSEDIUM",
    "FORME": "SUSP. BUV.",
    "DOSAGE": "1MG/ML",
    "COND": "FL./200ML + PIPETTE DOSEUSE",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["domperidone"],
    "InteractionIndexLink": ["domperidone"],
    "N_ENREGISTREMENT": "311/10 F 047/17",
    "CODE_DCI": "10 F 047",
    "DCI": "DOMPERIDONE",
    "NOM_COMMERCIALE": "NOZEUM",
    "FORME": "SIROP",
    "DOSAGE": "1MG/ML",
    "COND": "FL DE 200 ML",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE GROUPEMENT PHARMACEUTIQUE ALGERIEN (LGPA)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/9/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "4/9/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["domperidone"],
    "InteractionIndexLink": ["domperidone"],
    "N_ENREGISTREMENT": "065/ 10 F 047 /03/15",
    "CODE_DCI": "10 F 047",
    "DCI": "DOMPERIDONE",
    "NOM_COMMERCIALE": "PERIDIUM",
    "FORME": "SOL. BUV.",
    "DOSAGE": "1MG/ML",
    "COND": "FL/200ML",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GENERICLAB SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "23/3/2003",
    "DATE_D_ENREGISTREMENT_FINAL": "26/10/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["domperidone"],
    "InteractionIndexLink": ["domperidone"],
    "N_ENREGISTREMENT": "099/ 10 F 047 /98/12",
    "CODE_DCI": "10 F 047",
    "DCI": "DOMPERIDONE",
    "NOM_COMMERCIALE": "PERIDYS",
    "FORME": "SUSP.BUV.",
    "DOSAGE": "1MG/ML",
    "COND": "FL/200ML + SERING. P. ADMINIST. ORALE. DE 5ML GRADUEE EN KG",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PIERRE FABRE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/4/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "17/6/2012",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["ondansetron"],
    "InteractionIndexLink": ["ondansetron"],
    "N_ENREGISTREMENT": "317/ 10 F 048 /21",
    "CODE_DCI": "10 F 048",
    "DCI": "Chlorhydrate d'ondansétron dihydraté exprimé en Ondansétron",
    "NOM_COMMERCIALE": "ONDANSETRON INPHA-MédiS",
    "FORME": "Solution injectable en IV",
    "DOSAGE": "2MG/ML (OU 4MG/2ML ET 8MG/4ML)",
    "COND": "B/5 de 4ML et B/5 de 2ML",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INPHA-MEDIS /SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/4/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "4/4/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["ondansetron"],
    "InteractionIndexLink": ["ondansetron"],
    "N_ENREGISTREMENT": "001/ 10 F 048 /05/16",
    "CODE_DCI": "10 F 048",
    "DCI": "ONDANSETRON",
    "NOM_COMMERCIALE": "SETRON",
    "FORME": "SOL INJ",
    "DOSAGE": "2MG/ML (OU 4MG/2ML ET 8MG/4ML)",
    "COND": "B/5AMP  2ML ET 4ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMACEUTICALS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/9/2005",
    "DATE_D_ENREGISTREMENT_FINAL": "2/2/2016",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "10 F 051",
    "DCI": "TRIMEBUTINE MALEATE",
    "NOM_COMMERCIALE": "COLOSTOP",
    "FORME": "COMPRIME",
    "DOSAGE": "100MG",
    "COND": "B/20",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "544/ 10 F 051 /06/19",
    "CODE_DCI": "10 F 051",
    "DCI": "TRIMEBUTINE MALEATE",
    "NOM_COMMERCIALE": "GASTRIMED",
    "FORME": "COMPRIME",
    "DOSAGE": "100MG",
    "COND": "B/20",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "WORLD MEDECINE LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/12/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "24/7/2019",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "289/ 10 F 051 /04/14",
    "CODE_DCI": "10 F 051",
    "DCI": "TRIMEBUTINE MALEATE",
    "NOM_COMMERCIALE": "SAPBRIDATE",
    "FORME": "COMPRIME",
    "DOSAGE": "100MG",
    "COND": "B/20",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRATER RAZES FORME SECHE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "31/5/2004",
    "DATE_D_ENREGISTREMENT_FINAL": "4/5/2014",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "050/ 10 F 051 /96/13",
    "CODE_DCI": "10 F 051",
    "DCI": "TRIMEBUTINE MALEATE",
    "NOM_COMMERCIALE": "TRANSACALM",
    "FORME": "COMPRIME",
    "DOSAGE": "100MG",
    "COND": "B/30",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANDOZ SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/10/1996",
    "DATE_D_ENREGISTREMENT_FINAL": "4/6/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "16/10 F051/400",
    "CODE_DCI": "10 F 051",
    "DCI": "TRIMEBUTINE MALEATE",
    "NOM_COMMERCIALE": "TRIBEMEX",
    "FORME": "COMPRIME",
    "DOSAGE": "100MG",
    "COND": "B/20",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "KPMA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "06/10/16",
    "DATE_D_ENREGISTREMENT_FINAL": "06/10/16",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "235/ 10 F 051 /02/18",
    "CODE_DCI": "10 F 051",
    "DCI": "TRIMEBUTINE MALEATE",
    "NOM_COMMERCIALE": "TRIMEBUTINE B",
    "FORME": "COMPRIME",
    "DOSAGE": "100MG",
    "COND": "B/20",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIO-GALENIC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "23/1/2002",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "293/ 10 F 051 /13",
    "CODE_DCI": "10 F 051",
    "DCI": "TRIMEBUTINE MALEATE",
    "NOM_COMMERCIALE": "TRIMEBUTINE BIOCARE",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "100MG",
    "COND": "B/20",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOCARE SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/6/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "25/6/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "10 F 051",
    "DCI": "TRIMEBUTINE MALEATE",
    "NOM_COMMERCIALE": "TRIMEBUTINE HUP",
    "FORME": "COMPRIME",
    "DOSAGE": "100MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "462/ 10 F 052 /21",
    "CODE_DCI": "10 F 052",
    "DCI": "Trimébutine base",
    "NOM_COMMERCIALE": "COLOSTOP",
    "FORME": "GRANULÉ. P. SUSP. BUV. (EN FLACON)",
    "DOSAGE": "0.787G/100G (4.8MG/ML)",
    "COND": "B/1FL. DE 250ML DE SUSP. BUV. APRES RECONST.",
    "LISTE": "LISTE II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHYSIOPHARM / SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/3/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "18/3/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "380/ 10 F 052 /12",
    "CODE_DCI": "10 F 052",
    "DCI": "TRIMEBUTINE MALEATE",
    "NOM_COMMERCIALE": "DEBRITINE",
    "FORME": "GRLES. P. SUSP. BUV. (EN FLACON)",
    "DOSAGE": "0.787G/100G (4.8MG/ML)",
    "COND": "B/1FL. DE 250ML DE SUSP. BUV. APRES RECONST.",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HUP.P.PHARMA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "31/5/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "31/5/2012",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "10 F 052",
    "DCI": "TRIMEBUTINE MALEATE",
    "NOM_COMMERCIALE": "TRIMEBUTINE B",
    "FORME": "GRLES. SUSP. BUV.",
    "DOSAGE": "0.787G/100G",
    "COND": "FL./250ML CONTENANT 152.5G DE GRLES. + GOBELET DOSEUR",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "010/ 10 F 052 /99/14",
    "CODE_DCI": "10 F 052",
    "DCI": "TRIMEBUTINE",
    "NOM_COMMERCIALE": "TRIMEDAT",
    "FORME": "GRLES.SUSP. BUV. EN FLACON",
    "DOSAGE": "24MG/5ML (0.7870G POUR 100G)",
    "COND": "FL/250ML",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LIFEPHARMA SPA (ITALFARMACO GROUP)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ITALIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/11/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "22/6/2014",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["ondansetron"],
    "InteractionIndexLink": ["ondansetron"],
    "N_ENREGISTREMENT": "317/ 10 F 093 /12/17",
    "CODE_DCI": "10 F 093",
    "DCI": "ONDANSETRON CHLORHYDRATE DIHYDRATE EXPRIME EN ONDANSETRON",
    "NOM_COMMERCIALE": "ONDANSETRON INPHA-MEDIS",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "4MG",
    "COND": "B/10",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INPHA-MEDIS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/3/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "31/12/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["ondansetron"],
    "InteractionIndexLink": ["ondansetron"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "10 F 093",
    "DCI": "Ondansetron",
    "NOM_COMMERCIALE": "ONDANSETRON-INPHA-MédiS 4mg",
    "FORME": "comp pel",
    "DOSAGE": "4mg/comp",
    "COND": "bt de 10",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["ondansetron"],
    "InteractionIndexLink": ["ondansetron"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "10 F 093",
    "DCI": "ONDANSETRON CHLORHYDRATE DIHYDRATE EXPRIME EN ONDANSETRON",
    "NOM_COMMERCIALE": "SETREME",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "4MG",
    "COND": "B/28",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["ondansetron"],
    "InteractionIndexLink": ["ondansetron"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "10 F 093",
    "DCI": "ONDANSETRON CHLORHYDRATE DIHYDRATE EXPRIME EN ONDANSETRON",
    "NOM_COMMERCIALE": "SETREME",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "4MG",
    "COND": "B/7",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["ondansetron"],
    "InteractionIndexLink": ["ondansetron"],
    "N_ENREGISTREMENT": "317/ 10 F 094 /12/17",
    "CODE_DCI": "10 F 094",
    "DCI": "ONDANSETRON CHLORHYDRATE DIHYDRATE EXPRIME EN ONDANSETRON",
    "NOM_COMMERCIALE": "ONDANSETRON INPHA-MEDIS",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "8MG",
    "COND": "B/10",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INPHA-MEDIS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/3/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "31/12/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["ondansetron"],
    "InteractionIndexLink": ["ondansetron"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "10 F 094",
    "DCI": "Ondansetron",
    "NOM_COMMERCIALE": "ONDANSETRON-INPHA-MédiS 8mg",
    "FORME": "comp pel",
    "DOSAGE": "8 mg/comp",
    "COND": "bt de 10",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["ondansetron"],
    "InteractionIndexLink": ["ondansetron"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "10 F 094",
    "DCI": "ONDANSETRON CHLORHYDRATE DIHYDRATE EXPRIME EN ONDANSETRON",
    "NOM_COMMERCIALE": "SETREME",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "8MG",
    "COND": "B/28",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["ondansetron"],
    "InteractionIndexLink": ["ondansetron"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "10 F 094",
    "DCI": "ONDANSETRON CHLORHYDRATE DIHYDRATE EXPRIME EN ONDANSETRON",
    "NOM_COMMERCIALE": "SETREME",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "8MG",
    "COND": "B/7",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "366/ 10 F 095 /16",
    "CODE_DCI": "10 F 095",
    "DCI": "TRIMEBUTINE MALEATE",
    "NOM_COMMERCIALE": "DEBRICALM",
    "FORME": "SUPPO",
    "DOSAGE": "100MG",
    "COND": "B/10",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL 4 A SANTE INDUSTRIE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/2/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "15/2/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["metopimazine"],
    "N_ENREGISTREMENT": "21/10 F148/263",
    "CODE_DCI": "10 F 148",
    "DCI": "METOPIMAZINE",
    "NOM_COMMERCIALE": "VOMLESS",
    "FORME": "SUPPO",
    "DOSAGE": "5MG",
    "COND": "B/10",
    "LISTE": "LISTE II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES BIOPHARM/SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/04/21",
    "DATE_D_ENREGISTREMENT_FINAL": "22/04/21",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "003/ 10 F 150 /06/14",
    "CODE_DCI": "10 F 150",
    "DCI": "TRIMEBUTINE MALEATE",
    "NOM_COMMERCIALE": "TRIMEBUTINE SAIDAL",
    "FORME": "GRLES. SUSP. BUV. EN SACHET-DOSE",
    "DOSAGE": "74.4MG/SACHET- DOSE",
    "COND": "B/20 -  B/30",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SAIDAL GROUPE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/10/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "19/3/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["metoclopramide"],
    "InteractionIndexLink": ["metoclopramide"],
    "N_ENREGISTREMENT": "366/ 10 F 152 /16",
    "CODE_DCI": "10 F 152",
    "DCI": "METOCLOPRAMIDE",
    "NOM_COMMERCIALE": "METOPRAM",
    "FORME": "SUPPO",
    "DOSAGE": "10MG",
    "COND": "B/10",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL 4 A SANTE INDUSTRIE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/6/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "26/6/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["domperidone"],
    "InteractionIndexLink": ["domperidone"],
    "N_ENREGISTREMENT": "235/ 10 F 157 /20",
    "CODE_DCI": "10 F 157",
    "DCI": "Dompéridone",
    "NOM_COMMERCIALE": "DOMPERIDONE BGL",
    "FORME": "Comprimé orodispersible",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "LISTE II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOGALENIC / SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/2/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "14/3/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["domperidone"],
    "InteractionIndexLink": ["domperidone"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "10 F 157",
    "DCI": "DOMPERIDONE",
    "NOM_COMMERCIALE": "NAUSEDIUM",
    "FORME": "COMP. ORODISPERS.",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["ondansetron"],
    "InteractionIndexLink": ["ondansetron"],
    "N_ENREGISTREMENT": "503/  10 F 187 /16",
    "CODE_DCI": "10 F 187",
    "DCI": "ONDANSETRON CHLORHYDRATE DIHYDRATE EXPRIME EN ONDANSETRON",
    "NOM_COMMERCIALE": "NAUSETRON",
    "FORME": "SIROP",
    "DOSAGE": "4MG/5ML",
    "COND": "FL 50ML + CUILLERE MESURE",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "AFROPHARM SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/2/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "15/2/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "462/10 F 193/17",
    "CODE_DCI": "10 F 193",
    "DCI": "TRIMEBUTINE MALEATE",
    "NOM_COMMERCIALE": "COLOSTOP",
    "FORME": "COMPRIME",
    "DOSAGE": "200MG",
    "COND": "B/30",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHYSIOPHARM SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/2/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "20/2/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "231/ 10 F 193 /14",
    "CODE_DCI": "10 F 193",
    "DCI": "TRIMEBUTINE MALEATE",
    "NOM_COMMERCIALE": "DIGESTAT",
    "FORME": "COMPRIME",
    "DOSAGE": "200MG",
    "COND": "B/30",
    "LISTE": "LISTE II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES SALEM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/4/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "28/4/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "400/ 10 F 193 /16",
    "CODE_DCI": "10 F 193",
    "DCI": "TRIMEBUTINE MALEATE",
    "NOM_COMMERCIALE": "TRIBEMEX",
    "FORME": "COMPRIME",
    "DOSAGE": "200MG",
    "COND": "B/30",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "KPMA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/7/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "19/7/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "235/ 10 F 193 /13",
    "CODE_DCI": "10 F 193",
    "DCI": "TRIMEBUTINE MALEATE",
    "NOM_COMMERCIALE": "TRIMEBUTINE B",
    "FORME": "COMPRIME",
    "DOSAGE": "200MG",
    "COND": "B/30",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIO-GALENIC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/8/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "5/9/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "293/ 10 F 193 /15",
    "CODE_DCI": "10 F 193",
    "DCI": "TRIMEBUTINE MALEATE",
    "NOM_COMMERCIALE": "TRIMEBUTINE BIOCARE",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "200MG",
    "COND": "B/30",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOCARE SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/3/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "18/3/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["ondansetron"],
    "InteractionIndexLink": ["ondansetron"],
    "N_ENREGISTREMENT": "366/ 10 F 205 /16",
    "CODE_DCI": "10 F 205",
    "DCI": "ONDANSETRON",
    "NOM_COMMERCIALE": "NAUSETRON",
    "FORME": "SUPPO.",
    "DOSAGE": "16 MG",
    "COND": "B/02",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL 4 A SANTE INDUSTRIE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "16/2/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "16/2/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["dimenhydrinate"],
    "InteractionIndexLink": ["dimenhydrinate"],
    "N_ENREGISTREMENT": "348 /10 F 210/ 348",
    "CODE_DCI": "10 F 210",
    "DCI": "Dimenhydrinate",
    "NOM_COMMERCIALE": "VOVAMINE",
    "FORME": "CP SEC",
    "DOSAGE": "50 MG",
    "COND": "B/20",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "API",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "16/6/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "16/6/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "311/ 10 G 054 /16",
    "CODE_DCI": "10 G 054",
    "DCI": "ALGINATE DE SODIUM / BICARBONATE DE SODIUM",
    "NOM_COMMERCIALE": "GASTRIUM",
    "FORME": "SUSP. BUV.",
    "DOSAGE": "50MG/26.7MG/ML",
    "COND": "B/1 FlaCON DE 200 ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL LABORATOIRES GROUPEMENT PHARMACEUTIQUE ALGERIEN (LGPA)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "11/5/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "11/5/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "468/10 G 054/19",
    "CODE_DCI": "10 G 054",
    "DCI": "ALGINATE DE SODIUM/BICARBONATE DE SODIUM",
    "NOM_COMMERCIALE": "GATIMOX AROME FENOUIL",
    "FORME": "SUSP BUV",
    "DOSAGE": "500MG/267MG",
    "COND": "B/12 ET 24 STICKS UNIDOSES DE 10ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NADPHARMADIC PRODUCTION",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/3/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "25/3/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "10 G 054",
    "DCI": "ALGINATE DE SODIUM/BICARBONATE DE SODIUM",
    "NOM_COMMERCIALE": "NOBAC",
    "FORME": "SUSP BUV",
    "DOSAGE": "50MG/26.7MG/ML",
    "COND": "Flacon 150mg",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "10 G 054",
    "DCI": "ALGINATE DE SODIUM / BICARBONATE DE SODIUM",
    "NOM_COMMERCIALE": "NOBAC ADULTE",
    "FORME": "SUSP. BUV.",
    "DOSAGE": "50MG/26.7MG/ML",
    "COND": "B/1FL. DE 250ML (ADULTE)",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "10 G 054",
    "DCI": "ALGINATE DE SODIUM/BICARBONATE DE SODIUM",
    "NOM_COMMERCIALE": "NOBAC Goût Fraise",
    "FORME": "susp buv en sachet",
    "DOSAGE": "50MG/26.7MG/ML",
    "COND": "B/24",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "10 G 054",
    "DCI": "ALGINATE DE SODIUM/BICARBONATE DE SODIUM",
    "NOM_COMMERCIALE": "NOBAC Goût anis",
    "FORME": "susp buv en sachet",
    "DOSAGE": "50MG/26.7MG/ML",
    "COND": "B/24",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "10 G 054",
    "DCI": "ALGINATE DE SODIUM/BICARBONATE DE SODIUM",
    "NOM_COMMERCIALE": "NOBAC Goût menthe",
    "FORME": "susp buv en sachet",
    "DOSAGE": "50MG/26.7MG/ML",
    "COND": "B/24",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "10 G 054",
    "DCI": "Alginate de sodium / bicarbonate de sodium",
    "NOM_COMMERCIALE": "Peptidac",
    "FORME": "Suspension buvable",
    "DOSAGE": "250mg/ 133.5mg/5ml",
    "COND": "Flacon 200 ml + goblet doseur 15ml",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["calcium carbimide"],
    "InteractionIndexLink": ["calcium"],
    "N_ENREGISTREMENT": "263/10 G 206/17",
    "CODE_DCI": "10 G 206",
    "DCI": "ALGINATE DE SODIUM / BICARBONATE DE SODIUM/CARBONATE DE CALCIUM",
    "NOM_COMMERCIALE": "NOBAC",
    "FORME": "COMPRIME A CROQUER",
    "DOSAGE": "500 MG/267 MG/160 MG",
    "COND": "B /16",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOPHARM SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/3/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "7/3/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["loperamide"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "10 H 056",
    "DCI": "Lopéramide Chlorhydrate",
    "NOM_COMMERCIALE": "DIARYL",
    "FORME": "GLES.",
    "DOSAGE": "2MG",
    "COND": "B/20",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["loperamide"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "035/ 10 H 056 /07",
    "CODE_DCI": "10 H 056",
    "DCI": "Lopéramide Chlorhydrate",
    "NOM_COMMERCIALE": "DIMEPRA",
    "FORME": "GLES.",
    "DOSAGE": "2MG",
    "COND": "B/20",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMALLIANCE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/12/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "4/12/2007",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["loperamide"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "10 H 056",
    "DCI": "Lopéramide Chlorhydrate",
    "NOM_COMMERCIALE": "DYAREX",
    "FORME": "GLES",
    "DOSAGE": "2MG",
    "COND": "B/20",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["loperamide"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "21/10 H 056/549",
    "CODE_DCI": "10 H 056",
    "DCI": "LOPERAMIDE CHLORHYDRATE",
    "NOM_COMMERCIALE": "EVOPERAMIDE",
    "FORME": "GELULE",
    "DOSAGE": "2MG",
    "COND": "B/20",
    "LISTE": "LISTE II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES EVOLAB/SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/04/21",
    "DATE_D_ENREGISTREMENT_FINAL": "25/04/21",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["loperamide"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "318/10 H 056/17",
    "CODE_DCI": "10 H 056",
    "DCI": "Lopéramide Chlorhydrate",
    "NOM_COMMERCIALE": "LOPERAMIDE NS",
    "FORME": "GLES",
    "DOSAGE": "2MG",
    "COND": "B/20",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMIDAL NS SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/3/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "7/3/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["loperamide"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "077/ 10 H 056 /18",
    "CODE_DCI": "10 H 056",
    "DCI": "Lopéramide Chlorhydrate",
    "NOM_COMMERCIALE": "LOPEREX",
    "FORME": "COMPRIME",
    "DOSAGE": "2MG",
    "COND": "B/20",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE ALGERIEN DU MEDICAMENT SARL (LAM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "11/1/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "11/1/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["loperamide"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "039/ 10 H 056 /00/15",
    "CODE_DCI": "10 H 056",
    "DCI": "Lopéramide Chlorhydrate",
    "NOM_COMMERCIALE": "LOPERIDAL",
    "FORME": "GLES.",
    "DOSAGE": "2MG",
    "COND": "B/20",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOPHAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/4/2003",
    "DATE_D_ENREGISTREMENT_FINAL": "29/12/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["loperamide"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "16/06/10 H 056/003",
    "CODE_DCI": "10 H 056",
    "DCI": "LOPERAMIDE CHLORHYDRATE",
    "NOM_COMMERCIALE": "LOPESTIN",
    "FORME": "GELULE",
    "DOSAGE": "02MG",
    "COND": "B/20",
    "LISTE": "LISTE II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES EPE GROUPE INDUSTRIEL SAIDAL/ SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/08/06",
    "DATE_D_ENREGISTREMENT_FINAL": "27/01/20",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "101/ 10 H 132 /04",
    "CODE_DCI": "10 H 132",
    "DCI": "SACCHAROMYCES BOULARDII",
    "NOM_COMMERCIALE": "ULTRA-LEVURE",
    "FORME": "GLES",
    "DOSAGE": "200MG",
    "COND": "B/10",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOCODEX",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "21/1/2004",
    "DATE_D_ENREGISTREMENT_FINAL": "21/1/2004",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "101/ 10 H 133 /04",
    "CODE_DCI": "10 H 133",
    "DCI": "SACCHAROMYCES BOULARDII",
    "NOM_COMMERCIALE": "ULTRA-LEVURE",
    "FORME": "PDRE. SOL ORALE",
    "DOSAGE": "100MG",
    "COND": "B/14 SACHETS",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOCODEX",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "21/1/2004",
    "DATE_D_ENREGISTREMENT_FINAL": "21/1/2004",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["loperamide"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "317/ 10 H 144 /05/12",
    "CODE_DCI": "10 H 144",
    "DCI": "Lopéramide Chlorhydrate",
    "NOM_COMMERCIALE": "INPHADIUM",
    "FORME": "SIROP",
    "DOSAGE": "0.2MG/ML",
    "COND": "FL/125ML+PIPETTE DOSEUSE GRADUEE EN KG",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INPHA MEDIS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "14/6/2005",
    "DATE_D_ENREGISTREMENT_FINAL": "18/1/2012",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["racecadotril"],
    "N_ENREGISTREMENT": "268/10 H 177/19",
    "CODE_DCI": "10 H 177",
    "DCI": "RACECADOTRIL",
    "NOM_COMMERCIALE": "CELOFON NOURRISSON",
    "FORME": "PDRE ORALE EN SACHET DOSE UNIDOSE",
    "DOSAGE": "10MG",
    "COND": "B/16 SACHETS DOSE",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MERINAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "11/12/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "19/12/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["racecadotril"],
    "N_ENREGISTREMENT": "293/10 H 177/20",
    "CODE_DCI": "10 H 177",
    "DCI": "RACECADOTRIL",
    "NOM_COMMERCIALE": "DIACARE",
    "FORME": "PDRE ORALE ENSACHET DOSE",
    "DOSAGE": "10MG",
    "COND": "B/16 SACHETS",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOCARE SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/3/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "19/3/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["racecadotril"],
    "N_ENREGISTREMENT": "289/10 H 177/19",
    "CODE_DCI": "10 H 177",
    "DCI": "RACECADOTRIL",
    "NOM_COMMERCIALE": "DIARFAN",
    "FORME": "GRANULES P/SUSP BUV EN SACHET DOSE",
    "DOSAGE": "10MG",
    "COND": "B/16 SACHETS DOSE",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRATER RAZES FORME SECHE SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/12/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "19/12/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["racecadotril"],
    "N_ENREGISTREMENT": "263/10 H 177/17",
    "CODE_DCI": "10 H 177",
    "DCI": "RACECADOTRIL",
    "NOM_COMMERCIALE": "TIOPAM NOURISSONS",
    "FORME": "PDRE. ORALE EN SACHET DOSE",
    "DOSAGE": "10MG/SACH.",
    "COND": "B/16",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOPHARM SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/4/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "12/4/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["racecadotril"],
    "N_ENREGISTREMENT": "380/10 H 177/20",
    "CODE_DCI": "10 H 177",
    "DCI": "RACECADOTRIL",
    "NOM_COMMERCIALE": "TIOTRIL",
    "FORME": "POUDRE ORALE EN SACHET-DOSE",
    "DOSAGE": "10MG",
    "COND": "B/16 SACHETS",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL HUP.P.PHARMA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/12/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "29/12/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["racecadotril"],
    "N_ENREGISTREMENT": "20/10 H177/380",
    "CODE_DCI": "10 H 177",
    "DCI": "RACECADOTRIL",
    "NOM_COMMERCIALE": "TIOTRIL",
    "FORME": "POUDRE ORALE EN SACHET-DOSE",
    "DOSAGE": "10MG",
    "COND": "B/16 SACHETS",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "laboratoires HUP.P PHARMA Sarl",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/12/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "29/12/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["racecadotril"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "10 H 177",
    "DCI": "RACECADOTRIL",
    "NOM_COMMERCIALE": "TIOTRIL",
    "FORME": "PDRE. ORALE EN SACHET DOSE",
    "DOSAGE": "10MG/SACH.",
    "COND": "B/16",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["racecadotril"],
    "N_ENREGISTREMENT": "268 / 10 H 178 /21",
    "CODE_DCI": "10 H 178",
    "DCI": "Racécadotril",
    "NOM_COMMERCIALE": "CELOFON ENFANTS",
    "FORME": "Poudre orale en sachet-dose",
    "DOSAGE": "30MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MERINAL / SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/03/21",
    "DATE_D_ENREGISTREMENT_FINAL": "28/03/21",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["racecadotril"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "10 H 178",
    "DCI": "RACECADOTRIL",
    "NOM_COMMERCIALE": "CELOFON Enfant",
    "FORME": "PDRE. ORALE EN SACHET DOSE",
    "DOSAGE": "30MG/SACH.",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["racecadotril"],
    "N_ENREGISTREMENT": "268 / 10 H 178 /21",
    "CODE_DCI": "10 H 178",
    "DCI": "Racécadotril",
    "NOM_COMMERCIALE": "CÉLOFON enfants",
    "FORME": "Poudre orale en sachet-dose",
    "DOSAGE": "30MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MERINAL / SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/3/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "28/3/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["racecadotril"],
    "N_ENREGISTREMENT": "293/10 H 178/20",
    "CODE_DCI": "10 H 178",
    "DCI": "RACECADOTRIL",
    "NOM_COMMERCIALE": "DIACARE",
    "FORME": "PDRE ORALE ENSACHET DOSE",
    "DOSAGE": "30MG",
    "COND": "B/30 SACHETS",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOCARE SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/3/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "19/3/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["racecadotril"],
    "N_ENREGISTREMENT": "289/10 H 178/20",
    "CODE_DCI": "10 H 178",
    "DCI": "Racécadotril",
    "NOM_COMMERCIALE": "DIARFAN",
    "FORME": "Granules P/Susp  buvable en Sachet Dose",
    "DOSAGE": "30MG",
    "COND": "B/30 SACHETS DOSE",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRATER RAZES FORME SECHE SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/1/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "9/1/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["racecadotril"],
    "N_ENREGISTREMENT": "235/10 H 178/17",
    "CODE_DCI": "10 H 178",
    "DCI": "RACECADOTRIL",
    "NOM_COMMERCIALE": "DOCATRIL",
    "FORME": "PDRE. ORALE EN SACHET DOSE",
    "DOSAGE": "30MG/SACH.",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOGALENIC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/5/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "17/5/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["racecadotril"],
    "N_ENREGISTREMENT": "263/10 H 178/17",
    "CODE_DCI": "10 H 178",
    "DCI": "RACECADOTRIL",
    "NOM_COMMERCIALE": "TIOPAM ENFANT",
    "FORME": "PDRE. ORALE EN SACHET DOSE",
    "DOSAGE": "30MG/SACH.",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOPHARM SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/6/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "12/6/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["racecadotril"],
    "N_ENREGISTREMENT": "380/10 H 178/20",
    "CODE_DCI": "10 H 178",
    "DCI": "RACECADOTRIL",
    "NOM_COMMERCIALE": "TIOTRIL",
    "FORME": "POUDRE ORALE EN SACHET-DOSE",
    "DOSAGE": "30MG",
    "COND": "B/30 SACHETS",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL HUP.P.PHARMA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/12/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "29/12/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["racecadotril"],
    "N_ENREGISTREMENT": "20/10 H178/380",
    "CODE_DCI": "10 H 178",
    "DCI": "RACECADOTRIL",
    "NOM_COMMERCIALE": "TIOTRIL",
    "FORME": "POUDRE ORALE EN SACHET-DOSE",
    "DOSAGE": "30MG",
    "COND": "B/30SACHETS",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "laboratoires HUP.P PHARMA Sarl",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/12/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "29/12/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["racecadotril"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "10 H 178",
    "DCI": "RACECADOTRIL",
    "NOM_COMMERCIALE": "TIOTRIL",
    "FORME": "PDRE. ORALE EN SACHET DOSE",
    "DOSAGE": "30MG/SACH.",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "147/ 10 K 060 /98/18",
    "CODE_DCI": "10 K 060",
    "DCI": "Pancréatine",
    "NOM_COMMERCIALE": "CREON 12 000 U",
    "FORME": "GLES.GAST.RESIS",
    "DOSAGE": "150 MG",
    "COND": "PILULIER DE 60",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ABBOTT PRODUCT SAS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "14/11/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "24/1/2018",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "528/10 L 062/17",
    "CODE_DCI": "10 L 062",
    "DCI": "LACTULOSE",
    "NOM_COMMERCIALE": "EASYLACT",
    "FORME": "SOL BUV",
    "DOSAGE": "66.5% ( 66.5 g/100ml)",
    "COND": "FL/200ML+GOBLET DOSEUR DE 15ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JANIS MED SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/12/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "4/12/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "10 L 062",
    "DCI": "Lactulose",
    "NOM_COMMERCIALE": "Ezilax",
    "FORME": "Sirop",
    "DOSAGE": "10mg/15ml",
    "COND": "B/300ml",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "10 L 062",
    "DCI": "Lactulose",
    "NOM_COMMERCIALE": "INPHALAC",
    "FORME": "Sirop",
    "DOSAGE": "0.606",
    "COND": "Flacon 200ml",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "073/ 10 L 062 /01/18",
    "CODE_DCI": "10 L 062",
    "DCI": "LACTULOSE",
    "NOM_COMMERCIALE": "ISOLACT",
    "FORME": "SOL. BUV. SANS SUCRE",
    "DOSAGE": "66.50 %",
    "COND": "FL/150ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ISOPHARM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "11/11/2001",
    "DATE_D_ENREGISTREMENT_FINAL": "2/4/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "320/ 10 L 062 /06/12",
    "CODE_DCI": "10 L 062",
    "DCI": "LACTULOSE",
    "NOM_COMMERCIALE": "LACTULOSE AGD",
    "FORME": "SIROP",
    "DOSAGE": "66.7%",
    "COND": "FL/200ML+GODET GRADUE EN ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIAN GENERICS DEVELOPPEMENT PHARM  (AGD PHARM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/2/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "21/8/2012",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "065/10 L 062/19",
    "CODE_DCI": "10 L 062",
    "DCI": "LACTULOSE",
    "NOM_COMMERCIALE": "LACTULOSE GL",
    "FORME": "SOL BUV",
    "DOSAGE": "66.5% ( 10 g/15 ml)",
    "COND": "FL/200ML+GOBLET DOSEUR",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GENERICLAB SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "5/5/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "5/5/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "21/10 L 062/400",
    "CODE_DCI": "10 L 062",
    "DCI": "LACTULOSE",
    "NOM_COMMERCIALE": "LACTUMEX",
    "FORME": "SOLUTION BUVABLE",
    "DOSAGE": "66.5%",
    "COND": "FLC 150ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL KHROUB PHARMACEUTICAL MANUFACTURING ALGERIA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/04/21",
    "DATE_D_ENREGISTREMENT_FINAL": "12/04/21",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "10 L 062",
    "DCI": "LACTULOSE",
    "NOM_COMMERCIALE": "LACTUMEX",
    "FORME": "SOL. BUV. SANS SUCRE",
    "DOSAGE": "0.665",
    "COND": "FL/150ML",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["potassium"],
    "N_ENREGISTREMENT": "020/ 10 L 086 /96/15",
    "CODE_DCI": "10 L 086",
    "DCI": "POLYETHYLENE GLYCOL 4000 / SULFATE DE SODIUM ANHYDRE / BICARBONATE DE SODIUM / CHLORURE DE SODIUM / CHLORURE DE POTASSIUM",
    "NOM_COMMERCIALE": "FORTRANS",
    "FORME": "PDRE. P. SOL. BUV. EN SACHET-DOSE",
    "DOSAGE": "64G/5.7G/1.68G/1.46G/0.75G/SACHET",
    "COND": "B/04 SACHETS",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "IPSEN PHARMA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/10/1996",
    "DATE_D_ENREGISTREMENT_FINAL": "18/3/2015",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "031/ 10 L 097 /98/17",
    "CODE_DCI": "10 L 097",
    "DCI": "LACTULOSE",
    "NOM_COMMERCIALE": "DUPHALAC",
    "FORME": "SOL.BUV.SACHET",
    "DOSAGE": "10G/15ML",
    "COND": "B/20",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOLVAY PHARMA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/8/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "9/8/1998",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "10 L 097",
    "DCI": "LACTULOSE",
    "NOM_COMMERCIALE": "DUPHALOSE",
    "FORME": "SOL. BUV. EN SACHET-DOSE",
    "DOSAGE": "10G/15ML",
    "COND": "B/20 SACHETS-DOSE DE 15 ML",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "073/10 L 097/1",
    "CODE_DCI": "10 L 097",
    "DCI": "LACTULOSE",
    "NOM_COMMERCIALE": "ISOLACT",
    "FORME": "SOL BUV",
    "DOSAGE": "66.50 %",
    "COND": "B/20 SACHETS DOSE DE 15ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ISOPHARM SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/12/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "30/12/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "10 L 097",
    "DCI": "LACTULOSE",
    "NOM_COMMERCIALE": "ISOLACT",
    "FORME": "SOL BUV",
    "DOSAGE": "0.665",
    "COND": "B/20 SACHETS DOSE DE 15ML",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "10 L 097",
    "DCI": "LACTULOSE",
    "NOM_COMMERCIALE": "ISOLACT",
    "FORME": "SOL. BUV. EN SACHET-DOSE",
    "DOSAGE": "10G/15ML",
    "COND": "B/20 SACHETS-DOSE DE 15 ML",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "468/ 10 L 097 /14",
    "CODE_DCI": "10 L 097",
    "DCI": "LACTULOSE",
    "NOM_COMMERCIALE": "LACTUNAD",
    "FORME": "SOL. BUV. EN SACHET-DOSE",
    "DOSAGE": "10G/15ML",
    "COND": "B/20 SACHETS-DOSE DE 15 ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NADPHARMADIC PRODUCTION SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/10/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "15/10/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["macrogol"],
    "InteractionIndexLink": ["macrogol"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "10 L 098",
    "DCI": "MACROGOL 4000  (POLYETHYLENE GLYCOL 4000)",
    "NOM_COMMERCIALE": "FORLAX",
    "FORME": "PRDE SOL BUV",
    "DOSAGE": "10G/SACHET",
    "COND": "B/20 SACHETS DOSE",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["macrogol"],
    "InteractionIndexLink": ["macrogol"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "10 L 098",
    "DCI": "MACROGOL 4000",
    "NOM_COMMERCIALE": "OROLAX",
    "FORME": "PDRE P/SOL BUV EN SACHET-DOSE",
    "DOSAGE": "10G/SACHET",
    "COND": "B/20 SACHETS",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["macrogol"],
    "InteractionIndexLink": ["macrogol"],
    "N_ENREGISTREMENT": "235/10 L 098/19",
    "CODE_DCI": "10 L 098",
    "DCI": "MACROGOL 4000",
    "NOM_COMMERCIALE": "PROLAX",
    "FORME": "PDRE P/SOL BUV EN SACHET-DOSE",
    "DOSAGE": "10G/SACHET",
    "COND": "B/20 SACHETS",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOGALENIC SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/12/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "30/12/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["calcipotriol"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "10 L 106",
    "DCI": "Calcipotriol",
    "NOM_COMMERCIALE": "DAIVONEX",
    "FORME": "Crème",
    "DOSAGE": "50µg/g",
    "COND": "T/ 30 g",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["charbon vegetal officinal", "rhubarbe", "sene"],
    "N_ENREGISTREMENT": "078/ 10 L 138 /97/16",
    "CODE_DCI": "10 L 138",
    "DCI": "CHARBON  VEGETAL / EXTRAIT DE RHUBARBE / FEUILLES DE SENE/SOUFRE PURIFIE",
    "NOM_COMMERCIALE": "EUCARBON",
    "FORME": "COMPRIME",
    "DOSAGE": "180MG / 25MG /105MG/50 MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "TRENKA CHM PHARMA FABRIK GES M.B.H.",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "AUTRICHE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/11/1997",
    "DATE_D_ENREGISTREMENT_FINAL": "27/4/2016",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["bisacodyl"],
    "InteractionIndexLink": ["bisacodyl"],
    "N_ENREGISTREMENT": "304/10 L 162/08/16",
    "CODE_DCI": "10 L 162",
    "DCI": "Bisacodyl",
    "NOM_COMMERCIALE": "GYLAXA",
    "FORME": "Comprimé pelliculé gastro-résistant",
    "DOSAGE": "5MG",
    "COND": "B/20",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GEOPHARM / SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/2/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "27/9/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["macrogol"],
    "InteractionIndexLink": ["macrogol"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "10 L 189",
    "DCI": "MACROGOL 4000 (OU PEG=POLYETHYLENE GLYCOL 4000)",
    "NOM_COMMERCIALE": "FORLAX 4G",
    "FORME": "PDRE. SOL. BUV. EN SACH.-DOSE",
    "DOSAGE": "4G/SACH.",
    "COND": "B/20SACH-DOSE",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["macrogol"],
    "InteractionIndexLink": ["macrogol"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "10 L 189",
    "DCI": "MACROGOL 4000 (OU PEG=POLYETHYLENE GLYCOL 4000)",
    "NOM_COMMERCIALE": "OROLAX",
    "FORME": "PDRE. SOL. BUV. EN SACH.-DOSE",
    "DOSAGE": "4G/SACH.",
    "COND": "B/20SACH-DOSE",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "10 L 191",
    "DCI": "PICOSULFATE DE SODIUM",
    "NOM_COMMERCIALE": "PONCTUEL",
    "FORME": "SOL. BUV.",
    "DOSAGE": "0.75G/100ML",
    "COND": "B/1FL. COMPT.-GTTES. DE 30ML",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["magnesium (hydroxyde de)"],
    "N_ENREGISTREMENT": "275/ 10 L 203 /15",
    "CODE_DCI": "10 L 203",
    "DCI": "PICOSULFATE DE SODIUM /OXYDE DE MAGNESIUM LéGER / ACIDE CITRIQUE",
    "NOM_COMMERCIALE": "PICOPREP",
    "FORME": "POUDRE POUR SOLUTION BUVABLE EN SACHET",
    "DOSAGE": "10MG/3.5MG/12G /SACHET",
    "COND": "B/2",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FERRING ARZNEIMITTEL GMBH",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "France",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/12/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "13/12/2015",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "067/ 10 L 208 /18",
    "CODE_DCI": "10 L 208",
    "DCI": "Phosphate monosodique monohydraté / phosphate disodique anhydre",
    "NOM_COMMERCIALE": "COLOKIT",
    "FORME": "COMPRIME",
    "DOSAGE": "1102 MG / 398 MG",
    "COND": "PILULIER  DE 32 CP CONTENANT 2 SACHETS DE DESSICANT",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MAYLOLY SPINDLER",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "France",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/6/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "18/6/2018",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["docusate sodium"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "311/ 10 M 063 /13",
    "CODE_DCI": "10 M 063",
    "DCI": "DOCUSATE SODIQUE",
    "NOM_COMMERCIALE": "REGULAX",
    "FORME": "GEL RECTAL",
    "DOSAGE": "0.12G/10G",
    "COND": "B/06TUBES CANULES DE 10G",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE GROUPEMENT PHARMACEUTIQUE ALGERIEN (LGPA)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/4/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "15/4/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["paraffine"],
    "N_ENREGISTREMENT": "073/ 10 M 066 /98/18",
    "CODE_DCI": "10 M 066",
    "DCI": "HUILE DE PARAFFINE LIQUIDE",
    "NOM_COMMERCIALE": "ISOFFINE",
    "FORME": "SOL. BUV.",
    "DOSAGE": "88.70G/100ML",
    "COND": "FL/150 ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ISOPHARM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/7/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "2/4/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["paraffine"],
    "N_ENREGISTREMENT": "318/ 10 M 066 /13",
    "CODE_DCI": "10 M 066",
    "DCI": "HUILE DE PARAFFINE LIQUIDE",
    "NOM_COMMERCIALE": "LAXAFINE",
    "FORME": "HUILE BUVABLE",
    "DOSAGE": "100ML/100ML (100%)",
    "COND": "B/1FL. DE 125ML ET B/1FL. DE 250ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMIDAL N.S. SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/5/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "12/5/2013",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["glycerol"],
    "N_ENREGISTREMENT": "231/10 M 069 /14",
    "CODE_DCI": "10 M 069",
    "DCI": "GLYCEROL",
    "NOM_COMMERCIALE": "GLYCERINE LS ENFANT",
    "FORME": "SUPPOS",
    "DOSAGE": "1.20G",
    "COND": "B/10",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SALEM LABORATOIRES",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "8/6/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "8/6/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["glycerol"],
    "N_ENREGISTREMENT": "231/ 10 M 070 /14",
    "CODE_DCI": "10 M 070",
    "DCI": "GLYCEROL",
    "NOM_COMMERCIALE": "GLYCERINE LS ADULTE",
    "FORME": "SUPPOS ADULTE",
    "DOSAGE": "1.8G",
    "COND": "B/10",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SALEM LABORATOIRES",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/7/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "27/7/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["glycerol"],
    "N_ENREGISTREMENT": "231/ 10 M 124 /14",
    "CODE_DCI": "10 M 124",
    "DCI": "GLYCEROL",
    "NOM_COMMERCIALE": "GLYCERINE LS BEBE",
    "FORME": "SUPPO.BEBE",
    "DOSAGE": "0.72G",
    "COND": "B/10",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SALEM LABORATOIRES",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/6/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "1/6/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["glycerol"],
    "N_ENREGISTREMENT": "366/ 10 M 199 /15",
    "CODE_DCI": "10 M 199",
    "DCI": "GLYCEROL",
    "NOM_COMMERCIALE": "GLYCERINE BEBES",
    "FORME": "SUPPO.",
    "DOSAGE": "0.642G",
    "COND": "B/10",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "4A SANTE INDUSTRIE SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/6/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "5/9/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["glycerol"],
    "N_ENREGISTREMENT": "366/ 10 M 200 /15",
    "CODE_DCI": "10 M 200",
    "DCI": "GLYCEROL",
    "NOM_COMMERCIALE": "GLYCERINE ENFANTS",
    "FORME": "SUPPO.",
    "DOSAGE": "1.23G",
    "COND": "B/10",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "4A SANTE INDUSTRIE SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/6/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "5/6/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["glycerol"],
    "N_ENREGISTREMENT": "366/ 10 M 201 /15",
    "CODE_DCI": "10 M 201",
    "DCI": "GLYCEROL",
    "NOM_COMMERCIALE": "GLYCERINE ADULTE",
    "FORME": "SUPPO.",
    "DOSAGE": "2.04G",
    "COND": "B/10",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "4A SANTE INDUSTRIE SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/6/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "5/9/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["mesalazine"],
    "InteractionIndexLink": ["mesalazine"],
    "N_ENREGISTREMENT": "263/10 N 075/17",
    "CODE_DCI": "10 N 075",
    "DCI": "MESALAZINE",
    "NOM_COMMERCIALE": "MELAZA",
    "FORME": "GELULE. LP",
    "DOSAGE": "500MG",
    "COND": "B/90",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOPHARM SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/10/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "2/10/2017",
    "TYPE": "Gé",
    "STATUT": "F PREMIX",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["mesalazine"],
    "InteractionIndexLink": ["mesalazine"],
    "N_ENREGISTREMENT": "275/ 10 N 075 /03/15",
    "CODE_DCI": "10 N 075",
    "DCI": "MESALAZINE",
    "NOM_COMMERCIALE": "PENTASA",
    "FORME": "COMPRIME A LIBERATION PROLONGEE",
    "DOSAGE": "500MG",
    "COND": "B/100",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FERRING GMBH",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALLEMAGNE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/9/2003",
    "DATE_D_ENREGISTREMENT_FINAL": "22/2/2016",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["mesalazine"],
    "InteractionIndexLink": ["mesalazine"],
    "N_ENREGISTREMENT": "263/ 10 N 076 /21",
    "CODE_DCI": "10 N 076",
    "DCI": "Mésalazine",
    "NOM_COMMERCIALE": "MELAZA",
    "FORME": "Suppositoire",
    "DOSAGE": "500MG",
    "COND": "B/15",
    "LISTE": "LISTE II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOPHARM / SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/2/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "4/2/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["mesalazine"],
    "InteractionIndexLink": ["mesalazine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "10 N 076",
    "DCI": "MESALAZINE",
    "NOM_COMMERCIALE": "ROVAZINE",
    "FORME": "SUPPO.",
    "DOSAGE": "500MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["mesalazine"],
    "InteractionIndexLink": ["mesalazine"],
    "N_ENREGISTREMENT": "031/ 10 N 076 /97/16",
    "CODE_DCI": "10 N 076",
    "DCI": "MESALAZINE",
    "NOM_COMMERCIALE": "ROWASA",
    "FORME": "SUPPO.",
    "DOSAGE": "500MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOLVAY PHARMA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/12/1997",
    "DATE_D_ENREGISTREMENT_FINAL": "29/6/2016",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["mesalazine"],
    "InteractionIndexLink": ["mesalazine"],
    "N_ENREGISTREMENT": "231/ 10 N 076 /16",
    "CODE_DCI": "10 N 076",
    "DCI": "MESALAZINE",
    "NOM_COMMERCIALE": "SALAZA",
    "FORME": "SUPPO.",
    "DOSAGE": "500MG",
    "COND": "B/15",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SALEM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "11/4/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "11/4/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["mesalazine"],
    "InteractionIndexLink": ["mesalazine"],
    "N_ENREGISTREMENT": "275/ 10 N 077 /04/15",
    "CODE_DCI": "10 N 077",
    "DCI": "MESALAZINE",
    "NOM_COMMERCIALE": "PENTASA",
    "FORME": "SUSP. RECT.",
    "DOSAGE": "1G/100ML",
    "COND": "B/05 RECIPIENTS UNIDOSES EN FLACON PE DE 100ML AVEC CANULE",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FERRING S.A.S",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/1/2004",
    "DATE_D_ENREGISTREMENT_FINAL": "31/3/2015",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "10 N 078",
    "DCI": "SALAZOSULFAPYRIDINE",
    "NOM_COMMERCIALE": "SALAZOPYRINE",
    "FORME": "COMPRIME",
    "DOSAGE": "500MG",
    "COND": "B/100",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["mesalazine"],
    "InteractionIndexLink": ["mesalazine"],
    "N_ENREGISTREMENT": "263/ 10 N 131 /19",
    "CODE_DCI": "10 N 131",
    "DCI": "Mesalazine",
    "NOM_COMMERCIALE": "MELAZA",
    "FORME": "SUPPO.",
    "DOSAGE": "1G",
    "COND": "B/15",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOPHARM SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "21/1/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "21/1/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["mesalazine"],
    "InteractionIndexLink": ["mesalazine"],
    "N_ENREGISTREMENT": "275/ 10 N 131 /04/15",
    "CODE_DCI": "10 N 131",
    "DCI": "MESALAZINE",
    "NOM_COMMERCIALE": "PENTASA",
    "FORME": "SUPPO.",
    "DOSAGE": "1G",
    "COND": "B/15",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FERRING S.A.S",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/1/2004",
    "DATE_D_ENREGISTREMENT_FINAL": "3/11/2015",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "10 N 176",
    "DCI": "Mesalamine",
    "NOM_COMMERCIALE": "PENTAZINE",
    "FORME": "Sachet",
    "DOSAGE": "1 G",
    "COND": "Boite de 120.",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["mesalazine"],
    "InteractionIndexLink": ["mesalazine"],
    "N_ENREGISTREMENT": "289/10 N 176/17",
    "CODE_DCI": "10 N 176",
    "DCI": "Mésalazine",
    "NOM_COMMERCIALE": "PENTAZINE LP",
    "FORME": "Microgranules à libération prolongée  en sachets",
    "DOSAGE": "1G/SACH.",
    "COND": "B/120SACH.",
    "LISTE": "LISTE II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRATER RAZES FORME SECHE /  SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/3/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "7/1/2021",
    "TYPE": "Gé",
    "STATUT": "F microgranules",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "10 N 202",
    "DCI": "Mesalamine",
    "NOM_COMMERCIALE": "PENTAZINE",
    "FORME": "Sachet",
    "DOSAGE": "500 mg",
    "COND": "Boite de 60.",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["mesalazine"],
    "InteractionIndexLink": ["mesalazine"],
    "N_ENREGISTREMENT": "289/ 10 N 202 /20",
    "CODE_DCI": "10 N 202",
    "DCI": "Mésalazine",
    "NOM_COMMERCIALE": "PENTAZINE LP",
    "FORME": "Microgranules à libération prolongée  en sachets",
    "DOSAGE": "500MG/SACHET",
    "COND": "B/60 SACHETS",
    "LISTE": "LISTE II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRATER RAZES FORME SECHE /  SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/7/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "7/1/2021",
    "TYPE": "Gé",
    "STATUT": "F microgranules",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": ["lidocaine"],
    "InteractionIndexLink": ["lidocaine", "zinc"],
    "N_ENREGISTREMENT": "179/ 10 P 122 / 01/16",
    "CODE_DCI": "10 P 122",
    "DCI": "CARRAGHENATES/DIOXYDE DE TITANE/OXYDE DE ZINC/LIDOCAINE",
    "NOM_COMMERCIALE": "TITANOREINE A LA LIDOCAINE 2%",
    "FORME": "CREME",
    "DOSAGE": "2.5G/2G/2G/2G/100G",
    "COND": "T/20G",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MARTIN-JOHNSON&JOHNSON-MSD",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "21/8/2001",
    "DATE_D_ENREGISTREMENT_FINAL": "6/3/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["zinc"],
    "N_ENREGISTREMENT": "179/ 10 P 123 / 01/16",
    "CODE_DCI": "10 P 123",
    "DCI": "CARRAGHENATES/DIOXYDE DE TITANE/OXYDE DE ZINC",
    "NOM_COMMERCIALE": "TITANOREINE",
    "FORME": "SUPPO.",
    "DOSAGE": "0.3G/0.2G/0.4G",
    "COND": "B/12",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MARTIN-JOHNSON&JOHNSON-MSD",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/9/2001",
    "DATE_D_ENREGISTREMENT_FINAL": "6/3/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["acide ursodesoxycholique"],
    "N_ENREGISTREMENT": "321/ 10 R 101 /17",
    "CODE_DCI": "10 R 101",
    "DCI": "Acide Ursodésoxycholique",
    "NOM_COMMERCIALE": "TIALYZ",
    "FORME": "Comprimé",
    "DOSAGE": "200MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOVITAL SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/1/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "17/1/2021",
    "TYPE": "Gé",
    "STATUT": "F prémix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["acide ursodesoxycholique"],
    "N_ENREGISTREMENT": "376/ 10 R 101 /98/15",
    "CODE_DCI": "10 R 101",
    "DCI": "Acide ursodesoxycholique",
    "NOM_COMMERCIALE": "URSOLVAN",
    "FORME": "GLES.",
    "DOSAGE": "200MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANOFI AVENTIS FRANCE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/8/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "22/9/2015",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Gastro enterologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["acide ursodesoxycholique"],
    "N_ENREGISTREMENT": "067/ 10 R 211 /20",
    "CODE_DCI": "10 R 211",
    "DCI": "Acide Ursodésoxycholique",
    "NOM_COMMERCIALE": "CHOLURSO",
    "FORME": "Comprimé pelliculé",
    "DOSAGE": "250MG",
    "COND": "B/60",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MAYOLY SPINDLER",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/8/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "27/8/2020",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36  MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "067/ 10 S 160 /07/14",
    "CODE_DCI": "10 S 160",
    "DCI": "UREE 13C",
    "NOM_COMMERCIALE": "HELIKIT",
    "FORME": "PDRE. SOL. BUV.",
    "DOSAGE": "75MG",
    "COND": "B/1FL. PDRE. (13C UREE) + 1SACH. PDRE.(AC. CITRIQUE ANHYD.) + 02PAILLES + 1KIT DE CONTRÔLE (4T. DE PRELEV)",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MAYOLY SPINDLER",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/6/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "15/10/2014",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "079/ 10 U 130 /03/18",
    "CODE_DCI": "10 U 130",
    "DCI": "CITRATE DE BETAINE",
    "NOM_COMMERCIALE": "CIBETAINE",
    "FORME": "SOL. BUV. EN AMP.",
    "DOSAGE": "2G/5ML",
    "COND": "B/20AMP. DE 5ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE  ALGERIEN DE DEVELOPPEMENT  PHARMACEUTIQUE   (LAD)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/12/2003",
    "DATE_D_ENREGISTREMENT_FINAL": "31/12/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["econazole"],
    "InteractionIndexLink": ["econazole"],
    "N_ENREGISTREMENT": "263/11 A 001/20",
    "CODE_DCI": "11 A 001",
    "DCI": "ECONAZOLE NITRATE",
    "NOM_COMMERCIALE": "ECOGYNAN",
    "FORME": "OVULE",
    "DOSAGE": "150MG",
    "COND": "B/03",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOPHARM SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/5/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "19/5/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Gynécologie"]
  },
  {
    "PregnancyIndexLink": ["econazole"],
    "InteractionIndexLink": ["econazole"],
    "N_ENREGISTREMENT": "20/11 A001/263",
    "CODE_DCI": "11 A 001",
    "DCI": "ECONAZOLE NITRATE",
    "NOM_COMMERCIALE": "ECOGYNAN",
    "FORME": "OVULE",
    "DOSAGE": "150MG",
    "COND": "B/3",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SPA BIOPHARM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/5/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "19/5/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Gynécologie"]
  },
  {
    "PregnancyIndexLink": ["econazole"],
    "InteractionIndexLink": ["econazole"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "11 A 001",
    "DCI": "ECONAZOLE NITRATE",
    "NOM_COMMERCIALE": "ECOVAR",
    "FORME": "OVULES GYNECO.",
    "DOSAGE": "150MG",
    "COND": "B/03",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gynécologie"]
  },
  {
    "PregnancyIndexLink": ["econazole"],
    "InteractionIndexLink": ["econazole"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "11 A 001",
    "DCI": "ECONAZOLE NITRATE",
    "NOM_COMMERCIALE": "GYNOVASOL",
    "FORME": "OVULES",
    "DOSAGE": "150MG",
    "COND": "B/03",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gynécologie"]
  },
  {
    "PregnancyIndexLink": ["metronidazole"],
    "InteractionIndexLink": ["metronidazole"],
    "N_ENREGISTREMENT": "263/ 11 A 002 /96/13",
    "CODE_DCI": "11 A 002",
    "DCI": "METRONIDAZOLE",
    "NOM_COMMERCIALE": "FLAGYL",
    "FORME": "OVULE VAGI.",
    "DOSAGE": "500MG",
    "COND": "B/10",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOPHARM ALGERIE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "5/11/1996",
    "DATE_D_ENREGISTREMENT_FINAL": "13/8/2013",
    "TYPE": "Ré",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Gynécologie"]
  },
  {
    "PregnancyIndexLink": ["metronidazole"],
    "InteractionIndexLink": ["metronidazole"],
    "N_ENREGISTREMENT": "18/11 A002/400",
    "CODE_DCI": "11 A 002",
    "DCI": "METRONIDAZOLE",
    "NOM_COMMERCIALE": "FONGYMEX",
    "FORME": "OVULES",
    "DOSAGE": "500MG",
    "COND": "B/10",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "KPMA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "09/07/18",
    "DATE_D_ENREGISTREMENT_FINAL": "09/07/18",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Gynécologie"]
  },
  {
    "PregnancyIndexLink": ["metronidazole"],
    "InteractionIndexLink": ["metronidazole"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "11 A 002",
    "DCI": "METRONIDAZOLE",
    "NOM_COMMERCIALE": "FONGYNE",
    "FORME": "OVULES GYNECO.",
    "DOSAGE": "500MG",
    "COND": "B/10",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gynécologie"]
  },
  {
    "PregnancyIndexLink": ["metronidazole"],
    "InteractionIndexLink": ["metronidazole"],
    "N_ENREGISTREMENT": "035/11 A 002/16",
    "CODE_DCI": "11 A 002",
    "DCI": "METRONIDAZOLE",
    "NOM_COMMERCIALE": "IMUZOLE",
    "FORME": "OVULE VAGI.",
    "DOSAGE": "500MG",
    "COND": "B/10",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMALLIANCE EURL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/11/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "9/11/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Gynécologie"]
  },
  {
    "PregnancyIndexLink": ["metronidazole"],
    "InteractionIndexLink": ["metronidazole"],
    "N_ENREGISTREMENT": "366/ 11 A 002 /07/13",
    "CODE_DCI": "11 A 002",
    "DCI": "METRONIDAZOLE",
    "NOM_COMMERCIALE": "METROFAGYL",
    "FORME": "OVULES",
    "DOSAGE": "500MG",
    "COND": "B/10",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "4A SANTE INDUSTRIE SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/12/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "7/7/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Gynécologie"]
  },
  {
    "PregnancyIndexLink": ["neomycin", "nystatin"],
    "InteractionIndexLink": ["polymyxine b"],
    "N_ENREGISTREMENT": "087/ 11 A 003 /98/16",
    "CODE_DCI": "11 A 003",
    "DCI": "NEOMYCINE/ POLYMYXINE B/ NYSTATINE",
    "NOM_COMMERCIALE": "POLYGYNAX",
    "FORME": "CAPSULE MOLLE VAGINALE",
    "DOSAGE": "35 000UI/35 000UI/100 000UI",
    "COND": "B/12",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INNOTECH INTERNATIONAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/6/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "9/8/2016",
    "TYPE": "Ré",
    "STATUT": "C",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Gynécologie"]
  },
  {
    "PregnancyIndexLink": ["neomycin", "nystatin"],
    "InteractionIndexLink": ["polymyxine b"],
    "N_ENREGISTREMENT": "263/11 A 003/20",
    "CODE_DCI": "11 A 003",
    "DCI": "SULFATE DE NEOMYCINE/ SULFATE DE POLYMYXINE B/ NYSTATINE",
    "NOM_COMMERCIALE": "POLYVAX",
    "FORME": "OVULE",
    "DOSAGE": "35000U.I./ 35000U.I./ 100000U.I.",
    "COND": "B/12",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES BIOPHARM/SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/11/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "22/11/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Gynécologie"]
  },
  {
    "PregnancyIndexLink": ["neomycin", "nystatin"],
    "InteractionIndexLink": ["polymyxine b"],
    "N_ENREGISTREMENT": "574/ 11 A 003 /21",
    "CODE_DCI": "11 A 003",
    "DCI": "NEOMYCINE/POLYMYXINE B/NYSTATINE",
    "NOM_COMMERCIALE": "WELLGYNAX",
    "FORME": "Capsule molle vaginale",
    "DOSAGE": "35 000UI/35 000UI/100 000UI",
    "COND": "B/12",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOPROPHAL / SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/3/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "7/3/2021",
    "TYPE": "Gé",
    "STATUT": "C",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Gynécologie"]
  },
  {
    "PregnancyIndexLink": ["estriol"],
    "InteractionIndexLink": ["estriol"],
    "N_ENREGISTREMENT": "467/ 11 A 046 /99/17",
    "CODE_DCI": "11 A 046",
    "DCI": "ESTRIOL",
    "NOM_COMMERCIALE": "OVESTIN",
    "FORME": "OVULES",
    "DOSAGE": "0.5MG",
    "COND": "B/15",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ASPEN PHARMA SCHWEIZ GMBH",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SUISSE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/6/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "19/7/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Gynécologie"]
  },
  {
    "PregnancyIndexLink": ["metronidazole", "neomycin", "nystatin"],
    "InteractionIndexLink": ["metronidazole"],
    "N_ENREGISTREMENT": "235/ 11 A 067 /21",
    "CODE_DCI": "11 A 067",
    "DCI": "Métronidazole / Sulfate de néomycine /Nystatine",
    "NOM_COMMERCIALE": "GYNOVAL",
    "FORME": "Comprimé vaginal",
    "DOSAGE": "500MG/65000UI/100000UI",
    "COND": "B/10",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOGALENIC / SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/2/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "7/2/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Gynécologie"]
  },
  {
    "PregnancyIndexLink": ["metronidazole", "neomycin", "nystatin"],
    "InteractionIndexLink": ["metronidazole"],
    "N_ENREGISTREMENT": "269/ 11 A 067 /03/15",
    "CODE_DCI": "11 A 067",
    "DCI": "METRONIDAZOLE / NEOMYCINE SULFATE / NYSTATINE",
    "NOM_COMMERCIALE": "TERGYNAN",
    "FORME": "COMP. VAGINAL",
    "DOSAGE": "500MG/65000UI/100000UI",
    "COND": "B/10",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BOUCHARA-RECORDATI",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/9/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "31/5/2015",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Gynécologie"]
  },
  {
    "PregnancyIndexLink": ["econazole"],
    "InteractionIndexLink": ["econazole"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "11 A 071",
    "DCI": "ECONAZOLE NITRATE",
    "NOM_COMMERCIALE": "ECOVAR LP",
    "FORME": "OVULE  GYNECO. LP.",
    "DOSAGE": "150MG",
    "COND": "B/01",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gynécologie"]
  },
  {
    "PregnancyIndexLink": ["econazole"],
    "InteractionIndexLink": ["econazole"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "11 A 071",
    "DCI": "ECONAZOLE NITRATE",
    "NOM_COMMERCIALE": "GYNOVASOL LP",
    "FORME": "OVULE LP.",
    "DOSAGE": "150MG",
    "COND": "B/01",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gynécologie"]
  },
  {
    "PregnancyIndexLink": ["clotrimazole"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "11 A 083",
    "DCI": "CLOTRIMAZOLE",
    "NOM_COMMERCIALE": "MYCOTEN 1",
    "FORME": "COMP. VAG.",
    "DOSAGE": "500MG",
    "COND": "B/01 + 01APPLICATEUR",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gynécologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["ornidazole"],
    "N_ENREGISTREMENT": "177/ 11 A 084 /12",
    "CODE_DCI": "11 A 084",
    "DCI": "ORNIDAZOLE",
    "NOM_COMMERCIALE": "ORNISID",
    "FORME": "COMP. VAGINAL",
    "DOSAGE": "500MG",
    "COND": "B/03",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ABDI IBRAHIM ILAÇ SANAYI VE TICARET A.S",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "TURQUIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "8/11/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "8/11/2012",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "11 A 085",
    "DCI": "SERTACONAZOLE NITRATE",
    "NOM_COMMERCIALE": "GYNODERMOFIX",
    "FORME": "OVULE",
    "DOSAGE": "300MG",
    "COND": "B/01",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gynécologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "231/11 A 085/20",
    "CODE_DCI": "11 A 085",
    "DCI": "SERTACONAZOLE NITRATE",
    "NOM_COMMERCIALE": "GYNOMIX",
    "FORME": "OVULE",
    "DOSAGE": "300MG",
    "COND": "B/01",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SALEM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/2/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "6/2/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Gynécologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "366/ 11 A 085 /16",
    "CODE_DCI": "11 A 085",
    "DCI": "SERTACONAZOLE",
    "NOM_COMMERCIALE": "SERTAZOLE",
    "FORME": "OVULE",
    "DOSAGE": "300MG",
    "COND": "B/01",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "4 A SANTE INDUSTRIE SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/1/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "10/1/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Gynécologie"]
  },
  {
    "PregnancyIndexLink": ["lidocaine", "metronidazole", "miconazole"],
    "InteractionIndexLink": ["lidocaine", "metronidazole", "miconazole"],
    "N_ENREGISTREMENT": "20/11 A091/521",
    "CODE_DCI": "11 A 091",
    "DCI": "METRONIDAZOLE/ MICONAZOLE/ LIDOCAINE",
    "NOM_COMMERCIALE": "LIMENDA-L",
    "FORME": "OVULE",
    "DOSAGE": "750MG/ 200MG/ 100MG /OVULE",
    "COND": "B/7 OVULES ET 7 DOIGTIERS",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES WORLD MEDICINE ILAç SAN. VE TIC AS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "TURQUIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "5/10/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "5/10/2020",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["miconazole"],
    "InteractionIndexLink": ["miconazole"],
    "N_ENREGISTREMENT": "20/11 A090/521",
    "CODE_DCI": "11 A090",
    "DCI": "METRINIDAZOLE/ MICONAZOLE NITRATE",
    "NOM_COMMERCIALE": "LIMENDA",
    "FORME": "OVULES",
    "DOSAGE": "750MG / 200MG",
    "COND": "B/7OVULES ET 7 DOIGTIERS",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES WORLD MEDICINE ILAç SAN. VE TIC .A.S",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "TURQUIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "5/10/20",
    "DATE_D_ENREGISTREMENT_FINAL": "5/10/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "579/ 11 B 087 /21",
    "CODE_DCI": "11 B 087",
    "DCI": "ATOSIBAN ACETATE EXPRIME EN ATOSIBAN",
    "NOM_COMMERCIALE": "ATOSIBAN EVER PHARMA",
    "FORME": "SOL. INJ. IV",
    "DOSAGE": "7.5MG/ML (6.75MG/0.9ML)",
    "COND": "FLC 0.9ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES EVER VALINJCT GmbH",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "AUTRICHE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/04/21",
    "DATE_D_ENREGISTREMENT_FINAL": "29/04/21",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "275/ 11 B 087 /15",
    "CODE_DCI": "11 B 087",
    "DCI": "ATOSIBAN ACETATE EXPRIME EN ATOSIBAN",
    "NOM_COMMERCIALE": "TRACTOCILE",
    "FORME": "SOL. INJ. IV.",
    "DOSAGE": "7.5MG/ML (6.75MG/0.9ML)",
    "COND": "B/01 FL. DE 0.9ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FERRING PHARMACEUTICALS A/S",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "DANEMARK",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/9/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "22/9/2015",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "48 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "275/ 11 B 088 /15",
    "CODE_DCI": "11 B 088",
    "DCI": "ATOSIBAN ACETATE EXPRIME EN ATOSIBAN",
    "NOM_COMMERCIALE": "TRACTOCILE",
    "FORME": "SOL. A DILUER P. PERF. IV",
    "DOSAGE": "7.5MG/ML (37.5MG/5ML)",
    "COND": "B/01 FL. DE 5ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FERRING PHARMACEUTICALS A/S",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "DANEMARK",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/9/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "22/9/2015",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "48 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["dydrogesterone with estradiol", "estradiol"],
    "InteractionIndexLink": ["dydrogesterone", "estradiol"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "11 D 061",
    "DCI": "ESTRADIOL/DYDROGESTERONE",
    "NOM_COMMERCIALE": "CLIMASTON",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "2MG/10MG",
    "COND": "B/28",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gynécologie"]
  },
  {
    "PregnancyIndexLink": ["dydrogesterone with estradiol", "estradiol"],
    "InteractionIndexLink": ["dydrogesterone", "estradiol"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "11 D 065",
    "DCI": "ESTRADIOL /DYDROGESTERONE",
    "NOM_COMMERCIALE": "CLIMASTON",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "1MG/10MG",
    "COND": "B/28",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gynécologie"]
  },
  {
    "PregnancyIndexLink": ["dydrogesterone with estradiol", "estradiol"],
    "InteractionIndexLink": ["dydrogesterone", "estradiol"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "11 D 066",
    "DCI": "ESTRADIOL/DYDROGESTERONE",
    "NOM_COMMERCIALE": "CLIMASTON",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "1MG/5MG",
    "COND": "B/28",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gynécologie"]
  },
  {
    "PregnancyIndexLink": ["oxytocin"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "526/11 E 019/17",
    "CODE_DCI": "11 E 019",
    "DCI": "Oxytocine",
    "NOM_COMMERCIALE": "POSTUITRIN",
    "FORME": "SOL.INJ.EN AMP",
    "DOSAGE": "5UI/ML",
    "COND": "B/3AMP. DE 1ML",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE ULAGAY.ILAC SANAYI TURK",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "TURQUIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "31/5/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "31/5/2017",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Gynécologie"]
  },
  {
    "PregnancyIndexLink": ["oxytocin"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "550/ 11 E 019 /99/19",
    "CODE_DCI": "11 E 019",
    "DCI": "Oxytocine",
    "NOM_COMMERCIALE": "SYNTOCINON",
    "FORME": "CONCENTRE P/ IV OU SOL INJ IMSOL.INJ.",
    "DOSAGE": "5UI/ML",
    "COND": "B/5AMP. DE 1ML",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BGP PRODUCTS GMBH",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SUISSE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/1/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "5/11/2019",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Gynécologie"]
  },
  {
    "PregnancyIndexLink": ["oxytocin"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "001/ 11 E 089 /18",
    "CODE_DCI": "11 E 089",
    "DCI": "Oxytocine",
    "NOM_COMMERCIALE": "LABROXIN",
    "FORME": "SOL.INJ. IM / IV",
    "DOSAGE": "5UI/0.5ML",
    "COND": "B/06 AMP. DE 0.5 ML",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMACEUTICALS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "11/2/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "11/2/2018",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["benzalkonium"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "11 G 024",
    "DCI": "BENZALKONIUM CHLORURE",
    "NOM_COMMERCIALE": "PHARMATEX",
    "FORME": "CREME VAG.",
    "DOSAGE": "1.2%",
    "COND": "T/72G",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gynécologie"]
  },
  {
    "PregnancyIndexLink": [
      "desogestrel with ethinylestradiol",
      "ethinylestradiol"
    ],
    "InteractionIndexLink": ["desogestrel", "ethinylestradiol"],
    "N_ENREGISTREMENT": "005/ 11 H 026 /96/16",
    "CODE_DCI": "11 H 026",
    "DCI": "ETHINYLESTRADIOL/DESOGESTREL",
    "NOM_COMMERCIALE": "MARVELON",
    "FORME": "COMPRIME",
    "DOSAGE": "0.03MG/0.15MG",
    "COND": "B/3*21",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ORGANON N.V.",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PAYS BAS",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/9/1996",
    "DATE_D_ENREGISTREMENT_FINAL": "4/1/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Gynécologie"]
  },
  {
    "PregnancyIndexLink": ["levonorgestrel"],
    "InteractionIndexLink": ["levonorgestrel"],
    "N_ENREGISTREMENT": "030/ 11 H 027 /98/16",
    "CODE_DCI": "11 H 027",
    "DCI": "LEVONORGESTREL",
    "NOM_COMMERCIALE": "MICROVAL",
    "FORME": "COMPRIME",
    "DOSAGE": "0.03MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "WYETH LEDERLE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "8/11/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "12/3/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Gynécologie"]
  },
  {
    "PregnancyIndexLink": ["ethinylestradiol", "levonorgestrel"],
    "InteractionIndexLink": ["ethinylestradiol", "levonorgestrel"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "11 H 040",
    "DCI": "LEVONORGESTREL/ETHINYLESTRADIOL",
    "NOM_COMMERCIALE": "MICROGYNON",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "0.15MG/0.03MG",
    "COND": "B/ 63",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gynécologie"]
  },
  {
    "PregnancyIndexLink": ["ethinylestradiol", "levonorgestrel"],
    "InteractionIndexLink": ["ethinylestradiol", "levonorgestrel"],
    "N_ENREGISTREMENT": "045/ 11 H 040 /98/15",
    "CODE_DCI": "11 H 040",
    "DCI": "LEVONORGESTREL / ETHINYLESTRADIOL",
    "NOM_COMMERCIALE": "MINIDRIL",
    "FORME": "COMPRIME",
    "DOSAGE": "0.15MG/0.03MG",
    "COND": "B/21",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PFIZER HOLDING FRANCE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "8/11/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "13/12/2015",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Gynécologie"]
  },
  {
    "PregnancyIndexLink": [
      "desogestrel with ethinylestradiol",
      "ethinylestradiol"
    ],
    "InteractionIndexLink": ["desogestrel", "ethinylestradiol"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "11 H 049",
    "DCI": "Désogestrel/Ethinylestradiol",
    "NOM_COMMERCIALE": "MARILON",
    "FORME": "Comprimé",
    "DOSAGE": "150/20 ug",
    "COND": "B/21",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gynécologie"]
  },
  {
    "PregnancyIndexLink": [
      "desogestrel with ethinylestradiol",
      "ethinylestradiol"
    ],
    "InteractionIndexLink": ["desogestrel", "ethinylestradiol"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "11 H 049",
    "DCI": "ETHINYLESTRADIOL/DESOGESTREL",
    "NOM_COMMERCIALE": "MERCILON",
    "FORME": "COMPRIME",
    "DOSAGE": "0.02MG/0.15MG",
    "COND": "B/21",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gynécologie"]
  },
  {
    "PregnancyIndexLink": ["ethinylestradiol", "levonorgestrel"],
    "InteractionIndexLink": ["ethinylestradiol", "levonorgestrel"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "11 H 050",
    "DCI": "ETHINYLESTRADIOL / LEVONORGESTREL",
    "NOM_COMMERCIALE": "LOGYNON",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "30µG/0.05MG/6JRS - 40µG/0.075MG/5JRS - 30µG/0.125MG/10JRS",
    "COND": "B/21",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gynécologie"]
  },
  {
    "PregnancyIndexLink": ["ethinylestradiol", "gestoden"],
    "InteractionIndexLink": ["ethinylestradiol"],
    "N_ENREGISTREMENT": "424/11 H 062/01/16",
    "CODE_DCI": "11 H 062",
    "DCI": "ETHINYLESTRADIOL/GESTODENE",
    "NOM_COMMERCIALE": "MELIANE",
    "FORME": "COMP. ENRO.",
    "DOSAGE": "20µG/75µG",
    "COND": "B/21",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BAYER HEALTHCARE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/1/2001",
    "DATE_D_ENREGISTREMENT_FINAL": "4/1/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Gynécologie"]
  },
  {
    "PregnancyIndexLink": ["ethinylestradiol", "gestoden"],
    "InteractionIndexLink": ["ethinylestradiol"],
    "N_ENREGISTREMENT": "285/ 11 H 062 /18",
    "CODE_DCI": "11 H 062",
    "DCI": "Ethinylestradiol / Gestodène",
    "NOM_COMMERCIALE": "SUNYA",
    "FORME": "Comprimé enrobé",
    "DOSAGE": "20µG/75µG",
    "COND": "B/21",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "Union Pharmaceutique Constantinoise (UPC) / SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/11/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "7/11/2018",
    "TYPE": "Gé",
    "STATUT": "C. primaire",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Gynécologie"]
  },
  {
    "PregnancyIndexLink": ["ethinylestradiol", "gestoden"],
    "InteractionIndexLink": ["ethinylestradiol"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "11 H 062",
    "DCI": "ETHINYLESTRADIOL / GESTODENE",
    "NOM_COMMERCIALE": "SUNYA®",
    "FORME": "Comprimé enrobé",
    "DOSAGE": "20/75 ug",
    "COND": "Boite de 21",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gynécologie"]
  },
  {
    "PregnancyIndexLink": ["cyproterone acetate (2 mg daily PO)", "estradiol"],
    "InteractionIndexLink": ["cyproterone", "estradiol"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "11 H 063",
    "DCI": "ESTRADIOL VALERATE / CYPROTERONE ACETATE",
    "NOM_COMMERCIALE": "CLIMENE",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "2MG/1MG",
    "COND": "B/21",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gynécologie"]
  },
  {
    "PregnancyIndexLink": ["estradiol", "gestoden"],
    "InteractionIndexLink": ["estradiol"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "11 H 069",
    "DCI": "ETHINYL ESTRADIOL /  GESTODENE",
    "NOM_COMMERCIALE": "MINESSE",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "15µG/60µG",
    "COND": "B/28",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gynécologie"]
  },
  {
    "PregnancyIndexLink": ["desogestrel with ethinylestradiol"],
    "InteractionIndexLink": ["desogestrel"],
    "N_ENREGISTREMENT": "169/11 H 072/21",
    "CODE_DCI": "11 H 072",
    "DCI": "Désogestrel",
    "NOM_COMMERCIALE": "ANTIGONE",
    "FORME": "Comprimé pelliculé",
    "DOSAGE": "0.075MG",
    "COND": "B/28",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BESINS INTERNATIONAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/2/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "15/2/2021",
    "TYPE": "Gé",
    "STATUT": "Conditionnement (GPE)",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Gynécologie"]
  },
  {
    "PregnancyIndexLink": ["desogestrel with ethinylestradiol"],
    "InteractionIndexLink": ["desogestrel"],
    "N_ENREGISTREMENT": "005/ 11 H 072 /07/15",
    "CODE_DCI": "11 H 072",
    "DCI": "DESOGESTREL",
    "NOM_COMMERCIALE": "CERAZETTE",
    "FORME": "COMPRIME",
    "DOSAGE": "0.075MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ORGANON N.V.",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PAYS BAS",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/7/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "26/2/2015",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Gynécologie"]
  },
  {
    "PregnancyIndexLink": ["desogestrel with ethinylestradiol"],
    "InteractionIndexLink": ["desogestrel"],
    "N_ENREGISTREMENT": "532/11 H 072/17",
    "CODE_DCI": "11 H 072",
    "DCI": "DESOGESTREL",
    "NOM_COMMERCIALE": "DESIRETT",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "0.075MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EXELTIS GERMANY GMBH",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "Allemagne",
    "DATE_D_ENREGISTREMENT_INITIAL": "23/10/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "23/10/2017",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Gynécologie"]
  },
  {
    "PregnancyIndexLink": ["desogestrel with ethinylestradiol"],
    "InteractionIndexLink": ["desogestrel"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "11 H 072",
    "DCI": "DESOGESTREL",
    "NOM_COMMERCIALE": "DESOGESTREL PHARBIL®",
    "FORME": "Comprimé pelliculé",
    "DOSAGE": "75 ug",
    "COND": "Boite de 28",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gynécologie"]
  },
  {
    "PregnancyIndexLink": ["desogestrel with ethinylestradiol"],
    "InteractionIndexLink": ["desogestrel"],
    "N_ENREGISTREMENT": "285/11 H 072/20",
    "CODE_DCI": "11 H 072",
    "DCI": "DESOGESTREL",
    "NOM_COMMERCIALE": "DESONETTE",
    "FORME": "COMP. PELL.",
    "DOSAGE": "0.75µG/CP",
    "COND": "B/28",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "UNION PHARMACEUTIQUE CONSTANTINOISE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/4/2011",
    "DATE_D_ENREGISTREMENT_FINAL": "16/12/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Gynécologie"]
  },
  {
    "PregnancyIndexLink": ["desogestrel with ethinylestradiol"],
    "InteractionIndexLink": ["desogestrel"],
    "N_ENREGISTREMENT": "285/11 H 072/18",
    "CODE_DCI": "11 H 072",
    "DCI": "Désogestrel",
    "NOM_COMMERCIALE": "DESONETTE",
    "FORME": "Comprimé pelliculé",
    "DOSAGE": "75µG",
    "COND": "B/28",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "Union Pharmaceutique Constantinoise (UPC) / SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/4/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "16/12/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Gynécologie"]
  },
  {
    "PregnancyIndexLink": ["desogestrel with ethinylestradiol"],
    "InteractionIndexLink": ["desogestrel"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "11 H 072",
    "DCI": "DESOGESTREL",
    "NOM_COMMERCIALE": "DESONETTE",
    "FORME": "Comp",
    "DOSAGE": "75MCG",
    "COND": "Boite de 28",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gynécologie"]
  },
  {
    "PregnancyIndexLink": ["etonogestrel"],
    "InteractionIndexLink": ["etonogestrel"],
    "N_ENREGISTREMENT": "005/ 11 H 074 /13",
    "CODE_DCI": "11 H 074",
    "DCI": "ETONOGESTREL",
    "NOM_COMMERCIALE": "IMPLANON NXT",
    "FORME": "IMPLANT P. USAGE SOUS CUTANE",
    "DOSAGE": "68MG/IMPLANT",
    "COND": "B/1APPLICATEUR CONTENANT UN IMPLANT",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ORGANON N.V.",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PAYS BAS",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/8/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "7/8/2013",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Gynécologie"]
  },
  {
    "PregnancyIndexLink": [
      "drospirenone with ethinylestradiol",

      "ethinylestradiol"
    ],
    "InteractionIndexLink": ["drospirenone", "ethinylestradiol"],
    "N_ENREGISTREMENT": "532 / 11 H 078/ 19",
    "CODE_DCI": "11 H 078",
    "DCI": "ETHINYLESTRADIOL/  DROSPIRENONE",
    "NOM_COMMERCIALE": "DIVA",
    "FORME": "CP PELL",
    "DOSAGE": "0.03 MG/ 3MG",
    "COND": "B/21",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EXELTIS MAGYARORSZAG KFT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HONGRIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/6/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "26/6/2019",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["levonorgestrel"],
    "InteractionIndexLink": ["levonorgestrel"],
    "N_ENREGISTREMENT": "424/ 11 J 077 /08/19",
    "CODE_DCI": "11 J 077",
    "DCI": "LEVONORGESTREL",
    "NOM_COMMERCIALE": "MIRENA 20µG/24H",
    "FORME": "SYSTÈME DE DIFFUSION INTRA-UTERIN",
    "DOSAGE": "52MG/DISPOSITIF",
    "COND": "B/01 SYSTÈME DE DIFFUSION INTRA-UTERIN  MUNI D'INSERTEUR (EVO-INSERTEUR)",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BAYER OY",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FINLANDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/12/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "20/3/2019",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["ganirelix"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "11 N 079",
    "DCI": "GANIRELIX",
    "NOM_COMMERCIALE": "ORGALUTRAN",
    "FORME": "SOL. INJ. SC EN SERING. PREREMPL.",
    "DOSAGE": "0.5MG/ML (0.25MG/0.5ML)",
    "COND": "B/1SERING. PREREMPLIES DE 5ML ET B/5SERING. PREREMPLIES DE 5ML",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Gynécologie"]
  },
  {
    "PregnancyIndexLink": ["dienogest with ethinylestradiol"],
    "InteractionIndexLink": ["dienogest"],
    "N_ENREGISTREMENT": "424/ 11 P 086 /14",
    "CODE_DCI": "11 P 086",
    "DCI": "DIENOGEST",
    "NOM_COMMERCIALE": "VISANNE",
    "FORME": "COMPRIME",
    "DOSAGE": "2MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BAYER PHARMA AG",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALLEMAGNE",
    "DATE_D_ENREGISTREMENT_INITIAL": "31/3/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "31/3/2014",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["acenocoumarol"],
    "N_ENREGISTREMENT": "013/12 A 001/99/16",
    "CODE_DCI": "12 A 001",
    "DCI": "Acenocoumarol",
    "NOM_COMMERCIALE": "NOVAROL",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "4MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDUSTRIA FARMACEUTICA NOVA ARGENTIA SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ITALIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "21/11/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "11/9/2016",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "60 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Hématologie et hémostase"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["acenocoumarol"],
    "N_ENREGISTREMENT": "540 / 12 A 001 /98/19",
    "CODE_DCI": "12 A 001",
    "DCI": "Acénocoumarol",
    "NOM_COMMERCIALE": "SINTROM",
    "FORME": "Comprimé quadri-sécable",
    "DOSAGE": "4MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MEDIUS AG",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SUISSE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/11/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "7/1/2021",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "60 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Hématologie et hémostase"]
  },
  {
    "PregnancyIndexLink": ["acide acetylsalicylique"],
    "InteractionIndexLink": ["acide acetylsalicylique"],
    "N_ENREGISTREMENT": "20/06/12 A 131/003",
    "CODE_DCI": "12 A 131",
    "DCI": "ACIDE ACETYLSALICYLIQUE",
    "NOM_COMMERCIALE": "ACEPRAL CARDIO",
    "FORME": "COMPRIME",
    "DOSAGE": "100MG",
    "COND": "B/30 ET B/100",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES EPE GROUPE INDUSTRIEL SAIDAL/ SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/02/20",
    "DATE_D_ENREGISTREMENT_FINAL": "27/02/20",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Hématologie et hémostase"]
  },
  {
    "PregnancyIndexLink": ["acide acetylsalicylique"],
    "InteractionIndexLink": ["acide acetylsalicylique"],
    "N_ENREGISTREMENT": "447/ 12 A 131 /09/18",
    "CODE_DCI": "12 A 131",
    "DCI": "ACIDE ACETYLSALICYLIQUE",
    "NOM_COMMERCIALE": "ASPEC",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "100MG",
    "COND": "B/98",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEKER SARL (SARL LABORATOIRE BEKER ALGERIE)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/12/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "18/4/2018",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Hématologie et hémostase"]
  },
  {
    "PregnancyIndexLink": ["acide acetylsalicylique"],
    "InteractionIndexLink": ["acide acetylsalicylique"],
    "N_ENREGISTREMENT": "235/ 12 A 131 /21",
    "CODE_DCI": "12 A 131",
    "DCI": "Acide acétylsalicylique",
    "NOM_COMMERCIALE": "ASPICARD",
    "FORME": "Comprimé sécable",
    "DOSAGE": "100MG",
    "COND": "B/30 et B/98",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOGALENIC / SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/4/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "4/4/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Hématologie et hémostase"]
  },
  {
    "PregnancyIndexLink": ["acide acetylsalicylique"],
    "InteractionIndexLink": ["acide acetylsalicylique"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "12 A 131",
    "DCI": "ACIDE ACETYLSALICYLIQUE",
    "NOM_COMMERCIALE": "ASPICARD",
    "FORME": "comprimé",
    "DOSAGE": "100 mg",
    "COND": "BOITE DE 30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Hématologie et hémostase"]
  },
  {
    "PregnancyIndexLink": ["acide acetylsalicylique"],
    "InteractionIndexLink": ["acide acetylsalicylique"],
    "N_ENREGISTREMENT": "149/ 12 A 131 /21",
    "CODE_DCI": "12 A 131",
    "DCI": "Acide acétylsalicylique",
    "NOM_COMMERCIALE": "ASPINOVA",
    "FORME": "Comprimé",
    "DOSAGE": "100MG",
    "COND": "B/30 ET B/90",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVAPHARM TRADING / SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/3/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "28/3/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Hématologie et hémostase"]
  },
  {
    "PregnancyIndexLink": ["acide acetylsalicylique"],
    "InteractionIndexLink": ["acide acetylsalicylique"],
    "N_ENREGISTREMENT": "263/ 12 A 131 /07/18",
    "CODE_DCI": "12 A 131",
    "DCI": "ACIDE ACETYLSALICYLIQUE",
    "NOM_COMMERCIALE": "ASPIRINE CARDIO",
    "FORME": "GELULE",
    "DOSAGE": "100MG",
    "COND": "PILULIER/30 ET PILULIER/90",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOPHARM SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/11/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "20/3/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Hématologie et hémostase"]
  },
  {
    "PregnancyIndexLink": ["acide acetylsalicylique"],
    "InteractionIndexLink": ["acide acetylsalicylique"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "12 A 131",
    "DCI": "ACIDE ACETYLSALICYLIQUE",
    "NOM_COMMERCIALE": "GEASPERIQUE",
    "FORME": "GELULE",
    "DOSAGE": "100MG",
    "COND": "B/10",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Hématologie et hémostase"]
  },
  {
    "PregnancyIndexLink": ["ticagrelor"],
    "InteractionIndexLink": ["ticagrelor"],
    "N_ENREGISTREMENT": "256/ 12 A 166 /13",
    "CODE_DCI": "12 A 166",
    "DCI": "TICAGRELOR",
    "NOM_COMMERCIALE": "BRILIQUE",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "90MG",
    "COND": "B/60 ET B/100",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "B/100 RESERVEE AUX HÔPITAUX",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ASTRAZENECA AB",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SUEDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/9/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "15/9/2013",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["apixaban"],
    "InteractionIndexLink": ["apixaban"],
    "N_ENREGISTREMENT": "263/12 A 193/20",
    "CODE_DCI": "12 A 193",
    "DCI": "APIXABAN",
    "NOM_COMMERCIALE": "BIOPEXA",
    "FORME": "COMP PELL",
    "DOSAGE": "2.5MG",
    "COND": "B/60",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOPHARM SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "16/2/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "16/2/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["apixaban"],
    "InteractionIndexLink": ["apixaban"],
    "N_ENREGISTREMENT": "529 / 12 A 193 /17",
    "CODE_DCI": "12 A 193",
    "DCI": "Apixaban",
    "NOM_COMMERCIALE": "ELIQUIS",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "2.5 MG",
    "COND": "B/20 ET B/60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "Laboratoire BMS / PFIZER EEIG",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ROYAUME UNI",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/12/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "25/12/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["apixaban"],
    "InteractionIndexLink": ["apixaban"],
    "N_ENREGISTREMENT": "352/ 12 A 193 /21",
    "CODE_DCI": "12 A 193",
    "DCI": "Apixaban",
    "NOM_COMMERCIALE": "XIBAN",
    "FORME": "Comprimé pelliculé",
    "DOSAGE": "2.5MG",
    "COND": "B/60 et B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/4/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "7/4/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["apixaban"],
    "InteractionIndexLink": ["apixaban"],
    "N_ENREGISTREMENT": "263/12 A 200/19",
    "CODE_DCI": "12 A 200",
    "DCI": "APIXABAN",
    "NOM_COMMERCIALE": "BIOPEXA",
    "FORME": "COMP PELL",
    "DOSAGE": "5MG",
    "COND": "B/60",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOPHARM SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "11/12/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "11/12/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["apixaban"],
    "InteractionIndexLink": ["apixaban"],
    "N_ENREGISTREMENT": "529/12 A 200/20",
    "CODE_DCI": "12 A 200",
    "DCI": "APIXABAN",
    "NOM_COMMERCIALE": "ELIQUIS",
    "FORME": "COMP PELL",
    "DOSAGE": "5MG",
    "COND": "B/60",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BRISTOL-MYRS SQUIBB/PFIZER EEIG",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ROYAUME UNI",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/3/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "18/3/2020",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["apixaban"],
    "InteractionIndexLink": ["apixaban"],
    "N_ENREGISTREMENT": "352/ 12 A 200 /21",
    "CODE_DCI": "12 A 200",
    "DCI": "Apixaban",
    "NOM_COMMERCIALE": "XIBAN",
    "FORME": "Comprimé pelliculé",
    "DOSAGE": "5MG",
    "COND": "B/60 et B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/4/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "7/4/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "19/13 B014/380",
    "CODE_DCI": "12 B 014",
    "DCI": "CEFATOXIME SODIQUE",
    "NOM_COMMERCIALE": "CEFOTAX HUP",
    "FORME": "POUDRE P.SOL INJ IM/IV",
    "DOSAGE": "1G",
    "COND": "B/1 FLACON DE POUDRE ET UNE AMPOULE DE SOLVANTB/10 FLACONS DE POUDRE",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "laboratoires HUP.P PHARMA Sarl",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "02/04/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "02/04/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["tinzaparin"],
    "InteractionIndexLink": ["tinzaparine"],
    "N_ENREGISTREMENT": "083/ 12 B 078 /99/13",
    "CODE_DCI": "12 B 078",
    "DCI": "TINZAPARINE SODIQUE  (HBPM)",
    "NOM_COMMERCIALE": "INNOHEP",
    "FORME": "SOL.INJ.SC EN SERING. PREREMPL.",
    "DOSAGE": "10 000UI ANTI-XA/0.5ML",
    "COND": "B/02 SERING. PREREMPL. DE 0.5ML ET B/10 SERING. PREREMPL. DE 0.5ML(AVEC SYSTÈME DE SECURITE D'AIGUILLE)",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LEO",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/10/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "17/7/2013",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Hématologie et hémostase"]
  },
  {
    "PregnancyIndexLink": ["tinzaparin"],
    "InteractionIndexLink": ["tinzaparine"],
    "N_ENREGISTREMENT": "083/ 12 B 079 /99/13",
    "CODE_DCI": "12 B 079",
    "DCI": "TINZAPARINE SODIQUE  (HBPM)",
    "NOM_COMMERCIALE": "INNOHEP",
    "FORME": "SOL.INJ.SC EN SERING. PREREMPL.",
    "DOSAGE": "14 000UI ANTI-XA/0.7ML",
    "COND": "B/02 SERING. PREREMPL. DE 0.7ML ET B/10 SERING. PREREMPL. DE 0.7ML(AVEC SYSTÈME DE SECURITE D'AIGUILLE)",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LEO",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/10/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "17/7/2013",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Hématologie et hémostase"]
  },
  {
    "PregnancyIndexLink": ["tinzaparin"],
    "InteractionIndexLink": ["tinzaparine"],
    "N_ENREGISTREMENT": "083/ 12 B 080 /99/13",
    "CODE_DCI": "12 B 080",
    "DCI": "TINZAPARINE SODIQUE  (HBPM)",
    "NOM_COMMERCIALE": "INNOHEP",
    "FORME": "SOL.INJ.SC EN SERING. PREREMPL.",
    "DOSAGE": "18 000UI ANTI-XA/0.9ML",
    "COND": "B/02 SERING. PREREMPL. DE 0.9ML ET B/10 SERING. PREREMPL. DE 0.9ML(AVEC SYSTÈME DE SECURITE D'AIGUILLE)",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LEO",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/10/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "17/7/2013",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Hématologie et hémostase"]
  },
  {
    "PregnancyIndexLink": ["enoxaparin"],
    "InteractionIndexLink": ["enoxaparine"],
    "N_ENREGISTREMENT": "471/ 12 B 081 /13",
    "CODE_DCI": "12 B 081",
    "DCI": "ENOXAPARINE SODIQUE  (HEPARINE A BAS POIDS MOLECULAIRE HBPM)",
    "NOM_COMMERCIALE": "LOMOH-20",
    "FORME": "SOL. INJ. SC/IV ET INTRAVASCULAIRE",
    "DOSAGE": "2000UI ANTI-Xa/0.2ML (CORRESPONDANT A 20MG/0.2ML)",
    "COND": "B/1SERING. PREREMPL. DE 0.2ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF.",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EMCURE PHARMACEUTICALS LTD",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/1/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "13/1/2013",
    "TYPE": "",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Hématologie et hémostase"]
  },
  {
    "PregnancyIndexLink": ["enoxaparin"],
    "InteractionIndexLink": ["enoxaparine"],
    "N_ENREGISTREMENT": "376/ 12 B 081 /96/15",
    "CODE_DCI": "12 B 081",
    "DCI": "ENOXAPARINE SODIQUE  (HEPARINE A BAS POIDS MOLECULAIRE HBPM)",
    "NOM_COMMERCIALE": "LOVENOX",
    "FORME": "SOL.INJ.SC. ET INTRAVASCULAIRE EN SERING. PREREMPL.",
    "DOSAGE": "2 000UI ANTI-XA/0.2ML (CORRESPONDANT A 20MG/0.2ML)",
    "COND": "B/02 SERING. ET B 6 SERING PREREMPL. DE 0.2ML AVEC SYSTÈME DE SECURITE",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANOFI AVENTIS FRANCE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/11/1996",
    "DATE_D_ENREGISTREMENT_FINAL": "13/12/2015",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Hématologie et hémostase"]
  },
  {
    "PregnancyIndexLink": ["enoxaparin"],
    "InteractionIndexLink": ["enoxaparine"],
    "N_ENREGISTREMENT": "433/12 B 081/20",
    "CODE_DCI": "12 B 081",
    "DCI": "Enoxaparine sodique",
    "NOM_COMMERCIALE": "VARENOX",
    "FORME": "SOL INJ S/C et  I/V en seringue préremplie",
    "DOSAGE": "2000UI ANTI -XA/0.2ML",
    "COND": "B/02 SERINGUES",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRATER RAZES SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "5/2/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "5/2/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Hématologie et hémostase"]
  },
  {
    "PregnancyIndexLink": ["enoxaparin"],
    "InteractionIndexLink": ["enoxaparine"],
    "N_ENREGISTREMENT": "471/ 12 B 082 /13",
    "CODE_DCI": "12 B 082",
    "DCI": "ENOXAPARINE SODIQUE  (HEPARINE A BAS POIDS MOLECULAIRE HBPM)",
    "NOM_COMMERCIALE": "LOMOH-40",
    "FORME": "SOL. INJ. SC/IV ET INTRAVASCULAIRE",
    "DOSAGE": "4000UI ANTI-Xa/0.4ML (CORRESPONDANT A 40MG/0.4ML)",
    "COND": "B/1SERING. PREREMPL. DE 0.4ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF.",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EMCURE PHARMACEUTICALS LTD",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/1/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "13/1/2013",
    "TYPE": "",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Hématologie et hémostase"]
  },
  {
    "PregnancyIndexLink": ["enoxaparin"],
    "InteractionIndexLink": ["enoxaparine"],
    "N_ENREGISTREMENT": "376/ 12 B 082 /96/15",
    "CODE_DCI": "12 B 082",
    "DCI": "ENOXAPARINE SODIQUE  (HEPARINE A BAS POIDS MOLECULAIRE HBPM)",
    "NOM_COMMERCIALE": "LOVENOX",
    "FORME": "SOL.INJ.SC. ET INTRAVASCULAIRE EN SERING. PREREMPL.",
    "DOSAGE": "4 000UI ANTI-XA/0.4ML (CORRESPONDANT A 40MG/0.4ML)",
    "COND": "B/02 ET B/6 SERING. PREREMPL. DE 0.4ML AVEC SYSTÈME DE SECURITE",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANOFI AVENTIS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/11/1996",
    "DATE_D_ENREGISTREMENT_FINAL": "13/12/2015",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Hématologie et hémostase"]
  },
  {
    "PregnancyIndexLink": ["enoxaparin"],
    "InteractionIndexLink": ["enoxaparine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "12 B 082",
    "DCI": "ENOXAPARINE SODIQUE",
    "NOM_COMMERCIALE": "THERANOX",
    "FORME": "SOL INJ S/C ET I/V EN SERINGUE PRE REMPLIE",
    "DOSAGE": "4000UI ANTI-XA/0.4ML",
    "COND": "B/02 SERINGUES",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Hématologie et hémostase"]
  },
  {
    "PregnancyIndexLink": ["enoxaparin"],
    "InteractionIndexLink": ["enoxaparine"],
    "N_ENREGISTREMENT": "433/12 B 082/20",
    "CODE_DCI": "12 B 082",
    "DCI": "Enoxaparine sodique",
    "NOM_COMMERCIALE": "VARENOX",
    "FORME": "SOL INJ S/C et  I/V en seringue préremplie",
    "DOSAGE": "4000UI ANTI-XA/0.4ML",
    "COND": "B/02 SERINGUES",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRATER RAZES SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "5/2/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "5/2/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Hématologie et hémostase"]
  },
  {
    "PregnancyIndexLink": ["enoxaparin"],
    "InteractionIndexLink": ["enoxaparine"],
    "N_ENREGISTREMENT": "471/ 12 B 083 /13",
    "CODE_DCI": "12 B 083",
    "DCI": "ENOXAPARINE SODIQUE  (HEPARINE A BAS POIDS MOLECULAIRE HBPM)",
    "NOM_COMMERCIALE": "LOMOH-60",
    "FORME": "SOL. INJ. SC/IV ET INTRAVASCULAIRE",
    "DOSAGE": "6000UI ANTI-Xa/0.6ML (CORRESPODANT A 60MG/0.6ML)",
    "COND": "B/1SERING. PREREMPL. DE 0.6ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF.",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EMCURE PHARMACEUTICALS LTD",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/1/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "13/1/2013",
    "TYPE": "",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Hématologie et hémostase"]
  },
  {
    "PregnancyIndexLink": ["enoxaparin"],
    "InteractionIndexLink": ["enoxaparine"],
    "N_ENREGISTREMENT": "376/ 12 B 083 /96/15",
    "CODE_DCI": "12 B 083",
    "DCI": "ENOXAPARINE SODIQUE  (HEPARINE A BAS POIDS MOLECULAIRE HBPM)",
    "NOM_COMMERCIALE": "LOVENOX",
    "FORME": "SOL.INJ.SC. ET INTRAVASCULAIRE EN SERING. PREREMPL.",
    "DOSAGE": "6 000UI ANTI-X/0.6ML    (CORRESPONDANT A 60MG/0.6ML)",
    "COND": "B/02 ET B/10 SERING. PREREMPL. DE 0.6ML AVEC SYSTÈME DE SECURITE",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANOFI AVENTIS FRANCE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/11/1996",
    "DATE_D_ENREGISTREMENT_FINAL": "2/12/2015",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Hématologie et hémostase"]
  },
  {
    "PregnancyIndexLink": ["enoxaparin"],
    "InteractionIndexLink": ["enoxaparine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "12 B 083",
    "DCI": "ENOXAPARINE SODIQUE",
    "NOM_COMMERCIALE": "THERANOX",
    "FORME": "SOL INJ S/C ET I/V EN SERINGUE PRE REMPLIE",
    "DOSAGE": "6000UI ANTI-XA/0.6ML",
    "COND": "B/02 SERINGUES",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Hématologie et hémostase"]
  },
  {
    "PregnancyIndexLink": ["enoxaparin"],
    "InteractionIndexLink": ["enoxaparine"],
    "N_ENREGISTREMENT": "433/12 B 083/20",
    "CODE_DCI": "12 B 083",
    "DCI": "Enoxaparine sodique",
    "NOM_COMMERCIALE": "VARENOX",
    "FORME": "SOL INJ S/C et  I/V en seringue préremplie",
    "DOSAGE": "6000UI ANTI-XA/0.6ML",
    "COND": "B/02 SERINGUES",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRATER RAZES SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "5/2/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "5/2/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Hématologie et hémostase"]
  },
  {
    "PregnancyIndexLink": ["enoxaparin"],
    "InteractionIndexLink": ["enoxaparine"],
    "N_ENREGISTREMENT": "471/ 12 B 084 /13",
    "CODE_DCI": "12 B 084",
    "DCI": "ENOXAPARINE SODIQUE  (HEPARINE A BAS POIDS MOLECULAIRE HBPM)",
    "NOM_COMMERCIALE": "LOMOH-80",
    "FORME": "SOL. INJ. SC/IV ET INTRAVASCULAIRE",
    "DOSAGE": "8000UI ANTI-Xa/0.8ML (CORRESPONDANT A 80MG/0.8ML)",
    "COND": "B/1SERING. PREREMPL. DE 0.8ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF.",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EMCURE PHARMACEUTICALS LTD",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/1/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "13/1/2013",
    "TYPE": "",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Hématologie et hémostase"]
  },
  {
    "PregnancyIndexLink": ["enoxaparin"],
    "InteractionIndexLink": ["enoxaparine"],
    "N_ENREGISTREMENT": "376/ 12 B 084 /96/15",
    "CODE_DCI": "12 B 084",
    "DCI": "ENOXAPARINE SODIQUE  (HEPARINE A BAS POIDS MOLECULAIRE HBPM)",
    "NOM_COMMERCIALE": "LOVENOX",
    "FORME": "SOL.INJ.SC. ET INTRAVASCULAIRE EN SERING. PREREMPL.",
    "DOSAGE": "8 000UI ANTI-XA/0.8ML (CORRESPONDANT A 80MG/0.8ML)",
    "COND": "B/02 et b/10 SERING. PREREMPL. DE 0.8ML AVEC SYSTÈME DE SECURITE",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANOFI AVENTIS FRANCE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/11/1996",
    "DATE_D_ENREGISTREMENT_FINAL": "2/12/2015",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Hématologie et hémostase"]
  },
  {
    "PregnancyIndexLink": ["enoxaparin"],
    "InteractionIndexLink": ["enoxaparine"],
    "N_ENREGISTREMENT": "433/12 B 084/20",
    "CODE_DCI": "12 B 084",
    "DCI": "Enoxaparine sodique",
    "NOM_COMMERCIALE": "VARENOX",
    "FORME": "SOL INJ S/C et  I/V en seringue préremplie",
    "DOSAGE": "8000UI ANTI-XA/0.8ML",
    "COND": "B/02 SERINGUES",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRATER RAZES SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "5/2/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "5/2/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Hématologie et hémostase"]
  },
  {
    "PregnancyIndexLink": ["nadroparin"],
    "InteractionIndexLink": ["nadroparine calcique"],
    "N_ENREGISTREMENT": "467/ 12 B 087 /97/19",
    "CODE_DCI": "12 B 087",
    "DCI": "NADROPARINE CALCIQUE (HBPM)",
    "NOM_COMMERCIALE": "FRAXIPARINE",
    "FORME": "SOL INJ SC EN SER PRE REMPL.",
    "DOSAGE": "2 850UI ANTI XA/0.3ML",
    "COND": "B/2 ET 10",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ASPEN PHARMA SCHWEIZ GMBH",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SUISSE",
    "DATE_D_ENREGISTREMENT_INITIAL": "8/11/1997",
    "DATE_D_ENREGISTREMENT_FINAL": "26/3/2019",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["nadroparin"],
    "InteractionIndexLink": ["nadroparine calcique"],
    "N_ENREGISTREMENT": "467/ 12 B 088 /02/18",
    "CODE_DCI": "12 B 088",
    "DCI": "NADROPARINE CALCIQUE (HEPARINE A BAS POIDS MOLECULAIRE HBPM)",
    "NOM_COMMERCIALE": "FRAXIPARINE",
    "FORME": "SOL.INJ.SC EN SERING. PREREMPL.",
    "DOSAGE": "3 800UI AXa/0.4ML",
    "COND": "B/10",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ASPEN PHARMA SCHWEIZ GMBH",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SUISSE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/9/2002",
    "DATE_D_ENREGISTREMENT_FINAL": "13/11/2018",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["nadroparin"],
    "InteractionIndexLink": ["nadroparine calcique"],
    "N_ENREGISTREMENT": "467/ 12 B 089 /97 /18",
    "CODE_DCI": "12 B 089",
    "DCI": "NADROPARINE CALCIQUE (HEPARINE A BAS POIDS MOLECULAIRE HBPM)",
    "NOM_COMMERCIALE": "FRAXIPARINE",
    "FORME": "SOL.INJ.SC EN SERING. PREREMPL.",
    "DOSAGE": "5 700U I ANTI XA/0.6ML",
    "COND": "B/10",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ASPEN PHARMA SCHWEIZ GMBH",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SUISSE",
    "DATE_D_ENREGISTREMENT_INITIAL": "8/11/1997",
    "DATE_D_ENREGISTREMENT_FINAL": "31/10/2018",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["tinzaparin"],
    "InteractionIndexLink": ["tinzaparine"],
    "N_ENREGISTREMENT": "083/ 12 B 097 /03/13",
    "CODE_DCI": "12 B 097",
    "DCI": "TINZAPARINE SODIQUE (HBPM)",
    "NOM_COMMERCIALE": "INNOHEP",
    "FORME": "SOL.INJ.SC EN SERING. PREREMPL.",
    "DOSAGE": "2 500UI ANTI XA/0.25ML",
    "COND": "B/02 SERING. PREREMPL. DE 0.25ML AVEC SYSTÈME DE SECURITE D'AIGUILLE",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LEO",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/5/2003",
    "DATE_D_ENREGISTREMENT_FINAL": "17/7/2013",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Hématologie et hémostase"]
  },
  {
    "PregnancyIndexLink": ["tinzaparin"],
    "InteractionIndexLink": ["tinzaparine"],
    "N_ENREGISTREMENT": "083/ 12 B 098 /03/13",
    "CODE_DCI": "12 B 098",
    "DCI": "TINZAPARINE SODIQUE (HBPM)",
    "NOM_COMMERCIALE": "INNOHEP",
    "FORME": "SOL.INJ.SC EN SERING. PREREMPL.",
    "DOSAGE": "3 500UI ANTI-XA/0.35ML",
    "COND": "B/02 SERING. PREREMPL. DE 0.35ML AVEC SYSTÈME DE SECURITE D'AIGUILLE",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LEO",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/5/2003",
    "DATE_D_ENREGISTREMENT_FINAL": "17/7/2013",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Hématologie et hémostase"]
  },
  {
    "PregnancyIndexLink": ["tinzaparin"],
    "InteractionIndexLink": ["tinzaparine"],
    "N_ENREGISTREMENT": "083/ 12 B 099 /03/13",
    "CODE_DCI": "12 B 099",
    "DCI": "TINZAPARINE SODIQUE  (HBPM)",
    "NOM_COMMERCIALE": "INNOHEP",
    "FORME": "SOL.INJ.SC EN SERING. PREREMPL.",
    "DOSAGE": "4 500UI ANTI-XA/0.45ML",
    "COND": "B/02 SERING. PREREMPL. DE 0.45ML AVEC SYSTÈME DE SECURITE D'AIGUILLE",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LEO",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/5/2003",
    "DATE_D_ENREGISTREMENT_FINAL": "17/7/2013",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Hématologie et hémostase"]
  },
  {
    "PregnancyIndexLink": ["dalteparin"],
    "InteractionIndexLink": ["dalteparine sodique"],
    "N_ENREGISTREMENT": "045/ 12 B 163 /13",
    "CODE_DCI": "12 B 163",
    "DCI": "DALTEPARINE SODIQUE",
    "NOM_COMMERCIALE": "FRAGMINE",
    "FORME": "SOL. INJ. EN SERING. PREREMPL.",
    "DOSAGE": "2 500UI ANTI-XA/0.2ML",
    "COND": "B/02SERING. PREREMPL. DE 0.2ML AVEC SYSTÈME DE SECURITE DE L'AIGUILLE",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PFIZER HOLDING FRANCE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/5/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "2/5/2013",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["dalteparin"],
    "InteractionIndexLink": ["dalteparine sodique"],
    "N_ENREGISTREMENT": "045/ 12 B 164 /13",
    "CODE_DCI": "12 B 164",
    "DCI": "DALTEPARINE SODIQUE",
    "NOM_COMMERCIALE": "FRAGMINE",
    "FORME": "SOL. INJ. EN SERING. PREREMPL.",
    "DOSAGE": "5 000UI ANTI-XA/0.2ML",
    "COND": "B/02SERING. PREREMPL. DE 0.2ML AVEC SYSTÈME DE SECURITE DE L'AIGUILLE",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PFIZER HOLDING FRANCE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/5/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "2/5/2013",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["dalteparin"],
    "InteractionIndexLink": ["dalteparine sodique"],
    "N_ENREGISTREMENT": "045/ 12 B 165 /13",
    "CODE_DCI": "12 B 165",
    "DCI": "DALTEPARINE SODIQUE",
    "NOM_COMMERCIALE": "FRAGMINE",
    "FORME": "SOL. INJ. EN SERING. PREREMPL.",
    "DOSAGE": "7 500 UI ANTI-XA/0.75ml",
    "COND": "B/02SERING. PREREMPL. DE 0.75ML AVEC SYSTÈME DE SECURITE DE L'AIGUILLE",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PFIZER HOLDING FRANCE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/5/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "2/5/2013",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["dalteparin"],
    "InteractionIndexLink": ["dalteparine sodique"],
    "N_ENREGISTREMENT": "045/ 12 B 169 /14",
    "CODE_DCI": "12 B 169",
    "DCI": "DALTEPARINE SODIQUE",
    "NOM_COMMERCIALE": "FRAGMINE",
    "FORME": "SOL INJ EN SERINGUE PRE-REMPLIE",
    "DOSAGE": "10 000UI ANTI-XA/1ML",
    "COND": "B/02 SERINGUES PRE-REMPLIES 1ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PFIZER HOLDING FRANCE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/5/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "4/5/2014",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["acide folique"],
    "InteractionIndexLink": ["acide folique"],
    "N_ENREGISTREMENT": "348/ 12 E 020 /15",
    "CODE_DCI": "12 E 020",
    "DCI": "ACIDE FOLIQUE",
    "NOM_COMMERCIALE": "ACIDE FOLIQUE - API",
    "FORME": "COMPRIME",
    "DOSAGE": "5MG",
    "COND": "B/20",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIAN PHARMACEUTICAL INSTITUTE (API) SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/5/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "13/5/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Hématologie et hémostase"]
  },
  {
    "PregnancyIndexLink": ["acide folique"],
    "InteractionIndexLink": ["acide folique"],
    "N_ENREGISTREMENT": "077/12 E 020/17",
    "CODE_DCI": "12 E 020",
    "DCI": "ACIDE FOLIQUE",
    "NOM_COMMERCIALE": "CIFLODINE",
    "FORME": "GELULE",
    "DOSAGE": "5MG",
    "COND": "B/60",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABOIRATOIRE ALGERIEN DU MEDICAMENT (LAM )",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/6/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "12/6/2017",
    "TYPE": "Gé",
    "STATUT": "F PREMIX",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Hématologie et hémostase"]
  },
  {
    "PregnancyIndexLink": ["acide folique"],
    "InteractionIndexLink": ["acide folique"],
    "N_ENREGISTREMENT": "418/ 12 E 020 /14",
    "CODE_DCI": "12 E 020",
    "DCI": "ACIDE FOLIQUE",
    "NOM_COMMERCIALE": "FOLACID",
    "FORME": "COMPRIME",
    "DOSAGE": "5MG",
    "COND": "B/60",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NEOMEDIC SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/11/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "30/11/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Hématologie et hémostase"]
  },
  {
    "PregnancyIndexLink": ["acide folique"],
    "InteractionIndexLink": ["acide folique"],
    "N_ENREGISTREMENT": "320/12 E 020/20",
    "CODE_DCI": "12 E 020",
    "DCI": "ACIDE FOLIQUE",
    "NOM_COMMERCIALE": "FOLACIQ",
    "FORME": "COMPRIME.",
    "DOSAGE": "05MG",
    "COND": "B/60",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES AGD PHARM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "14/4/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "14/4/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Hématologie et hémostase"]
  },
  {
    "PregnancyIndexLink": ["acide folique"],
    "InteractionIndexLink": ["acide folique"],
    "N_ENREGISTREMENT": "242/ 12 E 020 /04/17",
    "CODE_DCI": "12 E 020",
    "DCI": "ACIDE FOLIQUE",
    "NOM_COMMERCIALE": "FOLIDEN",
    "FORME": "COMPRIME",
    "DOSAGE": "5MG",
    "COND": "B/60",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GROUPE SANTE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "21/7/2004",
    "DATE_D_ENREGISTREMENT_FINAL": "11/12/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Hématologie et hémostase"]
  },
  {
    "PregnancyIndexLink": ["acide folique"],
    "InteractionIndexLink": ["acide folique"],
    "N_ENREGISTREMENT": "470/ 12 E 020 /13",
    "CODE_DCI": "12 E 020",
    "DCI": "ACIDE FOLIQUE",
    "NOM_COMMERCIALE": "FONITRA",
    "FORME": "COMPRIME",
    "DOSAGE": "5MG",
    "COND": "B/60",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MM (SARL LABORATOIRES MM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/9/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "30/9/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Hématologie et hémostase"]
  },
  {
    "PregnancyIndexLink": ["acide folique"],
    "InteractionIndexLink": ["acide folique"],
    "N_ENREGISTREMENT": "380/ 12 E 020 /14/21",
    "CODE_DCI": "12 E 020",
    "DCI": "Acide folique",
    "NOM_COMMERCIALE": "HUPFOLIQ",
    "FORME": "Comprimé",
    "DOSAGE": "5MG",
    "COND": "B/60",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HUP.P.PHARMA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/7/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "28/3/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Hématologie et hémostase"]
  },
  {
    "PregnancyIndexLink": ["acide folique"],
    "InteractionIndexLink": ["acide folique"],
    "N_ENREGISTREMENT": "380/ 12 E 020 /14",
    "CODE_DCI": "12 E 020",
    "DCI": "ACIDE FOLIQUE",
    "NOM_COMMERCIALE": "HUPFOLIQ",
    "FORME": "COMPRIME",
    "DOSAGE": "5MG",
    "COND": "B/60",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HUP.P.PHARMA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/7/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "6/7/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Hématologie et hémostase"]
  },
  {
    "PregnancyIndexLink": ["acide folique"],
    "InteractionIndexLink": ["acide folique"],
    "N_ENREGISTREMENT": "462/12 E 020/19",
    "CODE_DCI": "12 E 020",
    "DCI": "ACIDE FOLIQUE",
    "NOM_COMMERCIALE": "PHYSIOFOL",
    "FORME": "COMP",
    "DOSAGE": "5MG",
    "COND": "B/60",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHYSIOPHARM SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Hématologie et hémostase"]
  },
  {
    "PregnancyIndexLink": ["acide folique"],
    "InteractionIndexLink": ["acide folique"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "12 E 020",
    "DCI": "ACIDE FOLIQUE",
    "NOM_COMMERCIALE": "ZANITRA",
    "FORME": "CPR",
    "DOSAGE": "5 MG",
    "COND": "BT/60",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Hématologie et hémostase"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["cyanocobalamine"],
    "N_ENREGISTREMENT": "003/ 12 E 021/98/20",
    "CODE_DCI": "12 E 021",
    "DCI": "CYANOCOBALAMINE",
    "NOM_COMMERCIALE": "COBAMINE",
    "FORME": "SOL. INJ.",
    "DOSAGE": "1000µG/ML",
    "COND": "B/5 AMP. DE 1ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EPE GROUPE INDUSTRIEL SAIDAL SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "21/12/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "5/1/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Hématologie et hémostase"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["cyanocobalamine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "12 E 021",
    "DCI": "CYANOCOBALAMINE",
    "NOM_COMMERCIALE": "VIT B12",
    "FORME": "SOL INJ",
    "DOSAGE": "1000µG/ML",
    "COND": "B/05 AMPS DE 1ML",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Hématologie et hémostase"]
  },
  {
    "PregnancyIndexLink": ["fer"],
    "InteractionIndexLink": ["fer"],
    "N_ENREGISTREMENT": "077/ 12 E 025 /98/16",
    "CODE_DCI": "12 E 025",
    "DCI": "FEREDETATE DE SODIUM",
    "NOM_COMMERCIALE": "FEROLAM",
    "FORME": "SIROP",
    "DOSAGE": "4.75 G/100ML",
    "COND": "FL/125ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE ALGERIEN DU MEDICAMENT  (LAM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/5/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "26/7/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Hématologie et hémostase"]
  },
  {
    "PregnancyIndexLink": ["fer"],
    "InteractionIndexLink": ["fer"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "12 E 026",
    "DCI": "FUMARATE FERREUX (fer)",
    "NOM_COMMERCIALE": "FUMACUR",
    "FORME": "COMPRIME",
    "DOSAGE": "200MG",
    "COND": "B/80",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Hématologie et hémostase"]
  },
  {
    "PregnancyIndexLink": ["epoetin alfa"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "286/ 12 E 061 /12",
    "CODE_DCI": "12 E 061",
    "DCI": "EPOETINE ALFA  (OU ERYTHROPOÏETINE HUMAINE RECOMBINANTE)",
    "NOM_COMMERCIALE": "RELIPOIETIN 2000",
    "FORME": "SOL. INJ. SC OU IV",
    "DOSAGE": "2 000UI/0.5ML",
    "COND": "B/1SERING. PREREMPLIE DE 0.5ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CHIMIE PHARMACIE COMMERCE MULTIPLE SARL (CPCM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/1/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "10/1/2012",
    "TYPE": "",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["epoetin alfa"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "286/ 12 E 062 /12",
    "CODE_DCI": "12 E 062",
    "DCI": "EPOETINE ALFA  (OU ERYTHROPOÏETINE HUMAINE RECOMBINANTE)",
    "NOM_COMMERCIALE": "RELIPOIETIN 4000",
    "FORME": "SOL. INJ. SC OU IV",
    "DOSAGE": "4 000UI/0.4ML",
    "COND": "B/1SERING. PREREMPLIE DE 0.4ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CHIMIE PHARMACIE COMMERCE MULTIPLE SARL (CPCM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/1/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "10/1/2012",
    "TYPE": "",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["epoetin alfa"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "286/ 12 E 063 /12",
    "CODE_DCI": "12 E 063",
    "DCI": "EPOETINE ALFA  (OU ERYTHROPOÏETINE HUMAINE RECOMBINANTE)",
    "NOM_COMMERCIALE": "RELIPOIETIN 10 000",
    "FORME": "SOL. INJ. SC/ IV",
    "DOSAGE": "10 000UI/ML",
    "COND": "B/1SERING. PREREMPLIE DE 1ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CHIMIE PHARMACIE COMMERCE MULTIPLE SARL (CPCM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/1/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "10/1/2012",
    "TYPE": "",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["iron polymaltose (parenteral)"],
    "InteractionIndexLink": ["fer"],
    "N_ENREGISTREMENT": "438/ 12 E 077 /09 /16",
    "CODE_DCI": "12 E 077",
    "DCI": "HYDROXYDE FERRIQUE POLYMALTOSE EXPRIME EN FER FERRIQUE",
    "NOM_COMMERCIALE": "COSMOFER",
    "FORME": "SOL. INJ.IM/IV OU PERF.",
    "DOSAGE": "50MG/ML  (OU 100MG/2ML) DE FER FERRIQUE",
    "COND": "B/5AMP. DE 2ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMACOSMOS A/S",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "DANEMARK",
    "DATE_D_ENREGISTREMENT_INITIAL": "31/5/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "6/3/2017",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "30 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Hématologie et hémostase"]
  },
  {
    "PregnancyIndexLink": ["acide folique", "fer"],
    "InteractionIndexLink": ["acide folique", "fer"],
    "N_ENREGISTREMENT": "099/ 12 E 078 /99/13",
    "CODE_DCI": "12 E 078",
    "DCI": "SULFATE FERREUX DESSECHE EXPRIME EN FER FERREUX /  ACIDE FOLIQUE",
    "NOM_COMMERCIALE": "TARDYFERON B9",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "50MG / 0.35MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PIERRE FABRE MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/6/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "15/9/2013",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["iron polymaltose (oral)"],
    "InteractionIndexLink": ["fer"],
    "N_ENREGISTREMENT": "079/ 12 E 106 /09/17",
    "CODE_DCI": "12 E 106",
    "DCI": "HYDROXYDE FERRIQUE POLYMALTOSE EXPRIME EN FER FERRIQUE",
    "NOM_COMMERCIALE": "FER 3+",
    "FORME": "SOL. BUV. AMP.",
    "DOSAGE": "20MG/ML (100MG/5ML)",
    "COND": "B/30AMP. DE 5ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE  ALGERIEN DE DEVELOPPEMENT  PHARMACEUTIQUE   (LAD)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/5/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "18/6/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Hématologie et hémostase"]
  },
  {
    "PregnancyIndexLink": ["iron polymaltose (oral)"],
    "InteractionIndexLink": ["fer"],
    "N_ENREGISTREMENT": "480/ 12 E 106 /13",
    "CODE_DCI": "12 E 106",
    "DCI": "HYDROXYDE FERRIQUE POLYMALTOSE EXPRIME EN FER FERRIQUE",
    "NOM_COMMERCIALE": "FERROCURE",
    "FORME": "SOL. BUV. EN AMP.",
    "DOSAGE": "20MG/ML (100MG/5ML)",
    "COND": "B/20AMP. DE 5ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GENIS EURL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/10/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "20/10/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Hématologie et hémostase"]
  },
  {
    "PregnancyIndexLink": ["iron polymaltose (oral)"],
    "InteractionIndexLink": ["fer"],
    "N_ENREGISTREMENT": "304/ 12 E 106 /16",
    "CODE_DCI": "12 E 106",
    "DCI": "HYDROXYDE FERRIQUE POLYMALTOSE EXPRIME EN FER FERRIQUE",
    "NOM_COMMERCIALE": "GEOFER",
    "FORME": "SOL. BUV. EN FLACONS",
    "DOSAGE": "20MG/ML (100MG/5ML)",
    "COND": "B/10 FLACONS DE 5ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL GEOPHARM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "11/5/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "11/5/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Hématologie et hémostase"]
  },
  {
    "PregnancyIndexLink": ["iron polymaltose (oral)"],
    "InteractionIndexLink": ["fer"],
    "N_ENREGISTREMENT": "20/01/12 E106/426",
    "CODE_DCI": "12 E 106",
    "DCI": "COMPLEXE D'HYDROXYDE POLYMALTOSE DE FER III ÉQUIVALENT A 100MG DE FER ÉLEMENTAIRE",
    "NOM_COMMERCIALE": "TRIFER",
    "FORME": "SOL BUV",
    "DOSAGE": "100MG DE FER ELEMENTAIRE",
    "COND": "B/10FL. DE 5ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES ABDI IBRAHIM REMEDE PHARMA SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "5/12/2001",
    "DATE_D_ENREGISTREMENT_FINAL": "31/5/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Hématologie et hémostase"]
  },
  {
    "PregnancyIndexLink": ["iron polymaltose (oral)"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "12 E 106",
    "DCI": "COMPLEXE HYDROXYDE POLYMALTOSE",
    "NOM_COMMERCIALE": "TRIFER",
    "FORME": "SOL Buv",
    "DOSAGE": "100mg/5ml",
    "COND": "Boite de 10 flacons de 5ml",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Hématologie et hémostase"]
  },
  {
    "PregnancyIndexLink": ["acide folique", "fer"],
    "InteractionIndexLink": ["acide folique", "fer"],
    "N_ENREGISTREMENT": "268/12 E 108/03/18",
    "CODE_DCI": "12 E 108",
    "DCI": "COMPLEXE DE FER II - GLYCINE SULFATE / ACIDE FOLIQUE",
    "NOM_COMMERCIALE": "FERRO SANOL GYN",
    "FORME": "GLES à gran .gastro-résist",
    "DOSAGE": "454.13MG équivalent en Fer (2+) 80MG/1MG",
    "COND": "B/50",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MERINAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "23/3/2003",
    "DATE_D_ENREGISTREMENT_FINAL": "31/12/2018",
    "TYPE": "Ré",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Hématologie et hémostase"]
  },
  {
    "PregnancyIndexLink": ["iron polymaltose (oral)"],
    "InteractionIndexLink": ["fer"],
    "N_ENREGISTREMENT": "177/ 12 E 109 /05/14",
    "CODE_DCI": "12 E 109",
    "DCI": "HYDROXYDE FERRIQUE POLYMALTOSE EXPRIME EN FER FERRIQUE",
    "NOM_COMMERCIALE": "FERRUM HAUSMANN",
    "FORME": "SIROP",
    "DOSAGE": "10MG/ML (50MG/5ML)",
    "COND": "FL150ML+ cuillère mesure de 5ml",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ABDI IBRAHIM ILAÇ SANAYI VE TICARET AS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "TURQUIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/11/2005",
    "DATE_D_ENREGISTREMENT_FINAL": "1/6/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Hématologie et hémostase"]
  },
  {
    "PregnancyIndexLink": ["iron polymaltose (oral)"],
    "InteractionIndexLink": ["fer"],
    "N_ENREGISTREMENT": "304/ 12 E 109 /18",
    "CODE_DCI": "12 E 109",
    "DCI": "HYDROXYDE FERRIQUE POLYMALTOSE EXPRIME EN FER FERRIQUE",
    "NOM_COMMERCIALE": "GEOFER",
    "FORME": "SIROP",
    "DOSAGE": "10MG/ML (50MG/5ML)",
    "COND": "FL100ML+ cuillère mesure de 5ml",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL GEOPHARM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/4/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "30/4/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Hématologie et hémostase"]
  },
  {
    "PregnancyIndexLink": ["iron polymaltose (oral)"],
    "InteractionIndexLink": ["fer"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "12 E 109",
    "DCI": "HYDROXYDE FERRIQUE POLYMALTOSE EXPRIME EN FER FERRIQUE",
    "NOM_COMMERCIALE": "OROFER",
    "FORME": "SIROP",
    "DOSAGE": "10MG/ML (50MG/5ML)",
    "COND": "FL./100ML + GOBELET DOSEUR",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Hématologie et hémostase"]
  },
  {
    "PregnancyIndexLink": ["iron polymaltose (oral)"],
    "InteractionIndexLink": ["fer"],
    "N_ENREGISTREMENT": "242/ 12 E 109 /18",
    "CODE_DCI": "12 E 109",
    "DCI": "HYDROXYDE FERRIQUE POLYMALTOSE EXPRIME EN FER FERRIQUE",
    "NOM_COMMERCIALE": "POLYFER",
    "FORME": "SIROP",
    "DOSAGE": "10MG/ML (50MG/5ML)",
    "COND": "FL100ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GROUPE SANTE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "31/1/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "31/1/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Hématologie et hémostase"]
  },
  {
    "PregnancyIndexLink": ["iron polymaltose (oral)"],
    "InteractionIndexLink": ["fer"],
    "N_ENREGISTREMENT": "426/ 12 E 109 /08/20",
    "CODE_DCI": "12 E 109",
    "DCI": "HYDROXYDE FERRIQUE POLYMALTOSE EXPRIME EN FER FERRIQUE",
    "NOM_COMMERCIALE": "SELOFER-50",
    "FORME": "SIROP",
    "DOSAGE": "10MG/ML (50MG/5ML)",
    "COND": "B/1FL./150ML + PIPETTE GRADUEE",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ABDI IBRAHIM REMEDE PHARMA SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/12/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "5/2/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Hématologie et hémostase"]
  },
  {
    "PregnancyIndexLink": ["epoetin alfa"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "329/ 12 E 112 /06/17",
    "CODE_DCI": "12 E 112",
    "DCI": "EPOETINE ALPHA (ERYTHROPOIETINE HUMAINE RECOMBINANTE)",
    "NOM_COMMERCIALE": "EPOTIN",
    "FORME": "SOL. INJ. IV/SC",
    "DOSAGE": "2000UI/ML (SOIT 16.8µG//FL DE 1ML)",
    "COND": "B/10FL. DE 1ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GULF PHARMACEUTICAL INDUSTRIES  (JULPHAR)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EMIRATS ARABES UNIS",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/7/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "3/8/2017",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["folic acid", "fer"],
    "InteractionIndexLink": ["acide folique", "fer"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "12 E 125",
    "DCI": "IRON FERROUS (fer) / FOLIC ACID (acide folique)",
    "NOM_COMMERCIALE": "ZANITRA PLUS",
    "FORME": "GELULE",
    "DOSAGE": "49.297MG/ 0.50MG",
    "COND": "BT/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Hématologie et hémostase"]
  },
  {
    "PregnancyIndexLink": ["fer"],
    "InteractionIndexLink": ["fer"],
    "N_ENREGISTREMENT": "418/12 E 128/20",
    "CODE_DCI": "12 E 128",
    "DCI": "FER SOUS FORME DE SULFATE FERREUX",
    "NOM_COMMERCIALE": "NEOFERON",
    "FORME": "COMP. PELL.",
    "DOSAGE": "80MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES NEOMEDIC/ SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/12/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "7/12/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Hématologie et hémostase"]
  },
  {
    "PregnancyIndexLink": ["fer"],
    "InteractionIndexLink": ["fer"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "12 E 128",
    "DCI": "FER FERREUX (DCI)   (SOUS FORME DE SULFATE FERREUX)",
    "NOM_COMMERCIALE": "TARDYFERON",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "80MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Hématologie et hémostase"]
  },
  {
    "PregnancyIndexLink": ["acide folique", "iron polymaltose (oral)"],
    "InteractionIndexLink": ["acide folique", "fer"],
    "N_ENREGISTREMENT": "504/ 12 E 133 /16",
    "CODE_DCI": "12 E 133",
    "DCI": "COMPLEXE HYDROXYDE FERRIQUE POLYMALTOSE EXPRIME EN FER FERRIQUE / ACIDE FOLIQUE",
    "NOM_COMMERCIALE": "NOVO FER PLUS",
    "FORME": "COMPRIME A SUCER",
    "DOSAGE": "100MG/0.35MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL NOVO MEDIS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/7/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "24/7/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Hématologie et hémostase"]
  },
  {
    "PregnancyIndexLink": ["acide folique", "iron polymaltose (oral)"],
    "InteractionIndexLink": ["acide folique", "fer"],
    "N_ENREGISTREMENT": "426/ 12 E 133 /13/20",
    "CODE_DCI": "12 E 133",
    "DCI": "FER FERRIQUE (SOUS FORME DE COMPLEXE  D'HDYROXYDE FERRIQUE POLYMALTOSE) / ACIDE FOLIQUE",
    "NOM_COMMERCIALE": "SELOFER FOL",
    "FORME": "COMPRIME A SUCER",
    "DOSAGE": "100MG / 0.35MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ABDI IBRAHIM REMEDE PHARMA SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/9/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "8/4/2020",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Hématologie et hémostase"]
  },
  {
    "PregnancyIndexLink": ["acide folique", "iron polymaltose (oral)"],
    "InteractionIndexLink": ["acide folique", "fer"],
    "N_ENREGISTREMENT": "177/ 12 E 133 /07/16",
    "CODE_DCI": "12 E 133",
    "DCI": "COMPLEXE HYDROXYDE FERRIQUE POLYMALTOSE EXPRIME EN FER FERRIQUE / ACIDE FOLIQUE",
    "NOM_COMMERCIALE": "TRIFER FOL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "100MG/0.35MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ABDI IBRAHIM ILAÇ SANAYI VE TICARET A.S",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "TURQUIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/11/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "22/2/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Hématologie et hémostase"]
  },
  {
    "PregnancyIndexLink": ["iron polymaltose (oral)"],
    "InteractionIndexLink": ["fer"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "12 E 134",
    "DCI": "HYDORXIDE FERRIQUE POLYMALTOSE (fer)",
    "NOM_COMMERCIALE": "FERRUM HAUSMAN GOUTTE",
    "FORME": "Gttes buv",
    "DOSAGE": "50mg/ml",
    "COND": "Boite de un flacon de 30  ml",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Hématologie et hémostase"]
  },
  {
    "PregnancyIndexLink": ["iron polymaltose (oral)"],
    "InteractionIndexLink": ["fer"],
    "N_ENREGISTREMENT": "20/14/12 E134/177",
    "CODE_DCI": "12 E 134",
    "DCI": "HYDROXYDE FERRIQUE POLYMALTOSE EXPRIME EN FER FERRIQUE",
    "NOM_COMMERCIALE": "FERRUM HAUSMANN GOUTTES",
    "FORME": "SOL. BUV. GTTES.",
    "DOSAGE": "50MG/ML",
    "COND": "B/01FL.COMPT. GTTES DE 30ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ABDI IBRAHIM REMEDE PHARMA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/8/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "31/5/2020",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "60 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Hématologie et hémostase"]
  },
  {
    "PregnancyIndexLink": ["fer"],
    "InteractionIndexLink": ["fer"],
    "N_ENREGISTREMENT": "471/ 12 E 135 /13",
    "CODE_DCI": "12 E 135",
    "DCI": "COMPLEXE D'HYDROXIDE FERRIQUE-SACCHAROSE EXPRIME EN FER FERRIQUE",
    "NOM_COMMERCIALE": "ENCIFER",
    "FORME": "SOL. INJ. P. PERF. IV OU EN INJ. DANS LE DIALYSEUR",
    "DOSAGE": "20MG/ML (100MG/5ML)",
    "COND": "B/01FL. DE 5ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EMCURE PHARMACEUTICALS LTD",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "14/1/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "14/1/2013",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["fer"],
    "InteractionIndexLink": ["fer"],
    "N_ENREGISTREMENT": "329/ 12 E 135 /13",
    "CODE_DCI": "12 E 135",
    "DCI": "COMPLEXE D'HYDROXIDE FERRIQUE-SACCHAROSE EXPRIME EN FER FERRIQUE",
    "NOM_COMMERCIALE": "FEROMAX",
    "FORME": "SOL. INJ. P. PERF. IV OU EN INJ. DANS LE DIALYSEUR",
    "DOSAGE": "20MG/ML (100MG/5ML)",
    "COND": "B/05AMP. DE 5ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GULF PHARMACEUTICAL INDUSTRIES (JULPHAR)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EMIRATS ARABES UNIS",
    "DATE_D_ENREGISTREMENT_INITIAL": "8/10/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "8/10/2013",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["fer"],
    "InteractionIndexLink": ["fer"],
    "N_ENREGISTREMENT": "20/15/12 E135/433",
    "CODE_DCI": "12 E 135",
    "DCI": "COMPLEXE D'HYDROXYDE FERRIQUE- SACCHAROSE EXPRIMÉ EN FER ÉLÉMENT",
    "NOM_COMMERCIALE": "RAZIFER",
    "FORME": "SOLUTION INJ IV",
    "DOSAGE": "100MG/ 5ML",
    "COND": "B/ 5 AMPOULES",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SPA LES LABORATOIRES FRATER RAZES",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "31/5/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "29/9/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["fer"],
    "InteractionIndexLink": ["fer"],
    "N_ENREGISTREMENT": "433/ 12 E 135 /15/20",
    "CODE_DCI": "12 E 135",
    "DCI": "Complexe d’hydroxyde ferrique-saccharose exprimé en Fer élément (ferrique)",
    "NOM_COMMERCIALE": "RAZIFER",
    "FORME": "SOL. A DILUER P. PERF. IV",
    "DOSAGE": "100MG/5ML",
    "COND": "B/05 AMP. DE 5ML",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRATER RAZES SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "31/5/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "29/9/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["fer"],
    "InteractionIndexLink": ["fer"],
    "N_ENREGISTREMENT": "393/ 12 E 135 /07/14",
    "CODE_DCI": "12 E 135",
    "DCI": "COMPLEXE D'HYDROXIDE FERRIQUE-SACCHAROSE EXPRIME EN FER FERRIQUE",
    "NOM_COMMERCIALE": "VENOFER",
    "FORME": "SOL. INJ. PERF. IV OU EN INJ. DANS LE DIALYSEUR",
    "DOSAGE": "20MG/ML (100MG/5ML)",
    "COND": "B/05AMP. DE 5ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "VIFOR INTERNATIONAL INC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SUISSE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/11/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "28/10/2014",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["fer"],
    "InteractionIndexLink": ["fer"],
    "N_ENREGISTREMENT": "20/12 E 135/543",
    "CODE_DCI": "12 E 135",
    "DCI": "COMPLEXE D'HYDROXYDE FERRIQUE- SACCHAROSE EXPRIMÉ EN FER ÉLÉMENT",
    "NOM_COMMERCIALE": "VIVFER",
    "FORME": "SOL. INJ (I.M/I.V)",
    "DOSAGE": "100MG/ 5ML",
    "COND": "B/ 5 AMPOULES",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOTHERA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/9/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "30/9/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "25 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["cyanocobalamine"],
    "N_ENREGISTREMENT": "543/12 E 142/19",
    "CODE_DCI": "12 E 142",
    "DCI": "CYANOCOBALAMINE",
    "NOM_COMMERCIALE": "COBAVIT",
    "FORME": "SOL INJ ET BUV",
    "DOSAGE": "1000µG/2ML",
    "COND": "B/05 AMPS",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOTHERA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/7/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "1/7/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Hématologie et hémostase"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["cyanocobalamine"],
    "N_ENREGISTREMENT": "19/12 E142/380",
    "CODE_DCI": "12 E 142",
    "DCI": "CYANOCOBALAMINE",
    "NOM_COMMERCIALE": "VIT B 12",
    "FORME": "SOL INJ IM ET BUVABLE",
    "DOSAGE": "1000µG/2ML",
    "COND": "B/5AMPOULES DE 2ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "laboratoires HUP.P PHARMA Sarl",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "02/04/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "02/04/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Hématologie et hémostase"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["cyanocobalamine"],
    "N_ENREGISTREMENT": "433/12 E 142/17",
    "CODE_DCI": "12 E 142",
    "DCI": "CYANOCOBALAMINE (OU VIT.B12)",
    "NOM_COMMERCIALE": "VITAMINE B12 RAZES",
    "FORME": "SOL.INJ. ET BUV",
    "DOSAGE": "500 µG/ML (OU 1000µG/2ML)",
    "COND": "B/5AMP.",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRATER RAZES",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/9/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "7/9/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Hématologie et hémostase"]
  },
  {
    "PregnancyIndexLink": ["iron polymaltose (oral)"],
    "InteractionIndexLink": ["fer"],
    "N_ENREGISTREMENT": "504/ 12 E 149 /16",
    "CODE_DCI": "12 E 149",
    "DCI": "FER FERRIQUE (SOUS FORME DE COMPLEXE D'HYDROXYDE FERRIQUE POLYMALTOSE)",
    "NOM_COMMERCIALE": "NOVO FER",
    "FORME": "COMPRIME A SUCER",
    "DOSAGE": "100MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL NOVO MEDIS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/7/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "26/7/2016",
    "TYPE": "26/7/2016",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Hématologie et hémostase"]
  },
  {
    "PregnancyIndexLink": ["iron polymaltose (oral)"],
    "InteractionIndexLink": ["fer"],
    "N_ENREGISTREMENT": "242/ 12 E 149 /21",
    "CODE_DCI": "12 E 149",
    "DCI": "Complexe d’hydroxyde ferrique-polymaltose exprimé en Fer élément",
    "NOM_COMMERCIALE": "POLYFER",
    "FORME": "Comprimé sécable à sucer",
    "DOSAGE": "100MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GROUPE SANTE / SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "21/3/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "21/3/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Hématologie et hémostase"]
  },
  {
    "PregnancyIndexLink": ["iron polymaltose (oral)"],
    "InteractionIndexLink": ["fer"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "12 E 152",
    "DCI": "HYDROXYDE FERRIQUE POLYMALTOSE EXPRIME EN FER FERRIQUE",
    "NOM_COMMERCIALE": "OROFER PLUS",
    "FORME": "SIROP",
    "DOSAGE": "20MG/ML (100MG/5ML)",
    "COND": "FL./100ML + GOBELET DOSEUR  DE 15ML",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Hématologie et hémostase"]
  },
  {
    "PregnancyIndexLink": ["iron polymaltose (oral)"],
    "InteractionIndexLink": ["fer"],
    "N_ENREGISTREMENT": "426/12 E 152/08/20",
    "CODE_DCI": "12 E 152",
    "DCI": "COMPLEXE HYDROXYDE FERRIQUE POLYMALTOSE EXPRIME EN FER FERRIQUE",
    "NOM_COMMERCIALE": "SELOFER-100",
    "FORME": "SIROP.",
    "DOSAGE": "100MG/5ML",
    "COND": "B/ 1 FLC DE 150ML + 01 CAPSULE A VIS EN PLASTIQUE A L'EPREUVE DES ENFANTS+ CUILLERE MESURE",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES ABDIBRAHIM REMEDE PHARMA SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/12/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "17/12/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Hématologie et hémostase"]
  },
  {
    "PregnancyIndexLink": ["iron polymaltose (oral)"],
    "InteractionIndexLink": ["fer"],
    "N_ENREGISTREMENT": "426/ 12 E 152 /08/15",
    "CODE_DCI": "12 E 152",
    "DCI": "HYDROXYDE FERRIQUE POLYMALTOSE EXPRIME EN FER FERRIQUE",
    "NOM_COMMERCIALE": "SELOFER-100",
    "FORME": "SIROP",
    "DOSAGE": "20MG/ML (100MG/5ML)",
    "COND": "FL./150ML + 1CUILLERE GRADUEE",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ABDI IBRAHIM REMEDE PHARMA SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/12/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "31/3/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Hématologie et hémostase"]
  },
  {
    "PregnancyIndexLink": ["iron polymaltose (parenteral)"],
    "InteractionIndexLink": ["fer"],
    "N_ENREGISTREMENT": "001/12 E 199/19",
    "CODE_DCI": "12 E 199",
    "DCI": "Carboxymaltose ferrique exprimé en fer",
    "NOM_COMMERCIALE": "FERINJECT",
    "FORME": "SOL INJ P/PERF IV OU P/INJ DS DIALYSEUR",
    "DOSAGE": "50 MG/ML",
    "COND": "B/1FL DE 10 ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMACEUTICALS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/4/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "29/4/2019",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["tenecteplase"],
    "InteractionIndexLink": ["tenecteplase"],
    "N_ENREGISTREMENT": "519/ 12 F 129 /17",
    "CODE_DCI": "12 F 129",
    "DCI": "Ténectéplase GENNOVA",
    "NOM_COMMERCIALE": "ELAXIM",
    "FORME": "PDRE. ET SOLV. INJ. IV",
    "DOSAGE": "1000 U/ML OU 5MG/ML (10 000U/10ML OU 50MG/10ML)",
    "COND": "B/1FL. DE PDRE + 1/FL DE 10 ML EPPI + 01 SERINGUE DE 10 ML AVEC AIGUILLE + 03 LINGETTES ALCOLISéES",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GENNOVA BIOPHARMACEUTICALS LTD",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/12/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "25/12/2017",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["rivaroxaban"],
    "InteractionIndexLink": ["rivaroxaban"],
    "N_ENREGISTREMENT": "20/12 F159/293",
    "CODE_DCI": "12 F 159",
    "DCI": "RIVAROXABAN",
    "NOM_COMMERCIALE": "INHIXA",
    "FORME": "COMP PELL",
    "DOSAGE": "10MG",
    "COND": "B/30B/100",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOCARE SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "8/11/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "8/11/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["rivaroxaban"],
    "InteractionIndexLink": ["rivaroxaban"],
    "N_ENREGISTREMENT": "447/12 F 159/16",
    "CODE_DCI": "12 F 159",
    "DCI": "RIVAROXABAN",
    "NOM_COMMERCIALE": "TROMBIX",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "LIste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL BEKER",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/9/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "27/9/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["rivaroxaban"],
    "InteractionIndexLink": ["rivaroxaban"],
    "N_ENREGISTREMENT": "424/ 12 F 159 /09/16",
    "CODE_DCI": "12 F 159",
    "DCI": "RIVAROXABAN",
    "NOM_COMMERCIALE": "XARELTO",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "10MG",
    "COND": "B/05 - B/10 - B/30 - B/100",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BAYER HEALTHCARE AG",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALLEMAGNE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/12/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "11/5/2016",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["rivaroxaban"],
    "InteractionIndexLink": ["rivaroxaban"],
    "N_ENREGISTREMENT": "035/12 F 167/17",
    "CODE_DCI": "12 F 167",
    "DCI": "RIVAROXABAN",
    "NOM_COMMERCIALE": "RYVOL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "15MG",
    "COND": "B/30 ET B/40 ET B/42",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMALLIANCE EURL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/6/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "29/6/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["rivaroxaban"],
    "InteractionIndexLink": ["rivaroxaban"],
    "N_ENREGISTREMENT": "447/ 12 F 167 /16",
    "CODE_DCI": "12 F 167",
    "DCI": "RIVAROXABAN",
    "NOM_COMMERCIALE": "TROMBIX",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "15MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL BEKER",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "5/9/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "5/9/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["rivaroxaban"],
    "InteractionIndexLink": ["rivaroxaban"],
    "N_ENREGISTREMENT": "424/ 12 F 167 /13",
    "CODE_DCI": "12 F 167",
    "DCI": "RIVAROXABAN",
    "NOM_COMMERCIALE": "XARELTO",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "15MG",
    "COND": "B/14 - B/42 - B/100",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BAYER PHARMA AG",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALLEMAGNE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/10/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "27/10/2013",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["rivaroxaban"],
    "InteractionIndexLink": ["rivaroxaban"],
    "N_ENREGISTREMENT": "289 / 12 F 168 /21",
    "CODE_DCI": "12 F 168",
    "DCI": "Rivaroxaban",
    "NOM_COMMERCIALE": "RIVALTO",
    "FORME": "Comprimé pelliculé",
    "DOSAGE": "15MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRATER RAZES FORME SECHE SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/3/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "18/3/2021",
    "TYPE": "Gé",
    "STATUT": "F prémix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["rivaroxaban"],
    "InteractionIndexLink": ["rivaroxaban"],
    "N_ENREGISTREMENT": "289 / 12 F 168 /21",
    "CODE_DCI": "12 F 168",
    "DCI": "Rivaroxaban",
    "NOM_COMMERCIALE": "RIVALTO",
    "FORME": "Comprimé pelliculé",
    "DOSAGE": "20MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRATER RAZES FORME SECHE SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/4/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "6/4/2021",
    "TYPE": "Gé",
    "STATUT": "F prémix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["rivaroxaban"],
    "InteractionIndexLink": ["rivaroxaban"],
    "N_ENREGISTREMENT": "035/12 F 168/18",
    "CODE_DCI": "12 F 168",
    "DCI": "RIVAROXABAN",
    "NOM_COMMERCIALE": "RYVOL",
    "FORME": "COMP PELL",
    "DOSAGE": "20MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMALLIANCE EURL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/10/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "29/10/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["rivaroxaban"],
    "InteractionIndexLink": ["rivaroxaban"],
    "N_ENREGISTREMENT": "447/12 F 168/16",
    "CODE_DCI": "12 F 168",
    "DCI": "RIVAROXABAN",
    "NOM_COMMERCIALE": "TROMBIX",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "20MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL BEKER",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/12/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "4/12/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["rivaroxaban"],
    "InteractionIndexLink": ["rivaroxaban"],
    "N_ENREGISTREMENT": "424/ 12 F 168 /13",
    "CODE_DCI": "12 F 168",
    "DCI": "RIVAROXABAN",
    "NOM_COMMERCIALE": "XARELTO",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "20MG",
    "COND": "B/28 - B/100",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BAYER PHARMA AG",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALLEMAGNE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/10/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "20/10/2013",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["dabigatran etexilate"],
    "InteractionIndexLink": ["dabigatran"],
    "N_ENREGISTREMENT": "152/12 F 183/16",
    "CODE_DCI": "12 F 183",
    "DCI": "DABIGATRAN ETEXILATE MESILATE",
    "NOM_COMMERCIALE": "PRADAXA",
    "FORME": "GELULE",
    "DOSAGE": "75 MG",
    "COND": "B/30",
    "LISTE": "LIste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BOEHRINGER INGELHEIM INTERNATIONAL GMBH",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "Allemagne",
    "DATE_D_ENREGISTREMENT_INITIAL": "16/4/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "16/4/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["dabigatran etexilate"],
    "InteractionIndexLink": ["dabigatran"],
    "N_ENREGISTREMENT": "152/12 F 184/16",
    "CODE_DCI": "12 F 184",
    "DCI": "DABIGATRAN ETEXILATE MESILATE",
    "NOM_COMMERCIALE": "PRADAXA",
    "FORME": "GELULE",
    "DOSAGE": "110 MG",
    "COND": "B/30 ET B/60",
    "LISTE": "LIste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BOEHRINGER INGELHEIM INTERNATIONAL GMBH",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "Allemagne",
    "DATE_D_ENREGISTREMENT_INITIAL": "16/4/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "16/4/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["dabigatran etexilate"],
    "InteractionIndexLink": ["dabigatran"],
    "N_ENREGISTREMENT": "152/12 F 185/16",
    "CODE_DCI": "12 F 185",
    "DCI": "DABIGATRAN ETEXILATE MESILATE",
    "NOM_COMMERCIALE": "PRADAXA",
    "FORME": "GELULE",
    "DOSAGE": "150 MG",
    "COND": "B/60",
    "LISTE": "LIste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BOEHRINGER INGELHEIM INTERNATIONAL GMBH",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "Allemagne",
    "DATE_D_ENREGISTREMENT_INITIAL": "16/4/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "16/4/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "255/ 12 H 039 /98/16",
    "CODE_DCI": "12 H 039",
    "DCI": "ETAMSYLATE",
    "NOM_COMMERCIALE": "DICYNONE",
    "FORME": "SOL.INJ.",
    "DOSAGE": "250MG",
    "COND": "B/6AMP. DE 2ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANOFI SYNTHELABO",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/5/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "4/7/2016",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "60MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Hématologie et hémostase"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "433/ 12 H 039 /19",
    "CODE_DCI": "12 H 039",
    "DCI": "ETAMSYLATE",
    "NOM_COMMERCIALE": "ETAMCYNONE",
    "FORME": "SOL.INJ.",
    "DOSAGE": "250MG/2ML",
    "COND": "B/ 10 AMP. DE 2ML  ET B/ 50 AMP. DE 2ML",
    "LISTE": "",
    "P1": "HOP (B/10) ET  (B/ 50 AMP)",
    "P2": "OFF (B/10)",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRATER RAZES",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/5/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "20/5/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Hématologie et hémostase"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "304/ 12 H 039 /21",
    "CODE_DCI": "12 H 039",
    "DCI": "Etamsylate",
    "NOM_COMMERCIALE": "NOVAMSIL",
    "FORME": "Solution injectable",
    "DOSAGE": "250MG/2ML",
    "COND": "B/6AMP. DE 2ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GEOPHARM / SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "14/3/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "14/3/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Hématologie et hémostase"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "426/ 12 H 040 /98/21",
    "CODE_DCI": "12 H 040",
    "DCI": "Etamsylate",
    "NOM_COMMERCIALE": "DICYNONE",
    "FORME": "Comprimé",
    "DOSAGE": "250MG",
    "COND": "B/20",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ABDI IBRAHIM REMEDE PHARMA (AIRP) / SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/5/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "14/3/2021",
    "TYPE": "Ré",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "60 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Hématologie et hémostase"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "013/ 12 H 040 /99/18",
    "CODE_DCI": "12 H 040",
    "DCI": "ETAMSYLATE",
    "NOM_COMMERCIALE": "NOVASMIL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "250MG",
    "COND": "B/20",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVA ARGENTIA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ITALIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/11/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "9/11/1999",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Hématologie et hémostase"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "370/ 12 J 042 /07/16",
    "CODE_DCI": "12 J 042",
    "DCI": "ALBUMINE HUMAINE",
    "NOM_COMMERCIALE": "ALBUMINE HUMAINE 20% BIOTEST",
    "FORME": "SOL. PERF.",
    "DOSAGE": "20 %",
    "COND": "FL./ 50ML ET FL./100ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOTEST PHARMA GmBH",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALLEMAGNE",
    "DATE_D_ENREGISTREMENT_INITIAL": "16/4/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "6/3/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "298/ 12 J 042 /08/15",
    "CODE_DCI": "12 J 042",
    "DCI": "ALBUMINE HUMAINE",
    "NOM_COMMERCIALE": "HUMAN ALBUMIN BAXTER",
    "FORME": "SOL. INJ.",
    "DOSAGE": "20% (OU 0.2G/ML)",
    "COND": "FL./50ML ET FL./100ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BAXTER A.G.",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "AUTRICHE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/1/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "2/12/2015",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "513/ 12 J 042 /16",
    "CODE_DCI": "12 J 042",
    "DCI": "ALBUMINE HUMAINE",
    "NOM_COMMERCIALE": "VIALEBEX",
    "FORME": "SOLUTION POUR PERFUSION IV",
    "DOSAGE": "200MG/ML ( 20%)",
    "COND": "BOITE DE 01 FLACON DE 50ML (10G/50ML) . BOITE DE 01 FLACON DE 100ML (20G/100ML)",
    "LISTE": "",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LFB BIOMEDICAMENTS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/6/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "26/6/2016",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["octocog alfa (factor VIII - rch)"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "298/ 12 J 044 /14",
    "CODE_DCI": "12 J 044",
    "DCI": "OCTOCOG ALFA (FACTEUR VIII DE COAGULATION HUMAIN RECOMBINANT ANTI-HEMOPHILIQUE)",
    "NOM_COMMERCIALE": "ADVATE",
    "FORME": "PDRE ET SOLVANT P/ SOL INJ IV",
    "DOSAGE": "500UI/FL DE PDRE (50UI/ML)",
    "COND": "B/01FL DE PDRE+01 SERINGUE A USAGE UNIQUE DE 10ML + 01 FL DE SOLVANT (EPPI)",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BAXTER AG",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "AUTRICHE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/7/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "27/7/2014",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["VIII facteur"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "370/ 12 J 044 /07/16",
    "CODE_DCI": "12 J 044",
    "DCI": "FACTEUR HUMAIN VIII  ANTI HEMOPHILIQUE",
    "NOM_COMMERCIALE": "HAEMOCTIN SDH 500",
    "FORME": "PDRE. +  SOLV. INJ.",
    "DOSAGE": "500UI",
    "COND": "B/1+ 1FL./ 10ML",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOTEST PHARMA GmBH",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALLEMAGNE",
    "DATE_D_ENREGISTREMENT_INITIAL": "16/4/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "12/3/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["VIII facteur"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "286/ 12 J 044 /12",
    "CODE_DCI": "12 J 044",
    "DCI": "FACTEUR VIII DE COAGULATION HUMAINE",
    "NOM_COMMERCIALE": "HEMOREL-A",
    "FORME": "LYOPH. ET SOLV. P. PREPARATION INJ. IV",
    "DOSAGE": "500UI/FL. DE LYOPH.",
    "COND": "B/1FL. DE PDRE. + 1FL. DE 10ML DE SOLV. (EPPI)+ DISPOSITIF D'INJECTION",
    "LISTE": "",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CHIMIE PHARMACIE COMMERCE MULTIPLE SARL (CPCM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/1/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "10/1/2012",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["VIII facteur"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "298/ 12 J 044 /04/16",
    "CODE_DCI": "12 J 044",
    "DCI": "FACTEUR VIII DE COAGULATION HUMAINE",
    "NOM_COMMERCIALE": "IMMUNATE 500UI",
    "FORME": "PDRE. LYOPH. ET SOLV. P. SOL. INJ.",
    "DOSAGE": "500UI/FL. DE PDRE.",
    "COND": "B/1FL. DE PDRE. LYOPH.+1FL. DE 5ML DE SOLV. (E.P.P.I)+1DISPOSITIF DE TRANSFERT AVEC FILTRE+1SERINGUE A USAGE UNIQUE+1AIGUILLE STERILE+1SYSTEME DE PERFUSION A AILETTES",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BAXTER AG",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "AUTRICHE",
    "DATE_D_ENREGISTREMENT_INITIAL": "23/3/2004",
    "DATE_D_ENREGISTREMENT_FINAL": "2/2/2016",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["VIII facteur"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "469/ 12 J 044 /16",
    "CODE_DCI": "12 J 044",
    "DCI": "FACTEUR VIII DE COAGULATION HUMAINE",
    "NOM_COMMERCIALE": "OCTANATE",
    "FORME": "POUDRE. ET SOLV. P. PREPARATION INJ. IV",
    "DOSAGE": "500UI/FL. DE  POUDRE",
    "COND": "B/1FL. DE PDRE. + 1FL. DE 10ML DE SOLV. (EPPI)+ DISPOSITIF D'INJECTION",
    "LISTE": "",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "OCTAPHARMA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "France",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/6/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "22/6/2016",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["IX facteur"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "298/ 12 J 104 /04/13",
    "CODE_DCI": "12 J 104",
    "DCI": "FACTEUR IX DE COAGULATION HUMAINE",
    "NOM_COMMERCIALE": "IMMUNINE 600",
    "FORME": "PDRE. LYOPH. ET SOLV. P. SOL. INJ. OU P. PERF.",
    "DOSAGE": "600UI/FL. DE PDRE.",
    "COND": "B/1FL. DE PDRE. LYOPH.+1FL. DE 5ML DE SOLV. (E.P.P.I)+1AIGUILLE DE TRANSFERET+1AIGUIILE D'AERATION+1AIGUILLE FILTRE+1AIGUILLE JETABLE+1SERINGUE JETABLE (5ML)+1DISPOSITIF DE PERFUSION",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BAXTER AG",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "AUTRICHE",
    "DATE_D_ENREGISTREMENT_INITIAL": "23/3/2004",
    "DATE_D_ENREGISTREMENT_FINAL": "2/5/2013",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["octocog alfa (factor VIII - rch)"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "298/ 12 J 154 /14",
    "CODE_DCI": "12 J 154",
    "DCI": "OCTOCOG ALFA (FACTEUR VIII DE COAGULATION HUMAIN RECOMBINANT ANTI-HEMOPHILIQUE)",
    "NOM_COMMERCIALE": "ADVATE",
    "FORME": "PDRE ET SOLVANT P/ SOL INJ IV",
    "DOSAGE": "250UI/FL DE PDRE (50UI/ML)",
    "COND": "B/01FL DE PDRE+01 SERINGUE A USAGE UNIQUE DE 10ML + 01 FL DE SOLVANT (EPPI)",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BAXTER AG",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "AUTRICHE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/7/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "27/7/2014",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["octocog alfa (factor VIII - rch)"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "298/ 12 J 155 /14",
    "CODE_DCI": "12 J 155",
    "DCI": "OCTOCOG ALFA (FACTEUR VIII DE COAGULATION HUMAIN RECOMBINANT ANTI-HEMOPHILIQUE)",
    "NOM_COMMERCIALE": "ADVATE",
    "FORME": "PDRE ET SOLVANT P/SOL INJ IV",
    "DOSAGE": "1000UI/FL DE PDRE  (50UI/ML)",
    "COND": "B/01FL DE PDRE+01 SERINGUE A USAGE UNIQUE DE 10ML + 01 FL DE SOLVANT (EPPI)",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BAXTER AG",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "AUTRICHE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/7/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "27/7/2014",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["eptacog alfa (activated Factor VII - rch)"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "069/ 12 J 160 /13",
    "CODE_DCI": "12 J 160",
    "DCI": "EPTACOG ALFA (ACTIVE)",
    "NOM_COMMERCIALE": "NOVOSEVEN",
    "FORME": "PDRE. LYOPH. ET SOLV. P. SOL. INJ.",
    "DOSAGE": "1MG/FL. DE PDRE. (50KUI/FL. DE PDRE.)",
    "COND": "B/1FL. DE PDRE. + 1FL. DE SOLVT.",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVO NORDISK",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "DANEMARK",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/2/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "24/2/2013",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["eptacog alfa (activated Factor VII - rch)"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "069/ 12 J 161 /13",
    "CODE_DCI": "12 J 161",
    "DCI": "EPTACOG ALFA (ACTIVE)",
    "NOM_COMMERCIALE": "NOVOSEVEN",
    "FORME": "PDRE. LYOPH. ET SOLV. P. SOL. INJ.",
    "DOSAGE": "2MG/FL. DE PDRE. (100KUI/FL. DE PDRE.)",
    "COND": "B/1FL. DE PDRE. + 1FL. DE SOLVT.",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVO NORDISK",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "DANEMARK",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/2/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "24/2/2013",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["eptacog alfa (activated Factor VII - rch)"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "069/ 12 J 162 /13",
    "CODE_DCI": "12 J 162",
    "DCI": "EPTACOG ALFA (ACTIVE)",
    "NOM_COMMERCIALE": "NOVOSEVEN",
    "FORME": "PDRE. LYOPH. ET SOLV. P. SOL. INJ.",
    "DOSAGE": "5MG/FL. DE PDRE. (250KUI/FL. DE PDRE.)",
    "COND": "B/1FL. DE PDRE. + 1FL. DE SOLVT.",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVO NORDISK",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "DANEMARK",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/2/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "24/2/2013",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["IX facteur"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "370/ 12 J 170 /14",
    "CODE_DCI": "12 J 170",
    "DCI": "FACTEUR IX DE COAGULATION HUMAINE",
    "NOM_COMMERCIALE": "HEAMONINE 500",
    "FORME": "PDRE. ET SOLV. P. SOL. INJ. IV",
    "DOSAGE": "500UI/FL. DE PDRE.",
    "COND": "B/01 FL. DE PDRE. + 01 FL. DE SOLV. (5ML) + SERING. JETABLE (5ML) + SYST. D. TRANSFERT A DOUBLE FILTRE",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOTEST PHARMA GMBH",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALLEMAGNE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/12/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "30/12/2014",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "485/ 12 J 171 /14",
    "CODE_DCI": "12 J 171",
    "DCI": "IMMUNOGLOBULINE HUMAINE ANTI-D",
    "NOM_COMMERCIALE": "RHOPHYLAC 300",
    "FORME": "SOL. INJ. EN SERING. PREREMPL. IM/IV",
    "DOSAGE": "150μG/ML (300μG/2ML OU 1500UI/2ML)",
    "COND": "B/01SERING. PREREMPL. DE 2ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CSL BEHRING AG",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SUISSE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/10/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "28/10/2014",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["WILLEBRAND Facteur"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "513/ 12 J 181 /16",
    "CODE_DCI": "12 J 181",
    "DCI": "FACTEUR WILLEBRAND HUMAIN",
    "NOM_COMMERCIALE": "WILFACTIN",
    "FORME": "POUDRE ET SOLVANT POUR SOLUTION INJECTABLE IV",
    "DOSAGE": "1000 UI/ 10 ML",
    "COND": "B/ 01 FLACON DE POUDRE DE 10 G + 01 FLACON DE SOL DE 10ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LFB BIOMEDICAMENTS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/6/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "22/6/2016",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["fibrinogen"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "513/ 12 J 182 /16",
    "CODE_DCI": "12 J 182",
    "DCI": "FIBRINOGENE HUMAIN",
    "NOM_COMMERCIALE": "CLOTTAFACT",
    "FORME": "POUDRE ET SOLVANT POUR SOLUTION INJECTABLE I",
    "DOSAGE": "1.5G/100ML",
    "COND": "B/01 FLACON DE POUDRE + 01 FLACON DE SOLVANT 100ML +SYSTÈME DE TRANSFERT MUNI D'UN event à FILTRE STERILISANT",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LFB BIOMEDICAMENTS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/6/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "22/6/2016",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["octocog alfa (factor VIII - rch)"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "069/12 J 186/17",
    "CODE_DCI": "12 J 186",
    "DCI": "Turoctocog alfa (Facteur VIII de coagulation humain ADN recombinant)",
    "NOM_COMMERCIALE": "NOVO EIGHT",
    "FORME": "PDRE ET SOLV. SOL. INJ",
    "DOSAGE": "250 UI",
    "COND": "B/ 1 FL DE DPRE  +1 ADAPTEUR POUR FL+ 1 SERINGUE PRE-REMPLIE + 1 TIGE DE PISTON",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVO NORDISK A/S",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "DANEMARK",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/3/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "28/2/2021",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "30 MOIS OU 48 MOIS ???",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["octocog alfa (factor VIII - rch)"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "069/12 J 187/17",
    "CODE_DCI": "12 J 187",
    "DCI": "Turoctocog alfa (Facteur VIII de coagulation humain ADN recombinant)",
    "NOM_COMMERCIALE": "NOVO EIGHT",
    "FORME": "PDRE ET SOLV. SOL. INJ",
    "DOSAGE": "500 UI",
    "COND": "B/ 1 FL DE DPRE  +1 ADAPTEUR POUR FL+ 1 SERINGUE PRE-REMPLIE + 1 TIGE DE PISTON",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVO NORDISK A/S",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "DANEMARK",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/3/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "28/2/2021",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "30 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["octocog alfa (factor VIII - rch)"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "069/12 J 188/17",
    "CODE_DCI": "12 J 188",
    "DCI": "Turoctocog alfa (Facteur VIII de coagulation humain ADN recombinant)",
    "NOM_COMMERCIALE": "NOVO EIGHT",
    "FORME": "PDRE ET SOLV. SOL. INJ",
    "DOSAGE": "1000 UI",
    "COND": "B/ 1 FL DE DPRE  +1 ADAPTEUR POUR FL+ 1 SERINGUE PRE-REMPLIE + 1 TIGE DE PISTON",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVO NORDISK A/S",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "DANEMARK",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/3/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "28/2/2021",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "30 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["thrombin"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "469/ 12 J 191 /19",
    "CODE_DCI": "12 J 191",
    "DCI": "Complexe humain plasmatique prothrombinique",
    "NOM_COMMERCIALE": "OCTAPLEX :",
    "FORME": "PDRE ET SOLV. SOL. PER",
    "DOSAGE": "500 UI",
    "COND": "B/ 01 FL  DE PDRE + 01 FL DE SOLV DE 20ML",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "OCTAPHARMA PHARMAZEUTIKA  PRODUKTIONSGES.M.B.H.",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "Autriche",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/2/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "10/2/2019",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["moroctocog alfa (factor VIII - rch)"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "045/ 12 J 195 /18",
    "CODE_DCI": "12 J 195",
    "DCI": "Moroctocog alfa ( Facteur  de Coagulation Humaine VIII ADNr) PFIZER",
    "NOM_COMMERCIALE": "REFACTO AF",
    "FORME": "PDRE ET SOLV. SOL. INJ IV",
    "DOSAGE": "250UI/FL",
    "COND": "B/1 KIT : 1FL. DE PDRE. + 1SERING. PREREMPL. DE 4ML DE SOLV (CHLORURE DE SODIUM à 0.9 %+ EPPI) +1 ADAPTEUR POUR FL + 1 NECESSAIRE DE PER +2 TAMPONS D'ALCOOL + 1 paPANSSEMENT + 1 COMPRESSE DE GAZE",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PFIZER LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ROYAUME UNI",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/6/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "18/6/2018",
    "TYPE": "BIOS",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["moroctocog alfa (factor VIII - rch)"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "045/ 12 J 196 /18",
    "CODE_DCI": "12 J 196",
    "DCI": "Moroctocog alfa ( Facteur  de Coagulation Humaine VIII ADNr) PFIZER",
    "NOM_COMMERCIALE": "REFACTO AF",
    "FORME": "PDRE ET SOLV. SOL. INJ IV",
    "DOSAGE": "500 UI/FL (125UI/ML)",
    "COND": "B/1 KIT : 1FL. DE PDRE. + 1SERING. PREREMPL. DE 4ML DE SOLV (CHLORURE DE SODIUM à 0.9 %+ EPPI) +1 ADAPTEUR POUR FL + 1 NECESSAIRE DE PER +2 TAMPONS D'ALCOOL + 1 paPANSSEMENT + 1 COMPRESSE DE GAZE",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PFIZER LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ROYAUME UNI",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/6/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "18/6/2018",
    "TYPE": "BIOS",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["moroctocog alfa (factor VIII - rch)"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "21/12 J 203/045",
    "CODE_DCI": "12 J 203",
    "DCI": "MOROCTOCOG ALFA (FACTEUR VIII DE COAGULATION HUMAINE VIII ADNr)",
    "NOM_COMMERCIALE": "REFACTO AF",
    "FORME": "POUDRE ET SOLVANT POUR SOL. INJ. IV",
    "DOSAGE": "1000UI",
    "COND": "B/1 KIT : 1 FLC DE POUDRE DE 10ML+ 1 SERINGUE PREREMPLIE DE 4ML DE SOLVANT + 1 DISPOSITIF DE RECONSTITUTION AVEC UN ADAPTATEUR POUR FLC STREILE DE PERFUSION + 1 NECESSAIRE STERILE POUR PERFUSION + 2 TAMPONS D'ALCOOL + 1 PANSEMENT + 1 COMPRESSE",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES PFIZER LTD.",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ROYAUME UNI",
    "DATE_D_ENREGISTREMENT_INITIAL": "06/06/21",
    "DATE_D_ENREGISTREMENT_FINAL": "06/06/21",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["moroctocog alfa (factor VIII - rch)"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "21/12 J 204/045",
    "CODE_DCI": "12 J 204",
    "DCI": "MOROCTOCOG ALFA (FACTEUR VIII DE COAGULATION HUMAINE VIII ADNr)",
    "NOM_COMMERCIALE": "REFACTO AF",
    "FORME": "POUDRE ET SOLVANT POUR SOL. INJ. IV",
    "DOSAGE": "2000UI",
    "COND": "B/1 KIT : 1 FLC DE POUDRE DE 10ML+ 1 SERINGUE PREREMPLIE DE 4ML DE SOLVANT + 1 DISPOSITIF DE RECONSTITUTION AVEC UN ADAPTATEUR POUR FLC STREILE DE PERFUSION + 1 NECESSAIRE STERILE POUR PERFUSION + 2 TAMPONS D'ALCOOL + 1 PANSEMENT + 1 COMPRESSE",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES PFIZER LTD.",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ROYAUME UNI",
    "DATE_D_ENREGISTREMENT_INITIAL": "06/06/21",
    "DATE_D_ENREGISTREMENT_FINAL": "06/06/21",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "286/ 12 K 042 /12",
    "CODE_DCI": "12 K 042",
    "DCI": "ALBUMINE HUMAINE",
    "NOM_COMMERCIALE": "ALBUREL",
    "FORME": "SOL. P. PERF. IV",
    "DOSAGE": "20% (20G/100ML)",
    "COND": "B/1FL. DE 50ML ET B/1FL. DE 100ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "",
    "OBS": "PHARMACO- VIGILANCE : SUSPENSION TEMPORAIRE",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CHIMIE PHARMACIE COMMERCE MULTIPLE SARL (CPCM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/1/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "10/1/2012",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["lenograstim"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "376/12 L 064/97/17",
    "CODE_DCI": "12 L 064",
    "DCI": "LENOGRASTIME RHU G-CSF",
    "NOM_COMMERCIALE": "GRANOCYTE 34",
    "FORME": "POUDRE ET SOLVANT POUR SOL INJ S/C IV",
    "DOSAGE": "33.6 MUI",
    "COND": "B/05 FL DE POUDRE +05 SERINGUES PRE-REMPLIES DE SOLVANT +02 AIGUILLES",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANOFI AB",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SUEDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/2/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "27/2/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "30 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["epoetin alfa"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "357/ 12 L 145 /09/15",
    "CODE_DCI": "12 L 145",
    "DCI": "EPOETINE ALFA (ERYTHROPOIETINE HUMAINE RECOMBINANTE )",
    "NOM_COMMERCIALE": "HEMAX",
    "FORME": "LYOPH. ET SOLV. SOL. INJ. IV/SC",
    "DOSAGE": "3000UI/FL. DE PDRE.",
    "COND": "B/1FL. DE PDRE. + 1SERING. PREREMPL. DE 2ML DE SOLV.",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIO SIDUS S.A.",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ARGENTINE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/10/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "8/11/2015",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["eltrombopag"],
    "InteractionIndexLink": ["eltrombopag"],
    "N_ENREGISTREMENT": "068/12 L 172/16",
    "CODE_DCI": "12 L 172",
    "DCI": "ELTROMBOPAG OLAMINE",
    "NOM_COMMERCIALE": "REVOLADE",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "25 MG",
    "COND": "B/28",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVARTIS PHARMA SCHWEIZ AG",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SUISSE",
    "DATE_D_ENREGISTREMENT_INITIAL": "5/3/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "5/3/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "48 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["eltrombopag"],
    "InteractionIndexLink": ["eltrombopag"],
    "N_ENREGISTREMENT": "068/12 L 173/16",
    "CODE_DCI": "12 L 173",
    "DCI": "ELTROMBOPAG OLAMINE",
    "NOM_COMMERCIALE": "REVOLADE",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "50 MG",
    "COND": "B/28",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVARTIS PHARMA SCHWEIZ AG",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SUISSE",
    "DATE_D_ENREGISTREMENT_INITIAL": "5/3/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "5/3/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "48 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["darbepoetin alfa"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "481/ 12 L 174 /15",
    "CODE_DCI": "12 L 174",
    "DCI": "DARBEPOETINE ALFA",
    "NOM_COMMERCIALE": "ARANESP",
    "FORME": "SOL. INJ. SC./IV. EN SERINGUE PREREMPLIE",
    "DOSAGE": "25µG/ML (10µG/0.4ML)",
    "COND": "B/04 SERINGUES PREREMPLIES DE 0.4ML SANS SYST. DE SECURITE",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "AMGEN EUROPE B.V.",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PAYS BAS",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/9/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "10/9/2015",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["darbepoetin alfa"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "481/ 12 L 175 /15",
    "CODE_DCI": "12 L 175",
    "DCI": "DARBEPOETINE ALFA",
    "NOM_COMMERCIALE": "ARANESP",
    "FORME": "SOL. INJ. SC./IV. EN SERINGUE PREREMPLIE",
    "DOSAGE": "40µG/ML (20µG/0.5ML)",
    "COND": "B/04 SERINGUES PREREMPLIES DE 0.5ML SANS SYST. DE SECURITE",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "AMGEN EUROPE B.V.",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PAYS BAS",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/12/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "13/12/2015",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["darbepoetin alfa"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "481/ 12 L 176 /15",
    "CODE_DCI": "12 L 176",
    "DCI": "DARBEPOETINE ALFA",
    "NOM_COMMERCIALE": "ARANESP",
    "FORME": "SOL. INJ. SC./IV. EN SERINGUE PREREMPLIE",
    "DOSAGE": "100µG/ML (30µG/0.3ML) (50µG/0.5ML)",
    "COND": "B/04 SERINGUES PREREMPLIES DE 0.3ML AVEC SYST. DE SECURITE ; B/04 SERINGUES PREREMPLIES DE 0.3ML SANS SYST. DE SECURITE ; B/04 SERINGUES PREREMPLIES DE 0.5ML AVEC SYST. DE SECURITE ; B/04 SERINGUES PREREMPLIES DE 0.5ML SANS SYST. DE SECURITE",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "AMGEN EUROPE B.V.",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PAYS BAS",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/9/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "2/9/2015",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["darbepoetin alfa"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "481/ 12 L 177 /15",
    "CODE_DCI": "12 L 177",
    "DCI": "DARBEPOETINE ALFA",
    "NOM_COMMERCIALE": "ARANESP",
    "FORME": "SOL. INJ. SC./IV. EN SERINGUE PREREMPLIE",
    "DOSAGE": "200µG/ML (60µG/0.3ML) (80µG/0.4ML) (100µG/0.5ML)",
    "COND": "B/04 SERINGUES PREREMPLIES DE 0.3ML AVEC SYST. DE SECURITE ; B/04 SERINGUES PREREMPLIES DE 0.3ML SANS SYST. DE SECURITE ; B/04 SERINGUES PREREMPLIES DE 0.4ML AVEC SYST. DE SECURITE ; B/04 SERINGUES PREREMPLIES DE 0.4ML SANS SYST. DE SECURITE ; B/04 SERINGUES PREREMPLIES DE 0.5ML AVEC SYST. DE SECURITE ; B/04 SERINGUES PREREMPLIES DE 0.5ML SANS SYST. DE SECURITE",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "AMGEN EUROPE B.V.",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PAYS BAS",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/9/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "10/9/2015",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["darbepoetin alfa"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "481/ 12 L 178 /15",
    "CODE_DCI": "12 L 178",
    "DCI": "DARBEPOETINE ALFA",
    "NOM_COMMERCIALE": "ARANESP",
    "FORME": "SOL. INJ. SC./IV. EN SERINGUE PREREMPLIE",
    "DOSAGE": "500µG/ML (150µG/0.3ML) (300µG/0.6ML) (500µG/1.0ML)",
    "COND": "B/04 SERINGUES PREREMPLIES DE 0.3ML AVEC SYST. DE SECURITE ; B/04 SERINGUES PREREMPLIES DE 0.3ML SANS SYST. DE SECURITE ; B/01 SERINGUE PREREMPLIE DE 0.6ML AVEC SYST. DE SECURITE ; B/01 SERINGUE PREREMPLIE DE 0.6ML SANS SYST. DE SECURITE ; B/01 SERINGUE PREREMPLIE DE 1.0ML AVEC SYST. DE SECURITE ; B/01 SERINGUE PREREMPLIE DE 1.0ML SANS SYST. DE SECURITE ;",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "AMGEN EUROPE B.V.",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PAYS BAS",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/9/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "10/9/2015",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["romiplostim"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "481/ 12 L 179 /16",
    "CODE_DCI": "12 L 179",
    "DCI": "ROMIPLOSTIM",
    "NOM_COMMERCIALE": "N PLATE",
    "FORME": "PDRE. P. SOL. INJ. SC",
    "DOSAGE": "250µG/FL. DE PDRE.",
    "COND": "B/01 FL. DE PDRE.",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "AMGEN EUROPE B.V",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PAYS BAS",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/2/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "4/2/2016",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "60 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["romiplostim"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "481/ 12 L 180 /15",
    "CODE_DCI": "12 L 180",
    "DCI": "ROMIPLOSTIM",
    "NOM_COMMERCIALE": "N PLATE",
    "FORME": "PDRE. P. SOL. INJ. SC",
    "DOSAGE": "500µG/FL. DE PDRE.",
    "COND": "B/01 FL. DE PDRE.",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "AMGEN EUROPE B.V.",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PAYS BAS",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/6/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "29/6/2015",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "60 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["filgrastim"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "481/ 12 L 182 /99/17",
    "CODE_DCI": "12 L 189",
    "DCI": "FILGRASTIM",
    "NOM_COMMERCIALE": "NEUPOGEN",
    "FORME": "SOL.INJ. S/C IV EN SERINGUE PRE REMPLIE",
    "DOSAGE": "300µG",
    "COND": "B/1 SERINGUE",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "AMGEN EUROPE BV",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PAYS BAS",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/6/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "19/3/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "30 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["filgrastim"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "080/12 L 189/17",
    "CODE_DCI": "12 L 189",
    "DCI": "FILGRASTIM",
    "NOM_COMMERCIALE": "ZARZIO",
    "FORME": "SOL.INJ. S/C IV EN SERINGUE PRE REMPLIE",
    "DOSAGE": "300µG",
    "COND": "B/5 SERINGUES DE 0.5 ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANDOZ GMBH",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "AUTRICHE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/3/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "28/3/2017",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "30 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["filgrastim"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "481/ 12 L 190/99/17",
    "CODE_DCI": "12 L 190",
    "DCI": "FILGRASTIM",
    "NOM_COMMERCIALE": "NEUPOGEN",
    "FORME": "SOL.INJ. S/C IV EN SERINGUE PRE REMPLIE",
    "DOSAGE": "480µG",
    "COND": "B/1 SERINGUE",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "AMGEN EUROPE BV",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PAYS BAS",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/6/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "19/3/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "30 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["filgrastim"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "080/12 L 190/17",
    "CODE_DCI": "12 L 190",
    "DCI": "FILGRASTIM",
    "NOM_COMMERCIALE": "ZARZIO",
    "FORME": "SOL.INJ. S/C IV EN SERINGUE PRE REMPLIE",
    "DOSAGE": "480µG",
    "COND": "B/5 SERINGUE",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANDOZ GMBH",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "AUTRICHE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/3/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "28/3/2017",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "30 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["pegfilgrastim"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "481 /12 L 197/18",
    "CODE_DCI": "12 L 197",
    "DCI": "PEGFILGRASTIM amgen",
    "NOM_COMMERCIALE": "NEULASTIM",
    "FORME": "SOL.INJ. S/C",
    "DOSAGE": "6 MG",
    "COND": "B/1 SERINGUE PRE REMPLIE DE 0.6 ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "AMGEN EUROPE B.V ( ABR)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PAYS BAS",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/8/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "7/8/2018",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["gentamicin"],
    "InteractionIndexLink": ["gentamicine"],
    "N_ENREGISTREMENT": "538/ 13 A 003 /18",
    "CODE_DCI": "13 A 003",
    "DCI": "Gentamicine SULFATE",
    "NOM_COMMERCIALE": "S-GENTA",
    "FORME": "SOL.INJ.IM/IV",
    "DOSAGE": "10MG/ML",
    "COND": "B/10 AMP DE 1 ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SWISS PARENTERALS PVT.LTD.",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/4/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "25/4/2018",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["gentamicin"],
    "InteractionIndexLink": ["gentamicine"],
    "N_ENREGISTREMENT": "433/ 13 A 004 /13",
    "CODE_DCI": "13 A 004",
    "DCI": "GENTAMICINE SULFATE EXPRIME EN GENTAMICINE",
    "NOM_COMMERCIALE": "GENTAXYN",
    "FORME": "SOL. INJ. IM/IV",
    "DOSAGE": "20MG/ML (40MG/2ML)",
    "COND": "B/5AMP. DE 2ML ET B/50AMP. DE 2ML*",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "B/50 RESERVEE AUX HÔPITAUX",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRATER RAZES SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/7/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "2/7/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["gentamicin"],
    "InteractionIndexLink": ["gentamicine"],
    "N_ENREGISTREMENT": "20/13 A004/543",
    "CODE_DCI": "13 A 004",
    "DCI": "GENTAMICINE SULFATE EXPRIMÉE EN GENTAMICINE",
    "NOM_COMMERCIALE": "GENTHERAXINE",
    "FORME": "SOL INJ IM / IV",
    "DOSAGE": "20MG/ ML",
    "COND": "B/50 AMPOULES DE 2ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOTHERA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/06/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "10/06/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["gentamicin"],
    "InteractionIndexLink": ["gentamicine"],
    "N_ENREGISTREMENT": "109/ 13 A 005 /99/17",
    "CODE_DCI": "13 A 005",
    "DCI": "GENTAMICINE",
    "NOM_COMMERCIALE": "EPIGENT",
    "FORME": "SOL.INJ. IM / IV",
    "DOSAGE": "80MG/2ML",
    "COND": "B/1",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EIPICO",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EGYPTE",
    "DATE_D_ENREGISTREMENT_INITIAL": "21/4/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "27/2/2017",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["gentamicin"],
    "InteractionIndexLink": ["gentamicine"],
    "N_ENREGISTREMENT": "317/13 A 005/20",
    "CODE_DCI": "13 A 005",
    "DCI": "GENTAMICINE (SULFATE)",
    "NOM_COMMERCIALE": "GENTA 80",
    "FORME": "SOL. INJ (I.M/I.V)",
    "DOSAGE": "80MG/2ML (40MG/ML)",
    "COND": "B/05",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES INPHA-MEDIS SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/12/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "13/12/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["gentamicin"],
    "InteractionIndexLink": ["gentamicine"],
    "N_ENREGISTREMENT": "380/ 13 A 005 /19",
    "CODE_DCI": "13 A 005",
    "DCI": "GENTAMICINE SULFATE EXPRIME EN GENTAMICINE",
    "NOM_COMMERCIALE": "GENTACINE",
    "FORME": "SOL. INJ. IM/IV",
    "DOSAGE": "40MG/ML (80MG/2ML)",
    "COND": "B/01AMP. DE 2ML ET B/50AMP. DE 2ML ET B/03 AMP. DE 2ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF.",
    "OBS": "B/50 RESERVEE AUX HÔPITAUX",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HUPP PHARMA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/4/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "24/4/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["gentamicin"],
    "InteractionIndexLink": ["gentamicine"],
    "N_ENREGISTREMENT": "304/ 13 A 005 /08/21",
    "CODE_DCI": "13 A 005",
    "DCI": "Gentamicine sulfate exprimé en Gentamicine",
    "NOM_COMMERCIALE": "GENTAMYCINE GEO",
    "FORME": "Solution injectable",
    "DOSAGE": "40MG/ML (OU 80MG/2ML)",
    "COND": "B/3 AMP. DE 2ML -  B/50 AMP.DE 2ML",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "B/50 RESERVEE AUX HÔPITAUX",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GEOPHARM/ SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/7/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "4/4/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["gentamicin"],
    "InteractionIndexLink": ["gentamicine"],
    "N_ENREGISTREMENT": "433/ 13 A 005 /13/20",
    "CODE_DCI": "13 A 005",
    "DCI": "Gentamicine sulfate exprimé en Gentamicine",
    "NOM_COMMERCIALE": "GENTAXYN",
    "FORME": "Solution injectable IM/IV",
    "DOSAGE": "40MG/ML (80MG/2ML)",
    "COND": "B/03 AMP. DE 2ML ET B/50AMP. DE 2ML",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF.",
    "OBS": "B/50 RESERVEE AUX HÔPITAUX",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRATER RAZES SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "5/3/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "19/3/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["gentamicin"],
    "InteractionIndexLink": ["gentamicine"],
    "N_ENREGISTREMENT": "20/13 A005/543",
    "CODE_DCI": "13 A 005",
    "DCI": "GENTAMICINE SULFATE EXPRIMÉE EN GENTAMICINE",
    "NOM_COMMERCIALE": "GENTHERAXINE",
    "FORME": "SOL INJ IM / IV",
    "DOSAGE": "40MG / ML",
    "COND": "B/50 AMPOULES DE 2ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOTHERA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/06/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "10/06/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["amikacin"],
    "InteractionIndexLink": ["amikacine"],
    "N_ENREGISTREMENT": "011/ 13 A 454 /98/17",
    "CODE_DCI": "13 A 454",
    "DCI": "AMIKACINE SULFATE EXPRIME EN AMIKACINE",
    "NOM_COMMERCIALE": "LIKACIN",
    "FORME": "SOL.INJ. IM/IV",
    "DOSAGE": "125MG/ML (250MG/2ML)",
    "COND": "B/50FL. DE 2ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ITALIANO BIOCHIMICO FARMACEUTICO LISAPHARMA SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ITALIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/8/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "5/11/2017",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["tobramycin"],
    "InteractionIndexLink": ["tobramycine"],
    "N_ENREGISTREMENT": "389/ 13 A 465 /12",
    "CODE_DCI": "13 A 465",
    "DCI": "TOBRAMYCINE SULFATE EXPRIME EN TOBRAMYCINE",
    "NOM_COMMERCIALE": "EREMCINE",
    "FORME": "SOL. INJ. IM OU IV LENTE",
    "DOSAGE": "10MG/ML (25MG/2.5ML)",
    "COND": "B/1FL. DE 2.5ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EREMPHARMA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "8/5/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "8/5/2012",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["tobramycin"],
    "InteractionIndexLink": ["tobramycine"],
    "N_ENREGISTREMENT": "389/ 13 A 466 /12",
    "CODE_DCI": "13 A 466",
    "DCI": "TOBRAMYCINE SULFATE EXPRIME EN TOBRAMYCINE",
    "NOM_COMMERCIALE": "EREMCINE",
    "FORME": "SOL. INJ. IM OU IV LENTE",
    "DOSAGE": "50MG/ML (75MG/1.5ML)",
    "COND": "B/1FL. DE 1.5ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EREMPHARMA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "8/5/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "8/5/2012",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["cefalexin"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "035/13 B 010/18",
    "CODE_DCI": "13 B 010",
    "DCI": "CEFALEXINE MONOHYDRATE EXPRIME EN CEFALEXINE ANHYDRE",
    "NOM_COMMERCIALE": "ANCEFAL",
    "FORME": "COMP PELL",
    "DOSAGE": "500MG",
    "COND": "B/10 ET B/20",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMALLIANCE EURL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "11/12/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "11/12/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["cefalexin"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "055/ 13 B 010 /98/17",
    "CODE_DCI": "13 B 010",
    "DCI": "CEFALEXINE",
    "NOM_COMMERCIALE": "CEPHADAR FORTE",
    "FORME": "GLES.",
    "DOSAGE": "500MG",
    "COND": "B/20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "DAR AL DAWA DEVELOPMENT & INVESTMENT Co Ltd",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/6/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "4/6/2017",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["cefalexin"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "173/ 13 B 010 /98/17",
    "CODE_DCI": "13 B 010",
    "DCI": "CEFALEXINE",
    "NOM_COMMERCIALE": "CEPHALEX",
    "FORME": "GLES.",
    "DOSAGE": "500MG",
    "COND": "B/20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "TABUK",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ARABIE SAOUDITE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/9/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "29/6/2017",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["cefalexin"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "263/ 13 B 010 /97/16",
    "CODE_DCI": "13 B 010",
    "DCI": "CEFALEXINE MONOHYDRATEE EXPRIME EN CEFALEXINE",
    "NOM_COMMERCIALE": "KEFORAL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "500MG",
    "COND": "B/12",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOPHARM ALGERIE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/10/1997",
    "DATE_D_ENREGISTREMENT_FINAL": "2/2/2016",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["cefalexin"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "001/ 13 B 010 /06/17",
    "CODE_DCI": "13 B 010",
    "DCI": "CEFALEXINE",
    "NOM_COMMERCIALE": "LEXIN",
    "FORME": "GLES.",
    "DOSAGE": "500MG",
    "COND": "B/20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMACEUTICALS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/9/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "18/6/2017",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["cefalexin"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "039/ 13 B 010 /15",
    "CODE_DCI": "13 B 010",
    "DCI": "CEFALEXINE MONOHYDRATEE EXPRIME EN CEFALEXINE",
    "NOM_COMMERCIALE": "LEXINAL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "500MG",
    "COND": "B/12",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOPHAL SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/12/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "13/12/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["cefalexin"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "039/13 B 010/17",
    "CODE_DCI": "13 B 010",
    "DCI": "CEFALEXINE MONOHYDRATEE EXPRIME EN CEFALEXINE",
    "NOM_COMMERCIALE": "LEXINAL",
    "FORME": "GELULE",
    "DOSAGE": "500MG",
    "COND": "B/20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOPHAL SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/1/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "17/1/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["cefalexin"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "226/ 13 B 010 /99/17",
    "CODE_DCI": "13 B 010",
    "DCI": "CEFALEXINE MONOHYDRATEE EXPRIME EN CEFALEXINE",
    "NOM_COMMERCIALE": "MIDAFLEX",
    "FORME": "GLES.",
    "DOSAGE": "500MG",
    "COND": "B/20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MIDDLE EAST PHARMACEUTICAL AND CHEMICAL INDUSTRIES.MEDICAL APPLIANCES Co",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/11/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "26/11/2017",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["cefalexin"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "166/ 13 B 010 /98/17",
    "CODE_DCI": "13 B 010",
    "DCI": "CEFALEXINE",
    "NOM_COMMERCIALE": "RAMOXIN",
    "FORME": "GLES",
    "DOSAGE": "500MG",
    "COND": "B/20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "RAM PHARMACEUTICAL INDUSTRIES",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/6/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "4/12/2017",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["cefalexin"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "174/ 13 B 010 /99/16",
    "CODE_DCI": "13 B 010",
    "DCI": "CEFALEXINE",
    "NOM_COMMERCIALE": "UNILEXIN",
    "FORME": "GLES.",
    "DOSAGE": "500MG",
    "COND": "B/20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "UNITED PHARMACEUTICAL MANUFACTURING (UPM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/7/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "13/6/2016",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["cefalexin"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "035/ 13 B 011/18",
    "CODE_DCI": "13 B 011",
    "DCI": "CEFALEXINE MONOHYDRATEE EXPRIME EN CEFALEXINE",
    "NOM_COMMERCIALE": "ANCEFAL",
    "FORME": "PDRE POUR SUSPENSSION BUVABLE",
    "DOSAGE": "125MG/5ML",
    "COND": "FL/60 ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMALLIANCE EURL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/9/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "26/9/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["cefalexin"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "055/ 13 B 011/98/16",
    "CODE_DCI": "13 B 011",
    "DCI": "CEFALEXINE",
    "NOM_COMMERCIALE": "CEPHADAR",
    "FORME": "PDRE.OR.",
    "DOSAGE": "125MG/5ML",
    "COND": "FL/100ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "DAR AL DAWA DEVELOPMENT & INVESTMENT Co Ltd",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/9/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "12/3/2017",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["cefalexin"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "039/ 13 B 011 /18",
    "CODE_DCI": "13 B 011",
    "DCI": "CEFALEXINE MONOHYDRATEE",
    "NOM_COMMERCIALE": "LEXINAL",
    "FORME": "PDRE POUR SUSPENSSION BUVABLE",
    "DOSAGE": "125MG/5ML",
    "COND": "FL/100ML ET BOUCHON DOSEUR",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOPHAL SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "23/5/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "23/5/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["cefalexin"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "166/ 13 B 011 /98/17",
    "CODE_DCI": "13 B 011",
    "DCI": "CEFALEXINE",
    "NOM_COMMERCIALE": "RAMOXIN",
    "FORME": "SUSP.OR.",
    "DOSAGE": "125MG/5ML",
    "COND": "FL/100ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "RAM PHARMACEUTICAL INDUSTRIES CO.LTD.",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/6/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "4/9/2017",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["cefazolin"],
    "InteractionIndexLink": ["cefazoline"],
    "N_ENREGISTREMENT": "19/13 B012/380",
    "CODE_DCI": "13 B 012",
    "DCI": "CEFAZOLINE SODIQUE",
    "NOM_COMMERCIALE": "CEFALIZOL HUP",
    "FORME": "POUDRE P.SOL INJ IM/IV",
    "DOSAGE": "1G",
    "COND": "1-B/1 FLACON DE POUDRE ET UNE AMPOULE DE SOLVANT2-B/10 FLACONS DE POUDRE",
    "LISTE": "Liste I",
    "P1": "1- HOP 2-HOP",
    "P2": "2-OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "laboratoires HUP.P PHARMA Sarl",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "02/04/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "02/04/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["cefazolin"],
    "InteractionIndexLink": ["cefazoline"],
    "N_ENREGISTREMENT": "039/ 13 B 012 /06/19",
    "CODE_DCI": "13 B 012",
    "DCI": "CEFAZOLINE SODIQUE EXPRIME EN CEFAZOLINE",
    "NOM_COMMERCIALE": "CEFAZAL",
    "FORME": "PDRE. SOL. INJ. I.V.",
    "DOSAGE": "1G/FL. DE PDRE.",
    "COND": "B/50FL. DE PDRE.",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "B/50 RESERVE AUX HÔP.",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOCIETE PHARMACEUTIQUE ALGERIENNE (SOPHAL)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/2/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "29/4/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["cefazolin"],
    "InteractionIndexLink": ["cefazoline"],
    "N_ENREGISTREMENT": "18/06/13 B012/039",
    "CODE_DCI": "13 B 012",
    "DCI": "CEFAZOLINE SODIQUE EXPRIME EN CEFAZOLINE",
    "NOM_COMMERCIALE": "CEFAZAL",
    "FORME": "PDRE. SOL. INJ. I.V.",
    "DOSAGE": "1G/FL. DE PDRE.",
    "COND": "B/50FL. DE PDRE.",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "B/50 RESERVE AUX HÔP.",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOCIETE PHARMACEUTIQUE ALGERIENNE (SOPHAL)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/02/06",
    "DATE_D_ENREGISTREMENT_FINAL": "29/04/18",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["cefazolin"],
    "InteractionIndexLink": ["cefazoline"],
    "N_ENREGISTREMENT": "369/ 13 B 012 /15",
    "CODE_DCI": "13 B 012",
    "DCI": "CEFAZOLINE SODIQUE EXPRIME EN CAFAZOLINE",
    "NOM_COMMERCIALE": "NODILOF",
    "FORME": "PDRE. P. SOL. INJ. IM/IV",
    "DOSAGE": "1G/FL. DE PDRE.",
    "COND": "B/01 FL. DE PDRE. + 01 AMP. DE 10ML DE SOLV. (EPPI)",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JERUSALEM PHARMACEUTICALS CO LTD",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PALESTINE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/1/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "25/1/2015",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["cefazolin"],
    "InteractionIndexLink": ["cefazoline"],
    "N_ENREGISTREMENT": "039/ 13 B 013 /07/18",
    "CODE_DCI": "13 B 013",
    "DCI": "CEFAZOLINE SODIQUE EXPRIME EN CEFAZOLINE",
    "NOM_COMMERCIALE": "CEFAZAL",
    "FORME": "PDRE. SOL. INJ. IM",
    "DOSAGE": "1G",
    "COND": "B/01FL. PDRE. + 01AMP. DE SOLVANT. (LIDOCAINE 0.8%) DE 05ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOCIETE PHARMACEUTIQUE ALGERIENNE (SOPHAL)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/11/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "29/4/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["cefazolin"],
    "InteractionIndexLink": ["cefazoline"],
    "N_ENREGISTREMENT": "023/ 13 B 013 /08/16",
    "CODE_DCI": "13 B 013",
    "DCI": "CEFAZOLINE",
    "NOM_COMMERCIALE": "CEFAZOL",
    "FORME": "PDRE. ET SOLV. SOL. INJ.IM",
    "DOSAGE": "200MG/ML (OU 1G/5ML)",
    "COND": "B/1FL. DE PDRE + 1AMP. DE SOLVANT (LIDOCAINE) 5ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "UNIMED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "TUNISIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/6/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "2/2/2016",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["cefazolin"],
    "InteractionIndexLink": ["cefazoline"],
    "N_ENREGISTREMENT": "178/ 13 B 013 /99/16",
    "CODE_DCI": "13 B 013",
    "DCI": "CEFAZOLINE",
    "NOM_COMMERCIALE": "ZEPILEN",
    "FORME": "PDRE.SOL.INJ. IM",
    "DOSAGE": "1G/FL. DE PDRE.",
    "COND": "B/1+1",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MEDOCHEMIE LTD",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CHYPRE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/2/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "12/3/2017",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "30 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["cefazolin"],
    "InteractionIndexLink": ["cefazoline"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "13 B 013",
    "DCI": "Cefazoline",
    "NOM_COMMERCIALE": "Zepilen",
    "FORME": "Pdre. Sol. Inj.",
    "DOSAGE": "1g",
    "COND": "B/1",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["cefotaxime"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "323/ 13 B 014 /16",
    "CODE_DCI": "13 B 014",
    "DCI": "CEFOTAXIME SODIQUE EXPRIME EN CEFOTAXIME",
    "NOM_COMMERCIALE": "CEFODEX",
    "FORME": "POUDRE ET SOLVANT POUR PREPARATION INJECTABLE IM ET IV",
    "DOSAGE": "1GR/FLACON",
    "COND": "B/01 FLACON DE POUDRE + 01 FLACON DE SOLVANT",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL CONTINENTAL PHARM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/2/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "29/2/2016",
    "TYPE": "Gé",
    "STATUT": "C",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["cefotaxime"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "039/ 13 B 014 /06/18",
    "CODE_DCI": "13 B 014",
    "DCI": "CEFOTAXIME SODIQUE EXPRIME EN CEFOTAXIME",
    "NOM_COMMERCIALE": "CEFOTAL",
    "FORME": "PDRE. SOL. INJ.",
    "DOSAGE": "1G/FL. DE PDRE.",
    "COND": "B/50FL. DE PDRE.",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOCIETE PHARMACEUTIQUE ALGERIENNE (SOPHAL)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/2/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "18/7/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["ceftriaxone"],
    "InteractionIndexLink": ["ceftriaxone"],
    "N_ENREGISTREMENT": "001/ 13 B 019 /02/13",
    "CODE_DCI": "13 B 019",
    "DCI": "CEFTRIAXONE SODIQUE EXPRIME EN CEFTRIAXONE",
    "NOM_COMMERCIALE": "CEFTRIAXONA HIKMA",
    "FORME": "PDRE. ET SOLV. P. SOL. INJ. IV",
    "DOSAGE": "1G/FL. DE PDRE.",
    "COND": "B/1FL. DE PDRE. + 1AMP. DE 10ML DE SOLV.(E.P.P.I.)",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA FARMACEUTICA (Portugal) SA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PORTUGAL",
    "DATE_D_ENREGISTREMENT_INITIAL": "5/1/2002",
    "DATE_D_ENREGISTREMENT_FINAL": "30/7/2013",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["ceftriaxone"],
    "InteractionIndexLink": ["ceftriaxone"],
    "N_ENREGISTREMENT": "20/13 B019/039",
    "CODE_DCI": "13 B 019",
    "DCI": "CEFTRIAXONE SODIQUE",
    "NOM_COMMERCIALE": "CETRIAL",
    "FORME": "PDRE P.PREPARATION INJ IV",
    "DOSAGE": "1G/FL",
    "COND": "B/50 FL",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES SOPHAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/07/20",
    "DATE_D_ENREGISTREMENT_FINAL": "29/07/20",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["ceftriaxone"],
    "InteractionIndexLink": ["ceftriaxone"],
    "N_ENREGISTREMENT": "380/ 13 B 019 /02/19",
    "CODE_DCI": "13 B 019",
    "DCI": "CEFTRIAXONE SODIQUE EXPRIME EN CEFTRIAXONE",
    "NOM_COMMERCIALE": "CETRIAXONE HUP",
    "FORME": "PDRE. ET SOLV. P. SOL. INJ. IV",
    "DOSAGE": "1G/FL. DE PDRE.",
    "COND": "B/01 FL ET B/50 FL DE POUDRE",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HUP.P PHARMA  SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["ceftriaxone"],
    "InteractionIndexLink": ["ceftriaxone"],
    "N_ENREGISTREMENT": "556/ 13 B 019 /21",
    "CODE_DCI": "13 B 019",
    "DCI": "Ceftriaxone sodique exprimé en Ceftriaxone",
    "NOM_COMMERCIALE": "ZAFOTRIAXONE",
    "FORME": "Poudre pour solution injectable  IV/IM",
    "DOSAGE": "1G/FL. DE PDRE.",
    "COND": "B/10 FL",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "IMGSA GROUPE Industrie Pharmaceutique / SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "3/3/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "3/3/2021",
    "TYPE": "Gé",
    "STATUT": "C",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["cefalexin"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "13 B 156",
    "DCI": "Cefalexine monohydrate exprimé en cefalexine anhydre",
    "NOM_COMMERCIALE": "Ancefal",
    "FORME": "Poudre suspension buvable",
    "DOSAGE": "250mg/5ml",
    "COND": "Flacon 60 ml",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["cefalexin"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "173/ 13 B 156 /99/19",
    "CODE_DCI": "13 B 156",
    "DCI": "CEFALEXINE MONOHYDRATEE EXPRIME EN CEFALEXINE",
    "NOM_COMMERCIALE": "CEPHALEX",
    "FORME": "PDRE .SUSP BUV.",
    "DOSAGE": "250MG/5ML",
    "COND": "FL/100ML DE SUSP APRES RECONS + GOBELET DOSEUR",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "TABUK PHARMACEUTICALS MANUFATURING COMPANY",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ARABIE SAOUDITE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/2/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "7/5/2019",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["cefalexin"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "263/13 B 156/98/16",
    "CODE_DCI": "13 B 156",
    "DCI": "CEFALEXINE",
    "NOM_COMMERCIALE": "KEFORAL",
    "FORME": "PDRE. SUSP BUV",
    "DOSAGE": "250MG/5ML",
    "COND": "FL/60ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOPHARM SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "14/1/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "11/9/2016",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["cefalexin"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "001/ 13 B 156 /06/20",
    "CODE_DCI": "13 B 156",
    "DCI": "CEFALEXINE MONOHYDRATEE EXPRIME EN CEFALEXINE",
    "NOM_COMMERCIALE": "LEXIN 250",
    "FORME": "SUSP. BUV.",
    "DOSAGE": "250MG/5ML",
    "COND": "FL.100ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMA ALGERIA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/12/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "15/3/2020",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["cefalexin"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "039/ 13 B 156 /18",
    "CODE_DCI": "13 B 156",
    "DCI": "CEFALEXINE",
    "NOM_COMMERCIALE": "LEXINAL",
    "FORME": "PDRE .SOL BUV.",
    "DOSAGE": "250MG/5ML",
    "COND": "FL/100ML ET BOUCHON DOSEUR",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOPHAL SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/5/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "17/5/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "269/ 13 B 193 /99/16",
    "CODE_DCI": "13 B 193",
    "DCI": "CEFRADINE",
    "NOM_COMMERCIALE": "ZEEFRA",
    "FORME": "GLES.",
    "DOSAGE": "500MG",
    "COND": "B/12",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BOUCHARA-RECORDATI",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "11/3/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "31/1/2018",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "13 B 197",
    "DCI": "Cefixime trihydraté exprimé en cefixime anhydre",
    "NOM_COMMERCIALE": "Cefimax",
    "FORME": "Poudre suspension buvable",
    "DOSAGE": "40mg/5ml",
    "COND": "Flacon 40 ml",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "039/ 13 B 197 /19",
    "CODE_DCI": "13 B 197",
    "DCI": "CEFIXIME TRIHYDRATE EXPRIME EN CEFIXIME ANHYDRE",
    "NOM_COMMERCIALE": "OROKAL",
    "FORME": "PDRE.SUSP.BUV.",
    "DOSAGE": "40MG/5ML",
    "COND": "FL/40ML + PIPETTE DE 5 ML GRADUEE EN KG",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOPHAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "376/ 13 B 197 /99/15",
    "CODE_DCI": "13 B 197",
    "DCI": "CEFIXIME TRIHYDRATE EXPRIME EN CEFIXIME ANHYDRE",
    "NOM_COMMERCIALE": "OROKEN NOUR",
    "FORME": "PDRE.SUSP.BUV.",
    "DOSAGE": "40MG/5ML",
    "COND": "FL/13.3G",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANOFI AVENTIS FRANCE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/6/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "13/12/2015",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "13 B 198",
    "DCI": "Cefixime trihydraté exprimé en cefixime anhydre",
    "NOM_COMMERCIALE": "Cefimax",
    "FORME": "Poudre suspension buvable",
    "DOSAGE": "100mg/5ml",
    "COND": "Flacon 40 ml",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "039/ 13 B 198 /18",
    "CODE_DCI": "13 B 198",
    "DCI": "CEFIXIME TRIHYDRATE EXPRIME EN CEFIXIME ANHYDRE",
    "NOM_COMMERCIALE": "ORAKAL",
    "FORME": "PDRE.SUSP.BUV.",
    "DOSAGE": "100MG/5ML",
    "COND": "F L/ 40 ML ET PIPETTE GRADUEE",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOPHAL SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/6/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "6/3/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "039/ 13 B 198 /18",
    "CODE_DCI": "13 B 198",
    "DCI": "CEFIXIME TRIHYDRATE EXPRIME EN CEFIXIME ANHYDRE",
    "NOM_COMMERCIALE": "OROKAL",
    "FORME": "PDRE.SUSP.BUV.",
    "DOSAGE": "100MG/5ML",
    "COND": "F L/ 40 ML ET PIPETTE GRADUEE",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOPHAL SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "01/06/99",
    "DATE_D_ENREGISTREMENT_FINAL": "06/03/17",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "230/ 13 B 198 /99/16",
    "CODE_DCI": "13 B 198",
    "DCI": "CEFIXIME TRIHYDRATE EXPRIME EN CEFIXIME ANHYDRE",
    "NOM_COMMERCIALE": "OROKEN ENF",
    "FORME": "PDRE.SUSP.BUV.",
    "DOSAGE": "100MG/5ML",
    "COND": "FL/13.3G",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "AVENTIS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/6/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "6/3/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "13 B 201",
    "DCI": "Cefixime trihydraté exprimé en cefixime anhydre",
    "NOM_COMMERCIALE": "Cefimax",
    "FORME": "Comprimé pelliculé",
    "DOSAGE": "200 mg",
    "COND": "Boite 08",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "039/ 13 B 201 /16",
    "CODE_DCI": "13 B 201",
    "DCI": "CEFIXIME TRIHYDRATEE EXPRIME EN CEFIXIME",
    "NOM_COMMERCIALE": "OROKAL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "200MG",
    "COND": "B/08",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOCIETE PHARMACEUTIQUE ALGERIENNE (SOPHAL)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/6/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "13/6/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "376/ 13 B 201 /99/14",
    "CODE_DCI": "13 B 201",
    "DCI": "CEFIXIME TRIHYDRATE EXPRIME EN CEFIXIME ANHYDRE",
    "NOM_COMMERCIALE": "OROKEN",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "200MG",
    "COND": "B/08",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANOFI AVENTIS FRANCE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/6/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "21/9/2014",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "173/ 13 B 201 /07/17",
    "CODE_DCI": "13 B 201",
    "DCI": "CEFIXIME TRIHYDRATE EXPRIME EN CEFIXIME ANHYDRE",
    "NOM_COMMERCIALE": "WINEX",
    "FORME": "GLES.",
    "DOSAGE": "200MG",
    "COND": "B/08",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "TABUK PHARMACEUTICL MANUFACTURING COMPANY",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ARABIE SAOUDITE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/4/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "21/6/2017",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["cefuroxime"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "369/ 13 B  208 /08/15",
    "CODE_DCI": "13 B 208",
    "DCI": "Cefuroxime axetil exprime en cefuroxime",
    "NOM_COMMERCIALE": "CEFROZINE",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "250MG",
    "COND": "B/10",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JERUSALEM PHARMACEUTICALS CO LTD",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PALESTINE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/12/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "15/7/2015",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["cefuroxime"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "226/ 13 B 208 /09/18",
    "CODE_DCI": "13 B 208",
    "DCI": "Cefuroxime axetil exprime en cefuroxime",
    "NOM_COMMERCIALE": "CEFUCARE",
    "FORME": "COMPRIME",
    "DOSAGE": "250MG",
    "COND": "B/10",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MIDDLE EAST PHARMACEUTICAL AND CHEMICAL INDUSTRIES.MEDICAL APPLIANCES Co",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/8/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "18/4/2018",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["cefuroxime"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "055/ 13 B 208 /08/15",
    "CODE_DCI": "13 B 208",
    "DCI": "Cefuroxime axetil exprime en cefuroxime",
    "NOM_COMMERCIALE": "DAROXIME",
    "FORME": "COMPRIME",
    "DOSAGE": "250MG",
    "COND": "PILULIER/14",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "DAR AL DAWA DEVELOPMENT & INVESTMENT Co Ltd",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/3/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "13/5/2015",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["cefuroxime"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "001/13 B 208 / 20",
    "CODE_DCI": "13 B 208",
    "DCI": "Céfuroxime axétil exprimé en céfuroxime",
    "NOM_COMMERCIALE": "U-Cef",
    "FORME": "Comprimé pelliculé",
    "DOSAGE": "250MG",
    "COND": "B/14",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMA ALGERIA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/12/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "15/12/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["cefuroxime"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "039/ 13 B 208 /18",
    "CODE_DCI": "13 B 208",
    "DCI": "Cefuroxime axetil exprime en cefuroxime",
    "NOM_COMMERCIALE": "ZINETAL",
    "FORME": "COMPRIME",
    "DOSAGE": "250MG",
    "COND": "PILULIER/14",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOPHAL SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/10/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "9/10/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["cefuroxime"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "039/ 13 B 208 /18",
    "CODE_DCI": "13 B 208",
    "DCI": "Cefuroxime axetil exprime en cefuroxime",
    "NOM_COMMERCIALE": "ZINETAL",
    "FORME": "COMPRIME",
    "DOSAGE": "250MG",
    "COND": "B/14",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOPHAL SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "09/10/18",
    "DATE_D_ENREGISTREMENT_FINAL": "09/10/18",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["cefuroxime"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "112/ 13 B 208 /00/17",
    "CODE_DCI": "13 B 208",
    "DCI": "Cefuroxime axetil exprime en cefuroxime",
    "NOM_COMMERCIALE": "ZINNAT",
    "FORME": "COMPRIME",
    "DOSAGE": "250MG",
    "COND": "B/14",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GLAXO WELLCOME",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ROYAUME UNI",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/1/2000",
    "DATE_D_ENREGISTREMENT_FINAL": "18/6/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["cefuroxime"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "173/ 13 B 208 /06/17",
    "CODE_DCI": "13 B 208",
    "DCI": "Cefuroxime axetil exprime en cefuroxime",
    "NOM_COMMERCIALE": "ZINOXIMOR",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "250MG",
    "COND": "B/14",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "TABUK PHARMACEUTICAL MANUFACTURING COMPANY",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ARABIE SAOUDITE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/12/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "10/9/2017",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["cefuroxime"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "13 B 208",
    "DCI": "Cefuroxime Axetil",
    "NOM_COMMERCIALE": "ZINOXIMOR",
    "FORME": "Comprimés pélliculés",
    "DOSAGE": "250 mg/5ml",
    "COND": "B/14",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["cefuroxime"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "13 B 208",
    "DCI": "Cefuroxime axétil exprimé en cefuroxime",
    "NOM_COMMERCIALE": "Zynax",
    "FORME": "Comprimé pelliculé",
    "DOSAGE": "250 mg",
    "COND": "Boite 08",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["ceftazidime"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "023/ 13 B 212 /13",
    "CODE_DCI": "13 B 212",
    "DCI": "CEFTAZIDIME PENTAHYDRATE EXPRIME EN CEFTAZIDIME",
    "NOM_COMMERCIALE": "CEFTAZIM",
    "FORME": "PDRE. P. SOL. INJ. IM/IV",
    "DOSAGE": "500MG/FL. DE PDRE. (ENFANT ET NOURRISSON)",
    "COND": "B/1FL. DE PDRE. P. ENFANT ET NOURRISSON",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "UNIMED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "TUNISIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/3/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "10/3/2013",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["ceftazidime"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "380/ 13 B 213 /21",
    "CODE_DCI": "13 B 213",
    "DCI": "Ceftazidime pentahydraté exprimé en Ceftazidime",
    "NOM_COMMERCIALE": "CAFAZIDIME HUP",
    "FORME": "PDRE. SOL. INJ. IM/IV",
    "DOSAGE": "1G/FL. DE PDRE.",
    "COND": "B/1FL. DE PDRE.",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES HUP.P PHARMA / SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/2/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "17/2/2021",
    "TYPE": "Gé",
    "STATUT": "F prémix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["ceftazidime"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "023/ 13 B 213 /13",
    "CODE_DCI": "13 B 213",
    "DCI": "CEFTAZIDIME PENTAHYDRATE EXPRIME EN CEFTAZIDIME",
    "NOM_COMMERCIALE": "CEFTAZIM",
    "FORME": "PDRE. P. SOL. INJ. IM/IV",
    "DOSAGE": "1G/FL. DE PDRE. (ADULTE)",
    "COND": "B/1FL. DE PDRE.",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "UNIMED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "TUNISIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/3/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "20/3/2013",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["cefalexin"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "035/13 B 223/18",
    "CODE_DCI": "13 B 223",
    "DCI": "CEFALEXINE MONOHYDRATE EXPRIME EN CEFALEXINE ANHYDRE",
    "NOM_COMMERCIALE": "ANCEFAL",
    "FORME": "COMP PELL",
    "DOSAGE": "1G",
    "COND": "B/06 ET B/12",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMALLIANCE EURL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/5/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "27/5/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["cefalexin"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "380/ 13 B 223 /19",
    "CODE_DCI": "13 B 223",
    "DCI": "CEFALEXINE MONOHYDRATEE EXPRIME EN CEFALEXINE",
    "NOM_COMMERCIALE": "KEFALEX",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "1G",
    "COND": "B/12",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HUPP PHARMA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/4/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "29/4/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["cefalexin"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "001/ 13 B 223 /06/19",
    "CODE_DCI": "13 B 223",
    "DCI": "CEFALEXINE MONOHYDRATEE EXPRIME EN CEFALEXINE",
    "NOM_COMMERCIALE": "LEXIN",
    "FORME": "COMPRIME",
    "DOSAGE": "1G",
    "COND": "B/12",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMACEUTICALS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/12/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "17/4/2019",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["cefalexin"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "039/ 13 B 223 /15",
    "CODE_DCI": "13 B 223",
    "DCI": "CEFALEXINE MONOHYDRATEE EXPRIME EN CEFALEXINE",
    "NOM_COMMERCIALE": "LEXINAL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "1G",
    "COND": "B/12",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOPHAL SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/12/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "2/12/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["cefalexin"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "18/13 B223/039",
    "CODE_DCI": "13 B 223",
    "DCI": "CEFALEXINE MONOHYDRATEE",
    "NOM_COMMERCIALE": "LEXINAL SOPHAL",
    "FORME": "COMP PELL",
    "DOSAGE": "1G",
    "COND": "B/12",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES SOPHAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/05/19",
    "DATE_D_ENREGISTREMENT_FINAL": "19/05/19",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["cefuroxime"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "112/ 13 B 224 /00/17",
    "CODE_DCI": "13 B 224",
    "DCI": "Cefuroxime axetil exprime en cefuroxime",
    "NOM_COMMERCIALE": "ZINNAT",
    "FORME": "SUSP. BUV.",
    "DOSAGE": "125MG/5ML",
    "COND": "FL/70ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GLAXO WELLCOME",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ROYAUME UNI",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/6/2000",
    "DATE_D_ENREGISTREMENT_FINAL": "27/2/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["cefuroxime"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "13 B 224",
    "DCI": "Cefuroxime axétil exprimé en cefuroxime",
    "NOM_COMMERCIALE": "Zynax",
    "FORME": "granulé pour suspension buvable",
    "DOSAGE": "125 mg / 5 ml",
    "COND": "Flacon de 200 ml contenant 70 ml de suspension",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["cefaclor"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "13 B 259",
    "DCI": "Céfaclor",
    "NOM_COMMERCIALE": "Orocef",
    "FORME": "SUSPENSION BUVABLE",
    "DOSAGE": "125mg/5ml",
    "COND": "flacon de 60ml",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["cefaclor"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "173/ 13 B 259 /03/18",
    "CODE_DCI": "13 B 259",
    "DCI": "CEFACLOR",
    "NOM_COMMERCIALE": "TABICLOR",
    "FORME": "SUSP BUV",
    "DOSAGE": "125MG/5ML",
    "COND": "FL/75ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "TABUK PHARMACEUTICALS MANUFATURING COMPANY",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ARABIE SAOUDITE",
    "DATE_D_ENREGISTREMENT_INITIAL": "3/8/2003",
    "DATE_D_ENREGISTREMENT_FINAL": "26/11/2018",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["cefaclor"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "055/ 13 B 260 /12",
    "CODE_DCI": "13 B 260",
    "DCI": "CEFACLOR MONOHYDRATE EXPRIME EN CAFACLOR",
    "NOM_COMMERCIALE": "CLORACEF FORTE 250",
    "FORME": "GRLES. P. SUSP. BUV. EN FLACON",
    "DOSAGE": "250MG/5ML",
    "COND": "B/1FL. DE 75ML DE SUSP. BUV. APRES RECONST.+UNE CUILLERE MESURE GRADUEE A 2.5ML ET A 5ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "DAR AL DAWA DEVELOPMENT & INVESTMENT Co Ltd",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/4/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "30/4/2012",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["cefaclor"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "039/13 B 260/20",
    "CODE_DCI": "13 B 260",
    "DCI": "CEFACLOR MONOHYDRATE EXPRIME EN CEFACLOR",
    "NOM_COMMERCIALE": "CLORAFAL",
    "FORME": "PDRE P/ SUSP BUV",
    "DOSAGE": "250MG/5ML",
    "COND": "B/01 FL DE 60ML AVEC PIPETTE DE 5ML",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOCIETE PHARMACEUTIQUE ALGERIENNE (SOPHAL)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/5/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "4/5/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["cefaclor"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "225/ 13 B 260 /06/13",
    "CODE_DCI": "13 B 260",
    "DCI": "CEFACLOR MONOHYDRATE EXPRIME EN CAFACLOR",
    "NOM_COMMERCIALE": "DICEF",
    "FORME": "PDRE. P. SUSP. BUV.",
    "DOSAGE": "250MG/5ML",
    "COND": "B/1FL DE 75MLDE SUSP. BUV. APRES RECONST.+UNE CUILLERE-MESURE",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JAZEERA PHARMACEUTICAL INDUSTRIES",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ARABIE SAOUDITE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/7/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "24/2/2013",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["cefaclor"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "035/13 B 260/20",
    "CODE_DCI": "13 B 260",
    "DCI": "CEFACLOR MONOHYDRATE EXPRIME EN CEFACLOR",
    "NOM_COMMERCIALE": "OROCEF",
    "FORME": "SUSP BUV",
    "DOSAGE": "250MG/5ML",
    "COND": "B/01 FL DE 60ML",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMALLIANCE EURL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/1/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "15/1/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["cefaclor"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "173/ 13 B 260 /03/17",
    "CODE_DCI": "13 B 260",
    "DCI": "CEFACLOR",
    "NOM_COMMERCIALE": "TABICLOR",
    "FORME": "SUSP BUV+BOUCHON DOSEUR GRADUE",
    "DOSAGE": "250MG/5ML",
    "COND": "FL/75ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "TABUK PHARMACEUTICAL MANUFACTURING COMPANY",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ARABIE SAOUDITE",
    "DATE_D_ENREGISTREMENT_INITIAL": "3/8/2003",
    "DATE_D_ENREGISTREMENT_FINAL": "4/9/2017",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["cefaclor"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "039/ 13 B 262 /18",
    "CODE_DCI": "13 B 262",
    "DCI": "CEFACLOR",
    "NOM_COMMERCIALE": "CLORAFAL",
    "FORME": "GLES",
    "DOSAGE": "500MG",
    "COND": "B/16",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOPHAL SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/12/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "24/12/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["cefaclor"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "13 B 262",
    "DCI": "CEFACLOR MONOHYDRATE EXPRIME EN CAFACLOR",
    "NOM_COMMERCIALE": "DICEF 500 MG",
    "FORME": "GLES",
    "DOSAGE": "500MG",
    "COND": "B/15",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["cefaclor"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "173/ 13 B 262 /03/17",
    "CODE_DCI": "13 B 262",
    "DCI": "CEFACLOR",
    "NOM_COMMERCIALE": "TABICLOR",
    "FORME": "GLES",
    "DOSAGE": "500MG",
    "COND": "B/15",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "TABUK PHARMACEUTICAL MANUFACTURING COMPANY",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ARABIE SAOUDITE",
    "DATE_D_ENREGISTREMENT_INITIAL": "3/8/2003",
    "DATE_D_ENREGISTREMENT_FINAL": "18/6/2017",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "226/ 13 B 294 /08 /18",
    "CODE_DCI": "13 B 294",
    "DCI": "CEFIXIME",
    "NOM_COMMERCIALE": "BETIXIM",
    "FORME": "GLES.",
    "DOSAGE": "400MG",
    "COND": "B/05",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MIDDLE EAST PHARMACEUTICAL AND CHEMICAL INDUSTRIES.MEDICAL APPLIANCES Co",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/5/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "19/3/2018",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "039/13 B 294/17",
    "CODE_DCI": "13 B 294",
    "DCI": "CEFIXIME TRIHYDRATE",
    "NOM_COMMERCIALE": "OROKAL",
    "FORME": "GLES.",
    "DOSAGE": "400MG",
    "COND": "B/06",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOPHAL SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/5/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "28/5/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "173/ 13 B 294 /07/17",
    "CODE_DCI": "13 B 294",
    "DCI": "CEFIXIME",
    "NOM_COMMERCIALE": "WINEX",
    "FORME": "GLES.",
    "DOSAGE": "400MG",
    "COND": "B/06",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "TABUK PHARMACEUTICL MANUFACTURING COMPANY",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ARABIE SAOUDITE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/6/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "30/7/2017",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["cefuroxime"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "369/ 13 B 296 /08/15",
    "CODE_DCI": "13 B 296",
    "DCI": "Cefuroxime axetil exprime en cefuroxime",
    "NOM_COMMERCIALE": "CEFROZINE",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "500MG",
    "COND": "B/10",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JERUSALEM PHARMACEUTICALS CO LTD",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PALESTINE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/12/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "15/7/2015",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["cefuroxime"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "001/13 B 296/20",
    "CODE_DCI": "13 B 296",
    "DCI": "CEFUROXIME AXETIL",
    "NOM_COMMERCIALE": "U-CEF",
    "FORME": "COMP. PELL.",
    "DOSAGE": "500MG",
    "COND": "B/14",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES HIKMA PHARMA ALGERIE/ SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "16/12/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "16/12/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["cefuroxime"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "001/13 B 296 / 20",
    "CODE_DCI": "13 B 296",
    "DCI": "Céfuroxime axétil exprimé en céfuroxime",
    "NOM_COMMERCIALE": "U-Cef",
    "FORME": "Comprimé pelliculé",
    "DOSAGE": "500MG",
    "COND": "B/14",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMA ALGERIA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "16/12/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "16/12/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["cefuroxime"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "039/ 13 B 296 /18",
    "CODE_DCI": "13 B 296",
    "DCI": "Cefuroxime axetil exprime en cefuroxime",
    "NOM_COMMERCIALE": "ZINETAL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "500MG",
    "COND": "B/14",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOPHAL  SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/10/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "9/10/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["cefuroxime"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "173/ 13 B 296 /06 /18",
    "CODE_DCI": "13 B 296",
    "DCI": "Cefuroxime axetil exprime en cefuroxime",
    "NOM_COMMERCIALE": "ZINOXIMOR 500",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "500MG",
    "COND": "B/14",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "TABUK PHARMACEUTICAL MANUFACTURING COMPANY",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ARABIE SAOUDITE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/12/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "7/8/2018",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["cefuroxime"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "13 B 296",
    "DCI": "Cefuroxime axétil exprimé en cefuroxime",
    "NOM_COMMERCIALE": "Zynax",
    "FORME": "Comprimé pelliculé",
    "DOSAGE": "500 mg",
    "COND": "Boite 08",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "001/ 13 B 298 /07/19",
    "CODE_DCI": "13 B 298",
    "DCI": "CEFADROXIL MONOHYDRATE EXPRIME EN CEFADROXIL ANHYDRE",
    "NOM_COMMERCIALE": "CEDROX",
    "FORME": "COMPRIME",
    "DOSAGE": "1G",
    "COND": "B/12",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMACEUTICALS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/1/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "039/13 B 298/16",
    "CODE_DCI": "13 B 298",
    "DCI": "CEFADROXIL MONOHYDRATE EXPRIME EN CEFADROXIL ANHYDRE",
    "NOM_COMMERCIALE": "CEDROXAL",
    "FORME": "COMPRIME",
    "DOSAGE": "1G",
    "COND": "B/12",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOPHAL SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/12/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "19/12/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "20/13 B298/380",
    "CODE_DCI": "13 B 298",
    "DCI": "CEFADROXIL MONOHYDRATE EXPRIME EN CEFADROXIL ANHYDRE",
    "NOM_COMMERCIALE": "DROXIFAL",
    "FORME": "COMP",
    "DOSAGE": "1G",
    "COND": "B/12",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "laboratoires HUP.P PHARMA Sarl",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/12/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "28/12/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "001/ 13 B 318 /07/19",
    "CODE_DCI": "13 B 318",
    "DCI": "CEFDINIR",
    "NOM_COMMERCIALE": "OMNICEF",
    "FORME": "CAPSULE ORALE",
    "DOSAGE": "300MG",
    "COND": "B/10",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMA ALGERIA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/5/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "30/12/2019",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "039/13 B 318/17",
    "CODE_DCI": "13 B 318",
    "DCI": "CEFDINIR",
    "NOM_COMMERCIALE": "OMNIFAL",
    "FORME": "GELULES",
    "DOSAGE": "300MG",
    "COND": "B/10",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOPHAL SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/2/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "12/2/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "001/ 13 B 319 /07/14",
    "CODE_DCI": "13 B 319",
    "DCI": "CEFDINIR",
    "NOM_COMMERCIALE": "OMNICEF",
    "FORME": "SUSP. BUV.",
    "DOSAGE": "125MG/5ML",
    "COND": "FL./40ML ET FL./80ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMACEUTICALS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/5/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "6/7/2014",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "039/ 13 B 319 /20",
    "CODE_DCI": "13 B 319",
    "DCI": "Cefdinir",
    "NOM_COMMERCIALE": "OMNIFAL",
    "FORME": "PDRE. P. SUSP. BUV.",
    "DOSAGE": "125MG/5ML",
    "COND": "FL./40ML ET FL./80ML",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOPHAL / SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/12/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "30/3/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "039/ 13 B 319 /20",
    "CODE_DCI": "13 B 319",
    "DCI": "Cefdinir",
    "NOM_COMMERCIALE": "OMNIFAL",
    "FORME": "PDRE. P. SUSP. BUV.",
    "DOSAGE": "125MG/5ML",
    "COND": "FL./40ML ET FL./80ML",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOPHAL / SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/12/20",
    "DATE_D_ENREGISTREMENT_FINAL": "30/03/21",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "18/13 B320/380",
    "CODE_DCI": "13 B 320",
    "DCI": "CEFOPERAZONE SODIQUE EXPRIMÉE EN CEFOPERAZONE",
    "NOM_COMMERCIALE": "CEFOPERAZ HUP",
    "FORME": "PDRE P.SOL INJ IM/IV",
    "DOSAGE": "1G",
    "COND": "B/100 FLACONS",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "laboratoires HUP.P PHARMA Sarl",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/12/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "24/12/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "286/ 13 B 320 /12",
    "CODE_DCI": "13 B 320",
    "DCI": "CEFOPERAZONE SODIQUE EXPRIME EN CEFOPERAZONE",
    "NOM_COMMERCIALE": "PERAZ 1000",
    "FORME": "PDRE. P. SOL. INJ. IM/IV",
    "DOSAGE": "1 000MG/FL. DE PDRE.",
    "COND": "GRDE. BOITE CONTENANT 100BOITES DE 1FLACON DE PDRE.",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CHIMIE PHARMACIE COMMERCE MULTIPLE SARL (CPCM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/1/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "10/1/2012",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "18/13 B321/380",
    "CODE_DCI": "13 B 321",
    "DCI": "CEFOPERAZONE SODIQUEEXPRIME EN CEFOPERAZONE",
    "NOM_COMMERCIALE": "CEFOPERAZ HUP",
    "FORME": "POUDRE P.SOL INJ IM/IV",
    "DOSAGE": "2G",
    "COND": "B/100 FLACONS",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "laboratoires HUP.P PHARMA Sarl",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/12/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "24/12/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "286/ 13 B 321 /12",
    "CODE_DCI": "13 B 321",
    "DCI": "CEFOPERAZONE SODIQUE EXPRIME EN CEFOPERAZONE",
    "NOM_COMMERCIALE": "PERAZ 2000",
    "FORME": "PDRE. P. SOL. INJ. IM/IV",
    "DOSAGE": "2 000MG/FL. DE PDRE.",
    "COND": "GRDE. BOITE CONTENANT 100BOITES DE 1FLACON DE PDRE.",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CHIMIE PHARMACIE COMMERCE MULTIPLE SARL (CPCM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/1/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "10/1/2012",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["cefpodoxime"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "039/ 13 B 333 /19",
    "CODE_DCI": "13 B 333",
    "DCI": "CEFPODOXIME (SOUS FORME DE CEFPODOXIME PROXETIL)",
    "NOM_COMMERCIALE": "RELOXAL",
    "FORME": "GRLES.SUSP. BUV.",
    "DOSAGE": "40MG/5ML (OU 8MG/ML)",
    "COND": "B/1FL.DE 100ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOCIETE PHARMACEUTIQUE ALGERIENNE SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/5/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "13/5/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "039/ 13 B 463 /14",
    "CODE_DCI": "13 B 463",
    "DCI": "CEFTIZOXIME SODIQUE EXPRIME EN CEFTIZOXIME",
    "NOM_COMMERCIALE": "CETIZAL",
    "FORME": "PDRE P/ SOL INJ IM/IV",
    "DOSAGE": "1G",
    "COND": "B/50 FL",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOPHAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "31/3/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "31/3/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "286/ 13 B 463 /12",
    "CODE_DCI": "13 B 463",
    "DCI": "CEFTIZOXIME SODIQUE EXPRIME EN CEFTIZOXIME",
    "NOM_COMMERCIALE": "TIZO 1000",
    "FORME": "PDRE. P. SOL. INJ. IM/IV",
    "DOSAGE": "1 000MG/FL. DE PDRE.",
    "COND": "B/1FL. DE PDRE.",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CHIMIE PHARMACIE COMMERCE MULTIPLE SARL (CPCM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/1/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "10/1/2012",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["cefaclor"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "055/ 13 B 473 /14",
    "CODE_DCI": "13 B 473",
    "DCI": "CEFACLOR MONOHYDRATE EXPRIME EN CAFACLOR",
    "NOM_COMMERCIALE": "CLORACEF MR",
    "FORME": "COMP. PELLI. LM",
    "DOSAGE": "500MG",
    "COND": "B/10",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "DAR AL DAWA DEVELOPMENT & INVESTMENT Co Ltd",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/12/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "25/12/2014",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["cefaclor"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "055/ 13 B 474 /14",
    "CODE_DCI": "13 B 474",
    "DCI": "CEFACLOR MONOHYDRATE EXPRIME EN CAFACLOR",
    "NOM_COMMERCIALE": "CLORACEF MR",
    "FORME": "COMP. PELLI. LM",
    "DOSAGE": "750MG",
    "COND": "B/10",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "DAR AL DAWA DEVELOPMENT & INVESTMENT Co Ltd",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/12/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "25/12/2014",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["doxycycline"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "13 C 020",
    "DCI": "DOXYCYCLINE(SOUS FOPME D'HYCLATE)",
    "NOM_COMMERCIALE": "DOTUR",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "100MG",
    "COND": "B/10",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["tetracycline"],
    "InteractionIndexLink": ["lymecycline", "tetracycline"],
    "N_ENREGISTREMENT": "123/ 13 C 246 /03/14",
    "CODE_DCI": "13 C 246",
    "DCI": "LYMECYCLINE (EXPRIME EN TETRACYCLINE BASE)",
    "NOM_COMMERCIALE": "TETRALYSAL",
    "FORME": "GLES",
    "DOSAGE": "150MG",
    "COND": "B/16",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GALDERMA INTERNATIONAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/12/2003",
    "DATE_D_ENREGISTREMENT_FINAL": "21/9/2014",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["doxycycline"],
    "InteractionIndexLink": ["doxycycline"],
    "N_ENREGISTREMENT": "380/ 13 C 444 /15",
    "CODE_DCI": "13 C 444",
    "DCI": "DOXYCYCLINE MONOHYDRATE EXPRIME EN DOXYCYCLINE",
    "NOM_COMMERCIALE": "DOXYNUP",
    "FORME": "COMP. DISPERS.",
    "DOSAGE": "100MG",
    "COND": "B/06",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HUP.P.PHARMA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/6/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "24/6/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["tigecycline"],
    "InteractionIndexLink": ["tigecycline"],
    "N_ENREGISTREMENT": "045/ 13 C 485  /17",
    "CODE_DCI": "13 C 485",
    "DCI": "Tigécycline",
    "NOM_COMMERCIALE": "TYGACIL",
    "FORME": "POUDRE  POUR SOLUTION POUR PERFUSION IV",
    "DOSAGE": "50 MG / FL",
    "COND": "B/10 FLS DE POUDRE DE 5ML",
    "LISTE": "LISTE I",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PFIZER LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ROYAUME UNI",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/12/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "25/12/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["clindamycin"],
    "InteractionIndexLink": ["clindamycine"],
    "N_ENREGISTREMENT": "166/ 13 D 025 /98/15",
    "CODE_DCI": "13 D 025",
    "DCI": "CLINDAMYCINE CHLORHYDRATE EXPRIME EN CLINDAMYCINE",
    "NOM_COMMERCIALE": "CLINARAM",
    "FORME": "GLES",
    "DOSAGE": "150MG",
    "COND": "B/16",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "RAM PHARMACEUTICAL INDUSTRIES",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/6/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "31/5/2015",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["erythromycin"],
    "InteractionIndexLink": ["erythromycine"],
    "N_ENREGISTREMENT": "050/ 13 E 028 /98/16",
    "CODE_DCI": "13 E 028",
    "DCI": "ERYTHROMYCINE",
    "NOM_COMMERCIALE": "ERYBESAN",
    "FORME": "GRLES.SUSP.BUV.",
    "DOSAGE": "200MG/5ML",
    "COND": "FL/60 ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANDOZ SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/1/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "25/4/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["erythromycin"],
    "InteractionIndexLink": ["erythromycine"],
    "N_ENREGISTREMENT": "055/ 13 E 028 /99/14",
    "CODE_DCI": "13 E 028",
    "DCI": "ERYTHROMYCINE",
    "NOM_COMMERCIALE": "ERYTHRODAR",
    "FORME": "SUSP.BUV.",
    "DOSAGE": "200MG/5ML",
    "COND": "FL/100 ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "DAR AL DAWA DEVELOPMENT & INVESTMENT Co Ltd",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/2/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "19/3/2014",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["pristinamycine"],
    "N_ENREGISTREMENT": "376/ 13 E 030 /96/16",
    "CODE_DCI": "13 E 030",
    "DCI": "PRISTINAMYCINE",
    "NOM_COMMERCIALE": "PYOSTACINE",
    "FORME": "COMP.PELLI.SEC.",
    "DOSAGE": "500MG",
    "COND": "B/16",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANOFI AVENTIS FRANCE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "14/12/1996",
    "DATE_D_ENREGISTREMENT_FINAL": "7/3/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "48 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["spiramycine"],
    "InteractionIndexLink": ["spiramycine"],
    "N_ENREGISTREMENT": "235/13 E 031/19",
    "CODE_DCI": "13 E 031",
    "DCI": "SPIRAMYCINE",
    "NOM_COMMERCIALE": "PRAMYCINE",
    "FORME": "COMP PELL",
    "DOSAGE": "1.5MUI",
    "COND": "B/16",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOGALENIC SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "3O/10/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "3O/10/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["spiramycine"],
    "InteractionIndexLink": ["spiramycine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "13 E 031",
    "DCI": "SPIRAMYCINE",
    "NOM_COMMERCIALE": "ROVADAL",
    "FORME": "COMPRIME",
    "DOSAGE": "1 500 000UI",
    "COND": "B/16",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["spiramycine"],
    "InteractionIndexLink": ["spiramycine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "13 E 031",
    "DCI": "SPIRAMYCINE",
    "NOM_COMMERCIALE": "ROVAMYCINE",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "1 500 000UI",
    "COND": "B/16",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["spiramycine"],
    "InteractionIndexLink": ["spiramycine"],
    "N_ENREGISTREMENT": "380/ 13 E 031 /19",
    "CODE_DCI": "13 E 031",
    "DCI": "SPIRAMYCINE",
    "NOM_COMMERCIALE": "ROVAMYNE",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "1 500 000UI",
    "COND": "B/16",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HUPP PHARMA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/7/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "10/7/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["spiramycine"],
    "InteractionIndexLink": ["spiramycine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "13 E 031",
    "DCI": "SPIRAMYCINE",
    "NOM_COMMERCIALE": "SPIRA",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "1 500 000UI",
    "COND": "B/16",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["spiramycine"],
    "InteractionIndexLink": ["spiramycine"],
    "N_ENREGISTREMENT": "293/ 13 E 031 /05/20",
    "CODE_DCI": "13 E 031",
    "DCI": "SPIRAMYCINE",
    "NOM_COMMERCIALE": "SPIRACARE",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "1 500 000UI",
    "COND": "B/16",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOCARE SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "14/6/2005",
    "DATE_D_ENREGISTREMENT_FINAL": "4/5/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["spiramycine"],
    "InteractionIndexLink": ["spiramycine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "13 E 031",
    "DCI": "Spiramycine",
    "NOM_COMMERCIALE": "SPIRACARE",
    "FORME": "Comprimés",
    "DOSAGE": "1.5 MUI",
    "COND": "Boite de  16",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["spiramycine"],
    "InteractionIndexLink": ["spiramycine"],
    "N_ENREGISTREMENT": "470 / 13 E 031 /21",
    "CODE_DCI": "13 E 031",
    "DCI": "Spiramycine",
    "NOM_COMMERCIALE": "SPIRALEX",
    "FORME": "Comprimé pelliculé",
    "DOSAGE": "1.5MUI",
    "COND": "B/16",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE M.M / SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "21/3/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "21/3/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["spiramycine"],
    "InteractionIndexLink": ["spiramycine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "13 E 031",
    "DCI": "SPIRAMYCINE",
    "NOM_COMMERCIALE": "SPIRAMEX",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "1.5 MUI",
    "COND": "BOITE DE 16",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["spiramycine"],
    "InteractionIndexLink": ["spiramycine"],
    "N_ENREGISTREMENT": "039/ 13 E 031 /05/15",
    "CODE_DCI": "13 E 031",
    "DCI": "SPIRAMYCINE",
    "NOM_COMMERCIALE": "SPIRAMYNAL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "1 500 000UI",
    "COND": "B/16",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOCIETE PHARMACEUTIQUE ALGERIENNE (SOPHAL)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/4/2005",
    "DATE_D_ENREGISTREMENT_FINAL": "2/8/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["spiramycine"],
    "InteractionIndexLink": ["spiramycine"],
    "N_ENREGISTREMENT": "235/13 E 032/19",
    "CODE_DCI": "13 E 032",
    "DCI": "SPIRAMYCINE",
    "NOM_COMMERCIALE": "PRAMYCINE",
    "FORME": "COMP PELL",
    "DOSAGE": "3MUI",
    "COND": "B/16",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOGALENIC SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "3O/10/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "3O/10/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["spiramycine"],
    "InteractionIndexLink": ["spiramycine"],
    "N_ENREGISTREMENT": "003 / 13 E 032 /09/18",
    "CODE_DCI": "13 E 032",
    "DCI": "SPIRAMYCINE",
    "NOM_COMMERCIALE": "ROVADAL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "3 000 000UI",
    "COND": "B/15 ET B/10",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SAIDAL GROUPE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/3/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "12/2/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["spiramycine"],
    "InteractionIndexLink": ["spiramycine"],
    "N_ENREGISTREMENT": "428/ 13 E 032 /96/17",
    "CODE_DCI": "13 E 032",
    "DCI": "SPIRAMYCINE",
    "NOM_COMMERCIALE": "ROVAMYCINE",
    "FORME": "COMP.PELLI.SEC.",
    "DOSAGE": "3 000 000UI",
    "COND": "B/16",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "WINTHROP PHARMA SAIDAL SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "11/12/1996",
    "DATE_D_ENREGISTREMENT_FINAL": "26/11/2017",
    "TYPE": "Ré",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["spiramycine"],
    "InteractionIndexLink": ["spiramycine"],
    "N_ENREGISTREMENT": "380/ 13 E 032 /19",
    "CODE_DCI": "13 E 032",
    "DCI": "SPIRAMYCINE",
    "NOM_COMMERCIALE": "ROVAMYNE",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "3 000 000UI",
    "COND": "B/10",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HUPP PHARMA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/4/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "29/4/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["spiramycine"],
    "InteractionIndexLink": ["spiramycine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "13 E 032",
    "DCI": "SPIRAMYCINE",
    "NOM_COMMERCIALE": "SPIRA",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "3 000 000UI",
    "COND": "B/10",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["spiramycine"],
    "InteractionIndexLink": ["spiramycine"],
    "N_ENREGISTREMENT": "293/ 13 E 032 /05/21",
    "CODE_DCI": "13 E 032",
    "DCI": "Spiramycine",
    "NOM_COMMERCIALE": "SPIRACARE",
    "FORME": "Comprimé pelliculé",
    "DOSAGE": "3 MUI",
    "COND": "B/10",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOCARE / SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/5/2005",
    "DATE_D_ENREGISTREMENT_FINAL": "18/3/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["spiramycine"],
    "InteractionIndexLink": ["spiramycine"],
    "N_ENREGISTREMENT": "470/ 13 E 032 /21",
    "CODE_DCI": "13 E 032",
    "DCI": "Spiramycine",
    "NOM_COMMERCIALE": "SPIRALEX",
    "FORME": "Comprimé pelliculé",
    "DOSAGE": "3 MUI",
    "COND": "B/10",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE M.M / SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "14/3/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "14/3/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["spiramycine"],
    "InteractionIndexLink": ["spiramycine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "13 E 032",
    "DCI": "SPIRAMYCINE",
    "NOM_COMMERCIALE": "SPIRAMEX",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "3 MUI",
    "COND": "BOITE DE 10",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["spiramycine"],
    "InteractionIndexLink": ["spiramycine"],
    "N_ENREGISTREMENT": "039/ 13 E 032 /04/15",
    "CODE_DCI": "13 E 032",
    "DCI": "SPIRAMYCINE",
    "NOM_COMMERCIALE": "SPIRAMYNAL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "3000 000UI",
    "COND": "B/10",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOCIETE PHARMACEUTIQUE ALGERIENNE (SOPHAL)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/12/2004",
    "DATE_D_ENREGISTREMENT_FINAL": "2/8/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["spiramycine"],
    "InteractionIndexLink": ["spiramycine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "13 E 154",
    "DCI": "SPIRAMYCINE",
    "NOM_COMMERCIALE": "ROVADAL",
    "FORME": "SIROP",
    "DOSAGE": "0.375MUI/5ML",
    "COND": "FL./150ML",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["spiramycine"],
    "InteractionIndexLink": ["spiramycine"],
    "N_ENREGISTREMENT": "503/13 E 154/17",
    "CODE_DCI": "13 E 154",
    "DCI": "SPIRAMYCINE",
    "NOM_COMMERCIALE": "SPIRAMYCINE AFRO",
    "FORME": "SIROP",
    "DOSAGE": "0.375MUI/5ML",
    "COND": "FL./150ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "AFRO PHARM SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/6/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "12/6/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["spiramycine"],
    "InteractionIndexLink": ["spiramycine"],
    "N_ENREGISTREMENT": "073/13 E 154/19",
    "CODE_DCI": "13 E 154",
    "DCI": "SPIRAMYCINE",
    "NOM_COMMERCIALE": "SPIRAMYCINE ISO",
    "FORME": "SIROP",
    "DOSAGE": "0.375MUI/5ML",
    "COND": "FL./150ML AVEC GOBLET DOSEUR",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ISOPHARM SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "21/5/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "21/5/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["azithromycin"],
    "InteractionIndexLink": ["azithromycine"],
    "N_ENREGISTREMENT": "003/ 13 E 176 /07/21",
    "CODE_DCI": "13 E 176",
    "DCI": "Azithromycine dihydrate exprimé en Azithromycine",
    "NOM_COMMERCIALE": "AZIMYCINE",
    "FORME": "Gélule",
    "DOSAGE": "250MG",
    "COND": "B/06",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EPE GROUPE INDUSTRIEL  SAIDAL / SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/4/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "15/2/2021",
    "TYPE": "Gé",
    "STATUT": "F prémix",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["azithromycin"],
    "InteractionIndexLink": ["azithromycine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "13 E 176",
    "DCI": "AZITHROMYCINE DIHYDRATEE EXPRIMEE EN AZITHROMYCINE",
    "NOM_COMMERCIALE": "BINOZYT",
    "FORME": "GLES.",
    "DOSAGE": "250MG",
    "COND": "B/06",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["azithromycin"],
    "InteractionIndexLink": ["azithromycine"],
    "N_ENREGISTREMENT": "468/ 13 E 176/13",
    "CODE_DCI": "13 E 176",
    "DCI": "Azithromycine Dihydratee Exprimee En Azithromycine",
    "NOM_COMMERCIALE": "MYCINAD",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "250MG",
    "COND": "B/06",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NADPHARMADIC PRODUCTION SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/12/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "18/12/2013",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["azithromycin"],
    "InteractionIndexLink": ["azithromycine"],
    "N_ENREGISTREMENT": "352/ 13 E 176 /06/18",
    "CODE_DCI": "13 E 176",
    "DCI": "Azithromycine dihydrate exprimé en Azithromycine",
    "NOM_COMMERCIALE": "ZETRON",
    "FORME": "Gélule",
    "DOSAGE": "250MG",
    "COND": "B/06",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "31/7/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "14/3/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["azithromycin"],
    "InteractionIndexLink": ["azithromycine"],
    "N_ENREGISTREMENT": "035/ 13 E 176 /15",
    "CODE_DCI": "13 E 176",
    "DCI": "Azithromycine Dihydratee Exprimee En Azithromycine",
    "NOM_COMMERCIALE": "ZOTRIX",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "250MG",
    "COND": "B/06",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMALLIANCE EURL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/6/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "24/6/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["azithromycin"],
    "InteractionIndexLink": ["azithromycine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "13 E 177",
    "DCI": "AZITHROMYCINE DIHYDRATEE EXPRIMEE EN AZITHROMYCINE",
    "NOM_COMMERCIALE": "BINOZYT",
    "FORME": "PDRE. SOL. BUV.",
    "DOSAGE": "40MG/ML (200MG/5ML)",
    "COND": "FL/15ML",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["azithromycin"],
    "InteractionIndexLink": ["azithromycine"],
    "N_ENREGISTREMENT": "001/ 13 E 177 /05/19",
    "CODE_DCI": "13 E 177",
    "DCI": "Azithromycine Dihydratee Exprimee En Azithromycine",
    "NOM_COMMERCIALE": "ZOMAX",
    "FORME": "POUDRE POUR SUSPENSION ORALE EN FLACON",
    "DOSAGE": "40MG/ML  (200MG/5ML ET 300MG/7.5ML)",
    "COND": "B/1FL. DE 15ML APRES RECONSTIT. (200MG/5ML)+UNE AMP. D'EAU PURIFIEE + UNE CUILLERE MESURE DE 5ML ET  B/1FL. DE 22.5ML APRES RECONSTIT.(300MG/7.5ML)+UNE AMP. D'EAU PURIFIEE + UNE CUILLERE MESURE DE 5ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA  PHARMACEUTICALS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/11/2005",
    "DATE_D_ENREGISTREMENT_FINAL": "6/7/2011",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["azithromycin"],
    "InteractionIndexLink": ["azithromycine"],
    "N_ENREGISTREMENT": "035/ 13 E 177 /15",
    "CODE_DCI": "13 E 177",
    "DCI": "Azithromycine Dihydratee Exprimee En Azithromycine",
    "NOM_COMMERCIALE": "ZOTRIX",
    "FORME": "PDRE. P. SUSP. BUV.",
    "DOSAGE": "40MG/ML",
    "COND": "B/01 FL. DE 15ML.30ML.37.5ML DE SUSP. BUV. APRES RECONSTITUTION + 01 PIPETTE GRADUEE",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMALLIANCE EURL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "31/5/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "26/7/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["roxithromycin"],
    "InteractionIndexLink": ["roxithromycine"],
    "N_ENREGISTREMENT": "055/ 13 E 185 /01/13",
    "CODE_DCI": "13 E 185",
    "DCI": "ROXITHROMYCINE",
    "NOM_COMMERCIALE": "ROXAMED",
    "FORME": "COMP. ENRO.",
    "DOSAGE": "150MG",
    "COND": "B/10",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "DAR AL DAWA DEVELOPMENT & INVESTMENT Co Ltd",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "21/8/2001",
    "DATE_D_ENREGISTREMENT_FINAL": "17/7/2013",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["roxithromycin"],
    "InteractionIndexLink": ["roxithromycine"],
    "N_ENREGISTREMENT": "510/13 E 185/17",
    "CODE_DCI": "13 E 185",
    "DCI": "ROXITHROMYCINE",
    "NOM_COMMERCIALE": "ROXIBACT ALEMBIC MAMI",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "150MG",
    "COND": "B/10",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALEMBIC MAMI",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/2/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "12/2/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["roxithromycin"],
    "InteractionIndexLink": ["roxithromycine"],
    "N_ENREGISTREMENT": "380/ 13 E 185 /12",
    "CODE_DCI": "13 E 185",
    "DCI": "ROXITHROMYCINE",
    "NOM_COMMERCIALE": "ROXITHROMYCINE HUP",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "150MG",
    "COND": "B/10",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HUP.P.PHARMA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/6/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "17/6/2012",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["roxithromycin"],
    "InteractionIndexLink": ["roxithromycine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "13 E 185",
    "DCI": "Roxithromycine",
    "NOM_COMMERCIALE": "Roxid",
    "FORME": "Comprimé",
    "DOSAGE": "150 mg",
    "COND": "Boite 10",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["josamycine"],
    "InteractionIndexLink": ["josamycine"],
    "N_ENREGISTREMENT": "374/ 13 E 188 /99/15",
    "CODE_DCI": "13 E 188",
    "DCI": "JOSAMYCINE PROPIONATE EXPRIME EN JOSAMYCINE",
    "NOM_COMMERCIALE": "JOSACINE",
    "FORME": "GRLES.SUSP.BUV",
    "DOSAGE": "125MG/5 ML",
    "COND": "B/01 FL. DE 15G CORRESPONDANT A 60ML DE SUSP. RECONSTITUEE AVEC SERINGUE P. ADMINISTRATION ORALE",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ASTELLAS PHARMA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/1/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "26/2/2015",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "60 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["josamycine"],
    "InteractionIndexLink": ["josamycine"],
    "N_ENREGISTREMENT": "374/ 13 E 189 /99/15",
    "CODE_DCI": "13 E 189",
    "DCI": "JOSAMYCINE PROPIONATE EXPRIME EN JOSAMYCINE",
    "NOM_COMMERCIALE": "JOSACINE",
    "FORME": "GRLES.SUSP.BUV",
    "DOSAGE": "250MG/5ML",
    "COND": "B/01 FL. DE 15G CORRESPONDANT A 60ML DE SUSP. RECONSTITUEE AVEC SERINGUE P. ADMINISTRATION ORALE",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ASTELLAS PHARMA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/1/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "26/2/2015",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "60 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["josamycine"],
    "InteractionIndexLink": ["josamycine"],
    "N_ENREGISTREMENT": "374/ 13 E 190 /99/15",
    "CODE_DCI": "13 E 190",
    "DCI": "JOSAMYCINE PROPIONATE EXPRIME EN JOSAMYCINE",
    "NOM_COMMERCIALE": "JOSACINE",
    "FORME": "GRLES.SUSP.BUV",
    "DOSAGE": "500MG /5ML",
    "COND": "B/01 FL. DE 20G CORRESPONDANT A 60ML DE SUSP. RECONSTITUEE AVEC SERINGUE P. ADMINISTRATION ORALE",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ASTELLAS PHARMA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "8/3/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "26/2/2015",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "60 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["josamycine"],
    "InteractionIndexLink": ["josamycine"],
    "N_ENREGISTREMENT": "374/ 13 E 202 /99/15",
    "CODE_DCI": "13 E 202",
    "DCI": "JOSAMYCINE",
    "NOM_COMMERCIALE": "JOSACINE",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "500MG",
    "COND": "B/20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ASTELLAS PHARMA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/3/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "26/2/2015",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "60 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["clarithromycin"],
    "InteractionIndexLink": ["clarithromycine"],
    "N_ENREGISTREMENT": "352/13 E 215/06/17",
    "CODE_DCI": "13 E 215",
    "DCI": "CLARITHROMYCINE",
    "NOM_COMMERCIALE": "ARICLARE",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "500MG",
    "COND": "B/14",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KEDNDI INDUSTRIE DU MEDICAMENT SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/7/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "16/6/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["clarithromycin"],
    "InteractionIndexLink": ["clarithromycine"],
    "N_ENREGISTREMENT": "055/ 13 E 215 /07/18",
    "CODE_DCI": "13 E 215",
    "DCI": "CLARITHROMYCINE",
    "NOM_COMMERCIALE": "CLARIDAR 500",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "500MG",
    "COND": "B/14",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "DAR AL DAWA DEVELOPMENT & INVESTMENT Co Ltd",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/5/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "8/4/2018",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["clarithromycin"],
    "InteractionIndexLink": ["clarithromycine"],
    "N_ENREGISTREMENT": "039/13 E 215/11/16",
    "CODE_DCI": "13 E 215",
    "DCI": "CLARITHROMYCINE",
    "NOM_COMMERCIALE": "CLARITAL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "500MG",
    "COND": "B/14",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOCIETE PHARMACEUTIQUE ALGERIENNE (SOPHAL)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/4/2011",
    "DATE_D_ENREGISTREMENT_FINAL": "15/11/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["clarithromycin"],
    "InteractionIndexLink": ["clarithromycine"],
    "N_ENREGISTREMENT": "235/13 E 215/19",
    "CODE_DCI": "13 E 215",
    "DCI": "CLARITHROMYCINE",
    "NOM_COMMERCIALE": "CLARITHRO",
    "FORME": "COMP PELL",
    "DOSAGE": "500MG",
    "COND": "B/14",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOGALENIC SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/11/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "25/11/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["clarithromycin"],
    "InteractionIndexLink": ["clarithromycine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "13 E 215",
    "DCI": "CLARITHROMYCINE",
    "NOM_COMMERCIALE": "RITOCINE",
    "FORME": "COMP PELL",
    "DOSAGE": "500MG",
    "COND": "B/10",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["clarithromycin"],
    "InteractionIndexLink": ["clarithromycine"],
    "N_ENREGISTREMENT": "147/ 13 E 215 /00/17",
    "CODE_DCI": "13 E 215",
    "DCI": "CLARITHROMYCINE",
    "NOM_COMMERCIALE": "ZECLAR",
    "FORME": "COMPRIME",
    "DOSAGE": "500MG",
    "COND": "B/14",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ABBOTT FRANCE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/11/2000",
    "DATE_D_ENREGISTREMENT_FINAL": "19/7/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["clarithromycin"],
    "InteractionIndexLink": ["clarithromycine"],
    "N_ENREGISTREMENT": "055/ 13 E 244 /07/20",
    "CODE_DCI": "13 E 244",
    "DCI": "CLARITHROMYCINE",
    "NOM_COMMERCIALE": "CLARIDAR 250",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "250MG",
    "COND": "B/14",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "DAR AL DAWA DEVELOPMENT & INVESTMENT Co Ltd",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/4/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "8/4/2020",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["clarithromycin"],
    "InteractionIndexLink": ["clarithromycine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "13 E 244",
    "DCI": "Clarithromycine",
    "NOM_COMMERCIALE": "Claridar 250",
    "FORME": "PDRE SUSP BUV",
    "DOSAGE": "250MG/5ML",
    "COND": "FL/100ML",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["clarithromycin"],
    "InteractionIndexLink": ["clarithromycine"],
    "N_ENREGISTREMENT": "035/13 E 244/19",
    "CODE_DCI": "13 E 244",
    "DCI": "CLARITHROMYCINE",
    "NOM_COMMERCIALE": "RITOCINE",
    "FORME": "COMP PELL",
    "DOSAGE": "250MG",
    "COND": "B/10 ET B/14",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMALLIANCE EURL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "11/12/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "11/12/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["clarithromycin"],
    "InteractionIndexLink": ["clarithromycine"],
    "N_ENREGISTREMENT": "147/ 13 E 244 /01/13",
    "CODE_DCI": "13 E 244",
    "DCI": "CLARITHROMYCINE",
    "NOM_COMMERCIALE": "ZECLAR",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "250MG",
    "COND": "B/10",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ABBOTT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/6/2001",
    "DATE_D_ENREGISTREMENT_FINAL": "4/2/2013",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["clarithromycin"],
    "InteractionIndexLink": ["clarithromycine"],
    "N_ENREGISTREMENT": "055/ 13 E 297 /12",
    "CODE_DCI": "13 E 297",
    "DCI": "CLARITHROMYCINE",
    "NOM_COMMERCIALE": "CLARIDAR 250",
    "FORME": "PDRE. P. SUSP. BUV. EN FLACON",
    "DOSAGE": "250MG/5ML",
    "COND": "B/1FL. DE 100ML DE SUSP. BUV. APRES RECONST.+UNE CUILLERE MESURE GRADUEE A 2.5ML ET A 5ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "DAR AL DAWA DEVELOPMENT & INVESTMENT Co Ltd",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/4/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "30/4/2012",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["clarithromycin"],
    "InteractionIndexLink": ["clarithromycine"],
    "N_ENREGISTREMENT": "380/ 13 E 297 /19",
    "CODE_DCI": "13 E 297",
    "DCI": "CLARITHROMYCINE",
    "NOM_COMMERCIALE": "HUCLAR",
    "FORME": "PDRE. P. SUSP. BUV. EN FLACON",
    "DOSAGE": "250MG/5ML",
    "COND": "B/1FL. DE 100ML DE SUSP. BUV. APRES RECONST+  SEREINGUE",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HUPP PHARMA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["clarithromycin"],
    "InteractionIndexLink": ["clarithromycine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "13 E 297",
    "DCI": "CLARITHROMYCINE",
    "NOM_COMMERCIALE": "HUCLAR",
    "FORME": "PDRE. P. SUSP. BUV. EN FLACON",
    "DOSAGE": "250MG/5ML  (OU 50MG)",
    "COND": "B/1FL. DE 100ML DE SUSP. BUV. APRES RECONST+  SEREINGUE",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["azithromycin"],
    "InteractionIndexLink": ["azithromycine"],
    "N_ENREGISTREMENT": "039/ 13 E 299 /12/18",
    "CODE_DCI": "13 E 299",
    "DCI": "Azithromycine Dihydratee Exprimee En Azithromycine",
    "NOM_COMMERCIALE": "AZITHRAL",
    "FORME": "COMPRIME PELLICULE SECABLE",
    "DOSAGE": "500MG",
    "COND": "B/03",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOCIETE PHARMACEUTIQUE ALGERIENNE (SOPHAL)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/2/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "22/5/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["azithromycin"],
    "InteractionIndexLink": ["azithromycine"],
    "N_ENREGISTREMENT": "380/ 13 E 299 /12",
    "CODE_DCI": "13 E 299",
    "DCI": "Azithromycine Dihydratee Exprimee En Azithromycine",
    "NOM_COMMERCIALE": "AZITHROM HUP",
    "FORME": "COMPRIME PELLICULE SECABLE",
    "DOSAGE": "500MG",
    "COND": "B/03",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HUP.P.PHARMA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/5/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "15/5/2012",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["azithromycin"],
    "InteractionIndexLink": ["azithromycine"],
    "N_ENREGISTREMENT": "447/ 13 E 299 /13",
    "CODE_DCI": "13 E 299",
    "DCI": "Azithromycine Dihydratee Exprimee En Azithromycine",
    "NOM_COMMERCIALE": "AZITHROMYCINE BEKER",
    "FORME": "COMPRIME PELLICULE SECABLE",
    "DOSAGE": "500MG",
    "COND": "B/03",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEKER SARL (SARL LABORATOIRE BEKER ALGERIE)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/2/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "15/2/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["azithromycin"],
    "InteractionIndexLink": ["azithromycine"],
    "N_ENREGISTREMENT": "318/13 E 299/17",
    "CODE_DCI": "13 E 299",
    "DCI": "Azithromycine Dihydratee Exprimee En Azithromycine",
    "NOM_COMMERCIALE": "AZITHROMYCINE NS",
    "FORME": "COMPRIME PELLICULE SECABLE",
    "DOSAGE": "500MG",
    "COND": "B/03",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMIDAL NS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/5/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "7/5/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["azithromycin"],
    "InteractionIndexLink": ["azithromycine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "13 E 299",
    "DCI": "AZITHROMYCINE DIHYDRATEE EXPRIMEE EN AZITHROMYCINE",
    "NOM_COMMERCIALE": "BINOZYT",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "500MG",
    "COND": "B/03",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["azithromycin"],
    "InteractionIndexLink": ["azithromycine"],
    "N_ENREGISTREMENT": "468/ 13 E 299 /18",
    "CODE_DCI": "13 E 299",
    "DCI": "Azithromycine Dihydratee Exprimee En Azithromycine",
    "NOM_COMMERCIALE": "MYCINAD",
    "FORME": "COMPRIME PELLICULE SECABLE",
    "DOSAGE": "500MG",
    "COND": "B/03",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NADPHARMADIC production",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/4/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "22/4/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["azithromycin"],
    "InteractionIndexLink": ["azithromycine"],
    "N_ENREGISTREMENT": "468/ 13 E 299/ 13",
    "CODE_DCI": "13 E 299",
    "DCI": "Azithromycine Dihydratee Exprimee En Azithromycine",
    "NOM_COMMERCIALE": "MYCINAD",
    "FORME": "COMPRIME PELLICULE SECABLE",
    "DOSAGE": "500MG",
    "COND": "B/03",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NADPHARMADIC PRODUCTION SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/11/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "27/11/2013",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["azithromycin"],
    "InteractionIndexLink": ["azithromycine"],
    "N_ENREGISTREMENT": "352/ 13 E 299 /15",
    "CODE_DCI": "13 E 299",
    "DCI": "Azithromycine Dihydratee Exprimee En Azithromycine",
    "NOM_COMMERCIALE": "ZETRON",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "500MG",
    "COND": "B/03",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/4/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "26/4/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["azithromycin"],
    "InteractionIndexLink": ["azithromycine"],
    "N_ENREGISTREMENT": "045/ 13 E 299 /06/13",
    "CODE_DCI": "13 E 299",
    "DCI": "Azithromycine Dihydratee Exprimee En Azithromycine",
    "NOM_COMMERCIALE": "ZITHROMAX",
    "FORME": "COMPRIME PELLICULE SECABLE",
    "DOSAGE": "500MG",
    "COND": "B/03",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PFIZER PHARM ALGERIE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/4/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "8/10/2013",
    "TYPE": "Ré",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["azithromycin"],
    "InteractionIndexLink": ["azithromycine"],
    "N_ENREGISTREMENT": "21/13 E 299/235",
    "CODE_DCI": "13 E 299",
    "DCI": "Azithromycine dihydrate exprimé en Azithromycine",
    "NOM_COMMERCIALE": "ZITHROMYCINE BGL",
    "FORME": "COMP. PELL. SEC.",
    "DOSAGE": "500MG",
    "COND": "B/03",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES SARL BIOGALENIC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "08/06/21",
    "DATE_D_ENREGISTREMENT_FINAL": "08/06/21",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["azithromycin"],
    "InteractionIndexLink": ["azithromycine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "13 E 299",
    "DCI": "AZITHROMYCINE DIHYDRATEE EXPRIMEE EN AZITHROMYCINE",
    "NOM_COMMERCIALE": "ZOMAX",
    "FORME": "COMPRIME",
    "DOSAGE": "500MG",
    "COND": "B/03",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["azithromycin"],
    "InteractionIndexLink": ["azithromycine"],
    "N_ENREGISTREMENT": "035/ 13 E 299 /15",
    "CODE_DCI": "13 E 299",
    "DCI": "Azithromycine Dihydratee Exprimee En Azithromycine",
    "NOM_COMMERCIALE": "ZOTRIX",
    "FORME": "COMPRIME PELLICULE SECABLE",
    "DOSAGE": "500MG",
    "COND": "B/03",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMALLIANCE EURL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/7/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "9/7/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["spiramycine", "metronidazole"],
    "InteractionIndexLink": ["metronidazole", "spiramycine"],
    "N_ENREGISTREMENT": "470 / 13 E 300 /21",
    "CODE_DCI": "13 E 300",
    "DCI": "Spiramycine / Métronidazole",
    "NOM_COMMERCIALE": "ODONGYL",
    "FORME": "Comprimé pelliculé",
    "DOSAGE": "750. 000UI/125MG",
    "COND": "B/20",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE M.M / SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "21/3/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "21/3/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["spiramycine", "metronidazole"],
    "InteractionIndexLink": ["metronidazole", "spiramycine"],
    "N_ENREGISTREMENT": "293/ 13 E 300 /06/12",
    "CODE_DCI": "13 E 300",
    "DCI": "SPIRAMYCINE / METRONIDAZOLE",
    "NOM_COMMERCIALE": "OROGYL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "750 000UI/125MG",
    "COND": "B/20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOCARE SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/4/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "15/10/2012",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["spiramycine", "metronidazole"],
    "InteractionIndexLink": ["metronidazole", "spiramycine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "13 E 300",
    "DCI": "Spiramycine + Métronidazole",
    "NOM_COMMERCIALE": "OROGYL",
    "FORME": "Comprimés",
    "DOSAGE": "750.000ui+125mg",
    "COND": "Boite de  20",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["spiramycine", "metronidazole"],
    "InteractionIndexLink": ["metronidazole", "spiramycine"],
    "N_ENREGISTREMENT": "21/13 E300/380",
    "CODE_DCI": "13 E 300",
    "DCI": "SPIRAMYCINE/ METRONIDAZOLE",
    "NOM_COMMERCIALE": "SPIDOGYL",
    "FORME": "COMP PELL",
    "DOSAGE": "750000UI/125MG",
    "COND": "B/20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "laboratoires HUP.P PHARMA Sarl",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/03/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "28/03/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["spiramycine", "metronidazole"],
    "InteractionIndexLink": ["metronidazole", "spiramycine"],
    "N_ENREGISTREMENT": "263/ 13 E 300 /07/17",
    "CODE_DCI": "13 E 300",
    "DCI": "SPIRAMYCINE / METRONIDAZOLE",
    "NOM_COMMERCIALE": "SPIRADENT",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "750. 000UI/125MG",
    "COND": "B/20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOPHARM SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/6/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "29/6/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["spiramycine", "metronidazole"],
    "InteractionIndexLink": ["metronidazole", "spiramycine"],
    "N_ENREGISTREMENT": "293/ 13 E 307 /07/21",
    "CODE_DCI": "13 E 307",
    "DCI": "Spiramycine / Métronidazole",
    "NOM_COMMERCIALE": "BI-OROGYL",
    "FORME": "Comprimé pelliculé",
    "DOSAGE": "1.5MUI/250MG",
    "COND": "B/10",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOCARE SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/7/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "4/4/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["spiramycine", "metronidazole"],
    "InteractionIndexLink": ["metronidazole", "spiramycine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "13 E 307",
    "DCI": "Spiramycine / Métronidazole",
    "NOM_COMMERCIALE": "BI-OROGYL",
    "FORME": "comprimés 1.5MUI+ 250mg",
    "DOSAGE": "1.5MUI+ 250mg",
    "COND": "Boite de 10",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["spiramycine", "metronidazole"],
    "InteractionIndexLink": ["metronidazole", "spiramycine"],
    "N_ENREGISTREMENT": "21/13 E307/380",
    "CODE_DCI": "13 E 307",
    "DCI": "SPIRAMYCINE/ METRONIDAZOLE",
    "NOM_COMMERCIALE": "BISPIDOGYL",
    "FORME": "COMP PELL",
    "DOSAGE": "1.5MUI/250MG",
    "COND": "B/10",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "laboratoires HUP.P PHARMA Sarl",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/03/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "28/03/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["spiramycine", "metronidazole"],
    "InteractionIndexLink": ["metronidazole", "spiramycine"],
    "N_ENREGISTREMENT": "263/ 13 E 307 /09/17",
    "CODE_DCI": "13 E 307",
    "DCI": "SPIRAMYCINE / METRONIDAZOLE",
    "NOM_COMMERCIALE": "BISPIRADENT",
    "FORME": "COMP. PELLI. SEC.",
    "DOSAGE": "1.5MUI/250MG",
    "COND": "B/10",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOPHARM SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/12/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "8/10/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["spiramycine", "metronidazole"],
    "InteractionIndexLink": ["metronidazole", "spiramycine"],
    "N_ENREGISTREMENT": "235 / 13 E 307 /21",
    "CODE_DCI": "13 E 307",
    "DCI": "Spiramycine / Métronidazole",
    "NOM_COMMERCIALE": "BUCCOGYL",
    "FORME": "Comprimé pelliculé",
    "DOSAGE": "1.5MUI/250MG",
    "COND": "B/10",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOGALENIC / SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/3/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "28/3/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["clarithromycin"],
    "InteractionIndexLink": ["clarithromycine"],
    "N_ENREGISTREMENT": "055/ 13 E 323 /12",
    "CODE_DCI": "13 E 323",
    "DCI": "CLARITHROMYCINE",
    "NOM_COMMERCIALE": "CLARIDAR 125",
    "FORME": "PDRE. P. SUSP. BUV. EN FLACON",
    "DOSAGE": "125MG/5ML",
    "COND": "B/1FL. DE 60ML DE SUSP. BUV. APRES RECONST.+UNE CUILLERE MESURE GRADUEE A 2.5ML ET A 5ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "DAR AL DAWA DEVELOPMENT & INVESTMENT Co Ltd",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/4/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "30/4/2012",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["clarithromycin"],
    "InteractionIndexLink": ["clarithromycine"],
    "N_ENREGISTREMENT": "380/ 13 E 323 /19",
    "CODE_DCI": "13 E 323",
    "DCI": "CLARITHROMYCINE",
    "NOM_COMMERCIALE": "HUCLAR",
    "FORME": "GRLES. P. SUSP. BUV. EN FLACON",
    "DOSAGE": "125MG/5ML",
    "COND": "B/1FL. DE 100 ML DE SUSP. BUV. APRES RECONST.+ SERINGUE",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HUPP PHARMA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/4/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "29/4/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["clarithromycin"],
    "InteractionIndexLink": ["clarithromycine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "13 E 323",
    "DCI": "CLARITHROMYCINE",
    "NOM_COMMERCIALE": "HUCLAR",
    "FORME": "GRLES. P. SUSP. BUV. EN FLACON",
    "DOSAGE": "125MG/5ML (OU 25MG)",
    "COND": "B/1FL. DE 100 ML DE SUSP. BUV. APRES RECONST.+ SERINGUE",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["clarithromycin"],
    "InteractionIndexLink": ["clarithromycine"],
    "N_ENREGISTREMENT": "147/ 13 E 323 /08/16",
    "CODE_DCI": "13 E 323",
    "DCI": "CLARITHROMYCINE",
    "NOM_COMMERCIALE": "ZECLAR 25",
    "FORME": "GRLES. SUSP. BUV.",
    "DOSAGE": "125MG/5ML",
    "COND": "FL./100ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ABBOTT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "23/3/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "16/4/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["metronidazole"],
    "InteractionIndexLink": ["metronidazole"],
    "N_ENREGISTREMENT": "528/ 13 F 199 /18",
    "CODE_DCI": "13 F  199",
    "DCI": "METRONIDAZOLE",
    "NOM_COMMERCIALE": "METAZOLE",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "500MG",
    "COND": "B/20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JANIS MED SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/12/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "25/12/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["metronidazole"],
    "InteractionIndexLink": ["metronidazole"],
    "N_ENREGISTREMENT": "268/ 13 F 199 /16",
    "CODE_DCI": "13 F  199",
    "DCI": "METRONIDAZOLE",
    "NOM_COMMERCIALE": "RONIDAZ 500",
    "FORME": "COMPRIME",
    "DOSAGE": "500MG",
    "COND": "B/20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MERINAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/6/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "29/6/2016",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": false,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["metronidazole"],
    "InteractionIndexLink": ["metronidazole"],
    "N_ENREGISTREMENT": "276/ 13 F 038 /05/16",
    "CODE_DCI": "13 F 038",
    "DCI": "METRONIDAZOLE",
    "NOM_COMMERCIALE": "BIODAZOLE",
    "FORME": "SOL. INJ.",
    "DOSAGE": "500MG",
    "COND": "B/1FL. DE 100ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "UNIQUE PHARMACETICAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/9/2005",
    "DATE_D_ENREGISTREMENT_FINAL": "2/2/2016",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["metronidazole"],
    "InteractionIndexLink": ["metronidazole"],
    "N_ENREGISTREMENT": "380/ 13 F 038 /19",
    "CODE_DCI": "13 F 038",
    "DCI": "METRONIDAZOLE",
    "NOM_COMMERCIALE": "MEDROGYL",
    "FORME": "SOL. INJ. IV",
    "DOSAGE": "5MG/ML (500MG/100ML)",
    "COND": "FL./100ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HUPP PHARMA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/4/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "24/4/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["metronidazole"],
    "InteractionIndexLink": ["metronidazole"],
    "N_ENREGISTREMENT": "129/ 13 F 038 /01/14",
    "CODE_DCI": "13 F 038",
    "DCI": "METRONIDAZOLE",
    "NOM_COMMERCIALE": "METRONIDAZOLE BIEFFE MEDITAL",
    "FORME": "SOL.INJ",
    "DOSAGE": "500MG/100ML ( 0.5%)",
    "COND": "POCHES DE 100ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIEFFE MEDITAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ITALIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/11/2001",
    "DATE_D_ENREGISTREMENT_FINAL": "25/11/2001",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["metronidazole"],
    "InteractionIndexLink": ["metronidazole"],
    "N_ENREGISTREMENT": "433/ 13 F 038 /13",
    "CODE_DCI": "13 F 038",
    "DCI": "METRONIDAZOLE",
    "NOM_COMMERCIALE": "METRONIDAZOLE RAZES 0.5%",
    "FORME": "SOL. INJ. P. PERF.",
    "DOSAGE": "5MG/ML (500MG/100ML)",
    "COND": "FL./100ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRATER RAZES SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/6/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "25/6/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["metronidazole"],
    "InteractionIndexLink": ["metronidazole"],
    "N_ENREGISTREMENT": "263/ 13 F 039 /96/18",
    "CODE_DCI": "13 F 039",
    "DCI": "METRONIDAZOLE",
    "NOM_COMMERCIALE": "FLAGYL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "250MG",
    "COND": "B/20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOPHARM SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "5/11/1996",
    "DATE_D_ENREGISTREMENT_FINAL": "9/10/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["metronidazole"],
    "InteractionIndexLink": ["metronidazole"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "13 F 039",
    "DCI": "METRONIDAZOLE",
    "NOM_COMMERCIALE": "IMUZOLE",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "250MG",
    "COND": "B/20",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["metronidazole"],
    "InteractionIndexLink": ["metronidazole"],
    "N_ENREGISTREMENT": "079/ 13 F 039 /99/19",
    "CODE_DCI": "13 F 039",
    "DCI": "METRONIDAZOLE",
    "NOM_COMMERCIALE": "MEDAZOL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "250MG",
    "COND": "B/20",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE  ALGERIEN DE DEVELOPPEMENT  PHARMACEUTIQUE   (LAD)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/3/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "30/12/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["metronidazole"],
    "InteractionIndexLink": ["metronidazole"],
    "N_ENREGISTREMENT": "20/01/13 F 039/003",
    "CODE_DCI": "13 F 039",
    "DCI": "METRONIDAZOLE",
    "NOM_COMMERCIALE": "METROGYL",
    "FORME": "COMP.",
    "DOSAGE": "250MG",
    "COND": "B/20",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES EPE GROUPE INDUSTRIEL SAIDAL/ SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "09/11/01",
    "DATE_D_ENREGISTREMENT_FINAL": "27/12/20",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["metronidazole"],
    "InteractionIndexLink": ["metronidazole"],
    "N_ENREGISTREMENT": "20/13 F039/039",
    "CODE_DCI": "13 F 039",
    "DCI": "METRONIDAZOLE",
    "NOM_COMMERCIALE": "METRONIDAL",
    "FORME": "COMP PELL",
    "DOSAGE": "250 MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES SOPHAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "16/12/20",
    "DATE_D_ENREGISTREMENT_FINAL": "16/12/20",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["metronidazole"],
    "InteractionIndexLink": ["metronidazole"],
    "N_ENREGISTREMENT": "447/ 13 F 039 /15",
    "CODE_DCI": "13 F 039",
    "DCI": "METRONIDAZOLE",
    "NOM_COMMERCIALE": "METRONIDAZOLE BEKER",
    "FORME": "GLES.",
    "DOSAGE": "250MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEKER SARL (SARL LABORATOIRE BEKER ALGERIE)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/7/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "30/7/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["metronidazole"],
    "InteractionIndexLink": ["metronidazole"],
    "N_ENREGISTREMENT": "21/15/13 F039/447",
    "CODE_DCI": "13 F 039",
    "DCI": "METRONIDAZOLE",
    "NOM_COMMERCIALE": "METRONIDAZOLE BEKER",
    "FORME": "GLES.",
    "DOSAGE": "250MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL LABORATOIRE BEKER",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/07/15",
    "DATE_D_ENREGISTREMENT_FINAL": "26/04/21",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["metronidazole"],
    "InteractionIndexLink": ["metronidazole"],
    "N_ENREGISTREMENT": "470/ 13 F 039 /13",
    "CODE_DCI": "13 F 039",
    "DCI": "METRONIDAZOLE",
    "NOM_COMMERCIALE": "METRONIDAZOLE MM",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "250MG",
    "COND": "B/20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MM (SARL LABORATOIRES MM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/4/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "18/4/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["metronidazole"],
    "InteractionIndexLink": ["metronidazole"],
    "N_ENREGISTREMENT": "268/ 13 F 039 /16",
    "CODE_DCI": "13 F 039",
    "DCI": "METRONIDAZOLE",
    "NOM_COMMERCIALE": "RONIDAZ 250",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "250MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL LABORATOIRES MERINAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "11/4/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "11/4/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["metronidazole"],
    "InteractionIndexLink": ["metronidazole"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "13 F 040",
    "DCI": "METRONIDAZOLE BENZOATE EXPRIME EN METRONIDAZOLE",
    "NOM_COMMERCIALE": "FLAGYL",
    "FORME": "SUSP.BUV.",
    "DOSAGE": "125MG/5ML",
    "COND": "FL/120 ML + CUILLERE MESURE DE 5ML",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["metronidazole"],
    "InteractionIndexLink": ["metronidazole"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "13 F 040",
    "DCI": "METRONIDAZOLE BENZOATE EXPRIME EN METRONIDAZOLE",
    "NOM_COMMERCIALE": "FLAZOL",
    "FORME": "SUSP. BUV.",
    "DOSAGE": "125MG/5ML",
    "COND": "FL/120ML + BOUCHON DOSEUR",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["metronidazole"],
    "InteractionIndexLink": ["metronidazole"],
    "N_ENREGISTREMENT": "317/ 13 F 040 /16",
    "CODE_DCI": "13 F 040",
    "DCI": "METRONIDAZOLE BENZOATE EXPRIME EN METRONIDAZOLE",
    "NOM_COMMERCIALE": "METAGYL",
    "FORME": "SUSPENSION BUVABLE",
    "DOSAGE": "125MG/5ML",
    "COND": "FL/125ML + GOBLET DOSEUR",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INPHA-MEDIS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/7/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "26/7/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["rivaroxaban"],
    "InteractionIndexLink": ["rivaroxaban"],
    "N_ENREGISTREMENT": "20/12 F167/293",
    "CODE_DCI": "13 F 167",
    "DCI": "RIVAROXABAN",
    "NOM_COMMERCIALE": "INHIXA",
    "FORME": "COMP PELL",
    "DOSAGE": "15MG",
    "COND": "B/14 B/28B/42",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOCARE SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "8/11/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "8/11/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["rivaroxaban"],
    "InteractionIndexLink": ["rivaroxaban"],
    "N_ENREGISTREMENT": "20/12 F168/293",
    "CODE_DCI": "13 F 168",
    "DCI": "RIVAROXABAN",
    "NOM_COMMERCIALE": "INHIXA",
    "FORME": "COMP PELL",
    "DOSAGE": "20MG",
    "COND": "B/28",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOCARE SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "8/11/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "8/11/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["metronidazole"],
    "InteractionIndexLink": ["metronidazole"],
    "N_ENREGISTREMENT": "263/ 13 F 199 /12",
    "CODE_DCI": "13 F 199",
    "DCI": "METRONIDAZOLE",
    "NOM_COMMERCIALE": "BIODAZOLE",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "500MG",
    "COND": "B/20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOPHARM SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "8/11/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "4/2/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["metronidazole"],
    "InteractionIndexLink": ["metronidazole"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "13 F 199",
    "DCI": "METRONIDAZOLE",
    "NOM_COMMERCIALE": "FLAZOL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "500MG",
    "COND": "B/20",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["metronidazole"],
    "InteractionIndexLink": ["metronidazole"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "13 F 199",
    "DCI": "METRONIDAZOLE",
    "NOM_COMMERCIALE": "IMUZOLE",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "500MG",
    "COND": "B/20",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["metronidazole"],
    "InteractionIndexLink": ["metronidazole"],
    "N_ENREGISTREMENT": "003/ 13 F 199 /05/16",
    "CODE_DCI": "13 F 199",
    "DCI": "METRONIDAZOLE",
    "NOM_COMMERCIALE": "METROGYL",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "500MG",
    "COND": "B/20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SAIDALGROUPE INDUSTRIEL EPE/SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/2/2005",
    "DATE_D_ENREGISTREMENT_FINAL": "20/12/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["metronidazole"],
    "InteractionIndexLink": ["metronidazole"],
    "N_ENREGISTREMENT": "447/ 13 F 199 /15",
    "CODE_DCI": "13 F 199",
    "DCI": "METRONIDAZOLE",
    "NOM_COMMERCIALE": "METRONIDAZOLE BEKER",
    "FORME": "GLES.",
    "DOSAGE": "500MG",
    "COND": "B/20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEKER SARL (SARL LABORATOIRE BEKER ALGERIE)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/7/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "30/7/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["metronidazole"],
    "InteractionIndexLink": ["metronidazole"],
    "N_ENREGISTREMENT": "380/ 13 F 199 /14",
    "CODE_DCI": "13 F 199",
    "DCI": "METRONIDAZOLE",
    "NOM_COMMERCIALE": "METRONIDAZOLE HUP",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "500MG",
    "COND": "B/20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HUP.P.PHARMA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/11/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "2/11/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["metronidazole"],
    "InteractionIndexLink": ["metronidazole"],
    "N_ENREGISTREMENT": "470/ 13 F 199 /13",
    "CODE_DCI": "13 F 199",
    "DCI": "METRONIDAZOLE",
    "NOM_COMMERCIALE": "METRONIDAZOLE MM",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "500MG",
    "COND": "B/20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MM (SARL LABORATOIRES MM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "21/7/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "21/7/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["metronidazole"],
    "InteractionIndexLink": ["metronidazole"],
    "N_ENREGISTREMENT": "001/ 13 F 199 /07/14",
    "CODE_DCI": "13 F 199",
    "DCI": "METRONIDAZOLE",
    "NOM_COMMERCIALE": "NIDAZOLE",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "500MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMACEUTICALS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/6/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "1/10/2014",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["secnidazole"],
    "N_ENREGISTREMENT": "289/ 13 F 330 /15",
    "CODE_DCI": "13 F 330",
    "DCI": "SECNIDAZOLE ANHYDRE",
    "NOM_COMMERCIALE": "SECNIDOLEX",
    "FORME": "MICROGRANULES  EN SACHET- DOSE",
    "DOSAGE": "2G/SACHET- DOSE",
    "COND": "B/01",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRATER RAZES SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/12/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "13/12/2015",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["amoxicillin"],
    "InteractionIndexLink": ["amoxicilline"],
    "N_ENREGISTREMENT": "003/ 13 G 042 /99/16",
    "CODE_DCI": "13 G 042",
    "DCI": "AMOXICILLINE SODIQUE EXPRIME EN AMOXICILLINE",
    "NOM_COMMERCIALE": "AMOXYPEN",
    "FORME": "PDRE. P. SOL. INJ. IM (solvant  LIDOCAINE) ET IM/IV (sans solvant)",
    "DOSAGE": "500MG/FL. DE PDRE.",
    "COND": "B/1FL. DE PDRE.+1AMP. DE 5ML DE SOLV. (ALCOOL BENZYLIQUE 3%) (IM) ET BOITE DE 50FL. DE PDRE.SANS SOLV.* (IM/IV)",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "B/50 RESERVEE AUX HOPITAUX",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EPE GROUPE INDUSTRIEL SAIDAL/SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/1/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "8/5/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["amoxicillin"],
    "InteractionIndexLink": ["amoxicilline"],
    "N_ENREGISTREMENT": "003/ 13 G 043 /99/16",
    "CODE_DCI": "13 G 043",
    "DCI": "AMOXICILLINE SODIQUE EXPRIME EN AMOXICILLINE",
    "NOM_COMMERCIALE": "AMOXYPEN",
    "FORME": "PDRE. P. SOL. INJ. IM (solvant  LIDOCAINE) ET IM/IV (sans solvant)",
    "DOSAGE": "1G/FL. DE PDRE.",
    "COND": "B/1FL. DE PDRE.+1AMP. DE 5ML DE SOLV. (ALCOOL BENZYLIQUE 3%) (IM) ET BOITE DE 50FL. DE PDRE.SANS SOLV.* (IM/IV)",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "B/50 RESERVEE AUX HOPITAUX",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EPE GROUPE INDUSTRIEL SAIDAL/SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/1/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "8/5/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["amoxicillin"],
    "InteractionIndexLink": ["amoxicilline"],
    "N_ENREGISTREMENT": "10/13 G043/293",
    "CODE_DCI": "13 G 043",
    "DCI": "AMOXICILLINE SODIQUE",
    "NOM_COMMERCIALE": "BIOPAMOX",
    "FORME": "PDRE P.SOL INJ",
    "DOSAGE": "1G/FL",
    "COND": "- B/ 01FL DE PDRE+ 01 AMP DE 5ML DE SOLVANT -B/50FL DE PDRE",
    "LISTE": "Liste I",
    "P1": "B/ 1FL +1 : HOP B/50FL : HOP",
    "P2": "B/ 1FL +1 : OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOCARE SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "16/12/12",
    "DATE_D_ENREGISTREMENT_FINAL": "24/06/15",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["amoxicillin"],
    "InteractionIndexLink": ["amoxicilline"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "13 G 043",
    "DCI": "AMOXICILLINE SODIQUE EXPRIME EN AMOXICILLINE",
    "NOM_COMMERCIALE": "BIOPAMOX",
    "FORME": "PDRE. P. SOL. INJ. IM",
    "DOSAGE": "1G/FL. DE PDRE.",
    "COND": "B/01 FL. DE PDRE. + 01 AMP. DE 5ML DE SOLV. (ALCOOL BENZYLIQUE+EPPI) ET B/50 FL. DE PDRE.",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["amoxicillin"],
    "InteractionIndexLink": ["amoxicilline"],
    "N_ENREGISTREMENT": "039/ 13 G 045 /97/18",
    "CODE_DCI": "13 G 045",
    "DCI": "AMOXICILLINE TRIHYDRATEE EXPRIME EN AMOXICILLINE",
    "NOM_COMMERCIALE": "AMOXAL",
    "FORME": "GLES.",
    "DOSAGE": "500MG",
    "COND": "B/12",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOCIETE PHARMACEUTIQUE ALGERIENNE (SOPHAL)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/11/1997",
    "DATE_D_ENREGISTREMENT_FINAL": "8/4/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["amoxicillin"],
    "InteractionIndexLink": ["amoxicilline"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "13 G 045",
    "DCI": "AMOXICILLINE TRIHYDRATEE EXPRIME EN AMOXICILLINE",
    "NOM_COMMERCIALE": "AMOXIMEX",
    "FORME": "GLES.",
    "DOSAGE": "500MG",
    "COND": "B/12",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["amoxicillin"],
    "InteractionIndexLink": ["amoxicilline"],
    "N_ENREGISTREMENT": "003/ 13 G 045 /98/17",
    "CODE_DCI": "13 G 045",
    "DCI": "AMOXICILLINE TRIHYDRATEE EXPRIME EN AMOXICILLINE",
    "NOM_COMMERCIALE": "AMOXYPEN",
    "FORME": "GLES.",
    "DOSAGE": "500MG",
    "COND": "B/12",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EPE GROUPE INDUSTRIEL SAIDAL/SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/1/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "30/7/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["amoxicillin"],
    "InteractionIndexLink": ["amoxicilline"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "13 G 045",
    "DCI": "AMOXICILLINE TRIHYDRATEE EXPRIME EN AMOXICILLINE",
    "NOM_COMMERCIALE": "BIOPAMOX",
    "FORME": "GLES.",
    "DOSAGE": "500MG",
    "COND": "B/12",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["amoxicillin"],
    "InteractionIndexLink": ["amoxicilline"],
    "N_ENREGISTREMENT": "039/ 13 G 046 /13",
    "CODE_DCI": "13 G 046",
    "DCI": "AMOXICILLINE TRIHYDRATEE EXPRIME EN AMOXICILLINE",
    "NOM_COMMERCIALE": "AMOXAL",
    "FORME": "PDRE. P. SUSP. BUV.",
    "DOSAGE": "125MG/5ML",
    "COND": "B/1FL. DE 60ML DE SUSP. BUV. APRES RECONST.+GOBELET DOSEUR",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOCIETE PHARMACEUTIQUE ALGERIENNE (SOPHAL)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/6/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "25/6/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["amoxicillin"],
    "InteractionIndexLink": ["amoxicilline"],
    "N_ENREGISTREMENT": "380/ 13 G 046 /09/14",
    "CODE_DCI": "13 G 046",
    "DCI": "AMOXICILLINE TRIHYDRATE EXPRIME EN AMOXICILLINE",
    "NOM_COMMERCIALE": "AMOXICILLINE EG",
    "FORME": "PDRE. SUSP. BUV.",
    "DOSAGE": "125MG/5ML",
    "COND": "FL./60ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HUP.P.PHARMA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/3/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "25/12/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["amoxicillin"],
    "InteractionIndexLink": ["amoxicilline"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "13 G 046",
    "DCI": "AMOXICILLINE TRIHYDRATE EXPRIME EN AMOXICILLINE",
    "NOM_COMMERCIALE": "AMOXIMEX",
    "FORME": "PDRE. P. SUSP. BUV.",
    "DOSAGE": "125MG/5ML",
    "COND": "B/1FL. DE 60ML DE SUSP. BUV. APRES RECONST.+UNE CUILLERE MESURE DE 5ML",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["amoxicillin"],
    "InteractionIndexLink": ["amoxicilline"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "13 G 046",
    "DCI": "AMOXICILLINE TRIHYDRATE EXPRIME EN AMOXICILLINE",
    "NOM_COMMERCIALE": "AMOXYPEN",
    "FORME": "PDRE. SUSP. BUV.",
    "DOSAGE": "125MG/5ML",
    "COND": "FL./60ML",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["amoxicillin"],
    "InteractionIndexLink": ["amoxicilline"],
    "N_ENREGISTREMENT": "039/ 13 G 047 /99/13",
    "CODE_DCI": "13 G 047",
    "DCI": "AMOXICILLINE TRIHYDRATE EXPRIME EN AMOXICILLINE",
    "NOM_COMMERCIALE": "AMOXAL",
    "FORME": "PDRE. P. SUSP. BUV.",
    "DOSAGE": "250MG/5ML",
    "COND": "B/1FL. DE 60ML DE SUSP. BUV. APRES  RECONST.+ GOBELET DOSEUR",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOCIETE PHARMACEUTIQUE ALGERIENNE (SOPHAL)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/7/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "21/7/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["amoxicillin"],
    "InteractionIndexLink": ["amoxicilline"],
    "N_ENREGISTREMENT": "380/ 13 G 047 /07/13",
    "CODE_DCI": "13 G 047",
    "DCI": "AMOXICILLINE TRIHYDRATE EXPRIME EN AMOXICILLINE",
    "NOM_COMMERCIALE": "AMOXICILLINE EG",
    "FORME": "PDRE. P. SUSP. BUV.",
    "DOSAGE": "250MG/5ML",
    "COND": "B/1FL. DE 60ML DE SUSP. BUV. APRES RECONST. + UNE CUILLERE-MESURE",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HUP.P.PHARMA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/7/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "24/2/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["amoxicillin"],
    "InteractionIndexLink": ["amoxicilline"],
    "N_ENREGISTREMENT": "400/ 13 G 047 /05/11",
    "CODE_DCI": "13 G 047",
    "DCI": "AMOXICILLINE TRIHYDRATE EXPRIME EN AMOXICILLINE",
    "NOM_COMMERCIALE": "AMOXIMEX",
    "FORME": "PDRE. P. SUSP. BUV.",
    "DOSAGE": "250MG/5ML",
    "COND": "FL/60ML DE SUSP. BUV. APRES RECONST.+UNE  CUILLERE MESURE",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "KHROUB PHARMACEUTICAL MANUFACTURING ALGERIA SARL (KPMA)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/3/2005",
    "DATE_D_ENREGISTREMENT_FINAL": "25/8/2011",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["amoxicillin"],
    "InteractionIndexLink": ["amoxicilline"],
    "N_ENREGISTREMENT": "003/ 13 G 047 /99/17",
    "CODE_DCI": "13 G 047",
    "DCI": "AMOXICILLINE TRIHYDRATE EXPRIME EN AMOXICILLINE",
    "NOM_COMMERCIALE": "AMOXYPEN",
    "FORME": "PDRE. P. SUSP. BUV.",
    "DOSAGE": "250MG/5ML",
    "COND": "FL/60ML DE SOL. APRES RECONSTIT.",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EPE GROUPE INDUSTRIEL SAIDAL/SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/2/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "8/10/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["amoxicillin"],
    "InteractionIndexLink": ["amoxicilline"],
    "N_ENREGISTREMENT": "293/ 13 G 047 /11/17",
    "CODE_DCI": "13 G 047",
    "DCI": "AMOXICILLINE TRIHYDRATE EXPRIME EN AMOXICILLINE",
    "NOM_COMMERCIALE": "BIOPAMOX",
    "FORME": "PDRE. P. SUSP. BUV.",
    "DOSAGE": "250MG/5ML",
    "COND": "FL./60ML ET FL./100ML (DE SUSP. BUV. APRES RECONSTITUTION) AVEC UN BOUCHON DOSEUR GRADUE",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOCARE SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/3/2011",
    "DATE_D_ENREGISTREMENT_FINAL": "5/11/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["amoxicillin"],
    "InteractionIndexLink": ["amoxicilline"],
    "N_ENREGISTREMENT": "073/ 13 G 047 /19",
    "CODE_DCI": "13 G 047",
    "DCI": "AMOXICILLINE",
    "NOM_COMMERCIALE": "HIMOXYL",
    "FORME": "PDRE. P. SUSP. BUV.",
    "DOSAGE": "250MG/5ML",
    "COND": "FL/60ML DE SOL. APRES RECONSTIT AVEC CUILLERE MESURE DE 5 ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GENIS SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/6/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "10/6/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["amoxicillin"],
    "InteractionIndexLink": ["amoxicilline"],
    "N_ENREGISTREMENT": "055/ 13 G 050 /12",
    "CODE_DCI": "13 G 050",
    "DCI": "AMOXICILLINE TRIHYDRATE EXPRIME EN AMOXICILLINE / ACIDE CLAVULANIQUE SEL DE POTASSIUM EXPRIME EN ACIDE CLAVULANIQUE",
    "NOM_COMMERCIALE": "CLAVODA R 625",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "500MG/125MG",
    "COND": "B/14",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "DAR AL DAWA DEVELOPMENT & INVESTMENT Co Ltd",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "8/11/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "8/11/2012",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["amoxicillin"],
    "InteractionIndexLink": ["amoxicilline"],
    "N_ENREGISTREMENT": "323/13 G 050/17",
    "CODE_DCI": "13 G 050",
    "DCI": "AMOXICILLINE TRIHYDRATE EXPRIME EN AMOXICILLINE / ACIDE CLAVULANIQUE SEL DE POTASSIUM EXPRIME EN ACIDE CLAVULANIQUE",
    "NOM_COMMERCIALE": "CLAVODEX",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "500MG/125MG",
    "COND": "B/12",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CONTINENTAL PHARM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/4/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "20/4/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["amoxicillin"],
    "InteractionIndexLink": ["amoxicilline"],
    "N_ENREGISTREMENT": "190/ 13 G 050 /00/15",
    "CODE_DCI": "13 G 050",
    "DCI": "AMOXICILLINE TRIHYDRATE EXPRIME EN AMOXICILLINE / ACIDE CLAVULANIQUE SEL DE POTASSIUM EXPRIME EN ACIDE CLAVULANIQUE",
    "NOM_COMMERCIALE": "KLAVOX",
    "FORME": "COMP. ENRO.",
    "DOSAGE": "500MG/125MG",
    "COND": "B/20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SAUDI PHARMACEUTICAL INDUSTRIES & MEDICAL APPLIANCES COORPORATION (SPIMACO)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ARABIE SAOUDITE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/11/2000",
    "DATE_D_ENREGISTREMENT_FINAL": "31/5/2015",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["amoxicillin"],
    "InteractionIndexLink": ["amoxicilline"],
    "N_ENREGISTREMENT": "323/13 G 051/16",
    "CODE_DCI": "13 G 051",
    "DCI": "AMOXICILLINE TRIHYDRATE EXPRIME EN AMOXICILLINE / ACIDE CLAVULANIQUE SEL DE POTASSIUM EXPRIME EN ACIDE CLAVULANIQUE",
    "NOM_COMMERCIALE": "CLAVODEX",
    "FORME": "PDRE.P.SUP.BUV.",
    "DOSAGE": "250MG/62.5MG/5ML",
    "COND": "B/1FL. DE 60ML DE SUSP. BUV. APRES RECONST.+UNE CUILLERE MESURE",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CONTINENTAL PHARM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/12/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "4/12/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["ampicillin"],
    "InteractionIndexLink": ["ampicilline"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "13 G 053",
    "DCI": "AMPICILLINE SODIQUE EXPRIME EN AMPICILLINE",
    "NOM_COMMERCIALE": "AMPILINE",
    "FORME": "PDRE. P. SOL. INJ.",
    "DOSAGE": "500MG/FL. DE PDRE",
    "COND": "B/1FL. DE PDRE + 1AMP. DE 5ML DE SOLV.(E.P.P.I)  ET  B/50FL. DE PDRE SANS SOLV.",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["ampicillin"],
    "InteractionIndexLink": ["ampicilline"],
    "N_ENREGISTREMENT": "003/ 13 G 054 /98/18",
    "CODE_DCI": "13 G 054",
    "DCI": "AMPICILLINE SODIQUE EXPRIME EN AMPICILLINE",
    "NOM_COMMERCIALE": "AMPILINE",
    "FORME": "PDRE. P. SOL. INJ.",
    "DOSAGE": "1G/FL. DE PDRE.",
    "COND": "B/1FL. DE PDRE. + 1AMP. DE 5ML DESOLV.  (EPPI)   ET   B/50FL. DE PDRE. SANS SOLV.",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "B/50 RESERVEE AUX HÔPITAUX",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EPE GROUPE INDUSTRIEL SAIDAL/SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "8/11/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "20/8/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["ampicillin"],
    "InteractionIndexLink": ["ampicilline"],
    "N_ENREGISTREMENT": "10/13 G 054/293",
    "CODE_DCI": "13 G 054",
    "DCI": "AMPICILLINE SODIQUE EXPRIME EN AMPICILLINE",
    "NOM_COMMERCIALE": "AMPINAX",
    "FORME": "PDRE. P. SUSP. INJ. IM",
    "DOSAGE": "1G/FLC",
    "COND": "B/ 1 FLC DE POUDRE + 01 AMPL DE 5ML SOLV.",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "B/50FL. DE PDRE. RESERVEE AUX HOPITAUX",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE SARL BIOCARE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/11/14",
    "DATE_D_ENREGISTREMENT_FINAL": "18/11/14",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["ampicillin"],
    "InteractionIndexLink": ["ampicilline"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "13 G 054",
    "DCI": "AMPICILLINE SODIQUE EXPRIME EN AMPICILLINE",
    "NOM_COMMERCIALE": "AMPINAX",
    "FORME": "PDRE. ET SOLV. P. SOL. INJ. IM/IV",
    "DOSAGE": "1G/FL. DE PDRE.",
    "COND": "B/1FL. DE PDRE. + 1AMP. DE 5ML DE SOLV. (EPPI) ET B/50FL. DE PDRE.",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["ampicillin"],
    "InteractionIndexLink": ["ampicilline"],
    "N_ENREGISTREMENT": "039/ 13 G 055 /13",
    "CODE_DCI": "13 G 055",
    "DCI": "AMPICILLINE TRIHYDRATE EXPRIME EN AMPICILLINE",
    "NOM_COMMERCIALE": "AMPAL",
    "FORME": "PDRE. P. SUSP. BUV.",
    "DOSAGE": "125MG/5ML",
    "COND": "B/1FL. DE 60ML DE SUSP. BUV. APRES RECONST.+GOBELET DOSEUR",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOCIETE PHARMACEUTIQUE ALGERIENNE (SOPHAL)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/6/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "25/6/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["ampicillin"],
    "InteractionIndexLink": ["ampicilline"],
    "N_ENREGISTREMENT": "039/ 13 G 056 /13",
    "CODE_DCI": "13 G 056",
    "DCI": "AMPICILLINE TRIHYDRATE EXPRIME EN AMPICILLINE",
    "NOM_COMMERCIALE": "AMPAL",
    "FORME": "PDRE. P. SUSP. BUV.",
    "DOSAGE": "250MG/5ML",
    "COND": "FL. DE 60ML DE SUSP. BUV. APRES RECONST.+ GOBELET DOSEUR",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOCIETE PHARMACEUTIQUE ALGERIENNE (SOPHAL)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/5/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "12/5/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["ampicillin"],
    "InteractionIndexLink": ["ampicilline"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "13 G 056",
    "DCI": "AMPICILLINE TRIHYDRATE EXPRIME EN AMPICILLINE",
    "NOM_COMMERCIALE": "AMPINAX",
    "FORME": "PDRE. P. SUSP. BUV.",
    "DOSAGE": "250MG/5ML",
    "COND": "FL./60ML  ET  FL./100ML  (DE SUSP. BUV. APRES RECONSTITUTION)",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["ampicillin"],
    "InteractionIndexLink": ["ampicilline"],
    "N_ENREGISTREMENT": "039/ 13 G 058 /97/18",
    "CODE_DCI": "13 G 058",
    "DCI": "AMPICILLINE TRIHYDRATE EXPRIME EN AMPICILLINE",
    "NOM_COMMERCIALE": "AMPAL",
    "FORME": "GLES.",
    "DOSAGE": "500MG",
    "COND": "B/12",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOCIETE PHARMACEUTIQUE ALGERIENNE (SOPHAL)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/11/1997",
    "DATE_D_ENREGISTREMENT_FINAL": "28/5/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["ampicillin"],
    "InteractionIndexLink": ["ampicilline"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "13 G 058",
    "DCI": "AMPICILLINE TRIHYDRATE EXPRIME EN AMPICILLINE",
    "NOM_COMMERCIALE": "AMPIMEX",
    "FORME": "GLES.",
    "DOSAGE": "500MG",
    "COND": "B/12",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["ampicillin"],
    "InteractionIndexLink": ["ampicilline"],
    "N_ENREGISTREMENT": "10/04/13 G 058/293",
    "CODE_DCI": "13 G 058",
    "DCI": "AMPICILLINE TRIHYDRATE",
    "NOM_COMMERCIALE": "AMPINAX",
    "FORME": "GLES",
    "DOSAGE": "500MG",
    "COND": "B/12",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE SARL BIOCARE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "21/01/04",
    "DATE_D_ENREGISTREMENT_FINAL": "22/11/10",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["benzathine penicillin"],
    "InteractionIndexLink": ["benzylpenicilline"],
    "N_ENREGISTREMENT": "293/ 13 G 060 /11/19",
    "CODE_DCI": "13 G 060",
    "DCI": "BENZATHINE BENZYLPENICILLINE",
    "NOM_COMMERCIALE": "EXTENCINE",
    "FORME": "PDRE. P. SUSP. INJ. IM",
    "DOSAGE": "600 000UI/FL. DE PDRE.",
    "COND": "B/01 FL. DE PDRE. + 01 AMP. DE 5ML DE SOLV.(EPPI) ET B/50FL. DE PDRE.",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "B/50FL. DE PDRE. RESERVEE AUX HOPITAUX",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOCARE SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/04/11",
    "DATE_D_ENREGISTREMENT_FINAL": "14/03/19",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["benzathine penicillin"],
    "InteractionIndexLink": ["benzylpenicilline"],
    "N_ENREGISTREMENT": "003/ 13 G 060 /05/16",
    "CODE_DCI": "13 G 060",
    "DCI": "BENZATHINE BENZYLPENICILLINE",
    "NOM_COMMERCIALE": "RETARCILINE",
    "FORME": "PRDE. SOL. INJ.",
    "DOSAGE": "600 000UI/FL. DE PDRE.",
    "COND": "B/01+01  ET B/50FL.",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EPE GROUPE INDUSTRIEL SAIDAL/SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "23/10/2005",
    "DATE_D_ENREGISTREMENT_FINAL": "8/5/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["benzathine penicillin"],
    "InteractionIndexLink": ["benzylpenicilline"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "13 G 061",
    "DCI": "BENZATHINE BENZYLPENICILLINE",
    "NOM_COMMERCIALE": "EXTENCINE",
    "FORME": "PDRE. P. SUSP. INJ. IM",
    "DOSAGE": "1 200 000UI/FL. DE PDRE.",
    "COND": "B/01FL. DE PDRE. + 01AMP. DE 5ML DE SOLV.(EPPI)",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["benzathine penicillin"],
    "InteractionIndexLink": ["benzylpenicilline"],
    "N_ENREGISTREMENT": "293/ 13 G 061 /11/19",
    "CODE_DCI": "13 G 061",
    "DCI": "BENZATHINE BENZYLPENICILLINE",
    "NOM_COMMERCIALE": "MMF",
    "FORME": "PDRE. P. SUSP. INJ. IM",
    "DOSAGE": "1 200 000UI/FL. DE PDRE.",
    "COND": "B/01FL. DE PDRE. + 01AMP. DE 5ML DE SOLV.(EPPI) ET B/50FL. DE PDRE.",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "B/50FL. DE PDRE. RESERVEE AUX HOPITAUX",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOCARE SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/04/11",
    "DATE_D_ENREGISTREMENT_FINAL": "25/03/19",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["benzathine penicillin"],
    "InteractionIndexLink": ["benzylpenicilline"],
    "N_ENREGISTREMENT": "003/ 13 G 061 /05/16",
    "CODE_DCI": "13 G 061",
    "DCI": "BENZATHINE BENZYLPENICILLINE",
    "NOM_COMMERCIALE": "RETARCILINE",
    "FORME": "PRDE. SOL. INJ.",
    "DOSAGE": "1 200 000UI/FL. DE PDRE.",
    "COND": "B/01+01  ET B/50FL.",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EPE GROUPE INDUSTRIEL SAIDAL/SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "23/10/2005",
    "DATE_D_ENREGISTREMENT_FINAL": "8/5/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["benzathine penicillin"],
    "InteractionIndexLink": ["benzylpenicilline"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "13 G 062",
    "DCI": "BENZYLPENICILLINE SODIQUE",
    "NOM_COMMERCIALE": "GECTAPEN",
    "FORME": "PDRE. ET SOLV. P. SOL. INJ. IM/IV  ET  PDRE. P. SOL.INJ. IM/IV",
    "DOSAGE": "500 000UI/FL. DE PDRE.",
    "COND": "B/01FL. DE PDRE. + 01AMP. DE 5ML DE SOLV. (EPPI)",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["benzathine penicillin"],
    "InteractionIndexLink": ["benzylpenicilline"],
    "N_ENREGISTREMENT": "003/ 13 G 063 /98/19",
    "CODE_DCI": "13 G 063",
    "DCI": "BENZYLPENICILLINE SODIQUE SOUS FORME SODIQUE",
    "NOM_COMMERCIALE": "GECTAPEN",
    "FORME": "PDRE. ET SOLV. P. SOL. INJ. IM/IV  ET  PDRE. P. SOL.INJ. IM/IV",
    "DOSAGE": "1 000 000UI/FL. DE PDRE.",
    "COND": "B/01FL. DE PDRE. + 01AMP. DE 5ML DE SOLV. (EPPI)  ET B/50FL. DE PDRE.",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "B/50FL. DE PDRE. RESERVEE AUX HOPITAUX",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EPE GROUPE INDUSTRIEL SAIDAL/SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "8/11/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "MANQUE DATE",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["benzathine penicillin"],
    "InteractionIndexLink": ["benzylpenicilline"],
    "N_ENREGISTREMENT": "293/ 13 G 063 /11",
    "CODE_DCI": "13 G 063",
    "DCI": "BENZYLPENICILLINE sodique",
    "NOM_COMMERCIALE": "PENI G BIOCARE",
    "FORME": "PDRE. P. SUSP. INJ. IM",
    "DOSAGE": "1 M.UI/FL. DE PDRE.",
    "COND": "B/01 FL. DE PDRE. + 01 AMP. DE 5ML DE SOLV.(EPPI) ET B/50FL. DE PDRE.",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "B/50FL. DE PDRE. RESERVEE AUX HOPITAUX",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOCARE SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/04/11",
    "DATE_D_ENREGISTREMENT_FINAL": "13/04/11",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["benzathine penicillin"],
    "InteractionIndexLink": ["benzylpenicilline"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "13 G 063",
    "DCI": "BENZYLPENICILLINE SODIQUE",
    "NOM_COMMERCIALE": "PENI G BIOCARE",
    "FORME": "PDRE. P. SOL. INJ. IM/IV",
    "DOSAGE": "1 000 000UI/FL.DE PDRE.",
    "COND": "B/01FL. DE PDRE. + 01AMP. DE 5ML DE SOLV.(EPPI)",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["oxacillin"],
    "InteractionIndexLink": ["oxacilline"],
    "N_ENREGISTREMENT": "293/ 13 G 069 /10/16",
    "CODE_DCI": "13 G 069",
    "DCI": "OXACILLINE SODIQUE EXPRIME EN OXACILLINE",
    "NOM_COMMERCIALE": "OXACARE",
    "FORME": "PDRE. ET SOLV. P. SOL. INJ/IV",
    "DOSAGE": "1G/FL. DE PDRE.",
    "COND": "B/01FL. DE PDRE. + 01AMP. DE 5ML DE SOLV. (EPPI) ET  B/50FL. DE PDRE.",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "B/50FL. DE PDRE. RESERVEE AUX HOPITAUX",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOCARE SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "21/10/2010",
    "DATE_D_ENREGISTREMENT_FINAL": "12/4/2016",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["phenoxymethylpenicillin"],
    "InteractionIndexLink": ["phenoxymethylpenicilline"],
    "N_ENREGISTREMENT": "003/ 13 G 071 /99/16",
    "CODE_DCI": "13 G 071",
    "DCI": "PHENOXYMETHYLPENICILLINE POTASSIQUE EXPRIME EN PHENOXYMETHYLPENICILLINE",
    "NOM_COMMERCIALE": "ORAPEN",
    "FORME": "PDRE.SUSP.OR.",
    "DOSAGE": "250 000UI/5ML",
    "COND": "FL/60 ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EPE GROUPE INDUSTRIEL SAIDAL/SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/2/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "8/5/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["phenoxymethylpenicillin"],
    "InteractionIndexLink": ["phenoxymethylpenicilline"],
    "N_ENREGISTREMENT": "003/ 13 G 072 /96/16",
    "CODE_DCI": "13 G 072",
    "DCI": "PHENOXYMETHYLPENICILLINE POTASSIQUE EXPRIME EN PHENOXYMETHYLPENICILLINE",
    "NOM_COMMERCIALE": "ORAPEN",
    "FORME": "COMPRIME",
    "DOSAGE": "1000 000UI",
    "COND": "B/12",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EPE GROUPE INDUSTRIEL SAIDAL/SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "31/12/1996",
    "DATE_D_ENREGISTREMENT_FINAL": "8/5/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["phenoxymethylpenicillin"],
    "InteractionIndexLink": ["phenoxymethylpenicilline"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "13 G 072",
    "DCI": "PHENOXYMETHYLPENICILLINE POTASSIQUE EXPRIME EN PHENOXYMETHYLPENICILLINE",
    "NOM_COMMERCIALE": "PENICILLINE-CIMEX",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "1 000 000UI",
    "COND": "B/12",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["phenoxymethylpenicillin"],
    "InteractionIndexLink": ["phenoxymethylpenicilline"],
    "N_ENREGISTREMENT": "039/ 13 G 072 /98/18",
    "CODE_DCI": "13 G 072",
    "DCI": "PHENOXYMETHYLPENICILLINE POTASSIQUE EXPRIME EN PHENOXYMETHYLPENICILLINE",
    "NOM_COMMERCIALE": "PENIVAL",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "1 000 000UI",
    "COND": "B/12",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOCIETE PHARMACEUTIQUE ALGERIENNE (SOPHAL)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/2/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "17/5/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["oxacillin"],
    "InteractionIndexLink": ["oxacilline"],
    "N_ENREGISTREMENT": "323/ 13 G 160 /12",
    "CODE_DCI": "13 G 160",
    "DCI": "OXACILLINE SODIQUE EXPRIME EN OXACILLINE",
    "NOM_COMMERCIALE": "OXADEX",
    "FORME": "GLES.",
    "DOSAGE": "500MG",
    "COND": "B/12",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CONTINENTAL PHARM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "8/4/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "8/4/2012",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["amoxicillin"],
    "InteractionIndexLink": ["amoxicilline"],
    "N_ENREGISTREMENT": "001/ 13 G 181 /13",
    "CODE_DCI": "13 G 181",
    "DCI": "AMOXICILLINE TRIHYDRATEE EXPRIME EN AMOXICILLINE / ACIDE CLAVULANIQUE POTASSIQUE EXPRIME EN ACIDE CLAVULANIQUE",
    "NOM_COMMERCIALE": "AMOCLAN 8:1",
    "FORME": "PDRE. P. SUSP. BUV. ENFANT ET NOURRISSON",
    "DOSAGE": "100MG/12.5MG/ML",
    "COND": "B/1FL.DE 30ML (NOURRISSON) - B/1FL.DE 60ML (ENFANT) DE SUSP. BUV. APRES RECONST. + PIPETTE GRADUEE",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMA ALGERIA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/7/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "7/7/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["amoxicillin"],
    "InteractionIndexLink": ["amoxicilline"],
    "N_ENREGISTREMENT": "305/ 13 G 181 /99/17",
    "CODE_DCI": "13 G 181",
    "DCI": "AMOXICILLINE TRIHYDRATEE EXPRIME EN AMOXICILLINE / ACIDE CLAVULANIQUE POTASSIQUE EXPRIME EN ACIDE CLAVULANIQUE",
    "NOM_COMMERCIALE": "AUGMENTIN ENFANT ET AUGMENTIN NOURRISSON",
    "FORME": "PDRE. P. SUSP. BUV.",
    "DOSAGE": "100MG/12.5MG/ML",
    "COND": "B/FL. DE PDRE. DE 30ML DE SUSP. BUV. ET B/1FL. DE PDRE. DE 60ML  DE SUSP. BUV. (APRES RECONSTITUTION)",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GLAXO SMITHKLINE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "14/2/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "29/6/2017",
    "TYPE": "Ré",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["amoxicillin"],
    "InteractionIndexLink": ["amoxicilline"],
    "N_ENREGISTREMENT": "293/ 13 G 181 /13/21",
    "CODE_DCI": "13 G 181",
    "DCI": "Amoxicilline trihydratée exprimé en  Amoxicilline / Clavulanate de potassium exprimé en Acide Clavulanique",
    "NOM_COMMERCIALE": "BIOCLAV",
    "FORME": "PDRE. P. SUSP. BUV. ENFANT",
    "DOSAGE": "100MG/12.5MG/ML",
    "COND": "B/1FL. DE 60ML DE SUSP. BUV. APRES RECONST. + 1SERING. GRADUEE EN KG",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOCARE SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/8/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "30/3/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["amoxicillin"],
    "InteractionIndexLink": ["amoxicilline"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "13 G 181",
    "DCI": "Amoxicilline/Acide clavulanique",
    "NOM_COMMERCIALE": "BIOCLAV SIROP ENF",
    "FORME": "PDR SUS BUV",
    "DOSAGE": "100mg / 125 mg/1ml",
    "COND": "Boite de 1Flde60 ml",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["amoxicillin"],
    "InteractionIndexLink": ["amoxicilline"],
    "N_ENREGISTREMENT": "480/ 13 G 181 /16",
    "CODE_DCI": "13 G 181",
    "DCI": "AMOXICILLINE TRIHYDRATEE EXPRIME EN AMOXICILLINE / ACIDE CLAVULANIQUE POTASSIQUE EXPRIME EN ACIDE CLAVULANIQUE",
    "NOM_COMMERCIALE": "CLAMOCLAV ENFANT ET NOURRISSON",
    "FORME": "PDRE POUR SUSPENSSION BUVABLE",
    "DOSAGE": "100MG/12.5MG/ML",
    "COND": "/1FLACON DE 30ML  DE SUSP. BUV. APRES RECONST. +SERING. P. ADMINIST. ORALE GRADUEE EN KG (NOURRISSON) ET B/1FLACON DE 60ML  DE SUSP. BUV. APRES RECONST. +SERING. P. ADMINIST. ORALE GRADUEE EN KG (ENFANT)",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EURL GENIS PHARMACEUTIQUE ET PARAPHARMACEUTIQUE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/10/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "6/10/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["amoxicillin"],
    "InteractionIndexLink": ["amoxicilline"],
    "N_ENREGISTREMENT": "003/ 13 G 181 /13/21",
    "CODE_DCI": "13 G 181",
    "DCI": "Amoxicilline trihydratée exprimé en  Amoxicilline / Clavulanate de potassium exprimé en Acide Clavulanique",
    "NOM_COMMERCIALE": "CLAMOXYPEN",
    "FORME": "PDRE. P. SUSP. BUV. NOURRISSONS ET ENFANTS",
    "DOSAGE": "100MG/12.5MG/ML",
    "COND": "B/1FLACON DE 30ML  DE SUSP. BUV. APRES RECONST. + SERINGUE DOSEUSE  pour administration  orale graduée en KG (NOURRISSON) ET B/1FLACON DE 60ML  DE SUSP. BUV. APRES RECONST. + SERINGUE DOSEUSE  pour administration  orale graduée en KG (ENFANTS)",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EPE GROUPE INDUSTRIEL SAIDAL / SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/4/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "28/3/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["amoxicillin"],
    "InteractionIndexLink": ["amoxicilline"],
    "N_ENREGISTREMENT": "323/13 G 181/17",
    "CODE_DCI": "13 G 181",
    "DCI": "AMOXICILLINE TRIHYDRATEE EXPRIME EN AMOXICILLINE / ACIDE CLAVULANIQUE POTASSIQUE EXPRIME EN ACIDE CLAVULANIQUE",
    "NOM_COMMERCIALE": "CLAVODEX",
    "FORME": "PDRE. P. SUSP. BUV.",
    "DOSAGE": "100MG/12.5MG/ML",
    "COND": "FL /60 ML  ET FL/30 ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CONTINENTAL PHARM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "23/3/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "23/3/2017",
    "TYPE": "Gé",
    "STATUT": "F PREMIX",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["amoxicillin"],
    "InteractionIndexLink": ["amoxicilline"],
    "N_ENREGISTREMENT": "001/ 13 G 182 /05/13",
    "CODE_DCI": "13 G 182",
    "DCI": "AMOXICILLINE SODIQUE EXPRIME EN AMOXICILLINE / ACIDE CLAVULANIQUE POTASSIQUE EXPRIME EN ACIDE CLAVULANIQUE",
    "NOM_COMMERCIALE": "AMOCLAN",
    "FORME": "PDRE. P. SOL. INJ. IV",
    "DOSAGE": "1G/200MG",
    "COND": "B/1FL. DE PDRE.",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMACEUTICALS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/9/2005",
    "DATE_D_ENREGISTREMENT_FINAL": "7/4/2013",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["amoxicillin"],
    "InteractionIndexLink": ["amoxicilline"],
    "N_ENREGISTREMENT": "001/ 13 G 204 /13/19",
    "CODE_DCI": "13 G 204",
    "DCI": "AMOXICILLINE TRIHYDRATEE EXPRIMEE EN AMOXICILLINE / ACIDE CLAVULANIQUE POTASSIQUE EXPRIME EN ACIDE CLAVULANIQUE",
    "NOM_COMMERCIALE": "AMOCLAN 8:1",
    "FORME": "PDRE. P. SUSP. BUV. EN SACHET DOSE",
    "DOSAGE": "500MG/62.5MG",
    "COND": "B/12 ET B/14",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMA ALGERIA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/6/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "MANQUE DATE",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["amoxicillin"],
    "InteractionIndexLink": ["amoxicilline"],
    "N_ENREGISTREMENT": "20/04/13 G204/305",
    "CODE_DCI": "13 G 204",
    "DCI": "AMOXICILLINE / ACIDE CLAVULANIQUE",
    "NOM_COMMERCIALE": "AUGMENTIN ENFANT",
    "FORME": "PDRE P.SUSP BUVABLE EN SACHETS DOSE",
    "DOSAGE": "500MG/ 62.5MG",
    "COND": "B/12",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES GLAXO SMITHKLINE ALGERIE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/3/2004",
    "DATE_D_ENREGISTREMENT_FINAL": "8/11/2020",
    "TYPE": "Ré",
    "STATUT": "F Prémix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["amoxicillin"],
    "InteractionIndexLink": ["amoxicilline"],
    "N_ENREGISTREMENT": "293/ 13 G 204 /13",
    "CODE_DCI": "13 G 204",
    "DCI": "AMOXICILLINE TRIHYDRATEE EXPRIMEE EN AMOXICILLINE / ACIDE CLAVULANIQUE POTASSIQUE EXPRIME EN ACIDE CLAVULANIQUE",
    "NOM_COMMERCIALE": "BIOCLAV 8:1",
    "FORME": "PDRE. P. SUSP. BUV. EN SACHET DOSE",
    "DOSAGE": "500MG/62.5MG",
    "COND": "B/12 ET B/14",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOCARE SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/11/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "27/11/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["amoxicillin"],
    "InteractionIndexLink": ["amoxicilline"],
    "N_ENREGISTREMENT": "323/13 G 204/17",
    "CODE_DCI": "13 G 204",
    "DCI": "AMOXICILLINE TRIHYDRATEE EXPRIMEE EN AMOXICILLINE / ACIDE CLAVULANIQUE POTASSIQUE EXPRIME EN ACIDE CLAVULANIQUE",
    "NOM_COMMERCIALE": "CLAVODEX",
    "FORME": "PDRE. P. SUSP. BUV. EN SACHET DOSE",
    "DOSAGE": "500MG/62.5MG",
    "COND": "B/12 ET B/14",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CONTINENTAL PHARM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/8/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "30/8/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["amoxicillin"],
    "InteractionIndexLink": ["amoxicilline"],
    "N_ENREGISTREMENT": "039/ 13 G 220 /13",
    "CODE_DCI": "13 G 220",
    "DCI": "AMOXICILLINE TRIHYDRATEE EXPRIME EN AMOXICILLINE",
    "NOM_COMMERCIALE": "AMOXAL",
    "FORME": "PDRE. P. SUSP. BUV.",
    "DOSAGE": "500MG/5ML",
    "COND": "B/1FL. DE 60ML DE SUSP. BUV. APRES RECONST. + GOBELET DOSEUR",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOCIETE PHARMACEUTIQUE ALGERIENNE (SOPHAL)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/7/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "2/7/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["amoxicillin"],
    "InteractionIndexLink": ["amoxicilline"],
    "N_ENREGISTREMENT": "380/ 13 G 220 /07/13",
    "CODE_DCI": "13 G 220",
    "DCI": "AMOXICILLINE TRIHYDRATEE EXPRIME EN AMOXICILLINE",
    "NOM_COMMERCIALE": "AMOXICILLINE EG",
    "FORME": "PDRE. P. SUSP. BUV.",
    "DOSAGE": "500MG/5ML",
    "COND": "B/1FL. DE 60ML DE SUSP. BUV. APRES RECONST. + UNE CUILLERE-MESURE",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HUP.P.PHARMA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/7/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "5/3/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["amoxicillin"],
    "InteractionIndexLink": ["amoxicilline"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "13 G 220",
    "DCI": "AMOXICILLINE TRIHYDRATEE EXPRIME EN AMOXICILLINE",
    "NOM_COMMERCIALE": "AMOXIMEX",
    "FORME": "PDRE. P. SUSP. BUV.",
    "DOSAGE": "500MG/5ML",
    "COND": "B/1FL. DE 60ML DE SUSP.  BUV. APRES RECONST.+UNE CUILLERE MESURE DE 5ML",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["amoxicillin"],
    "InteractionIndexLink": ["amoxicilline"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "13 G 220",
    "DCI": "AMOXICILLINE TRIHYDRATEE EXPRIME EN AMOXICILLINE",
    "NOM_COMMERCIALE": "AMOXYPEN",
    "FORME": "PDRE. SUSP. BUV.",
    "DOSAGE": "500MG/5ML",
    "COND": "FL./60ML",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["amoxicillin"],
    "InteractionIndexLink": ["amoxicilline"],
    "N_ENREGISTREMENT": "293/ 13 G 220 /13",
    "CODE_DCI": "13 G 220",
    "DCI": "AMOXICILLINE TRIHYDRATEE EXPRIME EN AMOXICILLINE",
    "NOM_COMMERCIALE": "BIOPAMOX",
    "FORME": "PDRE. P. SUSP. BUV.",
    "DOSAGE": "500MG/5ML",
    "COND": "B/1FL. DE 60ML DE SUSP. BUV. APRES RECONST. +  BOUCHON DOSEUR GRADUE",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOCARE SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/7/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "17/7/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["amoxicillin"],
    "InteractionIndexLink": ["amoxicilline"],
    "N_ENREGISTREMENT": "293/ 13 G 220 /13",
    "CODE_DCI": "13 G 220",
    "DCI": "AMOXICILLINE TRIHYDRATEE EXPRIME EN AMOXICILLINE",
    "NOM_COMMERCIALE": "BIOPAMOX",
    "FORME": "PDRE. P. SUSP. BUV.",
    "DOSAGE": "500MG/5ML",
    "COND": "B/1FL. DE 60ML DE SUSP. BUV. APRES RECONST. + BOUCHON DOSEUR GRADUE",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOCARE SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/07/13",
    "DATE_D_ENREGISTREMENT_FINAL": "17/07/13",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["amoxicillin"],
    "InteractionIndexLink": ["amoxicilline"],
    "N_ENREGISTREMENT": "001/ 13 G 220 /14",
    "CODE_DCI": "13 G 220",
    "DCI": "AMOXICILLINE TRIHYDRATEE EXPRIME EN AMOXICILLINE",
    "NOM_COMMERCIALE": "PENAMOX",
    "FORME": "PDRE P/ SUSP BUV",
    "DOSAGE": "500MG/5ML",
    "COND": "B/01 FL 60ML APRES RECONSTITUTION+CUILLERE MEUSURE 5ML",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMA ALGERIA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "8/6/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "8/6/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["amoxicillin"],
    "InteractionIndexLink": ["amoxicilline"],
    "N_ENREGISTREMENT": "039/ 13 G 230 /08/18",
    "CODE_DCI": "13 G 230",
    "DCI": "AMOXICILLINE TRIHYDRATEE EXPRIME EN AMOXICILLINE",
    "NOM_COMMERCIALE": "AMOXAL",
    "FORME": "COMP. DISPERS.",
    "DOSAGE": "1G",
    "COND": "B/12 ET B/14",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOCIETE PHARMACEUTIQUE ALGERIENNE (SOPHAL)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/4/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "28/1/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["amoxicillin"],
    "InteractionIndexLink": ["amoxicilline"],
    "N_ENREGISTREMENT": "380/ 13 G 230 /03/14",
    "CODE_DCI": "13 G 230",
    "DCI": "AMOXICILLINE TRIHYDRATEE EXPRIME EN AMOXICILLINE",
    "NOM_COMMERCIALE": "AMOXICILLINE EG",
    "FORME": "COMP. DISPERS.",
    "DOSAGE": "1G",
    "COND": "B/14",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HUP.P.PHARMA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/7/2003",
    "DATE_D_ENREGISTREMENT_FINAL": "23/9/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["amoxicillin"],
    "InteractionIndexLink": ["amoxicilline"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "13 G 230",
    "DCI": "AMOXICILLINE TRIHYDRATEE EXPRIME EN AMOXICILLINE",
    "NOM_COMMERCIALE": "AMOXIMEX",
    "FORME": "COMP. DISPERS.",
    "DOSAGE": "1G",
    "COND": "B/06 ET B/14",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["amoxicillin"],
    "InteractionIndexLink": ["amoxicilline"],
    "N_ENREGISTREMENT": "003/ 13 G 230 /07/16",
    "CODE_DCI": "13 G 230",
    "DCI": "AMOXICILLINE TRIHYDRATEE EXPRIME EN AMOXICILLINE",
    "NOM_COMMERCIALE": "AMOXYPEN",
    "FORME": "COMP. DISPER.",
    "DOSAGE": "1G",
    "COND": "B/14 - B/16",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EPE GROUPE INDUSTRIEL SAIDAL/SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/11/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "8/5/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["amoxicillin"],
    "InteractionIndexLink": ["amoxicilline"],
    "N_ENREGISTREMENT": "001/ 13 G 230 /15",
    "CODE_DCI": "13 G 230",
    "DCI": "AMOXICILLINE TRIHYDRATEE EXPRIME EN AMOXICILLINE",
    "NOM_COMMERCIALE": "PENAMOX D",
    "FORME": "COMP. DISPERS. SEC.",
    "DOSAGE": "1G",
    "COND": "B/14",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMA ALGERIA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/2/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "22/2/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["amoxicillin"],
    "InteractionIndexLink": ["amoxicilline"],
    "N_ENREGISTREMENT": "287/ 13 G 230 /07/13",
    "CODE_DCI": "13 G 230",
    "DCI": "AMOXICILLINE TRIHYDRATE EXPRIME EN AMOXICILLINE",
    "NOM_COMMERCIALE": "SAIFOXYL",
    "FORME": "COMP. DISPERS.",
    "DOSAGE": "1G",
    "COND": "B/14",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIAN PHARMACEUTICS UNION  SARL (APU)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/11/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "29/5/2013",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["amoxicillin"],
    "InteractionIndexLink": ["amoxicilline"],
    "N_ENREGISTREMENT": "293/ 13 G 245 /13",
    "CODE_DCI": "13 G 245",
    "DCI": "AMOXICILLINE TRIHYDRATEE EXPRIME EN AMOXICILLINE / ACIDE CLAVULANIQUE POTASSIQUE EXPRIME EN ACIDE CLAVULANIQUE",
    "NOM_COMMERCIALE": "BIOCLAV",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "500MG/62.5MG",
    "COND": "B/16 ET B/24",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOCARE SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/10/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "27/10/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["amoxicillin"],
    "InteractionIndexLink": ["amoxicilline"],
    "N_ENREGISTREMENT": "323/13 G 245/17",
    "CODE_DCI": "13 G 245",
    "DCI": "AMOXICILLINE TRIHYDRATEE EXPRIME EN AMOXICILLINE / ACIDE CLAVULANIQUE POTASSIQUE EXPRIME EN ACIDE CLAVULANIQUE",
    "NOM_COMMERCIALE": "CLAVODEX",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "500MG / 62.5MG",
    "COND": "B/16 - B/24",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CONTINENTAL PHARM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/4/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "20/4/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["amoxicillin"],
    "InteractionIndexLink": ["amoxicilline"],
    "N_ENREGISTREMENT": "001/ 13 G 266 /04/13",
    "CODE_DCI": "13 G 266",
    "DCI": "AMOXICILLINE TRIHYDRATEE EXPRIMEE EN AMOXICILLINE / ACIDE CLAVULANIQUE POTASSIQUE EXPRIME EN ACIDE CLAVULANIQUE",
    "NOM_COMMERCIALE": "AMOCLAN BID",
    "FORME": "PDRE. P.  SUSP. BUV.",
    "DOSAGE": "400MG/57MG/5ML",
    "COND": "B/1FL. DE 35ML ET B/1FL. DE 70ML (DE SUSPENSION BUVABLE APRES RECONSTITUTION) AVEC PIPIETTE GRADUEE EN KG",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMACEUTICALS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "3/1/2004",
    "DATE_D_ENREGISTREMENT_FINAL": "20/10/2013",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["amoxicillin"],
    "InteractionIndexLink": ["amoxicilline"],
    "N_ENREGISTREMENT": "055/ 13 G 266 /12",
    "CODE_DCI": "13 G 266",
    "DCI": "AMOXICILLINE (SOUS FORME TRIHYDRATEE) / ACIDE CLAVULANIQUE (SOUS FORME POTASSIQUE)",
    "NOM_COMMERCIALE": "CLAVODAR FORTE 400/57",
    "FORME": "PDRE. P. SUSP. BUV.",
    "DOSAGE": "400MG / 57MG",
    "COND": "B/1FL. DE 70ML DE SUSP. BUV. APRES RECONST. + UNE CUILLERE MESURE DE 5ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "DAR AL DAWA DEVELOPMENT & INVESTMENT Co Ltd",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "3/5/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "3/5/2012",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["amoxicillin"],
    "InteractionIndexLink": ["amoxicilline"],
    "N_ENREGISTREMENT": "323/13 G 266/16",
    "CODE_DCI": "13 G 266",
    "DCI": "AMOXICILLINE TRIHYDRATEE EXPRIMEE EN AMOXICILLINE / ACIDE CLAVULANIQUE POTASSIQUE EXPRIME EN ACIDE CLAVULANIQUE",
    "NOM_COMMERCIALE": "CLAVODEX DUO",
    "FORME": "PDRE. P.  SUSP. BUV.",
    "DOSAGE": "400MG/57MG/5ML",
    "COND": "F/70 ML ET F/36 ML+PIPETTE GRADUEE",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CONTINENTAL PHARM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/12/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "4/12/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["amoxicillin"],
    "InteractionIndexLink": ["amoxicilline"],
    "N_ENREGISTREMENT": "001/ 13 G 267 /04/13",
    "CODE_DCI": "13 G 267",
    "DCI": "AMOXICILLINE TRIHYDRATEE EXPRIMEE EN AMOXICILLINE / ACIDE CLAVULANIQUE POTASSIQUE EXPRIME EN ACIDE CLAVULANIQUE",
    "NOM_COMMERCIALE": "AMOCLAN BID",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "875MG/125MG",
    "COND": "PILULIER/10",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMACEUTICALS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "3/1/2004",
    "DATE_D_ENREGISTREMENT_FINAL": "7/7/2013",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["amoxicillin"],
    "InteractionIndexLink": ["amoxicilline"],
    "N_ENREGISTREMENT": "055/ 13 G 267 /12",
    "CODE_DCI": "13 G 267",
    "DCI": "AMOXICILLINE (SOUS FORME TRIHYDRATEE) / ACIDE CLAVULANIQUE (SOUS FORME POTASSIQUE)",
    "NOM_COMMERCIALE": "CLAVODAR 1G",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "875MG /125MG",
    "COND": "B/14",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "DAR AL DAWA DEVELOPMENT & INVESTMENT Co Ltd",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "3/5/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "3/5/2012",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["amoxicillin"],
    "InteractionIndexLink": ["amoxicilline"],
    "N_ENREGISTREMENT": "323/13 G 267/17",
    "CODE_DCI": "13 G 267",
    "DCI": "AMOXICILLINE TRIHYDRAT2E /ACIDE CLAVULANIQUE POTASSIQUE",
    "NOM_COMMERCIALE": "CLAVODEX DUO",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "875MG/125MG",
    "COND": "B/10 ET DE 12",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CONTINENTAL PHARM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/4/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "20/4/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["amoxicillin"],
    "InteractionIndexLink": ["amoxicilline"],
    "N_ENREGISTREMENT": "293/ 13 G 268 /16",
    "CODE_DCI": "13 G 268",
    "DCI": "AMOXICILLINE TRIHYDRATEE EXPRIME EN AMOXICILLINE",
    "NOM_COMMERCIALE": "BIOPAMOX",
    "FORME": "GRANULés POUR SUSPENSION BUVABLE",
    "DOSAGE": "1G/SACHET",
    "COND": "B/08",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOCARE SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/2/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "2/2/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["amoxicillin"],
    "InteractionIndexLink": ["amoxicilline"],
    "N_ENREGISTREMENT": "480/ 13 G 268 /14",
    "CODE_DCI": "13 G 268",
    "DCI": "AMOXICILLINE TRIHYDRATE E EXPRIME EN AMOXICILLINE ANHYDRE",
    "NOM_COMMERCIALE": "HIMOXYL",
    "FORME": "PDRE P. SUSP. BUV. EN SACHET-DOSE",
    "DOSAGE": "1G/SACHET",
    "COND": "B/14",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EURL GENIS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "21/1/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "21/1/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["amoxicillin"],
    "InteractionIndexLink": ["amoxicilline"],
    "N_ENREGISTREMENT": "001/ 13 G 269 /13/19",
    "CODE_DCI": "13 G 269",
    "DCI": "AMOXICILLINE TRIHYDRATEE EXPRIME EN AMOXICILLINE /ACIDE CLAVULANIQUE POTASSIQUE EXPRIME EN ACIDE CLAVULANIQUE",
    "NOM_COMMERCIALE": "AMOCLAN 8:1",
    "FORME": "PDRE P. SUSP. BUV. EN SACHET-DOSE",
    "DOSAGE": "1G/125MG/SACHET",
    "COND": "B/14 ET B/12",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMA ALGERIA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/7/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "15/4/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["amoxicillin"],
    "InteractionIndexLink": ["amoxicilline"],
    "N_ENREGISTREMENT": "305/ 13 G 269 /04/15",
    "CODE_DCI": "13 G 269",
    "DCI": "AMOXICILLINE TRIHYDRATEE EXPRIME EN AMOXICILLINE /ACIDE CLAVULANIQUE POTASSIQUE EXPRIME EN ACIDE CLAVULANIQUE",
    "NOM_COMMERCIALE": "AUGMENTIN ADULTE",
    "FORME": "PDRE P. SUSP. BUV. EN SACHET-DOSE",
    "DOSAGE": "1G/125MG/SACHET",
    "COND": "B/12",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GLAXOSMITHKLINE ALGERIE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/4/2004",
    "DATE_D_ENREGISTREMENT_FINAL": "29/1/2015",
    "TYPE": "Ré",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["amoxicillin"],
    "InteractionIndexLink": ["amoxicilline"],
    "N_ENREGISTREMENT": "293/ 13 G 269 /13",
    "CODE_DCI": "13 G 269",
    "DCI": "AMOXICILLINE TRIHYDRATEE EXPRIME EN AMOXICILLINE /ACIDE CLAVULANIQUE POTASSIQUE EXPRIME EN ACIDE CLAVULANIQUE",
    "NOM_COMMERCIALE": "BIOCLAV 8:1",
    "FORME": "PDRE P. SUSP. BUV. EN SACHET-DOSE",
    "DOSAGE": "1G/125MG/SACHET",
    "COND": "B/08 - B/12 - B/14",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOCARE SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "21/7/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "21/7/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["amoxicillin"],
    "InteractionIndexLink": ["amoxicilline"],
    "N_ENREGISTREMENT": "480/13 G 269/16",
    "CODE_DCI": "13 G 269",
    "DCI": "AMOXICILLINE TRIHYDRATEE EXPRIME EN AMOXICILLINE /ACIDE CLAVULANIQUE POTASSIQUE EXPRIME EN ACIDE CLAVULANIQUE",
    "NOM_COMMERCIALE": "CLAMOCLAV",
    "FORME": "PDRE P. SUSP. BUV. EN SACHET-DOSE",
    "DOSAGE": "1G/125MG/SACHET",
    "COND": "B/12",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EURL GENIS PRODUITS PHARMACEUTIQUES ET PARA PHARMACEUTIQUES",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/10/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "9/10/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["amoxicillin"],
    "InteractionIndexLink": ["amoxicilline"],
    "N_ENREGISTREMENT": "323/13 G 269/17",
    "CODE_DCI": "13 G 269",
    "DCI": "AMOXICILLINE TRIHYDRATEE EXPRIME EN AMOXICILLINE /ACIDE CLAVULANIQUE POTASSIQUE EXPRIME EN ACIDE CLAVULANIQUE",
    "NOM_COMMERCIALE": "CLAVODEX",
    "FORME": "PDRE P. SUSP. BUV. EN SACHET-DOSE",
    "DOSAGE": "1G/125MG/SACHET",
    "COND": "B/12SACH.ET B/14",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CONTINENTAL PHARM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/8/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "30/8/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["amoxicillin"],
    "InteractionIndexLink": ["amoxicilline"],
    "N_ENREGISTREMENT": "352/ 13 G 280 /08/16",
    "CODE_DCI": "13 G 280",
    "DCI": "AMOXICILLINE/ ACIDE CLAVULANIQUE",
    "NOM_COMMERCIALE": "TABUKLAV",
    "FORME": "PDRE. ET SOLV. SOL. INJ.",
    "DOSAGE": "500MG/100MG",
    "COND": "B/1FL. DE PDRE + 1AMP. DE 10 ML DE SOLVANT",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI PHARMACEUTICALS MANUFACTURING COMPANY",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/12/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "4/2/2016",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["amoxicillin"],
    "InteractionIndexLink": ["amoxicilline"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "13 G 301",
    "DCI": "AMOXICILLINE TRIHYDRATEE EXPRIME EN AMOXICILLINE",
    "NOM_COMMERCIALE": "AMOXYPEN",
    "FORME": "COMP. DISPERS.",
    "DOSAGE": "500MG",
    "COND": "B/12",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["amoxicillin"],
    "InteractionIndexLink": ["amoxicilline"],
    "N_ENREGISTREMENT": "001/ 13 G 301 /15",
    "CODE_DCI": "13 G 301",
    "DCI": "AMOXICILLINE TRIHYDRATEE EXPRIME EN AMOXICILLINE",
    "NOM_COMMERCIALE": "PENAMOX D",
    "FORME": "COMP. DISPERS. SEC.",
    "DOSAGE": "500MG",
    "COND": "B/12",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMA ALGERIA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/5/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "13/5/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["phenoxymethylpenicillin"],
    "InteractionIndexLink": ["phenoxymethylpenicilline"],
    "N_ENREGISTREMENT": "003/ 13 G 306 /09/16",
    "CODE_DCI": "13 G 306",
    "DCI": "PHENOXYMETHYLPENICILLINE",
    "NOM_COMMERCIALE": "ORAPEN",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "1 500 000UI",
    "COND": "B/12",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EPE GROUPE INDUSTRIEL SAIDAL/SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/2/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "8/5/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["phenoxymethylpenicillin"],
    "InteractionIndexLink": ["phenoxymethylpenicilline"],
    "N_ENREGISTREMENT": "039/ 13 G 306 /12/18",
    "CODE_DCI": "13 G 306",
    "DCI": "PHENOXYMETHYLPENICILLINE POTASSIQUE",
    "NOM_COMMERCIALE": "PENIVAL",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "1 500 000UI",
    "COND": "B/12",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOCIETE PHARMACEUTIQUE ALGERIENNE (SOPHAL)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/2/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "22/5/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["meropenem"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "178/ 13 G 470 /18",
    "CODE_DCI": "13 G 470",
    "DCI": "Méropénéme trihydraté exprimé en méropénéme",
    "NOM_COMMERCIALE": "ARCHIFAR",
    "FORME": "POUDRE POR SOLU. INJECT OU PERF IV",
    "DOSAGE": "1G/FL DE PDRE",
    "COND": "B/10 FLACONS DE  POUDRE",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MEDOCHEMIE LTD",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CHYPRE",
    "DATE_D_ENREGISTREMENT_INITIAL": "31/1/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "31/1/2018",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["meropenem"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "001/ 13 G 470 /16",
    "CODE_DCI": "13 G 470",
    "DCI": "MEROPENEME TRIHYDRATE EXPRIME EN MEROPENEME ANHYDRE",
    "NOM_COMMERCIALE": "MEPRA",
    "FORME": "POUDRE POR SOLU. INJECT OU PERF IV",
    "DOSAGE": "1G/FL DE PDRE",
    "COND": "B/10 FLACONS DE 20ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA FARMACEUTICA (Portugal) SA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PORTUGAL",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/1/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "17/1/2016",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["meropenem"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "256/ 13 G 470 /14",
    "CODE_DCI": "13 G 470",
    "DCI": "MEROPENEME TRIHYDRATE EXPRIME EN MEROPENEME ANHYDRE",
    "NOM_COMMERCIALE": "MERONEM",
    "FORME": "PDRE P. SOL INJ IV",
    "DOSAGE": "1G/FL DE PDRE",
    "COND": "B/10 FL DE POUDRE",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ASTRA ZENECA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "3/8/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "3/8/2014",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "48 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["meropenem"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "001/ 13 G 477 /16",
    "CODE_DCI": "13 G 477",
    "DCI": "MEROPENEME TRIHYDRATE EXPRIME EN MEROPENEME ANHYDRE",
    "NOM_COMMERCIALE": "MEPRA",
    "FORME": "POUDRE POR SOLU. INJECT OU PERF IV",
    "DOSAGE": "500MG/FLACON",
    "COND": "B/10FLACONS DE 20 ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA FARMACEUTICA (Portugal) SA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PORTUGAL",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/3/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "13/3/2016",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["ofloxacin"],
    "InteractionIndexLink": ["levofloxacine"],
    "N_ENREGISTREMENT": "055/ 13 K 227 /13",
    "CODE_DCI": "13 K 227",
    "DCI": "Levofloxacine hemihydrate exprime en Levofloxacine",
    "NOM_COMMERCIALE": "MATADOR 250",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "250MG",
    "COND": "B/07",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "DAR AL DAWA DEVELOPMENT & INVESTMENT Co Ltd",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "3/11/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "3/11/2013",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["ofloxacin"],
    "InteractionIndexLink": ["levofloxacine"],
    "N_ENREGISTREMENT": "317/ 13 K 228 /12/17",
    "CODE_DCI": "13 K 228",
    "DCI": "Levofloxacine hemihydrate exprime en Levofloxacine",
    "NOM_COMMERCIALE": "LEVOFLOX",
    "FORME": "COMP. PELLI. SEC.",
    "DOSAGE": "500MG",
    "COND": "B/05 ET B/10",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INPHA-MEDIS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/5/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "31/12/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["ofloxacin"],
    "InteractionIndexLink": ["levofloxacine"],
    "N_ENREGISTREMENT": "20/13 K228/380",
    "CODE_DCI": "13 K 228",
    "DCI": "LEVOFLOXACINE HEMIHYDRATE EXPRIME EN LEVOFLOXACINE",
    "NOM_COMMERCIALE": "LEVOQUIN",
    "FORME": "COMP PELL SECABLES",
    "DOSAGE": "500MG",
    "COND": "B/10",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "laboratoires HUP.P PHARMA Sarl",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/12/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "29/12/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["ofloxacin"],
    "InteractionIndexLink": ["levofloxacine"],
    "N_ENREGISTREMENT": "380/13 K 228/20",
    "CODE_DCI": "13 K 228",
    "DCI": "LEVOFLOXACINE HEMIHYDRATE EXPRIME EN LEVOFLOXACINE",
    "NOM_COMMERCIALE": "LEVOQUIN",
    "FORME": "COMP. PELL. SEC.",
    "DOSAGE": "500MG",
    "COND": "B/10",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL HUP.P.PHARMA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/12/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "29/12/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["ofloxacin"],
    "InteractionIndexLink": ["levofloxacine"],
    "N_ENREGISTREMENT": "352/ 13 K 228 /18",
    "CODE_DCI": "13 K 228",
    "DCI": "Levofloxacine hemihydrate exprime en Levofloxacine",
    "NOM_COMMERCIALE": "LOXAMOX",
    "FORME": "COMP.PELLI. SEC.",
    "DOSAGE": "500MG",
    "COND": "B/05",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/8/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "1/8/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["ofloxacin"],
    "InteractionIndexLink": ["levofloxacine"],
    "N_ENREGISTREMENT": "055/ 13 K 228 /15",
    "CODE_DCI": "13 K 228",
    "DCI": "Levofloxacine hemihydrate exprime en Levofloxacine",
    "NOM_COMMERCIALE": "MATADOR 500",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "500MG",
    "COND": "B/07",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "DAR AL DAWA DEVELOPMENT & INVESTMENT Co Ltd",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/10/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "19/10/2015",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["norfloxacin"],
    "InteractionIndexLink": ["norfloxacine"],
    "N_ENREGISTREMENT": "039/13 K 229/17",
    "CODE_DCI": "13 K 229",
    "DCI": "NORFLOXACINE",
    "NOM_COMMERCIALE": "NORFLOXAL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "400 MG",
    "COND": "B/16",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOPHAL SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "5/11/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "5/11/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["ofloxacin"],
    "InteractionIndexLink": ["levofloxacine"],
    "N_ENREGISTREMENT": "433/ 13 K 231 /13",
    "CODE_DCI": "13 K 231",
    "DCI": "Levofloxacine hemihydrate exprime en Levofloxacine",
    "NOM_COMMERCIALE": "LEVOFLOXACINE RAZES",
    "FORME": "SOL. P. PERF.",
    "DOSAGE": "5MG/ML",
    "COND": "FL./100ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRATER-RAZES SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/6/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "25/4/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["ciprofloxacin"],
    "InteractionIndexLink": ["ciprofloxacine"],
    "N_ENREGISTREMENT": "20/13 K251/380",
    "CODE_DCI": "13 K 251",
    "DCI": "CIPROFLOXACINE SOUS FORME HYDROCHLORIDE",
    "NOM_COMMERCIALE": "CIFLOXACINE",
    "FORME": "SOL INJ P.PERF IV",
    "DOSAGE": "2MG/ML",
    "COND": "B/1 FLACON DE 100ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "laboratoires HUP.P PHARMA Sarl",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/11/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "25/11/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["ciprofloxacin"],
    "InteractionIndexLink": ["ciprofloxacine"],
    "N_ENREGISTREMENT": "433/ 13 K 251 /14",
    "CODE_DCI": "13 K 251",
    "DCI": "CIPROFLOXACINE",
    "NOM_COMMERCIALE": "CIPROFLOXACINE RAZES",
    "FORME": "SOL INJ P/ PERF IV",
    "DOSAGE": "2MG/ML (200MG/100ML) (400MG/200ML)",
    "COND": "B/01 DE FL. DE 100ML CAISSE/48 BOITES ;  B/01 DE FL. DE 200ML CAISSE/24 BOITES",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRATER-RAZES SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/4/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "1/4/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["ciprofloxacin"],
    "InteractionIndexLink": ["ciprofloxacine"],
    "N_ENREGISTREMENT": "286/ 13 K 251 /12",
    "CODE_DCI": "13 K 251",
    "DCI": "CIPROFLOXACINE",
    "NOM_COMMERCIALE": "INDPRO",
    "FORME": "SOL. INJ. P. PERF. IV",
    "DOSAGE": "2MG/ML (200MG/100ML)",
    "COND": "B/1FL. DE 100ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CHIMIE PHARMACIE COMMERCE MULTIPLE SARL (CPCM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/1/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "10/1/2012",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["ciprofloxacin"],
    "InteractionIndexLink": ["ciprofloxacine"],
    "N_ENREGISTREMENT": "039/ 13 K 252 /15",
    "CODE_DCI": "13 K 252",
    "DCI": "CIPROFLOXACINE CHLORHYDRATE EXPRIME EN CIPROFLOXACINE",
    "NOM_COMMERCIALE": "CIPROFLOXAL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "250MG",
    "COND": "B/10",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "MEDICAMENT SOUMIS A PRESCRIPTION HOSPITALIER",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOPHAL SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/12/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "29/12/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["ciprofloxacin"],
    "InteractionIndexLink": ["ciprofloxacine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "13 K 252",
    "DCI": "CIPROFLOXACINE CHLORHYDRATE EXPRIME EN CIPROFLOXACINE",
    "NOM_COMMERCIALE": "CIPROLON",
    "FORME": "COMPRIME",
    "DOSAGE": "250MG",
    "COND": "B/10",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["ciprofloxacin"],
    "InteractionIndexLink": ["ciprofloxacine"],
    "N_ENREGISTREMENT": "293/ 13 K 252 /13",
    "CODE_DCI": "13 K 252",
    "DCI": "CIPROFLOXACINE CHLORHYDRATE EXPRIME EN CIPROFLOXACINE",
    "NOM_COMMERCIALE": "CIPROTEK",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "250MG",
    "COND": "B/10",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "MEDICAMENT SOUMIS A PRESCRIPTION HOSPITALIERE",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOCARE SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "11/6/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "26/7/2016",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["ciprofloxacin"],
    "InteractionIndexLink": ["ciprofloxacine"],
    "N_ENREGISTREMENT": "268/13 K 252/07/17",
    "CODE_DCI": "13 K 252",
    "DCI": "CIPROFLOXACINE CHLORHYDRATE EXPRIME EN CIPROFLOXACINE",
    "NOM_COMMERCIALE": "FLOCINE",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "250MG",
    "COND": "B/10",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MERINAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/8/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "29/1/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["ciprofloxacin"],
    "InteractionIndexLink": ["ciprofloxacine"],
    "N_ENREGISTREMENT": "468/ 13 K 252 /14",
    "CODE_DCI": "13 K 252",
    "DCI": "CIPROFLOXACINE CHLORHYDRATE EXPRIME EN CIPROFLOXACINE",
    "NOM_COMMERCIALE": "LOXANAD",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "250MG",
    "COND": "B/10",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "SOUMIS A PRESCRIPTION HOSPITALIERE",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NADPHARMADIC PRODUCTION",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/6/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "15/6/2014",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["ciprofloxacin"],
    "InteractionIndexLink": ["ciprofloxacine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "13 K 252",
    "DCI": "Ciprofloxacine",
    "NOM_COMMERCIALE": "Proflox®",
    "FORME": "Comprimé pelliculé",
    "DOSAGE": "250 mg",
    "COND": "Boite de 10",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["ciprofloxacin"],
    "InteractionIndexLink": ["ciprofloxacine"],
    "N_ENREGISTREMENT": "20/13 K253/380",
    "CODE_DCI": "13 K 253",
    "DCI": "CIPROFLOXACINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "CIFLOXACINE",
    "FORME": "COMP PELL SECABLES",
    "DOSAGE": "500MG",
    "COND": "B/10",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "laboratoires HUP.P PHARMA Sarl",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/6/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "24/6/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["ciprofloxacin"],
    "InteractionIndexLink": ["ciprofloxacine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "13 K 253",
    "DCI": "CIPROFLOXACINE CHLORHYRATE MONOHYDRATE EXPRIME EN CIPROFLOXACINE",
    "NOM_COMMERCIALE": "CIPRO 500",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "500MG",
    "COND": "B/14",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["ciprofloxacin"],
    "InteractionIndexLink": ["ciprofloxacine"],
    "N_ENREGISTREMENT": "055/ 13 K 253 /02/12",
    "CODE_DCI": "13 K 253",
    "DCI": "CIPROFLOXACINE CHLORHYDRATE EXPRIME EN CIPROFLOXACINE",
    "NOM_COMMERCIALE": "CIPRODAR",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "500MG",
    "COND": "B/10",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "MEDICAMENT SOUMIS A PRESCRIPTION HOSPITALIERE",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "DAR AL DAWA DEVELOPMENT & INVESTMENT Co Ltd",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/3/2002",
    "DATE_D_ENREGISTREMENT_FINAL": "30/10/2012",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["ciprofloxacin"],
    "InteractionIndexLink": ["ciprofloxacine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "13 K 253",
    "DCI": "Ciprofloxacine",
    "NOM_COMMERCIALE": "CIPRODAR 500",
    "FORME": "Comp",
    "DOSAGE": "500mg",
    "COND": "12:00 AM",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["ciprofloxacin"],
    "InteractionIndexLink": ["ciprofloxacine"],
    "N_ENREGISTREMENT": "428/ 13 K 253 /13",
    "CODE_DCI": "13 K 253",
    "DCI": "CIPROFLOXACINE CHLORHYDRATE EXPRIME EN CIPROFLOXACINE",
    "NOM_COMMERCIALE": "CIPROFLOXACINE  ZENTIVA",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "500MG",
    "COND": "B/10",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "MEDICAMENT SOUMIS A PRESCRIPTION HOSPITALIERE",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "WINTHROP PHARMA SAIDAL SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/7/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "7/7/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["ciprofloxacin"],
    "InteractionIndexLink": ["ciprofloxacine"],
    "N_ENREGISTREMENT": "447/ 13 K 253 /12",
    "CODE_DCI": "13 K 253",
    "DCI": "CIPROFLOXACINE CHLORHYDRATE EXPRIME EN CIPROFLOXACINE",
    "NOM_COMMERCIALE": "CIPROFLOXACINE BEKER",
    "FORME": "COMP. PELLI. SEC.",
    "DOSAGE": "500MG",
    "COND": "B/10",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "MEDICAMENT SOUMIS A PRESCRIPTION HOSPITALIERE",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEKER SARL (SARL LABORATOIRE BEKER ALGERIE)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/12/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "10/12/2012",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["ciprofloxacin"],
    "InteractionIndexLink": ["ciprofloxacine"],
    "N_ENREGISTREMENT": "039/ 13 K 253 /15",
    "CODE_DCI": "13 K 253",
    "DCI": "CIPROFLOXACINE CHLORHYDRATE EXPRIME EN CIPROFLOXACINE",
    "NOM_COMMERCIALE": "CIPROFLOXAL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "500MG",
    "COND": "B/10",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "MEDICAMENT SOUMIS A PRESCRIPTION HOSPITALIERE",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOPHAL SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/12/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "10/1/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["ciprofloxacin"],
    "InteractionIndexLink": ["ciprofloxacine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "13 K 253",
    "DCI": "CIPROFLOXACINE CHLORHYDRATE EXPRIME EN CIPROFLOXACINE",
    "NOM_COMMERCIALE": "CIPROLON",
    "FORME": "COMPRIME",
    "DOSAGE": "500MG",
    "COND": "B/10",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["ciprofloxacin"],
    "InteractionIndexLink": ["ciprofloxacine"],
    "N_ENREGISTREMENT": "293/ 13 K 253 /13",
    "CODE_DCI": "13 K 253",
    "DCI": "CIPROFLOXACINE CHLORHYDRATE EXPRIME EN CIPROFLOXACINE",
    "NOM_COMMERCIALE": "CIPROTEK",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "500MG",
    "COND": "B/10",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "MEDICAMENT SOUMIS A PRESCRIPTION HOSPITALIERE",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOCARE SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/5/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "26/7/2016",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["ciprofloxacin"],
    "InteractionIndexLink": ["ciprofloxacine"],
    "N_ENREGISTREMENT": "268/13 K 253/07/18",
    "CODE_DCI": "13 K 253",
    "DCI": "CIPROFLOXACINE CHLORHYRATE MONOHYDRATE EXPRIME EN CIPROFLOXACINE",
    "NOM_COMMERCIALE": "FLOCINE",
    "FORME": "COMP. PELLI.SEC.",
    "DOSAGE": "500MG",
    "COND": "B/10",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "MEDICAMENT SOUMIS A PRESCRIPTION HOSPITALIERE",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MERINAL SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/8/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "2/4/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["ciprofloxacin"],
    "InteractionIndexLink": ["ciprofloxacine"],
    "N_ENREGISTREMENT": "468/ 13 K 253 /14",
    "CODE_DCI": "13 K 253",
    "DCI": "CIPROFLOXACINE CHLORHYDRATE (EXPRIME EN CIPROFLOXACINE)",
    "NOM_COMMERCIALE": "LOXANAD",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "500 MG",
    "COND": "B/10",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NADPHARMADIC PRODUCTION",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "8/6/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "8/6/2014",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["ciprofloxacin"],
    "InteractionIndexLink": ["ciprofloxacine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "13 K 253",
    "DCI": "Ciprofloxacine s/f chloryhydrate monohydratée",
    "NOM_COMMERCIALE": "Proflox",
    "FORME": "Comprimé enrobé",
    "DOSAGE": "500 mg",
    "COND": "Boite 10",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["ciprofloxacin"],
    "InteractionIndexLink": ["ciprofloxacine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "13 K 253",
    "DCI": "CIPROFLOXACINE CHLORHYRATE MONOHYDRATE EXPRIME EN CIPROFLOXACINE",
    "NOM_COMMERCIALE": "QUINOX",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "500MG",
    "COND": "B/10",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["ciprofloxacin"],
    "InteractionIndexLink": ["ciprofloxacine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "13 K 254",
    "DCI": "CIPROFLOXACINE CHLORHYRATE MONOHYDRATE EXPRIME EN CIPROFLOXACINE",
    "NOM_COMMERCIALE": "CIPRO 750",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "750MG",
    "COND": "B/14",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["ciprofloxacin"],
    "InteractionIndexLink": ["ciprofloxacine"],
    "N_ENREGISTREMENT": "447/ 13 K 254 /13",
    "CODE_DCI": "13 K 254",
    "DCI": "CIPROFLOXACINE CHLORHYDRATE EXPRIME EN CIPROFLOXACINE",
    "NOM_COMMERCIALE": "CIPROFLOXACINE BEKER",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "750MG",
    "COND": "B/10",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "MEDICAMENT SOUMIS A PRESCRIPTION HOSPITALIERE",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEKER SARL (SARL LABORATOIRE BEKER ALGERIE)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/3/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "20/3/2013",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["ciprofloxacin"],
    "InteractionIndexLink": ["ciprofloxacine"],
    "N_ENREGISTREMENT": "352/ 13 K 254 /12 /18",
    "CODE_DCI": "13 K 254",
    "DCI": "CIPROFLOXACINE CHLORHYRATE MONOHYDRATE EXPRIME EN CIPROFLOXACINE",
    "NOM_COMMERCIALE": "QUINOX",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "750MG",
    "COND": "B/10",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "MEDICAMENT SOUMIS A PRESCRIPTION HOSPITALIERE",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/3/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "8/4/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "48 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["gemifloxacine"],
    "InteractionIndexLink": ["gemifloxacine"],
    "N_ENREGISTREMENT": "001/ 13 K 334 /09/16",
    "CODE_DCI": "13 K 334",
    "DCI": "GEMIFLOXACINE MESYLATE EXPRIME EN GEMIFLOXACINE",
    "NOM_COMMERCIALE": "FACTIVE",
    "FORME": "COMPRIME",
    "DOSAGE": "320MG",
    "COND": "B/05",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMACEUTICALS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/3/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "11/9/2016",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "48 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["gemifloxacine"],
    "InteractionIndexLink": ["gemifloxacine"],
    "N_ENREGISTREMENT": "352 / 13 K 334 /15",
    "CODE_DCI": "13 K 334",
    "DCI": "GEMIFLOXACINE MESYLATE EXPRIME EN GEMIFLOXACINE",
    "NOM_COMMERCIALE": "GEMIXINE",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "320MG",
    "COND": "B/10",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/4/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "29/4/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["ciprofloxacin"],
    "InteractionIndexLink": ["ciprofloxacine"],
    "N_ENREGISTREMENT": "352/ 13 K 467 /12/18",
    "CODE_DCI": "13 K 467",
    "DCI": "CIPROFLOXACINE CHLORHYRATE MONOHYDRATE EXPRIME EN CIPROFLOXACINE",
    "NOM_COMMERCIALE": "QUINOX LP",
    "FORME": "COMPRIME A LIBERATION PROLONGEE",
    "DOSAGE": "1G",
    "COND": "B/05",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "MEDICAMENT SOUMIS A PRESCRIPTION HOSPITALIERE",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "21/8/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "2/4/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["ofloxacin"],
    "InteractionIndexLink": ["levofloxacine"],
    "N_ENREGISTREMENT": "352/ 13 K 468 /18",
    "CODE_DCI": "13 K 468",
    "DCI": "Levofloxacine hemihydrate exprime en Levofloxacine",
    "NOM_COMMERCIALE": "LOXAMOX",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "750MG",
    "COND": "B/05",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SPA EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/8/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "1/8/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["ofloxacin"],
    "InteractionIndexLink": ["levofloxacine"],
    "N_ENREGISTREMENT": "055/ 13 K 468 /12",
    "CODE_DCI": "13 K 468",
    "DCI": "Levofloxacine hemihydrate exprime en Levofloxacine",
    "NOM_COMMERCIALE": "MATADOR 750",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "750MG",
    "COND": "B/05",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "DAR AL DAWA DEVELOPMENT & INVESTMENT Co Ltd",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/11/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "7/11/2012",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["sulfamethoxazole", "trimethoprim"],
    "InteractionIndexLink": ["sulfamethoxazole", "trimethoprime"],
    "N_ENREGISTREMENT": "503/ 13 M 090 /16",
    "CODE_DCI": "13 M 090",
    "DCI": "SULFAMETHOXAZOLE / TRIMETHOPRIME",
    "NOM_COMMERCIALE": "BACTISOL",
    "FORME": "SUSPENSION BUVABLE",
    "DOSAGE": "200MG/40MG/5ML",
    "COND": "BOITE DE 01 FLACON DE 100ML + CM DE 5ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "AFROPHARM SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/6/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "26/6/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["sulfamethoxazole", "trimethoprim"],
    "InteractionIndexLink": ["sulfamethoxazole", "trimethoprime"],
    "N_ENREGISTREMENT": "242/ 13 M 090 /05/20",
    "CODE_DCI": "13 M 090",
    "DCI": "SULFAMETHOXAZOLE / TRIMETHOPRIME",
    "NOM_COMMERCIALE": "COTRIM",
    "FORME": "SUSP.BUV.",
    "DOSAGE": "200MG/40MG/5ML",
    "COND": "F/100ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GROUPE SANTE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "5/6/2005",
    "DATE_D_ENREGISTREMENT_FINAL": "25/5/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["sulfamethoxazole", "trimethoprim"],
    "InteractionIndexLink": ["sulfamethoxazole", "trimethoprime"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "13 M 090",
    "DCI": "SULFAMETHOXAZOLE / TRIMETHOPRIME",
    "NOM_COMMERCIALE": "COTRIMOXAZOLE",
    "FORME": "SUSP.BUV.",
    "DOSAGE": "200MG/40MG/5ML",
    "COND": "FL/100ML",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["sulfamethoxazole", "trimethoprim"],
    "InteractionIndexLink": ["sulfamethoxazole", "trimethoprime"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "13 M 090",
    "DCI": "SULFAMETHOXAZOLE / TRIMETHOPRIME",
    "NOM_COMMERCIALE": "DIPRIM",
    "FORME": "SUSP. BUV.",
    "DOSAGE": "200MG/40MG/5ML",
    "COND": "B/1FL. DE 100ML+UN BOUCHON DOSEUR",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["sulfamethoxazole", "trimethoprim"],
    "InteractionIndexLink": ["sulfamethoxazole", "trimethoprime"],
    "N_ENREGISTREMENT": "538/ 13 M 091/18",
    "CODE_DCI": "13 M 091",
    "DCI": "SULFAMETHOXAZOLE / TRIMETHOPRIME",
    "NOM_COMMERCIALE": "C-ZOLE",
    "FORME": "SOL INJ POUR PERF IV",
    "DOSAGE": "80 MG/400MG ( 16MG/ML /80 MG/ML)",
    "COND": "B/10 AMP DE 5 ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SWISS PARENTERALS PVT.LTD.",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/3/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "7/3/2018",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 mois",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["sulfamethoxazole", "trimethoprim"],
    "InteractionIndexLink": ["sulfamethoxazole", "trimethoprime"],
    "N_ENREGISTREMENT": "039/13 M 092/99/18",
    "CODE_DCI": "13 M 092",
    "DCI": "SULFAMETHOXAZOLE / TRIMETHOPRIME",
    "NOM_COMMERCIALE": "COTRIMOXAL",
    "FORME": "COMPRIME",
    "DOSAGE": "400MG/80MG",
    "COND": "B/20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOPHAL SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/7/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "30/5/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["sulfamethoxazole", "trimethoprim"],
    "InteractionIndexLink": ["sulfamethoxazole", "trimethoprime"],
    "N_ENREGISTREMENT": "20/97/13 M092/003",
    "CODE_DCI": "13 M 092",
    "DCI": "SULFAMÉTHOXAZOLE / TRIMETHOPRIME",
    "NOM_COMMERCIALE": "PRIMAZOL",
    "FORME": "COMPRIME",
    "DOSAGE": "400MG/80MG",
    "COND": "B/20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SAIDAL GROUPE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "5/1/1997",
    "DATE_D_ENREGISTREMENT_FINAL": "29/9/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["sulfamethoxazole", "trimethoprim"],
    "InteractionIndexLink": ["sulfamethoxazole", "trimethoprime"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "13 M 092",
    "DCI": "SULFAMETHOXAZOLE/TRIMETHOPRIME",
    "NOM_COMMERCIALE": "PRIMAZOL",
    "FORME": "CPR",
    "DOSAGE": "480 MG",
    "COND": "BT/20",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["sulfamethoxazole", "trimethoprim"],
    "InteractionIndexLink": ["sulfamethoxazole", "trimethoprime"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "13 M 092",
    "DCI": "SULFAMETHOXAZOLE / TRIMETHOPRIME",
    "NOM_COMMERCIALE": "SULPRIM",
    "FORME": "COMP.",
    "DOSAGE": "400MG/80MG",
    "COND": "B/20",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["sulfamethoxazole", "trimethoprim"],
    "InteractionIndexLink": ["sulfamethoxazole", "trimethoprime"],
    "N_ENREGISTREMENT": "039/ 13 M 169 /12/18",
    "CODE_DCI": "13 M 169",
    "DCI": "SULFAMETHOXAZOLE / TRIMETHOPRIME",
    "NOM_COMMERCIALE": "COTRIMOXAL FORTE",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "800MG/160MG",
    "COND": "B/20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOCIETE PHARMACEUTIQUE ALGERIENNE (SOPHAL)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/1/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "5/6/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["ACIDE FUSIDIQUE"],
    "InteractionIndexLink": ["acide fusidique"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "13 N 179",
    "DCI": "Acide Fusidique",
    "NOM_COMMERCIALE": "ACFUSID",
    "FORME": "Comprimé",
    "DOSAGE": "250 mg",
    "COND": "Boite de 10",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["ACIDE FUSIDIQUE"],
    "InteractionIndexLink": ["acide fusidique"],
    "N_ENREGISTREMENT": "293/ 13 N 179 /18",
    "CODE_DCI": "13 N 179",
    "DCI": "ACIDE FUSIDIQUE",
    "NOM_COMMERCIALE": "FUCARE",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "250MG",
    "COND": "B/10",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOCARE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/12/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "24/12/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["sodium fusidate (fusidic acid)"],
    "InteractionIndexLink": ["acide fusidique"],
    "N_ENREGISTREMENT": "418/ 13 N 179 /21",
    "CODE_DCI": "13 N 179",
    "DCI": "Acide fusidique exprimé en Fusidate de sodium",
    "NOM_COMMERCIALE": "FUCIDE",
    "FORME": "Comprimé pelliculé",
    "DOSAGE": "250MG",
    "COND": "B/10",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NEOMEDIC / SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/2/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "4/2/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["sodium fusidate (fusidic acid)"],
    "InteractionIndexLink": ["acide fusidique"],
    "N_ENREGISTREMENT": "083/ 13 N 179 /99/16",
    "CODE_DCI": "13 N 179",
    "DCI": "ACIDE FUSIDIQUE OU FUSIDATE DE SODIUM SEL",
    "NOM_COMMERCIALE": "FUCIDINE",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "250MG",
    "COND": "B/10",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LEO",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/6/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "4/1/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["sodium fusidate (fusidic acid)"],
    "InteractionIndexLink": ["acide fusidique"],
    "N_ENREGISTREMENT": "20/13 N179/380",
    "CODE_DCI": "13 N 179",
    "DCI": "FUSIDATE DE SODIUM (acide fusidique)",
    "NOM_COMMERCIALE": "FUSIDAC",
    "FORME": "COMP PELL",
    "DOSAGE": "250MG",
    "COND": "B/10",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "laboratoires HUP.P PHARMA Sarl",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/8/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "9/8/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["ACIDE FUSIDIQUE"],
    "InteractionIndexLink": ["acide fusidique"],
    "N_ENREGISTREMENT": "065/13 N 180/18",
    "CODE_DCI": "13 N 180",
    "DCI": "ACIDE FUSIDIQUE",
    "NOM_COMMERCIALE": "FUCIDANE GL",
    "FORME": "SUSP BUV",
    "DOSAGE": "250MG/5ML",
    "COND": "FL/90ML + CUILLERE MESURE",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GENERICLAB SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/12/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "13/12/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["ACIDE FUSIDIQUE"],
    "InteractionIndexLink": ["acide fusidique"],
    "N_ENREGISTREMENT": "528/ 13 N 180 /19",
    "CODE_DCI": "13 N 180",
    "DCI": "ACIDE FUSIDIQUE",
    "NOM_COMMERCIALE": "FUCIMED",
    "FORME": "SUSP.BUV",
    "DOSAGE": "250MG/5ML",
    "COND": "FL/90ML + CUILLERE MESURE",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JANIS MED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/3/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "26/3/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["aciclovir"],
    "InteractionIndexLink": ["aciclovir"],
    "N_ENREGISTREMENT": "065/ 13 P 097 /15",
    "CODE_DCI": "13 P 097",
    "DCI": "ACICLOVIR",
    "NOM_COMMERCIALE": "ACICLOVIR GL",
    "FORME": "COMPRIME",
    "DOSAGE": "200MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL GENERIC LAB",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/11/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "10/11/2015",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "24 mois",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["aciclovir"],
    "InteractionIndexLink": ["aciclovir"],
    "N_ENREGISTREMENT": "190/ 13 P 097 /98/13",
    "CODE_DCI": "13 P 097",
    "DCI": "ACICLOVIR",
    "NOM_COMMERCIALE": "CLOVIR",
    "FORME": "COMPRIME",
    "DOSAGE": "200MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOCIETE SAOUDIENNE SPIMACO ALGERIE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/11/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "7/7/2013",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["aciclovir"],
    "InteractionIndexLink": ["aciclovir"],
    "N_ENREGISTREMENT": "035/13 P 097/17",
    "CODE_DCI": "13 P 097",
    "DCI": "ACICLOVIR",
    "NOM_COMMERCIALE": "CLOVIRAX",
    "FORME": "COMPRIME",
    "DOSAGE": "200MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMALLIANCE EURL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "21/6/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "21/6/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["aciclovir"],
    "InteractionIndexLink": ["aciclovir"],
    "N_ENREGISTREMENT": "149/ 13 P 097 /16",
    "CODE_DCI": "13 P 097",
    "DCI": "ACICLOVIR",
    "NOM_COMMERCIALE": "NOVACLOVIR",
    "FORME": "COMPRIME",
    "DOSAGE": "200MG",
    "COND": "B/25",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVAPHARM TRADING SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/6/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "26/6/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["aciclovir"],
    "InteractionIndexLink": ["aciclovir"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "13 P 097",
    "DCI": "aciclovir",
    "NOM_COMMERCIALE": "Novaclovir 200 mg comprimé",
    "FORME": "comprimé",
    "DOSAGE": "200 mg",
    "COND": "BOITE DE 20",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["aciclovir"],
    "InteractionIndexLink": ["aciclovir"],
    "N_ENREGISTREMENT": "450/ 13 P 098 /07/15",
    "CODE_DCI": "13 P 098",
    "DCI": "ACICLOVIR",
    "NOM_COMMERCIALE": "ACICLOVIR MYLAN",
    "FORME": "PDRE. SOL. INJ. IV",
    "DOSAGE": "250MG/FL. DE PDRE.",
    "COND": "B/05 FL. DE PDRE.",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MYLAN S.A.S",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/6/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "4/10/2015",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["lamivudine"],
    "InteractionIndexLink": ["lamivudine"],
    "N_ENREGISTREMENT": "524/13 P 236/19",
    "CODE_DCI": "13 P 236",
    "DCI": "LAMIVUDINE",
    "NOM_COMMERCIALE": "HEPTAVIR-150",
    "FORME": "COMP PELL SEC",
    "DOSAGE": "150MG",
    "COND": "BOITE DE 1 FL / 60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HETERO LABS LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/3/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "17/3/2019",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "48 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["lamivudine"],
    "InteractionIndexLink": ["lamivudine"],
    "N_ENREGISTREMENT": "450/13 P 236/17",
    "CODE_DCI": "13 P 236",
    "DCI": "LAMIVUDINE",
    "NOM_COMMERCIALE": "LAMIVUDINE MYLAN",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "150MG",
    "COND": "B/60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MYLAN LABORATOIRES LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/10/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "24/10/2017",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["lamivudine"],
    "InteractionIndexLink": ["lamivudine"],
    "N_ENREGISTREMENT": "182/ 13 P 237 /03/17",
    "CODE_DCI": "13 P 237",
    "DCI": "LAMIVUDINE",
    "NOM_COMMERCIALE": "LAMIVIR",
    "FORME": "SOL. BUV.",
    "DOSAGE": "10MG/ML",
    "COND": "FL/100ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CIPLA LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/7/2003",
    "DATE_D_ENREGISTREMENT_FINAL": "14/6/2017",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["zidovudine"],
    "InteractionIndexLink": ["zidovudine"],
    "N_ENREGISTREMENT": "524 / 13 P 274 /17",
    "CODE_DCI": "13 P 274",
    "DCI": "ZIDOVUDINE",
    "NOM_COMMERCIALE": "ZIDONE OS",
    "FORME": "SOL BUV",
    "DOSAGE": "10MG/ML (50MG/5ML)",
    "COND": "B/1FL 240 ML + SERINGUE DOSEUSE DE 10 ML + PIPETTE DOSEUSE DE 1.5 ML",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "M/S HETERO LABS LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/12/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "4/12/2017",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["lamivudine", "zidovudine"],
    "InteractionIndexLink": ["lamivudine", "zidovudine"],
    "N_ENREGISTREMENT": "182/ 13 P 277 /05/17",
    "CODE_DCI": "13 P 277",
    "DCI": "Lamivudine/Zidovudine",
    "NOM_COMMERCIALE": "DUOVIR",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "150MG/300MG",
    "COND": "B/60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CIPLA LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/9/2005",
    "DATE_D_ENREGISTREMENT_FINAL": "23/7/2017",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["lamivudine", "zidovudine"],
    "InteractionIndexLink": ["lamivudine", "zidovudine"],
    "N_ENREGISTREMENT": "508/ 13 P 277 /19",
    "CODE_DCI": "13 P 277",
    "DCI": "Lamivudine/Zidovudine",
    "NOM_COMMERCIALE": "LAMIHOPEZ",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "150MG/300MG",
    "COND": "B/60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MACLEODS PHARMACEUTICALS LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/1/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "13/1/2019",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["lamivudine", "zidovudine"],
    "InteractionIndexLink": ["lamivudine", "zidovudine"],
    "N_ENREGISTREMENT": "524/13 P 277/20",
    "CODE_DCI": "13 P 277",
    "DCI": "LAMIVUDINE/ ZIDOVUDINE",
    "NOM_COMMERCIALE": "ZIDOLAM",
    "FORME": "COMP. PELL. SEC",
    "DOSAGE": "150MG/ 300MG",
    "COND": "B/ 1 FLC DE 60",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HETERO LABS LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDIA",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/8/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "26/8/2020",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "48 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["nevirapine"],
    "InteractionIndexLink": ["nevirapine"],
    "N_ENREGISTREMENT": "524 / 13 P 278 /19",
    "CODE_DCI": "13 P 278",
    "DCI": "Nevirapine",
    "NOM_COMMERCIALE": "NEVIVIR",
    "FORME": "COMPRIME",
    "DOSAGE": "200 MG",
    "COND": "B/1FL DE 60",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HETERO LABS LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/3/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "17/3/2019",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["ribavirin"],
    "InteractionIndexLink": ["ribavirine"],
    "N_ENREGISTREMENT": "024/ 13 P 281 /12",
    "CODE_DCI": "13 P 281",
    "DCI": "RIBAVIRINE",
    "NOM_COMMERCIALE": "REBETOL",
    "FORME": "GLES.",
    "DOSAGE": "200MG",
    "COND": "B/84 - B/140 - B/168",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MERCK SHARP & DOHME LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ROYAUME UNI",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/8/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "26/8/2012",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["ribavirin"],
    "InteractionIndexLink": ["ribavirine"],
    "N_ENREGISTREMENT": "447/13 P 281/17",
    "CODE_DCI": "13 P 281",
    "DCI": "RIBAVIRINE",
    "NOM_COMMERCIALE": "RIBAVIRINE BEKER",
    "FORME": "GLES.",
    "DOSAGE": "200MG",
    "COND": "B/170",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL BEKER",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/3/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "12/3/2017",
    "TYPE": "Gé",
    "STATUT": "C",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["efavirenz"],
    "InteractionIndexLink": ["efavirenz"],
    "N_ENREGISTREMENT": "182/ 13 P 287 /13",
    "CODE_DCI": "13 P 287",
    "DCI": "EFAVIRENZ",
    "NOM_COMMERCIALE": "EFAVIR-600",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "600MG",
    "COND": "PILULIER DE 30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CIPLA LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/1/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "20/1/2013",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["efavirenz"],
    "InteractionIndexLink": ["efavirenz"],
    "N_ENREGISTREMENT": "524/13 P 287/20",
    "CODE_DCI": "13 P 287",
    "DCI": "EFAVIRENZ",
    "NOM_COMMERCIALE": "HEVAZ 600",
    "FORME": "COMP. PELL",
    "DOSAGE": "600MG",
    "COND": "B/ 1 PILULIER DE 30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HETERO LABS LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDIA",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/8/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "13/8/2020",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "48 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["zidovudine"],
    "InteractionIndexLink": ["zidovudine"],
    "N_ENREGISTREMENT": "508/ 13 P 288 /16",
    "CODE_DCI": "13 P 288",
    "DCI": "ZIDOVUDINE",
    "NOM_COMMERCIALE": "ZIDOHOPE 300",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "300 MG",
    "COND": "PILLULIER DE 60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MACLEODS PHARMACEUTICALS LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/3/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "13/3/2016",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36  MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["zidovudine"],
    "InteractionIndexLink": ["zidovudine"],
    "N_ENREGISTREMENT": "524/13 P 288/20",
    "CODE_DCI": "13 P 288",
    "DCI": "ZIDOVUDINE",
    "NOM_COMMERCIALE": "ZIDONE",
    "FORME": "COMP. PELL",
    "DOSAGE": "300MG",
    "COND": "B/ 1 FLC DE 60",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HETERO LABS LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDIA",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/8/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "27/8/2020",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "48 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["oseltamivir"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "352/ 13 P 290 /14",
    "CODE_DCI": "13 P 290",
    "DCI": "OSELTAMIVIR PHOSPHATE EXPRIME EN OSELTAMIVIR",
    "NOM_COMMERCIALE": "VIROZEL",
    "FORME": "GLES",
    "DOSAGE": "75MG",
    "COND": "PILULIER/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/11/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "2/11/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["entecavir"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "017/ 13 P 313 /08/17",
    "CODE_DCI": "13 P 313",
    "DCI": "ENTECAVIR",
    "NOM_COMMERCIALE": "BARACLUDE",
    "FORME": "COMPRIME",
    "DOSAGE": "0.5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BRISTOL MYERS SQUIBB COMPANY",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ETATS UNIS D'AMERIQUE",
    "DATE_D_ENREGISTREMENT_INITIAL": "31/5/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "23/7/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["entecavir"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "426/ 13 P 313 /19",
    "CODE_DCI": "13 P 313",
    "DCI": "ENTECAVIR",
    "NOM_COMMERCIALE": "BRAVIR",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "0.5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ABDI IBRAHIM REMEDE PHARMA SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/4/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "24/4/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["entecavir"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "216/ 13 P 313 /16",
    "CODE_DCI": "13 P 313",
    "DCI": "ENTECAVIR",
    "NOM_COMMERCIALE": "ERTIVIX",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "0.5 MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "RANBAXY (MALAYSIA) SDN.BHD",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MALAISIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/6/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "26/6/2016",
    "TYPE": "Gé",
    "STATUT": "i",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["entecavir"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "017/ 13 P 314 /08/17",
    "CODE_DCI": "13 P 314",
    "DCI": "ENTECAVIR",
    "NOM_COMMERCIALE": "BARACLUDE",
    "FORME": "COMPRIME",
    "DOSAGE": "1MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BRISTOL MYERS SQUIBB COMPANY",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ETATS UNIS D'AMERIQUE",
    "DATE_D_ENREGISTREMENT_INITIAL": "31/5/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "23/7/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["entecavir"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "216/  13 P 314 /16",
    "CODE_DCI": "13 P 314",
    "DCI": "ENTECAVIR",
    "NOM_COMMERCIALE": "ERTIVIX",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "1MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "RANBAXY (MALAYSIA) SDN.BHD",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MALAISIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/6/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "26/6/2016",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["boceprevir"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "024/ 13 P 472 /15",
    "CODE_DCI": "13 P 472",
    "DCI": "BOCEPREVIR",
    "NOM_COMMERCIALE": "VICTRELIS",
    "FORME": "GELULE",
    "DOSAGE": "200 MG",
    "COND": "B/336",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MSD LTD",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "UNITED KINGDOM",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/12/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "13/12/2015",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["sofosbuvir"],
    "InteractionIndexLink": ["sofosbuvir"],
    "N_ENREGISTREMENT": "352/ 13 P  475/18",
    "CODE_DCI": "13 P 475",
    "DCI": "SOFOSBUVIR",
    "NOM_COMMERCIALE": "NAPIVIR",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "400MG",
    "COND": "B/28",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SPA EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/3/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "13/3/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["sofosbuvir"],
    "InteractionIndexLink": ["sofosbuvir"],
    "N_ENREGISTREMENT": "447/ 13 P  475/15",
    "CODE_DCI": "13 P 475",
    "DCI": "SOFOSBUVIR",
    "NOM_COMMERCIALE": "SOFOS",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "400MG",
    "COND": "B/28",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL BEKER",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/11/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "19/11/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 Mois",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["sofosbuvir"],
    "InteractionIndexLink": ["sofosbuvir"],
    "N_ENREGISTREMENT": "268/13 P 475/19",
    "CODE_DCI": "13 P 475",
    "DCI": "SOFOSBUVIR",
    "NOM_COMMERCIALE": "SOFOSBUVIR MERINAL",
    "FORME": "COMP PELL",
    "DOSAGE": "400MG",
    "COND": "B/28",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MERINAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["ledipasvir", "sofosbuvir"],
    "InteractionIndexLink": ["sofosbuvir"],
    "N_ENREGISTREMENT": "20/13 P476/352",
    "CODE_DCI": "13 P 476",
    "DCI": "SOFOSBUVIR/ LEDIPASVIR ACÉTONE EXPRIMÉ EN LEDIPASVIR",
    "NOM_COMMERCIALE": "HEPAVONI",
    "FORME": "COM PELL BICOUCHE",
    "DOSAGE": "400MG/ 90MG",
    "COND": "FL/ 28",
    "LISTE": "LISTE II",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES EL KENDI INDUSTRIE DU MÉDICAMENT SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/9/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "29/9/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["ledipasvir", "sofosbuvir"],
    "InteractionIndexLink": ["sofosbuvir"],
    "N_ENREGISTREMENT": "447/ 13 P 476 /16",
    "CODE_DCI": "13 P 476",
    "DCI": "SOFOSBUVIR/LEDIPASVIR",
    "NOM_COMMERCIALE": "SOFOSLED",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "400MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL LABORATOIRE BEKER ALGERIE)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/4/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "17/4/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["valaciclovir"],
    "InteractionIndexLink": ["valaciclovir"],
    "N_ENREGISTREMENT": "330/ 13 P 479/17",
    "CODE_DCI": "13 P 479",
    "DCI": "VALACICLOVIR CHLORHYDRATE",
    "NOM_COMMERCIALE": "RANCLOVIR",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "500 MG",
    "COND": "B/10",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SUN PHARMACEUTICAL INDUSTRIES LTD",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/2/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "27/2/2017",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["daclatasvir", "sofosbuvir"],
    "InteractionIndexLink": ["sofosbuvir"],
    "N_ENREGISTREMENT": "477/13 P 479/17",
    "CODE_DCI": "13 P 479",
    "DCI": "SOFOSBUVIR/ DACLATASVIR DICHLORHYDRATE EXPRIME EN DACLATASVIR",
    "NOM_COMMERCIALE": "SOFOSDAC",
    "FORME": "COMP. PELL.",
    "DOSAGE": "400MG/ 60MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL LABORATOIRES BEKER",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/11/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "30/11/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["raltegravir"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "024/13 P 480/17",
    "CODE_DCI": "13 P 480",
    "DCI": "RALTEGRAVIR",
    "NOM_COMMERCIALE": "ISENTRESS",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "400 MG",
    "COND": "B/ 01 FL DE 60",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MERCK SHARP DOHME LTD",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ROYAUME UNI",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/5/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "19/5/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "30 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["emtricitabine", "tenofovir disoproxil fumarate"],
    "InteractionIndexLink": ["tenofovir disoproxil"],
    "N_ENREGISTREMENT": "524/13 P 481/17",
    "CODE_DCI": "13 P 481",
    "DCI": "EMTRICITABINE /TENOFOVIR DISPROXIL FUMARATE",
    "NOM_COMMERCIALE": "TENOF EM",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "200 MG/300MG ( equivalent à 245 mg de tenofovir disoproxil)",
    "COND": "FL  DE 30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HETERO LABS LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/3/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "20/3/2017",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["tenofovir disoproxil fumarate"],
    "InteractionIndexLink": ["tenofovir disoproxil"],
    "N_ENREGISTREMENT": "524/13 P 483/17",
    "CODE_DCI": "13 P 483",
    "DCI": "TENOFOVIR DISOPROXIL FUMARATE",
    "NOM_COMMERCIALE": "TENOF",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "300 MG",
    "COND": "FL HDPE DE 30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HETERO LABS LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/3/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "20/3/2017",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["ritonavir"],
    "InteractionIndexLink": ["ritonavir"],
    "N_ENREGISTREMENT": "524/13 P 484/17",
    "CODE_DCI": "13 P 484",
    "DCI": "RITONAVIR",
    "NOM_COMMERCIALE": "RITNA",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "100 MG",
    "COND": "B/01 FL DE 30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HETERO LABS LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/3/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "19/3/2017",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["daclatasvir"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "447/13 P 486/17",
    "CODE_DCI": "13 P 486",
    "DCI": "DACLATASVIR  DICHLORHYDRATE",
    "NOM_COMMERCIALE": "DACLA",
    "FORME": "COMP PELL SEC",
    "DOSAGE": "60 MG",
    "COND": "B/28",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL BEKER",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/9/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "10/9/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["abacavir"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "524/ 13 P 490/19",
    "CODE_DCI": "13 P 490",
    "DCI": "Abacavir sulfate experime en abacavir",
    "NOM_COMMERCIALE": "ABAVIR OS",
    "FORME": "SOL BUV",
    "DOSAGE": "20 MG/ML",
    "COND": "B/1  FL DE 240 ML ET SEREINGUE FRADUEE DE 10 ML",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HETERO LABS LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/6/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "26/6/2019",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["abacavir"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "524/ 13 P 491/19",
    "CODE_DCI": "13 P 491",
    "DCI": "Abacavir sulfate experime en abacavir",
    "NOM_COMMERCIALE": "ABAVIR",
    "FORME": "CP PELL",
    "DOSAGE": "300 MG",
    "COND": "B/1  PILULIER DE 60",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HETERO LABS LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/6/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "26/6/2019",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["darunavir"],
    "InteractionIndexLink": ["darunavir"],
    "N_ENREGISTREMENT": "524/13 P 494/20",
    "CODE_DCI": "13 P 494",
    "DCI": "DARUNAVIR",
    "NOM_COMMERCIALE": "DANAVIR",
    "FORME": "COMP. PELL",
    "DOSAGE": "600MG",
    "COND": "B/60",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HETERO LABS LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDIA",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/12/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "7/12/2020",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["darunavir"],
    "InteractionIndexLink": ["darunavir"],
    "N_ENREGISTREMENT": "095/13 P 494/19",
    "CODE_DCI": "13 P 494",
    "DCI": "DARUNAVIR ETHANOLATE EXPRIME EN DARUNAVIR",
    "NOM_COMMERCIALE": "PREZISTA",
    "FORME": "COMP PELL",
    "DOSAGE": "600MG",
    "COND": "B/01 PILULIER DE 60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JANSSEN CILAG INTERNATIONAL N.V",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "Belgique",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/7/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "28/7/2019",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["valganciclovir"],
    "InteractionIndexLink": ["valganciclovir"],
    "N_ENREGISTREMENT": "330 / 13 P 495/ 19",
    "CODE_DCI": "13 P 495",
    "DCI": "Valganciclovir chlorhydrate exprime en Valganciclovir",
    "NOM_COMMERCIALE": "RANCYTE",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "450 MG",
    "COND": "B / 01 FL DE 60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SUN PHARMACEUTICAL INDUSTRIES LTD",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "16/6/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "16/6/2019",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["valganciclovir"],
    "InteractionIndexLink": ["valganciclovir"],
    "N_ENREGISTREMENT": "1/13 P 495/536",
    "CODE_DCI": "13 P 495",
    "DCI": "VALGANCICLOVIR CHLORHYDRATE EXPRIME EN VALGANCICLOVIR",
    "NOM_COMMERCIALE": "VALGANCICLOVIR TABLETS USP",
    "FORME": "COMP PELL",
    "DOSAGE": "450MG",
    "COND": "B/ 01 FL DE 60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "Dr.REDDY's LABORATORIES LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDIA",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/04/21",
    "DATE_D_ENREGISTREMENT_FINAL": "26/04/21",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["darunavir"],
    "InteractionIndexLink": ["darunavir"],
    "N_ENREGISTREMENT": "095/13 P 497/19",
    "CODE_DCI": "13 P 497",
    "DCI": "DARUNAVIR ETHANOLATE EXPRIME EN DARUNAVIR",
    "NOM_COMMERCIALE": "PREZISTA",
    "FORME": "SUSP BUV",
    "DOSAGE": "100MG/ML",
    "COND": "B/01 FL 200ML+PIPETTE DOSEUSE GRADUEE EN ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JANSSEN CILAG INTERNATIONAL N.V",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "Belgique",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/7/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "28/7/2019",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["sofosbuvir", "velpatasvir"],
    "InteractionIndexLink": ["sofosbuvir", "velpatasvir"],
    "N_ENREGISTREMENT": "447/13 P 500/19",
    "CODE_DCI": "13 P 500",
    "DCI": "SOFOSBUVIR/VELPATASVIR",
    "NOM_COMMERCIALE": "SOVELBEK",
    "FORME": "COMP PELL",
    "DOSAGE": "400MG/100MG",
    "COND": "B/28",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEKER SARL (SARL LABORATOIRE BEKER ALGERIE)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/12/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "18/12/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [
      "emtricitabine",

      "efavirenz",
      "tenofovir disoproxil fumarate"
    ],
    "InteractionIndexLink": ["efavirenz", "tenofovir disoproxil"],
    "N_ENREGISTREMENT": "20/13 P501/524",
    "CODE_DCI": "13 P 501",
    "DCI": "EFAVIRENZ / EMTRICITABINE/ TÉNOFOVIR DISOPROXIL FUMARATE",
    "NOM_COMMERCIALE": "EFTEM",
    "FORME": "COMP PELL",
    "DOSAGE": "600MG / 200MG / 300 MG",
    "COND": "COMP PELL",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LES LABORATOIRES HETERO LABS LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDIA",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/8/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "26/8/2020",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [
      "emtricitabine",

      "efavirenz",
      "tenofovir disoproxil fumarate"
    ],
    "InteractionIndexLink": ["efavirenz", "tenofovir disoproxil"],
    "N_ENREGISTREMENT": "524/13 P 501/20",
    "CODE_DCI": "13 P 501",
    "DCI": "EFAVIRENZ/ EMTRICITABINE/ TENOFOVIR DISOPROXIL FUMARATE",
    "NOM_COMMERCIALE": "EFTEM",
    "FORME": "COMP. PELL",
    "DOSAGE": "600MG/ 200MG/ 300MG",
    "COND": "B/ 1 FLC DE 30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HETERO LABS LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDIA",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/8/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "26/8/2020",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["amphotericin B (liposomal)"],
    "InteractionIndexLink": ["amphotericine b"],
    "N_ENREGISTREMENT": "017/ 13 R 105 /99/16",
    "CODE_DCI": "13 R 105",
    "DCI": "AMPHOTERICINE B",
    "NOM_COMMERCIALE": "FUNGIZONE",
    "FORME": "PDRE.SOL.INJ.IV",
    "DOSAGE": "50MG",
    "COND": "B/01",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BRISTOL MYERS SQUIBB",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/2/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "5/3/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["amphotericin B (liposomal)"],
    "InteractionIndexLink": ["amphotericine b"],
    "N_ENREGISTREMENT": "017/ 13 R 106 /96/15",
    "CODE_DCI": "13 R 106",
    "DCI": "AMPHOTERICINE B",
    "NOM_COMMERCIALE": "FUNGIZONE",
    "FORME": "SUSP.BUV.",
    "DOSAGE": "10% (10G/100ML)",
    "COND": "FL/40ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BRISTOL MYERS SQUIBB",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/9/1996",
    "DATE_D_ENREGISTREMENT_FINAL": "25/1/2015",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["amphotericin B (liposomal)"],
    "InteractionIndexLink": ["amphotericine b"],
    "N_ENREGISTREMENT": "304/ 13 R 106 /21",
    "CODE_DCI": "13 R 106",
    "DCI": "Amphotéricine B",
    "NOM_COMMERCIALE": "MYTRICINE",
    "FORME": "Solution buvable",
    "DOSAGE": "10% (10G/100ML)",
    "COND": "FL/40ML",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GEOPHARM / SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "23/2/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "23/2/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["amphotericin B (liposomal)"],
    "InteractionIndexLink": ["amphotericine b"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "13 R 106",
    "DCI": "AMPHOTERICINE",
    "NOM_COMMERCIALE": "MYTRICINE",
    "FORME": "SOL BUV",
    "DOSAGE": "0.1",
    "COND": "flacon de 40 m",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["fluconazole"],
    "InteractionIndexLink": ["fluconazole"],
    "N_ENREGISTREMENT": "001/ 13 R 107 /97/16",
    "CODE_DCI": "13 R 107",
    "DCI": "FLUCONAZOLE",
    "NOM_COMMERCIALE": "FLUCAND",
    "FORME": "SOL.INJ.IV.",
    "DOSAGE": "2MG/ML (OU 200MG/100ML)",
    "COND": "FL/100 ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMACEUTICALS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/12/1997",
    "DATE_D_ENREGISTREMENT_FINAL": "2/2/2016",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["fluconazole"],
    "InteractionIndexLink": ["fluconazole"],
    "N_ENREGISTREMENT": "433/13 R 107/19",
    "CODE_DCI": "13 R 107",
    "DCI": "FLUCONAZOLE",
    "NOM_COMMERCIALE": "FLUMIKOZ",
    "FORME": "SOL P/PERF I/V",
    "DOSAGE": "200MG/100ML",
    "COND": "FL/100ML",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRATER RAZES",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/12/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "19/12/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["fluconazole"],
    "InteractionIndexLink": ["fluconazole"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "13 R 108",
    "DCI": "FLUCONAZOLE",
    "NOM_COMMERCIALE": "VIRCET",
    "FORME": "GLES.",
    "DOSAGE": "100MG",
    "COND": "B/07",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["griseofulvin"],
    "InteractionIndexLink": ["griseofulvine"],
    "N_ENREGISTREMENT": "003/ 13 R 110 /96/13",
    "CODE_DCI": "13 R 110",
    "DCI": "GRISEOFULVINE",
    "NOM_COMMERCIALE": "FONGENAL",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "250MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SAIDAL (SAIDALGROUPE INDUSTRIEL EPE/SPA)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/12/1996",
    "DATE_D_ENREGISTREMENT_FINAL": "27/10/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["fluconazole"],
    "InteractionIndexLink": ["fluconazole"],
    "N_ENREGISTREMENT": "268/ 13 R 155 /06/13",
    "CODE_DCI": "13 R 155",
    "DCI": "FLUCONAZOLE",
    "NOM_COMMERCIALE": "AMIKOZ 50",
    "FORME": "GLES.",
    "DOSAGE": "50MG",
    "COND": "B/03 ET B/07",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MERINAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "5/4/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "2/4/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["fluconazole"],
    "InteractionIndexLink": ["fluconazole"],
    "N_ENREGISTREMENT": "242/13 R 155/19",
    "CODE_DCI": "13 R 155",
    "DCI": "FLUCONAZOLE",
    "NOM_COMMERCIALE": "CANDIFLU",
    "FORME": "GLES",
    "DOSAGE": "50MG",
    "COND": "B/10",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GROUPE SANTE SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/7/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "17/7/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["fluconazole"],
    "InteractionIndexLink": ["fluconazole"],
    "N_ENREGISTREMENT": "286/ 13 R 155 /04/14",
    "CODE_DCI": "13 R 155",
    "DCI": "FLUCONAZOLE",
    "NOM_COMMERCIALE": "DIFLU-Gé",
    "FORME": "GLES",
    "DOSAGE": "50MG",
    "COND": "B/03",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CHIMIE PHARMACIE COMMERCE MULTIPLE (CPCM) SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/11/2004",
    "DATE_D_ENREGISTREMENT_FINAL": "8/6/2014",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["fluconazole"],
    "InteractionIndexLink": ["fluconazole"],
    "N_ENREGISTREMENT": "293/ 13 R 155 /09/17",
    "CODE_DCI": "13 R 155",
    "DCI": "FLUCONAZOLE",
    "NOM_COMMERCIALE": "DIFLUCARE",
    "FORME": "GLES.",
    "DOSAGE": "50MG",
    "COND": "B/03",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOCARE SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/4/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "2/5/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["fluconazole"],
    "InteractionIndexLink": ["fluconazole"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "13 R 155",
    "DCI": "FLUCONAZOLE",
    "NOM_COMMERCIALE": "FLUCAND",
    "FORME": "GLES.",
    "DOSAGE": "50MG",
    "COND": "B/03 ET B/07",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["fluconazole"],
    "InteractionIndexLink": ["fluconazole"],
    "N_ENREGISTREMENT": "318/ 13 R 155 /15",
    "CODE_DCI": "13 R 155",
    "DCI": "FLUCONAZOLE",
    "NOM_COMMERCIALE": "FLUCAZOL",
    "FORME": "GLES.",
    "DOSAGE": "50MG",
    "COND": "B/7",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMIDAL N.S. SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/12/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "2/12/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["fluconazole"],
    "InteractionIndexLink": ["fluconazole"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "13 R 155",
    "DCI": "FLUCONAZOLE",
    "NOM_COMMERCIALE": "FLUCAZOLE",
    "FORME": "GLES.",
    "DOSAGE": "150MG",
    "COND": "B/4",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["fluconazole"],
    "InteractionIndexLink": ["fluconazole"],
    "N_ENREGISTREMENT": "418/ 13 R 155 /13",
    "CODE_DCI": "13 R 155",
    "DCI": "FLUCONAZOLE",
    "NOM_COMMERCIALE": "FLUCONALE",
    "FORME": "GLES.",
    "DOSAGE": "50MG",
    "COND": "B/03 ET B/07",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NEOMEDIC SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/1/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "13/1/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["fluconazole"],
    "InteractionIndexLink": ["fluconazole"],
    "N_ENREGISTREMENT": "462/ 13 R 155/ 21",
    "CODE_DCI": "13 R 155",
    "DCI": "Fluconazole",
    "NOM_COMMERCIALE": "FLUCONAZOLE  PHYSIOPHARM",
    "FORME": "Gélule",
    "DOSAGE": "50MG",
    "COND": "B/03",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHYSIOPHARM / SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/2/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "17/2/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["fluconazole"],
    "InteractionIndexLink": ["fluconazole"],
    "N_ENREGISTREMENT": "195/ 13 R 155/ 13",
    "CODE_DCI": "13 R 155",
    "DCI": "FLUCONAZOLE",
    "NOM_COMMERCIALE": "FLUCONAZOLE IVAL",
    "FORME": "GLES",
    "DOSAGE": "50MG",
    "COND": "B/03",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMA IVAL SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/11/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "19/11/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["fluconazole"],
    "InteractionIndexLink": ["fluconazole"],
    "N_ENREGISTREMENT": "521/ 13 R 155/ 13",
    "CODE_DCI": "13 R 155",
    "DCI": "FLUCONAZOLE",
    "NOM_COMMERCIALE": "FLUCONAZOLE IVAL",
    "FORME": "GLES",
    "DOSAGE": "50MG",
    "COND": "B/03",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "WORLD MEDECINE LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/11/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "19/11/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["fluconazole"],
    "InteractionIndexLink": ["fluconazole"],
    "N_ENREGISTREMENT": "309/ 13 R 155 /14",
    "CODE_DCI": "13 R 155",
    "DCI": "FLUCONAZOLE",
    "NOM_COMMERCIALE": "FLUCONAZOLE LDM",
    "FORME": "GELULE",
    "DOSAGE": "50MG",
    "COND": "B/03",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES DE DIAGNOSTIC MAGHREBINS (LDM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/3/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "19/3/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["fluconazole"],
    "InteractionIndexLink": ["fluconazole"],
    "N_ENREGISTREMENT": "045/ 13 R 155 /98/15",
    "CODE_DCI": "13 R 155",
    "DCI": "FLUCONAZOLE",
    "NOM_COMMERCIALE": "FLUCONAZOLE PFIZER",
    "FORME": "GLES.",
    "DOSAGE": "50MG",
    "COND": "B/03",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PFIZER PHARM ALGERIE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/11/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "31/3/2015",
    "TYPE": "Ré",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["fluconazole"],
    "InteractionIndexLink": ["fluconazole"],
    "N_ENREGISTREMENT": "21/13/ R155/361",
    "CODE_DCI": "13 R 155",
    "DCI": "FLUCONAZOLE",
    "NOM_COMMERCIALE": "FLUGIC",
    "FORME": "GELULE",
    "DOSAGE": "50MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES SARL/ BIOHDER GROUP",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "05/04/21",
    "DATE_D_ENREGISTREMENT_FINAL": "05/04/21",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["fluconazole"],
    "InteractionIndexLink": ["fluconazole"],
    "N_ENREGISTREMENT": "317/ 13 R 155 /16",
    "CODE_DCI": "13 R 155",
    "DCI": "FLUCONAZOLE",
    "NOM_COMMERCIALE": "FLUKAS",
    "FORME": "GLES",
    "DOSAGE": "50MG",
    "COND": "B/10",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INPHA MEDIS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/9/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "27/9/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["fluconazole"],
    "InteractionIndexLink": ["fluconazole"],
    "N_ENREGISTREMENT": "352/13 R 155/20",
    "CODE_DCI": "13 R 155",
    "DCI": "FLUCONAZOLE",
    "NOM_COMMERCIALE": "LOMAZEL",
    "FORME": "GELULE",
    "DOSAGE": "50MG",
    "COND": "B/ 03",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SPA/ EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "16/12/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "16/12/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["fluconazole"],
    "InteractionIndexLink": ["fluconazole"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "13 R 155",
    "DCI": "FLUCONAZOLE",
    "NOM_COMMERCIALE": "MYCOFLUCON",
    "FORME": "GLES.",
    "DOSAGE": "50MG",
    "COND": "B/03",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["fluconazole"],
    "InteractionIndexLink": ["fluconazole"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "13 R 155",
    "DCI": "FLUCONAZOLE",
    "NOM_COMMERCIALE": "MYCOZAN",
    "FORME": "GLES.",
    "DOSAGE": "50MG",
    "COND": "B/03",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["fluconazole"],
    "InteractionIndexLink": ["fluconazole"],
    "N_ENREGISTREMENT": "518/ 13 R 155 /18",
    "CODE_DCI": "13 R 155",
    "DCI": "Fluconazole",
    "NOM_COMMERCIALE": "MYKODAN",
    "FORME": "GLES",
    "DOSAGE": "50MG",
    "COND": "B/10",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "TASSILI ARAB PHARMACEUTICAL COMPANY / SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/4/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "30/4/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["fluconazole"],
    "InteractionIndexLink": ["fluconazole"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "13 R 155",
    "DCI": "FLUCONAZOLE",
    "NOM_COMMERCIALE": "VEFLAT",
    "FORME": "GLES.",
    "DOSAGE": "50MG",
    "COND": "B/03",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["fluconazole"],
    "InteractionIndexLink": ["fluconazole"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "13 R 155",
    "DCI": "FLUCONAZOLE",
    "NOM_COMMERCIALE": "VIRCET",
    "FORME": "GLES.",
    "DOSAGE": "50MG",
    "COND": "B/07",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["fluconazole"],
    "InteractionIndexLink": ["fluconazole"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "13 R 170",
    "DCI": "FLUCONAZOLE",
    "NOM_COMMERCIALE": "VIRCET",
    "FORME": "GLES.",
    "DOSAGE": "200MG",
    "COND": "B/07",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["terbinafine"],
    "InteractionIndexLink": ["terbinafine"],
    "N_ENREGISTREMENT": "549/ 13 R 172 /19",
    "CODE_DCI": "13 R 172",
    "DCI": "TERBINAFINE CHLORHYDRATE EXPRIME EN TERBINAFINE",
    "NOM_COMMERCIALE": "EVOMISIL",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "250MG",
    "COND": "B/20",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EVOLAB SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "21/1/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "21/1/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["terbinafine"],
    "InteractionIndexLink": ["terbinafine"],
    "N_ENREGISTREMENT": "549/ 13 R 172 /19",
    "CODE_DCI": "13 R 172",
    "DCI": "TERBINAFINE CHLORHYDRATE EXPRIME EN TERBINAFINE",
    "NOM_COMMERCIALE": "EVOMISIL",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "250MG",
    "COND": "B/20",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL/EVOLAB",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "21/1/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "21/1/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["terbinafine"],
    "InteractionIndexLink": ["terbinafine"],
    "N_ENREGISTREMENT": "003/ 13 R 172 /07/20",
    "CODE_DCI": "13 R 172",
    "DCI": "Chlorhydrate de Terbinafine exprimé en Terbinafine",
    "NOM_COMMERCIALE": "LAMIDAZ",
    "FORME": "Comprimé pelliculé",
    "DOSAGE": "250MG",
    "COND": "B/20",
    "LISTE": "LISTE II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EPE GROUPE INDUSTRIEL SAIDAL /  SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/3/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "15/2/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["terbinafine"],
    "InteractionIndexLink": ["terbinafine"],
    "N_ENREGISTREMENT": "177/ 13 R 172 /07/12",
    "CODE_DCI": "13 R 172",
    "DCI": "TERBINAFINE CHLORHYDRATE EXPRIME EN TERBINAFINE",
    "NOM_COMMERCIALE": "LAMINOX",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "250MG",
    "COND": "B/14",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ABDI IBRAHIM ILAÇ SANAYI VE TICARET A.Ş",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "TURQUIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/5/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "5/12/2012",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["terbinafine"],
    "InteractionIndexLink": ["terbinafine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "13 R 172",
    "DCI": "Terbinafine Chlorhydrate",
    "NOM_COMMERCIALE": "TENASIL",
    "FORME": "Comprimé sécable",
    "DOSAGE": "250 mg",
    "COND": "B/14",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["terbinafine"],
    "InteractionIndexLink": ["terbinafine"],
    "N_ENREGISTREMENT": "035/ 13 R 172 /14",
    "CODE_DCI": "13 R 172",
    "DCI": "TERBINAFINE CHLORHYDRATE EXPRIME EN TERBINAFINE",
    "NOM_COMMERCIALE": "TERBIFINE",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "250MG",
    "COND": "B/10 ET B/20",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMALLIANCE EURL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/7/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "13/7/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["terbinafine"],
    "InteractionIndexLink": ["terbinafine"],
    "N_ENREGISTREMENT": "418/ 13 R 172 /15",
    "CODE_DCI": "13 R 172",
    "DCI": "TERBINAFINE CHLORHYDRATE EXPRIME EN TERBINAFINE",
    "NOM_COMMERCIALE": "TERBIL",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "250MG",
    "COND": "B/10 ET B/20",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NEOMEDIC SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/5/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "24/5/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["terbinafine"],
    "InteractionIndexLink": ["terbinafine"],
    "N_ENREGISTREMENT": "447/13 R 172/16",
    "CODE_DCI": "13 R 172",
    "DCI": "TERBINAFINE CHLORHYDRATE EXPRIME EN TERBINAFINE",
    "NOM_COMMERCIALE": "TERBINAFINE BEKER",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "250MG",
    "COND": "B/20",
    "LISTE": "LISTE II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL BEKER",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/11/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "2/11/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["terbinafine"],
    "InteractionIndexLink": ["terbinafine"],
    "N_ENREGISTREMENT": "309/ 13 R 172 /08/15",
    "CODE_DCI": "13 R 172",
    "DCI": "TERBINAFINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "TERBINAFINE LDM",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "250MG",
    "COND": "B/14",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES DE DIAGNOSTIC MAGHREBINS (LDM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/5/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "6/9/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["terbinafine"],
    "InteractionIndexLink": ["terbinafine"],
    "N_ENREGISTREMENT": "263/ 13 R 172 /14",
    "CODE_DCI": "13 R 172",
    "DCI": "TERBINAFINE CHLORHYDRATE EXPRIME EN TERBINAFINE",
    "NOM_COMMERCIALE": "TERBINAN",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "250MG",
    "COND": "B/14",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOPHARM SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/4/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "15/4/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["terbinafine"],
    "InteractionIndexLink": ["terbinafine"],
    "N_ENREGISTREMENT": "149/ 13 R 172 /16",
    "CODE_DCI": "13 R 172",
    "DCI": "TERBINAFINE CHLORHYDRATE EXPRIME EN TERBINAFINE",
    "NOM_COMMERCIALE": "TERFINEX",
    "FORME": "COMPRIME",
    "DOSAGE": "250MG",
    "COND": "B/20",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVA PHARM TRADING SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/4/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "27/4/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["terbinafine"],
    "InteractionIndexLink": ["terbinafine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "13 R 172",
    "DCI": "terbinafine",
    "NOM_COMMERCIALE": "TERFINEX comp 250 mg",
    "FORME": "comp",
    "DOSAGE": "250 mg",
    "COND": "boite de 20",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["fluconazole"],
    "InteractionIndexLink": ["fluconazole"],
    "N_ENREGISTREMENT": "268/ 13 R 258 /06/13",
    "CODE_DCI": "13 R 258",
    "DCI": "FLUCONAZOLE",
    "NOM_COMMERCIALE": "AMIKOZ 150",
    "FORME": "GLES.",
    "DOSAGE": "150MG",
    "COND": "B/01",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MERINAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "8/7/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "2/4/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["fluconazole"],
    "InteractionIndexLink": ["fluconazole"],
    "N_ENREGISTREMENT": "418/ 13 R 258 /14",
    "CODE_DCI": "13 R 258",
    "DCI": "FLUCONAZOLE",
    "NOM_COMMERCIALE": "DIFLUCARE",
    "FORME": "GLES",
    "DOSAGE": "150MG",
    "COND": "B/01",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "23/9/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "23/9/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["fluconazole"],
    "InteractionIndexLink": ["fluconazole"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "13 R 258",
    "DCI": "FLUCONAZOLE",
    "NOM_COMMERCIALE": "FLUCAND",
    "FORME": "GLES.",
    "DOSAGE": "150MG",
    "COND": "B/01",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["fluconazole"],
    "InteractionIndexLink": ["fluconazole"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "13 R 258",
    "DCI": "FLUCONAZOLE",
    "NOM_COMMERCIALE": "FLUCONALE",
    "FORME": "GELULE",
    "DOSAGE": "150MG",
    "COND": "BOITE 01",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["fluconazole"],
    "InteractionIndexLink": ["fluconazole"],
    "N_ENREGISTREMENT": "462/ 13 R 258 /21",
    "CODE_DCI": "13 R 258",
    "DCI": "Fluconazole",
    "NOM_COMMERCIALE": "FLUCONAZOLE  PHYSIOPHARM",
    "FORME": "Gélule",
    "DOSAGE": "150MG",
    "COND": "B/01",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHYSIOPHARM / SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "5/4/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "5/4/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["fluconazole"],
    "InteractionIndexLink": ["fluconazole"],
    "N_ENREGISTREMENT": "293/ 13 R 258 /14",
    "CODE_DCI": "13 R 258",
    "DCI": "FLUCONAZOLE",
    "NOM_COMMERCIALE": "FLUCONAZOLE BIOCARE",
    "FORME": "GLES",
    "DOSAGE": "150MG",
    "COND": "B/01",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOCARE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/4/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "15/4/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["fluconazole"],
    "InteractionIndexLink": ["fluconazole"],
    "N_ENREGISTREMENT": "380/ 13 R 258 /14",
    "CODE_DCI": "13 R 258",
    "DCI": "FLUCONAZOLE",
    "NOM_COMMERCIALE": "FLUCONAZOLE HUP",
    "FORME": "GLES",
    "DOSAGE": "150MG",
    "COND": "B/01",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HUP.P.PHARMA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/7/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "13/7/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["fluconazole"],
    "InteractionIndexLink": ["fluconazole"],
    "N_ENREGISTREMENT": "195/ 13 R 258 /13",
    "CODE_DCI": "13 R 258",
    "DCI": "FLUCONAZOLE",
    "NOM_COMMERCIALE": "FLUCONAZOLE IVAL",
    "FORME": "GLES.",
    "DOSAGE": "150MG",
    "COND": "B/01",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMA IVAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "11/6/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "11/6/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["fluconazole"],
    "InteractionIndexLink": ["fluconazole"],
    "N_ENREGISTREMENT": "309/ 13 R 258 /07/14",
    "CODE_DCI": "13 R 258",
    "DCI": "FLUCONAZOLE",
    "NOM_COMMERCIALE": "FLUCONAZOLE LDM",
    "FORME": "GLES.",
    "DOSAGE": "150MG",
    "COND": "B/01",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES DE DIAGNOSTIC MAGHREBINS (LDM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/11/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "25/12/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["fluconazole"],
    "InteractionIndexLink": ["fluconazole"],
    "N_ENREGISTREMENT": "317/ 13 R 258 /12/17",
    "CODE_DCI": "13 R 258",
    "DCI": "FLUCONAZOLE",
    "NOM_COMMERCIALE": "FLUKAS",
    "FORME": "GLES.",
    "DOSAGE": "150MG",
    "COND": "B/01 ET B/04",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INPHA-MEDIS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/1/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "31/12/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["fluconazole"],
    "InteractionIndexLink": ["fluconazole"],
    "N_ENREGISTREMENT": "20/13 R 258/352",
    "CODE_DCI": "13 R 258",
    "DCI": "FLUCONAZOLE",
    "NOM_COMMERCIALE": "LOMAZEL",
    "FORME": "GELULE",
    "DOSAGE": "150MG",
    "COND": "B/01",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SPA EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "16/12/20",
    "DATE_D_ENREGISTREMENT_FINAL": "16/12/20",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["fluconazole"],
    "InteractionIndexLink": ["fluconazole"],
    "N_ENREGISTREMENT": "447/ 13 R 258 /11",
    "CODE_DCI": "13 R 258",
    "DCI": "FLUCONAZOLE",
    "NOM_COMMERCIALE": "MYCOZAN",
    "FORME": "GLES.",
    "DOSAGE": "150MG",
    "COND": "B/01",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEKER SARL (SARL LABORATOIRE BEKER ALGERIE)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/6/2011",
    "DATE_D_ENREGISTREMENT_FINAL": "19/6/2011",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["fluconazole"],
    "InteractionIndexLink": ["fluconazole"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "13 R 258",
    "DCI": "FLUCONAZOLE",
    "NOM_COMMERCIALE": "VEFLAT",
    "FORME": "GLES.",
    "DOSAGE": "150MG",
    "COND": "B/01",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["fluconazole"],
    "InteractionIndexLink": ["fluconazole"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "13 R 258",
    "DCI": "FLUCONAZOLE",
    "NOM_COMMERCIALE": "VIRCET",
    "FORME": "GLES.",
    "DOSAGE": "150MG",
    "COND": "B/01",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["caspofungin"],
    "InteractionIndexLink": ["caspofungine"],
    "N_ENREGISTREMENT": "176/13 R 284/17",
    "CODE_DCI": "13 R 284",
    "DCI": "CASPOFUNGINE ACETATE EXPRIME EN CASPOFUNGINE",
    "NOM_COMMERCIALE": "AFUNDAS-L",
    "FORME": "PDRE lyophilisée P. SOL. A DILUER P. PERF. IV",
    "DOSAGE": "50MG/FL. DE PDRE.",
    "COND": "B/1FL. DE PDRE.",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MUSTAFA NEVZAT ILAC SANAYI AS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "TURQUIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/4/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "12/4/2017",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["caspofungin"],
    "InteractionIndexLink": ["caspofungine"],
    "N_ENREGISTREMENT": "024/ 13 R 284 /06/18",
    "CODE_DCI": "13 R 284",
    "DCI": "CASPOFUNGINE ACETATE EXPRIME EN CASPOFUNGINE",
    "NOM_COMMERCIALE": "CANCIDAS",
    "FORME": "PDRE. P. SOL. A DILUER P. PERF. IV",
    "DOSAGE": "50MG/FL. DE PDRE.",
    "COND": "B/1FL. DE PDRE.",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MERCK SHARP & DOHME LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ROYAUME UNI",
    "DATE_D_ENREGISTREMENT_INITIAL": "23/7/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "2/7/2018",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["caspofungin"],
    "InteractionIndexLink": ["caspofungine"],
    "N_ENREGISTREMENT": "176/13 R 285/17",
    "CODE_DCI": "13 R 285",
    "DCI": "CASPOFUNGINE ACETATE EXPRIME EN CASPOFUNGINE",
    "NOM_COMMERCIALE": "AFUNDAS-L",
    "FORME": "PDRE lyophilisée P. SOL. A DILUER P. PERF. IV",
    "DOSAGE": "70MG/FL. DE PDRE.",
    "COND": "B/1FL. DE PDRE.",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MUSTAFA NEVZAT ILAC SANAYI AS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "TURQUIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/4/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "12/4/2017",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["caspofungin"],
    "InteractionIndexLink": ["caspofungine"],
    "N_ENREGISTREMENT": "024/ 13 R 285 /06/18",
    "CODE_DCI": "13 R 285",
    "DCI": "CASPOFUNGINE ACETATE EXPRIME EN CASPOFUNGINE",
    "NOM_COMMERCIALE": "CANCIDAS",
    "FORME": "PDRE. P. SOL. A DILUER P. PERF. IV",
    "DOSAGE": "70MG/FL. DE PDRE.",
    "COND": "B/1FL. DE PDRE.",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MERCK SHARP & DOHME LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ROYAUME UNI",
    "DATE_D_ENREGISTREMENT_INITIAL": "23/7/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "5/6/2018",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["voriconazole"],
    "InteractionIndexLink": ["voriconazole"],
    "N_ENREGISTREMENT": "045/ 13 R 337 /09/17",
    "CODE_DCI": "13 R 337",
    "DCI": "VORICONAZOLE",
    "NOM_COMMERCIALE": "VFEND",
    "FORME": "PDRE. SOL PERF.IV",
    "DOSAGE": "200MG/FL. DE PDRE. (OU 10MG/ML DE SOL. RECONSTITUEE)",
    "COND": "B/1FL. DE PDRE.",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PFIZER LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ROYAUME UNI",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/7/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "29/6/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["voriconazole"],
    "InteractionIndexLink": ["voriconazole"],
    "N_ENREGISTREMENT": "352/13 R 338/18",
    "CODE_DCI": "13 R 338",
    "DCI": "VORICONAZOLE",
    "NOM_COMMERCIALE": "VECANZOL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "200MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SPA EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "31/1/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "31/1/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["voriconazole"],
    "InteractionIndexLink": ["voriconazole"],
    "N_ENREGISTREMENT": "447/13 R 338/16",
    "CODE_DCI": "13 R 338",
    "DCI": "VORICONAZOLE",
    "NOM_COMMERCIALE": "VORICONAZOLE BEKER",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "200MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEKER SARL (SARL LABORATOIRE BEKER ALGERIE)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/12/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "20/12/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["voriconazole"],
    "InteractionIndexLink": ["voriconazole"],
    "N_ENREGISTREMENT": "352/13 R 443/18",
    "CODE_DCI": "13 R 443",
    "DCI": "VORICONAZOLE",
    "NOM_COMMERCIALE": "VECANZOL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "50MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SPA EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "31/1/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "31/1/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["voriconazole"],
    "InteractionIndexLink": ["voriconazole"],
    "N_ENREGISTREMENT": "045/ 13 R 443 /09/16",
    "CODE_DCI": "13 R 443",
    "DCI": "VORICONAZOLE",
    "NOM_COMMERCIALE": "VFEND",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "50MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PFIZER LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ROYAUME UNI",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/9/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "29/6/2016",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["voriconazole"],
    "InteractionIndexLink": ["voriconazole"],
    "N_ENREGISTREMENT": "447/13 R 443/16",
    "CODE_DCI": "13 R 443",
    "DCI": "VORICONAZOLE",
    "NOM_COMMERCIALE": "VORICONAZOLE BEKER",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "50MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEKER SARL (SARL LABORATOIRE BEKER ALGERIE)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/12/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "20/12/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["itraconazole"],
    "InteractionIndexLink": ["itraconazole"],
    "N_ENREGISTREMENT": "546/ 13 R 464 /21",
    "CODE_DCI": "13 R 464",
    "DCI": "Itraconazole",
    "NOM_COMMERCIALE": "ITRACONYX",
    "FORME": "Gélule",
    "DOSAGE": "100MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ONYX Industrie Pharmaceutique / SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/1/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "7/1/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["itraconazole"],
    "InteractionIndexLink": ["itraconazole"],
    "N_ENREGISTREMENT": "352/ 13 R 464 /14",
    "CODE_DCI": "13 R 464",
    "DCI": "ITRACONAZOLE",
    "NOM_COMMERCIALE": "ITRASPOR",
    "FORME": "GLES.",
    "DOSAGE": "100MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/11/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "30/11/2014",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["itraconazole"],
    "InteractionIndexLink": ["itraconazole"],
    "N_ENREGISTREMENT": "293/ 13 R 464 /12",
    "CODE_DCI": "13 R 464",
    "DCI": "ITRACONAZOLE",
    "NOM_COMMERCIALE": "ITRAZON",
    "FORME": "GLES.",
    "DOSAGE": "100MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOCARE SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/3/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "13/6/2016",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Infectiologie"]
  },
  {
    "PregnancyIndexLink": ["posaconazole"],
    "InteractionIndexLink": ["posaconazole"],
    "N_ENREGISTREMENT": "024/13 R 482/17",
    "CODE_DCI": "13 R 482",
    "DCI": "POSACONAZOLE",
    "NOM_COMMERCIALE": "NOXAFIL",
    "FORME": "SUSP BUV",
    "DOSAGE": "40MG/ML",
    "COND": "B/01 FL DE 105ML+UNE CUILLERE MESURE DE 2.5 ML ET 5 ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MERCK SHARP & DOHME LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ROYAUME UNI",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/6/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "29/6/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "345/13 U 503/20",
    "CODE_DCI": "13 U 503",
    "DCI": "Vaccin grippal quadrivalent  inactivé à virion fragmenté",
    "NOM_COMMERCIALE": "VAXIGRIP TETRA",
    "FORME": "Suspension injectable",
    "DOSAGE": "15µg d'hémagglutinine / souche",
    "COND": "B/1 SERINGUE PRE- REMPLIE DE  0.5ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANOFI PASTEUR S.A",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/10/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "2/5/2021",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "12MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["COVID-19 Vaccine - SARS-CoV-2 rS (NVX-CoV2373)"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "576/ 13 U 504 / 21",
    "CODE_DCI": "13 U 504",
    "DCI": "Vaccin pour la prévention du coronavirus COVID-19 (Nom international non exclusif)",
    "NOM_COMMERCIALE": "GAM-COVID-Vac combination vector vaccine to prevent coronaviral infection caused by SARS-CoV-2 virus",
    "FORME": "Solution injectable IM",
    "DOSAGE": "0.5ML/DOSE (composant I) et 0.5ML/DOSE (composant II)",
    "COND": "B/01 FL (composant I)/ B/01 FL (composant II) OU B/05 AMP. (composant I)/ B/05 AMP. (composant II)",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "Laboratoires FSBI N.F. Gamaleya RCEM of the Ministry of Health of Russia",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "RUSSIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/1/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "10/1/2021",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "06 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "298/ 13 V 451 /12",
    "CODE_DCI": "13 V 451",
    "DCI": "IMMUNOGLOBULINE HUMAINE NORMALE (Ig IV)",
    "NOM_COMMERCIALE": "KIOVIG",
    "FORME": "SOL. P. PERF. IV",
    "DOSAGE": "100MG/ML (2.5G/25ML- 5G/50ML - 10G/100ML)",
    "COND": "FL/25ML - FL/50ML - FL/100ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BAXTER AG",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "AUTRICHE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/12/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "10/12/2012",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "485/ 13 V 451 /14",
    "CODE_DCI": "13 V 451",
    "DCI": "IMMUNOGLOBULINE HUMAINE NORMALE 1G IV",
    "NOM_COMMERCIALE": "PRIVIGEN",
    "FORME": "SOL P/ PERF IV",
    "DOSAGE": "100MG/ML",
    "COND": "FL/25ML (2.5G)+FL/50ML (5G) ET FL/100ML (10G)",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CSL BEHRING AG",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SUISSE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/5/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "12/5/2014",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "370/ 13 V 471 /14",
    "CODE_DCI": "13 V 471",
    "DCI": "IMMUNOGLOBULINE HUMAINE NORMALE POLYVALENTE (Ig IV)",
    "NOM_COMMERCIALE": "INTRATECT",
    "FORME": "SOL. P. PERF. IV",
    "DOSAGE": "50MG/ML (2.5G/50ML OU 5G/100ML OU 10G/200ML)",
    "COND": "B/01 FL. MUNI D'UN BOUCHON ET D'UNE CAPSULE",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOTEST PHARMA GMBH",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALLEMAGNE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/12/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "30/12/2014",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "469/13 V 471/17",
    "CODE_DCI": "13 V 471",
    "DCI": "IMMUNOGLOBULINE HUMAINE NORMALE",
    "NOM_COMMERCIALE": "OCTAGAM",
    "FORME": "SOL. P. PERF. IV",
    "DOSAGE": "50MG/ML (2.5G/50ML OU 5G/100ML OU 10G/200ML)",
    "COND": "B/1 FL DE 50 ML ET B/ 1FL DE100 ML  ET B/ 1 FL DE 200 ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "OCTAPHARM PHARMAZEUTICA PRODUKTIONSGES.m.b.H",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "AUTRICHE",
    "DATE_D_ENREGISTREMENT_INITIAL": "31/5/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "31/5/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "513/ 13 V 471 /16",
    "CODE_DCI": "13 V 471",
    "DCI": "IMMUNOGLOBULINE HUMAINE NORMALE",
    "NOM_COMMERCIALE": "TELGENE",
    "FORME": "POUDRE + SOLVANT POUR PREPARATION INJ POUR PERFUSION",
    "DOSAGE": "50MG/ML",
    "COND": "FLACON DE POUDRE DE 5g ou de 10g et flacon de solvant de 100 ml ou 200 ml avec systéme d'un transfert muni d'un évent à filtre stérilisant",
    "LISTE": "LISTE  I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LFB BIOMEDICAMENTS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/6/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "22/6/2016",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "370/13 V 493/19",
    "CODE_DCI": "13 V 493",
    "DCI": "IMMUNOGLOBULINE HUMAINE DE L'HEPETITE B",
    "NOM_COMMERCIALE": "HEPATECT CP",
    "FORME": "SOL P/ PERF",
    "DOSAGE": "50UI/ML",
    "COND": "B/01 FL DE 2ML ET DE 100ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOTEST PHARMA GmbH",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "Allemagne",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/7/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "28/7/2019",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "370/13 V 498/19",
    "CODE_DCI": "13 V 498",
    "DCI": "IMMUNOGLOBULINE HUMAINE DE L'HEPETITE B",
    "NOM_COMMERCIALE": "FOVEPTA 200UI-UI",
    "FORME": "SOL INJ EN SERINGUE PRE-REMPLIE",
    "DOSAGE": "500UI/ML",
    "COND": "B/01 SERINGUE PRE-REMPLIE DE 0.4ML (200UI/0.4ML)",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOTEST PHARMA GmbH",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "Allemagne",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/7/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "28/7/2019",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "498/13 V 499/19",
    "CODE_DCI": "13 V 499",
    "DCI": "PALIVISUMAB",
    "NOM_COMMERCIALE": "SYNAGIS",
    "FORME": "SOL INJ",
    "DOSAGE": "100MG/ML",
    "COND": "B/01 FL DE SOL 1ML (100MG/ML) ET B/01FL DE SOL 0.5ML (50MG/0.5ML)",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ABBVIE DEUTCHLAND GMBH & CO.KG",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "Allemagne",
    "DATE_D_ENREGISTREMENT_INITIAL": "31/12/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "485 / 13 V 505 /20",
    "CODE_DCI": "13 V 505",
    "DCI": "Immunoglobuline humaine de l'hépatite B",
    "NOM_COMMERCIALE": "HEPATITIS B IMMUNOGLOBULIN P BEHRING",
    "FORME": "Solution injectable I.M en seringue pré-remplie",
    "DOSAGE": "200UI/ML",
    "COND": "B/1 seringue pré-remplie de 1ML",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CSL BEHRING GmbH",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALLEMAGNE",
    "DATE_D_ENREGISTREMENT_INITIAL": "16/8/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "16/8/2020",
    "TYPE": "",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "485 / 13 V 506 /20",
    "CODE_DCI": "13 V 506",
    "DCI": "Immunoglobuline humaine de l'hépatite B",
    "NOM_COMMERCIALE": "HEPATITIS B IMMUNOGLOBULIN P BEHRING",
    "FORME": "Solution injectable I.M en seringue pré-remplie",
    "DOSAGE": "1000UI/5ML",
    "COND": "B/1 seringue pré-remplie de 5ML",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CSL BEHRING GmbH",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALLEMAGNE",
    "DATE_D_ENREGISTREMENT_INITIAL": "16/8/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "16/8/2020",
    "TYPE": "",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["imipenem with cilastatin"],
    "InteractionIndexLink": ["imipenem"],
    "N_ENREGISTREMENT": "216/ 13 W 187 /10/16",
    "CODE_DCI": "13 W 187",
    "DCI": "IMIPENEM (SOUS FORME MONOHYDRATEE) / CILASTATINE (SOUS FORME SODIQUE)",
    "NOM_COMMERCIALE": "CILANEM",
    "FORME": "PDRE. SOL. INJ.",
    "DOSAGE": "500MG/500MG/FL. DE PDRE.",
    "COND": "B/1FL. DE PDRE.",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "RANBAXY LABORATORIES LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "8/2/2010",
    "DATE_D_ENREGISTREMENT_FINAL": "2/2/2016",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["imipenem with cilastatin"],
    "InteractionIndexLink": ["imipenem"],
    "N_ENREGISTREMENT": "039/ 13 W 187 /09/16",
    "CODE_DCI": "13 W 187",
    "DCI": "IMIPENEM (SOUS FORME MONOHYDRATEE) / CILASTATINEACIDE (SOUS FORME SODIQUE)",
    "NOM_COMMERCIALE": "IMECISTAL",
    "FORME": "PDRE. PERF. IV",
    "DOSAGE": "500MG!/500MG/FL. DE PDRE DE 20ML",
    "COND": "B/1FL. DE PDRE.",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOCIETE PHARMACEUTIQUE ALGERIENNE (SOPHAL)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "3/9/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "26/6/2016",
    "TYPE": "Gé",
    "STATUT": "C IIaire",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["imipenem with cilastatin"],
    "InteractionIndexLink": ["imipenem"],
    "N_ENREGISTREMENT": "039/ 13 W 187 /09/20",
    "CODE_DCI": "13 W 187",
    "DCI": "IMIPENEM (SOUS FORME MONOHYDRATEE) / CILASTATINEACIDE (SOUS FORME SODIQUE)",
    "NOM_COMMERCIALE": "IMECISTAL",
    "FORME": "PDRE. PERF. IV",
    "DOSAGE": "500MG!/500MG/FL. DE PDRE DE 20ML",
    "COND": "B/10FL. DE PDRE DE 10ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOCIETE PHARMACEUTIQUE ALGERIENNE (SOPHAL)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "03/09/09",
    "DATE_D_ENREGISTREMENT_FINAL": "09/08/20",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["imipenem with cilastatin"],
    "InteractionIndexLink": ["imipenem"],
    "N_ENREGISTREMENT": "556/ 13 W 187 /21",
    "CODE_DCI": "13 W 187",
    "DCI": "Imipénem monohydraté exprimé en Imipénem anhydre  / Cilastatine sodique exprimé en Cilastatine",
    "NOM_COMMERCIALE": "SAMIPENEM",
    "FORME": "Poudre pour solution  pour perfusion",
    "DOSAGE": "500MG/500MG /FL.",
    "COND": "B/1FL. DE PDRE. DE 20ML",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "IMGSA GROUPE Industrie Pharmaceutique / SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "3/3/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "3/3/2021",
    "TYPE": "Gé",
    "STATUT": "C",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["vancomycin"],
    "InteractionIndexLink": ["vancomycine"],
    "N_ENREGISTREMENT": "450/ 13 X 096 /07/16",
    "CODE_DCI": "13 X 096",
    "DCI": "VANCOMYCINE (SOUS FORME DE CHLORHYDRATE)",
    "NOM_COMMERCIALE": "VANCOMYCINE MYLAN",
    "FORME": "PDRE. SOL. PERF.",
    "DOSAGE": "500MG/FL DE PDRE.",
    "COND": "B/1FL.DE PDRE",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MYLAN",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "23/2/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "26/7/2016",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["teicoplanin"],
    "InteractionIndexLink": ["teicoplanine"],
    "N_ENREGISTREMENT": "376/ 13 X 339 /09/16",
    "CODE_DCI": "13 X 339",
    "DCI": "TEICOPLANINE",
    "NOM_COMMERCIALE": "TARGOCID",
    "FORME": "LYOPH. ET SOLV. P. USAGE PARENTERAL IM/IV",
    "DOSAGE": "200MG/FL.DE PDRE.",
    "COND": "B/01FL. DE PDRE. + 01AMP. DE 3.2ML DE SOLV. (EPPI)",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANOFI AVENTIS FRANCE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/12/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "31/1/2018",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["teicoplanin"],
    "InteractionIndexLink": ["teicoplanine"],
    "N_ENREGISTREMENT": "376/ 13 X 340 /09/16",
    "CODE_DCI": "13 X 340",
    "DCI": "TEICOPLANINE",
    "NOM_COMMERCIALE": "TARGOCID",
    "FORME": "LYOPH. ET SOLV. P. USAGE PARENTERAL IM/IV",
    "DOSAGE": "400MG/FL.DE PDRE.",
    "COND": "B/01FL. DE PDRE. + 01AMP. DE 3.2ML DE SOLV. (EPPI)",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANOFI AVENTIS FRANCE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/12/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "6/3/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["glimepiride"],
    "InteractionIndexLink": ["glimepiride"],
    "N_ENREGISTREMENT": "462/ 14 A 188 /16",
    "CODE_DCI": "14  A 188",
    "DCI": "GLIMEPIRIDE",
    "NOM_COMMERCIALE": "GLIMEPIRIDE PHYSIOPHARM",
    "FORME": "COMPRIME",
    "DOSAGE": "2MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL PHYSIOPHARM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "11/4/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "19/4/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "280/ 14 G 185 /15",
    "CODE_DCI": "14  G 185",
    "DCI": "EAU POUR PREPARATIONS INJECTABLES",
    "NOM_COMMERCIALE": "WIPACK",
    "FORME": "SOLUTION POUR DILUTION DE MéDICAMENT DESTINéS A ETRE INJECTéS EN IM /IV",
    "DOSAGE": "AMPOULE DE 5 ML",
    "COND": "B/50",
    "LISTE": "",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES INDUSTRIE MéDICO CHIRURGICALES SARL IMC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/12/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "2/12/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["glibenclamide"],
    "InteractionIndexLink": ["glibenclamide"],
    "N_ENREGISTREMENT": "20/01/14 A003/003",
    "CODE_DCI": "14 A 003",
    "DCI": "GLIBENCLAMIDE",
    "NOM_COMMERCIALE": "DIABENIL",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "5MG",
    "COND": "B/60 - B/100",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SAIDAL GROUPE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/6/2001",
    "DATE_D_ENREGISTREMENT_FINAL": "29/9/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36  MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["glibenclamide"],
    "InteractionIndexLink": ["glibenclamide"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "14 A 003",
    "DCI": "GLIBENCLAMIDE",
    "NOM_COMMERCIALE": "GLIBIL",
    "FORME": "COMPRIME",
    "DOSAGE": "5MG",
    "COND": "B/100",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["gliclazide"],
    "InteractionIndexLink": ["gliclazide"],
    "N_ENREGISTREMENT": "003/ 14 A 004 /97/17",
    "CODE_DCI": "14 A 004",
    "DCI": "GLICLAZIDE",
    "NOM_COMMERCIALE": "DIAPHAG",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "80MG",
    "COND": "B/60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EPE GROUPE INDUSTRIEL SAIDAL/SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/7/1997",
    "DATE_D_ENREGISTREMENT_FINAL": "2/7/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["metformin"],
    "InteractionIndexLink": ["metformine"],
    "N_ENREGISTREMENT": "235/ 14 A 006 /14",
    "CODE_DCI": "14 A 006",
    "DCI": "METFORMINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "DIABAMINE BGL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "500MG",
    "COND": "B/50",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIO-GALENIC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "31/3/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "31/3/2014",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["metformin"],
    "InteractionIndexLink": ["metformine"],
    "N_ENREGISTREMENT": "293/ 14 A 006 /16",
    "CODE_DCI": "14 A 006",
    "DCI": "METFORMINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "FORMENTIN",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "500MG",
    "COND": "B/30ETB/50ETB/100",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOCARE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/6/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "13/6/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["metformin"],
    "InteractionIndexLink": ["metformine"],
    "N_ENREGISTREMENT": "380/ 14 A 006 /14",
    "CODE_DCI": "14 A 006",
    "DCI": "METFORMINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "GLUCOFORMINE",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "500MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HUP.P.PHARMA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/4/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "15/4/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["metformin"],
    "InteractionIndexLink": ["metformine"],
    "N_ENREGISTREMENT": "400/14 A 006/16",
    "CODE_DCI": "14 A 006",
    "DCI": "METFORMINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "GLUCOMEX",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "500MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "KPMA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/12/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "4/12/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["metformin"],
    "InteractionIndexLink": ["metformine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "14 A 006",
    "DCI": "METFORMINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "NEXECOR",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "500MG",
    "COND": "B/28 - B/98",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["metformin"],
    "InteractionIndexLink": ["metformine"],
    "N_ENREGISTREMENT": "368/ 14 A 006 /07/13",
    "CODE_DCI": "14 A 006",
    "DCI": "METFORMINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "NOVOFORMINE",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "500MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALDAPH SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/9/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "8/11/2015",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "60 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["metformin"],
    "InteractionIndexLink": ["metformine"],
    "N_ENREGISTREMENT": "462/ 14 A 006 /13",
    "CODE_DCI": "14 A 006",
    "DCI": "METFORMINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "PHYSIOPHORMINE",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "500MG",
    "COND": "B/50",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHYSIOPHARM SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "3/11/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "3/11/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["metformin"],
    "InteractionIndexLink": ["metformine"],
    "N_ENREGISTREMENT": "235/ 14 A 007 /10/16",
    "CODE_DCI": "14 A 007",
    "DCI": "METFORMINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "DIABAMINE BGL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "850MG",
    "COND": "B/100",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIO-GALENIC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/11/2010",
    "DATE_D_ENREGISTREMENT_FINAL": "12/4/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["metformin"],
    "InteractionIndexLink": ["metformine"],
    "N_ENREGISTREMENT": "003/ 14 A 007 /05/16",
    "CODE_DCI": "14 A 007",
    "DCI": "METFORMINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "DIAGUANID",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "850MG",
    "COND": "B/30 ET B/90 ET B/120",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EPE  GROUPE INDUSTRIEL SAIDAL SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/2/2005",
    "DATE_D_ENREGISTREMENT_FINAL": "11/5/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["metformin"],
    "InteractionIndexLink": ["metformine"],
    "N_ENREGISTREMENT": "077/ 14 A 007 /16",
    "CODE_DCI": "14 A 007",
    "DCI": "METFORMINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "FARMIDOX",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "850MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE ALGERIEN DU MEDICAMENT SARL (LAM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/8/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "1/8/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["metformin"],
    "InteractionIndexLink": ["metformine"],
    "N_ENREGISTREMENT": "293/ 14 A 007 /07/16",
    "CODE_DCI": "14 A 007",
    "DCI": "METFORMINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "FORMENTIN",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "850MG",
    "COND": "B/30 ET B/100",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOCARE SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/9/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "18/1/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["metformin"],
    "InteractionIndexLink": ["metformine"],
    "N_ENREGISTREMENT": "380/ 14 A 007 /13",
    "CODE_DCI": "14 A 007",
    "DCI": "METFORMINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "GLUCOFORMINE",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "850MG",
    "COND": "B/30 ET B/100",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HUP.P.PHARMA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "31/10/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "31/10/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["metformin"],
    "InteractionIndexLink": ["metformine"],
    "N_ENREGISTREMENT": "400/14 A 007/16",
    "CODE_DCI": "14 A 007",
    "DCI": "METFORMINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "GLUCOMEX",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "850MG",
    "COND": "B/30ET B/90",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "KPMA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/12/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "4/12/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["metformin"],
    "InteractionIndexLink": ["metformine"],
    "N_ENREGISTREMENT": "468/ 14 A 007 /15",
    "CODE_DCI": "14 A 007",
    "DCI": "METFORMINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "GLUCONAD",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "850MG",
    "COND": "B/30 - B/60 - B/90 - B/120",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NADPHARMADIC PRODUCTION SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "3/3/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "3/3/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["metformin"],
    "InteractionIndexLink": ["metformine"],
    "N_ENREGISTREMENT": "062/ 14 A 007 /97/13",
    "CODE_DCI": "14 A 007",
    "DCI": "METFORMINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "GLUCOPHAGE 850",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "850MG",
    "COND": "B/100",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MERCK SANTE S.A.S",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/8/1997",
    "DATE_D_ENREGISTREMENT_FINAL": "10/12/2015",
    "TYPE": "Ré",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "60 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["metformin"],
    "InteractionIndexLink": ["metformine"],
    "N_ENREGISTREMENT": "490/ 14 A 007 /15",
    "CODE_DCI": "14 A 007",
    "DCI": "METFORMINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "GLUCOTAC",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "850MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMA SPHERE SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/1/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "18/1/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["metformin"],
    "InteractionIndexLink": ["metformine"],
    "N_ENREGISTREMENT": "352/ 14 A 007 /05",
    "CODE_DCI": "14 A 007",
    "DCI": "METFORMINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "METFOR 850",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "850MG",
    "COND": "B/60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/11/2005",
    "DATE_D_ENREGISTREMENT_FINAL": "29/11/2005",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["metformin"],
    "InteractionIndexLink": ["metformine"],
    "N_ENREGISTREMENT": "367/ 14 A 007 /99/15",
    "CODE_DCI": "14 A 007",
    "DCI": "METFORMINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "METFORAL",
    "FORME": "COMP. PELLI. SEC.",
    "DOSAGE": "850MG",
    "COND": "B/30 - B/90",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GUIDOTTI SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ITALIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/7/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "25/1/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "60 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["metformin"],
    "InteractionIndexLink": ["metformine"],
    "N_ENREGISTREMENT": "289/ 14 A 007 /07/16",
    "CODE_DCI": "14 A 007",
    "DCI": "METFORMINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "METOPHAGE",
    "FORME": "COMPRIME",
    "DOSAGE": "850MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRATERS RAZES FORME SECHE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/9/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "27/4/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["metformin"],
    "InteractionIndexLink": ["metformine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "14 A 007",
    "DCI": "METFORMINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "NEXECOR",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "850MG",
    "COND": "B/30 - B/90",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["metformin"],
    "InteractionIndexLink": ["metformine"],
    "N_ENREGISTREMENT": "368/ 14 A 007 /07/13",
    "CODE_DCI": "14 A 007",
    "DCI": "METFORMINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "NOVOFORMINE",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "850MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALDAPH SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/9/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "8/11/2015",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "60 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["metformin"],
    "InteractionIndexLink": ["metformine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "14 A 007",
    "DCI": "METFORMINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "PHYSIOPHORMINE",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "850MG",
    "COND": "B/30. B/90 ET B/120",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["metformin"],
    "InteractionIndexLink": ["metformine"],
    "N_ENREGISTREMENT": "062/ 14 A 008 /99/16",
    "CODE_DCI": "14 A 008",
    "DCI": "METFORMINE EMBONATE",
    "NOM_COMMERCIALE": "STAGID",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "700MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MERCK LIPHA SANTE S.A.S",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/5/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "4/2/2016",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["acarbose"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "289/14 A 136/16",
    "CODE_DCI": "14 A 136",
    "DCI": "ACARBOSE",
    "NOM_COMMERCIALE": "ACARLYSE",
    "FORME": "COMPRIME",
    "DOSAGE": "50MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRATERS RAZES FORME SECHE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/12/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "19/12/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["acarbose"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "418/14 A 136/16",
    "CODE_DCI": "14 A 136",
    "DCI": "ACARBOSE",
    "NOM_COMMERCIALE": "ACROBAY",
    "FORME": "COMPRIME",
    "DOSAGE": "50MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL NEOMEDIC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/10/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "19/10/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["acarbose"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "293/14 A 136/17",
    "CODE_DCI": "14 A 136",
    "DCI": "ACARBOSE",
    "NOM_COMMERCIALE": "ARBOSE",
    "FORME": "COMPRIME",
    "DOSAGE": "50MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOCARE SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/4/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "12/4/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["acarbose"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "263/14 A 136/16",
    "CODE_DCI": "14 A 136",
    "DCI": "ACARBOSE",
    "NOM_COMMERCIALE": "CORECT",
    "FORME": "COMPRIME",
    "DOSAGE": "50MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOPHARM SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/12/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "19/12/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["acarbose"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "235/14 A 136/19",
    "CODE_DCI": "14 A 136",
    "DCI": "ACARBOSE",
    "NOM_COMMERCIALE": "DIACARBOSE",
    "FORME": "COMPRIME",
    "DOSAGE": "50MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOGALENIC/SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/3/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "4/3/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["acarbose"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "231/ 14 A 136 /16",
    "CODE_DCI": "14 A 136",
    "DCI": "ACARBOSE",
    "NOM_COMMERCIALE": "GLUCAR",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "50MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE SALEM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/9/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "27/9/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["acarbose"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "149/ 14 A 136 /14",
    "CODE_DCI": "14 A 136",
    "DCI": "ACARBOSE",
    "NOM_COMMERCIALE": "GLUCONOVA",
    "FORME": "COMPRIME",
    "DOSAGE": "50MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVAPHARM TRADING SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/10/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "13/10/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["acarbose"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "14 A 136",
    "DCI": "acarbose",
    "NOM_COMMERCIALE": "GLUCONOVA 50 mg",
    "FORME": "comprimé",
    "DOSAGE": "50 mg",
    "COND": "BOITE DE 30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["acarbose"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "001/ 14 A 136 /14",
    "CODE_DCI": "14 A 136",
    "DCI": "ACARBOSE",
    "NOM_COMMERCIALE": "GLYACARB",
    "FORME": "COMPRIME",
    "DOSAGE": "50MG",
    "COND": "B/30 ET B/90",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMA ALGERIA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/12/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "30/12/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["acarbose"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "447/14 A 136/16",
    "CODE_DCI": "14 A 136",
    "DCI": "ACARBOSE",
    "NOM_COMMERCIALE": "GLYBEK",
    "FORME": "COMPRIME",
    "DOSAGE": "50MG",
    "COND": "B/30 ET B/90",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL LABORATOIRE BEKER",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/6/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "13/6/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["acarbose"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "035/ 14 A 136 /16",
    "CODE_DCI": "14 A 136",
    "DCI": "ACARBOSE",
    "NOM_COMMERCIALE": "LARIMEL",
    "FORME": "COMPRIME",
    "DOSAGE": "50MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMALLIANCE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/1/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "17/1/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["acarbose"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "14 A 136",
    "DCI": "Acarbose",
    "NOM_COMMERCIALE": "Larimel",
    "FORME": "Comprimé",
    "DOSAGE": "50  mg",
    "COND": "Boite 90",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["glimepiride"],
    "InteractionIndexLink": ["glimepiride"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "14 A 187",
    "DCI": "GLIMEPIRIDE",
    "NOM_COMMERCIALE": "AMAPIRIDE HUP",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "1MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["glimepiride"],
    "InteractionIndexLink": ["glimepiride"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "14 A 187",
    "DCI": "GLIMEPIRIDE",
    "NOM_COMMERCIALE": "AMAREL",
    "FORME": "COMPRIME",
    "DOSAGE": "1MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["glimepiride"],
    "InteractionIndexLink": ["glimepiride"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "14 A 187",
    "DCI": "GLIMEPIRIDE",
    "NOM_COMMERCIALE": "GLIMEPIRIDE BEKER",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "1MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["glimepiride"],
    "InteractionIndexLink": ["glimepiride"],
    "N_ENREGISTREMENT": "293/ 14 A 187 /07/12",
    "CODE_DCI": "14 A 187",
    "DCI": "GLIMEPIRIDE",
    "NOM_COMMERCIALE": "GLIMICARE",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "1MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOCARE SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/8/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "25/9/2012",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["glimepiride"],
    "InteractionIndexLink": ["glimepiride"],
    "N_ENREGISTREMENT": "492/ 14 A 187 /16",
    "CODE_DCI": "14 A 187",
    "DCI": "GLIMEPIRIDE",
    "NOM_COMMERCIALE": "GLODEC",
    "FORME": "COMPRIME",
    "DOSAGE": "1MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SPA SOPRODIM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/2/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "15/2/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["glimepiride"],
    "InteractionIndexLink": ["glimepiride"],
    "N_ENREGISTREMENT": "001/ 14 A 187 /07/16",
    "CODE_DCI": "14 A 187",
    "DCI": "GLIMEPIRIDE",
    "NOM_COMMERCIALE": "GLORION",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "1MG",
    "COND": "B/30 ET B/90",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMACEUTICALS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/7/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "27/9/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["glimepiride"],
    "InteractionIndexLink": ["glimepiride"],
    "N_ENREGISTREMENT": "447/ 14 A 187 /16",
    "CODE_DCI": "14 A 187",
    "DCI": "GLIMEPIRIDE",
    "NOM_COMMERCIALE": "GLUMEPIRIDE BEKER",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "1MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL LABORATOIRES BEKER",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/3/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "13/3/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["glimepiride"],
    "InteractionIndexLink": ["glimepiride"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "14 A 187",
    "DCI": "GLIMEPIRIDE",
    "NOM_COMMERCIALE": "IRYS 1MG",
    "FORME": "COMP. PELLI. SEC.",
    "DOSAGE": "1MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["glimepiride"],
    "InteractionIndexLink": ["glimepiride"],
    "N_ENREGISTREMENT": "003/ 14 A 187 /05/21",
    "CODE_DCI": "14 A 187",
    "DCI": "Glimépiride",
    "NOM_COMMERCIALE": "LAVIDA",
    "FORME": "Comprimé",
    "DOSAGE": "1MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EPE GROUPE INDUSTRIEL SAIDAL/SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/9/2005",
    "DATE_D_ENREGISTREMENT_FINAL": "17/2/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["glimepiride"],
    "InteractionIndexLink": ["glimepiride"],
    "N_ENREGISTREMENT": "352/ 14 A 187 /08/18",
    "CODE_DCI": "14 A 187",
    "DCI": "GLIMEPIRIDE",
    "NOM_COMMERCIALE": "PIRAMYL",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "1MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/5/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "22/4/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["glimepiride"],
    "InteractionIndexLink": ["glimepiride"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "14 A 187",
    "DCI": "GLIMEPIRIDE",
    "NOM_COMMERCIALE": "ROZEMIDE",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "1MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["glimepiride"],
    "InteractionIndexLink": ["glimepiride"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "14 A 188",
    "DCI": "GLIMEPIRIDE",
    "NOM_COMMERCIALE": "AMAPIRIDE HUP",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "2MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["glimepiride"],
    "InteractionIndexLink": ["glimepiride"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "14 A 188",
    "DCI": "GLIMEPIRIDE",
    "NOM_COMMERCIALE": "AMAREL",
    "FORME": "COMPRIME",
    "DOSAGE": "2MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["glimepiride"],
    "InteractionIndexLink": ["glimepiride"],
    "N_ENREGISTREMENT": "447/ 14 A 188 /13/18",
    "CODE_DCI": "14 A 188",
    "DCI": "GLIMEPIRIDE",
    "NOM_COMMERCIALE": "GLIMEPIRIDE BEKER",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "2MG",
    "COND": "B/30 ET B/90",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEKER SARL (SARL LABORATOIRE BEKER ALGERIE)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/5/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "4/6/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 mois",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["glimepiride"],
    "InteractionIndexLink": ["glimepiride"],
    "N_ENREGISTREMENT": "309/ 14 A 188 /13",
    "CODE_DCI": "14 A 188",
    "DCI": "GLIMEPIRIDE",
    "NOM_COMMERCIALE": "GLIMEPIRIDE LDM",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "2MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES  DE DIAGNOSTICS MAGHREBINS (LDM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "11/6/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "13/3/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["glimepiride"],
    "InteractionIndexLink": ["glimepiride"],
    "N_ENREGISTREMENT": "293/ 14 A 188 /07/13",
    "CODE_DCI": "14 A 188",
    "DCI": "GLIMEPIRIDE",
    "NOM_COMMERCIALE": "GLIMICARE",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "2MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOCARE SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/8/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "11/6/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["glimepiride"],
    "InteractionIndexLink": ["glimepiride"],
    "N_ENREGISTREMENT": "492/14 A 188/17",
    "CODE_DCI": "14 A 188",
    "DCI": "GLIMEPIRIDE",
    "NOM_COMMERCIALE": "GLODEC 2",
    "FORME": "COMPRIME",
    "DOSAGE": "2MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOPRODIM SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/2/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "12/2/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["glimepiride"],
    "InteractionIndexLink": ["glimepiride"],
    "N_ENREGISTREMENT": "001/ 14 A 188 /07/17",
    "CODE_DCI": "14 A 188",
    "DCI": "GLIMEPIRIDE",
    "NOM_COMMERCIALE": "GLORION",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "2MG",
    "COND": "B/30 ET B/90",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMACEUTICALS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "3/4/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "10/9/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["glimepiride"],
    "InteractionIndexLink": ["glimepiride"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "14 A 188",
    "DCI": "GLIMEPIRIDE",
    "NOM_COMMERCIALE": "IRYS 2MG",
    "FORME": "COMP. PELLI. SEC.",
    "DOSAGE": "2MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["glimepiride"],
    "InteractionIndexLink": ["glimepiride"],
    "N_ENREGISTREMENT": "20/05/14 A188/003",
    "CODE_DCI": "14 A 188",
    "DCI": "GLIMEPIRIDE",
    "NOM_COMMERCIALE": "LAVIDA",
    "FORME": "COMPRIMÉ SÉCABLE",
    "DOSAGE": "2MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SAIDAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/9/2005",
    "DATE_D_ENREGISTREMENT_FINAL": "4/5/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["glimepiride"],
    "InteractionIndexLink": ["glimepiride"],
    "N_ENREGISTREMENT": "352/ 14 A 188 /08/18",
    "CODE_DCI": "14 A 188",
    "DCI": "GLIMEPIRIDE",
    "NOM_COMMERCIALE": "PIRAMYL",
    "FORME": "COMPRIME",
    "DOSAGE": "2MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/5/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "22/4/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["glimepiride"],
    "InteractionIndexLink": ["glimepiride"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "14 A 188",
    "DCI": "GLIMEPIRIDE",
    "NOM_COMMERCIALE": "ROZEMIDE",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "2MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["glimepiride"],
    "InteractionIndexLink": ["glimepiride"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "14 A 189",
    "DCI": "GLIMEPIRIDE",
    "NOM_COMMERCIALE": "AMAPIRIDE HUP",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "3MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["glimepiride"],
    "InteractionIndexLink": ["glimepiride"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "14 A 189",
    "DCI": "GLIMEPIRIDE",
    "NOM_COMMERCIALE": "AMAREL",
    "FORME": "COMPRIME",
    "DOSAGE": "3MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["glimepiride"],
    "InteractionIndexLink": ["glimepiride"],
    "N_ENREGISTREMENT": "447/ 14 A 189 /13/18",
    "CODE_DCI": "14 A 189",
    "DCI": "GLIMEPIRIDE",
    "NOM_COMMERCIALE": "GLIMEPIRIDE BEKER",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "3MG",
    "COND": "B/30 ET B/90",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEKER SARL (SARL LABORATOIRE BEKER ALGERIE)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/7/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "18/7/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["glimepiride"],
    "InteractionIndexLink": ["glimepiride"],
    "N_ENREGISTREMENT": "309/14 A 189/17",
    "CODE_DCI": "14 A 189",
    "DCI": "GLIMEPIRIDE",
    "NOM_COMMERCIALE": "GLIMEPIRIDE LDM",
    "FORME": "COMPRIME",
    "DOSAGE": "3MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LDM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/1/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "9/1/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["glimepiride"],
    "InteractionIndexLink": ["glimepiride"],
    "N_ENREGISTREMENT": "293/ 14 A 189 /07/13",
    "CODE_DCI": "14 A 189",
    "DCI": "GLIMEPIRIDE",
    "NOM_COMMERCIALE": "GLIMICARE",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "3MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOCARE SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/8/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "29/5/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["glimepiride"],
    "InteractionIndexLink": ["glimepiride"],
    "N_ENREGISTREMENT": "492/14 A 189/17",
    "CODE_DCI": "14 A 189",
    "DCI": "GLIMEPIRIDE",
    "NOM_COMMERCIALE": "GLODEC 3",
    "FORME": "COMPRIME",
    "DOSAGE": "3MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOPRODIM SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/2/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "7/2/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["glimepiride"],
    "InteractionIndexLink": ["glimepiride"],
    "N_ENREGISTREMENT": "001/ 14 A 189 /07/16",
    "CODE_DCI": "14 A 189",
    "DCI": "GLIMEPIRIDE",
    "NOM_COMMERCIALE": "GLORION",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "3MG",
    "COND": "B/30 ET B/90",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMACEUTICALS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/7/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "6/10/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["glimepiride"],
    "InteractionIndexLink": ["glimepiride"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "14 A 189",
    "DCI": "GLIMEPIRIDE",
    "NOM_COMMERCIALE": "IRYS 3MG",
    "FORME": "COMP. PELLI. SEC.",
    "DOSAGE": "3MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["glimepiride"],
    "InteractionIndexLink": ["glimepiride"],
    "N_ENREGISTREMENT": "20/05/14 A189/003",
    "CODE_DCI": "14 A 189",
    "DCI": "GLIMEPIRIDE",
    "NOM_COMMERCIALE": "LAVIDA",
    "FORME": "COMPRIMÉ SÉCABLE",
    "DOSAGE": "3MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SAIDAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/9/2005",
    "DATE_D_ENREGISTREMENT_FINAL": "31/5/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["glimepiride"],
    "InteractionIndexLink": ["glimepiride"],
    "N_ENREGISTREMENT": "352/ 14 A 189 /08/18",
    "CODE_DCI": "14 A 189",
    "DCI": "GLIMEPIRIDE",
    "NOM_COMMERCIALE": "PIRAMYL",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "3MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/5/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "27/4/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["glimepiride"],
    "InteractionIndexLink": ["glimepiride"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "14 A 189",
    "DCI": "GLIMEPIRIDE",
    "NOM_COMMERCIALE": "ROZEMIDE",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "3MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["glimepiride"],
    "InteractionIndexLink": ["glimepiride"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "14 A 190",
    "DCI": "GLIMEPIRIDE",
    "NOM_COMMERCIALE": "AMAPIRIDE HUP",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "4MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["glimepiride"],
    "InteractionIndexLink": ["glimepiride"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "14 A 190",
    "DCI": "GLIMEPIRIDE",
    "NOM_COMMERCIALE": "AMAREL",
    "FORME": "COMPRIME",
    "DOSAGE": "4MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["glimepiride"],
    "InteractionIndexLink": ["glimepiride"],
    "N_ENREGISTREMENT": "447/ 14 A 190 /13/18",
    "CODE_DCI": "14 A 190",
    "DCI": "GLIMEPIRIDE",
    "NOM_COMMERCIALE": "GLIMEPIRIDE BEKER",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "4MG",
    "COND": "B/30 ET B/90",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEKER SARL (SARL LABORATOIRE BEKER ALGERIE)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/7/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "30/7/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["glimepiride"],
    "InteractionIndexLink": ["glimepiride"],
    "N_ENREGISTREMENT": "462/ 14 A 190 /16",
    "CODE_DCI": "14 A 190",
    "DCI": "GLIMEPIRIDE",
    "NOM_COMMERCIALE": "GLIMEPIRIDE PHYSIOPHARM",
    "FORME": "COMPRIME",
    "DOSAGE": "4MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL PHYSIOPHARM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/4/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "19/4/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["glimepiride"],
    "InteractionIndexLink": ["glimepiride"],
    "N_ENREGISTREMENT": "293/ 14 A 190 /07/12",
    "CODE_DCI": "14 A 190",
    "DCI": "GLIMEPIRIDE",
    "NOM_COMMERCIALE": "GLIMICARE",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "4MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOCARE LABORATOIRES SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/8/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "25/9/2012",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["glimepiride"],
    "InteractionIndexLink": ["glimepiride"],
    "N_ENREGISTREMENT": "492/14 A 190/17",
    "CODE_DCI": "14 A 190",
    "DCI": "GLIMEPIRIDE",
    "NOM_COMMERCIALE": "GLODEC",
    "FORME": "COMPRIME",
    "DOSAGE": "4MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOPRODIM SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/2/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "12/2/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["glimepiride"],
    "InteractionIndexLink": ["glimepiride"],
    "N_ENREGISTREMENT": "001/ 14 A 190 /07/16",
    "CODE_DCI": "14 A 190",
    "DCI": "GLIMEPIRIDE",
    "NOM_COMMERCIALE": "GLORION",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "4MG",
    "COND": "B/30 ET B/90",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMACEUTICALS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "3/4/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "6/10/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["glimepiride"],
    "InteractionIndexLink": ["glimepiride"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "14 A 190",
    "DCI": "GLIMEPIRIDE",
    "NOM_COMMERCIALE": "IRYS 4MG",
    "FORME": "COMP. PELLI. SEC.",
    "DOSAGE": "4MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["glimepiride"],
    "InteractionIndexLink": ["glimepiride"],
    "N_ENREGISTREMENT": "20/05/14 A190/003",
    "CODE_DCI": "14 A 190",
    "DCI": "GLIMEPIRIDE",
    "NOM_COMMERCIALE": "LAVIDA",
    "FORME": "COMPRIMÉ SÉCABLE",
    "DOSAGE": "4MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SAIDAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/9/2005",
    "DATE_D_ENREGISTREMENT_FINAL": "26/9/2005",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["glimepiride"],
    "InteractionIndexLink": ["glimepiride"],
    "N_ENREGISTREMENT": "352/ 14 A 190 /08/19",
    "CODE_DCI": "14 A 190",
    "DCI": "GLIMEPIRIDE",
    "NOM_COMMERCIALE": "PIRAMYL",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "4MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI PHARMACEUTICALS MANUFACTURING COMPANY",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/7/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "14/2/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["glimepiride"],
    "InteractionIndexLink": ["glimepiride"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "14 A 190",
    "DCI": "Glimépiride",
    "NOM_COMMERCIALE": "Rozemide",
    "FORME": "Comprimé sécable",
    "DOSAGE": "4 mg",
    "COND": "Boite 30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["repaglinide"],
    "InteractionIndexLink": ["repaglinide"],
    "N_ENREGISTREMENT": "263/ 14 A 200 /18",
    "CODE_DCI": "14 A 200",
    "DCI": "Répaglinide",
    "NOM_COMMERCIALE": "BIONORM",
    "FORME": "COMPRIME",
    "DOSAGE": "0.5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOPHARM SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/4/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "30/4/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["repaglinide"],
    "InteractionIndexLink": ["repaglinide"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "14 A 200",
    "DCI": "REPAGLINIDE",
    "NOM_COMMERCIALE": "DIABENORM",
    "FORME": "CPR",
    "DOSAGE": "0.5 MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["repaglinide"],
    "InteractionIndexLink": ["repaglinide"],
    "N_ENREGISTREMENT": "293/ 14 A 200 /14",
    "CODE_DCI": "14 A 200",
    "DCI": "Répaglinide",
    "NOM_COMMERCIALE": "DIAGLINIDE",
    "FORME": "COMPRIME",
    "DOSAGE": "0.5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOCARE LABORATOIRES SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/9/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "1/9/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["repaglinide"],
    "InteractionIndexLink": ["repaglinide"],
    "N_ENREGISTREMENT": "001/ 14 A 200 /14/20",
    "CODE_DCI": "14 A 200",
    "DCI": "Répaglinide",
    "NOM_COMMERCIALE": "GLINIX",
    "FORME": "Comprimé",
    "DOSAGE": "0.5MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMA ALGERIA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/9/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "18/6/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "60MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["repaglinide"],
    "InteractionIndexLink": ["repaglinide"],
    "N_ENREGISTREMENT": "317/ 14 A 200 /15",
    "CODE_DCI": "14 A 200",
    "DCI": "Répaglinide",
    "NOM_COMMERCIALE": "GLYCENORM",
    "FORME": "COMPRIME",
    "DOSAGE": "0.5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INPHA MEDIS SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/10/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "26/10/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["repaglinide"],
    "InteractionIndexLink": ["repaglinide"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "14 A 200",
    "DCI": "Repaglinide",
    "NOM_COMMERCIALE": "Glycenorm 0.5mg",
    "FORME": "comp",
    "DOSAGE": "0.5mg/comp",
    "COND": "bt de 30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["repaglinide"],
    "InteractionIndexLink": ["repaglinide"],
    "N_ENREGISTREMENT": "447/14 A 200/17",
    "CODE_DCI": "14 A 200",
    "DCI": "Répaglinide",
    "NOM_COMMERCIALE": "REPAGLINIDE BEKER",
    "FORME": "COMPRIME",
    "DOSAGE": "0.5MG",
    "COND": "B/30 ET B/90",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEKER SARL (SARL LABORATOIRE BEKER ALGERIE)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/1/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "29/1/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["repaglinide"],
    "InteractionIndexLink": ["repaglinide"],
    "N_ENREGISTREMENT": "149/14 A 200/17",
    "CODE_DCI": "14 A 200",
    "DCI": "Répaglinide",
    "NOM_COMMERCIALE": "SUCRONORME",
    "FORME": "COMPRIME",
    "DOSAGE": "0.5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVAPHARM TRADING",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/5/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "2/5/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["repaglinide"],
    "InteractionIndexLink": ["repaglinide"],
    "N_ENREGISTREMENT": "263/ 14 A 201 /18",
    "CODE_DCI": "14 A 201",
    "DCI": "Répaglinide",
    "NOM_COMMERCIALE": "BIONORM",
    "FORME": "COMPRIME",
    "DOSAGE": "1MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOPHARM SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/4/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "30/4/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["repaglinide"],
    "InteractionIndexLink": ["repaglinide"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "14 A 201",
    "DCI": "REPAGLINIDE",
    "NOM_COMMERCIALE": "DIABENORM",
    "FORME": "CPR",
    "DOSAGE": "1 MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["repaglinide"],
    "InteractionIndexLink": ["repaglinide"],
    "N_ENREGISTREMENT": "293/ 14 A 201 /14",
    "CODE_DCI": "14 A 201",
    "DCI": "Répaglinide",
    "NOM_COMMERCIALE": "DIAGLINIDE",
    "FORME": "COMPRIME",
    "DOSAGE": "1MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOCARE LABORATOIRES SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/9/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "1/9/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["repaglinide"],
    "InteractionIndexLink": ["repaglinide"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "14 A 201",
    "DCI": "Répaglinide",
    "NOM_COMMERCIALE": "DIAGLINIDE",
    "FORME": "Comprimés",
    "DOSAGE": "01 mg",
    "COND": "Boite de 30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["repaglinide"],
    "InteractionIndexLink": ["repaglinide"],
    "N_ENREGISTREMENT": "001/ 14 A 201 /14/20",
    "CODE_DCI": "14 A 201",
    "DCI": "Répaglinide",
    "NOM_COMMERCIALE": "GLINIX",
    "FORME": "Comprimé",
    "DOSAGE": "1MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMA ALGERIA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/9/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "19/5/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "60MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["repaglinide"],
    "InteractionIndexLink": ["repaglinide"],
    "N_ENREGISTREMENT": "317/ 14 A 201 /15",
    "CODE_DCI": "14 A 201",
    "DCI": "Répaglinide",
    "NOM_COMMERCIALE": "GLYCENORM",
    "FORME": "COMPRIME",
    "DOSAGE": "1MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INPHA MEDIS SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/11/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "10/11/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["repaglinide"],
    "InteractionIndexLink": ["repaglinide"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "14 A 201",
    "DCI": "Repaglinide",
    "NOM_COMMERCIALE": "Glycenorm 1mg",
    "FORME": "comp",
    "DOSAGE": "1mg/comp",
    "COND": "bt de 30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["repaglinide"],
    "InteractionIndexLink": ["repaglinide"],
    "N_ENREGISTREMENT": "418/14 A 201/17",
    "CODE_DCI": "14 A 201",
    "DCI": "Répaglinide",
    "NOM_COMMERCIALE": "NEONORM",
    "FORME": "COMPRIME",
    "DOSAGE": "1MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NEOMEDIC SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/2/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "7/2/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["repaglinide"],
    "InteractionIndexLink": ["repaglinide"],
    "N_ENREGISTREMENT": "447/14 A 201/17",
    "CODE_DCI": "14 A 201",
    "DCI": "Répaglinide",
    "NOM_COMMERCIALE": "REPAGLINIDE BEKER",
    "FORME": "COMPRIME",
    "DOSAGE": "1MG",
    "COND": "B/30 ET B/90",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEKER SARL (SARL LABORATOIRE BEKER ALGERIE)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/1/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "9/1/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["repaglinide"],
    "InteractionIndexLink": ["repaglinide"],
    "N_ENREGISTREMENT": "149/14 A 201/17",
    "CODE_DCI": "14 A 201",
    "DCI": "Répaglinide",
    "NOM_COMMERCIALE": "SUCRONORME",
    "FORME": "COMPRIME",
    "DOSAGE": "1MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVAPHARM TRADING",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/5/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "2/5/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["repaglinide"],
    "InteractionIndexLink": ["repaglinide"],
    "N_ENREGISTREMENT": "263/ 14 A 202 /18",
    "CODE_DCI": "14 A 202",
    "DCI": "Répaglinide",
    "NOM_COMMERCIALE": "BIONORM",
    "FORME": "COMPRIME",
    "DOSAGE": "2MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOPHARM SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/4/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "2/4/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["repaglinide"],
    "InteractionIndexLink": ["repaglinide"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "14 A 202",
    "DCI": "REPAGLINIDE",
    "NOM_COMMERCIALE": "DIABENORM",
    "FORME": "CPR",
    "DOSAGE": "2 MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["repaglinide"],
    "InteractionIndexLink": ["repaglinide"],
    "N_ENREGISTREMENT": "293/ 14 A 202 /14",
    "CODE_DCI": "14 A 202",
    "DCI": "Répaglinide",
    "NOM_COMMERCIALE": "DIAGLINIDE",
    "FORME": "COMPRIME",
    "DOSAGE": "2MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOCARE LABORATOIRES SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/9/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "1/9/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["repaglinide"],
    "InteractionIndexLink": ["repaglinide"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "14 A 202",
    "DCI": "Répaglinide",
    "NOM_COMMERCIALE": "DIAGLINIDE",
    "FORME": "Comprimés",
    "DOSAGE": "02 mg",
    "COND": "Boite de 30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["repaglinide"],
    "InteractionIndexLink": ["repaglinide"],
    "N_ENREGISTREMENT": "21/14 A 202/235",
    "CODE_DCI": "14 A 202",
    "DCI": "REPAGLINIDE",
    "NOM_COMMERCIALE": "GLINIDIA",
    "FORME": "COMPRIME",
    "DOSAGE": "02MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES SARL BIOGALENIC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "08/06/21",
    "DATE_D_ENREGISTREMENT_FINAL": "08/06/21",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["repaglinide"],
    "InteractionIndexLink": ["repaglinide"],
    "N_ENREGISTREMENT": "001/ 14 A 202 /14/20",
    "CODE_DCI": "14 A 202",
    "DCI": "Répaglinide",
    "NOM_COMMERCIALE": "GLINIX",
    "FORME": "Comprimé",
    "DOSAGE": "2MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMA ALGERIA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/9/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "19/5/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "60MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["repaglinide"],
    "InteractionIndexLink": ["repaglinide"],
    "N_ENREGISTREMENT": "317/ 14 A 202 /15",
    "CODE_DCI": "14 A 202",
    "DCI": "Répaglinide",
    "NOM_COMMERCIALE": "GLYCENORM",
    "FORME": "COMPRIME",
    "DOSAGE": "2MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INPHA MEDIS SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/10/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "12/10/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["repaglinide"],
    "InteractionIndexLink": ["repaglinide"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "14 A 202",
    "DCI": "Repaglinide",
    "NOM_COMMERCIALE": "Glycenorm 2mg",
    "FORME": "comp",
    "DOSAGE": "2mg/comp",
    "COND": "bt de 30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["repaglinide"],
    "InteractionIndexLink": ["repaglinide"],
    "N_ENREGISTREMENT": "418/14 A 202/17",
    "CODE_DCI": "14 A 202",
    "DCI": "Répaglinide",
    "NOM_COMMERCIALE": "NEONORM",
    "FORME": "COMPRIME",
    "DOSAGE": "2MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NEOMEDIC SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/2/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "7/2/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["repaglinide"],
    "InteractionIndexLink": ["repaglinide"],
    "N_ENREGISTREMENT": "447/14A 202/17",
    "CODE_DCI": "14 A 202",
    "DCI": "Répaglinide",
    "NOM_COMMERCIALE": "REPAGLINIDE BEKER",
    "FORME": "COMPRIME",
    "DOSAGE": "2MG",
    "COND": "B/30 ET B/90",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE BEKER ALGERIE)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/1/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "17/1/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["repaglinide"],
    "InteractionIndexLink": ["repaglinide"],
    "N_ENREGISTREMENT": "065/ 14 A 202 /15",
    "CODE_DCI": "14 A 202",
    "DCI": "Répaglinide",
    "NOM_COMMERCIALE": "REPAGLINIDE GL",
    "FORME": "COMPRIME",
    "DOSAGE": "2MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GENERICLAB SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/7/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "9/7/2015",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["repaglinide"],
    "InteractionIndexLink": ["repaglinide"],
    "N_ENREGISTREMENT": "462/ 14 A 202 /19",
    "CODE_DCI": "14 A 202",
    "DCI": "Répaglinide",
    "NOM_COMMERCIALE": "REPAGLINIDE PHYSIOPHARM",
    "FORME": "COMPRIME",
    "DOSAGE": "2MG",
    "COND": "B/30",
    "LISTE": "LISTEI",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL PHYSIOPHARM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/9/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "15/9/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["repaglinide"],
    "InteractionIndexLink": ["repaglinide"],
    "N_ENREGISTREMENT": "289/14 A 202/20",
    "CODE_DCI": "14 A 202",
    "DCI": "Répaglinide",
    "NOM_COMMERCIALE": "REPAGLYSE",
    "FORME": "Comprimé",
    "DOSAGE": "2MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRATER RAZES FORME SECHE SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/3/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "19/5/2020",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["repaglinide"],
    "InteractionIndexLink": ["repaglinide"],
    "N_ENREGISTREMENT": "149/ 14 A 202 /18",
    "CODE_DCI": "14 A 202",
    "DCI": "Répaglinide",
    "NOM_COMMERCIALE": "SUCRONORME",
    "FORME": "COMPRIME",
    "DOSAGE": "2MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL NOVAPHARM TRADING",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/3/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "19/3/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["metformin"],
    "InteractionIndexLink": ["metformine"],
    "N_ENREGISTREMENT": "235/ 14 A 224 /14",
    "CODE_DCI": "14 A 224",
    "DCI": "METFORMINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "DIABAMINE BGL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "1000MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIO-GALENIC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "31/3/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "31/3/2014",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["metformin"],
    "InteractionIndexLink": ["metformine"],
    "N_ENREGISTREMENT": "20/14/14 A224/003",
    "CODE_DCI": "14 A 224",
    "DCI": "METFORMINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "DIAGUANID",
    "FORME": "COMP. PELLI. SEC.",
    "DOSAGE": "1000MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SAIDALGROUPE INDUSTRIEL EPE/SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/7/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "31/5/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["metformin"],
    "InteractionIndexLink": ["metformine"],
    "N_ENREGISTREMENT": "293/ 14 A 224 /16",
    "CODE_DCI": "14 A 224",
    "DCI": "METFORMINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "FORMENTIN",
    "FORME": "COMP. PELLI. SEC.",
    "DOSAGE": "1000MG",
    "COND": "B/30-B/100",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOCARE SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/6/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "26/6/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["metformin"],
    "InteractionIndexLink": ["metformine"],
    "N_ENREGISTREMENT": "380/ 14 A 224/14",
    "CODE_DCI": "14 A 224",
    "DCI": "METFORMINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "GLUCOFORMINE",
    "FORME": "COMP. PELLI. SEC.",
    "DOSAGE": "1000MG",
    "COND": "B/30 ET B/100",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HUP.P.PHARMA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/1/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "6/1/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["metformin"],
    "InteractionIndexLink": ["metformine"],
    "N_ENREGISTREMENT": "400/14 A 224/16",
    "CODE_DCI": "14 A 224",
    "DCI": "METFORMINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "GLUCOMEX",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "1000MG",
    "COND": "B/90",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "KPMA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/12/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "19/12/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["metformin"],
    "InteractionIndexLink": ["metformine"],
    "N_ENREGISTREMENT": "062/ 14 A 224 /07/17",
    "CODE_DCI": "14 A 224",
    "DCI": "METFORMINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "GLUCOPHAGE",
    "FORME": "COMP. PELLI. SEC.",
    "DOSAGE": "1000MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MERCK SANTE S.A.S",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/3/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "29/6/2017",
    "TYPE": "Ré",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["metformin"],
    "InteractionIndexLink": ["metformine"],
    "N_ENREGISTREMENT": "367/ 14 A 224 /15",
    "CODE_DCI": "14 A 224",
    "DCI": "METFORMINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "METFORAL 1000",
    "FORME": "COMP. PELLI. SEC.",
    "DOSAGE": "1000MG",
    "COND": "B/30 ET B/60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GUIDOTTI SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ITALIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "31/5/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "31/5/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["metformin"],
    "InteractionIndexLink": ["metformine"],
    "N_ENREGISTREMENT": "447/ 14 A 224 /12",
    "CODE_DCI": "14 A 224",
    "DCI": "METFORMINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "NEXECOR",
    "FORME": "COMP. PELLI. SEC.",
    "DOSAGE": "1000MG",
    "COND": "B/90",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEKER SARL (SARL LABORATOIRE BEKER ALGERIE)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/1/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "30/1/2012",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["metformin"],
    "InteractionIndexLink": ["metformine"],
    "N_ENREGISTREMENT": "368/14 A 224/10/16",
    "CODE_DCI": "14 A 224",
    "DCI": "METFORMINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "NOVOFORMINE",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "1000MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALDAPH SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/5/2010",
    "DATE_D_ENREGISTREMENT_FINAL": "19/10/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["metformin"],
    "InteractionIndexLink": ["metformine"],
    "N_ENREGISTREMENT": "462/ 14 A 224 /13",
    "CODE_DCI": "14 A 224",
    "DCI": "METFORMINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "PHYSIOPHORMINE",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "1000MG",
    "COND": "B/30 - B/60 ET B/90",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHYSIOPHARM SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/5/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "12/5/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["gliclazide"],
    "InteractionIndexLink": ["gliclazide"],
    "N_ENREGISTREMENT": "040/ 14 A 303 /06/21",
    "CODE_DCI": "14 A 303",
    "DCI": "Gliclazide",
    "NOM_COMMERCIALE": "DIAMICRON",
    "FORME": "Comprimé à liberation modifiée",
    "DOSAGE": "30MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SERVIER",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/10/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "1/3/2021",
    "TYPE": "Ré",
    "STATUT": "Fabricant (PRODIPHAL ET LDM)",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["gliclazide"],
    "InteractionIndexLink": ["gliclazide"],
    "N_ENREGISTREMENT": "263/14 A 303/16",
    "CODE_DCI": "14 A 303",
    "DCI": "GLICLAZIDE",
    "NOM_COMMERCIALE": "GLATIX",
    "FORME": "COMP. LM",
    "DOSAGE": "30MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOPHARM SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/11/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "9/11/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["gliclazide"],
    "InteractionIndexLink": ["gliclazide"],
    "N_ENREGISTREMENT": "039/ 14 A 303 /13",
    "CODE_DCI": "14 A 303",
    "DCI": "GLICLAZIDE",
    "NOM_COMMERCIALE": "GLAZIDAL LP",
    "FORME": "MICRGLES. LP EN GLES.",
    "DOSAGE": "30MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOCIETE PHARMACEUTIQUE ALGERIENNE (SOPHAL)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/4/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "15/4/2013",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["gliclazide"],
    "InteractionIndexLink": ["gliclazide"],
    "N_ENREGISTREMENT": "325/ 14 A 303 /14",
    "CODE_DCI": "14 A 303",
    "DCI": "GLICLAZIDE",
    "NOM_COMMERCIALE": "GLICLAZIDE BGL",
    "FORME": "COMP.PELLI. LM.",
    "DOSAGE": "30MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIO-GALENIC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "16/2/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "16/2/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["gliclazide"],
    "InteractionIndexLink": ["gliclazide"],
    "N_ENREGISTREMENT": "437/ 14 A 303 /13",
    "CODE_DCI": "14 A 303",
    "DCI": "GLICLAZIDE",
    "NOM_COMMERCIALE": "GLICRON",
    "FORME": "COMP. PELLI. LM",
    "DOSAGE": "30MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CHEMICAL FARMA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/3/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "20/3/2013",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["gliclazide"],
    "InteractionIndexLink": ["gliclazide"],
    "N_ENREGISTREMENT": "149/14 A 303/20",
    "CODE_DCI": "14 A 303",
    "DCI": "GLICLAZIDE",
    "NOM_COMMERCIALE": "NOVAMICRON",
    "FORME": "COMP LIBERATION MODIFIEE",
    "DOSAGE": "30MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVAPHARM TRADING SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/1/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "15/1/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "367/ 14 A 305 /07/15",
    "CODE_DCI": "14 A 305",
    "DCI": "GLIQUIDONE",
    "NOM_COMMERCIALE": "GLURENOR",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "30MG",
    "COND": "B/40",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GUIDOTTI S.P.A.",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ITALIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/3/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "13/5/2015",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "48MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["glimepiride"],
    "InteractionIndexLink": ["glimepiride"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "14 A 324",
    "DCI": "GLIMEPIRIDE",
    "NOM_COMMERCIALE": "AMAREL",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "6MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["glimepiride"],
    "InteractionIndexLink": ["glimepiride"],
    "N_ENREGISTREMENT": "293/ 14 A 324 /13",
    "CODE_DCI": "14 A 324",
    "DCI": "GLIMEPIRIDE",
    "NOM_COMMERCIALE": "GLIMICARE",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "6MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOCARE SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/8/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "7/8/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["glimepiride"],
    "InteractionIndexLink": ["glimepiride"],
    "N_ENREGISTREMENT": "317/ 14 A 324 /12/18",
    "CODE_DCI": "14 A 324",
    "DCI": "GLIMEPIRIDE",
    "NOM_COMMERCIALE": "IRYS",
    "FORME": "COMP. PELLI. SEC.",
    "DOSAGE": "6MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INPHA-MEDIS SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "16/12/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "29/4/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["glimepiride"],
    "InteractionIndexLink": ["glimepiride"],
    "N_ENREGISTREMENT": "003/ 14 A 324 /09/21",
    "CODE_DCI": "14 A 324",
    "DCI": "Glimépiride",
    "NOM_COMMERCIALE": "LAVIDA",
    "FORME": "Comprimé  sécable",
    "DOSAGE": "6MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EPE GROUPE INDUSTRIEL SAIDAL/SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/3/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "17/2/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["acarbose"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "231/ 14 A 341 /16",
    "CODE_DCI": "14 A 341",
    "DCI": "ACARBOSE",
    "NOM_COMMERCIALE": "GLUCAR",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "100MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES SALEM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/9/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "27/9/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["acarbose"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "424/ 14 A 341 /12",
    "CODE_DCI": "14 A 341",
    "DCI": "ACARBOSE",
    "NOM_COMMERCIALE": "GLUCOBAY",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "100MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BAYER SCHERING PHARMA AG",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALLEMAGNE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/7/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "13/7/2012",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["acarbose"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "149/14 A 341/17",
    "CODE_DCI": "14 A 341",
    "DCI": "ACARBOSE",
    "NOM_COMMERCIALE": "GLUCONOVA",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "100MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVAPHARM TRADING",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/3/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "19/3/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["acarbose"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "447/14 A 341/16",
    "CODE_DCI": "14 A 341",
    "DCI": "ACARBOSE",
    "NOM_COMMERCIALE": "GLYBEK",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "100MG",
    "COND": "B/30 ET B/90",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL BEKER",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "8/11/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "8/11/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["sitagliptin"],
    "InteractionIndexLink": ["sitagliptine"],
    "N_ENREGISTREMENT": "462/14 A 342/17",
    "CODE_DCI": "14 A 342",
    "DCI": "SITAGLIPTINE PHOSPHATE MONOHYDRATE EXPRIME EN SITAGLIPTINE",
    "NOM_COMMERCIALE": "DALVEX",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "100MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHYSIOPHARM SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/5/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "28/5/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["sitagliptin"],
    "InteractionIndexLink": ["sitagliptine"],
    "N_ENREGISTREMENT": "352/14 A 342/16",
    "CODE_DCI": "14 A 342",
    "DCI": "SITAGLIPTINE PHOSPHATE MONOHYDRATE EXPRIME EN SITAGLIPTINE",
    "NOM_COMMERCIALE": "DIATAG",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "100MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI DU MEDICAMENT SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/3/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "12/3/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["sitagliptin"],
    "InteractionIndexLink": ["sitagliptine"],
    "N_ENREGISTREMENT": "001/ 14 A 342 /15",
    "CODE_DCI": "14 A 342",
    "DCI": "SITAGLIPTINE PHOSPHATE MONOHYDRATE EXPRIME EN SITAGLIPTINE",
    "NOM_COMMERCIALE": "GLYSAVIA",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "100MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMA ALGERIA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "8/11/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "8/11/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["sitagliptin"],
    "InteractionIndexLink": ["sitagliptine"],
    "N_ENREGISTREMENT": "024/ 14 A 342 /12",
    "CODE_DCI": "14 A 342",
    "DCI": "SITAGLIPTINE PHOSPHATE MONOHYDRATE EXPRIME EN SITAGLIPTINE",
    "NOM_COMMERCIALE": "JANUVIA",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "100MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "MEDICAMENT SOUMIS A PRESCRIPTION RESTREINTE: PRESCRIPTION SPECIALISEE",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MERCK SHARP & DOHME LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ROYAUME UNI",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/8/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "26/8/2012",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["sitagliptin"],
    "InteractionIndexLink": ["sitagliptine"],
    "N_ENREGISTREMENT": "263/ 14 A 342 /15",
    "CODE_DCI": "14 A 342",
    "DCI": "SITAGLIPTINE PHOSPHATE MONOHYDRATE EXPRIME EN SITAGLIPTINE",
    "NOM_COMMERCIALE": "JEGA",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "100MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOPHARM SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/5/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "13/5/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["sitagliptin"],
    "InteractionIndexLink": ["sitagliptine"],
    "N_ENREGISTREMENT": "447/14 A 342/16",
    "CODE_DCI": "14 A 342",
    "DCI": "SITAGLIPTINE PHOSPHATE MONOHYDRATE EXPRIME EN SITAGLIPTINE",
    "NOM_COMMERCIALE": "SITAGLIPTINE",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "100MG",
    "COND": "B/30 ET B/90",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL BEKER",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/11/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "9/11/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["sitagliptin"],
    "InteractionIndexLink": ["sitagliptine"],
    "N_ENREGISTREMENT": "235/ 14 A 342 /16",
    "CODE_DCI": "14 A 342",
    "DCI": "SITAGLIPTINE PHOSPHATE MONOHYDRATE EXPRIME EN SITAGLIPTINE",
    "NOM_COMMERCIALE": "SITANORM",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "100MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOGALENIC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "11/4/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "11/4/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["vildagliptin"],
    "InteractionIndexLink": ["vildagliptine"],
    "N_ENREGISTREMENT": "546/ 14 A 345 /21",
    "CODE_DCI": "14 A 345",
    "DCI": "Vildagliptine",
    "NOM_COMMERCIALE": "GALVINE",
    "FORME": "Comprimé",
    "DOSAGE": "50MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ONYX Industrie Pharmaceutique / SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/2/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "7/2/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["vildagliptin"],
    "InteractionIndexLink": ["vildagliptine"],
    "N_ENREGISTREMENT": "068/ 14 A 345 /13",
    "CODE_DCI": "14 A 345",
    "DCI": "Vildagliptine",
    "NOM_COMMERCIALE": "GALVUS",
    "FORME": "COMPRIME",
    "DOSAGE": "50MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVARTIS PHARMA SCHWEIZ AG",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SUISSE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/1/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "30/1/2014",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["vildagliptin"],
    "InteractionIndexLink": ["vildagliptine"],
    "N_ENREGISTREMENT": "352/ 14 A 345 /16",
    "CODE_DCI": "14 A 345",
    "DCI": "Vildagliptine",
    "NOM_COMMERCIALE": "GLAVIP",
    "FORME": "COMPRIME",
    "DOSAGE": "50MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIES DES MEDICAMENTS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/7/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "19/7/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["metformin"],
    "InteractionIndexLink": ["metformine"],
    "N_ENREGISTREMENT": "462/ 14 A 351 /15",
    "CODE_DCI": "14 A 351",
    "DCI": "METFORMINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "PHYSIOPHORMINE",
    "FORME": "PDRE. P. SOL. BUV. EN SACHET-DOSE",
    "DOSAGE": "500MG/SACHET",
    "COND": "B/30 SACHETS",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHYSIOPHARM SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/7/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "26/7/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["metformin"],
    "InteractionIndexLink": ["metformine"],
    "N_ENREGISTREMENT": "462/ 14 A 352 /15",
    "CODE_DCI": "14 A 352",
    "DCI": "METFORMINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "PHYSIOPHORMINE",
    "FORME": "PDRE. P. SOL. BUV. EN SACHET-DOSE",
    "DOSAGE": "850MG/SACHET",
    "COND": "B/30 SACHETS",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHYSIOPHARM SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "3/11/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "3/11/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["metformin"],
    "InteractionIndexLink": ["metformine"],
    "N_ENREGISTREMENT": "462/ 14 A 353 /15",
    "CODE_DCI": "14 A 353",
    "DCI": "METFORMINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "PHYSIOPHORMINE",
    "FORME": "PDRE. P. SOL. BUV. EN SACHET-DOSE",
    "DOSAGE": "1000MG/SACHET",
    "COND": "B/30 SACHETS",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHYSIOPHARM SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/10/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "27/10/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["sitagliptin"],
    "InteractionIndexLink": ["sitagliptine"],
    "N_ENREGISTREMENT": "447/14 A 357/17",
    "CODE_DCI": "14 A 357",
    "DCI": "SITAGLIPTINE PHOSPHATE MONOHYDRATE EXPRIME EN SITAGLIPTINE",
    "NOM_COMMERCIALE": "SITAGLIPTINE BEKER",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "50 MG",
    "COND": "B/30 ET B/90",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEKER SARL (SARL LABORATOIRE BEKER ALGERIE)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/5/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "7/5/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["sitagliptin"],
    "InteractionIndexLink": ["sitagliptine"],
    "N_ENREGISTREMENT": "235/14 A 357/17",
    "CODE_DCI": "14 A 357",
    "DCI": "SITAGLIPTINE PHOSPHATE MONOHYDRATE EXPRIME EN SITAGLIPTINE",
    "NOM_COMMERCIALE": "SITANORM",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "50 MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOGALENIC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/9/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "4/9/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["metformin"],
    "InteractionIndexLink": ["metformine"],
    "N_ENREGISTREMENT": "352/14 A 360/17",
    "CODE_DCI": "14 A 360",
    "DCI": "VIDAGLIPTINE/METFORMINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "VILDAMETFOR",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "50MG/1000MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/5/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "28/5/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["metformin", "vildagliptin"],
    "InteractionIndexLink": ["metformine", "vildagliptine"],
    "N_ENREGISTREMENT": "352/ 14 A 361/17",
    "CODE_DCI": "14 A 361",
    "DCI": "VILDAGLIPTINE/METFORMINE HYDROCHLORIDE",
    "NOM_COMMERCIALE": "VILDAMETFOR",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "50MG/850MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/6/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "18/6/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["metformin"],
    "InteractionIndexLink": ["metformine"],
    "N_ENREGISTREMENT": "001/14 A 362/17",
    "CODE_DCI": "14 A 362",
    "DCI": "METFORMINE HYDROCHLORIDE",
    "NOM_COMMERCIALE": "METLESS LP",
    "FORME": "COMPRIME A LIBERATION PROLONGEE",
    "DOSAGE": "500MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMA ALGERIA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/10/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "24/10/2017",
    "TYPE": "Gé",
    "STATUT": "F PREMIX",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["metformin"],
    "InteractionIndexLink": ["metformine"],
    "N_ENREGISTREMENT": "001/14 A 363/17",
    "CODE_DCI": "14 A 363",
    "DCI": "METFORMINE HYDROCHLORIDE",
    "NOM_COMMERCIALE": "METLESS LP",
    "FORME": "COMPRIME A LIBERATION PROLONGEE",
    "DOSAGE": "750 MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMA ALGERIA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/10/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "24/10/2017",
    "TYPE": "Gé",
    "STATUT": "F PREMIX",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["metformin"],
    "InteractionIndexLink": ["metformine"],
    "N_ENREGISTREMENT": "352/14 A 364/17",
    "CODE_DCI": "14 A 364",
    "DCI": "METFORMINE HYDROCHLORIDE",
    "NOM_COMMERCIALE": "METFOR LP",
    "FORME": "COMPRIME A LIBERATION PROLONGEE",
    "DOSAGE": "1G",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/9/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "10/9/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["metformin"],
    "InteractionIndexLink": ["metformine"],
    "N_ENREGISTREMENT": "001/14 A 364/17",
    "CODE_DCI": "14 A 364",
    "DCI": "METFORMINE HYDROCHLORIDE",
    "NOM_COMMERCIALE": "METLESS LP",
    "FORME": "COMPRIME A LIBERATION PROLONGEE",
    "DOSAGE": "1G",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMA ALGERIA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/10/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "24/10/2017",
    "TYPE": "Gé",
    "STATUT": "F PREMIX",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "392/14 A 367/19",
    "CODE_DCI": "14 A 367",
    "DCI": "GEMIGLIPTINE TARTRATESESQUIHYDRATE",
    "NOM_COMMERCIALE": "ZEMIGLO",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "50MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANOFI AVENTIS SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "Ré",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["alogliptin benzoate"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "001/ 14 A 372 / 20",
    "CODE_DCI": "14 A 372",
    "DCI": "Alogliptine benzoate",
    "NOM_COMMERCIALE": "VIPIDIA",
    "FORME": "Comprimé pelliculé",
    "DOSAGE": "12.5MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMA ALGERIA SARL (S/L TAKEDA)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/5/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "4/5/2020",
    "TYPE": "Gé",
    "STATUT": "F  mélange final",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["alogliptin benzoate"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "20/14 A372/001",
    "CODE_DCI": "14 A 372",
    "DCI": "ALOGLIPTINE BENZOATE",
    "NOM_COMMERCIALE": "VIPIDIA",
    "FORME": "COMP PELL",
    "DOSAGE": "12.5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMA ALGERIE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/5/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "4/5/2020",
    "TYPE": "",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["alogliptin benzoate"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "001/ 14 A 373 / 20",
    "CODE_DCI": "14 A 373",
    "DCI": "Alogliptine benzoate",
    "NOM_COMMERCIALE": "VIPIDIA",
    "FORME": "Comprimé pelliculé",
    "DOSAGE": "25MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMA ALGERIA SARL (S/L TAKEDA)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/5/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "4/5/2020",
    "TYPE": "Gé",
    "STATUT": "F  mélange final",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["alogliptin benzoate"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "20/14 A373/001",
    "CODE_DCI": "14 A 373",
    "DCI": "ALOGLIPTINE BENZOATE",
    "NOM_COMMERCIALE": "VIPIDIA",
    "FORME": "COMP PELL",
    "DOSAGE": "25MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMA ALGERIE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/5/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "4/5/2020",
    "TYPE": "",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["metformin", "alogliptin benzoate"],
    "InteractionIndexLink": ["metformine"],
    "N_ENREGISTREMENT": "001/ 14 A 374 / 20",
    "CODE_DCI": "14 A 374",
    "DCI": "Alogliptine benzoate / Metformine Chlorhydrate",
    "NOM_COMMERCIALE": "VIPDOMET",
    "FORME": "Comprimé pelliculé",
    "DOSAGE": "12.5MG/500MG",
    "COND": "B/60",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMA ALGERIA SARL (S/L TAKEDA)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/9/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "29/9/2020",
    "TYPE": "Ré",
    "STATUT": "F  mélange final",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["metformin", "alogliptin benzoate"],
    "InteractionIndexLink": ["metformine"],
    "N_ENREGISTREMENT": "20/14 A374/001",
    "CODE_DCI": "14 A 374",
    "DCI": "ALOGLIPTINE BENZOATE / METFORMINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "VIPDOMET",
    "FORME": "COMP PELL",
    "DOSAGE": "12.5MG/ 500MG",
    "COND": "B/60",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES HIKMA PHARMA ALGERIA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIA",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/9/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "29/9/2020",
    "TYPE": "Gé",
    "STATUT": "F Mélange final",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["metformin", "alogliptin benzoate"],
    "InteractionIndexLink": ["metformine"],
    "N_ENREGISTREMENT": "001/ 14 A 375 / 20",
    "CODE_DCI": "14 A 375",
    "DCI": "Alogliptine benzoate / Metformine Chlorhydrate",
    "NOM_COMMERCIALE": "VIPDOMET",
    "FORME": "Comprimé pelliculé",
    "DOSAGE": "12.5MG/1000MG",
    "COND": "B/60",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMA ALGERIA SARL (S/L TAKEDA)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/9/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "29/9/2020",
    "TYPE": "Ré",
    "STATUT": "F  mélange final",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["metformin", "alogliptin benzoate"],
    "InteractionIndexLink": ["metformine"],
    "N_ENREGISTREMENT": "20/ 14 A375/001",
    "CODE_DCI": "14 A 375",
    "DCI": "ALOGLIPTINE BENZOATE / METFORMINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "VIPDOMET",
    "FORME": "COMP PELL",
    "DOSAGE": "12.5MG / 1000MG",
    "COND": "B/60",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES HIKMA PHARMA ALGERIA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIA",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/9/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "29/9/2020",
    "TYPE": "Gé",
    "STATUT": "F Mélange final",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["dapagliflozin"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "001/14 A 376/20",
    "CODE_DCI": "14 A 376",
    "DCI": "DAPAGLIFLOZINE PROPANEDIOL",
    "NOM_COMMERCIALE": "VALENS",
    "FORME": "COMP. PELL.",
    "DOSAGE": "05MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMA ALGERIA/SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/12/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "27/12/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["dapagliflozin"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "001/14 A 376 / 20",
    "CODE_DCI": "14 A 376",
    "DCI": "Dapagliflozine Propanediol Monohydraté exprimé en Dapagliflozine",
    "NOM_COMMERCIALE": "VALENS",
    "FORME": "Comprimé pelliculé",
    "DOSAGE": "5MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMA ALGERIA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/12/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "27/12/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["dapagliflozin"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "001/14 A 377/20",
    "CODE_DCI": "14 A 377",
    "DCI": "DAPAGLIFLOZINE PROPANEDIOL",
    "NOM_COMMERCIALE": "VALENS",
    "FORME": "COMP. PELL.",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES HIKMA PHARMA ALGERIE/ SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/12/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "7/12/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["dapagliflozin"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "001/14 A 377 / 20",
    "CODE_DCI": "14 A 377",
    "DCI": "Dapagliflozine Propanediol Monohydraté exprimé en Dapagliflozine",
    "NOM_COMMERCIALE": "VALENS",
    "FORME": "Comprimé pelliculé",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMA ALGERIA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/12/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "7/12/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [
      "insulin aspart",
      "insulin degludec",
      "insulin detemir",
      "insulin glargine",
      "insulin glulisine",
      "insulin lispro"
    ],
    "InteractionIndexLink": ["insuline"],
    "N_ENREGISTREMENT": "230/ 14 B 153 /03/16",
    "CODE_DCI": "14 B 153",
    "DCI": "INSULINE HUMAINE RAPIDE",
    "NOM_COMMERCIALE": "INSUMAN RAPID",
    "FORME": "SOL INJ",
    "DOSAGE": "100UI/ML",
    "COND": "B/5 CART 3ML  ( POUR OPTIPEN )",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "AVENTIS  PHARMA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALLEMAGNE",
    "DATE_D_ENREGISTREMENT_INITIAL": "3/12/2003",
    "DATE_D_ENREGISTREMENT_FINAL": "6/3/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [
      "insulin aspart",
      "insulin degludec",
      "insulin detemir",
      "insulin glargine",
      "insulin glulisine",
      "insulin lispro"
    ],
    "InteractionIndexLink": ["insuline"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "14 B 155",
    "DCI": "INSULINE HUMAINE INTERMEDIAIRE MONOPHASIQUE",
    "NOM_COMMERCIALE": "INSULATARD HM PENFILL",
    "FORME": "SUSP INJ",
    "DOSAGE": "100UI/ML",
    "COND": "B/5 CART. DE 1.5 ML ET B/5CART DE 3ML",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": [
      "insulin aspart",
      "insulin degludec",
      "insulin detemir",
      "insulin glargine",
      "insulin glulisine",
      "insulin lispro"
    ],
    "InteractionIndexLink": [
      "insuline humaine hemisynthetique isophane biphasique"
    ],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "14 B 157",
    "DCI": "INSULINE HUMAINE INTERMEDIAIRE BIPHASIQUE",
    "NOM_COMMERCIALE": "MIXTARD 30 HM PENFILL",
    "FORME": "SUSP INJ",
    "DOSAGE": "100UI/ML",
    "COND": "B/5 CART. DE 1.5 ML ET B/5CART DE 3ML",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": [
      "insulin aspart",
      "insulin degludec",
      "insulin detemir",
      "insulin glargine",
      "insulin glulisine",
      "insulin lispro"
    ],
    "InteractionIndexLink": [
      "insuline",
      "insuline humaine hemisynthetique isophane"
    ],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "14 B 192",
    "DCI": "INSULINE HUMAINE/INSULINE ISOPHANE 30%/70%",
    "NOM_COMMERCIALE": "MIXTARD 30HM",
    "FORME": "SUSP INJ",
    "DOSAGE": "100UI/ML",
    "COND": "FL/10ML",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": [
      "insulin aspart",
      "insulin degludec",
      "insulin detemir",
      "insulin glargine",
      "insulin glulisine",
      "insulin lispro"
    ],
    "InteractionIndexLink": [
      "insuline",
      "insuline humaine hemisynthetique isophane"
    ],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "14 B 193",
    "DCI": "INSULINE ISOPHANE",
    "NOM_COMMERCIALE": "INSULATARD HM",
    "FORME": "SUSP INJ",
    "DOSAGE": "100UI/ML",
    "COND": "FL/10ML",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": [
      "insulin aspart",
      "insulin degludec",
      "insulin detemir",
      "insulin glargine",
      "insulin glulisine",
      "insulin lispro"
    ],
    "InteractionIndexLink": [
      "insuline",
      "insuline humaine hemisynthetique isophane biphasique"
    ],
    "N_ENREGISTREMENT": "376/ 14 B 193 /02/16",
    "CODE_DCI": "14 B 193",
    "DCI": "INSULINE HUMAINE ISOPHANE",
    "NOM_COMMERCIALE": "INSUMAN BASAL",
    "FORME": "SUSP .INJ. SC EN FL.",
    "DOSAGE": "100UI/ML (3.5MG/ML)",
    "COND": "B/1FL DE 5ML",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANOFI AVENTIS DEUTSCHLAND",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALLEMAGNE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/6/2002",
    "DATE_D_ENREGISTREMENT_FINAL": "6/3/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": [
      "insulin aspart",
      "insulin degludec",
      "insulin detemir",
      "insulin glargine",
      "insulin glulisine",
      "insulin lispro"
    ],
    "InteractionIndexLink": ["insuline"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "14 B 194",
    "DCI": "INSULINE HUMAINE MONOCOMPOSEE",
    "NOM_COMMERCIALE": "ACTRAPID HM",
    "FORME": "SOL INJ",
    "DOSAGE": "100UI/ML",
    "COND": "FL/10ML",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": [
      "insulin aspart",
      "insulin degludec",
      "insulin detemir",
      "insulin glargine",
      "insulin glulisine",
      "insulin lispro"
    ],
    "InteractionIndexLink": ["insuline", "insuline lispro"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "14 B 195",
    "DCI": "INSULINE LISPRO",
    "NOM_COMMERCIALE": "HUMALOG 100",
    "FORME": "SOL. INJ. SC/IV EN CARTOUCHE POUR STYLO",
    "DOSAGE": "100UI/ML (3.5MG/ML)",
    "COND": "B/05 CARTOUCHES DE 3ML",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": [
      "insulin aspart",
      "insulin degludec",
      "insulin detemir",
      "insulin glargine",
      "insulin glulisine",
      "insulin lispro"
    ],
    "InteractionIndexLink": ["insuline", "insuline glargine"],
    "N_ENREGISTREMENT": "376/ 14 B 213 /03/16",
    "CODE_DCI": "14 B 213",
    "DCI": "INSULINE GLARGINE",
    "NOM_COMMERCIALE": "LANTUS",
    "FORME": "SOL. INJ. SC EN CART.",
    "DOSAGE": "100UI/ML",
    "COND": "B/5CART. DE 3ML  (POUR OPTIPEN )",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANOFI AVENTIS DEUTSCHLAND GmBH",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALLEMAGNE",
    "DATE_D_ENREGISTREMENT_INITIAL": "3/12/2003",
    "DATE_D_ENREGISTREMENT_FINAL": "7/3/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [
      "insulin aspart",
      "insulin degludec",
      "insulin detemir",
      "insulin glargine",
      "insulin glulisine",
      "insulin lispro"
    ],
    "InteractionIndexLink": ["insuline", "insuline glargine"],
    "N_ENREGISTREMENT": "034/14 B 215/17",
    "CODE_DCI": "14 B 215",
    "DCI": "INSULINE GLARGINE LILLY",
    "NOM_COMMERCIALE": "ABASAGLAR",
    "FORME": "SOL. INJ. EN STYLO PREREMPLI KWIKPEN",
    "DOSAGE": "100UI/ML (3.64MG/ML)",
    "COND": "B/05 STYLOS PREREMLIS DE 3 ML",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ELI LILLY OPERATIONS GMBH",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "AUTRICHE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/7/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "20/7/2017",
    "TYPE": "BIO",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": [
      "insulin aspart",
      "insulin degludec",
      "insulin detemir",
      "insulin glargine",
      "insulin glulisine",
      "insulin lispro"
    ],
    "InteractionIndexLink": ["insuline", "insuline glargine"],
    "N_ENREGISTREMENT": "494/14 B 215/17",
    "CODE_DCI": "14 B 215",
    "DCI": "INSULINE GLARGINE",
    "NOM_COMMERCIALE": "BASALOG ONE",
    "FORME": "SOL. INJ. EN STYLO PREREMPLI",
    "DOSAGE": "100UI/ML (3.64MG/ML)",
    "COND": "B/05 STYLOS PREREMLIS DE 3 ML",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOCON LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "16/1/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "16/1/2017",
    "TYPE": "BIO",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": [
      "insulin aspart",
      "insulin degludec",
      "insulin detemir",
      "insulin glargine",
      "insulin glulisine",
      "insulin lispro"
    ],
    "InteractionIndexLink": ["insuline", "insuline glargine"],
    "N_ENREGISTREMENT": "376/ 14 B 215 /09/16",
    "CODE_DCI": "14 B 215",
    "DCI": "INSULINE GLARGINE",
    "NOM_COMMERCIALE": "LANTUS SOLOSTAR",
    "FORME": "SOL. INJ. EN STYLO PREREMPLI",
    "DOSAGE": "100UI/ML (3.64MG/ML)",
    "COND": "B/05 STYLOS PREREMPLIS SOLOSTAR DE 3ML",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANOFI AVENTIS DEUTSCHLAND GMbH",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALLEMAGNE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/7/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "26/1/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": [
      "insulin aspart",
      "insulin degludec",
      "insulin detemir",
      "insulin glargine",
      "insulin glulisine",
      "insulin lispro"
    ],
    "InteractionIndexLink": ["insuline", "insuline asparte"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "14 B 223",
    "DCI": "INSULINE ASPARTE",
    "NOM_COMMERCIALE": "NOVORAPID FLEXPEN",
    "FORME": "SOL. INJ.",
    "DOSAGE": "100UI/ML",
    "COND": "B/05 STYLOS MULTIDOSES PRE-REMPLIS JETABLES DE 3ML",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": [
      "insulin aspart",
      "insulin degludec",
      "insulin detemir",
      "insulin glargine",
      "insulin glulisine",
      "insulin lispro",
      "protamine"
    ],
    "InteractionIndexLink": ["insuline", "insuline asparte"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "14 B 225",
    "DCI": "INSULINE ASPARTE / INSULINE ASPARTE PROTAMINE 30/70%",
    "NOM_COMMERCIALE": "NOVOMIX 30 FLEXPEN",
    "FORME": "SUSP. INJ.",
    "DOSAGE": "100UI/ML",
    "COND": "B/05 STYLOS MULTIDOSES PRE-REMPLIS JETABLES DE 3ML",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": [
      "insulin aspart",
      "insulin degludec",
      "insulin detemir",
      "insulin glargine",
      "insulin glulisine",
      "insulin lispro"
    ],
    "InteractionIndexLink": ["insuline"],
    "N_ENREGISTREMENT": "069/ 14 B 227 /07/16",
    "CODE_DCI": "14 B 227",
    "DCI": "INSULINE DETEMIR",
    "NOM_COMMERCIALE": "LEVEMIR FLEXPEN",
    "FORME": "SOL. INJ. S/C",
    "DOSAGE": "100U/ML (OU 100UI/ML)",
    "COND": "B/05 STYLOS PRE REMPLIS MULTIDOSE JETABLES DE 3ML",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVO NORDISK",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "DANEMARK",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/6/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "4/1/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": [
      "insulin aspart",
      "insulin degludec",
      "insulin detemir",
      "insulin glargine",
      "insulin glulisine",
      "insulin lispro"
    ],
    "InteractionIndexLink": ["insuline"],
    "N_ENREGISTREMENT": "376/ 14 B 312 /08/16",
    "CODE_DCI": "14 B 312",
    "DCI": "INSULINE GLULISINE",
    "NOM_COMMERCIALE": "APIDRA",
    "FORME": "SOL. INJ. EN CARTOUCHE SC",
    "DOSAGE": "100UI/ML",
    "COND": "B/03 CART.  DE 3ML POUR (OPTICLIK OU POUR OPTIPEN)",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANOFI AVENTIS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALLEMAGNE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/4/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "6/3/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [
      "insulin aspart",
      "insulin degludec",
      "insulin detemir",
      "insulin glargine",
      "insulin glulisine",
      "insulin lispro",
      "protamine"
    ],
    "InteractionIndexLink": ["insuline", "insuline lispro"],
    "N_ENREGISTREMENT": "034/ 14 B 326 /09/16",
    "CODE_DCI": "14 B 326",
    "DCI": "INSULINE LISPRO 25% / INSULINE LISPRO PROTAMINE 75%",
    "NOM_COMMERCIALE": "HUMALOG MIX 25",
    "FORME": "SUSP. INJ. SC EN CARTOUCHE POUR STYLO",
    "DOSAGE": "100UI/ML (3.5MG/ML)",
    "COND": "B/05 CARTOUCHES DE 3ML",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ELI LILLY NEDERLAND B.V.",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PAYS BAS",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/9/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "19/7/2016",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": [
      "insulin aspart",
      "insulin degludec",
      "insulin detemir",
      "insulin glargine",
      "insulin glulisine",
      "insulin lispro",
      "protamine"
    ],
    "InteractionIndexLink": ["insuline", "insuline lispro"],
    "N_ENREGISTREMENT": "034/ 14 B 327 /09/16",
    "CODE_DCI": "14 B 327",
    "DCI": "INSULINE LISPRO 50% / INSULINE LISPRO PROTAMINE 50%",
    "NOM_COMMERCIALE": "HUMALOG MIX 50",
    "FORME": "SUSP. INJ. SC EN CARTOUCHE POUR STYLO",
    "DOSAGE": "100UI/ML (3.5MG/ML)",
    "COND": "B/05 CARTOUCHES DE 3ML",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ELI LILLY NEDERLAND B.V.",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PAYS BAS",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/6/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "22/2/2016",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": [
      "insulin aspart",
      "insulin degludec",
      "insulin detemir",
      "insulin glargine",
      "insulin glulisine",
      "insulin lispro"
    ],
    "InteractionIndexLink": ["insuline"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "14 B 332",
    "DCI": "INSULINE GLULISINE",
    "NOM_COMMERCIALE": "APIDRA SOLOSTAR",
    "FORME": "SOL. INJ. EN STYLO PREREMPLI",
    "DOSAGE": "100UI/ML (3.49MG/ML)",
    "COND": "B/05 STYLOS PREREMPLIS SOLOSTAR DE 3ML",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": [
      "insulin aspart",
      "insulin degludec",
      "insulin detemir",
      "insulin glargine",
      "insulin glulisine",
      "insulin lispro"
    ],
    "InteractionIndexLink": ["insuline", "insuline lispro"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "14 B 337",
    "DCI": "INSULINE LISPRO",
    "NOM_COMMERCIALE": "HUMALOG KIWIKPEN",
    "FORME": "SOL. INJ. SC EN STYLO PREREMPLI",
    "DOSAGE": "100UI/ML (3.5MG/ML)",
    "COND": "B/05 STYLOS PREREMPLIS DE 3ML",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": [
      "insulin aspart",
      "insulin degludec",
      "insulin detemir",
      "insulin glargine",
      "insulin glulisine",
      "insulin lispro",
      "protamine"
    ],
    "InteractionIndexLink": ["insuline", "insuline lispro"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "14 B 338",
    "DCI": "INSULINE LISPRO 25% / INSULINE LISPRO PROTAMINE 75%",
    "NOM_COMMERCIALE": "HUMALOG MIX 25 KIWIKPEN",
    "FORME": "SUSP. INJ. SC EN STYLO PREREMPLI",
    "DOSAGE": "100UI/ML (3.5MG/ML)",
    "COND": "B/05 STYLOS PREREMPLIS DE 3ML",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": [
      "insulin aspart",
      "insulin degludec",
      "insulin detemir",
      "insulin glargine",
      "insulin glulisine",
      "insulin lispro",
      "protamine"
    ],
    "InteractionIndexLink": ["insuline", "insuline lispro"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "14 B 339",
    "DCI": "INSULINE LISPRO 50% / INSULINE LISPRO PROTAMINE 50%",
    "NOM_COMMERCIALE": "HUMALOG MIX 50 KIWIKPEN",
    "FORME": "SUSP. INJ. SC EN STYLO PREREMPLI",
    "DOSAGE": "100UI/ML (3.5MG/ML)",
    "COND": "B/05 STYLOS PREREMPLIS DE 3ML",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": [
      "insulin aspart",
      "insulin degludec",
      "insulin detemir",
      "insulin glargine",
      "insulin glulisine",
      "insulin lispro"
    ],
    "InteractionIndexLink": [
      "insuline",
      "insuline asparte",
      "insuline asparte isophane biphasique",
      "insuline dégludec",
      "insuline glargine",
      "insuline humaine biosynthetique",
      "insuline humaine biosynthetique zinc",
      "insuline humaine hemisynthetique d'origine porcine",
      "insuline humaine hemisynthetique isophane",
      "insuline humaine hemisynthetique isophane biphasique",
      "insuline humaine recombinante",
      "insuline humaine recombinante isophane",
      "insuline humaine recombinante isophane biphasique",
      "insuline humaine recombinante zinc",
      "insuline humaine recombinante zinc cristalline",
      "insuline lispro",
      "insuline porcine"
    ],
    "N_ENREGISTREMENT": "069/14 B 369/19",
    "CODE_DCI": "14 B 369",
    "DCI": "INSULINE DEGLUDEC/INSULINE ASPARTE",
    "NOM_COMMERCIALE": "RYZODEG FLEXTOUCH",
    "FORME": "SOL INJ S/C EN STYLO PREREMPLI",
    "DOSAGE": "100UI/ML",
    "COND": "B/05 STYLOS PRE-REMPLIS MUNIS DE CARTOUCHES DE 3ML DE SOLUTION (300UI/3ML)",
    "LISTE": "LISTE II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVO NORDISK A/S",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "DANEMARK",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/12/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "15/12/2019",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "30MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [
      "insulin aspart",
      "insulin degludec",
      "insulin detemir",
      "insulin glargine",
      "insulin glulisine",
      "insulin lispro",
      "liraglutide (rys)"
    ],
    "InteractionIndexLink": ["insuline", "insuline dégludec"],
    "N_ENREGISTREMENT": "069/14 B 370/19",
    "CODE_DCI": "14 B 370",
    "DCI": "INSULINE DEGLUDEC/LIRAGLUTIDE",
    "NOM_COMMERCIALE": "XULTOPHY",
    "FORME": "SOL INJ EN STYLO PRE-REMPLI",
    "DOSAGE": "100UI/ML 3.6MG/ML",
    "COND": "B/05 STYLOS PRE-REMPLIS MUNIS DE CARTOUCHES DE 3ML DE SOLUTION (300UI/3ML)",
    "LISTE": "LISTE II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVO NORDISK A/S",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "DANEMARK",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/12/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "15/12/2019",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [
      "insulin aspart",
      "insulin degludec",
      "insulin detemir",
      "insulin glargine",
      "insulin glulisine",
      "insulin lispro"
    ],
    "InteractionIndexLink": ["insuline", "insuline dégludec"],
    "N_ENREGISTREMENT": "069/14 B 371/20",
    "CODE_DCI": "14 B 371",
    "DCI": "INSULINE DEGLUDEC",
    "NOM_COMMERCIALE": "TRESIBA FLEXTOUCH",
    "FORME": "SOL INJ S/C EN STYLO PRE REMPLI",
    "DOSAGE": "100UI/1ML",
    "COND": "B/05 STYLOS PREREMPLIS MUNIS DE CARTOUCHE DE 3ML",
    "LISTE": "LISTE II",
    "P1": "OFF",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVO NORDISK A/S",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "DANEMARK",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/1/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "20/1/2020",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "30MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [
      "insulin aspart",
      "insulin degludec",
      "insulin detemir",
      "insulin glargine",
      "insulin glulisine",
      "insulin lispro"
    ],
    "InteractionIndexLink": ["insuline", "insuline glargine"],
    "N_ENREGISTREMENT": "21/14 B 384/376",
    "CODE_DCI": "14 B 384",
    "DCI": "INSULINE GLARGINE",
    "NOM_COMMERCIALE": "TOUJEO SOLOSTAR",
    "FORME": "SOL. INJ. EN STYLO PREREMPLI",
    "DOSAGE": "300UI/ML",
    "COND": "B/5 STYLOS DE 105ML",
    "LISTE": "LISTE II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANOFI AVENTIS DEUTSCHLAND GmbH",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALLEMAGNE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/04/21",
    "DATE_D_ENREGISTREMENT_FINAL": "25/04/21",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "30 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["glucagon"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "069/ 14 C 139 /98/17",
    "CODE_DCI": "14 C 139",
    "DCI": "Glucagon chlorhydrate exprimé en glucagon",
    "NOM_COMMERCIALE": "GLUCAGEN HYPOKIT",
    "FORME": "PDRE ET SOLVANT PR SOL INJ",
    "DOSAGE": "1MG/ML",
    "COND": "B/1FL. DE PDR + 1 SERING. DE 1ML DE SOLV.",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVO NORDISK",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "DANEMARK",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/11/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "31/1/2018",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "255/ 14 D 022 /98/16",
    "CODE_DCI": "14 D 022",
    "DCI": "POLYSTIRENE SULFONATE DE SODIUM",
    "NOM_COMMERCIALE": "KAYEXALATE",
    "FORME": "PDRE.SUSP.OR. et REC.",
    "DOSAGE": "15G/MESURETTE",
    "COND": "B/454G",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANOFI SYNTHELABO",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/1/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "6/3/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "48 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["cyproheptadine"],
    "InteractionIndexLink": ["cyproheptadine"],
    "N_ENREGISTREMENT": "077/ 14 F 024 /03/14",
    "CODE_DCI": "14 F 024",
    "DCI": "CYPROHEPTADINE CHLORHYDRATE EXPRIME EN CYPROHEPTADINE",
    "NOM_COMMERCIALE": "HEPTAL",
    "FORME": "SIROP",
    "DOSAGE": "2MG/5ML",
    "COND": "FL/125ML",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE ALGERIEN DU MEDICAMENT  (LAM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/6/2003",
    "DATE_D_ENREGISTREMENT_FINAL": "27/2/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["cyproheptadine"],
    "InteractionIndexLink": ["cyproheptadine"],
    "N_ENREGISTREMENT": "073/ 14 F 024 /98/18",
    "CODE_DCI": "14 F 024",
    "DCI": "CYPROHEPTADINE CHLORHYDRATE EXPRIME EN CYPROHEPTADINE",
    "NOM_COMMERCIALE": "ISOCTINE",
    "FORME": "SOL.BUV.",
    "DOSAGE": "2MG/5ML",
    "COND": "FL/100ML",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ISOPHARM ALGERIE SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/12/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "20/3/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["cyproheptadine"],
    "InteractionIndexLink": ["cyproheptadine"],
    "N_ENREGISTREMENT": "242/ 14 F 025 /10/17",
    "CODE_DCI": "14 F 025",
    "DCI": "CYPROHEPTADINE CHLORHYDRATE EXPRIME EN CYPROHEPTADINE",
    "NOM_COMMERCIALE": "LAPETI",
    "FORME": "COMPRIME",
    "DOSAGE": "4MG",
    "COND": "B/20",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GROUPE SANTE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/11/2010",
    "DATE_D_ENREGISTREMENT_FINAL": "12/2/2017",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["cyproheptadine"],
    "InteractionIndexLink": ["cyproheptadine"],
    "N_ENREGISTREMENT": "097/ 14 F 025 /09/14",
    "CODE_DCI": "14 F 025",
    "DCI": "CYPROHEPTADINE CHLORHYDRATE EXPRIME EN CYPROHEPTADINE",
    "NOM_COMMERCIALE": "MODESTAMINE",
    "FORME": "COMPRIME",
    "DOSAGE": "4MG",
    "COND": "B/20",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANAMED SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/3/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "8/6/2014",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["cyproheptadine"],
    "InteractionIndexLink": ["cyproheptadine"],
    "N_ENREGISTREMENT": "418/ 14 F 025 /12/19",
    "CODE_DCI": "14 F 025",
    "DCI": "CYPROHEPTADINE CHLORHYDRATE EXPRIME EN CYPROHEPTADINE",
    "NOM_COMMERCIALE": "ORYACTINE",
    "FORME": "COMPRIME",
    "DOSAGE": "4MG",
    "COND": "B/20",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NEOMEDIC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/10/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "13/4/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["cyproheptadine"],
    "InteractionIndexLink": ["cyproheptadine"],
    "N_ENREGISTREMENT": "285/ 14 F 025 /99/20",
    "CODE_DCI": "14 F 025",
    "DCI": "CYPROHEPTADINE CHLORHYDRATE EXPRIME EN CYPROHEPTADINE",
    "NOM_COMMERCIALE": "PERIACTINE",
    "FORME": "COMPRIME",
    "DOSAGE": "4MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "UNION PHARMACEUTIQUE CONSTANTINOISE (UPC) SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "16/1/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "4/5/2020",
    "TYPE": "Ré",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["calcium carbimide"],
    "InteractionIndexLink": ["calcium"],
    "N_ENREGISTREMENT": "348/ 14 G 027 /11",
    "CODE_DCI": "14 G 027",
    "DCI": "BROMO-GALACTOGLUCONATE DE CALCIUM",
    "NOM_COMMERCIALE": "CALCIBRO",
    "FORME": "COMP. EFFERV.",
    "DOSAGE": "2G",
    "COND": "T/20",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIAN PHARMACEUTICAL INSTITUT (API)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/11/2011",
    "DATE_D_ENREGISTREMENT_FINAL": "27/11/2011",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["calcium carbimide"],
    "InteractionIndexLink": ["calcium"],
    "N_ENREGISTREMENT": "280 / 14 G 028/18",
    "CODE_DCI": "14 G 028",
    "DCI": "Chlorure de calcium héxahydraté",
    "NOM_COMMERCIALE": "CALCIPACK",
    "FORME": "SOL INJ A DILUER",
    "DOSAGE": "10G / 100ML ( 10%)",
    "COND": "B / 50 AMP DE 10 ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "IMC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/7/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "24/7/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["calcium carbimide"],
    "InteractionIndexLink": ["calcium"],
    "N_ENREGISTREMENT": "268/14 G 029/07/18",
    "CODE_DCI": "14 G 029",
    "DCI": "CALCIUM CARBONATE EXPRIME EN CALCIUM ELEMENT",
    "NOM_COMMERCIALE": "CALCIDOSE",
    "FORME": "PDRE. SUSP. BUV.EN SACHET DOSE",
    "DOSAGE": "500MG/SACHET DOSE (1250MG/SACHET DOSE DE CARBONATE DE CALCIUM )",
    "COND": "B/30",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MERINAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/12/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "1/8/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["calcium carbimide"],
    "InteractionIndexLink": ["calcium"],
    "N_ENREGISTREMENT": "388/ 14 G 029 /11",
    "CODE_DCI": "14 G 029",
    "DCI": "CALCIUM CARBONATE EXPRIME EN CALCIUM ELEMENT",
    "NOM_COMMERCIALE": "CALCIUM HYSA 500",
    "FORME": "PDRE. P. SUSP. BUV. EN SACH.",
    "DOSAGE": "500MG DE CALCIUM (1250MG DE CALCIUM CARBONATE)",
    "COND": "B/30",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HYSA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "14/6/2011",
    "DATE_D_ENREGISTREMENT_FINAL": "14/6/2011",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["calcium carbimide"],
    "InteractionIndexLink": ["calcium"],
    "N_ENREGISTREMENT": "263/ 14 G 029 /15",
    "CODE_DCI": "14 G 029",
    "DCI": "CARBONATE DE CALCIUM EXPRIME EN CALCIUM ELEMENT",
    "NOM_COMMERCIALE": "KINADYN CALCIUM",
    "FORME": "PDRE. P. SUSP. BUV. EN SACHET DOSE",
    "DOSAGE": "500MG/SACHET",
    "COND": "B/30SACHETS",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOPHARM SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/3/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "18/3/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["calcium carbimide"],
    "InteractionIndexLink": ["calcium"],
    "N_ENREGISTREMENT": "235/14 G 029/17",
    "CODE_DCI": "14 G 029",
    "DCI": "CARBONATE DE CALCIUM EXPRIME EN CALCIUM ELEMENT",
    "NOM_COMMERCIALE": "OSSECAL",
    "FORME": "PDRE. P. SUSP. BUV. EN SACHET DOSE",
    "DOSAGE": "500MG/SACHET",
    "COND": "B/30SACHETS",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOGALENIC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/6/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "18/6/2017",
    "TYPE": "G",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["Cholécalciférol"],
    "N_ENREGISTREMENT": "079/ 14 G 037 /98/08",
    "CODE_DCI": "14 G 037",
    "DCI": "PHOSPHATE TRICALCIQUE / FLUORURE DE SODIUM / VITAMINE D3 / ASCORBATE DE SODIUM",
    "NOM_COMMERCIALE": "NEOCALCIGENOL",
    "FORME": "SUSP.BUV.",
    "DOSAGE": "125MG/0.5MG/8µG/22.50MG/5ML",
    "COND": "FL/125 ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE  ALGERIEN DE DEVELOPPEMENT  PHARMACEUTIQUE   (LAD PHARMA)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "23/12/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "17/9/2008",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["levocarnitine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "14 G 038",
    "DCI": "LEVOCARNITINE",
    "NOM_COMMERCIALE": "LEVOTYNE",
    "FORME": "SOL. BUV.",
    "DOSAGE": "10% (10G/100ML)",
    "COND": "B/1FL. DE 100ML",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "433/ 14 G 042 /15",
    "CODE_DCI": "14 G 042",
    "DCI": "EAU POUR PREPARATIONS INJECTABLES IM/IV",
    "NOM_COMMERCIALE": "EAU POUR PREPARATIONS INJECTABLES RAZES",
    "FORME": "---",
    "DOSAGE": "---",
    "COND": "FL/500ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRATER RAZES SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/1/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "18/1/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "60 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "280/ 14 G 042 /13/18",
    "CODE_DCI": "14 G 042",
    "DCI": "EAU POUR PREPARATIONS INJECTABLES IM/IV",
    "NOM_COMMERCIALE": "WI PACK",
    "FORME": "",
    "DOSAGE": "FL/500ML",
    "COND": "FL/500ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDUSTRIES MEDICO-CHIRURGICALES (IMC) SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/3/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "25/7/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "003/ 14 G 044 /97/17",
    "CODE_DCI": "14 G 044",
    "DCI": "GLUCOSE",
    "NOM_COMMERCIALE": "GLUCOSE 5%",
    "FORME": "SOL.INJ. PERF.",
    "DOSAGE": "5% FL. 500ML",
    "COND": "POCHE DE 500ML AVEC 2TWIN VALVES",
    "LISTE": "",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EPE GROUPE INDUSTRIEL SAIDAL/SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "5/1/1997",
    "DATE_D_ENREGISTREMENT_FINAL": "16/7/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "280/ 14 G 044 /01/18",
    "CODE_DCI": "14 G 044",
    "DCI": "GLUCOSE",
    "NOM_COMMERCIALE": "GLUCOSE 5%",
    "FORME": "SOLUTE MASSIF P. PERF.",
    "DOSAGE": "5 %",
    "COND": "POCHE DE 500ML ET  FLACON EN POLYPROPYLENE DE 500ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDUSTRIES MEDICO-CHIRURGICALES (IMC) SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/1/2001",
    "DATE_D_ENREGISTREMENT_FINAL": "8/4/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "POCHE DE 500 ML 18 MOIS /FLACON DE 500 ML 24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "280/ 14 G 046 /12/18",
    "CODE_DCI": "14 G 046",
    "DCI": "GLUCOSE MONOHYDRATEE EXPRIME EN GLUCOSE ANHYDRE",
    "NOM_COMMERCIALE": "GLUCOPACK",
    "FORME": "SO. INJ. P. PERF. IV",
    "DOSAGE": "10 %",
    "COND": "FL. EN POLYPROYLENE DE 500ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDUSTRIES MEDICO-CHIRURGICALES (IMC) SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/9/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "30/5/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "280/ 14 G 048 /13/21",
    "CODE_DCI": "14 G 048",
    "DCI": "GLUCOSE MONOHYDRATE EXPRIME EN GLUCOSE ANHYDRE",
    "NOM_COMMERCIALE": "GLUCOPACK",
    "FORME": "SOL. INJ. P. PERF. IV",
    "DOSAGE": "15 %",
    "COND": "FLC 500ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDUSTRIES MEDICO-CHIRURGICALES (IMC)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/8/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "14/4/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [
      "magnesium (hydroxyde de)",
      "magnesium (trisilicate de)"
    ],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "14 G 054",
    "DCI": "MAGNESIUM",
    "NOM_COMMERCIALE": "ENERMAG",
    "FORME": "AMP.BUV",
    "DOSAGE": "1.5 G",
    "COND": "B/20",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [
      "magnesium (hydroxyde de)",
      "magnesium (trisilicate de)"
    ],
    "N_ENREGISTREMENT": "319/ 14 G 054 /08",
    "CODE_DCI": "14 G 054",
    "DCI": "MAGNESIUM PIDOLATE",
    "NOM_COMMERCIALE": "PYROMAG",
    "FORME": "SOL. BUV.",
    "DOSAGE": "0.15G/ML  (15%) (750MG/5ML)* (EQUIV. 12.2MG/ML DE MAGNESIUM)",
    "COND": "B/20AMP. DE 10ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ARAB PHARM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/12/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "15/12/2008",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [
      "magnesium (hydroxyde de)",
      "magnesium (trisilicate de)"
    ],
    "N_ENREGISTREMENT": "248/ 14 G 054 /03",
    "CODE_DCI": "14 G 054",
    "DCI": "MAGNESIUM PIDOLATE",
    "NOM_COMMERCIALE": "TONIMAG",
    "FORME": "AMP.BUV.",
    "DOSAGE": "1.5MG/5ML",
    "COND": "B/20",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE PHARMACIEN MEHALLA (LPM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "23/3/2003",
    "DATE_D_ENREGISTREMENT_FINAL": "23/3/2003",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [
      "magnesium (hydroxyde de)",
      "magnesium (trisilicate de)"
    ],
    "N_ENREGISTREMENT": "433/14 G 055/20",
    "CODE_DCI": "14 G 055",
    "DCI": "Sulfate de  Magnésium  heptahydraté",
    "NOM_COMMERCIALE": "RAZIMAG",
    "FORME": "Solution injectable IV",
    "DOSAGE": "15% (1.5G/10ML)",
    "COND": "B/50 AMPS",
    "LISTE": "",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRATER RAZES SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "16/7/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "16/7/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "075/ 14 G 056 /98",
    "CODE_DCI": "14 G 056",
    "DCI": "OLIGOELEMENTS",
    "NOM_COMMERCIALE": "NONAN",
    "FORME": "SOL.INJ.",
    "DOSAGE": "",
    "COND": "B/25 FL de 50 ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "AGUETTANT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/10/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "28/10/1998",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["potassium"],
    "N_ENREGISTREMENT": "075/ 14 G 059 /00",
    "CODE_DCI": "14 G 059",
    "DCI": "CHLORURE DE POTASSIUM",
    "NOM_COMMERCIALE": "CHLORURE DE POTASSIUM AGUETTANT",
    "FORME": "SOL.INJ.",
    "DOSAGE": "10 %",
    "COND": "B/50AMP. DE  20ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "AGUETTANT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "16/8/2000",
    "DATE_D_ENREGISTREMENT_FINAL": "16/8/2000",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["potassium"],
    "N_ENREGISTREMENT": "280/14 G 059/17",
    "CODE_DCI": "14 G 059",
    "DCI": "CHLORURE DE POTASSIUM",
    "NOM_COMMERCIALE": "KALIPACK",
    "FORME": "SOL.INJ.A DILUER",
    "DOSAGE": "10% ( 0.1G/ML)",
    "COND": "10ML",
    "LISTE": "liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDUSTRIES MEDICO-CHIRURGICALES (IMC)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/6/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "18/6/2017",
    "TYPE": "GE",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["potassium"],
    "N_ENREGISTREMENT": "320/14 G 061/20",
    "CODE_DCI": "14 G 061",
    "DCI": "GLUCONATE DE POTASSIUM",
    "NOM_COMMERCIALE": "K-PLUS",
    "FORME": "SIROP.",
    "DOSAGE": "15 %",
    "COND": "FLC 200ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES AGD PHARM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "5/10/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "5/10/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["potassium"],
    "N_ENREGISTREMENT": "20/14 G061/320",
    "CODE_DCI": "14 G 061",
    "DCI": "GLUCONATE DE POTASSIUM",
    "NOM_COMMERCIALE": "K-PLUS",
    "FORME": "SIROP",
    "DOSAGE": "15 %",
    "COND": "FL/ 200ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL AGD PHARM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "5/10/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "5/10/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["potassium"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "14 G 061",
    "DCI": "gluconate de potassium",
    "NOM_COMMERCIALE": "K-Plus",
    "FORME": "sirop",
    "DOSAGE": "0.15",
    "COND": "Flacon de 200 ml",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["potassium"],
    "N_ENREGISTREMENT": "003/ 14 G 061 /97/20",
    "CODE_DCI": "14 G 061",
    "DCI": "POTASSIUM GLUCONATE",
    "NOM_COMMERCIALE": "KALIGON",
    "FORME": "SIROP",
    "DOSAGE": "15 %",
    "COND": "FL/120ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EPE GROUPE INDUSTRIEL SAIDAL/SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/12/1997",
    "DATE_D_ENREGISTREMENT_FINAL": "27/12/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["potassium"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "14 G 061",
    "DCI": "POTASSIUM GLUCONATE",
    "NOM_COMMERCIALE": "KALIGON",
    "FORME": "SIROP",
    "DOSAGE": "0.15",
    "COND": "FL/120ML",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["potassium"],
    "N_ENREGISTREMENT": "003/ 14 G 065 /97/21",
    "CODE_DCI": "14 G 065",
    "DCI": "Chlorure de sodium / Chlorure de potassium/Citrate de sodium sous forme trisodique dihydraté /Glucose anhydre",
    "NOM_COMMERCIALE": "REHYDRAX",
    "FORME": "PDRE.ORALE EN .SACHETS",
    "DOSAGE": "2.6G/ 1.5G /2.9G/ 13.5G / SACHET",
    "COND": "B/100SACH. DE 20.5G",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EPE GROUPE INDUSTRIEL  SAIDAL / SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/8/1997",
    "DATE_D_ENREGISTREMENT_FINAL": "15/2/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["potassium"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "14 G 065",
    "DCI": "CHLORURE DE SODIUM/CHLORURE DE POTASSIUM/CITRATE DE SODIUM SOUS FORME TRISODIQUE DIHYDRATEE /GLUCOSE ANHYDRE",
    "NOM_COMMERCIALE": "REHYDRAX",
    "FORME": "PDRE.OR.SACH.",
    "DOSAGE": "2.6G/ 1.5G /2.9G/ 13.5G / SACH. DE 20.5G",
    "COND": "B/100SACH. DE 20.5G",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["calcium carbimide"],
    "InteractionIndexLink": ["calcium", "potassium"],
    "N_ENREGISTREMENT": "280/ 14 G 066 /11/20",
    "CODE_DCI": "14 G 066",
    "DCI": "SODIUM CHLORURE / POTASSIUM CHLORURE / CALCIUM CHLORURE DIHYDRATE / SODIUM LACTATE",
    "NOM_COMMERCIALE": "LACTAFLEX",
    "FORME": "SOL. P. PERF.",
    "DOSAGE": "0.6G  / 0.04G / 0.027G /0.320G /100ML (131.23mmol Sodium / 5.37mmol Potassium / 1.83mmol de Calcium / 111.69mmol de Chlorures / 28.56mmol de Lactates /L)",
    "COND": "POCHE DE 500ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES SARL INDUSTRIES MEDICO-CHIRURGICALES (IMC)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/2/2011",
    "DATE_D_ENREGISTREMENT_FINAL": "22/11/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "003/ 14 G 078 /97/17",
    "CODE_DCI": "14 G 078",
    "DCI": "SODIUM CHLORURE",
    "NOM_COMMERCIALE": "CHLORURE DE SODIUM 0.9%",
    "FORME": "SOL.INJ. PERF.",
    "DOSAGE": "0.9%",
    "COND": "POCHE DE 250 ML AVEC 2 TWIN VALVES ET POCHE DE 500 ML AVEC 2 TWIN VALVES",
    "LISTE": "",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EPE  GROUPE INDUSTRIEL SAIDAL SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "5/1/1997",
    "DATE_D_ENREGISTREMENT_FINAL": "7/3/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "280/ 14 G 078 /00/18",
    "CODE_DCI": "14 G 078",
    "DCI": "SODIUM CHLORURE ISOTONIQUE",
    "NOM_COMMERCIALE": "CHLORURE DE SODIUM 0.9%",
    "FORME": "SOLUTE .MASSIF P. PERF.",
    "DOSAGE": "0.9%",
    "COND": "POCHE DE 500ML ET FLACON EN POLYPROPYLENE DE 500ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDUSTRIES MEDICO-CHIRURGICALES (IMC)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "16/8/2000",
    "DATE_D_ENREGISTREMENT_FINAL": "27/5/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "129/ 14 G 078 /99",
    "CODE_DCI": "14 G 078",
    "DCI": "SODIUM CHLORURE",
    "NOM_COMMERCIALE": "CHLORURE DE SODIUM BIEFFE",
    "FORME": "SOL INJ.",
    "DOSAGE": "0.9%",
    "COND": "POCHE DE 500ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIEFFE MEDITAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ITALIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/1/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "13/1/1999",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["calcium carbimide"],
    "InteractionIndexLink": ["calcium"],
    "N_ENREGISTREMENT": "433/14 G 080/19",
    "CODE_DCI": "14 G 080",
    "DCI": "CALCIUM CHLORURE",
    "NOM_COMMERCIALE": "CHLORURE DE CALCIUM RAZES 10%",
    "FORME": "SOL INJ IV LENTE",
    "DOSAGE": "1G/10ML",
    "COND": "AMP TRANSPARENTE DE 10ML B/50 AMPS",
    "LISTE": "",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRATER RAZES SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/10/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "29/10/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "003/ 14 G 080 /14",
    "CODE_DCI": "14 G 080",
    "DCI": "CHLORURE DE SODIUM",
    "NOM_COMMERCIALE": "CHLORURE DE SODIUM HYPERTONIQUE SAIDAL",
    "FORME": "SOL INJ A DILUER P/ PERF IV",
    "DOSAGE": "10 %",
    "COND": "B/50 AMPS DE 10ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SAIDALGROUPE INDUSTRIEL EPE/SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/4/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "13/4/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "280/14 G 080 /15",
    "CODE_DCI": "14 G 080",
    "DCI": "SODIUM CHLORURE",
    "NOM_COMMERCIALE": "NATRIPACK",
    "FORME": "SOLUTION INJECTABLE A DILUER",
    "DOSAGE": "10 %",
    "COND": "B/50 AMPOULES DE 10ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRS INDUSTRIES MEDICO-CHIRURGICALES SARL IMC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/12/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "13/12/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["calcium carbimide"],
    "InteractionIndexLink": ["calcium"],
    "N_ENREGISTREMENT": "007/ 14 G 104 /98/14",
    "CODE_DCI": "14 G 104",
    "DCI": "CALCIUM GLUCONOLACTATE/CARBONATE DE CALCIUM",
    "NOM_COMMERCIALE": "CALCIUM SANDOZ",
    "FORME": "PDRE  EN SACH. POUR SOL.BUV.",
    "DOSAGE": "3.40G/0.150G/SACHET OU 500MG EN CALCIUM ELEMENT",
    "COND": "B/30",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANDOZ",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/9/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "24/3/2014",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["calcium carbimide"],
    "InteractionIndexLink": ["calcium"],
    "N_ENREGISTREMENT": "077/ 14 G 135 /97/15",
    "CODE_DCI": "14 G 135",
    "DCI": "CALCIUM PIDOLATE EXPRIME EN CALCIUM ELEMENT",
    "NOM_COMMERCIALE": "CALCIAL",
    "FORME": "SIROP",
    "DOSAGE": "67.5MG/5ML (0.5G/5ML EN CALCIUM PIDOLATE)",
    "COND": "FL/125ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE ALGERIEN DU MEDICAMENT  (LAM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/12/1997",
    "DATE_D_ENREGISTREMENT_FINAL": "31/3/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["calcium carbimide"],
    "InteractionIndexLink": ["calcium"],
    "N_ENREGISTREMENT": "079/ 14 G 135 /97/19",
    "CODE_DCI": "14 G 135",
    "DCI": "CALCIUM PIDOLATE EXPRIME EN CALCIUM ELEMENT",
    "NOM_COMMERCIALE": "CALCIFOR",
    "FORME": "SIROP",
    "DOSAGE": "67.5MG/5ML EN CALCIUM ELEMENT (10%  EN CALCIUM PIDOLATE)",
    "COND": "FL/125ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE  ALGERIEN DE DEVELOPPEMENT  PHARMACEUTIQUE   (LAD)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/12/1997",
    "DATE_D_ENREGISTREMENT_FINAL": "6/4/2009",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["calcium carbimide"],
    "InteractionIndexLink": ["calcium"],
    "N_ENREGISTREMENT": "149/14 G 141/17",
    "CODE_DCI": "14 G 141",
    "DCI": "CALCIUM CARBONATE",
    "NOM_COMMERCIALE": "CALCIUM NOVAGENERICS",
    "FORME": "COMPRIME A SUCER SECABLE",
    "DOSAGE": "500MG",
    "COND": "B/60",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVAPHARM TRADING SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/1/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "9/1/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["calcium carbimide"],
    "InteractionIndexLink": ["calcium"],
    "N_ENREGISTREMENT": "490/ 14 G 141 /18",
    "CODE_DCI": "14 G 141",
    "DCI": "CALCIUM CARBONATE EXPRIME EN CALCIUM ELEMENT",
    "NOM_COMMERCIALE": "KALCITAB",
    "FORME": "COMPRIME",
    "DOSAGE": "500MG",
    "COND": "B/60",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL PHARMASPHERE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/9/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "19/9/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["calcium carbimide"],
    "InteractionIndexLink": ["calcium"],
    "N_ENREGISTREMENT": "235/14 G 141/18",
    "CODE_DCI": "14 G 141",
    "DCI": "CALCIUM CARBONATE EXPRIME EN CALCIUM ELEMENT",
    "NOM_COMMERCIALE": "OSSECAL",
    "FORME": "COMPRIME A SUCER",
    "DOSAGE": "500MG",
    "COND": "B/60",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOGALENIC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/5/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "30/5/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [
      "magnesium (hydroxyde de)",
      "magnesium (trisilicate de)"
    ],
    "N_ENREGISTREMENT": "067/ 14 G 161 /06",
    "CODE_DCI": "14 G 161",
    "DCI": "ASPARTATE DE MAGNESIUM DIHYDRATE",
    "NOM_COMMERCIALE": "MEGAMAG",
    "FORME": "GLES.",
    "DOSAGE": "400MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MAYOLY SPINDLER",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/12/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "10/12/2006",
    "TYPE": "Ré",
    "STATUT": "C",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [
      "magnesium (hydroxyde de)",
      "magnesium (trisilicate de)"
    ],
    "N_ENREGISTREMENT": "077/ 14 G 162 /98/14",
    "CODE_DCI": "14 G 162",
    "DCI": "MAGNESIUM PIDOLATE",
    "NOM_COMMERCIALE": "ACTIMAG",
    "FORME": "SIROP",
    "DOSAGE": "15% (0.75G/5ML SOIT 61MG/5ML DE MAGNESIUM ELEMENT)",
    "COND": "FL/200ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE ALGERIEN DU MEDICAMENT (LAM) SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/6/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "6/7/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [
      "magnesium (hydroxyde de)",
      "magnesium (trisilicate de)"
    ],
    "N_ENREGISTREMENT": "073/ 14 G 162 /98/09",
    "CODE_DCI": "14 G 162",
    "DCI": "MAGNESIUM PIDOLATE",
    "NOM_COMMERCIALE": "ISOMAG",
    "FORME": "SOL.BUV.",
    "DOSAGE": "15 %",
    "COND": "FL/150ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ISOPHARM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/8/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "24/9/2009",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [
      "magnesium (hydroxyde de)",
      "magnesium (trisilicate de)"
    ],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "14 G 162",
    "DCI": "MAGNESIUM PIDOLATE",
    "NOM_COMMERCIALE": "ISOMAG",
    "FORME": "SOL.BUV.",
    "DOSAGE": "0.15",
    "COND": "FL/150ML",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [
      "magnesium (hydroxyde de)",
      "magnesium (trisilicate de)"
    ],
    "N_ENREGISTREMENT": "242/ 14 G 162 /06",
    "CODE_DCI": "14 G 162",
    "DCI": "MAGNESIUM PIDOLATE",
    "NOM_COMMERCIALE": "MAGNE",
    "FORME": "SIROP",
    "DOSAGE": "15% ( OU 0.75G/5ML)",
    "COND": "FL./125ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GROUPE SANTE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/10/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "17/10/2006",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [
      "magnesium (hydroxyde de)",
      "magnesium (trisilicate de)"
    ],
    "N_ENREGISTREMENT": "079/ 14 G 162 /10",
    "CODE_DCI": "14 G 162",
    "DCI": "MAGNESIUM ELEMENT (SOUS FORME DE MAGNESIUM PIDOLATE)",
    "NOM_COMMERCIALE": "VITAMAG",
    "FORME": "SOL. BUV. EN FL.",
    "DOSAGE": "61MG/5ML DE MAGNESIUM (SOIT 0.75G/5ML OU 15% DE MAGNESIUM PIDOLATE )",
    "COND": "FL./125ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LAD PHARMA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/5/2010",
    "DATE_D_ENREGISTREMENT_FINAL": "13/5/2010",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "075/ 14 G 170 /00",
    "CODE_DCI": "14 G 170",
    "DCI": "CHLORURE DE SODIUM",
    "NOM_COMMERCIALE": "URO 3000CHLORURE DE SODIUM 0.9%",
    "FORME": "SOL. P. IRRIGATION VESICALE",
    "DOSAGE": "0.9%",
    "COND": "CARTON DE 4 POCH. EN PVC DE 3L",
    "LISTE": "",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "AGUETTANT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/2/2000",
    "DATE_D_ENREGISTREMENT_FINAL": "27/2/2000",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["calcium carbimide"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "14 G 175",
    "DCI": "calcium-cholecarciferol",
    "NOM_COMMERCIALE": "CALCIUM D3",
    "FORME": "comp a sucer",
    "DOSAGE": "500 mg-400 UI",
    "COND": "boite de 60",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["calcium carbimide"],
    "InteractionIndexLink": ["calcium", "cholecalciferol"],
    "N_ENREGISTREMENT": "521/ 14 G 175 /09/18",
    "CODE_DCI": "14 G 175",
    "DCI": "CHOLECALCIFEROL  / CALCIUM CARBONATE EXPRIME EN CALCIUM ELEMENT",
    "NOM_COMMERCIALE": "CALCIUM D3 IVAL",
    "FORME": "COMPRIME A CROQUER",
    "DOSAGE": "400UI/500MG",
    "COND": "B/60",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL WORLD MEDECINE LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/4/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "24/4/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["calcium carbimide"],
    "InteractionIndexLink": ["calcium", "cholecalciferol"],
    "N_ENREGISTREMENT": "149/14 G 175/17",
    "CODE_DCI": "14 G 175",
    "DCI": "CHOLECALCIFEROL  / CALCIUM CARBONATE EXPRIME EN CALCIUM ELEMENT",
    "NOM_COMMERCIALE": "CALCIUM D3 NOVAGENERICS",
    "FORME": "COMPRIME A SUCER",
    "DOSAGE": "400UI/500MG",
    "COND": "PILULIER DE 60",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVAPHARM TRADING SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/3/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "29/3/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["calcium carbimide"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "14 G 175",
    "DCI": "calcium-cholecarciferol",
    "NOM_COMMERCIALE": "CALCIUM D3 NOVAGENERICS",
    "FORME": "comp a sucer",
    "DOSAGE": "500 mg-400 UI",
    "COND": "boite de 60",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["calcium carbimide"],
    "InteractionIndexLink": ["calcium", "cholecalciferol"],
    "N_ENREGISTREMENT": "039/14 G 175/17",
    "CODE_DCI": "14 G 175",
    "DCI": "CHOLECALCIFEROL / CALCIUM CARBONATE EXPRIME EN CALCIUM ELEMENT",
    "NOM_COMMERCIALE": "CALCIUM D3 SOPHAL",
    "FORME": "COMP. A SUCER OU A CROQUER",
    "DOSAGE": "400UI/500MG",
    "COND": "B/60",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOPHAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/7/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "2/7/2017",
    "TYPE": "GE",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["calcium carbimide"],
    "InteractionIndexLink": ["calcium", "cholecalciferol"],
    "N_ENREGISTREMENT": "348/ 14 G 175 /08",
    "CODE_DCI": "14 G 175",
    "DCI": "CHOLECALCIFEROL / CALCIUM CARBONATE EXPRIME EN CALCIUM ELEMENT",
    "NOM_COMMERCIALE": "FIXECAL",
    "FORME": "COMPRIME A SUCER",
    "DOSAGE": "400UI/500MG",
    "COND": "B/28",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIAN PHARMACEUTICAL INSTITUT (API)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/12/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "17/12/2008",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["calcium carbimide"],
    "InteractionIndexLink": ["calcium", "cholecalciferol"],
    "N_ENREGISTREMENT": "087/14 G 175/99/16",
    "CODE_DCI": "14 G 175",
    "DCI": "CHOLECALCIFEROL  / CALCIUM CARBONATE EXPRIME EN CALCIUM ELEMENT",
    "NOM_COMMERCIALE": "IDEOS",
    "FORME": "COMPRIME A CROQUER",
    "DOSAGE": "400UI/500MG",
    "COND": "B DE 2 TUBES DE 15 CP",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INNOTECH INTERNATIONAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "21/8/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "28/12/2016",
    "TYPE": "Ré",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["calcium carbimide"],
    "InteractionIndexLink": ["calcium", "cholecalciferol"],
    "N_ENREGISTREMENT": "235/  14 G 175 /15",
    "CODE_DCI": "14 G 175",
    "DCI": "CHOLECALCIFEROL  / CALCIUM CARBONATE EXPRIME EN CALCIUM ELEMENT",
    "NOM_COMMERCIALE": "OSSE D3",
    "FORME": "COMPRIME A SUCER",
    "DOSAGE": "400UI/500MG",
    "COND": "B DE 1 FLACON DE 60",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOGALENIC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/12/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "2/12/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["calcium carbimide"],
    "InteractionIndexLink": ["calcium", "cholecalciferol"],
    "N_ENREGISTREMENT": "571/14 G 175/20",
    "CODE_DCI": "14 G 175",
    "DCI": "CARBONATE DE CALCIUM EXPRIME EN CALCIUM ELEMENT/ CHOLECALCIFEROL",
    "NOM_COMMERCIALE": "OSSEANS D3",
    "FORME": "COMP. A CROQUER OU A SUCER",
    "DOSAGE": "500MG/ 400U.I",
    "COND": "B/60",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL/LABORATOIRE MOBEN",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/12/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "17/12/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "433/ 14 G 183 /15",
    "CODE_DCI": "14 G 183",
    "DCI": "EAU POUR PREPARATIONS INJECTABLES IM/IV",
    "NOM_COMMERCIALE": "EAU POUR PREPARATIONS INJECTABLES RAZES",
    "FORME": "---",
    "DOSAGE": "AMP. DE 2ML",
    "COND": "B/50 AMP. DE 2ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRATER RAZES SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/1/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "25/1/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "543/ 14 G 185 /19",
    "CODE_DCI": "14 G 185",
    "DCI": "EAU POUR PREPARATIONS INJECTABLES IM/IV",
    "NOM_COMMERCIALE": "EAU POUR PREPARATION INJECTABLE BIOTHERA",
    "FORME": "---",
    "DOSAGE": "AMP. DE 5ML",
    "COND": "B/50 AMP. DE 5ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOTHERA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "14/3/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "14/3/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "433/ 14 G 185 /15",
    "CODE_DCI": "14 G 185",
    "DCI": "EAU POUR PREPARATIONS INJECTABLES IM/IV",
    "NOM_COMMERCIALE": "EAU POUR PREPARATIONS INJECTABLES RAZES",
    "FORME": "---",
    "DOSAGE": "AMP. DE 5ML",
    "COND": "B/50 AMP. DE 5ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRATER RAZES SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/1/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "18/1/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "543/ 14 G 186 /19",
    "CODE_DCI": "14 G 186",
    "DCI": "EAU POUR PREPARATION INJECTABLE IM/IV",
    "NOM_COMMERCIALE": "EAU POUR PREPARATION INJECTABLE BIOTHERA",
    "FORME": "---",
    "DOSAGE": "AMP. DE 10ML",
    "COND": "B/50AMP. DE 10ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOTHERA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "14/3/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "14/3/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "433/ 14 G 186 /13",
    "CODE_DCI": "14 G 186",
    "DCI": "EAU POUR PREPARATION INJECTABLE IM/IV",
    "NOM_COMMERCIALE": "EAU POUR PREPARATION INJECTABLE RAZES",
    "FORME": "---",
    "DOSAGE": "AMP. DE 10ML",
    "COND": "B/50AMP. DE 10ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRATER-RAZES SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/4/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "7/4/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "280/ 14 G 186 /15",
    "CODE_DCI": "14 G 186",
    "DCI": "EAU POUR PREPARATION INJECTABLE",
    "NOM_COMMERCIALE": "WIPACK",
    "FORME": "SOLUTION POUR DILUTION DE MéDICAMENT DESTINéS A ETRE INJECTéS EN IM /IV",
    "DOSAGE": "AMPOULE DE 10 ML",
    "COND": "B/50 AMP. DE 10ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES INDUSTRIE MéDICO CHIRURGICALES SARL IMC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/12/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "2/12/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [
      "magnesium (hydroxyde de)",
      "magnesium (trisilicate de)"
    ],
    "N_ENREGISTREMENT": "273/ 14 G 229 /06",
    "CODE_DCI": "14 G 229",
    "DCI": "OXYDE DE MAGNESIUM",
    "NOM_COMMERCIALE": "MAGNO SANOL",
    "FORME": "GLES.",
    "DOSAGE": "250MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SCHWARZ PHARMA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALLEMAGNE",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/7/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "1/7/2006",
    "TYPE": "Gé",
    "STATUT": "C",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [
      "magnesium (hydroxyde de)",
      "magnesium (trisilicate de)"
    ],
    "N_ENREGISTREMENT": "235 / 14 G 229/18",
    "CODE_DCI": "14 G 229",
    "DCI": "OXYDE DE MAGNESIUM",
    "NOM_COMMERCIALE": "O MAG",
    "FORME": "GLES.",
    "DOSAGE": "250MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOGALENIC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/1/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "29/1/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["calcium carbimide"],
    "InteractionIndexLink": ["calcium"],
    "N_ENREGISTREMENT": "348/ 14 G 315 /08",
    "CODE_DCI": "14 G 315",
    "DCI": "CALCIUM CARBONATE EXPRIME EN CALCIUM ELEMENT",
    "NOM_COMMERCIALE": "CALCIUM API",
    "FORME": "COMP. EFFER.",
    "DOSAGE": "500MG",
    "COND": "FL./20",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIAN PHARMACEUTICAL INSTITUT (API)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/3/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "19/3/2008",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["calcium carbimide"],
    "InteractionIndexLink": [
      "calcium",
      "magnesium (hydroxyde de)",
      "magnesium (trisilicate de)",
      "potassium"
    ],
    "N_ENREGISTREMENT": "280/ 14 G 317 /08/19",
    "CODE_DCI": "14 G 317",
    "DCI": "Glucose monohydraté /Chlorure de sodium /Chlorure de potassium/ Gluconate de calcium /Chlorure de magnésium",
    "NOM_COMMERCIALE": "BIOHYDRATE",
    "FORME": "SOL. de réhydratation P/PERF",
    "DOSAGE": "5.5G/0.3G/0.2G/ 0.1G/0.05G/100ML",
    "COND": "POCHE/500ML    FLACON/500ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDUSTRIES MEDICO-CHIRURGICALES (IMC) /SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/12/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "14/4/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "POCHE: 18MOIS   FLACON: 24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["calcium carbimide"],
    "InteractionIndexLink": [
      "calcium",
      "magnesium (hydroxyde de)",
      "magnesium (trisilicate de)",
      "potassium"
    ],
    "N_ENREGISTREMENT": "280/ 14 G 317 /08",
    "CODE_DCI": "14 G 317",
    "DCI": "GLUCOSE MONOHYDRATE/CHLORURE DE SODIUM/CHLORURE DE POTASSIUM/GLUCONATE DE CALCIUM/CHLORURE DE MAGNESIUM",
    "NOM_COMMERCIALE": "BIOHYDRATE",
    "FORME": "SOL.DE REHYDRATATION VOIE PARENTERALE",
    "DOSAGE": "5.5G/0.3G/0.2G/0.1G/0.05G/100ML",
    "COND": "POCHE/500ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDUSTRIES MEDICO-CHIRURGICALES (IMC)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/12/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "17/12/2008",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [
      "magnesium (hydroxyde de)",
      "magnesium (trisilicate de)"
    ],
    "N_ENREGISTREMENT": "079/ 14 G 333 /03/18",
    "CODE_DCI": "14 G 333",
    "DCI": "MAGNESIUM ELEMENT  (SOUS FORME DE MAGNESIUM PIDOLATE)",
    "NOM_COMMERCIALE": "VITAMAG",
    "FORME": "SOL.BUV. EN AMP.",
    "DOSAGE": "127MG/5ML DE MAGNESIUM  (1.5G/5ML DE PIDOLATE DE MAGNESIUM))",
    "COND": "B/30 AMP. DE 5ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE  ALGERIEN DE DEVELOPPEMENT  PHARMACEUTIQUE   (LAD)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/7/2003",
    "DATE_D_ENREGISTREMENT_FINAL": "11/11/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "280/ 14 G 347/14",
    "CODE_DCI": "14 G 347",
    "DCI": "GLUCOSE MONOHYDRATE EXPRIME EN GLUCOSE ANHYDRE",
    "NOM_COMMERCIALE": "GLUCOPACK",
    "FORME": "SOL.INJ.P. PERF",
    "DOSAGE": "3G/100ML",
    "COND": "POCHE/500ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDUSTRIES MEDICO-CHIRURGICALES (IMC)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/1/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "6/1/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "280/ 14 G 347/14/21",
    "CODE_DCI": "14 G 347",
    "DCI": "Glucose monohydraté exprimé en Glucose anhydre",
    "NOM_COMMERCIALE": "GLUCOPACK",
    "FORME": "SOL.INJ.P. PERF",
    "DOSAGE": "3G/100ML 30G/100ML (30%)",
    "COND": "FLACON/500ML",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDUSTRIES MEDICO-CHIRURGICALES (IMC) / SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/1/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "21/2/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [
      "magnesium (hydroxyde de)",
      "magnesium (trisilicate de)"
    ],
    "N_ENREGISTREMENT": "263/ 14 G 356 /16",
    "CODE_DCI": "14 G 356",
    "DCI": "CARONATE DE MAGNESIUM EXPRIME EN MAGNESIUM",
    "NOM_COMMERCIALE": "KINADYN MG",
    "FORME": "POUDRE POR SOLUTION BUVABLE",
    "DOSAGE": "3MG/SACHET",
    "COND": "B/20",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOPHARM /SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "5/9/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "5/9/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["acide ascorbique"],
    "N_ENREGISTREMENT": "162/ 14 H 085 /98",
    "CODE_DCI": "14 H 085",
    "DCI": "ACIDE ASCORBIQUE",
    "NOM_COMMERCIALE": "VITAMINE C",
    "FORME": "SOL.INJ.",
    "DOSAGE": "500MG/5ML",
    "COND": "B/100AMP.",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CHINA MEHECO",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CHINE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/10/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "19/10/1998",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["acide ascorbique"],
    "N_ENREGISTREMENT": "18/97/14 H 086/003",
    "CODE_DCI": "14 H 086",
    "DCI": "ACIDE ASCORBIQUE",
    "NOM_COMMERCIALE": "VITA-C",
    "FORME": "COMPRIME",
    "DOSAGE": "500MG",
    "COND": "PILULIER DE 20",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES EPE GROUPE INDUSTRIEL SAIDAL/ SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/12/97",
    "DATE_D_ENREGISTREMENT_FINAL": "14/05/18",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [
      "magnesium (hydroxyde de)",
      "magnesium (trisilicate de)"
    ],
    "N_ENREGISTREMENT": "079/ 14 H 087 /98/19",
    "CODE_DCI": "14 H 087",
    "DCI": "ASCORBATE DE SODIUM / GLUTAMATE DE SODIUM / CHLORHYDRATE  DE LYSINE / ASPARTATE DE MAGNESIUM",
    "NOM_COMMERCIALE": "TONIC + C",
    "FORME": "AMP.BUV.",
    "DOSAGE": "60MG / 250MG / 100MG / 100MG /100ML",
    "COND": "B/20 AMP. DE 5ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE  ALGERIEN DE DEVELOPPEMENT  PHARMACEUTIQUE SARL   (LAD PHARMA)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/9/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "25/11/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["alfacalcidol"],
    "N_ENREGISTREMENT": "174/ 14 H 088 /19",
    "CODE_DCI": "14 H 088",
    "DCI": "ALFACALCIDOL",
    "NOM_COMMERCIALE": "SUPRA CALCI",
    "FORME": "CAPSULE MOLLE",
    "DOSAGE": "1µG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "UNITED PHARMACEUTICALS MANUFACTURING COMPANY LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "21/4/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "21/4/2019",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["alfacalcidol"],
    "N_ENREGISTREMENT": "083/ 14 H 088 /98/15",
    "CODE_DCI": "14 H 088",
    "DCI": "ALFACALCIDOL",
    "NOM_COMMERCIALE": "UN-ALFA",
    "FORME": "CAPSULE ORALE",
    "DOSAGE": "1µG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LEO PHARMA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/11/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "9/6/2015",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["fer"],
    "InteractionIndexLink": ["alfacalcidol"],
    "N_ENREGISTREMENT": "174/14 H 089/19",
    "CODE_DCI": "14 H 089",
    "DCI": "ALFACALCIDOL (OU 1 ALPHA-HYDROXYCHOLECALCIFEROL)",
    "NOM_COMMERCIALE": "SUPRA CALCI",
    "FORME": "CAPSULE MOLLE",
    "DOSAGE": "0.25µG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "24 MOIS",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "THE UNITED PHARMACEUTICAL MANUFACTURING COMPANY LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "14/8/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "14/8/2019",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["alfacalcidol"],
    "N_ENREGISTREMENT": "083/ 14 H 089 /98/15",
    "CODE_DCI": "14 H 089",
    "DCI": "ALFACALCIDOL",
    "NOM_COMMERCIALE": "UN-ALFA",
    "FORME": "CAPSULE ORALE",
    "DOSAGE": "0.25 µG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LEO PHARMA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/11/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "26/7/2015",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "351/ 14 H 092 /97",
    "CODE_DCI": "14 H 092",
    "DCI": "CALCIFEDIOL",
    "NOM_COMMERCIALE": "DEDROGYL",
    "FORME": "SOL. BUV GTTES",
    "DOSAGE": "5µG/GTTE.",
    "COND": "FL./10ML",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "DESMA PHARMA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "23/3/1997",
    "DATE_D_ENREGISTREMENT_FINAL": "31/7/2006",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["cholecalciferol"],
    "N_ENREGISTREMENT": "543/14 H 095/19",
    "CODE_DCI": "14 H 095",
    "DCI": "CHOLECALCIFEROL",
    "NOM_COMMERCIALE": "D-THREE",
    "FORME": "SOL INJ IM ET BUV",
    "DOSAGE": "200 000UI/ML",
    "COND": "B/01 AMP DE 2ML CONTENANT 1ML DE SOLUTION",
    "LISTE": "LISTE II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOTHERA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "09/10/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "09/10/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["cholecalciferol"],
    "N_ENREGISTREMENT": "380/14 H 095/20",
    "CODE_DCI": "14 H 095",
    "DCI": "CHOLECALCIFEROL",
    "NOM_COMMERCIALE": "VIT D3",
    "FORME": "SOL.INJ. IM. ET SOL. BUV.",
    "DOSAGE": "200 000UI/1ML",
    "COND": "B/01 AMP",
    "LISTE": "LISTE II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HUPP PHARMA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "14/4/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "14/4/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["cholecalciferol"],
    "N_ENREGISTREMENT": "269/ 14 H 095 /97/15",
    "CODE_DCI": "14 H 095",
    "DCI": "CHOLECALCIFEROL",
    "NOM_COMMERCIALE": "VITAMINE D3 B.O.N",
    "FORME": "SOL.INJ. IM. ET SOL. BUV.",
    "DOSAGE": "200 000UI/ML",
    "COND": "B/01 AMP. DE 1ML",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BOUCHARA-RECORDATI",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/11/1997",
    "DATE_D_ENREGISTREMENT_FINAL": "31/5/2015",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "48 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["cholecalciferol"],
    "N_ENREGISTREMENT": "433/14 H 095/20",
    "CODE_DCI": "14 H 095",
    "DCI": "Cholécalciférol",
    "NOM_COMMERCIALE": "VITAMINE D3 RAZES",
    "FORME": "Solution injectable IM ou Solution buvable",
    "DOSAGE": "200 000 UI/1ML",
    "COND": "B/01 AMP DE 2ML CONTENANT 1ML DE SOLUTION",
    "LISTE": "LISTE II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRATER RAZES SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/4/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "12/4/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "14 H 097",
    "DCI": "MULTIVITAMINES",
    "NOM_COMMERCIALE": "VITAFORM",
    "FORME": "SIROP",
    "DOSAGE": "50 ML",
    "COND": "50 ML",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "242/ 14 H 097 /06",
    "CODE_DCI": "14 H 097",
    "DCI": "COMPLEXE VITAMINIQUE",
    "NOM_COMMERCIALE": "VITAM",
    "FORME": "SIROP",
    "DOSAGE": "",
    "COND": "F/125ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GROUPE SANTE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/4/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "19/4/2006",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["calcium carbimide"],
    "InteractionIndexLink": ["calcium", "ergocalciferol"],
    "N_ENREGISTREMENT": "152/ 14 H 098 /99",
    "CODE_DCI": "14 H 098",
    "DCI": "ERGOCALCIFEROL / GLUCONATE DE CALCIUM / LACTATE DE CALCIUM",
    "NOM_COMMERCIALE": "FRUBIOSE VIT D 1000 U.I",
    "FORME": "SUSP.BUV.",
    "DOSAGE": "1000UI/129MG/36.8 MG/5 ML",
    "COND": "B/20AMP.",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BOEHRINGER INGELHEIM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/3/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "22/3/1999",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["calcium carbimide"],
    "InteractionIndexLink": ["calcium", "ergocalciferol"],
    "N_ENREGISTREMENT": "152/ 14 H 099 /99",
    "CODE_DCI": "14 H 099",
    "DCI": "ERGOCALCIFEROL / GLUCONATE DE CALCIUM / LACTATE DE CALCIUM",
    "NOM_COMMERCIALE": "FRUBIOSE VIT D 5000 U.I",
    "FORME": "SUSP.BUV.",
    "DOSAGE": "5000UI/500MG/350MG/5ML",
    "COND": "B/20AMP",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BOEHRINGER INGELHEIM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/3/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "22/3/1999",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "348/ 14 H 102 /08",
    "CODE_DCI": "14 H 102",
    "DCI": "PYRIDOXINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "PYRIDOXINE API",
    "FORME": "COMPRIME",
    "DOSAGE": "250MG",
    "COND": "B/20",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIAN PHARMACEUTICAL INSTITUT (API)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/9/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "10/9/2008",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "348/ 14 H 109 /08",
    "CODE_DCI": "14 H 109",
    "DCI": "THIAMINE NITRATE",
    "NOM_COMMERCIALE": "THIAMINE API",
    "FORME": "COMPRIME",
    "DOSAGE": "250MG",
    "COND": "B/20",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIAN PHARMACEUTICAL INSTITUT (API)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/9/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "10/9/2008",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "348/ 14 H 110 /06",
    "CODE_DCI": "14 H 110",
    "DCI": "TOCOPHEROL",
    "NOM_COMMERCIALE": "API E",
    "FORME": "COMPRIME A CROQUER",
    "DOSAGE": "100MG",
    "COND": "B/20",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIAN PHARMACEUTICAL INSTITUTE  (API)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "11/11/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "11/11/2006",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "348/ 14 H 112 /06",
    "CODE_DCI": "14 H 112",
    "DCI": "THIAMINE/PYRIDOXINE",
    "NOM_COMMERCIALE": "APIROVIT",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "250MG/250MG",
    "COND": "B/20",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIAN PHARMACEUTICAL INSTITUTE (API)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/6/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "20/6/2006",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "380/ 14 H 112 /15",
    "CODE_DCI": "14 H 112",
    "DCI": "THIAMINE CHLORHYDRATE / PYRIDOXINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "BIROVIT HUP",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "250MG/250MG",
    "COND": "B/20",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HUP.P.PHARMA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/3/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "18/3/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "14 H 112",
    "DCI": "THIAMINE/PYRIDOXINE",
    "NOM_COMMERCIALE": "NEUROVIT",
    "FORME": "COMPRIME",
    "DOSAGE": "250MG/250MG",
    "COND": "B/20",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "039/ 14 H 112 /00/14",
    "CODE_DCI": "14 H 112",
    "DCI": "THIAMINE CHLORHYDRATE / PYRIDOXINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "NOVITAL",
    "FORME": "COMPRIME",
    "DOSAGE": "250MG/250MG",
    "COND": "B/20",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOCIETE PHARMACEUTIQUE ALGERIENNE (SOPHAL) SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/7/2000",
    "DATE_D_ENREGISTREMENT_FINAL": "8/6/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "235/ 14 H 112 /15",
    "CODE_DCI": "14 H 112",
    "DCI": "THIAMINE MONONITRATE / PYRIDOXINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "VITAMINE B1 B6 BGL",
    "FORME": "COMPRIME",
    "DOSAGE": "250MG/250MG",
    "COND": "B/20",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOGALENIC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/10/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "19/10/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "317/ 14 H 112 /16",
    "CODE_DCI": "14 H 112",
    "DCI": "THIAMINE MONONITRATE / PYRIDOXINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "VITAZYME",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "250MG/250MG",
    "COND": "B/20",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INPHA MEDIS SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/8/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "9/8/2016",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "14 H 112",
    "DCI": "B1B6",
    "NOM_COMMERCIALE": "Vitazyme Cp 250mg/250mg",
    "FORME": "comp pel",
    "DOSAGE": "250-250mg/comp",
    "COND": "bt de 20",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["acide ascorbique"],
    "N_ENREGISTREMENT": "16/14 H 115/268",
    "CODE_DCI": "14 H 115",
    "DCI": "ACIDE ASCORBIQUE ASCORBATE DE SODIUM EXPRIME EN ACIDE ASCORBIQUE",
    "NOM_COMMERCIALE": "CITAMINE",
    "FORME": "COMP. A CROQUER",
    "DOSAGE": "250MG",
    "COND": "B/20",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES MERINAL SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "09/11/16",
    "DATE_D_ENREGISTREMENT_FINAL": "09/11/16",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["acide ascorbique"],
    "N_ENREGISTREMENT": "079/ 14 H 115 /99/19",
    "CODE_DCI": "14 H 115",
    "DCI": "ACIDE ASCORBIQUE",
    "NOM_COMMERCIALE": "LADOSCORBINE",
    "FORME": "COMPRIME A CROQUER",
    "DOSAGE": "500MG",
    "COND": "B/12",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE  ALGERIEN DE DEVELOPPEMENT  PHARMACEUTIQUE   (LAD)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "14/2/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "10/7/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["acide ascorbique"],
    "N_ENREGISTREMENT": "348/ 14 H 168 /08",
    "CODE_DCI": "14 H 168",
    "DCI": "ACIDE ASCORBIQUE",
    "NOM_COMMERCIALE": "APISCORBUT",
    "FORME": "COMP. EFFERV.",
    "DOSAGE": "500MG",
    "COND": "B/20",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIAN PHARMACEUTICAL INSTITUTE (API)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/5/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "17/5/2008",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["acide ascorbique"],
    "N_ENREGISTREMENT": "050/ 14 H 168 /99",
    "CODE_DCI": "14 H 168",
    "DCI": "ACIDE ASCORBIQUE",
    "NOM_COMMERCIALE": "VITAMINE  C",
    "FORME": "COMP.EFFER.",
    "DOSAGE": "500MG",
    "COND": "T/16",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANDOZ SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/1/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "27/1/1999",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "348/ 14 H 171 /16",
    "CODE_DCI": "14 H 171",
    "DCI": "ASPARTATE D'ARGININE",
    "NOM_COMMERCIALE": "SARGENINE",
    "FORME": "COMP.EFFER.",
    "DOSAGE": "1G",
    "COND": "B/01 TUBE DE 20",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL ALGERIAN PHARMACEUTICAL INSTITUT (API)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "11/4/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "11/4/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "079/ 14 H 172 /00/19",
    "CODE_DCI": "14 H 172",
    "DCI": "ARGININE ASPARTATE",
    "NOM_COMMERCIALE": "ARGINOR",
    "FORME": "SOL. BUV. AMP.",
    "DOSAGE": "1G/5ML",
    "COND": "B/20 AMP. DE 5ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE  ALGERIEN DE DEVELOPPEMENT  PHARMACEUTIQUE SARL   (LAD PHARMA)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/7/2000",
    "DATE_D_ENREGISTREMENT_FINAL": "25/11/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "459/ 14 H 172 /99/09",
    "CODE_DCI": "14 H 172",
    "DCI": "ARGININE ASPARTATE",
    "NOM_COMMERCIALE": "SARGENOR",
    "FORME": "SOL. BUV. AMP.",
    "DOSAGE": "1G/5ML",
    "COND": "B/20 AMP. DE 5ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MEDA PHARMA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/7/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "7/3/2009",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "177/ 14 H 177/98/08",
    "CODE_DCI": "14 H 177",
    "DCI": "COMPLEXE VITAMINIQUE + OLIGOELEMENTS",
    "NOM_COMMERCIALE": "MEGADYN",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "",
    "COND": "B/30",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ABDI IBRAHIM ILAÇ SAN VE TIC A.Ş.",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "TURQUIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/12/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "15/12/2008",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["acide ascorbique"],
    "N_ENREGISTREMENT": "079/ 14 H 207 /06/19",
    "CODE_DCI": "14 H 207",
    "DCI": "ARGININE ASPARTATE / ACIDE ASCORBIQUE",
    "NOM_COMMERCIALE": "ARGINOR + C",
    "FORME": "AMP. BUV.",
    "DOSAGE": "1.5G/0.5G/5ML",
    "COND": "B/20 AMP DE 5ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE  ALGERIEN DE DEVELOPPEMENT  PHARMACEUTIQUE SARL   (LAD PHARMA)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/10/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "25/11/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["acide ascorbique"],
    "N_ENREGISTREMENT": "459/ 14 H 207 /03/09",
    "CODE_DCI": "14 H 207",
    "DCI": "ARGININE ASPARTATE / ACIDE ASCORBIQUE",
    "NOM_COMMERCIALE": "SARGENOR VITAMINE C",
    "FORME": "SOL.BUV. AMP.",
    "DOSAGE": "1.5G/0.5G/5ML",
    "COND": "B/20AMP. DE 5ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MEDA PHARMA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/8/2003",
    "DATE_D_ENREGISTREMENT_FINAL": "7/3/2009",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["cyanocobalamine"],
    "N_ENREGISTREMENT": "293/ 14 H 212 /06/16",
    "CODE_DCI": "14 H 212",
    "DCI": "THIAMINE / PYRIDOXINE / CYANOCOBALAMINE",
    "NOM_COMMERCIALE": "TROIS B",
    "FORME": "COMP. ENRO.",
    "DOSAGE": "125MG/125MG/0.55MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOCARE SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/12/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "10/1/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [
      "magnesium (hydroxyde de)",
      "magnesium (trisilicate de)"
    ],
    "N_ENREGISTREMENT": "079/ 14 H 216 /04",
    "CODE_DCI": "14 H 216",
    "DCI": "ASCORBATE DE SODIUM / GLUTAMATE DE SODIUM / CHLORHYDRATE DE LYSINE / ASPARTATE DE MAGNESIUM",
    "NOM_COMMERCIALE": "TONI C 1000",
    "FORME": "AMP. BUV.",
    "DOSAGE": "1G/250MG/100MG/100MG",
    "COND": "B/20 AMP. DE 5ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE ALGERIEN DE DEVELOPPEMENT PHARMACEUTIQUE  (LAD)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/2/2004",
    "DATE_D_ENREGISTREMENT_FINAL": "7/2/2004",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["cyanocobalamine"],
    "N_ENREGISTREMENT": "317/ 14 H 220/15",
    "CODE_DCI": "14 H 220",
    "DCI": "THIAMINE MONONITRATE / PYRIDOXINE CHLORHYDRATE / CYANOCOBALAMINE",
    "NOM_COMMERCIALE": "TRI-B",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "200MG/100MG/1MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INPHA-MEDIS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "3/11/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "3/11/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["cyanocobalamine"],
    "N_ENREGISTREMENT": "380/ 14 H 220 /15",
    "CODE_DCI": "14 H 220",
    "DCI": "THIAMINE MONONITRATE / PYRIDOXINE CHLORHYDRATE / CYANOCOBALAMINE",
    "NOM_COMMERCIALE": "TRI-B-VIT HUP",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "200MG/100MG/1MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HUP.P.PHARMA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/4/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "26/4/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "101/ 14 H 221 /06",
    "CODE_DCI": "14 H 221",
    "DCI": "MALATE DE CITRILLUNE",
    "NOM_COMMERCIALE": "STIMOL",
    "FORME": "SOL. BUV.",
    "DOSAGE": "1G/10ML",
    "COND": "B/18AMP.",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOCODEX",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/10/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "17/10/2006",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["acide ascorbique"],
    "N_ENREGISTREMENT": "348/ 14 H 222 /07",
    "CODE_DCI": "14 H 222",
    "DCI": "ACIDE ASCORBIQUE",
    "NOM_COMMERCIALE": "APISCORBUT",
    "FORME": "COMP. EFFERV.",
    "DOSAGE": "1G",
    "COND": "B/20",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIAN PHARMACEUTICAL INSTITUTE (API)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/2/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "4/2/2007",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["acide ascorbique"],
    "N_ENREGISTREMENT": "395/ 14 H 222 /08",
    "CODE_DCI": "14 H 222",
    "DCI": "ACIDE ASCORBIQUE",
    "NOM_COMMERCIALE": "LAROSCORBINE",
    "FORME": "COMP. EFFERV.",
    "DOSAGE": "1G",
    "COND": "B/10",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BAYER SANTE FAMILLIALE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "23/12/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "23/12/2008",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["acide ascorbique"],
    "N_ENREGISTREMENT": "201/ 14 H 222 /07/13",
    "CODE_DCI": "14 H 222",
    "DCI": "ACIDE ASCORBIQUE",
    "NOM_COMMERCIALE": "VITAMINE C UPSA EFFERVESCENTE",
    "FORME": "COMP. EFFERV.",
    "DOSAGE": "1G",
    "COND": "B/20",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PROPHARMAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/3/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "22/12/2013",
    "TYPE": "Ré",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "079/ 14 H 302 /09",
    "CODE_DCI": "14 H 302",
    "DCI": "ARGININE ASPARTATE",
    "NOM_COMMERCIALE": "ARGINOR ENFANT",
    "FORME": "SOL.BUV.AMP.",
    "DOSAGE": "0.5G/5ML",
    "COND": "B/20AMP. DE 20ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE  ALGERIEN DE DEVELOPPEMENT  PHARMACEUTIQUE   (LAD)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "23/9/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "23/9/2009",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "459/ 14 H 302 /06",
    "CODE_DCI": "14 H 302",
    "DCI": "ARGININE ASPARTATE",
    "NOM_COMMERCIALE": "SARGENOR ENFANT",
    "FORME": "SOL. BUV. AMP.",
    "DOSAGE": "0.5G/5ML",
    "COND": "B/20AMP. DE 5ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MEDA PHARMA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "31/7/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "31/7/2006",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["calcium carbimide"],
    "InteractionIndexLink": ["calcium", "cholecalciferol"],
    "N_ENREGISTREMENT": "235/ 14 H 325 /18",
    "CODE_DCI": "14 H 325",
    "DCI": "CHOLECALCIFEROL / CALCIUM CARBONATE EXPRIME EN CALCIUM ELEMENT",
    "NOM_COMMERCIALE": "CALCIDOSE VITAMINE D",
    "FORME": "PDRE. ORALE",
    "DOSAGE": "400UI/500MG/SACHET",
    "COND": "B/30 SACHETS",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOGALENIC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/10/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "28/10/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["calcium carbimide"],
    "InteractionIndexLink": ["calcium", "cholecalciferol"],
    "N_ENREGISTREMENT": "268/ 14 H 325 /09",
    "CODE_DCI": "14 H 325",
    "DCI": "CHOLECALCIFEROL / CALCIUM CARBONATE EXPRIME EN CALCIUM ELEMENT",
    "NOM_COMMERCIALE": "CALCIDOSE VITAMINE D",
    "FORME": "PDRE. ORALE EN SACH.-DOSE",
    "DOSAGE": "400UI/500MG/SACHET",
    "COND": "B/30 SACHETS",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MERINAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/4/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "22/4/2009",
    "TYPE": "Ré",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["calcium carbimide"],
    "InteractionIndexLink": ["calcium", "cholecalciferol"],
    "N_ENREGISTREMENT": "268/ 14 H 325 /09/16",
    "CODE_DCI": "14 H 325",
    "DCI": "CHOLECALCIFEROL / CALCIUM CARBONATE EXPRIME EN CALCIUM ELEMENT",
    "NOM_COMMERCIALE": "CALCIDOSE VITAMINE D",
    "FORME": "PDRE. ORALE EN SACH.-DOSE",
    "DOSAGE": "400UI/500MG/SACHET",
    "COND": "B/30 SACHETS",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MERINAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/04/09",
    "DATE_D_ENREGISTREMENT_FINAL": "05/09/16",
    "TYPE": "Ré",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["calcium carbimide"],
    "InteractionIndexLink": ["calcium", "cholecalciferol"],
    "N_ENREGISTREMENT": "293/14 H 325/20",
    "CODE_DCI": "14 H 325",
    "DCI": "CALCIUM CARBONATE/CHOLECALCIFEROL",
    "NOM_COMMERCIALE": "CALVITACARE",
    "FORME": "PDRE P/SUSP BUV",
    "DOSAGE": "500MG/400UI",
    "COND": "B/30 SACHETS",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOCARE SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/1/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "22/1/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["calcium carbimide"],
    "InteractionIndexLink": ["calcium", "cholecalciferol"],
    "N_ENREGISTREMENT": "235/ 14 H 325 /18",
    "CODE_DCI": "14 H 325",
    "DCI": "CHOLECALCIFEROL / CALCIUM CARBONATE EXPRIME EN CALCIUM ELEMENT",
    "NOM_COMMERCIALE": "OSSE D3",
    "FORME": "PDRE. ORALE",
    "DOSAGE": "400UI/500MG/SACHET",
    "COND": "B/30 SACHETS",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOGALENIC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/10/18",
    "DATE_D_ENREGISTREMENT_FINAL": "28/10/18",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": ["acide folique", "vitamin A"],
    "InteractionIndexLink": ["acide folique", "vitamine a"],
    "N_ENREGISTREMENT": "348/ 14 H 334 /09",
    "CODE_DCI": "14 H 334",
    "DCI": "VITAMINE A / VITAMINE D3 / VIATAMINE E / VITAMINE B1 /  VITAMINE B2/ VITAMINE B6 / NICOTINAMIDE /ACIDE FOLIQUE / ACIDE PANTHOTENIQUE / BIOTINE / VITAMINE B12 / VITAMINE C / BETA CAROTENE",
    "NOM_COMMERCIALE": "ASTENIA",
    "FORME": "COMP. EFFERV.",
    "DOSAGE": "0.4MG/0.005MG/10MG/1.4MG/1.6MG/2MG/18MG/0.2MG/6MG/0.150MG/0.001MG/  60MG/2.4MG",
    "COND": "T/20",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIAN PHARMACEUTICAL INSTITUT (API)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/12/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "30/12/2009",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["calcium carbimide"],
    "InteractionIndexLink": ["calcium", "ergocalciferol"],
    "N_ENREGISTREMENT": "003/ 14 H 340 /97/16",
    "CODE_DCI": "14 H 340",
    "DCI": "ERGOCALCIFEROL (OU VIT D2) / GLUCONATE DE CALCIUM / PHOSPHATE BICALCIQUE",
    "NOM_COMMERCIALE": "FRUBIAL FAIBLE",
    "FORME": "SOL. BUV.",
    "DOSAGE": "1500UI/125.5MG/20.45MG/5ML",
    "COND": "B/20AMP. DE 5ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EPE GROUPE INDUSTRIEL SAIDAL/SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/8/1997",
    "DATE_D_ENREGISTREMENT_FINAL": "8/5/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "18MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "348/14 H 358/17",
    "CODE_DCI": "14 H 358",
    "DCI": "ACETATE ALPHA TOCOPHEROL",
    "NOM_COMMERCIALE": "API E",
    "FORME": "CP A CROQUER ET A SUCER",
    "DOSAGE": "500 MG",
    "COND": "B/02 TUBES DE 10",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL ALGERIAN PHARMACEUTICAL INSTITUT (API)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/3/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "12/3/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "092/ 14 J 173 /00/16",
    "CODE_DCI": "14 J 173",
    "DCI": "OXOGLURATE D'ORNITHINE EXPRIME EN OXOGLURATE DE L(+)ORNITHINE MONOHYDRATE",
    "NOM_COMMERCIALE": "CETORNAN",
    "FORME": "PDRE. P. SOL. BUV. OU GASTRO-ENTERALE",
    "DOSAGE": "5G/SACHET-DOSE",
    "COND": "B/10 SACHETS",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CHIESI S.A.",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/6/2000",
    "DATE_D_ENREGISTREMENT_FINAL": "16/4/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "235/ 14 J 173 /15",
    "CODE_DCI": "14 J 173",
    "DCI": "OXOGLURATE D'ORNITHINE EXPRIME EN OXOGLURATE DE L(+)ORNITHINE MONOHYDRATE",
    "NOM_COMMERCIALE": "OKAGé",
    "FORME": "PDRE. P. SOL. BUV. OU GASTRO-ENTERALE",
    "DOSAGE": "5G/SACHET-DOSE",
    "COND": "B/10 SACHETS",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOGALENIC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/10/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "26/10/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "450/ 14 J 173 /15",
    "CODE_DCI": "14 J 173",
    "DCI": "OXOGLURATE D'ORNITHINE EXPRIME EN OXOGLURATE DE L(+)ORNITHINE MONOHYDRATE",
    "NOM_COMMERCIALE": "OXOGLURATE D'ORNITHINE MYLAN",
    "FORME": "PDRE. P. SOL. BUV. OU GASTRO-ENTERALE",
    "DOSAGE": "5G/SACHET-DOSE",
    "COND": "B/10 SACHETS",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MYLAN SAS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/5/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "13/5/2015",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "18 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Métabolisme et Diabétologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "332/ 14 K 124 /08",
    "CODE_DCI": "14 K 124",
    "DCI": "HUILE DE SOJA PURIFIEE",
    "NOM_COMMERCIALE": "INTRALIPIDE 20%",
    "FORME": "EMULSION PERF.IV",
    "DOSAGE": "20G/100ML",
    "COND": "POCHE DE 500ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRESENIUS KABI",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "23/2/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "23/2/2008",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "427/ 14 K 322 /08",
    "CODE_DCI": "14 K 322",
    "DCI": "ACIDES AMINES / GLUCOSE / LIPIDES",
    "NOM_COMMERCIALE": "OLICLINOMEL N4- 550E",
    "FORME": "EMULSION PERF. IV",
    "DOSAGE": "5.5%/20%/10%",
    "COND": "POCHE/2000ML (3COMPART.800ML/800ML/400ML)",
    "LISTE": "",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CLINTEC PARENTERAL S.A.",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/1/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "6/1/2009",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "427/ 14 K 323 /08/16",
    "CODE_DCI": "14 K 323",
    "DCI": "ACIDES AMINES / GLUCOSE / LIPIDES",
    "NOM_COMMERCIALE": "OLICLINOMEL N7-1000 E",
    "FORME": "EMULSION PERF. IV",
    "DOSAGE": "10%/40%/20%",
    "COND": "POCHE/1000ML (3COMPART.400ML/400ML/200ML) ET POCHE/2000ML (3COMPART.800ML/800ML/400ML)",
    "LISTE": "",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CLINTEC PARENTERAL S.A.",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/1/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "29/6/2016",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "288/ 14 L 130 /12/19",
    "CODE_DCI": "14 L 130",
    "DCI": "LAIT SANS PHENYLALANINE",
    "NOM_COMMERCIALE": "PKU ANAMIX INFANT",
    "FORME": "PDRE. P. NOURRISSON AGE DE 0 A 1AN",
    "DOSAGE": "",
    "COND": "B/400G",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NUTRICIA NUTRITION CLINIQUE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/11/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "29/7/2019",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "18MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "474/ 14 L 131 /03/13",
    "CODE_DCI": "14 L 131",
    "DCI": "LAIT EN POUDRE SANS PROTEINES DE LAIT DE VACHE",
    "NOM_COMMERCIALE": "APTAMIL PEPTI JUNIOR",
    "FORME": "LAIT EN POUDRE",
    "DOSAGE": "",
    "COND": "B/400G",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "DANONE NUTRICIA A &O",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/10/2003",
    "DATE_D_ENREGISTREMENT_FINAL": "10/1/2013",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "288/ 14 L 343 /13/19",
    "CODE_DCI": "14 L 343",
    "DCI": "LAIT SANS PHENYLALANINE",
    "NOM_COMMERCIALE": "XP MAXAMAID",
    "FORME": "PDRE.P. ENFANT AGE DE 1AN A 8ANS.",
    "DOSAGE": "",
    "COND": "B/500G",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NUTRICIA NUTRITION CLINIQUE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/1/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "29/7/2019",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "288/ 14 L 344 /13/19",
    "CODE_DCI": "14 L 344",
    "DCI": "LAIT SANS PHENYLALANINE",
    "NOM_COMMERCIALE": "XP MAXAMUM",
    "FORME": "PDRE. P ENFANTS DES 8ANS. ADOLESCENTS ET ADULTES DONT LES FEMMES ENCEINTES",
    "DOSAGE": "",
    "COND": "B/500G",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NUTRICIA NUTRITION CLINIQUE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/2/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "27/1/2019",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "079/14 M 314/08/16",
    "CODE_DCI": "14 M 314",
    "DCI": "FACTEUR DE CROISSANCE EPIDERMIQUE HUMAIN RECOMBINANT (F.C.E. HUM. REC.)",
    "NOM_COMMERCIALE": "HEBERPROT- P 75",
    "FORME": "LYOPH. ET SOLV. SOL. INJ. INTRA-LESIONNELLE ET PERI-LESIONNELLE",
    "DOSAGE": "15µG/ML",
    "COND": "B/1FL. DE PDRE. + 1AMP. DE SOLV. 5ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE ALGERIEN DE DEVELOPPEMENT PHARMACEUTIQUE (LAD PHARMA)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/4/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "20/12/2016",
    "TYPE": "Ré",
    "STATUT": "C",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["imiglucerase"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "339/ 14 N 316 /06/18",
    "CODE_DCI": "14 N 316",
    "DCI": "IMIGLUCERASE",
    "NOM_COMMERCIALE": "CEREZYME 400",
    "FORME": "PDRE. A DILUER SOL. PERF. IV",
    "DOSAGE": "400 UNITES D'IMIGLUCERASE / FL. DE PDRE.",
    "COND": "B/01FL.  DE PDRE. 400UI",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GENZYME EUROPE B.V.",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PAYS BAS",
    "DATE_D_ENREGISTREMENT_INITIAL": "23/7/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "26/11/2018",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["galsulfase"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "439/ 14 N 331 /09/18",
    "CODE_DCI": "14 N 331",
    "DCI": "GALSULFASE",
    "NOM_COMMERCIALE": "NAGLAZYME",
    "FORME": "CONC. PERF.",
    "DOSAGE": "1MG/ML (OU 5MG/5ML)",
    "COND": "B/1FL. DE 5ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOMARIN EUROPE LTD",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ROYAUME UNI",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/7/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "26/11L2018",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["laronidase"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "339/ 14 N 348 /15",
    "CODE_DCI": "14 N 348",
    "DCI": "LARONIDASE",
    "NOM_COMMERCIALE": "ALDURAZYME",
    "FORME": "SOL. A DILUER P. PERF. IV",
    "DOSAGE": "100U DE LARONIDASE /ML (500U DE LARONIDASE /ML)",
    "COND": "B/01 FL. DE 5ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GENZYME EUROPE B.V.",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PAYS BAS",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/6/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "17/6/2015",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["agalsidase alfa", "agalsidase beta"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "339/ 14 N 349 /15",
    "CODE_DCI": "14 N 349",
    "DCI": "AGALSIDASE BETA",
    "NOM_COMMERCIALE": "FABRAZYME",
    "FORME": "PDRE. P/SOL. A DILUER P/PERFUSION IV",
    "DOSAGE": "35MG/FL. DE PDRE.",
    "COND": "B/01 FL. DE PDRE.",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GENZYME EUROPE B.V.",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PAYS BAS",
    "DATE_D_ENREGISTREMENT_INITIAL": "11/5/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "11/5/2015",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["velaglucerase alfa"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "493/ 14 N 350 /15",
    "CODE_DCI": "14 N 350",
    "DCI": "VELAGLUCERASE ALFA",
    "NOM_COMMERCIALE": "VPRIV",
    "FORME": "PDRE. P. SOL. P. PERF. IV",
    "DOSAGE": "400 U DE VELAGLUCERASE ALFA / FL. DE PDRE. (100U DE VELAGLUCERASE /ML APRES RECONSTITUTION)",
    "COND": "B/01 FL. DE PDRE.",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SHIRE HUMAN GENETIC THERAPIES INC (SHIRE HGT)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ETATS UNIS D'AMERIQUE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/6/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "18/6/2015",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["idursulfase"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "493/ 14 N 353 /16",
    "CODE_DCI": "14 N 353",
    "DCI": "IDURSULFASE SHIRE",
    "NOM_COMMERCIALE": "ELAPRASE",
    "FORME": "SOLUT. A DILUER POUR PERF IV",
    "DOSAGE": "2MG/ML",
    "COND": "1 FL 3 ML (6MG/3ML)",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SHIRE HUMAN GENETIC THERAPIES INC (SHIRE HGT)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "USA",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/2/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "22/2/2016",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["alglucosidase alfa"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "339/14 N 354/17",
    "CODE_DCI": "14 N 354",
    "DCI": "ALGLUCOSIDASE ALFA",
    "NOM_COMMERCIALE": "MYOZYME",
    "FORME": "POUDRE POUR SOLUTION A DILUER POUR PERFUSION IV",
    "DOSAGE": "50 MG/FL APRES RECONSTITUTION 5MG/ML D'ALGLUCOSIDASE ALFA .APRES LA DILUTION LA CONCENTRATION VARIE DE 0.5 à 4MG/ML",
    "COND": "B/01 FL DE POUDRE",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GENZYME EUROPE B.V.",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PAYS BAS",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/9/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "4/9/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["agalsidase alfa", "agalsidase beta"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "493/14 N 355/16",
    "CODE_DCI": "14 N 355",
    "DCI": "AGALSIDASE ALFA",
    "NOM_COMMERCIALE": "REPLAGAL",
    "FORME": "SOL A DILUER POUR PERFUSION IV",
    "DOSAGE": "1 MG/ML",
    "COND": "B/01 FL DE 5 ML",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SHIRE HUMAN GENETIC THERAPIES AB",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SUEDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/3/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "20/3/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["idursulfase"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "507/ 14 N 359/16",
    "CODE_DCI": "14 N 359",
    "DCI": "IDURSULFASE-BETA GREEN CROSS",
    "NOM_COMMERCIALE": "HUNTERASE",
    "FORME": "SOLUT. A DILUER POUR PERF IV",
    "DOSAGE": "2MG/ML",
    "COND": "1 FL 3 ML (6MG/3ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GREEN CROSS CORPORATION",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "COREE",
    "DATE_D_ENREGISTREMENT_INITIAL": "21/3/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "21/3/2016",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "550/14 N 365/20",
    "CODE_DCI": "14 N 365",
    "DCI": "NITISONE",
    "NOM_COMMERCIALE": "MDK-NITISONE",
    "FORME": "GLES",
    "DOSAGE": "5MG",
    "COND": "B/60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MENDELIKABS INC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CANADA",
    "DATE_D_ENREGISTREMENT_INITIAL": "8/1/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "8/1/2020",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["nitisinone"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "533/14 N 365/17",
    "CODE_DCI": "14 N 365",
    "DCI": "NITISINONE",
    "NOM_COMMERCIALE": "ORFADIN",
    "FORME": "GELULE",
    "DOSAGE": "5MG",
    "COND": "B/01 FL DE 60",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SWEDISH ORPHAN BIOVITRUM INTERNATIONAL AB",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SUEDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/9/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "10/9/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "18 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "550/14 N 366/19",
    "CODE_DCI": "14 N 366",
    "DCI": "NITISONE",
    "NOM_COMMERCIALE": "MDK-NITISONE",
    "FORME": "GLES",
    "DOSAGE": "10MG",
    "COND": "B/60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MENDELIKABS INC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CANADA",
    "DATE_D_ENREGISTREMENT_INITIAL": "8/1/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "8/1/2020",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["nitisinone"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "533/14 N 366/17",
    "CODE_DCI": "14 N 366",
    "DCI": "NITISINONE",
    "NOM_COMMERCIALE": "ORFADIN",
    "FORME": "GELULE",
    "DOSAGE": "10MG",
    "COND": "B/01 FL DE 60",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SWEDISH ORPHAN BIOVITRUM INTERNATIONAL AB",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SUEDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/9/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "10/9/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "18 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "439/14 N 368/19",
    "CODE_DCI": "14 N 368",
    "DCI": "ELOSULFATE ALPHA",
    "NOM_COMMERCIALE": "VIMIZIM",
    "FORME": "SOL A DILUER P/PERF IV",
    "DOSAGE": "1MG/ML",
    "COND": "B/01 FLDE 5ML (5MG/5ML)",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOMARIN INTERNATIONAL LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "Irlande",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/112019",
    "DATE_D_ENREGISTREMENT_FINAL": "27/112019",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["liraglutide (rys)"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "069/ 14 P 346 /14",
    "CODE_DCI": "14 P 346",
    "DCI": "LIRAGLUTIDE",
    "NOM_COMMERCIALE": "VICTOZA",
    "FORME": "SOL INJ S/C EN STYLO PREREMPLIE MULTIDOSE",
    "DOSAGE": "6MG/ML",
    "COND": "B/02 STYLOS DE 3ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVO-NORDISK AS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "DANEMARK",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/4/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "1/4/2014",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["sodium valproate (valproic acid)"],
    "InteractionIndexLink": ["acide valproique"],
    "N_ENREGISTREMENT": "255/ 15 A 001 /97/16",
    "CODE_DCI": "15 A 001",
    "DCI": "VALPROATE DE SODIUM (acide valproique)",
    "NOM_COMMERCIALE": "DEPAKINE",
    "FORME": "COMP. GASTRORESIST.",
    "DOSAGE": "200MG",
    "COND": "B/40",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANOFI",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/11/1997",
    "DATE_D_ENREGISTREMENT_FINAL": "7/3/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["sodium valproate (valproic acid)"],
    "InteractionIndexLink": ["acide valproique"],
    "N_ENREGISTREMENT": "330/ 15 A 001 /05",
    "CODE_DCI": "15 A 001",
    "DCI": "VALPROATE DE SODIUM (acide valproique)",
    "NOM_COMMERCIALE": "ENCORATE",
    "FORME": "COMPRIME",
    "DOSAGE": "200MG",
    "COND": "B/100 ET B/40",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SUN PHARMACEUTICAL INDUSTRIES LTD",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/9/2005",
    "DATE_D_ENREGISTREMENT_FINAL": "28/9/2005",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["sodium valproate (valproic acid)"],
    "InteractionIndexLink": ["acide valproique"],
    "N_ENREGISTREMENT": "255/ 15 A 002 /97",
    "CODE_DCI": "15 A 002",
    "DCI": "VALPROATE DE SODIUM (acide valproique)",
    "NOM_COMMERCIALE": "DEPAKINE",
    "FORME": "COMP GASTR RESIST.",
    "DOSAGE": "500MG",
    "COND": "B/40",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANOFI SYNTHELABO",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/8/1997",
    "DATE_D_ENREGISTREMENT_FINAL": "4/8/1997",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["sodium valproate (valproic acid)"],
    "InteractionIndexLink": ["acide valproique"],
    "N_ENREGISTREMENT": "330/ 15 A 002 /05",
    "CODE_DCI": "15 A 002",
    "DCI": "VALPROATE DE SODIUM (acide valproique)",
    "NOM_COMMERCIALE": "ENCORATE 500",
    "FORME": "COMPRIME",
    "DOSAGE": "500MG",
    "COND": "B/100 ET B/40",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SUN PHARMACEUTICAL INDUSTRIES LTD",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/9/2005",
    "DATE_D_ENREGISTREMENT_FINAL": "28/9/2005",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["sodium valproate (valproic acid)"],
    "InteractionIndexLink": ["acide valproique"],
    "N_ENREGISTREMENT": "430/ 15 A 003 /09",
    "CODE_DCI": "15 A 003",
    "DCI": "VALPROATE DE SODIUM (acide valproique)",
    "NOM_COMMERCIALE": "CONVEP",
    "FORME": "SOL.BUV.",
    "DOSAGE": "200MG/ML",
    "COND": "FL./60ML + SERINGUE DOSEUSE",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ILADJ PHARMACEUTIQUE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/2/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "28/2/2009",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["sodium valproate (valproic acid)"],
    "InteractionIndexLink": ["acide valproique"],
    "N_ENREGISTREMENT": "20/98/15 A003/392",
    "CODE_DCI": "15 A 003",
    "DCI": "VALPROATE DE SODIUM (acide valproique)",
    "NOM_COMMERCIALE": "DEPAKINE",
    "FORME": "SOL.BUV.",
    "DOSAGE": "200MG/ML",
    "COND": "B/1FL DE 40ML + SERING. P. ADMINIST. ORALE GRADUEE EN MG",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANOFI AVENTIS SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/2/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "5/10/2020",
    "TYPE": "Ré",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["sodium valproate (valproic acid)"],
    "InteractionIndexLink": ["acide valproique"],
    "N_ENREGISTREMENT": "317/15 A 003/17",
    "CODE_DCI": "15 A 003",
    "DCI": "VALPROATE DE SODIUM (acide valproique)",
    "NOM_COMMERCIALE": "IPAKINE",
    "FORME": "SOL. BUV.",
    "DOSAGE": "200MG/ML",
    "COND": "FL 40ML+PIPETTE GRADuée",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INPHA MEDIS SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/6/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "29/6/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["sodium valproate (valproic acid)"],
    "InteractionIndexLink": ["acide valproique"],
    "N_ENREGISTREMENT": "073/15 A 003/16",
    "CODE_DCI": "15 A 003",
    "DCI": "VALPROATE DE SODIUM (acide valproique)",
    "NOM_COMMERCIALE": "ISOLEP",
    "FORME": "SOL.BUV.",
    "DOSAGE": "200MG/ML",
    "COND": "FL/50ML",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ISOPHARM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/11/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "15/11/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["sodium valproate (valproic acid)"],
    "InteractionIndexLink": ["acide valproique"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "15 A 003",
    "DCI": "Valproate de Na (acide valproique)",
    "NOM_COMMERCIALE": "Ipakine Sol Buv",
    "FORME": "sol buv",
    "DOSAGE": "200mg/ml",
    "COND": "flacon 40ml",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["sodium valproate (valproic acid)"],
    "InteractionIndexLink": ["acide valproique"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "15 A 003",
    "DCI": "Acide valproique (Valproate)",
    "NOM_COMMERCIALE": "Isolep",
    "FORME": "Sol buv",
    "DOSAGE": "200mg/ml",
    "COND": "flacon 50ml",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["sodium valproate (valproic acid)"],
    "InteractionIndexLink": ["acide valproique"],
    "N_ENREGISTREMENT": "077/ 15 A 003 /08/16",
    "CODE_DCI": "15 A 003",
    "DCI": "VALPROATE DE SODIUM (acide valproique)",
    "NOM_COMMERCIALE": "MEVAKINE",
    "FORME": "SOL. BUV.",
    "DOSAGE": "200MG/ML",
    "COND": "FL./100ML + PIPETTE GRAD.",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE ALGERIEN DU MEDICAMENT (LAM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "14/7/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "4/2/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["sodium valproate (valproic acid)"],
    "InteractionIndexLink": ["acide valproique"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "15 A 003",
    "DCI": "VALPROATE DE SODIUM (acide valproique)",
    "NOM_COMMERCIALE": "MEVAKINE",
    "FORME": "Solution buvable",
    "DOSAGE": "200mg/ml",
    "COND": "flacon de 100 ml",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["sodium valproate (valproic acid)"],
    "InteractionIndexLink": ["acide valproique"],
    "N_ENREGISTREMENT": "318/15 A 003/17",
    "CODE_DCI": "15 A 003",
    "DCI": "VALPROATE DE SODIUM (acide valproique)",
    "NOM_COMMERCIALE": "PAKEDAL",
    "FORME": "SOL.BUV.",
    "DOSAGE": "200MG/ML",
    "COND": "FL/100 ML",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL PHARMIDAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/1/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "17/1/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["sodium valproate (valproic acid)"],
    "InteractionIndexLink": ["acide valproique"],
    "N_ENREGISTREMENT": "462/15 A 003/17",
    "CODE_DCI": "15 A 003",
    "DCI": "VALPROATE DE SODIUM (acide valproique)",
    "NOM_COMMERCIALE": "PHYSIOLONE",
    "FORME": "SOL.BUV.",
    "DOSAGE": "200MG/ML",
    "COND": "FL/100 ML +SERINGUE DOSEUSE",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHYSIOPHARM SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/3/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "26/3/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["sodium valproate (valproic acid)"],
    "InteractionIndexLink": ["acide valproique"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "15 A 003",
    "DCI": "VALPROATE DE SODIUM (acide valproique)",
    "NOM_COMMERCIALE": "PHYSIOPINE",
    "FORME": "SOL.BUV.",
    "DOSAGE": "200MG/ML",
    "COND": "FL/100 ML +SERINGUE DOSEUSE",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["sodium valproate (valproic acid)"],
    "InteractionIndexLink": ["acide valproique"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "15 A 003",
    "DCI": "VALPROATE DE SODIUM (acide valproique)",
    "NOM_COMMERCIALE": "PHYSIOPINE",
    "FORME": "Solution buvable",
    "DOSAGE": "200mg/ml",
    "COND": "Flacon de 100ml",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["sodium valproate (valproic acid)"],
    "InteractionIndexLink": ["acide valproique"],
    "N_ENREGISTREMENT": "503/ 15 A 003 /15",
    "CODE_DCI": "15 A 003",
    "DCI": "VALPROATE DE SODIUM (acide valproique)",
    "NOM_COMMERCIALE": "VALPROATE AFRO",
    "FORME": "SOL. BUV.",
    "DOSAGE": "200MG/ML",
    "COND": "FL 40ML.60ML.100ML PIPETTE GRADuée",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "AFROPHARM SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/12/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "13/12/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["sodium valproate (valproic acid)"],
    "InteractionIndexLink": ["acide valproique"],
    "N_ENREGISTREMENT": "235/ 15 A 003 /12 /18",
    "CODE_DCI": "15 A 003",
    "DCI": "VALPROATE DE SODIUM (acide valproique)",
    "NOM_COMMERCIALE": "VALPROATE DE SODIUM (acide valproique) BGL",
    "FORME": "SOL. BUV.",
    "DOSAGE": "200MG/ML",
    "COND": "B/1FL. DE 40ML + 1SERING. GRADUEE",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIO-GALENIC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/1/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "10/6/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["carbamazepine"],
    "InteractionIndexLink": ["carbamazepine"],
    "N_ENREGISTREMENT": "079/ 15 A 004 /98/08",
    "CODE_DCI": "15 A 004",
    "DCI": "CARBAMAZEPINE",
    "NOM_COMMERCIALE": "AZEPAL",
    "FORME": "COMPRIME",
    "DOSAGE": "200MG",
    "COND": "B/20",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE  ALGERIEN DE DEVELOPPEMENT  PHARMACEUTIQUE   (LAD)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/1/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "5/10/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["carbamazepine"],
    "InteractionIndexLink": ["carbamazepine"],
    "N_ENREGISTREMENT": "263/ 15 A 004 /06",
    "CODE_DCI": "15 A 004",
    "DCI": "CARBAMAZEPINE",
    "NOM_COMMERCIALE": "BIOMAZINE",
    "FORME": "COMPRIME",
    "DOSAGE": "200MG",
    "COND": "B/30",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOPHARM ALGERIE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/7/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "1/7/2006",
    "TYPE": "Gé",
    "STATUT": "C",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["carbamazepine"],
    "InteractionIndexLink": ["carbamazepine"],
    "N_ENREGISTREMENT": "055/ 15 A 004 /98/16",
    "CODE_DCI": "15 A 004",
    "DCI": "CARBAMAZEPINE",
    "NOM_COMMERCIALE": "CARBATOL",
    "FORME": "COMPRIME",
    "DOSAGE": "200MG",
    "COND": "B/30",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "DAR AL DAWA DEVELOPMENT & INVESTMENT Co Ltd",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/10/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "12/3/2017",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "60 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["carbamazepine"],
    "InteractionIndexLink": ["carbamazepine"],
    "N_ENREGISTREMENT": "235/ 15 A 004 /14",
    "CODE_DCI": "15 A 004",
    "DCI": "CARBAMAZEPINE",
    "NOM_COMMERCIALE": "CARBIMOL",
    "FORME": "COMPRIME",
    "DOSAGE": "200MG",
    "COND": "B/30",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIO-GALENIC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "31/3/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "31/3/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["carbamazepine"],
    "InteractionIndexLink": ["carbamazepine"],
    "N_ENREGISTREMENT": "263/ 15 A 004 /14",
    "CODE_DCI": "15 A 004",
    "DCI": "CARBAMAZEPINE",
    "NOM_COMMERCIALE": "NEUPAX",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "200MG",
    "COND": "B/30",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOPHARM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/4/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "28/4/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["carbamazepine"],
    "InteractionIndexLink": ["carbamazepine"],
    "N_ENREGISTREMENT": "178/ 15 A 004 /99/15",
    "CODE_DCI": "15 A 004",
    "DCI": "CARBAMAZEPINE",
    "NOM_COMMERCIALE": "TAVER",
    "FORME": "COMPRIME",
    "DOSAGE": "200MG",
    "COND": "B/50",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MEDOCHEMIE LTD",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CHYPRE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/6/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "29/12/2015",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "60MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["carbamazepine"],
    "InteractionIndexLink": ["carbamazepine"],
    "N_ENREGISTREMENT": "068/ 15 A 004 /98/15",
    "CODE_DCI": "15 A 004",
    "DCI": "CARBAMAZEPINE",
    "NOM_COMMERCIALE": "TEGRETOL",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "200MG",
    "COND": "B/50",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVARTIS PHARMA SCHWEIZ AG",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SUISSE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/11/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "18/3/2015",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "60 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["carbamazepine"],
    "InteractionIndexLink": ["carbamazepine"],
    "N_ENREGISTREMENT": "263/ 15 A 006 /14",
    "CODE_DCI": "15 A 006",
    "DCI": "CARBAMAZEPINE",
    "NOM_COMMERCIALE": "NEUPAX",
    "FORME": "SUSP. BUV.",
    "DOSAGE": "20MG/ML",
    "COND": "B/01 FL. 180 ML + SERINGUE P. ADMIN. ORALE DE 10ML GRADUEE",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOPHARM SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/11/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "2/11/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36  MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["carbamazepine"],
    "InteractionIndexLink": ["carbamazepine"],
    "N_ENREGISTREMENT": "068/ 15 A 006 /97",
    "CODE_DCI": "15 A 006",
    "DCI": "CARBAMAZEPINE",
    "NOM_COMMERCIALE": "TEGRETOL",
    "FORME": "SUSP.BUV.",
    "DOSAGE": "100MG/5ML",
    "COND": "FL/150ML",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVARTIS PHARMA S.A.",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/8/1997",
    "DATE_D_ENREGISTREMENT_FINAL": "4/8/1997",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["carbamazepine"],
    "InteractionIndexLink": ["carbamazepine"],
    "N_ENREGISTREMENT": "317/ 15 A 006 /18",
    "CODE_DCI": "15 A 006",
    "DCI": "CARBAMAZEPINE",
    "NOM_COMMERCIALE": "TEGRIDIS",
    "FORME": "SUSP. BUV.",
    "DOSAGE": "20MG/ML",
    "COND": "B/01 FL. 150 ML + SERINGUE P. ADMIN. ORALE DE 10ML GRADUEE A 0.25 ML",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INPHA-MEDIS SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/12/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "4/12/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24  MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["clonazepam"],
    "InteractionIndexLink": ["clonazepam"],
    "N_ENREGISTREMENT": "242/ 15 A 008 /09",
    "CODE_DCI": "15 A 008",
    "DCI": "CLONAZEPAM",
    "NOM_COMMERCIALE": "CLONA",
    "FORME": "COMPRIME",
    "DOSAGE": "2MG",
    "COND": "B/20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GROUPE SANTE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/2/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "10/2/2009",
    "TYPE": "Gé",
    "STATUT": "C",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["clonazepam"],
    "InteractionIndexLink": ["clonazepam"],
    "N_ENREGISTREMENT": "013/ 15 A 008 /99/14",
    "CODE_DCI": "15 A 008",
    "DCI": "CLONAZEPAM",
    "NOM_COMMERCIALE": "NOVATRIL",
    "FORME": "COMPRIME",
    "DOSAGE": "2MG",
    "COND": "B/40",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDUSTRIA FARMACEUTICA NOVA ARGENTIA SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ITALIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "21/11/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "6/7/2014",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "60 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["clonazepam"],
    "InteractionIndexLink": ["clonazepam"],
    "N_ENREGISTREMENT": "097/ 15 A 008 /09/17",
    "CODE_DCI": "15 A 008",
    "DCI": "CLONAZEPAM",
    "NOM_COMMERCIALE": "RIVOMED",
    "FORME": "COMP QUADRISEC.",
    "DOSAGE": "2MG",
    "COND": "B/40",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANAMED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/7/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "19/7/2009",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["clonazepam"],
    "InteractionIndexLink": ["clonazepam"],
    "N_ENREGISTREMENT": "242/ 15 A 009 /10/18",
    "CODE_DCI": "15 A 009",
    "DCI": "CLONAZEPAM",
    "NOM_COMMERCIALE": "CLONA",
    "FORME": "SOL. BUV. GTTES.",
    "DOSAGE": "2.5MG/ML",
    "COND": "FL. COMPTE GTTES. DE 20ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GROUPE SANTE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/3/2010",
    "DATE_D_ENREGISTREMENT_FINAL": "7/5/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["phenobarbital"],
    "InteractionIndexLink": ["phenobarbital"],
    "N_ENREGISTREMENT": "376/ 15 A 012 /96/09",
    "CODE_DCI": "15 A 012",
    "DCI": "PHENOBARBITAL (SOUS FORME SODIQUE)",
    "NOM_COMMERCIALE": "GARDENAL",
    "FORME": "LYOPH. ET SOLV.POUR .SOL.INJ",
    "DOSAGE": "40MG/FL. DE LYOPH.",
    "COND": "B/1FL. DE LYOPH. + 1AMP. DE 2ML DE SOLV. (EPPI)",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANOFI AVENTIS France",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "5/11/1996",
    "DATE_D_ENREGISTREMENT_FINAL": "8/12/2009",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["phenobarbital"],
    "InteractionIndexLink": ["phenobarbital"],
    "N_ENREGISTREMENT": "079/ 15 A 013 /13",
    "CODE_DCI": "15 A 013",
    "DCI": "PHENOBARBITAL",
    "NOM_COMMERCIALE": "SEVENAL",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "50MG",
    "COND": "B/20",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE  ALGERIEN DE DEVELOPPEMENT  PHARMACEUTIQUE SARL (LAD PHARMA)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/1/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "13/1/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["phenobarbital"],
    "InteractionIndexLink": ["phenobarbital"],
    "N_ENREGISTREMENT": "242/15 A 014/20",
    "CODE_DCI": "15 A 014",
    "DCI": "PHENOBARBITAL",
    "NOM_COMMERCIALE": "NERVAL",
    "FORME": "COMP. SEC.",
    "DOSAGE": "100MG",
    "COND": "B/ 20",
    "LISTE": "LISTE II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES GROUPE SANTE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "21/7/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "16/12/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["phenobarbital"],
    "InteractionIndexLink": ["phenobarbital"],
    "N_ENREGISTREMENT": "235/ 15 A 014 /07/18",
    "CODE_DCI": "15 A 014",
    "DCI": "PHENOBARBITAL",
    "NOM_COMMERCIALE": "PHENOXAL",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "100MG",
    "COND": "B/20",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIO-GALENIC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/7/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "1/8/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["phenobarbital"],
    "InteractionIndexLink": ["phenobarbital"],
    "N_ENREGISTREMENT": "079/ 15 A 014 /98/08",
    "CODE_DCI": "15 A 014",
    "DCI": "PHENOBARBITAL",
    "NOM_COMMERCIALE": "SEVENAL",
    "FORME": "COMPRIME",
    "DOSAGE": "100MG",
    "COND": "B/20",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE  ALGERIEN DE DEVELOPPEMENT  PHARMACEUTIQUE   (LAD)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/4/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "28/3/2009",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["carbamazepine"],
    "InteractionIndexLink": ["carbamazepine"],
    "N_ENREGISTREMENT": "235/ 15 A 036 /10",
    "CODE_DCI": "15 A 036",
    "DCI": "CARBAMAZEPINE",
    "NOM_COMMERCIALE": "CARBIMOL LP",
    "FORME": "COMP. PELLI. SEC. LP",
    "DOSAGE": "400MG",
    "COND": "B/30",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIO-GALENIC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "16/3/2010",
    "DATE_D_ENREGISTREMENT_FINAL": "16/3/2010",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["carbamazepine"],
    "InteractionIndexLink": ["carbamazepine"],
    "N_ENREGISTREMENT": "068/ 15 A 036 /97/16",
    "CODE_DCI": "15 A 036",
    "DCI": "CARBAMAZEPINE",
    "NOM_COMMERCIALE": "TEGRETOL LP",
    "FORME": "COMP. PELLI. SEC. LP",
    "DOSAGE": "400MG",
    "COND": "B/30",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVARTIS PHARMA SCHWEIZ AG.",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SUISSE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/11/1997",
    "DATE_D_ENREGISTREMENT_FINAL": "24/5/2016",
    "TYPE": "Ré",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36 mois",
    "availableInAlgeria": true,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["carbamazepine"],
    "InteractionIndexLink": ["carbamazepine"],
    "N_ENREGISTREMENT": "330/ 15 A 036 /05",
    "CODE_DCI": "15 A 036",
    "DCI": "CARBAMAZEPINE",
    "NOM_COMMERCIALE": "ZEPTOL CR 400",
    "FORME": "COMPRIME A LIBERATION PROLONGEE",
    "DOSAGE": "400MG",
    "COND": "B/30 ET B/50",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SUN PHARMACEUTICAL INDUSTRIES LTD",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/9/2005",
    "DATE_D_ENREGISTREMENT_FINAL": "28/9/2005",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["carbamazepine"],
    "InteractionIndexLink": ["carbamazepine"],
    "N_ENREGISTREMENT": "330/ 15 A 036 /05/18",
    "CODE_DCI": "15 A 036",
    "DCI": "CARBAMAZEPINE",
    "NOM_COMMERCIALE": "ZEPTOL CR 400",
    "FORME": "COMPRIME A LIBERATION PROLONGEE",
    "DOSAGE": "400MG",
    "COND": "B/30 ET B/50",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SUN PHARMACEUTICAL INDUSTRIES LTD",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/09/05",
    "DATE_D_ENREGISTREMENT_FINAL": "09/10/18",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 mois",
    "availableInAlgeria": true,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["sodium valproate (valproic acid)"],
    "InteractionIndexLink": ["acide valproique"],
    "N_ENREGISTREMENT": "255/ 15 A 043 /99/17",
    "CODE_DCI": "15 A 043",
    "DCI": "VALPROATE DE SODIUM (acide valproique)",
    "NOM_COMMERCIALE": "20/98/15 A003/392",
    "FORME": "COMP.PELLI. SEC. LP",
    "DOSAGE": "500MG",
    "COND": "B/30",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANOFISYNTHELABO",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/12/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "19/3/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["sodium valproate (valproic acid)"],
    "InteractionIndexLink": ["acide valproique"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "15 A 043",
    "DCI": "VALPROATE DE SODIUM (acide valproique)",
    "NOM_COMMERCIALE": "DEPAKINE CHRONO",
    "FORME": "COMP.PELLI. SEC. LP",
    "DOSAGE": "500MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["sodium valproate (valproic acid)"],
    "InteractionIndexLink": ["acide valproique"],
    "N_ENREGISTREMENT": "149/15 A 043/20",
    "CODE_DCI": "15 A 043",
    "DCI": "VALPROATE DE SODIUM (acide valproique)",
    "NOM_COMMERCIALE": "EPILKINE CHRONO",
    "FORME": "COMP PELL SEC LP",
    "DOSAGE": "500MG (333MG D'ACIDE VALPROIQUE SEL SODIIQUE + 147MG D'ACIDE VALPROIQUE)",
    "COND": "PILULIER/30",
    "LISTE": "LISTE II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVAPHARM TRADING SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/5/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "4/5/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["sodium valproate (valproic acid)"],
    "InteractionIndexLink": ["acide valproique"],
    "N_ENREGISTREMENT": "574/15 A 043/20",
    "CODE_DCI": "15 A 043",
    "DCI": "VALPROATE DE SODIUM (acide valproique)",
    "NOM_COMMERCIALE": "VALPROATE CHRONO",
    "FORME": "COMP. PELL. SEC. LP.",
    "DOSAGE": "500MG",
    "COND": "B/30",
    "LISTE": "LISTE II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES SPA SOPROPHAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/12/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "29/12/2020",
    "TYPE": "Gé",
    "STATUT": "F melange final",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["sodium valproate (valproic acid)"],
    "InteractionIndexLink": ["acide valproique"],
    "N_ENREGISTREMENT": "242/ 15 A 043 /09",
    "CODE_DCI": "15 A 043",
    "DCI": "VALPROATE DE SODIUM (acide valproique)",
    "NOM_COMMERCIALE": "VALPROCIDE GS CHRONO 500",
    "FORME": "COMP. SEC. LP",
    "DOSAGE": "500MG (333MG D'ACIDE VALPROIQUE SEL SODIIQUE + 147MG D'ACIDE VALPROIQUE)",
    "COND": "B/30",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GROUPE SANTE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "8/12/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "8/12/2009",
    "TYPE": "Gé",
    "STATUT": "C",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["lamotrigine"],
    "InteractionIndexLink": ["lamotrigine"],
    "N_ENREGISTREMENT": "352/ 15 A 051 /10",
    "CODE_DCI": "15 A 051",
    "DCI": "LAMOTRIGINE",
    "NOM_COMMERCIALE": "AMITRAL",
    "FORME": "COMP. DISPERS.",
    "DOSAGE": "5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/3/2010",
    "DATE_D_ENREGISTREMENT_FINAL": "28/3/2010",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["lamotrigine"],
    "InteractionIndexLink": ["lamotrigine"],
    "N_ENREGISTREMENT": "242/ 15 A 051 /10",
    "CODE_DCI": "15 A 051",
    "DCI": "LAMOTRIGINE",
    "NOM_COMMERCIALE": "LAMITOR",
    "FORME": "COMP. DISPERS.",
    "DOSAGE": "5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GROUPE SANTE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/12/2010",
    "DATE_D_ENREGISTREMENT_FINAL": "22/12/2010",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["lamotrigine"],
    "InteractionIndexLink": ["lamotrigine"],
    "N_ENREGISTREMENT": "447/ 15 A 051/16",
    "CODE_DCI": "15 A 051",
    "DCI": "LAMOTRIGINE",
    "NOM_COMMERCIALE": "LAMOTRIGINE BEKER",
    "FORME": "COMP. DISPERS.",
    "DOSAGE": "5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEKER SARL (SARL LABORATOIRE BEKER ALGERIE)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/4/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "19/4/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["lamotrigine"],
    "InteractionIndexLink": ["lamotrigine"],
    "N_ENREGISTREMENT": "352/ 15 A 052 /10",
    "CODE_DCI": "15 A 052",
    "DCI": "LAMOTRIGINE",
    "NOM_COMMERCIALE": "AMITRAL",
    "FORME": "COMP. DISPERS.",
    "DOSAGE": "25MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "11/3/2010",
    "DATE_D_ENREGISTREMENT_FINAL": "11/3/2010",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["lamotrigine"],
    "InteractionIndexLink": ["lamotrigine"],
    "N_ENREGISTREMENT": "293/ 15 A 052 /18",
    "CODE_DCI": "15 A 052",
    "DCI": "LAMOTRIGINE",
    "NOM_COMMERCIALE": "BIOLAM",
    "FORME": "COMP. DISPERS. OU. A CROQUER",
    "DOSAGE": "25MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOCARE  SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "14/5/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "14/5/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["lamotrigine"],
    "InteractionIndexLink": ["lamotrigine"],
    "N_ENREGISTREMENT": "20/15 A052/380",
    "CODE_DCI": "15 A 052",
    "DCI": "LAMOTRIGINE",
    "NOM_COMMERCIALE": "LAMITRIGINE",
    "FORME": "COMP DISPERSIBLES",
    "DOSAGE": "25MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "laboratoires HUP.P PHARMA Sarl",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/07/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "29/07/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["lamotrigine"],
    "InteractionIndexLink": ["lamotrigine"],
    "N_ENREGISTREMENT": "20/15 A052/380",
    "CODE_DCI": "15 A 052",
    "DCI": "LAMOTRIGINE",
    "NOM_COMMERCIALE": "LAMITRIGINE",
    "FORME": "COMP DISPERSIBLES",
    "DOSAGE": "25MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "laboratoires HUP.P PHARMA Sarl",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/07/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "29/07/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["lamotrigine"],
    "InteractionIndexLink": ["lamotrigine"],
    "N_ENREGISTREMENT": "20/15 A052/492",
    "CODE_DCI": "15 A 052",
    "DCI": "LAMOTRIGINE",
    "NOM_COMMERCIALE": "LAMOTRIG",
    "FORME": "COMP DISPERSIBLES",
    "DOSAGE": "25MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES SPA SOPRODIM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "14/10/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "14/10/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["lamotrigine"],
    "InteractionIndexLink": ["lamotrigine"],
    "N_ENREGISTREMENT": "447/ 15 A 052 /13",
    "CODE_DCI": "15 A 052",
    "DCI": "LAMOTRIGINE",
    "NOM_COMMERCIALE": "LAMOTRIGINE BEKER",
    "FORME": "COMP. DISPERS.",
    "DOSAGE": "25MG",
    "COND": "B/56",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEKER SARL (SARL LABORATOIRE BEKER ALGERIE)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/3/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "23/1/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["lamotrigine"],
    "InteractionIndexLink": ["lamotrigine"],
    "N_ENREGISTREMENT": "352/ 15 A 053 /10",
    "CODE_DCI": "15 A 053",
    "DCI": "LAMOTRIGINE",
    "NOM_COMMERCIALE": "AMITRAL",
    "FORME": "COMP. DISPERS.",
    "DOSAGE": "100MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "11/3/2010",
    "DATE_D_ENREGISTREMENT_FINAL": "11/3/2010",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["lamotrigine"],
    "InteractionIndexLink": ["lamotrigine"],
    "N_ENREGISTREMENT": "293/ 15 A 053 /18",
    "CODE_DCI": "15 A 053",
    "DCI": "LAMOTRIGINE",
    "NOM_COMMERCIALE": "BIOLAM",
    "FORME": "COMP. DISPERS. OU. A CROQUER",
    "DOSAGE": "100MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOCARE  SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "14/5/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "14/5/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["lamotrigine"],
    "InteractionIndexLink": ["lamotrigine"],
    "N_ENREGISTREMENT": "20/15 A053/380",
    "CODE_DCI": "15 A 053",
    "DCI": "LAMOTRIGINE",
    "NOM_COMMERCIALE": "LAMITRIGINE",
    "FORME": "COMP DISPERSIBLES",
    "DOSAGE": "100MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "laboratoires HUP.P PHARMA Sarl",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/07/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "29/07/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["lamotrigine"],
    "InteractionIndexLink": ["lamotrigine"],
    "N_ENREGISTREMENT": "20/15 A053/492",
    "CODE_DCI": "15 A 053",
    "DCI": "LAMOTRIGINE",
    "NOM_COMMERCIALE": "LAMOTRIG",
    "FORME": "COMP DISPERSIBLES",
    "DOSAGE": "100MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES SPA SOPRODIM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "14/10/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "14/10/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["lamotrigine"],
    "InteractionIndexLink": ["lamotrigine"],
    "N_ENREGISTREMENT": "447/ 15 A 053 /13",
    "CODE_DCI": "15 A 053",
    "DCI": "LAMOTRIGINE",
    "NOM_COMMERCIALE": "LAMOTRIGINE BEKER",
    "FORME": "COMP. DISPERS.",
    "DOSAGE": "100MG",
    "COND": "B/56",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEKER SARL (SARL LABORATOIRE BEKER ALGERIE)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/3/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "20/3/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["lamotrigine"],
    "InteractionIndexLink": ["lamotrigine"],
    "N_ENREGISTREMENT": "035/ 15 A 053 /21",
    "CODE_DCI": "15 A 053",
    "DCI": "Lamotrigine",
    "NOM_COMMERCIALE": "LATRIGINE",
    "FORME": "Comprimé dispersible ou à croquer",
    "DOSAGE": "100MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMALLIANCE / EURL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "21/2/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "21/2/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["lamotrigine"],
    "InteractionIndexLink": ["lamotrigine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "15 A 063",
    "DCI": "LAMOTRIGINE",
    "NOM_COMMERCIALE": "LAMOGINE",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "25MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["lamotrigine"],
    "InteractionIndexLink": ["lamotrigine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "15 A 064",
    "DCI": "LAMOTRIGINE",
    "NOM_COMMERCIALE": "LAMITOR",
    "FORME": "Comprimé",
    "DOSAGE": "50 mg",
    "COND": "Boite de  40 Cp",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["lamotrigine"],
    "InteractionIndexLink": ["lamotrigine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "15 A 064",
    "DCI": "LAMOTRIGINE",
    "NOM_COMMERCIALE": "LAMITRIGINE",
    "FORME": "Comp",
    "DOSAGE": "50mg",
    "COND": "30 Cps",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["lamotrigine"],
    "InteractionIndexLink": ["lamotrigine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "15 A 064",
    "DCI": "LAMOTRIGINE",
    "NOM_COMMERCIALE": "LAMOGINE",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "50MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["lamotrigine"],
    "InteractionIndexLink": ["lamotrigine"],
    "N_ENREGISTREMENT": "20/15 A064/492",
    "CODE_DCI": "15 A 064",
    "DCI": "LAMOTRIGINE",
    "NOM_COMMERCIALE": "LAMOTRIG",
    "FORME": "COMP DISPERSIBLES",
    "DOSAGE": "50MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES SPA SOPRODIM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "14/10/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "14/10/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["lamotrigine"],
    "InteractionIndexLink": ["lamotrigine"],
    "N_ENREGISTREMENT": "20/15 A064/492",
    "CODE_DCI": "15 A 064",
    "DCI": "LAMOTRIGINE",
    "NOM_COMMERCIALE": "LAMOTRIG",
    "FORME": "COMP DISPERSIBLES",
    "DOSAGE": "50MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES SPA SOPRODIM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "14/10/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "14/10/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["pregabalin"],
    "InteractionIndexLink": ["pregabaline"],
    "N_ENREGISTREMENT": "045/ 15 A 065 /06/16",
    "CODE_DCI": "15 A 065",
    "DCI": "Prégabaline",
    "NOM_COMMERCIALE": "LYRICA",
    "FORME": "GLES.",
    "DOSAGE": "25MG",
    "COND": "B/56",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PFIZER LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ROYAUME UNI",
    "DATE_D_ENREGISTREMENT_INITIAL": "11/10/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "3/5/2016",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["pregabalin"],
    "InteractionIndexLink": ["pregabaline"],
    "N_ENREGISTREMENT": "035/ 15 A 065 /14",
    "CODE_DCI": "15 A 065",
    "DCI": "Prégabaline",
    "NOM_COMMERCIALE": "PREGABA",
    "FORME": "GLES",
    "DOSAGE": "25MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMALLIANCE EURL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/7/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "13/7/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["pregabalin"],
    "InteractionIndexLink": ["pregabaline"],
    "N_ENREGISTREMENT": "510/ 15 A 066 /16",
    "CODE_DCI": "15 A 066",
    "DCI": "Prégabaline",
    "NOM_COMMERCIALE": "LEPTICA",
    "FORME": "GLES",
    "DOSAGE": "50MG",
    "COND": "B/60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALEMBIC MAMI SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/9/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "27/9/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["pregabalin"],
    "InteractionIndexLink": ["pregabaline"],
    "N_ENREGISTREMENT": "235/15 A 066/19",
    "CODE_DCI": "15 A 066",
    "DCI": "Prégabaline",
    "NOM_COMMERCIALE": "LIPRAG",
    "FORME": "GLES",
    "DOSAGE": "50MG",
    "COND": "B/60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOGALENIC / SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/2/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "4/2/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["pregabalin"],
    "InteractionIndexLink": ["pregabaline"],
    "N_ENREGISTREMENT": "045/ 15 A 066 /06/16",
    "CODE_DCI": "15 A 066",
    "DCI": "Prégabaline",
    "NOM_COMMERCIALE": "LYRICA",
    "FORME": "GLES.",
    "DOSAGE": "50MG",
    "COND": "B/56",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PFIZER PHARMA ALGERIE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "11/10/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "13/6/2016",
    "TYPE": "Ré",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["pregabalin"],
    "InteractionIndexLink": ["pregabaline"],
    "N_ENREGISTREMENT": "352/15 A 066/17",
    "CODE_DCI": "15 A 066",
    "DCI": "Prégabaline",
    "NOM_COMMERCIALE": "LYRIZIN",
    "FORME": "GLES",
    "DOSAGE": "50MG",
    "COND": "B/60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI DU MEDICAMENT SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "8/10/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "8/10/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["pregabalin"],
    "InteractionIndexLink": ["pregabaline"],
    "N_ENREGISTREMENT": "097/ 15 A 066 /16",
    "CODE_DCI": "15 A 066",
    "DCI": "Prégabaline",
    "NOM_COMMERCIALE": "NEURAXON",
    "FORME": "GLES.",
    "DOSAGE": "50MG",
    "COND": "B/60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANAMED SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/6/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "13/6/2016",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["pregabalin"],
    "InteractionIndexLink": ["pregabaline"],
    "N_ENREGISTREMENT": "263/ 15 A 066 /15",
    "CODE_DCI": "15 A 066",
    "DCI": "Prégabaline",
    "NOM_COMMERCIALE": "NEURICA",
    "FORME": "GLES.",
    "DOSAGE": "50MG",
    "COND": "B/60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOPHARM SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/3/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "18/3/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["pregabalin"],
    "InteractionIndexLink": ["pregabaline"],
    "N_ENREGISTREMENT": "035/ 15 A 066 /14",
    "CODE_DCI": "15 A 066",
    "DCI": "Prégabaline",
    "NOM_COMMERCIALE": "PREGABA",
    "FORME": "GLES",
    "DOSAGE": "50MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMALLIANCE EURL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/7/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "13/7/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["pregabalin"],
    "InteractionIndexLink": ["pregabaline"],
    "N_ENREGISTREMENT": "447/ 15 A 066 /13 /18",
    "CODE_DCI": "15 A 066",
    "DCI": "Prégabaline",
    "NOM_COMMERCIALE": "PREGABALINE BEKER",
    "FORME": "GLES.",
    "DOSAGE": "50MG",
    "COND": "B/60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEKER SARL (SARL LABORATOIRE BEKER ALGERIE)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "11/6/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["pregabalin"],
    "InteractionIndexLink": ["pregabaline"],
    "N_ENREGISTREMENT": "309/ 15 A 066 /13",
    "CODE_DCI": "15 A 066",
    "DCI": "Prégabaline",
    "NOM_COMMERCIALE": "PREGABALINE LDM",
    "FORME": "GLES.",
    "DOSAGE": "50MG",
    "COND": "B/60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES DE DIAGNOSTIC MAGHREBINS (LDM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/8/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "25/8/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["pregabalin"],
    "InteractionIndexLink": ["pregabaline"],
    "N_ENREGISTREMENT": "149/ 15 A 066 /15",
    "CODE_DCI": "15 A 066",
    "DCI": "Prégabaline",
    "NOM_COMMERCIALE": "PRERICA",
    "FORME": "GLES.",
    "DOSAGE": "50MG",
    "COND": "B/60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVAPHARM TRADING SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/4/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "26/4/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["pregabalin"],
    "InteractionIndexLink": ["pregabaline"],
    "N_ENREGISTREMENT": "001/ 15 A 066 /13",
    "CODE_DCI": "15 A 066",
    "DCI": "Prégabaline",
    "NOM_COMMERCIALE": "REGAB",
    "FORME": "GLES.",
    "DOSAGE": "50MG",
    "COND": "B/56",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMA ALGERIA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/5/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "29/5/2013",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["pregabalin"],
    "InteractionIndexLink": ["pregabaline"],
    "N_ENREGISTREMENT": "289/ 15 A 066 /12",
    "CODE_DCI": "15 A 066",
    "DCI": "Prégabaline",
    "NOM_COMMERCIALE": "RICABALINE",
    "FORME": "MICROGLES. EN GLES.",
    "DOSAGE": "50MG",
    "COND": "B/60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRATER RAZES FORME SECHE SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/10/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "25/6/2019",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["pregabalin"],
    "InteractionIndexLink": ["pregabaline"],
    "N_ENREGISTREMENT": "418/15 A 066/17",
    "CODE_DCI": "15 A 066",
    "DCI": "Prégabaline",
    "NOM_COMMERCIALE": "YRICAL",
    "FORME": "GLES.",
    "DOSAGE": "50MG",
    "COND": "B/56",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NEOMEDIC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/2/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "7/2/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["pregabalin"],
    "InteractionIndexLink": ["pregabaline"],
    "N_ENREGISTREMENT": "177/15 A 068/18",
    "CODE_DCI": "15 A 068",
    "DCI": "Prégabaline",
    "NOM_COMMERCIALE": "GABALYSE",
    "FORME": "GLES.",
    "DOSAGE": "150MG",
    "COND": "B/56",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ABDI IBRAHIM ILAC SANAYI Ve",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/10/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "19/10/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["pregabalin"],
    "InteractionIndexLink": ["pregabaline"],
    "N_ENREGISTREMENT": "544 /15 A 068/18",
    "CODE_DCI": "15 A 068",
    "DCI": "Prégabaline",
    "NOM_COMMERCIALE": "GALARA",
    "FORME": "GLES.",
    "DOSAGE": "150MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL WORLD MEDECINE LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/7/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "24/7/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["pregabalin"],
    "InteractionIndexLink": ["pregabaline"],
    "N_ENREGISTREMENT": "510/15 A 068/16",
    "CODE_DCI": "15 A 068",
    "DCI": "Prégabaline",
    "NOM_COMMERCIALE": "LEPTICA",
    "FORME": "GLES.",
    "DOSAGE": "150MG",
    "COND": "B/60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALEMBIC MAMI SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/10/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "19/10/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["pregabalin"],
    "InteractionIndexLink": ["pregabaline"],
    "N_ENREGISTREMENT": "235/ 15 A 068 /19",
    "CODE_DCI": "15 A 068",
    "DCI": "Prégabaline",
    "NOM_COMMERCIALE": "LIPRAG",
    "FORME": "GLES",
    "DOSAGE": "150MG",
    "COND": "B/60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOGALENIC / SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/1/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "30/1/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["pregabalin"],
    "InteractionIndexLink": ["pregabaline"],
    "N_ENREGISTREMENT": "352/15 A 068/17",
    "CODE_DCI": "15 A 068",
    "DCI": "Prégabaline",
    "NOM_COMMERCIALE": "LYRIZIN",
    "FORME": "GLES.",
    "DOSAGE": "150MG",
    "COND": "B/60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/2/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "7/2/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["pregabalin"],
    "InteractionIndexLink": ["pregabaline"],
    "N_ENREGISTREMENT": "173/15 A 068/18",
    "CODE_DCI": "15 A 068",
    "DCI": "Prégabaline",
    "NOM_COMMERCIALE": "NERVAX",
    "FORME": "GLES.",
    "DOSAGE": "150MG",
    "COND": "B/60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "TABUK ALGERIE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/5/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "27/5/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["pregabalin"],
    "InteractionIndexLink": ["pregabaline"],
    "N_ENREGISTREMENT": "097 /15 A 068/ 16",
    "CODE_DCI": "15 A 068",
    "DCI": "Prégabaline",
    "NOM_COMMERCIALE": "NEURAXON 150",
    "FORME": "GLES",
    "DOSAGE": "150MG",
    "COND": "B/60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANAMED SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/8/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "1/8/2016",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["pregabalin"],
    "InteractionIndexLink": ["pregabaline"],
    "N_ENREGISTREMENT": "263/ 15 A 068 /15",
    "CODE_DCI": "15 A 068",
    "DCI": "Prégabaline",
    "NOM_COMMERCIALE": "NEURICA",
    "FORME": "GLES.",
    "DOSAGE": "150MG",
    "COND": "B/60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOPHARM SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "31/3/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "31/3/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["pregabalin"],
    "InteractionIndexLink": ["pregabaline"],
    "N_ENREGISTREMENT": "035/ 15 A 068 /14",
    "CODE_DCI": "15 A 068",
    "DCI": "Prégabaline",
    "NOM_COMMERCIALE": "PREGABA",
    "FORME": "GLES.",
    "DOSAGE": "150MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMALLIANCE EURL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/10/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "13/10/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["pregabalin"],
    "InteractionIndexLink": ["pregabaline"],
    "N_ENREGISTREMENT": "447/ 15 A 068 /13/18",
    "CODE_DCI": "15 A 068",
    "DCI": "Prégabaline",
    "NOM_COMMERCIALE": "PREGABALINE BEKER",
    "FORME": "GLES.",
    "DOSAGE": "150MG",
    "COND": "B/60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEKER SARL (SARL LABORATOIRE BEKER ALGERIE)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/5/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "27/5/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["pregabalin"],
    "InteractionIndexLink": ["pregabaline"],
    "N_ENREGISTREMENT": "309/ 15 A 068 /13",
    "CODE_DCI": "15 A 068",
    "DCI": "Prégabaline",
    "NOM_COMMERCIALE": "PREGABALINE LDM",
    "FORME": "GLES.",
    "DOSAGE": "150MG",
    "COND": "B/60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES  DE DIAGNOSTIC MAGHREBINS (LDM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/9/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "30/9/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["pregabalin"],
    "InteractionIndexLink": ["pregabaline"],
    "N_ENREGISTREMENT": "149/ 15 A 068 /15",
    "CODE_DCI": "15 A 068",
    "DCI": "Prégabaline",
    "NOM_COMMERCIALE": "PRERICA",
    "FORME": "GLES.",
    "DOSAGE": "150MG",
    "COND": "B/60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVAPHARM TRADING SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/3/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "18/3/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["pregabalin"],
    "InteractionIndexLink": ["pregabaline"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "15 A 068",
    "DCI": "PREGABALINE",
    "NOM_COMMERCIALE": "PRERICA 150 mg",
    "FORME": "gelule",
    "DOSAGE": "150 mg",
    "COND": "BOITE DE 60",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["pregabalin"],
    "InteractionIndexLink": ["pregabaline"],
    "N_ENREGISTREMENT": "001/ 15 A 068 /13/18",
    "CODE_DCI": "15 A 068",
    "DCI": "Prégabaline",
    "NOM_COMMERCIALE": "REGAB",
    "FORME": "GLES.",
    "DOSAGE": "150MG",
    "COND": "B/56",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMA ALGERIA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "5/3/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "29/1/2018",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["pregabalin"],
    "InteractionIndexLink": ["pregabaline"],
    "N_ENREGISTREMENT": "289/ 15 A 068 /12/19",
    "CODE_DCI": "15 A 068",
    "DCI": "Prégabaline",
    "NOM_COMMERCIALE": "RICABALINE",
    "FORME": "GLES.",
    "DOSAGE": "150MG",
    "COND": "B/60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRATER RAZES FORME SECHE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/1/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "25/6/2019",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["pregabalin"],
    "InteractionIndexLink": ["pregabaline"],
    "N_ENREGISTREMENT": "418/15 A 068/17",
    "CODE_DCI": "15 A 068",
    "DCI": "Prégabaline",
    "NOM_COMMERCIALE": "YRICAL",
    "FORME": "GLES.",
    "DOSAGE": "150MG",
    "COND": "B/56",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NEOMEDIC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/2/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "7/2/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["pregabalin"],
    "InteractionIndexLink": ["pregabaline"],
    "N_ENREGISTREMENT": "177 /15 A 069/18",
    "CODE_DCI": "15 A 069",
    "DCI": "Prégabaline",
    "NOM_COMMERCIALE": "GABALYSE",
    "FORME": "GLES.",
    "DOSAGE": "300MG",
    "COND": "B/56",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ABDI IBRAHIM ILAC SANAYI Ve",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "TURQUIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/12/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "25/12/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["pregabalin"],
    "InteractionIndexLink": ["pregabaline"],
    "N_ENREGISTREMENT": "544 /15 A 069/18",
    "CODE_DCI": "15 A 069",
    "DCI": "Prégabaline",
    "NOM_COMMERCIALE": "GALARA",
    "FORME": "GLES.",
    "DOSAGE": "300MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL WORLD MEDECINE LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/7/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "24/7/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["pregabalin"],
    "InteractionIndexLink": ["pregabaline"],
    "N_ENREGISTREMENT": "510/15 A 069/16",
    "CODE_DCI": "15 A 069",
    "DCI": "Prégabaline",
    "NOM_COMMERCIALE": "LEPTICA",
    "FORME": "GLES.",
    "DOSAGE": "300MG",
    "COND": "B/60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALEMBIC MAMI SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/11/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "9/11/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["pregabalin"],
    "InteractionIndexLink": ["pregabaline"],
    "N_ENREGISTREMENT": "045/ 15 A 069 /06",
    "CODE_DCI": "15 A 069",
    "DCI": "Prégabaline",
    "NOM_COMMERCIALE": "LYRICA",
    "FORME": "GLES.",
    "DOSAGE": "300MG",
    "COND": "B/56",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PFIZER LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ROYAUME UNI",
    "DATE_D_ENREGISTREMENT_INITIAL": "11/10/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "11/10/2006",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["pregabalin"],
    "InteractionIndexLink": ["pregabaline"],
    "N_ENREGISTREMENT": "352/15 A 069/17",
    "CODE_DCI": "15 A 069",
    "DCI": "Prégabaline",
    "NOM_COMMERCIALE": "LYRIZIN",
    "FORME": "GLES.",
    "DOSAGE": "300MG",
    "COND": "B/60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/2/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "12/2/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["pregabalin"],
    "InteractionIndexLink": ["pregabaline"],
    "N_ENREGISTREMENT": "035/ 15 A 069 /14",
    "CODE_DCI": "15 A 069",
    "DCI": "Prégabaline",
    "NOM_COMMERCIALE": "PREGABA",
    "FORME": "GLES.",
    "DOSAGE": "300MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMALLIANCE EURL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/12/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "15/12/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["pregabalin"],
    "InteractionIndexLink": ["pregabaline"],
    "N_ENREGISTREMENT": "447 / 15 A 069 /13/18",
    "CODE_DCI": "15 A 069",
    "DCI": "Prégabaline",
    "NOM_COMMERCIALE": "PREGABALINE BEKER",
    "FORME": "GLES.",
    "DOSAGE": "300MG",
    "COND": "B/60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEKER SARL (SARL LABORATOIRE BEKER ALGERIE)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/3/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "1/8/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["pregabalin"],
    "InteractionIndexLink": ["pregabaline"],
    "N_ENREGISTREMENT": "309/ 15 A 069 /13",
    "CODE_DCI": "15 A 069",
    "DCI": "Prégabaline",
    "NOM_COMMERCIALE": "PREGABALINE LDM",
    "FORME": "GLES.",
    "DOSAGE": "300MG",
    "COND": "B/60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES  DE DIAGNOSTIC MAGHREBINS (LDM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/9/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "30/9/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["pregabalin"],
    "InteractionIndexLink": ["pregabaline"],
    "N_ENREGISTREMENT": "001/ 15 A 069 /13",
    "CODE_DCI": "15 A 069",
    "DCI": "Prégabaline",
    "NOM_COMMERCIALE": "REGAB",
    "FORME": "GLES.",
    "DOSAGE": "300MG",
    "COND": "B/56",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMA ALGERIA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "5/3/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "5/3/2013",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["pregabalin"],
    "InteractionIndexLink": ["pregabaline"],
    "N_ENREGISTREMENT": "289/ 15 A 069 /15",
    "CODE_DCI": "15 A 069",
    "DCI": "Prégabaline",
    "NOM_COMMERCIALE": "RICABALINE",
    "FORME": "MICROGRANULES EN GLES",
    "DOSAGE": "300MG",
    "COND": "B/60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRATER RAZES FORME SECHE SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/7/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "30/7/2015",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["levetiracetam"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "293/ 15 A 072 /15",
    "CODE_DCI": "15 A 072",
    "DCI": "LEVETIRACETAM",
    "NOM_COMMERCIALE": "BIOCETAM",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "250MG",
    "COND": "B/60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOCARE SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/7/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "30/7/2015",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["levetiracetam"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "468/ 15 A 072 /15",
    "CODE_DCI": "15 A 072",
    "DCI": "LEVETIRACETAM",
    "NOM_COMMERCIALE": "EGORIE",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "250MG",
    "COND": "B/64",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NADPHARMADIC PRODUCTION SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/7/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "30/7/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["levetiracetam"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "035/ 15 A 072 /16",
    "CODE_DCI": "15 A 072",
    "DCI": "LEVETIRACETAM",
    "NOM_COMMERCIALE": "EPILEPTAM",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "250MG",
    "COND": "B/60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMALLIANCE EURL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/2/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "4/2/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["levetiracetam"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "20/15 A072/177",
    "CODE_DCI": "15 A 072",
    "DCI": "LÉVÉTIRACETAM",
    "NOM_COMMERCIALE": "EPIX",
    "FORME": "COMP PELL",
    "DOSAGE": "250MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES ABDI IBRAHIM REMEDE PHARMA SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/10/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "25/10/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["levetiracetam"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "15 A 072",
    "DCI": "LEVETIRACETAM",
    "NOM_COMMERCIALE": "EPIXX",
    "FORME": "COMP PELLICULE",
    "DOSAGE": "250MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["levetiracetam"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "20/15 A072/173",
    "CODE_DCI": "15 A 072",
    "DCI": "LEVETIRACETAM",
    "NOM_COMMERCIALE": "KEPACETAM",
    "FORME": "COMP PELL",
    "DOSAGE": "250MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES EURL TABUK ALGERIE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "14/10/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "14/10/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["levetiracetam"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "352/ 15 A 072 /13",
    "CODE_DCI": "15 A 072",
    "DCI": "LEVETIRACETAM",
    "NOM_COMMERCIALE": "KEPAM",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "250MG",
    "COND": "B/60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/7/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "7/7/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["levetiracetam"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "046/ 15 A 072 /07",
    "CODE_DCI": "15 A 072",
    "DCI": "LEVETIRACETAM",
    "NOM_COMMERCIALE": "KEPPRA",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "250MG",
    "COND": "B/60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "UCB S.A",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BELGIQUE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/5/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "9/5/2007",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["levetiracetam"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "447/15 A  072/16",
    "CODE_DCI": "15 A 072",
    "DCI": "LEVETIRACETAM",
    "NOM_COMMERCIALE": "LEVETIRACETAM BEKER",
    "FORME": "COMP PELL SECABLE",
    "DOSAGE": "250MG",
    "COND": "B/60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEKER SARL (SARL LABORATOIRE BEKER ALGERIE)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/1/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "4/1/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["levetiracetam"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "309/ 15 A 072 /14",
    "CODE_DCI": "15 A 072",
    "DCI": "LEVETIRACETAM",
    "NOM_COMMERCIALE": "LEVETIRACETAM LDM",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "250MG",
    "COND": "B/60",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES DE DIAGNOSTIC MAGHREBINS (LDM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/7/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "27/7/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["levetiracetam"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "149/ 15 A 072 /18",
    "CODE_DCI": "15 A 072",
    "DCI": "LEVETIRACETAM",
    "NOM_COMMERCIALE": "LEVETIRACETAM NOVOGENERICS",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "250MG",
    "COND": "B/60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVAPHARM TRADING SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/4/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "30/4/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["levetiracetam"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "001/ 15 A 072 /13",
    "CODE_DCI": "15 A 072",
    "DCI": "LEVETIRACETAM",
    "NOM_COMMERCIALE": "VETRAM",
    "FORME": "COMP. PELLI. SEC.",
    "DOSAGE": "250MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMA ALGERIA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/9/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "4/7/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["levetiracetam"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "293/ 15 A 073 /16",
    "CODE_DCI": "15 A 073",
    "DCI": "LEVETIRACETAM",
    "NOM_COMMERCIALE": "BIOCETAM",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "500MG",
    "COND": "B/60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOCARE SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/2/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "22/2/2016",
    "TYPE": "Gé",
    "STATUT": "Fpremix",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["levetiracetam"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "035/ 15 A 073 /16",
    "CODE_DCI": "15 A 073",
    "DCI": "LEVETIRACETAM",
    "NOM_COMMERCIALE": "EPILEPTAM",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "500MG",
    "COND": "B/60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMALLIANCE EURL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/2/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "4/2/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["levetiracetam"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "177/15 A 073/20",
    "CODE_DCI": "15 A 073",
    "DCI": "LEVETIRACETAM",
    "NOM_COMMERCIALE": "EPIXX",
    "FORME": "COMP. PELL",
    "DOSAGE": "500MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES ABDI IBRAHIM. ILAç SANAYI. VE TICARET A.S",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "TURQUIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/12/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "27/12/2020",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["levetiracetam"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "20/15 A073/173",
    "CODE_DCI": "15 A 073",
    "DCI": "LEVETIRACETAM",
    "NOM_COMMERCIALE": "KEPACETAM",
    "FORME": "COMP PELL",
    "DOSAGE": "500MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES EURL TABUK ALGERIE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "14/10/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "14/10/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["levetiracetam"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "352/ 15 A 073 /13",
    "CODE_DCI": "15 A 073",
    "DCI": "LEVETIRACETAM",
    "NOM_COMMERCIALE": "KEPAM",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "500MG",
    "COND": "B/60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "31/7/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "31/7/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["levetiracetam"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "447/15 A 073/16",
    "CODE_DCI": "15 A 073",
    "DCI": "LEVETIRACETAM",
    "NOM_COMMERCIALE": "LEVETIRACETAM BEKER",
    "FORME": "COMP PELL SECABLE",
    "DOSAGE": "500MG",
    "COND": "B/60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL BEKER",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/12/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "4/12/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["levetiracetam"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "309/15 A 073/17",
    "CODE_DCI": "15 A 073",
    "DCI": "LEVETIRACETAM",
    "NOM_COMMERCIALE": "LEVETIRACETAM LDM",
    "FORME": "COMP PELL SECABLE",
    "DOSAGE": "500MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LDM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/1/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "29/1/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["levetiracetam"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "001/ 15 A 073/ 13/20",
    "CODE_DCI": "15 A 073",
    "DCI": "Lévétiracétam",
    "NOM_COMMERCIALE": "VETRAM",
    "FORME": "Comprimé pelliculé sécable",
    "DOSAGE": "500MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMA ALGERIA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/11/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "10/6/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["topiramate"],
    "InteractionIndexLink": ["topiramate"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "15 A 081",
    "DCI": "TOPIRAMATE",
    "NOM_COMMERCIALE": "REPANIDE",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "25MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["topiramate"],
    "InteractionIndexLink": ["topiramate"],
    "N_ENREGISTREMENT": "352/15 A 081/16",
    "CODE_DCI": "15 A 081",
    "DCI": "TOPIRAMATE",
    "NOM_COMMERCIALE": "TOPICLOMAX",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "25MG",
    "COND": "B/60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/11/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "9/11/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["topiramate"],
    "InteractionIndexLink": ["topiramate"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "15 A 082",
    "DCI": "TOPIRAMATE",
    "NOM_COMMERCIALE": "REPANIDE",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "50MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["topiramate"],
    "InteractionIndexLink": ["topiramate"],
    "N_ENREGISTREMENT": "352/15 A 082/16",
    "CODE_DCI": "15 A 082",
    "DCI": "TOPIRAMATE",
    "NOM_COMMERCIALE": "TOPICLOMAX",
    "FORME": "COMP. ENRO.",
    "DOSAGE": "50MG",
    "COND": "B/60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/11/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "9/11/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["topiramate"],
    "InteractionIndexLink": ["topiramate"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "15 A 083",
    "DCI": "TOPIRAMATE",
    "NOM_COMMERCIALE": "REPANIDE",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "100MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["topiramate"],
    "InteractionIndexLink": ["topiramate"],
    "N_ENREGISTREMENT": "352/15 A 083/16",
    "CODE_DCI": "15 A 083",
    "DCI": "TOPIRAMATE",
    "NOM_COMMERCIALE": "TOPICLOMAX",
    "FORME": "COMP. ENRO.",
    "DOSAGE": "100MG",
    "COND": "B/60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/11/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "9/11/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["topiramate"],
    "InteractionIndexLink": ["topiramate"],
    "N_ENREGISTREMENT": "352/15 A 084/17",
    "CODE_DCI": "15 A 084",
    "DCI": "TOPIRAMATE",
    "NOM_COMMERCIALE": "TOPICLOMAX",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "200 MG",
    "COND": "B/60",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI  DU MEDICAMENT SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/9/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "10/9/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["gabapentin"],
    "InteractionIndexLink": ["gabapentine"],
    "N_ENREGISTREMENT": "001/ 15 A 086 /08/17",
    "CODE_DCI": "15 A 086",
    "DCI": "Gabapentine",
    "NOM_COMMERCIALE": "GABATREX",
    "FORME": "GLES.",
    "DOSAGE": "300MG",
    "COND": "B/50",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMA ALGERIA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/1/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "23/10/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["gabapentin"],
    "InteractionIndexLink": ["gabapentine"],
    "N_ENREGISTREMENT": "318/ 15 A 086 /15",
    "CODE_DCI": "15 A 086",
    "DCI": "Gabapentine",
    "NOM_COMMERCIALE": "NEURALGIN",
    "FORME": "GLES.",
    "DOSAGE": "300MG",
    "COND": "B/90",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMIDAL N.S. SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/12/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "2/12/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["gabapentin"],
    "InteractionIndexLink": ["gabapentine"],
    "N_ENREGISTREMENT": "173/ 15 A 086 /08/18",
    "CODE_DCI": "15 A 086",
    "DCI": "Gabapentine",
    "NOM_COMMERCIALE": "NEUROPLEX",
    "FORME": "GLES.",
    "DOSAGE": "300MG",
    "COND": "B/50",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "TABUK ALGERIE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "8/2/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "8/2/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["gabapentin"],
    "InteractionIndexLink": ["gabapentine"],
    "N_ENREGISTREMENT": "21/15 A 087/149",
    "CODE_DCI": "15 A 087",
    "DCI": "GABAPENTINE",
    "NOM_COMMERCIALE": "GABAMAX",
    "FORME": "GELULES",
    "DOSAGE": "400MG",
    "COND": "B/50 GELULES",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL NOVAPHARM TRADING",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "08/06/21",
    "DATE_D_ENREGISTREMENT_FINAL": "08/06/21",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["gabapentin"],
    "InteractionIndexLink": ["gabapentine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "15 A 087",
    "DCI": "Gabapentine",
    "NOM_COMMERCIALE": "GABAMAX®",
    "FORME": "gélule",
    "DOSAGE": "400 mg",
    "COND": "boite de 50",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["gabapentin"],
    "InteractionIndexLink": ["gabapentine"],
    "N_ENREGISTREMENT": "001/ 15 A 087 /08/17",
    "CODE_DCI": "15 A 087",
    "DCI": "Gabapentine",
    "NOM_COMMERCIALE": "GABATREX",
    "FORME": "GLES.",
    "DOSAGE": "400MG",
    "COND": "B/50",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMA ALGERIA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/2/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "23/10/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["gabapentin"],
    "InteractionIndexLink": ["gabapentine"],
    "N_ENREGISTREMENT": "173/ 15 A 087 /18",
    "CODE_DCI": "15 A 087",
    "DCI": "Gabapentine",
    "NOM_COMMERCIALE": "NEUROPLEX",
    "FORME": "GLES.",
    "DOSAGE": "400MG",
    "COND": "B/50",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "TABUK ALGERIE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/2/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "9/2/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["lamotrigine"],
    "InteractionIndexLink": ["lamotrigine"],
    "N_ENREGISTREMENT": "380/ 15 A 089 /20",
    "CODE_DCI": "15 A 089",
    "DCI": "Lamotrigine",
    "NOM_COMMERCIALE": "LAMITRIGINE",
    "FORME": "Comprimé dispersible",
    "DOSAGE": "50MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HUP.P.PHARMA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/7/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "3/3/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["lamotrigine"],
    "InteractionIndexLink": ["lamotrigine"],
    "N_ENREGISTREMENT": "492/ 15 A 089 /20",
    "CODE_DCI": "15 A 089",
    "DCI": "Lamotrigine",
    "NOM_COMMERCIALE": "LAMORIG",
    "FORME": "Comprimé dispersible",
    "DOSAGE": "50MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOPRODIUM / SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "14/10/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "1/3/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["lamotrigine"],
    "InteractionIndexLink": ["lamotrigine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "15 A 090",
    "DCI": "LAMOTRIGINE",
    "NOM_COMMERCIALE": "LAMOGINE",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "100MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["sodium valproate (valproic acid)"],
    "InteractionIndexLink": ["acide valproique"],
    "N_ENREGISTREMENT": "352/ 15 A 092 /09/18",
    "CODE_DCI": "15 A 092",
    "DCI": "ACIDE VALPROIQUE (SOUS FORME DE VALPROATE DE SODIUM (acide valproique))",
    "NOM_COMMERCIALE": "SOPVAL",
    "FORME": "SIROP",
    "DOSAGE": "200MG/5ML (OU 40MG/ML)",
    "COND": "FL./200ML",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/10/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "10/9/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["levetiracetam"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "352/ 15 A 100 /13/18",
    "CODE_DCI": "15 A 100",
    "DCI": "LEVETIRACETAM",
    "NOM_COMMERCIALE": "KEPAM",
    "FORME": "SIROP",
    "DOSAGE": "100MG/ML",
    "COND": "FL./125ML - FL./200ML - FL./300ML (+BOUCHON DE SECURITE ENFANT+PIPETTE GRADUEE DE 2ML.5ML.ET 10ML)",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "21/7/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "28/12/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["levetiracetam"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "001/ 15 A 100 /13",
    "CODE_DCI": "15 A 100",
    "DCI": "LEVETIRACETAM",
    "NOM_COMMERCIALE": "VETRAM",
    "FORME": "SIROP",
    "DOSAGE": "100MG/ML",
    "COND": "B/1FL. DE 120ML + SERING. DOSEUSE GRADU. EN MG",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMA ALGERIA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "8/10/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "8/10/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["pregabalin"],
    "InteractionIndexLink": ["pregabaline"],
    "N_ENREGISTREMENT": "177/15 A 101/19",
    "CODE_DCI": "15 A 101",
    "DCI": "Prégabaline",
    "NOM_COMMERCIALE": "GABALYSE",
    "FORME": "GLES.",
    "DOSAGE": "75MG",
    "COND": "B/56",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ABDI IBRAHIM ILAÇ SANAYI VE TICARET A.S",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "TURQUIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/1/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "9/1/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["pregabalin"],
    "InteractionIndexLink": ["pregabaline"],
    "N_ENREGISTREMENT": "352/15 A 101/17",
    "CODE_DCI": "15 A 101",
    "DCI": "Prégabaline",
    "NOM_COMMERCIALE": "LYRIZIN",
    "FORME": "GLES.",
    "DOSAGE": "75MG",
    "COND": "B/60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "8/10/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "8/10/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["pregabalin"],
    "InteractionIndexLink": ["pregabaline"],
    "N_ENREGISTREMENT": "263/ 15 A 101 /15",
    "CODE_DCI": "15 A 101",
    "DCI": "Prégabaline",
    "NOM_COMMERCIALE": "NEURICA",
    "FORME": "GLES.",
    "DOSAGE": "75MG",
    "COND": "B/60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOPHARM SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/10/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "19/10/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["pregabalin"],
    "InteractionIndexLink": ["pregabaline"],
    "N_ENREGISTREMENT": "447/ 15 A 101 /16",
    "CODE_DCI": "15 A 101",
    "DCI": "Prégabaline",
    "NOM_COMMERCIALE": "PREGABALINE BEKER",
    "FORME": "GLES",
    "DOSAGE": "75MG",
    "COND": "B/60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL BEKER",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "5/9/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "5/9/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["pregabalin"],
    "InteractionIndexLink": ["pregabaline"],
    "N_ENREGISTREMENT": "001/ 15 A 101 /13",
    "CODE_DCI": "15 A 101",
    "DCI": "Prégabaline",
    "NOM_COMMERCIALE": "REGAB",
    "FORME": "GLES.",
    "DOSAGE": "75MG",
    "COND": "B/56",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMA ALGERIA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "31/7/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "31/7/2013",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["levetiracetam"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "293 /15 A 102 /16",
    "CODE_DCI": "15 A 102",
    "DCI": "LEVETIRACETAM",
    "NOM_COMMERCIALE": "BIOCETAM",
    "FORME": "COMP. PELL. SEC",
    "DOSAGE": "750MG",
    "COND": "B/60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOCARE SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/2/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "22/2/2016",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "24mois",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["levetiracetam"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "177/15 A 102/20",
    "CODE_DCI": "15 A 102",
    "DCI": "LEVETIRACETAM",
    "NOM_COMMERCIALE": "EPIXX",
    "FORME": "COMP. PELL",
    "DOSAGE": "750MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES ABDI IBRAHIM. ILAç SANAYI. VE TICARET A.S",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "TURQUIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/12/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "27/12/2020",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["levetiracetam"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "352/15 A 102 /18",
    "CODE_DCI": "15 A 102",
    "DCI": "LEVETIRACETAM",
    "NOM_COMMERCIALE": "KEPAM",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "750MG",
    "COND": "B/60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/8/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "1/8/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["levetiracetam"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "001/ 15 A 102/ 13",
    "CODE_DCI": "15 A 102",
    "DCI": "LEVETIRACETAM",
    "NOM_COMMERCIALE": "VETRAM",
    "FORME": "COMP. PELL. SEC",
    "DOSAGE": "750MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMA ALGERIA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/11/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "26/7/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["levetiracetam"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "293/ 15 A 105 /16",
    "CODE_DCI": "15 A 105",
    "DCI": "LEVETIRACETAM",
    "NOM_COMMERCIALE": "BIOCETAM",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "1000MG",
    "COND": "B/60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOCARE SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/2/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "22/2/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["levetiracetam"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "177/ 15 A 105 /21",
    "CODE_DCI": "15 A 105",
    "DCI": "Lévétiracétam",
    "NOM_COMMERCIALE": "EPIXX",
    "FORME": "Comprimé pelliculé",
    "DOSAGE": "1000MG",
    "COND": "B/60",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ABDI IBRAHIM ILAÇ SAN. VE TIC. A. Ş.",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "TURQUIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/4/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "12/4/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["levetiracetam"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "352/15 A 109/19",
    "CODE_DCI": "15 A 109",
    "DCI": "LEVETIRACETAM",
    "NOM_COMMERCIALE": "KEPAM LP",
    "FORME": "COMP PELL LP",
    "DOSAGE": "750MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/12/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "30/12/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["levetiracetam"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "001/15 A 109/17",
    "CODE_DCI": "15 A 109",
    "DCI": "LEVETIRACETAM",
    "NOM_COMMERCIALE": "VETRAM LP",
    "FORME": "COMP PELL LP",
    "DOSAGE": "750 MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMA ALGERIA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/9/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "10/9/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["levetiracetam"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "352/15 A 10/19",
    "CODE_DCI": "15 A 110",
    "DCI": "LEVETIRACETAM",
    "NOM_COMMERCIALE": "KEPAM LP",
    "FORME": "COMP PELL LP",
    "DOSAGE": "500MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/12/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "30/12/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["levetiracetam"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "001/15 A 110/17",
    "CODE_DCI": "15 A 110",
    "DCI": "LEVETIRACETAM",
    "NOM_COMMERCIALE": "VETRAM LP",
    "FORME": "COMP PELL LP",
    "DOSAGE": "500 MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMA ALGERIA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/10/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "24/10/2017",
    "TYPE": "Gé",
    "STATUT": "F PREMIX",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["phenytoin sodium"],
    "InteractionIndexLink": ["phenytoine"],
    "N_ENREGISTREMENT": "551/15 A 125/19",
    "CODE_DCI": "15 A 125",
    "DCI": "PHENYTOINE SODIQUE",
    "NOM_COMMERCIALE": "FENTEX",
    "FORME": "SOL INJ IV/IM",
    "DOSAGE": "250MG/5ML",
    "COND": "B/ 05 FL 5ML ET B/10 FL 5ML",
    "LISTE": "LISTE II",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MS PHARMA-JORDAN",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/12/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "30/12/2019",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["lamotrigine"],
    "InteractionIndexLink": ["lamotrigine"],
    "N_ENREGISTREMENT": "20/15 A089/380",
    "CODE_DCI": "15 A 189",
    "DCI": "LAMOTRIGINE",
    "NOM_COMMERCIALE": "LAMITRIGINE",
    "FORME": "COMP DISPERSIBLES",
    "DOSAGE": "50MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "laboratoires HUP.P PHARMA Sarl",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "03/03/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "03/03/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["lamotrigine"],
    "InteractionIndexLink": ["lamotrigine"],
    "N_ENREGISTREMENT": "20/15 A089/380",
    "CODE_DCI": "15 A 189",
    "DCI": "LAMOTRIGINE",
    "NOM_COMMERCIALE": "LAMITRIGINE",
    "FORME": "COMP DISPERSIBLES",
    "DOSAGE": "50MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "laboratoires HUP.P PHARMA Sarl",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "03/03/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "03/03/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["ergotamine"],
    "InteractionIndexLink": ["ergotamine"],
    "N_ENREGISTREMENT": "121/ 15 B 018 /99",
    "CODE_DCI": "15 B 018",
    "DCI": "ERGOTAMINE TARTRATE  ASSOCIE",
    "NOM_COMMERCIALE": "ASIA  MIGRAINE",
    "FORME": "COMPRIME",
    "DOSAGE": "1MG",
    "COND": "B/20",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ASIA PHARMACEUTICALS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SYRIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "3/3/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "3/3/1999",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["dihydroergotamine"],
    "InteractionIndexLink": ["dihydroergotamine"],
    "N_ENREGISTREMENT": "073/ 15 B 021 /04",
    "CODE_DCI": "15 B 021",
    "DCI": "DIHYDROERGOTAMINE",
    "NOM_COMMERCIALE": "ISOTAMINE",
    "FORME": "GTTE BUV",
    "DOSAGE": "2MG/ML",
    "COND": "FL/50ML",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ISOPHARM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/11/2004",
    "DATE_D_ENREGISTREMENT_FINAL": "10/11/2004",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["pizotifen"],
    "InteractionIndexLink": ["pizotifene"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "15 B 022",
    "DCI": "PIZOTIFENE (SOUS FORME DE MALATE)",
    "NOM_COMMERCIALE": "MIGRAZEN",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "0.5MG DE PIZOTIFENE (0.73MG DE MALATE)",
    "COND": "B/50",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "207/ 15 B 044 /00/08",
    "CODE_DCI": "15 B 044",
    "DCI": "CITICOLINE",
    "NOM_COMMERCIALE": "SOMAZINA",
    "FORME": "SOL.INJ.IM IV",
    "DOSAGE": "125MG/ML  (OU 500MG/4ML )",
    "COND": "B/5AMP DE 4ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FERRER INTERNATIONAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ESPAGNE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/3/2000",
    "DATE_D_ENREGISTREMENT_FINAL": "23/3/2008",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "317/ 15 B 045 /09",
    "CODE_DCI": "15 B 045",
    "DCI": "CITICOLINE (SOUS FORME MONOSODIQUE)",
    "NOM_COMMERCIALE": "CICOLINA",
    "FORME": "SOL. BUV.",
    "DOSAGE": "100MG/ML (OU 10G/100ML)",
    "COND": "FL./60ML + PIPETTE DOSEUSE",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INPHA-MEDIS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/4/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "19/4/2009",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["sumatriptan"],
    "InteractionIndexLink": ["sumatriptan"],
    "N_ENREGISTREMENT": "242/ 15 B 059 /04",
    "CODE_DCI": "15 B 059",
    "DCI": "SUMATRIPTAN SUCCINATE",
    "NOM_COMMERCIALE": "CALMIG",
    "FORME": "COMPRIME",
    "DOSAGE": "50MG",
    "COND": "B/2  ET B/6",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GROUPE SANTE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/3/2004",
    "DATE_D_ENREGISTREMENT_FINAL": "6/3/2004",
    "TYPE": "Gé",
    "STATUT": "C",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["sumatriptan"],
    "InteractionIndexLink": ["sumatriptan"],
    "N_ENREGISTREMENT": "447/15 B 059/16",
    "CODE_DCI": "15 B 059",
    "DCI": "SUMATRIPTAN SUCCINATE EXPRIME EN SUMATRIPAN",
    "NOM_COMMERCIALE": "MIGREX",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "50MG",
    "COND": "B/06",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL BEKER",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/11/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "2/11/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["eletriptan"],
    "InteractionIndexLink": ["eletriptan"],
    "N_ENREGISTREMENT": "045/ 15 B 070 /09/16",
    "CODE_DCI": "15 B 070",
    "DCI": "ELETRIPTAN HYDROBROMURE EXPRIME EN ELETRIPTAN",
    "NOM_COMMERCIALE": "RELPAX",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "20MG",
    "COND": "B/03",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PFIZER PHARMA GmbH",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALLEMAGNE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/7/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "26/7/2016",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["eletriptan"],
    "InteractionIndexLink": ["eletriptan"],
    "N_ENREGISTREMENT": "045/ 15 B 071 /09",
    "CODE_DCI": "15 B 071",
    "DCI": "ELETRIPTAN HYDROBROMURE EXPRIME EN ELETRIPTAN",
    "NOM_COMMERCIALE": "RELPAX",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "40MG",
    "COND": "B/03",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PFIZER PHARMA GmbH",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALLEMAGNE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/7/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "19/7/2009",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["zolmitriptan"],
    "InteractionIndexLink": ["zolmitriptan"],
    "N_ENREGISTREMENT": "352/15 B 118/18",
    "CODE_DCI": "15 B 118",
    "DCI": "Zolmitriptan",
    "NOM_COMMERCIALE": "ZOMIPTAN",
    "FORME": "COMP. ORO.",
    "DOSAGE": "2.5 MG",
    "COND": "B/20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/9/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "27/9/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["zolmitriptan"],
    "InteractionIndexLink": ["zolmitriptan"],
    "N_ENREGISTREMENT": "352/15 B 119/18",
    "CODE_DCI": "15 B 119",
    "DCI": "Zolmitriptan",
    "NOM_COMMERCIALE": "ZOMIPTAN",
    "FORME": "COMP. ORO.",
    "DOSAGE": "5 MG",
    "COND": "B/20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/9/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "27/9/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["neostigmine"],
    "InteractionIndexLink": ["neostigmine"],
    "N_ENREGISTREMENT": "433/ 15 C 024 /20",
    "CODE_DCI": "15 C 024",
    "DCI": "Méthylsulfate de Néostigmine",
    "NOM_COMMERCIALE": "NEOSTIGMINE RAZES",
    "FORME": "Solution injectable IM.IV.S/C",
    "DOSAGE": "0.5MG/ML",
    "COND": "B/10 AMPS",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRATER RAZES SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "31/3/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "19/5/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["pyridostigmine"],
    "InteractionIndexLink": ["pyridostigmine"],
    "N_ENREGISTREMENT": "465/ 15 C 026 /05/17",
    "CODE_DCI": "15 C 026",
    "DCI": "PYRIDOSTIGMINE BROMURE",
    "NOM_COMMERCIALE": "MESTINON",
    "FORME": "DRG.",
    "DOSAGE": "60MG",
    "COND": "B/20 ET B/150",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MEDA PHARMACEUTICALS SWITZERLAND GMBH",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SUISSE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/10/2005",
    "DATE_D_ENREGISTREMENT_FINAL": "24/1/2018",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["levodopa", "carbidopa"],
    "InteractionIndexLink": ["levodopa"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "15 D 031",
    "DCI": "LEVODOPA/CARBIDOPA",
    "NOM_COMMERCIALE": "LEVOCARB",
    "FORME": "COMP",
    "DOSAGE": "100MG/10MG",
    "COND": "B/100",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["levodopa", "carbidopa"],
    "InteractionIndexLink": ["levodopa"],
    "N_ENREGISTREMENT": "178/ 15 D 031 /98/19",
    "CODE_DCI": "15 D 031",
    "DCI": "LEVODOPA / CARBIDOPA",
    "NOM_COMMERCIALE": "LEVOMED",
    "FORME": "COMPRIME",
    "DOSAGE": "100MG/10MG",
    "COND": "B/100",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MEDOCHEMIE LTD",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CHYPRE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/12/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "14/8/2019",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["levodopa", "carbidopa"],
    "InteractionIndexLink": ["levodopa"],
    "N_ENREGISTREMENT": "235/15 D 031/19",
    "CODE_DCI": "15 D 031",
    "DCI": "LEVODOPA/CARBIDOPA",
    "NOM_COMMERCIALE": "LVOCARB",
    "FORME": "COMP",
    "DOSAGE": "100MG/10MG",
    "COND": "B/100",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOGALENIC SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/12/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "30/12/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["levodopa", "carbidopa"],
    "InteractionIndexLink": ["levodopa"],
    "N_ENREGISTREMENT": "235/ 15 D 032 /11",
    "CODE_DCI": "15 D 032",
    "DCI": "LEVODOPA / CARBIDOPA",
    "NOM_COMMERCIALE": "LEVOCARB",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "250MG/25MG",
    "COND": "B/100",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIO-GALENIC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/8/2011",
    "DATE_D_ENREGISTREMENT_FINAL": "24/8/2011",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["levodopa", "carbidopa"],
    "InteractionIndexLink": ["levodopa"],
    "N_ENREGISTREMENT": "149/15 D 032 /21",
    "CODE_DCI": "15 D 032",
    "DCI": "Lévodopa / Carbidopa monohydraté exprimé en Carbidopa anhydre",
    "NOM_COMMERCIALE": "LEVODOZ",
    "FORME": "Comprimé sécable",
    "DOSAGE": "250MG/25MG",
    "COND": "B/100",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVAPHARM TRADING / SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/4/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "4/4/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["levodopa", "carbidopa"],
    "InteractionIndexLink": ["levodopa"],
    "N_ENREGISTREMENT": "178/ 15 D 032 /99",
    "CODE_DCI": "15 D 032",
    "DCI": "LEVODOPA / CARBIDOPA",
    "NOM_COMMERCIALE": "LEVOMED",
    "FORME": "COMPRIME",
    "DOSAGE": "250MG/25MG",
    "COND": "B/100",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MEDOCHEMIE LTD",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CHYPRE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/1/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "17/1/1999",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["trihexyphenidyl"],
    "InteractionIndexLink": ["trihexyphenidyle"],
    "N_ENREGISTREMENT": "285/ 15 D 033 /98/07",
    "CODE_DCI": "15 D 033",
    "DCI": "TRIHEXYPHENIDYLE",
    "NOM_COMMERCIALE": "PARKINANE  LP",
    "FORME": "GLES.LP",
    "DOSAGE": "2MG",
    "COND": "B/50",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "UNION PHARMACEUTIQUE CONSTANTINOISE (UPC)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/12/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "17/6/2007",
    "TYPE": "Ré",
    "STATUT": "C",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["trihexyphenidyl"],
    "InteractionIndexLink": ["trihexyphenidyle"],
    "N_ENREGISTREMENT": "285/ 15 D 034 /98/07",
    "CODE_DCI": "15 D 034",
    "DCI": "TRIHEXYPHENIDYLE",
    "NOM_COMMERCIALE": "PARKINANE  LP",
    "FORME": "GLES.LP",
    "DOSAGE": "5MG",
    "COND": "B/20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "UNION PHARMACEUTIQUE CONSTANTINOISE (UPC)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/12/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "17/6/2007",
    "TYPE": "Ré",
    "STATUT": "C",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["trihexyphenidyl"],
    "InteractionIndexLink": ["trihexyphenidyle"],
    "N_ENREGISTREMENT": "235/ 15 D 062 /05",
    "CODE_DCI": "15 D 062",
    "DCI": "TRIHEXYPHENIDYLE CHLORHYDRATE",
    "NOM_COMMERCIALE": "PARKIDYL",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "5MG",
    "COND": "B/20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIO-GALENIC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/11/2005",
    "DATE_D_ENREGISTREMENT_FINAL": "6/11/2005",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["trihexyphenidyl"],
    "InteractionIndexLink": ["trihexyphenidyle"],
    "N_ENREGISTREMENT": "242/ 15 D 062 /10/18",
    "CODE_DCI": "15 D 062",
    "DCI": "TRIHEXYPHENIDYLE CHLORHYDRATE",
    "NOM_COMMERCIALE": "SOWEL",
    "FORME": "COMPRIME",
    "DOSAGE": "5MG",
    "COND": "B/20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GROUPE SANTE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/3/2010",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["entacapone"],
    "InteractionIndexLink": ["entacapone"],
    "N_ENREGISTREMENT": "352/ 15 D 077 /15",
    "CODE_DCI": "15 D 077",
    "DCI": "ENTACAPONE",
    "NOM_COMMERCIALE": "CANTAPONE",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "200MG",
    "COND": "PILULIER/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/7/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "26/7/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["entacapone"],
    "InteractionIndexLink": ["entacapone"],
    "N_ENREGISTREMENT": "068/ 15 D 077 /07",
    "CODE_DCI": "15 D 077",
    "DCI": "ENTACAPONE",
    "NOM_COMMERCIALE": "COMTAN",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "200MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVARTIS PHARMA AG",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SUISSE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/5/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "7/5/2007",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["trihexyphenidyl"],
    "InteractionIndexLink": ["trihexyphenidyle"],
    "N_ENREGISTREMENT": "235/ 15 D 093 /09",
    "CODE_DCI": "15 D 093",
    "DCI": "TRIHEXYPHENIDYLE CHLORHYDRATE",
    "NOM_COMMERCIALE": "PARKIDYL",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "2MG",
    "COND": "B/20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIO-GALENIC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/12/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "6/12/2009",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["trihexyphenidyl"],
    "InteractionIndexLink": ["trihexyphenidyle"],
    "N_ENREGISTREMENT": "242/ 15 D 093 /10",
    "CODE_DCI": "15 D 093",
    "DCI": "TRIHEXYPHENIDYLE CHLORHYDRATE",
    "NOM_COMMERCIALE": "SOWEL",
    "FORME": "COMPRIME",
    "DOSAGE": "2MG",
    "COND": "B/20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GROUPE SANTE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/3/2010",
    "DATE_D_ENREGISTREMENT_FINAL": "17/3/2010",
    "TYPE": "Gé",
    "STATUT": "C",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["ropinirole"],
    "InteractionIndexLink": ["ropinirole"],
    "N_ENREGISTREMENT": "352/ 15 D 097 /11",
    "CODE_DCI": "15 D 097",
    "DCI": "ROPINIROLE CHLORHYDRATE EXPRIME EN ROPINIROLE",
    "NOM_COMMERCIALE": "KEPNIROL",
    "FORME": "COMP. ENRO.",
    "DOSAGE": "0.25MG",
    "COND": "B/20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/3/2011",
    "DATE_D_ENREGISTREMENT_FINAL": "1/3/2011",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["ropinirole"],
    "InteractionIndexLink": ["ropinirole"],
    "N_ENREGISTREMENT": "352/ 15 D 098 /11",
    "CODE_DCI": "15 D 098",
    "DCI": "ROPINIROLE CHLORHYDRATE EXPRIME EN ROPINIROLE",
    "NOM_COMMERCIALE": "KEPNIROL",
    "FORME": "COMP. ENRO.",
    "DOSAGE": "1MG",
    "COND": "B/20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/3/2011",
    "DATE_D_ENREGISTREMENT_FINAL": "1/3/2011",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["pramipexole"],
    "InteractionIndexLink": ["pramipexole"],
    "N_ENREGISTREMENT": "352/15 D 120/19",
    "CODE_DCI": "15 D 120",
    "DCI": "Pramipexole Dichlorhydrate",
    "NOM_COMMERCIALE": "DOPREXOL",
    "FORME": "COMPRIME A LIBERATION PROLONGEE",
    "DOSAGE": "0.375 MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/5/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "13/5/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["pramipexole"],
    "InteractionIndexLink": ["pramipexole"],
    "N_ENREGISTREMENT": "352/15 D 121/19",
    "CODE_DCI": "15 D 121",
    "DCI": "Pramipexole Dichlorhydrate",
    "NOM_COMMERCIALE": "DOPREXOL",
    "FORME": "COMPRIME A LIBERATION PROLONGEE",
    "DOSAGE": "0.75 MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/5/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "13/5/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["pramipexole"],
    "InteractionIndexLink": ["pramipexole"],
    "N_ENREGISTREMENT": "352/15 D 122/19",
    "CODE_DCI": "15 D 122",
    "DCI": "Pramipexole Dichlorhydrate",
    "NOM_COMMERCIALE": "DOPREXOL",
    "FORME": "COMPRIME A LIBERATION PROLONGEE",
    "DOSAGE": "1.5 MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/5/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "13/5/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["pramipexole"],
    "InteractionIndexLink": ["pramipexole"],
    "N_ENREGISTREMENT": "352/15 D 123/19",
    "CODE_DCI": "15 D 123",
    "DCI": "Pramipexole Dichlorhydrate",
    "NOM_COMMERCIALE": "DOPREXOL",
    "FORME": "COMPRIME A LIBERATION PROLONGEE",
    "DOSAGE": "4.5 MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/5/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "13/5/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "263/15 D 124/19",
    "CODE_DCI": "15 D 124",
    "DCI": "RASAGLINE MESILATE",
    "NOM_COMMERCIALE": "BIOLECT",
    "FORME": "COMPRIME",
    "DOSAGE": "1MG",
    "COND": "B/01 PILULIER 30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOPHARM SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "3/4/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "3/4/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["donepezil"],
    "InteractionIndexLink": ["donepezil"],
    "N_ENREGISTREMENT": "380/ 15 F 074 /11",
    "CODE_DCI": "15 F 074",
    "DCI": "DONEPEZIL CHLORHYDRATE",
    "NOM_COMMERCIALE": "ARIDONE HUP",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "5MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HUP.P.PHARMA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/8/2011",
    "DATE_D_ENREGISTREMENT_FINAL": "25/8/2011",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["donepezil"],
    "InteractionIndexLink": ["donepezil"],
    "N_ENREGISTREMENT": "173/ 15 F 074 /18",
    "CODE_DCI": "15 F 074",
    "DCI": "DONEPEZIL CHLORHYDRATE",
    "NOM_COMMERCIALE": "DEMENTILE",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EURL TABUK ALGERIE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/3/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "20/3/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["donepezil"],
    "InteractionIndexLink": ["donepezil"],
    "N_ENREGISTREMENT": "001/ 15 F 074 /14",
    "CODE_DCI": "15 F 074",
    "DCI": "DONEPEZIL CHLORHYDRATE",
    "NOM_COMMERCIALE": "DONCEPT",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMA ALGERIA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/7/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "6/7/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["donepezil"],
    "InteractionIndexLink": ["donepezil"],
    "N_ENREGISTREMENT": "447/ 15 F 074 /13/18",
    "CODE_DCI": "15 F 074",
    "DCI": "DONEPEZIL CHLORHYDRATE",
    "NOM_COMMERCIALE": "DONEPEZIL BEKER",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEKER SARL (SARL LABORATOIRE BEKER ALGERIE)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/8/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "25/7/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["donepezil"],
    "InteractionIndexLink": ["donepezil"],
    "N_ENREGISTREMENT": "317/ 15 F 074 /11",
    "CODE_DCI": "15 F 074",
    "DCI": "DONEPEZIL CHLORHYDRATE",
    "NOM_COMMERCIALE": "DOPEZIL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INPHA-MEDIS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/8/2011",
    "DATE_D_ENREGISTREMENT_FINAL": "24/8/2011",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["donepezil"],
    "InteractionIndexLink": ["donepezil"],
    "N_ENREGISTREMENT": "263/ 15 F 074 /14",
    "CODE_DCI": "15 F 074",
    "DCI": "DONEPEZIL CHLORHYDRATE",
    "NOM_COMMERCIALE": "SYNOSIA",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOPHARM SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/11/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "2/11/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["donepezil"],
    "InteractionIndexLink": ["donepezil"],
    "N_ENREGISTREMENT": "380/ 15 F 075 /11",
    "CODE_DCI": "15 F 075",
    "DCI": "DONEPEZIL CHLORHYDRATE",
    "NOM_COMMERCIALE": "ARIDONE HUP",
    "FORME": "COMP. PELLI. SEC.",
    "DOSAGE": "10MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HUP.P.PHARMA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/8/2011",
    "DATE_D_ENREGISTREMENT_FINAL": "25/8/2011",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["donepezil"],
    "InteractionIndexLink": ["donepezil"],
    "N_ENREGISTREMENT": "173/ 15 F 075 /16",
    "CODE_DCI": "15 F 075",
    "DCI": "DONEPEZIL CHLORHYDRATE",
    "NOM_COMMERCIALE": "DEMENTILE",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "TABUK ALGERIE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/6/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "13/6/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["donepezil"],
    "InteractionIndexLink": ["donepezil"],
    "N_ENREGISTREMENT": "001/ 15 F 075 /14",
    "CODE_DCI": "15 F 075",
    "DCI": "DONEPEZIL CHLORHYDRATE",
    "NOM_COMMERCIALE": "DONCEPT",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMA ALGERIA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/7/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "6/7/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["donepezil"],
    "InteractionIndexLink": ["donepezil"],
    "N_ENREGISTREMENT": "447/ 15 F 075 /13",
    "CODE_DCI": "15 F 075",
    "DCI": "DONEPEZIL CHLORHYDRATE",
    "NOM_COMMERCIALE": "DONEPEZIL BEKER",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "10MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEKER SARL (SARL LABORATOIRE BEKER ALGERIE)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/8/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "13/8/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["donepezil"],
    "InteractionIndexLink": ["donepezil"],
    "N_ENREGISTREMENT": "317/ 15 F 075 /11",
    "CODE_DCI": "15 F 075",
    "DCI": "DONEPEZIL CHLORHYDRATE",
    "NOM_COMMERCIALE": "DOPEZIL 10MG",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INPHA-MEDIS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/7/2011",
    "DATE_D_ENREGISTREMENT_FINAL": "6/7/2011",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["donepezil"],
    "InteractionIndexLink": ["donepezil"],
    "N_ENREGISTREMENT": "263/ 15 F 075 /14",
    "CODE_DCI": "15 F 075",
    "DCI": "DONEPEZIL CHLORHYDRATE",
    "NOM_COMMERCIALE": "SYNOSIA",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOPHARM SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/11/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "13/11/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["rivastigmine"],
    "InteractionIndexLink": ["rivastigmine"],
    "N_ENREGISTREMENT": "352/15 F 099/16",
    "CODE_DCI": "15 F 099",
    "DCI": "RIVASTIGMINE TARTRATE EXPRIME EN RIVASTIGMINE",
    "NOM_COMMERCIALE": "RESTILON",
    "FORME": "SOLUTION BUV",
    "DOSAGE": "2MG/ML",
    "COND": "B/1 FL DE 120ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DES MEDICAMENTS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/12/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "4/12/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["rivastigmine"],
    "InteractionIndexLink": ["rivastigmine"],
    "N_ENREGISTREMENT": "318/ 15 F 099 /11",
    "CODE_DCI": "15 F 099",
    "DCI": "RIVASTIGMINE HYDROGENOTARTRATE EXPRIME EN RIVASTIGMINE",
    "NOM_COMMERCIALE": "RIVASTIG",
    "FORME": "SOL. BUV.",
    "DOSAGE": "2MG/ML",
    "COND": "B/1FL. DE 125ML + SERING. DOSEUSE DE 3ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMIDAL N.S. SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/9/2011",
    "DATE_D_ENREGISTREMENT_FINAL": "20/9/2011",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["donepezil"],
    "InteractionIndexLink": ["donepezil"],
    "N_ENREGISTREMENT": "035/ 15 F 103 /15",
    "CODE_DCI": "15 F 103",
    "DCI": "DONEPEZIL CHLORHYDRATE",
    "NOM_COMMERCIALE": "DORICEPT",
    "FORME": "COMP ORODISPERSIBLE",
    "DOSAGE": "5 MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMALLIANCE EURL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/10/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "26/10/2015",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["donepezil"],
    "InteractionIndexLink": ["donepezil"],
    "N_ENREGISTREMENT": "352/15 F 103/17",
    "CODE_DCI": "15 F 103",
    "DCI": "DONEPEZIL CHLORHYDRATE",
    "NOM_COMMERCIALE": "KYNCEPT",
    "FORME": "COMP ORODISPERSIBLE",
    "DOSAGE": "5 MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/4/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "10/4/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["donepezil"],
    "InteractionIndexLink": ["donepezil"],
    "N_ENREGISTREMENT": "323/15 F 104/20",
    "CODE_DCI": "15 F 104",
    "DCI": "DONEPEZIL",
    "NOM_COMMERCIALE": "DONEPEDEX",
    "FORME": "COMP. ORO.",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CONTINENTAL PHARM LABORATOIRE/ SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/12/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "22/12/2020",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["donepezil"],
    "InteractionIndexLink": ["donepezil"],
    "N_ENREGISTREMENT": "323/15 F 104/20",
    "CODE_DCI": "15 F 104",
    "DCI": "DONEPEZIL",
    "NOM_COMMERCIALE": "DONEPEDEX",
    "FORME": "COMP. ORO.",
    "DOSAGE": "05MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CONTINENTAL PHARM LABORATOIRE/ SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/12/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "15/12/2020",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["donepezil"],
    "InteractionIndexLink": ["donepezil"],
    "N_ENREGISTREMENT": "035/ 15 F 104 /15",
    "CODE_DCI": "15 F 104",
    "DCI": "DONEPEZIL CHLORHYDRATE",
    "NOM_COMMERCIALE": "DORICEPT",
    "FORME": "COMP ORODISPERSIBLE",
    "DOSAGE": "10 MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMALLIANCE EURL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/10/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "26/10/2015",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["donepezil"],
    "InteractionIndexLink": ["donepezil"],
    "N_ENREGISTREMENT": "352/15 F 104/17",
    "CODE_DCI": "15 F 104",
    "DCI": "DONEPEZIL CHLORHYDRATE",
    "NOM_COMMERCIALE": "KYNCEPT",
    "FORME": "COMP ORODISPERSIBLE",
    "DOSAGE": "10 MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "23/3/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "23/3/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["rivastigmine"],
    "InteractionIndexLink": ["rivastigmine"],
    "N_ENREGISTREMENT": "352/15 F 106/16",
    "CODE_DCI": "15 F 106",
    "DCI": "RIVASTIGMINE TARTRATE EXPRIME EN RIVASTIGMINE",
    "NOM_COMMERCIALE": "RESTILON",
    "FORME": "GELULE",
    "DOSAGE": "1.5MG",
    "COND": "B/ 1 FL DE 60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DES MEDICAMENTS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/12/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "4/12/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["rivastigmine"],
    "InteractionIndexLink": ["rivastigmine"],
    "N_ENREGISTREMENT": "263/ 15 F 106 /16",
    "CODE_DCI": "15 F 106",
    "DCI": "RIVASTIGMINE HYDROGENOTARTRATE EXPRIME EN RIVASTIGMINE",
    "NOM_COMMERCIALE": "RIVASTI",
    "FORME": "GELULE",
    "DOSAGE": "1.5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOHARM SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/4/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "25/4/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOis",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["rivastigmine"],
    "InteractionIndexLink": ["rivastigmine"],
    "N_ENREGISTREMENT": "352/15 F 107/17",
    "CODE_DCI": "15 F 107",
    "DCI": "RIVASTIGMINE HYDROGENOTARTRATE EXPRIME EN RIVASTIGMINE",
    "NOM_COMMERCIALE": "RESTILON",
    "FORME": "GELULE",
    "DOSAGE": "3MG",
    "COND": "B/60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DES MEDICAMENTS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/1/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "9/1/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["rivastigmine"],
    "InteractionIndexLink": ["rivastigmine"],
    "N_ENREGISTREMENT": "263/ 15 F 107 /16",
    "CODE_DCI": "15 F 107",
    "DCI": "RIVASTIGMINE HYDROGENOTARTRATE EXPRIME EN RIVASTIGMINE",
    "NOM_COMMERCIALE": "RIVASTI",
    "FORME": "GELULE",
    "DOSAGE": "3MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOPHARM SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/4/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "19/4/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["rivastigmine"],
    "InteractionIndexLink": ["rivastigmine"],
    "N_ENREGISTREMENT": "352/15 F 108/17",
    "CODE_DCI": "15 F 108",
    "DCI": "RIVASTIGMINE HYDROGENOTARTRATE EXPRIME EN RIVASTIGMINE",
    "NOM_COMMERCIALE": "RESTILON",
    "FORME": "GELULE",
    "DOSAGE": "4.5MG",
    "COND": "B/1 FL DE 60 GELULES",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DES MEDICAMENTS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/1/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "17/1/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["rivastigmine"],
    "InteractionIndexLink": ["rivastigmine"],
    "N_ENREGISTREMENT": "263/ 15 F 108 /16",
    "CODE_DCI": "15 F 108",
    "DCI": "RIVASTIGMINE HYDROGENOTARTRATE EXPRIME EN RIVASTIGMINE",
    "NOM_COMMERCIALE": "RIVASTI",
    "FORME": "GELULE",
    "DOSAGE": "4.5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOPHARM SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "11/5/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "11/5/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["rivastigmine"],
    "InteractionIndexLink": ["rivastigmine"],
    "N_ENREGISTREMENT": "352/15 F 113/17",
    "CODE_DCI": "15 F 113",
    "DCI": "RIVASTIGMINE TARTRATE EXPRIME EN RIVASTIGMINE",
    "NOM_COMMERCIALE": "RESTILON",
    "FORME": "GELULE",
    "DOSAGE": "6 MG",
    "COND": "B/60",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/6/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "4/9/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["memantine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "352/15 F 114/17",
    "CODE_DCI": "15 F 114",
    "DCI": "MEMANTINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "ALZHANTINE",
    "FORME": "CP PELL SEC",
    "DOSAGE": "5 MG",
    "COND": "B/60",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "5/11/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "5/11/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["memantine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "352/15 F 115/17",
    "CODE_DCI": "15 F 115",
    "DCI": "MEMANTINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "ALZHANTINE",
    "FORME": "CP PELL SEC",
    "DOSAGE": "10 MG",
    "COND": "B/60",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/9/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "19/9/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["memantine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "447/15 F 115/18",
    "CODE_DCI": "15 F 115",
    "DCI": "MEMANTINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "MEMANTINE BEKER",
    "FORME": "CP PELL SEC",
    "DOSAGE": "10 MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEKER SARL (SARL LABORATOIRE BEKER ALGERIE)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/3/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "20/3/2018",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["memantine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "055/15 F 115/19",
    "CODE_DCI": "15 F 115",
    "DCI": "MEMANTINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "MIRALE",
    "FORME": "CP PELL SEC",
    "DOSAGE": "10 MG",
    "COND": "B/28",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "DAR AL DAWA DEVELOPMENT & INVESTMENT Co Ltd",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/7/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "10/7/2019",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["memantine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "15 F 117",
    "DCI": "Chlorhydrate de Mémantine",
    "NOM_COMMERCIALE": "Mémantine BEKER",
    "FORME": "Comprimé pelliculé 20mg.",
    "DOSAGE": "20MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["memantine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "20/15 F130/352",
    "CODE_DCI": "15 F 130",
    "DCI": "MÉMANTINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "ALZHANTINE LP",
    "FORME": "GELULES LP",
    "DOSAGE": "7MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES EL KENDI INDUSTRIE DU MÉDICAMENT SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "8/11/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "8/11/2020",
    "TYPE": "Gé",
    "STATUT": "F Pellets à LP",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["memantine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "20/15 F131/352",
    "CODE_DCI": "15 F 131",
    "DCI": "MÉMANTINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "ALZHANTINE LP",
    "FORME": "GELULES LP",
    "DOSAGE": "28MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES EL KENDI INDUSTRIE DU MÉDICAMENT SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "8/11/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "8/11/2020",
    "TYPE": "Gé",
    "STATUT": "F Pellets à LP",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["memantine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "20/15 F131/352",
    "CODE_DCI": "15 F 131",
    "DCI": "MÉMANTINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "ALZHANTINE LP",
    "FORME": "GELULES LP",
    "DOSAGE": "14 MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES EL KENDI INDUSTRIE DU MÉDICAMENT SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "08/11/20",
    "DATE_D_ENREGISTREMENT_FINAL": "08/11/20",
    "TYPE": "Gé",
    "STATUT": "F Pellets à LP",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["memantine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "20/15 F132/352",
    "CODE_DCI": "15 F 132",
    "DCI": "MÉMANTINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "ALZHANTINE LP",
    "FORME": "GELULES LP",
    "DOSAGE": "28MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES EL KENDI INDUSTRIE DU MÉDICAMENT SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "8/11/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "8/11/2020",
    "TYPE": "Gé",
    "STATUT": "F Pellets à LP",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["interferon beta-1a"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "062/ 15 G 055 /02/15",
    "CODE_DCI": "15 G 055",
    "DCI": "INTERFERON BETA 1A",
    "NOM_COMMERCIALE": "REBIF",
    "FORME": "SOL. INJ. SC.",
    "DOSAGE": "44µG/0.5ML (12MUI/0.5ML)",
    "COND": "B/12 SERINGUES PREREMPLIES DE 0.5ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MERCK SERONO EUROPE LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ROYAUME UNI",
    "DATE_D_ENREGISTREMENT_INITIAL": "14/12/2002",
    "DATE_D_ENREGISTREMENT_FINAL": "26/7/2015",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "18 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["interferon beta-1a"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "375/ 15 G 078 /07",
    "CODE_DCI": "15 G 078",
    "DCI": "INTERFERON BETA 1A RECOMBINANT",
    "NOM_COMMERCIALE": "AVONEX",
    "FORME": "SOL INJ IM",
    "DOSAGE": "30µG/0.5ML (OU 6MUI/0.5ML)",
    "COND": "B/04 SERINGUES  PRE REMPLIES DE 0.5ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOGEN IDEC LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ROYAUME UNI",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/5/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "12/5/2007",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["interferon beta-1a"],
    "InteractionIndexLink": ["interferon alfa"],
    "N_ENREGISTREMENT": "062/ 15 G 078 /07/15",
    "CODE_DCI": "15 G 078",
    "DCI": "INTERFERON BETA 1A",
    "NOM_COMMERCIALE": "REBIF",
    "FORME": "SOL. INJ. SC. EN SERINGUE PREREMPLIE",
    "DOSAGE": "22µG/0.5ML (6MUI/0.5ML)",
    "COND": "B/12 SERINGUES PREREMPLIES DE 0.5ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MERCK SERONO EUROPE LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ROYAUME UNI",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/9/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "22/9/2015",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "18 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["natalizumab"],
    "InteractionIndexLink": ["natalizumab"],
    "N_ENREGISTREMENT": "375/ 15 G 091 /09/16",
    "CODE_DCI": "15 G 091",
    "DCI": "NATALIZUMAB",
    "NOM_COMMERCIALE": "TYSABRI",
    "FORME": "CONCENTRE A DILUER P. PERF.",
    "DOSAGE": "300MG/FL. DE CONC. (20MG/ML)",
    "COND": "B/01FL. DE 15ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOGEN IDEC LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ROYAUME UNI",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/12/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "19/1/2016",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "48MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["interferon beta-1b"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "424/ 15 G 096 /12",
    "CODE_DCI": "15 G 096",
    "DCI": "INTERFERON BETA-1B RECOMBINANT",
    "NOM_COMMERCIALE": "BETAFERON",
    "FORME": "PDRE. ET SOLV. P. SOL. INJ. SC",
    "DOSAGE": "250µG/ML (8MUI/ML) DE SOL. RECONSTITUEE",
    "COND": "B/15PRESENTATIONS UNITAIRES CONTENANT CHACUNE 1FLACON DE PDRE.+1SERING.PREREMPLIE DE 1.2ML DE SOLV.+2TAMPONS IMBIBES D'ALCOOL+1ADAPTEUR POUR FLACON AVEC AIGUILLE",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BAYER SCHERING PHARMA AG",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALLEMAGNE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/1/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "10/1/2012",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": ["interferon beta-1a"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "062/15 G 111/17",
    "CODE_DCI": "15 G 111",
    "DCI": "INTERFERON BETA 1-A",
    "NOM_COMMERCIALE": "REBIF",
    "FORME": "SOL INJ S/C EN CARTOUCHES",
    "DOSAGE": "22 UG /0.5 ML",
    "COND": "COFFRET DE 04 CARTOUCHES PRE REMPLIES DE 1.5 ML",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MERCK SERNO EUROPE LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ROYAUME UNI",
    "DATE_D_ENREGISTREMENT_INITIAL": "21/6/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "21/6/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "18 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["interferon beta-1a"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "062/15 G 112/17",
    "CODE_DCI": "15 G 112",
    "DCI": "INTERFERON BETA 1-A",
    "NOM_COMMERCIALE": "REBIF",
    "FORME": "SOL INJ S/C EN CARTOUCHES",
    "DOSAGE": "44UG /0.5 ML",
    "COND": "COFFRET DE 04 CARTOUCHES PRE REMPLIES DE 1.5 ML",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MERCK SERNO EUROPE LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ROYAUME UNI",
    "DATE_D_ENREGISTREMENT_INITIAL": "21/6/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "21/6/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "18 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["fingolimod"],
    "InteractionIndexLink": ["fingolimod"],
    "N_ENREGISTREMENT": "068/15 G 125/19",
    "CODE_DCI": "15 G 125",
    "DCI": "FINGOLIMOD CHLORHYDRATE EXPRIME EN FINGOLIMOD",
    "NOM_COMMERCIALE": "GILENYA",
    "FORME": "GLES",
    "DOSAGE": "0.5MG",
    "COND": "B/28",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVARTIS PHARMASCHWEIZ AG",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SUISSE",
    "DATE_D_ENREGISTREMENT_INITIAL": "8/1/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "8/1/2020",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["dimethyl fumarate"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "20/15 G127/263",
    "CODE_DCI": "15 G 127",
    "DCI": "DIMETHYLFUMARATE",
    "NOM_COMMERCIALE": "CLEDERA",
    "FORME": "GÉLULE CONTENANT MICRO-COMP GASTRO-RÉSISTANTS",
    "DOSAGE": "120MG",
    "COND": "B/14",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES BIOPHARM SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "08/11/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "08/11/2020",
    "TYPE": "Gé",
    "STATUT": "F Mini-tablets",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["dimethyl fumarate"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "001/15 G 127/19",
    "CODE_DCI": "15 G 127",
    "DCI": "DIMETHYLFUMARATE",
    "NOM_COMMERCIALE": "SCLERA",
    "FORME": "GLES GASTRORESISTANTES",
    "DOSAGE": "120MG",
    "COND": "B/14",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMA ALGERIA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "31/12/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "31/12/2019",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["dimethyl fumarate"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "20/15 G128/263",
    "CODE_DCI": "15 G 128",
    "DCI": "DIMETHYLFUMARATE",
    "NOM_COMMERCIALE": "CLEDERA",
    "FORME": "GÉLULE CONTENANT MICRO-COMP GASTRO-RÉSISTANTS",
    "DOSAGE": "240MG",
    "COND": "B/56",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES BIOPHARM SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "08/11/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "08/11/2020",
    "TYPE": "Gé",
    "STATUT": "F Mini-tablets",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["dimethyl fumarate"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "001/15 G 128/19",
    "CODE_DCI": "15 G 128",
    "DCI": "DIMETHYLFUMARATE",
    "NOM_COMMERCIALE": "SCLERA",
    "FORME": "GLES GASTRORESISTANTES",
    "DOSAGE": "240MG",
    "COND": "B/56",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMA ALGERIA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "31/12/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "31/12/2019",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["fampridine"],
    "InteractionIndexLink": ["fampridine"],
    "N_ENREGISTREMENT": "263/15 G 133/20",
    "CODE_DCI": "15 G 133",
    "DCI": "FAMPRIDINE",
    "NOM_COMMERCIALE": "SCLERYL",
    "FORME": "COMP PELL LP",
    "DOSAGE": "10MG",
    "COND": "B/14",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOPHARM SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "05/04/020",
    "DATE_D_ENREGISTREMENT_FINAL": "05/04/020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["glatiramer"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "543/15 G 134 /21",
    "CODE_DCI": "15 G 134",
    "DCI": "Acétate de Glatiramère",
    "NOM_COMMERCIALE": "GLATHERA",
    "FORME": "Solution injectable en sringue pré-remplie",
    "DOSAGE": "40MG/ML",
    "COND": "B/02 Seringues prè-remplies de 1ML",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOTHERA / SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/2/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "28/2/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["phenobarbital"],
    "InteractionIndexLink": ["menthe", "phenobarbital"],
    "N_ENREGISTREMENT": "263/ 15 J 085 /07",
    "CODE_DCI": "15 J 085",
    "DCI": "ETHER ETHYLIQUE  DE L'ACIDE ALPHA BROMO ISO VALERIANATE / PHENOBARBITAL / HUILE DE MENTHE POIVREE",
    "NOM_COMMERCIALE": "SEDACOR",
    "FORME": "SOL. BUV. GTTES.",
    "DOSAGE": "20MG/18.26MG/1.42MG/ML",
    "COND": "FL./30ML",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOPHARM ALGERIE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/11/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "18/11/2007",
    "TYPE": "Ré",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "065/ 15 K 045 /16",
    "CODE_DCI": "15 K 045",
    "DCI": "CITICOLINE SOUS FORME SODIQUE",
    "NOM_COMMERCIALE": "CITICOLINE GL",
    "FORME": "SOL. BUV.",
    "DOSAGE": "100MG/ML",
    "COND": "B/01 FL DE40 ML  +1SERINGUE GRADUEE",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL GENERIC LAB",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/7/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "19/7/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "073/ 15 K 045 /09/18",
    "CODE_DCI": "15 K 045",
    "DCI": "CITICOLINE SOUS FORME SODIQUE",
    "NOM_COMMERCIALE": "CITICOLINE ISO",
    "FORME": "SOL. BUV. GTTES.",
    "DOSAGE": "100MG/ML",
    "COND": "FL./50ML AVEC PIPETTE GRADUEE",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ISOPHARM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/12/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "30/4/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "088/ 15 K 045 /10",
    "CODE_DCI": "15 K 045",
    "DCI": "CITICOLINE SOUS FORME SODIQUE",
    "NOM_COMMERCIALE": "CITICOLINE PHARMAGHREB",
    "FORME": "SOL. BUV.",
    "DOSAGE": "100MG/ML (OU 10G/100ML)",
    "COND": "FL./30ML + PIPETTE GRADUEE",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMAGHREB",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/6/2010",
    "DATE_D_ENREGISTREMENT_FINAL": "2/6/2010",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "352/ 15 K 045 /09",
    "CODE_DCI": "15 K 045",
    "DCI": "CITICOLINE SOUS FORME SODIQUE",
    "NOM_COMMERCIALE": "SOMACOLINE",
    "FORME": "SOL. BUV. GTTES.",
    "DOSAGE": "100MG/ML",
    "COND": "FL./30ML + PIPETTE GRADUEE",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/12/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "24/12/2009",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "207/ 15 K 045 /00/18",
    "CODE_DCI": "15 K 045",
    "DCI": "CITICOLINE SOUS FORME SODIQUE",
    "NOM_COMMERCIALE": "SOMAZINA",
    "FORME": "SOL. BUV. GTTES.",
    "DOSAGE": "100MG/ML*(10G/100ML)",
    "COND": "B/1FL DE 30ML + SERINGUE DOSEUSE",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FERRER INTERNATIONAL SA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ESPAGNE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/3/2000",
    "DATE_D_ENREGISTREMENT_FINAL": "22/4/2018",
    "TYPE": "Ré",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Neurologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "207/ 15 K 094 /09",
    "CODE_DCI": "15 K 094",
    "DCI": "CITICOLINE SOUS FORME SODIQUE",
    "NOM_COMMERCIALE": "SOMAZINA",
    "FORME": "",
    "DOSAGE": "250MG/ML (OU 1000MG/4ML)",
    "COND": "B/03AMP. DE 4ML  -  B/10AMP. DE 4ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FERRER INTERNATIONAL S.A.",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ESPAGNE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/12/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "30/12/2009",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["olanzapine"],
    "InteractionIndexLink": ["olanzapine"],
    "N_ENREGISTREMENT": "149/ 16 D 100 /16",
    "CODE_DCI": "16  D 100",
    "DCI": "OLANZAPINE",
    "NOM_COMMERCIALE": "NOVAPREXA",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL NOVAPHARM TRADING",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/2/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "4/2/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["amitriptyline"],
    "InteractionIndexLink": ["amitriptyline"],
    "N_ENREGISTREMENT": "065/ 16 A 001 /04/13",
    "CODE_DCI": "16 A 001",
    "DCI": "AMITRIPTYLINE CHLORHYDRATE EXPRIME EN AMITRIPTYLINE",
    "NOM_COMMERCIALE": "ATRYLINE",
    "FORME": "COMP. ENRO.",
    "DOSAGE": "25MG",
    "COND": "B/60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GENERICLAB SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "21/1/2004",
    "DATE_D_ENREGISTREMENT_FINAL": "4/2/2013",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["amitriptyline"],
    "InteractionIndexLink": ["amitriptyline"],
    "N_ENREGISTREMENT": "380/16 A 001/16",
    "CODE_DCI": "16 A 001",
    "DCI": "AMITRIPTYLINE CHLORHYDRATE EXPRIME EN AMITRIPTYLINE",
    "NOM_COMMERCIALE": "LAROXYLINE",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "25MG",
    "COND": "B/60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HUP.P.PHARMA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/10/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "19/10/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["amitriptyline"],
    "InteractionIndexLink": ["amitriptyline"],
    "N_ENREGISTREMENT": "242/ 16 A 001 /03/16",
    "CODE_DCI": "16 A 001",
    "DCI": "AMITRIPTYLINE CHLORHYDRATE EXPRIME EN AMITRIPTYLINE",
    "NOM_COMMERCIALE": "MITRIL",
    "FORME": "COMPRIME",
    "DOSAGE": "25MG",
    "COND": "B/60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GROUPE SANTE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/10/2003",
    "DATE_D_ENREGISTREMENT_FINAL": "13/6/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["amitriptyline"],
    "InteractionIndexLink": ["amitriptyline"],
    "N_ENREGISTREMENT": "065/ 16 A 002 /04/14",
    "CODE_DCI": "16 A 002",
    "DCI": "AMITRIPTYLINE CHLORHYDRATE EXPRIME EN AMITRIPTYLINE",
    "NOM_COMMERCIALE": "ATRYLINE",
    "FORME": "COMP. ENRO.",
    "DOSAGE": "50MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GENERIC LAB",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "21/1/2004",
    "DATE_D_ENREGISTREMENT_FINAL": "21/9/2014",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["amitriptyline"],
    "InteractionIndexLink": ["amitriptyline"],
    "N_ENREGISTREMENT": "380/6 A 002/16",
    "CODE_DCI": "16 A 002",
    "DCI": "AMITRIPTYLINE CHLORHYDRATE EXPRIME EN AMITRIPTYLINE",
    "NOM_COMMERCIALE": "LAROXYLINE",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "50MG",
    "COND": "B/20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HUP.P.PHARMA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/10/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "19/10/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["amitriptyline"],
    "InteractionIndexLink": ["amitriptyline"],
    "N_ENREGISTREMENT": "242/ 16 A 002 /05/17",
    "CODE_DCI": "16 A 002",
    "DCI": "AMITRIPTYLINE CHLORHYDRATE EXPRIME EN AMITRIPTYLINE",
    "NOM_COMMERCIALE": "MITRIL",
    "FORME": "COMPRIME",
    "DOSAGE": "50MG",
    "COND": "B/20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GROUPE SANTE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "8/5/2005",
    "DATE_D_ENREGISTREMENT_FINAL": "10/4/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["amitriptyline"],
    "InteractionIndexLink": ["amitriptyline"],
    "N_ENREGISTREMENT": "457/ 16 A 003 /09",
    "CODE_DCI": "16 A 003",
    "DCI": "AMITRIPTYLINE CHLORHYDRATE EXPRIME EN AMITRIPTYLINE",
    "NOM_COMMERCIALE": "AMATRILINE",
    "FORME": "SOL.BUV.GTTES.",
    "DOSAGE": "4% (40MG/ML)",
    "COND": "FL./30ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOMEDIAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/12/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "24/12/2009",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["amitriptyline"],
    "InteractionIndexLink": ["amitriptyline"],
    "N_ENREGISTREMENT": "088/ 16 A 003 /03",
    "CODE_DCI": "16 A 003",
    "DCI": "AMITRIPTYLINE CHLORHYDRATE EXPRIME EN AMITRIPTYLINE",
    "NOM_COMMERCIALE": "AMITRIPTYLINE",
    "FORME": "SOL. BUV. GTTES.",
    "DOSAGE": "4% (40MG/ML)",
    "COND": "FL./20ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMAGHREB",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/11/2003",
    "DATE_D_ENREGISTREMENT_FINAL": "15/11/2003",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["amitriptyline"],
    "InteractionIndexLink": ["amitriptyline"],
    "N_ENREGISTREMENT": "400/16 A 003/16",
    "CODE_DCI": "16 A 003",
    "DCI": "AMITRIPTYLINE CHLORHYDRATE EXPRIME EN AMITRIPTYLINE",
    "NOM_COMMERCIALE": "AMITRIPTYLINE KPMA",
    "FORME": "SOL. BUV. GTTES.",
    "DOSAGE": "4% (40MG/ML)",
    "COND": "FL./20ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "KPMA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/7/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "4/7/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["amitriptyline"],
    "InteractionIndexLink": ["amitriptyline"],
    "N_ENREGISTREMENT": "079/ 16 A 003 /97/09",
    "CODE_DCI": "16 A 003",
    "DCI": "AMITRIPTYLINE CHLORHYDRATE EXPRIME EN AMITRIPTYLINE",
    "NOM_COMMERCIALE": "ANXIOL",
    "FORME": "SOL. BUV. GTTES.",
    "DOSAGE": "4% (40MG/ML)",
    "COND": "B/1FL.COMPTE GTTES DE 15ML - B/1FL.COMPTE GTTES DE 20ML -B/1FL.COMPTE GTTES DE 30ML - B/1FL.COMPTE GTTES DE 50ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE  ALGERIEN DE DEVELOPPEMENT  PHARMACEUTIQUE  SARL (LAD PHARMA)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/12/1997",
    "DATE_D_ENREGISTREMENT_FINAL": "23/9/2009",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["amitriptyline"],
    "InteractionIndexLink": ["amitriptyline"],
    "N_ENREGISTREMENT": "065/ 16 A 003 /08/14",
    "CODE_DCI": "16 A 003",
    "DCI": "AMITRIPTYLINE CHLORHYDRATE EXPRIME EN AMITRIPTYLINE",
    "NOM_COMMERCIALE": "ATRYLINE",
    "FORME": "GTTES. BUV.",
    "DOSAGE": "4% (40MG/ML)",
    "COND": "FL. COMPT.GTTES DE  20ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GENERICLAB SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "14/7/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "12/5/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["amitriptyline"],
    "InteractionIndexLink": ["amitriptyline"],
    "N_ENREGISTREMENT": "319/ 16 A 003 /06",
    "CODE_DCI": "16 A 003",
    "DCI": "AMITRIPTYLINE CHLORHYDRATE EXPRIME EN AMITRIPTYLINE",
    "NOM_COMMERCIALE": "GEROXYL",
    "FORME": "SOL. BUV. GTTES",
    "DOSAGE": "4% (40MG/ML)",
    "COND": "FL./20ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ARAB PHARM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/4/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "26/4/2006",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["amitriptyline"],
    "InteractionIndexLink": ["amitriptyline"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "16 A 003",
    "DCI": "Amitriptyline",
    "NOM_COMMERCIALE": "GEROXYL",
    "FORME": "GOUTTE BUVABLE",
    "DOSAGE": "0.04",
    "COND": "FLACON DE 20 ml",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["amitriptyline"],
    "InteractionIndexLink": ["amitriptyline"],
    "N_ENREGISTREMENT": "073/16 A 003/98/16",
    "CODE_DCI": "16 A 003",
    "DCI": "AMITRIPTYLINE CHLORHYDRATE EXPRIME EN AMITRIPTYLINE",
    "NOM_COMMERCIALE": "ISOPTYL",
    "FORME": "SOL. BUV. GTTES.",
    "DOSAGE": "4% (40MG/ML)",
    "COND": "FL./20ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ISOPHARM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/4/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "19/10/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["amitriptyline"],
    "InteractionIndexLink": ["amitriptyline"],
    "N_ENREGISTREMENT": "242/ 16 A 003 /06",
    "CODE_DCI": "16 A 003",
    "DCI": "AMITRIPTYLINE CHLORHYDRATE EXPRIME EN AMITRIPTYLINE",
    "NOM_COMMERCIALE": "MITRIL",
    "FORME": "SOL. BUV. EN GTTES",
    "DOSAGE": "4% (40MG/ML)",
    "COND": "FL./30ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GROUPE SANTE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/4/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "19/4/2006",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["clomipramine"],
    "InteractionIndexLink": ["clomipramine"],
    "N_ENREGISTREMENT": "322/ 16 A 004 /97",
    "CODE_DCI": "16 A 004",
    "DCI": "CLOMIPRAMINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "ANAFRANIL",
    "FORME": "SOL.INJ.",
    "DOSAGE": "25MG/2ML",
    "COND": "B/05",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "DEFIANTE FARMACEUTICA LDA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PORTUGAL",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/11/1997",
    "DATE_D_ENREGISTREMENT_FINAL": "31/12/2003",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["clomipramine"],
    "InteractionIndexLink": ["clomipramine"],
    "N_ENREGISTREMENT": "322/ 16 A 005 /97/09",
    "CODE_DCI": "16 A 005",
    "DCI": "CLOMIPRAMINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "ANAFRANIL",
    "FORME": "COMP.ENRO.",
    "DOSAGE": "10MG",
    "COND": "B/60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "DEFIANTE FARMACEUTICA LTD",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PORTUGAL",
    "DATE_D_ENREGISTREMENT_INITIAL": "8/11/1997",
    "DATE_D_ENREGISTREMENT_FINAL": "2/5/2009",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["clomipramine"],
    "InteractionIndexLink": ["clomipramine"],
    "N_ENREGISTREMENT": "235/ 16 A 005 /09",
    "CODE_DCI": "16 A 005",
    "DCI": "CLOMIPRAMINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "CLONAPRIME",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "10MG",
    "COND": "B/60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIO-GALENIC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/12/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "24/12/2009",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["clomipramine"],
    "InteractionIndexLink": ["clomipramine"],
    "N_ENREGISTREMENT": "012/ 16 A 005 /96/17",
    "CODE_DCI": "16 A 005",
    "DCI": "CLOMIPRAMINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "CRONIL",
    "FORME": "DRG.",
    "DOSAGE": "10MG",
    "COND": "B/60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CROVIS PHILCOM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ITALIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/10/1996",
    "DATE_D_ENREGISTREMENT_FINAL": "23/7/2017",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["clomipramine"],
    "InteractionIndexLink": ["clomipramine"],
    "N_ENREGISTREMENT": "499/ 16 A 006 /97/17",
    "CODE_DCI": "16 A 006",
    "DCI": "CLOMIPRAMINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "ANAFRANIL",
    "FORME": "COMP.ENRO.",
    "DOSAGE": "25MG",
    "COND": "B/50",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SIGMA-TAU FRANCE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/11/1997",
    "DATE_D_ENREGISTREMENT_FINAL": "16/4/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "60 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["clomipramine"],
    "InteractionIndexLink": ["clomipramine"],
    "N_ENREGISTREMENT": "330/ 16 A 006 /07",
    "CODE_DCI": "16 A 006",
    "DCI": "CLOMIPRAMINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "CLOFRANIL",
    "FORME": "COMPRIME",
    "DOSAGE": "25MG",
    "COND": "B/50",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SUN PHARMACEUTICAL INDUSTRIES LTD",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/5/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "7/5/2007",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["clomipramine"],
    "InteractionIndexLink": ["clomipramine"],
    "N_ENREGISTREMENT": "235/ 16 A 006 /10",
    "CODE_DCI": "16 A 006",
    "DCI": "CLOMIPRAMINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "CLONAPRIME",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "25MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIO-GALENIC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "8/2/2010",
    "DATE_D_ENREGISTREMENT_FINAL": "8/2/2010",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["clomipramine"],
    "InteractionIndexLink": ["clomipramine"],
    "N_ENREGISTREMENT": "012/ 16 A 006 /96/16",
    "CODE_DCI": "16 A 006",
    "DCI": "CLOMIPRAMINE CHLORHYDRATE EXPRIME EN CLOMIPRAMINE",
    "NOM_COMMERCIALE": "CRONIL",
    "FORME": "DRG.",
    "DOSAGE": "25MG",
    "COND": "B/50",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CROVIS PHILCOM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ITALIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/10/1996",
    "DATE_D_ENREGISTREMENT_FINAL": "2/2/2016",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "60 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["clomipramine"],
    "InteractionIndexLink": ["clomipramine"],
    "N_ENREGISTREMENT": "166/ 16 A 006 /98",
    "CODE_DCI": "16 A 006",
    "DCI": "CLOMIPRAMINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "TRIANIL",
    "FORME": "COMPRIME",
    "DOSAGE": "25MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "RAM PHARMACEUTICAL INDUSTRIES",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "16/8/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "16/8/1998",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["clomipramine"],
    "InteractionIndexLink": ["clomipramine"],
    "N_ENREGISTREMENT": "322/ 16 A 007 /97/09",
    "CODE_DCI": "16 A 007",
    "DCI": "CLOMIPRAMINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "ANAFRANIL",
    "FORME": "COMP.ENRO.",
    "DOSAGE": "75MG",
    "COND": "B/20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "DEFIANTE FARMACEUTICA LTD",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PORTUGAL",
    "DATE_D_ENREGISTREMENT_INITIAL": "8/11/1997",
    "DATE_D_ENREGISTREMENT_FINAL": "2/5/2009",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["clomipramine"],
    "InteractionIndexLink": ["clomipramine"],
    "N_ENREGISTREMENT": "235/ 16 A 007 /12/18",
    "CODE_DCI": "16 A 007",
    "DCI": "CLOMIPRAMINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "CLONAPRIME",
    "FORME": "COMP. PELLI. SEC.",
    "DOSAGE": "75MG",
    "COND": "B/20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIO-GALENIC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/1/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "4/3/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["clomipramine"],
    "InteractionIndexLink": ["clomipramine"],
    "N_ENREGISTREMENT": "012/ 16 A 007 /96/16",
    "CODE_DCI": "16 A 007",
    "DCI": "CLOMIPRAMINE CHLORHYDRATE EXPRIME EN CLOMIPRAMINE",
    "NOM_COMMERCIALE": "CRONIL",
    "FORME": "DRG.",
    "DOSAGE": "75MG",
    "COND": "B/20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CROVIS PHILCOM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ITALIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/10/1996",
    "DATE_D_ENREGISTREMENT_FINAL": "2/2/2016",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "60 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["mianserin"],
    "InteractionIndexLink": ["mianserine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "16 A 014",
    "DCI": "MIANSERINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "TOLVON (ATHYMIL)",
    "FORME": "COMPRIME",
    "DOSAGE": "30MG",
    "COND": "B/20",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["trimipramine"],
    "InteractionIndexLink": ["trimipramine"],
    "N_ENREGISTREMENT": "376/ 16 A 017 /96/17",
    "CODE_DCI": "16 A 017",
    "DCI": "TRIMIPRAMINE",
    "NOM_COMMERCIALE": "SURMONTIL",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "25MG",
    "COND": "B/50",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "RHONE POULENC RORER",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/11/1996",
    "DATE_D_ENREGISTREMENT_FINAL": "6/3/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["trimipramine"],
    "InteractionIndexLink": ["trimipramine"],
    "N_ENREGISTREMENT": "263/ 16 A 018 /96/10",
    "CODE_DCI": "16 A 018",
    "DCI": "TRIMIPRAMINE MESILATE EXPRIME EN TRIMIPRAMINE",
    "NOM_COMMERCIALE": "SURMONTIL",
    "FORME": "SOL.BUV.GTTES.",
    "DOSAGE": "4 %",
    "COND": "FL.COMPTE GTTES./30ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOPHARM ALGERIE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "5/11/1996",
    "DATE_D_ENREGISTREMENT_FINAL": "28/3/2010",
    "TYPE": "Ré",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["trimipramine"],
    "InteractionIndexLink": ["trimipramine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "16 A 018",
    "DCI": "TRIMIPRAMINE MESILATE EXPRIME EN TRIMIPRAMINE",
    "NOM_COMMERCIALE": "SURMONTIL",
    "FORME": "SOL.BUV.GTTES.",
    "DOSAGE": "0.04",
    "COND": "FL.COMPTE GTTES./30ML",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["fluoxetine"],
    "InteractionIndexLink": ["fluoxetine"],
    "N_ENREGISTREMENT": "318/16 A 078/17",
    "CODE_DCI": "16 A 078",
    "DCI": "FLUOXETINE CHLORHYDRATE EXPRIME EN FLUOXETINE",
    "NOM_COMMERCIALE": "DINALEXIN",
    "FORME": "GLES",
    "DOSAGE": "20MG",
    "COND": "B/14",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMIDAL NS SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/3/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "19/3/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["fluoxetine"],
    "InteractionIndexLink": ["fluoxetine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "16 A 078",
    "DCI": "FLUOXETINE",
    "NOM_COMMERCIALE": "FLUOXAC",
    "FORME": "GLES",
    "DOSAGE": "20MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["fluoxetine"],
    "InteractionIndexLink": ["fluoxetine"],
    "N_ENREGISTREMENT": "268/ 16 A 078 /05/11",
    "CODE_DCI": "16 A 078",
    "DCI": "FLUOXETINE CHLORHYDRATE EXPRIME EN FLUOXETINE",
    "NOM_COMMERCIALE": "FLUOXETINE MERINAL",
    "FORME": "GLES.",
    "DOSAGE": "20MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MERINAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/2/2005",
    "DATE_D_ENREGISTREMENT_FINAL": "20/10/2011",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["fluoxetine"],
    "InteractionIndexLink": ["fluoxetine"],
    "N_ENREGISTREMENT": "418/ 16 A 078 /09",
    "CODE_DCI": "16 A 078",
    "DCI": "FLUOXETINE CHLORHYDRATE EXPRIME EN FLUOXETINE",
    "NOM_COMMERCIALE": "NEOXETINE",
    "FORME": "GLES.",
    "DOSAGE": "20MG",
    "COND": "B/20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOEMEDIC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/9/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "24/9/2009",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["fluoxetine"],
    "InteractionIndexLink": ["fluoxetine"],
    "N_ENREGISTREMENT": "317/ 16 A 078 /11",
    "CODE_DCI": "16 A 078",
    "DCI": "FLUOXETINE CHLORHYDRATE EXPRIME EN FLUOXETINE",
    "NOM_COMMERCIALE": "ROSAL",
    "FORME": "GLES.",
    "DOSAGE": "20MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INPHA-MEDIS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/10/2011",
    "DATE_D_ENREGISTREMENT_FINAL": "20/10/2011",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["fluoxetine"],
    "InteractionIndexLink": ["fluoxetine"],
    "N_ENREGISTREMENT": "285/ 16 A 088 /06",
    "CODE_DCI": "16 A 088",
    "DCI": "FLUOXETINE",
    "NOM_COMMERCIALE": "FLUOXETINE UPC",
    "FORME": "SOL. BUV.",
    "DOSAGE": "20MG/5ML",
    "COND": "F/70ML AVEC  PIPETTE GRADUEE",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "UNION PHARMACEUTIQUE CONSTANTINOISE (UPC)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/6/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "20/6/2006",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["paroxetine"],
    "InteractionIndexLink": ["paroxetine"],
    "N_ENREGISTREMENT": "286/ 16 A 095 /16",
    "CODE_DCI": "16 A 095",
    "DCI": "PAROXETINE CHLORHYDRATE HEMIHYDRATE (EXPRIME EN PAROXETINE)",
    "NOM_COMMERCIALE": "ADDNOK",
    "FORME": "COMP. PELLI. SEC.",
    "DOSAGE": "20MG",
    "COND": "B/14",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CPCM SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/6/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "13/6/2016",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["paroxetine"],
    "InteractionIndexLink": ["paroxetine"],
    "N_ENREGISTREMENT": "352/ 16 A 095 /10/16",
    "CODE_DCI": "16 A 095",
    "DCI": "PAROXETINE CHLORHYDRATE EXPRIME EN PAROXETINE",
    "NOM_COMMERCIALE": "DEPRETINE",
    "FORME": "COMP. ENRO.",
    "DOSAGE": "20MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "11/3/2010",
    "DATE_D_ENREGISTREMENT_FINAL": "11/4/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["paroxetine"],
    "InteractionIndexLink": ["paroxetine"],
    "N_ENREGISTREMENT": "305/ 16 A 095 /00/10",
    "CODE_DCI": "16 A 095",
    "DCI": "PAROXETINE CHLORHYDRATE HEMIHYDRATE EXPRIME EN PAROXETINE",
    "NOM_COMMERCIALE": "DEROXAT",
    "FORME": "COMP. PELLI. SEC.",
    "DOSAGE": "20MG",
    "COND": "B/14",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GLAXOSMITHKLINE ALGERIE SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/1/2000",
    "DATE_D_ENREGISTREMENT_FINAL": "15/6/2010",
    "TYPE": "Ré",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["paroxetine"],
    "InteractionIndexLink": ["paroxetine"],
    "N_ENREGISTREMENT": "263/16 A 095/17",
    "CODE_DCI": "16 A 095",
    "DCI": "PAROXETINE CHLORHYDRATE HEMIHYDRATE EXPRIME EN PAROXETINE",
    "NOM_COMMERCIALE": "DOZAX",
    "FORME": "COMP. PELLI. SEC.",
    "DOSAGE": "20MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOPHARM SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/3/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "12/3/2017",
    "TYPE": "G",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["paroxetine"],
    "InteractionIndexLink": ["paroxetine"],
    "N_ENREGISTREMENT": "318/16 A 095/17",
    "CODE_DCI": "16 A 095",
    "DCI": "PAROXETINE CHLORHYDRATE ANHYDRE (EXPRIME EN PAROXETINE)",
    "NOM_COMMERCIALE": "PAREXAT",
    "FORME": "COMP. PELLI. SEC.",
    "DOSAGE": "20MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMIDAL NS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/5/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "28/5/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["paroxetine"],
    "InteractionIndexLink": ["paroxetine"],
    "N_ENREGISTREMENT": "289/ 16 A 095 /17",
    "CODE_DCI": "16 A 095",
    "DCI": "Chlorhydrate de paroxétine hémihydraté exprimé en Paroxétine",
    "NOM_COMMERCIALE": "PAROLYX",
    "FORME": "Comprimé pelliculé sécable",
    "DOSAGE": "20MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRATER RAZES FORME SECHE SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/10/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "9/12/2020",
    "TYPE": "Gé",
    "STATUT": "F prémix",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["paroxetine"],
    "InteractionIndexLink": ["paroxetine"],
    "N_ENREGISTREMENT": "289/16 A 095/17",
    "CODE_DCI": "16 A 095",
    "DCI": "PAROXETINE CHLORHYDRATE HEMIHYDRATE EXPRIME EN PAROXETINE",
    "NOM_COMMERCIALE": "PAROLYX",
    "FORME": "COMP. PELL. SEC.",
    "DOSAGE": "20MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES FRATER-RAZES FORME SECHE/ SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/10/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "9/12/2020",
    "TYPE": "Gé",
    "STATUT": "Fpremix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["paroxetine"],
    "InteractionIndexLink": ["paroxetine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "16 A 095",
    "DCI": "PAROXETINE",
    "NOM_COMMERCIALE": "PAROXAT ® 20",
    "FORME": "comprimé pelliculé sécable",
    "DOSAGE": "20 mg",
    "COND": "boîte de 30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["paroxetine"],
    "InteractionIndexLink": ["paroxetine"],
    "N_ENREGISTREMENT": "447/ 16 A 095 /13",
    "CODE_DCI": "16 A 095",
    "DCI": "PAROXETINE CHLORHYDRATE HEMIHYDRATE EXPRIME EN PAROXETINE",
    "NOM_COMMERCIALE": "PAROXETINE BEKER",
    "FORME": "COMP. PELLI. SEC.",
    "DOSAGE": "20MG",
    "COND": "B/14 - B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEKER SARL (SARL LABORATOIRE BEKER ALGERIE)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/8/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "9/8/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["paroxetine"],
    "InteractionIndexLink": ["paroxetine"],
    "N_ENREGISTREMENT": "235/16 A 095/17",
    "CODE_DCI": "16 A 095",
    "DCI": "PAROXETINE CHLORHYDRATE HEMIHYDRATE EXPRIME EN PAROXETINE",
    "NOM_COMMERCIALE": "PAROXETINE BGL",
    "FORME": "COMP. PELLI. SEC.",
    "DOSAGE": "20MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOGALENIC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "5/11/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "5/11/2017",
    "TYPE": "GE",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["paroxetine"],
    "InteractionIndexLink": ["paroxetine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "16 A 095",
    "DCI": "PAROXETINE CHLORHYDRATE HEMIHYDRATE EXPRIME EN PAROXETINE",
    "NOM_COMMERCIALE": "PAROXETINE GL",
    "FORME": "COMP. PELLI. SEC.",
    "DOSAGE": "20MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["paroxetine"],
    "InteractionIndexLink": ["paroxetine"],
    "N_ENREGISTREMENT": "468/ 16 A 095 /14",
    "CODE_DCI": "16 A 095",
    "DCI": "PAROXETINE CHLORHYDRATE HEMIHYDRATE (EXPRIME EN PAROXETINE)",
    "NOM_COMMERCIALE": "PAROXINAD",
    "FORME": "COMP. PELLI. SEC.",
    "DOSAGE": "20MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NADPHARMADIC PRODUCTION SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/10/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "13/10/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["paroxetine"],
    "InteractionIndexLink": ["paroxetine"],
    "N_ENREGISTREMENT": "268/16 A 095/17",
    "CODE_DCI": "16 A 095",
    "DCI": "PAROXETINE CHLORHYDRATE HEMIHYDRATE EXPRIME EN PAROXETINE",
    "NOM_COMMERCIALE": "PAXETINE",
    "FORME": "COMP. PELLI. SEC.",
    "DOSAGE": "20MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MERINAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/5/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "7/5/2017",
    "TYPE": "GE",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["paroxetine"],
    "InteractionIndexLink": ["paroxetine"],
    "N_ENREGISTREMENT": "035/16 A 095/20",
    "CODE_DCI": "16 A 095",
    "DCI": "PAROXETINE HYDROCHLORIDE ANHYDRE EXPRIME EN PAROXETINE",
    "NOM_COMMERCIALE": "PROSAREX",
    "FORME": "COMP. PELL. SEC",
    "DOSAGE": "20MG",
    "COND": "B/14",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES PHARMALLIANCE EURL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/11/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "25/11/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["clozapine"],
    "InteractionIndexLink": ["clozapine"],
    "N_ENREGISTREMENT": "068/ 16 A 096 /00:20",
    "CODE_DCI": "16 A 096",
    "DCI": "CLOZAPINE",
    "NOM_COMMERCIALE": "LEPONEX",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "25MG",
    "COND": "B/50",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BGP PRODUCTS GMBH",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SWITZERLAND SUISSE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/6/2000",
    "DATE_D_ENREGISTREMENT_FINAL": "8/1/2020",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["clozapine"],
    "InteractionIndexLink": ["clozapine"],
    "N_ENREGISTREMENT": "550/ 16 A 097 /00/19",
    "CODE_DCI": "16 A 097",
    "DCI": "CLOZAPINE",
    "NOM_COMMERCIALE": "LEPONEX",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "100MG",
    "COND": "B/50",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BGP PRODUCTS GMBH",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SWITZERLAND SUISSE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/6/2000",
    "DATE_D_ENREGISTREMENT_FINAL": "31/12/2019",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["sertraline"],
    "InteractionIndexLink": ["sertraline"],
    "N_ENREGISTREMENT": "289/16 A 099/16",
    "CODE_DCI": "16 A 099",
    "DCI": "SERTRALINE CHLORHYDRATE EXPRIME EN SERTRALINE",
    "NOM_COMMERCIALE": "SERLOFT",
    "FORME": "GLES",
    "DOSAGE": "50MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRATER RAZES FORME SECHE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/11/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "9/11/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["sertraline"],
    "InteractionIndexLink": ["sertraline"],
    "N_ENREGISTREMENT": "317/ 16 A 099 /14/20",
    "CODE_DCI": "16 A 099",
    "DCI": "SERTRALINE CHLORHYDRATE EXPRIME EN SERTRALINE",
    "NOM_COMMERCIALE": "SERVAL",
    "FORME": "GLES",
    "DOSAGE": "50MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INPHA-MEDIS SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/7/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "12/4/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["sertraline"],
    "InteractionIndexLink": ["sertraline"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "16 A 099",
    "DCI": "SERTRALINE CHLORHYDRATE EXPRIME EN SERTRALINE",
    "NOM_COMMERCIALE": "SOLOTIK",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "50MG",
    "COND": "PILULIER/15",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["sertraline"],
    "InteractionIndexLink": ["sertraline"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "16 A 099",
    "DCI": "Sertraline",
    "NOM_COMMERCIALE": "Serval 50",
    "FORME": "Gélule",
    "DOSAGE": "50mg/gélule",
    "COND": "bt de 30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["sertraline"],
    "InteractionIndexLink": ["sertraline"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "16 A 099",
    "DCI": "SERTRALINE CHLORHYDRATE EXPRIME EN SERTRALINE",
    "NOM_COMMERCIALE": "ZEXIL",
    "FORME": "GLES.",
    "DOSAGE": "50MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["sertraline"],
    "InteractionIndexLink": ["sertraline"],
    "N_ENREGISTREMENT": "045/ 16 A 099 /99/11",
    "CODE_DCI": "16 A 099",
    "DCI": "SERTRALINE CHLORHYDRATE EXPRIME EN SERTRALINE",
    "NOM_COMMERCIALE": "ZOLOFT",
    "FORME": "GLES.",
    "DOSAGE": "50MG",
    "COND": "B/14",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PFIZER PHARM ALGERIE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/3/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "10/5/2011",
    "TYPE": "Ré",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["escitalopram"],
    "InteractionIndexLink": ["escitalopram"],
    "N_ENREGISTREMENT": "317/ 16 A 105 /16",
    "CODE_DCI": "16 A 105",
    "DCI": "ESCITALOPRAM OXALATE EXPRIME EN ESCITALOPRAM",
    "NOM_COMMERCIALE": "CELOPRAM",
    "FORME": "COMP. PELLI.SEC.",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ÏNPHA MEDIS SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/10/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "6/10/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["escitalopram"],
    "InteractionIndexLink": ["escitalopram"],
    "N_ENREGISTREMENT": "447/ 16 A 105 /12",
    "CODE_DCI": "16 A 105",
    "DCI": "ESCITALOPRAM OXALATE EXPRIME EN ESCITALOPRAM",
    "NOM_COMMERCIALE": "ESCITALOPRAM BEKER",
    "FORME": "COMP PELLICULE SECABLE",
    "DOSAGE": "10MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEKER SARL (SARL LABORATOIRE BEKER ALGERIE)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "21/10/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "21/10/2012",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["escitalopram"],
    "InteractionIndexLink": ["escitalopram"],
    "N_ENREGISTREMENT": "177/ 16 A 105 /19",
    "CODE_DCI": "16 A 105",
    "DCI": "ESCITALOPRAM OXALATE EXPRIME EN ESCITALOPRAM",
    "NOM_COMMERCIALE": "ESCITOL",
    "FORME": "COMP PELLICULE SECABLE",
    "DOSAGE": "10MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ABDI IBRAHIM ILAC SANAYI Ve",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "TURQUIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/4/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "15/4/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["escitalopram"],
    "InteractionIndexLink": ["escitalopram"],
    "N_ENREGISTREMENT": "242/16 A 105/20",
    "CODE_DCI": "16 A 105",
    "DCI": "ESCITALOPRAM OXALATE EXPRIME EN ESCITALOPRAM",
    "NOM_COMMERCIALE": "ESTONYL",
    "FORME": "COMP PELL SEC",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GROUPE SANTE SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "8/4/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "8/4/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["escitalopram"],
    "InteractionIndexLink": ["escitalopram"],
    "N_ENREGISTREMENT": "21/16 A105/173",
    "CODE_DCI": "16 A 105",
    "DCI": "ESCITALOPRAM OXALATE EXPRIME EN ESCITALOPRAM",
    "NOM_COMMERCIALE": "IBINOR",
    "FORME": "COMP PELL SECABLE",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EURL/ TABUK ALGERIE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "14/04/21",
    "DATE_D_ENREGISTREMENT_FINAL": "14/04/21",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["escitalopram"],
    "InteractionIndexLink": ["escitalopram"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "16 A 105",
    "DCI": "ESCITALOPRAM OXALATE",
    "NOM_COMMERCIALE": "IBINOR 10 MG",
    "FORME": "Comprimé pélliculé sécable",
    "DOSAGE": "10mg",
    "COND": "boite de 30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["escitalopram"],
    "InteractionIndexLink": ["escitalopram"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "16 A 105",
    "DCI": "ESCITALOPRAM OXALATE",
    "NOM_COMMERCIALE": "SCIPRAL",
    "FORME": "Comprimés pelliculé scecable",
    "DOSAGE": "10mg",
    "COND": "boite de 28",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["escitalopram"],
    "InteractionIndexLink": ["escitalopram"],
    "N_ENREGISTREMENT": "352/ 16 A 105 /12",
    "CODE_DCI": "16 A 105",
    "DCI": "ESCITALOPRAM OXALATE EXPRIME EN ESCITALOPRAM",
    "NOM_COMMERCIALE": "TALOPREX",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/3/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "29/3/2012",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["duloxetine"],
    "InteractionIndexLink": ["duloxetine"],
    "N_ENREGISTREMENT": "352/ 16 A 106 /18",
    "CODE_DCI": "16 A 106",
    "DCI": "DULOXETINE CHLORHYDRATE EXPRIME EN DULOXETINE",
    "NOM_COMMERCIALE": "BALTAXINE",
    "FORME": "GLES. GASTRO-RESIST.",
    "DOSAGE": "30MG",
    "COND": "PILULIER DE 30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SPA EL KENDI  Industrie du Médicament",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "31/10/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "31/10/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["duloxetine"],
    "InteractionIndexLink": ["duloxetine"],
    "N_ENREGISTREMENT": "034/ 16 A 106 /07/15",
    "CODE_DCI": "16 A 106",
    "DCI": "DULOXETINE CHLORHYDRATE EXPRIME EN DULOXETINE",
    "NOM_COMMERCIALE": "CYMBALTA",
    "FORME": "GLES. GASTRO-RESIST.",
    "DOSAGE": "30MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ELI LILLY NEDERLAND B.V.",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PAYS BAS",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/7/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "6/5/2015",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["duloxetine"],
    "InteractionIndexLink": ["duloxetine"],
    "N_ENREGISTREMENT": "289/16 A 106/17",
    "CODE_DCI": "16 A 106",
    "DCI": "DULOXETINE CHLORHYDRATE EXPRIME EN DULOXETINE",
    "NOM_COMMERCIALE": "CYMOXETINE",
    "FORME": "GELULE GASTRO RESISTANTE",
    "DOSAGE": "30MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRATER RAZES FORME SECHE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "5/11/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "5/11/2017",
    "TYPE": "GE",
    "STATUT": "F PREMIX",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["duloxetine"],
    "InteractionIndexLink": ["duloxetine"],
    "N_ENREGISTREMENT": "001/ 16 A 106 /15",
    "CODE_DCI": "16 A 106",
    "DCI": "DULOXETINE CHLORHYDRATE EXPRIME EN DULOXETINE",
    "NOM_COMMERCIALE": "DULOX",
    "FORME": "MICRO-GRANUL. EN GLES.",
    "DOSAGE": "30MG",
    "COND": "PILULIER/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMA ALGERIA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/9/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "22/9/2015",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["duloxetine"],
    "InteractionIndexLink": ["duloxetine"],
    "N_ENREGISTREMENT": "286/ 16 A 106 /16",
    "CODE_DCI": "16 A 106",
    "DCI": "DULOXETINE CHLORHYDRATE EXPRIME EN DULOXETINE",
    "NOM_COMMERCIALE": "WYSERIN",
    "FORME": "MICRO-GRANUL. EN GLES.",
    "DOSAGE": "30MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CPCM SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/9/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "27/9/2016",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "24mois",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["duloxetine"],
    "InteractionIndexLink": ["duloxetine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "16 A 107",
    "DCI": "Duloxetine",
    "NOM_COMMERCIALE": "Baltaxine",
    "FORME": "Gélule",
    "DOSAGE": "60mg",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["duloxetine"],
    "InteractionIndexLink": ["duloxetine"],
    "N_ENREGISTREMENT": "035/ 16 A 107 /15",
    "CODE_DCI": "16 A 107",
    "DCI": "DULOXETINE CHLORHYDRATE EXPRIME EN DULOXETINE",
    "NOM_COMMERCIALE": "CYACETINE",
    "FORME": "GLES. A MICROGRANULES GASTRO-RESIST.",
    "DOSAGE": "60MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMALLIANCE EURL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/1/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "25/1/2015",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["duloxetine"],
    "InteractionIndexLink": ["duloxetine"],
    "N_ENREGISTREMENT": "034/ 16 A 107 /07/15",
    "CODE_DCI": "16 A 107",
    "DCI": "DULOXETINE CHLORHYDRATE EXPRIME EN DULOXETINE",
    "NOM_COMMERCIALE": "CYMBALTA",
    "FORME": "GLES. GASTRO-RESIST.",
    "DOSAGE": "60MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ELI LILLY NEDERLAND B.V.",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PAYS BAS",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/7/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "6/5/2015",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["duloxetine"],
    "InteractionIndexLink": ["duloxetine"],
    "N_ENREGISTREMENT": "289/16 A 107/17",
    "CODE_DCI": "16 A 107",
    "DCI": "DULOXETINE CHLORHYDRATE EXPRIME EN DULOXETINE",
    "NOM_COMMERCIALE": "CYMOXETINE",
    "FORME": "MICRO-GRANUL. EN GLES.",
    "DOSAGE": "60MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRATER RAZES FORME SECHE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "5/11/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "5/11/2017",
    "TYPE": "GE",
    "STATUT": "F PREMIX",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["duloxetine"],
    "InteractionIndexLink": ["duloxetine"],
    "N_ENREGISTREMENT": "001/ 16 A 107 /15",
    "CODE_DCI": "16 A 107",
    "DCI": "DULOXETINE CHLORHYDRATE EXPRIME EN DULOXETINE",
    "NOM_COMMERCIALE": "DULOX",
    "FORME": "MICRO-GRANUL. EN GLES.",
    "DOSAGE": "60MG",
    "COND": "PILULIER/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMA ALGERIA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/9/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "22/9/2015",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["duloxetine"],
    "InteractionIndexLink": ["duloxetine"],
    "N_ENREGISTREMENT": "286/ 16 A 107 /16",
    "CODE_DCI": "16 A 107",
    "DCI": "DULOXETINE CHLORHYDRATE EXPRIME EN DULOXETINE",
    "NOM_COMMERCIALE": "WYSERIN",
    "FORME": "MICRO-GRANUL. EN GLES.",
    "DOSAGE": "60MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CPCM SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/9/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "27/9/2016",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["sertraline"],
    "InteractionIndexLink": ["sertraline"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "16 A 115",
    "DCI": "SERTRALINE (SOUS FORME DE CHLORHYDRATE)",
    "NOM_COMMERCIALE": "SOLOTIK",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "100MG",
    "COND": "PILULIER/15",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["venlafaxine"],
    "InteractionIndexLink": ["venlafaxine"],
    "N_ENREGISTREMENT": "286/ 16 A 125 /14",
    "CODE_DCI": "16 A 125",
    "DCI": "VENLAFAXINE CHLORHYDRATE EXPRIME EN VENLAFAXINE",
    "NOM_COMMERCIALE": "AVISINE",
    "FORME": "GLES LP",
    "DOSAGE": "37.5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CHIMIE PHARMACIE COMMERCE MULTIPLE (CPCM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/5/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "12/5/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["venlafaxine"],
    "InteractionIndexLink": ["venlafaxine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "16 A 125",
    "DCI": "VENLAFAXINE CHLORHYDRATE EXPRIME EN VENLAFAXINE",
    "NOM_COMMERCIALE": "FLAXYNE",
    "FORME": "GLES.LP",
    "DOSAGE": "37.5MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["venlafaxine"],
    "InteractionIndexLink": ["venlafaxine"],
    "N_ENREGISTREMENT": "317/ 16 A 125 /15",
    "CODE_DCI": "16 A 125",
    "DCI": "VENLAFAXINE CHLORHYDRATE EXPRIME EN VENLAFAXINE",
    "NOM_COMMERCIALE": "TEDEMA LP",
    "FORME": "MICROGRANULES LP  EN GLES",
    "DOSAGE": "37.5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INPHA MEDIS SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/12/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "5/9/2016",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["venlafaxine"],
    "InteractionIndexLink": ["venlafaxine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "16 A 125",
    "DCI": "Venlafaxine",
    "NOM_COMMERCIALE": "Tedema LP 37.5mg",
    "FORME": "Gélule",
    "DOSAGE": "37.5mg/gélule",
    "COND": "bt de 30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["venlafaxine"],
    "InteractionIndexLink": ["venlafaxine"],
    "N_ENREGISTREMENT": "263/ 16 A 125 /21",
    "CODE_DCI": "16 A 125",
    "DCI": "Chlorhydrate de Venlafaxine exprimé en Vnelafaxine",
    "NOM_COMMERCIALE": "VENFAX",
    "FORME": "Gélule à microgranules à libération prolongée",
    "DOSAGE": "37.5MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOPHARM / SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/2/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "17/2/2021",
    "TYPE": "Gé",
    "STATUT": "Fabricant ( CPCM)",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["venlafaxine"],
    "InteractionIndexLink": ["venlafaxine"],
    "N_ENREGISTREMENT": "472/ 16 A 125 /14",
    "CODE_DCI": "16 A 125",
    "DCI": "VENLAFAXINE CHLORHYDRATE EXPRIME EN VENLAFAXINE",
    "NOM_COMMERCIALE": "VENLAFAXINE GEBER",
    "FORME": "GLES LP",
    "DOSAGE": "37.5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GEBERHEALTH",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "8/6/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "8/6/2014",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["venlafaxine"],
    "InteractionIndexLink": ["venlafaxine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "16 A 125",
    "DCI": "Venlafaxine Chlorhydrate",
    "NOM_COMMERCIALE": "VENLAXOR L.P 37.50MG",
    "FORME": "Gélule",
    "DOSAGE": "37.5 mg",
    "COND": "Boite de 30.",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["venlafaxine"],
    "InteractionIndexLink": ["venlafaxine"],
    "N_ENREGISTREMENT": "289/16 A 125/16",
    "CODE_DCI": "16 A 125",
    "DCI": "VENLAFAXINE CHLORHYDRATE EXPRIME EN VENLAFAXINE",
    "NOM_COMMERCIALE": "VENLAXOR LP",
    "FORME": "GLES LP",
    "DOSAGE": "37.5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRATER RAZES FORME SECHE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/11/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "9/11/2016",
    "TYPE": "Gé",
    "STATUT": "F PREMIX",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["venlafaxine"],
    "InteractionIndexLink": ["venlafaxine"],
    "N_ENREGISTREMENT": "286/ 16 A 126 /14",
    "CODE_DCI": "16 A 126",
    "DCI": "VENLAFAXINE CHLORHYDRATE EXPRIME EN VENLAFAXINE",
    "NOM_COMMERCIALE": "AVISINE",
    "FORME": "GLES LP",
    "DOSAGE": "75 MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CHIMIE PHARMACIE COMMERCE MULTIPLE (CPCM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/5/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "12/5/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["venlafaxine"],
    "InteractionIndexLink": ["venlafaxine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "16 A 126",
    "DCI": "VENLAFAXINE CHLORHYDRATE EXPRIME EN VENLAFAXINE",
    "NOM_COMMERCIALE": "FLAXYNE",
    "FORME": "GLES. LP",
    "DOSAGE": "75MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["venlafaxine"],
    "InteractionIndexLink": ["venlafaxine"],
    "N_ENREGISTREMENT": "472/ 16 A 126 /14",
    "CODE_DCI": "16 A 126",
    "DCI": "VENLAFAXINE CHLORHYDRATE EXPRIME EN VENLAFAXINE",
    "NOM_COMMERCIALE": "VENLAFAXINE GEBER",
    "FORME": "GLES LP",
    "DOSAGE": "75MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GEBERHEALTH",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "8/6/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "8/6/2014",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["venlafaxine"],
    "InteractionIndexLink": ["venlafaxine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "16 A 126",
    "DCI": "Venlafaxine Chlorhydrate",
    "NOM_COMMERCIALE": "VENLAXOR L.P 75MG",
    "FORME": "Gélule",
    "DOSAGE": "75 mg",
    "COND": "Boite de 30.",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["venlafaxine"],
    "InteractionIndexLink": ["venlafaxine"],
    "N_ENREGISTREMENT": "289/16 A 126/16",
    "CODE_DCI": "16 A 126",
    "DCI": "VENLAFAXINE CHLORHYDRATE EXPRIME EN VENLAFAXINE",
    "NOM_COMMERCIALE": "VENLAXOR LP",
    "FORME": "GLES LP",
    "DOSAGE": "75 MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRATER RAZES FORME SECHE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/10/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "19/10/2016",
    "TYPE": "Gé",
    "STATUT": "FPRémix",
    "DUREE_DE_STABILITE": "24MOIIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["escitalopram"],
    "InteractionIndexLink": ["escitalopram"],
    "N_ENREGISTREMENT": "317/ 16 A 130 /16",
    "CODE_DCI": "16 A 130",
    "DCI": "ESCITALOPRAM OXALATE EXPRIME EN ESCITALOPRAM",
    "NOM_COMMERCIALE": "CELOPRAM",
    "FORME": "COMP. PELLI. SEC",
    "DOSAGE": "20MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INPHA MEDIS SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/10/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "6/10/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["escitalopram"],
    "InteractionIndexLink": ["escitalopram"],
    "N_ENREGISTREMENT": "321/ 16 A 130 /09",
    "CODE_DCI": "16 A 130",
    "DCI": "ESCITALOPRAM OXALATE EXPRIME EN ESCITALOPRAM",
    "NOM_COMMERCIALE": "DEPRESS",
    "FORME": "COMPRIME",
    "DOSAGE": "20MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOVITAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/3/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "28/3/2009",
    "TYPE": "Gé",
    "STATUT": "C",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["escitalopram"],
    "InteractionIndexLink": ["escitalopram"],
    "N_ENREGISTREMENT": "177/ 16 A 130 /09/19",
    "CODE_DCI": "16 A 130",
    "DCI": "ESCITALOPRAM OXALATE EXPRIME EN ESCITALOPRAM",
    "NOM_COMMERCIALE": "ESCITOL",
    "FORME": "COMPRIME",
    "DOSAGE": "20MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ABDI IBRAHIM ILAÇ SANAYI VE TICARET A.S",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "TURQUIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/4/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "10/1/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["escitalopram"],
    "InteractionIndexLink": ["escitalopram"],
    "N_ENREGISTREMENT": "20/09/16 A131/177",
    "CODE_DCI": "16 A 131",
    "DCI": "ESCITALOPRAM OXALATE EXPRIMÉ EN ESCITALOPRAM",
    "NOM_COMMERCIALE": "ESCITOL",
    "FORME": "SOL. BUV. GTTES.",
    "DOSAGE": "10MG/ML",
    "COND": "FL./15ML AVEC COMPTE GOUTTES",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE ABDI IBRAHIM REMEDE PHARMA SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/4/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "8/11/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["escitalopram"],
    "InteractionIndexLink": ["escitalopram"],
    "N_ENREGISTREMENT": "035 / 16 A 133 /21",
    "CODE_DCI": "16 A 133",
    "DCI": "Oxalate d'Escitalopram exprimé en Escitalopram",
    "NOM_COMMERCIALE": "CITOPLEX",
    "FORME": "Comprimé pelliculé",
    "DOSAGE": "5MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMALLIANCE / EURL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "21/3/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "21/3/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["paroxetine"],
    "InteractionIndexLink": ["paroxetine"],
    "N_ENREGISTREMENT": "352/ 16 A 154 /12/17",
    "CODE_DCI": "16 A 154",
    "DCI": "Paroxetine (sous forme de chlorhydrate hemihydratée)",
    "NOM_COMMERCIALE": "DEPRETINE",
    "FORME": "COMP. ENRO.",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/1/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "27/12/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["paroxetine"],
    "InteractionIndexLink": ["paroxetine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "16 A 154",
    "DCI": "PAROXETINE",
    "NOM_COMMERCIALE": "PAROLYX",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "10 MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["paroxetine"],
    "InteractionIndexLink": ["paroxetine"],
    "N_ENREGISTREMENT": "235/16 A 154/17",
    "CODE_DCI": "16 A 154",
    "DCI": "PAROXETINE (SOUS FORME DE CHLORHYDRATE HEMIHYDRATE)",
    "NOM_COMMERCIALE": "PAROXETIL BGL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOGALENIC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/2/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "12/2/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["amitriptyline"],
    "InteractionIndexLink": ["amitriptyline"],
    "N_ENREGISTREMENT": "418/ 16 A 158 /13",
    "CODE_DCI": "16 A 158",
    "DCI": "AMITRIPTYLINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "DEPRESTAT LP",
    "FORME": "MICRGLES. LP EN GLES.",
    "DOSAGE": "25MG",
    "COND": "B/60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NEOMEDIC SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/3/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "10/3/2013",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["sertraline"],
    "InteractionIndexLink": ["sertraline"],
    "N_ENREGISTREMENT": "317/ 16 A 159 /14/20",
    "CODE_DCI": "16 A 159",
    "DCI": "SERTRALINE CHLORHYDRATE (EXPRIME EN SERTRALINE)",
    "NOM_COMMERCIALE": "SERVAL",
    "FORME": "GLES",
    "DOSAGE": "25MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INPHA-MEDIS SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/7/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "12/4/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["escitalopram"],
    "InteractionIndexLink": ["escitalopram"],
    "N_ENREGISTREMENT": "317/ 16 A 165 /16",
    "CODE_DCI": "16 A 165",
    "DCI": "ESCITALOPRAM OXALATE EXPRIME EN ESCITALOPRAM",
    "NOM_COMMERCIALE": "CELOPRAM",
    "FORME": "SOLUTION BUVABLE EN GOUTTES",
    "DOSAGE": "20MG/ML",
    "COND": "B/01 FLACON DE 30ML  AVEC COMPTE GOUTTE",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INPHA MEDIS SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/10/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "6/10/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["clorazepate"],
    "InteractionIndexLink": ["clorazepate"],
    "N_ENREGISTREMENT": "255/ 16 B 021 /98",
    "CODE_DCI": "16 B 021",
    "DCI": "CLORAZEPATE DIPOTASSIQUE",
    "NOM_COMMERCIALE": "TRANXENE",
    "FORME": "LYOPHILISAT",
    "DOSAGE": "20MG/2ML",
    "COND": "B/5+5",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANOFI SYNTHELABO",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/4/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "20/4/1998",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["clorazepate"],
    "InteractionIndexLink": ["clorazepate"],
    "N_ENREGISTREMENT": "255/ 16 B 022 /98",
    "CODE_DCI": "16 B 022",
    "DCI": "CLORAZEPATE DIPOTASSIQUE",
    "NOM_COMMERCIALE": "TRANXENE",
    "FORME": "LYOPHILISAT",
    "DOSAGE": "50MG /2.5 ML",
    "COND": "B/5+5",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANOFI SYNTHELABO",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/4/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "20/4/1998",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["clorazepate"],
    "InteractionIndexLink": ["clorazepate"],
    "N_ENREGISTREMENT": "231/ 16 B 023 /09",
    "CODE_DCI": "16 B 023",
    "DCI": "CLORAZEPATE DIPOTASSIQUE",
    "NOM_COMMERCIALE": "CLORAXENE",
    "FORME": "GLES.",
    "DOSAGE": "5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SALEM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/7/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "19/7/2009",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["clorazepate"],
    "InteractionIndexLink": ["clorazepate"],
    "N_ENREGISTREMENT": "235/16 B 023/20",
    "CODE_DCI": "16 B 023",
    "DCI": "CLORAZEPATE DIPOTASSIQUE",
    "NOM_COMMERCIALE": "NOXENE",
    "FORME": "GLES",
    "DOSAGE": "5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOGALENIC SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/7/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "12/7/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["clorazepate"],
    "InteractionIndexLink": ["clorazepate"],
    "N_ENREGISTREMENT": "097/ 16 B 023 /08",
    "CODE_DCI": "16 B 023",
    "DCI": "CLORAZEPATE DIPOTASSIQUE",
    "NOM_COMMERCIALE": "TRANOXANE",
    "FORME": "GLES.",
    "DOSAGE": "5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANAMED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/4/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "27/4/2008",
    "TYPE": "Gé",
    "STATUT": "C",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["clorazepate"],
    "InteractionIndexLink": ["clorazepate"],
    "N_ENREGISTREMENT": "376/ 16 B 023 /97/08",
    "CODE_DCI": "16 B 023",
    "DCI": "CLORAZEPATE DIPOTASSIQUE",
    "NOM_COMMERCIALE": "TRANXENE",
    "FORME": "GLES.",
    "DOSAGE": "5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANOFI AVENTIS FRANCE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "8/11/1997",
    "DATE_D_ENREGISTREMENT_FINAL": "6/1/2009",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["clorazepate"],
    "InteractionIndexLink": ["clorazepate"],
    "N_ENREGISTREMENT": "231/ 16 B 024 /09",
    "CODE_DCI": "16 B 024",
    "DCI": "CLORAZEPATE DIPOTASSIQUE",
    "NOM_COMMERCIALE": "CLORAXENE",
    "FORME": "GLES.",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SALEM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/7/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "19/7/2009",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["clorazepate"],
    "InteractionIndexLink": ["clorazepate"],
    "N_ENREGISTREMENT": "235/16 B 024/20",
    "CODE_DCI": "16 B 024",
    "DCI": "CLORAZEPATE DIPOTASSIQUE",
    "NOM_COMMERCIALE": "NOXENE",
    "FORME": "GLES",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOGALENIC SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/7/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "12/7/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["clorazepate"],
    "InteractionIndexLink": ["clorazepate"],
    "N_ENREGISTREMENT": "097/ 16 B 024 /08",
    "CODE_DCI": "16 B 024",
    "DCI": "CLORAZEPATE DIPOTASSIQUE",
    "NOM_COMMERCIALE": "TRANOXANE",
    "FORME": "GLES.",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANAMED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/4/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "27/4/2008",
    "TYPE": "Gé",
    "STATUT": "C",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["clorazepate"],
    "InteractionIndexLink": ["clorazepate"],
    "N_ENREGISTREMENT": "376/ 16 B 024 /97/09",
    "CODE_DCI": "16 B 024",
    "DCI": "CLORAZEPATE DIPOTASSIQUE",
    "NOM_COMMERCIALE": "TRANXENE",
    "FORME": "GLES.",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANOFI AVENTIS FRANCE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "8/11/1997",
    "DATE_D_ENREGISTREMENT_FINAL": "8/12/2009",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["diazepam"],
    "InteractionIndexLink": ["diazepam"],
    "N_ENREGISTREMENT": "235/ 16 B 029 /10",
    "CODE_DCI": "16 B 029",
    "DCI": "DIAZEPAM",
    "NOM_COMMERCIALE": "XAVEL",
    "FORME": "SOL. BUV. GTTES.",
    "DOSAGE": "1% (OU 10MG/ML)",
    "COND": "B/1FL. COMPT. GTTES DE 20ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIO-GALENIC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/10/2010",
    "DATE_D_ENREGISTREMENT_FINAL": "6/10/2010",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["hydroxyzine"],
    "InteractionIndexLink": ["hydroxyzine"],
    "N_ENREGISTREMENT": "046/ 16 B 039 /98",
    "CODE_DCI": "16 B 039",
    "DCI": "HYDROXYZINE",
    "NOM_COMMERCIALE": "ATARAX",
    "FORME": "SOL.INJ.",
    "DOSAGE": "50MG/ML",
    "COND": "B/6AMP. DE 2ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "UCB PHARMA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "16/9/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "16/9/1998",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["hydroxyzine"],
    "InteractionIndexLink": ["hydroxyzine"],
    "N_ENREGISTREMENT": "046/ 16 B 040 /98",
    "CODE_DCI": "16 B 040",
    "DCI": "HYDROXYZINE",
    "NOM_COMMERCIALE": "ATARAX",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "25MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "UCB PHARMA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "16/9/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "16/9/1998",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["hydroxyzine"],
    "InteractionIndexLink": ["hydroxyzine"],
    "N_ENREGISTREMENT": "012/ 16 B 040 /98/16",
    "CODE_DCI": "16 B 040",
    "DCI": "HYDROXYZINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "CROXIZINE",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "25MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CROVIS PHILCOM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ITALIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/8/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "2/2/2016",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "60 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["hydroxyzine"],
    "InteractionIndexLink": ["hydroxyzine"],
    "N_ENREGISTREMENT": "242/16 B 040/20",
    "CODE_DCI": "16 B 040",
    "DCI": "HYDROXYZINE HYDROCHLORIDE",
    "NOM_COMMERCIALE": "DURRAX",
    "FORME": "COMP PELL SEC",
    "DOSAGE": "25MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GROUPE SANTE SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/1/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "15/1/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["hydroxyzine"],
    "InteractionIndexLink": ["hydroxyzine"],
    "N_ENREGISTREMENT": "077/ 16 B 040 /08/16",
    "CODE_DCI": "16 B 040",
    "DCI": "HYDROXYZINE DICHLORHYDRATE",
    "NOM_COMMERCIALE": "HYDROXIL",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "25MG",
    "COND": "B/20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE ALGERIEN DU MEDICAMENT (LAM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/3/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "17/4/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "60MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["hydroxyzine"],
    "InteractionIndexLink": ["hydroxyzine"],
    "N_ENREGISTREMENT": "046/ 16 B 041 /98",
    "CODE_DCI": "16 B 041",
    "DCI": "HYDROXYZINE",
    "NOM_COMMERCIALE": "ATARAX",
    "FORME": "COMP.PELLI. SEC.",
    "DOSAGE": "100MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "UCB PHARMA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "16/9/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "31/5/2004",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["hydroxyzine"],
    "InteractionIndexLink": ["hydroxyzine"],
    "N_ENREGISTREMENT": "012/ 16 B 041 /98/16",
    "CODE_DCI": "16 B 041",
    "DCI": "HYDROXYZINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "CROXIZINE",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "100MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CROVIS PHILCOM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ITALIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "16/8/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "5/3/2017",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "60 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["lorazepam"],
    "InteractionIndexLink": ["lorazepam"],
    "N_ENREGISTREMENT": "468/ 16 B 042 /15",
    "CODE_DCI": "16 B 042",
    "DCI": "LORAZEPAM",
    "NOM_COMMERCIALE": "ANXIENAD",
    "FORME": "COMP. PELLI. SEC.",
    "DOSAGE": "1MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NADPHARMADIC PRODUCTION SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/3/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "18/3/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["lorazepam"],
    "InteractionIndexLink": ["lorazepam"],
    "N_ENREGISTREMENT": "320/ 16 B 042 /06",
    "CODE_DCI": "16 B 042",
    "DCI": "LORAZEPAM",
    "NOM_COMMERCIALE": "LORAZEPAM - AGD",
    "FORME": "COMP. QUADRISEC.",
    "DOSAGE": "1MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIAN GENERICS DEVELOPMENT  PHARMA  (AGD PHARMA)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/1/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "15/1/2007",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["lorazepam"],
    "InteractionIndexLink": ["lorazepam"],
    "N_ENREGISTREMENT": "242/16 B 042/17",
    "CODE_DCI": "16 B 042",
    "DCI": "LORAZEPAM",
    "NOM_COMMERCIALE": "MAPEZ",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "1MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GROUPE SANTE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/3/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "12/3/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["lorazepam"],
    "InteractionIndexLink": ["lorazepam"],
    "N_ENREGISTREMENT": "065/ 16 B 042 /07",
    "CODE_DCI": "16 B 042",
    "DCI": "LORAZEPAM",
    "NOM_COMMERCIALE": "ORZEPAM",
    "FORME": "COMPRIME",
    "DOSAGE": "1MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GENERICLAB SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/12/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "4/12/2007",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["lorazepam"],
    "InteractionIndexLink": ["lorazepam"],
    "N_ENREGISTREMENT": "20/98/16 B042/231",
    "CODE_DCI": "16 B 042",
    "DCI": "LORAZEPAM",
    "NOM_COMMERCIALE": "TEMESTA",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "1MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SALEM LABORATOIRES SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "8/11/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "14/10/2020",
    "TYPE": "Ré",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["lorazepam"],
    "InteractionIndexLink": ["lorazepam"],
    "N_ENREGISTREMENT": "320/ 16 B 043 /06",
    "CODE_DCI": "16 B 043",
    "DCI": "LORAZEPAM",
    "NOM_COMMERCIALE": "LORAZEPAM - AGD",
    "FORME": "COMP. QUADRISEC.",
    "DOSAGE": "2.5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIAN GENERICS DEVELOPMENT  PHARMA  (AGD PHARMA)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/1/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "15/1/2007",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["lorazepam"],
    "InteractionIndexLink": ["lorazepam"],
    "N_ENREGISTREMENT": "242/16 B 043/17",
    "CODE_DCI": "16 B 043",
    "DCI": "LORAZEPAM",
    "NOM_COMMERCIALE": "MAPEZ",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "2.5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GROUPE SANTE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/3/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "12/3/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["lorazepam"],
    "InteractionIndexLink": ["lorazepam"],
    "N_ENREGISTREMENT": "065/ 16 B 043 /04/12",
    "CODE_DCI": "16 B 043",
    "DCI": "LORAZEPAM",
    "NOM_COMMERCIALE": "ORZEPAM",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "2.5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GENERICLAB SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/7/2004",
    "DATE_D_ENREGISTREMENT_FINAL": "25/9/2012",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["lorazepam"],
    "InteractionIndexLink": ["lorazepam"],
    "N_ENREGISTREMENT": "20/98/16/ B043/231",
    "CODE_DCI": "16 B 043",
    "DCI": "LORAZEPAM",
    "NOM_COMMERCIALE": "TEMESTA",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "2.5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SALEM LABORATOIRES SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "8/11/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "14/10/2020",
    "TYPE": "Ré",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["prazepam"],
    "InteractionIndexLink": ["prazepam"],
    "N_ENREGISTREMENT": "045/ 16 B 078 /98/09",
    "CODE_DCI": "16 B 078",
    "DCI": "PRAZEPAM",
    "NOM_COMMERCIALE": "LYSANXIA",
    "FORME": "COMPRIME",
    "DOSAGE": "10MG",
    "COND": "B/40",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PFIZER PHARM ALGERIE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/3/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "7/3/2009",
    "TYPE": "Ré",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["prazepam"],
    "InteractionIndexLink": ["prazepam"],
    "N_ENREGISTREMENT": "242/16 B 078/17",
    "CODE_DCI": "16 B 078",
    "DCI": "PRAZEPAM",
    "NOM_COMMERCIALE": "PRAZEPAM GS",
    "FORME": "COMPRIME",
    "DOSAGE": "10MG",
    "COND": "B/40",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GROUPE SANTE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/1/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "17/1/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["prazepam"],
    "InteractionIndexLink": ["prazepam"],
    "N_ENREGISTREMENT": "235/ 16 B 078 /10",
    "CODE_DCI": "16 B 078",
    "DCI": "PRAZEPAM",
    "NOM_COMMERCIALE": "PREZIVA",
    "FORME": "COMPRIME",
    "DOSAGE": "10MG",
    "COND": "B/40",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIO-GALENIC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/5/2010",
    "DATE_D_ENREGISTREMENT_FINAL": "13/5/2010",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["hydroxyzine"],
    "InteractionIndexLink": ["hydroxyzine"],
    "N_ENREGISTREMENT": "046/ 16 B 079 /98",
    "CODE_DCI": "16 B 079",
    "DCI": "HYDROXYZINE",
    "NOM_COMMERCIALE": "ATARAX",
    "FORME": "SIROP",
    "DOSAGE": "2MG/ML",
    "COND": "FL/200ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "UCB PHARMA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "16/9/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "1/7/2006",
    "TYPE": "Ré",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["hydroxyzine"],
    "InteractionIndexLink": ["hydroxyzine"],
    "N_ENREGISTREMENT": "242/ 16 B 079 /09/21",
    "CODE_DCI": "16 B 079",
    "DCI": "Chlorhydrate d'Hydroxyzine",
    "NOM_COMMERCIALE": "DURRAX",
    "FORME": "SIROP",
    "DOSAGE": "2MG/ML",
    "COND": "FL./100ML",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GROUPE SANTE / SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/4/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "18/3/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["hydroxyzine"],
    "InteractionIndexLink": ["hydroxyzine"],
    "N_ENREGISTREMENT": "077/ 16 B 079 /97/15",
    "CODE_DCI": "16 B 079",
    "DCI": "HYDROXYZINE DICHLORHYDRATE",
    "NOM_COMMERCIALE": "HYDROXIL",
    "FORME": "SIROP",
    "DOSAGE": "2MG/ML",
    "COND": "FL/200ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE ALGERIEN DU MEDICAMENT  (LAM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/12/1997",
    "DATE_D_ENREGISTREMENT_FINAL": "31/3/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["hydroxyzine"],
    "InteractionIndexLink": ["hydroxyzine"],
    "N_ENREGISTREMENT": "320/ 16 B 079 /06/18",
    "CODE_DCI": "16 B 079",
    "DCI": "HYDROXYZINE",
    "NOM_COMMERCIALE": "HYXYAH",
    "FORME": "SOL. BUV.",
    "DOSAGE": "2MG/ML",
    "COND": "FL/200ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIEN GENERIC DEVELOPPEMENT PHARM  (AGD PHARM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/6/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "11/1/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 mois",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["prazepam"],
    "InteractionIndexLink": ["prazepam"],
    "N_ENREGISTREMENT": "045/ 16 B 080 /98/16",
    "CODE_DCI": "16 B 080",
    "DCI": "PRAZEPAM",
    "NOM_COMMERCIALE": "LYSANXIA",
    "FORME": "SOL .BUV .GTTES.",
    "DOSAGE": "15MG/ML",
    "COND": "FL/20ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PFIZER",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "14/1/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "4/1/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["prazepam"],
    "InteractionIndexLink": ["prazepam"],
    "N_ENREGISTREMENT": "242/ 16 B 080 /16",
    "CODE_DCI": "16 B 080",
    "DCI": "PRAZEPAM",
    "NOM_COMMERCIALE": "PRAZEPAM GS",
    "FORME": "SOL .BUV .GTTES. + PIPETTE GRADUEE",
    "DOSAGE": "15MG/ML",
    "COND": "FL/20ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GROUPE SANTE SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "5/9/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "5/9/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["etifoxine"],
    "N_ENREGISTREMENT": "101/ 16 B 093 /04",
    "CODE_DCI": "16 B 093",
    "DCI": "ETIFOXINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "STRESAM",
    "FORME": "GLES.",
    "DOSAGE": "50MG",
    "COND": "B/24 ET B/60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOCODEX",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/6/2004",
    "DATE_D_ENREGISTREMENT_FINAL": "15/6/2004",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["bromazepam"],
    "InteractionIndexLink": ["bromazepam"],
    "N_ENREGISTREMENT": "242/ 16 B 098 /07/17",
    "CODE_DCI": "16 B 098",
    "DCI": "BROMAZEPAM",
    "NOM_COMMERCIALE": "ANXYPAM",
    "FORME": "COMP. QUADRISEC.",
    "DOSAGE": "6MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GROUPE SANTE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/9/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "4/9/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["bromazepam"],
    "InteractionIndexLink": ["bromazepam"],
    "N_ENREGISTREMENT": "235/ 16 B 098 /02/18",
    "CODE_DCI": "16 B 098",
    "DCI": "BROMAZEPAM",
    "NOM_COMMERCIALE": "BROMAZEPAM",
    "FORME": "COMP. QUADRI SEC.",
    "DOSAGE": "6MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIO-GALENIC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/9/2002",
    "DATE_D_ENREGISTREMENT_FINAL": "22/4/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["bromazepam"],
    "InteractionIndexLink": ["bromazepam"],
    "N_ENREGISTREMENT": "195/ 16 B 098 /07",
    "CODE_DCI": "16 B 098",
    "DCI": "BROMAZEPAM",
    "NOM_COMMERCIALE": "BROMAZEPAM IVAL",
    "FORME": "COMP. QUADRISEC.",
    "DOSAGE": "6MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMA IVAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/7/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "9/7/2007",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["bromazepam"],
    "InteractionIndexLink": ["bromazepam"],
    "N_ENREGISTREMENT": "462/ 16 B 098 /13",
    "CODE_DCI": "16 B 098",
    "DCI": "BROMAZEPAM",
    "NOM_COMMERCIALE": "BROMAZEPAM PHYSIOPHARM",
    "FORME": "COMP. QUADRISEC.",
    "DOSAGE": "6MG",
    "COND": "B/30 ET PILULIER DE 30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHYSIOPHARM SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/9/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "15/9/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["bromazepam"],
    "InteractionIndexLink": ["bromazepam"],
    "N_ENREGISTREMENT": "268/ 16 B 098 /05/16",
    "CODE_DCI": "16 B 098",
    "DCI": "BROMAZEPAM",
    "NOM_COMMERCIALE": "KIETYL",
    "FORME": "COMPRIME QUADRISECABLESECABLE",
    "DOSAGE": "6MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MERINAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/8/2005",
    "DATE_D_ENREGISTREMENT_FINAL": "11/5/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["bromazepam"],
    "InteractionIndexLink": ["bromazepam"],
    "N_ENREGISTREMENT": "285/ 16 B 098 /05/14",
    "CODE_DCI": "16 B 098",
    "DCI": "BROMAZEPAM",
    "NOM_COMMERCIALE": "LEXOPAM",
    "FORME": "COMP QUADRISEC.",
    "DOSAGE": "6MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "UNION PHARMACEUTIQUE CONSTANTINOISE (UPC) SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/5/2005",
    "DATE_D_ENREGISTREMENT_FINAL": "2/11/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["midazolam"],
    "InteractionIndexLink": ["midazolam"],
    "N_ENREGISTREMENT": "001/ 16 C 051 /08/15",
    "CODE_DCI": "16 C 051",
    "DCI": "MIDAZOLAM CHLORHYDRATE EXPRIME EN MIDAZOLAM",
    "NOM_COMMERCIALE": "HIKMA MIDAZOLAM",
    "FORME": "SOL. INJ. IM/IV",
    "DOSAGE": "5MG/ML (15MG/3ML)",
    "COND": "B/05AMP DE 3ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMACEUTICALS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/3/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "12/4/2015",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["midazolam"],
    "InteractionIndexLink": ["midazolam"],
    "N_ENREGISTREMENT": "331/ 16 C 051 /05",
    "CODE_DCI": "16 C 051",
    "DCI": "MIDAZOLAM",
    "NOM_COMMERCIALE": "IPNODIS",
    "FORME": "SOL INJ",
    "DOSAGE": "5MG/ML",
    "COND": "B/10AMP. DE 1ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MEDIS (LABORATOIRES DES MEDICAMENTS STERILES)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "TUNISIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/9/2005",
    "DATE_D_ENREGISTREMENT_FINAL": "28/9/2005",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["midazolam"],
    "InteractionIndexLink": ["midazolam"],
    "N_ENREGISTREMENT": "450/ 16 C 051 /08",
    "CODE_DCI": "16 C 051",
    "DCI": "MIDAZOLAM",
    "NOM_COMMERCIALE": "MIDAZOLAM MYLAN",
    "FORME": "SOL. INJ. IM/IV ET RECTALE",
    "DOSAGE": "5MG/ML (50MG/10ML)",
    "COND": "B/10AMP. DE 1ML -  B/10AMP. DE 10ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MYLAN",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/12/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "17/12/2008",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["midazolam"],
    "InteractionIndexLink": ["midazolam"],
    "N_ENREGISTREMENT": "551/16 C 051/19",
    "CODE_DCI": "16 C 051",
    "DCI": "MIDAZOLAM",
    "NOM_COMMERCIALE": "SEDALAM",
    "FORME": "SOL INJ IM/IV",
    "DOSAGE": "15MG/3ML (5MG/ML)",
    "COND": "B/05 FL 3ML FLACON EN VERRE CLASSE A",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MS PHARMA JORDAN",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/8/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "26/8/2019",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["zolpidem tartrate"],
    "InteractionIndexLink": ["zolpidem"],
    "N_ENREGISTREMENT": "549/ 16 C 095 /21",
    "CODE_DCI": "16 C 095",
    "DCI": "Tartrate de Zolpidem",
    "NOM_COMMERCIALE": "EVOZOLPIDEM",
    "FORME": "Comprimé pelliculé sécable",
    "DOSAGE": "10MG",
    "COND": "B/20",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EVOLAB / SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/3/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "28/3/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["zolpidem tartrate"],
    "InteractionIndexLink": ["zolpidem"],
    "N_ENREGISTREMENT": "255/ 16 C 095 /06/16",
    "CODE_DCI": "16 C 095",
    "DCI": "ZOLPIDEM",
    "NOM_COMMERCIALE": "STILNOX",
    "FORME": "COMP. PELLI. SEC.",
    "DOSAGE": "10MG",
    "COND": "B/14",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANOFI - SYNTHELABO FRANCE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "23/7/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "26/7/2016",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "48 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["zolpidem tartrate"],
    "InteractionIndexLink": ["zolpidem"],
    "N_ENREGISTREMENT": "065/ 16 C 095 /14",
    "CODE_DCI": "16 C 095",
    "DCI": "ZOLPIDEM TARTRATE",
    "NOM_COMMERCIALE": "ZOLIDRATE",
    "FORME": "COMP. PELLI. SEC.",
    "DOSAGE": "10MG",
    "COND": "B/20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GENERICLAB SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/1/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "30/1/2014",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["midazolam"],
    "InteractionIndexLink": ["midazolam"],
    "N_ENREGISTREMENT": "450/ 16 C 152 /08",
    "CODE_DCI": "16 C 152",
    "DCI": "MIDAZOLAM",
    "NOM_COMMERCIALE": "MIDAZOLAM MYLAN",
    "FORME": "SOL. INJ. IM IV ET RECTALE",
    "DOSAGE": "1MG/ML (OU 5MG/5ML)",
    "COND": "B/10 AMP. DE 5ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MYLAN SAS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/5/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "17/5/2008",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["midazolam"],
    "InteractionIndexLink": ["midazolam"],
    "N_ENREGISTREMENT": "551/16 C 152/19",
    "CODE_DCI": "16 C 152",
    "DCI": "Midazolam",
    "NOM_COMMERCIALE": "SEDALAM",
    "FORME": "SOL INJ IM/IV",
    "DOSAGE": "5MG/5ML",
    "COND": "B/10 FL DE 05 ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MS PHARMA JORDAN",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/6/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "25/6/2019",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["chlorpromazine"],
    "InteractionIndexLink": ["chlorpromazine"],
    "N_ENREGISTREMENT": "012/ 16 D 054 /98/13",
    "CODE_DCI": "16 D 054",
    "DCI": "CHLORPROMAZINE (CHLORHYDRATE) EXPRIME EN CHLORPROMAZINE",
    "NOM_COMMERCIALE": "DORMAZINE",
    "FORME": "DRG.",
    "DOSAGE": "100MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FARMACEUTICI CROVIS PH.I.L.COM. SRL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ITALIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/8/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "27/10/2013",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["chlorpromazine"],
    "InteractionIndexLink": ["chlorpromazine"],
    "N_ENREGISTREMENT": "376/ 16 D 054 /96/17",
    "CODE_DCI": "16 D 054",
    "DCI": "CHLORPROMAZINE",
    "NOM_COMMERCIALE": "LARGACTIL",
    "FORME": "COMP.PELLI. SEC.",
    "DOSAGE": "100MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANOFI AVENTIS FRANCE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "14/12/1996",
    "DATE_D_ENREGISTREMENT_FINAL": "12/4/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["chlorpromazine"],
    "InteractionIndexLink": ["chlorpromazine"],
    "N_ENREGISTREMENT": "097/ 16 D 054 /09",
    "CODE_DCI": "16 D 054",
    "DCI": "CHLORPROMAZINE CHLORHYDRATE EXPRIME EN CHLORPROMAZINE",
    "NOM_COMMERCIALE": "LARGAMED 100",
    "FORME": "COMP. PELLI. SEC.",
    "DOSAGE": "100MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANAMED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/4/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "6/4/2009",
    "TYPE": "Gé",
    "STATUT": "C",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["chlorpromazine"],
    "InteractionIndexLink": ["chlorpromazine"],
    "N_ENREGISTREMENT": "242/ 16 D 054 /03",
    "CODE_DCI": "16 D 054",
    "DCI": "CHLORPROMAZINE CHLORHYDRATE EXPRIME EN CHLORPROMAZINE",
    "NOM_COMMERCIALE": "PROMAZ",
    "FORME": "COMPRIME",
    "DOSAGE": "100MG",
    "COND": "B/20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GROUPE SANTE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/12/2003",
    "DATE_D_ENREGISTREMENT_FINAL": "7/12/2003",
    "TYPE": "Gé",
    "STATUT": "C",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["chlorpromazine"],
    "InteractionIndexLink": ["chlorpromazine"],
    "N_ENREGISTREMENT": "455/ 16 D 055 /99/15",
    "CODE_DCI": "16 D 055",
    "DCI": "CHLORPROMAZINE",
    "NOM_COMMERCIALE": "DORMAZINE",
    "FORME": "SUSP.BUV. GTTES",
    "DOSAGE": "4 %",
    "COND": "FL/30ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL GENCOPHARM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/11/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "9/12/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["chlorpromazine"],
    "InteractionIndexLink": ["chlorpromazine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "16 D 055",
    "DCI": "CHLORPROMAZINE",
    "NOM_COMMERCIALE": "DORMAZINE",
    "FORME": "SUSP.BUV. GTTES",
    "DOSAGE": "0.04",
    "COND": "FL/30ML",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["chlorpromazine"],
    "InteractionIndexLink": ["chlorpromazine"],
    "N_ENREGISTREMENT": "263/ 16 D 055 /96/09",
    "CODE_DCI": "16 D 055",
    "DCI": "CHLORPROMAZINE CHLORHYDRATE EXPRIME EN CHLORPROMAZINE",
    "NOM_COMMERCIALE": "LARGACTIL",
    "FORME": "SOL.BUV.GTTES.",
    "DOSAGE": "4 %",
    "COND": "FL/30ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOPHARM ALGERIE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "5/11/1996",
    "DATE_D_ENREGISTREMENT_FINAL": "6/12/2009",
    "TYPE": "Ré",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["chlorpromazine"],
    "InteractionIndexLink": ["chlorpromazine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "16 D 055",
    "DCI": "CHLORPROMAZINE CHLORHYDRATE EXPRIME EN CHLORPROMAZINE",
    "NOM_COMMERCIALE": "LARGACTIL",
    "FORME": "SOL.BUV.GTTES.",
    "DOSAGE": "0.04",
    "COND": "FL/30ML",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["chlorpromazine"],
    "InteractionIndexLink": ["chlorpromazine"],
    "N_ENREGISTREMENT": "400/ 16 D 055 /21",
    "CODE_DCI": "16 D 055",
    "DCI": "Chlorhydrate de Chlorpromazine exprimé en Chlorpromazine",
    "NOM_COMMERCIALE": "LAROMEX",
    "FORME": "Solution en gouttes buvables",
    "DOSAGE": "4 %",
    "COND": "FL/30ML",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "KHROUB PHARMACEUTICALL MANUFACTURING ALGERIA (KPMA) /SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "14/3/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "14/3/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["chlorpromazine"],
    "InteractionIndexLink": ["chlorpromazine"],
    "N_ENREGISTREMENT": "400/ 16 D 055 /21",
    "CODE_DCI": "16 D 055",
    "DCI": "Chlorhydrate de Chlorpromazine exprimé en Chlorpromazine",
    "NOM_COMMERCIALE": "LAROMEX",
    "FORME": "Solution en gouttes buvables",
    "DOSAGE": "4.00 %",
    "COND": "FL/30ML",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "KHROUB PHARMACEUTICALL MANUFACTURING ALGERIA (KPMA) /SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "14/03/21",
    "DATE_D_ENREGISTREMENT_FINAL": "14/03/21",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["chlorpromazine"],
    "InteractionIndexLink": ["chlorpromazine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "16 D 055",
    "DCI": "CHLORPROMAZINE CHLORHYDRATE EXPRIME EN CHLORPROMAZINE",
    "NOM_COMMERCIALE": "LAROMEX",
    "FORME": "SOL BUV GTTES",
    "DOSAGE": "0.04",
    "COND": "FL. COMPT.GTTES DE  30 ML",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["chlorpromazine"],
    "InteractionIndexLink": ["chlorpromazine"],
    "N_ENREGISTREMENT": "242/ 16 D 055 /06",
    "CODE_DCI": "16 D 055",
    "DCI": "CHLORPROMAZINE CHLORHYDRATE EXPRIME EN CHLORPROMAZINE",
    "NOM_COMMERCIALE": "PROMAZ",
    "FORME": "SOL. OR. EN GTTES.",
    "DOSAGE": "4 %",
    "COND": "FL/30ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GROUPE SANTE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/6/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "7/6/2006",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["promazine"],
    "InteractionIndexLink": ["levomepromazine"],
    "N_ENREGISTREMENT": "016/ 16 D 057 /98/16",
    "CODE_DCI": "16 D 057",
    "DCI": "LEVOMEPROMAZINE",
    "NOM_COMMERCIALE": "NOZINAN",
    "FORME": "COMP.PELLI. SEC.",
    "DOSAGE": "25MG",
    "COND": "B/20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "RHONE POULENC RORER",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "14/12/1996",
    "DATE_D_ENREGISTREMENT_FINAL": "14/12/1996",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["promazine"],
    "InteractionIndexLink": ["levomepromazine"],
    "N_ENREGISTREMENT": "378/16 D 058/20",
    "CODE_DCI": "16 D 058",
    "DCI": "LEVOMEPROMAZINE",
    "NOM_COMMERCIALE": "BIOZINAN BR",
    "FORME": "COMP PELL",
    "DOSAGE": "100MG",
    "COND": "B/20",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOREM SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "14/4/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "14/4/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["promazine"],
    "InteractionIndexLink": ["levomepromazine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "16 D 058",
    "DCI": "LEVOMEPROMAZINE MALEATE",
    "NOM_COMMERCIALE": "BIOZINAN BR",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "·  100mg",
    "COND": "-Boite de 20 comprimés pelliculés.",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["promazine"],
    "InteractionIndexLink": ["levomepromazine"],
    "N_ENREGISTREMENT": "013/ 16 D 058 /99/15",
    "CODE_DCI": "16 D 058",
    "DCI": "LEVOMEPROMAZINE MALEATE EXPRIME EN LEVOMEPROMAZINE",
    "NOM_COMMERCIALE": "NOVAZIN",
    "FORME": "COMP.ENRO.",
    "DOSAGE": "100MG",
    "COND": "B/20 - B/500",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "B/500 RESERVEE AUX HOPITAUX",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVA ARGENTIA SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ITALIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/11/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "26/2/2015",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "48 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["promazine"],
    "InteractionIndexLink": ["levomepromazine"],
    "N_ENREGISTREMENT": "242/ 16 D 059 /11",
    "CODE_DCI": "16 D 059",
    "DCI": "LEVOMEPROMAZINE CHLORHYDRATE EXPRIME EN LEVOMEPROMAZINE",
    "NOM_COMMERCIALE": "LEVOZAN",
    "FORME": "SOL. BUV. GTTES.",
    "DOSAGE": "4 %",
    "COND": "B/1FL. DE 30ML + 1COMPT. GTTES.",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GROUPE SANTE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "16/3/2011",
    "DATE_D_ENREGISTREMENT_FINAL": "16/3/2011",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["promazine"],
    "InteractionIndexLink": ["levomepromazine"],
    "N_ENREGISTREMENT": "242/16 D 059/11/20",
    "CODE_DCI": "16 D 059",
    "DCI": "LEVOMEPROMAZINE CHLORHYDRATE EXPRIME EN LEVOMEPROMAZINE",
    "NOM_COMMERCIALE": "LEVOZAN",
    "FORME": "SOL. BUVABLE EN GOUTTES",
    "DOSAGE": "4 %",
    "COND": "FLC 30ML+ COMPTE GOUTTE",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL GROUPE SANTE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "16/3/2011",
    "DATE_D_ENREGISTREMENT_FINAL": "29/12/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["promazine"],
    "InteractionIndexLink": ["levomepromazine"],
    "N_ENREGISTREMENT": "263/ 16 D 059 /96/09",
    "CODE_DCI": "16 D 059",
    "DCI": "LEVOMEPROMAZINE CHLORHYDRATE EXPRIME EN LEVOMEPROMAZINE",
    "NOM_COMMERCIALE": "NOZINAN",
    "FORME": "SOL.BUV.GTTES.",
    "DOSAGE": "4 %",
    "COND": "FL./30ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOPHARM ALGERIE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/11/1996",
    "DATE_D_ENREGISTREMENT_FINAL": "24/12/2009",
    "TYPE": "Ré",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["promazine"],
    "InteractionIndexLink": ["levomepromazine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "16 D 059",
    "DCI": "LEVOMEPROMAZINE CHLORHYDRATE EXPRIME EN LEVOMEPROMAZINE",
    "NOM_COMMERCIALE": "NOZINAN",
    "FORME": "SOL.BUV.GTTES.",
    "DOSAGE": "0.04",
    "COND": "FL./30ML",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["sulpiride"],
    "N_ENREGISTREMENT": "049/ 16 D 066 /97",
    "CODE_DCI": "16 D 066",
    "DCI": "SULPIRIDE",
    "NOM_COMMERCIALE": "DOGMATIL",
    "FORME": "GLES",
    "DOSAGE": "50MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INSTITUT MEDICAL ALGERIEN",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "8/11/1997",
    "DATE_D_ENREGISTREMENT_FINAL": "17/5/2005",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["sulpiride"],
    "N_ENREGISTREMENT": "235/ 16 D 066 /08",
    "CODE_DCI": "16 D 066",
    "DCI": "SULPIRIDE",
    "NOM_COMMERCIALE": "G-SULPIRIDE",
    "FORME": "GLES.",
    "DOSAGE": "50MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIO-GALENIC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/4/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "27/4/2008",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["sulpiride"],
    "N_ENREGISTREMENT": "050/ 16 D 066 /99",
    "CODE_DCI": "16 D 066",
    "DCI": "SULPIRIDE",
    "NOM_COMMERCIALE": "KANISAR",
    "FORME": "GLES",
    "DOSAGE": "50MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANDOZ SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/1/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "27/1/1999",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["sulpiride"],
    "N_ENREGISTREMENT": "518/16 D 066/17",
    "CODE_DCI": "16 D 066",
    "DCI": "SULPIRIDE",
    "NOM_COMMERCIALE": "SULAN",
    "FORME": "GLES.",
    "DOSAGE": "50MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "TAPHCO SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/8/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "28/8/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["sulpiride"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "16 D 066",
    "DCI": "Sulpiride",
    "NOM_COMMERCIALE": "SULAN 50",
    "FORME": "Gélule",
    "DOSAGE": "50 mg",
    "COND": "boîte de 30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["sulpiride"],
    "N_ENREGISTREMENT": "039/ 16 D 066 /14",
    "CODE_DCI": "16 D 066",
    "DCI": "SULPIRIDE",
    "NOM_COMMERCIALE": "SULPIDAL",
    "FORME": "GLES",
    "DOSAGE": "50MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOCIETE PHARMACEUTIQUE ALGERIENNE (SOPHAL)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/10/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "28/10/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["sulpiride"],
    "N_ENREGISTREMENT": "231/ 16 D 066 /09",
    "CODE_DCI": "16 D 066",
    "DCI": "SULPIRIDE",
    "NOM_COMMERCIALE": "SULPIRIDE LS",
    "FORME": "GLES.",
    "DOSAGE": "50MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SALEM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/3/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "28/3/2009",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["sulpiride"],
    "N_ENREGISTREMENT": "268/ 16 D 066 /05/10",
    "CODE_DCI": "16 D 066",
    "DCI": "SULPIRIDE",
    "NOM_COMMERCIALE": "SULPIRIDE MERINAL",
    "FORME": "GLES.",
    "DOSAGE": "50MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MERINAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "5/4/2005",
    "DATE_D_ENREGISTREMENT_FINAL": "24/11/2010",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["sulpiride"],
    "N_ENREGISTREMENT": "003/ 16 D 066 /96/13",
    "CODE_DCI": "16 D 066",
    "DCI": "SULPIRIDE",
    "NOM_COMMERCIALE": "SULPUREN",
    "FORME": "GLES.",
    "DOSAGE": "50MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SAIDAL (SAIDALGROUPE INDUSTRIEL EPE/SPA)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "31/12/1996",
    "DATE_D_ENREGISTREMENT_FINAL": "27/10/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["sulpiride"],
    "N_ENREGISTREMENT": "003/ 16 D 066 /96/20",
    "CODE_DCI": "16 D 066",
    "DCI": "SULPIRIDE",
    "NOM_COMMERCIALE": "SULPUREN",
    "FORME": "GLES.",
    "DOSAGE": "50MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SAIDAL (SAIDALGROUPE INDUSTRIEL EPE/SPA)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "31/12/96",
    "DATE_D_ENREGISTREMENT_FINAL": "27/01/20",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["sulpiride"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "16 D 066",
    "DCI": "SULPIRIDE",
    "NOM_COMMERCIALE": "SULRID",
    "FORME": "GLES.",
    "DOSAGE": "50MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["sulpiride"],
    "N_ENREGISTREMENT": "242/ 16 D 066 /11",
    "CODE_DCI": "16 D 066",
    "DCI": "SULPIRIDE",
    "NOM_COMMERCIALE": "SYNED",
    "FORME": "GLES.",
    "DOSAGE": "50MG",
    "COND": "B/20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GROUPE SANTE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/2/2011",
    "DATE_D_ENREGISTREMENT_FINAL": "28/2/2011",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["sulpiride"],
    "N_ENREGISTREMENT": "392/16 D 067/97/16",
    "CODE_DCI": "16 D 067",
    "DCI": "SULPIRIDE",
    "NOM_COMMERCIALE": "DOGMATIL SANS SUCRE",
    "FORME": "SOL. BUV.",
    "DOSAGE": "25MG/5ML OU 0.5%",
    "COND": "FL/200ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANOFI AVENTIS SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "14/7/1997",
    "DATE_D_ENREGISTREMENT_FINAL": "28/12/2016",
    "TYPE": "Ré",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["sulpiride"],
    "N_ENREGISTREMENT": "235/ 16 D 067 /09",
    "CODE_DCI": "16 D 067",
    "DCI": "SULPIRIDE",
    "NOM_COMMERCIALE": "G-SULPIRIDE",
    "FORME": "SOL. BUV.",
    "DOSAGE": "25MG/5ML (OU 0.5G/100ML)",
    "COND": "FL./200ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIO-GALENIC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/4/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "19/4/2009",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["sulpiride"],
    "N_ENREGISTREMENT": "319/ 16 D 067 /06",
    "CODE_DCI": "16 D 067",
    "DCI": "SULPIRIDE",
    "NOM_COMMERCIALE": "SULMATIL",
    "FORME": "SOL. BUV.",
    "DOSAGE": "25MG/5ML OU 0.5%",
    "COND": "FL/180 ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ARAB PHARM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/7/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "18/7/2006",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["sulpiride"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "16 D 067",
    "DCI": "SULPIRIDE",
    "NOM_COMMERCIALE": "SULMATIL",
    "FORME": "SOLUTION BUVABLE",
    "DOSAGE": "0.005",
    "COND": "FLACON DE 130 ml",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["sulpiride"],
    "N_ENREGISTREMENT": "400/16 D 067/17",
    "CODE_DCI": "16 D 067",
    "DCI": "SULPIRIDE",
    "NOM_COMMERCIALE": "SULPIMEX",
    "FORME": "SOL BUV SANS SUCRE",
    "DOSAGE": "25MG/5ML (0.5G/100ML)",
    "COND": "FL./200ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "KPMA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/3/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "7/3/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["sulpiride"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "16 D 067",
    "DCI": "SULPIRIDE",
    "NOM_COMMERCIALE": "SULPIMEX",
    "FORME": "SOL BUV",
    "DOSAGE": "25MG/5ML (OU 0.5G/100ML)",
    "COND": "FLACON DE 200 ML",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["sulpiride"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "16 D 067",
    "DCI": "SULPIRIDE",
    "NOM_COMMERCIALE": "SULPIDE",
    "FORME": "SOL BUV",
    "DOSAGE": "5 MG / ML",
    "COND": "FL/180ML",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["sulpiride"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "16 D 067",
    "DCI": "SULPIRIDE",
    "NOM_COMMERCIALE": "SULRID",
    "FORME": "SOL. BUV.",
    "DOSAGE": "0.5G/100ML",
    "COND": "FL./200ML",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["sulpiride"],
    "N_ENREGISTREMENT": "317/16 D 067/16",
    "CODE_DCI": "16 D 067",
    "DCI": "SULPIRIDE",
    "NOM_COMMERCIALE": "SUNADIL",
    "FORME": "SOLUTION BUVABLE",
    "DOSAGE": "0.5G/100ML",
    "COND": "FL /200ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INPHA-MEDIS SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/11/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "2/11/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["sulpiride"],
    "N_ENREGISTREMENT": "077/ 16 D 067 /03/14",
    "CODE_DCI": "16 D 067",
    "DCI": "SULPIRIDE",
    "NOM_COMMERCIALE": "SUPRIL",
    "FORME": "SOL.BUV.",
    "DOSAGE": "25MG/5ML (0.5G/100ML)",
    "COND": "FL./200ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE ALGERIEN DU MEDICAMENT SARL (LAM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/6/2003",
    "DATE_D_ENREGISTREMENT_FINAL": "13/11/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["sulpiride"],
    "N_ENREGISTREMENT": "242/ 16 D 067 /06",
    "CODE_DCI": "16 D 067",
    "DCI": "SULPIRIDE",
    "NOM_COMMERCIALE": "SYNED",
    "FORME": "SOL. BUV.",
    "DOSAGE": "25MG/5ML OU 0.5%",
    "COND": "FL./125ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GROUPE SANTE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/10/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "17/10/2006",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["sulpiride"],
    "N_ENREGISTREMENT": "285/ 16 D 067 /06/16",
    "CODE_DCI": "16 D 067",
    "DCI": "SULPIRIDE",
    "NOM_COMMERCIALE": "SYNEDIL Gé",
    "FORME": "SOL. BUV.",
    "DOSAGE": "25MG/5ML",
    "COND": "FL/200ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "UNION PHARMACEUTIQUE CONSTANTINOISE (UPC)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/6/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "19/4/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["sulpiride"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "16 D 067",
    "DCI": "Sulpiride",
    "NOM_COMMERCIALE": "Sunadil Sol Buv",
    "FORME": "sol buv",
    "DOSAGE": "0.5g/100ml",
    "COND": "flaconn 200ml",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["sulpiride"],
    "N_ENREGISTREMENT": "503/ 16 D 067 /16",
    "CODE_DCI": "16 D 067",
    "DCI": "SULPIRIDE",
    "NOM_COMMERCIALE": "sulpiryl",
    "FORME": "SOL. BUV.",
    "DOSAGE": "0.5G/100 ML OU 0.5%",
    "COND": "FL/180 ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "AFRO PHARM SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/4/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "12/4/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["fluphenazine"],
    "InteractionIndexLink": ["fluphenazine"],
    "N_ENREGISTREMENT": "330/ 16 D 083 /07",
    "CODE_DCI": "16 D 083",
    "DCI": "FLUPHENAZINE DECANOATE",
    "NOM_COMMERCIALE": "PROLINATE",
    "FORME": "SOL. INJ.",
    "DOSAGE": "25MG/ML",
    "COND": "B./05AMP. DE 1ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SUN PHARMACEUTICAL INDUSTRIES LTD",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/5/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "7/5/2007",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["haloperidol"],
    "InteractionIndexLink": ["haloperidol"],
    "N_ENREGISTREMENT": "095/16 D 084/98",
    "CODE_DCI": "16 D 084",
    "DCI": "HALOPERIDOL",
    "NOM_COMMERCIALE": "HALDOL",
    "FORME": "SOL INJ",
    "DOSAGE": "5MG/ML",
    "COND": "B/5 AMP de 1ml",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JANSSEN CILAG",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/4/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "20/4/1998",
    "TYPE": "RE",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["haloperidol"],
    "InteractionIndexLink": ["haloperidol"],
    "N_ENREGISTREMENT": "330/ 16 D 084 /08",
    "CODE_DCI": "16 D 084",
    "DCI": "HALOPERIDOL",
    "NOM_COMMERCIALE": "SENORM 5",
    "FORME": "SOL. INJ.",
    "DOSAGE": "5MG/ML",
    "COND": "B/5AMP. DE 1ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SUN PHARMACEUTICAL INDUSTRIES LTD",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "31/5/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "31/5/2008",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["haloperidol"],
    "InteractionIndexLink": ["haloperidol"],
    "N_ENREGISTREMENT": "400/16 D 085/16",
    "CODE_DCI": "16 D 085",
    "DCI": "HALOPERIDOL",
    "NOM_COMMERCIALE": "DERMA-T",
    "FORME": "SOL. BUV. GTTES.",
    "DOSAGE": "2MG/ML",
    "COND": "FL/20 MLET FL/50ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "KPMA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/12/16",
    "DATE_D_ENREGISTREMENT_FINAL": "28/12/16",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["haloperidol"],
    "InteractionIndexLink": ["haloperidol"],
    "N_ENREGISTREMENT": "319/ 16 D 085 /07",
    "CODE_DCI": "16 D 085",
    "DCI": "HALOPERIDOL",
    "NOM_COMMERCIALE": "HADOL",
    "FORME": "SOL. BUV. GTTES.",
    "DOSAGE": "2MG/ML",
    "COND": "FL./20ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ARAB PHARM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/5/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "12/5/2007",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["haloperidol"],
    "InteractionIndexLink": ["haloperidol"],
    "N_ENREGISTREMENT": "400/16 D 085/16",
    "CODE_DCI": "16 D 085",
    "DCI": "HALOPERIDOL",
    "NOM_COMMERCIALE": "HALDOMEX",
    "FORME": "SOL. BUV. GTTES.",
    "DOSAGE": "2MG/ML",
    "COND": "FL/20 ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "KPMA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/12/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "28/12/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["haloperidol"],
    "InteractionIndexLink": ["haloperidol"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "16 D 085",
    "DCI": "HALOPERIDOL",
    "NOM_COMMERCIALE": "HALDOMEX",
    "FORME": "SOL BUV GTTES",
    "DOSAGE": "2 MG / ML",
    "COND": "B/01 FL COMPTE GTTES DE 20ML",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["haloperidol"],
    "InteractionIndexLink": ["haloperidol"],
    "N_ENREGISTREMENT": "079/ 16 D 085 /00/08",
    "CODE_DCI": "16 D 085",
    "DCI": "HALOPERIDOL",
    "NOM_COMMERCIALE": "HALOL",
    "FORME": "SOL.BUV.GTTES.",
    "DOSAGE": "2MG/ML",
    "COND": "FL/15ML  -  FL/20ML  -   FL./50ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "FL./50ML RESERVE AUX HOP.",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE  ALGERIEN DE DEVELOPPEMENT  PHARMACEUTIQUE   (LAD)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/5/2000",
    "DATE_D_ENREGISTREMENT_FINAL": "27/4/2008",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["haloperidol"],
    "InteractionIndexLink": ["haloperidol"],
    "N_ENREGISTREMENT": "088/ 16 D 085 /03",
    "CODE_DCI": "16 D 085",
    "DCI": "HALOPERIDOL",
    "NOM_COMMERCIALE": "HALOPERIDOL",
    "FORME": "SOL.BUV.GTTES.",
    "DOSAGE": "2MG/ML OU 0.2%",
    "COND": "FL/20ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMAGHREB",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/6/2003",
    "DATE_D_ENREGISTREMENT_FINAL": "10/6/2003",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["haloperidol"],
    "InteractionIndexLink": ["haloperidol"],
    "N_ENREGISTREMENT": "235/ 16 D 085 /14",
    "CODE_DCI": "16 D 085",
    "DCI": "HALOPERIDOL",
    "NOM_COMMERCIALE": "HALOPERIDOL BGL",
    "FORME": "SOL BUV EN GTTES",
    "DOSAGE": "2MG/ML",
    "COND": "B/01 FL COMPTE GTTES/20ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOGALENIC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/7/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "24/5/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["haloperidol"],
    "InteractionIndexLink": ["haloperidol"],
    "N_ENREGISTREMENT": "065/ 16 D 085 /08/18",
    "CODE_DCI": "16 D 085",
    "DCI": "HALOPERIDOL",
    "NOM_COMMERCIALE": "HALOPERIDOL GENERICLAB",
    "FORME": "SOL. BUV.GTTES.",
    "DOSAGE": "2MG/ML (OU 0.2%)",
    "COND": "FL. COMPT.GTTES DE 15ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GENERICLAB SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "14/7/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "13/12/208",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["haloperidol"],
    "InteractionIndexLink": ["haloperidol"],
    "N_ENREGISTREMENT": "242/ 16 D 085 /06",
    "CODE_DCI": "16 D 085",
    "DCI": "HALOPERIDOL",
    "NOM_COMMERCIALE": "HOLIT FORT",
    "FORME": "SOL.BUV.GTTES.",
    "DOSAGE": "2MG/ML",
    "COND": "FL/15ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GROUPE SANTE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/10/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "17/10/2006",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["haloperidol"],
    "InteractionIndexLink": ["haloperidol"],
    "N_ENREGISTREMENT": "073/ 16 D 085 /99/09",
    "CODE_DCI": "16 D 085",
    "DCI": "HALOPERIDOL",
    "NOM_COMMERCIALE": "ISOPERIDOL",
    "FORME": "SOL.BUV.GTTES.",
    "DOSAGE": "2MG/ML",
    "COND": "FL/20 ML  -  FL/50ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "FL./50ML RESERVE AUX HÔPITAUX",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ISOPHARM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "14/2/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "6/12/2009",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["haloperidol"],
    "InteractionIndexLink": ["haloperidol"],
    "N_ENREGISTREMENT": "457/ 16 D 085 /11",
    "CODE_DCI": "16 D 085",
    "DCI": "HALOPERIDOL",
    "NOM_COMMERCIALE": "NEURALDOL",
    "FORME": "SOL. BUV. GTTES.",
    "DOSAGE": "2MG/ML",
    "COND": "B/1FL. COMPT. GTTES. DE 30ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOMEDIAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/4/2011",
    "DATE_D_ENREGISTREMENT_FINAL": "4/4/2011",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["haloperidol"],
    "InteractionIndexLink": ["haloperidol"],
    "N_ENREGISTREMENT": "263/ 16 D 085 /13",
    "CODE_DCI": "16 D 085",
    "DCI": "HALOPERIDOL",
    "NOM_COMMERCIALE": "VILBAR",
    "FORME": "SOL.BUV.GTTES.",
    "DOSAGE": "2MG/ML",
    "COND": "B/1FL. COMPT. GTTES. DE 30ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOPHARM ALGERIE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/9/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "15/9/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["risperidone"],
    "InteractionIndexLink": ["risperidone"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "16 D 089",
    "DCI": "Risperidone",
    "NOM_COMMERCIALE": "PSYDAL ODT",
    "FORME": "Comprimé  Orodispersible",
    "DOSAGE": "1mg",
    "COND": "Boite de 60",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["risperidone"],
    "InteractionIndexLink": ["risperidone"],
    "N_ENREGISTREMENT": "001/ 16 D 089 /08/18",
    "CODE_DCI": "16 D 089",
    "DCI": "Rispéridone",
    "NOM_COMMERCIALE": "RESPIROX",
    "FORME": "Comprimé pelliculé sécable",
    "DOSAGE": "1MG",
    "COND": "B/20 et B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMA ALGERIA/ SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/2/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "15/2/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["risperidone"],
    "InteractionIndexLink": ["risperidone"],
    "N_ENREGISTREMENT": "352/ 16 D 089 /10",
    "CODE_DCI": "16 D 089",
    "DCI": "RISPERIDONE",
    "NOM_COMMERCIALE": "RIPERAL",
    "FORME": "COMP. ENRO.",
    "DOSAGE": "1MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "8/2/2010",
    "DATE_D_ENREGISTREMENT_FINAL": "8/2/2010",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["risperidone"],
    "InteractionIndexLink": ["risperidone"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "16 D 089",
    "DCI": "RISPERIDONE",
    "NOM_COMMERCIALE": "RIPSYZEN",
    "FORME": "COMP. PELLI. SEC.",
    "DOSAGE": "1MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["risperidone"],
    "InteractionIndexLink": ["risperidone"],
    "N_ENREGISTREMENT": "263/ 16 D 089 /10/16",
    "CODE_DCI": "16 D 089",
    "DCI": "RISPERIDONE",
    "NOM_COMMERCIALE": "RISPAL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "1MG",
    "COND": "B/30 ET B/60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOPHARM /SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/5/2010",
    "DATE_D_ENREGISTREMENT_FINAL": "5/9/2016",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["risperidone"],
    "InteractionIndexLink": ["risperidone"],
    "N_ENREGISTREMENT": "149/ 16 D 089 /16",
    "CODE_DCI": "16 D 089",
    "DCI": "RISPERIDONE",
    "NOM_COMMERCIALE": "RISPEED",
    "FORME": "COMP PELL SEC",
    "DOSAGE": "1MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVAPHARM TRADING",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "11/4/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "11/4/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["risperidone"],
    "InteractionIndexLink": ["risperidone"],
    "N_ENREGISTREMENT": "095/16 D 089/20",
    "CODE_DCI": "16 D 089",
    "DCI": "RISPERIDONE",
    "NOM_COMMERCIALE": "RISPERDAL",
    "FORME": "COMP. PELL. SEC",
    "DOSAGE": "01MG",
    "COND": "B/60",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES JANSSEN CILAG",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/12/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "17/12/2020",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["risperidone"],
    "InteractionIndexLink": ["risperidone"],
    "N_ENREGISTREMENT": "095/16 D 089/20",
    "CODE_DCI": "16 D 089",
    "DCI": "RISPERIDONE",
    "NOM_COMMERCIALE": "RISPERDAL",
    "FORME": "COMP. PELL. SEC",
    "DOSAGE": "01MG",
    "COND": "B/60",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES JANSSEN CILAG",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/12/20",
    "DATE_D_ENREGISTREMENT_FINAL": "17/12/20",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["risperidone"],
    "InteractionIndexLink": ["risperidone"],
    "N_ENREGISTREMENT": "447/ 16 D 089 /15",
    "CODE_DCI": "16 D 089",
    "DCI": "RISPERIDONE",
    "NOM_COMMERCIALE": "RISPERIDONE BEKER",
    "FORME": "COMP. PELLI. SEC.",
    "DOSAGE": "1MG",
    "COND": "B/30 ET B/60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEKER SARL (SARL LABORATOIRE BEKER ALGERIE)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/5/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "13/5/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["risperidone"],
    "InteractionIndexLink": ["risperidone"],
    "N_ENREGISTREMENT": "235/ 16 D 089 /14",
    "CODE_DCI": "16 D 089",
    "DCI": "RISPERIDONE",
    "NOM_COMMERCIALE": "RISPERIDONE BGL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "1MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIO-GALENIC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "8/6/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "8/6/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["risperidone"],
    "InteractionIndexLink": ["risperidone"],
    "N_ENREGISTREMENT": "468/ 16 D 089 /14",
    "CODE_DCI": "16 D 089",
    "DCI": "RISPERIDONE",
    "NOM_COMMERCIALE": "RISPERNAD",
    "FORME": "COMP PELL SEC",
    "DOSAGE": "1MG",
    "COND": "B/60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NADPHARMADIC PRODUCTION SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "14/4/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "14/4/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["risperidone"],
    "InteractionIndexLink": ["risperidone"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "16 D 090",
    "DCI": "Risperidone",
    "NOM_COMMERCIALE": "PSYDAL ODT",
    "FORME": "Comprimé  Orodispersible",
    "DOSAGE": "2mg",
    "COND": "Boite de 60",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["risperidone"],
    "InteractionIndexLink": ["risperidone"],
    "N_ENREGISTREMENT": "001/ 16 D 090 /08/21",
    "CODE_DCI": "16 D 090",
    "DCI": "Rispéridone",
    "NOM_COMMERCIALE": "RESPIROX",
    "FORME": "Comprimé pelliculé sécable",
    "DOSAGE": "2MG",
    "COND": "B/20. B/30 et B/60",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMA ALGERIA/ SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/3/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "17/2/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["risperidone"],
    "InteractionIndexLink": ["risperidone"],
    "N_ENREGISTREMENT": "268/ 16 D 090 /19",
    "CODE_DCI": "16 D 090",
    "DCI": "RISPERIDONE",
    "NOM_COMMERCIALE": "RIPCYL",
    "FORME": "COMP. PELLI. SEC",
    "DOSAGE": "2MG",
    "COND": "B/30 ET B/60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MERINAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/1/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "15/1/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["risperidone"],
    "InteractionIndexLink": ["risperidone"],
    "N_ENREGISTREMENT": "352/ 16 D 090 /10",
    "CODE_DCI": "16 D 090",
    "DCI": "RISPERIDONE",
    "NOM_COMMERCIALE": "RIPERAL",
    "FORME": "COMP. ENRO.",
    "DOSAGE": "2MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/3/2010",
    "DATE_D_ENREGISTREMENT_FINAL": "28/3/2010",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["risperidone"],
    "InteractionIndexLink": ["risperidone"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "16 D 090",
    "DCI": "RISPERIDONE",
    "NOM_COMMERCIALE": "RIPSYZEN",
    "FORME": "COMP. ENRO. SEC.",
    "DOSAGE": "2MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["risperidone"],
    "InteractionIndexLink": ["risperidone"],
    "N_ENREGISTREMENT": "263/ 16 D 090 /10/16",
    "CODE_DCI": "16 D 090",
    "DCI": "RISPERIDONE",
    "NOM_COMMERCIALE": "RISPAL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "2MG",
    "COND": "B/60 ET B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOPHARM ALGERIE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/6/2010",
    "DATE_D_ENREGISTREMENT_FINAL": "5/9/2016",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["risperidone"],
    "InteractionIndexLink": ["risperidone"],
    "N_ENREGISTREMENT": "149/ 16 D 090 /15",
    "CODE_DCI": "16 D 090",
    "DCI": "RISPERIDONE",
    "NOM_COMMERCIALE": "RISPED",
    "FORME": "COMP. PELLI. SEC",
    "DOSAGE": "2MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVA PHARM TRADING SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/12/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "27/12/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["risperidone"],
    "InteractionIndexLink": ["risperidone"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "16 D 090",
    "DCI": "RISPERIDONE",
    "NOM_COMMERCIALE": "RISPERDAL",
    "FORME": "Comp Sec",
    "DOSAGE": "2mg",
    "COND": "b/60",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["risperidone"],
    "InteractionIndexLink": ["risperidone"],
    "N_ENREGISTREMENT": "095/16 D 090/20",
    "CODE_DCI": "16 D 090",
    "DCI": "RISPERIDONE",
    "NOM_COMMERCIALE": "RISPERIDAL",
    "FORME": "COMP. PELL. SEC.",
    "DOSAGE": "02MG",
    "COND": "B/ 60",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES JENSSEN CILAG",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/12/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "15/12/2020",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["risperidone"],
    "InteractionIndexLink": ["risperidone"],
    "N_ENREGISTREMENT": "447/ 16 D 090 /12",
    "CODE_DCI": "16 D 090",
    "DCI": "RISPERIDONE",
    "NOM_COMMERCIALE": "RISPERIDONE BEKER",
    "FORME": "COMP. PELLI. SEC",
    "DOSAGE": "2MG",
    "COND": "B/60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEKER SARL (SARL LABORATOIRE BEKER ALGERIE)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/4/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "27/4/2012",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["risperidone"],
    "InteractionIndexLink": ["risperidone"],
    "N_ENREGISTREMENT": "235/ 16 D 090 /15",
    "CODE_DCI": "16 D 090",
    "DCI": "RISPERIDONE",
    "NOM_COMMERCIALE": "RISPERIDONE BGL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "2MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOGALENIC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/5/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "4/5/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["risperidone"],
    "InteractionIndexLink": ["risperidone"],
    "N_ENREGISTREMENT": "468/ 16 D 090 /14",
    "CODE_DCI": "16 D 090",
    "DCI": "RISPERIDONE",
    "NOM_COMMERCIALE": "RISPERNAD",
    "FORME": "COMP PELL SEC",
    "DOSAGE": "2MG",
    "COND": "B/60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NADPHARMADIC PRODUCTION SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/5/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "28/5/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["risperidone"],
    "InteractionIndexLink": ["risperidone"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "16 D 091",
    "DCI": "Risperidone",
    "NOM_COMMERCIALE": "PSYDAL ODT",
    "FORME": "Comprimé  Orodispersible",
    "DOSAGE": "4mg",
    "COND": "Boite de 40",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["risperidone"],
    "InteractionIndexLink": ["risperidone"],
    "N_ENREGISTREMENT": "001/16 D 091/08/18",
    "CODE_DCI": "16 D 091",
    "DCI": "RISPERIDONE",
    "NOM_COMMERCIALE": "RESPIROX",
    "FORME": "Comprimé pelliculé sécable",
    "DOSAGE": "4MG",
    "COND": "B/20 et B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMA ALGERIA / SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "23/2/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "15/2/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["risperidone"],
    "InteractionIndexLink": ["risperidone"],
    "N_ENREGISTREMENT": "268/ 16 D 091 /19",
    "CODE_DCI": "16 D 091",
    "DCI": "Risperidone",
    "NOM_COMMERCIALE": "RIPCYL",
    "FORME": "COMP. PELLI. SEC.",
    "DOSAGE": "4MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MERINAL SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/1/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "9/1/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["risperidone"],
    "InteractionIndexLink": ["risperidone"],
    "N_ENREGISTREMENT": "352/ 16 D 091 /10",
    "CODE_DCI": "16 D 091",
    "DCI": "RISPERIDONE",
    "NOM_COMMERCIALE": "RIPERAL",
    "FORME": "COMP. ENRO.",
    "DOSAGE": "4MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "8/2/2010",
    "DATE_D_ENREGISTREMENT_FINAL": "8/2/2010",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["risperidone"],
    "InteractionIndexLink": ["risperidone"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "16 D 091",
    "DCI": "RISPERIDONE",
    "NOM_COMMERCIALE": "RIPSYZEN",
    "FORME": "COMP. ENRO. SEC.",
    "DOSAGE": "4MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["risperidone"],
    "InteractionIndexLink": ["risperidone"],
    "N_ENREGISTREMENT": "263/ 16 D 091 /10/16",
    "CODE_DCI": "16 D 091",
    "DCI": "RISPERIDONE",
    "NOM_COMMERCIALE": "RISPAL",
    "FORME": "COMP. PELLI. SEC.",
    "DOSAGE": "4MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOPHARM ALGERIE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/5/2010",
    "DATE_D_ENREGISTREMENT_FINAL": "27/9/2016",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["risperidone"],
    "InteractionIndexLink": ["risperidone"],
    "N_ENREGISTREMENT": "149/ 16 D 091 /16",
    "CODE_DCI": "16 D 091",
    "DCI": "RISPERIDONE",
    "NOM_COMMERCIALE": "RISPEED",
    "FORME": "COMP PELL SEC",
    "DOSAGE": "4MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVA PHARM TRADING SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/1/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "17/1/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["risperidone"],
    "InteractionIndexLink": ["risperidone"],
    "N_ENREGISTREMENT": "095/16 D 091/20",
    "CODE_DCI": "16 D 091",
    "DCI": "RISPERIDONE",
    "NOM_COMMERCIALE": "RISPERDAL",
    "FORME": "COMP. PELL. SEC",
    "DOSAGE": "04MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES JANSSEN CILAG",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/12/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "7/12/2020",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["risperidone"],
    "InteractionIndexLink": ["risperidone"],
    "N_ENREGISTREMENT": "095/16 D 091/20",
    "CODE_DCI": "16 D 091",
    "DCI": "RISPERIDONE",
    "NOM_COMMERCIALE": "RISPERDAL",
    "FORME": "COMP. PELL. SEC",
    "DOSAGE": "04MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES JANSSEN CILAG",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "07/12/20",
    "DATE_D_ENREGISTREMENT_FINAL": "07/12/20",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["risperidone"],
    "InteractionIndexLink": ["risperidone"],
    "N_ENREGISTREMENT": "447/ 16 D 091 /12",
    "CODE_DCI": "16 D 091",
    "DCI": "RISPERIDONE",
    "NOM_COMMERCIALE": "RISPERIDONE BEKER",
    "FORME": "COMP. PELLI. SEC.",
    "DOSAGE": "4MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEKER SARL (SARL LABORATOIRE BEKER ALGERIE)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/4/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "24/4/2012",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["risperidone"],
    "InteractionIndexLink": ["risperidone"],
    "N_ENREGISTREMENT": "235/ 16 D 091 /14",
    "CODE_DCI": "16 D 091",
    "DCI": "RISPERIDONE",
    "NOM_COMMERCIALE": "RISPERIDONE BGL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "4MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIO-GALENIC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "3/8/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "3/8/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["risperidone"],
    "InteractionIndexLink": ["risperidone"],
    "N_ENREGISTREMENT": "468/ 16 D 091 /14",
    "CODE_DCI": "16 D 091",
    "DCI": "RISPERIDONE",
    "NOM_COMMERCIALE": "RISPERNAD",
    "FORME": "COMP PELL SEC",
    "DOSAGE": "4MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NADPHARMADIC PRODUCTION",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "14/4/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "14/4/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["risperidone"],
    "InteractionIndexLink": ["risperidone"],
    "N_ENREGISTREMENT": "317/16 D 092/16",
    "CODE_DCI": "16 D 092",
    "DCI": "RISPERIDONE",
    "NOM_COMMERCIALE": "RESDONE",
    "FORME": "SOL.BUV.",
    "DOSAGE": "1MG/ML",
    "COND": "F/60ML +PIPETTE GRADUEE",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INPHA MEDIS SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/11/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "15/11/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["risperidone"],
    "InteractionIndexLink": ["risperidone"],
    "N_ENREGISTREMENT": "352/ 16 D 092 /13",
    "CODE_DCI": "16 D 092",
    "DCI": "RISPERIDONE",
    "NOM_COMMERCIALE": "RIPERAL",
    "FORME": "SOL. BUV. GTTES.",
    "DOSAGE": "1MG/ML",
    "COND": "B/1FL. DE 30ML ET B/1FL. DE 120ML (AVEC BOUCHON DE SECURITE ENFANT ET UNE SERING. ORALE GRADUEE EN ML)",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/9/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "15/9/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["risperidone"],
    "InteractionIndexLink": ["risperidone"],
    "N_ENREGISTREMENT": "263/ 16 D 092/16",
    "CODE_DCI": "16 D 092",
    "DCI": "RISPERIDONE",
    "NOM_COMMERCIALE": "RISPAL",
    "FORME": "SOL. BUVABLE EN GOUTE",
    "DOSAGE": "1MG/ML",
    "COND": "B/1 FLC DE 30ML+ 01 SERINGUE DOSEUSE GRADUEE DE 3ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOPHARM /SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/6/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "13/6/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["risperidone"],
    "InteractionIndexLink": ["risperidone"],
    "N_ENREGISTREMENT": "235/ 16 D 092 /14",
    "CODE_DCI": "16 D 092",
    "DCI": "RISPERIDONE",
    "NOM_COMMERCIALE": "RISPERIDONE BGL",
    "FORME": "SOL BUV",
    "DOSAGE": "1MG/ML",
    "COND": "B/01FL DE 60ML + SERINGUE GRADUEE EN MG/ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIO-GALENIC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/9/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "1/9/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["risperidone"],
    "InteractionIndexLink": ["risperidone"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "16 D 092",
    "DCI": "RISPERIDONE",
    "NOM_COMMERCIALE": "Resdone Sol Buv",
    "FORME": "sol buv",
    "DOSAGE": "1mg/ml",
    "COND": "Flacon 60ml",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["risperidone"],
    "InteractionIndexLink": ["risperidone"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "16 D 092",
    "DCI": "Risperidone",
    "NOM_COMMERCIALE": "Riperal",
    "FORME": "Gouttes buvables",
    "DOSAGE": "1mg/ml",
    "COND": "B/120ml",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["amisulpride"],
    "InteractionIndexLink": ["amisulpride"],
    "N_ENREGISTREMENT": "097/16 D 094/20",
    "CODE_DCI": "16 D 094",
    "DCI": "AMISULPRIDE",
    "NOM_COMMERCIALE": "AMIPRIDE",
    "FORME": "COMP SEC",
    "DOSAGE": "200MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANAMED SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "MANQUE DATE",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["amisulpride"],
    "InteractionIndexLink": ["amisulpride"],
    "N_ENREGISTREMENT": "447/ 16 D 094 /13/18",
    "CODE_DCI": "16 D 094",
    "DCI": "AMISULPRIDE",
    "NOM_COMMERCIALE": "AMISULPRIDE BEKER",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "200MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEKER SARL (SARL LABORATOIRE BEKER ALGERIE)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/9/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "23/1/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["amisulpride"],
    "InteractionIndexLink": ["amisulpride"],
    "N_ENREGISTREMENT": "309/16 D 094/17",
    "CODE_DCI": "16 D 094",
    "DCI": "AMISULPRIDE",
    "NOM_COMMERCIALE": "AMISULPRIDE LDM",
    "FORME": "COMPRIME",
    "DOSAGE": "200MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES DE DIAGNOSTIC MAGHREBINS (LDM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "23/3/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "23/3/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["amisulpride"],
    "InteractionIndexLink": ["amisulpride"],
    "N_ENREGISTREMENT": "035/16 D 094/17",
    "CODE_DCI": "16 D 094",
    "DCI": "AMISULPRIDE",
    "NOM_COMMERCIALE": "MISULAR",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "200 MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMALLIANCE EURL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "3/8/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "3/8/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["amisulpride"],
    "InteractionIndexLink": ["amisulpride"],
    "N_ENREGISTREMENT": "392/ 16 D 094 /06/15",
    "CODE_DCI": "16 D 094",
    "DCI": "AMISULPRIDE",
    "NOM_COMMERCIALE": "SOLIAN",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "200MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANOFI-AVENTIS ALGERIE SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "23/7/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "9/7/2015",
    "TYPE": "Ré",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["amisulpride"],
    "InteractionIndexLink": ["amisulpride"],
    "N_ENREGISTREMENT": "352/ 16 D 094 /11",
    "CODE_DCI": "16 D 094",
    "DCI": "AMISULPRIDE",
    "NOM_COMMERCIALE": "SUPRIMIDE",
    "FORME": "COMPRIME",
    "DOSAGE": "200MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "3/11/2011",
    "DATE_D_ENREGISTREMENT_FINAL": "26/6/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["olanzapine"],
    "InteractionIndexLink": ["olanzapine"],
    "N_ENREGISTREMENT": "492/16 D 099/19",
    "CODE_DCI": "16 D 099",
    "DCI": "OLANZAPINE",
    "NOM_COMMERCIALE": "DEPOLAN 5",
    "FORME": "COMP PELL",
    "DOSAGE": "5MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOPRODIM SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "3/12/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "3/12/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["olanzapine"],
    "InteractionIndexLink": ["olanzapine"],
    "N_ENREGISTREMENT": "352/ 16 D 099 /12/19",
    "CODE_DCI": "16 D 099",
    "DCI": "OLANZAPINE",
    "NOM_COMMERCIALE": "LANZAPREX",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/10/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "28/1/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["olanzapine"],
    "InteractionIndexLink": ["olanzapine"],
    "N_ENREGISTREMENT": "447/ 16 D 099 /09",
    "CODE_DCI": "16 D 099",
    "DCI": "OLANZAPINE",
    "NOM_COMMERCIALE": "OLANZA",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "5MG",
    "COND": "B/07 - B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEKER SARL (SARL LABORATOIRE BEKER ALGERIE)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/12/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "6/12/2009",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["olanzapine"],
    "InteractionIndexLink": ["olanzapine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "16 D 099",
    "DCI": "Olanzapine",
    "NOM_COMMERCIALE": "REXAPIN",
    "FORME": "Comprimé pelliculé",
    "DOSAGE": "5 mg",
    "COND": "Boite de 28 comprimé",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["olanzapine"],
    "InteractionIndexLink": ["olanzapine"],
    "N_ENREGISTREMENT": "492/16 D 100/19",
    "CODE_DCI": "16 D 100",
    "DCI": "OLANZAPINE",
    "NOM_COMMERCIALE": "DEPOLAN 10",
    "FORME": "COMP PELL",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOPRODIM SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "3/12/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "3/12/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["olanzapine"],
    "InteractionIndexLink": ["olanzapine"],
    "N_ENREGISTREMENT": "352/ 16 D 100 /12",
    "CODE_DCI": "16 D 100",
    "DCI": "OLANZAPINE",
    "NOM_COMMERCIALE": "LANZAPREX",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/10/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "15/10/2012",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["olanzapine"],
    "InteractionIndexLink": ["olanzapine"],
    "N_ENREGISTREMENT": "447/ 16 D 100 /10",
    "CODE_DCI": "16 D 100",
    "DCI": "OLANZAPINE",
    "NOM_COMMERCIALE": "OLANZA",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "10MG",
    "COND": "B/07 - B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEKER SARL (SARL LABORATOIRE BEKER ALGERIE)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/8/2010",
    "DATE_D_ENREGISTREMENT_FINAL": "17/8/2010",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["olanzapine"],
    "InteractionIndexLink": ["olanzapine"],
    "N_ENREGISTREMENT": "470/ 16 D 100 /13/18",
    "CODE_DCI": "16 D 100",
    "DCI": "OLANZAPINE",
    "NOM_COMMERCIALE": "OLANZAPINE MM",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "10MG",
    "COND": "B/07 ET B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MM (SARL LABORATOIRES MM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "31/7/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "25/7/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["olanzapine"],
    "InteractionIndexLink": ["olanzapine"],
    "N_ENREGISTREMENT": "468/ 16 D 100 /14",
    "CODE_DCI": "16 D 100",
    "DCI": "OLANZAPINE",
    "NOM_COMMERCIALE": "OLANZAPINE NAD",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "10MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NADPHARMADIC PRODUCTION SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/2/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "17/1/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["olanzapine"],
    "InteractionIndexLink": ["olanzapine"],
    "N_ENREGISTREMENT": "268/ 16 D 100 /09",
    "CODE_DCI": "16 D 100",
    "DCI": "OLANZAPINE",
    "NOM_COMMERCIALE": "OLANZEX",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MERINAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/7/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "1/7/2009",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["olanzapine"],
    "InteractionIndexLink": ["olanzapine"],
    "N_ENREGISTREMENT": "050/ 16 D 100 /11/17",
    "CODE_DCI": "16 D 100",
    "DCI": "OLANZAPINE",
    "NOM_COMMERCIALE": "OLZANID",
    "FORME": "COMP. ENRO.",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANDOZ SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/11/2011",
    "DATE_D_ENREGISTREMENT_FINAL": "10/4/2017",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["olanzapine"],
    "InteractionIndexLink": ["olanzapine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "16 D 100",
    "DCI": "Olanzapine",
    "NOM_COMMERCIALE": "REXAPIN",
    "FORME": "Comprimé pelliculé",
    "DOSAGE": "10 mg",
    "COND": "Boite de 28 comprimé",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["olanzapine"],
    "InteractionIndexLink": ["olanzapine"],
    "N_ENREGISTREMENT": "317/ 16 D 100 /10",
    "CODE_DCI": "16 D 100",
    "DCI": "OLANZAPINE",
    "NOM_COMMERCIALE": "VAINCOR 10MG",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "10MG",
    "COND": "B/7 - B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INPHA-MEDIS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/6/2010",
    "DATE_D_ENREGISTREMENT_FINAL": "2/6/2010",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["olanzapine"],
    "InteractionIndexLink": ["olanzapine"],
    "N_ENREGISTREMENT": "352/ 16 D 101 /10",
    "CODE_DCI": "16 D 101",
    "DCI": "OLANZAPINE",
    "NOM_COMMERCIALE": "LANZAPREX",
    "FORME": "COMP. ORODISPERS.",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/8/2010",
    "DATE_D_ENREGISTREMENT_FINAL": "19/8/2010",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["olanzapine"],
    "InteractionIndexLink": ["olanzapine"],
    "N_ENREGISTREMENT": "352/ 16 D 101 /10/19",
    "CODE_DCI": "16 D 101",
    "DCI": "OLANZAPINE",
    "NOM_COMMERCIALE": "LANZAPREX",
    "FORME": "COMP. ORODISPERS.",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SPA EL KENDI  Industrie du Médicament",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/3/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "10/2/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["olanzapine"],
    "InteractionIndexLink": ["olanzapine"],
    "N_ENREGISTREMENT": "149/ 16 D 101 /15",
    "CODE_DCI": "16 D 101",
    "DCI": "OLANZAPINE",
    "NOM_COMMERCIALE": "NOVAPREXA",
    "FORME": "COMP . ORODISPERS.",
    "DOSAGE": "10mg",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVAPHARM TRADING SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/12/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "2/12/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["olanzapine"],
    "InteractionIndexLink": ["olanzapine"],
    "N_ENREGISTREMENT": "447/ 16 D 101 /13",
    "CODE_DCI": "16 D 101",
    "DCI": "OLANZAPINE",
    "NOM_COMMERCIALE": "OLANZA ORO",
    "FORME": "COMP. ORODISPERS.",
    "DOSAGE": "10MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEKER SARL (SARL LABORATOIRE BEKER ALGERIE)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/3/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "26/3/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["olanzapine"],
    "InteractionIndexLink": ["olanzapine"],
    "N_ENREGISTREMENT": "263/16 D 101/16",
    "CODE_DCI": "16 D 101",
    "DCI": "OLANZAPINE",
    "NOM_COMMERCIALE": "OLANZOMAX",
    "FORME": "COMP ORODISPERSIBLE",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOPHARM SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/11/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "7/11/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["olanzapine"],
    "InteractionIndexLink": ["olanzapine"],
    "N_ENREGISTREMENT": "035/ 16 D 101 /16",
    "CODE_DCI": "16 D 101",
    "DCI": "OLANZAPINE",
    "NOM_COMMERCIALE": "OLPREXA",
    "FORME": "COMP. ORODISPERS.",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMALLIANCE EURL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "11/4/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "11/4/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["olanzapine"],
    "InteractionIndexLink": ["olanzapine"],
    "N_ENREGISTREMENT": "286/ 16 D 101 /14",
    "CODE_DCI": "16 D 101",
    "DCI": "OLANZAPINE",
    "NOM_COMMERCIALE": "PSYCHOLANZ ODT",
    "FORME": "COMP. ORODISPERS.",
    "DOSAGE": "10MG",
    "COND": "B/30 ET B/07",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CHIMIE PHARMACIE COMMERCE MULTIPLE (CPCM) SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/11/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "30/11/2014",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["olanzapine"],
    "InteractionIndexLink": ["olanzapine"],
    "N_ENREGISTREMENT": "001/16 D 101/11/16",
    "CODE_DCI": "16 D 101",
    "DCI": "OLANZAPINE",
    "NOM_COMMERCIALE": "SCHIZOPIN",
    "FORME": "COMP. ORODISPERS.",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMA ALGERIA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/7/2011",
    "DATE_D_ENREGISTREMENT_FINAL": "9/10/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["aripiprazole"],
    "InteractionIndexLink": ["aripiprazole"],
    "N_ENREGISTREMENT": "426/16 D 103/19",
    "CODE_DCI": "16 D 103",
    "DCI": "ARIPIPRAZOLE",
    "NOM_COMMERCIALE": "ABDIFLY",
    "FORME": "COMPRIME",
    "DOSAGE": "10MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ABDI IBRAHIM REMEDE PHARMA  SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/2/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "4/2/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["aripiprazole"],
    "InteractionIndexLink": ["aripiprazole"],
    "N_ENREGISTREMENT": "414/ 16 D 103 /08/16",
    "CODE_DCI": "16 D 103",
    "DCI": "ARIPIPRAZOLE",
    "NOM_COMMERCIALE": "ABILIFY",
    "FORME": "COMPRIME",
    "DOSAGE": "10MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ABDI IBRAHIM OTSUKA ILAç SAN.VE TIC. A.Ş.",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "TURQUIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/5/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "19/4/2016",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["aripiprazole"],
    "InteractionIndexLink": ["aripiprazole"],
    "N_ENREGISTREMENT": "352/ 16 D 103 /15",
    "CODE_DCI": "16 D 103",
    "DCI": "ARIPIPRAZOLE",
    "NOM_COMMERCIALE": "ABILIZOLE",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/1/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "25/1/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["aripiprazole"],
    "InteractionIndexLink": ["aripiprazole"],
    "N_ENREGISTREMENT": "001/ 16 D 103 /14",
    "CODE_DCI": "16 D 103",
    "DCI": "ARIPIPRAZOLE",
    "NOM_COMMERCIALE": "ARINIA",
    "FORME": "COMPRIME",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMA ALGERIA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/1/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "6/10/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["aripiprazole"],
    "InteractionIndexLink": ["aripiprazole"],
    "N_ENREGISTREMENT": "447/16 D 103/17",
    "CODE_DCI": "16 D 103",
    "DCI": "ARIPIPRAZOLE",
    "NOM_COMMERCIALE": "ARIPIPRAZOLE BEKER",
    "FORME": "COMPRIME",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEKER SARL (SARL LABORATOIRE BEKER ALGERIE)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/2/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "12/2/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["aripiprazole"],
    "InteractionIndexLink": ["aripiprazole"],
    "N_ENREGISTREMENT": "309/ 16 D 103 /15",
    "CODE_DCI": "16 D 103",
    "DCI": "ARIPIPRAZOLE",
    "NOM_COMMERCIALE": "ARIPIPRAZOLE LDM",
    "FORME": "COMPRIME",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES DE DIAGNOSTIC MAGHREBINS (LDM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/12/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "13/12/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["aripiprazole"],
    "InteractionIndexLink": ["aripiprazole"],
    "N_ENREGISTREMENT": "263/ 16 D 103 /14",
    "CODE_DCI": "16 D 103",
    "DCI": "ARIPIPRAZOLE",
    "NOM_COMMERCIALE": "ZOLIFY",
    "FORME": "COMPRIME",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOPHARM SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/6/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "15/6/2014",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["aripiprazole"],
    "InteractionIndexLink": ["aripiprazole"],
    "N_ENREGISTREMENT": "426/16 D 104/19",
    "CODE_DCI": "16 D 104",
    "DCI": "ARIPIPRAZOLE",
    "NOM_COMMERCIALE": "ABDIFLY",
    "FORME": "COMPRIME",
    "DOSAGE": "15MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ABDI IBRAHIM REMEDE PHARMA SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/2/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "4/2/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["aripiprazole"],
    "InteractionIndexLink": ["aripiprazole"],
    "N_ENREGISTREMENT": "511/ 16 D 104 /08/16",
    "CODE_DCI": "16 D 104",
    "DCI": "ARIPIPRAZOLE",
    "NOM_COMMERCIALE": "ABILIFY",
    "FORME": "COMPRIME",
    "DOSAGE": "15MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ABDI IBRAHIM OTSUKA ILAç SAN.VE TIC. A.Ş.",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "TURQUIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/5/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "27/4/2016",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["aripiprazole"],
    "InteractionIndexLink": ["aripiprazole"],
    "N_ENREGISTREMENT": "352/ 16 D 104 /15",
    "CODE_DCI": "16 D 104",
    "DCI": "ARIPIPRAZOLE",
    "NOM_COMMERCIALE": "ABILIZOLE",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "15MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/3/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "18/3/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["aripiprazole"],
    "InteractionIndexLink": ["aripiprazole"],
    "N_ENREGISTREMENT": "001/ 16 D 104 /14",
    "CODE_DCI": "16 D 104",
    "DCI": "ARIPIPRAZOLE",
    "NOM_COMMERCIALE": "ARINIA",
    "FORME": "COMPRIME",
    "DOSAGE": "15MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMA ALGERIA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "16/2/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "6/10/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["aripiprazole"],
    "InteractionIndexLink": ["aripiprazole"],
    "N_ENREGISTREMENT": "447/16 D 104/17",
    "CODE_DCI": "16 D 104",
    "DCI": "ARIPIPRAZOLE",
    "NOM_COMMERCIALE": "ARIPIPRAZOLE BEKER",
    "FORME": "COMPRIME",
    "DOSAGE": "15MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEKER SARL (SARL LABORATOIRE BEKER ALGERIE)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/1/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "29/1/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["aripiprazole"],
    "InteractionIndexLink": ["aripiprazole"],
    "N_ENREGISTREMENT": "309/ 16 D 104 /15",
    "CODE_DCI": "16 D 104",
    "DCI": "ARIPIPRAZOLE",
    "NOM_COMMERCIALE": "ARIPIPRAZOLE LDM",
    "FORME": "COMPRIME",
    "DOSAGE": "15MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES DE DIAGNOSTIC MAGHREBINS (LDM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/12/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "13/12/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["aripiprazole"],
    "InteractionIndexLink": ["aripiprazole"],
    "N_ENREGISTREMENT": "263/ 16 D 104 /16",
    "CODE_DCI": "16 D 104",
    "DCI": "ARIPIPRAZOLE",
    "NOM_COMMERCIALE": "ZOLIFY",
    "FORME": "COMPRIME",
    "DOSAGE": "15MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOPHARM SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/1/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "10/1/2016",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["atomoxetine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "352/ 16 D 110 /21",
    "CODE_DCI": "16 D 110",
    "DCI": "Chlorhydrate d'Atomoxétine exprimé en Atomoxétine",
    "NOM_COMMERCIALE": "STRATAN",
    "FORME": "Gélule",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT / SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/3/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "30/3/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["atomoxetine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "034/ 16 D 110 /08/17",
    "CODE_DCI": "16 D 110",
    "DCI": "ATOMOXETINE CHLORHYDRATE EXPRIME EN ATOMOXETINE",
    "NOM_COMMERCIALE": "STRATTERA",
    "FORME": "GLES. GASTRO-RESIST.",
    "DOSAGE": "10MG (ATOMOXETINE HYDROCHLORIDE 11.43MG)",
    "COND": "B/28",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LILLY S.A",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ESPAGNE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/5/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "8/10/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["atomoxetine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "20/16 D111/352",
    "CODE_DCI": "16 D 111",
    "DCI": "ATOMOXETINE HCL",
    "NOM_COMMERCIALE": "STRATAN",
    "FORME": "GELULE",
    "DOSAGE": "18MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SPA EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/02/20",
    "DATE_D_ENREGISTREMENT_FINAL": "25/02/20",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["atomoxetine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "16 D 111",
    "DCI": "ATOMOXETINE CHLORHYDRATE EXPRIME EN ATOMOXETINE",
    "NOM_COMMERCIALE": "STRATTERA",
    "FORME": "GLES. GASTRO-RESIST.",
    "DOSAGE": "18MG (ATOMOXETINE HYDROCHLORIDE 20.57MG)",
    "COND": "B/28",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["atomoxetine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "20/16 D112/352",
    "CODE_DCI": "16 D 112",
    "DCI": "ATOMOXETINE HCL",
    "NOM_COMMERCIALE": "STRATAN",
    "FORME": "GELULE",
    "DOSAGE": "25MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SPA EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/02/20",
    "DATE_D_ENREGISTREMENT_FINAL": "25/02/20",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["atomoxetine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "034/ 16 D 112 /08/17",
    "CODE_DCI": "16 D 112",
    "DCI": "ATOMOXETINE CHLORHYDRATE EXPRIME EN ATOMOXETINE",
    "NOM_COMMERCIALE": "STRATTERA",
    "FORME": "GLES. GASTRO-RESIST.",
    "DOSAGE": "25MG (ATOMOXETINE HYDROCHLORIDE 28.57MG)",
    "COND": "B/28",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LILLY S.A",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ESPAGNE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/5/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "3/8/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["atomoxetine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "20/16 D113/352",
    "CODE_DCI": "16 D 113",
    "DCI": "ATOMOXETINE HCL",
    "NOM_COMMERCIALE": "STRATAN",
    "FORME": "GELULE",
    "DOSAGE": "40 MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SPA EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/02/20",
    "DATE_D_ENREGISTREMENT_FINAL": "25/02/20",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["atomoxetine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "16 D 113",
    "DCI": "ATOMOXETINE CHLORHYDRATE EXPRIME EN ATOMOXETINE",
    "NOM_COMMERCIALE": "STRATTERA",
    "FORME": "GLES. GASTRO-RESIST.",
    "DOSAGE": "40MG (ATOMOXETINE HYDROCHLORIDE 45.71MG)",
    "COND": "B/28",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["atomoxetine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "034/ 16 D 114 /08/17",
    "CODE_DCI": "16 D 114",
    "DCI": "ATOMOXETINE CHLORHYDRATE EXPRIME EN ATOMOXETINE",
    "NOM_COMMERCIALE": "STRATTERA",
    "FORME": "GLES. GASTRO-RESIST.",
    "DOSAGE": "60MG (ATOMOXETINE HYDROCHLORIDE 68.56MG)",
    "COND": "B/28",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LILLY S.A",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ESPAGNE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/5/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "4/9/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["risperidone"],
    "InteractionIndexLink": ["risperidone"],
    "N_ENREGISTREMENT": "321/ 16 D 122 /08",
    "CODE_DCI": "16 D 122",
    "DCI": "RISPERIDONE",
    "NOM_COMMERCIALE": "RISPERONE",
    "FORME": "COMPRIME",
    "DOSAGE": "3MG",
    "COND": "B/60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOVITAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/6/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "4/6/2008",
    "TYPE": "Gé",
    "STATUT": "C",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["venlafaxine"],
    "InteractionIndexLink": ["venlafaxine"],
    "N_ENREGISTREMENT": "174/ 16 D 123 /08",
    "CODE_DCI": "16 D 123",
    "DCI": "VENLAFAXINE  (SOUS FORME DE VENLAFAXINE  CHLORHYDRATE)",
    "NOM_COMMERCIALE": "VENEXOR",
    "FORME": "COMPRIME",
    "DOSAGE": "37.5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "UNITED PHARMACEUTICAL MANUFACTURING Co LTD (UPM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "23/12/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "23/12/2008",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["venlafaxine"],
    "InteractionIndexLink": ["venlafaxine"],
    "N_ENREGISTREMENT": "174/ 16 D 124 /08",
    "CODE_DCI": "16 D 124",
    "DCI": "VENLAFAXINE  (SOUS FORME DE VENLAFAXINE  CHLORHYDRATE)",
    "NOM_COMMERCIALE": "VENEXOR",
    "FORME": "COMPRIME",
    "DOSAGE": "75MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "UNITED PHARMACEUTICAL MANUFACTURING Co LTD (UPM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "23/12/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "23/12/2008",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["haloperidol"],
    "InteractionIndexLink": ["haloperidol"],
    "N_ENREGISTREMENT": "095/ 16 D 127 /08",
    "CODE_DCI": "16 D 127",
    "DCI": "HALOPERIDOL (SOUS FORME DE DECANOATE )",
    "NOM_COMMERCIALE": "HALDOL DECANOAS",
    "FORME": "SOL.INJ. IM",
    "DOSAGE": "50MG/ML",
    "COND": "B/5AMP DE 1ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JANSSEN CILAG S.A.",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/1/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "6/1/2009",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["loxapine"],
    "N_ENREGISTREMENT": "285/ 16 D 132 /09",
    "CODE_DCI": "16 D 132",
    "DCI": "LOXAPINE SUCCINATE EXPRIME EN LOXAPINE",
    "NOM_COMMERCIALE": "LOXAPAC",
    "FORME": "COMPRIME",
    "DOSAGE": "100MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "UNION PHARMACEUTIQUE CONSTANTINOISE (UPC)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/3/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "28/3/2009",
    "TYPE": "Gé",
    "STATUT": "C",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["loxapine"],
    "N_ENREGISTREMENT": "446/ 16 D 134 /09/18",
    "CODE_DCI": "16 D 134",
    "DCI": "LOXAPINE",
    "NOM_COMMERCIALE": "LOXAPAC",
    "FORME": "SOL. BUV.",
    "DOSAGE": "25MG/ML",
    "COND": "B/1FL. DE 30ML AVEC SEINGUE",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EISAI SAS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/9/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "2/4/2018",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["risperidone"],
    "InteractionIndexLink": ["risperidone"],
    "N_ENREGISTREMENT": "286/ 16 D 142 /16",
    "CODE_DCI": "16 D 142",
    "DCI": "RISPERIDONE",
    "NOM_COMMERCIALE": "PSYDAL ODT",
    "FORME": "COMP. ORODISPERS",
    "DOSAGE": "1MG",
    "COND": "B/60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CPCM SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/2/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "22/2/2016",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["risperidone"],
    "InteractionIndexLink": ["risperidone"],
    "N_ENREGISTREMENT": "286/ 16 D 143 /16",
    "CODE_DCI": "16 D 143",
    "DCI": "RISPERIDONE",
    "NOM_COMMERCIALE": "PSYDAL ODT",
    "FORME": "COMP. ORODISPERS.",
    "DOSAGE": "2MG",
    "COND": "B/60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CPCM SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/1/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "10/1/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["risperidone"],
    "InteractionIndexLink": ["risperidone"],
    "N_ENREGISTREMENT": "447/ 16 D 143 /15",
    "CODE_DCI": "16 D 143",
    "DCI": "RISPERIDONE",
    "NOM_COMMERCIALE": "RISPERIDONE BEKER ORO",
    "FORME": "COMP. ORODISPERS.",
    "DOSAGE": "2MG",
    "COND": "B/60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEKER SARL (SARL LABORATOIRE BEKER ALGERIE)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/9/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "2/12/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["risperidone"],
    "InteractionIndexLink": ["risperidone"],
    "N_ENREGISTREMENT": "286/ 16 D 145 /16",
    "CODE_DCI": "16 D 145",
    "DCI": "RISPERIDONE",
    "NOM_COMMERCIALE": "PSYDAL ODT",
    "FORME": "COMP. ORODISPERS.",
    "DOSAGE": "4MG",
    "COND": "B/40",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CPCM SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/1/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "17/1/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["risperidone"],
    "InteractionIndexLink": ["risperidone"],
    "N_ENREGISTREMENT": "447/ 16 D 145 /14",
    "CODE_DCI": "16 D 145",
    "DCI": "RISPERIDONE",
    "NOM_COMMERCIALE": "RISPERIDONE BEKER ORO",
    "FORME": "COMP. ORODISPERS.",
    "DOSAGE": "4MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEKER SARL (SARL LABORATOIRE BEKER ALGERIE)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/7/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "13/7/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["risperidone"],
    "InteractionIndexLink": ["risperidone"],
    "N_ENREGISTREMENT": "573/16 D 145/21",
    "CODE_DCI": "16 D 145",
    "DCI": "Rispéridone",
    "NOM_COMMERCIALE": "RISPISAPH",
    "FORME": "Comprimé orodispersible",
    "DOSAGE": "4MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SAPHARM PRODUCTION / SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/2/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "15/2/2021",
    "TYPE": "Gé",
    "STATUT": "F prémix ( BIOREM) Libérateur (SAPHARM)",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["risperidone"],
    "InteractionIndexLink": ["risperidone"],
    "N_ENREGISTREMENT": "21/16 D145/573",
    "CODE_DCI": "16 D 145",
    "DCI": "RISPERIDONE",
    "NOM_COMMERCIALE": "RISPISAPH",
    "FORME": "COMP ORODISPERSIBLES",
    "DOSAGE": "04MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES SAPHARM PRODUCTION /SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/04/21",
    "DATE_D_ENREGISTREMENT_FINAL": "22/04/21",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["loxapine"],
    "N_ENREGISTREMENT": "285/ 16 D 146 /09",
    "CODE_DCI": "16 D 146",
    "DCI": "LOXAPINE SUCCINATE EXPRIME EN LOXAPINE",
    "NOM_COMMERCIALE": "LOXAPAC",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "25MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "UNION PHARMACEUTIQUE CONSTANTINOISE (UPC)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/9/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "24/9/2009",
    "TYPE": "Ré",
    "STATUT": "C",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["loxapine"],
    "N_ENREGISTREMENT": "446/ 16 D 147 /09/19",
    "CODE_DCI": "16 D 147",
    "DCI": "LOXAPINE",
    "NOM_COMMERCIALE": "LOXAPAC",
    "FORME": "SOL. INJ.IM",
    "DOSAGE": "25MG/ML (OU 50MG/2ML)",
    "COND": "B/10AMP. DE 2ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EISAI SAS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/9/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "11/12/2019",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["quetiapine"],
    "InteractionIndexLink": ["quetiapine"],
    "N_ENREGISTREMENT": "286/ 16 D 148 /16",
    "CODE_DCI": "16 D 148",
    "DCI": "QUETIAPINE FUMARATE EXPRIME EN QUETIAPINE",
    "NOM_COMMERCIALE": "SELOPRESS",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "25MG",
    "COND": "B/60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL CPCM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/3/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "13/3/2016",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["quetiapine"],
    "InteractionIndexLink": ["quetiapine"],
    "N_ENREGISTREMENT": "256/ 16 D 148 /09",
    "CODE_DCI": "16 D 148",
    "DCI": "QUETIAPINE FUMARATE EXPRIME EN QUETIAPINE",
    "NOM_COMMERCIALE": "SEROQUEL",
    "FORME": "COMP. ENRO.",
    "DOSAGE": "25MG",
    "COND": "B/60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ASTRA ZENECA UK LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ROYAUME UNI",
    "DATE_D_ENREGISTREMENT_INITIAL": "23/9/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "23/9/2009",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["quetiapine"],
    "InteractionIndexLink": ["quetiapine"],
    "N_ENREGISTREMENT": "286/ 16 D 149 /16",
    "CODE_DCI": "16 D 149",
    "DCI": "QUETIAPINE FUMARATE EXPRIME EN QUETIAPINE",
    "NOM_COMMERCIALE": "SELOPRESS",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "100MG",
    "COND": "B/60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CPCM SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/2/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "25/4/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["quetiapine"],
    "InteractionIndexLink": ["quetiapine"],
    "N_ENREGISTREMENT": "256/ 16 D 149 /09",
    "CODE_DCI": "16 D 149",
    "DCI": "QUETIAPINE FUMARATE EXPRIME EN QUETIAPINE",
    "NOM_COMMERCIALE": "SEROQUEL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "100MG",
    "COND": "B/60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ASTRA ZENECA UK LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ROYAUME UNI",
    "DATE_D_ENREGISTREMENT_INITIAL": "23/9/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "23/9/2009",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["quetiapine"],
    "InteractionIndexLink": ["quetiapine"],
    "N_ENREGISTREMENT": "352/ 16 D 150 /14",
    "CODE_DCI": "16 D 150",
    "DCI": "QUETIAPINE FUMARATE EXPRIME EN QUETIAPINE",
    "NOM_COMMERCIALE": "PINAQUINE",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "200MG",
    "COND": "B/60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/11/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "30/11/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["quetiapine"],
    "InteractionIndexLink": ["quetiapine"],
    "N_ENREGISTREMENT": "286/ 16 D 150 /16",
    "CODE_DCI": "16 D 150",
    "DCI": "QUETIAPINE FUMARATE EXPRIME EN QUETIAPINE",
    "NOM_COMMERCIALE": "SELOPRESS",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "200MG",
    "COND": "B/60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CPCM SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/2/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "22/2/2016",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["quetiapine"],
    "InteractionIndexLink": ["quetiapine"],
    "N_ENREGISTREMENT": "256/ 16 D 150 /09",
    "CODE_DCI": "16 D 150",
    "DCI": "QUETIAPINE FUMARATE EXPRIME EN QUETIAPINE",
    "NOM_COMMERCIALE": "SEROQUEL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "200MG",
    "COND": "B/60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ASTRA ZENECA UK LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ROYAUME UNI",
    "DATE_D_ENREGISTREMENT_INITIAL": "23/9/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "23/9/2009",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["quetiapine"],
    "InteractionIndexLink": ["quetiapine"],
    "N_ENREGISTREMENT": "510/16 D 151/17",
    "CODE_DCI": "16 D 151",
    "DCI": "QUETIAPINE FUMARATE EXPRIME EN QUETIAPINE",
    "NOM_COMMERCIALE": "Q-PINE ALEMBIC MAMI",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "300MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALMENCI MAMI SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/2/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "12/2/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["quetiapine"],
    "InteractionIndexLink": ["quetiapine"],
    "N_ENREGISTREMENT": "286/ 16 D 151 /16",
    "CODE_DCI": "16 D 151",
    "DCI": "QUETIAPINE FUMARATE EXPRIME EN QUETIAPINE",
    "NOM_COMMERCIALE": "SELOPRESS",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "300MG",
    "COND": "B/60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CPCM SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "16/2/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "16/2/2016",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "24 mois",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["quetiapine"],
    "InteractionIndexLink": ["quetiapine"],
    "N_ENREGISTREMENT": "256/ 16 D 151 /09",
    "CODE_DCI": "16 D 151",
    "DCI": "QUETIAPINE FUMARATE EXPRIME EN QUETIAPINE",
    "NOM_COMMERCIALE": "SEROQUEL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "300MG",
    "COND": "B/60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ASTRA ZENECA UK LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ROYAUME UNI",
    "DATE_D_ENREGISTREMENT_INITIAL": "23/9/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "23/9/2009",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["olanzapine"],
    "InteractionIndexLink": ["olanzapine"],
    "N_ENREGISTREMENT": "447/ 16 D155 /16",
    "CODE_DCI": "16 D 155",
    "DCI": "OLANZAPINE",
    "NOM_COMMERCIALE": "OLANZA ORO",
    "FORME": "COMP. ORODISPERS.",
    "DOSAGE": "5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEKER SARL (SARL LABORATOIRE BEKER ALGERIE)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/2/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "22/2/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["olanzapine"],
    "InteractionIndexLink": ["olanzapine"],
    "N_ENREGISTREMENT": "447/ 16 D155 /16",
    "CODE_DCI": "16 D 155",
    "DCI": "OLANZAPINE",
    "NOM_COMMERCIALE": "OLANZA ORO",
    "FORME": "COMP. ORODISPERS.",
    "DOSAGE": "5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEKER SARL (SARL LABORATOIRE BEKER ALGERIE)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/2/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "22/2/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["olanzapine"],
    "InteractionIndexLink": ["olanzapine"],
    "N_ENREGISTREMENT": "263/ 16 D 155 /16",
    "CODE_DCI": "16 D 155",
    "DCI": "OLANZAPINE",
    "NOM_COMMERCIALE": "OLANZOMAX",
    "FORME": "COMP. ORODISPERS.",
    "DOSAGE": "5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOPHARM/SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "5/9/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "5/9/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["olanzapine"],
    "InteractionIndexLink": ["olanzapine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "16 D 155",
    "DCI": "OLANZAPINE",
    "NOM_COMMERCIALE": "SCHIZOPIN",
    "FORME": "COMP. ORODISPERS.",
    "DOSAGE": "5MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["amisulpride"],
    "InteractionIndexLink": ["amisulpride"],
    "N_ENREGISTREMENT": "447/ 16 D 160 /16",
    "CODE_DCI": "16 D 160",
    "DCI": "AMISULPRIDE",
    "NOM_COMMERCIALE": "AMISULPRIDE BEKER",
    "FORME": "COMP. PELLI. SEC.",
    "DOSAGE": "400MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEKER SARL (SARL LABORATOIRE BEKER ALGERIE)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/6/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "13/6/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["amisulpride"],
    "InteractionIndexLink": ["amisulpride"],
    "N_ENREGISTREMENT": "309/ 16 D 160 /21",
    "CODE_DCI": "16 D 160",
    "DCI": "Amisulpride",
    "NOM_COMMERCIALE": "AMISULPRIDE LDM",
    "FORME": "Comprimé pelliculé sécable",
    "DOSAGE": "400MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES DE DIAGNOSTIC MAGHREBINS (LDM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "14/3/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "14/3/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["amisulpride"],
    "InteractionIndexLink": ["amisulpride"],
    "N_ENREGISTREMENT": "392/ 16 D 160 /14",
    "CODE_DCI": "16 D 160",
    "DCI": "AMISULPRIDE",
    "NOM_COMMERCIALE": "SOLIAN",
    "FORME": "COMP. PELLI. SEC.",
    "DOSAGE": "400MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANOFI AVENTIS ALGERIE SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/11/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "13/12/2015",
    "TYPE": "Ré",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["amisulpride"],
    "InteractionIndexLink": ["amisulpride"],
    "N_ENREGISTREMENT": "352/16 D 160/17",
    "CODE_DCI": "16 D 160",
    "DCI": "AMISULPRIDE",
    "NOM_COMMERCIALE": "SUPRIMIDE",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "400MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/5/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "28/5/2017",
    "TYPE": "GE",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["aripiprazole"],
    "InteractionIndexLink": ["aripiprazole"],
    "N_ENREGISTREMENT": "447/16 D 161/17",
    "CODE_DCI": "16 D 161",
    "DCI": "ARIPIPRAZOLE",
    "NOM_COMMERCIALE": "ARIPIPRAZOLE BEKER",
    "FORME": "COMPRIME",
    "DOSAGE": "20MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEKER SARL (SARL LABORATOIRE BEKER ALGERIE)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/1/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "29/1/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["aripiprazole"],
    "InteractionIndexLink": ["aripiprazole"],
    "N_ENREGISTREMENT": "263/ 16 D 161 /14",
    "CODE_DCI": "16 D 161",
    "DCI": "ARIPIPRAZOLE",
    "NOM_COMMERCIALE": "ZOLIFY",
    "FORME": "COMPRIME",
    "DOSAGE": "20MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOPHARM SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/11/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "30/11/2014",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["quetiapine"],
    "InteractionIndexLink": ["quetiapine"],
    "N_ENREGISTREMENT": "352/ 16 D 162 /14",
    "CODE_DCI": "16 D 162",
    "DCI": "QUETIAPINE FUMARATE EXPRIME EN QUETIAPINE",
    "NOM_COMMERCIALE": "PINAQUINE",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "50MG",
    "COND": "B/60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/12/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "15/12/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["quetiapine"],
    "InteractionIndexLink": ["quetiapine"],
    "N_ENREGISTREMENT": "510/16 D 162/17",
    "CODE_DCI": "16 D 162",
    "DCI": "QUETIAPINE FUMARATE EXPRIME EN QUETIAPINE",
    "NOM_COMMERCIALE": "Q-PINE ALEMBIC MAMI",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "50MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALEMBIC MAMI SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/3/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "27/3/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["quetiapine"],
    "InteractionIndexLink": ["quetiapine"],
    "N_ENREGISTREMENT": "352/ 16 D 164 /15",
    "CODE_DCI": "16 D 164",
    "DCI": "QUETIAPINE FUMARATE EXPRIME EN QUETIAPINE",
    "NOM_COMMERCIALE": "PINAQUINE LP",
    "FORME": "COMP. PELLI. LP",
    "DOSAGE": "200MG",
    "COND": "B/60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/7/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "26/7/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["quetiapine"],
    "InteractionIndexLink": ["quetiapine"],
    "N_ENREGISTREMENT": "001/16 D 164/17",
    "CODE_DCI": "16 D 164",
    "DCI": "Quétiapine Fumarate exprimé en quétiapine",
    "NOM_COMMERCIALE": "QUETAL LP",
    "FORME": "Comprimé pelliculé à libération prolongée",
    "DOSAGE": "200MG",
    "COND": "B/30 ET B/60",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMA ALGERIA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/6/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "19/5/2020",
    "TYPE": "Gé",
    "STATUT": "F prémix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["quetiapine"],
    "InteractionIndexLink": ["quetiapine"],
    "N_ENREGISTREMENT": "001/16 D 166/17",
    "CODE_DCI": "16 D 166",
    "DCI": "QUETIAPINE FUMARATE EXPRIME EN QUETIAPINE",
    "NOM_COMMERCIALE": "QUETAL LP",
    "FORME": "COMP PELL LP",
    "DOSAGE": "50 MG",
    "COND": "B/30 ET B/60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMA ALGERIA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/4/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "12/4/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["quetiapine"],
    "InteractionIndexLink": ["quetiapine"],
    "N_ENREGISTREMENT": "001/16 D 167/17",
    "CODE_DCI": "16 D 167",
    "DCI": "QUETIAPINE FUMARATE EXPRIME EN QUETIAPINE",
    "NOM_COMMERCIALE": "QUETAL LP",
    "FORME": "COMP PELL LP",
    "DOSAGE": "150 MG",
    "COND": "B/30 ET B/60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMA ALGERIA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/4/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "12/4/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["quetiapine"],
    "InteractionIndexLink": ["quetiapine"],
    "N_ENREGISTREMENT": "001/16 D 169/17",
    "CODE_DCI": "16 D 169",
    "DCI": "QUETIPINE FUMARATE EXPRIME EN QUETIAPINE",
    "NOM_COMMERCIALE": "QUETAL LP",
    "FORME": "CP PELL LP",
    "DOSAGE": "300 MG",
    "COND": "B/60",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMA ALGERIA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/5/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "28/5/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["quetiapine"],
    "InteractionIndexLink": ["quetiapine"],
    "N_ENREGISTREMENT": "477/16 D 169/18",
    "CODE_DCI": "16 D 169",
    "DCI": "QUETIAPINE FUMARATE EXPRIME EN QUETIAPINE",
    "NOM_COMMERCIALE": "QUETIAPINE BEKER LP",
    "FORME": "COMP. PELL. LP.",
    "DOSAGE": "300MG",
    "COND": "B/30 ET B/60",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL LABORATOIRES BEKER",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "5/6/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "5/6/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["quetiapine"],
    "InteractionIndexLink": ["quetiapine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "16 D 169",
    "DCI": "Quétiapine fumarate",
    "NOM_COMMERCIALE": "Quétiapine BEKER LP",
    "FORME": "Comprimé pelliculé à libération prolongée 300 mg. B/30 et B/60",
    "DOSAGE": "300MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["aripiprazole"],
    "InteractionIndexLink": ["aripiprazole"],
    "N_ENREGISTREMENT": "20/16 D170/426",
    "CODE_DCI": "16 D 170",
    "DCI": "ARIPIPRAZOLE",
    "NOM_COMMERCIALE": "ABDIFLY",
    "FORME": "COMP ORODISPERSIBLE",
    "DOSAGE": "10MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES ABDI IBRAHIM REMEDE PHARMA SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "05/10/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "05/10/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["aripiprazole"],
    "InteractionIndexLink": ["aripiprazole"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "16 D 170",
    "DCI": "ARIPIPRAZOLE",
    "NOM_COMMERCIALE": "ABDIFLY OD",
    "FORME": "COMP ORODISPERSIBLE",
    "DOSAGE": "10MG",
    "COND": "B/28",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["aripiprazole"],
    "InteractionIndexLink": ["aripiprazole"],
    "N_ENREGISTREMENT": "352/16 D 170/17",
    "CODE_DCI": "16 D 170",
    "DCI": "ARIPIPRAZOLE",
    "NOM_COMMERCIALE": "ABILIZOLE",
    "FORME": "CP ORODISPERSIBLE",
    "DOSAGE": "10 MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/5/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "28/5/2017",
    "TYPE": "G",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["aripiprazole"],
    "InteractionIndexLink": ["aripiprazole"],
    "N_ENREGISTREMENT": "447/16 D 170/17",
    "CODE_DCI": "16 D 170",
    "DCI": "ARIPIPRAZOLE",
    "NOM_COMMERCIALE": "ARIPIPRAZOLE BEKER ORO",
    "FORME": "COMP.ORO.",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL LABORATOIRE BEKER",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/2/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "20/2/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["aripiprazole"],
    "InteractionIndexLink": ["aripiprazole"],
    "N_ENREGISTREMENT": "426/16 D 171/20",
    "CODE_DCI": "16 D 171",
    "DCI": "ARIPIPRAZOLE",
    "NOM_COMMERCIALE": "ABDIFLY OD",
    "FORME": "COMP. ORO.",
    "DOSAGE": "15MG",
    "COND": "B/28",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES ABDIBRAHIM REMEDE PHARMA SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/12/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "29/12/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["aripiprazole"],
    "InteractionIndexLink": ["aripiprazole"],
    "N_ENREGISTREMENT": "352/16 D 171/17",
    "CODE_DCI": "16 D 171",
    "DCI": "ARIPIPRAZOLE",
    "NOM_COMMERCIALE": "ABILIZOLE",
    "FORME": "CP ORODISPERSIBLE",
    "DOSAGE": "15 MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/5/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "28/5/2017",
    "TYPE": "G",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["aripiprazole"],
    "InteractionIndexLink": ["aripiprazole"],
    "N_ENREGISTREMENT": "447/16 D 171/17",
    "CODE_DCI": "16 D 171",
    "DCI": "ARIPIPRAZOLE",
    "NOM_COMMERCIALE": "ARIPIPRAZOLE BEKER ORO",
    "FORME": "COMP.ORO.",
    "DOSAGE": "15MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL LABORATOIRE BEKER",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/2/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "20/2/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Psychiatrie"]
  },
  {
    "PregnancyIndexLink": ["paliperidone"],
    "InteractionIndexLink": ["paliperidone"],
    "N_ENREGISTREMENT": "095/16 D172/19",
    "CODE_DCI": "16 D 172",
    "DCI": "PALMIRATE DE PALIPERIDONE EXPRIME EN PALIPERIDONE",
    "NOM_COMMERCIALE": "XEPLION",
    "FORME": "SUSP INJ LP",
    "DOSAGE": "100MG/ML",
    "COND": "B/01  SER PRE-REMP DE 0.50 ML(50 MG/0.5ML) ET 02 AIGUILLES \nB/01  SER PRE-REMP DE 0.75 ML(75 MG/0.75ML) ET 02 AIGUILLES \nB/01  SER PRE-REMP DE 1ML (100MG/ML) ET 02 AIGUILLES    \nB/ 01  SER PRE-REMP DE 1.5ML (150MG/1.5ML) ET 02 AIGUILLES",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JANSSEN-CILAG INTERNATIONAL N.V",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "Belgique",
    "DATE_D_ENREGISTREMENT_INITIAL": "8/4/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "8/4/2019",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["aripiprazole"],
    "InteractionIndexLink": ["aripiprazole"],
    "N_ENREGISTREMENT": "352/16 D173/19",
    "CODE_DCI": "16 D 173",
    "DCI": "ARIPIPRAZOLE",
    "NOM_COMMERCIALE": "ABILIZOLE",
    "FORME": "SOL BUV",
    "DOSAGE": "1MG/ML",
    "COND": "FL/125 ML\nB/01  SER PRE-REMP DE 0.75 ML(75 MG/0.75ML) ET 02 AIGUILLES \nB/01  SER PRE-REMP DE 1ML (100MG/ML) ET 02 AIGUILLES    \nB/ 01  SER PRE-REMP DE 1.5ML (150MG/1.5ML) ET 02 AIGUILLES",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/3/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "29/3/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["calcium carbimide"],
    "InteractionIndexLink": ["calcium"],
    "N_ENREGISTREMENT": "496/ 16 G 163 /97/15",
    "CODE_DCI": "16 G 163",
    "DCI": "CALCIUM BROMOGALACTOGLUCONATE",
    "NOM_COMMERCIALE": "CALCIBRONAT",
    "FORME": "COMP.EFFER.",
    "DOSAGE": "2G",
    "COND": "B/20",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SPC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/11/1997",
    "DATE_D_ENREGISTREMENT_FINAL": "22/9/2015",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["oxybuprocaine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "185/17 A 001/17",
    "CODE_DCI": "17 A 001",
    "DCI": "OXYBUPROCAINE",
    "NOM_COMMERCIALE": "ANESTOCIL",
    "FORME": "COLLYRE EN SOLUTION",
    "DOSAGE": "0.4% (4mg/ml)",
    "COND": "FL/10ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GROUPEMENT PHARMACEUTIQUE ALGERIEN (GPA)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "21/6/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "21/6/2017",
    "TYPE": "GE",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "30 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": ["oxybuprocaine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "096/ 17 A 001 /98",
    "CODE_DCI": "17 A 001",
    "DCI": "OXYBUPROCAINE",
    "NOM_COMMERCIALE": "CEBESINE",
    "FORME": "COLLYRE EN SOLUTION",
    "DOSAGE": "0.4%",
    "COND": "FL/10ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CHAUVIN",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/4/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "27/4/1998",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": ["oxybuprocaine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "17 A 001",
    "DCI": "OXYBUPROCAINE",
    "NOM_COMMERCIALE": "CEBESINE",
    "FORME": "COLLYRE EN SOLUTION",
    "DOSAGE": "0.004",
    "COND": "FL/10ML",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": ["sodium cromoglycate"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "165/17 B 003/98",
    "CODE_DCI": "17 B 003",
    "DCI": "CROMOGLYCATE DE SODIUM",
    "NOM_COMMERCIALE": "APICROM",
    "FORME": "COLLYRE",
    "DOSAGE": "2 %",
    "COND": "F/10ML",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "AMMAN PHARMACEUTICAL INDUSTRIE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/10/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "7/10/1998",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["sodium cromoglycate"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "316/17 B 003/08",
    "CODE_DCI": "17 B 003",
    "DCI": "CROMOGLYCATE DE SODIUM",
    "NOM_COMMERCIALE": "CROMEDIL 2%",
    "FORME": "COLLYRE",
    "DOSAGE": "2 %",
    "COND": "B/30  RECIPIENTS UNIDOSES DE 0.3 ML",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EUROPHTA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MONACO",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/9/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "10/9/2008",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["sodium cromoglycate"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "135/17 B 003/98",
    "CODE_DCI": "17 B 003",
    "DCI": "CROMOGLYCATE DE SODIUM",
    "NOM_COMMERCIALE": "CROMOGLYCATE DE SODIUM",
    "FORME": "COLLYRE",
    "DOSAGE": "2 %",
    "COND": "FL/5 ML",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MEDICUBA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CUBA",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/11/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "10/11/1998",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["sodium cromoglycate"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "272/ 17 B 003 /98/09",
    "CODE_DCI": "17 B 003",
    "DCI": "CROMOGLYCATE DE SODIUM",
    "NOM_COMMERCIALE": "DADCROME",
    "FORME": "COLLYRE",
    "DOSAGE": "2 %",
    "COND": "F/10ML",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORAS PHARMACEUTICAL S.P.A.",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/10/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "28/2/2009",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["sodium cromoglycate"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "109/17 B 003/99",
    "CODE_DCI": "17 B 003",
    "DCI": "CROMOGLYCATE DE SODIUM",
    "NOM_COMMERCIALE": "EPICO",
    "FORME": "COLLYRE",
    "DOSAGE": "2 %",
    "COND": "FL/10",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EIPICO",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EGYPTE",
    "DATE_D_ENREGISTREMENT_INITIAL": "21/4/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "21/4/1999",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "022/17 B 100/09/16",
    "CODE_DCI": "17 B 100",
    "DCI": "ACIDE N-ACETYL ASPARTYL GLUTAMIQUE (SOUS FORME SEL DE SODIUM)",
    "NOM_COMMERCIALE": "NAABAK",
    "FORME": "COLLYRE EN SOLUTION (SANS CONSERVATEUR)",
    "DOSAGE": "4.9G/100ML",
    "COND": "FL/10ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "THEA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/12/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "29/6/2016",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "17 B 100",
    "DCI": "ACIDE N-ACETYL ASPARTYL GLUTAMIQUE (SOUS FORME DE SEL DE SODIUM)",
    "NOM_COMMERCIALE": "NAAXIA",
    "FORME": "COLLYRE",
    "DOSAGE": "4.9G/100ML",
    "COND": "FL/5ML",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": ["levocabastine (ophthalmic)"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "543/ 17 B 109 /21",
    "CODE_DCI": "17 B 109",
    "DCI": "Chlorhydrate de Lévocabastine exprimé en Lévocabastine",
    "NOM_COMMERCIALE": "BIOCABASTINE",
    "FORME": "Collyre en suspension",
    "DOSAGE": "0.05 %",
    "COND": "FL/5ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOTHERA / SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/2/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "7/2/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS  (30jours après ouverture)",
    "availableInAlgeria": true,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": ["levocabastine (ophthalmic)"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "17 B 109",
    "DCI": "LEVOCABASTINE HCL",
    "NOM_COMMERCIALE": "BIOCABASTINE COLLYRE 0.05%",
    "FORME": "collyre en solution\n sterile",
    "DOSAGE": "0.05%",
    "COND": "Boite d'un flacon de 5 ml",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "21/17 B109/543",
    "CODE_DCI": "17 B 109",
    "DCI": "LEVOCARBASTINE",
    "NOM_COMMERCIALE": "BIOCARBASTINE",
    "FORME": "COLLYRE EN SUSP",
    "DOSAGE": "0.05%",
    "COND": "FL/ 05ML",
    "LISTE": "LISTE II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOTHERA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "07/02/21",
    "DATE_D_ENREGISTREMENT_FINAL": "07/02/21",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": ["levocabastine (ophthalmic)"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "096/ 17 B 109 /99",
    "CODE_DCI": "17 B 109",
    "DCI": "LEVOCABASTINE",
    "NOM_COMMERCIALE": "LEVOPHTA",
    "FORME": "COLLYRE",
    "DOSAGE": "0.05 %",
    "COND": "FL/5ML",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CHAUVIN",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/5/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "4/5/1999",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": ["levocabastine (ophthalmic)"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "17 B 109",
    "DCI": "LEVOCABASTINE",
    "NOM_COMMERCIALE": "LEVOPHTA",
    "FORME": "COLLYRE",
    "DOSAGE": "0.0005",
    "COND": "FL/5ML",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["naphazoline"],
    "N_ENREGISTREMENT": "272/ 17 B 120 /07",
    "CODE_DCI": "17 B 120",
    "DCI": "ANTAZOLINE  (SULFATE) / NAPHAZOLINE (NITRATE)",
    "NOM_COMMERCIALE": "OPHTAZOLIN",
    "FORME": "COLLYRE",
    "DOSAGE": "5MG/0.25MG/ML",
    "COND": "FL./10ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORAS PHARMACEUTICAL SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/5/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "7/5/2007",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["olopatadine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "028/ 17 B 150 /09/16",
    "CODE_DCI": "17 B 150",
    "DCI": "OLOPATADINE (SOUS FORME DE CHLORHYDRATE)",
    "NOM_COMMERCIALE": "OPATANOL",
    "FORME": "COLLYRE EN SOLUTION",
    "DOSAGE": "1MG/ML (OU 5MG/5ML)",
    "COND": "FL./5ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALCON UK LTD",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ROYAUME UNI",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/9/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "12/3/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["olopatadine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "543/17 B 150/20",
    "CODE_DCI": "17 B 150",
    "DCI": "OLOPATADINE (SOUS FORME DE CHLORHYDRATE)",
    "NOM_COMMERCIALE": "OPATEK",
    "FORME": "COLLYRE EN SOLUTIO STERILE",
    "DOSAGE": "1MG/ML",
    "COND": "FL/5ML",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOTHERA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/5/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "4/5/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["olopatadine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "543/17 B 150/20",
    "CODE_DCI": "17 B 150",
    "DCI": "OLOPATADINE (SOUS FORME DE CHLORHYDRATE)",
    "NOM_COMMERCIALE": "OPATEK",
    "FORME": "COLLYRE EN SOLUTIO STERILE",
    "DOSAGE": "1MG/ML",
    "COND": "FL/5ML",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOTHERA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "04/05/20",
    "DATE_D_ENREGISTREMENT_FINAL": "04/05/20",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["ketotifen"],
    "InteractionIndexLink": ["ketotifene"],
    "N_ENREGISTREMENT": "022/ 17 B 171 /13",
    "CODE_DCI": "17 B 171",
    "DCI": "KETOTIFENE HYDROGENOFUMARATE EXPRIME EN KETOTIFENE",
    "NOM_COMMERCIALE": "ZALERG",
    "FORME": "COLLYRE EN SOLUTION (SANS CONSERVATEUR)",
    "DOSAGE": "0.25MG/ML",
    "COND": "B/1FL. DE 5ML",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "THEA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/10/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "20/10/2013",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": ["betaxolol (ophthalmic)"],
    "InteractionIndexLink": ["betaxolol"],
    "N_ENREGISTREMENT": "185/ 17 C 006 /17",
    "CODE_DCI": "17 C 006",
    "DCI": "BETAXOLOL CHLORHYDRATE EXPRIME EN BETAXOLOL",
    "NOM_COMMERCIALE": "BERTOCIL",
    "FORME": "COLLYRE",
    "DOSAGE": "( 5MG/ML) 0.5%",
    "COND": "FL/5ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GROUPEMENT PHARMACEUTIQUE ALGERIEN (GPA)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/12/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "4/12/2017",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "30 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["carteolol"],
    "N_ENREGISTREMENT": "096/ 17 C 007 /98",
    "CODE_DCI": "17 C 007",
    "DCI": "CARTEOLOL",
    "NOM_COMMERCIALE": "CARTEOL",
    "FORME": "COLLYRE",
    "DOSAGE": "1 %",
    "COND": "FL/3ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CHAUVIN",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/4/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "27/4/1998",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["pilocarpine"],
    "InteractionIndexLink": ["pilocarpine"],
    "N_ENREGISTREMENT": "165/ 17 C 009 /98",
    "CODE_DCI": "17 C 009",
    "DCI": "PILOCARPINE",
    "NOM_COMMERCIALE": "APICARPIN",
    "FORME": "COLLYRE",
    "DOSAGE": "1 %",
    "COND": "FL/10ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "AMMAN PHARMACEUTICAL INDUSTRIE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/10/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "7/10/1998",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["pilocarpine"],
    "InteractionIndexLink": ["pilocarpine"],
    "N_ENREGISTREMENT": "096/ 17 C 009 /98",
    "CODE_DCI": "17 C 009",
    "DCI": "PILOCARPINE (NITRATE)",
    "NOM_COMMERCIALE": "PILO 1",
    "FORME": "COLLYRE",
    "DOSAGE": "1 %",
    "COND": "FL/10ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CHAUVIN",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/4/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "27/4/1998",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["pilocarpine"],
    "InteractionIndexLink": ["pilocarpine"],
    "N_ENREGISTREMENT": "165/ 17 C 010 /98",
    "CODE_DCI": "17 C 010",
    "DCI": "PILOCARPINE",
    "NOM_COMMERCIALE": "APICARPIN",
    "FORME": "COLLYRE",
    "DOSAGE": "2 %",
    "COND": "FL/10ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "AMMAN PHARMACEUTICAL INDUSTRIE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/10/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "7/10/1998",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["timolol (ophthalmic)"],
    "InteractionIndexLink": ["timolol"],
    "N_ENREGISTREMENT": "317/ 17 C 012 /20",
    "CODE_DCI": "17 C 012",
    "DCI": "Timolol maléate exprimé en Timolol",
    "NOM_COMMERCIALE": "NORMOPTIC",
    "FORME": "Collyre en solution",
    "DOSAGE": "0.25 %",
    "COND": "B/1FL COMPTE-GOUTTES DE 5ML",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INPHA-MEDIS /SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "14/10/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "15/3/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": ["timolol (ophthalmic)"],
    "InteractionIndexLink": ["timolol"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "17 C 012",
    "DCI": "Timolol maléate",
    "NOM_COMMERCIALE": "Normoptic",
    "FORME": "collyre en sol",
    "DOSAGE": "0.0025",
    "COND": "flacon 05ml",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": ["timolol (ophthalmic)"],
    "InteractionIndexLink": ["timolol"],
    "N_ENREGISTREMENT": "272/ 17 C 012 /98/09",
    "CODE_DCI": "17 C 012",
    "DCI": "TIMOLOL MALEATE EXPRIME EN TIMOLOL",
    "NOM_COMMERCIALE": "OPHTAMOLOL",
    "FORME": "COLLYRE",
    "DOSAGE": "0.25 %",
    "COND": "F/5ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORAS PHARMACEUTICAL S.P.A.",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/10/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "24/12/2009",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": ["timolol (ophthalmic)"],
    "InteractionIndexLink": ["timolol"],
    "N_ENREGISTREMENT": "165/17 C 012/98",
    "CODE_DCI": "17 C 012",
    "DCI": "TIMOLOL",
    "NOM_COMMERCIALE": "TIMOLOL",
    "FORME": "COLLYRE",
    "DOSAGE": "0.25 %",
    "COND": "F/5ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "AMMAN PHARMACEUTICAL INDUSTRIE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/10/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "7/10/1998",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": ["timolol (ophthalmic)"],
    "InteractionIndexLink": ["timolol"],
    "N_ENREGISTREMENT": "165/17 C 013/98",
    "CODE_DCI": "17 C 013",
    "DCI": "TIMOLOL MALEATE EXPRIME EN TIMOLOL",
    "NOM_COMMERCIALE": "APIMOL",
    "FORME": "COLLYRE",
    "DOSAGE": "0.50 %",
    "COND": "F/5ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "AMMAN PHARMACEUTICAL INDUSTRIE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/10/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "7/10/1998",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": ["timolol (ophthalmic)"],
    "InteractionIndexLink": ["timolol"],
    "N_ENREGISTREMENT": "051/17 C 013/98",
    "CODE_DCI": "17 C 013",
    "DCI": "TIMOLOL MALEATE EXPRIME EN TIMOLOL",
    "NOM_COMMERCIALE": "DIGAOL",
    "FORME": "COLLYRE",
    "DOSAGE": "0.50 %",
    "COND": "FL/3ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LEURQUIN MEDIOLANUM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/6/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "30/6/1998",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": ["timolol (ophthalmic)"],
    "InteractionIndexLink": ["timolol"],
    "N_ENREGISTREMENT": "243/17 C 013/01",
    "CODE_DCI": "17 C 013",
    "DCI": "TIMOLOL MALEATE EXPRIME EN TIMOLOL",
    "NOM_COMMERCIALE": "MEDYOL",
    "FORME": "COLLYRE",
    "DOSAGE": "0.50 %",
    "COND": "FL/10ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MEDI PHARMA INTERNATIONAL (MEDICOLABS syrie)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SUYRIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "8/9/2001",
    "DATE_D_ENREGISTREMENT_FINAL": "8/9/2001",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": ["timolol (ophthalmic)"],
    "InteractionIndexLink": ["timolol"],
    "N_ENREGISTREMENT": "317/ 17 C 013 /20",
    "CODE_DCI": "17 C 013",
    "DCI": "Timolol maléate exprimé en Timolol",
    "NOM_COMMERCIALE": "NORMOPTIC",
    "FORME": "Collyre en solution",
    "DOSAGE": "0.50 %",
    "COND": "B/1FL COMPTE-GOUTTES DE 5ML",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INPHA-MEDIS /SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "14/10/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "15/3/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": ["timolol (ophthalmic)"],
    "InteractionIndexLink": ["timolol"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "17 C 013",
    "DCI": "Timolol maléate",
    "NOM_COMMERCIALE": "Normoptic",
    "FORME": "collyre en sol",
    "DOSAGE": "0.005",
    "COND": "flacon 05ml",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": ["timolol (ophthalmic)"],
    "InteractionIndexLink": ["timolol"],
    "N_ENREGISTREMENT": "272/ 17 C 013 /98/09",
    "CODE_DCI": "17 C 013",
    "DCI": "TIMOLOL MALEATE EXPRIME EN TIMOLOL",
    "NOM_COMMERCIALE": "OPHTAMOLOL",
    "FORME": "COLLYRE",
    "DOSAGE": "0.50 %",
    "COND": "F/5ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORAS PHARMACEUTICAL S.P.A.",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/10/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "27/1/2009",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": ["timolol (ophthalmic)"],
    "InteractionIndexLink": ["timolol"],
    "N_ENREGISTREMENT": "543/17 C 013/20",
    "CODE_DCI": "17 C 013",
    "DCI": "TIMOLOL MALEATE",
    "NOM_COMMERCIALE": "TIMODROP",
    "FORME": "COLLYRE EN SOLUTIO STERILE",
    "DOSAGE": "0.50 %",
    "COND": "FL/5ML",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOTHERA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/5/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "4/5/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": ["timolol (ophthalmic)"],
    "InteractionIndexLink": ["timolol"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "17 C 013",
    "DCI": "TIMOLOL MALEATE",
    "NOM_COMMERCIALE": "TIMODROP",
    "FORME": "COLLYRE EN SOLUTIO STERILE",
    "DOSAGE": "0.005",
    "COND": "FL/5ML",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": ["timolol (ophthalmic)"],
    "InteractionIndexLink": ["timolol"],
    "N_ENREGISTREMENT": "109/17 C 013/99",
    "CODE_DCI": "17 C 013",
    "DCI": "TIMOLOL",
    "NOM_COMMERCIALE": "TIMOLOL",
    "FORME": "COLLYRE",
    "DOSAGE": "0.50 %",
    "COND": "FL/5ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EIPICO",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EGYPTE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/6/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "9/6/1999",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": ["timolol (ophthalmic)"],
    "InteractionIndexLink": ["timolol"],
    "N_ENREGISTREMENT": "135/17 C 013/98",
    "CODE_DCI": "17 C 013",
    "DCI": "TIMOLOL",
    "NOM_COMMERCIALE": "TIMOLOL",
    "FORME": "COLLYRE",
    "DOSAGE": "0.50 %",
    "COND": "FL/5ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MEDICUBA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CUBA",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/11/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "10/11/1998",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["carteolol"],
    "N_ENREGISTREMENT": "096/ 17 C 101 /99",
    "CODE_DCI": "17 C 101",
    "DCI": "CARTEOLOL",
    "NOM_COMMERCIALE": "CARTEOL",
    "FORME": "COLLYRE",
    "DOSAGE": "2 %",
    "COND": "FL/3ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CHAUVIN",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/4/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "6/4/1999",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["dorzolamide"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "023/ 17 C 121 /08/14",
    "CODE_DCI": "17 C 121",
    "DCI": "DORZOLAMIDE CHLORHYDRATE EXPRIME EN DORZOLAMIDE",
    "NOM_COMMERCIALE": "ALZOR",
    "FORME": "COLLYRE EN SOLUTION",
    "DOSAGE": "2% (20MG/ML)",
    "COND": "FL./5ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "UNIMED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "TUNISIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "23/12/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "18/11/2014",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": ["dorzolamide"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "521/17 C 121/16",
    "CODE_DCI": "17 C 121",
    "DCI": "DORZOLAMIDE CHLORHYDRATE EXPRIME EN DORZOLAMIDE",
    "NOM_COMMERCIALE": "DORZAMED",
    "FORME": "COLLYRE EN SOLUTION",
    "DOSAGE": "2% (20MG/ML)",
    "COND": "FL./5ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "WORLD MEDECINE ILAC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "TURQUIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/12/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "29/12/2016",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": ["dorzolamide"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "071/ 17 C 121/ 13",
    "CODE_DCI": "17 C 121",
    "DCI": "DORZOLAMIDE CHLORHYDRATE EXPRIME EN DORZOLAMIDE",
    "NOM_COMMERCIALE": "DORZAMIDE",
    "FORME": "COLLYRE EN SOLUTION",
    "DOSAGE": "2% (20MG/ML)",
    "COND": "FL./5ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "OUBARI PHARMA & CO",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SYRIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/11/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "27/11/2013",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": ["dorzolamide"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "380/17 C 121/16",
    "CODE_DCI": "17 C 121",
    "DCI": "DORZOLAMIDE CHLORHYDRATE EXPRIME EN DORZOLAMIDE",
    "NOM_COMMERCIALE": "TRUSAMID",
    "FORME": "COLLYRE EN SOLUTION",
    "DOSAGE": "2% (20MG/ML)",
    "COND": "FL./5ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HUPP PHARMA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/11/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "2/11/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": ["dorzolamide"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "530/ 17 C 121 /00/17",
    "CODE_DCI": "17 C 121",
    "DCI": "DORZOLAMIDE CHLORHYDRATE EXPRIME EN DORZOLAMIDE",
    "NOM_COMMERCIALE": "TRUSOPT",
    "FORME": "COLLYRE EN SOLUTION",
    "DOSAGE": "2% (20MG/ML)",
    "COND": "FL./5ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MUNDI PHARMA PTY LTD",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "AUSTRALIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "14/3/2000",
    "DATE_D_ENREGISTREMENT_FINAL": "2/7/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": ["dorzolamide"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "386/17 C 121/09/17",
    "CODE_DCI": "17 C 121",
    "DCI": "DORZOLAMIDE CHLORHYDRATE EXPRIME EN DORZOLAMIDE",
    "NOM_COMMERCIALE": "XOLA JAM",
    "FORME": "COLLYRE EN SOLUTION",
    "DOSAGE": "2% (20MG/ML)",
    "COND": "FL./5ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JAMJOOM PHARMACEUTICAL INDUSTRY",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ARABIE SAOUDITE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/3/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "16/4/2017",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": ["dorzolamide"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "065/17 C 121/17",
    "CODE_DCI": "17 C 121",
    "DCI": "DORZOLAMIDE CHLORHYDRATE EXPRIME EN DORZOLAMIDE",
    "NOM_COMMERCIALE": "ZOLAMIDE",
    "FORME": "COLLYRE EN SOLUTION",
    "DOSAGE": "2% (20MG/ML)",
    "COND": "FL./5ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GENERIC LAB",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/1/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "9/1/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": ["latanoprost"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "543/17 C 127/20",
    "CODE_DCI": "17 C 127",
    "DCI": "LATANOPROST",
    "NOM_COMMERCIALE": "BIOLATAN",
    "FORME": "COLLYRE EN SOLUTION",
    "DOSAGE": "0.005%",
    "COND": "FL/5ML",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOTHERA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/2/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "4/2/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": ["latanoprost"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "543/17 C 127/20",
    "CODE_DCI": "17 C 127",
    "DCI": "LATANOPROST",
    "NOM_COMMERCIALE": "BIOLATAN",
    "FORME": "COLLYRE EN SOLUTION",
    "DOSAGE": "0.005%",
    "COND": "FL/5ML",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOTHERA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "01/02/20",
    "DATE_D_ENREGISTREMENT_FINAL": "01/02/20",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": ["latanoprost"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "423/ 17 C 127 /08/16",
    "CODE_DCI": "17 C 127",
    "DCI": "LATANOPROST",
    "NOM_COMMERCIALE": "LATANEKS",
    "FORME": "COLLYRE",
    "DOSAGE": "50µG/ML",
    "COND": "FL./2.5ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "DIAMOND PHARMA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SYRIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/12/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "12/2/2017",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": ["latanoprost"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "521/17 C 127/16",
    "CODE_DCI": "17 C 127",
    "DCI": "LATANOPROST",
    "NOM_COMMERCIALE": "LATASOPT",
    "FORME": "COLLYRE",
    "DOSAGE": "50µG/ML",
    "COND": "FL./2.5ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "WORLD MEDECINE ILAC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/12/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "29/12/2016",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": ["latanoprost"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "522/17 C 127/17",
    "CODE_DCI": "17 C 127",
    "DCI": "LATANOPROST",
    "NOM_COMMERCIALE": "LATAZ",
    "FORME": "COLLYRE",
    "DOSAGE": "50µG/ML (0.005%)",
    "COND": "F/2.5ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "RAFARM S.A",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GRECE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/3/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "20/3/2017",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": ["latanoprost"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "065/17 C 127/19",
    "CODE_DCI": "17 C 127",
    "DCI": "LATANOPROST",
    "NOM_COMMERCIALE": "XALAPROST",
    "FORME": "COLLYRE",
    "DOSAGE": "0.005% (OU 50µG/ML)",
    "COND": "B/01 FL2.5ML",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GENERIC LAB SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": ["latanoprost"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "076/ 17 C 127 /01",
    "CODE_DCI": "17 C 127",
    "DCI": "LATANOPROST",
    "NOM_COMMERCIALE": "XALATAN",
    "FORME": "COLLYRE",
    "DOSAGE": "50µG/ML (0.005%)",
    "COND": "F/2.5ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMACIA S.A.",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BELGIQUE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/12/2001",
    "DATE_D_ENREGISTREMENT_FINAL": "12/12/2001",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": ["travoprost"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "065/ 17C 139 /21",
    "CODE_DCI": "17 C 139",
    "DCI": "TRAVOPROST",
    "NOM_COMMERCIALE": "TRAVADROP",
    "FORME": "Collyre en solution",
    "DOSAGE": "40µG/ML",
    "COND": "FL COMPTE GOUTTE DE 5 ML CONTENANT 2.5 ML DE SOL",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GENERIC LAB / SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "31/3/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "31/3/2021",
    "TYPE": "Gé",
    "STATUT": "Fabricant    (Gencopharm) Libérateur (Genericlab)",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": ["travoprost"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "17 C 139",
    "DCI": "TRAVOPROST",
    "NOM_COMMERCIALE": "TRAVATAN",
    "FORME": "COLLYRE EN SOLUTION",
    "DOSAGE": "40µG/ML",
    "COND": "FL 2.5ML",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": ["travoprost"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "543/ 17C 139 /18",
    "CODE_DCI": "17 C 139",
    "DCI": "TRAVOPROST",
    "NOM_COMMERCIALE": "TRAVOST",
    "FORME": "COLLYRE EN SOLUTION",
    "DOSAGE": "40µG/ML",
    "COND": "FL COMPTE GOUTTE DE 5 ML CONTENANT 2.5 ML DE SOL",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOTHERA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/4/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "2/4/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": ["brinzolamide"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "028/ 17 C 140 /05/16",
    "CODE_DCI": "17 C 140",
    "DCI": "BRINZOLAMIDE",
    "NOM_COMMERCIALE": "AZOPT",
    "FORME": "COLLYRE EN SUSPENSION",
    "DOSAGE": "10MG/ML",
    "COND": "FL./5ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALCON UK LTD",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ROYAUME UNI",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/9/2005",
    "DATE_D_ENREGISTREMENT_FINAL": "16/4/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": ["dorzolamide", "timolol (ophthalmic)"],
    "InteractionIndexLink": ["timolol"],
    "N_ENREGISTREMENT": "530/ 17 C 141 /06/17",
    "CODE_DCI": "17 C 141",
    "DCI": "DORZOLAMIDE CHLORHYDRATE EXPRIME EN DORZOLAMIDE / TIMOLOL MALEATE EXPRIME EN TIMOLOL",
    "NOM_COMMERCIALE": "COSOPT",
    "FORME": "COLLYRE EN SOLUTION",
    "DOSAGE": "20MG/5MG/ML",
    "COND": "FL./5ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MUNDI PHARMA PTY LTD",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "AUSTRALIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "23/7/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "30/7/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": ["dorzolamide", "timolol (ophthalmic)"],
    "InteractionIndexLink": ["timolol"],
    "N_ENREGISTREMENT": "380/17 C 141/16",
    "CODE_DCI": "17 C 141",
    "DCI": "Dorzolamide chlorhydrate exprimé en Dorzolamide / Timolol maléate exprimé en Timolol",
    "NOM_COMMERCIALE": "COSOTIMOL",
    "FORME": "Collyre en solution",
    "DOSAGE": "20MG/5MG/ML",
    "COND": "B/1FL. DE 5ML",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HUP.P.PHARMA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/11/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "14/3/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": ["dorzolamide", "timolol (ophthalmic)"],
    "InteractionIndexLink": ["timolol"],
    "N_ENREGISTREMENT": "521/17 C 141/16",
    "CODE_DCI": "17 C 141",
    "DCI": "DORZOLAMIDE CHLORHYDRATE EXPRIME EN DORZOLAMIDE / TIMOLOL MALEATE EXPRIME EN TIMOLOL",
    "NOM_COMMERCIALE": "DORZASOPT",
    "FORME": "COLLYRE EN SOLUTION",
    "DOSAGE": "20MG/5MG/ML",
    "COND": "FL./5ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "WORLD MEDECINE ILAC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "TURQUIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/12/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "29/12/2016",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": ["dorzolamide", "timolol (ophthalmic)"],
    "InteractionIndexLink": ["timolol"],
    "N_ENREGISTREMENT": "522/17 C 141/18",
    "CODE_DCI": "17 C 141",
    "DCI": "DORZOLAMIDE CHLORHYDRATE EXPRIME EN DORZOLAMIDE / TIMOLOL MALEATE EXPRIME EN TIMOLOL",
    "NOM_COMMERCIALE": "OPTODROP-CO",
    "FORME": "COLLYRE EN SOLUTION",
    "DOSAGE": "20MG/5MG/ML",
    "COND": "FL./5ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "RAFARM S.A",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GRECE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/5/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "7/5/2018",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": ["dorzolamide", "timolol (ophthalmic)"],
    "InteractionIndexLink": ["timolol"],
    "N_ENREGISTREMENT": "543 /17 C 141/ 18",
    "CODE_DCI": "17 C 141",
    "DCI": "DORZOLAMIDE CHLORHYDRATE EXPRIME EN DORZOLAMIDE / TIMOLOL MALEATE EXPRIME EN TIMOLOL",
    "NOM_COMMERCIALE": "TIMOLAMID",
    "FORME": "COLLYRE EN SOLUTION",
    "DOSAGE": "20MG/5MG/ML",
    "COND": "FL./5ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOTHERA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/7/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "10/7/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": ["dorzolamide", "timolol (ophthalmic)"],
    "InteractionIndexLink": ["timolol"],
    "N_ENREGISTREMENT": "386/ 17 C 141 /09/16",
    "CODE_DCI": "17 C 141",
    "DCI": "DORZOLAMIDE CHLORHYDRATE EXPRIME EN DORZOLAMIDE / TIMOLOL MALEATE EXPRIME EN TIMOLOL",
    "NOM_COMMERCIALE": "XOLAMOL",
    "FORME": "COLLYRE EN SOLUTION",
    "DOSAGE": "20MG/5MG/ML",
    "COND": "FL./5ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JAMJOOM PHARMACEUTICAL INDUSTRY",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ARABIE SAOUDITE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/3/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "16/4/2017",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": ["dorzolamide", "timolol (ophthalmic)"],
    "InteractionIndexLink": ["timolol"],
    "N_ENREGISTREMENT": "065/17 C 141/17",
    "CODE_DCI": "17 C 141",
    "DCI": "DORZOLAMIDE CHLORHYDRATE EXPRIME EN DORZOLAMIDE / TIMOLOL MALEATE EXPRIME EN TIMOLOL",
    "NOM_COMMERCIALE": "ZOLAMIDE +",
    "FORME": "COLLYRE EN SOLUTION",
    "DOSAGE": "20MG/5MG/ML",
    "COND": "FL./5ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GENERICLAB SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/3/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "7/3/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["carteolol"],
    "N_ENREGISTREMENT": "096/ 17 C 146 /07/16",
    "CODE_DCI": "17 C 146",
    "DCI": "CARTEOLOL",
    "NOM_COMMERCIALE": "CARTEOL LP",
    "FORME": "COLLYRE EN SOLUTION A LIBERATION PROLONGEE",
    "DOSAGE": "1 %",
    "COND": "FL./3ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CHAUVIN S.A.",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/3/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "12/3/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["carteolol"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "17 C 146",
    "DCI": "CARTEOLOL",
    "NOM_COMMERCIALE": "CARTEOL LP",
    "FORME": "COLLYRE EN SOLUTION A LIBERATION PROLONGEE",
    "DOSAGE": "0.01",
    "COND": "FL./3ML",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["carteolol"],
    "N_ENREGISTREMENT": "096/ 17 C 147 /07/16",
    "CODE_DCI": "17 C 147",
    "DCI": "CARTEOLOL",
    "NOM_COMMERCIALE": "CARTEOL LP",
    "FORME": "COLLYRE EN SOLUTION A LIBERATION PROLONGEE",
    "DOSAGE": "2 %",
    "COND": "FL./3ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CHAUVIN S.A.",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/3/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "12/3/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["carteolol"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "17 C 147",
    "DCI": "CARTEOLOL",
    "NOM_COMMERCIALE": "CARTEOL LP",
    "FORME": "COLLYRE EN SOLUTION A LIBERATION PROLONGEE",
    "DOSAGE": "0.02",
    "COND": "FL./3ML",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": ["latanoprost", "timolol (ophthalmic)"],
    "InteractionIndexLink": ["timolol"],
    "N_ENREGISTREMENT": "543/17 C 162/20",
    "CODE_DCI": "17 C 162",
    "DCI": "LATANOPROST/TIMOLOL",
    "NOM_COMMERCIALE": "LATADUO",
    "FORME": "COLLYRE EN SOLUTION",
    "DOSAGE": "0.05MG/ML 5MG/ML",
    "COND": "FL/2.5ML",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOTHERA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/1/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "9/1/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": ["latanoprost", "timolol (ophthalmic)"],
    "InteractionIndexLink": ["timolol"],
    "N_ENREGISTREMENT": "543/17 C 162/20",
    "CODE_DCI": "17 C 162",
    "DCI": "LATANOPROST/TIMOLOL",
    "NOM_COMMERCIALE": "LATADUO",
    "FORME": "COLLYRE EN SOLUTION",
    "DOSAGE": "0.05MG/ML 5MG/ML",
    "COND": "FL/2.5ML",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOTHERA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "09/01/20",
    "DATE_D_ENREGISTREMENT_FINAL": "09/01/20",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": ["latanoprost", "timolol (ophthalmic)"],
    "InteractionIndexLink": ["timolol"],
    "N_ENREGISTREMENT": "045/ 17 C 162 /14",
    "CODE_DCI": "17 C 162",
    "DCI": "LATANOPROST / TIMOLOL",
    "NOM_COMMERCIALE": "XALACOM",
    "FORME": "COLLYRE",
    "DOSAGE": "50μG/5MG/ML (0.005%/0.5%)",
    "COND": "FL./2.5ML",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PFIZER HOLDING FRANCE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/10/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "27/10/2014",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": ["timolol (ophthalmic)"],
    "InteractionIndexLink": ["timolol"],
    "N_ENREGISTREMENT": "022/ 17 C 170 /13",
    "CODE_DCI": "17 C 170",
    "DCI": "TIMOLOL MALEATE EXPRIME EN TIMOLOL",
    "NOM_COMMERCIALE": "GELTIM LP",
    "FORME": "GEL OPHTALMIQUE EN RECIPIENT UNIDOSE",
    "DOSAGE": "1MG/G",
    "COND": "B/30RECIPIENTS UNIDOSE EN SACHET DE 10",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "THEA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/10/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "20/10/2013",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": ["bimatoprost"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "543/17 C 177/20",
    "CODE_DCI": "17 C 177",
    "DCI": "BIMATOPROST",
    "NOM_COMMERCIALE": "LUMERA",
    "FORME": "COLLYRE EN SOLUTION",
    "DOSAGE": "0.1MG/ML",
    "COND": "FL/3ML",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOTHERA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/5/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "4/5/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["bimatoprost"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "543/17 C 178/20",
    "CODE_DCI": "17 C 178",
    "DCI": "BIMATOPROST",
    "NOM_COMMERCIALE": "LUMERA",
    "FORME": "COLLYRE EN SOLUTION",
    "DOSAGE": "0.3MG/ML",
    "COND": "FL/3ML",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOTHERA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/5/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "19/5/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["bimatoprost"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "543/17 C 178/20",
    "CODE_DCI": "17 C 178",
    "DCI": "BIMATOPROST",
    "NOM_COMMERCIALE": "LUMERA",
    "FORME": "COLLYRE EN SOLUTION",
    "DOSAGE": "0.3MG/ML",
    "COND": "FL/3ML",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOTHERA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/05/20",
    "DATE_D_ENREGISTREMENT_FINAL": "19/05/20",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["chloramphenicol (ophthalmic)"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "096/ 17 D 015 /98",
    "CODE_DCI": "17 D 015",
    "DCI": "CHLORAMPHENICOL",
    "NOM_COMMERCIALE": "CEBENICOL",
    "FORME": "COLLYRE",
    "DOSAGE": "0.4%",
    "COND": "FL/5ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CHAUVIN",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/4/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "27/4/1998",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["tetracycline"],
    "InteractionIndexLink": ["chlortetracycline"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "17 D 017",
    "DCI": "CHLORTETRACYCLINE",
    "NOM_COMMERCIALE": "CLOMYCINE",
    "FORME": "PDE.OPHT.",
    "DOSAGE": "0.01",
    "COND": "T/5G",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": ["gentamicin"],
    "InteractionIndexLink": ["gentamicine"],
    "N_ENREGISTREMENT": "165/17 D 020/98",
    "CODE_DCI": "17 D 020",
    "DCI": "GENTAMICINE",
    "NOM_COMMERCIALE": "APIGEN",
    "FORME": "COLLYRE",
    "DOSAGE": "3MG/ML",
    "COND": "FL/10 ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "AMMAN PHARMACEUTICAL INDUSTRIE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/10/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "7/10/1998",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["gentamicin"],
    "InteractionIndexLink": ["gentamicine"],
    "N_ENREGISTREMENT": "272/ 17 D 020 /98/09",
    "CODE_DCI": "17 D 020",
    "DCI": "GENTAMICINE (SOUS FORME DE SULFATE)",
    "NOM_COMMERCIALE": "GENTADAR",
    "FORME": "COLLYRE",
    "DOSAGE": "3MG/ML",
    "COND": "FL./10ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORAS PHARMACEUTICAL S.P.A.",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/10/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "28/2/2009",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["gentamicin"],
    "InteractionIndexLink": ["gentamicine"],
    "N_ENREGISTREMENT": "188/17 D 020/99",
    "CODE_DCI": "17 D 020",
    "DCI": "GENTAMICINE (SOUS FORME DE SULFATE)",
    "NOM_COMMERCIALE": "GENTALEX",
    "FORME": "COLLYRE",
    "DOSAGE": "3MG/ML",
    "COND": "FL /5ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LEK",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SLOVENIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "16/3/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "16/3/1999",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["gentamicin"],
    "InteractionIndexLink": ["gentamicine"],
    "N_ENREGISTREMENT": "135/17 D 020/98",
    "CODE_DCI": "17 D 020",
    "DCI": "GENTAMICINE",
    "NOM_COMMERCIALE": "GENTAMYCINE",
    "FORME": "COLLYRE",
    "DOSAGE": "3MG/ML",
    "COND": "FL/5 ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MEDICUBA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CUBA",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/11/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "10/11/1998",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["gentamicin"],
    "InteractionIndexLink": ["gentamicine"],
    "N_ENREGISTREMENT": "185/17 D 020/17",
    "CODE_DCI": "17 D 020",
    "DCI": "GENTAMICINE (SOUS FORME DE SULFATE)",
    "NOM_COMMERCIALE": "GENTOCIL",
    "FORME": "COLLYRE",
    "DOSAGE": "3MG/ML (0.3%)",
    "COND": "FL /5ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GROUPEMENT PHARMACEUTIQUE ALGERIEN (GPA)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/6/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "4/6/2017",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["gentamicin"],
    "InteractionIndexLink": ["gentamicine"],
    "N_ENREGISTREMENT": "096/ 17 D 021 /98",
    "CODE_DCI": "17 D 021",
    "DCI": "GENTAMICINE (SOUS FORME DE SULFATE)",
    "NOM_COMMERCIALE": "GENTAMICINE CHAUVIN O.3%",
    "FORME": "PDE.OPHT.",
    "DOSAGE": "0.3%",
    "COND": "T/5G",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CHAUVIN",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/4/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "27/4/1998",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["neomycin"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "109/17 D 022/99",
    "CODE_DCI": "17 D 022",
    "DCI": "NEOMYCINE",
    "NOM_COMMERCIALE": "NEO EYE",
    "FORME": "COLLYRE",
    "DOSAGE": "0.35%",
    "COND": "FL/5 ML",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EIPICO",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EGYPTE",
    "DATE_D_ENREGISTREMENT_INITIAL": "21/4/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "21/4/1999",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["neomycin"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "272/ 17 D 022 /06",
    "CODE_DCI": "17 D 022",
    "DCI": "NEOMYCINE (SULFATE)",
    "NOM_COMMERCIALE": "OPHTAMYCIN",
    "FORME": "COLLYRE",
    "DOSAGE": "0.35%",
    "COND": "FL/10ML",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORAS PHARMACEUTICAL S.P.A.",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/7/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "26/7/2006",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["dexamethasone", "neomycin"],
    "InteractionIndexLink": ["dexamethasone"],
    "N_ENREGISTREMENT": "022/ 17 D 024 /99/16",
    "CODE_DCI": "17 D 024",
    "DCI": "Dexamethasone phosphate / Neomycine sulfate",
    "NOM_COMMERCIALE": "CHIBRO-CADRON",
    "FORME": "COLLYRE",
    "DOSAGE": "100MG/350000UI/100ML",
    "COND": "FL/5ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "THEA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/1/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "16/4/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": ["dexamethasone", "neomycin"],
    "InteractionIndexLink": ["dexamethasone"],
    "N_ENREGISTREMENT": "023/ 17 D 024 /99/15",
    "CODE_DCI": "17 D 024",
    "DCI": "DEXAMETHASONE PHOSPHATE SODIQUE EXPRIME EN DEXAMETHASONE/ NEOMYCINE SULFATE",
    "NOM_COMMERCIALE": "DEXAMEX",
    "FORME": "COLLYRE EN SOLUTION",
    "DOSAGE": "100MG/350000UI/100ML",
    "COND": "FL./5ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "UNIMED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "TUNISIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "5/1/2000",
    "DATE_D_ENREGISTREMENT_FINAL": "4/10/2015",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": ["dexamethasone", "neomycin"],
    "InteractionIndexLink": ["dexamethasone"],
    "N_ENREGISTREMENT": "165/ 17 D 024 /98",
    "CODE_DCI": "17 D 024",
    "DCI": "DEXAMETHASONE / NEOMYCINE",
    "NOM_COMMERCIALE": "NEODEX",
    "FORME": "COLLYRE",
    "DOSAGE": "100MG/350000UI/100ML",
    "COND": "FL/10ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "AMMAN PHARMACEUTICAL INDUSTRIE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/10/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "7/10/1998",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": ["dexamethasone", "neomycin"],
    "InteractionIndexLink": ["dexamethasone"],
    "N_ENREGISTREMENT": "119/ 17 D 024 /14",
    "CODE_DCI": "17 D 024",
    "DCI": "DEXAMETHASONE PHOSPHATE/ NEOMYCINE SULFATE EXPRIME EN NEOMYCINE",
    "NOM_COMMERCIALE": "NEODRON",
    "FORME": "COLLYRE",
    "DOSAGE": "1MG/3.5MG",
    "COND": "B/01 FL 5ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALEPPO PHARMACEUTICAL INDUSTRIES (ALPHA)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SYRIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "21/1/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "21/1/2014",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": ["neomycin"],
    "InteractionIndexLink": ["polymyxine b"],
    "N_ENREGISTREMENT": "096/ 17 D 027 /98",
    "CODE_DCI": "17 D 027",
    "DCI": "NEOMYCINE/POLYMYXINE B",
    "NOM_COMMERCIALE": "CEBEMYXINE",
    "FORME": "COLLYRE EN SOLUTION",
    "DOSAGE": "3 400UI/10 000UI",
    "COND": "FL/10ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CHAUVIN",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/4/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "27/4/1998",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["neomycin"],
    "InteractionIndexLink": ["polymyxine b"],
    "N_ENREGISTREMENT": "165/ 17 D 027 /98",
    "CODE_DCI": "17 D 027",
    "DCI": "NEOMYCINE/POLYMYXINE B",
    "NOM_COMMERCIALE": "NEOMIXIN",
    "FORME": "COLLYRE",
    "DOSAGE": "0.5%",
    "COND": "FL/10ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "AMMAN PHARMACEUTICAL INDUSTRIE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/10/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "13/10/1998",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["neomycin", "triamcinolone (topical)"],
    "InteractionIndexLink": ["triamcinolone"],
    "N_ENREGISTREMENT": "012/ 17 D 028 /98/13",
    "CODE_DCI": "17 D 028",
    "DCI": "NEOMYCINE (SULFATE) / TRIAMCINOLONE (ACETONIDE)",
    "NOM_COMMERCIALE": "CRONOLONE-NEO",
    "FORME": "PDE.OPHT.",
    "DOSAGE": "0.35 % / 0.1 %",
    "COND": "B/1T. DE 3G",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FARMACEUTICI CROVIS PH. IL. COM SRL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ITALIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/7/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "21/10/2013",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": ["norfloxacin"],
    "InteractionIndexLink": ["norfloxacine"],
    "N_ENREGISTREMENT": "165/ 17 D 029 /98",
    "CODE_DCI": "17 D 029",
    "DCI": "NORFLOXACINE",
    "NOM_COMMERCIALE": "APIFLOX",
    "FORME": "COLLYRE",
    "DOSAGE": "0.3% (OU 3MG/ML)",
    "COND": "FL/10ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "AMMAN PHARMACEUTICAL INDUSTRIE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/10/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "7/10/1998",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": ["norfloxacin"],
    "InteractionIndexLink": ["norfloxacine"],
    "N_ENREGISTREMENT": "022/17 D 029/99/16",
    "CODE_DCI": "17 D 029",
    "DCI": "NORFLOXACINE",
    "NOM_COMMERCIALE": "CHIBROXINE",
    "FORME": "COLLYRE",
    "DOSAGE": "0.3% (OU 3MG/ML)",
    "COND": "FL/5ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "THEA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/1/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "29/6/2016",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": ["norfloxacin"],
    "InteractionIndexLink": ["norfloxacine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "17 D 029",
    "DCI": "NORFLOXACINE",
    "NOM_COMMERCIALE": "NOROFLOX",
    "FORME": "COLLYRE EN SOLUTION",
    "DOSAGE": "0.3% (300 MG/100ML)",
    "COND": "BOITE DE 1 FLACON DE 5 ML",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "022/ 17 D 033 /99/15",
    "CODE_DCI": "17 D 033",
    "DCI": "RIFAMYCINE",
    "NOM_COMMERCIALE": "RIFAMYCINE CHIBRET",
    "FORME": "COLLYRE EN SOLUTION",
    "DOSAGE": "1 000 000 UI/100ML",
    "COND": "FL/10ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "THEA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/1/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "12/4/2015",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "022/ 17 D 034 /99/16",
    "CODE_DCI": "17 D 034",
    "DCI": "RIFAMYCINE (SODIQUE)",
    "NOM_COMMERCIALE": "RIFAMYCINE CHIBRET",
    "FORME": "PDE.OPHT.",
    "DOSAGE": "1000 000UI/100G (OU 1%)",
    "COND": "T/5G",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "THEA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/1/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "4/1/2017",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": ["ACIDE FUSIDIQUE"],
    "InteractionIndexLink": ["acide fusidique"],
    "N_ENREGISTREMENT": "501/ 17 D 104 /97/15",
    "CODE_DCI": "17 D 104",
    "DCI": "ACIDE FUSIDIQUE",
    "NOM_COMMERCIALE": "FUCITHALMIC",
    "FORME": "GEL OPHT",
    "DOSAGE": "1 %",
    "COND": "T/3G",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "AMDIPHARM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "IRELAND",
    "DATE_D_ENREGISTREMENT_INITIAL": "21/12/1997",
    "DATE_D_ENREGISTREMENT_FINAL": "2/12/2015",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["dexamethasone", "framycetin"],
    "InteractionIndexLink": ["dexamethasone"],
    "N_ENREGISTREMENT": "096/ 17 D 108 /99",
    "CODE_DCI": "17 D 108",
    "DCI": "FRAMYCETINE / DEXAMETHASONE",
    "NOM_COMMERCIALE": "FRAKIDEX",
    "FORME": "COLLYRE EN SOLUTION",
    "DOSAGE": "630.000UI/100MG/100ML",
    "COND": "FL/5ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CHAUVIN",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/5/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "4/5/1999",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["dexamethasone", "oxytetracycline"],
    "InteractionIndexLink": ["dexamethasone", "oxytetracycline"],
    "N_ENREGISTREMENT": "022/ 17 D 117 /00/13",
    "CODE_DCI": "17 D 117",
    "DCI": "DEXAMETHASONE/OXYTETRACYCLINE",
    "NOM_COMMERCIALE": "STERDEX",
    "FORME": "PDE .OPHT.EN RECIPIENT UNIDOSE",
    "DOSAGE": "0.267MG/1.335MG/RECIPIENT UNIDOSE",
    "COND": "B/12 RECIPIENTS UNIDOSE",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "THEA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "21/6/2000",
    "DATE_D_ENREGISTREMENT_FINAL": "27/11/2013",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["tobramycin"],
    "InteractionIndexLink": ["tobramycine"],
    "N_ENREGISTREMENT": "543/ 17 D 122 /18",
    "CODE_DCI": "17 D 122",
    "DCI": "TOBRAMYCINE",
    "NOM_COMMERCIALE": "OBRAX",
    "FORME": "COLLYRE",
    "DOSAGE": "0.30 %",
    "COND": "FL COMPTE GOUTTE DE 5 ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOTHERA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/4/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "2/4/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": ["tobramycin"],
    "InteractionIndexLink": ["tobramycine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "17 D 122",
    "DCI": "TOBRAMYCINE",
    "NOM_COMMERCIALE": "OBRAX",
    "FORME": "COLLYRE",
    "DOSAGE": "0.003",
    "COND": "FL COMPTE GOUTTE DE 5 ML",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": ["tobramycin"],
    "InteractionIndexLink": ["tobramycine"],
    "N_ENREGISTREMENT": "317/17 D 122/20",
    "CODE_DCI": "17 D 122",
    "DCI": "TOBRAMYCINE",
    "NOM_COMMERCIALE": "TOBRADIS",
    "FORME": "COLLYRE EN SOLUTION",
    "DOSAGE": "0.3% (3MG/ML)",
    "COND": "B/ 1 FLC COMPTE GOUTTE DE 5ML",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES INPHA-Médis SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/12/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "15/12/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": ["tobramycin"],
    "InteractionIndexLink": ["tobramycine"],
    "N_ENREGISTREMENT": "317/17 D 122/20",
    "CODE_DCI": "17 D 122",
    "DCI": "TOBRAMYCINE",
    "NOM_COMMERCIALE": "TOBRADIS",
    "FORME": "COLLYRE EN SOLUTION",
    "DOSAGE": "0.3% (3MG/ML)",
    "COND": "B/ 1 FLC COMPTE GOUTTE DE 5ML",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES INPHA-Médis SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/12/20",
    "DATE_D_ENREGISTREMENT_FINAL": "15/12/20",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": ["tobramycin"],
    "InteractionIndexLink": ["tobramycine"],
    "N_ENREGISTREMENT": "028/ 17 D 122 /01/16",
    "CODE_DCI": "17 D 122",
    "DCI": "TOBRAMYCINE",
    "NOM_COMMERCIALE": "TOBREX",
    "FORME": "COLLYRE",
    "DOSAGE": "300 000UI",
    "COND": "FL/5ML+COMPTE GOUTTE",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALCON",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "31/3/2001",
    "DATE_D_ENREGISTREMENT_FINAL": "11/9/2016",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": ["dexamethasone", "framycetin"],
    "InteractionIndexLink": ["dexamethasone"],
    "N_ENREGISTREMENT": "096/ 17 D 125 /01",
    "CODE_DCI": "17 D 125",
    "DCI": "FRAMYCETINE /DEXAMETHASONE",
    "NOM_COMMERCIALE": "FRAKIDEX",
    "FORME": "PDE.OPHT.",
    "DOSAGE": "315 000 UI/0.1G/100G",
    "COND": "T/5G",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CHAUVIN",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/2/2001",
    "DATE_D_ENREGISTREMENT_FINAL": "10/2/2001",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": ["neomycin"],
    "InteractionIndexLink": ["polymyxine b"],
    "N_ENREGISTREMENT": "096/ 17 D 129 /02",
    "CODE_DCI": "17 D 129",
    "DCI": "NEOMYCINE / POLYMYXINE B",
    "NOM_COMMERCIALE": "CEBEMYXINE",
    "FORME": "PDE OPHT",
    "DOSAGE": "340 000UI/1 000 000 UI /100G",
    "COND": "T/5G",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CHAUVIN",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/5/2002",
    "DATE_D_ENREGISTREMENT_FINAL": "6/5/2002",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["ciprofloxacin"],
    "InteractionIndexLink": ["ciprofloxacine"],
    "N_ENREGISTREMENT": "20/17 D131/317",
    "CODE_DCI": "17 D 131",
    "DCI": "CIPROFLOXACINE",
    "NOM_COMMERCIALE": "CIPRO",
    "FORME": "COLLYRE",
    "DOSAGE": "0.3%",
    "COND": "FL /05 ML",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INPHA MEDIS SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/05/20",
    "DATE_D_ENREGISTREMENT_FINAL": "19/05/20",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": ["ciprofloxacin"],
    "InteractionIndexLink": ["ciprofloxacine"],
    "N_ENREGISTREMENT": "272/ 17 D 131 /03/09",
    "CODE_DCI": "17 D 131",
    "DCI": "CIPROFLOXACINE  (SOUS FORME D' HDROCHLORIDE MONOHYDRATE)",
    "NOM_COMMERCIALE": "CIPRODAR",
    "FORME": "COLLYRE",
    "DOSAGE": "0.3%",
    "COND": "FL/10ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORAS PHARMACEUTICAL S.P.A.",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/7/2003",
    "DATE_D_ENREGISTREMENT_FINAL": "7/3/2009",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": ["ciprofloxacin"],
    "InteractionIndexLink": ["ciprofloxacine"],
    "N_ENREGISTREMENT": "543/ 17 D 131 /18",
    "CODE_DCI": "17 D 131",
    "DCI": "CIPROFLOXACINE CHLORHYDRATE EXPRIME EN CIPROFLOXACINE",
    "NOM_COMMERCIALE": "CIPROTEK",
    "FORME": "COLLYRE",
    "DOSAGE": "0.3%",
    "COND": "FL COMPTE GOUTTE DE 5 ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOTHERA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/9/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "26/9/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": ["ciprofloxacin"],
    "InteractionIndexLink": ["ciprofloxacine"],
    "N_ENREGISTREMENT": "543/ 17 D 131 /18",
    "CODE_DCI": "17 D 131",
    "DCI": "CIPROFLOXACINE CHLORHYDRATE EXPRIME EN CIPROFLOXACINE",
    "NOM_COMMERCIALE": "CIPROTEK",
    "FORME": "COLLYRE",
    "DOSAGE": "0.30 %",
    "COND": "FL COMPTE GOUTTE DE 5 ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOTHERA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/09/18",
    "DATE_D_ENREGISTREMENT_FINAL": "26/09/18",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": ["ciprofloxacin"],
    "InteractionIndexLink": ["ciprofloxacine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "17 D 131",
    "DCI": "CIPROFLOXACINE CHLORHYDRATE EXPRIME EN CIPROFLOXACINE",
    "NOM_COMMERCIALE": "CIPROTEK",
    "FORME": "COLLYRE",
    "DOSAGE": "0.003",
    "COND": "FL COMPTE GOUTTE DE 5 ML",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": ["ciprofloxacin"],
    "InteractionIndexLink": ["ciprofloxacine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "17 D 131",
    "DCI": "Ciprofloxacine",
    "NOM_COMMERCIALE": "CIPRO® 0.3 %",
    "FORME": "Collyre",
    "DOSAGE": "0.3 %",
    "COND": "Flacon de 5 ml",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": ["gentamicin", "indometacin"],
    "InteractionIndexLink": ["gentamicine", "indometacine"],
    "N_ENREGISTREMENT": "096/ 17 D 138 /04",
    "CODE_DCI": "17 D 138",
    "DCI": "INDOMETACINE/GENTAMICINE",
    "NOM_COMMERCIALE": "INDOBIOTIC",
    "FORME": "COLLYRE",
    "DOSAGE": "5MG/15 000UI/5ML",
    "COND": "FL/5ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CHAUVIN",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/6/2004",
    "DATE_D_ENREGISTREMENT_FINAL": "30/6/2004",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["betamethasone", "neomycin"],
    "InteractionIndexLink": ["betamethasone"],
    "N_ENREGISTREMENT": "272/ 17 D 144 /06",
    "CODE_DCI": "17 D 144",
    "DCI": "BETAMETHASONE SODIUM PHOSPHATE / NEOMYCINE SULFATE",
    "NOM_COMMERCIALE": "OPHTAMESONE N",
    "FORME": "COLLY. . SOL AURIC. .SOL. NAS.",
    "DOSAGE": "1MG/5MG/ML",
    "COND": "FL/10ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORAS PHARMACEUTICAL S.P.A.",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/7/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "26/7/2006",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["ciprofloxacin"],
    "InteractionIndexLink": ["ciprofloxacine"],
    "N_ENREGISTREMENT": "028/ 17 D 151 /08/16",
    "CODE_DCI": "17 D 151",
    "DCI": "CIPROFLOXACINE CHLORHYDRATE EXPRIME EN CIPROFLOXACINE",
    "NOM_COMMERCIALE": "CILOXAN",
    "FORME": "PDE.OPHT.",
    "DOSAGE": "0.3%",
    "COND": "T/3.5G",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALCON",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/1/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "11/9/2016",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["gatifloxacin"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "065/17 D 155/17",
    "CODE_DCI": "17 D 155",
    "DCI": "GATIFLOXACINE (SOUS FORME DE GATIFLOXACINE SESQUIHYDRATE)",
    "NOM_COMMERCIALE": "GATIFLOXACINE GL",
    "FORME": "COLLYRE",
    "DOSAGE": "0.3% ( 3mg/ml)",
    "COND": "FL./5ML",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GENERIC LAB",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/4/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "9/4/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["gatifloxacin"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "386/ 17 D 155 / 08",
    "CODE_DCI": "17 D 155",
    "DCI": "GATIFLOXACINE (SOUS FORME DE GATIFLOXACINE SESQUIHYDRATE)",
    "NOM_COMMERCIALE": "TYMER",
    "FORME": "COLLYRE",
    "DOSAGE": "0.3%",
    "COND": "FL./5ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JAMJOOM PHARMACEUTICAL INDUSTRY",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ARABIE SAOUDITE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/12/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "17/12/2008",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["ofloxacin"],
    "InteractionIndexLink": ["ofloxacine"],
    "N_ENREGISTREMENT": "065/17 D 157/17",
    "CODE_DCI": "17 D 157",
    "DCI": "Ofloxacine",
    "NOM_COMMERCIALE": "CORONOL",
    "FORME": "COLLYRE EN SOLUTION",
    "DOSAGE": "0.3% ( 3mg/ml)",
    "COND": "FL/5ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GENERIC LAB",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/5/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "7/5/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 mois",
    "availableInAlgeria": false,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": ["ofloxacin"],
    "InteractionIndexLink": ["ofloxacine"],
    "N_ENREGISTREMENT": "543/17 D 157/19",
    "CODE_DCI": "17 D 157",
    "DCI": "Ofloxacine",
    "NOM_COMMERCIALE": "OFLOTEK",
    "FORME": "COLLYRE EN SOLUTION",
    "DOSAGE": "0.3% ( 3mg/ml)",
    "COND": "FL COMPTE GOUTTES DE  5ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOTHERA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/4/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "22/4/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 mois",
    "availableInAlgeria": false,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": ["ofloxacin"],
    "InteractionIndexLink": ["ofloxacine"],
    "N_ENREGISTREMENT": "543/17 D 157/19",
    "CODE_DCI": "17 D 157",
    "DCI": "Ofloxacine",
    "NOM_COMMERCIALE": "OFLOTEK",
    "FORME": "COLLYRE EN SOLUTION",
    "DOSAGE": "0.3% ( 3mg/ml)",
    "COND": "FL COMPTE GOUTTES DE 5ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOTHERA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/04/19",
    "DATE_D_ENREGISTREMENT_FINAL": "22/04/19",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 mois",
    "availableInAlgeria": true,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": ["ofloxacin"],
    "InteractionIndexLink": ["ofloxacine"],
    "N_ENREGISTREMENT": "386/ 17 D 157 /12",
    "CODE_DCI": "17 D 157",
    "DCI": "Ofloxacine",
    "NOM_COMMERCIALE": "OPTIFLOX",
    "FORME": "COLLYRE EN SOLUTION",
    "DOSAGE": "0.3%",
    "COND": "FL/5ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JAMJOOM PHARMACEUTICAL INDUSTRY",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ARABIE SAOUDITE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/5/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "9/5/2012",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": ["dexamethasone", "tobramycin"],
    "InteractionIndexLink": ["dexamethasone", "tobramycine"],
    "N_ENREGISTREMENT": "20/17 D159/543",
    "CODE_DCI": "17 D 159",
    "DCI": "TOBRAMYCINE/ DEXAMETHASONE",
    "NOM_COMMERCIALE": "DEXATEK",
    "FORME": "COLLYRE EN SOL",
    "DOSAGE": "3MG/ 1MG",
    "COND": "FL/ 05ML",
    "LISTE": "LISTE II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOTHERA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/02/20",
    "DATE_D_ENREGISTREMENT_FINAL": "25/02/20",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["dexamethasone", "tobramycin"],
    "InteractionIndexLink": ["dexamethasone", "tobramycine"],
    "N_ENREGISTREMENT": "386/ 17 D 159 /09",
    "CODE_DCI": "17 D 159",
    "DCI": "TOBRAMYCINE / DEXAMETHASONE",
    "NOM_COMMERCIALE": "OPTIDEX-T",
    "FORME": "COLLYRE EN SUSPENSION",
    "DOSAGE": "0.3% / 0.1%",
    "COND": "FL./5ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JAMJOOM PHARMACEUTICAL INDUSTRY",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ARABIE SAOUDITE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/6/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "15/6/2009",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["dexamethasone", "tobramycin"],
    "InteractionIndexLink": ["dexamethasone", "tobramycine"],
    "N_ENREGISTREMENT": "065/ 17 D 159 /18",
    "CODE_DCI": "17 D 159",
    "DCI": "TOBRAMYCINE / DEXAMETHASONE",
    "NOM_COMMERCIALE": "TAUBRIGENE",
    "FORME": "COLLYRE",
    "DOSAGE": "0.3% / 0.1%",
    "COND": "FL./5ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL GENERIC LAB",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/10/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "9/10/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["azithromycin"],
    "InteractionIndexLink": ["azithromycine"],
    "N_ENREGISTREMENT": "022/17 D 164/09/16",
    "CODE_DCI": "17 D 164",
    "DCI": "Azithromycine Dihydratee Exprimee En Azithromycine",
    "NOM_COMMERCIALE": "AZYTER",
    "FORME": "COLLYRE EN SOLUTION EN RECIPIENT UNIDOSE",
    "DOSAGE": "15 MG/G",
    "COND": "B/06RECIPIENTS UNIDOSES SOUS SACHET",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "THEA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/12/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "11/9/2016",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "18 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": ["dexamethasone", "oxytetracycline"],
    "InteractionIndexLink": ["dexamethasone", "oxytetracycline"],
    "N_ENREGISTREMENT": "003/ 17 D 172/13",
    "CODE_DCI": "17 D 172",
    "DCI": "OXYTETRACYCLINE CHLORHYDRATE/ DEXAMETHASONE",
    "NOM_COMMERCIALE": "OXYDEX",
    "FORME": "PDE. OPHT",
    "DOSAGE": "0.5%/0.1%",
    "COND": "TUBE/3G",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SAIDALGROUPE INDUSTRIEL EPE/SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/12/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "27/12/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["ofloxacin"],
    "InteractionIndexLink": ["ofloxacine"],
    "N_ENREGISTREMENT": "185 /17 D 176/18",
    "CODE_DCI": "17 D 176",
    "DCI": "Ofloxacine",
    "NOM_COMMERCIALE": "FLOXEDOL",
    "FORME": "COLLY. EN GEL OPHTA",
    "DOSAGE": "0.3% (3 MG/ML)",
    "COND": "FL/10ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GROUPEMENT PHARMACEUTIQUE ALGERIEN (GPA)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "16/1/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "16/1/2018",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "179/ 17 E 037 /98/17",
    "CODE_DCI": "17 E 037",
    "DCI": "ACIDE BORIQUE/BORATE DE SODIUM",
    "NOM_COMMERCIALE": "DACRYOSERUM",
    "FORME": "SOL.LAVAGE OPHT.",
    "DOSAGE": "1.8%/1.2%",
    "COND": "FL/150 ML ET B/20RECIPIENTS UNIDOSES DE 5ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MC NEIL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/12/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "16/4/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS FL/150 ML ET 36 MOIS RECIPIENTS UNIDOSES DE 5 ML",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "022/ 17 E 119 /00/14",
    "CODE_DCI": "17 E 119",
    "DCI": "PICLOXYDINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "VITABACT",
    "FORME": "COLLYRE",
    "DOSAGE": "0.05 %",
    "COND": "FL/10ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "THEA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/2/2000",
    "DATE_D_ENREGISTREMENT_FINAL": "27/10/2014",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "096/ 17 E 158 /08/16",
    "CODE_DCI": "17 E 158",
    "DCI": "HEXAMIDINE (SOUS FORME DE DI-ISETHIONATE)",
    "NOM_COMMERCIALE": "DESOMEDINE",
    "FORME": "COLLYRE",
    "DOSAGE": "0.1%",
    "COND": "FL/10ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CHAUVIN S.A.",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/1/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "12/3/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["aciclovir (topical)"],
    "InteractionIndexLink": ["aciclovir"],
    "N_ENREGISTREMENT": "218/ 17 F 042 /99",
    "CODE_DCI": "17 F 042",
    "DCI": "ACICLOVIR",
    "NOM_COMMERCIALE": "ACICLOSINA",
    "FORME": "PDE.OPHT.",
    "DOSAGE": "3% (OU 30MG/G)",
    "COND": "T/5G",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CIPAN",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PORTUGAL",
    "DATE_D_ENREGISTREMENT_INITIAL": "21/8/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "21/8/1999",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["ganciclovir"],
    "InteractionIndexLink": ["ganciclovir"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "17 F 130",
    "DCI": "GANCICLOVIR",
    "NOM_COMMERCIALE": "VIRGAN",
    "FORME": "GEL.OPHT",
    "DOSAGE": "0.15%.",
    "COND": "T/5G",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": ["dexamethasone", "neomycin"],
    "InteractionIndexLink": ["dexamethasone", "polymyxine b"],
    "N_ENREGISTREMENT": "119/ 17 G 048 /14",
    "CODE_DCI": "17 G 048",
    "DCI": "DEXAMETHASONE/ NEOMYCINE SULFATE/ POLYMYXINE B SULFATE",
    "NOM_COMMERCIALE": "ALPHAXITROL",
    "FORME": "COLLYRE",
    "DOSAGE": "1MG/3500UI/6000UI",
    "COND": "FL/ COMPTE GTTES 5ML",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALEPPO PHARMACEUTICAL INDUSTRIES (ALPHA)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SYRIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/4/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "28/4/2014",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": ["dexamethasone", "neomycin"],
    "InteractionIndexLink": ["dexamethasone", "polymyxine b"],
    "N_ENREGISTREMENT": "455/ 17 G 048 /99/18",
    "CODE_DCI": "17 G 048",
    "DCI": "DEXAMETHASONE / NEOMYCINE SULFATE / POLYMYXINE B SULFATE",
    "NOM_COMMERCIALE": "MAXILODRE",
    "FORME": "COLLYRE",
    "DOSAGE": "100MG/350 000UI/60 0000UI /100ML",
    "COND": "B/1 FL COMPTE GTTES DE 3ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL GENCOPHARM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/11/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "18/6/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": ["dexamethasone", "neomycin"],
    "InteractionIndexLink": ["dexamethasone", "polymyxine b"],
    "N_ENREGISTREMENT": "023/ 17 G 048 /99/15",
    "CODE_DCI": "17 G 048",
    "DCI": "DEXAMETHASONE PHOSPHATE SODIQUE EXPRIME EN DEXAMETHASONE / NEOMYCINE SULFATE / POLYMYXINE B SULFATE",
    "NOM_COMMERCIALE": "P.N.D.",
    "FORME": "COLLYRE EN SOLUTION",
    "DOSAGE": "100MG/350000UI/600000UI/100ML",
    "COND": "FL/3ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "UNIMED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "TUNISIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "5/1/2000",
    "DATE_D_ENREGISTREMENT_FINAL": "4/10/2015",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": ["hydrocortisone"],
    "InteractionIndexLink": ["hydrocortisone"],
    "N_ENREGISTREMENT": "165/ 17 G 051 /98",
    "CODE_DCI": "17 G 051",
    "DCI": "HYDROCORTISONE",
    "NOM_COMMERCIALE": "HYDROCORT",
    "FORME": "COLLYRE",
    "DOSAGE": "1 %",
    "COND": "FL/10ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "AMMAN PHARMACEUTICAL INDUSTRIE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/10/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "13/10/1998",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["triamcinolone (topical)"],
    "InteractionIndexLink": ["triamcinolone"],
    "N_ENREGISTREMENT": "012/ 17 G 054 /98/13",
    "CODE_DCI": "17 G 054",
    "DCI": "TRIAMCINOLONE ACETONIDE",
    "NOM_COMMERCIALE": "CRONOLONE",
    "FORME": "PDE.OPHT.",
    "DOSAGE": "0.1%",
    "COND": "B/1T. DE 5G",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FARMACEUTICI CROVIS PH. IL. COM SRL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ITALIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/7/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "21/10/2013",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["dexamethasone", "neomycin"],
    "InteractionIndexLink": ["dexamethasone", "polymyxine b"],
    "N_ENREGISTREMENT": "068/ 17 G 110 /00/15",
    "CODE_DCI": "17 G 110",
    "DCI": "DEXAMETHASONE / NEOMYCINE SULFATE / POLYMYXINE B SULFATE",
    "NOM_COMMERCIALE": "MAXIDROL",
    "FORME": "PDE.OPHT.",
    "DOSAGE": "0.1G/350000UI/600000UI/100G",
    "COND": "T/3.5G",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVARTIS PHARMA SCHWEIZ AG",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SUISSE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/2/2000",
    "DATE_D_ENREGISTREMENT_FINAL": "9/8/2015",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["fluorometholone"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "389/ 17 G 134 /12",
    "CODE_DCI": "17 G 134",
    "DCI": "FLUOROMETHOLONE",
    "NOM_COMMERCIALE": "OPTIF JAM",
    "FORME": "COLLYRE EN SOLUTION",
    "DOSAGE": "0.1%",
    "COND": "FL/5ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JAMJOOM PHARMACEUTICAL INDUSTRY",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ARABIE SAOUDITE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/5/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "9/5/2012",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": ["fluorometholone"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "17 G 134",
    "DCI": "FLUOROMETHOLONE",
    "NOM_COMMERCIALE": "OPTIF JAM",
    "FORME": "COLLYRE EN SOLUTION",
    "DOSAGE": "0.001",
    "COND": "FL/5ML",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": ["prednisolone"],
    "InteractionIndexLink": ["prednisolone"],
    "N_ENREGISTREMENT": "272/ 17 G 142 /06",
    "CODE_DCI": "17 G 142",
    "DCI": "PREDNISOLONE",
    "NOM_COMMERCIALE": "OPHTAPRED",
    "FORME": "COLLYRE",
    "DOSAGE": "0.5%",
    "COND": "FL/10ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORAS PHARMACEUTICAL S.P.A.",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/6/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "27/6/2006",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["betamethasone"],
    "InteractionIndexLink": ["betamethasone"],
    "N_ENREGISTREMENT": "272/ 17 G 143 /06",
    "CODE_DCI": "17 G 143",
    "DCI": "BETAMETHASONE SODIUM PHOSPHATE",
    "NOM_COMMERCIALE": "OPHTAMESONE",
    "FORME": "COLLY. - SOL AURIC. -  SOL. NAS.",
    "DOSAGE": "1MG/ML",
    "COND": "FL/10ML",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORAS PHARMACEUTICAL S.P.A.",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/7/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "26/7/2006",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["prednisolone"],
    "InteractionIndexLink": ["prednisolone"],
    "N_ENREGISTREMENT": "386/ 17 G 167/12",
    "CODE_DCI": "17 G 167",
    "DCI": "PREDNISOLONE (SOUS FORME D'ACETATE)",
    "NOM_COMMERCIALE": "OPTIPRED",
    "FORME": "COLLYRE EN SUSPENSION",
    "DOSAGE": "1 %",
    "COND": "FL/5ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JAMJOOM PHARMACEUTICAL INDUSTRY",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ARABIE SAOUDITE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/5/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "15/5/2012",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": ["prednisolone"],
    "InteractionIndexLink": ["prednisolone"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "17 G 167",
    "DCI": "PREDNISOLONE (SOUS FORME D'ACETATE)",
    "NOM_COMMERCIALE": "OPTIPRED",
    "FORME": "COLLYRE EN SUSPENSION",
    "DOSAGE": "0.01",
    "COND": "FL/5ML",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": ["dexamethasone", "ofloxacin"],
    "InteractionIndexLink": ["dexamethasone", "ofloxacine"],
    "N_ENREGISTREMENT": "386/ 17 G 168 /12",
    "CODE_DCI": "17 G 168",
    "DCI": "DEXAMETHASONE / OFLOXACINE",
    "NOM_COMMERCIALE": "DEXAFLOX",
    "FORME": "COLLYRE EN SUSPENSION",
    "DOSAGE": "1MG/3MG/ML",
    "COND": "FL/5ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JAMJOOM PHARMACEUTICAL INDUSTRY",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ARABIE SAOUDITE",
    "DATE_D_ENREGISTREMENT_INITIAL": "14/5/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "14/5/2012",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["dexamethasone", "ofloxacin"],
    "InteractionIndexLink": ["dexamethasone", "ofloxacine"],
    "N_ENREGISTREMENT": "20/17 G 168/543",
    "CODE_DCI": "17 G 168",
    "DCI": "DEXAMETHASONE/ OFLOXACINE",
    "NOM_COMMERCIALE": "OFLODEXA",
    "FORME": "COLLYRE EN SOL.",
    "DOSAGE": "1MG/ 3MG",
    "COND": "FL/5ML",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOTHERA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/06/20",
    "DATE_D_ENREGISTREMENT_FINAL": "18/06/20",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["dexamethasone"],
    "InteractionIndexLink": ["dexamethasone"],
    "N_ENREGISTREMENT": "022/ 17 G 173 /14",
    "CODE_DCI": "17 G 173",
    "DCI": "DEXAMETHASONE PHOSPHATE SODIQUE EXPRIME EN DEXAMETHASONE PHOSPHATE",
    "NOM_COMMERCIALE": "DEXAFREE",
    "FORME": "COLLYRE",
    "DOSAGE": "1MG/ML",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "THEA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/3/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "19/3/2014",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["atropine"],
    "InteractionIndexLink": ["atropine"],
    "N_ENREGISTREMENT": "165/ 17 H 057 /98",
    "CODE_DCI": "17 H 057",
    "DCI": "ATROPINE",
    "NOM_COMMERCIALE": "APITROPIN",
    "FORME": "COLLYRE",
    "DOSAGE": "0.5%",
    "COND": "FL/10ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "AMMAN PHARMACEUTICAL INDUSTRIE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/10/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "7/10/1998",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": ["atropine"],
    "InteractionIndexLink": ["atropine"],
    "N_ENREGISTREMENT": "012/ 17 H 057 /99/13",
    "CODE_DCI": "17 H 057",
    "DCI": "ATROPINE (SULFATE) EXPRIME EN ATROPINE",
    "NOM_COMMERCIALE": "CROPINE",
    "FORME": "COLLYRE",
    "DOSAGE": "0.5%",
    "COND": "FL/15ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FARMACEUTICI CROVIS PH. IL. COM SRL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ITALIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/11/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "27/10/2013",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": ["atropine"],
    "InteractionIndexLink": ["atropine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "17 H 057",
    "DCI": "ATROPINE (SULFATE) EXPRIME EN ATROPINE",
    "NOM_COMMERCIALE": "CROPINE",
    "FORME": "COLLYRE",
    "DOSAGE": "0.005",
    "COND": "FL/15ML",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": ["atropine"],
    "InteractionIndexLink": ["atropine"],
    "N_ENREGISTREMENT": "165/ 17 H 058 /98",
    "CODE_DCI": "17 H 058",
    "DCI": "ATROPINE",
    "NOM_COMMERCIALE": "APITROPIN",
    "FORME": "COLLYRE",
    "DOSAGE": "1 %",
    "COND": "FL/10ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "AMMAN PHARMACEUTICAL INDUSTRIE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/10/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "7/10/1998",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": ["atropine"],
    "InteractionIndexLink": ["atropine"],
    "N_ENREGISTREMENT": "012/ 17 H 058 /99/13",
    "CODE_DCI": "17 H 058",
    "DCI": "ATROPINE (SULFATE) EXPRIME EN ATROPINE",
    "NOM_COMMERCIALE": "CROPINE",
    "FORME": "COLLYRE",
    "DOSAGE": "1 %",
    "COND": "FL/15ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FARMACEUTICI CROVIS PH. IL. COM SRL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ITALIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/11/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "27/10/2013",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": ["atropine"],
    "InteractionIndexLink": ["atropine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "17 H 058",
    "DCI": "ATROPINE (SULFATE) EXPRIME EN ATROPINE",
    "NOM_COMMERCIALE": "CROPINE",
    "FORME": "COLLYRE",
    "DOSAGE": "0.01",
    "COND": "FL/15ML",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": ["cyclopentolate"],
    "InteractionIndexLink": ["cyclopentolate"],
    "N_ENREGISTREMENT": "165/ 17 H 059 /98",
    "CODE_DCI": "17 H 059",
    "DCI": "CYCLOPENTOLATE",
    "NOM_COMMERCIALE": "PENTOLATE",
    "FORME": "COLLYRE",
    "DOSAGE": "0.5%",
    "COND": "FL/10ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "AMMAN PHARMACEUTICAL INDUSTRIE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/10/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "7/10/1998",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["phenylephrine"],
    "InteractionIndexLink": ["phenylephrine"],
    "N_ENREGISTREMENT": "165/ 17 H 061 /98",
    "CODE_DCI": "17 H 061",
    "DCI": "PHENYLEPHRINE",
    "NOM_COMMERCIALE": "APIFRIN -10",
    "FORME": "COLLYRE",
    "DOSAGE": "10 %",
    "COND": "FL/10ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "AMMAN PHARMACEUTICAL INDUSTRIE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/10/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "7/10/1998",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["phenylephrine"],
    "InteractionIndexLink": ["phenylephrine"],
    "N_ENREGISTREMENT": "316/17 H 061/97/16",
    "CODE_DCI": "17 H 061",
    "DCI": "PHENYLEPHRINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "NEOSYNEPHRINE FAURE 10%",
    "FORME": "COLLYRE EN SOLUTION",
    "DOSAGE": "10 %",
    "COND": "FL/5 ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EUROPHTA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MONACO",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/9/1997",
    "DATE_D_ENREGISTREMENT_FINAL": "4/1/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["tropicamide"],
    "InteractionIndexLink": ["tropicamide"],
    "N_ENREGISTREMENT": "022/ 17 H 062 /99/15",
    "CODE_DCI": "17 H 062",
    "DCI": "TROPICAMIDE",
    "NOM_COMMERCIALE": "MYDRIATICUM",
    "FORME": "COLLYRE EN SOLUTION",
    "DOSAGE": "0.5%",
    "COND": "FL./10ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "THEA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/1/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "12/10/2015",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": ["tropicamide"],
    "InteractionIndexLink": ["tropicamide"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "17 H 062",
    "DCI": "TROPICAMIDE",
    "NOM_COMMERCIALE": "MYDRIATICUM",
    "FORME": "COLLYRE EN SOLUTION",
    "DOSAGE": "0.005",
    "COND": "FL./10ML",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": ["tropicamide"],
    "InteractionIndexLink": ["tropicamide"],
    "N_ENREGISTREMENT": "023/ 17 H 062 /07/14",
    "CODE_DCI": "17 H 062",
    "DCI": "TROPICAMIDE",
    "NOM_COMMERCIALE": "MYDRICOL",
    "FORME": "COLLYRE EN SOLUTION",
    "DOSAGE": "0.5%",
    "COND": "FL./5ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "UNIMED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "TUNISIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/6/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "18/1/2015",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": ["cyclopentolate"],
    "InteractionIndexLink": ["cyclopentolate"],
    "N_ENREGISTREMENT": "185/ 17 H175 /17",
    "CODE_DCI": "17 H 175",
    "DCI": "CYCLOPENTOLATE CHLORHYDRATE",
    "NOM_COMMERCIALE": "CICLOPLEGICEDOL",
    "FORME": "COLLYRE",
    "DOSAGE": "( 10MG/ML)1 %",
    "COND": "FL/5ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GROUPEMENT PHARMACEUTIQUE ALGERIEN (GPA)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "11/12/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "11/12/2017",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["indometacin"],
    "InteractionIndexLink": ["indometacine"],
    "N_ENREGISTREMENT": "096/ 17 J 066 /98/17",
    "CODE_DCI": "17 J 066",
    "DCI": "Indométacine",
    "NOM_COMMERCIALE": "INDOCOLLYRE",
    "FORME": "COLLYRE",
    "DOSAGE": "0.1%",
    "COND": "B/01 FL DE 5ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CHAUVIN SA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/4/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "26/11/2017",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "18 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": ["indometacin"],
    "InteractionIndexLink": ["indometacine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "17 J 066",
    "DCI": "Indométacine",
    "NOM_COMMERCIALE": "INDOCOLLYRE",
    "FORME": "COLLYRE",
    "DOSAGE": "0.001",
    "COND": "B/01 FL DE 5ML",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": ["diclofenac"],
    "InteractionIndexLink": ["diclofenac"],
    "N_ENREGISTREMENT": "022/ 17 J 118 /09/17",
    "CODE_DCI": "17 J 118",
    "DCI": "Diclofénac sodique",
    "NOM_COMMERCIALE": "DICLOCED",
    "FORME": "COLLYRE",
    "DOSAGE": "1MG/ML",
    "COND": "FL/10ML",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "THEA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "24/10/2017",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": ["diclofenac"],
    "InteractionIndexLink": ["diclofenac"],
    "N_ENREGISTREMENT": "272/ 17 J 118 /02/09",
    "CODE_DCI": "17 J 118",
    "DCI": "Diclofénac sodique",
    "NOM_COMMERCIALE": "DICLOGESIC",
    "FORME": "COLLYRE",
    "DOSAGE": "0.1%",
    "COND": "FL/5ML",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORAS PHARMACEUTICAL S.P.A.",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "14/12/2002",
    "DATE_D_ENREGISTREMENT_FINAL": "28/2/2009",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": ["diclofenac"],
    "InteractionIndexLink": ["diclofenac"],
    "N_ENREGISTREMENT": "055/17 J 118/02/21",
    "CODE_DCI": "17 J 118",
    "DCI": "Diclofénac sodique",
    "NOM_COMMERCIALE": "DICLOGESIC",
    "FORME": "COLLYRE EN SOLUTION",
    "DOSAGE": "0.1%",
    "COND": "FLC COMPTE GOUTTE 05ML",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "DAR AL DAWA DEVELOPMENT & INVESTMENT Co Ltd",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/02/02",
    "DATE_D_ENREGISTREMENT_FINAL": "23/05/21",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": ["diclofenac"],
    "InteractionIndexLink": ["diclofenac"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "17 J 118",
    "DCI": "Diclofenac sodium",
    "NOM_COMMERCIALE": "Diclogesic 0.1%",
    "FORME": "COLLYRE",
    "DOSAGE": "0.001",
    "COND": "Fl/5ML",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": ["diclofenac"],
    "InteractionIndexLink": ["diclofenac"],
    "N_ENREGISTREMENT": "271/17 J 188/00",
    "CODE_DCI": "17 J 118",
    "DCI": "Diclofénac sodique",
    "NOM_COMMERCIALE": "VOLTARENE",
    "FORME": "COLLYRE",
    "DOSAGE": "0.1%",
    "COND": "FL/5ML",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVARTIS OPHTALMICS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "8/4/2000",
    "DATE_D_ENREGISTREMENT_FINAL": "8/4/2000",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": ["diclofenac"],
    "InteractionIndexLink": ["diclofenac"],
    "N_ENREGISTREMENT": "065/ 17 J 118 /16",
    "CODE_DCI": "17 J 118",
    "DCI": "Diclofénac sodique",
    "NOM_COMMERCIALE": "XINAC",
    "FORME": "COLLYRE",
    "DOSAGE": "0.1%",
    "COND": "FL/5ML",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GENCOPHARM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/4/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "19/4/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": ["diclofenac"],
    "InteractionIndexLink": ["diclofenac"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "17 J 118",
    "DCI": "Diclofénac sodique",
    "NOM_COMMERCIALE": "XINAC",
    "FORME": "COLLYRE",
    "DOSAGE": "0.001",
    "COND": "FL/5ML",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": ["nandrolone"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "096/ 17 K 075 /98",
    "CODE_DCI": "17 K 075",
    "DCI": "NANDROLONE",
    "NOM_COMMERCIALE": "KERATYL",
    "FORME": "COLLYRE",
    "DOSAGE": "1 %",
    "COND": "FL/5ML",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CHAUVIN",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/4/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "27/4/1998",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["RETINOL"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "17 K 078",
    "DCI": "RETINOL",
    "NOM_COMMERCIALE": "VITAMINE A",
    "FORME": "COLLYRE",
    "DOSAGE": "150 000UI",
    "COND": "FL/10ML",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": ["RETINOL"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "316/17 K 078/98/16",
    "CODE_DCI": "17 K 078",
    "DCI": "RETINOL",
    "NOM_COMMERCIALE": "VITAMINE A FAURE",
    "FORME": "COLLYRE",
    "DOSAGE": "150 000UI",
    "COND": "FL/10ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EUROPHTA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MONACO",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/4/1997",
    "DATE_D_ENREGISTREMENT_FINAL": "4/1/2017",
    "TYPE": "Ré",
    "STATUT": "i",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "096/ 17 K 133 /01",
    "CODE_DCI": "17 K 133",
    "DCI": "CARBOMERE 980",
    "NOM_COMMERCIALE": "LACRINORM",
    "FORME": "GEL.OPHT",
    "DOSAGE": "0.2%",
    "COND": "T/10G",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CHAUVIN",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/1/2001",
    "DATE_D_ENREGISTREMENT_FINAL": "24/1/2001",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["verteporfin"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "068/ 17 K 137 /05",
    "CODE_DCI": "17 K 137",
    "DCI": "VERTEPORFINE",
    "NOM_COMMERCIALE": "VISUDYNE",
    "FORME": "PDRE.SOL.INJ. IV",
    "DOSAGE": "15MG",
    "COND": "B/01FL. DE PDRE.",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVARTIS  S.A.S",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/9/2005",
    "DATE_D_ENREGISTREMENT_FINAL": "28/9/2005",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["acide ascorbique"],
    "N_ENREGISTREMENT": "093/ 17 L 082 /98",
    "CODE_DCI": "17 L 082",
    "DCI": "ACIDE ASCORBIQUE / VITAMINE E /RUTOSIDE",
    "NOM_COMMERCIALE": "VELITEN",
    "FORME": "COMPRIME",
    "DOSAGE": "200MG / 50MG / 200MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ZAMBON",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "8/11/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "8/11/1998",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "096/ 17 N 133 /08/16",
    "CODE_DCI": "17 N 133",
    "DCI": "CARBOMERE 980",
    "NOM_COMMERCIALE": "LIPOSIC",
    "FORME": "GEL OPHT.",
    "DOSAGE": "0.2% (OU 2MG/G)",
    "COND": "T/10G",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CHAUVIN S.A.",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "31/5/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "12/3/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "17 N 145",
    "DCI": "CARBOMERE 974P",
    "NOM_COMMERCIALE": "SICCAFLUID",
    "FORME": "GEL OPHT.",
    "DOSAGE": "2.5MG/G",
    "COND": "FL. COMPT. GTTES. 10G",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "386/ 17 N 160 /09",
    "CODE_DCI": "17 N 160",
    "DCI": "HYALURONATE DE SODIUM",
    "NOM_COMMERCIALE": "HYFRESH",
    "FORME": "COLLYRE EN SOLUTION",
    "DOSAGE": "0.2% (OU 2MG/ML)",
    "COND": "FL./10ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JAMJOOM PHARMACEUTICAL INDUSTRY",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ARABIE SAOUDITE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/4/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "19/4/2009",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "543/ 17 N 160 /21",
    "CODE_DCI": "17 N 160",
    "DCI": "Hyaluronate de sodium",
    "NOM_COMMERCIALE": "THERAFRESH",
    "FORME": "Collyre en solution",
    "DOSAGE": "0.2% (OU 2MG/ML)",
    "COND": "FL./10ML",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOTHERA / SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/1/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "7/1/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "543/ 17 N 160 /21",
    "CODE_DCI": "17 N 160",
    "DCI": "Hyaluronate de sodium",
    "NOM_COMMERCIALE": "THERAFRESH",
    "FORME": "Collyre en solution",
    "DOSAGE": "0.2% (OU 2MG/ML)",
    "COND": "FL./10ML",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOTHERA / SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "07/01/21",
    "DATE_D_ENREGISTREMENT_FINAL": "07/01/21",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "445/ 17 N 163 /09",
    "CODE_DCI": "17 N 163",
    "DCI": "HYPROMELLOSE",
    "NOM_COMMERCIALE": "ARTELAC",
    "FORME": "COLLYRE",
    "DOSAGE": "3.20MG/ML",
    "COND": "FL./10ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "DR GERHARD MANN CHEM-PHARM FABRIK GMBH",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALLEMAGNE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/9/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "24/9/2009",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["povidone iodée"],
    "N_ENREGISTREMENT": "022/ 17 N 169 /13",
    "CODE_DCI": "17 N 169",
    "DCI": "POVIDONE",
    "NOM_COMMERCIALE": "FLUIDABAK",
    "FORME": "COLLYRE EN SOLUTION",
    "DOSAGE": "1.5%",
    "COND": "FL./10ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "THEA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/10/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "20/10/2013",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["povidone iodée"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "17 N 169",
    "DCI": "POVIDONE",
    "NOM_COMMERCIALE": "FLUIDABAK",
    "FORME": "COLLYRE EN SOLUTION",
    "DOSAGE": "0.015",
    "COND": "FL./10ML",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Ophtalmologie"]
  },
  {
    "PregnancyIndexLink": ["ranibizumab"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "068/ 17 P 161 /09/17",
    "CODE_DCI": "17 P 161",
    "DCI": "RANIBIZUMAB",
    "NOM_COMMERCIALE": "LUCENTIS",
    "FORME": "SOL. INJ. INTRAVITREENNE",
    "DOSAGE": "10MG/ML (2.3MG/0.23ML)",
    "COND": "B/01FL (2.3 MG/0.23ML)+ 01AIGUI. POUR FILTRE",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVARTIS PHARMA SCHWEIZ AG",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SUISSE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/12/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "4/12/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["aflibercept"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "424/17 P 174/17",
    "CODE_DCI": "17 P 174",
    "DCI": "AFLIBERCEPT",
    "NOM_COMMERCIALE": "EYLEA",
    "FORME": "SOL INJ INTRAVITREENE",
    "DOSAGE": "40 MG/ML",
    "COND": "B/01 FL",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BAYER PHARMA AG",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALLEMAGNE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/3/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "7/3/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["fluorometholone", "sodium cromoglycate"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "386/ 17 R 166 /12",
    "CODE_DCI": "17 R 166",
    "DCI": "FLUOROMETHOLONE / CROMOGLYCATE DE SODIUM",
    "NOM_COMMERCIALE": "OPTIF PLUS",
    "FORME": "SUSP. OPHT.",
    "DOSAGE": "1MG / 20MG/ML",
    "COND": "B/01FL. DE 5ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JAMJOOM PHARMACEUTICALS COMPANY LTD",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ARABIE SAOUDITE",
    "DATE_D_ENREGISTREMENT_INITIAL": "5/12/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "5/12/2012",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "269/ 18 A 002 /98/15",
    "CODE_DCI": "18 A 002",
    "DCI": "RIFAMYCINE SODIQUE",
    "NOM_COMMERCIALE": "OTOFA",
    "FORME": "SOL AURIC . GTTES",
    "DOSAGE": "2.6G/100ML",
    "COND": "FL/10ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BOUCHARA-RECORDATI",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/8/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "31/5/2015",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Otologie"]
  },
  {
    "PregnancyIndexLink": ["ciprofloxacin"],
    "InteractionIndexLink": ["ciprofloxacine"],
    "N_ENREGISTREMENT": "268/ 18 A 026 /08/16",
    "CODE_DCI": "18 A 026",
    "DCI": "CIPROFLOXACINE CHLORHYDRATE EXPRIME EN CIPROFLOXACINE",
    "NOM_COMMERCIALE": "OTOCINE",
    "FORME": "SOL. AURI. STERILE",
    "DOSAGE": "2MG/ML (1MG/0.5ML)",
    "COND": "B/20 RECIPIENTS UNIDOSES DE 0.5ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MERINAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "23/12/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "22/2/2016",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Otologie"]
  },
  {
    "PregnancyIndexLink": ["ciprofloxacin"],
    "InteractionIndexLink": ["ciprofloxacine"],
    "N_ENREGISTREMENT": "A20/18 A026/380",
    "CODE_DCI": "18 A 026",
    "DCI": "CIPROFLOXACINE CHLORHYDRATE EXPRIMEEEN CIPROFLOXACINE",
    "NOM_COMMERCIALE": "OTOFLOX",
    "FORME": "SOL AURICULAIRE STERILE",
    "DOSAGE": "1MG/ 0.5ML",
    "COND": "B/20 RECIPIENTS UNIDOSE",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "laboratoires HUP.P PHARMA Sarl",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "31/03/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "31/03/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Otologie"]
  },
  {
    "PregnancyIndexLink": ["fluocinolone", "neomycin"],
    "InteractionIndexLink": ["polymyxine b"],
    "N_ENREGISTREMENT": "012/ 18 B 004 /98/14",
    "CODE_DCI": "18 B 004",
    "DCI": "FLUOCINOLONE  ACETONIDE /  NEOMYCINE  SULFATE / POLYMYXINE B SULFATE",
    "NOM_COMMERCIALE": "OTOCROVIS",
    "FORME": "SOL AURIC . GTTES",
    "DOSAGE": "0.025% / 0.35% / 1 000 000UI/100ML",
    "COND": "FL/10 ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CROVIS PHILCOM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ITALIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/7/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "4/5/2014",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["dexamethasone", "neomycin"],
    "InteractionIndexLink": ["dexamethasone", "polymyxine b"],
    "N_ENREGISTREMENT": "269/ 18 B 022 /03/15",
    "CODE_DCI": "18 B 022",
    "DCI": "NEOMYCINE SULFATE/POLYMYXINE B SULFATE/ DEXAMETHASONE METASULFOBENZOATE SODIQUE",
    "NOM_COMMERCIALE": "POLYDEXA",
    "FORME": "SOL AURIC . GTTES",
    "DOSAGE": "650.000UI/1000.000UI/0.100G/100ML",
    "COND": "FL/10.5ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BOUCHARA-RECORDATI",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/3/2003",
    "DATE_D_ENREGISTREMENT_FINAL": "31/5/2015",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Otologie"]
  },
  {
    "PregnancyIndexLink": [
      "fludrocortisone (systemic)",
      "lidocaine",
      "neomycin"
    ],
    "InteractionIndexLink": ["fludrocortisone", "lidocaine", "polymyxine b"],
    "N_ENREGISTREMENT": "093/ 18 B 023 /02",
    "CODE_DCI": "18 B 023",
    "DCI": "POLYMYXINE /NEOMYCINE/ACETATE DE FLUDROCORTISONE/LIDOCAINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "PANOTILE",
    "FORME": "SOL AURIC . GTTES",
    "DOSAGE": "1000 000UI /1G/ 0.1G / 4G",
    "COND": "FL/8ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ZAMBON",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "8/7/2002",
    "DATE_D_ENREGISTREMENT_FINAL": "8/7/2002",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Otologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "099/ 18 C 005 /98/16",
    "CODE_DCI": "18 C 005",
    "DCI": "ACETYL- DL- LEUCINE",
    "NOM_COMMERCIALE": "TANGANIL",
    "FORME": "SOL.INJ.",
    "DOSAGE": "500MG/5ML",
    "COND": "B/5AMP. DE 5ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PIERRE FABRE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/10/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "5/3/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Otologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "418/ 18 C 006 /21",
    "CODE_DCI": "18 C 006",
    "DCI": "Acétylleucine",
    "NOM_COMMERCIALE": "GANTANIL",
    "FORME": "Comprimé",
    "DOSAGE": "500MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NEOMEDIC / SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/2/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "4/2/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Otologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "099/ 18 C 006 /98",
    "CODE_DCI": "18 C 006",
    "DCI": "ACETYL- DL- LEUCINE",
    "NOM_COMMERCIALE": "TANGANIL",
    "FORME": "COMPRIME",
    "DOSAGE": "500MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PIERRE FABRE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/11/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "10/11/1998",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Otologie"]
  },
  {
    "PregnancyIndexLink": ["betahistine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "352/18 C 007/19",
    "CODE_DCI": "18 C 007",
    "DCI": "BETAHISTINE DICHLORHYDRATE",
    "NOM_COMMERCIALE": "ANATAX",
    "FORME": "COMP",
    "DOSAGE": "8MG",
    "COND": "B/20",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/12/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "30/12/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Otologie"]
  },
  {
    "PregnancyIndexLink": ["betahistine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "077/ 18 C 007 /07/16",
    "CODE_DCI": "18 C 007",
    "DCI": "BETAHISTINE",
    "NOM_COMMERCIALE": "MEVERC",
    "FORME": "COMPRIME",
    "DOSAGE": "8MG",
    "COND": "B/20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE ALGERIEN DU MEDICAMENT (LAM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/12/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "27/4/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Otologie"]
  },
  {
    "PregnancyIndexLink": ["betahistine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "450/18 C 007/97/19",
    "CODE_DCI": "18 C 007",
    "DCI": "BETAHISTINE DICHLORHDRATE",
    "NOM_COMMERCIALE": "SERC",
    "FORME": "COMP",
    "DOSAGE": "8MG",
    "COND": "B/100",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MYLAN MEDICAL SAS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "France",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/6/1997",
    "DATE_D_ENREGISTREMENT_FINAL": "24/7/2019",
    "TYPE": "Ré",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Otologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["ginkgo"],
    "N_ENREGISTREMENT": "079/ 18 C 019 /99",
    "CODE_DCI": "18 C 019",
    "DCI": "GINKGO BILOBA",
    "NOM_COMMERCIALE": "GINKOBA",
    "FORME": "SOL. BUV.",
    "DOSAGE": "40MG/ML",
    "COND": "FL/15ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE  ALGERIEN DE DEVELOPPEMENT  PHARMACEUTIQUE   (LAD)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/6/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "6/6/1999",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["ginkgo"],
    "N_ENREGISTREMENT": "020/ 18 C 019 /97/18",
    "CODE_DCI": "18 C 019",
    "DCI": "EXTRAIT DE GINKO BILOBA TITRE A 24% D'HETEROSIDES DE GINKGO BILOBA ET 6% DE GINKOLIDES-BILOBALIDE",
    "NOM_COMMERCIALE": "TANAKAN",
    "FORME": "SOL.BUV.",
    "DOSAGE": "40MG/ML",
    "COND": "FL/30ML+PIPETTE GRADUEE",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "IPSEN PHARMA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/8/1997",
    "DATE_D_ENREGISTREMENT_FINAL": "8/8/2018",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["ginkgo"],
    "N_ENREGISTREMENT": "020/ 18 C 021 /02/17",
    "CODE_DCI": "18 C 021",
    "DCI": "Ginkgo (Ginkgo Biloba ) extrait quantifié",
    "NOM_COMMERCIALE": "TANAKAN",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "40MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "IPSEN PHARMA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/6/2002",
    "DATE_D_ENREGISTREMENT_FINAL": "2/4/2018",
    "TYPE": "Ré",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["betahistine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "352/18 C 024/19",
    "CODE_DCI": "18 C 024",
    "DCI": "BETAHISTINE DICHLORHYDRATE",
    "NOM_COMMERCIALE": "ANATAX",
    "FORME": "COMP",
    "DOSAGE": "24MG",
    "COND": "B/60",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/12/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "30/12/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Otologie"]
  },
  {
    "PregnancyIndexLink": ["betahistine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "097/18 C 024/17",
    "CODE_DCI": "18 C 024",
    "DCI": "BETAHISTINE DICHLORHYDRATE",
    "NOM_COMMERCIALE": "BETAHIST",
    "FORME": "COMPRIME",
    "DOSAGE": "24MG",
    "COND": "B/60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANAMED SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/5/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "28/5/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Otologie"]
  },
  {
    "PregnancyIndexLink": ["betahistine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "18 C 024",
    "DCI": "betahistine dihydrochloride",
    "NOM_COMMERCIALE": "BETAHISTINE 24 MG",
    "FORME": "comprimé",
    "DOSAGE": "24 MG",
    "COND": "BOITE DE 60",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Otologie"]
  },
  {
    "PregnancyIndexLink": ["betahistine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "450/ 18 C 024 /06/19",
    "CODE_DCI": "18 C 024",
    "DCI": "BETAHISTINE",
    "NOM_COMMERCIALE": "BETASERC",
    "FORME": "COMPRIME",
    "DOSAGE": "24MG",
    "COND": "B/60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MYLAN MEDICAL SAS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "31/7/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "Ré",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Otologie"]
  },
  {
    "PregnancyIndexLink": ["betahistine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "263/ 18 C 024 /18",
    "CODE_DCI": "18 C 024",
    "DCI": "BETAHISTINE (SOUS FORME DE DICHLORHYDRATE",
    "NOM_COMMERCIALE": "VERSEC",
    "FORME": "COMPRIME",
    "DOSAGE": "24 MG",
    "COND": "B/60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NIOPHARM SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/4/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "22/4/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Otologie"]
  },
  {
    "PregnancyIndexLink": ["betahistine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "149/ 18 C 024 /15",
    "CODE_DCI": "18 C 024",
    "DCI": "BETAHISTINE (SOUS FORME DE DICHLORHYDRATE",
    "NOM_COMMERCIALE": "VERTIGO",
    "FORME": "COMPRIME",
    "DOSAGE": "24 MG",
    "COND": "B/60 ET B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVAPHARM TRADING",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/10/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "26/10/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Otologie"]
  },
  {
    "PregnancyIndexLink": ["betahistine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "352/18 C 025/19",
    "CODE_DCI": "18 C 025",
    "DCI": "BETAHISTINE DICHLORHYDRATE",
    "NOM_COMMERCIALE": "ANATAX",
    "FORME": "COMP SEC",
    "DOSAGE": "16MG",
    "COND": "B/20",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/12/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "30/12/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Otologie"]
  },
  {
    "PregnancyIndexLink": ["betahistine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "269/ 18 C 025 /08",
    "CODE_DCI": "18 C 025",
    "DCI": "BETAHISTINE (SOUS FORME DE DICHLORHYDRATE)",
    "NOM_COMMERCIALE": "LECTIL",
    "FORME": "COMP. SEC. ADULTE",
    "DOSAGE": "16MG",
    "COND": "B/45",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BOUCHARA-RECORDATI",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/1/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "6/1/2009",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Otologie"]
  },
  {
    "PregnancyIndexLink": ["betahistine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "077/ 18 C 025 /16",
    "CODE_DCI": "18 C 025",
    "DCI": "BETAHISTINE (SOUS FORME DE DICHLORHYDRATE)",
    "NOM_COMMERCIALE": "MEVERC",
    "FORME": "COMPRIME",
    "DOSAGE": "16MG",
    "COND": "B/20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE ALGERIEN DU MEDICAMENT SARL (LAM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/4/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "12/4/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Otologie"]
  },
  {
    "PregnancyIndexLink": ["ephedrine"],
    "InteractionIndexLink": ["ephedrine"],
    "N_ENREGISTREMENT": "096/ 18 D 015 /98",
    "CODE_DCI": "18 D 015",
    "DCI": "RESORCINOL / EPHEDRINE (CHLORHYDRATE)",
    "NOM_COMMERCIALE": "OSMOTOL",
    "FORME": "SOL. P. INST. AURC.",
    "DOSAGE": "0.10 %",
    "COND": "FL/10ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CHAUVIN",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/4/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "27/4/1998",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "096/ 18 D 016 /98/16",
    "CODE_DCI": "18 D 016",
    "DCI": "XYLENE",
    "NOM_COMMERCIALE": "CERULYSE",
    "FORME": "SOL. AURIC.",
    "DOSAGE": "5G/100G",
    "COND": "FL/10ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CHAUVIN",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/4/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "12/3/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["lidocaine"],
    "InteractionIndexLink": ["lidocaine"],
    "N_ENREGISTREMENT": "318/ 18 D 020 /16",
    "CODE_DCI": "18 D 020",
    "DCI": "PHENAZONE/CHLORHYDRATE DE LIDOCAINE",
    "NOM_COMMERCIALE": "ORICALM",
    "FORME": "SOLUTION AURIC",
    "DOSAGE": "4G/1G",
    "COND": "F/15 ML SOIT 16G",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMIDAL N.S. SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/1/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "10/1/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Otologie"]
  },
  {
    "PregnancyIndexLink": ["lidocaine"],
    "InteractionIndexLink": ["lidocaine"],
    "N_ENREGISTREMENT": "317/18 D 020/20",
    "CODE_DCI": "18 D 020",
    "DCI": "PHENAZONE/LIDOCAINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "OTIDIS",
    "FORME": "SOLUTION AURIC",
    "DOSAGE": "4%/1%",
    "COND": "F/15 ML SOIT 16G",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INPHA MEDIS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/4/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "12/4/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Otologie"]
  },
  {
    "PregnancyIndexLink": ["lidocaine"],
    "InteractionIndexLink": ["lidocaine"],
    "N_ENREGISTREMENT": "101/ 18 D 020 /00",
    "CODE_DCI": "18 D 020",
    "DCI": "PHENAZONE/CHLORHYDRATE DE LIDOCAINE",
    "NOM_COMMERCIALE": "OTIPAX",
    "FORME": "SOL. AURIC.",
    "DOSAGE": "4G/1G pour 100G de solution",
    "COND": "FL/15ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOCODEX",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "5/6/2000",
    "DATE_D_ENREGISTREMENT_FINAL": "5/6/2000",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Otologie"]
  },
  {
    "PregnancyIndexLink": ["docusate sodium"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "318/18 D 028/17",
    "CODE_DCI": "18 D 028",
    "DCI": "DOCUSATE DE SODIUM",
    "NOM_COMMERCIALE": "ORILYSE",
    "FORME": "SOL POUR INHALATION AURICULAIRE EN GOUTES",
    "DOSAGE": "0.5 G/100 ML ( 0.05G/10 ML)",
    "COND": "FL/10ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMIDAL NS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/6/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "12/6/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["FLUBENDAZOLE"],
    "InteractionIndexLink": ["FLUBENDAZOLE"],
    "N_ENREGISTREMENT": "304/ 19 B 004 /09",
    "CODE_DCI": "19 B 004",
    "DCI": "FLUBENDAZOLE",
    "NOM_COMMERCIALE": "FLUBENE",
    "FORME": "COMPRIME",
    "DOSAGE": "100MG",
    "COND": "B/06",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GEOPHARM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/7/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "1/7/2009",
    "TYPE": "Gé",
    "STATUT": "C",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Parazitologie"]
  },
  {
    "PregnancyIndexLink": ["FLUBENDAZOLE"],
    "InteractionIndexLink": ["FLUBENDAZOLE"],
    "N_ENREGISTREMENT": "149/19 B 004/17",
    "CODE_DCI": "19 B 004",
    "DCI": "FLUBENDAZOLE",
    "NOM_COMMERCIALE": "FLUVERBIEN",
    "FORME": "COMPRIME",
    "DOSAGE": "100MG",
    "COND": "B/06",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVAPHARM TRADING",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "8/10/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "8/10/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Parazitologie"]
  },
  {
    "PregnancyIndexLink": ["FLUBENDAZOLE"],
    "InteractionIndexLink": ["FLUBENDAZOLE"],
    "N_ENREGISTREMENT": "095/ 19 B 004 /98/16",
    "CODE_DCI": "19 B 004",
    "DCI": "FLUBENDAZOLE",
    "NOM_COMMERCIALE": "FLUVERMAL",
    "FORME": "COMPRIME",
    "DOSAGE": "100MG",
    "COND": "B/6",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JANSSEN CILAG",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/4/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "26/7/2016",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Parazitologie"]
  },
  {
    "PregnancyIndexLink": ["FLUBENDAZOLE"],
    "InteractionIndexLink": ["FLUBENDAZOLE"],
    "N_ENREGISTREMENT": "503/19 B 005/19",
    "CODE_DCI": "19 B 005",
    "DCI": "FLUBENDAZOLE",
    "NOM_COMMERCIALE": "FLUDAZOL",
    "FORME": "SUSP.BUV.",
    "DOSAGE": "100MG/5ML (2%)",
    "COND": "FL/30ML + CUILLERE A MESURE DE 5 ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "AFRO PHARM SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "5/5/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "5/5/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Parazitologie"]
  },
  {
    "PregnancyIndexLink": ["FLUBENDAZOLE"],
    "InteractionIndexLink": ["FLUBENDAZOLE"],
    "N_ENREGISTREMENT": "317/19 B 005/16",
    "CODE_DCI": "19 B 005",
    "DCI": "FLUBENDAZOLE",
    "NOM_COMMERCIALE": "FLUMOX",
    "FORME": "SUSP.BUV.",
    "DOSAGE": "100MG/5ML",
    "COND": "FL/30ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INPHA MEDIS SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/12/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "4/12/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Parazitologie"]
  },
  {
    "PregnancyIndexLink": ["FLUBENDAZOLE"],
    "InteractionIndexLink": ["FLUBENDAZOLE"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "19 B 005",
    "DCI": "FLUBENDAZOLE",
    "NOM_COMMERCIALE": "FLUMOX",
    "FORME": "SUSP.BUV.",
    "DOSAGE": "100MG/5ML (20MG/ML)",
    "COND": "FL/30ML",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Parazitologie"]
  },
  {
    "PregnancyIndexLink": ["FLUBENDAZOLE"],
    "InteractionIndexLink": ["FLUBENDAZOLE"],
    "N_ENREGISTREMENT": "318/19 B 005/19",
    "CODE_DCI": "19 B 005",
    "DCI": "FLUBENDAZOLE",
    "NOM_COMMERCIALE": "FLUVERDAL",
    "FORME": "SUSP BUV",
    "DOSAGE": "100MG/5ML",
    "COND": "B/01 FL/30ML AVEC UN GOBELET DOSEUR",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMIDAL N.S  SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "3O/10/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "3O/10/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Parazitologie"]
  },
  {
    "PregnancyIndexLink": ["FLUBENDAZOLE"],
    "InteractionIndexLink": ["FLUBENDAZOLE"],
    "N_ENREGISTREMENT": "095/ 19 B 005 /98/16",
    "CODE_DCI": "19 B 005",
    "DCI": "FLUBENDAZOLE",
    "NOM_COMMERCIALE": "FLUVERMAL",
    "FORME": "SUSP.BUV.",
    "DOSAGE": "100MG/5ML",
    "COND": "FL/30ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JANSSEN CILAG",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/4/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "4/1/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Parazitologie"]
  },
  {
    "PregnancyIndexLink": ["FLUBENDAZOLE"],
    "InteractionIndexLink": ["FLUBENDAZOLE"],
    "N_ENREGISTREMENT": "285/19 B 005/19",
    "CODE_DCI": "19 B 005",
    "DCI": "FLUBENDAZOLE",
    "NOM_COMMERCIALE": "FLUVERMI",
    "FORME": "SUSP.BUV.",
    "DOSAGE": "100MG/5ML (2%)",
    "COND": "FL/30ML + CUILLERE A MESURE DE 5 ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "UPC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "8/5/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "8/5/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Parazitologie"]
  },
  {
    "PregnancyIndexLink": ["FLUBENDAZOLE"],
    "InteractionIndexLink": ["FLUBENDAZOLE"],
    "N_ENREGISTREMENT": "088/19 B 005/19",
    "CODE_DCI": "19 B 005",
    "DCI": "FLUBENDAZOLE",
    "NOM_COMMERCIALE": "FLUVERZOL",
    "FORME": "SUSP BUV",
    "DOSAGE": "20MG/ML",
    "COND": "FL/30ML AVEC UNE CUILLERE 0 MEUSURE DE 5ML",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMAGREB",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/8/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "26/8/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Parazitologie"]
  },
  {
    "PregnancyIndexLink": ["FLUBENDAZOLE"],
    "InteractionIndexLink": ["FLUBENDAZOLE"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "19 B 005",
    "DCI": "Flubendazole",
    "NOM_COMMERCIALE": "Flubene",
    "FORME": "Suspension buvable",
    "DOSAGE": "20 mg/ml",
    "COND": "Flacon de 30 ml",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Parazitologie"]
  },
  {
    "PregnancyIndexLink": ["FLUBENDAZOLE"],
    "InteractionIndexLink": ["FLUBENDAZOLE"],
    "N_ENREGISTREMENT": "242/19 B 005/17",
    "CODE_DCI": "19 B 005",
    "DCI": "FLUBENDAZOLE",
    "NOM_COMMERCIALE": "OXYDAZOLE",
    "FORME": "SUSP.BUV.",
    "DOSAGE": "100MG/5ML (2%)",
    "COND": "FL/30ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GROUPE SANTE SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/6/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "28/6/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Parazitologie"]
  },
  {
    "PregnancyIndexLink": ["FLUBENDAZOLE"],
    "InteractionIndexLink": ["FLUBENDAZOLE"],
    "N_ENREGISTREMENT": "311/19 B 005/21",
    "CODE_DCI": "19 B 005",
    "DCI": "Flubendazole",
    "NOM_COMMERCIALE": "VEROFLUD",
    "FORME": "Suspension buvable",
    "DOSAGE": "100MG/5ML (2%)",
    "COND": "B/1 FL de 30ML + cuillère à mesure de 5 ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE GROUPEMENT PHARMACEUTIQUE ALGERIEN (LGPA) / SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/3/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "30/3/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Parazitologie"]
  },
  {
    "PregnancyIndexLink": ["FLUBENDAZOLE"],
    "InteractionIndexLink": ["FLUBENDAZOLE"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "19 B 005",
    "DCI": "Flubendazole",
    "NOM_COMMERCIALE": "VEROFLUD",
    "FORME": "Suspension  Buvable",
    "DOSAGE": "0.002",
    "COND": "Flacon de 30 ml",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Parazitologie"]
  },
  {
    "PregnancyIndexLink": ["FLUBENDAZOLE"],
    "InteractionIndexLink": ["FLUBENDAZOLE"],
    "N_ENREGISTREMENT": "235/19 B 005/21",
    "CODE_DCI": "19 B 005",
    "DCI": "Flubendazole",
    "NOM_COMMERCIALE": "ZOLOVER",
    "FORME": "Suspension buvable",
    "DOSAGE": "20MG/ML ( OU 100MG/5ML )",
    "COND": "B/1 FL de 30ML + cuillère à mesure de 5 ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE GROUPEMENT PHARMACEUTIQUE ALGERIEN (LGPA) / SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/3/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "30/3/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Parazitologie"]
  },
  {
    "PregnancyIndexLink": ["mebendazole"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "174/ 19 B 006 /99",
    "CODE_DCI": "19 B 006",
    "DCI": "MEBENDAZOLE",
    "NOM_COMMERCIALE": "VERMAZOL",
    "FORME": "COMPRIME",
    "DOSAGE": "100MG",
    "COND": "B/6",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "UNITED PHARMACEUTICAL MANUFACTURING (UPM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/7/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "13/7/1999",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["mebendazole"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "173/ 19 B 006 /98",
    "CODE_DCI": "19 B 006",
    "DCI": "MEBENDAZOLE",
    "NOM_COMMERCIALE": "WORMAZOL",
    "FORME": "COMPRIME A CROQUER",
    "DOSAGE": "100MG",
    "COND": "B/6",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "TABUK",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ARABIE SAOUDITE",
    "DATE_D_ENREGISTREMENT_INITIAL": "8/11/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "8/11/1998",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["mebendazole"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "173/ 19 B 007 /98",
    "CODE_DCI": "19 B 007",
    "DCI": "MEBENDAZOLE",
    "NOM_COMMERCIALE": "WORMAZOL",
    "FORME": "SUSP.BUV.",
    "DOSAGE": "100MG/5ML",
    "COND": "FL/30ML",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "TABUK",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ARABIE SAOUDITE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/9/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "27/9/1998",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["pyrantel embonate"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "045/ 19 B 010 /98",
    "CODE_DCI": "19 B 010",
    "DCI": "PYRANTEL",
    "NOM_COMMERCIALE": "COMBANTRIN",
    "FORME": "COMPRIME",
    "DOSAGE": "125MG",
    "COND": "B/6",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PFIZER PHARM ALGERIE  ALGERIA BUSINESS CENTER",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/11/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "25/2/2006",
    "TYPE": "Ré",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["pyrantel embonate"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "087/ 19 B 010 /98",
    "CODE_DCI": "19 B 010",
    "DCI": "PYRANTEL",
    "NOM_COMMERCIALE": "HELMINTOX",
    "FORME": "COMP.PELLI.SEC.",
    "DOSAGE": "125MG",
    "COND": "B/6",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INNOTECH INTERNATIONAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/2/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "9/2/1998",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["pyrantel embonate"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "045/ 19 B 011 /99",
    "CODE_DCI": "19 B 011",
    "DCI": "PYRANTEL",
    "NOM_COMMERCIALE": "COMBANTRIN",
    "FORME": "SIROP",
    "DOSAGE": "125MG/2.5ML",
    "COND": "FL/15ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PFIZER PHARM ALGERIE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/2/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "24/2/1999",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["pyrantel embonate"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "087/ 19 B 011 /98",
    "CODE_DCI": "19 B 011",
    "DCI": "PYRANTEL",
    "NOM_COMMERCIALE": "HELMINTOX",
    "FORME": "SIROP",
    "DOSAGE": "125MG/2.5ML",
    "COND": "FL/15ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INNOTECH INTERNATIONAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/2/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "9/2/1998",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["pyrantel embonate"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "087/ 19 B 028 /00",
    "CODE_DCI": "19 B 028",
    "DCI": "PYRANTEL",
    "NOM_COMMERCIALE": "HELMINTOX",
    "FORME": "COMP PELLI.SEC.",
    "DOSAGE": "250MG",
    "COND": "B/3",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INNOTECH INTERNATIONAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/7/2000",
    "DATE_D_ENREGISTREMENT_FINAL": "18/7/2000",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Parazitologie"]
  },
  {
    "PregnancyIndexLink": ["albendazole"],
    "InteractionIndexLink": ["albendazole"],
    "N_ENREGISTREMENT": "321/ 19 B 030 /06",
    "CODE_DCI": "19 B 030",
    "DCI": "ALBENDAZOLE",
    "NOM_COMMERCIALE": "OXYZOL",
    "FORME": "COMP. PELLI. SEC.",
    "DOSAGE": "400MG",
    "COND": "B/01",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOVITAL Sarl",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/7/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "26/7/2006",
    "TYPE": "Gé",
    "STATUT": "C",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Parazitologie"]
  },
  {
    "PregnancyIndexLink": ["albendazole"],
    "InteractionIndexLink": ["albendazole"],
    "N_ENREGISTREMENT": "235/ 19 B 030 /16",
    "CODE_DCI": "19 B 030",
    "DCI": "ALBENDAZOLE",
    "NOM_COMMERCIALE": "VERTEN",
    "FORME": "COMPRIME",
    "DOSAGE": "400 MG",
    "COND": "B/1 ET B/56",
    "LISTE": "Liste II",
    "P1": "HOP (B/01 ET B/56 )",
    "P2": "OFF (B/01)",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOGALENIC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/2/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "4/2/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Parazitologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "538/ 19 C 032 /18",
    "CODE_DCI": "19 C 032",
    "DCI": "Artésunate",
    "NOM_COMMERCIALE": "FALCI CARE",
    "FORME": "POUDRE ET SOLVANT POUR SOL INJ IV/IM",
    "DOSAGE": "60 MG",
    "COND": "B/ 01FL PDR DE 5ML + 01 AMP DE 01ML DE  BICARBONATE DE SDIUM BP 5%  (IM) + 01 AMP DE  5ML DE CHLORIDE DE SODIUM  BP 0.9% (IV)",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SWISS PARENTERALS PVT.LTD.",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/2/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "12/2/2018",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [
      "chloroquine (prophylaxis)",
      "chloroquine (treatment)"
    ],
    "InteractionIndexLink": ["chloroquine"],
    "N_ENREGISTREMENT": "20/19 C033/035",
    "CODE_DCI": "19 C 033",
    "DCI": "CHLOROQUINE PHOSPHATE",
    "NOM_COMMERCIALE": "CHLOROQUINE PHOSPHATE PHARMALLIANCE",
    "FORME": "COMP OPELL SÉCABLES",
    "DOSAGE": "500MG",
    "COND": "B/20",
    "LISTE": "LISTE II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EURL PHARMALLIANCE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/9/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "6/9/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Parazitologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "376/ 19 D 024 /96",
    "CODE_DCI": "19 D 024",
    "DCI": "ANTIMONIATE DE MEGLUMINE",
    "NOM_COMMERCIALE": "GLUCANTIME",
    "FORME": "SOL. INJ IM OU INJ LOCALE",
    "DOSAGE": "1.5G /5ML",
    "COND": "B/5",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANOFI AVENTIS FRANCE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/10/1996",
    "DATE_D_ENREGISTREMENT_FINAL": "16/4/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["tinidazole"],
    "InteractionIndexLink": ["tinidazole"],
    "N_ENREGISTREMENT": "293/ 19 D 026 /07/17",
    "CODE_DCI": "19 D 026",
    "DCI": "TINIDAZOLE",
    "NOM_COMMERCIALE": "FAGYX",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "500MG",
    "COND": "B/4",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOCARE SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/3/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "23/7/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["tinidazole"],
    "InteractionIndexLink": ["tinidazole"],
    "N_ENREGISTREMENT": "045/ 19 D 026 /98/06",
    "CODE_DCI": "19 D 026",
    "DCI": "TINIDAZOLE",
    "NOM_COMMERCIALE": "FASIGYNE",
    "FORME": "COMP.ENRO.",
    "DOSAGE": "500MG",
    "COND": "B/4",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PFIZER PHARM ALGERIE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/11/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "17/12/2006",
    "TYPE": "Ré",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["ibuprofen", "methocarbamol"],
    "InteractionIndexLink": ["ibuprofene"],
    "N_ENREGISTREMENT": "20/21 E073/268",
    "CODE_DCI": "2.10E+74",
    "DCI": "IBUPROFÈNE/ MÉTHOCARBAMOL",
    "NOM_COMMERCIALE": "MYOXYDOL",
    "FORME": "COM PELL BICOUCHE",
    "DOSAGE": "200MG/ 500MG",
    "COND": "B/30",
    "LISTE": "LISTE II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES MERINAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "05/10/20",
    "DATE_D_ENREGISTREMENT_FINAL": "05/10/20",
    "TYPE": "",
    "STATUT": "FPrémix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["mometasone"],
    "InteractionIndexLink": ["mometasone"],
    "N_ENREGISTREMENT": "18/22 E 036/235",
    "CODE_DCI": "2.20E+37",
    "DCI": "MOMETASONE FUROATE MONOHYDRATE EXPRIME EN MOMETHASONE",
    "NOM_COMMERCIALE": "MOMENEX",
    "FORME": "SUSP. POUR PULVERISATION NASALE",
    "DOSAGE": "50µG/DOSE",
    "COND": "FLC/120 PULV.",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES BIOGALENIC SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/05/18",
    "DATE_D_ENREGISTREMENT_FINAL": "30/05/18",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["beclometasone"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "182/ 20 A 003 /99",
    "CODE_DCI": "20 A 003",
    "DCI": "BECLOMETASONE",
    "NOM_COMMERCIALE": "BECLATE 250",
    "FORME": "SUSP.INHAL.",
    "DOSAGE": "250µG/BOUFFEE",
    "COND": "FL/200DOSES",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CIPLA LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/11/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "27/11/1999",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["beclometasone"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "092/ 20 A 003 /99",
    "CODE_DCI": "20 A 003",
    "DCI": "BECLOMETASONE",
    "NOM_COMMERCIALE": "BECLOJET",
    "FORME": "SUSP.INHAL.BUCCALE",
    "DOSAGE": "250µG/BOUFFEE",
    "COND": "FL/200DOSES",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CHIESI S.A.",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/2/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "17/2/1999",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["beclometasone"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "092/ 20 A 003 /98",
    "CODE_DCI": "20 A 003",
    "DCI": "BECLOMETASONE DIPROPIONATE",
    "NOM_COMMERCIALE": "CLENIL 250",
    "FORME": "AEROSOL",
    "DOSAGE": "250µG/BOUFFEE",
    "COND": "FL/200DOSES",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CHIESI S.P.A.",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ITALIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "31/3/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "31/3/1998",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["beclometasone"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "21/20 A 004/418",
    "CODE_DCI": "20 A 004",
    "DCI": "BECLOMETASONE DIPROPIONATE",
    "NOM_COMMERCIALE": "BECANOS",
    "FORME": "SUSP. POUR PULVERISATION NASALE",
    "DOSAGE": "50µG/DOSE",
    "COND": "FLC DE 100 DOSES",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES NEOMEDIC/SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/04/21",
    "DATE_D_ENREGISTREMENT_FINAL": "25/04/21",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["beclometasone"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "20 A 004",
    "DCI": "Béclométasone dipropionate",
    "NOM_COMMERCIALE": "BECANOS",
    "FORME": "Suspension",
    "DOSAGE": "0.0005",
    "COND": "12:00 AM",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["beclometasone"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "262/ 20 A 004 /98/16",
    "CODE_DCI": "20 A 004",
    "DCI": "BECLOMETASONE",
    "NOM_COMMERCIALE": "BECONASE",
    "FORME": "SUSP.NAS.",
    "DOSAGE": "50µG/ Dose",
    "COND": "FL/100DOSES",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GLAXOSMITHKLINE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/10/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "29/1/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["beclometasone"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "235/ 20 A 004 /14",
    "CODE_DCI": "20 A 004",
    "DCI": "BECLOMETASONE DIPROPIONATE MONOHYDRATE EXPRIME EN BECLOMETASONE DIPROPIONATE",
    "NOM_COMMERCIALE": "NASABEC",
    "FORME": "SUSP. P. PULVERIS. NASALE",
    "DOSAGE": "50µG/DOSE",
    "COND": "B/01 FL. PULVERIS. DE 100 DOSES",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIO-GALENIC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/12/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "30/12/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["ketotifen"],
    "InteractionIndexLink": ["ketotifene"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "20 A 012",
    "DCI": "KETOTIFENE  (SOUS FORME DE FUMARATE)",
    "NOM_COMMERCIALE": "TIFEN",
    "FORME": "COMPRIME",
    "DOSAGE": "1MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["ketotifen"],
    "InteractionIndexLink": ["ketotifene"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "20 A 012",
    "DCI": "KETOTIFENE  (SOUS FORME DE FUMARATE)",
    "NOM_COMMERCIALE": "TOTINAL",
    "FORME": "COMPRIME",
    "DOSAGE": "1MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["ketotifen"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "20 A 013",
    "DCI": "KETOTIFEN",
    "NOM_COMMERCIALE": "ALERFENE",
    "FORME": "SIROP",
    "DOSAGE": "1 MG /5ML",
    "COND": "125 ML",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["ketotifen"],
    "InteractionIndexLink": ["ketotifene"],
    "N_ENREGISTREMENT": "073/ 20 A 013 /97/18",
    "CODE_DCI": "20 A 013",
    "DCI": "KETOTIFENE  (SOUS FORME DE FUMARATE)",
    "NOM_COMMERCIALE": "HASSALYSE",
    "FORME": "SOL. BUV.",
    "DOSAGE": "1MG/5ML",
    "COND": "FL/100ML",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ISOPHARM-ALGERIE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "11/12/1997",
    "DATE_D_ENREGISTREMENT_FINAL": "28/1/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["ketotifen"],
    "InteractionIndexLink": ["ketotifene"],
    "N_ENREGISTREMENT": "242/ 20 A 013 /09",
    "CODE_DCI": "20 A 013",
    "DCI": "KETOTIFENE  (SOUS FORME DE FUMARATE)",
    "NOM_COMMERCIALE": "KETOF",
    "FORME": "SOL. BUV.",
    "DOSAGE": "1MG/5ML",
    "COND": "FL./100ML",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GROUPE SANTE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/1/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "27/1/2009",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["ketotifen"],
    "InteractionIndexLink": ["ketotifene"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "20 A 013",
    "DCI": "KETOTIFENE",
    "NOM_COMMERCIALE": "TIFEN",
    "FORME": "SIROP",
    "DOSAGE": "1MG/5ML",
    "COND": "FL/100 ML",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["ketotifen"],
    "InteractionIndexLink": ["ketotifene"],
    "N_ENREGISTREMENT": "077/ 20 A 013 /98",
    "CODE_DCI": "20 A 013",
    "DCI": "KETOTIFENE",
    "NOM_COMMERCIALE": "TOTILAM",
    "FORME": "SIROP",
    "DOSAGE": "1MG/5ML",
    "COND": "FL/125 ML",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE ALGERIEN DU MEDICAMENT  (LAM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/7/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "7/7/1998",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["ketotifen"],
    "InteractionIndexLink": ["ketotifene"],
    "N_ENREGISTREMENT": "068/ 20 A 013 /97/12",
    "CODE_DCI": "20 A 013",
    "DCI": "KETOTIFENE  (SOUS FORME DE FUMARATE)",
    "NOM_COMMERCIALE": "ZADITEN",
    "FORME": "SIROP SANS ALCOOL",
    "DOSAGE": "1MG/5ML",
    "COND": "B/1FL. DE 150ML + UNE CUILLERE. MESURE DE 5ML",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVARTIS PHARMA S.A. SCHWEIZ AG",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SUISSE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/6/1997",
    "DATE_D_ENREGISTREMENT_FINAL": "15/10/2012",
    "TYPE": "Ré",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["salbutamol"],
    "InteractionIndexLink": ["salbutamol"],
    "N_ENREGISTREMENT": "084/ 20 A 014 /00",
    "CODE_DCI": "20 A 014",
    "DCI": "SALBUTAMOL",
    "NOM_COMMERCIALE": "SALBUTAMOL",
    "FORME": "SOL.INJ",
    "DOSAGE": "0.5MG/ML",
    "COND": "B/10AMP. DE 1ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOLOGICI ITALIA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ITALIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/3/2000",
    "DATE_D_ENREGISTREMENT_FINAL": "22/3/2000",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["salbutamol"],
    "InteractionIndexLink": ["salbutamol"],
    "N_ENREGISTREMENT": "433/20 A 014/19",
    "CODE_DCI": "20 A 014",
    "DCI": "SALBUTAMOL SULFATE EXPRIME EN SALBUTAMO",
    "NOM_COMMERCIALE": "Slbutamol razes",
    "FORME": "SOL INJ S/C",
    "DOSAGE": "0.5MG/ML",
    "COND": "B/10 ET B/50 AMPS",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRATER RAZES",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/12/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "19/12/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["salbutamol"],
    "InteractionIndexLink": ["salbutamol"],
    "N_ENREGISTREMENT": "262/ 20 A 014 /99",
    "CODE_DCI": "20 A 014",
    "DCI": "SALBUTAMOL",
    "NOM_COMMERCIALE": "VENTOLINE",
    "FORME": "SOL.INJ.S/C",
    "DOSAGE": "0.5MG/ML",
    "COND": "B/6AMP",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GLAXOSMITHKLINE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/1/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "12/1/1999",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["salbutamol"],
    "InteractionIndexLink": ["salbutamol"],
    "N_ENREGISTREMENT": "118/ 20 A 015 /98",
    "CODE_DCI": "20 A 015",
    "DCI": "SALBUTAMOL",
    "NOM_COMMERCIALE": "ASMADIL",
    "FORME": "COMPRIME",
    "DOSAGE": "2MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ARAB PHARMACEUTICAL MANUFACTURING",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/10/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "19/10/1998",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["salbutamol"],
    "InteractionIndexLink": ["salbutamol"],
    "N_ENREGISTREMENT": "109/20 A 015/99/17",
    "CODE_DCI": "20 A 015",
    "DCI": "SALBUTAMOL",
    "NOM_COMMERCIALE": "SALBUTAMOL",
    "FORME": "COMPRIME",
    "DOSAGE": "2MG",
    "COND": "B/20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EIPICO",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EGYPT",
    "DATE_D_ENREGISTREMENT_INITIAL": "31/7/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "20/2/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["salbutamol"],
    "InteractionIndexLink": ["salbutamol"],
    "N_ENREGISTREMENT": "121/ 20 A 015 /06",
    "CODE_DCI": "20 A 015",
    "DCI": "SALBUTAMOL",
    "NOM_COMMERCIALE": "VANTAMED",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "2MG",
    "COND": "B/20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ASIA PHARMACEUTICALS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SYRIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/6/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "27/6/2006",
    "TYPE": "Gé",
    "STATUT": "C",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["salbutamol"],
    "InteractionIndexLink": ["salbutamol"],
    "N_ENREGISTREMENT": "242/ 20 A 016 /04/12",
    "CODE_DCI": "20 A 016",
    "DCI": "SALBUTAMOL  (SOUS FORME DE SULFATE)",
    "NOM_COMMERCIALE": "KOXMA",
    "FORME": "SIROP GOÛT ANANAS",
    "DOSAGE": "2MG/5ML",
    "COND": "FL/125ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GROUPE SANTE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/11/2004",
    "DATE_D_ENREGISTREMENT_FINAL": "9/1/2012",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["salbutamol"],
    "InteractionIndexLink": ["salbutamol"],
    "N_ENREGISTREMENT": "073/20 A 016/05/16",
    "CODE_DCI": "20 A 016",
    "DCI": "SALBUTAMOL",
    "NOM_COMMERCIALE": "RABWALYSE",
    "FORME": "SIROP",
    "DOSAGE": "0.40MG/ML OU 2MG/5ML",
    "COND": "FL/150ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ISOPHARM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/3/2005",
    "DATE_D_ENREGISTREMENT_FINAL": "2/11/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["salbutamol"],
    "InteractionIndexLink": ["salbutamol"],
    "N_ENREGISTREMENT": "077/ 20 A 016 /98/14",
    "CODE_DCI": "20 A 016",
    "DCI": "SALBUTAMOL (SOUS FORME DE SULFATE)",
    "NOM_COMMERCIALE": "SALBULAM",
    "FORME": "SOL. BUV. SANS SUCRE",
    "DOSAGE": "2MG/5ML",
    "COND": "FL/125ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE ALGERIEN DU MEDICAMENT  (LAM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/5/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "15/4/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["salbutamol"],
    "InteractionIndexLink": ["salbutamol"],
    "N_ENREGISTREMENT": "400/20 A 016/16",
    "CODE_DCI": "20 A 016",
    "DCI": "SALBUTAMOL  (SOUS FORME DE SULFATE)",
    "NOM_COMMERCIALE": "SALBUMEX",
    "FORME": "SOL BUV",
    "DOSAGE": "2MG/5ML",
    "COND": "FL/150ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "KPMA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/11/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "9/11/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["salbutamol"],
    "InteractionIndexLink": ["salbutamol"],
    "N_ENREGISTREMENT": "462/ 20 A 016 /16",
    "CODE_DCI": "20 A 016",
    "DCI": "SALBUTAMOL  SULFATE EXPIRIME EN SALBUTAMOL",
    "NOM_COMMERCIALE": "SALBUTAMOL  PHYSIOPHARM",
    "FORME": "SOL. BUV",
    "DOSAGE": "2MG/5ML",
    "COND": "B/01 FLACON DE 125ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL PHYSIOPHARM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/8/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "9/8/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["salbutamol"],
    "InteractionIndexLink": ["salbutamol"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "20 A 016",
    "DCI": "SALBUTAMOL  (SOUS FORME DE SULFATE)",
    "NOM_COMMERCIALE": "SALBUTAMOL SAIDAL",
    "FORME": "SIROP",
    "DOSAGE": "2MG/5ML",
    "COND": "FL/150ML",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["salbutamol"],
    "InteractionIndexLink": ["salbutamol"],
    "N_ENREGISTREMENT": "003/20 A 016/97/20",
    "CODE_DCI": "20 A 016",
    "DCI": "SALBUTAMOL SULFATE",
    "NOM_COMMERCIALE": "SALBUTAMOL-SAIDAL",
    "FORME": "SIROP.",
    "DOSAGE": "2MG/ML",
    "COND": "FLC 150ML",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EPE GROUPE INDUSTRIEL SAIDAL/SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/12/1997",
    "DATE_D_ENREGISTREMENT_FINAL": "22/11/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["salbutamol"],
    "InteractionIndexLink": ["salbutamol"],
    "N_ENREGISTREMENT": "079/ 20 A 016 /13",
    "CODE_DCI": "20 A 016",
    "DCI": "SALBUTAMOL  SULFATE EXPIRIME EN SALBUTAMOL",
    "NOM_COMMERCIALE": "XABUMOL",
    "FORME": "SOL. BUV.",
    "DOSAGE": "2MG/5ML  (0.04G/100ML)",
    "COND": "B/1FL. EN VERRE DE 125ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE  ALGERIEN DE DEVELOPPEMENT  PHARMACEUTIQUE SARL (LAD PHARMA)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/7/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "7/7/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["salbutamol"],
    "InteractionIndexLink": ["salbutamol"],
    "N_ENREGISTREMENT": "525/ 20 A 017 /17",
    "CODE_DCI": "20 A 017",
    "DCI": "SALBUTAMOL SULFATE EXPERIME EN SALBUTAMOL",
    "NOM_COMMERCIALE": "AEROL",
    "FORME": "SUSP POUR INHA",
    "DOSAGE": "100µG/BOUFFEE",
    "COND": "FL/200DOSES",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BERG LIFE SCIENCES",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "TUNISIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "5/4/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "5/4/2017",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["salbutamol"],
    "InteractionIndexLink": ["salbutamol"],
    "N_ENREGISTREMENT": "182/ 20 A 017 /99",
    "CODE_DCI": "20 A 017",
    "DCI": "SALBUTAMOL",
    "NOM_COMMERCIALE": "ASTHALIN",
    "FORME": "SOL.INHAL.BUCCAL.",
    "DOSAGE": "100µG/BOUFFEE",
    "COND": "FL/200DOSES",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CIPLA LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "5/1/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "5/1/1999",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["salbutamol"],
    "InteractionIndexLink": ["salbutamol"],
    "N_ENREGISTREMENT": "092/ 20 A 017 /98",
    "CODE_DCI": "20 A 017",
    "DCI": "SALBUTAMOL",
    "NOM_COMMERCIALE": "VENTMAX",
    "FORME": "AEROSOL",
    "DOSAGE": "100µG/DOSE",
    "COND": "FL/200DOSES",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CHIESI FARMACEUTICI SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ITALIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "31/3/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "31/3/1998",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["salbutamol"],
    "InteractionIndexLink": ["salbutamol"],
    "N_ENREGISTREMENT": "262/ 20 A 017 /98",
    "CODE_DCI": "20 A 017",
    "DCI": "SALBUTAMOL",
    "NOM_COMMERCIALE": "VENTOLINE",
    "FORME": "AEROSOL",
    "DOSAGE": "100µG/DOSE",
    "COND": "FL/200DOSES",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GLAXO SMITHKLINE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/10/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "28/10/1998",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["salbutamol"],
    "InteractionIndexLink": ["salbutamol"],
    "N_ENREGISTREMENT": "182/ 20 A 018 /99//16",
    "CODE_DCI": "20 A 018",
    "DCI": "SALBUTAMOL SULFATE EXPRIME EN SALBUTAMOL",
    "NOM_COMMERCIALE": "ASTHALIN",
    "FORME": "SOL.INHAL.PAR NEBULISEUR",
    "DOSAGE": "5MG/ML",
    "COND": "FL/15ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CIPLA LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/11/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "6/3/2017",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["salbutamol"],
    "InteractionIndexLink": ["salbutamol"],
    "N_ENREGISTREMENT": "262/ 20 A 018 /99",
    "CODE_DCI": "20 A 018",
    "DCI": "SALBUTAMOL",
    "NOM_COMMERCIALE": "VENTOLINE",
    "FORME": "SOL.NEB.",
    "DOSAGE": "5MG/ML",
    "COND": "FL/10ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GLAXOSMITHKLINE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/1/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "12/1/1999",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["theophylline and derivatives"],
    "InteractionIndexLink": ["theophylline"],
    "N_ENREGISTREMENT": "203/ 20 A 024 /00",
    "CODE_DCI": "20 A 024",
    "DCI": "THEOPHYLLINE",
    "NOM_COMMERCIALE": "DIFFUMAX",
    "FORME": "COMP.SEC.LP",
    "DOSAGE": "200MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MENARINI",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ITALIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/2/2000",
    "DATE_D_ENREGISTREMENT_FINAL": "27/2/2000",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["theophylline and derivatives"],
    "InteractionIndexLink": ["theophylline"],
    "N_ENREGISTREMENT": "099/ 20 A 024 /98",
    "CODE_DCI": "20 A 024",
    "DCI": "THEOPHYLLINE",
    "NOM_COMMERCIALE": "THEOSTAT LP",
    "FORME": "COMPRIME A LIBERATION PROLONGEE",
    "DOSAGE": "200MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PIERRE FABRE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/5/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "12/5/1998",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["budesonide"],
    "InteractionIndexLink": ["budesonide"],
    "N_ENREGISTREMENT": "182/ 20 A 044 /00/09",
    "CODE_DCI": "20 A 044",
    "DCI": "BUDESONIDE",
    "NOM_COMMERCIALE": "BUDECORT- 200",
    "FORME": "AEROSOL BUCCAL",
    "DOSAGE": "200µG/DOSE",
    "COND": "FL/200DOSES",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CIPLA LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/6/2000",
    "DATE_D_ENREGISTREMENT_FINAL": "1/6/2009",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["ipratropium bromide"],
    "InteractionIndexLink": ["ipratropium"],
    "N_ENREGISTREMENT": "152/ 20 A 046 /99/16",
    "CODE_DCI": "20 A 046",
    "DCI": "IPRATROPIUM BROMURE",
    "NOM_COMMERCIALE": "ATROVENT ENF.",
    "FORME": "SOL.INHAL.PAR NEBULISEUR",
    "DOSAGE": "0.25MG/2ML",
    "COND": "B/10 RECIPIENTS UNIDOSES DE  2ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BOEHRINGER INGELHEIM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/6/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "16/4/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["ipratropium bromide"],
    "InteractionIndexLink": ["ipratropium"],
    "N_ENREGISTREMENT": "152/ 20 A 047 /99/16",
    "CODE_DCI": "20 A 047",
    "DCI": "IPRATROPIUM BROMURE",
    "NOM_COMMERCIALE": "ATROVENT ADUL .",
    "FORME": "SOL.INHAL.PAR NEBULISEUR",
    "DOSAGE": "0.50MG/2ML",
    "COND": "B/10 RECIPIENTS UNIDOSES DE  2ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BOEHRINGER INGELHEIM France",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/6/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "26/6/2016",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["terbutaline"],
    "InteractionIndexLink": ["terbutaline"],
    "N_ENREGISTREMENT": "256/ 20 A 048 /97/14",
    "CODE_DCI": "20 A 048",
    "DCI": "TERBUTALINE SULFATE",
    "NOM_COMMERCIALE": "BRICANYL LP",
    "FORME": "COMPRIME A LIBERATION PROLONGEE",
    "DOSAGE": "5MG",
    "COND": "PILULIER/60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ASTRA ZENECA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/8/1997",
    "DATE_D_ENREGISTREMENT_FINAL": "3/8/2014",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["terbutaline"],
    "InteractionIndexLink": ["terbutaline"],
    "N_ENREGISTREMENT": "20/20 A043/400",
    "CODE_DCI": "20 A 049",
    "DCI": "TERBUTALINE SULFATE",
    "NOM_COMMERCIALE": "BRICAMEX",
    "FORME": "SOL BUV",
    "DOSAGE": "30 MG/ 100ML",
    "COND": "FL/ 150 ML",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "KPMA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/02/20",
    "DATE_D_ENREGISTREMENT_FINAL": "26/02/20",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["terbutaline"],
    "InteractionIndexLink": ["terbutaline"],
    "N_ENREGISTREMENT": "20/20 A043/400",
    "CODE_DCI": "20 A 049",
    "DCI": "TERBUTALINE SULFATE",
    "NOM_COMMERCIALE": "FRUBIOSE VIT D 1000 U.I",
    "FORME": "SOL BUV",
    "DOSAGE": "30 MG/ 100ML",
    "COND": "FL/ 150 ML",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "KPMA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/02/20",
    "DATE_D_ENREGISTREMENT_FINAL": "26/02/20",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["terbutaline"],
    "InteractionIndexLink": ["terbutaline"],
    "N_ENREGISTREMENT": "073/ 20 A 049 /10/18",
    "CODE_DCI": "20 A 049",
    "DCI": "TERBUTALINE SULFATE",
    "NOM_COMMERCIALE": "ISOBUTALINE",
    "FORME": "SOL.BUV. SANS SUCRE",
    "DOSAGE": "0.3MG/ML",
    "COND": "FL./150ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ISOPHARM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/2/2010",
    "DATE_D_ENREGISTREMENT_FINAL": "28/1/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["terbutaline"],
    "InteractionIndexLink": ["terbutaline"],
    "N_ENREGISTREMENT": "043/ 20 A 049 /98",
    "CODE_DCI": "20 A 049",
    "DCI": "TERBUTALINE",
    "NOM_COMMERCIALE": "TALIN",
    "FORME": "SIROP",
    "DOSAGE": "0.3MG/ML",
    "COND": "FL/100ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIAN PHARMACEUTICAL MANIFACTURING",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/6/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "15/6/1998",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["terbutaline"],
    "InteractionIndexLink": ["terbutaline"],
    "N_ENREGISTREMENT": "036/ 20 A 051 /97/14",
    "CODE_DCI": "20 A 051",
    "DCI": "TERBUTALINE SULFATE",
    "NOM_COMMERCIALE": "BRICANYL TURBUHALER",
    "FORME": "PDRE. P. INHAL. BUCC.",
    "DOSAGE": "0.5MG/ DOSE",
    "COND": "Fl./100DOSES",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ASTRA ZENECA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/8/1997",
    "DATE_D_ENREGISTREMENT_FINAL": "8/6/2014",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["theophylline and derivatives"],
    "InteractionIndexLink": ["theophylline"],
    "N_ENREGISTREMENT": "099/ 20 A 052 /99",
    "CODE_DCI": "20 A 052",
    "DCI": "THEOPHYLLINE",
    "NOM_COMMERCIALE": "THEOSTAT LP",
    "FORME": "COMPRIME A LIBERATION PROLONGEE",
    "DOSAGE": "300MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PIERRE FABRE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/6/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "9/6/1999",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["beclometasone"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "182/ 20 A 072 /99",
    "CODE_DCI": "20 A 072",
    "DCI": "BECLOMETASONE",
    "NOM_COMMERCIALE": "BECLATE - NASAL",
    "FORME": "AERO.NAS.",
    "DOSAGE": "50µG/BOUFFEE",
    "COND": "FL./120DOSES",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CIPLA LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/1/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "12/1/1999",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["fluticasone propionate"],
    "InteractionIndexLink": ["fluticasone"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "20 A 077",
    "DCI": "FLUTICASONE PROPIONATE",
    "NOM_COMMERCIALE": "FLEXODOZ",
    "FORME": "Suspension nasale",
    "DOSAGE": "50µG/DOSE",
    "COND": "Flacon pulvérisateur avec pompe doseuse. Flacon de 120 doses",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["fluticasone propionate"],
    "InteractionIndexLink": ["fluticasone"],
    "N_ENREGISTREMENT": "262/ 20 A 077 /00",
    "CODE_DCI": "20 A 077",
    "DCI": "FLUTICASONE PROPIONATE",
    "NOM_COMMERCIALE": "FLIXOTIDE",
    "FORME": "SUSP.INHAL.BUCCALE",
    "DOSAGE": "50µG/DOSE",
    "COND": "FL./120DOSES",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GLAXOSMITHKLINE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/1/2000",
    "DATE_D_ENREGISTREMENT_FINAL": "20/1/2000",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["fluticasone propionate"],
    "InteractionIndexLink": ["fluticasone"],
    "N_ENREGISTREMENT": "182/ 20 A 077 /09/17",
    "CODE_DCI": "20 A 077",
    "DCI": "FLUTICASONE PROPIONATE",
    "NOM_COMMERCIALE": "FLOHALE HFA 50 INHALER",
    "FORME": "SUSP. INHAL.BUCCALE EN SPYAY",
    "DOSAGE": "50µG/DOSE",
    "COND": "FL./120DOSES",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CIPLA LTD",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "11/5/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "6/3/2017",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["fluticasone propionate"],
    "InteractionIndexLink": ["fluticasone"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "20 A 077",
    "DCI": "Fluticasone propionate",
    "NOM_COMMERCIALE": "Flutinase 50µg/dose",
    "FORME": "Spray nasal",
    "DOSAGE": "50µg/dose",
    "COND": "boite de 01 flacon de 120 doses",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["fluticasone propionate"],
    "InteractionIndexLink": ["fluticasone"],
    "N_ENREGISTREMENT": "262/ 20 A 078 /00/16",
    "CODE_DCI": "20 A 078",
    "DCI": "FLUTICASONE PROPIONATE",
    "NOM_COMMERCIALE": "FLIXOTIDE",
    "FORME": "SUSP.INHAL.BUCCALE",
    "DOSAGE": "125µG/DOSE",
    "COND": "FL/120DOSES",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GLAXOSMITHKLINE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/1/2000",
    "DATE_D_ENREGISTREMENT_FINAL": "16/4/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["fluticasone propionate"],
    "InteractionIndexLink": ["fluticasone"],
    "N_ENREGISTREMENT": "182/ 20 A 078 /09",
    "CODE_DCI": "20 A 078",
    "DCI": "FLUTICASONE PROPIONATE",
    "NOM_COMMERCIALE": "FLOHALE HFA 125",
    "FORME": "SUSP. INHAL.BUCCALE EN SPYAY",
    "DOSAGE": "125µG/DOSE",
    "COND": "FL./120DOSES",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CIPLA LTD",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "11/5/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "11/5/2009",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["fluticasone propionate"],
    "InteractionIndexLink": ["fluticasone"],
    "N_ENREGISTREMENT": "262/ 20 A 079 /00",
    "CODE_DCI": "20 A 079",
    "DCI": "FLUTICASONE PROPIONATE",
    "NOM_COMMERCIALE": "FLIXOTIDE",
    "FORME": "SUSP.INHAL.BUCCALE",
    "DOSAGE": "250µG/DOSE",
    "COND": "FL/60DOSES",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GLAXOSMITHKLINE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/1/2000",
    "DATE_D_ENREGISTREMENT_FINAL": "20/1/2000",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["fluticasone propionate"],
    "InteractionIndexLink": ["fluticasone"],
    "N_ENREGISTREMENT": "182/ 20 A 079 /09",
    "CODE_DCI": "20 A 079",
    "DCI": "FLUTICASONE PROPIONATE",
    "NOM_COMMERCIALE": "FLOHALE HFA 250",
    "FORME": "SUSP. INHAL.BUCCALE EN SPYAY",
    "DOSAGE": "250µG/DOSE",
    "COND": "FL./120DOSES",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CIPLA LTD",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "11/5/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "11/5/2009",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["bambuterol"],
    "N_ENREGISTREMENT": "256/ 20 A 080 /04/14",
    "CODE_DCI": "20 A 080",
    "DCI": "BAMBUTEROL CHLORHYDRATE",
    "NOM_COMMERCIALE": "OXEOL",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ASTRA ZENECA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "16/2/2004",
    "DATE_D_ENREGISTREMENT_FINAL": "4/5/2014",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["budesonide"],
    "InteractionIndexLink": ["budesonide"],
    "N_ENREGISTREMENT": "256/ 20 A 081 /01/14",
    "CODE_DCI": "20 A 081",
    "DCI": "BUDESONIDE",
    "NOM_COMMERCIALE": "PULMICORT",
    "FORME": "SUSP. P.  INHAL. PAR NEBULISEUR EN RECIPIENT UNIDOSE",
    "DOSAGE": "0.5MG/2ML",
    "COND": "B/04ETUIS DE 05 RECIPIENTS UNIDOSES",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ASTRA ZENECA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "5/1/2002",
    "DATE_D_ENREGISTREMENT_FINAL": "16/2/2014",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["budesonide"],
    "InteractionIndexLink": ["budesonide"],
    "N_ENREGISTREMENT": "256/20 A 082/01/16",
    "CODE_DCI": "20 A 082",
    "DCI": "BUDESONIDE",
    "NOM_COMMERCIALE": "PULMICORT",
    "FORME": "SUSP. P.  INHAL. PAR NEBULISEUR EN RECIPIENT UNIDOSE",
    "DOSAGE": "1MG/ 2ML",
    "COND": "B/04ETUIS DE 05 RECIPIENTS UNIDOSES",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ASTRA ZENECA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "5/1/2002",
    "DATE_D_ENREGISTREMENT_FINAL": "4/1/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["budesonide"],
    "InteractionIndexLink": ["budesonide"],
    "N_ENREGISTREMENT": "256/ 20 A 089 /01",
    "CODE_DCI": "20 A 089",
    "DCI": "BUDESONIDE",
    "NOM_COMMERCIALE": "PULMICORT TURBUHALER",
    "FORME": "PDRE POUR INHAL BUCCALE",
    "DOSAGE": "200µG/DOSE",
    "COND": "FL/200 DOSES",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ASTRA ZENECA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "5/1/2002",
    "DATE_D_ENREGISTREMENT_FINAL": "5/1/2002",
    "TYPE": "Ré",
    "STATUT": "i",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["formoterol fumarate"],
    "InteractionIndexLink": ["fer"],
    "N_ENREGISTREMENT": "068/ 20 A 091 /02",
    "CODE_DCI": "20 A 091",
    "DCI": "FORMOTEROL FUMARATE (fer)",
    "NOM_COMMERCIALE": "FORADIL",
    "FORME": "PDRE POUR INHAL. EN GLES. AVEC INHALATEUR.",
    "DOSAGE": "12µG",
    "COND": "B/30 ET B/60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVARTIS PHARMA S.A.",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/11/2002",
    "DATE_D_ENREGISTREMENT_FINAL": "24/11/2002",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["formoterol fumarate"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "394/ 20 A 091 /12",
    "CODE_DCI": "20 A 091",
    "DCI": "FORMOTEROL HEMIFUMARATE",
    "NOM_COMMERCIALE": "FORMOTEROL ZENTIVA",
    "FORME": "PDRE. P. INHAL. EN GLES. + INHALATEUR.",
    "DOSAGE": "12µG",
    "COND": "B/60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "WINTHROP ARZNEIMITTEL GMBH",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALLEMAGNE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/11/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "7/11/2012",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["fluticasone propionate", "salmeterol xinafoate"],
    "InteractionIndexLink": ["fluticasone", "salmeterol"],
    "N_ENREGISTREMENT": "112/ 20 A 104 /03",
    "CODE_DCI": "20 A 104",
    "DCI": "FLUTICASONE PROPIONATE / SALMETEROL XINAFOATE EXPRIME EN SALMETEROL",
    "NOM_COMMERCIALE": "SERETIDE DISKUS",
    "FORME": "PDRE. P. INHAL.",
    "DOSAGE": "100µG/50µG/DOSE",
    "COND": "F/60DOSES",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GLAXO WELLCOME UK LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ROYAUME UNI",
    "DATE_D_ENREGISTREMENT_INITIAL": "31/12/2003",
    "DATE_D_ENREGISTREMENT_FINAL": "31/12/2003",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["fluticasone propionate", "salmeterol xinafoate"],
    "InteractionIndexLink": ["fluticasone", "salmeterol"],
    "N_ENREGISTREMENT": "112/ 20 A 105 /03",
    "CODE_DCI": "20 A 105",
    "DCI": "FLUTICASONE PROPIONATE / SALMETEROL XINAFOATE EXPRIME EN SALMETEROL",
    "NOM_COMMERCIALE": "SERETIDE DISKUS",
    "FORME": "PDRE. P. INHAL.",
    "DOSAGE": "250µG/50µG/DOSE",
    "COND": "F/60DOSES",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GLAXO WELLCOME UK LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ROYAUME UNI",
    "DATE_D_ENREGISTREMENT_INITIAL": "31/12/2003",
    "DATE_D_ENREGISTREMENT_FINAL": "31/12/2003",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["fluticasone propionate", "salmeterol xinafoate"],
    "InteractionIndexLink": ["fluticasone", "salmeterol"],
    "N_ENREGISTREMENT": "112/20 A 106/03/16",
    "CODE_DCI": "20 A 106",
    "DCI": "FLUTICASONE PROPIONATE / SALMETEROL XINAFOATE EXPRIME EN SALMETEROL",
    "NOM_COMMERCIALE": "SERETIDE DISKUS",
    "FORME": "PDRE. P. INHAL.",
    "DOSAGE": "500µG/50µG/DOSE",
    "COND": "F/60DOSES",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GLAXO WELLCOME UK LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ROYAUME UNI",
    "DATE_D_ENREGISTREMENT_INITIAL": "31/12/2003",
    "DATE_D_ENREGISTREMENT_FINAL": "11/9/2016",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["montelukast"],
    "InteractionIndexLink": ["montelukast"],
    "N_ENREGISTREMENT": "263/20 A 211/20",
    "CODE_DCI": "20 A 211",
    "DCI": "MONTELUKAST SODIQUE",
    "NOM_COMMERCIALE": "MEXAM",
    "FORME": "COMP. PELL.",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES BIOPHARM/SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/12/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "29/12/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["montelukast"],
    "InteractionIndexLink": ["montelukast"],
    "N_ENREGISTREMENT": "293/ 20 A 211/ 18",
    "CODE_DCI": "20 A 211",
    "DCI": "Montelukast  sodique exprime en montelukast",
    "NOM_COMMERCIALE": "MONKAST",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "10MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOCARE SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "3/9/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "3/9/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["montelukast"],
    "InteractionIndexLink": ["montelukast"],
    "N_ENREGISTREMENT": "352/ 20 A 211 /12/18",
    "CODE_DCI": "20 A 211",
    "DCI": "Montelukast  sodique exprime en montelukast",
    "NOM_COMMERCIALE": "MONTELAIR",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/3/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "9/4/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["montelukast"],
    "InteractionIndexLink": ["montelukast"],
    "N_ENREGISTREMENT": "20/20 A211/323",
    "CODE_DCI": "20 A 211",
    "DCI": "MONTELUKAST SODIUM EXPRIMÉ EN MONTELUKAST",
    "NOM_COMMERCIALE": "MONTELUDEX",
    "FORME": "COMP A CROQUER",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CONTINENTAL PHARM LABORATOIRE/ SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/10/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "25/10/2020",
    "TYPE": "Gé",
    "STATUT": "F Prémix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["montelukast"],
    "InteractionIndexLink": ["montelukast"],
    "N_ENREGISTREMENT": "447/ 20 A 211 /15",
    "CODE_DCI": "20 A 211",
    "DCI": "Montelukast  sodique exprime en montelukast",
    "NOM_COMMERCIALE": "MONTELUKAST BEKER",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL BEKER",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/10/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "26/10/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["montelukast"],
    "InteractionIndexLink": ["montelukast"],
    "N_ENREGISTREMENT": "304/ 20 A 211 /19",
    "CODE_DCI": "20 A 211",
    "DCI": "Montelukast  sodique exprime en montelukast",
    "NOM_COMMERCIALE": "MONTELUKAST GEO",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GEOPHARM SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["montelukast"],
    "InteractionIndexLink": ["montelukast"],
    "N_ENREGISTREMENT": "309/20 A 211/20",
    "CODE_DCI": "20 A 211",
    "DCI": "MONTELUKAST SODIUM",
    "NOM_COMMERCIALE": "MONTELUKAST LDM",
    "FORME": "COMP PELL",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE DE DIAGNOSTIC MAGHREBIN (LDM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/3/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "18/3/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["montelukast"],
    "InteractionIndexLink": ["montelukast"],
    "N_ENREGISTREMENT": "055/ 20 A 211/ 13",
    "CODE_DCI": "20 A 211",
    "DCI": "Montelukast  sodique exprime en montelukast",
    "NOM_COMMERCIALE": "MOTRINEX",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "DAR AL DAWA DEVELOPMENT & INVESTMENT Co Ltd",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/11/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "19/11/2013",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["montelukast"],
    "InteractionIndexLink": ["montelukast"],
    "N_ENREGISTREMENT": "426/ 20 A 211/ 19",
    "CODE_DCI": "20 A 211",
    "DCI": "Montelukast  sodique exprime en montelukast",
    "NOM_COMMERCIALE": "ONCEAIR",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "10MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ABDI IBRAHIM REMEDE PHARMA/SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "31/12/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "31/12/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["montelukast"],
    "InteractionIndexLink": ["montelukast"],
    "N_ENREGISTREMENT": "001/ 20 A 211 /16",
    "CODE_DCI": "20 A 211",
    "DCI": "Montelukast  sodique exprime en montelukast",
    "NOM_COMMERCIALE": "SINGASM",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMA ALGERIA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/3/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "13/3/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["montelukast"],
    "InteractionIndexLink": ["montelukast"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "20 A 211",
    "DCI": "Montelukast sodique exprimé en montelukast",
    "NOM_COMMERCIALE": "Temost",
    "FORME": "Comprimé pelliculé",
    "DOSAGE": "10 mg",
    "COND": "Boite de 30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["montelukast"],
    "InteractionIndexLink": ["montelukast"],
    "N_ENREGISTREMENT": "352/ 20 A 225 /13",
    "CODE_DCI": "20 A 225",
    "DCI": "Montelukast  sodique exprime en montelukast",
    "NOM_COMMERCIALE": "MONTELAIR",
    "FORME": "COMPRIME A CROQUER",
    "DOSAGE": "4MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "8/10/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "8/10/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["montelukast"],
    "InteractionIndexLink": ["montelukast"],
    "N_ENREGISTREMENT": "447/ 20 A 225 /15",
    "CODE_DCI": "20 A 225",
    "DCI": "Montelukast  sodique exprime en montelukast",
    "NOM_COMMERCIALE": "MONTELUKAST BEKER",
    "FORME": "COMPRIME A CROQUER",
    "DOSAGE": "4MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEKER SARL (SARL LABORATOIRE BEKER ALGERIE)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/2/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "22/2/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["montelukast"],
    "InteractionIndexLink": ["montelukast"],
    "N_ENREGISTREMENT": "055/ 20 A 225 /13",
    "CODE_DCI": "20 A 225",
    "DCI": "Montelukast  sodique exprime en montelukast",
    "NOM_COMMERCIALE": "MOTRINEX",
    "FORME": "COMPRIME A CROQUER",
    "DOSAGE": "4MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "DAR AL DAWA DEVELOPMENT & INVESTMENT Co Ltd",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/10/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "20/10/2013",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["montelukast"],
    "InteractionIndexLink": ["montelukast"],
    "N_ENREGISTREMENT": "426/ 20 A 225 /19",
    "CODE_DCI": "20 A 225",
    "DCI": "Montelukast  sodique exprime en montelukast",
    "NOM_COMMERCIALE": "ONCEAIR",
    "FORME": "COMPRIME A CROQUER",
    "DOSAGE": "4MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ABDI IBRAHIM REMEDE PHARMA/SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/3/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "9/3/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["montelukast"],
    "InteractionIndexLink": ["montelukast"],
    "N_ENREGISTREMENT": "001/ 20 A 225 /16",
    "CODE_DCI": "20 A 225",
    "DCI": "Montelukast  sodique exprime en montelukast",
    "NOM_COMMERCIALE": "SINGASM",
    "FORME": "COMPRIME A CROQUER",
    "DOSAGE": "4MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMA ALGERIA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/2/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "22/2/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["montelukast"],
    "InteractionIndexLink": ["montelukast"],
    "N_ENREGISTREMENT": "035/ 20 A 225 /18",
    "CODE_DCI": "20 A 225",
    "DCI": "Montelukast  sodique exprime en montelukast",
    "NOM_COMMERCIALE": "TEMOST",
    "FORME": "COMPRIME A CROQUER",
    "DOSAGE": "4MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMALLIANCE EURL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/7/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "9/7/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["montelukast"],
    "InteractionIndexLink": ["montelukast"],
    "N_ENREGISTREMENT": "263/20 A 226/20",
    "CODE_DCI": "20 A 226",
    "DCI": "MONTELUKAST SODIQUE",
    "NOM_COMMERCIALE": "MEXAM",
    "FORME": "COMP. A CROQUER",
    "DOSAGE": "05MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES BIOPHARM/SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/12/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "29/12/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["montelukast"],
    "InteractionIndexLink": ["montelukast"],
    "N_ENREGISTREMENT": "293/ 20 A 226 /18",
    "CODE_DCI": "20 A 226",
    "DCI": "Montelukast  sodique exprime en montelukast",
    "NOM_COMMERCIALE": "MONKAST",
    "FORME": "COMPRIME A CROQUER",
    "DOSAGE": "5MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOCARE LABORATOIRES SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "3/9/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "3/9/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["montelukast"],
    "InteractionIndexLink": ["montelukast"],
    "N_ENREGISTREMENT": "352/ 20 A 226 /13/18",
    "CODE_DCI": "20 A 226",
    "DCI": "Montelukast  sodique exprime en montelukast",
    "NOM_COMMERCIALE": "MONTELAIR",
    "FORME": "COMPRIME A CROQUER",
    "DOSAGE": "5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/10/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "28/1/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["montelukast"],
    "InteractionIndexLink": ["montelukast"],
    "N_ENREGISTREMENT": "20/20 A226/323",
    "CODE_DCI": "20 A 226",
    "DCI": "MONTELUKAST SODIUM EXPRIMÉ EN MONTELUKAST",
    "NOM_COMMERCIALE": "MONTELUDEX",
    "FORME": "COMP A CROQUER",
    "DOSAGE": "5MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CONTINENTAL PHARM LABORATOIRE/ SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/10/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "25/10/2020",
    "TYPE": "Gé",
    "STATUT": "F Prémix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["montelukast"],
    "InteractionIndexLink": ["montelukast"],
    "N_ENREGISTREMENT": "426/ 20 A 226 /18",
    "CODE_DCI": "20 A 226",
    "DCI": "Montelukast  sodique exprime en montelukast",
    "NOM_COMMERCIALE": "MONTELUKAST BEKER",
    "FORME": "COMPRIME A CROQUER",
    "DOSAGE": "5MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ABDI IBRAHIM REMEDE PHARMA/SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/2/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "25/2/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["montelukast"],
    "InteractionIndexLink": ["montelukast"],
    "N_ENREGISTREMENT": "447/ 20 A 226 /15",
    "CODE_DCI": "20 A 226",
    "DCI": "Montelukast  sodique exprime en montelukast",
    "NOM_COMMERCIALE": "MONTELUKAST BEKER",
    "FORME": "COMPRIME A CROQUER",
    "DOSAGE": "5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEKER SARL (SARL LABORATOIRE BEKER ALGERIE)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/2/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "22/2/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["montelukast"],
    "InteractionIndexLink": ["montelukast"],
    "N_ENREGISTREMENT": "309/20 A 226/20",
    "CODE_DCI": "20 A 226",
    "DCI": "MONTELUKAST SODIUM",
    "NOM_COMMERCIALE": "MONTELUKAST LDM",
    "FORME": "COMP A CROQUER",
    "DOSAGE": "5MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE DE DIAGNOSTIC MAGHREBIN (LDM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/3/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "18/3/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["montelukast"],
    "InteractionIndexLink": ["montelukast"],
    "N_ENREGISTREMENT": "055/ 20 A 226 /13",
    "CODE_DCI": "20 A 226",
    "DCI": "Montelukast  sodique exprime en montelukast",
    "NOM_COMMERCIALE": "MOTRINEX",
    "FORME": "COMPRIME A CROQUER",
    "DOSAGE": "5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "DAR AL DAWA DEVELOPMENT & INVESTMENT Co Ltd",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/10/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "20/10/2013",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["montelukast"],
    "InteractionIndexLink": ["montelukast"],
    "N_ENREGISTREMENT": "426/ 20 A 226 /18",
    "CODE_DCI": "20 A 226",
    "DCI": "Montelukast  sodique exprime en montelukast",
    "NOM_COMMERCIALE": "ONCEAIR",
    "FORME": "COMPRIME A CROQUER",
    "DOSAGE": "5MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ABDI IBRAHIM REMEDE PHARMA/SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/2/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "25/2/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["montelukast"],
    "InteractionIndexLink": ["montelukast"],
    "N_ENREGISTREMENT": "001/ 20 A 226 /16",
    "CODE_DCI": "20 A 226",
    "DCI": "Montelukast  sodique exprime en montelukast",
    "NOM_COMMERCIALE": "SINGASM",
    "FORME": "COMPRIME A CROQUER",
    "DOSAGE": "5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMA ALGERIA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/2/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "15/2/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["tiotropium bromide"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "152/ 20 A 234 /08",
    "CODE_DCI": "20 A 234",
    "DCI": "TIOTROPIUM BROMURE MONOHYDRATE EXPRIME EN TIOTROPIUM",
    "NOM_COMMERCIALE": "SPIRIVA",
    "FORME": "PDRE. P. INHALATION EN GLES.",
    "DOSAGE": "18µG",
    "COND": "B/30 ET B/30+INHALATEUR (HanDihaler)",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BOEHRINGER INGELHEIM PHARMA Gmbh & Co KG",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALLEMAGNE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/7/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "27/7/2008",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["formoterol fumarate"],
    "InteractionIndexLink": ["fer"],
    "N_ENREGISTREMENT": "182/ 20 A 239 /09/16",
    "CODE_DCI": "20 A 239",
    "DCI": "FORMOTEROL FUMARATE (fer)",
    "NOM_COMMERCIALE": "FORATEC HFA",
    "FORME": "SPRAY INHAL. BUCCALE",
    "DOSAGE": "12µG/DOSE",
    "COND": "FL./120DOSES",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CIPLA LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/9/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "29/6/2016",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["ipratropium bromide", "salbutamol"],
    "InteractionIndexLink": ["ipratropium", "salbutamol"],
    "N_ENREGISTREMENT": "263/ 20 A 241 /09",
    "CODE_DCI": "20 A 241",
    "DCI": "SALBUTAMOL SULFATE / BROMURE D'IPRATROPIUM ANHYDRE",
    "NOM_COMMERCIALE": "IPRALIN",
    "FORME": "PDRE. INHAL. EN GLES.",
    "DOSAGE": "200µG/40µG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOPHARM ALGERIE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/12/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "6/12/2009",
    "TYPE": "Gé",
    "STATUT": "C",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["salbutamol"],
    "InteractionIndexLink": ["salbutamol"],
    "N_ENREGISTREMENT": "263/ 20 A 242 /10",
    "CODE_DCI": "20 A 242",
    "DCI": "SALBUTAMOL SULFATE EXPRIME EN SALBUTAMOL",
    "NOM_COMMERCIALE": "ASTHALIN",
    "FORME": "PDRE. P. INHAL. EN GLES. + INHALATEUR.",
    "DOSAGE": "200µG/GLE.",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOPHARM ALGERIE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/5/2010",
    "DATE_D_ENREGISTREMENT_FINAL": "13/5/2010",
    "TYPE": "Gé",
    "STATUT": "C",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["montelukast"],
    "InteractionIndexLink": ["montelukast"],
    "N_ENREGISTREMENT": "263/ 20 A 245 /21",
    "CODE_DCI": "20 A 245",
    "DCI": "Montelukast  sodique exprimé en montelukast",
    "NOM_COMMERCIALE": "MEXAM",
    "FORME": "Granulés",
    "DOSAGE": "4MG/SACHET-DOSE",
    "COND": "B/30 SACHETS-DOSES",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOPHARM / SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/2/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "4/2/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["montelukast"],
    "InteractionIndexLink": ["montelukast"],
    "N_ENREGISTREMENT": "024/ 20 A 245 /15",
    "CODE_DCI": "20 A 245",
    "DCI": "Montelukast  sodique exprime en montelukast",
    "NOM_COMMERCIALE": "SINGULAIR",
    "FORME": "GRLES. EN SACHET-DOSE",
    "DOSAGE": "4MG/SACHET",
    "COND": "B/28 SACHETS",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MERCK SHARP & DOHME B.V.",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PAYS BAS",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/7/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "26/10/2015",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["omalizumab"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "068 / 20 A 246 /16",
    "CODE_DCI": "20 A 246",
    "DCI": "OMALIZUMAB",
    "NOM_COMMERCIALE": "XOLAIR",
    "FORME": "POUDRE ET SOLVANT POUR PREPARATION INJECTABLE S/C",
    "DOSAGE": "150MG/FL",
    "COND": "B/01 FLACON DE  POUDRE DE 5ML ET SOLV 2ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVARTIS PHARMA SCHWEIZ AG",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SUISSE",
    "DATE_D_ENREGISTREMENT_INITIAL": "3/5/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "3/5/2016",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "48 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["codeine"],
    "InteractionIndexLink": ["codeine"],
    "N_ENREGISTREMENT": "079/ 20 B 053 /98",
    "CODE_DCI": "20 B 053",
    "DCI": "CODEINE / EXTRAIT SEC AQUEUX D'ERYSIUM OFFICINAL",
    "NOM_COMMERCIALE": "EUPHON ADULTE",
    "FORME": "SIROP",
    "DOSAGE": "0.1G / 0.3G / 100ML",
    "COND": "F/150ML",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE  ALGERIEN DE DEVELOPPEMENT  PHARMACEUTIQUE   (LAD)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/10/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "7/12/2003",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["codeine"],
    "InteractionIndexLink": ["codeine"],
    "N_ENREGISTREMENT": "269/ 20 B 053 /98",
    "CODE_DCI": "20 B 053",
    "DCI": "CODEINE CAMPHOSULFONATE",
    "NOM_COMMERCIALE": "NEO-CODION ADULTE",
    "FORME": "SIROP",
    "DOSAGE": "0.1722G/100ML (CODEINE BASE  15.4MG/CUILLERE A SOUPE)",
    "COND": "FL/180 ML",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BOUCHARA-RECORDATI",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/9/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "19/6/2006",
    "TYPE": "Ré",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["codeine"],
    "InteractionIndexLink": ["codeine"],
    "N_ENREGISTREMENT": "079/ 20 B 053 /98/09",
    "CODE_DCI": "20 B 053",
    "DCI": "CODEINE",
    "NOM_COMMERCIALE": "TUSSICOD",
    "FORME": "SIROP. AD.",
    "DOSAGE": "0.05 %",
    "COND": "FL/125 ML",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE  ALGERIEN DE DEVELOPPEMENT  PHARMACEUTIQUE   (LAD)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/6/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "2/5/2009",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["codeine"],
    "InteractionIndexLink": ["codeine"],
    "N_ENREGISTREMENT": "269/ 20 B 054 /98/07",
    "CODE_DCI": "20 B 054",
    "DCI": "CODEINE CAMPHOSULFONATE EXPRIME EN CODEINE / BENZOATE DE SODIUM",
    "NOM_COMMERCIALE": "NEO-CODION ENFANT",
    "FORME": "SIROP",
    "DOSAGE": "3.285MG/61MG/5ML",
    "COND": "FL/125ML",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BOUCHARA-RECORDATI",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/9/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "4/11/2007",
    "TYPE": "Ré",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["codeine"],
    "InteractionIndexLink": ["codeine"],
    "N_ENREGISTREMENT": "269/ 20 B 069 /99/16",
    "CODE_DCI": "20 B 069",
    "DCI": "CODEINE",
    "NOM_COMMERCIALE": "NEO-CODION",
    "FORME": "COMPRIME",
    "DOSAGE": "25MG",
    "COND": "B/20",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BOUCHARA-RECORDATI",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "3/1/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "5/3/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["dextromethorphan"],
    "InteractionIndexLink": ["dextromethorphane", "mepyramine"],
    "N_ENREGISTREMENT": "285/ 20 B 102 /03/08",
    "CODE_DCI": "20 B 102",
    "DCI": "DEXTROMETHORPHANE BROMHYDRATE / MEPYRAMINE MALEATE",
    "NOM_COMMERCIALE": "ATUSSINE ADULTES",
    "FORME": "SIROP",
    "DOSAGE": "0.2G/0.2G/100ML",
    "COND": "FL/125ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "UNION PHARMACEUTIQUE CONSTANTINOISE (UPC)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/8/2003",
    "DATE_D_ENREGISTREMENT_FINAL": "17/12/2008",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["dextromethorphan", "guaifenesin"],
    "InteractionIndexLink": ["dextromethorphane", "mepyramine"],
    "N_ENREGISTREMENT": "285/ 20 B 103 /03/08",
    "CODE_DCI": "20 B 103",
    "DCI": "DEXTROMETHORPHANE BROMHYDRATE /  MEPYRAMINE MALEATE / GUAÏFENESINE",
    "NOM_COMMERCIALE": "ATUSSINE ENFANTS",
    "FORME": "SIROP",
    "DOSAGE": "0.1G/0.1G/0.4G/100ML",
    "COND": "FL/125ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "UNION PHARMACEUTIQUE CONSTANTINOISE (UPC)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/8/2003",
    "DATE_D_ENREGISTREMENT_FINAL": "17/12/2008",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["pholcodine"],
    "InteractionIndexLink": ["pholcodine"],
    "N_ENREGISTREMENT": "049/ 20 B 110 /04",
    "CODE_DCI": "20 B 110",
    "DCI": "PHOLCODINE",
    "NOM_COMMERCIALE": "RHINATHIOL AD TOUX SECHE",
    "FORME": "SIROP",
    "DOSAGE": "0.12 %",
    "COND": "FL/125ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INSTITUT MEDICAL ALGERIEN",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/3/2004",
    "DATE_D_ENREGISTREMENT_FINAL": "6/3/2004",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["codeine"],
    "InteractionIndexLink": ["codeine"],
    "N_ENREGISTREMENT": "235/ 20 B 203 /04",
    "CODE_DCI": "20 B 203",
    "DCI": "CODEINE/EXTRAIT FLUIDE D'ERYSIUM",
    "NOM_COMMERCIALE": "POLERY ADULTE",
    "FORME": "SIROP",
    "DOSAGE": "11.8MG/443MG/15ML",
    "COND": "FL/200ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIO-GALENIC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/12/2004",
    "DATE_D_ENREGISTREMENT_FINAL": "9/12/2004",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["dextromethorphan"],
    "InteractionIndexLink": ["dextromethorphane"],
    "N_ENREGISTREMENT": "317/20 B 206/16",
    "CODE_DCI": "20 B 206",
    "DCI": "DEXTROMETHORPHANE BROMHYDRATE",
    "NOM_COMMERCIALE": "TUSSIDEX",
    "FORME": "SIROP",
    "DOSAGE": "0.20 %",
    "COND": "FL./125ML + GOBELET DOSEUR GRADUE",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INPHA MEDIS SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/12/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "4/12/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["dextromethorphan"],
    "InteractionIndexLink": ["dextromethorphane"],
    "N_ENREGISTREMENT": "296/ 20 B 207 /09",
    "CODE_DCI": "20 B 207",
    "DCI": "DEXTROMETHORPHANE BROMHYDRATE",
    "NOM_COMMERCIALE": "HUMEX TOUX SECHE ENFANT",
    "FORME": "SIROP",
    "DOSAGE": "0.1G/100ML (OU 5MG/5ML)",
    "COND": "FL./125ML + GOBELET DOSEUR GRADUE",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "URGO",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/12/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "6/12/2009",
    "TYPE": "Ré",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["dextromethorphan"],
    "InteractionIndexLink": ["dextromethorphane"],
    "N_ENREGISTREMENT": "317/20B 207/16",
    "CODE_DCI": "20 B 207",
    "DCI": "DEXTROMETHORPHANE BROMHYDRATE",
    "NOM_COMMERCIALE": "TUSSIDEX",
    "FORME": "SIROP",
    "DOSAGE": "0.1G/100ML (OU 5MG/5ML)",
    "COND": "FL./125ML + GOBELET DOSEUR GRADUE",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INPHA MEDIS SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/12/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "4/12/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["pholcodine"],
    "InteractionIndexLink": ["pholcodine"],
    "N_ENREGISTREMENT": "20/97/20 B235/201",
    "CODE_DCI": "20 B 235",
    "DCI": "PHOLCODINE / GAIACOL",
    "NOM_COMMERCIALE": "BIOCALYPTOL A LA PHOLCODINE",
    "FORME": "SIROP",
    "DOSAGE": "131MG/19.75MG/100ML",
    "COND": "FL/200ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES SARL WORLD MEDICINE LIMITED ET PROPHARMAL SOUS LICENCE HYGIA PHARMA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/10/1997",
    "DATE_D_ENREGISTREMENT_FINAL": "5/10/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "60 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["dextromethorphan"],
    "InteractionIndexLink": ["dextromethorphane"],
    "N_ENREGISTREMENT": "296/ 20 B 240 /09",
    "CODE_DCI": "20 B 240",
    "DCI": "DEXTROMETHORPHANE BROMHYDRATE",
    "NOM_COMMERCIALE": "HUMEX TOUX SECHE ADULTE",
    "FORME": "SIROP",
    "DOSAGE": "0.133G/100ML (OU 20MG/15ML )",
    "COND": "FL./125ML + GOBELET DOSEUR GRADUE",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "URGO",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/12/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "6/12/2009",
    "TYPE": "Ré",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "20 C 034",
    "DCI": "OXELADINE",
    "NOM_COMMERCIALE": "EUPNEX",
    "FORME": "SIROP ADLT",
    "DOSAGE": "10 MG/5ML",
    "COND": "180 ML",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "269/ 20 C 036 /98/07",
    "CODE_DCI": "20 C 036",
    "DCI": "BENZOATE DE SODIUM / TEINTURE DE GRINDELIA / SIROP DE POLYGALA",
    "NOM_COMMERCIALE": "NEO-CODION NOURRISSONS",
    "FORME": "SIROP",
    "DOSAGE": "74.1MG/30.8MG/32.964MG/CUILLERE A CAFE",
    "COND": "FL/125 ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BOUCHARA-RECORDATI",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/8/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "22/7/2007",
    "TYPE": "Ré",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["oxomemazine"],
    "N_ENREGISTREMENT": "073/ 20 C 055 /97",
    "CODE_DCI": "20 C 055",
    "DCI": "OXOMEMAZINE",
    "NOM_COMMERCIALE": "OXOMEMAZINE",
    "FORME": "SOL.BUV.",
    "DOSAGE": "1MG/ML",
    "COND": "FL/100ML",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ISOPHARM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/11/1997",
    "DATE_D_ENREGISTREMENT_FINAL": "18/11/1997",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["oxomemazine"],
    "N_ENREGISTREMENT": "077/ 20 C 055 /02/09",
    "CODE_DCI": "20 C 055",
    "DCI": "OXOMEMAZINE",
    "NOM_COMMERCIALE": "OXOMERAL",
    "FORME": "SIROP",
    "DOSAGE": "1MG/ML",
    "COND": "FL/200ML",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE ALGERIEN DU MEDICAMENT  (LAM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "23/10/2002",
    "DATE_D_ENREGISTREMENT_FINAL": "6/4/2009",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["oxomemazine"],
    "N_ENREGISTREMENT": "088/ 20 C 055 /02/15",
    "CODE_DCI": "20 C 055",
    "DCI": "OXOMEMAZINE",
    "NOM_COMMERCIALE": "TOPLEX",
    "FORME": "SIROP",
    "DOSAGE": "1MG/ML",
    "COND": "FL/125ML",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMAGHREB",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "16/3/2002",
    "DATE_D_ENREGISTREMENT_FINAL": "18/1/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "263/ 20 C 099 /03/09",
    "CODE_DCI": "20 C 099",
    "DCI": "OCIMUM SANCTUM / GLYCERRHIZA GLABRA / CURCUMA LONGA / ZINGIBER OFFICINAL / ADHATODA VASICA / SOLANUM INDICUM / INULA RACEMOSA  / PIPER CUBEBA / TERMINALIA BELERICA / ALOE BARBADENSIS / MENTHOL.",
    "NOM_COMMERCIALE": "ZECUF AVEC SUCRE",
    "FORME": "SIROP A BASE  DE ONZE PLANTES MEDICINALES",
    "DOSAGE": "100MG / 60MG / 50MG / 10MG / 60MG / 20MG / 20MG / 10MG / 20MG / 50MG / 06MG par 10ML",
    "COND": "FL/120ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOPHARM ALGERIE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/3/2003",
    "DATE_D_ENREGISTREMENT_FINAL": "7/3/2009",
    "TYPE": "Ré",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "263/ 20 C 099 /09",
    "CODE_DCI": "20 C 099",
    "DCI": "OCIMUM SANCTUM / GLYCERRHIZA GLABRA / CURCUMA LONGA / ZINGIBER OFFICINAL / ADHATODA VASICA / SOLANUM INDICUM / INULA RACEMOSA  / PIPER CUBEBA / TERMINALIA BELERICA / ALOE BARBADENSIS / MENTHOL.",
    "NOM_COMMERCIALE": "ZECUF SANS SUCRE",
    "FORME": "SIROP A BASE  DE ONZE PLANTES MEDICINALES",
    "DOSAGE": "100MG / 60MG / 50MG / 10MG / 60MG / 20MG / 20MG / 10MG / 20MG / 50MG / 06MG PAR 10ML",
    "COND": "F/120ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOPHARM ALGERIE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/3/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "7/3/2009",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["eucalyptus"],
    "N_ENREGISTREMENT": "255/ 20 C 100 /05",
    "CODE_DCI": "20 C 100",
    "DCI": "TENOATE DE SODIUM / HUILE ESSENTIELLE D'EUCALYPTUS",
    "NOM_COMMERCIALE": "TROPHIRES-NOURRISSONS",
    "FORME": "SUPPO.",
    "DOSAGE": "0.095G/0.044G",
    "COND": "B/8",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANOFI-SYNTHELABO-OTC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/10/2005",
    "DATE_D_ENREGISTREMENT_FINAL": "12/10/2005",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "231/ 20 C 100 /03",
    "CODE_DCI": "20 C 100",
    "DCI": "TENOATE DE SODIUM",
    "NOM_COMMERCIALE": "TROPHYL N",
    "FORME": "SUPPO.NOUR",
    "DOSAGE": "95MG",
    "COND": "B/8",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SALEM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/6/2003",
    "DATE_D_ENREGISTREMENT_FINAL": "10/6/2003",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "231/ 20 C 101 /03",
    "CODE_DCI": "20 C 101",
    "DCI": "TENOATE DE SODIUM",
    "NOM_COMMERCIALE": "TROPHYL E",
    "FORME": "SUPPO.ENF",
    "DOSAGE": "190MG",
    "COND": "B/8",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SALEM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/6/2003",
    "DATE_D_ENREGISTREMENT_FINAL": "10/6/2003",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["pholcodine"],
    "InteractionIndexLink": ["pholcodine"],
    "N_ENREGISTREMENT": "049/ 20 C 111 /05",
    "CODE_DCI": "20 C 111",
    "DCI": "PHOLCODINE",
    "NOM_COMMERCIALE": "TUSSO RHINATHIOL TOUX SECHE ENFANT",
    "FORME": "SIROP",
    "DOSAGE": "0.06%",
    "COND": "F/125ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INSTITUT MEDICAL ALGERIEN",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/9/2005",
    "DATE_D_ENREGISTREMENT_FINAL": "4/9/2005",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "255/ 20 C 114 /05",
    "CODE_DCI": "20 C 114",
    "DCI": "PARACETAMOL/HUILE ESSENTIELLE DE PIN DE SYLVESTRE",
    "NOM_COMMERCIALE": "FEBRECTOL NOURRISSONS",
    "FORME": "SUPPO.",
    "DOSAGE": "150MG/20MG",
    "COND": "B/06",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANOFI-SYNTHELABO-OTC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/1/2005",
    "DATE_D_ENREGISTREMENT_FINAL": "1/1/2005",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "255/ 20 C 115 /05",
    "CODE_DCI": "20 C 115",
    "DCI": "PARACETAMOL/HUILE ESSENTIELLE DE PIN DE SYLVESTRE",
    "NOM_COMMERCIALE": "FEBRECTOL ENFANTS",
    "FORME": "SUPPO.",
    "DOSAGE": "300MG/30MG",
    "COND": "B/06",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANOFI-SYNTHELABO-OTC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/2/2005",
    "DATE_D_ENREGISTREMENT_FINAL": "1/2/2005",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "255/ 20 C 116 /05",
    "CODE_DCI": "20 C 116",
    "DCI": "PARACETAMOL/HUILE ESSENTIELLE DE PIN DE SYLVESTRE",
    "NOM_COMMERCIALE": "FEBRECTOL ADULTES",
    "FORME": "SUPPO.",
    "DOSAGE": "600MG/40MG",
    "COND": "B/06",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANOFI-SYNTHELABO-OTC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/2/2005",
    "DATE_D_ENREGISTREMENT_FINAL": "1/2/2005",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["eucalyptus"],
    "N_ENREGISTREMENT": "255/ 20 C 117 /05",
    "CODE_DCI": "20 C 117",
    "DCI": "TENOATE DE SODIUM/HUILE ESSENTIELLE D'EUCALYPTUS",
    "NOM_COMMERCIALE": "TROPHIRES-ADULTES",
    "FORME": "SUPPO.",
    "DOSAGE": "0.285G/0.110G",
    "COND": "B/08",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANOFI-SYNTHELABO-OTC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/10/2005",
    "DATE_D_ENREGISTREMENT_FINAL": "12/10/2005",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["eucalyptus", "paracetamol"],
    "N_ENREGISTREMENT": "255/ 20 C 118 /05",
    "CODE_DCI": "20 C 118",
    "DCI": "TENOATE DE SODIUM/HUILE ESSENTIELLE D'EUCALYPTUS/PARACETAMOL",
    "NOM_COMMERCIALE": "TROPHIRES COMPOSE NOURRISSONS",
    "FORME": "SUPPO.",
    "DOSAGE": "0.065G / 0.044G / 0.150G",
    "COND": "B/08",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANOFI-SYNTHELABO-OTC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/2/2005",
    "DATE_D_ENREGISTREMENT_FINAL": "2/2/2005",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["eucalyptus", "paracetamol"],
    "N_ENREGISTREMENT": "231/ 20 C 118 /05",
    "CODE_DCI": "20 C 118",
    "DCI": "TENOATE DE SODIUM/HUILE ESSENTIELLE D'EUCALYPTUS/PARACETAMOL",
    "NOM_COMMERCIALE": "TROPHYL PLUS N",
    "FORME": "SUPPO. NOURRISSON",
    "DOSAGE": "0.065G / 0.044G / 150MG",
    "COND": "B/08",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SALEM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "8/5/2005",
    "DATE_D_ENREGISTREMENT_FINAL": "8/5/2005",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["eucalyptus", "paracetamol"],
    "N_ENREGISTREMENT": "366/ 20 C 119 /09",
    "CODE_DCI": "20 C 119",
    "DCI": "TENOATE DE SODIUM / HUILE ESSENTIELLE D'EUCALYPTUS / PARACETAMOL",
    "NOM_COMMERCIALE": "THYNORES PLUS ENFANT",
    "FORME": "SUPPO.",
    "DOSAGE": "130MG/75MG/300MG",
    "COND": "B/10",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "4A SANTE INDUSTRIE SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/12/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "30/12/2009",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["eucalyptus", "paracetamol"],
    "N_ENREGISTREMENT": "255/ 20 C 119 /05",
    "CODE_DCI": "20 C 119",
    "DCI": "TENOATE DE SODIUM/HUILE ESSENTIELLE D'EUCALYPTUS/PARACETAMOL",
    "NOM_COMMERCIALE": "TROPHIRES COMPOSE ENFANTS",
    "FORME": "SUPPO.",
    "DOSAGE": "0.130G / 0.075G / 0.300G",
    "COND": "B/08",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANOFI-SYNTHELABO-OTC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/2/2005",
    "DATE_D_ENREGISTREMENT_FINAL": "1/2/2005",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["eucalyptus", "paracetamol"],
    "N_ENREGISTREMENT": "231/ 20 C 119 /05",
    "CODE_DCI": "20 C 119",
    "DCI": "TENOATE DE SODIUM/HUILE ESSENTIELLE D'EUCALYPTUS/PARACETAMOL",
    "NOM_COMMERCIALE": "TROPHYL PLUS E",
    "FORME": "SUPPO. ENFANT",
    "DOSAGE": "0.130G / 0.075G / 300MG",
    "COND": "B/08",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SALEM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "8/5/2005",
    "DATE_D_ENREGISTREMENT_FINAL": "8/5/2005",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["paracetamol"],
    "InteractionIndexLink": ["eucalyptus", "paracetamol"],
    "N_ENREGISTREMENT": "255/ 20 C 200 /05",
    "CODE_DCI": "20 C 200",
    "DCI": "TENOATE DE SODIUM/HUILE ESSENTIELLE D'EUCALYPTUS/PARACETAMOL",
    "NOM_COMMERCIALE": "TROPHIRES COMPOSE ADULTES",
    "FORME": "SUPPO.",
    "DOSAGE": "0.200G / 0.110G / 0.450G",
    "COND": "B/08",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANOFI-SYNTHELABO-OTC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/2/2005",
    "DATE_D_ENREGISTREMENT_FINAL": "1/2/2005",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["pholcodine"],
    "InteractionIndexLink": ["pholcodine"],
    "N_ENREGISTREMENT": "235/ 20 C 202 /05",
    "CODE_DCI": "20 C 202",
    "DCI": "PHOLCODINE/EXTRAIT FLUIDE D'ERYSIMUM",
    "NOM_COMMERCIALE": "POLERY ENFANTS",
    "FORME": "SIROP",
    "DOSAGE": "1MG/29.6MG",
    "COND": "FL./125ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIO-GALENIC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "5/6/2005",
    "DATE_D_ENREGISTREMENT_FINAL": "5/6/2005",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["eucalyptus"],
    "N_ENREGISTREMENT": "255/ 20 C 205 /05",
    "CODE_DCI": "20 C 205",
    "DCI": "TENOATE DE SODIUM/HUILE ESSENTIELLE D'EUCALYPTUS",
    "NOM_COMMERCIALE": "TROPHIRES-ENFANTS",
    "FORME": "SUPPO.",
    "DOSAGE": "0.190G / 0.075G",
    "COND": "B/08",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANOFI-SYNTHELABO-OTC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/10/2005",
    "DATE_D_ENREGISTREMENT_FINAL": "12/10/2005",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["eucalyptus"],
    "N_ENREGISTREMENT": "366/ 20 C 205 /09",
    "CODE_DCI": "20 C 205",
    "DCI": "TENOATE DE SODIUM / HUILE ESSENTIELLE D'EUCALYPTUS",
    "NOM_COMMERCIALE": "TYNORES ENFANT",
    "FORME": "SUPPO.",
    "DOSAGE": "0.190G/0.075G",
    "COND": "B/10",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "4A SANTE INDUSTRIE SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/12/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "24/12/2009",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["dextromethorphan"],
    "InteractionIndexLink": ["dextromethorphane", "mepyramine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "20 C 206",
    "DCI": "DEXTROMETHORPHANE BROMHYDRATE. MEPYRAMINE MALEATE",
    "NOM_COMMERCIALE": "Atussine Adultes",
    "FORME": "Sirop",
    "DOSAGE": "0.2/0.2 g/100 mL",
    "COND": "Fl 125 mL",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["dextromethorphan"],
    "InteractionIndexLink": ["dextromethorphane"],
    "N_ENREGISTREMENT": "153/ 20 C 206 /05",
    "CODE_DCI": "20 C 206",
    "DCI": "DEXTROMETHORPHANE BROMHYDRATE",
    "NOM_COMMERCIALE": "BRONCHOCALM ADULTES",
    "FORME": "SIROP",
    "DOSAGE": "0.2%",
    "COND": "FL/150ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ELAIA PHARM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/10/2005",
    "DATE_D_ENREGISTREMENT_FINAL": "30/10/2005",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["dextromethorphan"],
    "InteractionIndexLink": ["dextromethorphane"],
    "N_ENREGISTREMENT": "242/ 20 C 206 /06",
    "CODE_DCI": "20 C 206",
    "DCI": "DEXTROMETHORPHANE HYDROBROMIDE",
    "NOM_COMMERCIALE": "DEXSTOP 0.2%",
    "FORME": "SIROP",
    "DOSAGE": "0.2%",
    "COND": "FL./125ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GROUPE SANTE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/10/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "28/10/2006",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["dextromethorphan"],
    "InteractionIndexLink": ["dextromethorphane"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "20 C 206",
    "DCI": "Dextromethorphane",
    "NOM_COMMERCIALE": "TUSSIDEX 0.2 %",
    "FORME": "Solution buvable",
    "DOSAGE": "0.2 %",
    "COND": "Flacon de 125ml",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["dextromethorphan", "guaifenesin"],
    "InteractionIndexLink": ["dextromethorphane", "mepyramine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "20 C 207",
    "DCI": "DEXTROMETHORPHANE BROMHYDRATE. MEPYRAMINE MALEATE. GUAIFENESINE",
    "NOM_COMMERCIALE": "Atussine Enfants",
    "FORME": "Sirop",
    "DOSAGE": "0.1/0.1/0.4 g/100 mL",
    "COND": "Fl 125 mL",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["dextromethorphan"],
    "InteractionIndexLink": ["dextromethorphane"],
    "N_ENREGISTREMENT": "153/ 20 C 207 /05",
    "CODE_DCI": "20 C 207",
    "DCI": "DEXTROMETHORPHANE BROMHYDRATE",
    "NOM_COMMERCIALE": "BRONCHOCALM ENFANTS",
    "FORME": "SIROP",
    "DOSAGE": "0.1%",
    "COND": "FL/125ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ELAIA PHARM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/10/2005",
    "DATE_D_ENREGISTREMENT_FINAL": "30/10/2005",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["dextromethorphan"],
    "InteractionIndexLink": ["dextromethorphane"],
    "N_ENREGISTREMENT": "242/ 20 C 207/05",
    "CODE_DCI": "20 C 207",
    "DCI": "DEXTROMETHORPHANE HYDROBROMIDE",
    "NOM_COMMERCIALE": "DEXSTOP ENFANTS",
    "FORME": "SIROP",
    "DOSAGE": "O.1%",
    "COND": "FL/ 125ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GROUPE SANTE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/12/2005",
    "DATE_D_ENREGISTREMENT_FINAL": "19/12/2005",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["dextromethorphan"],
    "InteractionIndexLink": ["dextromethorphane"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "20 C 207",
    "DCI": "Dextromethorphane",
    "NOM_COMMERCIALE": "TUSSIDEX 0.1 %",
    "FORME": "Solution buvable",
    "DOSAGE": "0.1 %",
    "COND": "Flacon de 125ml",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["guaifenesin"],
    "InteractionIndexLink": ["terpine"],
    "N_ENREGISTREMENT": "077/ 20 C 214 /08/17",
    "CODE_DCI": "20 C 214",
    "DCI": "GUAIFENESINE (DCI) / BENZOATE DE SODIUM / TERPINE / EUCALYPTOL",
    "NOM_COMMERCIALE": "FLUPEX",
    "FORME": "SOLUTION BUV",
    "DOSAGE": "30MG/300MG/37.5MG/1.5MG/15ML",
    "COND": "FL./200ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE ALGERIEN DU MEDICAMENT (LAM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/5/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "26/11/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["oxomemazine"],
    "N_ENREGISTREMENT": "428/ 20 C 223 /96/07",
    "CODE_DCI": "20 C 223",
    "DCI": "OXOMEMAZINE",
    "NOM_COMMERCIALE": "TOPLEXIL",
    "FORME": "SIROP",
    "DOSAGE": "0.33MG/ML",
    "COND": "FL/150ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "WINTHROP PHARMA SAIDAL SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/11/1996",
    "DATE_D_ENREGISTREMENT_FINAL": "30/4/2007",
    "TYPE": "Ré",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "042/ 20 C 233 /08/18",
    "CODE_DCI": "20 C 233",
    "DCI": "BUTAMIRATE CITRATE",
    "NOM_COMMERCIALE": "SINECOD 0.15%",
    "FORME": "SIROP",
    "DOSAGE": "1.5MG/ML",
    "COND": "FL./200ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GSK  CONSUMER HEALTHCARE SCHWEIZ AG",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SUISSE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/5/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "Ré",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "235/ 20 D 041 /06/14",
    "CODE_DCI": "20 D 041",
    "DCI": "CARBOCYSTEINE",
    "NOM_COMMERCIALE": "BIOCARB  ENFANT",
    "FORME": "SIROP",
    "DOSAGE": "2 %",
    "COND": "FL./125ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIO-GALENIC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/7/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "19/3/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "311/ 20 D 041 /06",
    "CODE_DCI": "20 D 041",
    "DCI": "CARBOCYSTEINE",
    "NOM_COMMERCIALE": "BRONCHOLACTOL ENFANT",
    "FORME": "SIROP",
    "DOSAGE": "2 %",
    "COND": "FL/125ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE GROUPEMENT PHARMACEUTIQUE ALGERIEN (LGPA)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/12/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "2/12/2006",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "079/ 20 D 041 /98/09",
    "CODE_DCI": "20 D 041",
    "DCI": "CARBOCYSTEINE",
    "NOM_COMMERCIALE": "CARBOFLUID ENFANT",
    "FORME": "SIROP",
    "DOSAGE": "2 %",
    "COND": "FL/125 ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE  ALGERIEN DE DEVELOPPEMENT  PHARMACEUTIQUE   (LAD)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/1/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "6/4/2009",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "077/ 20 D 041 /08",
    "CODE_DCI": "20 D 041",
    "DCI": "CARBOCYSTEINE",
    "NOM_COMMERCIALE": "CARBOLAM",
    "FORME": "SIROP ENFANTS ET NOURRISSONS",
    "DOSAGE": "2 %",
    "COND": "FL./125ML + CUILLERE MESURE DE 5ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE ALGERIEN DU MEDICAMENT (LAM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "23/12/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "23/12/2008",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "400/20 D 041/16",
    "CODE_DCI": "20 D 041",
    "DCI": "CARBOCYSTEINE",
    "NOM_COMMERCIALE": "CARBOMEX",
    "FORME": "SIROP",
    "DOSAGE": "2 %",
    "COND": "FL /100ML+GOBLET DOSEUR",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "KPMA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/12/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "4/12/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "035/ 20 D 041 /06/18",
    "CODE_DCI": "20 D 041",
    "DCI": "CARBOCYSTEINE",
    "NOM_COMMERCIALE": "GRIPEX TOUX GRASSE",
    "FORME": "SOLUTION BUVABLE",
    "DOSAGE": "2 %",
    "COND": "FL./200 ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMALLIANCE EURL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/10/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "17/10/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "296/ 20 D 041 /07/13",
    "CODE_DCI": "20 D 041",
    "DCI": "CARBOCISTEINE",
    "NOM_COMMERCIALE": "HUMEX EXPECTORANT ENFANT",
    "FORME": "SIROP",
    "DOSAGE": "2% (100MG/5ML)",
    "COND": "B/1FL. DE 125ML AVEC GOBELET DOSEUR",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "URGO",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/3/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "13/8/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "073/ 20 D 041 /06",
    "CODE_DCI": "20 D 041",
    "DCI": "CARBOCYSTEINE",
    "NOM_COMMERCIALE": "MUCOLYSE ENFANT",
    "FORME": "SOL. BUV.",
    "DOSAGE": "2 %",
    "COND": "FL./100ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ISOPHARM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/1/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "6/1/2007",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "263/ 20 D 041 /09",
    "CODE_DCI": "20 D 041",
    "DCI": "CARBOCISTEINE",
    "NOM_COMMERCIALE": "PECTOSAN EXPECTORAN ENFANT",
    "FORME": "SIROP",
    "DOSAGE": "2% (OU 2G/100ML)",
    "COND": "FL./150ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOPHARM ALGERIE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/7/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "19/7/2009",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "242/ 20 D 041 /06",
    "CODE_DCI": "20 D 041",
    "DCI": "CARBOCYSTEINE",
    "NOM_COMMERCIALE": "PULMOFOR ENFANT",
    "FORME": "SOL. BUV.",
    "DOSAGE": "2 %",
    "COND": "FL/125ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GROUPE SANTE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/6/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "20/6/2006",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "049/ 20 D 041 /97",
    "CODE_DCI": "20 D 041",
    "DCI": "CARBOCYSTEINE",
    "NOM_COMMERCIALE": "RHINATHIOL ENFANT",
    "FORME": "SIROP",
    "DOSAGE": "2 %",
    "COND": "FL/125 ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INSTITUT MEDICAL ALGERIEN",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/11/1997",
    "DATE_D_ENREGISTREMENT_FINAL": "18/11/1997",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "285/ 20 D 041 /08",
    "CODE_DCI": "20 D 041",
    "DCI": "CARBOCYSTEINE",
    "NOM_COMMERCIALE": "RHINOLACTOL ENFANT",
    "FORME": "SIROP",
    "DOSAGE": "2 %",
    "COND": "FL./125ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "UNION PHARMACEUTIQUE CONSTANTINOISE (UPC)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "8/4/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "8/4/2008",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "235/ 20 D 042 /06/14",
    "CODE_DCI": "20 D 042",
    "DCI": "CARBOCYSTEINE",
    "NOM_COMMERCIALE": "BIOCARB ADULTE",
    "FORME": "SIROP",
    "DOSAGE": "5 %",
    "COND": "F/125ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIO-GALENIC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "11/11/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "6/1/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "311/ 20 D 042 /06",
    "CODE_DCI": "20 D 042",
    "DCI": "CARBOCYSTEINE",
    "NOM_COMMERCIALE": "BRONCHOLACTOL ADULTES",
    "FORME": "SIROP",
    "DOSAGE": "5 %",
    "COND": "FL/150ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE GROUPEMENT PHARMACEUTIQUE ALGERIEN (LGPA)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/12/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "2/12/2006",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "318/ 20 D 042 /07 /18",
    "CODE_DCI": "20 D 042",
    "DCI": "CARBOCYSTEINE",
    "NOM_COMMERCIALE": "CARBODAL SANS SUCRE",
    "FORME": "SOL. ORA.",
    "DOSAGE": "5 %",
    "COND": "FL./125ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMIDAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/6/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "16/7/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "079/ 20 D 042 /98/09",
    "CODE_DCI": "20 D 042",
    "DCI": "CARBOCYSTEINE",
    "NOM_COMMERCIALE": "CARBOFLUIDE ADULTE",
    "FORME": "SIROP",
    "DOSAGE": "5 %",
    "COND": "FL/125ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE  ALGERIEN DE DEVELOPPEMENT  PHARMACEUTIQUE   (LAD)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/1/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "1/7/2009",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "077/ 20 D 042 /08",
    "CODE_DCI": "20 D 042",
    "DCI": "CARBOCYSTEINE",
    "NOM_COMMERCIALE": "CARBOLAM",
    "FORME": "SIROP ADULTE",
    "DOSAGE": "5 %",
    "COND": "FL./125ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE ALGERIEN DU MEDICAMENT (LAM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "23/12/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "23/12/2008",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "400/20 D 042/17",
    "CODE_DCI": "20 D 042",
    "DCI": "CARBOCYSTEINE",
    "NOM_COMMERCIALE": "CARBOMEX",
    "FORME": "SOL BUV",
    "DOSAGE": "5 %",
    "COND": "FL/150ML +GOBLET DOSEUR DE 150 ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "KPMA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/2/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "20/2/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "035/20 D 042/17",
    "CODE_DCI": "20 D 042",
    "DCI": "CARBOCISTEINE",
    "NOM_COMMERCIALE": "GRIPEX TOUX GRASSE",
    "FORME": "SOL BUV",
    "DOSAGE": "5 %",
    "COND": "FL./200ML+UNE CUILLERE GRADUE DE 5ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMALLIANCE EURL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/9/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "10/9/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "296/ 20 D 042 /07/13",
    "CODE_DCI": "20 D 042",
    "DCI": "CARBOCISTEINE",
    "NOM_COMMERCIALE": "HUMEX EXPECTORANT ADULTE",
    "FORME": "SIROP",
    "DOSAGE": "5 %",
    "COND": "B/1FL. DE 125ML AVEC GOBELET DOSEUR",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "URGO",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/3/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "13/8/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "073/ 20 D 042 /06",
    "CODE_DCI": "20 D 042",
    "DCI": "CARBOCYSTEINE",
    "NOM_COMMERCIALE": "MUCOLYSE AD.",
    "FORME": "SOL. BUV.",
    "DOSAGE": "5 %",
    "COND": "F/150ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ISOPHARM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/1/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "6/1/2007",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "263/ 20 D 042 /09",
    "CODE_DCI": "20 D 042",
    "DCI": "CARBOCISTEINE",
    "NOM_COMMERCIALE": "PECTOSAN EXPECTORANT ADULTE",
    "FORME": "SIROP",
    "DOSAGE": "5 %",
    "COND": "FL./250ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOPHARM ALGERIE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/6/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "30/6/2009",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "242/ 20 D 042 /06",
    "CODE_DCI": "20 D 042",
    "DCI": "CARBOCYSTEINE",
    "NOM_COMMERCIALE": "PULMOFOR ADULTES",
    "FORME": "SOL. BUV.",
    "DOSAGE": "5 %",
    "COND": "FL./125ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GROUPE SANTE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/6/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "20/6/2006",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "049/ 20 D 042 /97",
    "CODE_DCI": "20 D 042",
    "DCI": "CARBOCYSTEINE",
    "NOM_COMMERCIALE": "RHINATHIOL  ADULTE",
    "FORME": "SIROP",
    "DOSAGE": "5 %",
    "COND": "FL/125ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INSTITUT MEDICAL ALGERIEN",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/11/1997",
    "DATE_D_ENREGISTREMENT_FINAL": "18/11/1997",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "285/ 20 D 042 /08",
    "CODE_DCI": "20 D 042",
    "DCI": "CARBOCISTEINE",
    "NOM_COMMERCIALE": "RHINOLACTOL",
    "FORME": "SIROP ADULTE",
    "DOSAGE": "5 %",
    "COND": "FL./150ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "UNION PHARMACEUTIQUE CONSTANTINOISE (UPC)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/3/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "19/3/2008",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "055/ 20 D 064 /98",
    "CODE_DCI": "20 D 064",
    "DCI": "AMBROXOL  (CHLORHYDRATE)",
    "NOM_COMMERCIALE": "AMBOLAR",
    "FORME": "SOL. BUV.",
    "DOSAGE": "0.3%",
    "COND": "FL/150ML",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "DAR AL DAWA DEVELOPMENT & INVESTMENT Co Ltd",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "8/11/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "17/10/2006",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "318/20 D 064/17",
    "CODE_DCI": "20 D 064",
    "DCI": "AMBROXOL  (CHLORHYDRATE)",
    "NOM_COMMERCIALE": "AMBRODAL",
    "FORME": "SOL. BUV.",
    "DOSAGE": "0.3%",
    "COND": "B/01 FL DE 100 ML",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMIDAL NS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/6/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "18/6/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "242/ 20 D 064 /07",
    "CODE_DCI": "20 D 064",
    "DCI": "AMBROXOL (CHLORHYDRATE)",
    "NOM_COMMERCIALE": "BROXOL",
    "FORME": "SIROP",
    "DOSAGE": "0.30 %",
    "COND": "FL./100ML",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GROUPE SANTE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/11/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "4/11/2007",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "077/ 20 D 064 /04",
    "CODE_DCI": "20 D 064",
    "DCI": "AMBROXOL (CHLORHYDRATE)",
    "NOM_COMMERCIALE": "FLUXOL",
    "FORME": "SOL BUV",
    "DOSAGE": "0.3%",
    "COND": "FL/200ML",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE ALGERIEN DU MEDICAMENT  (LAM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "16/3/2004",
    "DATE_D_ENREGISTREMENT_FINAL": "16/3/2004",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "317/ 20 D 064 /05/11",
    "CODE_DCI": "20 D 064",
    "DCI": "AMBROXOL (SOUS FORME DE CHLORHYDRATE)",
    "NOM_COMMERCIALE": "IXOL",
    "FORME": "SOL. BUV.",
    "DOSAGE": "0.3%",
    "COND": "FL./200ML",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INPHA-MEDIS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/2/2005",
    "DATE_D_ENREGISTREMENT_FINAL": "28/2/2011",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "073/20 D 064/07/20",
    "CODE_DCI": "20 D 064",
    "DCI": "AMBROXOL CHLORHYDRATE",
    "NOM_COMMERCIALE": "MUCOREX",
    "FORME": "SOL. BUVABLE",
    "DOSAGE": "0.3%",
    "COND": "FLC 150ML",
    "LISTE": "LISTE II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES SARL ISOPHARM ALGERIE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/7/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "22/11/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "079/ 20 D 064 /99/09",
    "CODE_DCI": "20 D 064",
    "DCI": "AMBROXOL  ( SOUS FORME DE CHLORHYDRATE)",
    "NOM_COMMERCIALE": "TOUXOL",
    "FORME": "SOL. BUV.",
    "DOSAGE": "0.3%",
    "COND": "FL/125 ML",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE  ALGERIEN DE DEVELOPPEMENT  PHARMACEUTIQUE   (LAD)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/7/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "19/4/2009",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["acetylcysteine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "235/20 D 083/19",
    "CODE_DCI": "20 D 083",
    "DCI": "N-ACETYLCYSTEINE",
    "NOM_COMMERCIALE": "ACETYLCYSTEINE BGL",
    "FORME": "GRANULES .SOL .BUV EN SACHET-DOSE",
    "DOSAGE": "200MG/SACHET-DOSE",
    "COND": "B/20 SACHETS",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOGALENIC SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "21/10/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "21/10/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["acetylcysteine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "093/20 D 083/01/16",
    "CODE_DCI": "20 D 083",
    "DCI": "N-ACETYLCYSTEINE",
    "NOM_COMMERCIALE": "FLUIMICIL EXPECTORANT ACETYLCYSTEINE",
    "FORME": "GRANULES .SOL .BUV EN SACHET-DOSE",
    "DOSAGE": "200MG/SACHET-DOSE",
    "COND": "B/30 SACHETS",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ZAMBON FRANCE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/2/2001",
    "DATE_D_ENREGISTREMENT_FINAL": "2/11/2016",
    "TYPE": "Ré",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["acetylcysteine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "195/ 20 D 083 /09",
    "CODE_DCI": "20 D 083",
    "DCI": "N-ACETYLCYSTEINE",
    "NOM_COMMERCIALE": "SOLMUCOL 200",
    "FORME": "GRLES. SOL. BUV. SACH-DOSE",
    "DOSAGE": "200MG",
    "COND": "B/20",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMA IVAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/6/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "10/6/2009",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "049/ 20 D 108 /04",
    "CODE_DCI": "20 D 108",
    "DCI": "CARBOCYTEINE",
    "NOM_COMMERCIALE": "RHINATHIOL AD SANS SUCRE",
    "FORME": "SIROP",
    "DOSAGE": "5 %",
    "COND": "FL/200ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INSTITUT MEDICAL ALGERIEN",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/3/2004",
    "DATE_D_ENREGISTREMENT_FINAL": "6/3/2004",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "079/ 20 D 201 /06",
    "CODE_DCI": "20 D 201",
    "DCI": "CARBOCYSTEINE",
    "NOM_COMMERCIALE": "MUCOLAD",
    "FORME": "GLES.",
    "DOSAGE": "375MG",
    "COND": "B/20",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE  ALGERIEN DE DEVELOPPEMENT  PHARMACEUTIQUE   (LAD)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/6/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "27/6/2006",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["bromhexine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "18/20 D204/400",
    "CODE_DCI": "20 D 204",
    "DCI": "BROMHEXINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "BROMHEXINE KPMA",
    "FORME": "SOL BUV",
    "DOSAGE": "10MG/ 5ML",
    "COND": "B/1 FL DE 60 ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "KPMA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "11/11/18",
    "DATE_D_ENREGISTREMENT_FINAL": "11/11/18",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["bromhexine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "073/ 20 D 204 /05",
    "CODE_DCI": "20 D 204",
    "DCI": "BROMHEXINE",
    "NOM_COMMERCIALE": "ISOLVON",
    "FORME": "SIROP",
    "DOSAGE": "10MG/5ML",
    "COND": "F/60ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ISOPHARM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "8/5/2005",
    "DATE_D_ENREGISTREMENT_FINAL": "8/5/2005",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "049/ 20 D 208 /05",
    "CODE_DCI": "20 D 208",
    "DCI": "CARBOCYSTEINE",
    "NOM_COMMERCIALE": "RHINATHIOL SANS SUCRE ENFANTS ET NOURRISSONS",
    "FORME": "SIROP",
    "DOSAGE": "2 %",
    "COND": "B/1FL 125ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INSTITUT MEDICAL ALGERIEN",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "21/11/2005",
    "DATE_D_ENREGISTREMENT_FINAL": "21/11/2005",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["acetylcysteine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "348/ 20 D 231 /08",
    "CODE_DCI": "20 D 231",
    "DCI": "ACETYLCYSTEINE OU N ACETYLCYSTEINE",
    "NOM_COMMERCIALE": "FLUIMEX",
    "FORME": "COMP. EFFER.",
    "DOSAGE": "200MG",
    "COND": "B/20",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIAN PHARMACEUTICAL INSTITUT (API)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/9/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "10/9/2008",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "476/ 20 D 232 /08/13",
    "CODE_DCI": "20 D 232",
    "DCI": "MEGLUMINE (BENZOATE  ANHYDRE) / POLYSORBATE 20",
    "NOM_COMMERCIALE": "FLUISEDAL SANS PROMETHAZINE",
    "FORME": "SIROP",
    "DOSAGE": "130MG/15MG/5ML",
    "COND": "B/1FL. DE 125ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MAGPHARM LABORATOIRES SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/5/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "22/2/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "052/ 20 E 043 /99",
    "CODE_DCI": "20 E 043",
    "DCI": "BALSAMIQUES POUR INHALATION",
    "NOM_COMMERCIALE": "BALSOFUMINE  SIMPLE",
    "FORME": "SOL. P. INHAL.",
    "DOSAGE": "",
    "COND": "FL/84ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANOFI WINTHROP",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/1/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "4/1/1999",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "088/ 20 E 043 /98",
    "CODE_DCI": "20 E 043",
    "DCI": "BALSAMIQUES POUR INHALATION",
    "NOM_COMMERCIALE": "RHUM 'NET",
    "FORME": "MECHE IMPREGNEE DANS 1ML DE SOLUTION",
    "DOSAGE": "",
    "COND": "INHALATEUR AVEC MECHE IMPREGNEE DANS 1ML DE SOLUTION",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMAGHREB",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "23/3/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "23/3/1998",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "052/ 20 E 070 /99",
    "CODE_DCI": "20 E 070",
    "DCI": "BALSAMIQUES POUR INHALATION",
    "NOM_COMMERCIALE": "BALSOFUMINE MENTHOLEE",
    "FORME": "SOL. P. INHAL.",
    "DOSAGE": "1 %",
    "COND": "FL/84ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANOFI WINTHROP",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/1/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "4/1/1999",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "052/ 20 E 071 /99",
    "CODE_DCI": "20 E 071",
    "DCI": "BALSAMIQUES POUR INHALATION",
    "NOM_COMMERCIALE": "BALSOFUMINE MENTHOLEE",
    "FORME": "SOL. P. INHAL.",
    "DOSAGE": "4 %",
    "COND": "FL/84ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANOFI WINTHROP",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/1/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "4/1/1999",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "088/ 20 E 076 /99",
    "CODE_DCI": "20 E 076",
    "DCI": "BALSAMIQUES POUR INHALATION",
    "NOM_COMMERCIALE": "VAPORHUM",
    "FORME": "BAUME",
    "DOSAGE": "",
    "COND": "POT/40G",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMAGHREB",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/7/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "13/7/1999",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["budesonide"],
    "InteractionIndexLink": ["budesonide"],
    "N_ENREGISTREMENT": "092/ 20 F 044 /10",
    "CODE_DCI": "20 F 044",
    "DCI": "BUDESONIDE DIPROPIONATE",
    "NOM_COMMERCIALE": "BUDIAIR 200µG ET BUDIAIR 200µG JET",
    "FORME": "SOL. SOUS PRESSION P. INHAL. BUCC.",
    "DOSAGE": "200µG/DOSE",
    "COND": "FL./200DOSES ET FL./200DOSES + CHAMBRE P. INHAL.(JET)",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CHIESI PHARMACEUTICI SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ITALIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/6/2010",
    "DATE_D_ENREGISTREMENT_FINAL": "2/6/2010",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["fluticasone propionate", "salmeterol"],
    "InteractionIndexLink": ["fluticasone"],
    "N_ENREGISTREMENT": "177/20 F 104/17",
    "CODE_DCI": "20 F 104",
    "DCI": "FLUTICASONE (SOUS FORME DE PROPIONATE) / SALMETEROL(SOUS FORME DE XINAFOATE)",
    "NOM_COMMERCIALE": "BREQUAL",
    "FORME": "CAPSULES CONTENANT PDRE.PR INHAL.",
    "DOSAGE": "100µG/50µG*",
    "COND": "B/60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ABDI IBRAHIM SANAYI VE TICARCET AS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "TURQUIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/7/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "5/10/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["fluticasone propionate", "salmeterol"],
    "InteractionIndexLink": ["fluticasone"],
    "N_ENREGISTREMENT": "321/ 20 F 104 /19",
    "CODE_DCI": "20 F 104",
    "DCI": "FLUTICASONE (SOUS FORME DE PROPIONATE) / SALMETEROL(SOUS FORME DE XINAFOATE)",
    "NOM_COMMERCIALE": "SALFLUZON",
    "FORME": "PDRE. INHAL. EN GLES. + INHALATEUR",
    "DOSAGE": "100µG/50µG/GELE.",
    "COND": "B/60 GELULE + INHALATEUR",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOVITAL SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/3/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "4/3/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["fluticasone propionate", "salmeterol"],
    "InteractionIndexLink": ["fluticasone"],
    "N_ENREGISTREMENT": "263/ 20 F 104 /09",
    "CODE_DCI": "20 F 104",
    "DCI": "FLUTICASONE (SOUS FORME DE PROPIONATE) / SALMETEROL(SOUS FORME DE XINAFOATE)",
    "NOM_COMMERCIALE": "SEROFLO",
    "FORME": "PDRE. INHAL. EN GLES. + INHALATEUR",
    "DOSAGE": "100µG/50µG/GELE.",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOPHARM ALGERIE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/12/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "6/12/2009",
    "TYPE": "Gé",
    "STATUT": "C",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["fluticasone propionate", "salmeterol"],
    "InteractionIndexLink": ["fluticasone"],
    "N_ENREGISTREMENT": "177/20 F 105/17",
    "CODE_DCI": "20 F 105",
    "DCI": "FLUTICASONE (SOUS FORME DE PROPIONATE) / SALMETEROL(SOUS FORME DE XINAFOATE)",
    "NOM_COMMERCIALE": "BREQUAL",
    "FORME": "CAPSULES CONTENANT PDRE.PR INHAL.",
    "DOSAGE": "250µG/50µG*",
    "COND": "B/60 +INHALATEUR DE QHALER",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ABDI IBRAHIM SANAYI VE TICARCET AS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "TURQUIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/7/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "2/7/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["fluticasone propionate", "salmeterol"],
    "InteractionIndexLink": ["fluticasone"],
    "N_ENREGISTREMENT": "321/20 F 105/19",
    "CODE_DCI": "20 F 105",
    "DCI": "FLUTICASONE (SOUS FORME DE PROPIONATE) / SALMETEROL(SOUS FORME DE XINAFOATE)",
    "NOM_COMMERCIALE": "SALFLUZON",
    "FORME": "CAPSULES CONTENANT PDRE.PR INHAL.",
    "DOSAGE": "250µG/50µG*",
    "COND": "B/60 +INHALATEUR",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOVITAL SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "14/3/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "14/3/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["fluticasone propionate", "salmeterol"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "263/ 20 F 105 /09",
    "CODE_DCI": "20 F 105",
    "DCI": "FLUTICASONE(SOUS FORME DE PROPIONATE) / SALMETEROL(SOUS FORME DE XINAFOATE)",
    "NOM_COMMERCIALE": "SEROFLO",
    "FORME": "PDRE. INHAL. EN GLES. + INHALATEUR",
    "DOSAGE": "250µG/50µG/GLE.",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOPHARM ALGERIE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/10/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "20/10/2009",
    "TYPE": "Gé",
    "STATUT": "C",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["salmeterol xinafoate"],
    "InteractionIndexLink": ["salmeterol"],
    "N_ENREGISTREMENT": "17/20 F106/177",
    "CODE_DCI": "20 F 106",
    "DCI": "FLUTOCASONE PROPIONATE / SALMÉTEROL XINAFOATE EXPRIMÉ EN SALMÉTEROL",
    "NOM_COMMERCIALE": "BREQUAL",
    "FORME": "CAPSULES CONTENANT DE LA PDRE P.INHALATION",
    "DOSAGE": "500µG / 50µG",
    "COND": "B/60 CAPSULES + 1 INHALATEUR QHALER",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES ABDI IBRAHIM REMEDE PHARMA SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/7/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "5/10/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["fluticasone propionate", "salmeterol"],
    "InteractionIndexLink": ["fluticasone"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "20 F 106",
    "DCI": "FLUTICASONE (SOUS FORME DE PROPIONATE) / SALMETEROL(SOUS FORME DE XINAFOATE)",
    "NOM_COMMERCIALE": "BREQUAL",
    "FORME": "CAPSULES CONTENANT PDRE.PR INHAL.",
    "DOSAGE": "500µG/50µG*",
    "COND": "B/60 +INHALATEUR DE QHALER",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["fluticasone propionate", "salmeterol"],
    "InteractionIndexLink": ["fluticasone"],
    "N_ENREGISTREMENT": "321/20 F 106/19",
    "CODE_DCI": "20 F 106",
    "DCI": "FLUTICASONE (SOUS FORME DE PROPIONATE)/ SALMETEROL(SOUS FORME DE XINAFOATE)",
    "NOM_COMMERCIALE": "SALFLUZON",
    "FORME": "CAPSULES CONTENANT PDRE.PR INHAL.",
    "DOSAGE": "500µG/50µG*",
    "COND": "B/60 +INHALATEUR",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOVITAL SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/3/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "4/3/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["budesonide (systemic)", "formoterol fumarate"],
    "InteractionIndexLink": ["budesonide"],
    "N_ENREGISTREMENT": "263/ 20 F 228 /09",
    "CODE_DCI": "20 F 228",
    "DCI": "BUDESONIDE / FORMOTEROL (SOUS FORME DE FUMARATE)",
    "NOM_COMMERCIALE": "FORACORT",
    "FORME": "PDRE. INHAL. EN GLES. + INHALATEUR",
    "DOSAGE": "100µG/6µG/GLE.",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOPHARM ALGERIE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/10/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "20/10/2009",
    "TYPE": "Gé",
    "STATUT": "C",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["budesonide (systemic)", "formoterol fumarate"],
    "InteractionIndexLink": ["budesonide"],
    "N_ENREGISTREMENT": "036/ 20 F 228 /07",
    "CODE_DCI": "20 F 228",
    "DCI": "BUDESONIDE / FORMOTEROL",
    "NOM_COMMERCIALE": "SYMBICORT TURBUHALER",
    "FORME": "PDRE. P. INHAL.",
    "DOSAGE": "100µG/6µG/DOSE",
    "COND": "FL./120DOSES",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ASTRA ZENECA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/5/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "12/5/2007",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["budesonide (systemic)", "formoterol fumarate"],
    "InteractionIndexLink": ["budesonide"],
    "N_ENREGISTREMENT": "263/ 20 F 229 /09",
    "CODE_DCI": "20 F 229",
    "DCI": "BUDESONIDE / FORMOTEROL (SOUS FORME DE FUMARATE)",
    "NOM_COMMERCIALE": "FORACORT",
    "FORME": "PDRE. INHAL. EN GLES. + INHALATEUR",
    "DOSAGE": "200µG/6µG/GLE.",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOPHARM ALGERIE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/10/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "20/10/2009",
    "TYPE": "Gé",
    "STATUT": "C",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["budesonide (systemic)", "formoterol fumarate"],
    "InteractionIndexLink": ["budesonide"],
    "N_ENREGISTREMENT": "036/20 F 229/07/16",
    "CODE_DCI": "20 F 229",
    "DCI": "BUDESONIDE / FORMOTEROL",
    "NOM_COMMERCIALE": "SYMBICORT TURBUHALER",
    "FORME": "PDRE. P. INHAL.",
    "DOSAGE": "200µG/6µG/DOSE",
    "COND": "FL./120DOSES",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ASTRA ZENECA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/5/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "4/1/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["budesonide (systemic)", "formoterol fumarate"],
    "InteractionIndexLink": ["budesonide"],
    "N_ENREGISTREMENT": "535/20 F 230/17",
    "CODE_DCI": "20 F 230",
    "DCI": "BUDESONIDE / FORMOTEROL ( FORMOTEROL FUMARATE )",
    "NOM_COMMERCIALE": "BUDEK PLUS",
    "FORME": "PDRE. P. INHAL. EN GELULE",
    "DOSAGE": "400µG/12µG/DOSE",
    "COND": "B/01 FL./60 GELULES + INHALATEUR ORAL",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATORIO DE PRODUCTOS ETICOS C.E.I.S.A",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PARAGUAY",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/9/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "10/9/2017",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["budesonide (systemic)", "formoterol fumarate"],
    "InteractionIndexLink": ["budesonide"],
    "N_ENREGISTREMENT": "036/20 F 230/07/16",
    "CODE_DCI": "20 F 230",
    "DCI": "BUDESONIDE / FORMOTEROL",
    "NOM_COMMERCIALE": "SYMBICORT TURBUHALER",
    "FORME": "PDRE. P. INHAL.",
    "DOSAGE": "400µG/12µG/DOSE",
    "COND": "FL./60DOSES",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ASTRA ZENECA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/5/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "4/1/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["budesonide (systemic)", "formoterol fumarate"],
    "InteractionIndexLink": ["budesonide", "fer"],
    "N_ENREGISTREMENT": "182/ 20 F 236 /09/16",
    "CODE_DCI": "20 F 236",
    "DCI": "BUDESONIDE / FORMOTEROL FUMARATE (fer)",
    "NOM_COMMERCIALE": "FORACORT HFA 100",
    "FORME": "SPRAY BUCCAL",
    "DOSAGE": "100µG/6µG/DOSE",
    "COND": "FL./120DOSES",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CIPLA LTD",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "11/5/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "6/3/2017",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["budesonide (systemic)", "formoterol fumarate"],
    "InteractionIndexLink": ["budesonide"],
    "N_ENREGISTREMENT": "358/ 20 F 236 /09",
    "CODE_DCI": "20 F 236",
    "DCI": "BUDESONIDE / FORMOTEROL (SOUS FORME DE FUMARATE DIHYDRATE)",
    "NOM_COMMERCIALE": "FORMONIDE",
    "FORME": "SUSP. INHAL.BUCCALE",
    "DOSAGE": "100µG/6µG/DOSE",
    "COND": "FL./120DOSES",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CADILA HEALTHCARE LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/9/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "24/9/2009",
    "TYPE": "Gé",
    "STATUT": "C",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["budesonide (systemic)", "formoterol fumarate"],
    "InteractionIndexLink": ["budesonide", "fer"],
    "N_ENREGISTREMENT": "182/ 20 F 237 /09",
    "CODE_DCI": "20 F 237",
    "DCI": "BUDESONIDE / FORMOTEROL FUMARATE (fer)",
    "NOM_COMMERCIALE": "FORACORT HFA 200",
    "FORME": "SPRAY BUCCAL",
    "DOSAGE": "200µG/6µG/DOSE",
    "COND": "FL./120DOSES",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CIPLA LTD",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "11/5/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "11/5/2009",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["budesonide (systemic)", "formoterol fumarate"],
    "InteractionIndexLink": ["budesonide"],
    "N_ENREGISTREMENT": "358/ 20 F 237 /09",
    "CODE_DCI": "20 F 237",
    "DCI": "BUDESONIDE / FORMOTEROL (SOUS FORME DE FUMARATE DIHYDRATE)",
    "NOM_COMMERCIALE": "FORMONIDE",
    "FORME": "SUSP. INHAL.BUCCALE",
    "DOSAGE": "200µG/6µG/DOSE",
    "COND": "FL./120DOSES",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CADILA HEALTHCARE LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/9/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "24/9/2009",
    "TYPE": "Gé",
    "STATUT": "C",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": ["beclometasone", "formoterol fumarate"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "092/ 20 F 244 /14",
    "CODE_DCI": "20 F 244",
    "DCI": "BECLOMETASONE DIPROPIONATE/ FORMOTEROL FUMARATE DIHYDRATE",
    "NOM_COMMERCIALE": "FOSTER",
    "FORME": "SOL P/ INHALATION",
    "DOSAGE": "100µG/6µG",
    "COND": "FL/120 DOSES",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CHIESI FARMACEUTICI SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ITALIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/3/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "19/3/2014",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "20 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Pneumologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "498/20 G 248/17",
    "CODE_DCI": "20 G 248",
    "DCI": "BERACTANT",
    "NOM_COMMERCIALE": "SURVANTA",
    "FORME": "SUSPENSION INTRATRACHEALE",
    "DOSAGE": "25 MG/ML",
    "COND": "B/1 FL DE 4ML (100 MG DE PHOSPHOLIPIDES/4ML) ET B/1FL DE 8ML (200 MG DE PHOSPHOLIPIDES/8 ML)",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ABBVIE CORPORATION",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CANADA",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/7/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "20/7/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "18 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "225/20 G 250/18",
    "CODE_DCI": "20 G 250",
    "DCI": "Calfactant",
    "NOM_COMMERCIALE": "INFASURF",
    "FORME": "SUSPENSION INTRATRACHEALE",
    "DOSAGE": "35 MG/ML",
    "COND": "B/1 FL DE 3ML (105 MG DE PHOSPHOLIPIDES/3ML) ET B/1FL DE 6 ML (210 MG DE PHOSPHOLIPIDES/6ML)",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JAZEERA PHARMACEUTICAL INDUSTRIES",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ARABIE SAOUDITE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/7/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "24/7/2018",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "18 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["acide niflumique"],
    "N_ENREGISTREMENT": "003/ 21 A 001 /98/17",
    "CODE_DCI": "21 A 001",
    "DCI": "ACIDE NIFLUMIQUE",
    "NOM_COMMERCIALE": "FLUCIDAL",
    "FORME": "PDE. DERM.",
    "DOSAGE": "3 %",
    "COND": "T/40G",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EPE GROUPE INDUSTRIEL SAIDAL/SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/1/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "29/1/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Rhumatologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["acide niflumique"],
    "N_ENREGISTREMENT": "366/ 21 A 001 /07/13",
    "CODE_DCI": "21 A 001",
    "DCI": "ACIDE NIFLUMIQUE",
    "NOM_COMMERCIALE": "NIFLURIC",
    "FORME": "PDE.DERM.",
    "DOSAGE": "3 %",
    "COND": "T/40G",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "4A SANTE INDUSTRIE SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/9/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "7/8/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Rhumatologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["acide niflumique"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "21 A 001",
    "DCI": "ACIDE NIFLUMIQUE",
    "NOM_COMMERCIALE": "NIFLURIC",
    "FORME": "PDE.DERM.",
    "DOSAGE": "0.03",
    "COND": "T/40G",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Rhumatologie"]
  },
  {
    "PregnancyIndexLink": ["dexamethasone"],
    "InteractionIndexLink": ["dexamethasone"],
    "N_ENREGISTREMENT": "169/ 21 A 003 /99",
    "CODE_DCI": "21 A 003",
    "DCI": "DEXAMETHASONE ACETATE / SALICYLAMIDE / SALICYLATE D'HYDROXYETHYLE",
    "NOM_COMMERCIALE": "PERCUTALGINE",
    "FORME": "GEL DERM.",
    "DOSAGE": "0.005% / 2% / 10%",
    "COND": "T/30G",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BESINS INTERNATIONAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/12/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "19/12/1999",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["diclofenac"],
    "InteractionIndexLink": ["diclofenac"],
    "N_ENREGISTREMENT": "263/ 21 A 004 /11",
    "CODE_DCI": "21 A 004",
    "DCI": "DICLOFENAC DIETHYLAMINE EXPRIME EN DICLOFENAC SODIQUE",
    "NOM_COMMERCIALE": "BIOFENAC",
    "FORME": "GEL DERM.",
    "DOSAGE": "1 %",
    "COND": "T/50G",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOPHARM SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/5/2011",
    "DATE_D_ENREGISTREMENT_FINAL": "30/5/2011",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Rhumatologie"]
  },
  {
    "PregnancyIndexLink": ["diclofenac"],
    "InteractionIndexLink": ["diclofenac"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "21 A 004",
    "DCI": "DICLOFENAC DIETHYLAMINE EXPRIME EN DICLOFENAC SODIQUE",
    "NOM_COMMERCIALE": "BIOFENAC",
    "FORME": "GEL DERM.",
    "DOSAGE": "0.01",
    "COND": "T/50G",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Rhumatologie"]
  },
  {
    "PregnancyIndexLink": ["diclofenac"],
    "InteractionIndexLink": ["diclofenac"],
    "N_ENREGISTREMENT": "003/ 21 A 004 /00/16",
    "CODE_DCI": "21 A 004",
    "DCI": "DICLOFENAC DIETHYLAMINE EXPRIME EN DICLOFENAC SODIQUE",
    "NOM_COMMERCIALE": "CLOGEL",
    "FORME": "GEL DERM.",
    "DOSAGE": "1 %",
    "COND": "T/30G",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EPE GROUPE INDUSTRIEL SAIDAL/SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "11/11/2000",
    "DATE_D_ENREGISTREMENT_FINAL": "11/5/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Rhumatologie"]
  },
  {
    "PregnancyIndexLink": ["diclofenac"],
    "InteractionIndexLink": ["diclofenac"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "21 A 004",
    "DCI": "DICLOFENAC DIETHYLAMINE EXPRIME EN DICLOFENAC SODIQUE",
    "NOM_COMMERCIALE": "CLOGEL",
    "FORME": "GEL DERM.",
    "DOSAGE": "0.01",
    "COND": "T/30G",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Rhumatologie"]
  },
  {
    "PregnancyIndexLink": ["diclofenac"],
    "InteractionIndexLink": ["diclofenac"],
    "N_ENREGISTREMENT": "418/ 21 A 004 /14",
    "CODE_DCI": "21 A 004",
    "DCI": "DICLOFENAC DIETHYLAMINE EXPRIME EN DICLOFENAC SODIQUE",
    "NOM_COMMERCIALE": "DEFLAMAC",
    "FORME": "GEL DERM.",
    "DOSAGE": "1 %",
    "COND": "T/50G",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NEOMEDIC SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/6/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "1/6/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Rhumatologie"]
  },
  {
    "PregnancyIndexLink": ["diclofenac"],
    "InteractionIndexLink": ["diclofenac"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "21 A 004",
    "DCI": "DICLOFENAC DIETHYLAMINE EXPRIME EN DICLOFENAC SODIQUE",
    "NOM_COMMERCIALE": "DEFLAMAC",
    "FORME": "GEL DERM.",
    "DOSAGE": "0.01",
    "COND": "T/50G",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Rhumatologie"]
  },
  {
    "PregnancyIndexLink": ["diclofenac"],
    "InteractionIndexLink": ["diclofenac"],
    "N_ENREGISTREMENT": "149/ 21 A 004 /11",
    "CODE_DCI": "21 A 004",
    "DCI": "DICLOFENAC DIETHYLAMINE EXPRIME EN DICLOFENAC SODIQUE",
    "NOM_COMMERCIALE": "DICLOFENAC NOVA GENERICS",
    "FORME": "GEL DERM.",
    "DOSAGE": "1 %",
    "COND": "T/50G",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVAPHARM TRADING",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/11/2011",
    "DATE_D_ENREGISTREMENT_FINAL": "5/9/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Rhumatologie"]
  },
  {
    "PregnancyIndexLink": ["diclofenac"],
    "InteractionIndexLink": ["diclofenac"],
    "N_ENREGISTREMENT": "319/ 21 A 004 /09",
    "CODE_DCI": "21 A 004",
    "DCI": "DICLOFENAC DIETHYLAMINE EXPRIME EN DICLOFENAC SODIQUE",
    "NOM_COMMERCIALE": "PHLOGOREN",
    "FORME": "GEL DERM.",
    "DOSAGE": "1 %",
    "COND": "T/50G",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ARAB PHARM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/7/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "1/7/2009",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Rhumatologie"]
  },
  {
    "PregnancyIndexLink": ["diclofenac"],
    "InteractionIndexLink": ["diclofenac"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "21 A 004",
    "DCI": "DICLOFENAC DE SODIUM",
    "NOM_COMMERCIALE": "PHLOGOREN",
    "FORME": "GEL",
    "DOSAGE": "0.01",
    "COND": "TUBE DE 50 g",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Rhumatologie"]
  },
  {
    "PregnancyIndexLink": ["diclofenac"],
    "InteractionIndexLink": ["diclofenac"],
    "N_ENREGISTREMENT": "352/ 21 A 004 /98/20",
    "CODE_DCI": "21 A 004",
    "DCI": "DICLOFENAC DIETHYLAMINE EXPRIME EN DICLOFENAC SODIQUE",
    "NOM_COMMERCIALE": "TABIFLEX COOL",
    "FORME": "GEL  EMULSION DERM.",
    "DOSAGE": "1 %",
    "COND": "B/01 TUBE DE 50G",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/12/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "18/3/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Rhumatologie"]
  },
  {
    "PregnancyIndexLink": ["diclofenac"],
    "InteractionIndexLink": ["diclofenac"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "21 A 004",
    "DCI": "DICLOFENAC DIETHYLAMINE EXPRIME EN DICLOFENAC SODIQUE",
    "NOM_COMMERCIALE": "TABIFLEX COOL",
    "FORME": "GEL  EMULSION DERM.",
    "DOSAGE": "0.01",
    "COND": "B/01 TUBE DE 50G",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Rhumatologie"]
  },
  {
    "PregnancyIndexLink": ["diclofenac"],
    "InteractionIndexLink": ["diclofenac"],
    "N_ENREGISTREMENT": "16/21 A 004/400",
    "CODE_DCI": "21 A 004",
    "DCI": "DICLOFENAC SODIQUE",
    "NOM_COMMERCIALE": "VOLTAMEX",
    "FORME": "GEL DERMIQUE",
    "DOSAGE": "1.00 %",
    "COND": "B/ 1 TUBE DE 50G",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "KPMA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/12/16",
    "DATE_D_ENREGISTREMENT_FINAL": "19/12/16",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Rhumatologie"]
  },
  {
    "PregnancyIndexLink": ["diclofenac"],
    "InteractionIndexLink": ["diclofenac"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "21 A 004",
    "DCI": "DICLOFENAC",
    "NOM_COMMERCIALE": "VOLTAMEX",
    "FORME": "GEL DERMIQUE",
    "DOSAGE": "0.01",
    "COND": "TUBE DE 50 G",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Rhumatologie"]
  },
  {
    "PregnancyIndexLink": ["diclofenac"],
    "InteractionIndexLink": ["diclofenac"],
    "N_ENREGISTREMENT": "267/ 21 A 004 /99/06",
    "CODE_DCI": "21 A 004",
    "DCI": "DICLOFENAC DIETHYLAMINE EXPRIME EN DICLOFENAC SODIQUE",
    "NOM_COMMERCIALE": "VOLTARENE EMULGEL",
    "FORME": "GEL DERM.",
    "DOSAGE": "1 %",
    "COND": "T/50G",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVARTIS SANTE FAMILIALE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/11/1997",
    "DATE_D_ENREGISTREMENT_FINAL": "20/6/2006",
    "TYPE": "Ré",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Rhumatologie"]
  },
  {
    "PregnancyIndexLink": ["diclofenac"],
    "InteractionIndexLink": ["diclofenac"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "21 A 004",
    "DCI": "DICLOFENAC DIETHYLAMINE EXPRIME EN DICLOFENAC SODIQUE",
    "NOM_COMMERCIALE": "VOLTARENE EMULGEL",
    "FORME": "GEL DERM.",
    "DOSAGE": "0.01",
    "COND": "T/50G",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Rhumatologie"]
  },
  {
    "PregnancyIndexLink": ["diclofenac"],
    "InteractionIndexLink": ["diclofenac"],
    "N_ENREGISTREMENT": "088/ 21 A 004 /04",
    "CODE_DCI": "21 A 004",
    "DCI": "Diclofénac sodique",
    "NOM_COMMERCIALE": "VOLTENAC",
    "FORME": "GEL DERM.",
    "DOSAGE": "1 %",
    "COND": "T/50G",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMAGHREB",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/2/2004",
    "DATE_D_ENREGISTREMENT_FINAL": "7/2/2004",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Rhumatologie"]
  },
  {
    "PregnancyIndexLink": ["diclofenac"],
    "InteractionIndexLink": ["diclofenac"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "21 A 004",
    "DCI": "Diclofénac sodique",
    "NOM_COMMERCIALE": "VOLTENAC",
    "FORME": "GEL DERM.",
    "DOSAGE": "0.01",
    "COND": "T/50G",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Rhumatologie"]
  },
  {
    "PregnancyIndexLink": ["diclofenac"],
    "InteractionIndexLink": ["diclofenac"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "21 A 004",
    "DCI": "Diclofenac diéthylamine exprimé en diclofenac sodique",
    "NOM_COMMERCIALE": "Voltum",
    "FORME": "Gel",
    "DOSAGE": "0.01",
    "COND": "Tube 50 gr",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Rhumatologie"]
  },
  {
    "PregnancyIndexLink": ["diclofenac"],
    "InteractionIndexLink": ["diclofenac"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "21 A 004",
    "DCI": "Diclofénac",
    "NOM_COMMERCIALE": "Voltum",
    "FORME": "Emulsion gel",
    "DOSAGE": "0.01",
    "COND": "Tube de 50g",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Rhumatologie"]
  },
  {
    "PregnancyIndexLink": ["piroxicam"],
    "InteractionIndexLink": ["piroxicam"],
    "N_ENREGISTREMENT": "035/21 A 005/17",
    "CODE_DCI": "21 A 005",
    "DCI": "PIROXICAM",
    "NOM_COMMERCIALE": "FELCAM",
    "FORME": "GEL",
    "DOSAGE": "0.5%",
    "COND": "T/50G",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EURL PHARMALLIANCE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/7/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "30/7/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Rhumatologie"]
  },
  {
    "PregnancyIndexLink": ["piroxicam"],
    "InteractionIndexLink": ["piroxicam"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "21 A 005",
    "DCI": "PIROXICAM",
    "NOM_COMMERCIALE": "FELCAM",
    "FORME": "GEL",
    "DOSAGE": "0.005",
    "COND": "T/50G",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Rhumatologie"]
  },
  {
    "PregnancyIndexLink": ["piroxicam"],
    "InteractionIndexLink": ["piroxicam"],
    "N_ENREGISTREMENT": "263/ 21 A 005 /12",
    "CODE_DCI": "21 A 005",
    "DCI": "PIROXICAM",
    "NOM_COMMERCIALE": "FENOXAM",
    "FORME": "GEL DERM.",
    "DOSAGE": "0.5%",
    "COND": "T/50G",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOPHARM ALGERIE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/3/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "20/3/2012",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Rhumatologie"]
  },
  {
    "PregnancyIndexLink": ["piroxicam"],
    "InteractionIndexLink": ["piroxicam"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "21 A 005",
    "DCI": "PIROXICAM",
    "NOM_COMMERCIALE": "FENOXAM",
    "FORME": "GEL DERM.",
    "DOSAGE": "0.005",
    "COND": "T/50G",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Rhumatologie"]
  },
  {
    "PregnancyIndexLink": ["piroxicam"],
    "InteractionIndexLink": ["piroxicam"],
    "N_ENREGISTREMENT": "352/ 21 A 005 /09",
    "CODE_DCI": "21 A 005",
    "DCI": "PIROXICAM",
    "NOM_COMMERCIALE": "ORTHOCAM",
    "FORME": "GEL DERM.",
    "DOSAGE": "0.5%",
    "COND": "T/25G",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/2/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "28/2/2009",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Rhumatologie"]
  },
  {
    "PregnancyIndexLink": ["piroxicam"],
    "InteractionIndexLink": ["piroxicam"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "21 A 005",
    "DCI": "Piroxicam",
    "NOM_COMMERCIALE": "Orthocam",
    "FORME": "Gel",
    "DOSAGE": "0.005",
    "COND": "B/25gm",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Rhumatologie"]
  },
  {
    "PregnancyIndexLink": ["piroxicam"],
    "InteractionIndexLink": ["piroxicam"],
    "N_ENREGISTREMENT": "366/ 21 A 005 /08",
    "CODE_DCI": "21 A 005",
    "DCI": "PIROXICAM",
    "NOM_COMMERCIALE": "PIROXENE",
    "FORME": "GEL DERM.",
    "DOSAGE": "0.5%",
    "COND": "T./40G",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "4A SANTE INDUSTRIE SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/4/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "27/4/2008",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Rhumatologie"]
  },
  {
    "PregnancyIndexLink": ["piroxicam"],
    "InteractionIndexLink": ["piroxicam"],
    "N_ENREGISTREMENT": "149/ 21 A 005 /12/18",
    "CODE_DCI": "21 A 005",
    "DCI": "PIROXICAM",
    "NOM_COMMERCIALE": "PIROXICAM NOVAGENERICS",
    "FORME": "GEL DERM.",
    "DOSAGE": "0.5%",
    "COND": "T/50G",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVAPHARM TRADING",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/3/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "2/4/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Rhumatologie"]
  },
  {
    "PregnancyIndexLink": ["piroxicam"],
    "InteractionIndexLink": ["piroxicam"],
    "N_ENREGISTREMENT": "003/ 21 A 005 /09/16",
    "CODE_DCI": "21 A 005",
    "DCI": "PIROXICAM",
    "NOM_COMMERCIALE": "PRIXAM",
    "FORME": "GEL DERM.",
    "DOSAGE": "0.5%",
    "COND": "T/50G",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SAIDAL GROUPE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/3/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "17/1/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Rhumatologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["acide niflumique"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "21 A 031",
    "DCI": "ACIDE NIFLUMIQUE",
    "NOM_COMMERCIALE": "GEMATE",
    "FORME": "GEL",
    "DOSAGE": "0.025",
    "COND": "TUBE DE 60g",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Rhumatologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["acide niflumique"],
    "N_ENREGISTREMENT": "319/ 21 A 031 /08",
    "CODE_DCI": "21 A 031",
    "DCI": "ACIDE NIFLUMIQUE",
    "NOM_COMMERCIALE": "GEMATE GEL",
    "FORME": "GEL DERM.",
    "DOSAGE": "2.5%",
    "COND": "T/60G",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ARAB PHARM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "14/7/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "14/7/2008",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Rhumatologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["acide niflumique"],
    "N_ENREGISTREMENT": "017/ 21 A 031 /99/15",
    "CODE_DCI": "21 A 031",
    "DCI": "ACIDE NIFLUMIQUE",
    "NOM_COMMERCIALE": "NIFLUGEL",
    "FORME": "GEL DERM.",
    "DOSAGE": "2.5%",
    "COND": "T/60G",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BRISTOL-MYERS SQUIBB",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/5/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "29/1/2015",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Rhumatologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["acide niflumique"],
    "N_ENREGISTREMENT": "400/ 21 A 031 /21",
    "CODE_DCI": "21 A 031",
    "DCI": "Acide Niflumique",
    "NOM_COMMERCIALE": "NIFLUMEX",
    "FORME": "Gel dermique",
    "DOSAGE": "2.5%",
    "COND": "T/50G",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "KHROUB PHARMACEUTICALL MANUFACTURING ALGERIA (KPMA) /SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "14/3/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "14/3/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Rhumatologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["acide niflumique"],
    "N_ENREGISTREMENT": "400/ 21 A 031 /21",
    "CODE_DCI": "21 A 031",
    "DCI": "Acide Niflumique",
    "NOM_COMMERCIALE": "NIFLUMEX",
    "FORME": "Gel dermique",
    "DOSAGE": "2.50 %",
    "COND": "T/50G",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "KHROUB PHARMACEUTICALL MANUFACTURING ALGERIA (KPMA) /SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "14/03/21",
    "DATE_D_ENREGISTREMENT_FINAL": "14/03/21",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Rhumatologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["acide niflumique"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "21 A 031",
    "DCI": "Acide niflumique",
    "NOM_COMMERCIALE": "NIFLUMEX",
    "FORME": "GEL",
    "DOSAGE": "0.025",
    "COND": "T/50G",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Rhumatologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["acide niflumique"],
    "N_ENREGISTREMENT": "366/ 21 A 031 /08",
    "CODE_DCI": "21 A 031",
    "DCI": "ACIDE NIFLUMIQUE",
    "NOM_COMMERCIALE": "NIFLURIC",
    "FORME": "GEL DERM.",
    "DOSAGE": "2.5%",
    "COND": "T/40G",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "4A SANTE INDUSTRIE SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/12/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "17/12/2008",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Rhumatologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["acide niflumique"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "21 A 031",
    "DCI": "ACIDE NIFLUMIQUE",
    "NOM_COMMERCIALE": "NIFLURIC",
    "FORME": "GEL DERM.",
    "DOSAGE": "0.025",
    "COND": "T/40G",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Rhumatologie"]
  },
  {
    "PregnancyIndexLink": ["ketoprofen"],
    "InteractionIndexLink": ["ketoprofene"],
    "N_ENREGISTREMENT": "319/ 21 A 032 /08",
    "CODE_DCI": "21 A 032",
    "DCI": "KETOPROFENE",
    "NOM_COMMERCIALE": "GEPROFEN",
    "FORME": "GEL DERM.",
    "DOSAGE": "2.5%",
    "COND": "T/60G",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ARAB PHARM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "23/12/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "23/12/2008",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Rhumatologie"]
  },
  {
    "PregnancyIndexLink": ["ketoprofen"],
    "InteractionIndexLink": ["ketoprofene"],
    "N_ENREGISTREMENT": "311/ 21 A 032 /15",
    "CODE_DCI": "21 A 032",
    "DCI": "KETOPROFENE",
    "NOM_COMMERCIALE": "K-PROFEN",
    "FORME": "GEL DERM.",
    "DOSAGE": "2.5%",
    "COND": "T/50G",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LGPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/12/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "27/12/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Rhumatologie"]
  },
  {
    "PregnancyIndexLink": ["ketoprofen"],
    "InteractionIndexLink": ["ketoprofene"],
    "N_ENREGISTREMENT": "366/ 21 A 032 /08",
    "CODE_DCI": "21 A 032",
    "DCI": "KETOPROFENE",
    "NOM_COMMERCIALE": "KETOFEN",
    "FORME": "GEL DERM.",
    "DOSAGE": "2.5%",
    "COND": "T./40G",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "4A SANTE INDUSTRIE SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/4/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "27/4/2008",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Rhumatologie"]
  },
  {
    "PregnancyIndexLink": ["ketoprofen"],
    "InteractionIndexLink": ["ketoprofene"],
    "N_ENREGISTREMENT": "20/21 A032/400",
    "CODE_DCI": "21 A 032",
    "DCI": "KETOPROFENE",
    "NOM_COMMERCIALE": "KETOMEX",
    "FORME": "GEL DERMIQUE",
    "DOSAGE": "2.5%",
    "COND": "B/ 1 TUBE DE 50G",
    "LISTE": "LISTE II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "KPMA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/11/20",
    "DATE_D_ENREGISTREMENT_FINAL": "25/11/20",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Rhumatologie"]
  },
  {
    "PregnancyIndexLink": ["ketoprofen"],
    "InteractionIndexLink": ["ketoprofene"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "21 A 032",
    "DCI": "KETOPROFENE",
    "NOM_COMMERCIALE": "KETOMEX",
    "FORME": "GEL DERMIQUE",
    "DOSAGE": "0.025",
    "COND": "TUBE DE 50 G",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Rhumatologie"]
  },
  {
    "PregnancyIndexLink": ["ketoprofen"],
    "InteractionIndexLink": ["ketoprofene"],
    "N_ENREGISTREMENT": "20/21 A032/546",
    "CODE_DCI": "21 A 032",
    "DCI": "KETOPROFENE",
    "NOM_COMMERCIALE": "KETONYX",
    "FORME": "GEL",
    "DOSAGE": "2.5%",
    "COND": "TUBE/ 50G",
    "LISTE": "LISTE II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES ONYX INDUSTRIE PHARMACEUTIQUE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "21/10/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "21/10/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Rhumatologie"]
  },
  {
    "PregnancyIndexLink": ["ketoprofen"],
    "InteractionIndexLink": ["ketoprofene"],
    "N_ENREGISTREMENT": "309/ 21 A 032 /16",
    "CODE_DCI": "21 A 032",
    "DCI": "KETOPROFENE",
    "NOM_COMMERCIALE": "KETOPROFENE LDM",
    "FORME": "GEL DERM.",
    "DOSAGE": "2.5%",
    "COND": "T/60G",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES  DE DIAGNOSTIC MAGHREBINS (LDM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "France",
    "DATE_D_ENREGISTREMENT_INITIAL": "11/4/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "11/4/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Rhumatologie"]
  },
  {
    "PregnancyIndexLink": ["ketoprofen"],
    "InteractionIndexLink": ["ketoprofene"],
    "N_ENREGISTREMENT": "203/ 21 A 032 /05/14",
    "CODE_DCI": "21 A 032",
    "DCI": "KETOPROFENE",
    "NOM_COMMERCIALE": "KETUM",
    "FORME": "GEL DERM.",
    "DOSAGE": "2.5%",
    "COND": "T/60G",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MENARINI FRANCE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "11/12/2005",
    "DATE_D_ENREGISTREMENT_FINAL": "27/2/2014",
    "TYPE": "Ré",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Rhumatologie"]
  },
  {
    "PregnancyIndexLink": ["dexamethasone"],
    "InteractionIndexLink": ["dexamethasone"],
    "N_ENREGISTREMENT": "169/ 21 A 035 /00",
    "CODE_DCI": "21 A 035",
    "DCI": "DEXAMETHASONE  /  SALICYLAMIDE  / SALICYLATE D''HYDROXYETHYLE",
    "NOM_COMMERCIALE": "PERCUTALGINE SPRAY",
    "FORME": "SOL.DERM.",
    "DOSAGE": "0.05% / 8.5% / 10%",
    "COND": "FLACON PRESSURISE DE 40ML AVEC POMPE DOSEUSE",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BESINS-ISCOVESCO",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/8/2000",
    "DATE_D_ENREGISTREMENT_FINAL": "1/8/2000",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["ibuprofen"],
    "InteractionIndexLink": ["ibuprofene"],
    "N_ENREGISTREMENT": "035/21 A 057/17",
    "CODE_DCI": "21 A 057",
    "DCI": "IBUPROFENE",
    "NOM_COMMERCIALE": "ANTALFEN",
    "FORME": "GEL DERM.",
    "DOSAGE": "5% ( 5G/100 G )",
    "COND": "T/50G",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMALLIANCE EURL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/9/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "10/9/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Rhumatologie"]
  },
  {
    "PregnancyIndexLink": ["ibuprofen"],
    "InteractionIndexLink": ["ibuprofene"],
    "N_ENREGISTREMENT": "309/21 A 057/19",
    "CODE_DCI": "21 A 057",
    "DCI": "IBUPROFENE",
    "NOM_COMMERCIALE": "IBUPRFENE LDM",
    "FORME": "GEL DERM.",
    "DOSAGE": "5% ( 5G/100 G )",
    "COND": "T/50G",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LDM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/3/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "29/3/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Rhumatologie"]
  },
  {
    "PregnancyIndexLink": ["ibuprofen"],
    "InteractionIndexLink": ["ibuprofene", "levomenthol"],
    "N_ENREGISTREMENT": "149/21 A 069/16",
    "CODE_DCI": "21 A 069",
    "DCI": "IBUPROFENE/LEVOMENTHOL",
    "NOM_COMMERCIALE": "IBUTHOL",
    "FORME": "GEL",
    "DOSAGE": "5G/3G POUR 100G",
    "COND": "TUBE DE 50G",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL NOVAPHARM TRADING",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/10/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "19/10/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Rhumatologie"]
  },
  {
    "PregnancyIndexLink": ["ibuprofen"],
    "InteractionIndexLink": ["ibuprofene", "levomenthol"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "21 A 069",
    "DCI": "ibuprofene / levomenthol",
    "NOM_COMMERCIALE": "IBUTHOL",
    "FORME": "gel",
    "DOSAGE": "5%-3%",
    "COND": "tube de 50 g",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Rhumatologie"]
  },
  {
    "PregnancyIndexLink": ["diclofenac"],
    "InteractionIndexLink": ["diclofenac"],
    "N_ENREGISTREMENT": "035/21 A 071/19",
    "CODE_DCI": "21 A 071",
    "DCI": "DICLOFENAC DIETHYLAMINE EXPRIME EN DICLOFENAC SODIQUE",
    "NOM_COMMERCIALE": "VOLTUM",
    "FORME": "GEL",
    "DOSAGE": "2 %",
    "COND": "TUBE/ 50G",
    "LISTE": "LISTE II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMALLIANCE EURL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "5/11/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "5/11/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["allopurinol"],
    "InteractionIndexLink": ["allopurinol"],
    "N_ENREGISTREMENT": "468/ 21 B 007 /13/20",
    "CODE_DCI": "21 B 007",
    "DCI": "ALLOPURINOL",
    "NOM_COMMERCIALE": "NADLORIC",
    "FORME": "COMPRIME",
    "DOSAGE": "100MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NADPHARMADIC PRODUCTION SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "21/5/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "8/1/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Rhumatologie"]
  },
  {
    "PregnancyIndexLink": ["allopurinol"],
    "InteractionIndexLink": ["allopurinol"],
    "N_ENREGISTREMENT": "109/ 21 B 007 /99",
    "CODE_DCI": "21 B 007",
    "DCI": "ALLOPURINOL",
    "NOM_COMMERCIALE": "NO URIC 100",
    "FORME": "COMPRIME",
    "DOSAGE": "100MG",
    "COND": "B/50",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EIPICO",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EGYPTE",
    "DATE_D_ENREGISTREMENT_INITIAL": "21/4/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "21/4/1999",
    "TYPE": "Gé",
    "STATUT": "C",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Rhumatologie"]
  },
  {
    "PregnancyIndexLink": ["allopurinol"],
    "InteractionIndexLink": ["allopurinol"],
    "N_ENREGISTREMENT": "166/ 21 B 007 /98/17",
    "CODE_DCI": "21 B 007",
    "DCI": "ALLOPURINOL",
    "NOM_COMMERCIALE": "ZANURIC 100",
    "FORME": "COMPRIME",
    "DOSAGE": "100MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "RAM PHARMACEUTICAL INDUSTRIES.CO.LTD.",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/8/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "4/9/2017",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Rhumatologie"]
  },
  {
    "PregnancyIndexLink": ["allopurinol"],
    "InteractionIndexLink": ["allopurinol"],
    "N_ENREGISTREMENT": "467/ 21 B 007 /98/14",
    "CODE_DCI": "21 B 007",
    "DCI": "ALLOPURINOL",
    "NOM_COMMERCIALE": "ZYLORIC",
    "FORME": "COMPRIME",
    "DOSAGE": "100MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ASPEN PHARMA TRADING LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "IRLANDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/11/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "27/2/2014",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "48 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Rhumatologie"]
  },
  {
    "PregnancyIndexLink": ["allopurinol"],
    "InteractionIndexLink": ["allopurinol"],
    "N_ENREGISTREMENT": "109/ 21 B 008 /99",
    "CODE_DCI": "21 B 008",
    "DCI": "ALLOPURINOL",
    "NOM_COMMERCIALE": "NO URIC 300",
    "FORME": "COMPRIME",
    "DOSAGE": "300MG",
    "COND": "B/20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EIPICO",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EGYPTE",
    "DATE_D_ENREGISTREMENT_INITIAL": "21/4/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "21/4/1999",
    "TYPE": "Gé",
    "STATUT": "C",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["allopurinol"],
    "InteractionIndexLink": ["allopurinol"],
    "N_ENREGISTREMENT": "166/ 21 B 008 /98/15",
    "CODE_DCI": "21 B 008",
    "DCI": "ALLOPURINOL",
    "NOM_COMMERCIALE": "ZANURIC",
    "FORME": "COMPRIME",
    "DOSAGE": "300MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "RAM PHARMACEUTICAL INDUSTRIES",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/8/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "31/5/2015",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["colchicine"],
    "InteractionIndexLink": ["colchicine"],
    "N_ENREGISTREMENT": "067/ 21 B 009 /98/19",
    "CODE_DCI": "21 B 009",
    "DCI": "COLCHICINE",
    "NOM_COMMERCIALE": "COLCHICINE OPOCALCIUM",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "1MG",
    "COND": "B/20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MAYOLI SPINDLER",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "16/5/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "28/7/2019",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "48 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Rhumatologie"]
  },
  {
    "PregnancyIndexLink": ["colchicine"],
    "InteractionIndexLink": ["colchicine"],
    "N_ENREGISTREMENT": "317/ 21 B 009 /14",
    "CODE_DCI": "21 B 009",
    "DCI": "COLCHICINE CRISTALISEE",
    "NOM_COMMERCIALE": "COLCHIMED",
    "FORME": "COMPRIME",
    "DOSAGE": "1MG",
    "COND": "B/20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INPHA MEDIS SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/11/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "13/11/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Rhumatologie"]
  },
  {
    "PregnancyIndexLink": ["colchicine"],
    "InteractionIndexLink": ["colchicine"],
    "N_ENREGISTREMENT": "400/ 21 B 009 /15",
    "CODE_DCI": "21 B 009",
    "DCI": "COLCHICINE CRISTALISEE",
    "NOM_COMMERCIALE": "COLCHIMEX",
    "FORME": "COMPRIME",
    "DOSAGE": "1MG",
    "COND": "B/20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "KHROUB PHARMACEUTICAL MANUFACTURING ALGERIA (KPMA)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/1/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "29/1/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Rhumatologie"]
  },
  {
    "PregnancyIndexLink": ["calcitonin salmon"],
    "InteractionIndexLink": ["calcitonine"],
    "N_ENREGISTREMENT": "011/ 21 C 012 /96/16",
    "CODE_DCI": "21 C 012",
    "DCI": "CALCITONINE SYNTHETIQUE DE SAUMON",
    "NOM_COMMERCIALE": "CALCO",
    "FORME": "SOL. INJ.",
    "DOSAGE": "100UI/ML",
    "COND": "B/5AMP. DE 1ML",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ITALIANO BIOCHIMICO FARMACEUTICO LISAPHARMA SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ITALIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/10/1996",
    "DATE_D_ENREGISTREMENT_FINAL": "5/3/2017",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["pamidronate"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "182/ 21 C 034 /14",
    "CODE_DCI": "21 C 034",
    "DCI": "PAMIDRONATE SODIUM",
    "NOM_COMMERCIALE": "PAMIDRIA",
    "FORME": "PDRE LYOPHILISEE P/INJ EN PERF IV",
    "DOSAGE": "90MG/FL.",
    "COND": "B/01 FL. DE LYOPHILISAT+ 01 AMP. DE SOLVANT DE 10ML (EPPI)",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CIPLA LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/1/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "30/1/2014",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["risedronate"],
    "InteractionIndexLink": ["acide risedronique"],
    "N_ENREGISTREMENT": "230/ 21 C 041 /03",
    "CODE_DCI": "21 C 041",
    "DCI": "Risedronate monosodique (acide risedronique)",
    "NOM_COMMERCIALE": "ACTONEL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "30MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "AVENTIS PHARMA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "23/4/2003",
    "DATE_D_ENREGISTREMENT_FINAL": "23/4/2003",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Rhumatologie"]
  },
  {
    "PregnancyIndexLink": ["risedronate"],
    "InteractionIndexLink": ["acide risedronique"],
    "N_ENREGISTREMENT": "317/ 21 C 041 /14",
    "CODE_DCI": "21 C 041",
    "DCI": "ACIDE RISEDRONIQUE SEL MONOSODIQUE (risedronate)",
    "NOM_COMMERCIALE": "OSTEOS",
    "FORME": "COMPRIME",
    "DOSAGE": "30MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INPHA-MEDIS SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/6/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "9/8/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Rhumatologie"]
  },
  {
    "PregnancyIndexLink": ["risedronate"],
    "InteractionIndexLink": ["acide risedronique"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "21 C 041",
    "DCI": "Risedronate monosodique (acide risedronique)",
    "NOM_COMMERCIALE": "Osteos 30 mg",
    "FORME": "comp pel",
    "DOSAGE": "30mg/comp",
    "COND": "bt de 30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Rhumatologie"]
  },
  {
    "PregnancyIndexLink": ["hydroxychloroquine"],
    "InteractionIndexLink": ["hydroxychloroquine"],
    "N_ENREGISTREMENT": "20/21 D020/003",
    "CODE_DCI": "21 D 020",
    "DCI": "HYDROXYCHLOROQUINE SULFATE",
    "NOM_COMMERCIALE": "HCQ-SAIDAL",
    "FORME": "COMP PELL",
    "DOSAGE": "200MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EPE GROUPE INDUSTRIEL SAIDAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/9/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "9/9/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Rhumatologie"]
  },
  {
    "PregnancyIndexLink": ["hydroxychloroquine"],
    "InteractionIndexLink": ["hydroxychloroquine"],
    "N_ENREGISTREMENT": "20/21 D020/003",
    "CODE_DCI": "21 D 020",
    "DCI": "HYDROXYCHLOROQUINE SULFATE",
    "NOM_COMMERCIALE": "HCQ-SAIDAL",
    "FORME": "COMP PELL",
    "DOSAGE": "200MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EPE GROUPE INDUSTRIEL SAIDAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "09/09/20",
    "DATE_D_ENREGISTREMENT_FINAL": "09/09/20",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Rhumatologie"]
  },
  {
    "PregnancyIndexLink": ["hydroxychloroquine"],
    "InteractionIndexLink": ["hydroxychloroquine"],
    "N_ENREGISTREMENT": "255/ 21 D 020 /98/16",
    "CODE_DCI": "21 D 020",
    "DCI": "HYDROXYCHLOROQUINE",
    "NOM_COMMERCIALE": "PLAQUENIL",
    "FORME": "COMP.ENRO.",
    "DOSAGE": "200MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANOFI SYNTHELABO",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/4/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "6/3/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Rhumatologie"]
  },
  {
    "PregnancyIndexLink": ["hydroxychloroquine"],
    "InteractionIndexLink": ["hydroxychloroquine"],
    "N_ENREGISTREMENT": "286/21 D 020/17",
    "CODE_DCI": "21 D 020",
    "DCI": "HYDROXYCHLOROQUINE SULFATE",
    "NOM_COMMERCIALE": "XARIA",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "200MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL CPCM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/3/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "20/3/2017",
    "TYPE": "Gé",
    "STATUT": "F PREMIX",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Rhumatologie"]
  },
  {
    "PregnancyIndexLink": ["risedronate"],
    "InteractionIndexLink": ["acide risedronique"],
    "N_ENREGISTREMENT": "230/ 21 D 040 /03",
    "CODE_DCI": "21 D 040",
    "DCI": "Risedronate monosodique (acide risedronique)",
    "NOM_COMMERCIALE": "ACTONEL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "5MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "AVENTIS  PHARMA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "23/4/2003",
    "DATE_D_ENREGISTREMENT_FINAL": "23/4/2003",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Rhumatologie"]
  },
  {
    "PregnancyIndexLink": ["risedronate"],
    "InteractionIndexLink": ["acide risedronique"],
    "N_ENREGISTREMENT": "317/ 21 D 040 /14",
    "CODE_DCI": "21 D 040",
    "DCI": "ACIDE RISEDRONIQUE SEL MONOSODIQUE (risedronate)",
    "NOM_COMMERCIALE": "OSTEOS",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "5MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INPHA-MEDIS SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/4/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "26/7/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Rhumatologie"]
  },
  {
    "PregnancyIndexLink": ["risedronate"],
    "InteractionIndexLink": ["acide risedronique"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "21 D 040",
    "DCI": "Risedronate monosodique (acide risedronique)",
    "NOM_COMMERCIALE": "Osteos 5 mg",
    "FORME": "comp pel",
    "DOSAGE": "5mg/comp",
    "COND": "bt de 30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Rhumatologie"]
  },
  {
    "PregnancyIndexLink": ["leflunomide"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "230/ 21 D 042 /03",
    "CODE_DCI": "21 D 042",
    "DCI": "LEFLUNOMIDE",
    "NOM_COMMERCIALE": "ARAVA",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "AVENTIS PHARMA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALLEMAGNE",
    "DATE_D_ENREGISTREMENT_INITIAL": "3/2/2003",
    "DATE_D_ENREGISTREMENT_FINAL": "3/2/2003",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["leflunomide"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "293/ 21 D 042 /19",
    "CODE_DCI": "21 D 042",
    "DCI": "LEFLUNOMIDE",
    "NOM_COMMERCIALE": "BIORAVA",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOCARE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/6/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "18/6/2019",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["leflunomide"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "230/ 21 D 043 /03",
    "CODE_DCI": "21 D 043",
    "DCI": "LEFLUNOMIDE",
    "NOM_COMMERCIALE": "ARAVA",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "20MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "AVENTIS PHARMA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALLEMAGNE",
    "DATE_D_ENREGISTREMENT_INITIAL": "3/2/2003",
    "DATE_D_ENREGISTREMENT_FINAL": "3/2/2003",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["leflunomide"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "293/ 21 D 043 /19",
    "CODE_DCI": "21 D 043",
    "DCI": "LEFLUNOMIDE",
    "NOM_COMMERCIALE": "BIORAVA",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "20MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOCARE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/6/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "16/6/2019",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["leflunomide"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "230/ 21 D 044 /03",
    "CODE_DCI": "21 D 044",
    "DCI": "LEFLUNOMIDE",
    "NOM_COMMERCIALE": "ARAVA",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "100MG",
    "COND": "B/3",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "AVENTIS PHARMA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALLEMAGNE",
    "DATE_D_ENREGISTREMENT_INITIAL": "3/2/2003",
    "DATE_D_ENREGISTREMENT_FINAL": "3/2/2003",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["risedronate"],
    "InteractionIndexLink": ["acide risedronique"],
    "N_ENREGISTREMENT": "317/ 21 D 046 /14",
    "CODE_DCI": "21 D 046",
    "DCI": "ACIDE RISEDRONIQUE SEL MONOSODIQUE (risedronate)",
    "NOM_COMMERCIALE": "OSTEOS",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "35MG",
    "COND": "B/04",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INPHA-MEDIS SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/6/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "5/9/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Rhumatologie"]
  },
  {
    "PregnancyIndexLink": ["risedronate"],
    "InteractionIndexLink": ["acide risedronique"],
    "N_ENREGISTREMENT": "447/ 21 D 046 /13/18",
    "CODE_DCI": "21 D 046",
    "DCI": "ACIDE RISEDRONIQUE MONOSODIQUE HEMIPENTAHYDRATE EXPRIME EN ACIDE RIDEDRONIQUE MONOSODIQUE (risedronate)",
    "NOM_COMMERCIALE": "OSTONEL ONCE A WEEK",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "35MG",
    "COND": "B/04",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEKER SARL (SARL LABORATOIRE BEKER ALGERIE)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "3/11/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "9/1/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Rhumatologie"]
  },
  {
    "PregnancyIndexLink": ["risedronate"],
    "InteractionIndexLink": ["acide risedronique"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "21 D 046",
    "DCI": "Risedronate monosodique (acide risedronique)",
    "NOM_COMMERCIALE": "Osteos 35 mg",
    "FORME": "comp pel",
    "DOSAGE": "35mg/comp",
    "COND": "bt de 04",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Rhumatologie"]
  },
  {
    "PregnancyIndexLink": ["risedronate"],
    "InteractionIndexLink": ["acide risedronique"],
    "N_ENREGISTREMENT": "352/ 21 D 046 /15",
    "CODE_DCI": "21 D 046",
    "DCI": "ACIDE RISEDRONIQUE MONOSODIQUE HEMIPENTAHYDRATE EXPRIME EN ACIDE RIDEDRONIQUE MONOSODIQUE (risedronate)",
    "NOM_COMMERCIALE": "RISONATE",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "35MG",
    "COND": "B/04",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/12/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "2/12/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Rhumatologie"]
  },
  {
    "PregnancyIndexLink": ["baclofen"],
    "InteractionIndexLink": ["baclofene"],
    "N_ENREGISTREMENT": "418/21 E 025/16",
    "CODE_DCI": "21 E 025",
    "DCI": "BACLOFENE",
    "NOM_COMMERCIALE": "BACLON",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "10MG",
    "COND": "B/50",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NEOMEDIC SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/12/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "4/12/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Rhumatologie"]
  },
  {
    "PregnancyIndexLink": ["baclofen"],
    "InteractionIndexLink": ["baclofene"],
    "N_ENREGISTREMENT": "012/ 21 E 025 /98/16",
    "CODE_DCI": "21 E 025",
    "DCI": "BACLOFENE",
    "NOM_COMMERCIALE": "BACRO",
    "FORME": "COMPRIME",
    "DOSAGE": "10MG",
    "COND": "B/50",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CROVIS PHILCOM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ITALIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "16/8/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "22/2/2016",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Rhumatologie"]
  },
  {
    "PregnancyIndexLink": ["baclofen"],
    "InteractionIndexLink": ["baclofene"],
    "N_ENREGISTREMENT": "20/21 E025/380",
    "CODE_DCI": "21 E 025",
    "DCI": "BACLOFENE",
    "NOM_COMMERCIALE": "CLORESAL",
    "FORME": "COMP",
    "DOSAGE": "10MG",
    "COND": "B/50",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "laboratoires HUP.P PHARMA Sarl",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/7/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "29/7/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Rhumatologie"]
  },
  {
    "PregnancyIndexLink": ["baclofen"],
    "InteractionIndexLink": ["baclofene"],
    "N_ENREGISTREMENT": "068/ 21 E 025 /98/15",
    "CODE_DCI": "21 E 025",
    "DCI": "BACLOFENE",
    "NOM_COMMERCIALE": "LIORESAL",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "10MG",
    "COND": "B/50",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVARTIS PHARMA SCHWEIZ AG",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/12/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "2/12/2015",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Rhumatologie"]
  },
  {
    "PregnancyIndexLink": ["baclofen"],
    "InteractionIndexLink": ["baclofene"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "21 E 025",
    "DCI": "Baclofene",
    "NOM_COMMERCIALE": "cloresal 10mg",
    "FORME": "comprimé sécable",
    "DOSAGE": "10mg",
    "COND": "B/50",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Rhumatologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "21 E 060",
    "DCI": "Tolperisone",
    "NOM_COMMERCIALE": "MEYORELAX",
    "FORME": "Comprimé Pelliculé",
    "DOSAGE": "150 mg",
    "COND": "Boite de 30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Rhumatologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "001/ 21 E 060 /16",
    "CODE_DCI": "21 E 060",
    "DCI": "TOLPERISONE CHLORHYDRATE",
    "NOM_COMMERCIALE": "MYDOCALM",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "150MG",
    "COND": "B/30 ET B/10",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMA ALGERIA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/5/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "24/5/2016",
    "TYPE": "Ré",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36  MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Rhumatologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "293/21 E 060/20",
    "CODE_DCI": "21 E 060",
    "DCI": "TOLPERISONE HYDROCHLORIDE",
    "NOM_COMMERCIALE": "MYORELAX",
    "FORME": "COMP PELL",
    "DOSAGE": "150MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOCARE SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/2/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "10/2/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Rhumatologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "418/ 21 E 060 /13/18",
    "CODE_DCI": "21 E 060",
    "DCI": "TOLPERISONE CHLORHYDRATE",
    "NOM_COMMERCIALE": "NEOCALM",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "150MG",
    "COND": "B/30 et B/10",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NEOMEDIC SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/2/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "9/4/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Rhumatologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "492/21 E 060/19",
    "CODE_DCI": "21 E 060",
    "DCI": "TOLPERISONE CHLORHYDRATE",
    "NOM_COMMERCIALE": "SOPRICALM",
    "FORME": "COMP PELL",
    "DOSAGE": "150MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOPRODIM SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "3/12/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "3/12/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Rhumatologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "304/21 E 060/21",
    "CODE_DCI": "21 E 060",
    "DCI": "Chlorhydrate de Tolpérisone",
    "NOM_COMMERCIALE": "TOLPECALM",
    "FORME": "Comprimé pelliculé",
    "DOSAGE": "150MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GEOPHARM / SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "14/3/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "14/3/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Rhumatologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "149/21 E 060/19",
    "CODE_DCI": "21 E 060",
    "DCI": "TOLPERISONE CHLORHYDRATE",
    "NOM_COMMERCIALE": "TOLPICALM",
    "FORME": "COMP PELL",
    "DOSAGE": "150MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVAPHARM TRADING SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Rhumatologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "268/21 E 070/17",
    "CODE_DCI": "21 E 070",
    "DCI": "THIOCOLCHICOSIDE",
    "NOM_COMMERCIALE": "MIOCED",
    "FORME": "MICROGRANULEEN GELULE",
    "DOSAGE": "4MG",
    "COND": "B/24",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MERINAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/6/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "12/6/2017",
    "TYPE": "Gé",
    "STATUT": "F PREMIX",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "231/21 E 070/16",
    "CODE_DCI": "21 E 070",
    "DCI": "THIOCOLCHICOSIDE",
    "NOM_COMMERCIALE": "RELAXAN",
    "FORME": "COMPRIME",
    "DOSAGE": "4MG",
    "COND": "B/10",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES SALEM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/12/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "19/12/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["methocarbamol"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "477/21 E 072/20",
    "CODE_DCI": "21 E 072",
    "DCI": "METHOCARBAMOL",
    "NOM_COMMERCIALE": "MUSCLAX",
    "FORME": "COMPRIME",
    "DOSAGE": "500MG",
    "COND": "B/20 ET B/60",
    "LISTE": "LISTE II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL LABORATOIRES BEKER",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/12/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "7/12/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["ibuprofen", "methocarbamol"],
    "InteractionIndexLink": ["ibuprofene"],
    "N_ENREGISTREMENT": "20/21 E073/268",
    "CODE_DCI": "21 E 073",
    "DCI": "IBUPROFÈNE/ MÉTHOCARBAMOL",
    "NOM_COMMERCIALE": "MYOXYDOL",
    "FORME": "COM PELL BICOUCHE",
    "DOSAGE": "200MG/ 500MG",
    "COND": "B/30",
    "LISTE": "LISTE II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES MERINAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "5/10/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "5/10/2020",
    "TYPE": "",
    "STATUT": "FPrémix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["ACIDE SALICYLIQUE"],
    "InteractionIndexLink": ["levomenthol", "acide acetylsalicylique"],
    "N_ENREGISTREMENT": "088/ 21 F 048 /09",
    "CODE_DCI": "21 F 048",
    "DCI": "LEVOMENTHOL / VERATROLE / RESORCINOL / ACIDE SALICYLIQUE",
    "NOM_COMMERCIALE": "SEPTHOL",
    "FORME": "GEL APPLI. CUTANEE",
    "DOSAGE": "260MG/125MG/15MG/50MG/50G",
    "COND": "T/50G",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMAGHREB",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/7/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "19/7/2009",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["ACIDE SALICYLIQUE"],
    "InteractionIndexLink": ["levomenthol", "acide acetylsalicylique"],
    "N_ENREGISTREMENT": "262/ 21 F 048 /06",
    "CODE_DCI": "21 F 048",
    "DCI": "LEVOMENTHOL / VERATROLE / RESORCINOL / ACIDE SALICYLIQUE",
    "NOM_COMMERCIALE": "SYNTHOL GEL",
    "FORME": "GEL",
    "DOSAGE": "0.52G/0.25G/0.03G/0.1G/100G",
    "COND": "T/100G",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GLAXO SMITHKLINE SANTE GRAND PUBLIC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/10/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "28/10/2006",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["camphre"],
    "N_ENREGISTREMENT": "20/09/21 F056/003",
    "CODE_DCI": "21 F 056",
    "DCI": "CAMPHRE",
    "NOM_COMMERCIALE": "LATENDRA",
    "FORME": "CREME DERM.",
    "DOSAGE": "4 %",
    "COND": "T/40G",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SAIDAL GROUPE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/3/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "31/5/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["strontium ranelate"],
    "InteractionIndexLink": ["strontium"],
    "N_ENREGISTREMENT": "040/ 21 G 049 /07",
    "CODE_DCI": "21 G 049",
    "DCI": "RANELATE DE STRONTIUM",
    "NOM_COMMERCIALE": "PROTOS",
    "FORME": "GRLES. SUSP. BUV. EN SACHET-DOSE",
    "DOSAGE": "2G/SACHET",
    "COND": "B/07 ET B/28 SACHETS",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SERVIER",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/3/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "7/3/2007",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["alendronate"],
    "InteractionIndexLink": ["acide alendronique"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "21 G 050",
    "DCI": "Acide alendronique sous forme d'alendronate monosodique trihydraté (alendronate)",
    "NOM_COMMERCIALE": "ALENDRONATE LDM",
    "FORME": "Comprimé",
    "DOSAGE": "70 mg",
    "COND": "Boîte de 04",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Rhumatologie"]
  },
  {
    "PregnancyIndexLink": ["alendronate"],
    "InteractionIndexLink": ["acide alendronique"],
    "N_ENREGISTREMENT": "263/ 21 G 050 /15",
    "CODE_DCI": "21 G 050",
    "DCI": "ALENDRONATE MONOSODIQUE TRIHYDRATE EXPRIME EN ACIDE ALENDRONIQUE (alendronate)",
    "NOM_COMMERCIALE": "DROMAX",
    "FORME": "COMPRIME",
    "DOSAGE": "70MG",
    "COND": "B/04",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOPHARM SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "31/5/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "31/5/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Rhumatologie"]
  },
  {
    "PregnancyIndexLink": ["alendronate"],
    "InteractionIndexLink": ["acide alendronique"],
    "N_ENREGISTREMENT": "035/ 21 G 050 /09/15",
    "CODE_DCI": "21 G 050",
    "DCI": "ACIDE ALENDRONIQUE MONOSODIQUE TRIHYDRATE EXPRIME EN ACIDE ALENDRONIQUE (alendronate)",
    "NOM_COMMERCIALE": "ENDRONAX",
    "FORME": "COMPRIME",
    "DOSAGE": "70MG",
    "COND": "B/04",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMALLIANCE EURL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/7/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "9/8/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Rhumatologie"]
  },
  {
    "PregnancyIndexLink": ["alendronate"],
    "InteractionIndexLink": ["acide alendronique"],
    "N_ENREGISTREMENT": "352/ 21 G 050 /11",
    "CODE_DCI": "21 G 050",
    "DCI": "ALENDRONATE MONOSODIQUE TRIHYDRATE EXPRIME EN ACIDE ALENDRONIQUE",
    "NOM_COMMERCIALE": "FOLENAT",
    "FORME": "COMPRIME",
    "DOSAGE": "70MG",
    "COND": "PILULIER/04",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/11/2011",
    "DATE_D_ENREGISTREMENT_FINAL": "27/11/2011",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Rhumatologie"]
  },
  {
    "PregnancyIndexLink": ["alendronate"],
    "InteractionIndexLink": ["acide alendronique"],
    "N_ENREGISTREMENT": "447/ 21 G 050 /16",
    "CODE_DCI": "21 G 050",
    "DCI": "ALENDRONATE MONOSODIQUE TRIHYDRATE EXPRIME EN ACIDE ALENDRONIQUE",
    "NOM_COMMERCIALE": "FOSACARE",
    "FORME": "COMPRIME",
    "DOSAGE": "70MG",
    "COND": "B/04",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOCARE SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/8/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "28/8/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Rhumatologie"]
  },
  {
    "PregnancyIndexLink": ["alendronate"],
    "InteractionIndexLink": ["acide alendronique"],
    "N_ENREGISTREMENT": "447/ 21 G 050 /16",
    "CODE_DCI": "21 G 050",
    "DCI": "ALENDRONATE MONOSODIQUE TRIHYDRATE EXPRIME EN ACIDE ALENDRONIQUE",
    "NOM_COMMERCIALE": "OSPORIX",
    "FORME": "COMPRIME",
    "DOSAGE": "70MG",
    "COND": "B/04",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES BEKER SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/4/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "27/4/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Rhumatologie"]
  },
  {
    "PregnancyIndexLink": ["alendronate"],
    "InteractionIndexLink": ["acide alendronique"],
    "N_ENREGISTREMENT": "149/ 21 G 050 /15",
    "CODE_DCI": "21 G 050",
    "DCI": "ALENDRONATE MONOSODIQUE TRIHYDRATE EXPRIME EN ACIDE ALENDRONIQUE",
    "NOM_COMMERCIALE": "OSTOMAX",
    "FORME": "COMPRIME",
    "DOSAGE": "70MG",
    "COND": "B/04",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVAPHARM TRADING SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/6/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "24/6/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Rhumatologie"]
  },
  {
    "PregnancyIndexLink": ["alendronate"],
    "InteractionIndexLink": ["acide alendronique"],
    "N_ENREGISTREMENT": "289/ 21 G 050 /07/14",
    "CODE_DCI": "21 G 050",
    "DCI": "ALENDRONATE MONOSODIQUE TRIHYDRATE EXPRIME EN ACIDE ALENDRONIQUE",
    "NOM_COMMERCIALE": "POROSIMAX",
    "FORME": "COMPRIME",
    "DOSAGE": "70MG",
    "COND": "B/04",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRATER SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/9/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "16/2/2014",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Rhumatologie"]
  },
  {
    "PregnancyIndexLink": ["alendronate"],
    "InteractionIndexLink": ["acide alendronique"],
    "N_ENREGISTREMENT": "380/21 G 050/20",
    "CODE_DCI": "21 G 050",
    "DCI": "ACIDE ALENDRONIQUE EXPRIME EN ALENDRONATE MONOSODIQUE TRIHYDRATE (alendronate)",
    "NOM_COMMERCIALE": "STEOMAX",
    "FORME": "COMPRIME",
    "DOSAGE": "70G",
    "COND": "B/04",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES HUP.P PHARMA Sarl",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/12/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "17/12/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Rhumatologie"]
  },
  {
    "PregnancyIndexLink": ["alendronate"],
    "InteractionIndexLink": ["acide alendronique"],
    "N_ENREGISTREMENT": "20/21 G050/380",
    "CODE_DCI": "21 G 050",
    "DCI": "ACIDE ALENDRONIQUE EXPRIME EN ALENDRONATE MONOSODIQUE TRIHYDRATE (alendronate)",
    "NOM_COMMERCIALE": "STEOMAX",
    "FORME": "COMP",
    "DOSAGE": "70MG",
    "COND": "B/4",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "laboratoires HUP.P PHARMA Sarl",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/12/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "17/12/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Rhumatologie"]
  },
  {
    "PregnancyIndexLink": ["raloxifene"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "352/ 21 G 054 /15",
    "CODE_DCI": "21 G 054",
    "DCI": "RALOXIFENE CHLORHYDRATE",
    "NOM_COMMERCIALE": "EVIFEN",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "60MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/3/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "18/3/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["teriparatide"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "034/ 21 G 055 /08/15",
    "CODE_DCI": "21 G 055",
    "DCI": "TERIPARATIDE",
    "NOM_COMMERCIALE": "FORTEO",
    "FORME": "SOL. INJ. SC. EN STYLO PREREMPLI",
    "DOSAGE": "250µG/ML (600µG/2.4ML) OU 20µG/DOSE",
    "COND": "B/01 STYLO PREREMPLI DE 2.4ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ELI LILLY NEDERLAND B.V.",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PAYS BAS",
    "DATE_D_ENREGISTREMENT_INITIAL": "23/12/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "19/10/2015",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["denosumab"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "481/ 21 G 065 /15",
    "CODE_DCI": "21 G 065",
    "DCI": "DENOSUMAB",
    "NOM_COMMERCIALE": "PROLIA",
    "FORME": "SOL. INJ. SC EN SERINGUE PREREMPLIE",
    "DOSAGE": "60MG/ML",
    "COND": "B/01 SERINGUE PREREMPLIE SECURISEE DE 1ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "AMGEN EUROPE B.V.",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PAYS BAS",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/6/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "29/6/2015",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["alendronate", "fer"],
    "InteractionIndexLink": ["acide alendronique", "cholecalciferol"],
    "N_ENREGISTREMENT": "289/ 21 G 066 /15",
    "CODE_DCI": "21 G 066",
    "DCI": "ACIDE ALENDRONIQUE MONOSODIQUE TRIHYDRATE EXPRIME EN ACIDE ALENDRONIQUE (alendronate) / CHOLECALCIFEROL",
    "NOM_COMMERCIALE": "POROSIMAX PLUS",
    "FORME": "COMPRIME",
    "DOSAGE": "70MG/5600UI",
    "COND": "B/04",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRATER RAZES FORME SECHE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/7/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "26/7/2015",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "18 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Rhumatologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "210/ 21 H 037 /01/16",
    "CODE_DCI": "21 H 037",
    "DCI": "INSAPONIFIABLE D'HUILE D'AVOCAT /  INSAPONIFIABLE D'HUILE DE SOJA",
    "NOM_COMMERCIALE": "PIASCLEDINE 300",
    "FORME": "GLES.",
    "DOSAGE": "100MG/200MG (TOTAL 300MG D'INSAPONIFIABLES AVOCAT-SOJA)",
    "COND": "B/15",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EXPANSCIENCE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "5/12/2001",
    "DATE_D_ENREGISTREMENT_FINAL": "26/7/2016",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "099/ 21 H 051 /09",
    "CODE_DCI": "21 H 051",
    "DCI": "SULFATE DE CHONDROÏTINE SODIQUE",
    "NOM_COMMERCIALE": "STRUCTUM",
    "FORME": "GLES.",
    "DOSAGE": "500MG",
    "COND": "B/60",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PIERRE FABRE MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/12/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "30/12/2009",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["leflunomide"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "21 J 042",
    "DCI": "LEFLUNOMIDE",
    "NOM_COMMERCIALE": "BIORAVA",
    "FORME": "Comprimé Pelliculé",
    "DOSAGE": "10 mg",
    "COND": "boite de 30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Rhumatologie"]
  },
  {
    "PregnancyIndexLink": ["leflunomide"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "510/21 J 042/17",
    "CODE_DCI": "21 J 042",
    "DCI": "LEFLUNOMIDE",
    "NOM_COMMERCIALE": "LEFLUBIC ALEMBIC MAMI",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALEMBIC MAMI SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/9/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "7/9/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Rhumatologie"]
  },
  {
    "PregnancyIndexLink": ["leflunomide"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "182/ 21 J 042 /10",
    "CODE_DCI": "21 J 042",
    "DCI": "LEFLUNOMIDE",
    "NOM_COMMERCIALE": "LEFUMIDE 10",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CIPLA LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/6/2010",
    "DATE_D_ENREGISTREMENT_FINAL": "2/6/2010",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Rhumatologie"]
  },
  {
    "PregnancyIndexLink": ["leflunomide"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "317/ 21 J 042 /15",
    "CODE_DCI": "21 J 042",
    "DCI": "LEFLUNOMIDE",
    "NOM_COMMERCIALE": "REDUPAR",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INPHA MEDIS SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/4/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "12/4/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Rhumatologie"]
  },
  {
    "PregnancyIndexLink": ["leflunomide"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "352/ 21 J 042 /14",
    "CODE_DCI": "21 J 042",
    "DCI": "LEFLUNOMIDE",
    "NOM_COMMERCIALE": "RUMAVA",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/10/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "13/10/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Rhumatologie"]
  },
  {
    "PregnancyIndexLink": ["leflunomide"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "21 J 043",
    "DCI": "LEFLUNOMIDE",
    "NOM_COMMERCIALE": "BIORAVA",
    "FORME": "Comprimé Pelliculé",
    "DOSAGE": "20 mg",
    "COND": "boite de 30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Rhumatologie"]
  },
  {
    "PregnancyIndexLink": ["leflunomide"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "182/ 21 J 043 /10",
    "CODE_DCI": "21 J 043",
    "DCI": "LEFLUNOMIDE",
    "NOM_COMMERCIALE": "LEFUMIDE 20",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "20MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CIPLA LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/6/2010",
    "DATE_D_ENREGISTREMENT_FINAL": "2/6/2010",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Rhumatologie"]
  },
  {
    "PregnancyIndexLink": ["leflunomide"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "317/ 21 J 043 /15",
    "CODE_DCI": "21 J 043",
    "DCI": "LEFLUNOMIDE",
    "NOM_COMMERCIALE": "REDUPAR",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "20MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INPHA MEDIS SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/4/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "12/4/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Rhumatologie"]
  },
  {
    "PregnancyIndexLink": ["leflunomide"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "352/ 21 J 043 /15/18",
    "CODE_DCI": "21 J 043",
    "DCI": "LEFLUNOMIDE",
    "NOM_COMMERCIALE": "RUMAVA",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "20MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/3/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "26/12/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Rhumatologie"]
  },
  {
    "PregnancyIndexLink": ["leflunomide"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "317/ 21 J 044 /15",
    "CODE_DCI": "21 J 044",
    "DCI": "LEFLUNOMIDE",
    "NOM_COMMERCIALE": "REDUPAR",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "100MG",
    "COND": "B/03",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INPHA MEDIS SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/4/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "12/4/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Rhumatologie"]
  },
  {
    "PregnancyIndexLink": ["adalimumab"],
    "InteractionIndexLink": ["adalimumab"],
    "N_ENREGISTREMENT": "21/21 J 058/481",
    "CODE_DCI": "21 J 058",
    "DCI": "ADALIMUMAB",
    "NOM_COMMERCIALE": "AMGEVITA",
    "FORME": "SOL. INJ. S/C EN SERINGUE PRE-REMPLIE",
    "DOSAGE": "40MG/0.8ML",
    "COND": "B/2 SERINGUE PRE-REMPLIES DE 0.8ML",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "AMGEN EUROPE B.V. (ABR)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PAYS BAS",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/05/21",
    "DATE_D_ENREGISTREMENT_FINAL": "12/05/21",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS (2° A 8°)",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["adalimumab"],
    "InteractionIndexLink": ["adalimumab"],
    "N_ENREGISTREMENT": "498/ 21 J 058 /09/16",
    "CODE_DCI": "21 J 058",
    "DCI": "ADALIMUMAB",
    "NOM_COMMERCIALE": "HUMIRA",
    "FORME": "SOL. INJ. SC EN SERING. PREREMPL.",
    "DOSAGE": "40MG/0.8ML",
    "COND": "B/02 SERING. UNIDOSES PREREMPL. DE 0.8ML+ 02TAMPONS D'ALCOOL",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ABBVIE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ROYAUME UNI",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/7/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "5/3/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["methotrexate"],
    "InteractionIndexLink": ["methotrexate"],
    "N_ENREGISTREMENT": "141/ 21 J 059 /10",
    "CODE_DCI": "21 J 059",
    "DCI": "METHOTREXATE DISODIQUE EXPRIME EN METHOTREXATE",
    "NOM_COMMERCIALE": "METHOTREXATE EBEWE",
    "FORME": "SOL. INJ. EN SERING. PREREMPL. SC/IM/IV",
    "DOSAGE": "10MG/ML  (OU 7.5MG/0.75ML - 10MG/ML - 15MG/1.5ML - 20MG/2ML)",
    "COND": "B/1SERING. PREREMPLIE DE 0.75ML - B/1SERING. PREREMPLIE DE 1ML - B/1SERING. PREREMPLIE DE 1.5ML -  B/1SERING. PREREMPLIE DE 2ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EBEWE PHARMA Ges.m.b.h.Nfg KG",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "AUTRICHE",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/2/2010",
    "DATE_D_ENREGISTREMENT_FINAL": "1/2/2010",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["etanercept"],
    "InteractionIndexLink": ["etanercept"],
    "N_ENREGISTREMENT": "045/ 21 J 062 /14",
    "CODE_DCI": "21 J 062",
    "DCI": "ETANERCEPT",
    "NOM_COMMERCIALE": "ENBREL",
    "FORME": "SOL. INJ. SC EN SERING. PREREMPL.",
    "DOSAGE": "50MG/SERING.",
    "COND": "COFFRET 04 SERING. PREREMPL. DE 1ML + 04 TAMPONS ALCOOLISES",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PFIZER LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ROYAUME UNI",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/11/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "13/11/2014",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "30 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["etanercept"],
    "InteractionIndexLink": ["etanercept"],
    "N_ENREGISTREMENT": "21/21 J 062/080",
    "CODE_DCI": "21 J 062",
    "DCI": "ETANERCEPT",
    "NOM_COMMERCIALE": "ERELZI",
    "FORME": "SOL. INJ. S/C EN SERINGUE PRE-REMPLIE",
    "DOSAGE": "50MG/SERINGUE",
    "COND": "B/4 SERINGUES PRE-REMPLIE DE 1ML",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANDOZ GmbH Autriche",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "AUTRICHE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/05/21",
    "DATE_D_ENREGISTREMENT_FINAL": "10/05/21",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS (2° A 8°)",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["etanercept"],
    "InteractionIndexLink": ["etanercept"],
    "N_ENREGISTREMENT": "045/ 21 J 063 /16",
    "CODE_DCI": "21 J 063",
    "DCI": "ETANERCEPT",
    "NOM_COMMERCIALE": "ENBREL",
    "FORME": "SOL. INJ. SC EN SERING. PREREMPL",
    "DOSAGE": "25MG/SERING",
    "COND": "COFFRET 04 SERING. PREREMPL. DE 1ML + 04 TAMPONS ALCOOLISES",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PFIZER LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ANGLETERRE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/4/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "25/4/2016",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "30 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["etanercept"],
    "InteractionIndexLink": ["etanercept"],
    "N_ENREGISTREMENT": "21/21 J 063/080",
    "CODE_DCI": "21 J 063",
    "DCI": "ETANERCEPT",
    "NOM_COMMERCIALE": "ERELZI",
    "FORME": "SOL. INJ. S/C EN SERINGUE PRE-REMPLIE",
    "DOSAGE": "25MG/SERINGUE",
    "COND": "B/4 SERINGUES PRE-REMPLIE DE 0.5ML",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANDOZ GmbH Autriche",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "AUTRICHE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/05/21",
    "DATE_D_ENREGISTREMENT_FINAL": "26/05/21",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS (2° A 8°)",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["tocilizumab (rch)"],
    "InteractionIndexLink": ["tocilizumab"],
    "N_ENREGISTREMENT": "128/ 21 J 068 /15",
    "CODE_DCI": "21 J 068",
    "DCI": "TOCILIZUMAB",
    "NOM_COMMERCIALE": "ACTEMRA",
    "FORME": "CONCENTRE POUR SOLUTION A DILUER POUR PERFUSION IV",
    "DOSAGE": "20MG/ML/FLACON",
    "COND": "BOITE DE 1 FLACON DE 4 ML ( 80 mg/4ml). 10ml (200mg/10ml). 20ml( 400 mg/20ml)",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ROCHE PHARMA (SWHWEIZ) LTD",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SUISSE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/12/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "2/12/2015",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "30 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["paracetamol", "pseudoephedrine", "triprolidine"],
    "InteractionIndexLink": ["paracetamol", "pseudoephedrine", "triprolidine"],
    "N_ENREGISTREMENT": "079/ 22 A 001 /12",
    "CODE_DCI": "22 A 001",
    "DCI": "TRIPROLIDINE CHLORHYDRATE / PSEUDOEPHEDRINE CHLORHYDRATE / PARACETAMOL",
    "NOM_COMMERCIALE": "RHINAFED",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "2.5MG/50MG/300MG",
    "COND": "B/20",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE  ALGERIEN DE DEVELOPPEMENT  PHARMACEUTIQUE   (LAD)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "31/5/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "31/5/2012",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["paracetamol", "pseudoephedrine", "triprolidine"],
    "InteractionIndexLink": ["paracetamol", "pseudoephedrine", "triprolidine"],
    "N_ENREGISTREMENT": "003/ 22 A 001 /01/14",
    "CODE_DCI": "22 A 001",
    "DCI": "TRIPROLIDINE CHLORHYDRATE / PSEUDOEPHEDRINE CHLORHYDRATE / PARACETAMOL",
    "NOM_COMMERCIALE": "RHUMAFED",
    "FORME": "COMPRIME",
    "DOSAGE": "2.5MG/50MG/300MG",
    "COND": "B/20",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SAIDALGROUPE INDUSTRIEL EPE/SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "8/1/2001",
    "DATE_D_ENREGISTREMENT_FINAL": "25/12/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["paracetamol", "pseudoephedrine", "triprolidine"],
    "InteractionIndexLink": ["paracetamol", "pseudoephedrine", "triprolidine"],
    "N_ENREGISTREMENT": "457/ 22 A 001 /11",
    "CODE_DCI": "22 A 001",
    "DCI": "TRIPROLIDINE CHLORHYDRATE / PSEUDOEPHEDRINE CHLORHYDRATE / PARACETAMOL",
    "NOM_COMMERCIALE": "SOMIFED",
    "FORME": "COMPRIME",
    "DOSAGE": "2.5MG/50MG/300MG",
    "COND": "B/20",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOMEDIAL SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/6/2011",
    "DATE_D_ENREGISTREMENT_FINAL": "19/6/2011",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["paracetamol", "pseudoephedrine", "triprolidine"],
    "InteractionIndexLink": ["paracetamol", "pseudoephedrine", "triprolidine"],
    "N_ENREGISTREMENT": "503/ 22 A 002 / 16",
    "CODE_DCI": "22 A 002",
    "DCI": "TRIPROLIDINE (SOUS FORME DE CHLORHYDRATE)  / PSEUDOEPHEDRINE (SOUS FORME DE CHLORHYDRATE) / PARACETAMOL",
    "NOM_COMMERCIALE": "RHUMAFRO",
    "FORME": "SOL .BUV.",
    "DOSAGE": "1.25MG/25MG/ 125MG /5ML",
    "COND": "FLACON DE 100 ML + GOBELET DOSEUR",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "AFRO PHARM SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/6/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "13/6/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["pseudoephedrine", "paracetamol", "triprolidine"],
    "InteractionIndexLink": ["paracetamol", "triprolidine"],
    "N_ENREGISTREMENT": "077/ 22 A 002 /03",
    "CODE_DCI": "22 A 002",
    "DCI": "TRIPROLIDINE (CHLORHYDRATE) / PSEUDOEPHEDRINE (CHLORHYDRATE) / PARACETAMOL",
    "NOM_COMMERCIALE": "RHUMOFEBRAL",
    "FORME": "SOL. BUV.",
    "DOSAGE": "1.25MG/25MG/125MG/5ML",
    "COND": "F/125ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE ALGERIEN DU MEDICAMENT  (LAM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "16/9/2003",
    "DATE_D_ENREGISTREMENT_FINAL": "16/9/2003",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["paracetamol", "pheniramine", "pseudoephedrine"],
    "InteractionIndexLink": ["paracetamol", "pseudoephedrine"],
    "N_ENREGISTREMENT": "296/ 22 A 029 /04/18",
    "CODE_DCI": "22 A 029",
    "DCI": "PARACETAMOL/PSEUDOEPHEDRINE (SOUS FORME DE CHLORHYDRATE) ET PARACETAMOL/CHLORPHENIRAMINE(SOUS FORME DE MALEATE)",
    "NOM_COMMERCIALE": "HUMEX RHUME",
    "FORME": "COMPRIME",
    "DOSAGE": "500MG/60MG (COMP.)  ET 500MG/04MG (GLES.)",
    "COND": "B/12 COMP. + 04 GLES.",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "URGO",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "21/1/2004",
    "DATE_D_ENREGISTREMENT_FINAL": "30/4/2018",
    "TYPE": "Ré",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["paracetamol", "pheniramine"],
    "InteractionIndexLink": ["acide ascorbique", "paracetamol", "pheniramine"],
    "N_ENREGISTREMENT": "293/22 A 032/19",
    "CODE_DCI": "22 A 032",
    "DCI": "PARACETAMOL / ACIDE ASCORBIQUE / PHENIRAMINE MALEATE",
    "NOM_COMMERCIALE": "BIOVEX",
    "FORME": "GRANULES POUR SOLUTION BUVABLE EN SACHET DOSE",
    "DOSAGE": "280 MG/ 100MG/ 10 MG",
    "COND": "B/08 SACHETS",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL BIOCARE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/4/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "1/4/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["paracetamol", "pheniramine"],
    "InteractionIndexLink": ["acide ascorbique", "paracetamol", "pheniramine"],
    "N_ENREGISTREMENT": "293/22 A 033/13",
    "CODE_DCI": "22 A 033",
    "DCI": "PARACETAMOL / ACIDE ASCORBIQUE / PHENIRAMINE MALEATE",
    "NOM_COMMERCIALE": "BIOVEX",
    "FORME": "GRANULES POUR SOL BUV EN SACHET ADULTE",
    "DOSAGE": "500MG/ 200MG/ 25MG",
    "COND": "B/08 SACHETS",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL BIOCARE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/12/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "2/12/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["paracetamol", "pheniramine"],
    "InteractionIndexLink": ["acide ascorbique", "paracetamol", "pheniramine"],
    "N_ENREGISTREMENT": "008 / 22 A 033 /08/16",
    "CODE_DCI": "22 A 033",
    "DCI": "PARACETAMOL / ACIDE ASCORBIQUE / MALEATE DE PHENIRAMINE",
    "NOM_COMMERCIALE": "FERVEX",
    "FORME": "GRLES. EN SACH.DE 13.1G",
    "DOSAGE": "0.5G/0.2G/0.025G/SACH.DE 13.1G",
    "COND": "B/08",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "UPSA CONSEIL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "23/2/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "5/11/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["paracetamol", "pheniramine"],
    "InteractionIndexLink": ["acide ascorbique", "paracetamol", "pheniramine"],
    "N_ENREGISTREMENT": "017/ 22 A 033 /13",
    "CODE_DCI": "22 A 033",
    "DCI": "PARACETAMOL / ACIDE ASCORBIQUE / PHENIRAMINE MALEATE",
    "NOM_COMMERCIALE": "FERVEX ADULTE SANS SUCRE",
    "FORME": "GRLES. P. SUSP. BUV. EN SACH.",
    "DOSAGE": "500MG/200MG/25MG/SACH.",
    "COND": "B/8",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BRISTOL-MYERS SQUIBB",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/9/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "30/9/2013",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["paracetamol", "pheniramine"],
    "InteractionIndexLink": ["acide ascorbique", "paracetamol", "pheniramine"],
    "N_ENREGISTREMENT": "235/22 A 033/19",
    "CODE_DCI": "22 A 033",
    "DCI": "PARACETAMOL/PHENIRAMINE MALEATE/ACIDE ASCORBIQUE",
    "NOM_COMMERCIALE": "RHYNEX",
    "FORME": "GRANULE POUR SOL BUV EN SACHET",
    "DOSAGE": "500MG/25MG/200MG",
    "COND": "B/08",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOGALENIC SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "3O/10/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "3O/10/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["paracetamol", "pheniramine", "phenylephrine"],
    "InteractionIndexLink": [
      "cafeine",
      "paracetamol",
      "pheniramine",
      "phenylephrine"
    ],
    "N_ENREGISTREMENT": "263/ 22 A 034 /08/14",
    "CODE_DCI": "22 A 034",
    "DCI": "PARACETAMOL / MALEATE DE PHENIRAMINE / PHENYLEPHRINE HYDROCHLORIDE / CAFEINE",
    "NOM_COMMERCIALE": "RYNZA",
    "FORME": "PDRE. SOL. BUV. EN SACH.-DOSE",
    "DOSAGE": "750MG/20MG/10MG/30MG/SACH. DE 5G",
    "COND": "B/05 SACH. DE 5G",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOPHARM SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "23/2/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "27/10/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [
      "ammonium chloride",
      "dextromethorphan",
      "diphenhydramine",
      "pseudoephedrine"
    ],
    "InteractionIndexLink": [
      "dextromethorphane",
      "diphenhydramine",
      "menthol racemique",
      "pseudoephedrine"
    ],
    "N_ENREGISTREMENT": "352/ 22 A 035 /08",
    "CODE_DCI": "22 A 035",
    "DCI": "DIPHENHYDRAMINE HYDROCHLORIDE / DEXTROMETHORPHANE HYDROBROMIDE / PSEUDOEPHEDRINE HYDROCHLORIDE / AMMONIUM CHLORIDE / SODIUM CITRATE / MENTHOL",
    "NOM_COMMERCIALE": "MENTEX",
    "FORME": "SIROP",
    "DOSAGE": "12.5MG/15MG/30MG/125MG/57MG/1MG/5ML",
    "COND": "FL./125ML + BOUCHON DOSEUR",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "23/2/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "23/2/2008",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["diphenhydramine", "paracetamol", "pseudoephedrine"],
    "InteractionIndexLink": [
      "diphenhydramine",
      "paracetamol",
      "pseudoephedrine"
    ],
    "N_ENREGISTREMENT": "039/ 22 A 041 /11/18",
    "CODE_DCI": "22 A 041",
    "DCI": "PARACETAMOL / PSEUDOEPHEDRINE  CHLORHYDRATE COMP. DE JOUR  ET PARACETAMOL / DIPHENHYDRAMINE  CHLORHYDRATE COMP. DE NUIT",
    "NOM_COMMERCIALE": "PARADIPAL",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "500MG/60MG  COMP. DE JOUR ET 500MG/25MG COMP. DE NUIT",
    "COND": "B/16 ( 12  COMPS. DE JOUR ET 04 COMPS. DE NUIT)",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOCIETE PHARMACEUTIQUE ALGERIENNE (SOPHAL)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "23/11/2011",
    "DATE_D_ENREGISTREMENT_FINAL": "22/5/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["paracetamol", "phenylephrine"],
    "InteractionIndexLink": ["cafeine", "paracetamol", "phenylephrine"],
    "N_ENREGISTREMENT": "309/ 22 A 042 /12/17",
    "CODE_DCI": "22 A 042",
    "DCI": "PARACETAMOL / CAFEINE / PHENYLEPHRINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "PANADOL RHUME + GRIPPE",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "500MG/25MG/5MG",
    "COND": "B/16",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES  DE DIAGNOSTIC MAGHREBINS (LDM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/7/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "5/10/2017",
    "TYPE": "Ré",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["ibuprofen", "pseudoephedrine"],
    "InteractionIndexLink": ["ibuprofene", "pseudoephedrine"],
    "N_ENREGISTREMENT": "035/ 22 A 043 /16",
    "CODE_DCI": "22 A 043",
    "DCI": "Ibuprofene / Pseudoephedrine chlorhydrate",
    "NOM_COMMERCIALE": "GRIPEX PLUS",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "200MG/30MG",
    "COND": "B/20",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMALLIANCE EURL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/1/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "10/1/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["ibuprofen", "pseudoephedrine"],
    "InteractionIndexLink": ["ibuprofene", "pseudoephedrine"],
    "N_ENREGISTREMENT": "518/ 22 A 043 /18",
    "CODE_DCI": "22 A 043",
    "DCI": "Ibuprofene / Pseudoephedrine chlorhydrate",
    "NOM_COMMERCIALE": "IBUPSO 200/30",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "200MG/30MG",
    "COND": "B/20",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "TASSILI ARAB PHARMACEUTICAL COMPANY / SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/6/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "20/6/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24  MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["ibuprofen", "pseudoephedrine"],
    "InteractionIndexLink": ["ibuprofene", "pseudoephedrine"],
    "N_ENREGISTREMENT": "039/ 22 A 043 /13",
    "CODE_DCI": "22 A 043",
    "DCI": "Ibuprofene / Pseudoephedrine chlorhydrate",
    "NOM_COMMERCIALE": "RHINEDAL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "200MG/30MG",
    "COND": "B/20",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOCIETE PHARMACEUTIQUE ALGERIENNE (SOPHAL)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "3/11/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "3/11/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["ibuprofen", "pseudoephedrine"],
    "InteractionIndexLink": ["ibuprofene", "pseudoephedrine"],
    "N_ENREGISTREMENT": "077/22 A 043/20",
    "CODE_DCI": "22 A 043",
    "DCI": "IBUPROFENE/ PSEUDOEPHEDRINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "RHUMOLAM",
    "FORME": "COMP PELL",
    "DOSAGE": "200MG/30MG",
    "COND": "B/20",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE ALGERIEN  DU MEDICAMENT SARL (LAM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "14/4/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "14/4/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["ibuprofen", "pseudoephedrine"],
    "InteractionIndexLink": ["ibuprofene", "pseudoephedrine"],
    "N_ENREGISTREMENT": "268/ 22 A 043 /13",
    "CODE_DCI": "22 A 043",
    "DCI": "Ibuprofene / Pseudoephedrine chlorhydrate",
    "NOM_COMMERCIALE": "XYDOL RHUME",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "200MG/30MG",
    "COND": "B/20",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MERINAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/2/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "4/2/2013",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["paracetamol", "pseudoephedrine", "triprolidine"],
    "InteractionIndexLink": ["paracetamol", "pseudoephedrine", "triprolidine"],
    "N_ENREGISTREMENT": "039/ 22 A 044 /13",
    "CODE_DCI": "22 A 044",
    "DCI": "PARACETAMOL / PSEUDOEPHEDRINE CHLORHYDRATE  / TRIPROLIDINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "TRIPARACETAL",
    "FORME": "COMPRIME",
    "DOSAGE": "500MG/60MG/2.5MG",
    "COND": "B/20",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOCIETE PHARMACEUTIQUE ALGERIENNE (SOPHAL)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/7/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "7/7/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["paracetamol", "pheniramine"],
    "InteractionIndexLink": ["paracetamol"],
    "N_ENREGISTREMENT": "296/22 A 046/17",
    "CODE_DCI": "22 A 046",
    "DCI": "PARACETAMOL /MALEATE DE CHLORPHENIRAMINE",
    "NOM_COMMERCIALE": "HUMEXLIB",
    "FORME": "GELULE",
    "DOSAGE": "500MG/4MG",
    "COND": "B/16",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "URGO",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/5/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "28/5/2017",
    "TYPE": "RE",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["pheniramine", "phenylephrine"],
    "InteractionIndexLink": ["phenylephrine"],
    "N_ENREGISTREMENT": "035/ 22 A 047 /99/19",
    "CODE_DCI": "22 A 047",
    "DCI": "PHENYLEPHRINE CHLORHYDRATE/CHLORPHENIRAMINE MALEATE",
    "NOM_COMMERCIALE": "GRIPEX",
    "FORME": "GLES. A MICROGRAN.LP",
    "DOSAGE": "10 MG/4MG",
    "COND": "B/10",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMALLIANCE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/8/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "26/1/2019",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "319/ 22 B 004 /07",
    "CODE_DCI": "22 B 004",
    "DCI": "THIOPHENE (SOUS FORME DE CARBOXYLATE DE SODIUM)",
    "NOM_COMMERCIALE": "GEFRANE",
    "FORME": "SOL. NAS.",
    "DOSAGE": "2 %",
    "COND": "FL./15ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ARAB PHARM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/11/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "18/11/2007",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["acetylcysteine (inhaled)"],
    "InteractionIndexLink": ["benzalkonium", "tuaminoheptane"],
    "N_ENREGISTREMENT": "093/ 22 B 031 /07",
    "CODE_DCI": "22 B 031",
    "DCI": "ACETYLCYSTEINE/TUAMINOHEPTANE/CHLORURE DE BENZALKONIUM",
    "NOM_COMMERCIALE": "RHINOFLUIMUCIL",
    "FORME": "SOL. PULV.NASALE",
    "DOSAGE": "100MG/50MG/1.25MG/10ML",
    "COND": "FL./10ML",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ZAMBON",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/6/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "20/6/2007",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["sodium cromoglycate"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "079/ 22 C 006 /11",
    "CODE_DCI": "22 C 006",
    "DCI": "CROMOGLYCATE DE SODIUM",
    "NOM_COMMERCIALE": "CROMOSOL",
    "FORME": "SOL. NAS.",
    "DOSAGE": "2 %",
    "COND": "FL. PULVERISAT. DE 15ML",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE  ALGERIEN DE DEVELOPPEMENT  PHARMACEUTIQUE   (LAD)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/4/2011",
    "DATE_D_ENREGISTREMENT_FINAL": "24/4/2011",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["sodium cromoglycate"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "272/ 22 C 006 /98/09",
    "CODE_DCI": "22 C 006",
    "DCI": "CROMOGLYCATE DE SODIUM",
    "NOM_COMMERCIALE": "DADCROME",
    "FORME": "SOL.NAS.",
    "DOSAGE": "2 %",
    "COND": "F/10ML",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORAS PHARMACEUTICAL SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/10/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "28/2/2009",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["fluticasone furoate"],
    "InteractionIndexLink": ["fluticasone"],
    "N_ENREGISTREMENT": "262/ 22 E 045 /15",
    "CODE_DCI": "22 E  045",
    "DCI": "FLUTICASONE FUROATE",
    "NOM_COMMERCIALE": "AVAMYS",
    "FORME": "SUSP. P. PULV. NAS.",
    "DOSAGE": "27.50µG/DOSE",
    "COND": "FL./120DOSES",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GALAXO GROUPE LTD",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ROYAUME UNI",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/12/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "27/12/2015",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["framycetin"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "269/ 22 E 014 /98",
    "CODE_DCI": "22 E 014",
    "DCI": "FRAMYCETINE",
    "NOM_COMMERCIALE": "ISOFRA",
    "FORME": "SOL . PULV . NAS.",
    "DOSAGE": "1.25 %",
    "COND": "FL/15ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BOUCHARA-RECORDATI",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/8/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "18/8/1998",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["framycetin"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "079/ 22 E 014 /98/09",
    "CODE_DCI": "22 E 014",
    "DCI": "FRAMYCETINE (SOUS FORME DE SULFATE)",
    "NOM_COMMERCIALE": "NIFRAMYCINE",
    "FORME": "SOL. NAS.",
    "DOSAGE": "1.25% (856 250UI/100ML)",
    "COND": "FL/15ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE  ALGERIEN DE DEVELOPPEMENT  PHARMACEUTIQUE   (LAD)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/12/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "11/5/2009",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["framycetin", "hydrocortisone"],
    "InteractionIndexLink": ["hydrocortisone"],
    "N_ENREGISTREMENT": "079/ 22 E 015 /08 /19",
    "CODE_DCI": "22 E 015",
    "DCI": "FRAMYCETINE / HYDROCORTISONE  (SOUS FORME DE FRAMYCETINE SULFATE / HYDROCORTISONE)",
    "NOM_COMMERCIALE": "NIFRAMYCINE HYDROCORTISONE",
    "FORME": "SOL. NASALE",
    "DOSAGE": "1.25G/0.1G/100ML",
    "COND": "FL./15ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE  ALGERIEN DE DEVELOPPEMENT  PHARMACEUTIQUE   (LAD)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "23/3/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "29/4/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "269/ 22 F 024 /99/16",
    "CODE_DCI": "22 E 024",
    "DCI": "BICLOTYMOL/LYSOZYME/ENOXOLONE",
    "NOM_COMMERCIALE": "HEXALYSE",
    "FORME": "COMPRIME A SUCER",
    "DOSAGE": "5MG/5MG/5MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BOUCHARA-RECORDATI",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/5/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "16/2/2016",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["fluticasone propionate"],
    "InteractionIndexLink": ["fluticasone"],
    "N_ENREGISTREMENT": "035/ 22 E 027 /08/15",
    "CODE_DCI": "22 E 027",
    "DCI": "FLUTICASONE PROPIONATE",
    "NOM_COMMERCIALE": "FLIXASONE",
    "FORME": "SPRAY NASAL",
    "DOSAGE": "50µG/DOSE",
    "COND": "FL./120DOSES (FL./20ML)",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMALLIANCE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "23/12/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "16/2/2016",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Rhinologie"]
  },
  {
    "PregnancyIndexLink": ["fluticasone propionate"],
    "InteractionIndexLink": ["fluticasone"],
    "N_ENREGISTREMENT": "112/ 22 E 027 /00",
    "CODE_DCI": "22 E 027",
    "DCI": "FLUTICASONE PROPIONATE",
    "NOM_COMMERCIALE": "FLIXONASE",
    "FORME": "SPRAY.NAS.",
    "DOSAGE": "50µG/DOSE",
    "COND": "FL/120DOSE",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GLAXO WELLCOME",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ROYAUME UNI",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/1/2000",
    "DATE_D_ENREGISTREMENT_FINAL": "20/1/2000",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Rhinologie"]
  },
  {
    "PregnancyIndexLink": ["fluticasone propionate"],
    "InteractionIndexLink": ["fluticasone"],
    "N_ENREGISTREMENT": "20/22 E027/418",
    "CODE_DCI": "22 E 027",
    "DCI": "FLUTICASONE PROPIONATE",
    "NOM_COMMERCIALE": "FLIXONE",
    "FORME": "SUSP P.PULVÉRISATION NASALE",
    "DOSAGE": "50µG/ DOSE",
    "COND": "FL / 120 DOSES MUNI D'UN ATOMISEUR POMPE DOSEUR",
    "LISTE": "LISTEI",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES SARL NEOMEDIC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "8/11/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "8/11/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Rhinologie"]
  },
  {
    "PregnancyIndexLink": ["fluticasone propionate"],
    "InteractionIndexLink": ["fluticasone"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "22 E 027",
    "DCI": "FLUTICASONE",
    "NOM_COMMERCIALE": "FLIXONE",
    "FORME": "Susp Pulv",
    "DOSAGE": "50mcg/dose",
    "COND": "01 flacon de 15 ml",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Rhinologie"]
  },
  {
    "PregnancyIndexLink": ["fluticasone propionate"],
    "InteractionIndexLink": ["fluticasone"],
    "N_ENREGISTREMENT": "182/ 22 E 027 /08",
    "CODE_DCI": "22 E 027",
    "DCI": "FLUTICASONE PROPIONATE",
    "NOM_COMMERCIALE": "FLOMIST",
    "FORME": "SPRAY NASAL",
    "DOSAGE": "50µG/DOSE",
    "COND": "FL./100DOSES",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CIPLA LTD",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "21/12/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "21/12/2008",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Rhinologie"]
  },
  {
    "PregnancyIndexLink": ["fluticasone propionate"],
    "InteractionIndexLink": ["fluticasone"],
    "N_ENREGISTREMENT": "235/ 22 E 027 /16",
    "CODE_DCI": "22 E 027",
    "DCI": "FLUTICASONE PROPIONATE",
    "NOM_COMMERCIALE": "FLUCASONE",
    "FORME": "SUSP NASAL EN SPRAY",
    "DOSAGE": "50µG/DOSE",
    "COND": "FL/120DOSES",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL BIOGALENIC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/7/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "26/7/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Rhinologie"]
  },
  {
    "PregnancyIndexLink": ["fluticasone propionate"],
    "InteractionIndexLink": ["fluticasone"],
    "N_ENREGISTREMENT": "20/22 E027/380",
    "CODE_DCI": "22 E 027",
    "DCI": "FLUTICASONE PROPIONATE",
    "NOM_COMMERCIALE": "FLUTINASE",
    "FORME": "SPRAY NASAL",
    "DOSAGE": "50µG/DOSE",
    "COND": "B/1 FLACON DE 120 DOSES",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "laboratoires HUP.P PHARMA Sarl",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/07/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "28/07/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Rhinologie"]
  },
  {
    "PregnancyIndexLink": ["triamcinolone (inhaled)"],
    "InteractionIndexLink": ["triamcinolone"],
    "N_ENREGISTREMENT": "235/22 E 028/17",
    "CODE_DCI": "22 E 028",
    "DCI": "TRIAMCINOLONE ACETONIDE",
    "NOM_COMMERCIALE": "NASACET",
    "FORME": "SUSP. P.PULV. NAS. EN FL. PULVERISATEUR",
    "DOSAGE": "55µG/DOSE",
    "COND": "FL/120 DOSES",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOGALENIC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/2/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "27/2/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Rhinologie"]
  },
  {
    "PregnancyIndexLink": ["triamcinolone (inhaled)"],
    "InteractionIndexLink": ["triamcinolone"],
    "N_ENREGISTREMENT": "230/ 22 E 028 /00/15",
    "CODE_DCI": "22 E 028",
    "DCI": "TRIAMCINOLONE ACETONIDE",
    "NOM_COMMERCIALE": "NASACORT",
    "FORME": "SUSP. P.PULV. NAS. EN FL. PULVERISATEUR",
    "DOSAGE": "55µG/DOSE",
    "COND": "B/01FL. DE 120 PULVERISATIONS (15ML)  + POMPE DOSEUSE + EMBOUT NASAL",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HUPP PHARMA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/4/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "24/4/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Rhinologie"]
  },
  {
    "PregnancyIndexLink": ["triamcinolone (inhaled)"],
    "InteractionIndexLink": ["triamcinolone"],
    "N_ENREGISTREMENT": "065/ 22 E 028 /18",
    "CODE_DCI": "22 E 028",
    "DCI": "TRIAMCINOLONE ACETONIDE",
    "NOM_COMMERCIALE": "NASALIX",
    "FORME": "SUSP. P.PULV. NAS. EN FL. PULVERISATEUR",
    "DOSAGE": "55µG/DOSE",
    "COND": "B/01FL. DE 120 PULVERISATIONS (15ML)",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GENCOPHARM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/6/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "13/6/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Rhinologie"]
  },
  {
    "PregnancyIndexLink": ["triamcinolone (inhaled)"],
    "InteractionIndexLink": ["triamcinolone"],
    "N_ENREGISTREMENT": "19/22 E028/380",
    "CODE_DCI": "22 E 028",
    "DCI": "ACETONIDE DE TRIAMCINOLONE",
    "NOM_COMMERCIALE": "NASALONE",
    "FORME": "SUSP P. PULVERISATION NASALE",
    "DOSAGE": "55µG/DOSE",
    "COND": "B/1 FLACON DE 15 ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "laboratoires HUP.P PHARMA Sarl",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/04/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "24/04/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Rhinologie"]
  },
  {
    "PregnancyIndexLink": ["triamcinolone (inhaled)"],
    "InteractionIndexLink": ["triamcinolone"],
    "N_ENREGISTREMENT": "380/ 22 E 028 /19",
    "CODE_DCI": "22 E 028",
    "DCI": "TriamCINOLONE ACETONIDE",
    "NOM_COMMERCIALE": "NASALONE",
    "FORME": "SUSP. P.PULV. NAS. EN FL. PULVERISATEUR",
    "DOSAGE": "55µG/DOSE",
    "COND": "B/01FL. DE 120 PULVERISATIONS (15ML)",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANOFI-AVENTIS FRANCE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "23/4/2000",
    "DATE_D_ENREGISTREMENT_FINAL": "9/7/2015",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Rhinologie"]
  },
  {
    "PregnancyIndexLink": ["triamcinolone (inhaled)"],
    "InteractionIndexLink": ["triamcinolone"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "22 E 028",
    "DCI": "Triamcinolone acétonide",
    "NOM_COMMERCIALE": "NASODIS",
    "FORME": "Susp p pulvérisation nasale",
    "DOSAGE": "55µg/dose",
    "COND": "Flacon de 120 doses",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Rhinologie"]
  },
  {
    "PregnancyIndexLink": ["triamcinolone (inhaled)"],
    "InteractionIndexLink": ["triamcinolone"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "22 E 028",
    "DCI": "TRIAMCINOLONE ACETONIDE",
    "NOM_COMMERCIALE": "nasadoze",
    "FORME": "SUSP. P. PULV. NAS.",
    "DOSAGE": "55µG/DOSE",
    "COND": "FL/120DOSES",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Rhinologie"]
  },
  {
    "PregnancyIndexLink": ["beclometasone"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "235/ 22 E 030 /18",
    "CODE_DCI": "22 E 030",
    "DCI": "BECLOMETASONE DIPROPIONATE",
    "NOM_COMMERCIALE": "NASABEC",
    "FORME": "SUSP EN PUL NASALE",
    "DOSAGE": "100µG/DOSE",
    "COND": "FL./200DOSES",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOGALENIC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/7/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "7/7/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Rhinologie"]
  },
  {
    "PregnancyIndexLink": ["beclometasone"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "092/ 22 E 030 /08",
    "CODE_DCI": "22 E 030",
    "DCI": "BECLOMETASONE DIPROPIONATE",
    "NOM_COMMERCIALE": "RINOCLENIL 100",
    "FORME": "SUSP. EN SPRAY NASALE",
    "DOSAGE": "100µG/DOSE",
    "COND": "FL./200DOSES",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CHIESI FARMACEUTICI SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ITALIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/3/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "30/3/2008",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["Rhinologie"]
  },
  {
    "PregnancyIndexLink": ["mometasone"],
    "InteractionIndexLink": ["mometasone"],
    "N_ENREGISTREMENT": "235 /22 E 036/18",
    "CODE_DCI": "22 E 036",
    "DCI": "MOMETASONE FUROATE MONOHYDRATE",
    "NOM_COMMERCIALE": "ETACID",
    "FORME": "SPRAY NASAL",
    "DOSAGE": "50µG/DOSE",
    "COND": "FL./140DOSES A",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "WORLD MEDECINE ILAC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "TURQUIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/2/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "27/2/2017",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Rhinologie"]
  },
  {
    "PregnancyIndexLink": ["mometasone"],
    "InteractionIndexLink": ["mometasone"],
    "N_ENREGISTREMENT": "521/22 E 036/17",
    "CODE_DCI": "22 E 036",
    "DCI": "MOMETASONE FUROATE MONOHYDRATE",
    "NOM_COMMERCIALE": "ETACID",
    "FORME": "SPRAY NASAL",
    "DOSAGE": "50µG/DOSE",
    "COND": "FL./140DOSES A",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "WORLD MEDECINE ILAC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "TURQUIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/2/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "27/2/2017",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Rhinologie"]
  },
  {
    "PregnancyIndexLink": ["mometasone"],
    "InteractionIndexLink": ["mometasone"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "22 E 036",
    "DCI": "Mometasone Furoate monohydraté",
    "NOM_COMMERCIALE": "MOMENEX",
    "FORME": "supsension pour pulverisation nasale",
    "DOSAGE": "50µg",
    "COND": "Flacon de 120 doses",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Rhinologie"]
  },
  {
    "PregnancyIndexLink": ["mometasone"],
    "InteractionIndexLink": ["mometasone"],
    "N_ENREGISTREMENT": "418 / 22 E  036 / 21",
    "CODE_DCI": "22 E 036",
    "DCI": "Furoate de Mométasone monohydraté exprimé en Furoate de Mométasone anhydre",
    "NOM_COMMERCIALE": "NASAMEX",
    "FORME": "SUSP. P. PULV. NAS.",
    "DOSAGE": "50µG/DOSE",
    "COND": "FL/120DOSES",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NEOMEDIC / SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "14/3/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "14/3/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Rhinologie"]
  },
  {
    "PregnancyIndexLink": ["mometasone"],
    "InteractionIndexLink": ["mometasone"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "22 E 036",
    "DCI": "MOMETASONE",
    "NOM_COMMERCIALE": "NASAMEX",
    "FORME": "SUSP PULV NASALE",
    "DOSAGE": "50MCG/DOSE",
    "COND": "flacon 120 doses",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Rhinologie"]
  },
  {
    "PregnancyIndexLink": ["mometasone"],
    "InteractionIndexLink": ["mometasone"],
    "N_ENREGISTREMENT": "027/ 22 E 036 /08/16",
    "CODE_DCI": "22 E 036",
    "DCI": "MOMETASONE FUROATE ANHYDRE",
    "NOM_COMMERCIALE": "NASONEX",
    "FORME": "SUSP. P. PULV. NAS.",
    "DOSAGE": "50µG/DOSE",
    "COND": "FL./120DOSES AVEC POMPE DOSEUSE",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SCHERING PLOUGH",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/12/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "26/7/2016",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Rhinologie"]
  },
  {
    "PregnancyIndexLink": ["mometasone"],
    "InteractionIndexLink": ["mometasone"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "22 E 036",
    "DCI": "MOMETASONE",
    "NOM_COMMERCIALE": "NOVASPRAY",
    "FORME": "SUSP. P. PULV. NAS.",
    "DOSAGE": "50µG/DOSE",
    "COND": "FL/120DOSES",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Rhinologie"]
  },
  {
    "PregnancyIndexLink": ["mometasone"],
    "InteractionIndexLink": ["mometasone"],
    "N_ENREGISTREMENT": "20/22 E036/380",
    "CODE_DCI": "22 E 036",
    "DCI": "MOMÉTASONE FUROATEMONOHYDRATÉE",
    "NOM_COMMERCIALE": "RHINONEX",
    "FORME": "SUSP P.PULVÉRISATION NASALE",
    "DOSAGE": "50µG/ DOSE",
    "COND": "FL / 120 DOSES AVEC POMPE DOSEUSE",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "laboratoires HUP.P PHARMA Sarl",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/7/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "28/7/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Rhinologie"]
  },
  {
    "PregnancyIndexLink": ["mometasone"],
    "InteractionIndexLink": ["mometasone"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "22 E 036",
    "DCI": "mométasone furoate",
    "NOM_COMMERCIALE": "Rhinonex",
    "FORME": "suspension pour pulvérisation \nnasale",
    "DOSAGE": "50ug par dose",
    "COND": "flacon de 120dose",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Rhinologie"]
  },
  {
    "PregnancyIndexLink": ["mometasone"],
    "InteractionIndexLink": ["mometasone"],
    "N_ENREGISTREMENT": "173/ 22 E  036 /16",
    "CODE_DCI": "22 E 036",
    "DCI": "MOMETASONE FUROATE ANHYDRE",
    "NOM_COMMERCIALE": "TASONEX",
    "FORME": "SPRAY NASAL",
    "DOSAGE": "50µG/DOSE",
    "COND": "FL/120DOSES",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "TABUK PHARMACEUTICAL MANUFACTURING COMPANY",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ARABIE SAOUDITE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/3/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "13/3/2016",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Rhinologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["oxymetazoline"],
    "N_ENREGISTREMENT": "157/ 22 F 018 /99/16",
    "CODE_DCI": "22 F 018",
    "DCI": "OXYMETAZOLINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "RESPIBIEN",
    "FORME": "SOL.NAS.",
    "DOSAGE": "0.5MG/ML",
    "COND": "FL/15ML",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CINFA  SA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ESPAGNE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/1/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "11/9/2016",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": ["oxymetazoline"],
    "N_ENREGISTREMENT": "235/ 22 F 018 /09",
    "CODE_DCI": "22 F 018",
    "DCI": "OXYMETAZOLINE (SOUS FORME DE CHLORHYDRATE)",
    "NOM_COMMERCIALE": "RESPINHAL",
    "FORME": "SOL. PULV. NASALE",
    "DOSAGE": "0.5MG/ML (OU 0.05%)",
    "COND": "FL./15ML",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIO-GALENIC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/5/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "2/5/2009",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "263/ 22 F 038 /09",
    "CODE_DCI": "22 F 038",
    "DCI": "ACIDE N-ACETYL ASPARTYL GLUTAMIQUE.SEL DE MAGNESIUM",
    "NOM_COMMERCIALE": "RHINAAXIA",
    "FORME": "SOL. PULV. NASALE",
    "DOSAGE": "6G/100ML",
    "COND": "FL./13ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOPHARM ALGERIE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/5/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "2/5/2009",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["budesonide"],
    "InteractionIndexLink": ["budesonide"],
    "N_ENREGISTREMENT": "235/22 F 039/20",
    "CODE_DCI": "22 F 039",
    "DCI": "BUDESONIDE",
    "NOM_COMMERCIALE": "DONICORT",
    "FORME": "SUSP P/PULVER NASALE",
    "DOSAGE": "64µG/DOSE",
    "COND": "FL/120 DOSES",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOGALENIC SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/3/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "18/3/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Rhinologie"]
  },
  {
    "PregnancyIndexLink": ["budesonide"],
    "InteractionIndexLink": ["budesonide"],
    "N_ENREGISTREMENT": "21/22 F039/380",
    "CODE_DCI": "22 F 039",
    "DCI": "BUDESONIDE",
    "NOM_COMMERCIALE": "RESPICORT",
    "FORME": "SUSP P.PULV NASALE",
    "DOSAGE": "64µG/DOSE",
    "COND": "B/1 FLACON DE 120 DOSES",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "laboratoires HUP.P PHARMA Sarl",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "14/03/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "14/03/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Rhinologie"]
  },
  {
    "PregnancyIndexLink": ["budesonide"],
    "InteractionIndexLink": ["budesonide"],
    "N_ENREGISTREMENT": "256/ 22 F  039 /06",
    "CODE_DCI": "22 F 039",
    "DCI": "BUDESONIDE",
    "NOM_COMMERCIALE": "RHINOCORT",
    "FORME": "SUSP. P. PULV. NAS.",
    "DOSAGE": "64µG/DOSE",
    "COND": "FL/120DOSES",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ASTRA ZENECA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/12/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "2/12/2006",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Rhinologie"]
  },
  {
    "PregnancyIndexLink": ["budesonide"],
    "InteractionIndexLink": ["budesonide"],
    "N_ENREGISTREMENT": "317 / 22 F 039 /21",
    "CODE_DCI": "22 F 039",
    "DCI": "Budésonide",
    "NOM_COMMERCIALE": "RHINODIS",
    "FORME": "SUSP P/PULVER NASALE",
    "DOSAGE": "64µG/DOSE",
    "COND": "FL/120 DOSES",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INPHA-MEDIS /SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/3/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "30/3/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Rhinologie"]
  },
  {
    "PregnancyIndexLink": ["budesonide"],
    "InteractionIndexLink": ["budesonide"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "22 F 039",
    "DCI": "BUDESONIDE",
    "NOM_COMMERCIALE": "RHINODOZE",
    "FORME": "SUSP. P. PULV. NAS.",
    "DOSAGE": "64µG/DOSE",
    "COND": "FLACON DE 120 DOSES",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Rhinologie"]
  },
  {
    "PregnancyIndexLink": ["budesonide"],
    "InteractionIndexLink": ["budesonide"],
    "N_ENREGISTREMENT": "065 / 22 F 039 /21",
    "CODE_DCI": "22 F 039",
    "DCI": "Budésonide",
    "NOM_COMMERCIALE": "RINONIDE",
    "FORME": "SUSP P/PULVER NASALE",
    "DOSAGE": "64µG/DOSE",
    "COND": "FL/120 DOSES",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GENERIC LAB / SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/4/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "7/4/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["Rhinologie"]
  },
  {
    "PregnancyIndexLink": ["budesonide"],
    "InteractionIndexLink": ["budesonide"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "22 F 039",
    "DCI": "Budésonide",
    "NOM_COMMERCIALE": "Respicort",
    "FORME": "suspension pour pulvérisation nasale",
    "DOSAGE": "64μg/dose",
    "COND": "flacon de 120dose",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Rhinologie"]
  },
  {
    "PregnancyIndexLink": ["azelastine hydrochloride"],
    "InteractionIndexLink": ["azelastine"],
    "N_ENREGISTREMENT": "20/22 G048/263",
    "CODE_DCI": "22 G 048",
    "DCI": "AZÉLASTINE CHLORHYDRATE/ QTé CORRESPONDANT EN AZÉLASTINE BASE",
    "NOM_COMMERCIALE": "NASALAST",
    "FORME": "SOL. POUR PELV NASALE",
    "DOSAGE": "0.1000G/ 0.0910 POUR 100ML DE SOLUTION/ UNE DOSE DE  0.14ML DÉLIVRE 0.127MG D'AZÉLASTINE BASE",
    "COND": "FL/ 17ML",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES BIOPHARM/ SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/9/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "29/9/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["chlorhexidine", "tetracaine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "099/ 23 B 007 /98/17",
    "CODE_DCI": "23 B 007",
    "DCI": "CHLORHEXIDINE/TETRACAINE",
    "NOM_COMMERCIALE": "ELUDRIL",
    "FORME": "COLLUTOIRE",
    "DOSAGE": "50MG/15MG pour 100ML",
    "COND": "FL/55 ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PIERRE FABRE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/5/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "5/3/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "055/ 23 B 012 /98",
    "CODE_DCI": "23 B 012",
    "DCI": "HEXETIDINE",
    "NOM_COMMERCIALE": "DAD MOUTH WASH",
    "FORME": "SOL.BAIN.BOUCHE",
    "DOSAGE": "0.1%",
    "COND": "FL/200 ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "DAR AL DAWA DEVELOPMENT & INVESTMENT Co Ltd",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/10/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "28/10/1998",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "285/ 23 B 012 /12/17",
    "CODE_DCI": "23 B 012",
    "DCI": "HEXETIDINE",
    "NOM_COMMERCIALE": "ORALVEX",
    "FORME": "SOL. P. BAIN DE BOUCHE",
    "DOSAGE": "0.1%",
    "COND": "B/1FL. DE 125ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "UNION PHARMACEUTIQUE CONSTANTINOISE (UPC)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "21/8/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "9/10/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["chloral hydrate"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "133/ 23 B 018 /98",
    "CODE_DCI": "23 B 018",
    "DCI": "AMYLEINE CHLORAL",
    "NOM_COMMERCIALE": "DOLODENT",
    "FORME": "SOLUTION  GINGIVALE",
    "DOSAGE": "0.75G/100G",
    "COND": "FL/36G",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GILBERT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/11/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "22/11/1998",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "269/ 23 B 020 /99/16",
    "CODE_DCI": "23 B 020",
    "DCI": "Biclotymol",
    "NOM_COMMERCIALE": "HEXASPRAY",
    "FORME": "COLLUTOIRE",
    "DOSAGE": "750MG/30G (0.75G/30G)",
    "COND": "FL. PRESSURISE DE 30G",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BOUCHARA-RECORDATI",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/5/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "5/3/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "60 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "437/ 23 B 023 /99/09",
    "CODE_DCI": "23 B 023",
    "DCI": "HEXETIDINE / SALICYLATE DE CHOLINE / CHLORBUTANOL HEMIHYDRATEE",
    "NOM_COMMERCIALE": "GIVALEX",
    "FORME": "SOL.BAIN.BOUCHE",
    "DOSAGE": "0.1G/0.5G/0.25G/100ML",
    "COND": "FL/125 ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CHEMICAL FARMA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/6/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "9/5/2009",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["chlorhexidine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "099/ 23 B 026 /99",
    "CODE_DCI": "23 B 026",
    "DCI": "CHLORHEXIDINE DIGLUCONATE /CHLOROBUTANOL HEMIHYDRATE",
    "NOM_COMMERCIALE": "ELUDRIL",
    "FORME": "BAIN DE BOUCHE",
    "DOSAGE": "0.5ML/0.5G/100ML",
    "COND": "FL/90 ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PIERRE FABRE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/6/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "9/6/1999",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["lidocaine"],
    "InteractionIndexLink": ["benzalkonium", "lidocaine"],
    "N_ENREGISTREMENT": "296/ 23 B 038 /08/19",
    "CODE_DCI": "23 B 038",
    "DCI": "BENZALKONIUM CHLORURE/LIDOCAINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "HUMEX MAL DE GORGE LIDOCAINE",
    "FORME": "COLLUTOIRE",
    "DOSAGE": "0.030G/0.300G/100ML",
    "COND": "B/1FL. PRESSURISE DE 35ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "URGO HEALTHCARE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "21/12/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "13/5/2019",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 mois",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["chlorhexidine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "388/ 23 B 039 /09",
    "CODE_DCI": "23 B 039",
    "DCI": "CHLORHEXIDINE (SOUS FORME DE DIGLUCONATE)",
    "NOM_COMMERCIALE": "HYSADRIL",
    "FORME": "BAIN DE BOUCHE",
    "DOSAGE": "0.20 %",
    "COND": "FL./190ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HYSA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/8/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "27/8/2009",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["cetylpyridinium"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "152/ 23 B 040 /13",
    "CODE_DCI": "23 B 040",
    "DCI": "CETYLPYRIDINIUM CHLORURE / LYSOSYME CHLORHYDRATE",
    "NOM_COMMERCIALE": "LYSOPAINE SANS SUCRE",
    "FORME": "COMPRIME A SUCER EDULCORE AU SORBITOL ET A LA SACCHARINE",
    "DOSAGE": "1.5MG / 20MG",
    "COND": "B/1T. DE 18  ET  B/2T. DE 18 (36)",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BOEHRINGER INGELHEIM France",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/5/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "29/5/2013",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["miconazole"],
    "InteractionIndexLink": ["miconazole"],
    "N_ENREGISTREMENT": "352/23 D 037/17",
    "CODE_DCI": "23 D 037",
    "DCI": "MICONAZOLE",
    "NOM_COMMERCIALE": "DAKTAZOL",
    "FORME": "GEL BUCCAL",
    "DOSAGE": "2G%",
    "COND": "T/40G+UNE CUILL7RE MESURE",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI DU MEDICAMENT SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/5/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "17/5/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Stomatologie"]
  },
  {
    "PregnancyIndexLink": ["miconazole"],
    "InteractionIndexLink": ["miconazole"],
    "N_ENREGISTREMENT": "418 / 23 D 037 /18",
    "CODE_DCI": "23 D 037",
    "DCI": "Miconazole",
    "NOM_COMMERCIALE": "DEKTAGEL",
    "FORME": "GEL BUCCAL",
    "DOSAGE": "2 %",
    "COND": "T/40G + CUILLIERE MESURE DE 5ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL NEOMEDIC",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "16/1/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "16/1/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Stomatologie"]
  },
  {
    "PregnancyIndexLink": ["miconazole"],
    "InteractionIndexLink": ["miconazole"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "23 D 037",
    "DCI": "Miconazole",
    "NOM_COMMERCIALE": "Daktazol",
    "FORME": "GEL BUCCAL",
    "DOSAGE": "0.02",
    "COND": "B/40gm",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Stomatologie"]
  },
  {
    "PregnancyIndexLink": ["miconazole"],
    "InteractionIndexLink": ["miconazole"],
    "N_ENREGISTREMENT": "149/ 23 D 037 /15",
    "CODE_DCI": "23 D 037",
    "DCI": "MICONAZOLE",
    "NOM_COMMERCIALE": "MICONAZOLE NOVAGENERICS",
    "FORME": "GEL BUCCAL",
    "DOSAGE": "2 %",
    "COND": "T/50G + CUILLIERE MESURE DE 5ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVAPHARM TRADING SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/7/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "30/7/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36  MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Stomatologie"]
  },
  {
    "PregnancyIndexLink": ["miconazole"],
    "InteractionIndexLink": ["miconazole"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "23 D 037",
    "DCI": "miconazole",
    "NOM_COMMERCIALE": "MICONAZOLE novagenerics",
    "FORME": "gel buccal",
    "DOSAGE": "0.02",
    "COND": "TUBE DE 50 G",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Stomatologie"]
  },
  {
    "PregnancyIndexLink": ["miconazole"],
    "InteractionIndexLink": ["miconazole"],
    "N_ENREGISTREMENT": "263/23 D 037/21",
    "CODE_DCI": "23 D 037",
    "DCI": "Miconazole",
    "NOM_COMMERCIALE": "ULCEGO",
    "FORME": "Gel buccal",
    "DOSAGE": "2 %",
    "COND": "T/50G",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOPHARM / SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/1/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "7/1/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["Stomatologie"]
  },
  {
    "PregnancyIndexLink": ["miconazole"],
    "InteractionIndexLink": ["miconazole"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "23 D 037",
    "DCI": "Miconazole",
    "NOM_COMMERCIALE": "ULCEGO",
    "FORME": "Gel buccal",
    "DOSAGE": "0.02",
    "COND": "T/50g",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["Stomatologie"]
  },
  {
    "PregnancyIndexLink": ["mesalazine"],
    "InteractionIndexLink": ["mesalazine"],
    "N_ENREGISTREMENT": "231/10 N 131/20",
    "CODE_DCI": "231/10 N 131/21",
    "DCI": "MESALAZINE",
    "NOM_COMMERCIALE": "SALAZA",
    "FORME": "SUPPO.",
    "DOSAGE": "1G",
    "COND": "B/15",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL LABORATOIRES SALEM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/11/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "22/11/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["naloxone"],
    "InteractionIndexLink": ["naloxone"],
    "N_ENREGISTREMENT": "450/ 24 B 016 /06",
    "CODE_DCI": "24 B 016",
    "DCI": "NALOXONE CHLORHYDRATE ANHYDRE",
    "NOM_COMMERCIALE": "NALOXONE MYLAN",
    "FORME": "SOL. INJ. IM/IV /SC",
    "DOSAGE": "0.4MG/ML",
    "COND": "B/10AMP.  DE 1ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MYLAN",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/7/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "26/7/2006",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "068/ 24 D 004 /98",
    "CODE_DCI": "24 D 004",
    "DCI": "DEFEROXAMINE",
    "NOM_COMMERCIALE": "DESFERAL",
    "FORME": "PDRE. ET SOLV. P. SOL. INJ.",
    "DOSAGE": "500MG/7.5ML",
    "COND": "B/1+1",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVARTIS PHARMA S.A.",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/12/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "28/7/2004",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["deferasirox"],
    "InteractionIndexLink": ["deferasirox"],
    "N_ENREGISTREMENT": "317/ 24 D 017 /16",
    "CODE_DCI": "24 D 017",
    "DCI": "Déférasirox",
    "NOM_COMMERCIALE": "CAPTAFER",
    "FORME": "COMP. DISPERS.",
    "DOSAGE": "125MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INPHA-MEDIS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/4/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "27/4/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["deferasirox"],
    "InteractionIndexLink": ["deferasirox"],
    "N_ENREGISTREMENT": "001/ 24 D 017 /15",
    "CODE_DCI": "24 D 017",
    "DCI": "Déférasirox",
    "NOM_COMMERCIALE": "DEFEROX",
    "FORME": "COMP. DISPERS.",
    "DOSAGE": "125MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMA ALGERIA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/5/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "6/5/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["deferasirox"],
    "InteractionIndexLink": ["deferasirox"],
    "N_ENREGISTREMENT": "068/ 24 D 017 /08",
    "CODE_DCI": "24 D 017",
    "DCI": "Déférasirox",
    "NOM_COMMERCIALE": "EXJADE",
    "FORME": "COMP. DISPERS.",
    "DOSAGE": "125MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVARTIS PHARMA SCHWEIZ AG",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SUISSE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/1/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "6/1/2009",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["deferasirox"],
    "InteractionIndexLink": ["deferasirox"],
    "N_ENREGISTREMENT": "447/24 D 017/17",
    "CODE_DCI": "24 D 017",
    "DCI": "Déférasirox",
    "NOM_COMMERCIALE": "KAPTIRON",
    "FORME": "COMP. DISPERS.",
    "DOSAGE": "125MG",
    "COND": "B/30 ET B/90",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEKER SARL (SARL LABORATOIRE BEKER ALGERIE)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/2/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "12/2/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["deferasirox"],
    "InteractionIndexLink": ["deferasirox"],
    "N_ENREGISTREMENT": "352/ 24 D 017 /16",
    "CODE_DCI": "24 D 017",
    "DCI": "Déférasirox",
    "NOM_COMMERCIALE": "KELOSIROX",
    "FORME": "COMP. DISPERS.",
    "DOSAGE": "125MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DES MEDICAMENTS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/10/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "6/10/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["deferasirox"],
    "InteractionIndexLink": ["deferasirox"],
    "N_ENREGISTREMENT": "317/ 24 D 018 /16",
    "CODE_DCI": "24 D 018",
    "DCI": "Déférasirox",
    "NOM_COMMERCIALE": "CAPTAFER",
    "FORME": "COMP. DISPERS.",
    "DOSAGE": "250MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INPHA-MEDIS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/3/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "13/3/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["deferasirox"],
    "InteractionIndexLink": ["deferasirox"],
    "N_ENREGISTREMENT": "001/ 24 D 018 /15",
    "CODE_DCI": "24 D 018",
    "DCI": "Déférasirox",
    "NOM_COMMERCIALE": "DEFEROX",
    "FORME": "COMP. DISPERS.",
    "DOSAGE": "250MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMA ALGERIA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/5/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "13/5/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["deferasirox"],
    "InteractionIndexLink": ["deferasirox"],
    "N_ENREGISTREMENT": "068/ 24 D 018 /08",
    "CODE_DCI": "24 D 018",
    "DCI": "Déférasirox",
    "NOM_COMMERCIALE": "EXJADE",
    "FORME": "COMP. DISPERS.",
    "DOSAGE": "250MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVARTIS PHARMA SCHWEIZ AG",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SUISSE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/1/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "6/1/2009",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["deferasirox"],
    "InteractionIndexLink": ["deferasirox"],
    "N_ENREGISTREMENT": "447/24 D 018/17",
    "CODE_DCI": "24 D 018",
    "DCI": "Déférasirox",
    "NOM_COMMERCIALE": "KAPTIRON",
    "FORME": "COMP. DISPERS.",
    "DOSAGE": "250MG",
    "COND": "B/30 ET B/90",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEKER SARL (SARL LABORATOIRE BEKER ALGERIE)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/1/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "29/1/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["deferasirox"],
    "InteractionIndexLink": ["deferasirox"],
    "N_ENREGISTREMENT": "352/24 D 018/16",
    "CODE_DCI": "24 D 018",
    "DCI": "Déférasirox",
    "NOM_COMMERCIALE": "KELOSIROX",
    "FORME": "COMP. DISPERS.",
    "DOSAGE": "250MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/11/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "9/11/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["deferasirox"],
    "InteractionIndexLink": ["deferasirox"],
    "N_ENREGISTREMENT": "317/ 24 D 019 /16",
    "CODE_DCI": "24 D 019",
    "DCI": "Déférasirox",
    "NOM_COMMERCIALE": "CAPTAFER",
    "FORME": "COMP. DISPERS.",
    "DOSAGE": "500MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INPHA-MEDIS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/4/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "25/4/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["deferasirox"],
    "InteractionIndexLink": ["deferasirox"],
    "N_ENREGISTREMENT": "001/ 24 D 019 /15",
    "CODE_DCI": "24 D 019",
    "DCI": "Déférasirox",
    "NOM_COMMERCIALE": "DEFEROX",
    "FORME": "COMP. DISPERS.",
    "DOSAGE": "500MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMA ALGERIA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "31/5/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "31/5/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["deferasirox"],
    "InteractionIndexLink": ["deferasirox"],
    "N_ENREGISTREMENT": "068/24 D 019/09/16",
    "CODE_DCI": "24 D 019",
    "DCI": "Déférasirox",
    "NOM_COMMERCIALE": "EXJADE",
    "FORME": "COMP. DISPERS.",
    "DOSAGE": "500MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVARTIS PHARMA SCHWIEIZ AG",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SUISSE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/6/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "11/9/2016",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["deferasirox"],
    "InteractionIndexLink": ["deferasirox"],
    "N_ENREGISTREMENT": "447/24 D 019/17",
    "CODE_DCI": "24 D 019",
    "DCI": "Déférasirox",
    "NOM_COMMERCIALE": "KAPTIRON",
    "FORME": "COMP. DISPERS.",
    "DOSAGE": "500MG",
    "COND": "B/30 ET B/90",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL BEKER",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/2/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "7/2/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["deferasirox"],
    "InteractionIndexLink": ["deferasirox"],
    "N_ENREGISTREMENT": "352/24 D 019/19",
    "CODE_DCI": "24 D 019",
    "DCI": "DEFERASIROX",
    "NOM_COMMERCIALE": "KELOSIROX",
    "FORME": "COMP DISPERS",
    "DOSAGE": "500MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/7/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "1/7/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["deferiprone"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "182/ 24 D 022 /06/16",
    "CODE_DCI": "24 D 022",
    "DCI": "DEFERIPRONE",
    "NOM_COMMERCIALE": "KELFER-250",
    "FORME": "GLES.",
    "DOSAGE": "250MG",
    "COND": "B/50",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CIPLA LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/12/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "6/3/2017",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["deferiprone"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "182/ 24 D 023 /06/16",
    "CODE_DCI": "24 D 023",
    "DCI": "DEFERIPRONE",
    "NOM_COMMERCIALE": "KELFER-500",
    "FORME": "COMP. ENRO.",
    "DOSAGE": "500MG",
    "COND": "B/50",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CIPLA LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/12/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "29/6/2016",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "099/ 25 B 006 /98",
    "CODE_DCI": "25 B 006",
    "DCI": "SERENOA REPENS",
    "NOM_COMMERCIALE": "PERMIXON",
    "FORME": "GLES.",
    "DOSAGE": "160MG",
    "COND": "B/60",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PIERRE FABRE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/11/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "10/11/1998",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["UroNephrologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "231/ 25 B 006 /19",
    "CODE_DCI": "25 B 006",
    "DCI": "SERENOA REPENS",
    "NOM_COMMERCIALE": "SEREXON",
    "FORME": "GLES.",
    "DOSAGE": "160MG",
    "COND": "B/60",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SALEM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/3/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "6/3/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["UroNephrologie"]
  },
  {
    "PregnancyIndexLink": ["alfuzosin"],
    "InteractionIndexLink": ["alfuzosine"],
    "N_ENREGISTREMENT": "289/ 25 B 022 /18",
    "CODE_DCI": "25 B 022",
    "DCI": "ALFUZOSINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "FRAXAL",
    "FORME": "COMP. PELLI. LP",
    "DOSAGE": "5MG",
    "COND": "B/60",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRATER RAZES FORME SECHE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "31/12/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "31/12/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["UroNephrologie"]
  },
  {
    "PregnancyIndexLink": ["alfuzosin"],
    "InteractionIndexLink": ["alfuzosine"],
    "N_ENREGISTREMENT": "376/ 25 B 022 /98/10",
    "CODE_DCI": "25 B 022",
    "DCI": "ALFUZOSINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "XATRAL LP",
    "FORME": "COMP. PELLI. LP",
    "DOSAGE": "5MG",
    "COND": "B/56",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANOFI AVENTIS FRANCE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/5/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "15/6/2010",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["UroNephrologie"]
  },
  {
    "PregnancyIndexLink": ["finasteride"],
    "InteractionIndexLink": ["finasteride"],
    "N_ENREGISTREMENT": "182/ 25 B 023 /04",
    "CODE_DCI": "25 B 023",
    "DCI": "FINASTERIDE",
    "NOM_COMMERCIALE": "FINCAR",
    "FORME": "COMPRIME",
    "DOSAGE": "5MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CIPLA LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/9/2004",
    "DATE_D_ENREGISTREMENT_FINAL": "22/9/2004",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["UroNephrologie"]
  },
  {
    "PregnancyIndexLink": ["finasteride"],
    "InteractionIndexLink": ["finasteride"],
    "N_ENREGISTREMENT": "504/ 25 B 023 /16",
    "CODE_DCI": "25 B 023",
    "DCI": "FINASTERIDE",
    "NOM_COMMERCIALE": "NOVASTERIDE",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "5MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVO MEDIS SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/1/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "10/1/2016",
    "TYPE": "Gé",
    "STATUT": "C",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["UroNephrologie"]
  },
  {
    "PregnancyIndexLink": ["finasteride"],
    "InteractionIndexLink": ["finasteride"],
    "N_ENREGISTREMENT": "098/ 25 B 023 /98/08",
    "CODE_DCI": "25 B 023",
    "DCI": "FINASTERIDE",
    "NOM_COMMERCIALE": "PROSTACARE",
    "FORME": "COMPRIME",
    "DOSAGE": "5MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HAYAT PHARMACEUTICAL INDUSTRIES Co LTD",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/4/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "29/6/2008",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["UroNephrologie"]
  },
  {
    "PregnancyIndexLink": ["finasteride"],
    "InteractionIndexLink": ["finasteride"],
    "N_ENREGISTREMENT": "504/ 25 B 023 /16",
    "CODE_DCI": "25 B 023",
    "DCI": "Finastéride",
    "NOM_COMMERCIALE": "PROSTADOZ",
    "FORME": "Comprimé pelliculé",
    "DOSAGE": "5MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVAPHARM TRADING / SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/3/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "28/3/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["UroNephrologie"]
  },
  {
    "PregnancyIndexLink": ["finasteride"],
    "InteractionIndexLink": ["finasteride"],
    "N_ENREGISTREMENT": "426/ 25 B 023 /09",
    "CODE_DCI": "25 B 023",
    "DCI": "FINASTERIDE",
    "NOM_COMMERCIALE": "PROSTAMED",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "5MG",
    "COND": "B/30",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "REMEDE PHARMA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/6/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "15/6/2009",
    "TYPE": "Gé",
    "STATUT": "C",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["UroNephrologie"]
  },
  {
    "PregnancyIndexLink": ["doxazosin"],
    "InteractionIndexLink": ["doxazosine"],
    "N_ENREGISTREMENT": "21/25 B041/289",
    "CODE_DCI": "25 B 041",
    "DCI": "DOXAZOSINE MESILATE EXPRIME EN DOXAZOSINE",
    "NOM_COMMERCIALE": "DOXALAR",
    "FORME": "COMP",
    "DOSAGE": "1MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES FRATER RAZES FORME SECHE / SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/04/21",
    "DATE_D_ENREGISTREMENT_FINAL": "22/04/21",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["doxazosin"],
    "InteractionIndexLink": ["doxazosine"],
    "N_ENREGISTREMENT": "352/ 25 B 041 /13",
    "CODE_DCI": "25 B 041",
    "DCI": "Doxazosine mésilate exprimé en doxazosine",
    "NOM_COMMERCIALE": "ZODURA",
    "FORME": "COMPRIME",
    "DOSAGE": "1MG",
    "COND": "B/20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/7/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "2/7/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["doxazosin"],
    "InteractionIndexLink": ["doxazosine"],
    "N_ENREGISTREMENT": "001/ 25 B 042 /16",
    "CODE_DCI": "25 B 042",
    "DCI": "Doxazosine mésilate exprimé en doxazosine",
    "NOM_COMMERCIALE": "CARDOX",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "2MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMA ALGERIA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/2/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "4/2/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["UroNephrologie"]
  },
  {
    "PregnancyIndexLink": ["doxazosin"],
    "InteractionIndexLink": ["doxazosine"],
    "N_ENREGISTREMENT": "045/ 25 B 042 /99/12",
    "CODE_DCI": "25 B 042",
    "DCI": "Doxazosine mésilate exprimé en doxazosine",
    "NOM_COMMERCIALE": "CARDULAR",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "2MG",
    "COND": "B/20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PFIZER PHARM ALGERIE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/12/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "18/1/2012",
    "TYPE": "Ré",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["UroNephrologie"]
  },
  {
    "PregnancyIndexLink": ["doxazosin"],
    "InteractionIndexLink": ["doxazosine"],
    "N_ENREGISTREMENT": "289 / 25 B 042  /21",
    "CODE_DCI": "25 B 042",
    "DCI": "Doxazosine mésilate exprimé en Doxazosine",
    "NOM_COMMERCIALE": "DOXALAR",
    "FORME": "Comprimé",
    "DOSAGE": "2MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRATER RAZES FORME SECHE SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/3/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "29/3/2021",
    "TYPE": "Gé",
    "STATUT": "F prémix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["UroNephrologie"]
  },
  {
    "PregnancyIndexLink": ["doxazosin"],
    "InteractionIndexLink": ["doxazosine"],
    "N_ENREGISTREMENT": "447/ 25 B 042 /13/18",
    "CODE_DCI": "25 B 042",
    "DCI": "Doxazosine mésilate exprimé en doxazosine",
    "NOM_COMMERCIALE": "DOXAZOSINE BEKER",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "2MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEKER SARL (SARL LABORATOIRE BEKER ALGERIE)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/6/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "2/7/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["UroNephrologie"]
  },
  {
    "PregnancyIndexLink": ["doxazosin"],
    "InteractionIndexLink": ["doxazosine"],
    "N_ENREGISTREMENT": "352/ 25 B 042 /13/18",
    "CODE_DCI": "25 B 042",
    "DCI": "Doxazosine mésilate exprimé en doxazosine",
    "NOM_COMMERCIALE": "ZODURA",
    "FORME": "COMPRIME",
    "DOSAGE": "2MG",
    "COND": "B/20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/8/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "3/9/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["UroNephrologie"]
  },
  {
    "PregnancyIndexLink": ["doxazosin"],
    "InteractionIndexLink": ["doxazosine"],
    "N_ENREGISTREMENT": "447/ 25 B 043 /15",
    "CODE_DCI": "25 B 043",
    "DCI": "Doxazosine mésilate exprimé en doxazosine",
    "NOM_COMMERCIALE": "DOXAZOSINE BEKER",
    "FORME": "COMPRIME",
    "DOSAGE": "4MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRE BEKER SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/12/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "2/12/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["UroNephrologie"]
  },
  {
    "PregnancyIndexLink": ["doxazosin"],
    "InteractionIndexLink": ["doxazosine"],
    "N_ENREGISTREMENT": "352/ 25 B 043 /13/18",
    "CODE_DCI": "25 B 043",
    "DCI": "Doxazosine mésilate exprimé en doxazosine",
    "NOM_COMMERCIALE": "ZODURA",
    "FORME": "COMPRIME",
    "DOSAGE": "4MG",
    "COND": "B/20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "21/7/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "7/11/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["UroNephrologie"]
  },
  {
    "PregnancyIndexLink": ["tamsulosin"],
    "InteractionIndexLink": ["tamsulosine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "25 B 047",
    "DCI": "TAMSULOSINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "GAMCET 0.4",
    "FORME": "Comp",
    "DOSAGE": "0.4 mg",
    "COND": "12:00 AM",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["UroNephrologie"]
  },
  {
    "PregnancyIndexLink": ["tamsulosin"],
    "InteractionIndexLink": ["tamsulosine"],
    "N_ENREGISTREMENT": "286/ 25 B 047 /15",
    "CODE_DCI": "25 B 047",
    "DCI": "TAMSULOSINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "OLSERAZ",
    "FORME": "GLES. A MICROGRANULES LP",
    "DOSAGE": "0.4MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "CHIMIE PHARMACIE COMMERCE MULTIPLE (CPCM) SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/4/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "12/4/2015",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "48 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["UroNephrologie"]
  },
  {
    "PregnancyIndexLink": ["tamsulosin"],
    "InteractionIndexLink": ["tamsulosine"],
    "N_ENREGISTREMENT": "320/ 25 B 047 /10",
    "CODE_DCI": "25 B 047",
    "DCI": "TAMSULOSINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "PROSTALOZINE LP",
    "FORME": "GLES. A MICROGRANULES  LP",
    "DOSAGE": "0.4MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIAN GENERICS DEVELOPMENT PHARM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/6/2010",
    "DATE_D_ENREGISTREMENT_FINAL": "27/6/2010",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["UroNephrologie"]
  },
  {
    "PregnancyIndexLink": ["tamsulosin"],
    "InteractionIndexLink": ["tamsulosine"],
    "N_ENREGISTREMENT": "088/ 25 B 047 /11",
    "CODE_DCI": "25 B 047",
    "DCI": "TAMSULOSINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "PROSTAM LP",
    "FORME": "MICROGRLES. LP EN GLES.",
    "DOSAGE": "0.4MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMAGHREB",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/10/2011",
    "DATE_D_ENREGISTREMENT_FINAL": "12/10/2011",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["UroNephrologie"]
  },
  {
    "PregnancyIndexLink": ["tamsulosin"],
    "InteractionIndexLink": ["tamsulosine"],
    "N_ENREGISTREMENT": "289/ 25 B 047 /12",
    "CODE_DCI": "25 B 047",
    "DCI": "TAMSULOSINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "PROSTASIR LP",
    "FORME": "MICROGRLES. LP EN GLES.",
    "DOSAGE": "0.4MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRATER RAZES FORME SECHE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/8/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "13/8/2012",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["UroNephrologie"]
  },
  {
    "PregnancyIndexLink": ["tamsulosin"],
    "InteractionIndexLink": ["tamsulosine"],
    "N_ENREGISTREMENT": "035/ 25 B 047 /14",
    "CODE_DCI": "25 B 047",
    "DCI": "TAMSULOSINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "SULOZIR LP",
    "FORME": "GELULE",
    "DOSAGE": "0.4MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMALLIANCE EURL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/10/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "28/10/2014",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["UroNephrologie"]
  },
  {
    "PregnancyIndexLink": ["tamsulosin"],
    "InteractionIndexLink": ["tamsulosine"],
    "N_ENREGISTREMENT": "352/ 25 B 047 /12 /17",
    "CODE_DCI": "25 B 047",
    "DCI": "TAMSULOSINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "TAMSIR LP",
    "FORME": "MICROGRLES. LP EN GLES.",
    "DOSAGE": "0.4MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/5/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "31/12/2017",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["UroNephrologie"]
  },
  {
    "PregnancyIndexLink": ["tamsulosin"],
    "InteractionIndexLink": ["tamsulosine"],
    "N_ENREGISTREMENT": "149/ 25 B 047 /14",
    "CODE_DCI": "25 B 047",
    "DCI": "TAMSULOSINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "TAMSULIX LP",
    "FORME": "MICROGRANULES LP EN GLES",
    "DOSAGE": "0.4MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVAPHARM TRADING SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/4/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "19/7/2016",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["UroNephrologie"]
  },
  {
    "PregnancyIndexLink": ["tamsulosin"],
    "InteractionIndexLink": ["tamsulosine"],
    "N_ENREGISTREMENT": "447/ 25 B 047 /15",
    "CODE_DCI": "25 B 047",
    "DCI": "TAMSULOSINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "TAMSULOSINE BEKER",
    "FORME": "GLES à MICROGRANULES à LIBéRATION PROLONGée",
    "DOSAGE": "0.4MG",
    "COND": "B/30 ET B/90",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABRATOIRE SARL BEKER",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/12/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "2/12/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["UroNephrologie"]
  },
  {
    "PregnancyIndexLink": ["tamsulosin"],
    "InteractionIndexLink": ["tamsulosine"],
    "N_ENREGISTREMENT": "470/ 25 B 047 /12",
    "CODE_DCI": "25 B 047",
    "DCI": "TAMSULOSINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "TAMSULOSINE MM LP",
    "FORME": "MICROGRLES. EN GLES. LP",
    "DOSAGE": "0.4MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MM (SARL LABORATOIRES MM)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/11/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "27/11/2012",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["UroNephrologie"]
  },
  {
    "PregnancyIndexLink": ["tamsulosin"],
    "InteractionIndexLink": ["tamsulosine"],
    "N_ENREGISTREMENT": "376/ 25 B 047 /09",
    "CODE_DCI": "25 B 047",
    "DCI": "TAMSULOSINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "TAMSULOSINE WINTHROP LP",
    "FORME": "GLES. LP",
    "DOSAGE": "0.4MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANOFI AVENTIS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/12/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "6/12/2009",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["UroNephrologie"]
  },
  {
    "PregnancyIndexLink": ["tamsulosin"],
    "InteractionIndexLink": ["tamsulosine"],
    "N_ENREGISTREMENT": "426/ 25 B 047 /12/19",
    "CODE_DCI": "25 B 047",
    "DCI": "TAMSULOSINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "TAMSUMED LP",
    "FORME": "MICROGRLES. LP EN GLES.",
    "DOSAGE": "0.4MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "REMEDE PHARMA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/3/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "19/6/2019",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["UroNephrologie"]
  },
  {
    "PregnancyIndexLink": ["tamsulosin"],
    "InteractionIndexLink": ["tamsulosine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "25 B 047",
    "DCI": "Tamsulosine",
    "NOM_COMMERCIALE": "Tamsir",
    "FORME": "Gélule LP",
    "DOSAGE": "0.4mg",
    "COND": "B/30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["UroNephrologie"]
  },
  {
    "PregnancyIndexLink": ["alfuzosin"],
    "InteractionIndexLink": ["alfuzosine"],
    "N_ENREGISTREMENT": "285/25 B 057/20",
    "CODE_DCI": "25 B 057",
    "DCI": "Chlorhydrate d'Alfuzosine",
    "NOM_COMMERCIALE": "ALFUZOX",
    "FORME": "Comprimé à liberation prolongée",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "Union Pharmaceutique Constantinoise (UPC) / SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/12/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "13/12/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["UroNephrologie"]
  },
  {
    "PregnancyIndexLink": ["alfuzosin"],
    "InteractionIndexLink": ["alfuzosine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "25 B 057",
    "DCI": "ALFUZOSINE",
    "NOM_COMMERCIALE": "ALFUZOX LP",
    "FORME": "COMP LP",
    "DOSAGE": "10MG",
    "COND": "Boite de 30",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["UroNephrologie"]
  },
  {
    "PregnancyIndexLink": ["alfuzosin"],
    "InteractionIndexLink": ["alfuzosine"],
    "N_ENREGISTREMENT": "433/25 B 057/18",
    "CODE_DCI": "25 B 057",
    "DCI": "ALFUZOSINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "FRAXAL",
    "FORME": "COMP PELL LP",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRATER RAZES FORME SECHE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "3/10/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "3/10/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["UroNephrologie"]
  },
  {
    "PregnancyIndexLink": ["alfuzosin"],
    "InteractionIndexLink": ["alfuzosine"],
    "N_ENREGISTREMENT": "352/25 B 057/10/16",
    "CODE_DCI": "25 B 057",
    "DCI": "ALFUZOSINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "PROSTAX LP",
    "FORME": "COMP PELL LP",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "11/3/2010",
    "DATE_D_ENREGISTREMENT_FINAL": "4/12/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["UroNephrologie"]
  },
  {
    "PregnancyIndexLink": ["alfuzosin"],
    "InteractionIndexLink": ["alfuzosine"],
    "N_ENREGISTREMENT": "",
    "CODE_DCI": "25 B 057",
    "DCI": "Alfuzosine chlorhydrate",
    "NOM_COMMERCIALE": "XAPROST",
    "FORME": "comprimé pelliculé a LP",
    "DOSAGE": "10 mg",
    "COND": "30 comprimés",
    "LISTE": "",
    "P1": "",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "",
    "DATE_D_ENREGISTREMENT_INITIAL": "",
    "DATE_D_ENREGISTREMENT_FINAL": "",
    "TYPE": "",
    "STATUT": "",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": ["UroNephrologie"]
  },
  {
    "PregnancyIndexLink": ["doxazosin"],
    "InteractionIndexLink": ["doxazosine"],
    "N_ENREGISTREMENT": "400/ 25 B 061 /09",
    "CODE_DCI": "25 B 061",
    "DCI": "Doxazosine mésilate exprimé en doxazosine",
    "NOM_COMMERCIALE": "DOXAMEX LP",
    "FORME": "COMPRIME A LIBERATION PROLONGEE",
    "DOSAGE": "4MG",
    "COND": "B/20",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "KHROUB PHARMACEUTICAL MANUFACTURING ALGERIA (KPMA)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/7/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "19/7/2009",
    "TYPE": "Gé",
    "STATUT": "C",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["doxazosin"],
    "InteractionIndexLink": ["doxazosine"],
    "N_ENREGISTREMENT": "045/ 25 B 061 /13",
    "CODE_DCI": "25 B 061",
    "DCI": "Doxazosine mésilate exprimé en doxazosine",
    "NOM_COMMERCIALE": "ZOXAN LP",
    "FORME": "COMPRIME A LIBERATION PROLONGEE",
    "DOSAGE": "4MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PFIZER HOLDING FRANCE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/4/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "7/4/2013",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["doxazosin"],
    "InteractionIndexLink": ["doxazosine"],
    "N_ENREGISTREMENT": "045/ 25 B 067 /13",
    "CODE_DCI": "25 B 067",
    "DCI": "Doxazosine mésilate exprimé en doxazosine",
    "NOM_COMMERCIALE": "ZOXAN LP",
    "FORME": "COMPRIME A LIBERATION PROLONGEE",
    "DOSAGE": "8MG",
    "COND": "B/28",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PFIZER HOLDING FRANCE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/4/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "7/4/2013",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["tamsulosin"],
    "InteractionIndexLink": ["tamsulosine"],
    "N_ENREGISTREMENT": "055/25 B 047/19",
    "CODE_DCI": "25 B 07",
    "DCI": "TAMSULOSINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "GAMCET",
    "FORME": "COMP PELL LP",
    "DOSAGE": "0.4MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "DAR AL DAWA DEVELOPEMENT AND INVESTMENT CO LTD",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "31/12/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "31/12/2019",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["oxybutynin"],
    "InteractionIndexLink": ["oxybutynine"],
    "N_ENREGISTREMENT": "255/ 25 D 008 /98",
    "CODE_DCI": "25 D 008",
    "DCI": "OXYBUTYNINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "DITROPAN",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "5MG",
    "COND": "B/60",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SANOFI SYNTHELABO",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/1/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "26/1/1998",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["oxybutynin"],
    "InteractionIndexLink": ["oxybutynine"],
    "N_ENREGISTREMENT": "019/ 25 D 008 /97/16",
    "CODE_DCI": "25 D 008",
    "DCI": "OXYBUTYNINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "DRIPTANE",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "5MG",
    "COND": "B/60",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FOURNIER",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/3/1997",
    "DATE_D_ENREGISTREMENT_FINAL": "12/3/2017",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "60 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["oxybutynin"],
    "InteractionIndexLink": ["oxybutynine"],
    "N_ENREGISTREMENT": "304/ 25 D 008 /05",
    "CODE_DCI": "25 D 008",
    "DCI": "OXYBUTYNINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "RINOSPAN",
    "FORME": "COMPRIME",
    "DOSAGE": "5MG",
    "COND": "B/20",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GEOPHARM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "23/10/2005",
    "DATE_D_ENREGISTREMENT_FINAL": "23/10/2005",
    "TYPE": "Gé",
    "STATUT": "C",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "013/ 25 E 014 /98/14",
    "CODE_DCI": "25 E 014",
    "DCI": "NITROXOLINE",
    "NOM_COMMERCIALE": "NAXOLIN",
    "FORME": "COMPRIME",
    "DOSAGE": "50MG",
    "COND": "B/60",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVA ARGENTIA SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ITALIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/7/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "22/6/2014",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "491/ 25 E 015 /15",
    "CODE_DCI": "25 E 015",
    "DCI": "NITROXOLINE",
    "NOM_COMMERCIALE": "NABYOL FORTE",
    "FORME": "COMP. ENRO.",
    "DOSAGE": "100MG",
    "COND": "B/50",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BOTTU S.A.",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MAROC",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/1/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "29/1/2015",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": ["UroNephrologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "013/ 25 E 015 /98/14",
    "CODE_DCI": "25 E 015",
    "DCI": "NITROXOLINE",
    "NOM_COMMERCIALE": "NAXOLIN",
    "FORME": "COMPRIME",
    "DOSAGE": "100MG",
    "COND": "B/50",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVA ARGENTIA SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ITALIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/7/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "13/7/2014",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["UroNephrologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "418/25 E 015/19",
    "CODE_DCI": "25 E 015",
    "DCI": "NITROXOLINE",
    "NOM_COMMERCIALE": "NEOBIOL",
    "FORME": "COMP PELL",
    "DOSAGE": "100MG",
    "COND": "B/50",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NEOMEDIC SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/12/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "22/12/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["UroNephrologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "462/ 25 E 015 /16",
    "CODE_DCI": "25 E 015",
    "DCI": "NITROXOLINE",
    "NOM_COMMERCIALE": "NOLIB",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "100MG",
    "COND": "B/50",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHYSIOPHARM SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/3/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "13/3/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": false,
    "DrugCategories": ["UroNephrologie"]
  },
  {
    "PregnancyIndexLink": ["fosfomycin trometamol"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "093/ 25 E 058 /07",
    "CODE_DCI": "25 E 058",
    "DCI": "FOSFOMYCINE",
    "NOM_COMMERCIALE": "MONURIL ADULTE",
    "FORME": "GRLES. SUSP. BUV.",
    "DOSAGE": "3G/SACHET",
    "COND": "B/01SACHET",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ZAMBON",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/9/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "18/9/2007",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["UroNephrologie"]
  },
  {
    "PregnancyIndexLink": ["fosfomycin trometamol"],
    "InteractionIndexLink": ["trometamol"],
    "N_ENREGISTREMENT": "293/ 25 E 058 /14",
    "CODE_DCI": "25 E 058",
    "DCI": "FOSFOMYCINE TROMETAMOL EXPRIME EN FOSFOMYCINE",
    "NOM_COMMERCIALE": "URICARE",
    "FORME": "GRLES. P. SOL. BUV.",
    "DOSAGE": "3G/SACHET",
    "COND": "B/01 SACHET",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOCARE SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/11/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "13/11/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": false,
    "DrugCategories": ["UroNephrologie"]
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "129/ 25 G 018 /99",
    "CODE_DCI": "25 G 018",
    "DCI": "DIALYSE EN POCHE ISOTONIQUE",
    "NOM_COMMERCIALE": "CAPD FORMULE 55",
    "FORME": "SOL . P. DIALYSE",
    "DOSAGE": "15G DE GLUCOSE / LITRE",
    "COND": "POCHE DE 2L",
    "LISTE": "",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIEFFE MEDITAL SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ITALIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/1/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "13/1/1999",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "336/ 25 G 019 /05",
    "CODE_DCI": "25 G 019",
    "DCI": "DIALYSE EN POCHE LIQUIDE HYPERTONIQUE",
    "NOM_COMMERCIALE": "CAPD / DPCA 3 - DIALYSE PERITONEALE CONTINUE  AMBULATOIRE STAY SAFE 3",
    "FORME": "SOL. GLUCOSE",
    "DOSAGE": "42.5G DE GLUCOSE / LITRE",
    "COND": "B/4 POCHES DE 2L",
    "LISTE": "",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRESINIUS MEDICAL CARE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALLEMAGNE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/11/2005",
    "DATE_D_ENREGISTREMENT_FINAL": "6/11/2005",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "129/ 25 G 019 /99",
    "CODE_DCI": "25 G 019",
    "DCI": "DIALYSE EN POCHE LIQUIDE HYPERTONIQUE",
    "NOM_COMMERCIALE": "CAPD FORMULE 62",
    "FORME": "SOL . P. DIALYSE",
    "DOSAGE": "42.5G DE GLUCOSE / LITRE",
    "COND": "POCHE DE 2L",
    "LISTE": "",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIEFFE MEDITAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ITALIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/1/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "13/1/1999",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "280/ 25 G 020 /06",
    "CODE_DCI": "25 G 020",
    "DCI": "CONCENTRE ACIDE POUR HEMODIALYSE AU BICARBONATE LIQUIDE",
    "NOM_COMMERCIALE": "RENACID A14 RENABIC L14",
    "FORME": "SOL. POUR HEMODIALYSE",
    "DOSAGE": "",
    "COND": "BIDON DE SOL. CONCENTREE ACIDE DE 10L ET BIDON DE SOL. AU BICARBONATE DE 10L",
    "LISTE": "",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDUSTRIE MEDICO-CHIRURGICALES  (IMC)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/3/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "7/3/2006",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "280/ 25 G 048 /04",
    "CODE_DCI": "25 G 048",
    "DCI": "CONCENTRE ACIDE POUR HEMODIALYSE",
    "NOM_COMMERCIALE": "CONCENTRE ACIDE POUR HEMODIALYSE AU BICARBONATE",
    "FORME": "SOL.",
    "DOSAGE": "",
    "COND": "BIDON/10L",
    "LISTE": "",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDUSTRIE MEDICO-CHIRURGICALES (IMC)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "11/5/2004",
    "DATE_D_ENREGISTREMENT_FINAL": "11/5/2004",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["calcium carbimide"],
    "InteractionIndexLink": [
      "calcium",
      "magnesium (hydroxyde de)",
      "magnesium (trisilicate de)",
      "potassium"
    ],
    "N_ENREGISTREMENT": "405/ 25 G 048 /08",
    "CODE_DCI": "25 G 048",
    "DCI": "CHLORURE DE SODIUM / CHLORURE DE POTASSIUM / CHLORURE DE CALCIUM / CHLORURE DE MAGNESIUM / ACIDE ACETIQUE",
    "NOM_COMMERCIALE": "SOFACID A1",
    "FORME": "SOL. CONC. ACIDE POUR HEMODIALYSE",
    "DOSAGE": "170.06G/5.49G/9.48G/5.62G/8.85G/L",
    "COND": "BIDON DE 10L",
    "LISTE": "",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOFARM SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/4/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "6/4/2009",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["calcium carbimide"],
    "InteractionIndexLink": [
      "calcium",
      "magnesium (hydroxyde de)",
      "magnesium (trisilicate de)",
      "potassium"
    ],
    "N_ENREGISTREMENT": "405/ 25 G 048 /08",
    "CODE_DCI": "25 G 048",
    "DCI": "CHLORURE DE SODIUM / CHLORURE DE POTASSIUM / CHLORURE DE CALCIUM / CHLORURE DE MAGNESIUM / ACIDE ACETIQUE / ACETATE DE SODIUM",
    "NOM_COMMERCIALE": "SOFACID A2",
    "FORME": "SOL. CONC. ACIDE POUR HEMODIALYSE",
    "DOSAGE": "210.70G/5.22G/9.00G/3.56G/6.31G/G",
    "COND": "BIDON/10L",
    "LISTE": "",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOFARM SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "23/2/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "23/2/2008",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "405/ 25 G 053 /08",
    "CODE_DCI": "25 G 053",
    "DCI": "CHLORURE DE SODIUM / BICARBONATE DE SODIUM",
    "NOM_COMMERCIALE": "SOFABIC",
    "FORME": "SOL.CONC. POUR HEMODIALYSE FORMULE BASIQUE AU BICARBONATE",
    "DOSAGE": "23.53G/69.95G/L",
    "COND": "BIDON/10L",
    "LISTE": "",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOFARM SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "23/2/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "23/2/2008",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "336/ 25 G 054 /05",
    "CODE_DCI": "25 G 054",
    "DCI": "DIALYSE EN POCHE LIQUIDE HYPERTONIQUE",
    "NOM_COMMERCIALE": "CAPD / DPCA 2 - DIALYSE PERITONEALE CONTINUE  AMBULATOIRE STAY SAFE 2",
    "FORME": "SOL. GLUCOSE",
    "DOSAGE": "15G GLUCOSE/LITRE",
    "COND": "B/04 POCHES DE 2L",
    "LISTE": "",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRESINIUS MEDICAL CARE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALLEMAGNE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/1/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "15/1/2006",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "336/ 25 G 055 /05",
    "CODE_DCI": "25 G 055",
    "DCI": "DIALYSE EN POCHE LIQUIDE HYPERTONIQUE",
    "NOM_COMMERCIALE": "CAPD / DPCA 4 - DIALYSE PERITONEALE CONTINUE  AMBULATOIRE STAY SAFE 4",
    "FORME": "SOL. GLUCOSE",
    "DOSAGE": "22.73G GLUCOSE/LITRE",
    "COND": "B/04 POCHES DE 2L",
    "LISTE": "",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRESINIUS MEDICAL CARE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALLEMAGNE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/11/2005",
    "DATE_D_ENREGISTREMENT_FINAL": "6/11/2005",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "280/ 25 G 056 /07",
    "CODE_DCI": "25 G 056",
    "DCI": "CONCENTRE ACIDE POUR HEMODIALYSE AU BICARBONATE  POUDRE",
    "NOM_COMMERCIALE": "RENACID A13",
    "FORME": "SOL. P. HEMODIALYSE",
    "DOSAGE": "",
    "COND": "BIDON 10L.",
    "LISTE": "",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDUSTRIES MEDICO-CHIRURGICALES (IMC)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/7/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "9/7/2007",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["calcium carbimide"],
    "InteractionIndexLink": [
      "calcium",
      "magnesium (hydroxyde de)",
      "magnesium (trisilicate de)"
    ],
    "N_ENREGISTREMENT": "298/ 25 G 062 /12",
    "CODE_DCI": "25 G 062",
    "DCI": "CHLORURE DE SODIUM / CHLORURE DE CALCIUM DIHYDRATE / CHLORURE DE MAGNESIUM HEXAHYDRATE / SOLUTION DE LACTATE DE SODIUM A 60% / GLUCOSE MONOHYDRATE",
    "NOM_COMMERCIALE": "DPCA FORMULE 91",
    "FORME": "SOL. P. DIALYSE CONTINUE AMBULATOIRE PERITONEALE",
    "DOSAGE": "5.670G/0.257G/ 0.152G/ 6.537G (3.922g/l de lactate de sodium pur)/ 25G  (correspondant à 22.7g/l ou 2.27% de glucose anhydre) / 1000mL SOIT : 132mmol/l en SODIUM. 1.75mmol/l en CALCIUM. 0.75mmol/l en MAGNESIUM. 35mmol/l en LACTATE . 102mmol/l en chlorure.  126.135mmol/L EN GLUCOSE ANHYDRE",
    "COND": "POCHE DOUBLE DE 2000ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BAXTER S.P.A",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ITALIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "3/5/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "3/5/2012",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["calcium carbimide"],
    "InteractionIndexLink": [
      "calcium",
      "magnesium (hydroxyde de)",
      "magnesium (trisilicate de)"
    ],
    "N_ENREGISTREMENT": "298/ 25 G 063 /12",
    "CODE_DCI": "25 G 063",
    "DCI": "GLUCOSE ANHYDRE (SOUS FORME MONOHYDRATEE) / SODIUM CHLORURE / CALCIUM CHLORURE DIHYDRATE / MAGNESIUM CHLORURE HEXAHYDRATE / SODIUM LACTATE",
    "NOM_COMMERCIALE": "DIANEAL PDA 1.36%",
    "FORME": "SOL. P. DIALYSE PERITONEALE",
    "DOSAGE": "13.6G/L (1.36%) DE GLUCOSE ANHYDRE . 15G/L DE GLUCOSE MONONHYDRATE/ (5.38G / 0.184/G / 0.051G / 4.480G)/L   SOIT 132mmole de sodium / 1.25mmole de calcium / 0.25mmole de magnésium  / 95.00 mole de chlorure / 40mmole de lactate )/L",
    "COND": "POCHE FLEXIBLE (SYSTÈME II CONNEXION A VIS LUER) VIAFLEX PVC DE FORMULE PL 146-3CARTON  DE 05 POCHES SIMPLES DE 2000ML.CARTON DE 02 POCHES SIMPLE DE 5000ML - CARTON DE 05 POCHES DOUBLES DE 2000ML .",
    "LISTE": "",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BAXTER HEALTHCARE LTD",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ROYAUME UNI",
    "DATE_D_ENREGISTREMENT_INITIAL": "8/11/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "8/11/2012",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["calcium carbimide"],
    "InteractionIndexLink": [
      "calcium",
      "magnesium (hydroxyde de)",
      "magnesium (trisilicate de)"
    ],
    "N_ENREGISTREMENT": "298/ 25 G 064 /12",
    "CODE_DCI": "25 G 064",
    "DCI": "GLUCOSE ANHYDRE (SOUS FORME MONOHYDRATEE) / SODIUM CHLORURE / SODIUM LACTATE / CALCIUM CHLORURE DIHYDRATE / MAGNESIUM CHLORURE HEXAHYDRATE",
    "NOM_COMMERCIALE": "DIANEAL PDA 2.27%",
    "FORME": "SOL. P. DIALYSE PERITONEALE",
    "DOSAGE": "22.70G/L (2.27%) DE GLUCOSE ANHYDRE . 25G/L SOUS FORME  MONONHYDRATE/ (5.38G/4.48G/0.184G/0.051G)/L SOIT 132mmole de sodium / 1.25mmole de calcium / 0.25mmole de magnésium  / 95.00 mole de chlorure / 40mmole de lactate )/L",
    "COND": "POCHE POCHE FLEXIBLE (SYSTÈME II CONNEXION A VIS LUER CARTON  DE 02 POCHES SIMPLES DE 2000ML. CARTON DE 05 POCHES SIMPLES DE 2000ML . CARTON DE 05 POCHES DOUBLES  DE 2000ML () VIAFLEX EN PVC DE FORMULE PL146)",
    "LISTE": "",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BAXTER HEALTHCARE LTD",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ROYAUME UNI",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/8/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "26/8/2012",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["calcium carbimide"],
    "InteractionIndexLink": [
      "calcium",
      "magnesium (hydroxyde de)",
      "magnesium (trisilicate de)"
    ],
    "N_ENREGISTREMENT": "298/ 25 G 065 /12",
    "CODE_DCI": "25 G 065",
    "DCI": "GLUCOSE ANHYDRE (SOUS FORME MONOHYDRATEE) / SODIUM CHLORURE / CALCIUM CHLORURE DIHYDRATE / MAGNESIUM CHLORURE HEXAHYDRATE / SODIUM LACTATE",
    "NOM_COMMERCIALE": "DIANEAL PDA 3.86%",
    "FORME": "SOL. P. DIALYSE PERITONEALE",
    "DOSAGE": "38.6G/L (3.86%) DE GLUCOSE ANHYDRE . 42.5G/L DE GLUCOSE MONONHYDRATE/ (5.38G / 0.184/G / 0.051G / 4.480G)/L   SOIT 132mmole de sodium / 1.25mmole de calcium / 0.25mmole de magnésium  / 95.00 mole de chlorure / 40mmole de lactate )/L",
    "COND": "POCHE FLEXIBLE (SYSTÈME II CONNEXION A VIS LUER) VIAFLEX PVC DE FORMULE PL 146-3CARTON  DE 05 POCHES SIMPLES DE 2000ML. CARTON DE 05 POCHES DOUBLES DE 2000ML .",
    "LISTE": "",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BAXTER HEALTHCARE LTD",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ROYAUME UNI",
    "DATE_D_ENREGISTREMENT_INITIAL": "8/11/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "8/11/2012",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["calcium carbimide"],
    "InteractionIndexLink": [
      "calcium",
      "magnesium (hydroxyde de)",
      "magnesium (trisilicate de)"
    ],
    "N_ENREGISTREMENT": "298/ 25 G 066 /12",
    "CODE_DCI": "25 G 066",
    "DCI": "ICODEXTRINE (DCI)/SODIUM CHLORURE/SODIUM LACTATE / CALCIUM CHLORURE / MAGNESIUM CHLORURE",
    "NOM_COMMERCIALE": "EXTRANEAL 7.5%",
    "FORME": "SOL. P. DIALYSE PERITONEALE",
    "DOSAGE": "75G/L (7.5%) D'ICODEXTRINE (5.4G/4.5G/0.257G/0.051G)/L SOIT PAR LITRE 133MMOL DE SODIUM. 1.75MMOL DE CALCIUM. 0.25MMOL DE MAGNESIUM. 96MMOL DE CHLORURE . 40MMOL DE LACTATE",
    "COND": "B/05POCHES SIMPLES DE 2L ET B/05POCHES DOUBLES DE 2L ( POCHES FLEXIBLES -SYSTÈME II CONNEXION A VIS LUER - VIAFLEX EN PVC DE FORMULE PL146-3)",
    "LISTE": "",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BAXTER HEALTHCARE LTD",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ROYAUME UNI",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/12/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "10/12/2012",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["calcium carbimide"],
    "InteractionIndexLink": [
      "calcium",
      "magnesium (hydroxyde de)",
      "magnesium (trisilicate de)"
    ],
    "N_ENREGISTREMENT": "332/25 G 072/16",
    "CODE_DCI": "25 G 072",
    "DCI": "SOLUTION A CHLORURE DE CALCIUM DIHYDRATE/CHLORURE DE MAGNESIUM HEXAHYDRATE/GLUCOSE ANHYDRE S/F MONOHYDRATE SOLUTION B CHLORURE DE SODIUM /BICARBONATE DE SODIUM",
    "NOM_COMMERCIALE": "MULTIBIC SANS SUCRE",
    "FORME": "SOLUTION POUR HEMOFILTRATION",
    "DOSAGE": "AVANT RECONSTITUTION solution A SOLUTION ACIDE A BASE DE GLUCOSE ET ELECTROLYTES 4.410G/2.033 G/2.00 G/20.00 G SOLUTION B SOLUTION ALCALIN A BASE DE BICARBONATE DE SODIUM ET DE CHLORURE DE SODIUM APRES RECONSTITUTION 6.136 G/2.940 G/0.2205 G/0.1017G/1.100G",
    "COND": "POCHE DE 05 L BI-COMPARTIMENTEE A ( 0.25 l) et B( 4.75 l)",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRESENIUS MEDICAL CARE DEUTSCHLAND GMBH",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALLEMAGNE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/3/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "6/3/2017",
    "TYPE": "RE",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "12 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "332/25 G 073/16",
    "CODE_DCI": "25 G 073",
    "DCI": "SOLUTION ACIDE A BASE DE GLUCOSE ET ELECTROLYTES +SOLUTION ALCALINE A BASE  DE BICARBONATE DE SODIUM ET DE CHLORURE DE SODIUM",
    "NOM_COMMERCIALE": "MULTIBIC 2 MMOL/L POTASSIUM",
    "FORME": "SOLUTION POUR HEMOFILTRATION",
    "DOSAGE": "COMPARTIMENT A (0.25 L) .COMPARTIMENT B (4.75 L )",
    "COND": "POCHE DE 05 L",
    "LISTE": "",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRESINIUS MEDICAL CARE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALLEMAGNE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/1/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "29/1/2017",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "12 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["calcium carbimide"],
    "InteractionIndexLink": [
      "calcium",
      "magnesium (hydroxyde de)",
      "magnesium (trisilicate de)",
      "potassium"
    ],
    "N_ENREGISTREMENT": "332/25 G 074/16",
    "CODE_DCI": "25 G 074",
    "DCI": "CHLORURE DE POTASSIUM/CHLORURE DE CALCIUM DIHYDRATE/CHLORURE DE MAGNESIUM HEXAHYDRATE/GLUCOSE ANHYDRE S/F MONOHYDRATE",
    "NOM_COMMERCIALE": "MUTI-BIC 3 MMOL/L POTASIUM",
    "FORME": "SOLUTION POUR HEMOFILTRATION",
    "DOSAGE": "AVANT RECONSTITUTION solution A SOLUTION ACIDE A BASE DE GLUCOSE ET ELECTROLYTES 4.473G/4.410G G/2.033G/22.00 G SOLUTION B SOLUTION ALCALIN A BASE DE BICARBONATE DE SODIUM ET DE CHLORURE DE SODIUM APRES RECONSTITUTION 0.2237G/6.136 G/2.940 G/0.2205 G/0.1017G/1.100",
    "COND": "POCHE DE 05 L BI-COMPARTIMENTEE A ( 0.25 l) et B( 4.75 l)",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRESENIUS MEDICAL CARE DEUTSCHLAND GMBH",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALLEMAGNE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/3/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "6/3/2017",
    "TYPE": "RE",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "12 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["calcium carbimide"],
    "InteractionIndexLink": [
      "calcium",
      "magnesium (hydroxyde de)",
      "magnesium (trisilicate de)",
      "potassium"
    ],
    "N_ENREGISTREMENT": "332/25 G 075/17",
    "CODE_DCI": "25 G 075",
    "DCI": "SOLUTION A CHLORURE DE POTASSIUM/CHLORURE DE CALCIUM DIHYDRATE/CHLORURE DE MAGNESIUM HEXAHYDRATE/GLUCOSE ANHYDRE S/F MONOHYDRATE SOLUTION B CHLORURE DE SODIUM /BICARBONATE DE SODIUM",
    "NOM_COMMERCIALE": "MUTI-BIC 4 MMOL/L POTASIUM",
    "FORME": "SOLUTION POUR HEMOFILTRATION",
    "DOSAGE": "AVANT RECONSTITUTION solution A SOLUTION ACIDE A BASE DE GLUCOSE ET ELECTROLYTES 5.964G/4.410G G/2.033G/22.00 G SOLUTION B SOLUTION ALCALIN A BASE DE BICARBONATE DE SODIUM ET DE CHLORURE DE SODIUM APRES RECONSTITUTION 0.2982G/6.136 G/2.940 G/0.2205 G/0.1017G/1.100",
    "COND": "POCHE DE 05 L BI-COMPARTIMENTEE A ( 0.25 l) et B( 4.75 l)",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRESENIUS MEDICAL CARE DEUTSCHLAND GMBH",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALLEMAGNE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/3/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "6/3/2017",
    "TYPE": "RE",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "12 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["mesterolone"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "070/ 25 H 021 /97",
    "CODE_DCI": "25 H 021",
    "DCI": "MESTEROLONE",
    "NOM_COMMERCIALE": "PROVIRON",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "25MG",
    "COND": "B/20",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SCHERING SA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/11/1997",
    "DATE_D_ENREGISTREMENT_FINAL": "18/11/1997",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["mesterolone"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "121/ 25 H 021 /06",
    "CODE_DCI": "25 H 021",
    "DCI": "MESTEROLONE",
    "NOM_COMMERCIALE": "ROVERON",
    "FORME": "COMPRIME SECABLE",
    "DOSAGE": "25MG",
    "COND": "B/20",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ASIA PHARMACEUTICALS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SYRIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/7/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "26/7/2006",
    "TYPE": "Gé",
    "STATUT": "C",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["sevelamer"],
    "InteractionIndexLink": ["sevelamer"],
    "N_ENREGISTREMENT": "471/ 25 M 059 /13",
    "CODE_DCI": "25 M 059",
    "DCI": "SEVELAMER",
    "NOM_COMMERCIALE": "FOSEAL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "800MG",
    "COND": "B/180",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF.",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EMCURE PHARMACEUTICALS LTD",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "14/1/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "14/1/2013",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["sevelamer"],
    "InteractionIndexLink": ["sevelamer"],
    "N_ENREGISTREMENT": "339/ 25 M 059 /09",
    "CODE_DCI": "25 M 059",
    "DCI": "SEVELAMER",
    "NOM_COMMERCIALE": "RENAGEL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "800MG",
    "COND": "PILULIER DE 180",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GENZYME EUROPE B.V.",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PAYS BAS",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/6/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "15/6/2009",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "273/ 25 N 035 /05",
    "CODE_DCI": "25 N  035",
    "DCI": "ALPROSTADIL",
    "NOM_COMMERCIALE": "EDEX",
    "FORME": "PDRE ET  SOLVT. SOL. INJ.",
    "DOSAGE": "20µG/ML",
    "COND": "B/2 CARTOUCHE BI-COMPARTIMENT DE 1ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SCHWARZ PHARMA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/12/2005",
    "DATE_D_ENREGISTREMENT_FINAL": "18/12/2005",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "273/ 25 N 034 /05",
    "CODE_DCI": "25 N 034",
    "DCI": "ALPROSTADIL",
    "NOM_COMMERCIALE": "EDEX",
    "FORME": "PDRE ET  SOLVT. SOL. INJ.",
    "DOSAGE": "10µG/ML",
    "COND": "B/2 CARTOUCHE BI-COMPARTIMENT DE 1ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SCHWARZ PHARMA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/12/2005",
    "DATE_D_ENREGISTREMENT_FINAL": "18/12/2005",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["sildenafil citrate"],
    "InteractionIndexLink": ["sildenafil"],
    "N_ENREGISTREMENT": "055/25 N 045/19",
    "CODE_DCI": "25 N 045",
    "DCI": "SILDENAFIL CITRATE",
    "NOM_COMMERCIALE": "APHRODIL",
    "FORME": "COMP PELL",
    "DOSAGE": "50MG",
    "COND": "B/04",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "DAR AL DAWA DEVELOPMENT & INVESTMENT Co Ltd",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/7/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "10/7/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["sildenafil citrate"],
    "InteractionIndexLink": ["sildenafil"],
    "N_ENREGISTREMENT": "352/25 N 045/10/20",
    "CODE_DCI": "25 N 045",
    "DCI": "SILDENAFIL CITRATE",
    "NOM_COMMERCIALE": "CILAGRA",
    "FORME": "",
    "DOSAGE": "50MG",
    "COND": "B/02 ET B/04",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SPA/ EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/8/2010",
    "DATE_D_ENREGISTREMENT_FINAL": "22/12/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["sildenafil citrate"],
    "InteractionIndexLink": ["sildenafil"],
    "N_ENREGISTREMENT": "352/ 25 N 045 /10/18",
    "CODE_DCI": "25 N 045",
    "DCI": "Sildénafil citrate",
    "NOM_COMMERCIALE": "CILAGRA",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "50MG",
    "COND": "B/04",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/8/2010",
    "DATE_D_ENREGISTREMENT_FINAL": "2/4/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["sildenafil citrate"],
    "InteractionIndexLink": ["sildenafil"],
    "N_ENREGISTREMENT": "149/ 25 N 045 /14",
    "CODE_DCI": "25 N 045",
    "DCI": "Sildénafil citrate",
    "NOM_COMMERCIALE": "ERECTA",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "50MG",
    "COND": "B/02 ET B/08",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVAPHARM TRADING SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/5/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "6/10/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["sildenafil citrate"],
    "InteractionIndexLink": ["sildenafil"],
    "N_ENREGISTREMENT": "304/ 25 N 045 /06/15",
    "CODE_DCI": "25 N 045",
    "DCI": "Sildénafil citrate",
    "NOM_COMMERCIALE": "FORCE MEN",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "50MG",
    "COND": "B/01. B/04",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL GEOPHARM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/3/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "2/12/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["sildenafil citrate"],
    "InteractionIndexLink": ["sildenafil"],
    "N_ENREGISTREMENT": "263/25 N 045/16",
    "CODE_DCI": "25 N 045",
    "DCI": "Sildénafil citrate",
    "NOM_COMMERCIALE": "HEXOR",
    "FORME": "COMP. ENRO.",
    "DOSAGE": "50MG",
    "COND": "B/02",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOPHARM SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/10/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "6/10/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["sildenafil citrate"],
    "InteractionIndexLink": ["sildenafil"],
    "N_ENREGISTREMENT": "426/ 25 N 045 /12",
    "CODE_DCI": "25 N 045",
    "DCI": "Sildénafil citrate",
    "NOM_COMMERCIALE": "INAGRA",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "50MG",
    "COND": "B/02 ET B/10",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "REMEDE PHARMA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/9/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "25/9/2012",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["sildenafil citrate"],
    "InteractionIndexLink": ["sildenafil"],
    "N_ENREGISTREMENT": "039/ 25 N 045 /13/18",
    "CODE_DCI": "25 N 045",
    "DCI": "Sildénafil citrate",
    "NOM_COMMERCIALE": "SILDEFAL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "50MG",
    "COND": "B/01 ET B/03",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOCIETE PHARMACEUTIQUE ALGERIENNE (SOPHAL)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/2/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "20/3/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["sildenafil citrate"],
    "InteractionIndexLink": ["sildenafil"],
    "N_ENREGISTREMENT": "428/ 25 N 045 /13",
    "CODE_DCI": "25 N 045",
    "DCI": "Sildénafil citrate",
    "NOM_COMMERCIALE": "SILDENAFIL ZENTIVA",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "50MG",
    "COND": "B/04",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "WINTHROP PHARMA SAIDAL SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/6/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "25/6/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["sildenafil citrate"],
    "InteractionIndexLink": ["sildenafil"],
    "N_ENREGISTREMENT": "418/ 25 N 045 /13",
    "CODE_DCI": "25 N 045",
    "DCI": "Sildénafil citrate",
    "NOM_COMMERCIALE": "SILVEGRA",
    "FORME": "MICROGLES. EN GLES.",
    "DOSAGE": "50MG",
    "COND": "B/03 ET B/07",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NEOMEDIC SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/2/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "4/2/2013",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["sildenafil citrate"],
    "InteractionIndexLink": ["sildenafil"],
    "N_ENREGISTREMENT": "447/ 25 N 045 /12",
    "CODE_DCI": "25 N 045",
    "DCI": "Sildénafil citrate",
    "NOM_COMMERCIALE": "VIABEK",
    "FORME": "COMP. PELLI. SEC",
    "DOSAGE": "50MG",
    "COND": "B/02 ET B/08",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEKER SARL (SARL LABORATOIRE BEKER ALGERIE)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/4/2012",
    "DATE_D_ENREGISTREMENT_FINAL": "24/4/2012",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "48MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["sildenafil citrate"],
    "InteractionIndexLink": ["sildenafil"],
    "N_ENREGISTREMENT": "003/ 25 N 045 /07/21",
    "CODE_DCI": "25 N 045",
    "DCI": "Sildénafil citrate exprimé en Sildénafil",
    "NOM_COMMERCIALE": "VIACTAL",
    "FORME": "Comprimé  sécable",
    "DOSAGE": "50MG",
    "COND": "B/02  -  B/08",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EPE GROUPE INDUSTRIEL SAIDAL/SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/7/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "17/2/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["sildenafil citrate"],
    "InteractionIndexLink": ["sildenafil"],
    "N_ENREGISTREMENT": "317/ 25 N 045 /10",
    "CODE_DCI": "25 N 045",
    "DCI": "Sildénafil citrate",
    "NOM_COMMERCIALE": "VIADIS",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "50MG",
    "COND": "B/02 ET B/04",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INPHA-MEDIS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/5/2010",
    "DATE_D_ENREGISTREMENT_FINAL": "10/5/2010",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["sildenafil citrate"],
    "InteractionIndexLink": ["sildenafil"],
    "N_ENREGISTREMENT": "242/ 25 N 045 /18",
    "CODE_DCI": "25 N 045",
    "DCI": "Sildénafil citrate",
    "NOM_COMMERCIALE": "VIAFIL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "50MG",
    "COND": "B/10",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GROUPE  SANTE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/10/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "9/10/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["sildenafil citrate"],
    "InteractionIndexLink": ["sildenafil"],
    "N_ENREGISTREMENT": "380/ 25 N 045 /16",
    "CODE_DCI": "25 N 045",
    "DCI": "Sildénafil citrate",
    "NOM_COMMERCIALE": "VIAGNAFIL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "50MG",
    "COND": "B/02 ET B/04",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HUP.P.PHARMA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/6/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "13/6/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["sildenafil citrate"],
    "InteractionIndexLink": ["sildenafil"],
    "N_ENREGISTREMENT": "045/ 25 N 045 /99/09",
    "CODE_DCI": "25 N 045",
    "DCI": "Sildénafil citrate",
    "NOM_COMMERCIALE": "VIAGRA",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "50MG",
    "COND": "B/02",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PFIZER PHARM ALGERIE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "5/10/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "6/4/2009",
    "TYPE": "Ré",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["sildenafil citrate"],
    "InteractionIndexLink": ["sildenafil"],
    "N_ENREGISTREMENT": "035/25 N 045/17",
    "CODE_DCI": "25 N 045",
    "DCI": "Sildénafil citrate",
    "NOM_COMMERCIALE": "VIANAFIL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "50MG",
    "COND": "B/4",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMALLIANCE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/3/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "7/3/2017",
    "TYPE": "GE",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["sildenafil citrate"],
    "InteractionIndexLink": ["sildenafil"],
    "N_ENREGISTREMENT": "079 / 25 N 045 / 16",
    "CODE_DCI": "25 N 045",
    "DCI": "Sildénafil citrate",
    "NOM_COMMERCIALE": "VIAREC",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "50MG",
    "COND": "B/04",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LAD PHARMA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/4/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "27/4/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["sildenafil citrate"],
    "InteractionIndexLink": ["sildenafil"],
    "N_ENREGISTREMENT": "470/ 25 N 045 /19",
    "CODE_DCI": "25 N 045",
    "DCI": "Sildénafil citrate",
    "NOM_COMMERCIALE": "VIRILOME",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "50MG",
    "COND": "B/02 ET B/10",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MM SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/5/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "13/5/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24  MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["sildenafil citrate"],
    "InteractionIndexLink": ["sildenafil"],
    "N_ENREGISTREMENT": "573/25 N 045/20",
    "CODE_DCI": "25 N 045",
    "DCI": "SILDENAFIL CITRATE EXPRIME EN SILDENAFIL",
    "NOM_COMMERCIALE": "VYACTIR",
    "FORME": "COMPRIME",
    "DOSAGE": "50MG",
    "COND": "B/10",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES SAPHARM PRODUCTION /SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/12/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "17/12/2020",
    "TYPE": "Gé",
    "STATUT": "Fpremix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["tadalafil"],
    "InteractionIndexLink": ["tadalafil"],
    "N_ENREGISTREMENT": "039/25 N 052/17",
    "CODE_DCI": "25 N 052",
    "DCI": "Tadalafil",
    "NOM_COMMERCIALE": "CIAFAL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "20MG",
    "COND": "B/1 ET B/2",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOPHAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/2/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "7/2/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["tadalafil"],
    "InteractionIndexLink": ["tadalafil"],
    "N_ENREGISTREMENT": "21/25 N 052/470",
    "CODE_DCI": "25 N 052",
    "DCI": "TADALAFIL",
    "NOM_COMMERCIALE": "CYALEX",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "20MG",
    "COND": "B/ 10",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL LABORATOIRES MM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/4/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "19/4/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["tadalafil"],
    "InteractionIndexLink": ["tadalafil"],
    "N_ENREGISTREMENT": "321/ 25 N 052 /07/18",
    "CODE_DCI": "25 N 052",
    "DCI": "Tadalafil",
    "NOM_COMMERCIALE": "EREXYL",
    "FORME": "Comprimé pelliculé",
    "DOSAGE": "20MG",
    "COND": "B/04",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOVITAL SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "1/8/2007",
    "DATE_D_ENREGISTREMENT_FINAL": "14/5/2018",
    "TYPE": "Gé",
    "STATUT": "F prémix",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["tadalafil"],
    "InteractionIndexLink": ["tadalafil"],
    "N_ENREGISTREMENT": "352/ 25 N 052 /13/19",
    "CODE_DCI": "25 N 052",
    "DCI": "Tadalafil",
    "NOM_COMMERCIALE": "ERIXIUM",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "20MG",
    "COND": "B/04 ET B/02",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/7/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "9/1/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["tadalafil"],
    "InteractionIndexLink": ["tadalafil"],
    "N_ENREGISTREMENT": "504/25 N 052/20",
    "CODE_DCI": "25 N 052",
    "DCI": "Tadalafil",
    "NOM_COMMERCIALE": "MEGALIS",
    "FORME": "Comprimé pelliculé",
    "DOSAGE": "20MG",
    "COND": "B/4 ET B/10",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVOMEDIS / SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/12/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "28/3/2021",
    "TYPE": "Gé",
    "STATUT": "F prémix (SANAMED) Libérateur (NOVOMEDIS)",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["tadalafil"],
    "InteractionIndexLink": ["tadalafil"],
    "N_ENREGISTREMENT": "149/ 25 N 052 /15",
    "CODE_DCI": "25 N 052",
    "DCI": "Tadalafil",
    "NOM_COMMERCIALE": "NOVALIS",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "20MG",
    "COND": "B/02",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVAPHARM TRADING SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/7/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "9/7/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["tadalafil"],
    "InteractionIndexLink": ["tadalafil"],
    "N_ENREGISTREMENT": "21/25 N 052/544",
    "CODE_DCI": "25 N 052",
    "DCI": "TADALAFIL",
    "NOM_COMMERCIALE": "TADAFORS",
    "FORME": "COMP. PELL.",
    "DOSAGE": "20MG",
    "COND": "B/04",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL WORLD MEDECINE LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/12/20",
    "DATE_D_ENREGISTREMENT_FINAL": "28/12/20",
    "TYPE": "Gé",
    "STATUT": "Fpremix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["tadalafil"],
    "InteractionIndexLink": ["tadalafil"],
    "N_ENREGISTREMENT": "447/ 25 N 052 /09",
    "CODE_DCI": "25 N 052",
    "DCI": "Tadalafil",
    "NOM_COMMERCIALE": "TADALIS",
    "FORME": "COMP. PELLI. SEC.",
    "DOSAGE": "20MG",
    "COND": "B/02 - B/08",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEKER SARL (SARL LABORATOIRE BEKER ALGERIE)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "6/12/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "6/12/2009",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["tadalafil"],
    "InteractionIndexLink": ["tadalafil"],
    "N_ENREGISTREMENT": "035/25 N 052/17",
    "CODE_DCI": "25 N 052",
    "DCI": "Tadalafil",
    "NOM_COMMERCIALE": "TAFIALYS",
    "FORME": "COMP. PELLI. SEC.",
    "DOSAGE": "20MG",
    "COND": "B/08 ET B/02",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMALLIANCE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "23/7/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "23/7/2017",
    "TYPE": "G",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["tadalafil"],
    "InteractionIndexLink": ["tadalafil"],
    "N_ENREGISTREMENT": "518/ 25 N 052 /18",
    "CODE_DCI": "25 N 052",
    "DCI": "Tadalafil",
    "NOM_COMMERCIALE": "TALAN",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "20MG",
    "COND": "B/04",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "TASSILI ARAB PHARMACEUTICAL COMPANY / SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/6/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "28/6/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["tadalafil"],
    "InteractionIndexLink": ["tadalafil"],
    "N_ENREGISTREMENT": "317/ 25 N 052 /10",
    "CODE_DCI": "25 N 052",
    "DCI": "Tadalafil",
    "NOM_COMMERCIALE": "VITALIS 20MG",
    "FORME": "COMP. PELLI. SEC.",
    "DOSAGE": "20MG",
    "COND": "B/02",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INPHA-MEDIS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/5/2010",
    "DATE_D_ENREGISTREMENT_FINAL": "10/5/2010",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["sildenafil citrate"],
    "InteractionIndexLink": ["sildenafil"],
    "N_ENREGISTREMENT": "149/25 N 060 /14",
    "CODE_DCI": "25 N 060",
    "DCI": "Sildénafil citrate",
    "NOM_COMMERCIALE": "ERECTA",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "100MG",
    "COND": "B/4",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVAPHARM TRADING",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/4/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "6/10/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["sildenafil citrate"],
    "InteractionIndexLink": ["sildenafil"],
    "N_ENREGISTREMENT": "447/ 25 N 060 /13",
    "CODE_DCI": "25 N 060",
    "DCI": "Sildénafil citrate",
    "NOM_COMMERCIALE": "VIABEK",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "100MG",
    "COND": "B/04",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BEKER SARL (SARL LABORATOIRE BEKER ALGERIE)",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/9/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "30/9/2013",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "48 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["sildenafil citrate"],
    "InteractionIndexLink": ["sildenafil"],
    "N_ENREGISTREMENT": "035/25 N 060/17",
    "CODE_DCI": "25 N 060",
    "DCI": "Sildénafil citrate",
    "NOM_COMMERCIALE": "VIANAFIL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "100MG",
    "COND": "B/04",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMALLIANCE EURL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/3/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "7/3/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["sildenafil citrate"],
    "InteractionIndexLink": ["sildenafil"],
    "N_ENREGISTREMENT": "079/ 25 N 060 /16",
    "CODE_DCI": "25 N 060",
    "DCI": "Sildénafil citrate",
    "NOM_COMMERCIALE": "VIAREC",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "100MG",
    "COND": "B/04",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LAD PHARMA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/5/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "24/5/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["UDENAFIL"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "001/ 25 N 070 /14",
    "CODE_DCI": "25 N 070",
    "DCI": "UDENAFIL",
    "NOM_COMMERCIALE": "ZYDENA",
    "FORME": "COMP PELL SEC",
    "DOSAGE": "100MG",
    "COND": "B/2",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMA ALGERIA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/4/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "28/4/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "30 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["UDENAFIL"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "001/25 N 071/16",
    "CODE_DCI": "25 N 071",
    "DCI": "UDENAFIL",
    "NOM_COMMERCIALE": "ZYDENA",
    "FORME": "COMP PELL SECABLE",
    "DOSAGE": "200MG",
    "COND": "B/2",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMA ALGERIA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/11/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "9/11/2016",
    "TYPE": "Ré",
    "STATUT": "FPREMIX",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["tadalafil"],
    "InteractionIndexLink": ["tadalafil"],
    "N_ENREGISTREMENT": "426/25 N 076/20",
    "CODE_DCI": "25 N 076",
    "DCI": "TADALAFIL",
    "NOM_COMMERCIALE": "ADONIS",
    "FORME": "COMP. PELL.",
    "DOSAGE": "05MG",
    "COND": "B/28",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMAX",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/12/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "22/12/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["tadalafil"],
    "InteractionIndexLink": ["tadalafil"],
    "N_ENREGISTREMENT": "039/25 N 076/17",
    "CODE_DCI": "25 N 076",
    "DCI": "TADALAFIL",
    "NOM_COMMERCIALE": "CIAFAL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "5MG",
    "COND": "B/28",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOPHAL SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "07/03/17",
    "DATE_D_ENREGISTREMENT_FINAL": "07/03/17",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["tadalafil"],
    "InteractionIndexLink": ["tadalafil"],
    "N_ENREGISTREMENT": "039/25 N 076/17",
    "CODE_DCI": "25 N 076",
    "DCI": "TADALAFIL",
    "NOM_COMMERCIALE": "CLAFAL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "5MG",
    "COND": "B/28",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SOPHAL SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/3/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "7/3/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["tadalafil"],
    "InteractionIndexLink": ["tadalafil"],
    "N_ENREGISTREMENT": "352/25 N 076/19",
    "CODE_DCI": "25 N 076",
    "DCI": "TADALAFIL",
    "NOM_COMMERCIALE": "ERIXIUM",
    "FORME": "COMP PELL",
    "DOSAGE": "5MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/8/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "26/8/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["tadalafil"],
    "InteractionIndexLink": ["tadalafil"],
    "N_ENREGISTREMENT": "447/25 N 076/16",
    "CODE_DCI": "25 N 076",
    "DCI": "TADALAFIL",
    "NOM_COMMERCIALE": "TADALIS",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "5MG",
    "COND": "B/30 ET B/90",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL BEKER",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "8/11/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "8/11/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["tadalafil"],
    "InteractionIndexLink": ["tadalafil"],
    "N_ENREGISTREMENT": "573/25 N 076/20",
    "CODE_DCI": "25 N 076",
    "DCI": "TADALAFIL",
    "NOM_COMMERCIALE": "TADILIX",
    "FORME": "COMP. PELL.",
    "DOSAGE": "05MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SAPHARM PRODUCTION / SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/12/20",
    "DATE_D_ENREGISTREMENT_FINAL": "17/12/20",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["tadalafil"],
    "InteractionIndexLink": ["tadalafil"],
    "N_ENREGISTREMENT": "055/25 N 076/17",
    "CODE_DCI": "25 N 076",
    "DCI": "TADALAFIL",
    "NOM_COMMERCIALE": "TYRA",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "5MG",
    "COND": "B/28",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "DAR AL DAWA DEVELOPMENT & INVESTMENT Co Ltd",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "JORDANIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "10/7/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "10/7/2019",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["vardenafil"],
    "InteractionIndexLink": ["vardenafil"],
    "N_ENREGISTREMENT": "352/25 N 077/18",
    "CODE_DCI": "25 N 077",
    "DCI": "Vardénafil hydrochloride trihydrate",
    "NOM_COMMERCIALE": "LIBIDOX",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "10 MG",
    "COND": "B/02 ET B/04",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SPA EL KENDI  Industrie du Médicament",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/12/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "26/12/2018",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["tadalafil"],
    "InteractionIndexLink": ["tadalafil"],
    "N_ENREGISTREMENT": "20/25 N078/039",
    "CODE_DCI": "25 N 078",
    "DCI": "TADALAFIL",
    "NOM_COMMERCIALE": "CIAFAL",
    "FORME": "COMP PELL",
    "DOSAGE": "2.5MG",
    "COND": "B/28",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES SOPHAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/08/20",
    "DATE_D_ENREGISTREMENT_FINAL": "27/08/20",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["dapoxetine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "001/ 25 N 080 /21",
    "CODE_DCI": "25 N 080",
    "DCI": "Dapoxétine Hydrochloride exprimé en Dapoxétine",
    "NOM_COMMERCIALE": "DURJOY",
    "FORME": "Comprimé pelliculé",
    "DOSAGE": "30MG",
    "COND": "B/03",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMA ALGERIA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/1/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "7/1/2021",
    "TYPE": "Gé",
    "STATUT": "F mélange final",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["dapoxetine"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "001/ 25 N 081 /21",
    "CODE_DCI": "25 N 0801",
    "DCI": "Dapoxétine Hydrochloride exprimé en Dapoxétine",
    "NOM_COMMERCIALE": "DURJOY",
    "FORME": "Comprimé pelliculé",
    "DOSAGE": "60MG",
    "COND": "B/03",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HIKMA PHARMA ALGERIA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/1/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "7/1/2021",
    "TYPE": "Gé",
    "STATUT": "F mélange final",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["solifenacin"],
    "InteractionIndexLink": ["solifenacine"],
    "N_ENREGISTREMENT": "293/25 P 068/21",
    "CODE_DCI": "25 P 068",
    "DCI": "Succinate de Solifénacine exprimé en Solifénacine",
    "NOM_COMMERCIALE": "FENACARE",
    "FORME": "Comprimé pelliculé",
    "DOSAGE": "5MG",
    "COND": "B/30",
    "LISTE": "LISTE II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOCARE / SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/3/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "30/3/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["solifenacin"],
    "InteractionIndexLink": ["solifenacine"],
    "N_ENREGISTREMENT": "173/25 P 068/16",
    "CODE_DCI": "25 P 068",
    "DCI": "Succinate de Solifénacine exprimé en Solifénacine",
    "NOM_COMMERCIALE": "SOLIFETAB  (ex URILAX)",
    "FORME": "Comprimé pelliculé",
    "DOSAGE": "5MG",
    "COND": "B/30",
    "LISTE": "LISTE II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "TABUK / EURL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/12/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "7/2/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["solifenacin"],
    "InteractionIndexLink": ["solifenacine"],
    "N_ENREGISTREMENT": "20/25 P068/352",
    "CODE_DCI": "25 P 068",
    "DCI": "SOLIFENACINE SUCCINATE",
    "NOM_COMMERCIALE": "VENACINE",
    "FORME": "COMP PELL",
    "DOSAGE": "5MG",
    "COND": "B/30",
    "LISTE": "LISTE II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SPA EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "31/03/20",
    "DATE_D_ENREGISTREMENT_FINAL": "31/03/20",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["solifenacin"],
    "InteractionIndexLink": ["solifenacine"],
    "N_ENREGISTREMENT": "347/ 25 P 068 /15",
    "CODE_DCI": "25 P 068",
    "DCI": "SOLIFENACINE SUCCINATE",
    "NOM_COMMERCIALE": "VESICARE",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "5MG",
    "COND": "B/30",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ASTELLAS PHARMA EUROPE B.V.",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PAYS BAS",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/6/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "9/6/2015",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["solifenacin"],
    "InteractionIndexLink": ["solifenacine"],
    "N_ENREGISTREMENT": "293/25 P 069/21",
    "CODE_DCI": "25 P 069",
    "DCI": "Succinate de Solifénacine exprimé en Solifénacine",
    "NOM_COMMERCIALE": "FENACARE",
    "FORME": "Comprimé pelliculé",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "LISTE II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOCARE / SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/3/2021",
    "DATE_D_ENREGISTREMENT_FINAL": "30/3/2021",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["solifenacin"],
    "InteractionIndexLink": ["solifenacine"],
    "N_ENREGISTREMENT": "065/25 P 069/17",
    "CODE_DCI": "25 P 069",
    "DCI": "SOLIFENACINE SUCCINATE",
    "NOM_COMMERCIALE": "SOLIFENACINE GL",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GENERICLAB SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/5/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "28/5/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["solifenacin"],
    "InteractionIndexLink": ["solifenacine"],
    "N_ENREGISTREMENT": "173/25 P 069/16",
    "CODE_DCI": "25 P 069",
    "DCI": "SOLIFENACINE SUCCINATE",
    "NOM_COMMERCIALE": "URILAX",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "TABUK ALGERIE",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/12/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "28/12/2016",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["solifenacin"],
    "InteractionIndexLink": ["solifenacine"],
    "N_ENREGISTREMENT": "352/25 P 069/17",
    "CODE_DCI": "25 P 069",
    "DCI": "SOLIFENACINE SUCCINATE",
    "NOM_COMMERCIALE": "VENACINE",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/6/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "12/6/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["solifenacin"],
    "InteractionIndexLink": ["solifenacine"],
    "N_ENREGISTREMENT": "347/ 25 P 069 /15",
    "CODE_DCI": "25 P 069",
    "DCI": "SOLIFENACINE SUCCINATE",
    "NOM_COMMERCIALE": "VESICARE",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "Liste II",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ASTELLAS PHARMA EUROPE B.V.",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PAYS BAS",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/6/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "9/6/2015",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "075/ 26 A 007 /98",
    "CODE_DCI": "26 A 007",
    "DCI": "GLYCOCOLLE",
    "NOM_COMMERCIALE": "URO 3000 GLYCOCOLLE AGUETTANT",
    "FORME": "SOL. P. IRRIGATION VESICALE",
    "DOSAGE": "1.5%",
    "COND": "B/4 POCH. DE 3000ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "AGUETTANT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/10/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "28/10/1998",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "419/ 26 B 014 /08",
    "CODE_DCI": "26 B 014",
    "DCI": "HYPOCHLORITE DE SODIUM",
    "NOM_COMMERCIALE": "DAKIN COOPER STABILISE",
    "FORME": "SOL. USAGE EXTERNE",
    "DOSAGE": "0.5% DE CHLORE ACTIF",
    "COND": "FL./250ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "COOPER  France",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "27/7/2008",
    "DATE_D_ENREGISTREMENT_FINAL": "27/7/2008",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "314/ 26 B 014 /04/19",
    "CODE_DCI": "26 B 014",
    "DCI": "HYPOCHLORITE DE SODIUM EXPRIME EN CHLORE ACTIF",
    "NOM_COMMERCIALE": "DAKIN RPP",
    "FORME": "SOL. USAGE EXTERNE",
    "DOSAGE": "0.5% DE CHLORE ACTIF (0.5G)",
    "COND": "FL/500ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "RIADH PHARMA EURL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/11/2004",
    "DATE_D_ENREGISTREMENT_FINAL": "16/7/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "319/ 26 B 015 /06",
    "CODE_DCI": "26 B 015",
    "DCI": "PEROXYDE D' HYDROGENE",
    "NOM_COMMERCIALE": "EAU OXYGENEE",
    "FORME": "SOL. USAGE EXTERNE",
    "DOSAGE": "10VOLUMES",
    "COND": "F/60ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ARAB PHARM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/4/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "26/4/2006",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "234/ 26 B 015 /02",
    "CODE_DCI": "26 B 015",
    "DCI": "PEROXYDE D'HYDROGENE",
    "NOM_COMMERCIALE": "EAU OXYGENEE",
    "FORME": "SOL. USAGE EXTERNE",
    "DOSAGE": "10 VOLUMES",
    "COND": "FL/100ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "RHUMEL PHARM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "30/3/2002",
    "DATE_D_ENREGISTREMENT_FINAL": "30/3/2002",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "464/ 26 B 015 /10",
    "CODE_DCI": "26 B 015",
    "DCI": "PEROXYDE D'HYDROGENE",
    "NOM_COMMERCIALE": "EAU OXYGENEE 10V",
    "FORME": "SOL. USAGE EXTERNE",
    "DOSAGE": "10 VOLUMES",
    "COND": "FL./1L",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABIOCO",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/9/2010",
    "DATE_D_ENREGISTREMENT_FINAL": "22/9/2010",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "314/ 26 B 015 /15",
    "CODE_DCI": "26 B 015",
    "DCI": "PEROXYDE D' HYDROGENE",
    "NOM_COMMERCIALE": "OXYDERM 10 V  RPP",
    "FORME": "SOL. USAGE EXTERNE",
    "DOSAGE": "10 V . FLACON DE 1000 ML PET",
    "COND": "F/1000 ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EURL RIADH PHARM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/12/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "2/12/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "088/ 26 B 017 /03",
    "CODE_DCI": "26 B 017",
    "DCI": "EOSINE AQUEUSE",
    "NOM_COMMERCIALE": "EOSINE AQUEUSE",
    "FORME": "SOL. USAGE EXTERNE",
    "DOSAGE": "2 %",
    "COND": "FL/100ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMAGHREB",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "12/1/2004",
    "DATE_D_ENREGISTREMENT_FINAL": "12/1/2004",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "234/ 26 B 017 /00",
    "CODE_DCI": "26 B 017",
    "DCI": "EOSINE AQUEUSE",
    "NOM_COMMERCIALE": "EOSINE AQUEUSE",
    "FORME": "SOL. USAGE EXTERNE",
    "DOSAGE": "2 %",
    "COND": "FL/100ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "RHUMEL PHARM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/7/2000",
    "DATE_D_ENREGISTREMENT_FINAL": "2/7/2000",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "234/ 26 B 020 /00",
    "CODE_DCI": "26 B 020",
    "DCI": "MERCUROCHROME",
    "NOM_COMMERCIALE": "MERCUROCHROME",
    "FORME": "SOL. USAGE EXTERNE",
    "DOSAGE": "2 %",
    "COND": "FL/100ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "RHUMEL PHARM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/7/2000",
    "DATE_D_ENREGISTREMENT_FINAL": "26/7/2000",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "088/ 26 B 020 /03",
    "CODE_DCI": "26 B 020",
    "DCI": "MERCURUCHROME",
    "NOM_COMMERCIALE": "MERCUROCHROME",
    "FORME": "SOL. USAGE EXTERNE",
    "DOSAGE": "2 %",
    "COND": "FL/100L",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMAGHREB",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/12/2003",
    "DATE_D_ENREGISTREMENT_FINAL": "7/12/2003",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["methylene blue"],
    "InteractionIndexLink": ["bleu de methylene"],
    "N_ENREGISTREMENT": "234/ 26 B 035 /00",
    "CODE_DCI": "26 B 035",
    "DCI": "BLEU DE METHYLENE",
    "NOM_COMMERCIALE": "BLEU DE METHYLENE",
    "FORME": "SOL. USAGE EXTERNE",
    "DOSAGE": "1 %",
    "COND": "FL/100ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "RHUMEL PHARM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "26/7/2000",
    "DATE_D_ENREGISTREMENT_FINAL": "26/7/2000",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "234/ 26 B 038 /02",
    "CODE_DCI": "26 B 038",
    "DCI": "ALCOOL ETHYLIQUE",
    "NOM_COMMERCIALE": "ALCOOL CHIRURGICAL 70°",
    "FORME": "SOL. USAGE EXTERNE",
    "DOSAGE": "70°",
    "COND": "FL./100ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "RHUMEL PHARM",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "16/3/2002",
    "DATE_D_ENREGISTREMENT_FINAL": "16/3/2002",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "314/ 26 B 038 /15",
    "CODE_DCI": "26 B 038",
    "DCI": "ALCOOL ETHYLIQUE",
    "NOM_COMMERCIALE": "ALCOOL CHIRURGICAL 70°",
    "FORME": "SOL. USAGE EXTERNE",
    "DOSAGE": "70°",
    "COND": "FL./1000ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "RIADH PHARMA EURL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/10/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "19/10/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "349/ 26 B 038 /06",
    "CODE_DCI": "26 B 038",
    "DCI": "ALCOOL ETHYLIQUE",
    "NOM_COMMERCIALE": "ALCOOL CHIRURGICAL 70°",
    "FORME": "SOL. USAGE EXTERNE",
    "DOSAGE": "70°",
    "COND": "FL/60ML ET FL/1000ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "BIOLAB",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/7/2006",
    "DATE_D_ENREGISTREMENT_FINAL": "18/7/2006",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "379/ 26 B 038 /09",
    "CODE_DCI": "26 B 038",
    "DCI": "ALCOOL ETHYLIQUE",
    "NOM_COMMERCIALE": "ALCOOL CHIRURGICAL 70°",
    "FORME": "SOL. USAGE EXTERNE",
    "DOSAGE": "70°",
    "COND": "FL./100ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ZH SANTE LABO SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/4/2009",
    "DATE_D_ENREGISTREMENT_FINAL": "20/4/2009",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "464/ 26 B 038 /10",
    "CODE_DCI": "26 B 038",
    "DCI": "ALCOOL ETHYLIQUE",
    "NOM_COMMERCIALE": "ALCOOL CHIRURGICAL 70°",
    "FORME": "SOL. USAGE EXTERNE",
    "DOSAGE": "70°",
    "COND": "FL./1000ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABIOCO",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/6/2010",
    "DATE_D_ENREGISTREMENT_FINAL": "17/6/2010",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "088/ 26 B 038 /03",
    "CODE_DCI": "26 B 038",
    "DCI": "ALCOOL ETHYLIQUE",
    "NOM_COMMERCIALE": "ALCOOL CHIRURGICAL 70°",
    "FORME": "SOL. USAGE EXTERNE",
    "DOSAGE": "70°",
    "COND": "FL./100ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PHARMAGHREB",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/11/2003",
    "DATE_D_ENREGISTREMENT_FINAL": "15/11/2003",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "314/ 26 B 041 /15",
    "CODE_DCI": "26 B 041",
    "DCI": "ALCOOL ETHYLIQUE",
    "NOM_COMMERCIALE": "ALCOOL CHIRURGICAL 90°",
    "FORME": "SOL. USAGE EXTERNE",
    "DOSAGE": "90°",
    "COND": "FL./1000ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "RIADH PHARMA EURL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/10/2015",
    "DATE_D_ENREGISTREMENT_FINAL": "19/10/2015",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "314/26 B 042/16",
    "CODE_DCI": "26 B 042",
    "DCI": "ALCOOL ETHYLIQUE 96°",
    "NOM_COMMERCIALE": "ALCOOL DENATURE RPP",
    "FORME": "SOL HYDRO ALCOOLIQUE CAMPHRE",
    "DOSAGE": "90°",
    "COND": "FL/1000ML",
    "LISTE": "",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "RIADH PHARMA EURL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "4/12/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "4/12/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["busulfan"],
    "InteractionIndexLink": ["busulfan"],
    "N_ENREGISTREMENT": "099/ 27 A 001 /13",
    "CODE_DCI": "27 A 001",
    "DCI": "BUSULFAN",
    "NOM_COMMERCIALE": "BUSILVEX",
    "FORME": "SOL. A DILUER P. PERF. IV",
    "DOSAGE": "6MG/ML (60MG/10ML)",
    "COND": "B/08FL. DE 10ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PIERRE FABRE MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "FRANCE",
    "DATE_D_ENREGISTREMENT_INITIAL": "18/2/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "18/2/2013",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["mycophenolate mofetil"],
    "InteractionIndexLink": ["mycophenolate mofetil", "mycophenolate sodique"],
    "N_ENREGISTREMENT": "317/ 27 A 002 /10/17",
    "CODE_DCI": "27 A 002",
    "DCI": "MYCOPHENOLATE MOFETIL",
    "NOM_COMMERCIALE": "MMF",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "500MG",
    "COND": "B/56",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INPHA-MEDIS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "15/8/2010",
    "DATE_D_ENREGISTREMENT_FINAL": "27/3/2017",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["mycophenolate mofetil"],
    "InteractionIndexLink": ["mycophenolate mofetil", "mycophenolate sodique"],
    "N_ENREGISTREMENT": "352/ 27 A 002 /14",
    "CODE_DCI": "27 A 002",
    "DCI": "MYCOPHENOLATE MOFETIL",
    "NOM_COMMERCIALE": "PHENOCEPT",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "500MG",
    "COND": "B/100",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL-KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/4/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "28/4/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["mycophenolate mofetil"],
    "InteractionIndexLink": ["mycophenolate mofetil", "mycophenolate sodique"],
    "N_ENREGISTREMENT": "317/ 27 A 003 /13",
    "CODE_DCI": "27 A 003",
    "DCI": "MYCOPHENOLATE MOFETIL",
    "NOM_COMMERCIALE": "MMF",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "250MG",
    "COND": "B/24",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INPHA-MEDIS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/7/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "13/3/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["anti-thymocyte immunoglobulin"],
    "InteractionIndexLink": [
      "immunoglobuline de lapin anti-lymphocyte t humain"
    ],
    "N_ENREGISTREMENT": "339/ 27 A 004 /13",
    "CODE_DCI": "27 A 004",
    "DCI": "IMMUNOGLOBULINE DE LAPIN ANTI-THYMOCYTES HUMAINS",
    "NOM_COMMERCIALE": "THYMOGLOBULINE",
    "FORME": "PDRE. P. SOL. P. PERF.",
    "DOSAGE": "25MG/FL. DE PDRE. (5MG/ML DE SOL. APRES RECONST.)",
    "COND": "B/1FL. DE PDRE.",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "GENZYME EUROPE B.V.",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PAYS BAS",
    "DATE_D_ENREGISTREMENT_INITIAL": "21/7/2013",
    "DATE_D_ENREGISTREMENT_FINAL": "21/7/2013",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["ciclosporin"],
    "InteractionIndexLink": ["ciclosporine"],
    "N_ENREGISTREMENT": "317/ 27 A 005 /14",
    "CODE_DCI": "27 A 005",
    "DCI": "CICLOSPORINE",
    "NOM_COMMERCIALE": "CICLAID",
    "FORME": "SOL. BUV.",
    "DOSAGE": "100MG/ML",
    "COND": "B/01 FL 50ML +SERINGUE GRADUEE EN ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INPHA-MEDIS SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "8/6/2014",
    "DATE_D_ENREGISTREMENT_FINAL": "8/6/2014",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["ciclosporin"],
    "InteractionIndexLink": ["ciclosporine"],
    "N_ENREGISTREMENT": "068/27 A 005 /99/18",
    "CODE_DCI": "27 A 005",
    "DCI": "CICLOSPORINE",
    "NOM_COMMERCIALE": "SANDIMMUN NEORAL",
    "FORME": "SOL .BUV.",
    "DOSAGE": "100MG/ML",
    "COND": "FL/50ML + SER DE 1ML ET SER DE 4 ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVARTIS PHARMA SCHWEIZ AG",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SUISSE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/6/1999",
    "DATE_D_ENREGISTREMENT_FINAL": "30/4/2018",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["ciclosporin"],
    "InteractionIndexLink": ["ciclosporine"],
    "N_ENREGISTREMENT": "068/ 27 A 006 /98/15",
    "CODE_DCI": "27 A 006",
    "DCI": "CICLOSPORINE",
    "NOM_COMMERCIALE": "SANDIMMUN NEORAL",
    "FORME": "CAPSULE MOLLE",
    "DOSAGE": "25MG",
    "COND": "B/50",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVARTIS PHARMA SCHWEIZ A.G",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SUISSE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/11/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "29/12/2015",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["ciclosporin"],
    "InteractionIndexLink": ["ciclosporine"],
    "N_ENREGISTREMENT": "068/ 27 A 007/98/15",
    "CODE_DCI": "27 A 007",
    "DCI": "CICLOSPORINE",
    "NOM_COMMERCIALE": "SANDIMMUN NEORAL",
    "FORME": "CAPSULE MOLLE",
    "DOSAGE": "50MG",
    "COND": "B/50",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVARTIS PHARMA SCHWEIZ A.G",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SUISSE",
    "DATE_D_ENREGISTREMENT_INITIAL": "9/3/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "29/12/2015",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["ciclosporin"],
    "InteractionIndexLink": ["ciclosporine"],
    "N_ENREGISTREMENT": "068/ 27 A 008 /98/15",
    "CODE_DCI": "27 A 008",
    "DCI": "CICLOSPORINE",
    "NOM_COMMERCIALE": "SANDIMMUN NEORAL",
    "FORME": "CAPSULE MOLLE",
    "DOSAGE": "100MG",
    "COND": "B/50",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVARTIS PHARMA SCHWEIZ A.G",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SUISSE",
    "DATE_D_ENREGISTREMENT_INITIAL": "29/11/1998",
    "DATE_D_ENREGISTREMENT_FINAL": "29/12/2015",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["tacrolimus"],
    "InteractionIndexLink": ["tacrolimus"],
    "N_ENREGISTREMENT": "317/ 27 A 009 /16",
    "CODE_DCI": "27 A 009",
    "DCI": "TACROLIMUS MONOHYDRATE EXPRIME EN TACROLIMUS",
    "NOM_COMMERCIALE": "TIM",
    "FORME": "GLES",
    "DOSAGE": "0.5MG",
    "COND": "B/100",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INPHA MEDIS SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/6/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "13/6/2016",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["tacrolimus"],
    "InteractionIndexLink": ["tacrolimus"],
    "N_ENREGISTREMENT": "317/ 27 A 010 /16",
    "CODE_DCI": "27 A 010",
    "DCI": "TACROLIMUS MONOHYDRATE EXPRIME EN TACROLIMUS",
    "NOM_COMMERCIALE": "TIM",
    "FORME": "GLES",
    "DOSAGE": "1MG",
    "COND": "B/100",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INPHA MEDIS SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "21/3/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "21/3/2016",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "24mois",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["tacrolimus"],
    "InteractionIndexLink": ["tacrolimus"],
    "N_ENREGISTREMENT": "471/27 A 010/17",
    "CODE_DCI": "27 A 010",
    "DCI": "TACROLIMUS MONOHYDRATE EXPRIME EN TACROLIMUS",
    "NOM_COMMERCIALE": "VINGRAF",
    "FORME": "GLES",
    "DOSAGE": "1MG",
    "COND": "B/10",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EMCURE PHARMA LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INDE",
    "DATE_D_ENREGISTREMENT_INITIAL": "5/3/2017",
    "DATE_D_ENREGISTREMENT_FINAL": "5/3/2017",
    "TYPE": "Gé",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["tacrolimus"],
    "InteractionIndexLink": ["tacrolimus"],
    "N_ENREGISTREMENT": "317/ 27 A 011 /16",
    "CODE_DCI": "27 A 011",
    "DCI": "TACROLIMUS MONOHYDRATE EXPRIME EN TACROLIMUS",
    "NOM_COMMERCIALE": "TIM",
    "FORME": "GLES",
    "DOSAGE": "5MG",
    "COND": "B/100",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "INPHA-MEDIS SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "21/3/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "21/3/2016",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "24mois",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["basiliximab"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "068/ 27 A 012 /16",
    "CODE_DCI": "27 A 012",
    "DCI": "Basiliximab",
    "NOM_COMMERCIALE": "SIMULECT",
    "FORME": "POUDRE ET SOLVANT POUR SOLUTION INJECTABLE OU POUR PERF. IV",
    "DOSAGE": "20MG /FLACON",
    "COND": "B/01 FLACON DE POUDRE + 01 FLACON DE SOLVANT 5ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVARTIS PHARMA SCHWEIZ AG",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SUISSE",
    "DATE_D_ENREGISTREMENT_INITIAL": "22/2/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "22/2/2016",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["eculizumab"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "509/ 27 A 013 /16",
    "CODE_DCI": "27 A 013",
    "DCI": "ECULIZUMAB",
    "NOM_COMMERCIALE": "SOLIRIS",
    "FORME": "SOLUTION à DILUER POUR PERFUSION IV",
    "DOSAGE": "10MG/ML (300MG/30ML)",
    "COND": "B/01 FLACON 30 ml",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALEXION EUROPE SAS",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "France",
    "DATE_D_ENREGISTREMENT_INITIAL": "23/3/2016",
    "DATE_D_ENREGISTREMENT_FINAL": "23/3/2016",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "30MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["ciclosporin"],
    "InteractionIndexLink": ["ciclosporine"],
    "N_ENREGISTREMENT": "068/ 27 A 014 /97/18",
    "CODE_DCI": "27 A 014",
    "DCI": "CICLOSPORINE",
    "NOM_COMMERCIALE": "SANDIMMUN",
    "FORME": "CONC.SOL.PER IV",
    "DOSAGE": "50MG/ML",
    "COND": "B/10FL./1ML",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "NOVARTIS PHARMA SCHWEIZ AG",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SUISSE",
    "DATE_D_ENREGISTREMENT_INITIAL": "2/6/1997",
    "DATE_D_ENREGISTREMENT_FINAL": "30/4/2018",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "48 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["sirolimus"],
    "InteractionIndexLink": ["sirolimus"],
    "N_ENREGISTREMENT": "045/ 27 A 015/18",
    "CODE_DCI": "27 A 015",
    "DCI": "Sirolimus",
    "NOM_COMMERCIALE": "RAPAMUNE",
    "FORME": "COMPRIME",
    "DOSAGE": "1MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PFIZER LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ROYAUME UNI",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/8/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "7/8/2018",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["sirolimus"],
    "InteractionIndexLink": ["sirolimus"],
    "N_ENREGISTREMENT": "045/ 27 A 016/18",
    "CODE_DCI": "27 A 016",
    "DCI": "Sirolimus",
    "NOM_COMMERCIALE": "RAPAMUNE",
    "FORME": "COMPRIME",
    "DOSAGE": "2 MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PFIZER LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ROYAUME UNI",
    "DATE_D_ENREGISTREMENT_INITIAL": "7/8/2018",
    "DATE_D_ENREGISTREMENT_FINAL": "7/8/2018",
    "TYPE": "Ré",
    "STATUT": "I",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["cefalexin"],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "380/13 B 010/19",
    "CODE_DCI": "3 B 010",
    "DCI": "CEFALEXINE MONOHYDRATEE EXPRIME EN CEFALEXINE",
    "NOM_COMMERCIALE": "KEFALEX",
    "FORME": "COMP PELL",
    "DOSAGE": "500MG",
    "COND": "B/12",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HUP.P.PHARMA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/11/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "25/11/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["alfuzosin"],
    "InteractionIndexLink": ["alfuzosine"],
    "N_ENREGISTREMENT": "380/25 B 057/19",
    "CODE_DCI": "5 B 057",
    "DCI": "ALFUZOSINECHLORHYDRTE EXPRIME EN ALFUZOSINE",
    "NOM_COMMERCIALE": "XAPROST LP",
    "FORME": "COMP PELL LP",
    "DOSAGE": "1OMG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HUP.P.PHARMA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "25/11/2019",
    "DATE_D_ENREGISTREMENT_FINAL": "25/11/2019",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["modafinil"],
    "InteractionIndexLink": ["modafinil"],
    "N_ENREGISTREMENT": "477/15 L 129/20",
    "CODE_DCI": "5 L 129",
    "DCI": "MODAFINIL",
    "NOM_COMMERCIALE": "PRO-EVEIL",
    "FORME": "COMPRIME.",
    "DOSAGE": "100MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SARL LABORATOIRES BEKER",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "19/2/2020",
    "DATE_D_ENREGISTREMENT_FINAL": "19/2/2020",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["ramipril"],
    "InteractionIndexLink": ["ramipril"],
    "N_ENREGISTREMENT": "20/06 E127/352",
    "CODE_DCI": "6.00E+127",
    "DCI": "RAMIPRIL",
    "NOM_COMMERCIALE": "HYDREA",
    "FORME": "COMP SECABLES",
    "DOSAGE": "2.5MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SPA EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "17/12/20",
    "DATE_D_ENREGISTREMENT_FINAL": "17/12/20",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["ramipril"],
    "InteractionIndexLink": ["ramipril"],
    "N_ENREGISTREMENT": "352/06 E 128/20",
    "CODE_DCI": "6.00E+128",
    "DCI": "RAMIPRIL",
    "NOM_COMMERCIALE": "RAMITRIM",
    "FORME": "COMP. SEC.",
    "DOSAGE": "5MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SPA/ EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "07/12/20",
    "DATE_D_ENREGISTREMENT_FINAL": "07/12/20",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["irbesartan"],
    "InteractionIndexLink": ["irbesartan"],
    "N_ENREGISTREMENT": "039/06 E 156/20",
    "CODE_DCI": "6.00E+156",
    "DCI": "IRBESARTAN",
    "NOM_COMMERCIALE": "AROVAL",
    "FORME": "COMP. PELL.",
    "DOSAGE": "150MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES SOCIETE PHARMACEUTIQUE ALGERIENNE-SOPHAL SPA-",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/12/20",
    "DATE_D_ENREGISTREMENT_FINAL": "13/12/20",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["irbesartan"],
    "InteractionIndexLink": ["irbesartan"],
    "N_ENREGISTREMENT": "195/ 06 E 156/11/21",
    "CODE_DCI": "6.00E+156",
    "DCI": "Irbesartan",
    "NOM_COMMERCIALE": "IPISART",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "150MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES SARL WORLD MEDECINE LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/02/11",
    "DATE_D_ENREGISTREMENT_FINAL": "26/05/21",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["irbesartan"],
    "InteractionIndexLink": ["irbesartan"],
    "N_ENREGISTREMENT": "039/06 E 157/20",
    "CODE_DCI": "6.00E+157",
    "DCI": "IRBESARTAN",
    "NOM_COMMERCIALE": "AROVAL",
    "FORME": "COMP. PELL.",
    "DOSAGE": "300MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES SOCIETE PHARMACEUTIQUE ALGERIENNE-SOPHAL SPA-",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/12/20",
    "DATE_D_ENREGISTREMENT_FINAL": "13/12/20",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["irbesartan"],
    "InteractionIndexLink": ["irbesartan"],
    "N_ENREGISTREMENT": "195/ 06 E 157/11/21",
    "CODE_DCI": "6.00E+157",
    "DCI": "Irbesartan",
    "NOM_COMMERCIALE": "IPISART",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "300MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES SARL WORLD MEDECINE LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "28/02/11",
    "DATE_D_ENREGISTREMENT_FINAL": "26/05/21",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["lercanidipine"],
    "InteractionIndexLink": ["lercanidipine"],
    "N_ENREGISTREMENT": "21/06 E168/380",
    "CODE_DCI": "6.00E+168",
    "DCI": "LERCANIDIPINE CHLORHYDRATE",
    "NOM_COMMERCIALE": "CARDIPINE",
    "FORME": "COMP PELL SECABLE",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "HUP.P.PHARMA SARL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "14/04/21",
    "DATE_D_ENREGISTREMENT_FINAL": "14/04/21",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["lercanidipine"],
    "InteractionIndexLink": ["lercanidipine"],
    "N_ENREGISTREMENT": "352/ 06 E 168 /14/21",
    "CODE_DCI": "6.00E+168",
    "DCI": "Chlorhydrate de Lercanidipine",
    "NOM_COMMERCIALE": "DEPADIUM",
    "FORME": "Comprimé pelliculé",
    "DOSAGE": "10MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "EL KENDI INDUSTRIE DU MEDICAMENT SPA",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "01/09/14",
    "DATE_D_ENREGISTREMENT_FINAL": "04/04/21",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "irbesartan"],
    "InteractionIndexLink": ["hydrochlorothiazide", "irbesartan"],
    "N_ENREGISTREMENT": "268/ 06 E 256 /15",
    "CODE_DCI": "6.00E+256",
    "DCI": "IRBESARTAN / HYDROCHLOROTHIAZIDE",
    "NOM_COMMERCIALE": "CO-ARADEX 300/25",
    "FORME": "COMPRIME",
    "DOSAGE": "300MG/25MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "MERINAL",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "24/06/15",
    "DATE_D_ENREGISTREMENT_FINAL": "24/06/15",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "36 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "irbesartan"],
    "InteractionIndexLink": ["hydrochlorothiazide", "irbesartan"],
    "N_ENREGISTREMENT": "544/06 E 256/11/21",
    "CODE_DCI": "6.00E+256",
    "DCI": "Irbesartan / Hydrochlorothiazide",
    "NOM_COMMERCIALE": "IPISART PLUS",
    "FORME": "COMPRIME PELLICULE",
    "DOSAGE": "300MG/25MG",
    "COND": "B/30",
    "LISTE": "Liste I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "WORLD MEDECINE LIMITED",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "20/09/11",
    "DATE_D_ENREGISTREMENT_FINAL": "26/05/21",
    "TYPE": "Gé",
    "STATUT": "Fprémix",
    "DUREE_DE_STABILITE": "36MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["telmisartan"],
    "InteractionIndexLink": ["telmisartan"],
    "N_ENREGISTREMENT": "039/06 E 264/20",
    "CODE_DCI": "6.00E+264",
    "DCI": "TELMISARTAN",
    "NOM_COMMERCIALE": "TELSTAL",
    "FORME": "COMPRIME",
    "DOSAGE": "80MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES SOCIETE PHARMACEUTIQUE ALGERIENNE-SOPHAL SPA-",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "13/12/20",
    "DATE_D_ENREGISTREMENT_FINAL": "13/12/20",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "ramipril"],
    "InteractionIndexLink": ["hydrochlorothiazide", "ramipril"],
    "N_ENREGISTREMENT": "352/06 E 277/20",
    "CODE_DCI": "6.00E+277",
    "DCI": "RAMIPRIL/ HYDROCHLOROTHIAZIDE",
    "NOM_COMMERCIALE": "RAMITRIM PLUS",
    "FORME": "COMP.",
    "DOSAGE": "05MG/ 12.5MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SPA/ EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "01/06/21",
    "DATE_D_ENREGISTREMENT_FINAL": "01/06/21",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "ramipril"],
    "InteractionIndexLink": ["hydrochlorothiazide", "ramipril"],
    "N_ENREGISTREMENT": "352/06 E 278/20",
    "CODE_DCI": "6.00E+278",
    "DCI": "RAMIPRIL/ HYDROCHLOROTHIAZIDE",
    "NOM_COMMERCIALE": "RAMITRIM PLUS",
    "FORME": "COMP.",
    "DOSAGE": "10MG/ 25MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SPA/ EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "01/06/21",
    "DATE_D_ENREGISTREMENT_FINAL": "01/06/21",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": ["hydrochlorothiazide", "ramipril"],
    "InteractionIndexLink": ["hydrochlorothiazide", "ramipril"],
    "N_ENREGISTREMENT": "352/06 E 289/20",
    "CODE_DCI": "6.00E+289",
    "DCI": "RAMIPRIL/ HYDROCHLOROTHIAZIDE",
    "NOM_COMMERCIALE": "RAMITRIM PLUS",
    "FORME": "COMP.",
    "DOSAGE": "10MG/ 12.5MG",
    "COND": "B/30",
    "LISTE": "LISTE I",
    "P1": "HOP",
    "P2": "OFF",
    "OBS": "",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "SPA/ EL KENDI INDUSTRIE DU MEDICAMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "ALGERIE",
    "DATE_D_ENREGISTREMENT_INITIAL": "01/06/21",
    "DATE_D_ENREGISTREMENT_FINAL": "01/06/21",
    "TYPE": "Gé",
    "STATUT": "F",
    "DUREE_DE_STABILITE": "24 MOIS",
    "availableInAlgeria": true,
    "DrugCategories": []
  },
  {
    "PregnancyIndexLink": [],
    "InteractionIndexLink": [],
    "N_ENREGISTREMENT": "N°ENREGISTREMENT",
    "CODE_DCI": "CODE",
    "DCI": "DENOMINATION COMMUNE INTERNATIONALE",
    "NOM_COMMERCIALE": "NOM DE MARQUE",
    "FORME": "FORME",
    "DOSAGE": "DOSAGE",
    "COND": "COND",
    "LISTE": "LISTE",
    "P1": "P1",
    "P2": "P2",
    "OBS": "OBS",
    "LABORATOIRES_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "LABORATOIRES DETENTEUR DE LA DECISION D'ENREGISTREMENT",
    "PAYS_DU_LABORATOIRE_DETENTEUR_DE_LA_DECISION_D_ENREGISTREMENT": "PAYS DU LABORATOIRE DETENTEUR DE LA DECISION D'ENREGISTREMENT",
    "DATE_D_ENREGISTREMENT_INITIAL": "DATE D'ENREGISTREMENT INITIAL",
    "DATE_D_ENREGISTREMENT_FINAL": "DATE D'ENREGISTREMENT  FINAL",
    "TYPE": "TYPE",
    "STATUT": "STATUT",
    "DUREE_DE_STABILITE": "DUREE DE STABILITE",
    "availableInAlgeria": true,
    "DrugCategories": ["Ophtalmologie", "Otologie", "Rhumatologie"]
  }
]
